- Trials with a EudraCT protocol (43,845)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: EFFICACY AND SECURITY OF SULTAMICILLIN IN PATIENTS WITH MILD TO MODERATE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42966 |
| Study title: EFFICACY AND TOLERANCE OF PARENTERAL SULBACTAM/AMPICILLIN AND ORAL UNASYN IN CHILDREN AND ADULTS WITH MODERATE TO SEVERE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43058 |
| Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE INFECTIONS IN CHILDREN AND ADULTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43057 |
| Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN VS. AMPICILLIN IN CHILDREN WITH ACUTE DIARRHEA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43013 |
| Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IM FOLLOWED BY SULTAMICILLIN PO IN NON-SEVERE INFECTIONS IN GENERAL PRACTICE. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42946 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY B.I.D. IN ADULTS WITH GYNECOLOGICAL OR OBSTETRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42985 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY IN PATIENTS WITH RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42984 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH ENT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42987 |
| Study title: TO COMPARE DOXYCYCLINE 50 MG WITH OXYTETRACYCLINE 250 MG BID IN THE TREATMENT OF INFLAMMATORY ACNE VULGARIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27335 |
| Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27595 |
| Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27958 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27450 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27814 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27667 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28029 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42986 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN CHILDREN WITH BACTERIAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42988 |
| Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN VS AMOXICILLIN IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42998 |
| Study title: EFFICACY AND TOLERATION OF UNASYN IN PEDIATRIC INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43015 |
| Study title: Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001.Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30881 |
| Study title: Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001.Kokki, H., A. Salonen, et al. "Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children." ; Paediatr Anaesth 11(1): 59-64, 2001. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30886 |
| Study title: Kokki, H., E. Nikanne, et al."The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children." ; Paediatr Anaesth 10(5): 531-5, 2000Kokki, H., E. Nikanne, et al."The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children." ; Paediatr Anaesth 10(5): 531-5, 2000 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30880 |
| Study title: Kokki, H., H. Tuomilehto, et al. "Pain management after adenoidectomy with ketoprofen: comparison of rectal and intravenous routes." ; Br J Anaesth 85(6): 836-40, 2000.Kokki, H., H. Tuomilehto, et al. "Pain management after adenoidectomy with ketoprofen: comparison of rectal and intravenous routes." ; Br J Anaesth 85(6): 836-40, 2000. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30882 |
| Study title: Multicentre, randomised, comparative double-blind and double placebo study in two parallel groups, of the efficacy and safety of ketoprofen (0.5 mg/kg/dose), versus ibuprofen (5 mg/kg/dose), in repeated doses, in the treatment of febrile conditions in children aged 1 year to 6 years. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): Ketoprofen-Study 3.pdf |
| View full study record |
| Document reference: 30863 |
| Study title: Pharmacokinetic study of ketoprofen in children during and after day-case surgery. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): Ketoprofen-Study 5.pdf |
| View full study record |
| Document reference: 30869 |
| Study title: Pharmacokinetic study of ketoprofen in children during and after day-case surgery - Kokki H. and Heikkinen M. - 15/05/1998. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30871 |
| Study title: Pharmacokinetics of a 24-hour intravenous ketoprofen infusion in children - Kokki H, Karvinen M, Jekunen - 2002, Acta Anaesthes Scand; 46/2: 194-198 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30877 |
| Study title: Rapport d'expert Profenid gélules 50 mg (extension des indications thérapeutiques (stomatologie)- Etude clinique du kétoprofène en pathologie dentaire - Pr. C. Lecointre - Oct. 1985 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30872 |
| Study title: RP19583: Gastro-Intestinal tolerance in young rats after a 4-week oral administration of ketoprofen pediatric syrup SA-CRVA 99-205 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30873 |
| Study title: Salonen, A., H. Kokki, et al. "The effect of ketoprofen on recovery after tonsillectomy in children: a 3-week follow-up study." Int J Pediatr Otorhinolaryngol 62(2): 143-50, 2002 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30883 |
| Study title: Subramaniam, R., B. Ghai, et al."A comparison of intravenous ketoprofen versus pethidine on peri-operative analgesia and post-operative nausea and vomiting in paediatric vitreoretinal surgery."; J Postgrad Med 49(2): 123-6, 2003. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30884 |
| Study title: Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46772 |
| Study title: Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13.Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46795 |
| Study title: High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569.High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46788 |
| Study title: Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46801 |
| Study title: Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46775 |
| Study title: Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5.Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46784 |
| Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534.Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46791 |
| Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534 |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46773 |
| Study title: Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34.Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46808 |
| Study title: Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73.Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46783 |
| Study title: Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6.Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6. |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46805 |
| Study title: Immunogenicity and safety of an inactivated Hepatitis A vaccine (80 AgU) after simultaneous administration with either Tetract-Hib+OPV or DtacP-IPC//Act-Hib vaccine in 16 to 19 month old toddlers (HAF29393) (1999) |
| Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41299 |
| Study title: Immunogenicity study for Tetra and Penta component vaccines in infants (1999) |
| Active substance: Trivalent Oral Poliomyelitis Vaccine (Vero cells) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41300 |
| Study title: A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. A comparison of the pupillary and cardiovascular effects of various mydriatic agents in preterm infants. Sindel BD, Baker MD, Maisels MJ, Weinstein J. J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):273-6. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): A comparison of the pupillary and cardiovascular effects.pdf |
| View full study record |
| Document reference: 46880 |
| Study title: Safety and efficacy of pressure limited power injection of iodinated contrast medium through central lines in childrenRIGSBY CK; AJR; 2007 vol.188 p.726 732Safety and efficacy of pressure limited power injection of iodinated contrast medium through central lines in childrenRIGSBY CK; AJR; 2007 vol.188 p.726 732 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30427 |
| Study title: Short term pediatric renal transplant survival : blood pressure and allograft function; MITSNEFES MM; Pediatr. Transplantation; 2001 vol.5 p.160-165Short term pediatric renal transplant survival : blood pressure and allograft function; MITSNEFES MM; Pediatr. Transplantation; 2001 vol.5 p.160-165 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30428 |
| Study title: Significance of 'blush' on computed tomography scan in children with liver injury; EUBANKS JW; J. Pediatr. Surg.; 2003 vol.38 n.3 p.363 366Significance of 'blush' on computed tomography scan in children with liver injury; EUBANKS JW; J. Pediatr. Surg.; 2003 vol.38 n.3 p.363 366 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30429 |
| Study title: Suspected appendicitis in children : focused CT technique for evaluation; FEFFERMAN NR; Radiology; 2001 vol.220 p.691-695Suspected appendicitis in children : focused CT technique for evaluation; FEFFERMAN NR; Radiology; 2001 vol.220 p.691-695 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30430 |
| Study title: Suspected appendicitis in children: rectal and intravenous contrast enhanced versus intravenous contrast-enhanced CT.; KHARBANDA AB; Radiology; 2007 vol.243 n.3 p.520 526Suspected appendicitis in children: rectal and intravenous contrast enhanced versus intravenous contrast-enhanced CT.; KHARBANDA AB; Radiology; 2007 vol.243 n.3 p.520 526 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30431 |
| Study title: Symptomatic intracranial stenosis : cerebrovascular complication from elective stent placement; JIANG WJ; Radiology; 2007 vol.243 n.1 188 197Symptomatic intracranial stenosis : cerebrovascular complication from elective stent placement; JIANG WJ; Radiology; 2007 vol.243 n.1 188 197 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30432 |
| Study title: The newer radiographic contrast media; EGGLI KD; Clin. Pediat.; 1992 vol.31 n.9 p.554 559The newer radiographic contrast media; EGGLI KD; Clin. Pediat.; 1992 vol.31 n.9 p.554 559 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30433 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27451 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27815 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27668 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28030 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27666 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27665 |
| Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28027 |
| Study title: 5-Fluorouracil cardiotoxicity: a unique mechanism for ischaemic cardiopathy and cardiac failure? Lieutaud T et al. Eur J Cancer. 1996 Feb;32A(2):368-9 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28314 |
| Study title: 5-Fluorouracil filtering surgery and neovascular glaucoma: Long-term follow-up of the original pilot study. Tsai JC et al. Ophthalmology. June 30, 1995, 887-93 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28286 |
| Study title: 5-Fluorouracil in childhood solid tumors. Haggard ME et al. Cancer Treat Rep. 1977 Jan-Feb 1, 69-71 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28325 |
| Study title: A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Hareyama M. Cancer. April 15, 2002, 2217-23 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28271 |
| Study title: Adjuvant chemotherapy for colorectal cancer: A Malaysian experience. Lim GCC et al. Medical Journal of Malaysia. September 8, 1997, 117-23 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28283 |
| Study title: Chemotherapy for unresectable pancreatoblastoma. Hord JD, Janco RL. Med Pediatr Oncol. 1996 Jun;26(6):432-3 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28313 |
| Study title: Chemotherapy of brain tumors in childhood. Review of the literature and pilot protocol. Kühl J. Klin Padiatr. 1988 May-Jun;200(3):214-20 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28321 |
| Study title: Chemotherapy-radiotherapy combination in lung neoplasms. Chenal C, Follezou JY, Fauchon F. Bull Cancer. 1979;66(2):189-90 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28324 |
| Study title: Choledochal cyst and squamous-cell carcinoma of the biliary tract. Harris M, Angus P, Davis ID. September 24, 2002, 491 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28269 |
| Study title: Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fracture - Facchini R., Selva G., Peretti G. - 1993 ( Drugs 1993, 46, Suppl. 1, p. 238) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30874 |
| Study title: Traitement anti-inflammatoire local par un gel de kétoprofène: données cliniques récentes |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45088 |
| Study title: Traitement de la fièvre chez l'enfant: faux problème ou vrai débat? - Bourrillon A. - 1991 (La Presse Médicale, 1991, 20(17), p.785) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30875 |
| Study title: Treatment of fever in childhood - Adam D. and Stankov G. - 1994 (Eur. J. Pediatr., 1994, 153, p 394-402) |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30876 |
| Study title: Tuomilehto, H. and H. Kokki "Parenteral ketoprofen for pain management after adenoidectomy: comparison of intravenous and intramuscular routes of administration." ; Acta Anaesthesiol Scand 46(2): 184-9, 2002. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30885 |
| Study title: A Phase IV Comparative Study Evaluating the Onset and Total Analgesia Using a Single Dose of Acetaminophen 1000 mg, Ketoprofen 25 mg, Ketoprofen 12.5 mg, or Placebo in Post-Operative Dental Pain |
| Active substance: KETOPROFEN AND PARACETAMOL |
| Study summary document link (including results): ketoprofen_paracetamol 95-531.pdf |
| View full study record |
| Document reference: 47777 |
| Study title: |
| Active substance: KETOPROFEN AND SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30893 |
| Study title: Kokki H, et all. The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children. Paediatr Anaesth. 2000;10(5):531-5. Kokki H, et all. The feasibility of pain treatment at home after adenoidectomy with ketoprofen tablets in small children. Paediatr Anaesth. 2000;10(5):531-5. |
| Active substance: KETOPROFEN AND SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30890 |
| Study title: Nikanne E, et all. Postoperative pain after adenoidectomy in children. Br J Anaesth. 1999 Jun;82(6):886-9. Nikanne E, et all. Postoperative pain after adenoidectomy in children. Br J Anaesth. 1999 Jun;82(6):886-9. |
| Active substance: KETOPROFEN AND SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30891 |
| Study title: A double-blind, randomised study to compare the efficacy of intravenous ketorolac tromethamine with morphine in relieving post-operative pain in children |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30895 |
| Study title: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF INTRAVENOUS KETOROLAC TROMETHAMINE IN THE PREVENTION AND TREATMENT OF POST-OPERATIVE PAIN IN CHILDREN [Study ID: MRE/KETI500/EUR] |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30898 |
| Study title: A Multi-centre randomised , double masked, vehicle controlled parallel group study evaluating the safety and tolerability of Ketorolac Tromethamine 0.5 % ophthalmic solution used four times daily for 6 weeks in normal paediatric subjects. |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45109 |
| Study title: A. Chmielewska - Comperative trial on ketotifen table and sirup with Zaditernem |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30906 |
| Study title: An open study to investigate the pharmacokinetics of intravenous ketorolac tromethamine, following intravenous administration to relieve post-operative pain in children |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30896 |
| Study title: AN OPEN STUDY TO INVESTIGATE THE PHARMACOKINETICS OF KETOROLAC TROMETHAMINE, FOLLOWING INTRAVENOUS ADMINISTRATION TO RELIEVE POST-OPERATIVE PAIN IN CHILDREN [Study ID: CRE/ANL/058] |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30897 |
| Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel study of the efficacy and safety of chlorofluorocarbon (CFC) and HFA-227 (non-CFC) formulations of IntalR (cromolyn sodium) metered dose inhaler (MDI) 2mg Qid in the treatment of asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32425 |
| Study title: A Multicenter,Open-Label, Controlled, Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32426 |
| Study title: A randomised , double blind, 3-Way Crossover study to compare the protective effect o single doses of an alternative propellanst (HFA-227) - Formulation of sodium Cromoglycate 2x5mg with Intal (Lomudal) MDI 2x5mg and HFA-227 placebo in asthmatic volunteer |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32427 |
| Study title: A Randomized, 3-Period, Multiple-Dose, Multicenter Study to Evaluate the Safety, Tolerability, and Plasma Concentration Profile of Montelukast Administered Once Daily as Oral Granules in Children Aged Less 1 to 3 Months |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32428 |
| Study title: A randomized, double-blind, multicenter study evaluating the effect of montelukast sodium as compared to salmeterol on the inhibition of exercise-induced bronchoconstriction in adult asthmatics |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32429 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Adding Either Montelukast Sodium or Salmeterol Xinafoate to Inhaled Fluticasone in Adult Asthmatics |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32430 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Adding Either Montelukast Sodium or Salmeterol Xinafoate to Inhaled Fluticasone in Adult Asthmatics (IMPACT Study – Investigation of Montelukast as a Partner Agent for Complementary Therapy) |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 908.pdf |
| View full study record |
| Document reference: 32431 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Oral Montelukast Sodium Versus Inhaled Fluticasone Propionate in Patients With MIld Persistent Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32432 |
| Study title: A Randomized, Double-Blind, Multicenter Study to Evaluate the Effect of Oral Montelukast Sodium versus inhaled Fluticasone Proportionate in Patients With Persistent Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 905 synopsis.pdf |
| View full study record |
| Document reference: 32433 |
| Study title: A randomized, multicenter, double blind study to evaluate the effect of adding montelukast sodium to inhaled budesonide compared to doubling the dose of inhaled budesonide in adult patients with asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 909.pdf |
| View full study record |
| Document reference: 47560 |
| Study title: A Randomized, Open Label, Cross-Over Study Comparing Parent/Guardian Preference for Montelukast Sodium Tablets or Cromolyn Sodium Aerosol (MDI) Treatment in their Children ages 6 to 11 with Chronic Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 065 Synopsis.pdf |
| View full study record |
| Document reference: 32405 |
| Study title: Randomized, Open-label Pilot Study Comparing the Effects of Montelukast Sodium Tablets, Fluticasone Aerosol (MDI) or Budesonide Turbuhaler® on Asthma Control in Mild Adult Asthmatics |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 076 CSR.pdf |
| View full study record |
| Document reference: 47559 |
| Study title: Dr. M. Chelly. Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines. |
| Active substance: MORNIFLUMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32435 |
| Study title: A double-blind, randomised parallel group comparison of the dose equivalence, clinical efficacy, safety and pharmacokinetics of controlled-release morphine tablets (MS Contin) and a continuous intravenous infusion of morphine in paediatric patients with severe pain of vaso-occlusive crisis. |
| Active substance: MORPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32436 |
| Study title: A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. Comment in: J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. PMID: 8014788. A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study. Bolt B, Benz B, Koerner F, Bossi E. J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. Comment in: J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. PMID: 8014788. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): A mydriatic eye-drop combination without systemic effects.pdf |
| View full study record |
| Document reference: 46878 |
| Study title: A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. Comment in: Optom Vis Sci. 2003 May;80(5):327-8. PMID: 12771658. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Gwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. Comment in: Optom Vis Sci. 2003 May;80(5):327-8. PMID: 12771658. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): A random8ized clinical trial of progressive addition lenses.pdf |
| View full study record |
| Document reference: 46867 |
| Study title: Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Gwiazda JE, Hyman L, Norton TT, Hussein ME, Marsh-Tootle W, Manny R, Wang Y, Everett D; COMET Group. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2143-51. Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Gwiazda JE, Hyman L, Norton TT, Hussein ME, Marsh-Tootle W, Manny R, Wang Y, Everett D; COMET Group. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2143-51. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Accommodation and related risk factors associated with myopi.pdf |
| View full study record |
| Document reference: 46866 |
| Study title: Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. Fleck BW, Dhillon B, Mitchell A. J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. Comment on: J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. PMID: 1432499. Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies. Fleck BW, Dhillon B, Mitchell A. J Pediatr Ophthalmol Strabismus. 1994 Mar-Apr;31(2):130. Comment on: J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):157-62. PMID: 1432499. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46876 |
| Study title: [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant] Walti H, Daoud P, Broussin B, Ryzman P, Moriette G, Relier JP. Arch Fr Pediatr. 1987 Jan;44(1):31-3. [Cardiovascular and digestive effects of 2 mydriatics in the low-birth-weight newborn infant] Walti H, Daoud P, Broussin B, Ryzman P, Moriette G, Relier JP. Arch Fr Pediatr. 1987 Jan;44(1):31-3. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Cardiovascular and digestive effects of 2 mydriatics.pdf |
| View full study record |
| Document reference: 46879 |
| Study title: Aggressive Fibromatosis of the Neck in Two Brothers: Diagnostic and Therapeutic Implications. Ludemann JP, Hughes CA, Bouzoukis J, Maddalozzo J, Goldman S. Journal of Otolaryngology 1999;28(5):288-292 1999;(5):288-292.Aggressive Fibromatosis of the Neck in Two Brothers: Diagnostic and Therapeutic Implications. Ludemann JP, Hughes CA, Bouzoukis J, Maddalozzo J, Goldman S. Journal of Otolaryngology 1999;28(5):288-292 1999;(5):288-292. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43286 |
| Study title: Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. Douglass EC et al. J Clin Oncol. 1993 Jan;11(1):96-9 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28317 |
| Study title: Clinical and histopathological characteristics of basal cell carcinoma in Korean patients. Cho S et al. J Dermatol. September 28, 1999, 494-501 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28278 |
| Study title: Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Evans AE et al. Cancer. 1982 Sep 1;50(5):821-6 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28323 |
| Study title: Effective adjuvant chemotherapy for advanced nasopharyngeal carcinoma in children: A final update of a long-term prospective study in a single institution. Ghim TT et al. J Pediatr Hematol Oncol. March 1, 1998, 131-5 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28280 |
| Study title: Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. Lee MJ et al. J Neuro-Oncol. December 1, 2006, 277-84 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 16807782.pdf |
| View full study record |
| Document reference: 28263 |
| Study title: Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cangir A et al. Cancer. 1990 Sep 1;66(5):887-93 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28320 |
| Study title: Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy. Leung TWT et al. Cancer, January 15, 2002, 421-7 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28272 |
| Study title: Fibrolamellar hepatocellular carcinoma in children and adolescents. Katzenstein HM et al. Cancer. 2003 Apr 15;97(8):2006-12 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 12673731.pdf |
| View full study record |
| Document reference: 28303 |
| Study title: Hepatoblastoma in children: A review. Raney B. J Pediatr Hematol Oncol. September 1, 1997, 418-22 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28281 |
| Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of acetaminophen 1000 mg, naproxen sodium 440 mg, naproxen sodium 220 mg or placebo in post-operative dental pain. |
| Active substance: NAPROXEN PARACETAMOL |
| Study summary document link (including results): naproxen_paracetamol 93-321.pdf |
| View full study record |
| Document reference: 47117 |
| Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of acetaminophen 1000 mg, naproxen sodium 440 mg, naproxen sodium 220 mg or placebo in post-operative dental pain. |
| Active substance: NAPROXEN PARACETAMOL |
| Study summary document link (including results): naproxen_paracetamol 93-322.pdf |
| View full study record |
| Document reference: 47118 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Naso-Heel S (drops) [AWB-AT] |
| Active substance: Naso-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40080 |
| Study title: A comparative study of the efficacity of nedocromil sodium and placebo given by pressurised aerosol in inhibiting exercise-induced bronchoconstrictor responses in children - R. Dahl et al. - 1985 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children - clinical documentation- K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46957 |
| Study title: A comparison of activityof a new pressurised aerosol formulation of Nedocromil Sodium and Placebo delivered by a standard Mouthpiece and a spacer device in Exercise challenge tests (Menthol/ Saccharin Formulation) - Dr M. Silvermann et al. - 1987 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46958 |
| Study title: A double- blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of vernal keratoconjunctivitis - Bonini - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46959 |
| Study title: Bullingham r,lloyd j,mroszczak e, an open study to investigate the pharmacokinetics of ketorolac tromethamine, following intravenous administration to relieve post-operative pain in children [study id: cre/anl/058] |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30903 |
| Study title: Goswamy Sharma M*,Schuerch M,Vardar T, Review of Adverse Events Reported with the Use of Toradol (Ketorolac) in Children 18 and under [Status: Period: Since introduction to January 31, 2000; International Birth Date: April 1990] |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30905 |
| Study title: Maunuksela EL, Kokki H, A double-blind, randomised study to compare the efficacy of intravenous ketorolac tromethamine with morphine in relieving post-operative pain in children |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30901 |
| Study title: Maunuksela EL, Olkkola KT, An open study to investigate the pharmacokinetics of intravenous ketorolac tromethamine, following intravenous administration to relieve post-operative pain in children |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30902 |
| Study title: Revell S,Review of adverse events associated with ketorolac (Toradol®) use in children, 1 January 1991 to 31 July 1995 |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30900 |
| Study title: Review of adverse events associated with ketorolac (Toradol®) use in children, 1 January 1991 to 31 July 1995; Syntex Report CL5136, March 1990 |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30894 |
| Study title: Review of Adverse Events Reported with the Use of Toradol (Ketorolac) in Children 18 and under [Status: Period: Since introduction to January 31, 2000; International Birth Date: April 1990] |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30899 |
| Study title: Spyt m,chapman j, a double-blind, randomised, placebo-controlled study to investigate the safety and efficacy of intravenous ketorolac tromethamine in the prevention and treatment of post-operative pain in children [study id: mre/keti500/eur] |
| Active substance: KETOROLAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30904 |
| Study title: |
| Active substance: KETOTIFEN |
| Study summary document link (including results): Zaditen Ophtha Paediatric Studies_C-08-97-003_EMA spreadsheet.xls |
| View full study record |
| Document reference: 47297 |
| Study title: |
| Active substance: KETOTIFEN |
| Study summary document link (including results): Zaditen Ophtha Paediatric Studies_C01-KETO-011_EMA spreadsheet.xls |
| View full study record |
| Document reference: 47298 |
| Study title: |
| Active substance: KETOTIFEN |
| Study summary document link (including results): Zaditen Ophtha Paediatric Studies_SHDR 42000-97-2_EMA spreadsheet.xls |
| View full study record |
| Document reference: 47300 |
| Study title: A multicentre , blinded group comparative study to demonstrate the safety of a flavoured alternative propellant (HFA 227) formulation of nedocromil sodium MDI 4mg qid compared with TILADE Mint (CFC propellant) 4 mg qid in adult and adolescent asthma - G. Huchon et al. - 09/04/1998 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46978 |
| Study title: A multicentre ouble-blind group comparative study nedocromil sodium 2% ophthalmic solution and oral Astemizole in the treatment of seasonal allergic conjunctivitis - Brovarone et al. - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46993 |
| Study title: GL/MST/280294 Phase IV 23-Jan-1998 - Anwendung von MST bei Kindern mit Tumorschmerzen. (MST in children with cancer pain.) (Germany) |
| Active substance: MORPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45147 |
| Study title: Klifo/MST/160891 - Post marketing surveillance, Drug monitoring, 06-Jul-1998. Beurteilung der Lebensqualität bei Patienten mit Krebsschmerzen unter Berücksichtigung ihrer Schmerztherapie gemäß Stufenplan WHO. (MST Mundipharma for treatment of cancer pain in practices) (Germany) |
| Active substance: MORPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45148 |
| Study title: Bannikov, Mihail Y.; Vasilenko, Inna V.: Anwendung von homöopathischen Komplexmitteln in der Behandlungakuter kindlicher Speiseröhrenverätzungen. Biol Med 2000 (29):253-254 [IIT-publication] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40074 |
| Study title: Kostromina V.P.et al: Estimation of detoxicational effects of antihomotoxic medicines in the treatment of children suffering from relapsing bronchitis and infected with mycobacteria. Biological Therapy (Ukraine), 2007, 3: 20-23 [IIT-publication] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40077 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Mucosa compositum (ampoules) [AWB-AT] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40076 |
| Study title: Samoilenko I.G.,Yulish E.I., Gadetskaya S.G., Buchtiarov E.V.: New approach to treat pediatric patients suffering from bronchial asthma associated with intracellular infection. Biological Therapy (Ukraine), 2006, 4: 10-13 [IIT-publication] |
| Active substance: Mucosa compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40075 |
| Study title: A 12-month, multicenter, open, single arm, pilot study to evaluate the safety, tolerability and efficacy of Myfortic® in combination with Neoral® and steroids in paediatric de novo renal transplant patients |
| Active substance: MYCOPHENOLIC ACID |
| Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls |
| View full study record |
| Document reference: 47289 |
| Study title: A prospective, open label, multicenter, international protocol to assess the efficacy and safety of Myfortic® in kidney transplant recipients |
| Active substance: MYCOPHENOLIC ACID |
| Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls |
| View full study record |
| Document reference: 32437 |
| Study title: Hanisch & Bock Title: Gelomyrtol forte in patients with acute and chronic bronchitis and sinusitis. A post-marketing surveillance study. |
| Active substance: Myrtol (Destillat aus einer Mischung von rektifiziertem Eukalyptusöl, rektifiziertem Süßorangenöl, rektifiziertem Myrtenöl und rektifiziertem Zitronenöl im Verhältnis 66:32:1:1)(HERB) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40079 |
| Study title: Sengespeick Title: Gelomyrtol forte in patients with acute respiratory diseases. A post-marketing surveillance study. |
| Active substance: Myrtol (Destillat aus einer Mischung von rektifiziertem Eukalyptusöl, rektifiziertem Süßorangenöl, rektifiziertem Myrtenöl und rektifiziertem Zitronenöl im Verhältnis 66:32:1:1)(HERB) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40078 |
| Study title: Open Label, Multicenter, Phase IIIB, Follow up Study to Investigate the Antibody Response to Hepatitis B, Acellular Pertussis and Inactivated Poliovirus Antigens one Month after the 4th Hexavac® Vaccination in Healthy Children, who Participated in the NeisVac-C Non-Interference Study 216 |
| Active substance: N. meningitidis group C polysaccharide conjugated to tetanus toxoid adsorbed on Al3+ |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41293 |
| Study title: Future of cannabis and cannabinoids in therapeutics |
| Active substance: NABILONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32440 |
| Study title: Nabilone vs. Compazine (Procloperazine) in the control of nausea and vomiting in cancer patients receiving chemotherapy |
| Active substance: NABILONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32442 |
| Study title: Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients |
| Active substance: NABILONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32280 |
| Study title: Nabilone: an alternative antiemetic for cancer chemotherapy |
| Active substance: NABILONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32279 |
| Study title: Use of cutoff pigtail catheters with intraluminal guidewires in interventional procedures in congenital heart disease; VERMA R; Cathet. Cardiovasc. Diagn.; 1994 vol.33 p.85 88Use of cutoff pigtail catheters with intraluminal guidewires in interventional procedures in congenital heart disease; VERMA R; Cathet. Cardiovasc. Diagn.; 1994 vol.33 p.85 88 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30434 |
| Study title: Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278Use of imaging for assessing anatomical relationships of tracheo bronchial anomalies associated with left pulmonary artery sling; LEE KH; Pediatr. Radiol.; 2001 vol.31 p.269 278 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30435 |
| Study title: Use of oral contrast material in abdominal trauma CT scans : is it dangerous ?; FEDERLE MP; J. Trauma.; 1995 vol.38 n.1 p.51 53Use of oral contrast material in abdominal trauma CT scans : is it dangerous ?; FEDERLE MP; J. Trauma.; 1995 vol.38 n.1 p.51 53 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30436 |
| Study title: Vena cavography with CO(2) versus with iodinated contrast material for inferior vena cava filter placement : a prospective evaluation; DEWALD CL; Radiology; 2000 vol.216 p.752 757Vena cavography with CO(2) versus with iodinated contrast material for inferior vena cava filter placement : a prospective evaluation; DEWALD CL; Radiology; 2000 vol.216 p.752 757 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30437 |
| Study title: fehlermoglichkeit bei der ausscheidungsurographie; Klingmuller V., Wissensch. Inform.; 1981 vol.7 n.4 p.93-99fehlermoglichkeit bei der ausscheidungsurographie; Klingmuller V., Wissensch. Inform.; 1981 vol.7 n.4 p.93-99 |
| Active substance: IOXAGLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30440 |
| Study title: peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155 peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155 |
| Active substance: IOXAGLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30441 |
| Study title: "can duplex doppler ultrasound replace computerized tomography in staging patients with renal cell carcinoma ?; BOS SD; Scand. J. Urol. Nephrol.; 1998 vol.32 p.87 91" "can duplex doppler ultrasound replace computerized tomography in staging patients with renal cell carcinoma ?; BOS SD; Scand. J. Urol. Nephrol.; 1998 vol.32 p.87 91" |
| Active substance: IOXITALAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30512 |
| Study title: Efficacy and tolerability of Ipratropium bromide solution in the prevention of exercise-induced bronchospasm in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U92-0573_synopsis.pdf |
| View full study record |
| Document reference: 30706 |
| Study title: Efficacy and usability of Sch 1000 in capsules with powder inhalator in paediatrics (pilot study). Phase III. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U82-0222_synopsis.pdf |
| View full study record |
| Document reference: 30672 |
| Study title: Efficacy of inhaled ipratropium bromide in acute bronchiolitis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30555 |
| Study title: Efficacy of inhaled ipratropium bromide in acute bronchiolitis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U98-0091_synopsis.pdf |
| View full study record |
| Document reference: 30716 |
| Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30549 |
| Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U90-0054_synopsis.pdf |
| View full study record |
| Document reference: 30699 |
| Study title: Evaluation of the therapeutic effect and tolerance of 4.5 mg Th 1165a suppositories in newborns and infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30587 |
| Study title: Evaluation of the therapeutic effect of Th 1165a-suppositories in children during the night compared with placebo. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30592 |
| Study title: Ipratropium bromide (Atrovent) maintenance therapy of bronchial asthma and spastic bronchitis: results of a multicenter study on 2557 cases. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30572 |
| Study title: A double-blind group comparative study, comparing nedocromil sodium (4mg*4 daily) Minty flavoured formulation and placebo in the management of bronchial asthma in children - E. Weinberg - 1992 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46960 |
| Study title: A double-blind comparative trial, placebo-controlled study to assess the efficacity of nedocromil sodium in the management of childhood grass-pollen asthma - L. Businco et al. - 1990 ( Clin Exp allergy vol 20) - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) -Clinical documentation -29/08/1995 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46961 |
| Study title: A double-blind group comparative study nedocromil sodium 2% ophthalmic solution, 2% sodium cromoglycate eye drops and placebo in the treatment of vernal keratoconjunctivitis - Hennawi - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46962 |
| Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of perennial allergic conjunctivitis - Alexander et al. - no date - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46963 |
| Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of trachoma - El Mofti - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46964 |
| Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of vernal keratoconjunctivitis - Dahan -1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46965 |
| Study title: A double-blind group comparative study of 2% nedocromil sodium eye drops in the treatment of seasonal allergic conjunctivitis - Easty et al. - 1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46966 |
| Study title: A double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of chronic allergic conjunctivitis - El Guindi - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46967 |
| Study title: A double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of vernal keratoconjunctivitis - Mostafa - 1989 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46968 |
| Study title: A double-blind group comparative trial comparing nedocromil sodium 8 mg per day via metered dose inhaler and placebo in the management of bronchial asthma in children - L. Businco - 1990 (Clin Exp Allergy vol 20) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46969 |
| Study title: A double-blind group comparative trial comparing nedocromil sodium and placebo in the management of bronchial asthma in children - G. Longo - 1986 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46970 |
| Study title: A Double-Blind Group-Comparative Multicentre Trial of Nedocromil Sodium Metered-Dose 1% Aqueous Nasal Spray and Placebo in the Treatment of Children with Saesonal Allergic Rhinitis Caused by Polen, Kitchingman G.,1993, Medical Report |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47016 |
| Study title: A Double-Blind Multicenter Group Comparison Study of the Safety and Effectiveness of 0,5% Nedocromil Sodium Nebulizer Solution QID vs. Placebo in the Management of Bronchila Asthma in Children (6-12 Years old), 1993, Medical Report |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47017 |
| Study title: A double-blind multicentre group comparative study of efficacy and safety of TILADE (nedocromil sodium) QID vsPlacebo in the management of bronchial asthma in children (6-12 years old) - R. Biondi - 1990 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46971 |
| Study title: A multicentre, open label assessment of the safety of flavoured non-CFC propellant (HFA-227) Formulation of necrodomil sodium 4 mg QID via metered dose inhaler over 40 weeks in adolescent and adult asthmatics - Claire Cutts et al. - 16/10/1996 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): Nedocromil-Study 3.pdf |
| View full study record |
| Document reference: 46995 |
| Study title: A phase III multicentre open study to assess the safety of a flavoured alternative propellant (HFA-227) formulation of Nedocromil sodium 4 mg metered-dose inhaler and FISONAIR holding chamber, 4 times daily for one year in children with asthma |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): Nedocromil-Study 2.pdf |
| View full study record |
| Document reference: 46996 |
| Study title: A pilot assessor blind crossover randomised comparison of the relative efficacies of nedocromil sodium 2% eyes drops 1 drop QDS and fluorometholone 0,1% eye drops QDS in the treatment of vernal keratoconjunctivitis - Professor KF Tabbara et al. - 08/12/1996 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): Nedocromil-Study 1.pdf |
| View full study record |
| Document reference: 46997 |
| Study title: A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching wit-h the conjunctival allergen challenge model - JV. Greiner et al. - 2003 (Clin. Ther vol 25) - Publication in Clinical Expert Statement - Renewal of the Marketing Autorisation for Nedocromil eye drops in Turkey - DR. Bruno Verdoncq - 22/01/2007 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47006 |
| Study title: A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma - KC Bergmann et al. - 1989 (Curr Med Res Opin vol 11) - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) -Clinical documentation -29/08/1995 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47023 |
| Study title: A randomised, multicenter, double-blind, placebo controlled , group comparative study of TILADE (Necrodomil Sodium) 4 mg QID vs. Placebo administrated via metered dose inhaler (MDI) in the treatment of children with asthma which is exacerbated by ragweed pollen - Don Bukstein et al. - 05/12/1995 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46998 |
| Study title: A randomised, multicenter, double-blind, placebo controlled, group comparative study of the absolute efficacy and safety of Tilade (Nedocromil sodium) 4 mg QID in the treatment of children 6-11 years of age with bronchial asthma- Mark Ellis et al. - 4/07/1994 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46999 |
| Study title: A Randomized Double-Blind Multicenter Group Comparative Study in the Absolute Efficacy and Safety of Nedocromil Sodium 0,5% Nebulizer Solution TID in the Treatment of Children 2-4 Years of Age with Bronchial Asthma, 1993, Medical Report |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47018 |
| Study title: A Report of a Double-Blind Multicentre Group Comparative Study of the Efficacy and safety of Nedocromil Sodium in the Management of Asthma |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47019 |
| Study title: Multicentre, randomised, single-blind study in four parallel groups comparing the dose-response relation of ketoprofen (0,25 mg/kg/dose; 0,5 mg/kg/dose; 1 mg/kg/dose) against Paracetamol (15 mg/kg/dose) in the treatment of fever in children aged from 2 years to 6 years - Reinert Ph et al. - 06/1997 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30867 |
| Study title: Multicentre, randomised, single-dose single-blind study in four parallel groups comparing the dose-response relationship of ketoprofen (0,25 mg/kg/dose; 0,5 mg/kg/dose; 1 mg/kg/dose) against Paracetamol (15 mg/kg/dose) in the treatment of febrile diseases in the child age from 6 months to 24 months - Bourrillon A. et al. - 16/06/1997 |
| Active substance: KETOPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30868 |
| Study title: Multicentre, randomized, single-dose single-blind study in four parallel groups comparing the dose response relation of ketoprofen (0.25 mg/kg/dose; 0.5 mg/kg/dose; 1 mg/kg/dose) against paracetamol (15 mg/kg/dose) in the treatment of fever in children aged from 2 years to 6 years |
| Active substance: KETOPROFEN |
| Study summary document link (including results): Ketoprofen-Study 1.pdf |
| View full study record |
| Document reference: 30865 |
| Study title: Multicentre, randomized, single-dose single-blind study in four parallel groups comparing the dose-response relationship of ketoprofen (0.25 mg/kg/dose; 0.5 mg/kg/dose; 1 mg/kg/dose) against paracetamol (15 mg/kg/dose) in the treatment of febrile diseases in child aged from 6 months to 24 months |
| Active substance: KETOPROFEN |
| Study summary document link (including results): Ketoprofen-Study 2.pdf |
| View full study record |
| Document reference: 30866 |
| Study title: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy |
| Active substance: NABILONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32439 |
| Study title: A Study of the Safety and Pharmacokinetics of Nabumetone and 6-MNA, and the Protein Binding of 6-MNA in Patients with Juvenile Rheumatoid Arthritis and in Healthy Adult Volunteers Following Repeated Oral Doses of Nabumetone (1000 mg) Chewable Tablets Report No. SB Document Number: BRL-014 117I RSD1- 00NTK/ |
| Active substance: Nabumetone |
| Study summary document link (including results): Study 222 Nabumetone.xls |
| View full study record |
| Document reference: 47216 |
| Study title: An open-label study assessing the population pharmacokinetics, safety and efficacy of nabumetone in patients with juvenile rheumatoid arthritis (JRA) requiring NSAID therapy. |
| Active substance: NABUMETONE |
| Study summary document link (including results): Nabumetone-14777262-ICHE3.pdf |
| View full study record |
| Document reference: 32444 |
| Study title: Laporte S, Mismetti P, Piquet P, Doubine S, Touchot A, Decousus H. Population pharmacokinetic of nadroparin calcium (Fraxiparine) in children hospitalised for open heart surgery. European Journal of Pharmaceutical Sciences 1999;8:119-25." EJPS 1999:8:119-25 |
| Active substance: NADROPARIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32448 |
| Study title: The use of CY216 (fraxiparine) in Paediatric haemodialysis Fraxiparine : premier symposium international; 01 Nov 1987-01 Nov 1987; Paris, France. 2005. 19-19. |
| Active substance: NADROPARIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32449 |
| Study title: Büttner-Nalbuphine and piritramid in the postoperative period in young children. |
| Active substance: NALBUPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32453 |
| Study title: Büttner-Nalbuphine and piritramid in the postoperative phase in young children. |
| Active substance: NALBUPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32452 |
| Study title: Habre-Analgesic and respiratory effect of nalbuphine and pethidine for adenotonsillectomy in children with obstructive sleep disorder. |
| Active substance: NALBUPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32451 |
| Study title: "A meta-analysisi of randomized, controlled trials comparing short and long-course antibiotic therapy for urinary tract infections in children - Keren R. - 2002 (Pediatrics, 109,5) - Publication in CES EXPCRC-CES0164-EN01 - Eugène D. - 25 Apr. 2003 -" |
| Active substance: Nalidixic acid |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32455 |
| Study title: Nalidixic acid : Critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 |
| Active substance: NALIDIXIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32454 |
| Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Quinolone arthropathy in juvenile New Zealand White rabbits.- Sharpnack DD. - 1994 |
| Active substance: Nalidixic acid |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32456 |
| Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Review of quinolone arthropathy in the dog. - Burkhardt JE - 1996 (Chemotherapy Journal, 5, 13:14-18) |
| Active substance: Nalidixic acid |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32457 |
| Study title: B. Kamiński - ,,Clinical trial of Naloxone Polfa" |
| Active substance: NALOXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32459 |
| Study title: Sandyk - Naloxone abolishes self-injuring in a mentally retarded child.Sandyk - Ann Neurol. 1985 May;17(5):520Sandyk - Naloxone abolishes self-injuring in a mentally retarded child.Sandyk - Ann Neurol. 1985 May;17(5):520 |
| Active substance: NALOXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32460 |
| Study title: Deas - Naltrexone treatment of adolescent alcoholics: an open-label pilot study. Deas et al. J Child Adolesc Psycho-pharmacol. 2005; 15(5):723-8.Deas - Naltrexone treatment of adolescent alcoholics: an open-label pilot study. Deas et al. J Child Adolesc Psycho-pharmacol. 2005; 15(5):723-8. |
| Active substance: NALTREXONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32461 |
| Study title: Effects of Naltrexone on the Autistic Syndrome, Double-Blind, Placebo Controlled Crossover Design Study |
| Active substance: NALTREXONE |
| Study summary document link (including results): Protocol DuP 393-015 Naltrexone.pdf |
| View full study record |
| Document reference: 32462 |
| Study title: Am J Roenge nol Radium Ther Nucl Med 1975;124:638-42. |
| Active substance: NANDROLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32447 |
| Study title: An Open-label Trial Evaluating the Safety and Efficacy of NOLVADEX (tamoxifen citrate) in the Treatment of McCune-Albright SyndromeAn Open-label Trial Evaluating the Safety and Efficacy of NOLVADEX (tamoxifen citrate) in the Treatment of McCune-Albright Syndrome |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): 6157US0013 CSR Synopsis[1].pdf |
| View full study record |
| Document reference: 43084 |
| Study title: An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. Haddad NARA, E-mail: nhaddad@iupui.edu], Eugster E. Journal of Pediatric Endocrinology & Metabolism~ 20(6):653-661, JUN 2007 2007;(6):-661, JUN.An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. Haddad NARA, E-mail: nhaddad@iupui.edu], Eugster E. Journal of Pediatric Endocrinology & Metabolism~ 20(6):653-661, JUN 2007 2007;(6):-661, JUN. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43252 |
| Study title: arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25(5):722-734.arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. Oncogene 2006; 25(5):722-734. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43133 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43108 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43129 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology 1999; 16(3):245-250.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology 1999; 16(3):245-250. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43148 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43187 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43197 |
| Study title: A double-blind multicentre group comparative study of efficacy of TILADE (Nedocromil sodium, 4 mg QID) in the management of bronchial asthma in children - H. Eigen - 1989 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46972 |
| Study title: A double-blind multicentre group comparative trial of the efficacy and safety of nedocromil sodium 4 mg four times daily and placebo by metered dose inhaler in the management of bronchial asthma in children - L. Armerio et al. - 1993 (Arch Dis Child vol 68) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46973 |
| Study title: A double-blind parallel group study comparing the effect of nedocromil sodium (4 mg TID) via a Nebuhaler. Device and placebo on bronchial hyperreactivity and diurnal variation in PEFR in children with asthma - P. Sly - 1993 (J. Asthma vol 30) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46974 |
| Study title: A double-blind randomised crossover investigation to compare the acceptability of Tiliade Mint 8 mg (4 puffs) twice saily taken by metered dose inhaler via the fusionair with Intal 20 mg (4 puffs) twice daily taken by metered dose inhaler via the fusionair in paediatric asthmatics aged 2-5 years - AJ. Williams - 1993 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46975 |
| Study title: A double-blind study to assess the efficacy and duration of protection of nedocromil sodium given by pressurised aerosol in asthmatic children in exercise challenge tests - A. Boner - 1985 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46976 |
| Study title: A double-blind, crossover trial comparing "Tilade" (Nedocromil sodium) 4 mg three times daily and "INTAL" (Sodium cromoglycate) 4 mg three times daily in the management of children with bronchial asthma, currently being treated with "INTAL", 2 mg three times daily but responding at a sub-optimal level - C. Mellis - 1990 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46977 |
| Study title: Comparison of the curative effect of IK 6 metered aerosol and its individual constituents in a provocation test with antigen inhalation. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30567 |
| Study title: Comparison of the curative effect of IK 6 metered aerosol and its individual constituents in a provocation test with antigen inhalation. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30668 |
| Study title: Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution in children with asthma (Should ipratropium bromide be preservative free ?). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30644 |
| Study title: Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution in children with asthma (Should ipratropium bromide be preservative free ?). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U88-0553 _synopsis.pdf |
| View full study record |
| Document reference: 30697 |
| Study title: Comparison of the long term effect of Fenoterol hydrobromide and Theophylline syrups in pre-school asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30610 |
| Study title: Comparison of the protective action of Berodual solution (IK 37) and Intal in cases of allergen-provoked bronchoconstriction in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30606 |
| Study title: Comparison of the protective action of Berodual solution (IK 37) and Intal in cases of allergen-provoked bronchoconstriction in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30667 |
| Study title: Comparison of the safety profile of fenoterol administered by Lactose inhalets (100 mcg/Inhalet) or by MDI (100 mcg/puff) in paediatric patients with asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30560 |
| Study title: Comparison of treatment with IK 6 and SCH 1000 used as capsules by means of a powder inhaler in paediatrics. Phase III. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30570 |
| Study title: "A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Greiner JV, Minno G. Clin. Ther. 2003 Jul; 25(7): 1988-2005. " "A placebo-controlled comparison of ketotifen fumarate and nedocromil sodium ophthalmic solutions for the prevention of ocular itching with the conjunctival allergen challenge model. Greiner JV, Minno G. Clin. Ther. 2003 Jul; 25(7): 1988-2005. " |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30953 |
| Study title: A. Chmielewska - Comperative trial on ketotifen table and sirup with Zaditernem |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30950 |
| Study title: Abelson MB. Six-week safety trial of ketotifen fumarate 0.025% ophthalmic solution in volunteers with normal ocular health. CIBA Vision Corp., Duluth, Georgia, USA: 23.11.1998. Abelson MB. Six-week safety trial of ketotifen fumarate 0.025% ophthalmic solution in volunteers with normal ocular health. CIBA Vision Corp., Duluth, Georgia, USA: 23.11.1998. |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26056 |
| Study title: DOSE RESPONSE STUDY OF EXERCISE-INDUCED ASTHMA IN ADOLESCENTS AND YOUNGADULTS. CONCENTRATIONS OF PRE-AND POST-EXERCISE PLASMA SAMPLES ATDIFFERENT DOSES OF CAPSULES, (KNGL 6604, BATCH NR. 001G7; 1MG). |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30951 |
| Study title: " Efficacy and safety of single- and multiple-dose ketotifen fumarate 0,025% ophthalmic solution in a pediatric population. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Pediatr Allergy Immunol 2004 Dec; 15(6):551-7" " Efficacy and safety of single- and multiple-dose ketotifen fumarate 0,025% ophthalmic solution in a pediatric population. Abelson MB, Ferzola NJ, McWhirter CL, Crampton HJ. Pediatr Allergy Immunol 2004 Dec; 15(6):551-7" |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30955 |
| Study title: Multicentre, double-masked, parallel-group, prospective, balanced-randomized, comparative trial using a vehicle and an active control. |
| Active substance: KETOTIFEN |
| Study summary document link (including results): Zaditen Ophtha Paediatric Studies_NHDR 42000-97-3_ EMA spreadsheet.xls |
| View full study record |
| Document reference: 47299 |
| Study title: Multicentre, randomised, double-dummy, controlled, dose-finding 120472 |
| Active substance: KETOTIFEN |
| Study summary document link (including results): Zaditen_TabulazioneReport_16Oct11.xls |
| View full study record |
| Document reference: 48187 |
| Study title: "Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Adv. Ther. 2002 Jul-Aug; 19(4): 161-9 " "Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Abelson MB, Chapin MJ, Kapik BM, Shams NB. Adv. Ther. 2002 Jul-Aug; 19(4): 161-9 " |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30954 |
| Study title: A Report of a Double-Blind Multicentre Group Comparative Study of the Efficacy and safety of Nedocromil Sodium in the Management of Asthma |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47951 |
| Study title: A single-blind, multicentre, randomised, group comparative, 12- week post-marketing surveillance study demonstrate the safety of sodium cromoglycate 5 mg MDI versus INTAL 5 mg (5MG/10 mg q.i.d.) in 3600 adults, adolescent and paedriatric asthmatic patients - Domège N et al. - 31/05/2001 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47000 |
| Study title: Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma - PD Sly et al. -1994 (BMJ vol 308) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46956 |
| Study title: Chronic cough in childhood : approch to diagnosis and treatment - DP. Parks et al. - 1988 (J. of pedriatrics vol 115) |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47025 |
| Study title: Comparison of nedocromil sodium and sodium cromoglycate administered by pressurised aerosol, with and without a spacer device in exercise-induced asthma in children - A. Comis et al. - 1993 (Eur Resp J vol 6) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47026 |
| Study title: J Clin Path 1976;29:626-33.; |
| Active substance: NANDROLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32446 |
| Study title: J Paediatr 1974; 84:109-10.; |
| Active substance: NANDROLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32445 |
| Study title: A Double Blind, Parallel, Multicentre Comparison of Tenoxicam with Naproxen in the Treatment of Children and Adolescents Suffering from Juvenile Chronic Arthritis (JCA). |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46953 |
| Study title: A randomised double blind multiple dose study to compare the analgesic efficacy and safety of Naproxen Sodium 220 mg and Ibuprofen 200 mg for the treatment of dysmenorrhea |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00138_study_synopsis.pdf |
| View full study record |
| Document reference: 47071 |
| Study title: A single-dose efficacy and safety comparison of Aleve®, Tylenol® No.3, and Placebo in dental pain |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01267_study_synopsis.pdf |
| View full study record |
| Document reference: 47143 |
| Study title: An Efficacy and Safety Study Comparing Single Doses of Aleve®, Extended Release Tylenol® and Placebo in Dental Pain |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01273_study_synopsis.pdf |
| View full study record |
| Document reference: 47146 |
| Study title: An efficacy and safety study comparing single doses of Aleve®, extended-release Tylenol and placebo in dental pain. |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01268_study_synopsis.pdf |
| View full study record |
| Document reference: 47144 |
| Study title: Antipyretic activity of naproxen in children: Comparison with aspirin and placebo. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46943 |
| Study title: Antipyretic effect of naproxen in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46935 |
| Study title: Bioavailability and efficacy of naproxen suspension in children with postoperative pain. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46940 |
| Study title: Bioavailability of naproxen suspension in pain compared with fever in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46946 |
| Study title: Clinical assessment of the antipyretic efficacy of naproxen compared to paracetamol in paediatric patients. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46954 |
| Study title: Clinical assessment of the entipyretic efficacy of naproxen compared with paracetamol in paediatric patients. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46951 |
| Study title: Comparison of naproxen sodium, Advil® and placebo in subjects with acute ankle sprains. |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01269_study_synopsis.pdf |
| View full study record |
| Document reference: 47145 |
| Study title: Double-blind clinical trial - naproxen sodium suspension vs placebo in postoperative adeno-tonsillectomy in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46934 |
| Study title: II/NAPS011/GER: Clinical assessment of the antipyretic efficacy of naproxen compared to paracetamol in paediatric patients. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46948 |
| Study title: Methodology Study Comparing Naproxen, Ibuprofen and Placebo in Subjects with Acute Ankle Sprains |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00919_study_synopsis.pdf |
| View full study record |
| Document reference: 47140 |
| Study title: Multiple Dose Safety and Efficacy Comparison of Naproxen with Placebo in the Treatment of Pain Secondary to Dental Impaction Surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00976_study_synopsis.pdf |
| View full study record |
| Document reference: 47141 |
| Study title: Multiple-dose safety and efficacy comparison of naproxen and placebo in the treatment of pain secondary to dental impaction surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00974_study_synopsis.pdf |
| View full study record |
| Document reference: 47072 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43207 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43211 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43221 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43231 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43241 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43324 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43146 |
| Study title: Comparison of treatment with IK 6 and SCH 1000 used as capsules by means of a powder inhaler in paediatrics. Phase III. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30673 |
| Study title: Determination of an effective dose of fenoterol, as free as possible from side effects for regular therapeutic use in obstructive respiratory tract diseases. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30619 |
| Study title: Dose and placebo comparison of Th 1165a suppositories (3.0 to 10.5 mg) in children with acute bronchospasm. Multicentre trial STK. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30582 |
| Study title: Double-blind, controlled trial to assess the efficacy of ipratropium bromide associated with high dose salbutamol by repeated nebulisation versus repeated nebulisation of salbutamol alone, for 120 minutes, in acute asthmatic attacks in young children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30554 |
| Study title: Double-blind, controlled trial to assess the efficacy of ipratropium bromide associated with high dose salbutamol by repeated nebulisation versus repeated nebulisation of salbutamol alone, for 120 minutes, in acute asthmatic attacks in young children |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U00-0090_synopsis.pdf |
| View full study record |
| Document reference: 30627 |
| Study title: Duovent inhalets compared with inhaler in asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30695 |
| Study title: Durban trial of Atrovent: statistical analysis of results. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30571 |
| Study title: Durban trial of Atrovent: statistical analysis of results. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U83-0398_synopsis.pdf |
| View full study record |
| Document reference: 30676 |
| Study title: Effect of ipratropium bromide on the diurnal variation of asthma in children |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U85-0252_synopsis.pdf |
| View full study record |
| Document reference: 30620 |
| Study title: Effect of ipratropium bromide on the diurnal variation of asthma in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30547 |
| Study title: Efficacy and suitability of IK 6 as a capsule administered with a powder inhaler in children. Phase III. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30674 |
| Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30542 |
| Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30629 |
| Study title: To evaluate, in an open pilot study, the effect on lungfunction of Ipratropium bromide inhalation solution and the additional effect of a beta 2-agonist (Salbutamol inhalation solution) in children with an acute attack of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U93-0136_synopsis.pdf |
| View full study record |
| Document reference: 30708 |
| Study title: Tolerability and acceptability of Ipratropium bromide - Dry powder form in children with asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U92-0812_synopsis.pdf |
| View full study record |
| Document reference: 30707 |
| Study title: Treatment of acute bronchial asthma comparison between epinephrine (injections - subcutaneous) and fenoterol (inhalation). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30616 |
| Study title: A comparison of the safety profile of fenoterol |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U99-0056_synopsis.pdf |
| View full study record |
| Document reference: 30742 |
| Study title: Duovent inhalets compared with inhaler in asthmatic children. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U82-0226_synopsis.pdf |
| View full study record |
| Document reference: 30728 |
| Study title: A multicentre double-blid group comparative study 2% nedocromil sodium eye drops and placebo in the treatment of seasonal allergic conjunctivitis - Kreindler et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46979 |
| Study title: A Multicentre double-blind group comparative study 2% nedocromil sodium eye drops and placebo in the treatment of seasonal allergic conjunctivitis - Leino et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46980 |
| Study title: A Multicentre double-blind group comparative study 2% nedocromil sodium eye drops and placebo in the treatment of seasonal allergic conjunctivitis- Blumenthal et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46981 |
| Study title: A multicentre double-blind group comparative study nedocromil sodium 2% ophthalmic solution, 2% sodium cromoglycate eye drops and placebo in the treatment of seasonal allergic conjunctivitis due to birch pollen - Posti et al. - 1989 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46982 |
| Study title: A multicentre double-blind group comparative study of 2% nedocromil sodium eye drops and placebo in the treatment of seasonal alllergic conjunctivitis - Greenbaum et al. -1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46983 |
| Study title: A multicentre double-blind group comparative study of 2% nedocromil sodium eye drops, 2% sodium cromoglycate and placebo in the treatment of seasonal Allergic conjunctivitis - Alexander et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46984 |
| Study title: A multicentre double-blind group comparative study of 2% nedocromil sodium ophthalmic solution and oral terfenadine in the treatment of seasonal allergic conjunctivitis - Stockwell et al. - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46985 |
| Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of seasonal allergic conjunctivitis - Bloch-Michel et al. - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46986 |
| Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of seasonal allergic conjunctivitis carried out in general practice - Rodgers et al. - 1988 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46987 |
| Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of seasonal allergic conjunctivitis in children - Berg et al. - 1989 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46988 |
| Study title: A multicentre double-blind group comparative study of nedocromil sodium 2% ophthalmic solution and placebo in the treatment of vernal keratoconjunctivitis- Mala - 1987 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46989 |
| Study title: A multicentre double-blind group comparative study of the efficacy and safety of nedocromil sodium 2% ophthalmic solution in the treatment of Ragweed-induced seasonal allergic conjunctivitis- Blumenthal et al. - 1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46991 |
| Study title: A multicentre double-blind group coparative study of nedocromil sodium 2% ophthalmic solution QID, BD and placebo in the treatment of perennial allergic conjunctivitis - Adenis et al. - 1990 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46992 |
| Study title: Multiple-dose safety and efficacy comparison of naproxen and placebo in the treatment of pain secondary to dental impaction surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-00975_study_synopsis.pdf |
| View full study record |
| Document reference: 47073 |
| Study title: Naproxen in secretory diarrhea in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46949 |
| Study title: Naproxen in the treatment with juvenile rheumatoid arthritis. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46938 |
| Study title: Naproxen suspension compared with placebo suspension as adjuncts to antibiotics in the treatment of acute otitis media in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46952 |
| Study title: Naproxen suspension in juvenile rheumatoid arthritis and other rheumatic manifestations in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46947 |
| Study title: Naproxen suspension in the treatment of postoperative pain in children: a multiple dose study. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46939 |
| Study title: Naproxen versus aspirin in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46937 |
| Study title: Naproxen versus codeine in paediatric pain. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46945 |
| Study title: Naproxen versus paracetamol in paediatric pyrexia: a single blind parallel study. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46950 |
| Study title: Naproxen, Ibuprofen and Placebo Dosing Compliance Study in Natural Common Colds |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01243_study_synopsis.pdf |
| View full study record |
| Document reference: 47074 |
| Study title: Naproxen, Ibuprofen and Placebo dosing compliance study in natural common colds. |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01244_study_synopsis.pdf |
| View full study record |
| Document reference: 47075 |
| Study title: Naproxen, ibuprofen, and placebo dosing compliance study in natural common colds |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01242_study_synopsis.pdf |
| View full study record |
| Document reference: 47142 |
| Study title: Open study of the metabolism of naproxen in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46936 |
| Study title: Pharmacokinetics of naproxen tablets and naproxen suspension in febrile adults and children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46955 |
| Study title: Richiamo con dapiprazolo collirio della midriasi da fenilefrina in pazienti a rischio e non |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46930 |
| Study title: Single dose methodology pilot study comparing the safety and efficacy of naproxen, ibuprofen and placebo in treatment of pain secondary to dental impaction surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01519_study_synopsis.pdf |
| View full study record |
| Document reference: 47147 |
| Study title: Single-dose efficacy comparison of Naproxen, ibuprofen and placebo in the treatment of pain secundary to dental impaction surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46933 |
| Study title: Single-Dose Safety and Efficacy Comparison of Naproxen and Ibuprofen with Placebo in the Treatment of Pain Secondary to Dental Impaction Surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-01555_study_synopsis.pdf |
| View full study record |
| Document reference: 47148 |
| Study title: Single-dose safety and efficacy comparison of Naproxen Sodium plus Caffeine to Naproxen Sodium, Caffeine and Placebo in Dental pain |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46932 |
| Study title: Single-dose safety and efficacy comparison of naproxen, acetaminophen and aspirin with placebo in the treatment of pain secondary to dental impaction surgery |
| Active substance: NAPROXEN |
| Study summary document link (including results): Bayer CC_Naproxen Sodium_CC-423289_study_synopsis.pdf |
| View full study record |
| Document reference: 47076 |
| Study title: Studio di valutazione dell'efficacia del dapiprazolo collirio nella preparazione del paziente da sottoporre all'intervento di yag-laser iridotomia e argon-laser trabeculoplastica |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46931 |
| Study title: Study of the plasma levels from a single dose of naproxen in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46944 |
| Study title: Use of naproxen in children. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46942 |
| Study title: Use of naproxen in children’s joint diseases. |
| Active substance: NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46941 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43166 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43171 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43177 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43185 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43195 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43205 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43342 |
| Study title: Effect of the combination of ipratropium bromide and fenoterol (berodual) in patients with asthmatic crises comparative study with fenoterol (Berotec). |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30729 |
| Study title: Efficacy and suitability of IK 6 as a capsule administered with a powder inhaler in children. Phase III. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30730 |
| Study title: Evaluation of the therapeutic action and tolerance of IK 37 in infants and children up to six years of age. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30731 |
| Study title: Report to Boehringer-Ingelheim, Australia on clinical trial to determine the optimum dose of nebulised ipratropium bromide (Atrovent) solution (0.020 %) in children with chronic asthma. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30732 |
| Study title: Safety profile of the combination ipratropium bromide (20 mcg)/fenoterol hydrobromide (50 mcg) 2 puffs t.i.d. delivered by an MDI aerosol formulated with CFC propellants compared to an MDI formulation with the propellant HFA 134a, in pediatric patients in asthma |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U84-0885_synopsis.pdf |
| View full study record |
| Document reference: 30733 |
| Study title: Statistical report - A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30734 |
| Study title: Statistical report - A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30735 |
| Study title: Statistical report: A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30736 |
| Study title: Study of pharmacodynamic and clinical response to bronchodual of asthmatic children with obstruction during the intercritical period. Clinical correlations and fuctions. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30737 |
| Study title: Study of pharmacodynamic and clinical response to bronchodual of asthmatic children with obstruction during the intercritical period. Clinical correlations and fuctions. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30738 |
| Study title: Study of the action of Berodual as a chronic treatment on the non-specific bronchial hyper-reactivity in children. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30739 |
| Study title: Study on the acceptance of the multicapsule inhalator Boehringer Ingelheim M. Berodual inhalets are used. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30740 |
| Study title: De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115)De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30816 |
| Study title: De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820)De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30815 |
| Study title: Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441)Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30786 |
| Study title: Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453)Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30795 |
| Study title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of PROVIGIL® (Modafinil) Treatment (100, 200 and 400mg/day) in Children and Adolescents with Excessive Sleepiness Associated with Narcolepsy. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45275 |
| Study title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of PROVIGIL® (Modafinil) Treatment (100,200 and 400mg/day) in Children and Adolescents with Excessive Sleepiness Associated with Obstructive Sleep Apnea/Hypopnea Syndrome. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45276 |
| Study title: A Randomized Open-Label Study to Compare the Relative Bioavailability of 170 mg of Modafinil Film-Coated Tablets to 200 mg of PROVIGIL® and to Assess the Pharmacokinetic and Safety Profile of Multiple Doses of the Modafinil Film-Coated Tablets Administered at Doses of 340 and 425 mg to Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45284 |
| Study title: A randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29566 |
| Study title: "ADHD: new pharmacological treatments on the horizon. FA Lopez, Journal of Developmental and Behavioral Pediatrics - JDBP 2006, 27(5): 410-6 "ADHD: new pharmacological treatments on the horizon. FA Lopez, Journal of Developmental and Behavioral Pediatrics - JDBP 2006, 27(5): 410-6 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45676 |
| Study title: An 8-Week, Open-Label Study to Characterize the Response to Modasomil (85-mg Film-Coated Tablet) Treatment at Dosages Up to 425 mg/day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period). |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45279 |
| Study title: An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45667 |
| Study title: "An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 "An open-label assessment of modafinil on attention and fatigue in adolescent and adult AD(H)D subjects.Duane D; Heimberger G; Welch A;Sleep 2004; 27(s)/A47 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45675 |
| Study title: Double Blind Study on the Effect of Modafinil in Urinary Incontinence of Neurologic Origin. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45285 |
| Study title: "Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. TA Rugino & TC Copley, Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2): 230-5. "Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. TA Rugino & TC Copley, Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(2): 230-5. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45663 |
| Study title: [Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation] Y Li, et al., Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering 2003, 16(4): 277-80.[Effects of modafinil on visual and auditory reaction abilities and subjective fatigue level during 48 h sleep deprivation] Y Li, et al., Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering 2003, 16(4): 277-80. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45660 |
| Study title: Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Fan DS, Rao SK, Ng JS, Yu CB, Lam DS. Clin Experiment Ophthalmol. 2004 Oct;32(5):462-7. Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Fan DS, Rao SK, Ng JS, Yu CB, Lam DS. Clin Experiment Ophthalmol. 2004 Oct;32(5):462-7. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Comparative study on the safety and efficacy.pdf |
| View full study record |
| Document reference: 46865 |
| Study title: Comparison of cyclopentolate versus tropicamide cycloplegia in children. Egashira SM, Kish LL, Twelker JD, Mutti DO, Zadnik K, Adams AJ. Optom Vis Sci. 1993 Dec;70(12):1019-26. Comparison of cyclopentolate versus tropicamide cycloplegia in children. Egashira SM, Kish LL, Twelker JD, Mutti DO, Zadnik K, Adams AJ. Optom Vis Sci. 1993 Dec;70(12):1019-26. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Comparison of cyclopentolate versus tropicamide cycloplegia .pdf |
| View full study record |
| Document reference: 46877 |
| Study title: Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides. Chew C, Rahman RA, Shafie SM, Mohamad Z. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73. Comparison of mydriatic regimens used in screening for retinopathy of prematurity in preterm infants with dark irides. Chew C, Rahman RA, Shafie SM, Mohamad Z. J Pediatr Ophthalmol Strabismus. 2005 May-Jun;42(3):166-73. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Comparison of mydriatic regimens used in screening for retin.pdf |
| View full study record |
| Document reference: 46863 |
| Study title: Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. Parisi ML, Scheiman M, Coulter RS. J Am Optom Assoc. 1996 May;67(5):266-72. Comparison of the effectiveness of a nondilated versus dilated fundus examination in the pediatric population. Parisi ML, Scheiman M, Coulter RS. J Am Optom Assoc. 1996 May;67(5):266-72. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Comparison of the effectiveness of a nondilated versus dilat.pdf |
| View full study record |
| Document reference: 46874 |
| Study title: Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A, Kuper H, Wedner S. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1025-31. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Cost-effectiveness of cycloplegic agents.pdf |
| View full study record |
| Document reference: 46862 |
| Study title: Effect of mydriatics on blood pressure in premature infants. Merritt JC, Kraybill EN. J Pediatr Ophthalmol Strabismus. 1981 Sep-Oct;18(5):42-6. Effect of mydriatics on blood pressure in premature infants. Merritt JC, Kraybill EN. J Pediatr Ophthalmol Strabismus. 1981 Sep-Oct;18(5):42-6. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Effect of mydriatics on blood pressure in premature infants.pdf |
| View full study record |
| Document reference: 46881 |
| Study title: Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. Khoo BK, Koh A, Cheong P, Ho NK. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. Khoo BK, Koh A, Cheong P, Ho NK. J Pediatr Ophthalmol Strabismus. 2000 Jan-Feb;37(1):15-20. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Combination Cyclopentolate and Phenylephrine for Mydriasis.pdf |
| View full study record |
| Document reference: 46873 |
| Study title: Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43352 |
| Study title: aTargeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Oncogene~ 25(5):722-734, FEB 2006 2006;(5):-734, FEB.aTargeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors. arcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Oncogene~ 25(5):722-734, FEB 2006 2006;(5):-734, FEB. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43253 |
| Study title: Baker SB, Burkey BA, Thornton P, LaRossa D, Disa J, Heckler FR. Juvenile gigantomastia: Presentation of four cases and review of the literature. Annals of Plastic Surgery 2001; 46(5) 517-526.Baker SB, Burkey BA, Thornton P, LaRossa D, Disa J, Heckler FR. Juvenile gigantomastia: Presentation of four cases and review of the literature. Annals of Plastic Surgery 2001; 46(5) 517-526. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43142 |
| Study title: Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. Lawrence SE, Arnold FK, Vethamuthu J, Lawson ML. Journal of Pediatrics 145(1)()(pp 71-76), 2004 Date of Publication: Jul 2004 2004;(1):71-76.Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. Lawrence SE, Arnold FK, Vethamuthu J, Lawson ML. Journal of Pediatrics 145(1)()(pp 71-76), 2004 Date of Publication: Jul 2004 2004;(1):71-76. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43267 |
| Study title: Braunstein GD. Current Concepts - Gynecomastia. New England Journal of Medicine 1993; 328(7):490-495.Braunstein GD. Current Concepts - Gynecomastia. New England Journal of Medicine 1993; 328(7):490-495. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43159 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43106 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43127 |
| Study title: Khan AKA, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 13 (1982) 523-528.Khan AKA, Truelove SC, Aronson JK. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 13 (1982) 523-528. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42898 |
| Study title: Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556)Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30798 |
| Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30785 |
| Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30783 |
| Study title: Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550)Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30802 |
| Study title: Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458)Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30803 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27422 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27424 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27787 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27789 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27410 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27775 |
| Study title: "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60. " |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45290 |
| Study title: "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. " "C1538d/312/AD/US et al. SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60. " "Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies. " "C1538d/312/AD/US et al. SB Wigal, et al., Primary Care Companion to the Journal of Clinical Psychiatry 2006, 8(6): 352-60. " |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45673 |
| Study title: Modafinil as adjunctive therapy in depressed outpatients. S Nasr, Annals of Clinical Psychiatry - Official Journal of the American Academy of Clinical Psychiatrists 2004, 16(3): 133-8. Modafinil as adjunctive therapy in depressed outpatients. S Nasr, Annals of Clinical Psychiatry - Official Journal of the American Academy of Clinical Psychiatrists 2004, 16(3): 133-8. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45671 |
| Study title: Modafinil as therapy for ADHD in children: a 4-week, double blind, placebo controlled study. Swanson JM; Biederman J; Boelliner SW; Lopez FA; J Psychopharmacol 2004; 18(s3)/A53 |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45659 |
| Study title: "Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study. SW Boellner, et al., Current Medical Research and Opinion 2006, 22(12): 2457-65. " |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45289 |
| Study title: Modafinil in children with ADHD: a double-blind, placebo-controlled study; Rugino TA; Samsock TC; Adkins L; Annu Meet Amer Psychiatry Assoc 2002; 77/32 Modafinil in children with ADHD: a double-blind, placebo-controlled study; Rugino TA; Samsock TC; Adkins L; Annu Meet Amer Psychiatry Assoc 2002; 77/32 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45669 |
| Study title: Modafinil in children with attention-deficit hyperactivity disorder. TA Rugino & TC Samsock, Pediatric Neurology 2003, 29(2): 136-42. Modafinil in children with attention-deficit hyperactivity disorder. TA Rugino & TC Samsock, Pediatric Neurology 2003, 29(2): 136-42. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45661 |
| Study title: "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45666 |
| Study title: PHARMACOKINETIC STUDY IN CHILDREN WITH HC 20-511 PAEDIATRIC SYRUP |
| Active substance: KETOTIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30952 |
| Study title: F. Rosaschino, L. Cattaneo, Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL), ACTA BIO MEDICA ATENEO PARMENSE 2004; 75; 171-178, |
| Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41339 |
| Study title: I. La Mantia, F. Nicolosi, L. Maiolino, A. Serra, Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immunostimulating vaccine, GIMMOC Quaderni di Microbiologia e Clinica, Vol XI, Q2, 2007, p1-8. |
| Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41338 |
| Study title: Effects and side effects of mydriatic eyedrops in neonates. O?üt MS, Bozkurt N, Ozek E, Birgen H, Kazoko?lú H, O?üt M. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. Effects and side effects of mydriatic eyedrops in neonates. O?üt MS, Bozkurt N, Ozek E, Birgen H, Kazoko?lú H, O?üt M. Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Effects and side effects of mydriatic eyedrops in neonates.pdf |
| View full study record |
| Document reference: 46875 |
| Study title: Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1581-5. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis. Ghose S, Garodia VK, Sachdev MS, Kumar H, Biswas NR, Pandey RM. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1581-5. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Evaluation of potentiating effect of a drop of lignocaine.pdf |
| View full study record |
| Document reference: 46871 |
| Study title: Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria. Hasebe S, Nonaka F, Nakatsuka C, Ohtsuki H. Jpn J Ophthalmol. 2005 Jan-Feb;49(1):23-30. Myopia control trial with progressive addition lenses in Japanese schoolchildren: baseline measures of refraction, accommodation, and heterophoria. Hasebe S, Nonaka F, Nakatsuka C, Ohtsuki H. Jpn J Ophthalmol. 2005 Jan-Feb;49(1):23-30. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Myopia control trial with progressive addition lenses.pdf |
| View full study record |
| Document reference: 46864 |
| Study title: Results of a monozygotic cotwin control study on a treatment for myopia. Schwartz JT. Prog Clin Biol Res. 1981;69 Pt C:249-58. Results of a monozygotic cotwin control study on a treatment for myopia. Schwartz JT. Prog Clin Biol Res. 1981;69 Pt C:249-58. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Results of a monozygotic cotwin control study on a treatment.pdf |
| View full study record |
| Document reference: 46882 |
| Study title: Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. Twelker JD, Mutti DO. Optom Vis Sci. 2001 Apr;78(4):215-22. Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. Twelker JD, Mutti DO. Optom Vis Sci. 2001 Apr;78(4):215-22. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Retinoscopy in infants using a near noncycloplegic technique.pdf |
| View full study record |
| Document reference: 46872 |
| Study title: Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. Seasonal variation in myopia progression and ocular elongation. Fulk GW, Cyert LA, Parker DA. Optom Vis Sci. 2002 Jan;79(1):46-51. 9. Baseline refractive and ocular component measures of children enrolled in the correction of myopia evaluation trial (COMET). Gwiazda J, Marsh-Tootle WL, Hyman L, Hussein M, Norton TT; COMET Study Group. Invest Ophthalmol Vis Sci. 2002 Feb;43(2):314-21. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): Seasonal variation in myopia progression and ocular elongati.pdf |
| View full study record |
| Document reference: 46869 |
| Study title: Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates. Caputo AR, Schnitzer RE. J Pediatr Ophthalmol Strabismus. 1978 Mar-Apr;15(2):109-22.Systemic response to mydriatic eyedrops in neonates: mydriatics in neonates. Caputo AR, Schnitzer RE. J Pediatr Ophthalmol Strabismus. 1978 Mar-Apr;15(2):109-22. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): systemic response to mydriatic eyedrops in neonates.pdf |
| View full study record |
| Document reference: 46883 |
| Study title: Kiron M. "Sulfasalazine Therapy in Inflammatory Bowel Disease" Gastroenterology Clinics of North Ameica - Vol. 18, No.1, March 1989 Kiron M. "Sulfasalazine Therapy in Inflammatory Bowel Disease" Gastroenterology Clinics of North Ameica - Vol. 18, No.1, March 1989 |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42876 |
| Study title: Kummerle-Deschner J, Dannecker G; Acta Paediatr (Norway), Aug 1995, 84(8) p952-4; sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.Kummerle-Deschner J, Dannecker G; Acta Paediatr (Norway), Aug 1995, 84(8) p952-4; sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42890 |
| Study title: Ozdogan H, Turunc M, Deringol B, Yurdakul S, Yazici H.; J Rheumatol 1986 Feb;13(1):124-5 Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.Ozdogan H, Turunc M, Deringol B, Yurdakul S, Yazici H.; J Rheumatol 1986 Feb;13(1):124-5 Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42891 |
| Study title: Rosenberg AM; J Pediatr (United States), Feb 1989, 114(2) p171-8; Advanced drug therapy for juvenile rheumatoid arthritis.Rosenberg AM; J Pediatr (United States), Feb 1989, 114(2) p171-8; Advanced drug therapy for juvenile rheumatoid arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42892 |
| Study title: Suschke HJ.; Monatsschr Kinderheilkd 1992 Sep;140(9):658-60; Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine Suschke HJ.; Monatsschr Kinderheilkd 1992 Sep;140(9):658-60; Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42893 |
| Study title: Taggart AJ, McDermott BJ, Roberts SD. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin Pharmacokinet 23 (1992) 311-320.Taggart AJ, McDermott BJ, Roberts SD. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis. Clin Pharmacokinet 23 (1992) 311-320. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42899 |
| Study title: van Rossum MA, Fiselier TJ, Franssen MJ, et al.; Arthritis Rheum (United States), May 1998, 41(5) p808-16; Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. van Rossum MA, Fiselier TJ, Franssen MJ, et al.; Arthritis Rheum (United States), May 1998, 41(5) p808-16; Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42894 |
| Study title: Varbanova BB, Dyankov ED; Adv Exp Med Biol (United States), 1999, 455 p331-6; Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.Varbanova BB, Dyankov ED; Adv Exp Med Biol (United States), 1999, 455 p331-6; Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42896 |
| Study title: Efficacy and tolerability of Benzoyl peroxide and detergent soap (Acne Aid) in the treatment of acne vulgaris (used together). |
| Active substance: SULFONATED SURFACTANT BLEND |
| Study summary document link (including results): Article 45_Ref_C0193_Final for Submission_07Nov2011.xlsx |
| View full study record |
| Document reference: 48308 |
| Study title: Assessment of the use of 3% Salicylic acid and 10% Sulphur soap in the treatment of Tinea versicolor. |
| Active substance: SULFUR AND SALICYLIC ACID |
| Study summary document link (including results): Article 45_Ref_C0192_Final For Submission_27 Oct 2011.xlsx |
| View full study record |
| Document reference: 48309 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Sulfur-Heel (tablets) [AWB-AT] |
| Active substance: Sulfur comp.-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40247 |
| Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27370 |
| Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27735 |
| Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27395 |
| Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27760 |
| Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27402 |
| Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27767 |
| Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27392 |
| Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27757 |
| Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27339 |
| Study title: Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449)Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30791 |
| Study title: Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299)Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30812 |
| Study title: Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443)Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30781 |
| Study title: Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455)Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30797 |
| Study title: O. T.Aksic, F.Rosaschino, L. Cattaneo, The evaluation of the clinical efficacy of a Polyvalent Mechanical Bacterial Lysate (PMBL) in a sample of 180 children of school age with recurrent respiratory infections, European Journal of Aerobiology, Environmental Medicine and Air-borne Infections, Vol 1, number 1/2005, p3-7 |
| Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae; |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41340 |
| Study title: Double-blind randomised and controlled clinical trial to assess the efficacy and safety of Symphytum herb extract cream 10% against 1% in the acceleration of wound healing |
| Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40249 |
| Study title: Effect of a Symphytum Ointment with Sports Injuries of the Knee Joint (Wirkung einer Symphytum-Salbe bei Sportver-letzungen des Kniegelenkes) |
| Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40044 |
| Study title: The Local Treatment of Acute Lateral Distortions of the Ankle Joint with an Ointment containing a Symphytum Active Substance complex ( Die Lokalbehandlung der akuten lateralen Distorsion des oberen Sprung-gelenkes mit einer Symphytum-Wirk-stoffkomplex-Salbe) |
| Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40139 |
| Study title: The Local Treatment of Contusions and Distortions of the Knee Joint with a Symphytum Active Substance Complex Ointment (Die Lokalbehandlung von Kontusionen und Distorsionen des Kniegelenkes mit einer Symphytum-Wirkstoffkomplex-Salbe) |
| Active substance: Kulturbeinwell / Preparation of fresh Symphytum x uplandicum herb (2-3:1) consisting of: 0.4 g of pressed juice of fresh Symphytum x uplandicum herb (3-8:1) and 0.6 g extract of the press residue of fresh Symphytum x uplandicum herb (3-10:1); solvent ethanol 30 % V/V - "HERB"/ Symphyti herbae recens succus liquidum (2-3:1), extr. solvent ethanol 30 % (Symphytum concentrat... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40248 |
| Study title: |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30978 |
| Study title: A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children – ISOLAURI E., JUNTUNEN M. and al. – 1991.A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children – ISOLAURI E., JUNTUNEN M. and al. – 1991. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30980 |
| Study title: A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children – OBERHELMAN R.A., GILMAN R.H. and al. – 1999.A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children – OBERHELMAN R.A., GILMAN R.H. and al. – 1999. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30981 |
| Study title: "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. "Modafinil in diurnal sleepiness. A study of 123 patients. F Laffont, et al., Sleep 1994, 17(8 Suppl): pl) pS113-5. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45674 |
| Study title: Modafinil: a treatment alternative for children with attention-deficit/hyperactivity disorder (ADHD). Rugino T; Child Adolesc Psychopharmacol News 2002;7(6)/5-7 Modafinil: a treatment alternative for children with attention-deficit/hyperactivity disorder (ADHD). Rugino T; Child Adolesc Psychopharmacol News 2002;7(6)/5-7 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45668 |
| Study title: Non-stimulant treatment of attention-deficit/hyperactivity disorder. SR Pliszka, CNS Spectrums 2003, 8(4): 253-8. Non-stimulant treatment of attention-deficit/hyperactivity disorder. SR Pliszka, CNS Spectrums 2003, 8(4): 253-8. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45672 |
| Study title: 13C-Urea breath test threshold calculation and evaluation for the detection of Helicobacter pylori infection in childrenStudy of the efficacy and tolerability of sodium valproate in the treatment of partial seizure and generalized epilepsy - Bittencourt P.R.M. - 4/03/1996 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39145 |
| Study title: 13C-Urea Breath Test to Diagnose Helicobactyer Pylori Infection in Children Aged up to 6 Years |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39146 |
| Study title: A 13C –urea breath test in children with Helicobacter pylori infection: assessment of eradication therapy and follow-up treatmentStatus Epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines - Campistol and al. - 1999 ( Rev. Neurol.1999 - 29 : 359-65 ) Publication 1 in Ergenyl Via Expert report on the clinical documentation - Hufnagel A. - 14/11/2006 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39144 |
| Study title: A rapid lateral flow stool antigen immunoassay and 14C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in childrenSodium Vallproate in status epilepticus - S. JHA 2003 (Neurol. India - 2003 - 51:421-2) Publication in Epilim-Reports of clinical studies Vol II - E. TRINKA - 06/11/2006 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39141 |
| Study title: Biokenetics and radiation doses for carbon-14 urea in adults and children undergoing the Helicobacter pylori breath testSpecific cognitive dysfunction in children with epileptic mothers. - Gaily et al. - Dev Med Child Neurol 1990;32-403-414. |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39143 |
| Study title: Diagnosis of Helicobacter pyloriThe longer term outcome of children born to mothers with epilepsy. - Adab et al. - J Neurol Neurosurg Psychiatry 2004;75:1575-83. |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39149 |
| Study title: Diagnostic accuracy of the 13C-urea breath test in children: Adjustment of the cut-off value according to ageTeratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE). - Arpino C et al. - Epilepsia 2000;41(11):1436-43. |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39147 |
| Study title: Frequency of Helicobacter Pylori infection in children under 4 years of ageThe epilepsies – febrile convulsions. - Trescher WH et al. - In : WG Bradley et al. Neurology in clinical practice. 4th edition. Elsevier edition 2004; vol II, chapter 73: 1963-64. |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39148 |
| Study title: Helicobacter pylori Infection in Pediatrics |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39150 |
| Study title: No radiation protection reasons for restrictions on 14C urea breath tests in childrenSodium Vallproate in status epilepticus - S. JHA 2003 (Neurol. India - 2003 - 51:421-2) Publication in Epilim-Reports of clinical studies Vol II - E. TRINKA - 06/11/2006 |
| Active substance: UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39142 |
| Study title: A Multicentre, Randomised, Controlled Trail of Therapeutic Lung Lavage in Ventilated Infants with Meconium Aspiration SyndromeThe treatment of childhood epilepsy with sodium valproate. - Haigh D et al. - Develop Med Child Neurol 1975;17:743-8 |
| Active substance: URINARY CONCREMENT SOLVENTS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39151 |
| Study title: Borgmann et al.Cystine Stones in a Tree-Year Old Boy; Zeitschr-Kinderderchirurgie 1978; 25 |
| Active substance: URINARY CONCREMENT SOLVENTS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39155 |
| Study title: Breitwieser et al. Conservative treatment of uric acid sone diathesis; Med. Welt 1967, 8: 2130-2135 |
| Active substance: URINARY CONCREMENT SOLVENTS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39156 |
| Study title: Efficacy and tolerability of Benzoyl peroxide and detergent soap (Acne Aid) in the treatment of acne vulgaris (used together).The use of Epilim at doses of greater than 1400 mg/day - Reckitt & Colman - 01/1975 |
| Active substance: URINARY CONCREMENT SOLVENTS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39152 |
| Study title: Retrospective survey for documentation of appllication and dosage of Sulfur comp.-Heel (tablets) in children < 12 years of age [Bef-020] |
| Active substance: Sulfur comp.-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40246 |
| Study title: Dalery J., Maillet J., de Villard R. - Traitment de dix-sept adolescents psychotiques par le dogmatil - Se. Hôp. Paris, 1985, 61 (19) 1327-1330 |
| Active substance: SULPIRIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42903 |
| Study title: Ensaio com a associacao bromazepam sulpiride (RO 10 7122) no tratamento de disturbios de conduta e de personalidade em criancas e adolescentes - Sarmento De Barros D. - 28/07/1981 |
| Active substance: SULPIRIDE |
| Study summary document link (including results): SULPIRIDE Study 81-01171-PT.xls |
| View full study record |
| Document reference: 42901 |
| Study title: Ensayo terapeutico con sulpiride en ninos con trastomos digestivos |
| Active substance: SULPIRIDE |
| Study summary document link (including results): SULPIRIDE Study 81-01233-ES.xls |
| View full study record |
| Document reference: 47997 |
| Study title: Zur therapie von verhaltensgestorten kindern mit sulpirid - Hoppner L. - 15/07/1981 |
| Active substance: SULPIRIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42902 |
| Study title: A CLINICAL EVALUATION OF STM FINE GRANULES FOR SUPPURATIVE OTITIS MEDIA OF CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43007 |
| Study title: A COMPARATIVE PHARMACOKINETIC STUDY OF SULTAMICILLIN (CP-49,952) AND AMPICILLIN IN INFANTS AND YOUNG CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42915 |
| Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF ACUTE TONSILLITIS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42958 |
| Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF SUPPURATIVE OTITIS MEDIA |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42959 |
| Study title: A COMPARATIVE STUDY OF SULTAMICILLIN AND AUGMENTIN IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42911 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42938 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42939 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42940 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42941 |
| Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42942 |
| Study title: A DOUBLE BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF DERMAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42957 |
| Study title: A DOUBLE-BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42960 |
| Study title: A MULTICENTER NON-COMPARATIVE STUDY FOR THE TREATMENT OF MODERATE UPPER RESPIRATORY TRACT INFECTION IN ADULT PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43045 |
| Study title: A MULTICENTER NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF STM FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43044 |
| Study title: A MULTICENTER STUDY OF SULTAMICILLIN (CP-49,952) A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICLLIN COMPARED WITH FLUCLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42943 |
| Study title: Evaluation of itraconazole oral solution in infants with oral thrush: an open trial comparing three, five or seven days of treatment with ten days of nystatin treatment. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45128 |
| Study title: Evaluation of itraconazole solution in infants with oral thrush: a multicentre trial comparing four different treatment durations. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129326_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45127 |
| Study title: Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452)Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30794 |
| Study title: Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319)Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30814 |
| Study title: Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178)Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30806 |
| Study title: Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30799 |
| Study title: Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30801 |
| Study title: Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457)Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30782 |
| Study title: Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446)Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30788 |
| Study title: Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441)Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30776 |
| Study title: Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740)Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30780 |
| Study title: Open Study of the Effect of Modafinil on Urinary Disorders in Relation to “Stress” Incontinence. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45286 |
| Study title: Pharmacokinetics and effect of modafinil in children with ADHD.Labellarte MJ; 47th Meet Am Acad Child Adolesc Psychiatry 2000;116 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45658 |
| Study title: "Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy.C1538a/ 302/NA/US US Modafinil in Narcolepsy Multicenter Study Group. Neurology 2000, 54(5): 1166-75." |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45292 |
| Study title: Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Y Dauvilliers, et al., pharmacogenomics Journal 2002, 2(1): 65-8. Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Y Dauvilliers, et al., pharmacogenomics Journal 2002, 2(1): 65-8. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45662 |
| Study title: "Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. MM Mitler, et al., Electroencephalography and Clinical Neurophysiology 1998, 107(1): 33-8. "Sleep latency on the maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. MM Mitler, et al., Electroencephalography and Clinical Neurophysiology 1998, 107(1): 33-8. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45665 |
| Study title: Study of the Effect of Modafinil in Children Presenting Psycho-intellectual and Motor Retardation. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45287 |
| Study title: Study with Modafinil in Child Psychiatry. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45288 |
| Study title: "Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy. RB Sangal, et al., Clinical Neurophysiology - Official Journal of the International Federation of Clinical Neurophysiology 1999, 110(6): 1041-7. "Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy. RB Sangal, et al., Clinical Neurophysiology - Official Journal of the International Federation of Clinical Neurophysiology 1999, 110(6): 1041-7. |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45664 |
| Study title: Die Verträglichkeit von Purethal |
| Active substance: Modified, adsorbed grass pollen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40073 |
| Study title: A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999.A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone. Lebwohl, Mark MD; The mometasone furoate study group. International Journal of Dermatology. 38(8):604-606, August 1999. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32284 |
| Study title: Assessment of Longitudinal Leg Growth Using Knemometry in Asthmatic Children 6-12 Years of Age During Treatment with Mometasone Furoate (SCH 32088) Dry Powder Inhaler or Placebo |
| Active substance: MOMETAZONE |
| Study summary document link (including results): I96-349_mometasone furoate.pdf |
| View full study record |
| Document reference: 48182 |
| Study title: Tropicamide (1%): an effective cycloplegic agent for myopic children. Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. Tropicamide (1%): an effective cycloplegic agent for myopic children. Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K; COMET Study Group. Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1728-35. |
| Active substance: TROPICAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46870 |
| Study title: |
| Active substance: TROPISETRON |
| Study summary document link (including results): Navoban 3901.xls |
| View full study record |
| Document reference: 47312 |
| Study title: Gaedicke G, Erttmann R, Henze G, Hartmann W, Drechsler S, Grass P, Faerber L, Kutz K Pharmacokinetics of the 5HT3 receptor antagonist tropisetron in children. Pediatr Hematol Oncol. 1996 Sep-Oct;13(5):405-16. |
| Active substance: TROPISETRON |
| Study summary document link (including results): Navoban 301_302_303.xls |
| View full study record |
| Document reference: 46884 |
| Study title: Suarez A, Stettler ER, Rey E, Pons G, Simonetta-Chateauneuf C, de Bruijn KM, Olive G, Lemerle J. "Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy." Eur J Cancer. 1994;30A(10):1436-41 |
| Active substance: TROPISETRON |
| Study summary document link (including results): Navoban ICS3 512-E-00.xls |
| View full study record |
| Document reference: 47313 |
| Study title: Danilov VV, Danilova TI, Clinical-urodynamic assessment of the efficacy of administration of Spasmex to children with neurogenic bladder dysfunction. Medical University of the Vladivostok Administration, Vladivostok 2001 |
| Active substance: TROSPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46885 |
| Study title: Wastell-H-J, Bartlett-K, Dale-G, Shein-A. Department of Clinical Biochemistry, Newcastle General Hospital, Newcastle upon Tyne. Biotinidase deficiency: a survey of 10 cases. Archives of disease in childhood, {Arch-Dis-Child}, Oct 1988, vol. 63, no. 10, p. 1244-9, ISSN: 1468-2044.Wastell-H-J, Bartlett-K, Dale-G, Shein-A. Department of Clinical Biochemistry, Newcastle General Hospital, Newcastle upon Tyne. Biotinidase deficiency: a survey of 10 cases. Archives of disease in childhood, {Arch-Dis-Child}, Oct 1988, vol. 63, no. 10, p. 1244-9, ISSN: 1468-2044. |
| Active substance: BIOTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22567 |
| Study title: Spasmo-lyt - Clinical trial for nocturnal and diurnal enuresis |
| Active substance: TROSPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46887 |
| Study title: Therapie der kindlichen Harninkontinenz mit Trospiumchlorid; Urologe (B) 1998; 38: 531-534Therapie der kindlichen Harninkontinenz mit Trospiumchlorid; Urologe (B) 1998; 38: 531-534 |
| Active substance: TROSPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46888 |
| Study title: Assessment of tolerance and immunogenicity of a ViCPs vaccine at 2 dosages |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47480 |
| Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47483 |
| Study title: Effectiveness of a Vi capsular polysaccharide vaccine |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47481 |
| Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47479 |
| Study title: Safety and dose related immunogenicity of the Vi capsular polysaccharide of Salmonella typhi (Pilot study) |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47478 |
| Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
| Active substance: Typhoid Vi Polysaccharide Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47482 |
| Study title: Muz V.A., Zubkova S.T., Bolshova-Zubkovskaya E.V: Ubichinon compositum preparation applied to optimize the treatment of ketoacidosis in children suffering from diabetes mellitus type 1. Biological Therapy (Ukraine), 2003, 3: 27-30 [IIT-publication]; |
| Active substance: Ubichinon compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40294 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Ubichinon compositum Ampullen (ampoules) [AWB-AT] |
| Active substance: Ubichinon compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40295 |
| Study title: The effect of coenzyme Q10 in ideopathic dilated cardiomyopathy in children. |
| Active substance: UBIDECARENONE (CO-ENZYME Q10) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39140 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42927 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42928 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42929 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42930 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42931 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42932 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42933 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42934 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42935 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42936 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42937 |
| Study title: A MULTICENTER SULTAMICILLIN (CP-49,952-15) PHASE III STUDY. A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AUGMENTIN FOR THE ASSESSMENT OF EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42912 |
| Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43037 |
| Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42971 |
| Study title: A NON-COMPARATIVE SHORT-TERM, OPEN STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF VARIOUS INFECTIONS IN PEDIATRIC INPATIENTS/OUTPATIENTS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42989 |
| Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43042 |
| Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43043 |
| Study title: A NON-COMPARATIVE STUDY OF SULTAMICILLIN SUSPENSION IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42920 |
| Study title: Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676)Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30778 |
| Study title: Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450)Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30792 |
| Study title: Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766). |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30817 |
| Study title: Open-label, single-centre, active control (nystatin), four parallel group study. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD118956_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 47579 |
| Study title: Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424)Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30777 |
| Study title: Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772)Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30790 |
| Study title: Pharmacokinetic study of itraconazole oral solution during chronic treatment in neutropenic children. (ITR-FRA-7) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129355_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45126 |
| Study title: Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302)Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30807 |
| Study title: Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334)Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30800 |
| Study title: Repeated-dose pharmacokinetics of itraconazole in oral solution, 5 mg/kg once daily for two weeks, in infants and children.(ITR-INT-21) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD118873_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45125 |
| Study title: Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. Vernon HJ, Lane AT, Weston W. J Am Acad Dermatol. 1991 Apr; 24(4):603-7.Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis. Vernon HJ, Lane AT, Weston W. J Am Acad Dermatol. 1991 Apr; 24(4):603-7. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32282 |
| Study title: Efficacy and Safety of Nasonex vs. Placebo in Subjects with SAR and Concomitant Asthma |
| Active substance: MOMETAZONE |
| Study summary document link (including results): Nasonex_Mometasone furoate_P03280.pdf |
| View full study record |
| Document reference: 47645 |
| Study title: Mometasone furoate in the treatment of atopic dermatitis in children; Publication on Journal of the European Academy of dermatology & Dermatology 2(1993)225 Mometasone furoate in the treatment of atopic dermatitis in children; Publication on Journal of the European Academy of dermatology & Dermatology 2(1993)225 |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32281 |
| Study title: Mometasone furoate nasal spray vs placebo in subjects with allergic rhinitis and cough. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): P01970.pdf |
| View full study record |
| Document reference: 48186 |
| Study title: One-Year, Double-Blind Safety Study of the Effects of Mometasone Furoate (SCH 32088) Dry Powder Inhaler (MF DPI) vs. Placebo on Growth of Children With Asthma |
| Active substance: MOMETAZONE |
| Study summary document link (including results): C97-384_mometasone furoate.pdf |
| View full study record |
| Document reference: 48178 |
| Study title: One-Year, Open-Label Safety Study of Mometasone Furoate (SCH 32088) Dry Powder Inhaler (MF DPI) and Beclomethasone Dipropionate (Vanceril® 84 mcg Double Strength) in Children With Asthma Previously Maintained on Inhaled Corticosteroids |
| Active substance: MOMETAZONE |
| Study summary document link (including results): C97-385_mometasone furoate.pdf |
| View full study record |
| Document reference: 48180 |
| Study title: Onset of Action of Mometasone Furoate Nasal Spray vs. Placebo in Induced Allergic Rhinitis in an Allergen Exposure Unit (AEU) |
| Active substance: MOMETAZONE |
| Study summary document link (including results): Nasonex_Mometasone furoate_P03431.pdf |
| View full study record |
| Document reference: 47646 |
| Study title: Placebo-Controlled Efficacy and Safety Study of a Once-Daily, PM Regimen of Mometasone Furoate (SCH 32088) Dry Powder in Asthmatics Previously Maintained on Short-acting Inhaled Beta-agonists |
| Active substance: MOMETAZONE |
| Study summary document link (including results): C98-475_mometasone furoates.pdf |
| View full study record |
| Document reference: 48179 |
| Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Administered Via Dry Powder Inhaler in the Treatment of Asthma in Children Previously Maintained on Inhaled Corticosteroids |
| Active substance: MOMETAZONE |
| Study summary document link (including results): P01431_mometasone furoate.pdf |
| View full study record |
| Document reference: 48183 |
| Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Administered ViaDry Powder Inhaler in the Treatment of Asthma in Children Previously Maintained on Inhaled Corticosteroids |
| Active substance: MOMETAZONE |
| Study summary document link (including results): P02236_mometasone furoate.pdf |
| View full study record |
| Document reference: 48184 |
| Study title: Marsden CD, et al. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984 Nov; 47(11): 116-73.Marsden CD, et al. The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 1984 Nov; 47(11): 116-73. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46744 |
| Study title: Nardocci N, et al. Acquired hemidystonia in childhood: a clinical and neuroradiological study of thirteen patients. Pediatr Neurol. 1996 Sep;15(2):108-13.Nardocci N, et al. Acquired hemidystonia in childhood: a clinical and neuroradiological study of thirteen patients. Pediatr Neurol. 1996 Sep;15(2):108-13. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46739 |
| Study title: Reddihough D, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol 1990 Nov; 32(11): 985- 9.Reddihough D, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol 1990 Nov; 32(11): 985- 9. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46741 |
| Study title: Rockland L, et al. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. Can J Psychiatry 1990 Oct; 35(7): 604-7. Erratum Can J Psychiatry 1991 Feb;36(1):73Rockland L, et al. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics. Can J Psychiatry 1990 Oct; 35(7): 604-7. Erratum Can J Psychiatry 1991 Feb;36(1):73 |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46742 |
| Study title: Saletu B, et al. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys. Biol Psychiatry 1974 Apr; 8(2): 177-89.Saletu B, et al. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys. Biol Psychiatry 1974 Apr; 8(2): 177-89. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46746 |
| Study title: Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and DaSilva, J. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys Biol.Psychiatry 1974;8:177-189. Marsden CD The treatment of severe dystonia in children and adults. J.Neurol.Neurosurg.Psych. 1984;47:1166-1173.Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and DaSilva, J. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys Biol.Psychiatry 1974;8:177-189. Marsden CD The treatment of severe dystonia in children and adults. J.Neurol.Neurosurg.Psych. 1984;47:1166-1173. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46735 |
| Study title: Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007 May; 22(5): 530-7.Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. J Child Neurol 2007 May; 22(5): 530-7. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46736 |
| Study title: Vogels OJ, et al. Focal dystonia and speech impairment responding to anticholinergic therapy. Pediatric Neurol 1994; 11(4): 346-8.Vogels OJ, et al. Focal dystonia and speech impairment responding to anticholinergic therapy. Pediatric Neurol 1994; 11(4): 346-8. |
| Active substance: TRIHEXYPHENIDYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46740 |
| Study title: 1989 1980 BOIGE N.,CARGILL G.,MASHAKO L.,CEZARD J.P.,NAVARRO J. TRIMEBUTINE INDUCED PHASE III LIKE ACTIVITY IN INFANTS WITH INTESTINAL MOTILITY DISORDERS J.PEDIATR.GASTROENTEROL.NUTR.,6,548-553,19871989 1980 BOIGE N.,CARGILL G.,MASHAKO L.,CEZARD J.P.,NAVARRO J. TRIMEBUTINE INDUCED PHASE III LIKE ACTIVITY IN INFANTS WITH INTESTINAL MOTILITY DISORDERS J.PEDIATR.GASTROENTEROL.NUTR.,6,548-553,1987 |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46759 |
| Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH MODERATE RESPIRATORY TRACT OR SKIN/SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43020 |
| Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43038 |
| Study title: A PROSPECTIVE, RANDOMIZED, THIRD-PARTY BLINDED, PLACEBO CONTROLLED EVALUATION OF AMPICILLIN/SULBACTAM VERSUS CLINDAMYCIN AS ADJUNCTIVE TREATMENT FOR WOMEN EXPERIENCING PRETERM LABOR |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42944 |
| Study title: A RANDOMIZED, OPEN LABEL, MULTICENTER TRIAL COMPARING ORAL SULTAMICILLIN 750 MG DAILY FOR 10 DAYS WITH AMOXICILLIN/CLAVULANIC 1500 MG DAILY FOR 10 DAYS FOR THE TREATMENT OF ACUTE EAR, NOSE AND THROAT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42919 |
| Study title: A STUDY OF THE PENETRATION CHARACTERISTICS OF SULTAMICILLIN (CP-49,952) INTO THE MIDDLE EAR FLUID OF PEDIATRIC PATIENTS WITH CHRONIC SERIOUS OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42910 |
| Study title: A THIRD PARTED BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY INFECTIONS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42926 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMACILLIN (CP-49,952-15) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42925 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AMOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43063 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CECLOR FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43064 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CLOXACILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42923 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND CLOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42924 |
| Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS IN PEDIATRIC PATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42917 |
| Study title: AN OPEN COMPARATIVE MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF STM VS. CEFACLOR IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42997 |
| Study title: AN OPEN COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL (STM 25-50MK)VS. ORAL AMOXYCILLIN (25-40 MK) IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43004 |
| Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF SULTAMICILLIN VS DOUBLE STRENGTH OF TRIMETHOPRIM-SULF. TABLETS FOR UNCOMPLICATED LOWER URINARY TRACT INFECTIONS IN WOMEN. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43019 |
| Study title: AN OPEN MULTICENTER NON-COMPARATIVE SHORT TERM STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF UPPER AND LOWER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC INPATIENTS/ OUTPATIENTS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42990 |
| Study title: AN OPEN NON COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42975 |
| Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY ON THE EFFICACY AND TOLERABILITY OF SULTAMICILLIN (SULBACTAM/AMPICILLIN) IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42964 |
| Study title: Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549)Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30796 |
| Study title: Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894)Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30804 |
| Study title: Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269)Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30805 |
| Study title: Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817)Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30813 |
| Study title: Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873)Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30809 |
| Study title: Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681)Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30808 |
| Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27705 |
| Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27493 |
| Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27857 |
| Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27503 |
| Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27867 |
| Study title: THREE OPEN COMPARATIVE STUDIES OF THE EFFICAY AND SAFETY OF FLUCONAZOLE AND KETOCONAZOLE, ITRACONAZOLE OR CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH PITYRIASIS VERSICOLOR |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27578 |
| Study title: TO ASSESS THE EFFICACY AND SAFETY OF FLUCONAZOLE I.V. (+ AMPHOTERICIN B BY ORAL ROUTE) VS. PLACEBO I.V. (+AMPHOTERICIN B BY ORAL ROUTE) TO PREVENT THE ONSET OF INFECTIONS WITH A MYCOTIC ETIOLOGY IN MULTICOLONIZED NEUTROPENIC PATIENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27461 |
| Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Dry Powder Inhaler (MF DPI) in the Treatment of Asthma in Children Previously Maintained on Beclomethasone Dipropionate (Vanceril® 84 mcg Double Strength) |
| Active substance: MOMETAZONE |
| Study summary document link (including results): C97-380_mometasone furoate.pdf |
| View full study record |
| Document reference: 48177 |
| Study title: Placebo-Controlled Efficacy and Safety Study of Mometasone Furoate Dry Powder Inhaler (MF DPI) in the Treatment of Asthma in Children Previously Maintained on Inhaled Corticosteroids |
| Active substance: MOMETAZONE |
| Study summary document link (including results): CI97-300_mometasone furoate.pdf |
| View full study record |
| Document reference: 48181 |
| Study title: Primotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. Pileggi Fde O, Vicente YA. J Pediatr Surg. 2007 Oct; 42(10):1749-52.Primotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. Pileggi Fde O, Vicente YA. J Pediatr Surg. 2007 Oct; 42(10):1749-52. |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32283 |
| Study title: A Multicenter, Double-Blind, Crossover Study Comparing the Clinical Effect of Combination MK-0476/Loratadine to MK-0476 in Patients With Chronic Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 0476_various_synopses.pdf |
| View full study record |
| Document reference: 47561 |
| Study title: A multicenter, double-blind, randomized, crossover study comparing montelukast sodium to placebo in 6- to 14-year-old patients with chronic asthma currently using inhaled corticosteroids (ICS) |
| Active substance: MONTELUKAST |
| Study summary document link (including results): 906 synopsis.pdf |
| View full study record |
| Document reference: 32406 |
| Study title: A Multicenter, Double-Blind, Randomized, Crossover Study Investigating the Clinical Effect of Montelukast in Patients With Concomitant Asthma and Allergic Rhinitis Upon Controlled Exposure to Cat Allergen |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32407 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing Montelukast With Placebo in Pediatrics Patients Aged 6 to 24 Months With Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32409 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing the Effect on Linear Growth of Montelukast with Placebo and Inhaled Beclomethasone in Pediatric Patients (Prepubertal, Tanner Stage I) With Mild Asthma |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32410 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Combination Montelukast/Loratadine in Patients With Seasonal Allergic Rhinitis (Fall Study) |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32411 |
| Study title: a Multicenter, Double-blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis - Fall Study |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32412 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Spring 2001 Study " |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32413 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32414 |
| Study title: EFFICACY AND SAFETY OF LACTEOL SACHET IN THE TREATMENT OF ACUTE DIARRHEA IN CHILDREN |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30975 |
| Study title: A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Seasonal Allergic Rhinitis Over a 4-Week Treatment Period-Fall 2001 |
| Active substance: MONTELUKAST |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32415 |
| Study title: 1999 - 1990 SPIROGLOU-K, PAROUTOGLOU-G. SPIROGLOU DYSPEPSIA IN CHILDREN - A REAL PROBLEM OF CHILDHOOD. HELLENIC JOURNAL OF GASTROENTEROLOGY {HELL-J-GASTROENTEROL}, 1999, VOL/ISS/PG. 12/2 (87-95)1999 - 1990 SPIROGLOU-K, PAROUTOGLOU-G. SPIROGLOU DYSPEPSIA IN CHILDREN - A REAL PROBLEM OF CHILDHOOD. HELLENIC JOURNAL OF GASTROENTEROLOGY {HELL-J-GASTROENTEROL}, 1999, VOL/ISS/PG. 12/2 (87-95) |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46752 |
| Study title: ante 1980 TOURSEL F.,FONTAINE G. ETUDE DE LA TRIMEBUTINE EN PEDIATRIE PEDIAT. L'OMNIPATRICIEN,N.8,1972ante 1980 TOURSEL F.,FONTAINE G. ETUDE DE LA TRIMEBUTINE EN PEDIATRIE PEDIAT. L'OMNIPATRICIEN,N.8,1972 |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46765 |
| Study title: ARMENGAUD.,LAGARDERE B. LE REFLUX GASTRO-OESOPHAGIEN DE L'ENFANT REV.PRAT.,34(29),1557-1565,1984ARMENGAUD.,LAGARDERE B. LE REFLUX GASTRO-OESOPHAGIEN DE L'ENFANT REV.PRAT.,34(29),1557-1565,1984 |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46761 |
| Study title: Boige-N, Cargill-G, Mashako-L, Cezard-J-P, Navarro-J. Hop Bretonneau, Serv Gastroenterol Pediat, F-75018 Paris, France. Trimebutine Induces Migrating Motor Complexes In Infants. Pediatric-Research, 1986, V20, N7, P692-692.Boige-N, Cargill-G, Mashako-L, Cezard-J-P, Navarro-J. Hop Bretonneau, Serv Gastroenterol Pediat, F-75018 Paris, France. Trimebutine Induces Migrating Motor Complexes In Infants. Pediatric-Research, 1986, V20, N7, P692-692. |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46760 |
| Study title: CHARRITAT J.L. MOTRICITE DIGESTIVE EN PEDIATRIE;UNE REALITE QUOTIDIENNE JAMA ED. FRANCAISE,238(SUPPL.),1992 MASHAKO M.N.L.,SONSINO E.,NAVARRO J.,MOUGENOT J.F.,GARGOURI A.,BOIGE N.,CEZ ARD J.P. MICROSCOPIC COLITIS: A NEW CAUSE OF CHRONIC DIARRHEA IN CHILDREN? J.PEDIAT.GASTROENTEROL.NUTR., 10(1),21-26,1990CHARRITAT J.L. MOTRICITE DIGESTIVE EN PEDIATRIE;UNE REALITE QUOTIDIENNE JAMA ED. FRANCAISE,238(SUPPL.),1992 MASHAKO M.N.L.,SONSINO E.,NAVARRO J.,MOUGENOT J.F.,GARGOURI A.,BOIGE N.,CEZ ARD J.P. MICROSCOPIC COLITIS: A NEW CAUSE OF CHRONIC DIARRHEA IN CHILDREN? J.PEDIAT.GASTROENTEROL.NUTR., 10(1),21-26,1990 |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46758 |
| Study title: CHOURAQUI J.P. COLIQUES DU NOURRISSON;ELLES CONSERNENT PRES DE 10 A 20% DES BEBES DE MOINS DE 4 MOIS REV.PRATIC.MED.GENERALE,8(321),27-33,1995CHOURAQUI J.P. COLIQUES DU NOURRISSON;ELLES CONSERNENT PRES DE 10 A 20% DES BEBES DE MOINS DE 4 MOIS REV.PRATIC.MED.GENERALE,8(321),27-33,1995 |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46756 |
| Study title: Czerwionka-Szaflarska-M, Sadowska-Krawczenko-I, Korbal-P. M. Czerwionka-Szaflarska, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Akademia Medyczna im. L. Rydygiera, Bydgoszcz, Poland. Gastroesophageal reflux in preterm infants. Pediatria Polska {PEDIATR-POL}, 2005, Vol/Iss/Pg. 80/9 (719-726),Czerwionka-Szaflarska-M, Sadowska-Krawczenko-I, Korbal-P. M. Czerwionka-Szaflarska, Katedra i Klinika Pediatrii, Alergologii i Gastroenterologii, Akademia Medyczna im. L. Rydygiera, Bydgoszcz, Poland. Gastroesophageal reflux in preterm infants. Pediatria Polska {PEDIATR-POL}, 2005, Vol/Iss/Pg. 80/9 (719-726), |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46748 |
| Study title: DELVAUX-M, WINGATE-D. GASTROENTEROLOGY UNIT, CHU RANGUEIL, TOULOUSE, FRANCE. TRIMEBUTINE: MECHANISM OF ACTION, EFFECTS ON GASTROINTESTINAL FUNCTION AND CLINICAL RESULTS. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH {J-INT-MED-RES} 1997 SEP- OCT, VOL: 25 (5), P: 225-46.DELVAUX-M, WINGATE-D. GASTROENTEROLOGY UNIT, CHU RANGUEIL, TOULOUSE, FRANCE. TRIMEBUTINE: MECHANISM OF ACTION, EFFECTS ON GASTROINTESTINAL FUNCTION AND CLINICAL RESULTS. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH {J-INT-MED-RES} 1997 SEP- OCT, VOL: 25 (5), P: 225-46. |
| Active substance: TRIMEBUTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46754 |
| Study title: Fluoxetine In The Treatment Of Premenstrual Dysphoric Disorder (Pmdd) In Adolescents : An Open-Label Pilot Study |
| Active substance: FLUOXETINE |
| Study summary document link (including results): Fluoxetine - B1Y-MC-HCLF Synopsis.pdf |
| View full study record |
| Document reference: 28329 |
| Study title: Fluoxetine Major Depressive Disorder |
| Active substance: FLUOXETINE |
| Study summary document link (including results): Fluoxetine - B1Y-IT-M002 Summary.pdf |
| View full study record |
| Document reference: 28340 |
| Study title: Fluoxetine V Mianserin D.B. Depressed Patients |
| Active substance: FLUOXETINE |
| Study summary document link (including results): Fluoxetine - B1Y-IT-M003 Summary.pdf |
| View full study record |
| Document reference: 28341 |
| Study title: "Fluoxetine Versus Placebo in Adolescent Depressed Patients " |
| Active substance: FLUOXETINE |
| Study summary document link (including results): fluoxetine B1Y-MC-HCCJ Clinical Study Summary.pdf |
| View full study record |
| Document reference: 28334 |
| Study title: Fluoxetine Versus Placebo in Childhood/Adolescent Depression |
| Active substance: FLUOXETINE |
| Study summary document link (including results): fluoxetine B1Y-MC-HCJE Clinical Study Summary.pdf |
| View full study record |
| Document reference: 47358 |
| Study title: Fluoxetine Versus Placebo In Social Phobia |
| Active substance: FLUOXETINE |
| Study summary document link (including results): Fluoxetine - B1Y-MC-HCHP Synopsis.pdf |
| View full study record |
| Document reference: 28327 |
| Study title: A double-blind, single oral dose study comparing the anti-pyretic properties of Ibuprofen, acetaminophen and placebo in the treatment of pyrexia associated with infectious disease in children and Pharmacodynamics of fever treatment with Ibuprofen |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29426 |
| Study title: A double-blind, single oral dose study comparing the anti-pyretic property of Ibuprofen, Acetaminophen, and placebo in the treatment of pyrexia associated with infectious disease in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29400 |
| Study title: Tan-C, Jereb-B, Exelby-P, et-al. Mem. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Experiences in the changing management of 143 children with Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-711).Tan-C, Jereb-B, Exelby-P, et-al. Mem. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Experiences in the changing management of 143 children with Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-711). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34855 |
| Study title: Tekinalp-G, Arat-O, Acar-S, et-al. Div. Ped., Sch. Med., Hacettepe Univ., Ankara, Turkey. Combination chemotherapy in Hodgkin's lymphoma: results in 63 adult and pediatric patients. Kanser {KANSER}, 1977, Vol/Iss/Pg. 7/1 (12-22).Tekinalp-G, Arat-O, Acar-S, et-al. Div. Ped., Sch. Med., Hacettepe Univ., Ankara, Turkey. Combination chemotherapy in Hodgkin's lymphoma: results in 63 adult and pediatric patients. Kanser {KANSER}, 1977, Vol/Iss/Pg. 7/1 (12-22). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34857 |
| Study title: Thomas-L, Andes-W-A. Dep. Med., Tulane Univ. Sch. Med., New Orleans, LA, United States. Fetal anomaly associated with successful chemotherapy for Hodgkin's disease during the first trimester of pregnancy. Clinical Research {CLIN-RES}, 1982, Vol/Iss/Pg. 30/2 (424A).Thomas-L, Andes-W-A. Dep. Med., Tulane Univ. Sch. Med., New Orleans, LA, United States. Fetal anomaly associated with successful chemotherapy for Hodgkin's disease during the first trimester of pregnancy. Clinical Research {CLIN-RES}, 1982, Vol/Iss/Pg. 30/2 (424A). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34858 |
| Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29550 |
| Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1996. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29551 |
| Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. Aug 1996. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29628 |
| Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29630 |
| Study title: A study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29504 |
| Study title: A study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgery. CSR 201. Protocol 89-925, Unpublished Report 360. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 89-925.pdf |
| View full study record |
| Document reference: 47450 |
| Study title: A study of the effects of Ibuprofen on post-operative pain in children undergoing adenotonsillectomy when given preoperative |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29416 |
| Study title: A study to compare the efficacy and tolerance of Ibuprofen syrup vs Propyphenazone in the treatment of feverish children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29415 |
| Study title: A Twelve-week, Multicenter, Double-Blind, Parallel-Group Study Comparing the Action of Ibuprofen Suspension and Aspirin in the Treatment of Active Juvenile Rheumatoid Arthritis (JRA) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI301.pdf |
| View full study record |
| Document reference: 47543 |
| Study title: Advil Liqui-Gel Migraine Headache Study I |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29521 |
| Study title: Advil Liquigel Dental Pain Study I |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29522 |
| Study title: Advil liquigel Dental pain study II |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29537 |
| Study title: Advil Liquigel Dental Pain Study III |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29524 |
| Study title: Advil Liquigel Headache Study II |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29523 |
| Study title: Advil liquigel maximum use safety and tolerance study |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29532 |
| Study title: An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993.An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33433 |
| Study title: An open label actual use study of the safety of childrens advil ibuprofen suspension (10mg/kg) in children with various sources of discomfort requiring the use of an analgesic. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29468 |
| Study title: An Open Label, Multicentre, Twenty-Four-Week, Dose-Ranging Study to Evaluate the Efficacy and Relative Long-Term Safety and Tolerability of Ibuprofen Suspension in the Treatment of ActiveJuvenile Rheumatoid Arthritis, as Compared with a Historical Control |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29402 |
| Study title: Med Sci (Paris). 2005 Nov;21(11):981-6. [Radiological innovations in the screening and diagnosis of the inborn errors of metabolism] [Article in French] Boddaert N, Ribeiro M, Touati G, Mention K, Valayanopoulos V, Nihoul-F, Brunelle F, de Lonlay P. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28093 |
| Study title: Ment Retard Dev Disabil Res Rev. 2000;6(3):220-6. Structural and functional imaging in children with partial epilepsy. Gaillard WD. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28174 |
| Study title: Neuro Endocrinol Lett. 2006 Oct;27(5):587-94. Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study. Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M, Palenicek T, HÃschl C. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28070 |
| Study title: Neuroimage. 2000 Aug;12(2):129-38. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Van Bogaert P, Massager N, Tugendhaft P, Wikler D, Damhaut P, Levivier M, Brotchi J, Goldman S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28176 |
| Study title: Neuroimaging Clin N Am. 2003 Nov;13(4):705-16, viii. Imaging the epileptic brain with positron emission tomography. Juhász C, Chugani HT. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28130 |
| Study title: Neurology. 1994 Dec;44(12):2331-6. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Manno EM, Sperling MR, Ding X, Jaggi J, Alavi A, O'Connor MJ, Reivich M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28203 |
| Study title: Green JS, Morgan B, Lauder I, Finlay DB, Allen M, Belton I. The correlation of bone scintigraphy and histological findings in patellar tendinitis. Nucl Med Commun. 1996 Mar;17(3):231-4. Green JS, Morgan B, Lauder I, Finlay DB, Allen M, Belton I. The correlation of bone scintigraphy and histological findings in patellar tendinitis. Nucl Med Commun. 1996 Mar;17(3):231-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43569 |
| Study title: Neurology. 2001 Nov 13;57(9):1629-36. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Fedi M, Reutens D, Okazawa H, Andermann F, Boling W, Dubeau F, White C, Nakai A, Gross DW, Andermann E, Diksic M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28165 |
| Study title: Gregg PJ, Barsoum MK, Clayton CB. Scintigraphic appearance of the tibia in the early stages following fracture. Clin Orthop Relat Res. 1983 May;(175):139-46. Gregg PJ, Barsoum MK, Clayton CB. Scintigraphic appearance of the tibia in the early stages following fracture. Clin Orthop Relat Res. 1983 May;(175):139-46. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44039 |
| Study title: Nuclear medicine studies of aging--IV. Femoral proximal to distal radionuclide uptake gradient. Grimmond AP, Hosain F, Spencer RP. Int J Rad Appl Instrum B. 1988;15(5):529-30. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43833 |
| Study title: Groot RH, van Merkesteyn JP, Bras J. Diffuse sclerosing osteomyelitis and florid osseous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Mar;81(3):333-42. Groot RH, van Merkesteyn JP, Bras J. Diffuse sclerosing osteomyelitis and florid osseous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Mar;81(3):333-42. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43570 |
| Study title: Groshar D, Alperson M, Liberson A. Bone scintigraphy in recurrent osteoid osteoma of the Talus. Clin Nucl Med. 1996 Oct;21(10):817-8. No abstract available. Groshar D, Alperson M, Liberson A. Bone scintigraphy in recurrent osteoid osteoma of the Talus. Clin Nucl Med. 1996 Oct;21(10):817-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43560 |
| Study title: D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24838 |
| Study title: D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60 D'Angio GJ et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349-60 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24839 |
| Study title: Davidoff AM et al, Endodermal sinus tumor in children, J Pediatr Surg. 1996 Aug;31(8):1075-8; discussion 1078-9, Davidoff AM et al, Endodermal sinus tumor in children, J Pediatr Surg. 1996 Aug;31(8):1075-8; discussion 1078-9, |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24840 |
| Study title: Acute oral toxicity of compound HOE 296 for neonatal rats - F.R Springman et al. - 6/02/1976 (Hoescht AG) - Publication in Part III - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24123 |
| Study title: Avaliacao clinica de um novo antimicotico, piridonico topico, HOE 296, em dermatofitoses - Clinical evaluation of a new topical pyridonium antimycotic, HOE 296, in dermatophytoses -L.N. Ermetice et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author-11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24134 |
| Study title: Behandlung bakteriell superinfizierter hautpilzerkrankungen - K. Jablonski - 1987 (Kassenartz vol 27) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24135 |
| Study title: Behandlung von schimmelpliz-mykosen mit iclopiroxolamin - B. Deichmann - 1986 (Schwerpunktmedizin vol 9) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24136 |
| Study title: Bericht über eine doppleblind-studie mit HOE 296 -creme - und canesten- creme (clotrimazol) - W. Adam et al. - 03/03/1978 - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24124 |
| Study title: Breite Praxis-Prufung (Phase III) mit HOE 296 (Ciclopirox -olamin) - H.G.Peil - No date - Publication in Part IV volume 3 - Batafren creme, Batafren Vaginalcreme, Batafren Duo klinische prufung - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24137 |
| Study title: Childhood white superficial onychomycosis caused by Trichophyton rubrum: Repor tof seven cases and review of the literature, Tanusin Ploysangam, Anne W. Lucky, J Am Acad Dermatol, 1997;36:29 32 |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24138 |
| Study title: Ciclopiroxolamin bei der Behandlundg von dermatomykosenbei kindern - E. Briscik et al. - 1988 (Min Ped vol 40) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24139 |
| Study title: Clinical results with the Antimycotic agent ciclopirox olamine - W. Adam et al. - No date - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24140 |
| Study title: Clinical study of HOE 296 Solution in Trichophytia Superficialis- Espesially on systemic Influence after application - S. Yoshida - 1975 (Clinical Medecine vol 17) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS- No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24125 |
| Study title: Clinical trial with ciclopirox vaginal cream in vulvovaginal candidiasis - José Leal de Queiroz et al . - september 1990 - Publication in Part clinical documentation - Batrafen Losung Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24141 |
| Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) - Humberto Bogaert et al. - No date - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24142 |
| Study title: Consideracoes terapeuticas sobre o uso de um novo antimicotico piridonico, o HOE 296, no tratamento topico de dermatofitoses - Therapeutical considerations about the use of a new piridonic antimycotic, HOE 296, in the topical treatment of dermatophytoses - Jarbas Porto et al. - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical Documentation Batrafen Losung- No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24145 |
| Study title: Dopplelblind - Vergleichsstuddie mit Ciclopiroxolamin-und Plazebo -Creme bei dermatophytosen - T Fredriksson et al.- 1981 (Arzneim. Forsch/ Drug Res ) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24146 |
| Study title: Thompson-E, Smith-K-L, Wilimas-J, Kumar-M. St Jude Child. Res. Hosp., Memphis, Tenn. 38101, United States. Radiation, chemotherapy, or both in childhood and adolescent Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM- ASSOC-CANCER-RES}, 1977, Vol/Iss/Pg. Vol.18/- (No.881).Thompson-E, Smith-K-L, Wilimas-J, Kumar-M. St Jude Child. Res. Hosp., Memphis, Tenn. 38101, United States. Radiation, chemotherapy, or both in childhood and adolescent Hodgkin's disease (HD). Proceedings of the American Association for Cancer Research {PROC-AM- ASSOC-CANCER-RES}, 1977, Vol/Iss/Pg. Vol.18/- (No.881). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34859 |
| Study title: Tucker-M-A, Meadows-A-T, Boice-Jr-J-D, et-al. Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, Bethesda, MD 20892, United States. Leukemia after therapy with alkylating agents for childhood cancer. Journal of the National Cancer Institute {J-NATL-CANCER-INST}, 1987, Vol/Iss/Pg. 78/3 (459-464).Tucker-M-A, Meadows-A-T, Boice-Jr-J-D, et-al. Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, Bethesda, MD 20892, United States. Leukemia after therapy with alkylating agents for ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34860 |
| Study title: Urban-Ch, Hackl-A, Kurz-R, et-al. Univ. Kinderklin., 8036 Graz, Austria. Hodgkin's disease. Problems in childhood. Onkologie {ONKOLOGIE}, 1981, Vol/Iss/Pg. 4/6 (331-341).Urban-Ch, Hackl-A, Kurz-R, et-al. Univ. Kinderklin., 8036 Graz, Austria. Hodgkin's disease. Problems in childhood. Onkologie {ONKOLOGIE}, 1981, Vol/Iss/Pg. 4/6 (331-341). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34861 |
| Study title: Neumann Y. Zur Prophylaxe bleibender Hirnschäden bei Risikoneugeborenen (Sozialpädiatrie 1980; 2: 52-56); Neumann Y. Zur Prophylaxe bleibender Hirnschäden bei Risikoneugeborenen (Sozialpädiatrie 1980; 2: 52-56); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35148 |
| Study title: Non-interventional study on the use of Proparakain-POS® in childrenNon-interventional study on the use of Proparakain-POS® in children |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35158 |
| Study title: Open-label quetiapine in the treatment of children and adolescents with autistic disorder J Child Adolesc Psychopharmacol. 1999;9(2):99-107Open-label quetiapine in the treatment of children and adolescents with autistic disorder J Child Adolesc Psychopharmacol. 1999;9(2):99-107 |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35164 |
| Study title: Petova J. Pyrithioxine in the prevention of late consequences of intrauterine and postnatal hypoxia and malnutrition in new-born babie (Med Welt 1965; 43: 2438-2444); Petova J. Pyrithioxine in the prevention of late consequences of intrauterine and postnatal hypoxia and malnutrition in new-born babie (Med Welt 1965; 43: 2438-2444); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35147 |
| Study title: Radmayr E. Zur Therapie der Entwicklungsretardierung mit Encephabol (Actic nerv sup 1978; 20: 85-8); Radmayr E. Zur Therapie der Entwicklungsretardierung mit Encephabol (Actic nerv sup 1978; 20: 85-8); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35146 |
| Study title: Rossignol Klinische und psychologische Langzeitprüfung der Wirkung von Encephabol (LC 9088) bei retardierten Kindern (Immex 1971; 1347-1359); Rossignol Klinische und psychologische Langzeitprüfung der Wirkung von Encephabol (LC 9088) bei retardierten Kindern (Immex 1971; 1347-1359); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35155 |
| Study title: An Open Multicenter Study in Pakistan to Investigate the Effects of Ibuprofen Syrup in Juvenile Pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS85 592.pdf |
| View full study record |
| Document reference: 47556 |
| Study title: Bush FM, Harrington WG, Harkins SW. Interexaminer comparison of bone scintigraphy and panoramic radiography of temporomandibular joints: correlation with signs and symptoms. J Prosthet Dent. 1992 Feb;67(2):246-51. Bush FM, Harrington WG, Harkins SW. Interexaminer comparison of bone scintigraphy and panoramic radiography of temporomandibular joints: correlation with signs and symptoms. J Prosthet Dent. 1992 Feb;67(2):246-51. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43710 |
| Study title: Bushnell D, Shirazi P, Khedkar N, Blank J. Ewing's sarcoma seen as a "cold" lesion on bone scans. Clin Nucl Med. 1983 Apr;8(4):173-4. No abstract available. Bushnell D, Shirazi P, Khedkar N, Blank J. Ewing's sarcoma seen as a "cold" lesion on bone scans. Clin Nucl Med. 1983 Apr;8(4):173-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44040 |
| Study title: Butler-Manuel PA, Justins D, Heatley FW. Sympathetically mediated anterior knee pain. Scintigraphy and anesthetic blockade in 19 patients. Acta Orthop Scand. 1992 Feb;63(1):90-3. Butler-Manuel PA, Justins D, Heatley FW. Sympathetically mediated anterior knee pain. Scintigraphy and anesthetic blockade in 19 patients. Acta Orthop Scand. 1992 Feb;63(1):90-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43705 |
| Study title: Bylander B, Hansson LI, Kärrholm J, Naversten Y. Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP. Acta Radiol Diagn (Stockh). 1983;24(1):85-96. Bylander B, Hansson LI, Kärrholm J, Naversten Y. Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP. Acta Radiol Diagn (Stockh). 1983;24(1):85-96. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44058 |
| Study title: Caglar M, Ceylan E, Ozyar E. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? Nucl Med Commun. 2003 Dec;24(12):1231-6. Caglar M, Ceylan E, Ozyar E. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up? Nucl Med Commun. 2003 Dec;24(12):1231-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43409 |
| Study title: Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994 Nov;21(11):1198-205. Caluser CI, Abdel-Dayem HM, Macapinlac HA, Scott A, Healey JH, Huvos A, Kalaigian H, Yeh SD, Larson SM. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994 Nov;21(11):1198-205. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43610 |
| Study title: Caniggia A, Vattimo A. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif Tissue Int. 1980;30(1):5-13. No abstract available. Caniggia A, Vattimo A. Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism. Calcif Tissue Int. 1980;30(1):5-13. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44144 |
| Study title: Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkörner E, Schulthess G. Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol. 2002 Aug;21(4):324-7. Caravatti M, Wiesli P, Uebelhart D, Germann D, Welzl-Hinterkörner E, Schulthess G. Coincidence of Behçet's disease and SAPHO syndrome. Clin Rheumatol. 2002 Aug;21(4):324-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43442 |
| Study title: Groshar D, Alperson M, Mendes DG, Barsky V, Liberson A. Bone scintigraphy findings in Lisfranc joint injury. Foot Ankle Int. 1995 Nov;16(11):710-1. Groshar D, Alperson M, Mendes DG, Barsky V, Liberson A. Bone scintigraphy findings in Lisfranc joint injury. Foot Ankle Int. 1995 Nov;16(11):710-1. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43577 |
| Study title: Groshar D, Rozenbaum M, Rosner I. Enthesopathies, inflammatory spondyloarthropathies and bone scintigraphy. J Nucl Med. 1997 Dec;38(12):2003-5. No abstract available. Groshar D, Rozenbaum M, Rosner I. Enthesopathies, inflammatory spondyloarthropathies and bone scintigraphy. J Nucl Med. 1997 Dec;38(12):2003-5. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43539 |
| Study title: Groves AM, Cheow H, Balan K, Courtney H, Bearcroft P, Dixon A. 16-MDCT in the detection of occult wrist fractures: a comparison with skeletal scintigraphy. AJR Am J Roentgenol. 2005 May;184(5):1470-4. Groves AM, Cheow H, Balan K, Courtney H, Bearcroft P, Dixon A. 16-MDCT in the detection of occult wrist fractures: a comparison with skeletal scintigraphy. AJR Am J Roentgenol. 2005 May;184(5):1470-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43388 |
| Study title: Groves AM, Cheow HK, Balan KK, Housden BA, Bearcroft PW, Dixon AK. 16-Detector multislice CT in the detection of stress fractures: a comparison with skeletal scintigraphy. Clin Radiol. 2005 Oct;60(10):1100-5. Groves AM, Cheow HK, Balan KK, Housden BA, Bearcroft PW, Dixon AK. 16-Detector multislice CT in the detection of stress fractures: a comparison with skeletal scintigraphy. Clin Radiol. 2005 Oct;60(10):1100-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43384 |
| Study title: Gruen GS, Mears DC, Tauxe WN. Distinguishing avascular necrosis from segmental impaction of the femoral head following an acetabular fracture: preliminary report. J Orthop Trauma. 1988;2(1):5-9. Gruen GS, Mears DC, Tauxe WN. Distinguishing avascular necrosis from segmental impaction of the femoral head following an acetabular fracture: preliminary report. J Orthop Trauma. 1988;2(1):5-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43829 |
| Study title: Moral DA, Piulachs CJ, Targarona Soler EM, Combalia AA, Ramon SR, Trias FM. Treatment of desmoid tumor. Medicina Clinica 1994; 102(7):250-253.Moral DA, Piulachs CJ, Targarona Soler EM, Combalia AA, Ramon SR, Trias FM. Treatment of desmoid tumor. Medicina Clinica 1994; 102(7):250-253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43157 |
| Study title: Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. Multimodal treatment of children with unresectable or recurrent desmoid tumors: An 11-year longitudinal observational study. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43266 |
| Study title: Noga CM, Brainard JA, Goldblum JR. Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. American Journal of Clinical Pathology 1999; 112(4):545.Noga CM, Brainard JA, Goldblum JR. Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. American Journal of Clinical Pathology 1999; 112(4):545. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43149 |
| Study title: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harrison SA, Neuschwander Tetri BA. Clinics In Liver Disease 2004;8(4):861-879 2004;(4):861-879.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Harrison SA, Neuschwander Tetri BA. Clinics In Liver Disease 2004;8(4):861-879 2004;(4):861-879. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43264 |
| Study title: Noncytotoxic Drug Therapy in Children with Unresectable Desmoid Tumors. Noncytotoxic Drug Therapy in Children with Unresectable Desmoid Tumors. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43297 |
| Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24147 |
| Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H.G Vogel - No date - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24148 |
| Study title: Empleo de HOE 296 (ciclopirox) en micosis superficiales - Dr Mario Magana Lorenzo - 1976 (Sem Med (Mex) vol 88) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24149 |
| Study title: Emprego de novo antimicotico, HOE-296, no tratamento topico de micoses superficiais - A.F Defina et al. -1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24150 |
| Study title: A SINGLE-BLIND (EVALUATOR BLIND) COMPARATIVE STUDY OF ORAL CLINDAMYCIN HYDROCHLORIDE 300 MG BID COMPARED AGAINST ORAL AUGMENTIN 1G BID IN THE TREATMENT OF ACUTE RECURRENT TONSILLITIS/PHARYNGITIS DUE TO GROUP A-B HEMOLYTIC STREPTOCOCCI. A MULTINATIONAL MUL |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): 251F-INF-9052-0280 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24363 |
| Study title: A STUDY TO COMPARE THE EFFICACY AND TOLERANCE OF CLINDAMYCIN WITH ERYTHROMYCIN IN THE TREATMENT OF FEMALES WITH CONFIRMED CHLAMYDIA TRACHOMARIS CERVICITIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11200134 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24373 |
| Study title: COMPARATIVE EFFICACY AND TOLERANCE OF CLEOCIN T GEL VERSUS ORAL MINOCYCLINE IN THE TREATMENT OF ACNE VULGARIS (PROTOCOL M/1112/0005) |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11120005 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24372 |
| Study title: COMPARATIVE EVALUATION OF CLINDAMYCIN VS CLINDAMYCIN PLUS TOBRAMYCIN IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): M11000093 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24368 |
| Study title: DOUBLE-BLIND RANDOMIZED COMPARISON OF 2% CLINDAMYCIN VAGINAL CREAM VS ORAL METRONIDAZOLE CAPSULES FOR THE TREATMENT OF BACTERIAL VAGINOSIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24367 |
| Study title: EFFICACY & SAFETY OF DALACIN C (CLINIDAMYCIN) IN ACUTE OR RECURRENT PHARYNGO-TONSILLITIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): CLIND-9052-285-INDIA EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24366 |
| Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE INTERNATIONAL MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF ORTHOPEDIC SURGICAL AND GENERAL MEDICAL INFECTIONS. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24358 |
| Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF SKIN AND SKIN STRUCTURE INFECTIONS. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24359 |
| Study title: OPEN LABEL COMPARATIVE, RANDOMIZED STUDY ASSESSING USEFULNESS OF RAPID MICROBIOLOGICAL DIAGNOSTICS IN PATIENTS WITH TONSILLITIS/PHARYNGITIS TREATED WITH CLINDAMYCIN |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24364 |
| Study title: PHASE IV CLINICAL STUDY OF CLINDAMYCIN PHAOSPHATE TOPICAL GEL IN THE TREATMENT OF ACNE VULGARIS |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24365 |
| Study title: A study of clobazam as monotherapy for the treatment of epilepsy in children - HOECHST-ROUSSEL Canada Inc - 26/07/1996 |
| Active substance: CLOBAZAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24375 |
| Study title: Essai du Clobazam en psychiatrie chez l'enfant - Dr MISES - No date |
| Active substance: CLOBAZAM |
| Study summary document link (including results): Clobazam STUDY Mises.xls |
| View full study record |
| Document reference: 24376 |
| Study title: Schreiber K. Pyrithioxin in der Behandlung Schädel-Hirn-Verletzter (Landarzt 1965; 41 (26): 1126-1128); Schreiber K. Pyrithioxin in der Behandlung Schädel-Hirn-Verletzter (Landarzt 1965; 41 (26): 1126-1128); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35153 |
| Study title: Weimann H.M. Erfahrung mit einem Neurodynamikum bei hirngeschädigten Kindern (Ärztl Praxis 1967; 38: 1437)Weimann H.M. Erfahrung mit einem Neurodynamikum bei hirngeschädigten Kindern (Ärztl Praxis 1967; 38: 1437) |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35156 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (drops) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40141 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (ampoules) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40142 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (ampoules) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40143 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Psorinoheel (drops) [AWB-AT] |
| Active substance: Psorinoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40144 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Pulsatilla compositum (ampoules) [AWB-AT] |
| Active substance: Pulsatilla compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40145 |
| Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28045 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27383 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27748 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27381 |
| Study title: Biebach und Kremer (2004): postmarketing-surveillance study |
| Active substance: pulverized active substances: gentian root (Gentianae radix) primrose flowers (Primulae flos) common sorrel herb (Rumicis herba) elder flowers (Sambuci flos) shop vervain wort (Verbenae herba) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40146 |
| Study title: A Randomized, Double-Blind, Placebocontrolled, Multicenter, Parallel-Arm Study Assessing the Efficacy, Safety, and Doseresponse of Ramipril for the Treatment of Hypertension in Children and Adolescents |
| Active substance: RAMIPRIL |
| Study summary document link (including results): Ramipril-Study 2.pdf |
| View full study record |
| Document reference: 35272 |
| Study title: A Randomized, Open-Label Study of the Pharmacokinetics and Safety of a Single Dose of Ramipril in Children and Adolescents |
| Active substance: RAMIPRIL |
| Study summary document link (including results): Ramipril-Study 1.pdf |
| View full study record |
| Document reference: 45718 |
| Study title: Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs. 2006;8(4):265-70.Ameen VZ, Pobiner BF, Giguere GC, Carter EG. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study. Paediatr Drugs. 2006;8(4):265-70. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35276 |
| Study title: Three-phase radionuclide bone imaging and magnetic resonance imaging detection of occult knee fractures in athletes. Giammarile F, Masciocchi C, Barile A, di Pietro M, Carducci A, Baschieri I. Eur J Nucl Med. 1994 Jun;21(6):493-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43622 |
| Study title: Intraoperative radioactive localization of osteoid osteomas: four case reports. Gille P, Nachin P, Aubert D, de la Salle R, Giordan H, Bidet R, Cardot JC. J Pediatr Orthop. 1986 Sep-Oct;6(5):596-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43895 |
| Study title: Gille P, Nachin P, Laurain JM, Aubert D. [Peroperative isotope labeling in surgery for osteoid osteoma. Apropos of 2 case reports] Rev Chir Orthop Reparatrice Appar Mot. 1985;71(2):123-6. French. Gille P, Nachin P, Laurain JM, Aubert D. [Peroperative isotope labeling in surgery for osteoid osteoma. Apropos of 2 case reports] Rev Chir Orthop Reparatrice Appar Mot. 1985;71(2):123-6. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43963 |
| Study title: Gips S, Ruchman RB, Groshar D. Bone imaging in Kohler's disease. Clin Nucl Med. 1997 Sep;22(9):636-7. No abstract available. Gips S, Ruchman RB, Groshar D. Bone imaging in Kohler's disease. Clin Nucl Med. 1997 Sep;22(9):636-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43543 |
| Study title: Cerebral infarction in child abuse. Diagnosis by technetium-99m methylene diphosphonate skeletal scintigraphy. Glasier CM, Seibert JJ, Williamson SL. Clin Nucl Med. 1987 Nov;12(11):897-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43842 |
| Study title: The gamut of increased whole bone activity in bone scintigraphy in children. Glasier CM, Seibert JJ, Williamson SL. Clin Nucl Med. 1987 Mar;12(3):192-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43872 |
| Study title: Goddard P, Bell J, Jackson P, Pitcher E, Bullimore JA, Davies ER. Pulmonary uptake of MDP: demonstration of site by correlation of emission and transmission computed tomography. West Engl Med J. 1990 Jun;105(2):43-6. No abstract available. Goddard P, Bell J, Jackson P, Pitcher E, Bullimore JA, Davies ER. Pulmonary uptake of MDP: demonstration of site by correlation of emission and transmission computed tomography. West Engl Med J. 1990 Jun;105(2):43-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43762 |
| Study title: Goh AS, Sundram FX, Kumar P. Radionuclide bone imaging in patients with low back pain presenting to the orthopaedic surgeon. Ann Acad Med Singapore. 1986 Oct;15(4):529-34. Goh AS, Sundram FX, Kumar P. Radionuclide bone imaging in patients with low back pain presenting to the orthopaedic surgeon. Ann Acad Med Singapore. 1986 Oct;15(4):529-34. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43892 |
| Study title: Goldman AB, Pavlov H, Schneider R. Radionuclide bone scanning in subtalar coalitions: differential considerations. AJR Am J Roentgenol. 1982 Mar;138(3):427-32. Goldman AB, Pavlov H, Schneider R. Radionuclide bone scanning in subtalar coalitions: differential considerations. AJR Am J Roentgenol. 1982 Mar;138(3):427-32. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44089 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43168 |
| Study title: Novoa FJ, Boronat M, Carrillo A, Tapia M, Diaz CJ, Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Hormone Research 2002;57(5-6):187-91 2002;(5-6):187-191.Novoa FJ, Boronat M, Carrillo A, Tapia M, Diaz CJ, Chirino R. Effects of tamoxifen on lipid profile and coagulation parameters in male patients with pubertal gynecomastia. Hormone Research 2002;57(5-6):187-91 2002;(5-6):187-191. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43101 |
| Study title: O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P et al. High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer 2001; 92(3):609-19.O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P et al. High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer 2001; 92(3):609-19. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43144 |
| Study title: Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer 2003; 97(4):1134-1135.Okuno SH, Edmonson JH. Combination chemotherapy for desmoid tumors. Cancer 2003; 97(4):1134-1135. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43141 |
| Study title: Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D et al. Journal of Neuro-Oncology 2006; 77(3):279-284.Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D et al. Journal of Neuro-Oncology 2006; 77(3):279-284. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43255 |
| Study title: Pediatric desmoid tumor: Retrospective analysis of 63 cases. Faulkner LB, Hajdu SI, Kher U, La QM, Exelby PR, Heller G et al. Journal of Clinical Oncology 13(11)()(pp 2813-2818), 1995 Date of Publication: Nov 1995 1995;(11):2813-2818.Pediatric desmoid tumor: Retrospective analysis of 63 cases. Faulkner LB, Hajdu SI, Kher U, La QM, Exelby PR, Heller G et al. Journal of Clinical Oncology 13(11)()(pp 2813-2818), 1995 Date of Publication: Nov 1995 1995;(11):2813-2818. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43302 |
| Study title: Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. Noga CM, Brainard JA, Goldblum JR. American Journal of Clinical Pathology 1999;112(4):545 1999;(4):545.Pelvic Fibromatosis: Clinicopathologic Study of 10 Cases. Noga CM, Brainard JA, Goldblum JR. American Journal of Clinical Pathology 1999;112(4):545 1999;(4):545. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43287 |
| Study title: Clinically silent pulmonary embolism due to transient protein S deficiency. Buffaz PD, Brut A. Clin Nucl Med. 1995 Nov;20(11):1016-7. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48258 |
| Study title: Comparative imaging. Septic pulmonary embolus. Sty JR, Lundeen BE, Friedberg DZ. Clin Nucl Med. 1993 Dec;18(12):1090-1. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48270 |
| Study title: Comparison of SPECT lung perfusion with transbronchial lung biopsy after lung transplantation. Colt HG, Cammilleri S, Khelifa F, Dumon JF, Garbe L, Noirclerc M, Kaphan G Am J Respir Crit Care Med. 1994 Aug;150(2):515-20. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48267 |
| Study title: Contribution of lymphoscintigraphy in the exploration of lymphedema in children Baulieu F 2003 J Mal Vasc. 2003 Dec; 28(5):269-76. Baulieu et al. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Baulieu F 2003.pdf |
| View full study record |
| Document reference: 48219 |
| Study title: Etude de tolérance et d'efficacité d'un anxiolytique chez l'enfant: le clobazam (Urbanyl). B. Grenier et J.C. Rolland 2/75 (Gazete Mèdicale de France; 82(8):861-864)Etude de tolérance et d'efficacité d'un anxiolytique chez l'enfant: le clobazam (Urbanyl). B. Grenier et J.C. Rolland 2/75 (Gazete Mèdicale de France; 82(8):861-864) |
| Active substance: CLOBAZAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24377 |
| Study title: A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis.Frankland AW, Walker SR. Clin Allergy. 1981 Sep;11(5):473-8. A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis.Frankland AW, Walker SR. Clin Allergy. 1981 Sep;11(5):473-8. |
| Active substance: CLOBETASONE |
| Study summary document link (including results): A clinical comparison of topical clobetasone butyrate and so.pdf |
| View full study record |
| Document reference: 24378 |
| Study title: Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.Williamson J, Eilon LA, Walker SR. Trans Ophthalmol Soc U K. 1981;101(1):27-9Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.Williamson J, Eilon LA, Walker SR. Trans Ophthalmol Soc U K. 1981;101(1):27-9 |
| Active substance: CLOBETASONE |
| Study summary document link (including results): Clobetasone butyrate eye drops effect on ocular inflammation.pdf |
| View full study record |
| Document reference: 24379 |
| Study title: AKUTE TOXIZITAET, KANINCHEN PER OS.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24391 |
| Study title: multicentre study of the efficacy and tolerability of clotrimazole 10% vaginal cream in the treatment of vaginal candidosis |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
| View full study record |
| Document reference: 24447 |
| Study title: safety and efficacy of bay b 5097 2vaginal cream in 3-day treatment as compared with 7-day treatment with econazole cream (gyno-pevaryl cream). |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0583_study_synopsis.pdf |
| View full study record |
| Document reference: 24454 |
| Study title: Vergleichende Prüfung von vier Clotrimazol-Zubereitungen |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24464 |
| Study title: Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque |
| Active substance: CLOTRIMAZOLE + SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24467 |
| Study title: "Essai randomisé, ouvert, en groupes parallèles, afin d'évaluer la non infériorité de la cloxacilline versus la pristinamycine en termes d'efficacité et de tolérance dans les infections cutanées à staphylocoque ou à streptocoque" |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24468 |
| Study title: "Evaluation de l'acceptabilité et de la tolérance de la cloxacilline poudre pédiatrique pour suspension buvable 250 mg, en sachets, dans les angines streptococciques et infections cutanées de l'enfant" |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24469 |
| Study title: |
| Active substance: CLOZAPINE |
| Study summary document link (including results): LEX123B 603-151 Art 45 listing 2011.xls |
| View full study record |
| Document reference: 24470 |
| Study title: |
| Active substance: CLOZAPINE |
| Study summary document link (including results): LEX123B 50504 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47361 |
| Study title: |
| Active substance: CLOZAPINE |
| Study summary document link (including results): LEX123J 51-63 Art 45 listing 2011.xls |
| View full study record |
| Document reference: 47362 |
| Study title: 48 hour human patch test for primary irritation of ciclopirox olamine shampoos (Tarmed included as a comparator). |
| Active substance: COAL TAR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24474 |
| Study title: 48 hour human patch test for primary irritation of ciclopirox olamine shampoos (Tarmed included as a comparator). |
| Active substance: Coal tar solution |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40134 |
| Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27746 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27393 |
| Study title: TO STUDY THE EFFICACY AND TOLERATION OF FCA WHEN GIVEN AT A SINGLE 400 MG DOSE IN THOSE PATIENTS WITH OP IN WHOM THE SINGLE 150 MG DOSE DID NOT INDUCE SYMPTOMS WITHIN 3-10 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27758 |
| Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27588 |
| Study title: TO STUDY THE SAFETY AND EFFICACY OF ORAL IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH NON-CANDIDA MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27951 |
| Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27376 |
| Study title: TOLERATION AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27741 |
| Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27463 |
| Study title: TOLERATION AND SAFETY OF ORAL FLUCONAZOLE IN THE PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27827 |
| Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27401 |
| Study title: A double-blind, single oral dose study, comparing the anti-pyretic properties of Ibuprofen, Acetaminophen, and placebo in the treatment of pyrexia associated with infectious disease in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-bpi302.pdf |
| View full study record |
| Document reference: 29399 |
| Study title: A double-blind, single-dose analgesic study comparing the safety and effectiveness of ibuprofen lysine 200 mg, acetylsalicylic acid 500 mg and placebo for the treatment of outpatients experiencing moderate to severe postoperative dental pain / A double-blind, single-dose study to investigate plasma ibuprofen concentrations and their relationship to clinicalanalgesic response in patients treated with dexibuprofen lysine, ibuprofen lysinate, ibuprofen (Motrin) or placebo for the relief of moderate or severe postoperative dental pain / a double-blind single-dose, analgesic pilot study comparing the safety and effectiveness of dexiprofen lysine ((s)-ibuprofen lysinate) 400 mg, (R)-Ibuprofen Lysinate 400mg, and placebo for the treatment of outpatients experiencing moderate or severe postope... |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29608 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43355 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1429-39. Epub 2005 Aug 26. Respiration artifacts in whole-body (18)F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Beyer T, Rosenbaum S, Veit P, Stattaus J, Müller SP, Difilippo FP, SchÃder H, Mawlawi O, Roberts F, Bockisch A, Kühl H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28099 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Jan;32(1):92-7. Epub 2004 Aug 21. Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT. Hosaka K, Ishii K, Sakamoto S, Sadato N, Fukuda H, Kato T, Sugimura K, Senda M; |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28119 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Epub 2005 Feb 15. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, Ra YS, Yeo JS, Ryu JS, Moon DH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28110 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Epub 2004 Dec 30. Comment in: Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):228-9; author reply 230. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, Lin WJ, Fu YK, Ng SH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28115 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1152-9. Epub 2005 Jun 18. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. Yen RF, Chen TH, Ting LL, Tzen KY, Pan MH, Hong RL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28101 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28091 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):13-21. Epub 2005 Sep 9. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Hellwig D, GrÃschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28096 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):683-91. Epub 2006 Feb 28. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28088 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):692-6. Epub 2006 Mar 3. Accuracy of transmission CT and FDG-PET in the detection of small pulmonary nodules with integrated PET/CT. Aquino SL, Kuester LB, Muse VV, Halpern EF, Fischman AJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28086 |
| Study title: Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1025-31. Epub 2006 Mar 25. Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease. Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, Chanova M, Hladikova M, Kodet R, Belohlavek O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28083 |
| Study title: Eur J Nucl Med. 1998 Jul;25(7):721-8. Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Stumpe KD, Urbinelli M, Steinert HC, Glanzmann C, Buck A, von Schulthess GK. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28192 |
| Study title: Eur J Nucl Med. 2000 May;27(5):590-4. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28178 |
| Study title: Eur J Nucl Med. 2001 Jun;28(6):704-10. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis. Wu H, Dimitrakopoulou-Strauss A, Heichel TO, Lehner B, Bernd L, Ewerbeck V, Burger C, Strauss LG. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28170 |
| Study title: Correlation of pulmonary 99mTc-DTPA ventilation and 99mTc-MAA perfusion scans with pulmonary function tests in asymptomatic asthmatic children. Dai ZK, Chen YW, Hsu JH, Huang MS, Chou SH, Wu JR. Nucl Med Commun. 2003 Jul;24(7):819-24 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48225 |
| Study title: Delayed restoration of lung perfusion after removal of aspirated foreign body. Suga K, Nishigauchi K, Kume N, Uchisako H, Yoshimizu T, Nakanishi T. Clin Nucl Med. 1995 Nov;20(11):1032-3. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48257 |
| Study title: Detection of multiple thromboembolism in congenital antithrombin III deficiency with indium-111-platelet scintigraphy. Kawasugi K, Gohchi K, Kuniyasu Y, Matsuda J, Kinoshita T J Nucl Med. 1994 Nov;35(11):1811-4. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Kawasugi K 1994.pdf |
| View full study record |
| Document reference: 48263 |
| Study title: Diagnosis of pulmonary embolus using ventilation/perfusion lung scintigraphy: more than 0.5 segment of ventilation/perfusion mismatch is sufficient. Howarth DM, Booker JA, Voutnis DD. Intern Med J. 2006 May;36(5):281-8 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48222 |
| Study title: Diaphragmatic hernia producing a perfusion defect and diffuse pulmonary vascular hypoplasia on lung imaging. Siraj QH, Clarke SE. Clin Nucl Med. 1994 Oct;19(10):917-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48265 |
| Study title: Distribution of radioactive aerosol in the airways of children and adolescents with bronchial hyper-responsiveness. Backer V, Mortensen J. Clin Physiol. 1992 Sep;12(5):575-85. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48276 |
| Study title: Early decortication for postpneumonic empyema in children. Effect on pulmonary perfusion. Eren N, Ozçelic C, Ener BK, Ozgen G, Solak H, Balci AE, Tas S. Scand J Thorac Cardiovasc Surg. 1995;29(3):125-9. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48261 |
| Study title: Early radionuclide detection of intrapulmonary shunts in children with liver disease. Grimon G, André L, Bernard O, Raffestin B, Desgrez A. J Nucl Med. 1994 Aug;35(8):1328-32. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48268 |
| Study title: Coccaro G, Khedkar NY, Peller PJ, Martinez CJ. An early false-negative bone scan in a spiral fracture. Clin Nucl Med. 1994 Sep;19(9):818-9. No abstract available. Coccaro G, Khedkar NY, Peller PJ, Martinez CJ. An early false-negative bone scan in a spiral fracture. Clin Nucl Med. 1994 Sep;19(9):818-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43615 |
| Study title: Stress fracture of the femoral neck in a child (stress fracture). Coldwell D, Gross GW, Boal DK. Pediatr Radiol. 1984;14(3):174-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44013 |
| Study title: Asymmetrical closure of epiphyses in a patient with sickle cell anemia. Collett-Solberg PF, Ware RE, O'Hara SM. J Pediatr Endocrinol Metab. 2002 Sep-Oct;15(8):1207-12. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43433 |
| Study title: Einfachblinde, randomisierte, Verum-kontrollierte, monozentrische Studie zum Nachweis der Nicht-Unterlegenheit von Leukichtan Gel vs. Betaisodona Salbe in der Behandlung von Schnitt-, Schürfwunden und Verbrennungen |
| Active substance: COD LIVER OIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24475 |
| Study title: Diaper dermatitis - Schanzer MC, Wilkin JK. - 1982 (Am Fam Physician 1982; 25(4):127-132) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24476 |
| Study title: Diaper dermatitis. Value of Vitamin A topically applied - Bosch-Banyeras M, Catala M et al - 1988 (Clin. Pediat. 1988, 27, 9:448-450) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24477 |
| Study title: Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis - Arad A, Mimouni D, Ben Amitai D, Zeharia A, Mimouni M. - 1999 (Dermatology 1999; 199(4):319-322) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24478 |
| Study title: Empfehlungen zur Lokaltherapie banaler Dermatosen im Kindesalter [Recommendations for local therapy of common dermatoses in children] - Stogmann W - 1984 (Wien Med.Wochenschr. 1984, 134(1):19-24) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24479 |
| Study title: Monographie-Entwürfe für Arzneimittel zur Behandlung des Windelekzems - no autor - 1991 ((Sonderdruck). Pharm Ind 1991; 53(I):152-158) |
| Active substance: COD LIVER OIL/ZINC OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24480 |
| Study title: Davidson A et al Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG) Eur J Cancer 1997 Oct;33(11):1816-22Davidson A et al Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG) Eur J Cancer 1997 Oct;33(11):1816-22 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24841 |
| Study title: Davies SM et al Toxicity of high-dose ifosfamide in children Cancer Chemother Pharmacol. 1989;24 Suppl 1:S8-10Davies SM et al Toxicity of high-dose ifosfamide in children Cancer Chemother Pharmacol. 1989;24 Suppl 1:S8-10 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24842 |
| Study title: de Andrea ML et al. A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminaryevaluation. J Clin Oncol. 1990 Apr;8(4):666-71de Andrea ML et al. A new treatment protocol for childhood non-Hodgkin's lymphoma: preliminaryevaluation. J Clin Oncol. 1990 Apr;8(4):666-71 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24843 |
| Study title: De Schepper J et al Renal function abnormalities after ifosfamide treatment in children Acta Paediatr. 1993 Apr;82(4):373-6De Schepper J et al Renal function abnormalities after ifosfamide treatment in children Acta Paediatr. 1993 Apr;82(4):373-6 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24844 |
| Study title: Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease Pediatr Blood Cancer. 2004 Mar;42(3):210-5Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease Pediatr Blood Cancer. 2004 Mar;42(3):210-5 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24845 |
| Study title: Delépine N et al CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas Biomed Pharmacother. 1986;40(5):173-5Delépine N et al CNS-side effects induced by Ifosfamide-Mesna in children with osteosarcomas Biomed Pharmacother. 1986;40(5):173-5 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24846 |
| Study title: Dieckmann K et al Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90 Int J Radiat Oncol Biol Phys 2003 Jul 1;56(3):644-52Dieckmann K et al Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90 Int J Radiat Oncol Biol Phys 2003 Jul 1;56(3):644-52 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24847 |
| Study title: A double-blind, single-dose comparison of ibuprofen vs. acetaminophen vs. placebo in the relief of post operative oral surgery pain. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29456 |
| Study title: A Double-Blind, Single-Oral-Dose Study Comparing the Antipyretic Properties of Ibuprofen, Acetaminophen, and Placebo in the Treatment of Pyrexia Associated with Infectious Diseases in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI303.pdf |
| View full study record |
| Document reference: 47544 |
| Study title: A multi-centre, double blind, parallel group, prospective, randomised study to compare the efficacy of a single dose of 10 mg/kg ibuprofen with 15 mg/kgparacetamol in febrile children aged from 3 months to 12 years followed by tolerability over up to three days of open label dosing |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29397 |
| Study title: A Multicenter, Double-Blind, Single-Oral-Dose Study Comparing the Action of Ibuprofen, Acetaminophen, and Placebo in the Treatment of Pediatric Patients with Postoperative Pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI304.pdf |
| View full study record |
| Document reference: 47545 |
| Study title: A MULTICENTER, OPEN-LABEL, MULTIPLE-DOSE STUDY TO DETERMINE THE SAFETY AND TOLERABILITY OF IBUPROFEN SUSPENSION IN THE TREATMENT OF MILD TO MODERATE PAIN OF VARIOUS ETIOLOGIES IN CHILDREN. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI-320.pdf |
| View full study record |
| Document reference: 47547 |
| Study title: A multicentre open label multiple dose study to determine the safety and tolerability of ibuprofen suspension in the treatment of mild to moderate pain of various etiologies in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI-320.pdf |
| View full study record |
| Document reference: 29461 |
| Study title: A MULTICENTRE, DOUBLE-BLIND, SINGLE-ORAL-DOSE STUDY COMPARING THE ACTION OF IBUPROFEN, ACETAMINOPHEN AND PLACEBO IN THE TREATMENT OF PEDIATRIC PATIENTS WITH POST-OPERATIVE PAIN |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29401 |
| Study title: A multicentre, open dose-response evaluation of the safety and efficacy of Ibuprofen syrup in children with juvenile chronic arthritis . |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29421 |
| Study title: A multicentre, open dose-response evaluation of the safety and efficacy of Ibuprofen syrup in children with juvenile chronic arthritis . |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29436 |
| Study title: A Multicentre, Open Dose-Response Evaluation of the Safety and Efficacy of Ibuprofen Syrup in Children with Juvenile Chronic Arthritis (XXM85101) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-M85-101.pdf |
| View full study record |
| Document reference: 47552 |
| Study title: A multicentre, open-label multiple-dose study to determine the safety and tolerability of Ibuprofen suspension in the treatment of mild to moderate pain of various aetiologies in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29429 |
| Study title: Comparision of pirenzepine, RANITIDINE and pirenzepine-RANITIDINE combination for reducing preoperative gastric fluid acidity and volume in children. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35275 |
| Study title: Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997 Sep-Oct;17(5):383-8.Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997 Sep-Oct;17(5):383-8. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35282 |
| Study title: Kaufman SS, Loseke CA, Young RJ, Perry DA. Ranitidine therapy for esophagitis in children with developmental disabilities. Clin Pediatr (Phila). 1996 Sep;35(9):451-6.Kaufman SS, Loseke CA, Young RJ, Perry DA. Ranitidine therapy for esophagitis in children with developmental disabilities. Clin Pediatr (Phila). 1996 Sep;35(9):451-6. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35284 |
| Study title: Eur Neurol. 1989;29 Suppl 3:16-24. [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. Hoffman JM, Guze BH, Baxter LR, Mazziotta JC, Phelps ME.Eur Neurol. 1989;29 Suppl 3:16-24. [18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies. Hoffman JM, Guze BH, Baxter LR, Mazziotta JC, Phelps ME. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28209 |
| Study title: Eur Spine J. 2001 Dec;10(6):534-9. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28163 |
| Study title: Gynecol Oncol. 1993 Nov;51(2):197-204. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28205 |
| Study title: An open multicentre study in Pakistan to investigate the effects of Ibuprofen syrup in juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29424 |
| Study title: An open multicentre study in Pakistan to investigate the effects of Ibuprofen syrup in juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29439 |
| Study title: An open study to evaluate the use of Ibuprofen suspension in the treatment of post-immunisation pyrexia in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29410 |
| Study title: An open Study to Evaluate the Use of Ibuprofen Suspension in the Treatment of Post-Immunisation Pyrexia in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29469 |
| Study title: An open study to evaluate the use of ibuprofen suspension in the treatment of post-immunisation pyrexia in children (BR1148). |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BR1148.pdf |
| View full study record |
| Document reference: 47550 |
| Study title: An Open-Label Study of the Safety of an Ibuprofen-Pseudoephedrine HCl Suspension in Children. Sep 1999. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29559 |
| Study title: An Open-Label, Multicentre, Twenty-Four Week Dose-Ranging Study to Evaluate the Efficacy and Relative Long-Term Safety and Tolerability of Ibuprofen Suspension in the Treatment of Active Juvenile Rheumatoid Arthritis as Compared to a Historical Control |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BPI308.pdf |
| View full study record |
| Document reference: 47546 |
| Study title: An open, multiple dose study of the efficacy and tolerability of ibuprofen suspension in the treatment of juvenile pain and pyrexia (BR01 18) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BR0118.pdf |
| View full study record |
| Document reference: 47549 |
| Study title: an open, multiple dose study of the efficacy and tolerability of Ibuprofen syrup in the treatment of juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29404 |
| Study title: An open, multiple-dose study of the efficacy and tolerability of Ibuprofen suspension in the treatment of juvenile pain and pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29408 |
| Study title: An open, multipledose study of the efficacy and tolerabili of ibuprofen syrup in the treatment of juvenile pyrexia (BR0105). |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BR0105.pdf |
| View full study record |
| Document reference: 47548 |
| Study title: An open, parallel-group, multiple dose study to compare the efficacy and tolerability of Ibuprofen suspension (Junifen) and Paracetamol suspension (Calpol Infant) in the symptomatic treatment of juvenile teething pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen BR1147.pdf |
| View full study record |
| Document reference: 29409 |
| Study title: Anti-pyretic activity of Ibuprofen and Paracetamol in children with pyrexia by Y K Amdekar, R Z Desai, India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29446 |
| Study title: Anti-pyretic activity of Ibuprofen suspension and Aspirin in children by Professor R S Satoskar, KEM hospital, Bombay, India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-m83079.pdf |
| View full study record |
| Document reference: 29447 |
| Study title: Connolly LP, Drubach LA, Treves ST. Localization of Tc-99m MDP in the rectus abdominis muscle without associated symptoms. Clin Nucl Med. 2003 Sep;28(9):769-70. Connolly LP, Drubach LA, Treves ST. Localization of Tc-99m MDP in the rectus abdominis muscle without associated symptoms. Clin Nucl Med. 2003 Sep;28(9):769-70. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43415 |
| Study title: Conrad GR, Sinha P. Severe bladder distortion mimics bone metastasis from pelvic rhabdomyosarcoma. Clin Nucl Med. 2002 Dec;27(12):929-31. No abstract available. Conrad GR, Sinha P. Severe bladder distortion mimics bone metastasis from pelvic rhabdomyosarcoma. Clin Nucl Med. 2002 Dec;27(12):929-31. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43426 |
| Study title: Constantinesco A, Brunot B, Demangeat JL, Foucher G, Farcot JM. Three phase bone scanning as an aid to early diagnosis in reflex sympathetic dystrophy of the hand. A study of eighty-nine cases. Ann Chir Main. 1986;5(2):93-104. English, French. Constantinesco A, Brunot B, Demangeat JL, Foucher G, Farcot JM. Three phase bone scanning as an aid to early diagnosis in reflex sympathetic dystrophy of the hand. A study of eighty-nine cases. Ann Chir Main. 1986;5(2):93-104. English, French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43920 |
| Study title: Cory DA, Siddiqui AR, Cohen MD. Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med. 1987;12(11):546-7. Cory DA, Siddiqui AR, Cohen MD. Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med. 1987;12(11):546-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43885 |
| Study title: Neurology. 2003 Mar 11;60(5):756-61. Comment in: Neurology. 2003 Mar 11;60(5):736-7. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Natsume J, Kumakura Y, Bernasconi N, Soucy JP, Nakai A, Rosa P, Fedi M, Dubeau F, Andermann F, Lisbona R, Bernasconi A, Diksic M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28150 |
| Study title: Neurosci Lett. 2007 Jul 11;422(2):91-6. Epub 2007 Jun 2.Modafinil-induced hippocampal activation in narcolepsy.Kim YK, Yoon IY, Shin YK, Cho SS, Kim SE. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28066 |
| Study title: Nippon Rinsho. 2000 Jan;58(1):204-11. [Drug-induced myocardial disease--adriamycin cardiotoxicity] [Article in Japanese] Wakasugi S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28177 |
| Study title: Nucl Med Commun. 1999 Mar;20(3):255-61. Positron emission tomography using 18F-fluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, Stützer H, Lackner K, Schicha H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28185 |
| Study title: Nucl Med Commun. 1999 Sep;20(9):845-8. Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma. Hain SF, O'Doherty MJ, Lucas JD, Smith MA. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28181 |
| Study title: Nucl Med Commun. 2002 Aug;23(8):773-7. Cerebral metabolic changes associated with Lyme disease. Newberg A, Hassan A, Alavi A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28157 |
| Study title: Nucl Med Commun. 2002 Nov;23(11):1079-83. 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients. Van Den Bossche B, Lambert B, De Winter F, Kolindou A, Dierckx RA, Noens L, Van De Wiele C. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28154 |
| Study title: Nucl Med Commun. 2002 Oct;23(10):961-5. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose. Ding HJ, Shiau YC, Wang JJ, Ho ST, Kao A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28155 |
| Study title: Nucl Med Commun. 2003 Dec;24(12):1225-30. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland. Wolf G, Aigner RM, Schaffler G, Schwarz T, Krippl P. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28139 |
| Study title: Donfrancesco A et al Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age Acta Paediatr Suppl. 2004 May;93(445):6-11Donfrancesco A et al Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age Acta Paediatr Suppl. 2004 May;93(445):6-11 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24849 |
| Study title: Dörffel W et al Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.Klin Padiatr 2003 May-Jun;215(3):139-45Dörffel W et al Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.Klin Padiatr 2003 May-Jun;215(3):139-45 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24850 |
| Study title: Dufour C et al Ifosfamide induced encephalopathy: 15 observations Arch Pediatr. 2006 Feb;13(2):140-5. Epub 2005 Dec 20. FrenchDufour C et al Ifosfamide induced encephalopathy: 15 observations Arch Pediatr. 2006 Feb;13(2):140-5. Epub 2005 Dec 20. French |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24852 |
| Study title: Dunkel IJ et al High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group J Clin Oncol 1998 Jan;16(1):222-8Dunkel IJ et al High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group J Clin Oncol 1998 Jan;16(1):222-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24853 |
| Study title: Dunst J et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):919-30.Dunst J et al. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):919-30. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24854 |
| Study title: Ensaio clinico e terapeutico com um novo antimicotico piridonico de emprego topico o HOE 296-Clinical and therapeutic trial with a new pyridonic anti-mycotic compound for topical use, the HOE 296 - Luiz Carlos Pereira et al. - 1974 (Rev Bras Clin Ter vol 3) - Publication in Part Clinical documentation Batrafen Losung-No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24151 |
| Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24152 |
| Study title: Estudo sobre o uso do ciclopirox (HOE 296) em Dermatologia : Resultados clinicos das micoses superficiais- Clinical effects of use of ciclopirox (HOE 296) in dermatology : therapeutic efficacy in superficial mycosis- Marcio lobo Jardim et al. - 1975 ( Rev Bras Clin Ter vol 4) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24153 |
| Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24154 |
| Study title: Evaluation of a new antifungal cream, ciclopirox alamine 1% in the treatment of cutaneous candidosis - Fillmore K. Bagatell et al. - 1985 (Clincals Therapeutics vol 8, N°1) -Publication in clinical studies (volume 5) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24155 |
| Study title: Evaluation of ciclopirox olamine for the treatment of tinea pedis : multicenter, double-blind comparatives studies - Albert M. Kligman et al.- 1985 (Clinical therapeutics vol 7, n°4) - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24156 |
| Study title: Experiencia clinica com um novo antimicotico : HOE 296-Clinical experience with HOE 296, a new antimycotic agent- R.D Azulay et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24157 |
| Study title: Fungal colonization in the very low birth weight infants - J.E Baley et al. - 1986 (Pedriatrics vol 78) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24158 |
| Study title: High prevalence of cervical dysplasia in female consorts of men with genital warts- T. Hockenstrom et al.- No date (Acta Derm Venereol vol 67) - Publication in clinical studies (volume 6) - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24159 |
| Study title: Kuusela AL, Ruuska T, Karikoski R, Laippala P, Ikonen RS, Janas M, Mäki M. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997 Feb;25(2):346-51.Kuusela AL, Ruuska T, Karikoski R, Laippala P, Ikonen RS, Janas M, Mäki M. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997 Feb;25(2):346-51. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35283 |
| Study title: Kuusela AL.Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F151-3.Kuusela AL.Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F151-3. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35281 |
| Study title: Orenstein SR, Blumer JL, Faessel HM, McGuire JA, Fung K, Li BU, Lavine JE, Grunow JE, Treem WR, Ciociola AA. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002 May;16(5):899-907.Orenstein SR, Blumer JL, Faessel HM, McGuire JA, Fung K, Li BU, Lavine JE, Grunow JE, Treem WR, Ciociola AA. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002 May;16(5):899-907. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35278 |
| Study title: Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35274 |
| Study title: A Dose-Escalation, Randomized Double-Blind Withdrawal Study of the Efficacy, Dose- Response, and Safety of Ramipril for the Treatment of Hypertension in Children and Adolescents |
| Active substance: RAMIPRIL |
| Study summary document link (including results): Ramipril-Study 3.pdf |
| View full study record |
| Document reference: 35271 |
| Study title: Kolygin-B-A, Fedoreev-G-A. Combination chemotherapy of Hodgkin disease in children. Neoplasma, {Neoplasma}, 1975, vol. 22, no. 2, p. 225-30, ISSN: 0028-2685.Kolygin-B-A, Fedoreev-G-A. Combination chemotherapy of Hodgkin disease in children. Neoplasma, {Neoplasma}, 1975, vol. 22, no. 2, p. 225-30, ISSN: 0028-2685. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34761 |
| Study title: Komp-D-M, Britton-H-A, Vietti-T-J, Humphrey-G-B. Southwest Oncol. Group, Operations Office, 3500 Rainbow Blvd, Suite 201, Kansas City, Kans. 66103, United States. Response of childhood histiocytosis X to procarbazine (NSC 77213). CANCER-CHEMOTHER-REP, 1974, Vol/Iss/Pg. 58/5 (719-722). Komp-D-M, Britton-H-A, Vietti-T-J, Humphrey-G-B. Southwest Oncol. Group, Operations Office, 3500 Rainbow Blvd, Suite 201, Kansas City, Kans. 66103, United States. Response of childhood histiocytosis X to procarbazine (NSC 77213). CANCER-CHEMOTHER-REP, 1974, Vol/Iss/Pg. 58/5 (719-722). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34762 |
| Study title: Krischer-J-P, Steuber-C-P, Vietti-T-J, Culbert-S-J, Ragab-A-H, Morgan-S-K, Berry-D-H, Hvizdala-E, Thomas-P-J, Land-V-J, et al. Department of Pediatrics, University of Florida, Gainesville. Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1989, vol. 17, no. 5, p. 401-8, ISSN: 0098-1532.Krischer-J-P, Steuber-C-P, Vietti-T-J, Culbert-S-J, Ragab-A-H, Morgan-S-K, Berry-D-H, Hvizdala-E, Thomas-P-J, Land-V-J, et al. Department of Pediatrics, University of Florida, Gainesville. Long-term results in the treatment of acute nonlymphocytic leukemia: a Pediatric Oncology Group Study. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1989, vol. 17, no. 5, p. 401-8, ISSN: 0... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34763 |
| Study title: Antipyretic activity of ibuprofen and paracetamol in children with pyrexia. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29472 |
| Study title: Antipyretic Activity of Ibuprofen Suspension and Paracetamol: Comparative Study in Children with Pyrexia. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-M83-111.pdf |
| View full study record |
| Document reference: 29465 |
| Study title: Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201)Autret−E et al. Comparative efficacy and tolerance of ibuprofen syrup and acetaminophen syrup in children with pyrexia associated with infectious diseases and treated with antibiotics. {EUR−J−CLIN−PHARMACOL}, 1994, Vol/Iss/Pg. 46/3 (197−201) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29590 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43096 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43124 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43182 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43192 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43202 |
| Study title: Nucl Med Commun. 2003 Jun;24(6):643-9. Persistent vegetative state: evaluation of brain metabolism and brain perfusion with PET and SPECT. Beuthien-Baumann B, Handrick W, Schmidt T, Burchert W, Oehme L, Kropp J, Schackert G, Pinkert J, Franke WG. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28147 |
| Study title: Nucl Med Commun. 2004 Feb;25(2):123-8. Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour. Novak L, Emri M, Molnar P, Balkay L, Lengyel Z, Tron L. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28124 |
| Study title: Nucl Med Commun. 2004 May;25(5):439-43. 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Gotthardt M, Battmann A, HÃffken H, Schurrat T, Pollum H, Beuter D, Gratz S, Béhé M, Bauhofer A, Klose KJ, Behr TM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28125 |
| Study title: Nucl Med Commun. 2006 Nov;27(11):893-9. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.Kaneko K, Sasaki M, Morioka T, Koga H, Abe K, Sawamoto H, Ohya N, Yoshiura T, Mihara F, Honda H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28074 |
| Study title: Nucl Med Commun. 2007 Apr;28(4):273-80.Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28068 |
| Study title: Oncol Rep. 2005 Nov;14(5):1209-14. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R, Carrai V, Nassi L, Bernardi F, Pieroni C, Bosi A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28094 |
| Study title: Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, Boers M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28121 |
| Study title: Paediatr Anaesth. 2007 Jul;17(7):616-21.Congenital hyperinsulinism - a review of the disorder and a discussion of the anesthesia management.Hardy OT, Litman RS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28067 |
| Study title: Pediatr Neurosurg. 1997 Mar;26(3):144-56. Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures. Duncan JD, Moss SD, Bandy DJ, Manwaring K, Kaplan AM, Reiman EM, Chen K, Lawson MA, Wodrich DL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28194 |
| Study title: Comparison of bone scan and radiograph sensitivity in the detection of steroid-induced ischemic necrosis of bone. Conklin JJ, Alderson PO, Zizic TM, Hungerford DS, Densereaux JY, Gober A, Wagner HN. Radiology. 1983 Apr;147(1):221-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44043 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43212 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43222 |
| Study title: HOE 296 - Its safety evaluated by laboratory test and its clinical effect- Y. Watanabe - 1975 (Journal of new Remedies and Clinicals vol 24) - Publication in Part clinical documentation-Batrafen Losung Study CIOMS -No author - 11/1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24160 |
| Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24161 |
| Study title: HOE 296, um novo antimicotico piridonicode emprego topico,com atividade antibacteriana adicional - Ney Romiti - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical documentation Batrafen Losung - Study CIOMS - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24162 |
| Study title: Investigacion clinica sobre el HOE 296 en demafitosis de la piel lampina y en pitiriasis versicolor - Antonio Gonzalvez-Ochoa et al. - 1974 (Rev Int Salud publica vol 34) - Publication in Part clinical Documentation Batrafen Losung - No author - 11/ 1999 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24163 |
| Study title: La ciclopiroxolamina nel trattamento della pityriasis versicolor (Ciclopiroxolamine in the treatment of pityriasis versicolor) - G. Trevisan et al. - 1988 (Giornale Italiano Di Dermatologica e Venerologica vol 123) - Publication in Part clinical documenta |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24164 |
| Study title: Multicentre Double-blind clinical trials of ciclopirox olamine cream 1%in the treatment of tinea corporis or tinea cruris -Humberto Bogaert et al. - 1986 (J Int Med Res vol 14) - Publication in clinical studies ( volume 3) - a double bind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/ 1988 - |
| Active substance: CICLOSPORIX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24165 |
| Study title: ANAFRANIL (G34586) 2 YR RAT 2 VOLS. RAW DATA - 11/28/73 |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24403 |
| Study title: ANAFRANIL-BIP. (ANAFRANIL & ANAFRANIL SLOW RELEASE); ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24386 |
| Study title: ANAFRANIL, TOFRANIL |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24404 |
| Study title: AUSTRALIEN GESAMT STUDIE RESULTATE 1976/77/78 |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24392 |
| Study title: AUSTRALIEN II ORD. IV OKTOBER 77, AUSTALIEN III PO./IV MAERZ 1978 |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24393 |
| Study title: CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC ACTIVITY AND TOLERABILITY OF ANAFRANIL 10MG DRAGEES IN CHILDREN SUFFERING FROM DEPRESSION, ANOREXIA, ENURESIS, SCHOOL-PHOBIA, PHOBIA AND OBSESSION OR ANXIETY |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24388 |
| Study title: effects of anafranil 10 mg in enuresic children |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24389 |
| Study title: G 34586, ANAFRANIL: PLASMA CONCENTRATIONS OF CLOMIPRAMINE AND DESMETHYL CLOMIPRAMINE IN CHILDREN AND ADOLESCENTS WITH OBSESSIVE COMPULSIVE DISORDER |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24387 |
| Study title: PRUEBA SOBRE POSIBLES EFECTOS PERJUDICIALES EN EL EMBRION. RATON, VIA ORAL |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24380 |
| Study title: PRUEFUNG AUF TERATOGENE WIRKUNG, RATTE.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24383 |
| Study title: REPRODUCTION STUDY, SEGMENT II, MOUSE.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24394 |
| Study title: REPRODUCTION STUDY, SEGMENT II, RAT.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24395 |
| Study title: REVIEW OF REPRODUCTION STUDIES DATED 7.8.72. (FRA NR.1); ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24396 |
| Study title: REVIEW OF REPRODUCTION STUDIES.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24397 |
| Study title: Kuehner-U, Bleher-E-A, Gretillat-P, et-al. Inst. Klin. Exp. Tum. Forsch. Klin., Strahlenther., Univ. Bern, Switzerland. Diagnosis and treatment of Hodgkin's disease in children. Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1976, Vol/Iss/Pg. 124/5 (408-410).Kuehner-U, Bleher-E-A, Gretillat-P, et-al. Inst. Klin. Exp. Tum. Forsch. Klin., Strahlenther., Univ. Bern, Switzerland. Diagnosis and treatment of Hodgkin's disease in children. Monatsschrift fur Kinderheilkunde {MONATSSCHR-KINDERHEILKD}, 1976, Vol/Iss/Pg. 124/5 (408-410). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34764 |
| Study title: Lampkin-B-C, Wong-K-Y, Kalinyak-K-A, et-al. Hematology-Oncology Division, Children's Hospital Medical Center, Cincinnati, OH 45229, United States. Solid malignancies in children and adolescents. Surgical Clinics of North America {SURG-CLIN-NORTH-AM}, 1985, Vol/Iss /Pg. 65/6 (1351-1386).Lampkin-B-C, Wong-K-Y, Kalinyak-K-A, et-al. Hematology-Oncology Division, Children's Hospital Medical Center, Cincinnati, OH 45229, United States. Solid malignancies in children and adolescents. Surgical Clinics of North America {SURG-CLIN-NORTH-AM}, 1985, Vol/Iss /Pg. 65/6 (1351-1386). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34765 |
| Study title: Lange-B, Littman-P, Schnaufer-L, Evans-A. Child. Hosp. Cancer Res. Cent., Univ. Pennsylvania, Philadelphia, Pa. 19104, United States. Treatment of Hodgkin's disease (HD) in children, 1970-1980. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-287).Lange-B, Littman-P, Schnaufer-L, Evans-A. Child. Hosp. Cancer Res. Cent., Univ. Pennsylvania, Philadelphia, Pa. 19104, United States. Treatment of Hodgkin's disease (HD) in children, 1970-1980. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-287). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34766 |
| Study title: Lange-B, Littman-P, Schnaufer-L, Evans-A. Treatment of advanced Hodgkin's disease in pediatric patients. Cancer, {Cancer}, Sep 1978, vol. 42, no. 3, p. 1141-5, ISSN: 0008-543X.Lange-B, Littman-P, Schnaufer-L, Evans-A. Treatment of advanced Hodgkin's disease in pediatric patients. Cancer, {Cancer}, Sep 1978, vol. 42, no. 3, p. 1141-5, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34767 |
| Study title: Bozkurt MF, Uğur O. Intra-arterial Tc-99m MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med. 2001 Feb;26(2):154-6. No abstract available. Bozkurt MF, Uğur O. Intra-arterial Tc-99m MDP injection mimicking reflex sympathetic dystrophy. Clin Nucl Med. 2001 Feb;26(2):154-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43462 |
| Study title: Braga FJ, Arbex MA, Haddad J, Maes A. Bone scintigraphy in testicular tumors. Clin Nucl Med. 2001 Feb;26(2):117-8. Braga FJ, Arbex MA, Haddad J, Maes A. Bone scintigraphy in testicular tumors. Clin Nucl Med. 2001 Feb;26(2):117-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43463 |
| Study title: TREATMENT OF OROPHARYNGEAL CANDIDIASIS RESISTANT TO FLUCONAZOLE A DAILY DOSE OF 400 MG FOR 7 DAYS. A PILOT DOSE STUDY USING 800, 1200 AND 1600 MG DAILY TO 7 DAYS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27766 |
| Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27498 |
| Study title: TREATMENT OF SYSTEMIC MYCOSIS WITH FLUCONAZOLE AND ITS IN VITRO ANTIFUNGAL ACTIVITY |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27862 |
| Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27407 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43217 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43341 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43351 |
| Study title: Wudy SA, Rodens K, Homoki J, Teller WM. Tamoxifen for treatment of sexual precocity in girls with McCune-Albright syndrome. Pediatric Reviews and Communications 1993; 7(2):115-120.Wudy SA, Rodens K, Homoki J, Teller WM. Tamoxifen for treatment of sexual precocity in girls with McCune-Albright syndrome. Pediatric Reviews and Communications 1993; 7(2):115-120. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43161 |
| Study title: Yaghan RJ, Bani-Hani KE. Male breast disorders in Jordan - Disease patterns and management problems. Saudi Medical Journal~ 25(12):1877-1883, December 2004 2004;(12):-1883, December.Yaghan RJ, Bani-Hani KE. Male breast disorders in Jordan - Disease patterns and management problems. Saudi Medical Journal~ 25(12):1877-1883, December 2004 2004;(12):-1883, December. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43097 |
| Study title: A randomized, double blinded, parallel group, multicenter study to explore the pharmaco-kinetics, safety, tolerability and efficacy of tamsulosin in pediatric patients with signs and symptoms of dysfunctional voiding |
| Active substance: TAMSULOSIN |
| Study summary document link (including results): 617-CL-310 Study synopsis_Tamsulosin.pdf |
| View full study record |
| Document reference: 43356 |
| Study title: Pharmacokinetics, safety, and tolerability of single oral doses (0.1, 0.2, 0.4 and 0.8 mg) of tamsulosin hydrochloride in children with voiding disorders |
| Active substance: TAMSULOSIN |
| Study summary document link (including results): Tamsulosin_U05-3269_synopsis.pdf |
| View full study record |
| Document reference: 43357 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tanacet-Heel (drops) [AWB-037] |
| Active substance: Tanacet-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40251 |
| Study title: Double blind, placebo controlled study of the efficacy of polytar in treatment of seborrhoeic dermatitis and eczema of the scalp. |
| Active substance: TAR AND ZINC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43358 |
| Study title: To study the effects of Fongitar (Polytar AF) in Pityriasis and squamous conditions of the scalp. |
| Active substance: TAR AND ZINC |
| Study summary document link (including results): Article 45_Ref_C0202_Final For Submission_27 Oct 2011.xlsx |
| View full study record |
| Document reference: 43359 |
| Study title: Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43283 |
| Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45065 |
| Study title: Effects of corticosteroid inhalation therapy on the deposition pattern of Tc-99m human serum albumin radioaerosols in asthma. Kao CH, Lin HT, Yu SL, Wang SJ, Lan JL. Lung. 1995;173(5):291-6. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48262 |
| Study title: Esophageal bronchus in an infant diagnosed by fortuitous intubation of the esophagus during ventilation imaging. Kohne RE, McLeary MS, Kirk GA, Young LW. Clin Nucl Med. 1996 Dec;21(12):990-3. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48248 |
| Study title: Esophageal dysmotility as a serendipitous observation on ventilation-perfusion imaging of the lungs. Moallem A, Hilfer C, Stein A. Clin Nucl Med. 1992 Jun;17(6):446-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48277 |
| Study title: Eur J Radiol. 1990 Sep-Oct;11(2):131-7. Contrast venography: from gold standard to 'golden backup' in clinically suspected deep vein thrombosis. de Valois JC, van Schaik CC, Verzijlbergen F, van Ramshorst B, Eikelboom BC, Meuwissen OJ. Eur J Radiol. 1990 Sep-Oct;11(2):131-7. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): de valois JC 1990.pdf |
| View full study record |
| Document reference: 48282 |
| Study title: Evaluation of the ventilation-perfusion ratio in lung diseases by simultaneous anterior and posterior image acquisition. Nakata Y, Narabayashi I, Sueyoshi K, Matsui R, Namba R, Tabuchi K. Ann Nucl Med. 1994 Nov;8(4):269-76. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48264 |
| Study title: Gamma probe-guided thoracoscopic surgery of small pulmonary nodules. Boni G, Bellina CR, Grosso M, Lucchi M, Manca G, Ambrogi MC, Volterrani D, Menconi G, Melfi FM, Gonfiotti A, Davini F, Angeletti CA, Bianchi R, Chella A. http://www.tumorionline.it/advertising.php Tumori. 2000 Jul-Aug;86(4):364-6. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48231 |
| Study title: Hepatopulmonary syndrome in Gaucher disease with right-to-left shunt: evaluation and measurement using Tc-99m MAA. Kim JH, Park CH, Pai MS, Hahn MH, Kim HJ. Clin Nucl Med. 1999 Mar;24(3):164-6. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48241 |
| Study title: Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Chest. 2000 Sep;118(3):615-24. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48233 |
| Study title: Fluoride concentration in plaque in adolescents after topical application of different fluoride varnishes. |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42424 |
| Study title: SEGMENT I, GENERAL REPRODUCTION PERFORMANCE, RATS.; ORIGIN=HAZLETON USA AND UK; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24384 |
| Study title: SEGMENT I, REPRODUCTIVE STUDY IN MALE AND FEMALE RATS.; ORIGIN=PCS US / SU; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24398 |
| Study title: SEGMENT III - PERINATAL WEANING STUDY, RATS.; ORIGIN=HAZLETON USA AND UK; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24385 |
| Study title: TERATOLOGY, ORAL RABBITS ;ORIGIN=HUNTINGDON |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24390 |
| Study title: TEST FOR TERATOGENIC EFFECT, MOUSE, ORALLY.; ORIGIN=PCS CH; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24399 |
| Study title: TEST ON TERATOGENIC EFFECT - MICE, ORAL ADMINISTRATION |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24402 |
| Study title: TEST ON TERATOGENIC EFFECT - RATS |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24382 |
| Study title: THE EFFECT OF G34586 UPON PREGNANCY IN THE NEW ZEALAND WHITE RABBIT.; ORIGIN=HUNTINGDON LIFE SCIENCES; CONTRACTOR=1; |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24400 |
| Study title: Clinical report on the efficacy and tolerability of Bromocodeina syrup in paediatric patients suffering from cough |
| Active substance: CODEINE |
| Study summary document link (including results): Codeine_Synopsis.doc |
| View full study record |
| Document reference: 47532 |
| Study title: Greene−S−L, Reed−C−E, Schroeter−A−L. Double−blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. Journal of the American Academy of Dermatology, {J−Am−Acad−Dermatol}, Apr 1985, vol. 12, no. 4, p. 669−75. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24486 |
| Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24483 |
| Study title: Moscati−R−M, Moore−G−P. Comparison of cimetidine and diphenhydramine in the treatment of acute urticaria. Annals of emergency medicine, {Ann−Emerg−Med}, Jan 1990, vol. 19, no. 1, p. 12−5. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24485 |
| Study title: Raphael−G−D, Angello−J−T, Wu−M−M, Druce−H−M. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate−to−severe seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology {ANN−ALLERGY−ASTHMA−IMMUNOL}, 2006, Vol/Iss/Pg. 96/4 (606−614). |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24484 |
| Study title: Russo−R−M, Gururaj−V−J, Allen−J−E. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. Journal of clinical pharmacology, {J−Clin−Pharmacol}, May−Jun 1976, vol. 16, no. 5−6, p. 284−8. |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24482 |
| Study title: Simons, K.J. et al.:Diphenhydramin: Pharmacokinetic and Pharmacodynamic in elderly Adults, Young Adults, and Children. J Clin Pharmacol 1990;30:665-671 |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24487 |
| Study title: Yoder−K−E, Shaffer−M−L, La−Tournous−S−J, Paul−I−M. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clinical Pediatrics {CLIN−PEDIATR}, 2006, Vol/Iss/Pg. 45/7 (633−640). |
| Active substance: CODEINE_AND_DIPHENHYDRAMINE_AND_L-MENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24481 |
| Study title: A multi-centre, double blind, parallel group, prospective, randomised study to compare the efficacy of a single dose of 10 mg/kg ibuprofen with 15 mg/kgparacetamol in febrile children aged from 3 months to 12 years followed by tolerability over up to thre |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24499 |
| Study title: TREATMENT OF VAGINAL CANDIDIASIS WITH A SINGLE ORAL DOSE OF FCA. MULTICENTER NON-COMPARATIVE OPEN STUDY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27772 |
| Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27486 |
| Study title: USEFULNESS OF DIFLUCAN THERAPY FOR SYSTEMIC FUNGAL INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISEASES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27850 |
| Study title: Acta Neurochir Suppl. 2005;95:165-8. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, Menon DK, Pickard JD, Hutchinson PJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28090 |
| Study title: Acta Neurol Belg. 2001 Dec;101(4):196-209. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine. Vander Borght T, Laloux P, Maes A, Salmon E, Goethals I, Goldman S; Belgian Society for Nuclear Medicine. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28162 |
| Study title: Ann Acad Med Singapore. 2004 Mar;33(2):183-5. Semi-quantitative measurements of normal organs with variable metabolic activity on FDG PET imaging. Tan LT, Ong KL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28126 |
| Study title: Ann Nucl Med. 2004 Apr;18(2):131-6. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. Koga H, Sasaki M, Kuwabara Y, Nakagawa M, Hayashi K, Kaneko K, Chen T, Honda H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28123 |
| Study title: Ann Nucl Med. 2004 Oct;18(7):579-84. Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy. Hikima A, Mochizuki H, Oriuchi N, Endo K, Morikawa A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28117 |
| Study title: Ann Nucl Med. 2005 Apr;19(2):101-8. The effect of oral contrast on large bowel activity in FDG-PET/CT. Otsuka H, Graham MM, Kubo A, Nishitani H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28103 |
| Study title: Ann Nucl Med. 2006 Jan;20(1):79-82. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. Kaneta T, Hakamatsuka T, Yamada T, Takase K, Sato A, Higano S, Kinomura S, Fukuda H, Takahashi S, Yamada S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28089 |
| Study title: Ann Oncol. 2005 Jul;16(7):1160-8. Epub 2005 Jun 6. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28102 |
| Study title: Anticancer Res. 1998 May-Jun;18(3B):2011-3. Escalating dose of oral ondansetron in the prevention of radiation induced emesis. Maisano R, Pergolizzi S, Settineri N. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28190 |
| Study title: A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. (Feb 1988) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29383 |
| Study title: A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. Feb 1988. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29618 |
| Study title: A phase III comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29494 |
| Study title: Khan SA et al.The treatment of chronic psoriasis a two centre comparative study 1981;225;(1356):932-4Khan SA et al.The treatment of chronic psoriasis a two centre comparative study 1981;225;(1356):932-4 |
| Active substance: TARS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43362 |
| Study title: Langner A et al. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutaneous medicine for the practitioner 1983;32;(3):290-1;295-6 Langner A et al. Treatment of psoriasis of the scalp with coal tar gel and shampoo preparations. Cutaneous medicine for the practitioner 1983;32;(3):290-1;295-6 |
| Active substance: TARS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43361 |
| Study title: Carter NJ, Brown A, Barrington SF, O'Doherty MJ, Nunan TO, Coakley AJ. A one-hour walk-in service for wrist trauma imaging. Nucl Med Commun. 1999 Dec;20(12):1161-4. Carter NJ, Brown A, Barrington SF, O'Doherty MJ, Nunan TO, Coakley AJ. A one-hour walk-in service for wrist trauma imaging. Nucl Med Commun. 1999 Dec;20(12):1161-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43495 |
| Study title: Haematologica. 2006 Apr;91(4):475-81. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I, Luminari S, Vitolo U, Sancetta R, Iannitto E, Trentin L, Stelitano C, Tavera S, Biggi A, Castagnoli A, Versari A, Gregianin M, Pelosi E, Torchio P, Levis A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28082 |
| Study title: Hepatology. 2006 Dec;44(6):1572-80. Comment in: Liver Transpl. 2007 Apr;13(4):622-3. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.Prytz H, Keiding S, BjÃrnsson E, Broomé U, Almer S, Castedal M, Munk OL; Swedish Internal Medicine Liver Club. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28071 |
| Study title: IEEE Trans Biomed Eng. 2005 Sep;52(9):1574-81. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection of epileptic foci. Muzik O, Pourabdollah S, Juhasz C, Chugani DC, Janisse J, Draghici S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28095 |
| Study title: Int J Nurs Stud. 2007 Aug;44(6):973-81. Epub 2006 Jun 16. Effects of acupressure on dysmenorrhea and skin temperature changes in college students: a non-randomized controlled trial. Jun EM, Chang S, Kang DH, Kim S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28080 |
| Study title: Isr J Med Sci. 1996 Oct;32(10):812-4. How to use information from echocardiography and magnetic resonance for diagnosing myocardial viability. Sechtem U. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28196 |
| Study title: J Am Coll Cardiol. 2000 Nov 1;36(5):1676-83. Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction. Rickers C, Sasse K, Buchert R, Stern H, van den Hoff J, Lübeck M, Weil J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28173 |
| Study title: J Cardiovasc Pharmacol. 1996 Apr;27(4):563-70. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. Steinmetz A, Schwartz T, Hehnke U, Kaffarnik H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28198 |
| Study title: J Child Neurol. 1994 Apr;9(2):155-61. Neuroimaging in infantile autism. Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28204 |
| Study title: J Child Neurol. 2006 Jun;21(6):456-62. Pilot study of positron emission tomography (PET) brain glucose metabolism to assess the efficacy of tongue and body acupuncture in cerebral palsy. Wong VC, Sun JG, Yeung DW. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28077 |
| Study title: J Child Neurol. 2006 Jun;21(6):463-73. Pilot study of efficacy of tongue and body acupuncture in children with visual impairment. Wong VC, Sun JG, Yeung DW. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28076 |
| Study title: J Clin Oncol. 2005 May 1;23(13):3030-7. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, Schmiegelow K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28104 |
| Study title: J Clin Psychiatry. 2002;63 Suppl 12:29-35. Management of ADHD in adults. Adler LA, Chua HC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28151 |
| Study title: Crone-Münzebrock W, Heller M, Witte G. [The importance of circumscript activity concentrations of the frontobasal region of the skull in skeletal scintigraphy (author's transl)] Radiol Diagn (Berl). 1981;22(6):815-8. German. No abstract available. Crone-Münzebrock W, Heller M, Witte G. [The importance of circumscript activity concentrations of the frontobasal region of the skull in skeletal scintigraphy (author's transl)] Radiol Diagn (Berl). 1981;22(6):815-8. German. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44131 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43340 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43350 |
| Study title: Chow PKH, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 2002;36(5):1221-6 2002;(5):1221-1226.Chow PKH, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ et al. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial. Hepatology 2002;36(5):1221-6 2002;(5):1221-1226. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43100 |
| Study title: Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen.Arush MWB, Postovsky S, Goldsher D, El Hasid R, Constantini S. Pediatric Hematology & Oncology~ 16(3):245-250, May-June, 1999 1999;(3):250, May-June, 1999. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43285 |
| Study title: Combination chemotherapy for desmoid tumors. Okuno SH, Edmonson JH. Cancer~ 97(4):1134-1135, February 15, 2003 2003;(4):-1135, February. Combination chemotherapy for desmoid tumors. Okuno SH, Edmonson JH. Cancer~ 97(4):1134-1135, February 15, 2003 2003;(4):-1135, February. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43273 |
| Study title: Complementary and alternative medical therapies for children with cancer. Kelly KM. European Journal of Cancer 2004;40(14):2041-2046 2004;(14):2041-2046.Complementary and alternative medical therapies for children with cancer. Kelly KM. European Journal of Cancer 2004;40(14):2041-2046 2004;(14):2041-2046. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43265 |
| Study title: Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 1996; 77(10):2058-2063.Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use. Cancer 1996; 77(10):2058-2063. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43117 |
| Study title: Comparative study of ibuprofen syrup and paracetamol in soft tissue injuries in children. |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24493 |
| Study title: Final Report from the Post Marketing Surveillance Study (Nurofen fur Kinder Fiebersaft) |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24498 |
| Study title: Ibuprofen vs paracetamol in soft tissue injuries in children. |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24494 |
| Study title: Nurofen for Children in Febrile Children. Data held in Ukraine. Copy report, Protocol, Ethics and correspondence. |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24495 |
| Study title: Report on a comparative assessment of the antipyretic activity of ibuprofen and paracetamol suspensions in children. |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24492 |
| Study title: Treatment of Pyrexia Associated with Infectious Disease in Children |
| Active substance: CODEINE_AND_IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24497 |
| Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24562 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24548 |
| Study title: Jenkin-D, Greenberg-M, Fitzgerald-A. Toronto-Sunnybrook Regional Cancer Centre, Princess Margaret Hospital, University of Toronto, Canada. Second malignant tumours in childhood Hodgkin's disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jun 1996, vol. 26, no. 6, p. 373-9, ISSN: 0098-1532.Jenkin-D, Greenberg-M, Fitzgerald-A. Toronto-Sunnybrook Regional Cancer Centre, Princess Margaret Hospital, University of Toronto, Canada. Second malignant tumours in childhood Hodgkin's disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jun 1996, vol. 26, no. 6, p. 373-9, ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34752 |
| Study title: Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. Katzenstein HM et al. J Clin Oncol. June 15, 2002, 2789-97 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 12065555.pdf |
| View full study record |
| Document reference: 28270 |
| Study title: Improved long-term survival with preoperative chemotherapy for hepatoblastoma. Ehrlich PF, Greenberg ML, Filler RM. J Pediatr Surg. 1997 Jul;32(7):999-1002 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 9247221.pdf |
| View full study record |
| Document reference: 28312 |
| Study title: Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007.Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29606 |
| Study title: Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. Malogolowkin MH et al. J Clin Oncol. 2006 Jun 20;24(18):2879-84 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28299 |
| Study title: Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. Ogita S. Regional Cancer Treatment. December 1, 1992, 106-9 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28291 |
| Study title: Intraoperative irradiation: Current and future status. Gunderson LL. Semin Oncol. December 1, 1997, 715-31 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28282 |
| Study title: Late complications after glaucoma filtering surgery with adjunctive 5- fluorouracil. Ticho U, Ophir A. Am J Ophthalmol. May 3, 1993, 506-10 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28293 |
| Study title: Management of a 16-year-old boy with adenocarcinoma at the esophageal gastric junction. Zotter H et al. Med Pediatr Oncol. 2001 Dec;37(6):557 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28307 |
| Study title: A phase III comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 93-344.pdf |
| View full study record |
| Document reference: 47455 |
| Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29557 |
| Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29625 |
| Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 93-330.pdf |
| View full study record |
| Document reference: 47453 |
| Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of ibuprofen chewable tablets 400 mg, ibuprofen suspension 400 mg/20 ml or placebo in post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29496 |
| Study title: A Phase IV Comparative Study Evaluating the Onset of Analgesia Using a Single Dose of Ibuprofen Chewable Tablets 400 mg, Ibuprofen Suspension 400 mg/20 mL, or Placebo in Post-Operative Dental Pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 95-524.pdf |
| View full study record |
| Document reference: 47456 |
| Study title: A phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrhea |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29479 |
| Study title: A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29548 |
| Study title: A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29627 |
| Study title: A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29491 |
| Study title: A randomised double blind nultiple-dose study comparing the efficacy and tolerability of Iburprofen versus Paracetamol (both syrup formulations) in the treatment of fever in children known with febrile convulsions |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen- br1178-vanEsch.xls |
| View full study record |
| Document reference: 29414 |
| Study title: A randomized double-blind single dose study comparing ibuprofen 200 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of pain following orthopedic surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29505 |
| Study title: Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, Henze E. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning. Nuklearmedizin. 2000 Aug;39(5):127-32. Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, Henze E. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning. Nuklearmedizin. 2000 Aug;39(5):127-32. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43477 |
| Study title: J Comput Assist Tomogr. 2003 Jul-Aug;27(4):525-9. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. Lee JK, Liu RS, Shiang HR, Pan DH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28144 |
| Study title: J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):743-8. Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. Lamusuo S, Ruottinen HM, Knuuti J, HärkÃnen R, Ruotsalainen U, Bergman J, Haaparanta M, Solin O, Mervaala E, Nousiainen U, Jääskeläinen S, Ylinen A, Kälviäinen R, Rinne JK, Vapalahti M, Rinne JO. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28193 |
| Study title: J Neurooncol. 2007 Mar;82(1):95-101. Epub 2006 Sep 22. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28073 |
| Study title: J Neurosurg. 1995 Mar;82(3):445-52. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28199 |
| Study title: J Neurosurg. 1999 Nov;91(5):797-803. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. Kaplan AM, Bandy DJ, Manwaring KH, Chen K, Lawson MA, Moss SD, Duncan JD, Wodrich DL, Schnur JA, Reiman EM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28180 |
| Study title: Autret−E et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. {Eur−J−Clin−Pharmacol}, 1997, vol. 51, no. 5, p. 367−71Autret−E et al. Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever. {Eur−J−Clin−Pharmacol}, 1997, vol. 51, no. 5, p. 367−71 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29578 |
| Study title: Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211)Autret−Leca−E et al. Ibuprofen versus paracetamol in pediatric fever: Objective and subjective findings from a randomized, blinded study. {CURR−MED−RES−OPIN}, 2007, Vol /Iss/Pg. 23/9 (2205−2211) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29567 |
| Study title: Brufen syrup in juvenile chronic polyarthritis, rheumatic fever soft tissue injuries and infectious disorders in children, The Boots Company, India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29431 |
| Study title: Brufen syrup in the treatment of juvenile pyrexia -expert report on the clinical documentation which is included in the product licence application |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29452 |
| Study title: Children’s Advil ® Cold & Sinus Suspension Multiple-Dose Safety Study in Children 2 to <12 Years Old |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29541 |
| Study title: Clark E. et al.: A Randomized, Controlled Traial of Acetaminophen, Ibuprofen, and Codeine for Acute Releif in children With Musculoskeletal Trauma; PAEDIATRICS Volume 119, Number 3, March 2007 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29546 |
| Study title: Clark E. et al.: A Randomized, Controlled Traial of Acetaminophen, Ibuprofen, and Codeine for Acute Releif in children With Musculoskeletal Trauma; PAEDIATRICS Volume 119, Number 3, March 2007Clark E. et al.: A Randomized, Controlled Traial of Acetaminophen, Ibuprofen, and Codeine for Acute Releif in children With Musculoskeletal Trauma; PAEDIATRICS Volume 119, Number 3, March 2007 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29607 |
| Study title: Clin Ther. 2007 Dec;29(12):2716-23. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma related symptoms. Kanabar D, Dale S, Rawat M.Clin Ther. 2007 Dec;29(12):2716-23. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma related symptoms. Kanabar D, Dale S, Rawat M. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29610 |
| Study title: Clinical trials of Ibuprofen Syrup in the Treatment of Juvenile Arthritis by Dr P Boonchob, Thailand |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-M83-104.pdf |
| View full study record |
| Document reference: 29453 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43232 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43242 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000; 18(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43314 |
| Study title: Pediatr Radiol. 2004 Mar;34(3):190-8. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. Hudson MM, Krasin MJ, Kaste SC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28137 |
| Study title: Pediatr Radiol. 2005 Feb;35(2):141-54. Epub 2004 Nov 16. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. Kaste SC, Howard SC, McCarville EB, Krasin MJ, Kogos PG, Hudson MM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28113 |
| Study title: Pharmacotherapy. 1992;12(5):369-75. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen metabolism in healthy subjects by positron emission tomography. Bednarczyk EM, Green JA, Nelson AD, Leisure GP, Little D, Adler LP, Berridge MS, Panacek EA, Miraldi FD. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28206 |
| Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):23-7. Cancer screening with FDG-PET. Ide M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28085 |
| Study title: Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera. Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N, Laurençon V, Henry-Amar M, Bardet S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28084 |
| Study title: Q J Nucl Med. 2003 Mar;47(1):41-5. Assessment of therapy response by FDG PET in pediatric patients. Franzius C, Schober O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28148 |
| Study title: Radiol Clin North Am. 2005 Jan;43(1):135-52. PET in pediatric diseases. Jadvar H, Alavi A, Mavi A, Shulkin BL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28112 |
| Study title: Radiology. 1996 Jun;199(3):743-50. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28197 |
| Study title: Radiology. 1998 Oct;209(1):253-8. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28189 |
| Study title: Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie. Mertens R et al. Cancer. 1997 Sep 1;80(5):951-9 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 9307197.pdf |
| View full study record |
| Document reference: 28311 |
| Study title: Nasopharyngeal carcinomas: Analysis of patient, tumor and treatment characteristics determining outcome. Erkal HS et al. Radiother Oncol. December 27, 2001, 247-56 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28273 |
| Study title: Neuroendocrine gastroenteropancreatic tumors: 11 Years of clinical experience. Cirillo F. Int J Med Biol Environ. July 1, 2001, 129-41 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28268 |
| Study title: New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Asilian A, Darougheh A, Shariati F. Dermatol Surg. July 1, 2006, 907-15 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28266 |
| Study title: Newer techniques in cancer chemotherapy. Markman M. Dis Mon. 1984 Jul;30(10):1-48 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28322 |
| Study title: Opinion and evidence in cancer: From the world literature. Am J Cancer. December 1, 2002, 153-63 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28267 |
| Study title: Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet! Samur M, Bozcuk HS. J Clin Oncol. 2003 Jun 15;21(12):2444 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28302 |
| Study title: Pediatric phase I trials in oncology: An analysis of study conduct efficiency. Lee DP, Skolnik JM, Adamson PC. J Clin Oncol. December 1, 2005, 8431-41 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28295 |
| Study title: Jenkin-R-D-T, Anderson-J-R, Chilcote-R-R, et-al. Children's Cancer Study Group, Los Angeles, CA 90031, United States. The treatment of localized non-Hodgkin's lymphoma in children: a report from the children's cancer study group. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1984, Vol/Iss/Pg. 2/2 (88-97).Jenkin-R-D-T, Anderson-J-R, Chilcote-R-R, et-al. Children's Cancer Study Group, Los Angeles, CA 90031, United States. The treatment of localized non-Hodgkin's lymphoma in children: a report from the children's cancer study group. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1984, Vol/Iss/Pg. 2/2 (88-97). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34754 |
| Study title: Jenkin-R-D-T, Berry-M-P. Dept. Radiat. Oncol., Ontario Cancer Inst., Toronto, Ontario, M4X 1K9, Canada. Hodgkin's disease in children. Seminars in Oncology {SEMIN-ONCOL}, 1980, Vol/Iss/Pg. 7/2 (202-211).Jenkin-R-D-T, Berry-M-P. Dept. Radiat. Oncol., Ontario Cancer Inst., Toronto, Ontario, M4X 1K9, Canada. Hodgkin's disease in children. Seminars in Oncology {SEMIN-ONCOL}, 1980, Vol/Iss/Pg. 7/2 (202-211). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34755 |
| Study title: Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D. University of Southern California School of Medicine, Los Angeles. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of neuro-oncology, {J-Neurooncol}, Jul 1989, vol. 7, no. 2, p. 165-77, ISSN: 0167-594X.Sposto-R, Ertel-I-J, Jenkin-R-D, Boesel-C-P, Venes-J-L, Ortega-J-A, Evans-A-E, Wara-W, Hammond-D. University of Southern California School of Medicine, Los Angeles. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. Journal of neuro... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34849 |
| Study title: Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. Brill DR. Sports nuclear medicine. Bone imaging for lower extremity pain in athletes. Clin Nucl Med. 1983 Mar;8(3):101-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44045 |
| Study title: Brown CV, Miller JH. Extraskeletal localization of MDP in soft tissue secondary to methotrexate infiltration. Clin Nucl Med. 1994 Apr;19(4):357-8. No abstract available. Brown CV, Miller JH. Extraskeletal localization of MDP in soft tissue secondary to methotrexate infiltration. Clin Nucl Med. 1994 Apr;19(4):357-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43629 |
| Study title: Brown JM. Berkey BD, Brooks JA. Discovery of a renal medullary carcinoma in an adolescent male with sickle cel l trait by Tc-99m methylene disphosponate bone scintigraphy. Clin Nucl Med 2008;33:896-900.Brown JM. Berkey BD, Brooks JA. Discovery of a renal medullary carcinoma in an adolescent male with sickle cel l trait by Tc-99m methylene disphosponate bone scintigraphy. Clin Nucl Med 2008;33:896-900. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47917 |
| Study title: Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. Brown JN. The suspected scaphoid fracture and isotope bone imaging. Injury. 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43590 |
| Study title: Brunetti A, Tedeschi E, Belfiore G, Salvatore M. [Neuroblastoma metastasis to the falx cerebri. A case report] Radiol Med (Torino). 1992 Apr;83(4):467-70. Italian. No abstract available. Brunetti A, Tedeschi E, Belfiore G, Salvatore M. [Neuroblastoma metastasis to the falx cerebri. A case report] Radiol Med (Torino). 1992 Apr;83(4):467-70. Italian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43699 |
| Study title: Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. Buck FM, Treumann TC, Winiker H, Strobel K. Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. J Magn Reson Imaging. 2007 Aug;26(2):422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43363 |
| Study title: Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. Burke TS, Tatum JL, Fratkin MJ, Baker K. Radionuclide bone imaging findings in recurrent calvarial infarction in sickle cell disease. J Nucl Med. 1988 Mar;29(3):411-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43825 |
| Study title: The complementary role of sequential 99mTc-MDP and 67Ga-citrate scanning in the diagnosis and follow-up of neuroblastoma. Garty I, Koren A, Goshen Y, Siplovich L in the Eur J Nucl Med. 1985;11(6-7):224-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43959 |
| Study title: Nearly total absence of pulmonary perfusion with corresponding technetium-99m MDP and gallium-67 uptake in a patient with mediastinal neuroblastoma. Garty I, Koren A, Moguilner G, Dharan M, Siplovitch L. Clin Nucl Med. 1985 Aug;10(8):579-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43934 |
| Study title: Comparison of dextranomer and streptokinase-streptodornase in the treatment of venous leg ulcers and other infected wounds.Hulkko A, Holopainen YV, Orava S, Kangas J, Kuusisto P, Hyvärinen E, Ervasti E, Silvennoinen E. Ann Chir Gynaecol. 1981;70(2):65-70. |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48946 |
| Study title: [Conservative treatment of anal cryptitis and fissure as well as anal thrombosis with a streptokinase-streptodornase gel]. [Article in German] Frank W, Wilhelm E, Bouillon M. ZFA (Stuttgart). 1982 Apr 30;58(12):713-6. |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48945 |
| Study title: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001505. Update of: Cochrane Database Syst Rev. 2000;(2):CD001505. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Lands LC, Stanojevic S.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001505. Update of: Cochrane Database Syst Rev. 2000;(2):CD001505. Oral non-steroidal anti-inflammatory drug therapy for cystic fibrosis. Lands LC, Stanojevic S. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29614 |
| Study title: Comparative evaluation of anti-pyretic activity of Ibuprofen and Aspirin in children with pyrexia o varied aetiology - India. (By P W Kandoth, M K Joshi, V R Joshi, R S Satoskar) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29432 |
| Study title: Comparative evaluation of anti-pyretic activity of Ibuprofen and Aspirin in children with pyrexia of varied aetiology by Prof P W Kandoth, M K Joshi, V R Joshi, R S Satoskar, India. J. Int. Med. Res. (1984) 12, 292 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29449 |
| Study title: Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29471 |
| Study title: Comparative study of ibuprofen syrup and paracetamol in soft tissue injuries in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29391 |
| Study title: COMPARATIVE STUDY OF IBUPROFEN SYRUP AND PARACETAMOL SYRUP IN SOFT TISSUE INJURIES IN CHILDREN |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS85-806-CSR.pdf |
| View full study record |
| Document reference: 47555 |
| Study title: Casara D, Bonazza A. Rhabdomyosarcoma concentrating Tc-99m MDP. J Nucl Med. 1983 Nov;24(11):1082-3. No abstract available. Casara D, Bonazza A. Rhabdomyosarcoma concentrating Tc-99m MDP. J Nucl Med. 1983 Nov;24(11):1082-3. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44024 |
| Study title: Cavailloles F, Bok B, Bensahel H. Bone scintigraphy in the diagnosis and follow up of Perthes' disease. Eur J Nucl Med. 1982;7(7):327-30. Cavailloles F, Bok B, Bensahel H. Bone scintigraphy in the diagnosis and follow up of Perthes' disease. Eur J Nucl Med. 1982;7(7):327-30. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44101 |
| Study title: Cawley KA, Dvorak AD, Wilmot MD. Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. J Nucl Med. 1983 Jan;24(1):14-6. Cawley KA, Dvorak AD, Wilmot MD. Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. J Nucl Med. 1983 Jan;24(1):14-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44062 |
| Study title: Celen Z, Zincirkeser S, Ozkiliç S, Nacar F. Evaluation of growth in children using quantitative bone scintigraphy. J Int Med Res. 1999;27(6):286-91. Celen Z, Zincirkeser S, Ozkiliç S, Nacar F. Evaluation of growth in children using quantitative bone scintigraphy. J Int Med Res. 1999;27(6):286-91. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43489 |
| Study title: Cermik TF, Salan A, Firat MF, Berkarda S. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Clin Nucl Med. 2003 Jul;28(7):599-600. No abstract available. Cermik TF, Salan A, Firat MF, Berkarda S. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma. Clin Nucl Med. 2003 Jul;28(7):599-600. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43417 |
| Study title: Cervelli V, Cipriani C, Migliano E, Giudiceandrea F, Cervelli G, Grimaldi M. SPECT in the long-term evaluation of osteointegration in intraoral and extraoral implantology. J Craniofac Surg. 1997 Sep;8(5):379-82. Cervelli V, Cipriani C, Migliano E, Giudiceandrea F, Cervelli G, Grimaldi M. SPECT in the long-term evaluation of osteointegration in intraoral and extraoral implantology. J Craniofac Surg. 1997 Sep;8(5):379-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43536 |
| Study title: Radiother Oncol. 2004 Dec;73(3):277-83. Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma. Lee YK, Cook G, Flower MA, Rowbottom C, Shahidi M, Sharma B, Webb S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28116 |
| Study title: Respiration. 2006;73(5):634-41. Epub 2006 May 5. Comment in: Respiration. 2006;73(5):587-9. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT. Naalsund A, Maublant J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28081 |
| Study title: Rofo. 1999 Aug;171(2):87-94. [The lymph node staging of malignant testicular germ-cell tumors] [Article in German] Krug B, Heidenreich A, Dietlein M, Lackner K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28183 |
| Study title: Semin Nucl Med. 1989 Oct;19(4):282-94. Monoclonal antibodies and neuroblastoma. Miraldi F. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28208 |
| Study title: Semin Nucl Med. 2007 Sep;37(5):316-31.PET and PET/CT in pediatric oncology. Jadvar H, Connolly LP, Fahey FH, Shulkin BL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28065 |
| Study title: Semin Nucl Med. 2007 Sep;37(5):357-81.Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Patil S, Biassoni L, Borgwardt L. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28064 |
| Study title: Stereotact Funct Neurosurg. 1995;64 Suppl 1:258-69. Early irradiation effects observed on magnetic resonance imaging and angiography, and positron emission tomography for arteriovenous malformations treated by Gamma Knife radiosurgery. Guo WY, Pan DH, Liu RS, Chung WY, Shiau CY, Cheng SS, Chang CY, Chen KY, Yeh SH, Lee LS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28200 |
| Study title: Thyroid. 2002 Feb;12(2):155-61. Implication of 2-18fluor-2-deoxyglucose positron emission tomography in the follow-up of Hürthle cell thyroid cancer. Plotkin M, Hautzel H, Krause BJ, Schmidt D, Larisch R, Mottaghy FM, Boemer AR, Herzog H, Vosberg H, Müller-Gärtner HW. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28160 |
| Study title: |
| Active substance: fluid extract derived from thyme (1 : 2-2.5); extracting agent: pursuant to DAB, tincture derived from ivy leaves (1 : 1); extracting agent: ethanol 70 vol. %. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40002 |
| Study title: Bentzinger C*,Biziere K,Plovin P,Dulac O,Chiron C,Girod R,Hewson G,Metcalfe S,Siegel J L, Clinical Final Study Report: Open-label exploratory study of the effects of acute i.v. flumazenil on interictal epileptic activity in pediatric patients with treated or untreated Lennox-Gastaut syndrome |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28213 |
| Study title: Hepatopulmonary syndrome: a rare complication of chronic liver disease in children. Yap FK, Aw MM, Quek SC, Quak S Ann Acad Med Singapore. 1999 Mar;28(2):290-3. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48238 |
| Study title: Hyperlucent lung secondary to homocystinuria. Herman J, Miller JH, Wang F. Pediatr Radiol. 1996 Sep;26(9):672-4. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48250 |
| Study title: Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study. Vettukattil JJ, Slavik Z, Lamb RK, Monro JL, Keeton BR, Tsang VT, Aldous AJ, Zivanovic A, Johns S, Lewington V, Salmon AP. Heart. 2000 Apr;83(4):425-8. Comment in: Heart. 2000 Nov;84(5):467-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48236 |
| Study title: Localization of Tc-99m MDP in neuroblastoma metastases to the liver and lung. Connolly LP, Bloom DA, Kozakewich H, Hoffer FA, Treves ST. Clin Nucl Med. 1996 Aug;21(8):629-33. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43563 |
| Study title: [Clinical evaluation of Kr-81m inhalation study through a dead space] [Article in Japanese]Kaku Igaku. 1990 Feb;27(2):125-31. Kurosawa H 1990 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48539 |
| Study title: Echizenya M et al. The 32nd annual meeting of Japanese Society of Sleep Research (7-9 November, 2007).Echizenya M et al. The 32nd annual meeting of Japanese Society of Sleep Research (7-9 November, 2007). |
| Active substance: MIANSERIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31985 |
| Study title: Sullivan-M-P, Fuller-L-M, Chen-T, Fisher-R, Fryer-C, Gehan-E,Gilchrist-G-S, Hays-D, Hanson-W, Heller-R, Higgins-G, Jenkin-D, Kung-F, Sheehan-W, Tefft-M, Ternberg-J, Wharam-M. Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report. Cancer treatment reports, {Cancer-Treat-Rep}, Apr 1982, vol. 66, no. 4, p. 937-47, ISSN: 0361-5960.Sullivan-M-P, Fuller-L-M, Chen-T, Fisher-R, Fryer-C, Gehan-E,Gilchrist-G-S, Hays-D, Hanson-W, Heller-R, Higgins-G, Jenkin-D, Kung-F, Sheehan-W, Tefft-M, Ternberg-J, Wharam-M. Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report. Cancer treatment reports, {Cancer-Treat-Rep}, Apr 1982, vol. 66, no. 4, p. 937-47, ISSN: 0361-5960. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34850 |
| Study title: Sullivan-M-P, Fuller-L-M. A chemotherapy-radiotherapy Rx regimen for children with stage 3 Hodgkin's disease. CA: a cancer journal for clinicians, {CA-Cancer-J-Clin}, Jul-Aug 1973, vol. 23, no. 4, p. 232-41, ISSN: 0007-9235.Sullivan-M-P, Fuller-L-M. A chemotherapy-radiotherapy Rx regimen for children with stage 3 Hodgkin's disease. CA: a cancer journal for clinicians, {CA-Cancer-J-Clin}, Jul-Aug 1973, vol. 23, no. 4, p. 232-41, ISSN: 0007-9235. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34851 |
| Study title: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report. Cancer, {Cancer}, 15 Jul 1987, vol. 60, no. 2, p. 173-7, ISSN: 0008-543X.Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report. Cancer, {Cancer}, 15 Jul 1987, vol. 60, no. 2, p. 173-7, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34852 |
| Study title: Tan-C-T. Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 291-302, ISSN: 0927-3042.Tan-C-T. Hodgkin's disease in children and adolescents. Experiences from the Memorial Sloan-Kettering Cancer Center, New York. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 291-302, ISSN: 0927-3042. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34856 |
| Study title: Tan-C, D-angio-G-J, Exelby-P-R, Lieberman-P-H, Watson-R-C, Cham-W-C, Murphy-M-L. The changing management of childhood Hodgkin's disease. Cancer, {Cancer}, Mar 1975, vol. 35, no. 3, p. 808-16, ISSN: 0008-543X.Tan-C, D-angio-G-J, Exelby-P-R, Lieberman-P-H, Watson-R-C, Cham-W-C, Murphy-M-L. The changing management of childhood Hodgkin's disease. Cancer, {Cancer}, Mar 1975, vol. 35, no. 3, p. 808-16, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34853 |
| Study title: Tan-C, Jereb-B, Chan-K-W, et-al. Dep. Pediatr., Meml. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Hodgkin's disease in children. Results of management between 1970-1981. Cancer {CANCER}, 1983, Vol/Iss/Pg. 51/9 (1720-1725).Tan-C, Jereb-B, Chan-K-W, et-al. Dep. Pediatr., Meml. Sloan-Kettering Cancer Cent., New York, NY 10021, United States. Hodgkin's disease in children. Results of management between 1970-1981. Cancer {CANCER}, 1983, Vol/Iss/Pg. 51/9 (1720-1725). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34854 |
| Study title: 51. Hanck A. Verhuetung und Behandlung der postoperativen Daratonie und anderer Formen des paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977;27:6878, 1881-4, 6887.51. Hanck A. Verhuetung und Behandlung der postoperativen Daratonie und anderer Formen des paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977;27:6878, 1881-4, 6887. |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35143 |
| Study title: 52. Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11. 52. Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11. |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35144 |
| Study title: Garty I, Koren A. Simultaneous demonstration of photopenic ("cold") and osteoblastic ("hot") skull metastases in a patient with neuroblastoma. Clin Nucl Med. 1985 Jul;10(7):529. No abstract available. Garty I, Koren A. Simultaneous demonstration of photopenic ("cold") and osteoblastic ("hot") skull metastases in a patient with neuroblastoma. Clin Nucl Med. 1985 Jul;10(7):529. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43937 |
| Study title: Pitfalls in the diagnosis of neuroblastoma by 99mTc-MDP scintigraphy: a case report. Garty I, Siplovich L, Moguilner J. Eur J Nucl Med. 1984;9(12):564-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44010 |
| Study title: Garty I, Tanzman M, Reiner S. Accumulation of technetium-99m MDP in distended ureter. A potential error in diagnosing osteoblastic bone activity. Clin Nucl Med. 1985 Sep;10(9):667. No abstract available. PMID: 2933203 [PubMed - indexed for MEDLINE] Garty I, Tanzman M, Reiner S. Accumulation of technetium-99m MDP in distended ureter. A potential error in diagnosing osteoblastic bone activity. Clin Nucl Med. 1985 Sep;10(9):667. No abstract available. PMID: 2933203 [PubMed - indexed for MEDLINE] |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43933 |
| Study title: Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. Gellad FE, Haney PJ, Sun JC, Robinson WL, Rao KC, Johnston GS. Imaging modalities of craniosynostosis with surgical and pathological correlation. Pediatr Radiol. 1985;15(5):285-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43962 |
| Study title: Gerety E, Siegel A. Thoracic lymph node visualization after a peritoneal leak study. Clin Nucl Med. 2001 Feb;26(2):157-8. No abstract available. Gerety E, Siegel A. Thoracic lymph node visualization after a peritoneal leak study. Clin Nucl Med. 2001 Feb;26(2):157-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43461 |
| Study title: Geusens E, Brys P, Ghekiere J, Samson I, Sciot R, Brock P, Baert AL. Langerhans cell histiocytosis of the cervical spine: case report of an unusual location. Eur Radiol. 1998;8(7):1142-4. Geusens E, Brys P, Ghekiere J, Samson I, Sciot R, Brock P, Baert AL. Langerhans cell histiocytosis of the cervical spine: case report of an unusual location. Eur Radiol. 1998;8(7):1142-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43526 |
| Study title: Ghelman B, Vigorita VJ. Postoperative radionuclide evaluation of osteoid osteomas. Radiology. 1983 Feb;146(2):509-12. Ghelman B, Vigorita VJ. Postoperative radionuclide evaluation of osteoid osteomas. Radiology. 1983 Feb;146(2):509-12. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44050 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43226 |
| Study title: Biol Psychiatry. 2000 Mar 15;47(6):540-7. A fenfluramine-activated FDG-PET study of borderline personality disorder. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28179 |
| Study title: Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. Chan WL, Carolan MG, Fernandes VB, Abbati DP. Planar versus SPET imaging in the assessment of condylar growth. Nucl Med Commun. 2000 Mar;21(3):285-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43484 |
| Study title: Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8. Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43839 |
| Study title: Visualization of the spleen with radiophosphate in severe combined immunodeficiency disease. Charron M, Rosenthall L. Visualization of the spleen with radiophosphate in severe combined immunodeficiency disease. Clin Nucl Med. 1988 May;13(5):339-41. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43816 |
| Study title: Cheng TH, Holman BL. Increased skeletal:renal uptake ratio: etiology and characteristics. Radiology. 1980 Aug;136(2):455-9. Cheng TH, Holman BL. Increased skeletal:renal uptake ratio: etiology and characteristics. Radiology. 1980 Aug;136(2):455-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44142 |
| Study title: Nuclear imaging and clinical features of childhood reflex neurovascular dystrophy: comparison with adults. Goldsmith DP, Vivino FB, Eichenfield AH, Athreya BH, Heyman S. Arthritis Rheum. 1989 Apr;32(4):480-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43789 |
| Study title: Goodear M, Styles CB. Stress fractures of the thoracic spine transverse processes in a water skier. Clin Nucl Med. 1999 Apr;24(4):285-6. No abstract available. Goodear M, Styles CB. Stress fractures of the thoracic spine transverse processes in a water skier. Clin Nucl Med. 1999 Apr;24(4):285-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43500 |
| Study title: The role of ultrasound and isotope scanning in the management of irritable hips. Gopakumar TS, Vaishya R, Klenerman L, Carty H. Eur J Radiol. 1992 Sep;15(2):113-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43690 |
| Study title: Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. Gordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. J Nucl Med. 1990 Feb;31(2):129-34. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43769 |
| Study title: Gordon I. Undeserved bad press for bone scans. Eur J Nucl Med. 1994 May;21(5):466. No abstract available. Gordon I. Undeserved bad press for bone scans. Eur J Nucl Med. 1994 May;21(5):466. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43625 |
| Study title: Gorenberg M, Groshar D, Israel O, Ben-Arush MW, Kolodny GM, Front D. Stress fractures associated with osteosarcoma of the lower limb. J Nucl Med. 1992 Sep;33(9):1699-700. Gorenberg M, Groshar D, Israel O, Ben-Arush MW, Kolodny GM, Front D. Stress fractures associated with osteosarcoma of the lower limb. J Nucl Med. 1992 Sep;33(9):1699-700. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43688 |
| Study title: [Postoperative care with varidase following phimosis surgery. A comparative study of various application forms]. [Article in German] Tuchen W, Inglis R. ZFA (Stuttgart). 1980 Dec 10;56(34):2419-22. |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48950 |
| Study title: The effectiveness of Varidase was evaluated in the local treatment of skin lesions, particularly wounds with fibrinous or necrotic crusts.Luger et al. 1981 |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48949 |
| Study title: Varidase topical (Streptokinase-Streptodornase) has been clinically evaluated in patients for its efficacy, tolerance, and side effects.Chang et al. 1980 |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48948 |
| Study title: da Rocha AB, Mans DRA, Regner A, Schwartsmann G. Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? Oncologist 2002; 7(1):17-33.da Rocha AB, Mans DRA, Regner A, Schwartsmann G. Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? Oncologist 2002; 7(1):17-33. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43175 |
| Study title: Davies SL, Moral MA. Peripheral precocious puberty. Drugs of the Future 2006; 31(8):713-718.Davies SL, Moral MA. Peripheral precocious puberty. Drugs of the Future 2006; 31(8):713-718. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43087 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43130 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43150 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43173 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin 2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999; 17(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43179 |
| Study title: Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders CNS Drugs. 2005;19(11):923-34. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders CNS Drugs. 2005;19(11):923-34. |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35165 |
| Study title: Bleckmann K.H. Erfahrungsbericht über die Anwendung von Pyrithioxin in der Kinderpraxis (Praxis der Kinderpsychologie und Kinderpsychiatrie 1965; 14(8): 316-7); Bleckmann K.H. Erfahrungsbericht über die Anwendung von Pyrithioxin in der Kinderpraxis (Praxis der Kinderpsychologie und Kinderpsychiatrie 1965; 14(8): 316-7); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35150 |
| Study title: Bönisch E. Erfahrungen mit Pyrithioxin bei hirngeschädigten Kindern mit autistischem Syndrom (3 Europ Kongress Pädopsychiatr 1967); Bönisch E. Erfahrungen mit Pyrithioxin bei hirngeschädigten Kindern mit autistischem Syndrom (3 Europ Kongress Pädopsychiatr 1967); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35151 |
| Study title: Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47); Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35145 |
| Study title: Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, Shockley DH, Weaver NL, Carlos RQ, Ransom JL. Ann Pharmacother. 2005 Jun;39(6):1029-33;Epub 2005 Apr 26. Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, Shockley DH, Weaver NL, Carlos RQ, Ransom JL. Ann Pharmacother. 2005 Jun;39(6):1029-33;Epub 2005 Apr 26. |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35157 |
| Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27405 |
| Study title: TO DETERMINE FLUCONAZOLE EFFICACY AND SAFETY IN AIDS PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27770 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27590 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF A SINGLE ORAL DOSE OF FLUCONAZOLE (150 MG) IN THE TREATMENT OF NON-SEVERE ORAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27953 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27592 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 100-400 MG ONCE A DAY IN THE TREATMENT OF CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27955 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27591 |
| Study title: Biomed Pharmacother. 2006 Nov;60(9):593-606. Epub 2006 Sep 1.18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours.Nanni C, Rubello D, Castellucci P, Farsad M, Franchi R, Rampin L, Gross MD, Al-Nahhas A, Fanti S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28075 |
| Study title: Blood. 2005 Aug 15;106(4):1376-81. Epub 2005 Apr 28. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28105 |
| Study title: Blood. 2006 Jan 1;107(1):52-9. Epub 2005 Sep 8. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D'Amore F, Boesen AM, Berthelsen AK, Specht L. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28097 |
| Study title: Br J Cancer. 2000 Oct;83(7):863-9. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28175 |
| Study title: Br J Cancer. 2004 Feb 9;90(3):620-5. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. Naumann R, Beuthien-Baumann B, Reiss A, Schulze J, Hänel A, Bredow J, Kühnel G, Kropp J, Hänel M, Laniado M, Kotzerke J, Ehninger G. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28136 |
| Study title: Br J Surg. 2006 Feb;93(2):243-9. Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, Hoekstra HJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28092 |
| Study title: Brain Dev. 2001 Dec;23 Suppl 1:S62-71. Neuroimaging studies in Rett syndrome. Naidu S, Kaufmann WE, Abrams MT, Pearlson GD, Lanham DC, Fredericksen KA, Barker PB, Horska A, Golay X, Mori S, Wong DF, Yablonski M, Moser HW, Johnston MV. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28164 |
| Study title: Brain Res Cogn Brain Res. 2004 Jan;18(2):142-8. Hostility differentiates the brain metabolic effects of nicotine. Fallon JH, Keator DB, Mbogori J, Turner J, Potkin SG. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28138 |
| Study title: Cancer Treat Rev. 2004 Feb;30(1):83-101. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Bastiaannet E, Groen H, Jager PL, Cobben DC, van der Graaf WT, Vaalburg W, Hoekstra HJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28134 |
| Study title: Cancer. 2001 Jul 15;92(2):434-9. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Kao CH, Tsai SC, Wang JJ, Ho YJ, Yen RF, Ho ST. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28169 |
| Study title: Cancer. 2001 Mar 1;91(5):889-99. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, Moser E, Glatting G, Kotzerke J, Guhlmann CA, Schirrmeister H, Reske SN. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28172 |
| Study title: Cancer. 2002 Feb 15;94(4):879-88. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28159 |
| Study title: Cephalalgia. 1998 Dec;18(10):690-6. Migraine with aura: a review of 81 patients at 10-20 years' follow-up. Cologno D, Torelli P, Manzoni GC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28187 |
| Study title: Childs Nerv Syst. 2006 Aug;22(8):810-20. Epub 2006 Jun 24. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Sood S, Chugani HT. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28079 |
| Study title: Chin Med J (Engl). 1997 Nov;110(11):875-8. Early intervention improves intellectual development in asphyxiated newborn infants. Intervention of Asphyxiated Newborn Infants Cooperative Research Group. Bao X, Sun S, Yu R, Sun J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28188 |
| Study title: A Randomized, Double-Blind Study of Ibuprofen L-Lysine Intravenous Solution in Premature Infants for the Early Treatment of PDA |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-FC00-01-CB88.pdf |
| View full study record |
| Document reference: 47551 |
| Study title: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Study of Acetaminophen 1000 mg and Ibuprofen 400 mg in Postoperative Dental Pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29481 |
| Study title: Bilateral accessory iliac horns: pathognomonic findings in Nail-patella syndrome. Scintigraphic evidence on bone scan. Goshen E, Schwartz A, Zilka LR, Zwas ST. Clin Nucl Med. 2000 Jun;25(6):476-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43483 |
| Study title: Gravili S, Bonazza A. [Multiple exostoses and bone scintigraphy. A clinical case] Radiol Med (Torino). 1990 Mar;79(3):258-9. Italian. No abstract available. Gravili S, Bonazza A. [Multiple exostoses and bone scintigraphy. A clinical case] Radiol Med (Torino). 1990 Mar;79(3):258-9. Italian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43767 |
| Study title: Gray RJ, Horner K, Testa HJ, Lloyd JJ, Sloan P. Condylar hyperplasia: correlation of histological and scintigraphic features. Dentomaxillofac Radiol. 1994 May;23(2):103-7. Gray RJ, Horner K, Testa HJ, Lloyd JJ, Sloan P. Condylar hyperplasia: correlation of histological and scintigraphic features. Dentomaxillofac Radiol. 1994 May;23(2):103-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43627 |
| Study title: J Neurosurg. 2006 Feb;104(2):238-53. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, Ben Taib NO, Rorive S, David P, Brotchi J, Levivier M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28087 |
| Study title: J Nucl Med. 1991 Apr;32(4):651-9. Epilepsy. Fisher RS, Frost JJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28207 |
| Study title: J Nucl Med. 1998 Jul;39(7):1302-5. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine. Schelbert HR, Hoh CK, Royal HD, Brown M, Dahlbom MN, Dehdashti F, Wahl RL. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28191 |
| Study title: J Nucl Med. 1999 Mar;40(3):399-405. 18F alpha-methyl tyrosine PET studies in patients with brain tumors. Inoue T, Shibasaki T, Oriuchi N, Aoyagi K, Tomiyoshi K, Amano S, Mikuni M, Ida I, Aoki J, Endo K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28186 |
| Study title: J Nucl Med. 1999 Oct;40(10):1637-43. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. Schulte M, Brecht-Krauss D, Werner M, Hartwig E, Sarkar MR, Keppler P, Kotzerke J, Guhlmann A, Delling G, Reske SN. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28182 |
| Study title: J Nucl Med. 2001 Aug;42(8):1139-43. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. SchÃder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28168 |
| Study title: J Nucl Med. 2001 Aug;42(8):1158-65. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal--based PET scanner in the presurgical evaluation of partial epilepsy. O'Brien TJ, Hicks RJ, Ware R, Binns DS, Murphy M, Cook MJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28167 |
| Study title: J Nucl Med. 2003 Aug;44(8):1200-9. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, Altman H, Keidar Z, Israel O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28142 |
| Study title: J Nucl Med. 2003 Jan;44(1):24-9. Comment on: J Nucl Med. 2003 Jan;44(1):30-2. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. Dizendorf EV, Baumert BG, von Schulthess GK, Lütolf UM, Steinert HC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28153 |
| Study title: J Nucl Med. 2004 Apr;45(4):559-66. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. SchÃder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28128 |
| Study title: J Nucl Med. 2004 Aug;45(8):1293-8. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, Salmon I, Brotchi J, Levivier M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28120 |
| Study title: J Nucl Med. 2004 Jul;45(7):1146-54. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. Levivier M, Massager N, Wikler D, Lorenzoni J, Ruiz S, Devriendt D, David P, Desmedt F, Simon S, Van Houtte P, Brotchi J, Goldman S. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28122 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253.Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 2000;18(6):1246-1253 2000;(6):1246-1253. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43322 |
| Study title: Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 200Broniscer A, Leite CDC, Lanchote VL, Machado TMS, Cristofani LM, Study Group. Radiation Therapy and High-Dose Tamoxifen in the Treatment of Patients With Diffuse Brainstem Gliomas: Results of a Brazilian Cooperative Study. Journal of Clinical Oncology 200 |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43330 |
| Study title: Penna C. Management of familial polyposis coli [French]. Journal de Chirurgie 2002; 139(5):260-267.Penna C. Management of familial polyposis coli [French]. Journal de Chirurgie 2002; 139(5):260-267. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43102 |
| Study title: Peripheral precocious puberty. Davies SL, Moral MA. Drugs of the Future 2006; 31(8):713-718.Peripheral precocious puberty. Davies SL, Moral MA. Drugs of the Future 2006; 31(8):713-718. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43254 |
| Study title: Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43298 |
| Study title: Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecological Endocrinology 2006; 22(12):698-703.Pierzynski P, Swiatecka J, Oczeretko E, Laudanski P, Batra S, Laudanski T. Effect of short-term, low-dose treatment with tamoxifen in patients with primary dysmenorrhea. Gynecological Endocrinology 2006; 22(12):698-703. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43136 |
| Study title: Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR, Blatt J et al. A Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. Clinical Cancer Research 1997; 3(7):1109-1115.Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR, Blatt J et al. A Phase I Study of High-Dose Tamoxifen for the Treatment of Refractory Malignant Gliomas of Childhood. Clinical Cancer Research 1997; 3(7):1109-1115. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43155 |
| Study title: Preemptive surgery. McAuliffe PF, Cance WG. Surgery (St Louis)~ 140(1):1-5, JUL 2006 2006;(St Louis):140-5, JULPreemptive surgery. McAuliffe PF, Cance WG. Surgery (St Louis)~ 140(1):1-5, JUL 2006 2006;(St Louis):140-5, JUL |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43258 |
| Study title: Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43288 |
| Study title: Pubertal gynecomastia. Pubertal gynecomastia. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43310 |
| Study title: Pulmonary lymphangioleiomyomatosis: A study of 69 patients. Pulmonary lymphangioleiomyomatosis: A study of 69 patients. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43291 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL AND/OR IV FLUCONAZOLE 200-400 MG ONCE A DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27954 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27439 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE (CAPSULES AND SYRUP) ONCE DAILY IN THE TREATMENT OF PATIENTS SUFFERING FROM ORAL ATROPHIC CANDIDIASIS WITH DENTURES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27804 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27418 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FCA 50 TO 200 O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27783 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27580 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 100-400 MG/DAY IN THE TREATMENT OF SYSTEMIC CANDIDIASIS/CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27943 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27420 |
| Study title: Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors. Pratt CB et al. Cancer. November 4, 1994, 2593-8 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28287 |
| Study title: Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors. Pratt CB et al. Cancer. November 4, 1994, 2593-8 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28298 |
| Study title: Preoperative UFT and calcium folinate and radiotherapy in rectal cancer. Hoff PM et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):129-31 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28309 |
| Study title: Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Rodriguez-Galindo C et al. Cancer. 2005 Feb 15;103(4):850-7. |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 15641027.pdf |
| View full study record |
| Document reference: 28301 |
| Study title: Randomized com+K9parison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. Ortega JA et al. J Clin Oncol. 2000 Jul;18(14):2665-75 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 10894865.pdf |
| View full study record |
| Document reference: 28308 |
| Study title: Relevance of high-dose chemotherapy in solid tumours. Nieboer P et al. Cancer Treat. Rev May 1, 2005, 210-25 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28297 |
| Study title: Robust Bayesian methods for monitoring clinical trials. Greenhouse JB, Wasserman L. Stat Med. 1995 Jun 30;14(12):1379-91 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28315 |
| Study title: A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle Sprains |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29480 |
| Study title: A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. Jun 1989. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29476 |
| Study title: A single dose double-blind study comparing the efficacy of ibuprofen and children's Tylenol elixir. (Feb 1988) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29384 |
| Study title: A single dose double-blind study comparing the efficacy of ibuprofen and children's Tylenol elixir. Feb 1988. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29616 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29556 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29626 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. CSR 187 Revised. Protocol 90-048, Unpublished Report 385. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 90-048.pdf |
| View full study record |
| Document reference: 47451 |
| Study title: A Single Dose, Randomized, Open-Label, Single Center, Three-Way Crossover Pharmacokinetic Study of Children’s Advil® Cold & Sinus Suspension in 6 To <12 Year Old Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29540 |
| Study title: A single-blind, parallel-group, multiple dose study comparing the efficacy and tolerability of Ibuprofen suspension and Paracetamol suspension in the treatment of juvenile pain and pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BR1151.pdf |
| View full study record |
| Document reference: 29412 |
| Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29492 |
| Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29516 |
| Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29561 |
| Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29565 |
| Study title: J Nucl Med. 2004 Oct;45(10):1669-76. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. Ng SH, Joseph CT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Lin WJ, Fu YK, Yen TC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28118 |
| Study title: J Nucl Med. 2005 Apr;46(4):560-6. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, Dollé F, Nihoul-Fékété C, Syrota A, Brunelle F. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28106 |
| Study title: J Nucl Med. 2005 Aug;46(8):1278-84. Association of vascular 18F-FDG uptake with vascular calcification. Dunphy MP, Freiman A, Larson SM, Strauss HW. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28100 |
| Study title: J Nucl Med. 2005 Feb;46(2):283-91. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? Yau YY, Chan WS, Tam YM, Vernon P, Wong S, Coel M, Chu SK. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28111 |
| Study title: J Nucl Med. 2005 Jan;46(1):52-9. Solid splenic masses: evaluation with 18F-FDG PET/CT. Metser U, Miller E, Kessler A, Lerman H, Lievshitz G, Oren R, Even-Sapir E. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28114 |
| Study title: J Nucl Med. 2005 Mar;46(3):405-10. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, Lin WJ, Fu YK, Lin CY. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28107 |
| Study title: Gray RJ, Sloan P, Quayle AA, Carter DH. Histopathological and scintigraphic features of condylar hyperplasia. Int J Oral Maxillofac Surg. 1990 Apr;19(2):65-71. Gray RJ, Sloan P, Quayle AA, Carter DH. Histopathological and scintigraphic features of condylar hyperplasia. Int J Oral Maxillofac Surg. 1990 Apr;19(2):65-71. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43765 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43227 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43237 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43247 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43319 |
| Study title: Acute hematogenous osteomyelitis of children: assessment of skeletal scintigraphy-based diagnosis in the era of MRI. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. J Nucl Med. 2002 Oct;43(10):1310-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43434 |
| Study title: Skeletal scintigraphy of young patients with low-back pain and a lumbosacral transitional vertebra. Connolly LP, d'Hemecourt PA, Connolly SA, Drubach LA, Micheli LJ, Treves ST. J Nucl Med. 2003 Jun;44(6):909-14. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43421 |
| Study title: Young athletes with low back pain: skeletal scintigraphy of conditions other than pars interarticularis stress. Connolly LP, Drubach LA, Connolly SA, Treves ST. Clin Nucl Med. 2004 Nov;29(11):689-93. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43396 |
| Study title: Yen TC, Chang YC, Chan SC, Chang JT, Hsu CH, Lin KJ, et al.. Epub 2004 Dec 30. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes? [yen-2005-c]Eur J Nucl Med Mol Imaging. 2005 May;32(5):541-8. Yen TC 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48717 |
| Study title: Buccally administered streptokinase: a double blind study.Macalister AD. Aust Dent J. 1966 Jun;11(3):165-7. |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48957 |
| Study title: Hoffman J, Stoll P, Yoo K, et al, An open-label study of the safety of flumazenil (Ro 15-1788) when used in children to reverse the residual CNS depressant effects of benzodiazepine-induced conscious sedation |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28211 |
| Study title: Min B*,Song D,Khayksi V,Zhang S,Choma N,Koss-Twardy S, An Open-label Study of the Safety of Flumazenil when Used in Children to Reverse the Residual Effects of Benzodiazepine-Induced Conscious Sedation-Bioanalytical Results, 02.12.94 |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28214 |
| Study title: NDA 20-073 (USA) Romazicon ® (flumazenil) injection, S-008 NDA 20-073 (USA) Pediatric labelling supplement December 12,1996 |
| Active substance: FLUMAZENIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28212 |
| Study title: Allen ED, Whitaker ER, Ryu G. Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma. Pediatr Pulmonol. 1997 Dec;24(6):397-405. |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28237 |
| Study title: Bodini A, Peroni DG, Zardini F, Corradi M, Alinovi R, Boner AL, Piacentini GL. Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children. Mediators Inflamm. 2006;2006(4):31919. |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28234 |
| Study title: Gillman SA, Anolik R, Schenkel E, Newman K. One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma. Clin Pediatr (Phila). 2002 Jun;41(5):333-40. |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28236 |
| Study title: Nakanishi A.K. et al.: A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 2003; 124: 790-795 |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28226 |
| Study title: Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest. 2003 Sep;124(3):790-4. |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28235 |
| Study title: Efficacy and safety of Ro-1788 in reversing the central effects of flunitrazepam used for induction of anesthesia. A double blind comparative clinical study Ro 15-1788 versus placebo |
| Active substance: FLUNITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28238 |
| Study title: Multicenter Study for Controlling the Efficacy and Tolerability of Topsym Creme |
| Active substance: FLUNITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28241 |
| Study title: An open study to evaluate the efficacy, safety and tolerance of the topical application of Varidase to treat patients with various kinds of open wounds with problems of inflammation, excessive accumulation of clotted blood or exudates, and tissue with necrosis.Wang et al. |
| Active substance: streptokinase and streptodornase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48947 |
| Study title: Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine. Ohse M et al. J Mass Spectrom. 2002 Sep;37(9):954-62 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28304 |
| Study title: Seventy-two patients' experience with an implantable drug delivery system for chimotherapy or total parenteral nutrition. Huang C-J. Chinese Medical Journal (Taipei). June 2, 1992, 158-63 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28294 |
| Study title: Some actual issues in chemotherapy of brain tumors in children. Sterba J. Klin Onkol. October 17, 2000, 112-5 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28276 |
| Study title: The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcninoma. Zhang Z, Wu M, Liu Q. Chin J Oncol. July 6, 1999, 214-6 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28279 |
| Study title: The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer. Hayashida S et al. Gan To Kagaku Ryoho. 1995 Apr;22(5):639-46 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28316 |
| Study title: Thromboembolic complications in children with cancer. Wiernikowski JT, Athale UH. Thromb Res. August 31, 2006, 137-52 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28264 |
| Study title: Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. Katzenstein HM et al. J Clin Oncol. 2002 Aug 15;20(16):3438-44 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): 12177104.pdf |
| View full study record |
| Document reference: 28305 |
| Study title: UFT plus calcium folinate/irinotecan in colorectal cancer. Twelves C. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):51-4 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28310 |
| Study title: Update of the subconjunctival THC:YAG (holmium) laser sclerostomy Ab externo clinical trial: 30-Month report. Iwach AG et al. Ophthalmic Surgery. March 7, 1994, 13-21 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28289 |
| Study title: Hoffecker E. Erfahrungen mit Encephabol in der kinderärztlichen Praxis (Ther d Gegenw1964: 913-917); Hoffecker E. Erfahrungen mit Encephabol in der kinderärztlichen Praxis (Ther d Gegenw1964: 913-917); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35152 |
| Study title: Logue G. The Effects of Pyrithioxine on the Behaviour and Intellectual Functioning of Learning-Disabled Children (S Afr Med J1974; 48: 2245-2246); Logue G. The Effects of Pyrithioxine on the Behaviour and Intellectual Functioning of Learning-Disabled Children (S Afr Med J1974; 48: 2245-2246); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35149 |
| Study title: Neu W. Erfahrungen mit Encephabol in der pädiatrischen Praxis (Landarzt 1965; 41 (12): 523-5245); Neu W. Erfahrungen mit Encephabol in der pädiatrischen Praxis (Landarzt 1965; 41 (12): 523-5245); |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35154 |
| Study title: A phase IV, open, multicentre study of the efficacy and tolerance of pre-exposure treatment with PCEC-Rabies-vaccine (Rabipur®) |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48380 |
| Study title: A Phase IV, randomized, single-blind, multicenter study with four vaccination groups: three different batches PCECV India, one batch PCECV Germany to compare immunogenicity and safety of PCEC Rabies Vaccine (PCECV) manufactured in Ankleshwar/India with PCECV manufactured in Marburg/Germany. |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48386 |
| Study title: An open, controlled, randomized and single-centre study to evaluate the effectiveness of a new economical schedule of rabies postexposure prophylaxis using purified chick embryo cell tissue culture (PCEC) rabies vaccine (Rabipur®, Behring Vaccines; now Novartis Vaccines) in the patients of 1 to 61 years of age. |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48381 |
| Study title: Clinical Documentation, other information. Geode ref. 920. March 1992 |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41431 |
| Study title: Expert report on clinical documentation. Geode ref. 460. March 1992. |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41430 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43236 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43246 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994; 79(2):51Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994; 79(2):51 |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43317 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43327 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):51Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):51 |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43334 |
| Study title: Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518.Metzger DL, Kerrigan JR. Estrogen Receptor Blockade with Tamoxifen Diminishes Growth Hormone Secretion in Boys: Evidence for a Stimulatory Role of Endogenous Estrogens during Male Adolescence. Journal of Clinical Endocrinology and Metabolism 1994;79(2):513-518 1994;(2):513-518. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43345 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43323 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: JMeza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: J |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43328 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43337 |
| Study title: Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17.Meza-Junco J, Montano-Loza A, Candelaria M. Treatment modalities in patients with hepatocellular carcinoma: A retrospective series in a single institution in Mexico. [Spanish]. Gastroenterologia y Hepatologia 27(1)()(pp 11-17), 2004 Date of Publication: Jan 2004 2004;(1):11-17. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43347 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tartephedreel (drops) [AWB-072] |
| Active substance: Tartephedreel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40252 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Tartephedreel (drops) [AWB-AT] |
| Active substance: Tartephedreel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40253 |
| Study title: 99Tcm-MAA lung scintigraphy in patients with Behçet's disease: its value and correlation with clinical course and other diagnostic modalities. Caglar M, Ergun E, Emri S. Nucl Med Commun. 2000 Feb;21(2):171-9. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48235 |
| Study title: A pilot study of the role of TC-99 radionuclide in localization of pulmonary nodular lesions for thoracoscopic resection. Chella A, Lucchi M, Ambrogi MC, Menconi G, Melfi FM, Gonfiotti A, Boni G, Angeletti CA. Eur J Cardiothorac Surg. 2000 Jul;18(1):17-21. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48234 |
| Study title: Abnormal brain perfusion demonstrated by Tc-99m MAA total-body scan in two children with complex congenital heart disease. Suga K, Kume N, Hirabayashi A, Kishimoto K, Hara A, Matsunaga N. Ann Nucl Med. 1998 Oct;12(5):297-302. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48242 |
| Study title: Acute paraquat intoxication: using nuclear pulmonary studies to predict patient outcome. Kao CH, Hsieh JF, Ho YJ, Hung DZ, Lin TJ, Ding HJ. Chest. 1999 Sep;116(3):709-14. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48239 |
| Study title: Alteration of pulmonary blood flow distribution in patients with congenital left to right cardiac shunt--pre- and postoperative study with macroaggregates of 99mTc-labeled human serum albumin. Hashimoto K, Nakamura Y, Matsui M, Suzuki K, Kurosawa H, Arai T. Jpn Circ J. 1993 Apr;57(4):291-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48272 |
| Study title: Rohypnol drops: results of acceptance trial in 220 children |
| Active substance: FLUNITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28240 |
| Study title: Study of the efficacy and safety of Ro 15-1788 in reversing the central effects of flunitrazepam used to induce and maintain general anesthesia |
| Active substance: FLUNITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28239 |
| Study title: [Current therapy aspects of intraocular tumors] Schüler AO, Bornfeld N. Ophthalmologe. 2000 Mar;97(3):207-22. |
| Active substance: FLUORESCEIN |
| Study summary document link (including results): Current therapy aspects of intraocular tumors.pdf |
| View full study record |
| Document reference: 28244 |
| Study title: Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. Holl RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM. J Pediatr. 1998 May;132(5):790-4. Comment in: J Pediatr. 1998 May;132(5):760-2. PMID: 9602180. |
| Active substance: FLUORESCEIN |
| Study summary document link (including results): Diabetic retinopathy in pediatric patients with type-1 diabe.pdf |
| View full study record |
| Document reference: 28247 |
| Study title: Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Schmidt D, Natt E, Neumann HP. Eur J Med Res. 2000 Feb 28;5(2):47-58. |
| Active substance: FLUORESCEIN |
| Study summary document link (including results): Long-term results of laser treatment for retinal angiomatosi.pdf |
| View full study record |
| Document reference: 28245 |
| Study title: Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. [No authors listed] Pediatrics. 2000 Feb;105(2):295-310. |
| Active substance: FLUORESCEIN |
| Study summary document link (including results): Supplemental therapeutic oxygen for prethreshold retinopathy.pdf |
| View full study record |
| Document reference: 28246 |
| Study title: Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44277 |
| Study title: Collier BD, Johnson RP, Carrera GF, Akhtar K, Isitman AT. Scintigraphic diagnosis of stress-induced incomplete fractures of the proximal tibia. J Trauma. 1984 Feb;24(2):156-60. Collier BD, Johnson RP, Carrera GF, Akhtar K, Isitman AT. Scintigraphic diagnosis of stress-induced incomplete fractures of the proximal tibia. J Trauma. 1984 Feb;24(2):156-60. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44007 |
| Study title: Colton CL, Hardy JG. Evaluation of a sterilizable radiation probe as an aid to the surgical treatment of osteoid-osteoma. Technical note. J Bone Joint Surg Am. 1983 Sep;65(7):1019-22. No abstract available. Colton CL, Hardy JG. Evaluation of a sterilizable radiation probe as an aid to the surgical treatment of osteoid-osteoma. Technical note. J Bone Joint Surg Am. 1983 Sep;65(7):1019-22. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44032 |
| Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis. Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med. 1985 Dec;26(12):1377-81. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48464 |
| Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med 1987 Dec;28{12):1835-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48470 |
| Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Cisneros GJ, Kaban LB. J Oral Maxillofac Surg 1984 Aug;42{8):513-20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48471 |
| Study title: Prospective study on immunogenicity of VERORAB® rabies vaccine administered by intramuscular or intradermal route concomitantly with TETRACOQ® to infants followed up at the Center of Pediatrics, Development and Health of Ho Chi Minh Ville, Vietnam |
| Active substance: Rabies virus (Wistar rabies PM/WI38-1503-3M strain), grown on a continuous Vero cell line, inactivated with betapropiolactone |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47472 |
| Study title: Double-Blind, Randomized Trial of the Pharmacokinetics of Dexecadotril (BP 1.01) and Racecadotril (BP 0.52) in Children One Month to Six Years Old Suffering From Acute Diarrhea (Ben Becher S) |
| Active substance: RACECADOTRIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35261 |
| Study title: ADAMSON P. PHARMACOLOGY OF ANTI-METABOLITES AND OTHER ANTI-LEUKEMIC AGENTS. 1999. Crisp Data Base National Institutes of Health. 2000. Ref Type: Report ADAMSON P. PHARMACOLOGY OF ANTI-METABOLITES AND OTHER ANTI-LEUKEMIC AGENTS. 1999. Crisp Data Base National Institutes of Health. 2000. Ref Type: Report |
| Active substance: RALTITREXED |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35262 |
| Study title: Beale P, Clarke S. Chapter 7: 'Tomudex': Clinical Development. In: Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy 1999; Totowa:Humana-181.Beale P, Clarke S. Chapter 7: 'Tomudex': Clinical Development. In: Anticancer Drug Development Guide: Antifolate Drugs in Cancer Therapy 1999; Totowa:Humana-181. |
| Active substance: RALTITREXED |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35263 |
| Study title: Clarke SJ, Beale PJ, Rivory LP. Clinical and preclinical pharmacokinetics of raltitrexed. Clinical Pharmacokinetics 2000;39(6):429-43 2000;(6):429-443. Clarke SJ, Beale PJ, Rivory LP. Clinical and preclinical pharmacokinetics of raltitrexed. Clinical Pharmacokinetics 2000;39(6):429-43 2000;(6):429-443. |
| Active substance: RALTITREXED |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35264 |
| Study title: Van CE. Raltitrexed ('Tomudex'). (Review, 54 refs). Expert Opinion on Investigational Drugs 1998;7(5):823-834 1998;(5):823-834. Van CE. Raltitrexed ('Tomudex'). (Review, 54 refs). Expert Opinion on Investigational Drugs 1998;7(5):823-834 1998;(5):823-834. |
| Active substance: RALTITREXED |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35265 |
| Study title: WIDEMANN B. Clinical development of novel drugs for children with ca. 2003. Crisp Data Base National Institutes of Health. 2004. Ref Type: Report WIDEMANN B. Clinical development of novel drugs for children with ca. 2003. Crisp Data Base National Institutes of Health. 2004. Ref Type: Report |
| Active substance: RALTITREXED |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35266 |
| Study title: WIDEMANN B. Novel Drugs for Children With Cancer /Neurofibromatosis. 2001. Crisp Data Base National Institutes of Health. 2003. WIDEMANN B. Novel Drugs for Children With Cancer /Neurofibromatosis. 2001. Crisp Data Base National Institutes of Health. 2003. |
| Active substance: RALTITREXED |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35267 |
| Study title: Jenkin-R-D-T, Boesel-C, Ertel-I, et-al. Childrens Cancer Study Group, University of Southern California, Pasadena, CA, United States. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children's Cancer Study Group. Journal of Neurosurgery {J-NEUROSURG}, 1987, Vol/Iss/Pg. 66/2 (227-233).Jenkin-R-D-T, Boesel-C, Ertel-I, et-al. Childrens Cancer Study Group, University of Southern California, Pasadena, CA, United States. Brain-stem tumors in childhood: A prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Children's Cancer Study Group. Journal of Neurosurgery {J-NEUROSURG}, 1987, Vol/Iss/Pg. 66/2... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34756 |
| Study title: Jenkin-R-D-T, Brown-T-C, Peters-M-V, Sonley-M-J. Princess Margaret Hosp., Toronto, Canada. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer {CANCER}, 1975, Vol/Iss/Pg. 35/3 sup (979-990).Jenkin-R-D-T, Brown-T-C, Peters-M-V, Sonley-M-J. Princess Margaret Hosp., Toronto, Canada. Hodgkin's disease in children. A retrospective analysis: 1958-73. Cancer {CANCER}, 1975, Vol/Iss/Pg. 35/3 sup (979-990). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34757 |
| Study title: Immunogenicity and efficacy of PCECV in a population bitten by animals at high risk of rabies infection |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48383 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247 |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43331 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43220 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43230 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43240 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000;22(3):247-251 2000;(3):247-251. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43250 |
| Study title: Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000; 22(3):247.Walter AW, Gajjar A, Reardon DA, Thompson SJ, Langston JW, Jones-Wallace D et al. Tamoxifen and Carboplatin for Children With Low-Grade Gliomas: A Pilot Study at St Jude Children's Research Hospital. Journal of Pediatric Hematology/Oncology 2000; 22(3):247. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43315 |
| Study title: Burt RW, Matthews TJ. Aseptic necrosis of the knee: bone scintigraphy. AJR Am J Roentgenol. 1982 Mar;138(3):571-3. No abstract available. Burt RW, Matthews TJ. Aseptic necrosis of the knee: bone scintigraphy. AJR Am J Roentgenol. 1982 Mar;138(3):571-3. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44088 |
| Study title: Arteriovenous shunt measurement during endovascular therapy for cerebrospinal lesions. Mariani L, Haldemann AR, Schroth G. AJNR Am J Neuroradiol. 1997 Oct;18(9):1679-89. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48246 |
| Study title: Assessment of peanut aspiration by MRI and lung perfusion scintigram. Morijiri M, Seto H, Kageyama M, Shimizu M, Nagayoshi T, Watanabe N, Kakishita M. J Comput Assist Tomogr. 1994 Sep-Oct;18(5):836-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48266 |
| Study title: Bilateral deep venous thrombosis in protein S deficiency. Detection by radionuclide venography. Wegener WA, Heyman S. Clin Nucl Med. 1990 Sep;15(9):618-22. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48283 |
| Study title: Bilateral pulmonary artery aneurysms in a patient with Behcet syndrome: evaluation with radionuclide angiography and V/Q lung scanning. Basoglu T, Canbaz F, Bernay I, Danaci M. Clin Nucl Med. 1998 Nov;23(11):735-8. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48243 |
| Study title: Changes in intracardiac shunt elicited by pneumonia. Caceres LJ, Khedkar NY, Martinez CJ, DuBrow I, Lakier J Clin Nucl Med. 1994 Apr;19(4):359-60. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48269 |
| Study title: Clinical significance of nonfocal scintigraphic findings in suspected tibial stress fractures.Chisin R, Milgrom C, Giladi M, Stein M, Margulies J, Kashtan H. Clin Orthop Relat Res. 1987 Jul;(220):200-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43858 |
| Study title: Chisin R, Noyek AM, Israel O, Witterick IJ, Front D, Kirsh JC. Contribution of nuclear medicine to the diagnosis and management of extracranial head and neck diseases (excluding thyroid and parathyroid). Isr J Med Sci. 1992 Mar-Apr;28(3-4):254-61. Review. Chisin R, Noyek AM, Israel O, Witterick IJ, Front D, Kirsh JC. Contribution of nuclear medicine to the diagnosis and management of extracranial head and neck diseases (excluding thyroid and parathyroid). Isr J Med Sci. 1992 Mar-Apr;28(3-4):254-61. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44264 |
| Study title: Chiu NT, Jou IM, Lee BF, Yao WJ, Tu DG, Wu PS. Symptomatic and asymptomatic accessory navicular bones: findings of Tc-99m MDP bone scintigraphy. Clin Radiol. 2000 May;55(5):353-5. Chiu NT, Jou IM, Lee BF, Yao WJ, Tu DG, Wu PS. Symptomatic and asymptomatic accessory navicular bones: findings of Tc-99m MDP bone scintigraphy. Clin Radiol. 2000 May;55(5):353-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43485 |
| Study title: Choong KK, Gulenchyn KY, Chamberlain MJ. 'Vascular scalp lesion' from cardiac activity. Clin Nucl Med. 1994 Aug;19(8):744-5. No abstract available. Choong KK, Gulenchyn KY, Chamberlain MJ. 'Vascular scalp lesion' from cardiac activity. Clin Nucl Med. 1994 Aug;19(8):744-5. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43619 |
| Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H. Strobel K. J Mag Reson Imaging 2007;26:422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48467 |
| Study title: A DOUBLE-BLIND MULTICENTER COMPARATIVE STUDY OF TWO DOSE REGIMENS OF ORAL CLINDAMYCIN HYDROCHLORIDE IN THE TREATMENT OF ACUTE TONSILLITIS/PHARYNGITIS DUE TO GROUP A BETA-HEMOLYTIC STREPTOCOCCI. |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): 251F-INF-0496-001 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 24361 |
| Study title: A PROSPECTIVE, STRATIFIED, RANDOMIZED, THIRD-PARTY BLINDED COMPARISON OF THE SAFETY AND EFFICACY OF CEFOPERAZONE PLUS PIPERACILLIN VERSUS CEFOPERAZONE PLUS AMIKACIN IN THERAPY OF INFECTED SOLID TUMOR PATIENTS RECEIVING CISPLATIN |
| Active substance: CLINDAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24360 |
| Study title: bay b 5097 500 mg vaginal tablet: efficacy and tolerance of bay b 5097 500 mg vaginal tablet as single or one day therapy of vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0420_study_synopsis.pdf |
| View full study record |
| Document reference: 24457 |
| Study title: BAY b 5097 Solution N Activity and Tolerability in Dermatomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24441 |
| Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24442 |
| Study title: BAY b 5097 Solution N Activity and Tolerance in Otomycoses. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0220_study_synopsis.pdf |
| View full study record |
| Document reference: 24443 |
| Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10 & econazole depot ovule 150 mg in the treatment of candida vaginitis. |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24445 |
| Study title: Comparative study on the efficacy of clotrimazole vaginal cream 10% and econazole depot ovule 150 mg in the treatment of Candida vaginitis |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0595_study_synopsis.pdf |
| View full study record |
| Document reference: 24448 |
| Study title: effectiveness and tolerance of bay b 5097 2 per cent vaginal cream on therapy for 3 days compared to therapy for 7 days with econazole 1 per cent vaginal cream (gyno-pevaryl cream) |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0396_study_synopsis.pdf |
| View full study record |
| Document reference: 24455 |
| Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0345_study_synopsis.pdf |
| View full study record |
| Document reference: 24444 |
| Study title: Efficacy and tolerability of clotrimazole vaginal cream 10 in comparison with clotrimazole vaginal tablets 500 mg after a single application in patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0473_study_synopsis.pdf |
| View full study record |
| Document reference: 24462 |
| Study title: efficacy and tolerability of clotrimazole vaginal tablets 100 mg (galenic formulation with lactic acid) in the 6-day-therapy in vaginal candida-infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0516_study_synopsis.pdf |
| View full study record |
| Document reference: 24451 |
| Study title: efficacy and tolerance of bay b 5097 vaginal cream 2% in the 3-day therapy compared to a 6-day therapy with Canesten vaginal cream 1% |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24453 |
| Study title: efficacy and tolerance of two galenical product formulations of canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0444_study_synopsis.pdf |
| View full study record |
| Document reference: 24458 |
| Study title: Gutachten über die klinische Prüfung von Mykichthol Paste |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf |
| View full study record |
| Document reference: 24465 |
| Study title: Jenkin-R-D, Anderson-J-R, Chilcote-R-R, Coccia-P, Exelby-P, Kersey-J, Kjeldsberg-C-R, Kushner-J, Meadows-A-T, Siegel-S, et al. The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience. IARC scientific publications, {IARC-Sci-Publ}, 1985, no. 60, p. 399-404, ISSN: 0300-5038.Jenkin-R-D, Anderson-J-R, Chilcote-R-R, Coccia-P, Exelby-P, Kersey-J, Kjeldsberg-C-R, Kushner-J, Meadows-A-T, Siegel-S, et al. The treatment of diffuse undifferentiated non-Hodgkin's lymphoma in children: the Childrens Cancer Study Group experience. IARC scientific publications, {IARC-Sci-Publ}, 1985, no. 60, p. 399-404, ISSN: 0300-5038. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34753 |
| Study title: Jurgens-H, Distler-W. Abteilung fur Hamatologie und Onkologie, Universitats-Kinderklinik, Moorenstrasse 5, W-4000 Dusseldorf 1, Germany. Puberty development and gonad function after treatment with cytostatics during childhood. Gynakologe {GYNAKOLOGE}, 1991, Vol/Iss/Pg. 24/2 (114-118), ISSN: 0017-5994. Jurgens-H, Distler-W. Abteilung fur Hamatologie und Onkologie, Universitats-Kinderklinik, Moorenstrasse 5, W-4000 Dusseldorf 1, Germany. Puberty development and gonad function after treatment with cytostatics during childhood. Gynakologe {GYNAKOLOGE}, 1991, Vol/Iss/Pg. 24/2 (114-118), ISSN: 0017-5994. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34758 |
| Study title: Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R. Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532.Kiltie-A-E, Lashford-L-S, Gattamaneni-H-R. Dr. H.R. Gattamaneni, NHS Trust, Christie Hospital, Wilmslow Road, Manchester M20 9BX, United Kingdom. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1997, Vol/Iss/Pg. 28/5 (348-354), ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34759 |
| Study title: Knerich-R, Butti-G, Pezzotta-S, et-al. Universita di Pavia, Dipartimento di Chirurgia, Sezione di Clinica Neurochirurgica, 27100 Pavia, Italy. Chemotherapy of malignant brain tumors in children. Minerva Medica {MINERVA-MED}, 1984, Vol/Iss/Pg. 75/24 (1441-1444).Knerich-R, Butti-G, Pezzotta-S, et-al. Universita di Pavia, Dipartimento di Chirurgia, Sezione di Clinica Neurochirurgica, 27100 Pavia, Italy. Chemotherapy of malignant brain tumors in children. Minerva Medica {MINERVA-MED}, 1984, Vol/Iss/Pg. 75/24 (1441-1444). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34760 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG O.D. IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27785 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27589 |
| Study title: TO DETERMINE THE EFFICACY, SAFETY AND TOLERATION OF ORAL/IV FLUCONAZOLE 50/100 MG/DAY IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27952 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27623 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDIASIS AND CRYPTOCOCCAL MENINGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27985 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27394 |
| Study title: Chirurg. 2001 Sep;72(9):1071-7. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group] [Article in German] Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, Schober O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28166 |
| Study title: Clin Nucl Med. 2002 Aug;27(8):572-7. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, Palestro CJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28156 |
| Study title: Clin Nucl Med. 2003 Aug;28(8):648-51. Thymic uptake of radiopharmaceuticals. Connolly LP, Connolly SA. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28143 |
| Study title: Clin Nucl Med. 2005 Mar;30(3):170-6. Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, Ito H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28109 |
| Study title: Diabetes Care. 2001 Mar;24(3):555-60. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group. Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28171 |
| Study title: Endocr Pract. 2003 Jul-Aug;9(4):273-9. Comment in: Endocr Pract. 2003 Jul-Aug;9(4):324-6. [18F]fluorodeoxyglucose triple-head coincidence imaging as an adjunct to 131I scanning for follow-up of papillary thyroid carcinoma. Gonzalo IT, Itti E, Mlikotic A, Pham le H, Cesar RB, Meignan M, Mishkin FS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28140 |
| Study title: Epilepsia. 2006;47 Suppl 2:71-5. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Metz-Lutz MN, Filippini M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28072 |
| Study title: Eur J Appl Physiol Occup Physiol. 1995;70(5):442-50. Pulmonary gas exchange and ventilatory responses to brief intense intermittent exercise in young trained and untrained adults. Chamari K, Ahmaidi S, Fabre C, Ramonatxo M, Préfaut C. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28202 |
| Study title: Eur J Haematol. 2007 Mar;78(3):206-12. Epub 2007 Jan 23. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Hutchings M, Loft A, Hansen M, Berthelsen AK, Specht L. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28069 |
| Study title: Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28158 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):581-7. Epub 2003 Jan 30. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, Kim SE. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28152 |
| Study title: Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):396-402. Epub 2003 Jan 9. Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Lassen U, Daugaard G, Eigtved A, Højgaard L, Damgaard K, Rørth M. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28149 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1064-72. Epub 2004 Mar 11. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28131 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, Chang YC, Yen TC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28133 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Bar-Shalom R, Gaitini D, Keidar Z, Israel O. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28132 |
| Study title: Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):811-9. Epub 2004 Feb 5. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Amthauer H, Denecke T, Rau B, Hildebrandt B, Hünerbein M, Ruf J, Schneider U, Gutberlet M, Schlag PM, Felix R, Wust P. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28135 |
| Study title: Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Epub 2005 Aug 31. Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28098 |
| Study title: The role of bone scan in the diagnosis of Jaffé-Lichtenstein-Uehlinger syndrome. Chroustova D, Votruba M, Sprindrich J, Sosna B. Nucl Med Rev Cent East Eur. 2004;7(1):87-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43398 |
| Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Cisneros GJ, Kaban LB. J Oral Maxillofac Surg. 1984 Aug;42(8):513-20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43992 |
| Study title: Allograft bone in the treatment of desmoplastic fibroma. A case report. Clayer M, Oakeshott R. Clin Orthop Relat Res. 1994 Mar;(300):219-24. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43632 |
| Study title: Camurati-Engelmann disease: contribution of bone scintigraphy to genetic counseling. Clybouw C, Desmyttere S, Bonduelle M, Piepsz A Genet Couns. 1994;5(2):195-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43638 |
| Study title: Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54. Chew FS, Hudson TM. Radionuclide bone scanning of osteosarcoma: falsely extended uptake patterns. AJR Am J Roentgenol. 1982 Jul;139(1):49-54. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44078 |
| Study title: J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, StÃver B, Henze G, Lemke AJ, Amthauer H. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28078 |
| Study title: Jpn Circ J. 1997 Mar;61(3):201-10. Myocardial blood flow and metabolism in patients with hypertrophic cardiomyopathy--a study with carbon-11 acetate and positron emission tomography. Ishiwata S, Maruno H, Senda M, Toyama H, Nishiyama S, Seki A. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28195 |
| Study title: Klin Padiatr. 2003 May-Jun;215(3):146-50. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations] [Article in German] Wickmann L, Lüders H, DÃrffel W. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28146 |
| Study title: Leuk Lymphoma. 1999 Aug;34(5-6):545-51. Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease. Wiedmann E, Baican B, Hertel A, Baum RP, Chow KU, Knupp B, Adams S, HÃr G, Hoelzer D, Mitrou PS. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28184 |
| Study title: Leuk Lymphoma. 2004 Jan;45(1):85-92. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28129 |
| Study title: Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. Leuk Lymphoma. 2007 Sep;48(9):1721-7. Comment in:Leuk Lymphoma. 2007 Sep;48(9):1667-9. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28063 |
| Study title: Lung Cancer. 2004 May;44(2):175-81. FDG-PET in staging lung cancer: how does it change the algorithm? Verhagen AF, Bootsma GP, Tjan-Heijnen VC, van der Wilt GJ, Cox AL, Brouwer MH, Corstens FH, Oyen WJ. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28127 |
| Study title: Investigation of the effectiveness and tolerance of a single administration of clotrimazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0581_study_synopsis.pdf |
| View full study record |
| Document reference: 24450 |
| Study title: Investigation of the effectiveness and tolerance of a single administration of clotrImazole vaginal tablet of 500 mg in cases of vaginal candida infection in comparison with a 6-day theraphy with clotrimazole vaginal tablets of 100 mg |
| Active substance: CLOTRIMAZOLE |
| Study summary document link (including results): Bayer CC_Clotrimazole_0460_study_synopsis.pdf |
| View full study record |
| Document reference: 24461 |
| Study title: Chou AJ et al Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience Cancer. 2005 Nov 15;104(10):2214-21Chou AJ et al Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience Cancer. 2005 Nov 15;104(10):2214-21 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24827 |
| Study title: Chow LM et al, Survival and late effects in children with Hodgkin's lymphoma treated with, MOPP/ABV and low-dose, extended-field irradiation, J Clin Oncol. 2006 Dec 20;24(36):5735-41Chow LM et al, Survival and late effects in children with Hodgkin's lymphoma treated with, MOPP/ABV and low-dose, extended-field irradiation, J Clin Oncol. 2006 Dec 20;24(36):5735-41 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24828 |
| Study title: Chow SN et al, Malignant ovarian germ cell tumors, Int J Gynaecol Obstet. 1996 May;53(2):151-8Chow SN et al, Malignant ovarian germ cell tumors, Int J Gynaecol Obstet. 1996 May;53(2):151-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24829 |
| Study title: Coze C et al. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology. Clin Oncol. 1997 Dec;15(12):3433-40Coze C et al. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology. Clin Oncol. 1997 Dec;15(12):3433-40 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24830 |
| Study title: Craft A et al Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study J Clin Oncol. 1998 Nov;16(11):3628-33Craft A et al Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study J Clin Oncol. 1998 Nov;16(11):3628-33 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24831 |
| Study title: Crist W et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995 Mar;13(3):610-30Crist W et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995 Mar;13(3):610-30 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24832 |
| Study title: Crist WM et a lIntergroup rhabdomyosarcoma study-IV: results for patients with nonmetastaticDiseaseJ Clin Oncol. 2001 Jun 15;19(12):3091-102Crist WM et a lIntergroup rhabdomyosarcoma study-IV: results for patients with nonmetastaticDiseaseJ Clin Oncol. 2001 Jun 15;19(12):3091-102 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24833 |
| Study title: Crist WM et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001 Jun 15;19(12):3091-102Crist WM et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001 Jun 15;19(12):3091-102 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24834 |
| Study title: Crooks GM et alI Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia J Pediatr Hematol Oncol. 1995 Feb;17(1):34-8Crooks GM et alI Ifosfamide and etoposide in recurrent childhood acute lymphoblastic leukemia J Pediatr Hematol Oncol. 1995 Feb;17(1):34-8 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24835 |
| Study title: Culbert SJ Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study.Cancer. 1991 Jan 1;67(1):37-42.Culbert SJ Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study.Cancer. 1991 Jan 1;67(1):37-42. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24836 |
| Study title: Cushing B et al, Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882, J Clin Oncol. 2004 Jul 1;22(13):2691-700, Cushing B et al, Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study—Pediatric Oncology Group 9049 and Children's Cancer Group 8882, J Clin Oncol. 2004 Jul 1;22(13):2691-700, |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24837 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF A SINGLE 400 MG ORAL/IV DOSE OF FLUCONAZOLE IN PATIENTS SUFFERING FROM CANDIDAL ESOPHAGITIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27759 |
| Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27427 |
| Study title: TO EVALUATE THE PHARMACOKINETIC PARAMETERS AFTER IV FLUCONAZOLE IN PATIENTS WITH EITHER 1. AIDS WITHOUT LIVER DISEASE OR 2. LIVER CIRRHOSIS OR SEVERE HEPATIC DISEASE IN COMPARISON WITH HEALTHY SUBJECTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27792 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27593 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF FLUCONAZOLE CAPSULES VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27956 |
| Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27594 |
| Study title: TO GATHER ADDITIONAL DATA ON THE SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS CRYPTOCOCCAL MENINGITIS. TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO IN THE INVESTIGATOR JUDGEMENT WOULD BENEFIT FROM TREATMENT WITH THIS AGENT |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27957 |
| Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27683 |
| Study title: Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) Warts in children: Treatment with 5-fluorouracil 5% cream and other painless alternatives. Cunningham B.B. Cosmetic Dermatology ( Cosmet. Dermatol. ) (United States) , May 1, 2004 , 17/5 SUPPL. 1 (9-12) |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28262 |
| Study title: Young patient trabeculectomy: Assessment of risk factors for failure. Sturmer J. Ophthalmology. June 18, 1993, 928-39 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28292 |
| Study title: A Double-Blind Placebo-Controlled Study of Fluoxetine and Clomipramine in the Treatment of Panic Disorder |
| Active substance: FLUOXETINE |
| Study summary document link (including results): Fluoxetine - B1Y-EW-HCHQ Synopsis.pdf |
| View full study record |
| Document reference: 28335 |
| Study title: Discontinuation Of Fluoxetine In Ocd |
| Active substance: FLUOXETINE |
| Study summary document link (including results): Fluoxetine - B1Y-SZ-IS38 Synopsis.pdf |
| View full study record |
| Document reference: 28331 |
| Study title: "Fluox20mg V Fluox40mg V Clomip75mg Out Pt. Maj. Depression |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28339 |
| Study title: Fluoxetine hydrocloride with enteric cover |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28342 |
| Study title: Chrisp P, Clissold SP. Foscarnet - a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.Chrisp P, Clissold SP. Foscarnet - a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. |
| Active substance: Foscarnet |
| Study summary document link (including results): Chrisp P and Clissold SP 1992.pdf |
| View full study record |
| Document reference: 39630 |
| Study title: Deruiter A, Thin RN. Genital herpes - a guide to pharmacological therapy. Drugs 1994; 47(2):297-304.Deruiter A, Thin RN. Genital herpes - a guide to pharmacological therapy. Drugs 1994; 47(2):297-304. |
| Active substance: Foscarnet |
| Study summary document link (including results): Deruiter A et al 1994.pdf |
| View full study record |
| Document reference: 39632 |
| Study title: "Benitez JG, Swanson-Biearman B, Krenzelok EP. Nystagmus secondary to fomepizole administration in a pediatric patient. J Toxicol Clin Toxicol. 2000;38(7):795-8. " "Benitez JG, Swanson-Biearman B, Krenzelok EP. Nystagmus secondary to fomepizole administration in a pediatric patient. J Toxicol Clin Toxicol. 2000;38(7):795-8. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28471 |
| Study title: "Brown MJ, Shannon MW, Woolf A, Boyer EW. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001 Oct;108(4):E77. " "Brown MJ, Shannon MW, Woolf A, Boyer EW. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001 Oct;108(4):E77. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28470 |
| Study title: "Bucaretchi F, Baracat EC. [Acute toxic exposure in children: an overview] J Pediatr (Rio J). 2005 Nov;81(5 Suppl):S212-22. Review. Portuguese. " "Bucaretchi F, Baracat EC. [Acute toxic exposure in children: an overview] J Pediatr (Rio J). 2005 Nov;81(5 Suppl):S212-22. Review. Portuguese. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28467 |
| Study title: Diagnosis, clinical picture and treatment of cytomegaloviral infection in children. Rossiiskii Vestnik Perinatologii i Pediatrii 1994; 39(3):16-19.Bendel A, Gross T, Woods W, Edelman C, Balfour H.Diagnosis, clinical picture and treatment of cytomegaloviral infection in children. Rossiiskii Vestnik Perinatologii i Pediatrii 1994; 39(3):16-19.Bendel A, Gross T, Woods W, Edelman C, Balfour H. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Bendel A et al 1993.pdf |
| View full study record |
| Document reference: 28569 |
| Study title: Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y et al. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. [Chinese]. Ding H, Ren H, Guo N, Huang X, Xu L, Zhang Y et al. [Risk factors of cytomegalovirus infection and antiviral efficacy in recipients of hematopoietic stem cell transplantation]. [Chinese]. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Ding H et al 2003.pdf |
| View full study record |
| Document reference: 28592 |
| Study title: Dini G, Castagnola E, Comoli P, van Tol MJD, Vossen JM. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplantation. 2001; 28 (Suppl 1):S18-S21.Dini G, Castagnola E, Comoli P, van Tol MJD, Vossen JM. Infections after stem cell transplantation in children: state of the art and recommendations. Bone Marrow Transplantation. 2001; 28 (Suppl 1):S18-S21. |
| Active substance: Foscarnet |
| Study summary document link (including results): Dini G et al 2001.pdf |
| View full study record |
| Document reference: 39644 |
| Study title: Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia [Review]. Drug Safety 2004; 27(15):1217-1233.Douglas MW, Johnson RW, Cunningham AL. Tolerability of treatments for postherpetic neuralgia [Review]. Drug Safety 2004; 27(15):1217-1233. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Douglas MW et al 2004.pdf |
| View full study record |
| Document reference: 28587 |
| Study title: Dwyer DE, Kesson AM. Advances in antiviral therapy. Current Opinion in Pediatrics 1997; 9(1):24-30.Dwyer DE, Kesson AM. Advances in antiviral therapy. Current Opinion in Pediatrics 1997; 9(1):24-30. |
| Active substance: Foscarnet |
| Study summary document link (including results): Dwyer DE et al 1997.pdf |
| View full study record |
| Document reference: 39659 |
| Study title: Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clinical Infectious Diseases 1997; 24(1):52-56.Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clinical Infectious Diseases 1997; 24(1):52-56. |
| Active substance: Foscarnet |
| Study summary document link (including results): Eddleston M et al 1997.pdf |
| View full study record |
| Document reference: 39660 |
| Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigoH Rockl. Unpublished. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28646 |
| Study title: Fucidin® ointment versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28647 |
| Study title: Open clinical studies with Gd-DTPA (dimeglumine gadopentetate) in cerebral and spinal diseases - Summary of studies at 22 hospitals. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_A23BSA_study_synopsis.pdf |
| View full study record |
| Document reference: 28835 |
| Study title: Open clinical study in dynamic MRI in rheumatic arthritis and related disease |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88135_study_synopsis.pdf |
| View full study record |
| Document reference: 28824 |
| Study title: Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87054_study_synopsis.pdf |
| View full study record |
| Document reference: 28821 |
| Study title: Open clinical study in MRI of intracranial and spinal tumors and other lesion of the CNS |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86224_study_synopsis.pdf |
| View full study record |
| Document reference: 28819 |
| Study title: Open label study of Gadopentetate Dimeglumine as a magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system (CNS) lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88492_study_synopsis.pdf |
| View full study record |
| Document reference: 28831 |
| Study title: Open label study of Gadopentetate Dimeglumine as an MRI contrast agent in pediatric patients presenting with symptoms of central nervous system lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88490_study_synopsis.pdf |
| View full study record |
| Document reference: 28828 |
| Study title: Open uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients (6-18 years) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28829 |
| Study title: Open-Label Study of Gadopentetate Dimeglumine as an magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
| View full study record |
| Document reference: 28832 |
| Study title: Open-Label Study of Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric Patients Presenting with Symptoms of Central Nervous System Lesions |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88488_study_synopsis.pdf |
| View full study record |
| Document reference: 28826 |
| Study title: Open-Label study of Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric Patients Presenting with Symptoms of Central Nervous System Lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88489_study_synopsis.pdf |
| View full study record |
| Document reference: 28827 |
| Study title: AN OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE EXTENDED TREATMENT OF EPILEPTIC SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28764 |
| Study title: AN OPEN-LABEL MULTICENTRE STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS AD-ON THERAPY AND MONOTHERAPY IN THE LONG-TERM TREATMENT OF EPILEPTIC SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28765 |
| Study title: AN OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF GABAPENTIN(NEURONTIN) IN COMPARISON WITH CARBAMAZEPINE IN THE LONG-TERM EXTENDED TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED EPILEPSY WHO ARE CONVERTED FROM PROTOCOL 945-077 |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28766 |
| Study title: AN OPEN-LABEL, SAFETY STUDY OF GABAPENTIN (CI-945) AS ADJUNCT THERAPY IN CHILDREN AGED 1 MONTH THROUGH 4 YEARS WITH SEIZURES UNCONTROLLED BY CURRENT ANTIVONVULSANT DRUGS |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28767 |
| Study title: AN OPEN-LABEL, UNCONTROLLED, MULTICENTER STUDY TO DETERMINE THE LONG TERM SAFETY AND EFFICACY OF GABAPENTIN (CI-945) ADMINISTERED AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTIEPILEPTIC DRUGS IN PATIENTS WITH MEDICALLY UNCONTROLLED PARTIAL OR GENERALIZED EPILEPTIC SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28768 |
| Study title: AN ORAL, RISING SINGLE-DOSE TOLERANCE, PHARMACONETIC, AND PHARMACODYNAMIC STUDY OF PD 200390 CAPSULTE DOSES COMPARING HEALTHY ELDERLY VOLUNTEERS TO HEALTHY YOUNG VOLUNTEERS |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28769 |
| Study title: COMPARATIVE CLINICAL TRIAL OF GABAPENTIN AND SODIUM VALPROATE AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILEPSIES: OPEN RANDOMIZED MULTICENTER TRIAL |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28770 |
| Study title: COMPARATIVE NEURONTIN TRIAL: RESPONSE ON LONG TERM ASSESSMENT |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28771 |
| Study title: Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192Time resolved contrast enhanced MR angiography of the hand with parallel imaging and view sharing: initial experience; Brauck K; Eur. Radiol.; 2007 vol.17 p.183-192 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28867 |
| Study title: Utilization of gadolinium DOTA in the diagnosis of tumors of the central nervous system of the child;Lipski S; Diagn. Interv. Radiol.; 1990 vol.2 p.163-167Utilization of gadolinium DOTA in the diagnosis of tumors of the central nervous system of the child;Lipski S; Diagn. Interv. Radiol.; 1990 vol.2 p.163-167 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28842 |
| Study title: Wirksamkeit und Verträglichkeit von Aknichthol N Lotio bei 40 Patienten mit leichter und mittelschwerer Akne vulgaris |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28878 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Galium-Heel (drops) [AWB-055] |
| Active substance: Galium-Heel /Galium-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40004 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Galium-Heel (drops) [AWB-AT] |
| Active substance: Galium-Heel/ Galium-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40003 |
| Study title: Pharmacokinetics and tolerability of i.v. ganciclovir and oral valganciclovir syrup formulation in paediatric renal transplant recipients. |
| Active substance: GANCICLOVIR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28879 |
| Study title: Safety and pharmacokinetics of i.v. ganciclovir and valganciclovir oral solution formulation in paediatric liver transplant recipients receiving treatment with i.v. ganciclovir for prevention of cytomegalovirus disease. |
| Active substance: GANCICLOVIR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28880 |
| Study title: Prospective, multicenter, reference-controlled observational study for the documentation of therapeutic efficay and tolerability in the use of Gastricumeel (tablets) or proton pump inhibitors in the treatment of gastritis or heartburn [AWB-502] |
| Active substance: Gastricumeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40005 |
| Study title: Final Report from the Post Marketing Surveillance Study (Nurofen fur Kinder Fiebersaft) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29396 |
| Study title: Final Study Report A Comparative Pharmacodynamic Evaluation of the Antipyretic Efficacy and Safety of Ibuprofen Liquid Vs Acetaminophen in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29458 |
| Study title: Renn−E. The antipyretic use of acetaminophen versus ibuprofen in a pediatric care setting. {P−T}, 2000, Vol/Iss/Pg. 25/8 (395−397)Renn−E. The antipyretic use of acetaminophen versus ibuprofen in a pediatric care setting. {P−T}, 2000, Vol/Iss/Pg. 25/8 (395−397) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29579 |
| Study title: Report on a comparative assessment of the anti-pyretic activity of Ibuprofen and Paracetamol suspensions in children. Prof T I Bhutta, Nishta Medical College, Multan |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29451 |
| Study title: Roth RP et al. Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol 1977; 86(2 pt. 1):235-42 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29515 |
| Study title: Sarrell−E−M et al. Antipyretic treatment in young children with fever: Acetaminophen, ibuprofen, or both alternating in a randomized, double−blind study. {ARCH−PEDIATR−ADOLESC− MED}, 2006, Vol/Iss/Pg. 160/2 (197−202)Sarrell−E−M et al. Antipyretic treatment in young children with fever: Acetaminophen, ibuprofen, or both alternating in a randomized, double−blind study. {ARCH−PEDIATR−ADOLESC− MED}, 2006, Vol/Iss/Pg. 160/2 (197−202) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29569 |
| Study title: Single parallel group study investigating the antipyretic properties of ibuprofen syrup vs acetylsalicylic acid syrup in febrile children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29467 |
| Study title: Single-blind parallel group study investigating the antipyretic properties of Ibuprofen syrup versus Acetylsalicylic acid syrup in febrile children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29420 |
| Study title: Single-Blind Parallel Group Study Investigating the Antipyretic Properties of Ibuprofen Syrup Versus Acetylsalicylic Acid Syrup in Febrile Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS83-078.pdf |
| View full study record |
| Document reference: 47553 |
| Study title: single-dose open study comparing Ibuprofen suspension and Paracetamol suspension in symptomatic therapy of juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BR9083.pdf |
| View full study record |
| Document reference: 29417 |
| Study title: Sperber SJ et al. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch Fam Med 2000; 9(10):979-85 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29510 |
| Study title: St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29544 |
| Study title: St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codeine in the young tonsillectomy. PubMed. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29605 |
| Study title: Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427)Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29589 |
| Study title: Study 1 - Ibuprofen in the treatment of postoperative pain in small children. A randomised double-blind-placebo controlled parallel group study |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29517 |
| Study title: Study of the efficacy and tolerance of Ibuprofen on hectic fever in systemic juvenile chronic arthritis (JCA) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29406 |
| Study title: Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37.Enright AM, Prober C. Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. [Review] [99 refs]. Herpes 2003; 10(2):32-37. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Enright AM et al 2003.pdf |
| View full study record |
| Document reference: 28594 |
| Study title: Franca IE, Poiaresbaptista A, Araujo CO, Borges FC, Lerias MG, Melo EL et Verrucous herpetic disseminated lesions in AIDS patients. European-Journal-of- Dermatology 1995; 5(3):212-215.Franca IE, Poiaresbaptista A, Araujo CO, Borges FC, Lerias MG, Melo EL et Verrucous herpetic disseminated lesions in AIDS patients. European-Journal-of- Dermatology 1995; 5(3):212-215. |
| Active substance: Foscarnet |
| Study summary document link (including results): Franca IE et al 1995.pdf |
| View full study record |
| Document reference: 39670 |
| Study title: Frangoul H, Wills M, Crossno C, Engel M, Domm J. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant. 2007 Dec;11(8):942-4.Frangoul H, Wills M, Crossno C, Engel M, Domm J. Acyclovir-resistant herpes simplex virus pneumonia post-unrelated stem cell transplantation: a word of caution. Pediatr Transplant. 2007 Dec;11(8):942-4. |
| Active substance: Foscarnet |
| Study summary document link (including results): Frangoul H et al 2007.pdf |
| View full study record |
| Document reference: 39617 |
| Study title: Freifeld A. 1993. The antimicrobial armamentarium. Hematology-Oncology Clinics of North America 1993; 7(4):813-839.Freifeld A. 1993. The antimicrobial armamentarium. Hematology-Oncology Clinics of North America 1993; 7(4):813-839. |
| Active substance: Foscarnet |
| Study summary document link (including results): Freifeld A. et al 1993.pdf |
| View full study record |
| Document reference: 39620 |
| Study title: Gambertoglio JG, Lilleby K, Meyers JD, Reusser P. 1992.Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. Journal of Infectious Diseases 1992;166(3):473-9 1992;(3):473-479.Gambertoglio JG, Lilleby K, Meyers JD, Reusser P. 1992.Phase i-ii trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. Journal of Infectious Diseases 1992;166(3):473-9 1992;(3):473-479. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser et al 1992.pdf |
| View full study record |
| Document reference: 39626 |
| Study title: Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36.Gershon AA. Prevention and treatment of VZV infections in patients with HIV. Herpes. 2001; 8(2):32-36. |
| Active substance: Foscarnet |
| Study summary document link (including results): Gershon AA 2001.pdf |
| View full study record |
| Document reference: 39645 |
| Study title: Glassner CL, Noormohamed SE. Pediatric HIV infection: a primer for pharmacists. Journal of the American Pharmaceutical Association (1996) 1996;36(10):580-95 1999;(1996):580-595.Glassner CL, Noormohamed SE. Pediatric HIV infection: a primer for pharmacists. Journal of the American Pharmaceutical Association (1996) 1996;36(10):580-95 1999;(1996):580-595. |
| Active substance: Foscarnet |
| Study summary document link (including results): Glassner CL et al 1996.pdf |
| View full study record |
| Document reference: 39648 |
| Study title: Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209.Griffiths PD. Progress in the clinical management of herpes virus infections. Antiviral-Chemistry- Chemotherapy 1995; 6(4):191-209. |
| Active substance: Foscarnet |
| Study summary document link (including results): Griffiths PD 1995.pdf |
| View full study record |
| Document reference: 39671 |
| Study title: Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208.Grose C. Childhood infections with human herpesviruses types 6, 7, and 8. Advances in Pediatric Infectious Diseases 1996; 12:181-208. |
| Active substance: Foscarnet |
| Study summary document link (including results): Grose C. 1996.pdf |
| View full study record |
| Document reference: 39666 |
| Study title: Gross G, Braun D. 2006. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of postmarketing surveillance]. Hautarzt 2006; 57(1):40-46.Gross G, Braun D. 2006. [Efficacy and tolerability of topical foscarnet sodium in treatment of herpes labialis. Results of postmarketing surveillance]. Hautarzt 2006; 57(1):40-46. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Gross G, Braun D 2006.pdf |
| View full study record |
| Document reference: 39590 |
| Study title: Haas H. 2005. Antiviral treatment in chickenpox. Antibiotiques. 7(3):171-176, SEP 2005 2005;(3):-176, Sep. 2005.Haas H. 2005. Antiviral treatment in chickenpox. Antibiotiques. 7(3):171-176, SEP 2005 2005;(3):-176, Sep. 2005. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Haas H. 2005.pdf |
| View full study record |
| Document reference: 39591 |
| Study title: Open-Label Study of Gadopentetate Dimeglumine as an MRI Contrast Agent in Pediatric patients Presenting with Symptoms of Central Nervous System Lesions. |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88491_study_synopsis.pdf |
| View full study record |
| Document reference: 28830 |
| Study title: Open-label, multicenter trial of Magnevist® enteral in magnetic resonance imaging of patients |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): ME90095 ME91005 ME91006.pdf |
| View full study record |
| Document reference: 28825 |
| Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Prof. Hadziselimovic (Clinical study) 25/9/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28997 |
| Study title: Aguiar AL, Couto-Silva AC, Vicente EJ, Freitas IC, Cruz T, Adan LF. Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues. Journal of Pediatric Endocrinology and Metabolism 19(11)()(pp 1327-1334), 2006 Date of Publication: Nov 2006 2006;(11):1327-1334.Aguiar AL, Couto-Silva AC, Vicente EJ, Freitas IC, Cruz T, Adan LF. Weight evolution in girls treated for idiopathic central precocious puberty with GnRH analogues. Journal of Pediatric Endocrinology and Metabolism 19(11)()(pp 1327-1334), 2006 Date of Publication: Nov 2006 2006;(11):1327-1334. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28999 |
| Study title: Albano MCC, Latronico AC, Arnhold IJP, Domenice S, Bloise W, Mendonca BB. Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. Journal of Pediatric Endocrinology and Metabolism 10(5)()(pp 499-503), 1997 Date of Publication: 1997 1997;(5):499-503.Albano MCC, Latronico AC, Arnhold IJP, Domenice S, Bloise W, Mendonca BB. Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. Journal of Pediatric Endocrinology and Metabolism 10(5)()(pp 499-503), 1997 Date of Publication: 1997 1997;(5):499-503. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29000 |
| Study title: Antoniazzi F, Zamboni G. Central precocious puberty: Current treatment options. Pediatric Drugs 2004;6(4):211-231 2004;(4):211-231.Antoniazzi F, Zamboni G. Central precocious puberty: Current treatment options. Pediatric Drugs 2004;6(4):211-231 2004;(4):211-231. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29001 |
| Study title: Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF, McNeill E, Young D, Donaldson MDC. Clinical Endocrinology 2004;61(5)(Suppl 2):626-34 2004;(5):626-634.Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Paterson WF, McNeill E, Young D, Donaldson MDC. Clinical Endocrinology 2004;61(5)(Suppl 2):626-34 2004;(5):626-634. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29002 |
| Study title: Breyer P, Haider A, Pescovitz O. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty. Clinical Obstetrics and Gynecology 1993; 36(3):764-772.Breyer P, Haider A, Pescovitz O. Gonadotropin-releasing hormone agonists in the treatment of girls with central precocious puberty. Clinical Obstetrics and Gynecology 1993; 36(3):764-772. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29004 |
| Study title: De B, V, Latronico AC, Arnhold IJP, Lo LSS, Domenice S, Albano MCC et al. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Archives of Disease in Childhood 1999; 80(3):2.De B, V, Latronico AC, Arnhold IJP, Lo LSS, Domenice S, Albano MCC et al. Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot. Archives of Disease in Childhood 1999; 80(3):2. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29005 |
| Study title: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29006 |
| Study title: A Phase I study of gemcitabine in children with refractory solid tumours |
| Active substance: GEMCITABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28883 |
| Study title: A Phase I study of gemcitabine in children with relapsed or refactory leukemia and non-Hodgkin's lymphoma |
| Active substance: GEMCITABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28882 |
| Study title: A phase II study of Gemcitabine in Children with Relapsed Acute Lymphoblastic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) |
| Active substance: GEMCITABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28881 |
| Study title: A phase II study of Gemcitabine in Children with Relapsed Acute Lymphoblastic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) |
| Active substance: GEMCITABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28884 |
| Study title: A PHASE II STUDY OF GEMCITABINE IN CHILDREN WITH SOLID TUMOURS OF MESENCHYMAL AND EMBRYONAL ORIGIN |
| Active substance: GEMCITABINE |
| Study summary document link (including results): Gemcitabine - B9E-SB-0325.pdf |
| View full study record |
| Document reference: 47212 |
| Study title: Phase II Study of Gemcitabine in Children with Relapsed Leukemia |
| Active substance: GEMCITABINE |
| Study summary document link (including results): Gemcitabine - B9E-SB-0350.pdf |
| View full study record |
| Document reference: 47213 |
| Study title: Phase III, controlled, open-label, randomized, single-center study to evaluate the safety and immunogenicity using four different vaccination schedules of tick-borne encephalitis (TBE) - polygeline free vaccine in adolescents and adults. |
| Active substance: Tick-Borne Encephalitis Virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48397 |
| Study title: Bronchial secretion and serum levels in children with cystic fibrosis treated with gentamicin. - Vogt E. - 1973 ( Praxis, 62 : 444-447) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28891 |
| Study title: Clinical an dLaboratory evaluation of Gentaimicin in Infants and Children. - Riley HD. & Al - 1971 (J. of infectious Dis. 124 Suppl: S236) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28892 |
| Study title: A double blind dose-ranging study of the efficacy and safety of prophylactic BRL-043694-A in controlling cytotoxic drug induced nausea and vomiting in paediatric patients with malignant disease |
| Active substance: GRANISETRON |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29022 |
| Study title: Physiologic changes induced by theophylline in the treatment of apnea in preterm infants.Davi MJ, Sankaran K, Simons KJ, Simons FE, Seshia MM, Rigatto H. J Pediatr. 1978 Jan;92(1):91-5. |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48958 |
| Study title: Continuation study for the prophylactic use of intravenous BRL-043694-A in controlling cytotoxic drug induced nausea and vomiting in paediatric patients with malignant disease |
| Active substance: GRANISETRON |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29023 |
| Study title: Pellier P, Wells K, Singh Saggu P, Bartlett J: A double blind dose ranging study comparing the efficacy and safety of two oral doses of Granisetron solution 20 mcg/kg bd and 40 mcg/kg bd for prophylaxis of cytotoxic induced emesis in paediatric patients with malignant disease |
| Active substance: GRANISETRON |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29026 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Graphites-Homaccord (drops) [AWB-AT] |
| Active substance: Graphites-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40014 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Graphites-Homaccord (ampoules) [AWB-AT] |
| Active substance: Graphites-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40015 |
| Study title: A short notice and intermediateterm control of success after triennial hypersensitation with Graminea Pollen-Depot- Allergoid (Allergovit); Age of patients: 6-67 Years |
| Active substance: Grasses |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47784 |
| Study title: In-vitro determination of Interleukin-5, Interferongamma as well as IgG4 and IgG1 as monitor parameters in correlation with their clinical course during the first 2 years of preseasonal immunotherapy with a grass allergoid 10.04.01 Age of patients:6-49 Years, 27 Patients. |
| Active substance: Grasses |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47783 |
| Study title: |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38444 |
| Study title: Taste Test Study by RSSL Pharma A taste testing study in healthy volunteers to investigate preference for Nurofen for Children Project Scrumptious |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29520 |
| Study title: The gas chromatographic determination of 2(4-isobutylphenyl )- propionic acid in Brufen suspension - paediatric ( modified formula ) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29433 |
| Study title: Pharmacovigilance of AlphanineSD; affinity purified, solvent detergent treated: An open label study of viral safety in previously untreated subjects with Haemophilia B. |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): 02 ATC 96-04 (synopsis).pdf |
| View full study record |
| Document reference: 47317 |
| Study title: 'Post marketing study in haemophilia B patients using Nonafact® 100 IU/ml powder and solvent for solution for injection (human coagulation factor IX) |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29134 |
| Study title: Post-marketing authorisation study of the efficacy and safety of coagulation factors FACTANE, BETAFACT, WILFACTIN/WILSTART |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29135 |
| Study title: Summary of Clinical Data on Children Treated with Nanotiv |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29132 |
| Study title: A Postlicensing Study to Determine Long-Term Safety of Alphanate® in Previously-Treated Patients Diagnosed with Severe Hemophilia A |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29144 |
| Study title: Clinical Study of Recovery and Half-Life of Factor VII Concentrate (Human Immuno 1988-1991) |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29142 |
| Study title: Compassionate Use of Factor VII, VH |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29141 |
| Study title: Low risk if viral infection after administration of vapor heated factor VII concentrate or factor IX complex in first time recipients of blood components |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29140 |
| Study title: Open-Label Clinical Study of Long-Term Treatment and Prophylaxis with Factor VII Concentrate (Human) Immuno, Vapor Heated" |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29138 |
| Study title: Single Patient Use of Factor VII Concentrate |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29143 |
| Study title: Study to determine the safety of virus inactivated factor concentrates in hemophiliacs naive to blood product administration (IFSS) |
| Active substance: HUMAN COAGULATION FACTOR VII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29139 |
| Study title: A study on the safety and efficacy of FEIBA VH Immuno in Hemophilia Patients with Inhibitors Hemophiliac Treatment Research Study |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): 05 ATG95-03 (full).pdf |
| View full study record |
| Document reference: 29148 |
| Study title: Clinical study to investigate the efficacy, safety and immunogenicity of Wilate in children < 6 years of age with inherited von willebrand disease. |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29157 |
| Study title: Efficacy and safety in children with severe Haemophilia A treated with OCTANATE (Phase III) |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29156 |
| Study title: Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery or invasive procedures in subjects with congenital von Willebrand disease |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29146 |
| Study title: Efficacy Study of FEIBA IMMUNO Vapor Heated Versus Factor IX Complex (Human) IMMUNO, Vapor Heated, in the Management of Patients with Hemophilia A with Inhibitors |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29150 |
| Study title: Evaluation of the Pharmacokinetic, Clinical Efficacyand Safety of the Concentrate of Factor VIII, Emoclot D.I., in patients affected by Haemophilia A |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): 06 IG95-01B (full).pdf |
| View full study record |
| Document reference: 29154 |
| Study title: Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS et al. 2005.Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.Antiviral Research. 68(3):147-153, DEC 2005 2005;(3):-153, Dec.2005.Han YX, Xue R, Zhao W, Zhou ZX, Li JN, Chen HS et al. 2005.Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection.Antiviral Research. 68(3):147-153, DEC 2005 2005;(3):-153, Dec.2005. |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39592 |
| Study title: Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008 Jan;27(1):75-7.Hatchette T, Tipples GA, Peters G, Alsuwaidi A, Zhou J, Mailman TL. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature. Pediatr Infect Dis J. 2008 Jan;27(1):75-7. |
| Active substance: Foscarnet |
| Study summary document link (including results): Hatchette T et al 2008.pdf |
| View full study record |
| Document reference: 39615 |
| Study title: Hick RW, Prose N. 2010. Penile erosions associated with foscarnet therapy in a child. Pediatr Dermatol. 2010 May-Jun;27(3):302-3.Hick RW, Prose N. 2010. Penile erosions associated with foscarnet therapy in a child. Pediatr Dermatol. 2010 May-Jun;27(3):302-3. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Hick RW et al 2010.pdf |
| View full study record |
| Document reference: 39601 |
| Study title: Hubacek P, Keslova P, Formankova R, Pochop P, Cinek O, Zajac M, Lochmanova J, Stary J, Sedlacek P. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatr Transplant. 2009 Nov;13(7):919- 22.Hubacek P, Keslova P, Formankova R, Pochop P, Cinek O, Zajac M, Lochmanova J, Stary J, Sedlacek P. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. Pediatr Transplant. 2009 Nov;13(7):919- 22. |
| Active substance: Foscarnet |
| Study summary document link (including results): Hubacek P et al 2009.pdf |
| View full study record |
| Document reference: 39609 |
| Study title: Idanpaan H, Aranko K. Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs. MNG Dukes & JK Aronsen (ed). Elsevier Science Publishers. 1992;322- 340.Idanpaan H, Aranko K. Miscellaneous antibacterial and antiviral drugs. In: Side effects of drugs. MNG Dukes & JK Aronsen (ed). Elsevier Science Publishers. 1992;322- 340. |
| Active substance: Foscarnet |
| Study summary document link (including results): Idanpaan H et al 1992.pdf |
| View full study record |
| Document reference: 39627 |
| Study title: Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.Ippoliti C, Morgan A, Warkentin D, Van BK, Mehra R, Khouri I. Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. |
| Active substance: Foscarnet |
| Study summary document link (including results): Ippoliti C et al 1997.pdf |
| View full study record |
| Document reference: 39661 |
| Study title: Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trial Group Protocol 151. Journal-of-Infectious- Diseases 1994; 170 (July): 189-193.Jacobson MA, Kramer F, Bassiakos Y, Hooton T, Polsky B, Geheb H et al. Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS Clinical Trial Group Protocol 151. Journal-of-Infectious- Diseases 1994; 170 (July): 189-193. |
| Active substance: Foscarnet |
| Study summary document link (including results): Jacobson MA _Kramer F et al 1994.pdf |
| View full study record |
| Document reference: 39633 |
| Study title: Jacobson MA,Causey D, Polsky B, Hardy D, Chown M, Davis R. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Journal of Infectious Diseases 1993; 168(2):444-448.Jacobson MA,Causey D, Polsky B, Hardy D, Chown M, Davis R. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Journal of Infectious Diseases 1993; 168(2):444-448. |
| Active substance: Foscarnet |
| Study summary document link (including results): Jacobson MA et al 1993.pdf |
| View full study record |
| Document reference: 39622 |
| Study title: Kawamura Y, Yoshikawa T. 2011. HHV-6 encephalopathy. Nippon Rinsho. 2011 Mar;69(3):423-8.Kawamura Y, Yoshikawa T. 2011. HHV-6 encephalopathy. Nippon Rinsho. 2011 Mar;69(3):423-8. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Kawamura Y 2011.pdf |
| View full study record |
| Document reference: 39598 |
| Study title: Keating MR. Antiviral agents. Mayo-clinic-proceedings 1992; 67(2):160-178.Keating MR. Antiviral agents. Mayo-clinic-proceedings 1992; 67(2):160-178. |
| Active substance: Foscarnet |
| Study summary document link (including results): Keating MR et al 1992.pdf |
| View full study record |
| Document reference: 39628 |
| Study title: Isaac H, Patel L, Meyer S, Hall CM, Cusick C, Price DA et al. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty. Hormone Research 2007; 68(4):157-163.Isaac H, Patel L, Meyer S, Hall CM, Cusick C, Price DA et al. Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty. Hormone Research 2007; 68(4):157-163. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28998 |
| Study title: Lebrethon M-C, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO. Linear Growth and Final Height after Treatment for Cushing's Disease in Childhood. Journal of Clinical Endocrinology and Metabolism 2000; 85(9):3262-3265.Lebrethon M-C, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO. Linear Growth and Final Height after Treatment for Cushing's Disease in Childhood. Journal of Clinical Endocrinology and Metabolism 2000; 85(9):3262-3265. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29007 |
| Study title: Untersuchung der Wirkamkeit einer neuen oralen Dareichungsform von Furosemid bei herinsuffizienten Kindern (abs) - Vogel M. et al. - 1990 (Monatschr Kinderheilkd, 138:488, abs 036) Publication in Clinical Expert Report - Dr Matti VERHO - 05/1995 - Volume 2 |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28642 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28723 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28724 |
| Study title: |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28725 |
| Study title: 4A. A report of patients with superficial skin sepsis treated with fucidin cream. An open assessment of Fucidin Cream as a treatment for superficial sepsis (Newby) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28669 |
| Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28720 |
| Study title: A comparative study of Fucidin® ointment (sodium fusidate 2%) and Cicatrin cream (neomycin sulphate 0.5%, bacitracin zinc 250u/g |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28692 |
| Study title: A comparison of Fucidin tablets and Flucloxacillin in skin and soft-tissue infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28694 |
| Study title: A comparison of Fucithalmic® eye drops and Chloramphenicol® eye ointment as single treatment in brasion corneae, corpus alieni corneae |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28650 |
| Study title: A comparison of Fusidic acid 1% viscous eye drops (Fucithalmic LEO) and neosporin eye ointment (Wellcome) in patients with external eye infections; Yacinto U Dy, Llacco Int. J. of clinical practices, Vol 7., No. 3., 1991 82 pts (4-75) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28708 |
| Study title: A comparison of fusidic acid gel 1% (Fucithalmic®) and chloramphenicol 0.5% in acute bacterial conjunctivits Carr WD, Journal Clin Research 1998;1:403-411 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28713 |
| Study title: A comparison of fusidic acid viscous eye drops and Chloramphenicol eye ointment in acute conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28697 |
| Study title: A comparison of low dose and standard dose systemic Fucidin® in skin and soft tissue infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28716 |
| Study title: A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28693 |
| Study title: A comparison of the efficacy of Fucidin® H cream(2% fusidic acid/1%hydrocortisone acetate) with Fucidin® cream(2% fusidic acid) in the management of patients with mild to moderate atopic eczema |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28672 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (tablets) in children aged up to 11 years old [AWB-063] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40018 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Gripp-Heel (tablets) [AWB-056] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40016 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to the treatment of Gripp-Heel (injection solution) [AWB-056] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40020 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (ampoules) [AWB-AT] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40017 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Gripp-Heel (tablets) [AWB-AT] |
| Active substance: Gripp-Heel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40019 |
| Study title: Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71Korppi M et al. Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 1991; 80(10):969-71 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29027 |
| Study title: Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42Lee PCL et al. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 2000; 52(9):1137-42 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29028 |
| Study title: Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45237 |
| Study title: Open clinical study to evaluate the reactogenicity of SmithKline Beecham Biologicals' Hib conjugate vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine when given as a booster dose to children at 15 to 18 months of age, previously primed with SB Bio's Hib tetanus conjugate and DTPa vaccines in study HIB-012. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41133 |
| Study title: Open label, randomised comparative assessment of the immunogenicity and reactogenicity of SmithKline Beecham's (SB's) diphteria/tetanus/acellular pertussis (DTPa) vaccine and SB's Hib with commercially available diphtheria/tetanus/whole cell pertussis (DTPw) and SB's Hib. Vaccines to be combined in the same syringe and administered to healthy infants as three consecutive doses at 2, 3 and 4 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41137 |
| Study title: Open randomised clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib tetanus conjugate vaccine, co-administered with SB Biologicals' DTPa vaccine either mixed in one syringe, or in two separate injections into opposite limbs, to healthy children around two years of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41141 |
| Study title: Open study to assess the immunogenicity and reactogenicity of a three-dose primary vaccination course against Haemophilus influenzae type b, diphtheria, tetanus, pertussis and hepatitis B in healthy infants at 6, 10 and 14 weeks of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41155 |
| Study title: Open, phase II clinical trial to assess long-term antibody persistence, before Td booster vaccination, in healthy children 5 to 6 years old, previously vaccinated with 4 doses of SB Biologicals¿ DTPa vaccine mixed with SB Biologicals¿ Hib conjugate vaccine in primary vaccination study Hib-006 (208108/005) and in booster vaccination study Hib-017 (208108/017). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41156 |
| Study title: Familiarization Phase of FEIBA Immuno Study (Hilgartner) |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): 03 IG405 (synopsis).pdf |
| View full study record |
| Document reference: 29149 |
| Study title: Human Plasma derived Antihemophilic Factor VIII: Evaluation of Efficacy, Tolerability and Safety in Previously Treated Severe Hemophilia A Patients. An Open non-Comparative Phase III Study. |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29153 |
| Study title: A dose-ranging study of Ibuprofen syrup in pyrexia in chlidren |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29427 |
| Study title: A dose-ranging study of Ibuprofen syrup in pyrexia in chlidren |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29440 |
| Study title: A double blind single-dose, Parallel study comparing Advil Liquigel to Excedrin Extra-Strength /Excedrin Migraine and to Placebo in Migraine Headache |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29527 |
| Study title: A double blind, single oral dose study, comparing the antipyretic properties of ibuprofen, acetaminophen and placebo in the treatment of pyrexia associated with infectious disease in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29464 |
| Study title: A double blind, single-dose, parallel group study comparing Advil Liquigel to Extra Strength Excedrin/Excedrin Migraine and to Placebo in Dental Pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29525 |
| Study title: A double-blind comparison of Ibuprofen and Paracetamol in juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29423 |
| Study title: A double-blind comparison of Ibuprofen and Paracetamol in juvenile pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29438 |
| Study title: A DOUBLE-BLIND COMPARISON OF IBUPROFEN AND PARACETAMOL IN JUVENILE PYREXIA |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS85-526.pdf |
| View full study record |
| Document reference: 47554 |
| Study title: A double-blind comparison of the safety and efficacy of a single dose of Children's Advil Ibuprofen suspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and suspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and a control vehicle in the relief of sore throat pain in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-WM-366.pdf |
| View full study record |
| Document reference: 29434 |
| Study title: A double-blind comparison of the safety and efficacy of a single dose of Children's Advil Ibuprofen uspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and suspension (10mg.kg~1), Acetaminophen (15mg.kg~1), and a control vehicle in the relief of sore throat pain in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29454 |
| Study title: A double-blind multicentre, multiple dose, parrallel group study comparing the efficacy of thre dose levels of Ibuprofen versus Acetaminophen in the Treatment of Pyrexia in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29394 |
| Study title: A Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29502 |
| Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29497 |
| Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29499 |
| Study title: Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in Pediatric Infectious Diseases. 2002; 13(1):22-30.Kimberlin DW. Antiviral therapy for cytomegalovirus infections in pediatric patients. Seminars in Pediatric Infectious Diseases. 2002; 13(1):22-30. |
| Active substance: Foscarnet |
| Study summary document link (including results): Kimberlin DW. et al 2002.pdf |
| View full study record |
| Document reference: 39637 |
| Study title: Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology. 2002; 17(12):1032-1037.Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RG, van Oostayen JA et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatric Nephrology. 2002; 17(12):1032-1037. |
| Active substance: Foscarnet |
| Study summary document link (including results): Kist-van Holthe JE et al 2002.pdf |
| View full study record |
| Document reference: 39638 |
| Study title: Leport C, Perronne C, Vilde JL. Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children). Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):837-842.Leport C, Perronne C, Vilde JL. Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children). Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):837-842. |
| Active substance: Foscarnet |
| Study summary document link (including results): Leport C et al 1998.pdf |
| View full study record |
| Document reference: 39652 |
| Study title: Ljungman P, Oberg G, Aschan J, Ehrnst A, Lonnqvist B, Pauksen K et al. Foscarnet for pre-emptive therapy of cmv infection detected by a leukocyte-based nested pcr in allogeneic bone marrow transplant patients. Bone Marrow Transplantation 1996;18(3):565-56Ljungman P, Oberg G, Aschan J, Ehrnst A, Lonnqvist B, Pauksen K et al. Foscarnet for pre-emptive therapy of cmv infection detected by a leukocyte-based nested pcr in allogeneic bone marrow transplant patients. Bone Marrow Transplantation 1996;18(3):565-56 |
| Active substance: Foscarnet |
| Study summary document link (including results): Ljungman P et al 1996.pdf |
| View full study record |
| Document reference: 39667 |
| Study title: Ljungman P. 1995 Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in Respiratory Infections 1995; 10(4):209-215. Ljungman P. 1995 Cytomegalovirus pneumonia: presentation, diagnosis, and treatment. Seminars in Respiratory Infections 1995; 10(4):209-215. |
| Active substance: Foscarnet |
| Study summary document link (including results): Ljungman P 1995.pdf |
| View full study record |
| Document reference: 39672 |
| Study title: Ma C, Wong CK, Wong BC, Chan KC, Lun SW, Lee N, Wu J, Cockram CS, Chan PK, Tang JW.Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin.J Med Virol. 2009 Jan;81(1):99-105.Ma C, Wong CK, Wong BC, Chan KC, Lun SW, Lee N, Wu J, Cockram CS, Chan PK, Tang JW.Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin.J Med Virol. 2009 Jan;81(1):99-105. |
| Active substance: Foscarnet |
| Study summary document link (including results): Ma C et al 2009.pdf |
| View full study record |
| Document reference: 39610 |
| Study title: Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21.Marshall BC, Koch WC. Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.Paediatr Drugs. 2009;11(5):309-21. |
| Active substance: Foscarnet |
| Study summary document link (including results): Marshall BC et al 2009.pdf |
| View full study record |
| Document reference: 39606 |
| Study title: Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases 189(8), 1355-1361. 2004. Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. Journal of Infectious Diseases 189(8), 1355-1361. 2004. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Mattes FM et al 2004.pdf |
| View full study record |
| Document reference: 28588 |
| Study title: Mazeron MC, Alain S. Active antiviral agents against human cytomegalovirus and their use in pediatrics. Archives de Pediatrie 1996; 3:Suppl-311s.Mazeron MC, Alain S. Active antiviral agents against human cytomegalovirus and their use in pediatrics. Archives de Pediatrie 1996; 3:Suppl-311s. |
| Active substance: Foscarnet |
| Study summary document link (including results): Mazeron MC et al 1996.pdf |
| View full study record |
| Document reference: 39668 |
| Study title: Mindel A. Recent advances in genital herpes. Annals of the Academy of Medicine, Singapore 1995; 24(4):584-592.Mindel A. Recent advances in genital herpes. Annals of the Academy of Medicine, Singapore 1995; 24(4):584-592. |
| Active substance: Foscarnet |
| Study summary document link (including results): Mindel A 1995.pdf |
| View full study record |
| Document reference: 39673 |
| Study title: A Prospective Blinded Read to Explore the Efficacy of MULTIHANCE and MAGNEVIST (0.10 mmol/kg) in Magnetic Resonance Imaging (MRI) of Brain and Spine Tumors in Pediatric Population |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28722 |
| Study title: Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. .Long-acting gonadotropin-releasing hormone agonists in the differential diagnosis of male precocious puberty. . |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29008 |
| Study title: Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8.Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29009 |
| Study title: Fucidin® tablets in cutaneous infection in comparison with pristinamycin tablets |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28695 |
| Study title: Fucithalmic in external eye infections. Fucithalmic in The Baltic States (adults & children) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28648 |
| Study title: Fucithalmic viscous eye drops in acute conjunctivitis Single-Blind, Ramdomized Comparison with Chloramphenicol Eye Drops ; J. Hvidberg Acta Ophthalmologica, vol 65, no 1. 1987 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28699 |
| Study title: Fucithalmic viscous eye drops in superficial eye infections Open non-comparative study |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28652 |
| Study title: Fucithalmic, chloramphenicol or no treatment after squint surgery in children: a single blind randomised study |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28719 |
| Study title: Fucithalmic® versus 1% rifamycin in acute conjunctivitis.Adenis J P, Arrata M, Gastaud P, Limon S, Massin M. J. Fr Ophtalmol 1989; 12(4): 317-322 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28653 |
| Study title: Fusidic Acid and the Treatment of Patients with Skin and Soft Tissue Infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28698 |
| Study title: Fusidic acid versus tobramycin in suspected bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28680 |
| Study title: Garborg-O, Nyjordet-R. Pyogenic Cutaneous Infections In East African Children Treated With Fucidin Ointment. Journal of Tropical Pediatrics and Environmental Child Health, 1971, vol. 17, no. 4, p. 153-157. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28663 |
| Study title: Garborg-O. Cutaneous staphylococcal infections in children treated by 2 per cent sodium fusidate ointment. Bruxelles medical, {Brux-Med}, Jun 1968, vol. 48, no. 6, p. 377-82, ISSN: 0068-3027. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28664 |
| Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Verduin-CM, Bernsen-RMD, et-al. Erasmus University and University Hospital Rotterdam, Rotterdam, The Netherlands. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ, {BMJ}, 26 Jan 2002, vol. 324, p. 203-206, ISSN: 0959-8138. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28656 |
| Study title: Koning-S, van-Suijlekom-Smit-LWA, Nouwen-JL, Op-t-Veld-Mulders-M, Snijders-S, et-al. Erasmus University Medical Center, Rotterdam, The Netherlands. Fusidic acid cream versus placebo in the treatment of impetigo: a double blind placebo controlled randomized trial. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, {41st-ICAAC}, 22 Sep 2001, p. 269. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28657 |
| Study title: Liddy-N. Intravenous fusidic acid in the newborn. Lancet, {Lancet}, 17 Mar 1973, vol. 1, no. 7803, p. 621, ISSN: 0140-6736. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28662 |
| Study title: Gentamycin in the treatment of infections in the premature infant. - Forti G. - 1968 (Antibiotica, Dec, 4:255)- Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28925 |
| Study title: Germs of the serratia genus as etiological agents in septicemic syndroms in children. - Negut M. -1972 (Arch. Roum. Path. Exp. Microbiol. 31,2: 225) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28926 |
| Study title: Intérêt de la gentalline 10mg en pédiatrie. Orsini A. - 1972 (Marseille Medical, 109, 12: 836-866) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28927 |
| Study title: Intravenous Gentamicin for infections complications in children wth acute leukemia. - Haghbin M. -1971 (J. Infectious Dis. Dec. Suppl 124:192) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28928 |
| Study title: Is the primary suture indicated in infected wounds in pediatric surgery?Is the primary suture indicated in infected wounds in pediatric surgery? |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28887 |
| Study title: La Gentamicine en pédiatrie - Dachy A. & Al. - 1972 (Medecine et Hygiène 1034: 1831-2) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28929 |
| Study title: La Gentamycine en pédiatrie - utilisation de la forme 10mg/1ml - Monnet P. -1970 (Lyon Medical, 224, 34: 432-439) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28930 |
| Study title: La pharmacocinetique de la gentamicine chez l'adulte et chez des enfants d'ages divers. - Simon C. - 1973 (Dec. Med. Welt, 16, 73 : 626-630) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28931 |
| Study title: Perinatal pharmacology of gentamicin. - Salvador G. - 1972 (Clinical research, 20,2: 252) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28932 |
| Study title: Pharmacokinetics of gentamicin during peritoneal dialysis in children - Juskon WJ. - 1976 (Kidney, 9, 5 : 430-8) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28933 |
| Study title: Pharmacokinetics of gentamicin in children and adults. - Siber GR. - 1975 (J. Infect. Dis., 132, 6: 637-631) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28934 |
| Study title: Pharmacologic evaluation of gentamicin in newborn infants. - McCracken - 1971 (J. of Infectious Dis. 124, Suppl: S214) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28935 |
| Study title: Serratia marcescens osteomyelitis in an infant. - Nelms DK. - 1968 (J. Pediat., 72: 222) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28937 |
| Study title: Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7. Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7. |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28885 |
| Study title: Study of a new antibiotic: injectable gentamicin therapy in paediatrics. - D'Oelsnitz M. - 1967 - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28938 |
| Study title: Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984;104:752-757.Wolfson MR, Bhutani VK, Shaffer TH, Bowen FW. Mechanics and energetics of breathing helium in infants with bronchopulmonary dysplasia. J Pediatr 1984;104:752-757. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29114 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepar compositum (ampoules) [AWB-AT] |
| Active substance: Hepar compositum-Heel - Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40024 |
| Study title: Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis - Greinacher A. et al. - 2005 (Thromb Haemost 2005; 94; 132-5) Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis - Greinacher A. et al. - 2005 (Thromb Haemost 2005; 94; 132-5) |
| Active substance: HEPARIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29116 |
| Study title: Heparin-induced thrombocytopenia associated thrombosis in pediatric intensive care patients - Schmugge M. et Al. - 2002 (Pediatrics, vol 109, No.1, January 2002, 1-4) Heparin-induced thrombocytopenia associated thrombosis in pediatric intensive care patients - Schmugge M. et Al. - 2002 (Pediatrics, vol 109, No.1, January 2002, 1-4) |
| Active substance: HEPARIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29115 |
| Study title: Prospective, bicenter, randomised, placebo-controlled, parallel group comparison trial to investigate the antiphlogistic efficacy and tolerance of a fixed combination of levomenol and heparin (Sensicutan ointment) in patients with atopic eczema |
| Active substance: HEPARIN AND LEVOMENOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29118 |
| Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, in the treatment of post-operative dental pain. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 87-732.pdf |
| View full study record |
| Document reference: 47446 |
| Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental pain. CSR 116. Protocol 87-759, Unpublished Report 242. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 87-759.pdf |
| View full study record |
| Document reference: 47448 |
| Study title: Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29594 |
| Study title: Ibuprofen and other NSAID usage in juvenile arthritis - a review of clinical data |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29443 |
| Study title: Ibuprofen in children with infective disorders - anti-pyretic efficacy - M A Phadke, P V Paranjape and,A S Joshi, B.J. Medical, College, India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29450 |
| Study title: IBUPROFEN IN THE TREATMENT OF POSTOPERATIVE PAIN IN SMALL CHILDREN. A RANDOMISED CDOUBLE-BLIND-PLACEBO CONTROLLED PARALLEL GROUP STUDY |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29473 |
| Study title: Ibuprofen vs paracetamol in soft tissue injuries in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29392 |
| Study title: Int J Clin Pract Suppl. 2003 Apr;(135):50-3. The safety of ibuprofen suspension in children. Lesko SMInt J Clin Pract Suppl. 2003 Apr;(135):50-3. The safety of ibuprofen suspension in children. Lesko SM |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29611 |
| Study title: JAMA. 1995 Mar 22-29;273(12):929-33.Links Comment in: JAMA. 1996 Apr 3;275(13):986. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. Lesko SM, Mitchell AAJAMA. 1995 Mar 22-29;273(12):929-33.Links Comment in: JAMA. 1996 Apr 3;275(13):986. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. Lesko SM, Mitchell AA |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29612 |
| Study title: Jawad SS & Eccles R. Effect of pseudoephedrine on nasal airflow in patients with nasal congestion associated with common cold. Rhinology 1998; 36(2):73-6 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29511 |
| Study title: Joshi−Y−M et al. Comparative evaluation of the antipyretic efficacy of ibuprofen and paracetamol. {Indian−Pediatr}, Aug 1990, vol. 27, no. 8, p. 803−6Joshi−Y−M et al. Comparative evaluation of the antipyretic efficacy of ibuprofen and paracetamol. {Indian−Pediatr}, Aug 1990, vol. 27, no. 8, p. 803−6 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29591 |
| Study title: Kandoth−P−W et al. Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. {J−Int−Med−Res}, 1984, vol. 12, no. 5, p. 292−7Kandoth−P−W et al. Comparative evaluation of antipyretic activity of ibuprofen and aspirin in children with pyrexia of varied aetiology. {J−Int−Med−Res}, 1984, vol. 12, no. 5, p. 292−7 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29601 |
| Study title: Kauffman−R−E et al. Antipyretic efficacy of ibuprofen vs acetaminophen. {AM−J−DIS−CHILD}, 1992, Vol /Iss/Pg. 146/5 (622−625)Kauffman−R−E et al. Antipyretic efficacy of ibuprofen vs acetaminophen. {AM−J−DIS−CHILD}, 1992, Vol /Iss/Pg. 146/5 (622−625) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29595 |
| Study title: Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29545 |
| Study title: Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. |
| Active substance: Foscarnet |
| Study summary document link (including results): Mocroft A et al 1996.pdf |
| View full study record |
| Document reference: 39669 |
| Study title: Morel C, Metge F, Roman S, Scheer S, Larricart P, Monin C et al. [Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients]. [French]. Journal Francais d Opthalmologie 2004; 27(1):7-13.Morel C, Metge F, Roman S, Scheer S, Larricart P, Monin C et al. [Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients]. [French]. Journal Francais d Opthalmologie 2004; 27(1):7-13. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Morel C et al 2004.pdf |
| View full study record |
| Document reference: 28589 |
| Study title: Moretti S, Zikos P, Van Lint MT, Tedone E, Oochini D, Gualandi F. Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (hsct): a randomised study. Bone Marrow Transplantation 1998;22(2):175-180Moretti S, Zikos P, Van Lint MT, Tedone E, Oochini D, Gualandi F. Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (hsct): a randomised study. Bone Marrow Transplantation 1998;22(2):175-180 |
| Active substance: Foscarnet |
| Study summary document link (including results): Moretti S et al 1998.pdf |
| View full study record |
| Document reference: 39653 |
| Study title: Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. |
| Active substance: Foscarnet |
| Study summary document link (including results): Naik HR et al 1995.pdf |
| View full study record |
| Document reference: 39674 |
| Study title: Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. 2007; Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease 2007; 9(1):11-15.Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. 2007; Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transplant Infectious Disease 2007; 9(1):11-15. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Narimatsu H et al. 2007.pdf |
| View full study record |
| Document reference: 39588 |
| Study title: New approaches to drug therapy in HIV infection and AIDS. AIDS-Forschung 1994; 9(6):283-294.Tabolin VA, Volodin NN, Geras k, V, Il i, I, Tikhonov VV.New approaches to drug therapy in HIV infection and AIDS. AIDS-Forschung 1994; 9(6):283-294.Tabolin VA, Volodin NN, Geras k, V, Il i, I, Tikhonov VV. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Tabolin VA et al 1994.pdf |
| View full study record |
| Document reference: 28570 |
| Study title: Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clinical & Diagnostic Virology 1997; 8(3):169-181.Numazaki K, Chiba S. Current aspects of diagnosis and treatment of cytomegalovirus infections in infants. Clinical & Diagnostic Virology 1997; 8(3):169-181. |
| Active substance: Foscarnet |
| Study summary document link (including results): Numazaki K et al 1997.pdf |
| View full study record |
| Document reference: 39662 |
| Study title: Numazaki K. Cytomegalovirus infection.Nippon Rinsho - Japanese Journal of Clinical Medicine. 2001; 59:Suppl-8.Numazaki K. Cytomegalovirus infection.Nippon Rinsho - Japanese Journal of Clinical Medicine. 2001; 59:Suppl-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Numazaki K 2001.pdf |
| View full study record |
| Document reference: 39646 |
| Study title: Ongrádi J, Kövesdi V, Medveczky GP. Human herpesvirus 6; Orv Hetil. 2010 Mar 28;151(13):523-32.Ongrádi J, Kövesdi V, Medveczky GP. Human herpesvirus 6; Orv Hetil. 2010 Mar 28;151(13):523-32. |
| Active substance: Foscarnet |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39604 |
| Study title: Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.Pediatr Blood Cancer. 2009 Sep;53(3):453-8.Paris C, Kopp K, King A, Santolaya ME, Zepeda AJ, Palma J. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.Pediatr Blood Cancer. 2009 Sep;53(3):453-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Paris C et al 2009.pdf |
| View full study record |
| Document reference: 39607 |
| Study title: Occella-C, Schiazza-L, Nemelka-O, Persi-A, Rampini-E. Ist.Sci. "G.Gaslini", Div.Dermatologica, Genova, Italia. Garze medicate con acido fusidico nella terapia topica Rassegna di Dermatologia e Sifilografia, vol.XXXV, n.unico, genn-dic 1982. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28660 |
| Study title: Perianal streptococcal dermatitis treated with oral fusidic acid: report of two cases |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28718 |
| Study title: Pharmacokinetics of fusidic acid given as an oral suspension to children |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28687 |
| Study title: Pharmacokinetics of fusidic acid in children after single dose administration |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28689 |
| Study title: Pyogenic cutaneous infections in east African children treated with Fucidin® ointment; Garborg O and Nyjordet R. 1971 J Trop Pediatr. Child Health, 17: 153-157 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28677 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86238_study_synopsis.pdf |
| View full study record |
| Document reference: 28820 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging of musculo-skeletal lesions in children and teenage patients, 16-18 years (phase III) |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87191_study_synopsis.pdf |
| View full study record |
| Document reference: 28822 |
| Study title: Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of brain lesions in children (2-6 years) (phase III). |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_87224_study_synopsis.pdf |
| View full study record |
| Document reference: 28823 |
| Study title: Phase II study with Gd-DTPA in body trunk and extremities |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_A23CQB_study_synopsis.pdf |
| View full study record |
| Document reference: 28836 |
| Study title: Tolerance and diagnostic quality of Gd-DTPA (SH L 451 AA) in MR tomography for the demonstration and demarcation of lesions in the region of the cranium and trunk |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86144_study_synopsis.pdf |
| View full study record |
| Document reference: 28817 |
| Study title: Uncontrolled multicentre study for the further demonstration of the tolerance and efficacy of dimeglumine gadopentatate on intravenous use in magnetic resonance imaging in adults |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_86110_study_synopsis.pdf |
| View full study record |
| Document reference: 28816 |
| Study title: A vein of galen aneurysm with an abnormal drain system: MRI findings;Desprechins B; Pediatr. Radiol.; 1995 vol.25 p.442-443A vein of galen aneurysm with an abnormal drain system: MRI findings;Desprechins B; Pediatr. Radiol.; 1995 vol.25 p.442-443 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28851 |
| Study title: Abdominale tumoren beim kind;Muller MF; ROFO; 1993 vol.158 n.1 p.9-14Abdominale tumoren beim kind;Muller MF; ROFO; 1993 vol.158 n.1 p.9-14 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28839 |
| Study title: Accoustic schwannoma: MR findings in 84 tumors;Mulkens TH; AJR; 1993 vol.160 p.395-398Accoustic schwannoma: MR findings in 84 tumors;Mulkens TH; AJR; 1993 vol.160 p.395-398 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28844 |
| Study title: Adrenoleucodystrophie: intérêt de l'IRM avec gadolinium;Romero C; J. Neuroradiol.; 1990 vol.17 p.267-276Adrenoleucodystrophie: intérêt de l'IRM avec gadolinium;Romero C; J. Neuroradiol.; 1990 vol.17 p.267-276 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28837 |
| Study title: Anwendungsbeobachtung zur Überprüfung der Wirksamkeit und Verträglichkeit von Leukichtan N 10 % Gel bei Patienten mit Schnittwunden, Schürfwunden oder Verbrennungen |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28877 |
| Study title: Chu WCW 2000; INCIDENCE OF ADVERSE EVENTS AFTER I.V. INJECTION OF MR CONTRAST AGENTS IN A CHINESE POPULATIONChu WCW 2000; INCIDENCE OF ADVERSE EVENTS AFTER I.V. INJECTION OF MR CONTRAST AGENTS IN A CHINESE POPULATION |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): Chu WCW 2000.pdf |
| View full study record |
| Document reference: 47567 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST®(G d DTPA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1357 Redacted.pdf |
| View full study record |
| Document reference: 47577 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Between 2 and 18 Years of Age by Intravenous Administration: A Randomized Double-Blind Comparison of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg with MAGNEVIST® (Gd DTPA) 0.1 mmol/kg (Protocol 50678-005, Study B) |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1358 Redacted.pdf |
| View full study record |
| Document reference: 47578 |
| Study title: Contrast Enhanced Magnetic Resonance Imaging of the Central Nervous System in Patients Less Than 2 Years of Age by Intravenous Administration: An Open Label Study of Gadodiamide Injection (Gd DTPA BMA) 0.1 mmol/kg |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SW1356 Redacted.pdf |
| View full study record |
| Document reference: 47576 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 488Radiology. 1994 Apr;191(1):155-64.Gadolinium-enhanced MR aortography. Prince MR. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28813 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 489 |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28814 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 490 |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28815 |
| Study title: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):313-22. Comment in: Int J Cardiovasc Imaging. 2005 Apr-Jun;21(2-3):323-4. Contrast-enhanced magnetic resonance angiography of the great arteries in patients with congenital heart disease: an accurate tool for planning catheter-guided interventions. Valsangiacomo Büchel ER, DiBernardo S, Bauersfeld U, Berger F. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28808 |
| Study title: Invest Ophthalmol Vis Sci. 2001 Jan;42(1):17-22. Structure-function correlation of laminar vascularity in human rectus extraocular muscles. Oh SY, Poukens V, Cohen MS, Demer JL. Invest Ophthalmol Vis Sci. 2001 Jan;42(1):17-22. Structure-function correlation of laminar vascularity in human rectus extraocular muscles. Oh SY, Poukens V, Cohen MS, Demer JL. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28804 |
| Study title: J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. J Magn Reson Imaging. 2002 Jan;15(1):31-8. Magnetic resonance imaging of pulmonary parenchymal disease using a modified breath-hold 3D gradient-echo technique: initial observations. Bader TR, Semelka RC, Pedro MS, Armao DM, Brown MA, Molina PL. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28809 |
| Study title: The current status of Gentamicin for the neonate and young infant. - Nelson JD. - 1972 (Amer. J. Dis. 124 1: 13-14) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28939 |
| Study title: The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis.The influence of locally implanted high doses of gentamicin on hearing and renal function of newborns treated for acute hematogenous osteomyelitis. |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28886 |
| Study title: The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis. - McCracken -1972 (Amer. J. Dis. 123: 547) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28940 |
| Study title: The treatment of pyoderma in children. Esterly NB. - 1970 (JAMA, 212,10: 1667-70) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28941 |
| Study title: Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25732 |
| Study title: To compare the antipyretic activity of ibuprofen suspension and paracetamol suspension. To evaluate the tolerability of ibuprofen suspension and paracetamol suspension. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Iboprofen-BR0115.pdf |
| View full study record |
| Document reference: 29405 |
| Study title: Treatment of Pyrexia Associated with Infectious Disease in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29395 |
| Study title: Vauzelle−Kervroedan−F et al. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. {J−PEDIATR}, 1997, Vol/Iss/Pg. 131/5 (683−687)Vauzelle−Kervroedan−F et al. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. {J−PEDIATR}, 1997, Vol/Iss/Pg. 131/5 (683−687) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29585 |
| Study title: Williams BO et al. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Ann Allergy Asthma Immunol 1996; 76(5):432-438 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29513 |
| Study title: Wilson−J−T et al. Single−dose, placebo−controlled comparative study of ibuprofen and acetaminophen antipyresis in children. {J−Pediatr}, Nov 1991, vol. 119, no. 5, p. 803−11Wilson−J−T et al. Single−dose, placebo−controlled comparative study of ibuprofen and acetaminophen antipyresis in children. {J−Pediatr}, Nov 1991, vol. 119, no. 5, p. 803−11 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29586 |
| Study title: Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29509 |
| Study title: Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526)Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29573 |
| Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. Stat Rpt 81. Protocol 7-714B, Unpublished Report 206. |
| Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
| Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 7-714B.pdf |
| View full study record |
| Document reference: 47431 |
| Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. Stat Rpt 87. Protocol 7-713B, Unpublished Report 212. |
| Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
| Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 7-713B.pdf |
| View full study record |
| Document reference: 47430 |
| Study title: A double-blind, multi-clinic, single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg plus caffeine 64 mg, ibuprofen 400 mg and placebo in the treatment of post-operative pain following third molar extraction. CSR 92. Protocol 87-714A, Unpublished Report 218. |
| Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
| Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 87-714A.pdf |
| View full study record |
| Document reference: 47433 |
| Study title: Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment.Journal of Pediatric Hematology/Oncology. 2005; 27(8):411-415.Patel SR, Ridwan RU, Ortin M. Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment.Journal of Pediatric Hematology/Oncology. 2005; 27(8):411-415. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Patel SR 2005.pdf |
| View full study record |
| Document reference: 39594 |
| Study title: Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28573 |
| Study title: Rachlis A. 1993. Mortality with foscarnet or ganciclovir for retinitis in AIDS. ACP Journal Club 1993;116(3):74 1993;(3):74.Rachlis A. 1993. Mortality with foscarnet or ganciclovir for retinitis in AIDS. ACP Journal Club 1993;116(3):74 1993;(3):74. |
| Active substance: Foscarnet |
| Study summary document link (including results): Rachlis A. 1993.pdf |
| View full study record |
| Document reference: 39624 |
| Study title: Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002; 99(4):1159- 1164.Reusser P, Einsele H, Lee J, Volin L, Rovira M, Engelhard D et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. Blood. 2002; 99(4):1159- 1164. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser P Einsele H et al 2002.pdf |
| View full study record |
| Document reference: 39639 |
| Study title: Reusser P. 2002 Challenges and options in the management of viral infections after stem cell transplantation. Supportive Care in Cancer. 2002; 10(3):197-203.Reusser P. 2002 Challenges and options in the management of viral infections after stem cell transplantation. Supportive Care in Cancer. 2002; 10(3):197-203. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser P et al 2002..pdf |
| View full study record |
| Document reference: 39640 |
| Study title: Reusser PE. 2002 Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002; 132(27-28):374- 378.Reusser PE. 2002 Management of viral infections in immunocompromised cancer patients. Swiss Medical Weekly. 2002; 132(27-28):374- 378. |
| Active substance: Foscarnet |
| Study summary document link (including results): Reusser PE 2002.pdf |
| View full study record |
| Document reference: 39641 |
| Study title: Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al. A controlled trial comparing foscarnet with vidarabine for acyclovir- resistant mucocutaneous herpes-simplex in the acquired- immunodeficiencysyndrome. New-England-Journalof- Medicine 325 (8): 551-555.Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J et al. A controlled trial comparing foscarnet with vidarabine for acyclovir- resistant mucocutaneous herpes-simplex in the acquired- immunodeficiencysyndrome. New-England-Journalof- Medicine 325 (8): 551-555. |
| Active substance: Foscarnet |
| Study summary document link (including results): Safrin S et al 1991.pdf |
| View full study record |
| Document reference: 39631 |
| Study title: Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542.Sarin P. GENITAL HERPES-SIMPLEX INFECTIONS IN PATIENTS WITH THE ACQUIRED- IMMUNODEFICIENCY-SYNDROME. Pharmacotherapy 1994; 14(5):529-542. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Sarin P. 1994.pdf |
| View full study record |
| Document reference: 28571 |
| Study title: Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95.Satwani P, Baldinger L, Freedman J, Jacobson JS, Guerra J, van de Ven C, Morris E, Garvin J, George D, Bradley MB, Bhatia M, Tallamy B, Schwartz J, Jin Z, Cairo MS.Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2009 Dec;15(12):1587-95. |
| Active substance: Foscarnet |
| Study summary document link (including results): Satwani P et al 2009.pdf |
| View full study record |
| Document reference: 39605 |
| Study title: Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. [Review] [109 refs]. Expert Review of Antiinfective Therapy 2004; 2(3):389-403.Schleiss MR, McVoy MA. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. [Review] [109 refs]. Expert Review of Antiinfective Therapy 2004; 2(3):389-403. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Schleiss MR and McVoy MA 2004.pdf |
| View full study record |
| Document reference: 28590 |
| Study title: Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast enhanced angiography; Feydy A; Radiology; 2006 vol.238 n.2 p.611-621Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast enhanced angiography; Feydy A; Radiology; 2006 vol.238 n.2 p.611-621 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28869 |
| Study title: AWB bei gastrointestinalen MykosenA large number of publications mentioning gadolinium without mentioning any commercial product name are available and can be provided upon request. |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28875 |
| Study title: Begutachtung der Dermichthol -fest und -flüssig bei einem ausgewählten dermatologischen Krankengut unter besonderer Berücksichtigung der Rasur mit Dermichthol-fest bei männlichen Patienten.Wrist ligament tears: evaluation of MRI and combined MDCT and MR arthrography; Moser T; AJR; 2007 vol.188 p.1278-1286 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28876 |
| Study title: Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA); Herborn CU; Invest. Radiol.; 2007 vol.42 p.58-62Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA); Herborn CU; Invest. Radiol.; 2007 vol.42 p.58-62 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28872 |
| Study title: EUV07: A phase III, open, randomized, controlled, primary vaccination study to assess the immunogenicity and the safety of CP20/20/5/3DT-IPV-PRP~T and ACTAcel given concomitantly with OPV vaccine and TETRAct-Hib given concomitantly with OPV vaccine at 6, 10, 14 weeks of age. All infants receiving hepatitis B vaccine (Recomvax B) at 0, 6, 14 weeks of age EUV06: Safety and immunogenicity of hepatitis B vaccine distributed by Aventis Pasteur Korea administered at 0-1-6 months when given in association with three Aventis Pasteur pertussis combination (1 whole cell and 2 acellular) vaccines administered at 2, 4 and 6 months in Mexican infants |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47181 |
| Study title: Open, parallel group. Active controlled study to evaluate immunogenicity and safety of Euvax B. |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47180 |
| Study title: Open, parallel group. Active controlled. To compare immunogenicity of Euvax B with other palsma-derived heptitis B vaccines according to vaccination schedule. |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47184 |
| Study title: Open, parallel group. Active controlled. To evaluate immunogenicity and safety of Euvax B |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47179 |
| Study title: Open, uncontrolled. To compare immunogenicity and safety of Eivax B according to vaccination schedules. |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47178 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepeel (tablets) [AWB-AT] |
| Active substance: Hepeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40025 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hepeel (ampoules) [AWB-AT] |
| Active substance: Hepeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40026 |
| Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
| Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21222 |
| Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
| Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10)./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10); extraction agent: ethanol 11% (m/m)./ HERB: extract from the roots of Pelargonium sidoides (1 : 9 - 11); extraction agent: ethanol 11% (m/m). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21218 |
| Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
| Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10)./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10); extraction agent: ethanol 11% (m/m)./ HERB: extract from the roots of Pelargonium sidoides (1 : 9 - 11); extraction agent: ethanol 11% (m/m). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21219 |
| Study title: Three randomized, double blind, placebo-controlled clinical trials: Efficacy and tolerability of Pelargonium extract EPs® 7630 in patients (1-18 resp. 6-18 years old) with acute bronchitis. |
| Active substance: HERB: 800 mg ethanolic extract (1+10) from the roots of Pelargonium reniforme/sidoides./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10)./ HERB: extract from the roots of Pelargonium sidoides (1 : 8 - 10); extraction agent: ethanol 11% (m/m)./ HERB: extract from the roots of Pelargonium sidoides (1 : 9 - 11); extraction agent: ethanol 11% (m/m). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21220 |
| Study title: Serrano A.C. Haloperidol. Its use in children.J Clin Psychiat. 1984, 141, 1195Serrano A.C. Haloperidol. Its use in children.J Clin Psychiat. 1984, 141, 1195 |
| Active substance: HALOPERIDOL |
| Study summary document link (including results): serrano_haloperidol.pdf |
| View full study record |
| Document reference: 29066 |
| Study title: A double-blind single dose within patient comparison of Optrex against control solution in volunteers with eye irritation after swimming |
| Active substance: Hamamelis water |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40022 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Hamamelis-Salbe-Heel (ointment) [AWB-AT] |
| Active substance: Hamamelis-Salbe-Heel S |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40021 |
| Study title: Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care Med 2003;4(3):353-7.Abd-Allah SA, Rogers MS, Terry M, Gross M, Perkin RM. Helium-oxygen therapy for pediatric acute severe asthma requiring mechanical ventilation. Pediatr Crit Care Med 2003;4(3):353-7. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29068 |
| Study title: BREATHE study |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): BREATHE -Heliox(Final-110804).xls |
| View full study record |
| Document reference: 45120 |
| Study title: Brown L, Sherwin T, Perez JE, Perez DU. Heliox as a temporizing measure for pediatric foreign body aspiration. Acad Emerg Med 2002;9(4):346-347.Brown L, Sherwin T, Perez JE, Perez DU. Heliox as a temporizing measure for pediatric foreign body aspiration. Acad Emerg Med 2002;9(4):346-347. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29069 |
| Study title: Bucci G, Cook CD. Studies of respiratory physiology in children. VI. Lung diffusing capacity, diffusing capacity of the pulmonary membrane and pulmonary capillary blood volume in congenital heart disease. J Clin Invest 1961 Aug;40(8 Pt 1-2):1431-41.Bucci G, Cook CD. Studies of respiratory physiology in children. VI. Lung diffusing capacity, diffusing capacity of the pulmonary membrane and pulmonary capillary blood volume in congenital heart disease. J Clin Invest 1961 Aug;40(8 Pt 1-2):1431-41. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29070 |
| Study title: Butt WW, Koren G, England S, Shear NH, Whyte H, Bryan CA, Swyer PR. Hypoxia associated with helium-oxygen therapy in neonates. J Pediatr 1985;106(3):474-477.Butt WW, Koren G, England S, Shear NH, Whyte H, Bryan CA, Swyer PR. Hypoxia associated with helium-oxygen therapy in neonates. J Pediatr 1985;106(3):474-477. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29071 |
| Study title: Piva JP, Amantea S, Barreto SS, Zelmanovitz F. The use of helium-oxygen mixture in the ventilation study of children with chronic obstructive lung disease. J Pediatr (Rio J) 2000 Jan-Feb;76(1):17-26.Piva JP, Amantea S, Barreto SS, Zelmanovitz F. The use of helium-oxygen mixture in the ventilation study of children with chronic obstructive lung disease. J Pediatr (Rio J) 2000 Jan-Feb;76(1):17-26. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29099 |
| Study title: Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10.Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29100 |
| Study title: Prefaut C, Lloret MC, Tronc JF, Michel FB, Chardon G. Density dependence of the maximal expiratory flow curves in normal and asthmatic children. Scand J Respir Dis 1979;60:109-118.Prefaut C, Lloret MC, Tronc JF, Michel FB, Chardon G. Density dependence of the maximal expiratory flow curves in normal and asthmatic children. Scand J Respir Dis 1979;60:109-118. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29101 |
| Study title: Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am J Emerg Med 2006 Jan;24(1):38-42. Rivera ML, Kim TY, Stewart GM, Minasyan L, Brown L. Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. Am J Emerg Med 2006 Jan;24(1):38-42. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29102 |
| Study title: Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD. Use of Helium-Oxygen Mixture in the Treatment of Postextubation Stridor in Pediatric Patients with Burns. J Burn Care Rehabil 1995;16:476-80.Rodeberg DA, Easter AJ, Washam MA, Housinger TA, Greenhalgh DG, Warden GD. Use of Helium-Oxygen Mixture in the Treatment of Postextubation Stridor in Pediatric Patients with Burns. J Burn Care Rehabil 1995;16:476-80. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29103 |
| Study title: IG 95-01B: Retrospective pharmacovilance study. Safety study on the double-inactivated human antihaemophilic factor concentrate (Fanhdi) Grifols, during prophylaxis and/or treatment of patients with haemophilia A. |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29151 |
| Study title: Incidence of inhibitors in previously untreated patients with severe haemophilia A treated with Octanate |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): 04 UK95-02 (full).pdf |
| View full study record |
| Document reference: 29155 |
| Study title: Post Marketing Pharmacovigilance Study (ATC 9503) with Profilate (SD, HT) |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29145 |
| Study title: Report UK 95-02: Retrospective review of inhibitor formation in a cohort of haemophilia A patients who received Alphanate (Alpha 8 ST) prophylactically |
| Active substance: HUMAN COAGULATION FACTOR VIII |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29152 |
| Study title: |
| Active substance: HUMAN COAGULATION FACTOR VIII AND HUMAN VON WILLEBRAND FACTOR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29159 |
| Study title: International clinical study to investigate the incidence of inhibitors in previously untreated patients with severe haemophilia A treated with Octate (=Wilate). |
| Active substance: HUMAN COAGULATION FACTOR VIII AND HUMAN VON WILLEBRAND FACTOR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29158 |
| Study title: Baker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219Baker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29161 |
| Study title: Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of IGIV3I GRIFOLS [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases (PID) |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): IG201 (synopsis).pdf |
| View full study record |
| Document reference: 45137 |
| Study title: Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45133 |
| Study title: Monocenter Post Marketing Observation Study Alphaglobin@ ATG 9304 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): 05 ATG9304(full).pdf |
| View full study record |
| Document reference: 47751 |
| Study title: Monocenter Post Marketing Observation Study Alphaglobin@ ATG 9410 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): 06 ATG9410(full).pdf |
| View full study record |
| Document reference: 47752 |
| Study title: MUL TICENTRE POST MARKETING OBSERVATION STUDY ALPHAGLOBIN@ AWB 9401 (PMOS 9401) |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): 04 AWB9401(full).pdf |
| View full study record |
| Document reference: 47750 |
| Study title: Multicentric post marketing observation study Alphaglobin’ 9301 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): 03 AGL9301(full).pdf |
| View full study record |
| Document reference: 45253 |
| Study title: Schleiss MR. 2005. Antiviral therapy of congenital cytomegalovirus infection.Seminars in Pediatric Infectious Diseases. 2005; 16(1):50-59.Schleiss MR. 2005. Antiviral therapy of congenital cytomegalovirus infection.Seminars in Pediatric Infectious Diseases. 2005; 16(1):50-59. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Schleiss MR 2005.pdf |
| View full study record |
| Document reference: 39595 |
| Study title: Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jager G et al. 2005. Viral infections in pediatric cancer patients. Klinische Padiatrie. 2005; 217(Suppl 1):S67-S84.Schuster FR, Simon A, Laws HJ, Beutel K, Groll AH, Jager G et al. 2005. Viral infections in pediatric cancer patients. Klinische Padiatrie. 2005; 217(Suppl 1):S67-S84. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Schuster FR et al 2005.pdf |
| View full study record |
| Document reference: 39596 |
| Study title: Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 1;46(9):1455-7.Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008 May 1;46(9):1455-7. |
| Active substance: Foscarnet |
| Study summary document link (including results): Shapira MY et al 2008.pdf |
| View full study record |
| Document reference: 39613 |
| Study title: Sharland M, Luck S, Griffiths P, Cotton M. 2011. Antiviral therapy of CMV disease in children. Adv Exp Med Biol. 2011;697:243-60.Sharland M, Luck S, Griffiths P, Cotton M. 2011. Antiviral therapy of CMV disease in children. Adv Exp Med Biol. 2011;697:243-60. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Sharland M 2011.pdf |
| View full study record |
| Document reference: 39599 |
| Study title: Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment. Drugs 1999; 57(2):187-206.Snoeck R, Andrei G, De CE. Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment. Drugs 1999; 57(2):187-206. |
| Active substance: Foscarnet |
| Study summary document link (including results): Snoeck R et al 1999.pdf |
| View full study record |
| Document reference: 39649 |
| Study title: Snoeck R, Andrei G, De CE. Novel agents for the therapy of varicella-zoster virus infections. Expert Opinion on Investigational Drugs. 2000; 9(8):1743-1751.Snoeck R, Andrei G, De CE. Novel agents for the therapy of varicella-zoster virus infections. Expert Opinion on Investigational Drugs. 2000; 9(8):1743-1751. |
| Active substance: Foscarnet |
| Study summary document link (including results): Snoeck R et al 2000.pdf |
| View full study record |
| Document reference: 39647 |
| Study title: SOCA, Lewis RA, Clogston P, Fainstein V, Gross R, Samo T Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group. Arch. Intern. Med. 1995; 155: 65-74.SOCA, Lewis RA, Clogston P, Fainstein V, Gross R, Samo T Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trial Group. Arch. Intern. Med. 1995; 155: 65-74. |
| Active substance: Foscarnet |
| Study summary document link (including results): SOCA, Lewis RA et al 1995.pdf |
| View full study record |
| Document reference: 39675 |
| Study title: Sohal A, Riordan A, Mallewa M, Solomon T, Kneen R. Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. J Child Neurol. 2009 Feb;24(2):215-8. Sohal A, Riordan A, Mallewa M, Solomon T, Kneen R. Successful treatment of cytomegalovirus polyradiculopathy in a 9-year-old child with congenital human immunodeficiency virus infection. J Child Neurol. 2009 Feb;24(2):215-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Sohal etal 2009.pdf |
| View full study record |
| Document reference: 39608 |
| Study title: Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O et al. 2005. Viral encephalitis: a review of diagnostic methods and guidelines for management. European Journal of Neurology. 2005; 12(5):331-343.Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O et al. 2005. Viral encephalitis: a review of diagnostic methods and guidelines for management. European Journal of Neurology. 2005; 12(5):331-343. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Steiner I 2005.pdf |
| View full study record |
| Document reference: 39597 |
| Study title: Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84(1):71-79.Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84(1):71-79. |
| Active substance: Foscarnet |
| Study summary document link (including results): Stocchi R et al 1999.pdf |
| View full study record |
| Document reference: 39650 |
| Study title: Efficacy and tolerability of Hametum® wound and healing ointment in children with superficial skin injuries and local inflammation of skin and mucosa |
| Active substance: HERB: aqueous distillate from fresh leaves and twigs of Hamamelis virginiana./ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6)/ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6), corresponding to 0.64 mg Hamamelis ketones./ HERB: distillate from fresh leaves and twigs of Hamamelis virginiana (1 : 1.6)./ HERB: Distillate from fresh leav... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40027 |
| Study title: Post-marketing surveillance study on the treatment of restlessness and nervous sleep disorder in children under 14 years of age (Euvegal® forte) |
| Active substance: HERB: dry extract from Valerian root (3 - 6 : 1), extraction agent: ethanol 62 % (w/w); dry extract from Balm leaves (4 - 6 : 1), extraction agent: ethanol 30 % (w/w)./ HERB: dry extract from Valerian root (4 - 5 : 1), dry extract from Balm leaves (4 - 6 : 1)./ HERB: Extract of Valerian root, corresp. to 640-800 mg drug; + Extract of Melissa leaf, corresp. 60 320-480 mg drug./ HERB: dry extract... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21221 |
| Study title: Götte and Roschke; päd (7) 2001 A supportive measure in the treatment of acute infections of the respiratory tract in children with recurring infections of the upper respiratory tract |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39727 |
| Study title: Künzer Th., Retrospective investigation on children (0-12 years) concerning safety and tolerability and dosage of Echinacin Liquidum |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39730 |
| Study title: A phase IIb randomised, multi-site clinical study to assess the immunogenicity and reactogenicity of formulation B of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine versus formulation A of SB Biologicals¿ Hib conjugate vaccine administered either mixed as single injection or separately into opposite thighs with SB Biologicals¿ DTPa vaccine as a three-dose primary vaccination course in healthy infants at 3, 4, and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41147 |
| Study title: A post-marketing surveillance study of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine in 3,000 Filipino subjects. Phase IV single-blind randomised study to assess the feasibility of syringe mixing of combined diphtheria, tetanus, whole cell Bordetella pertussis (DTPw) vaccine and Haemophilus influenzae type b (Hib) conjugate vaccine as a three dose primary vaccination course in healthy infants. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41151 |
| Study title: An open multicentric post marketing surveillance study of SmithKline Beecham haemophilus influenzae type B tetanus conjugate vaccine-Hiberix- administered according to local recommendations in infants and children up to the age of 5 years. Only Korean version-English title to be provided. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41157 |
| Study title: An open, parallel, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to the Pasteur-Mérieux´s Hib conjugate vaccine mixed with Pasteur-Mérieux´s DTPw vaccine as a booster vaccination to healthy children at 15 to 20 months, previously primed with three doses of commercially available DTPw and Hib conjugate vaccines. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41154 |
| Study title: An open, parallel, randomized clinical study to assess the reactogenicity of SmithKline Beecham (SB) Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine in comparison to Pasteur-Mérieux Connaught¿s (PMC) Hib conjugate vaccine mixed with PMCs¿ DTPw vaccine, as a three-dose primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41153 |
| Study title: An open, randomised clinical study to assess the reactogenicity of SB Biologicals¿ Hib conjugate vaccine administered mixed as single injection with SB Biologicals¿ DTPa vaccine in comparison to commercially available Hib conjugate vaccine and DTPw vaccine administered separately into opposite limbs as a booster vaccination in healthy infants at 18 months of age, previously primed with three doses of DTPw and Hib conjugate vaccines. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41149 |
| Study title: Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985Timewell R. M., Rosenthal A. L., Smith J. P., Cagle G. D., J Ped Opht & Strab 1983; 20, 1: 22-26; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28888 |
| Study title: Treatment of meningitis in children with intrathecal gentamicin. - Newman RL - 1967 (Vth Intern. Of Chemotherapy, Vienna, Vol 1/2: 895) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28943 |
| Study title: Treatment of urinary tract infection with gentamicin once or three times daily - Chong CY. - 2003 (Acta Paediatr 2003;92:291-6) - Publication in CES Renewal Application for Gentamicin sulfate - T. Darragon - 13 Sept. 2004 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28944 |
| Study title: Treatment of ventriculitis with gentamicin and cloxacillin in infants born with spina bifida - Lorber J. -1970 (Arch. Dis. Childhood, 45, 178) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28945 |
| Study title: Trial of a new antibiotic (gentamicin) in the treatment of diarrhea in infants. - Satge P. - No date - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28946 |
| Study title: Use of antibiotics in acute gastroenteritis among infants in hospital. - Valmon HB. - 1969 ( Lancet, 1 : 1122-3) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28947 |
| Study title: Zur Therapie der bakteriellen Wundinfektion von ulcera cruris. - Elle-broek U. - 1966 (Arztliche Praxis, XVIII, 27:1066-7) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28949 |
| Study title: Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR.Acta Psychiatr Scand. 2004 Feb;109(2):140-6. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP-CIT/SPECT study. Serra-Mestres J, Ring HA, Costa DC, Gacinovic S, Walker Z, Lees AJ, Robertson MM, Trimble MR. |
| Active substance: Gentian (root |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41500 |
| Study title: Biebach und Kremer (2004): postmarketing-surveillance study |
| Active substance: Gentian (root), powdered Common Sorrel (herb), powdered European Elder (flower), powdered pimrose (flower with calyx), powdered |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40007 |
| Study title: Dadamyan Z.S. Aflubin in the treatment and prophylaxis of influenza and other ARVIs in children, Moscow |
| Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40008 |
| Study title: Petukhova Z.N., Yablonskaya L.V., Burakhova S.V. Clinical effectiveness of Aflubin in the treatment of ARVI and influenza in children with joint diseases, Novosibirsk |
| Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40011 |
| Study title: Sitnikow I., Kisseljow W., Fjodeorow W., Alexandrowa E., Kremnowa N., Sitnikowa E., Marenko E. The pathogenic mechanisms of Aflubin in children with ARVI, Jaroslawl, 1999 |
| Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40010 |
| Study title: Utschajkin W.F., Charlamowa F.S., Sawenkowa M.S., Afanassjewa A.A. Aflubin in the treatment of ARVI associated with stenosing laryngotracheitis in children, Moscow, 2000 |
| Active substance: Gentiana D1, Aconitum D6, Bryonia D6, Ferrum phosphoricum D12, Acidum sarcolacticum D12 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40009 |
| Study title: Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8.Kuhn−J−J, Hendley−J−O, Adams−K−F, Clark−J−W, Gwaltney−J−M−Jr. Antitussive effect of guaifenesin in young adults with natural colds. Objective and subjective assessment. Chest, {Chest}, Dec 1982, vol. 82, no. 6, p. 713−8. |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29052 |
| Study title: Latte J & Taverner D. Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol 2007; 21(4):452-5Latte J & Taverner D. Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol 2007; 21(4):452-5 |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29041 |
| Study title: Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308.Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29051 |
| Study title: A double-blind placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29563 |
| Study title: A double-blind placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 87-752.pdf |
| View full study record |
| Document reference: 47447 |
| Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29501 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29490 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29489 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molars |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29487 |
| Study title: A double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29498 |
| Study title: A double-blind single-dose of Advil 400 vs. APAP 1000 vs. Placebo in the relief of post operative oral surgery pain. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29530 |
| Study title: A double-blind, multi-clinic single dose evaluation of the comparative analgesic efficacy of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29485 |
| Study title: a double-blind, multicentre multiple-dose, parallel-group study comparing the efficacy of three dose levels of Ibuprofen versus acetaminophen in the treatment of pyrexia in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-bpi310.pdf |
| View full study record |
| Document reference: 29403 |
| Study title: A double-blind, Multiple Dose Parallel group study Comparing Advil Liquigels to Celebrex and to Placebo in Dental Pain. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29528 |
| Study title: A double-blind, multiple-dose study of the anti-pyretic activity and tolerability of Ibuprofen and Paracetamol in burns pyrexia in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29428 |
| Study title: A double-blind, multiple-dose study of the anti-pyretic activity and tolerability of Ibuprofen and Paracetamol in burns pyrexia in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29441 |
| Study title: A DOUBLE-BLIND, MULTIPLE-DOSE STUDY OF THE ANTIPYRETIC ACTIVITY AND TOLERABILITY OF IBUPROFEN AND PARACETAMOL IN BURNS PYREXIA IN CHILDREN. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS87-515.pdf |
| View full study record |
| Document reference: 47558 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29562 |
| Study title: A double-blind, parallel-group, multiple-dose study to compare the efficacy and tolerability of Ibuprofen suspension (Junifen) and Paracetamol suspension in the treatment of children undergoing tonsillectomy |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29411 |
| Study title: A double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29503 |
| Study title: Teich SA, Cheung TW, Friedman AH. Systemic antiviral drugs used in ophthalmology. Survey-of- Ophthalmology 1992; 37(1):19-53.Teich SA, Cheung TW, Friedman AH. Systemic antiviral drugs used in ophthalmology. Survey-of- Ophthalmology 1992; 37(1):19-53. |
| Active substance: Foscarnet |
| Study summary document link (including results): Teich et al 1992.pdf |
| View full study record |
| Document reference: 39629 |
| Study title: Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317.Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases. 2002; 34(3):309-317. |
| Active substance: Foscarnet |
| Study summary document link (including results): Zerr DM et al 2002.pdf |
| View full study record |
| Document reference: 39643 |
| Study title: Ambrosioni G. - Activity and Tollerability of FZ 588 (Monuril) in the Treatment of Uncomplicated Low Internal Clinical Report, 1984 Varese L.A. et al.- Z1282 (Monuril) by Zambon Farmaceutici S.p.A. Internal clinical Report 1984 Ambrosioni G. - Activity and Tollerability of FZ 588 (Monuril) in the Treatment of Uncomplicated Low Internal Clinical Report, 1984 Varese L.A. et al.- Z1282 (Monuril) by Zambon Farmaceutici S.p.A. Internal clinical Report 1984 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45048 |
| Study title: Brunelli A. - Children's Recurrent Urinary Tract Infections. Single -Dose Therapy with Fosfomycin Trometamol In: Neu, Williams (eds), New Trends in Urinary Tract Infections. Int Symp., Rome 1987 Karger, Basel, pp. 307-311, 1988 Brunelli A. - Children's Recurrent Urinary Tract Infections. Single -Dose Therapy with Fosfomycin Trometamol In: Neu, Williams (eds), New Trends in Urinary Tract Infections. Int Symp., Rome 1987 Karger, Basel, pp. 307-311, 1988 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45047 |
| Study title: Careddu et al. Treatment of lower Urinary Tract infections in Children: single Dose Fosfomycin Trometamol Versus Pipemidic Acid. Chemioterapia, 6 pp 290-294, 1987Careddu et al. Treatment of lower Urinary Tract infections in Children: single Dose Fosfomycin Trometamol Versus Pipemidic Acid. Chemioterapia, 6 pp 290-294, 1987 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45045 |
| Study title: Principi N. et al. Fosfomycin Trometamol versus Netilmicin in Children's Lower Urinary Tract Infections. Chemotherapy, 36 suppl. 1 pp 41-45 1990 Principi N. et al. Fosfomycin Trometamol versus Netilmicin in Children's Lower Urinary Tract Infections. Chemotherapy, 36 suppl. 1 pp 41-45 1990 |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45046 |
| Study title: Tumbarello R., Chessa M. - Terapia Antibiotica Monodose nel Trattamento delle infezioni delle Basse Vie Urinarie in età pediatrica- Atti del Congresso Internazionale della Società Italiana di Pediatria, 25-28 settembre 1986- Capo Boi, Villasimius (CA), ppTumbarello R., Chessa M. - Terapia Antibiotica Monodose nel Trattamento delle infezioni delle Basse Vie Urinarie in età pediatrica- Atti del Congresso Internazionale della Società Italiana di Pediatria, 25-28 settembre 1986- Capo Boi, Villasimius (CA), pp |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45049 |
| Study title: Varese L.A., et al. - Z1282 (Fosfomycin Trometamol) an Antibacterial Agent as a single-Dose Therapy of lower Uncomplicated Urinary Tract Infection in Children - In: Joji Ishigami ed Recent advances in chemotherapy, Kyoto 1985. Tokyo University of Tokyo PrVarese L.A., et al. - Z1282 (Fosfomycin Trometamol) an Antibacterial Agent as a single-Dose Therapy of lower Uncomplicated Urinary Tract Infection in Children - In: Joji Ishigami ed Recent advances in chemotherapy, Kyoto 1985. Tokyo University of Tokyo Pr |
| Active substance: FOSFOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45050 |
| Study title: Study of Blood Pressure Reduction with Fosinopril in Children and Adolescent |
| Active substance: FOSINOPRIL |
| Study summary document link (including results): Protocol CV118-028 Fosinopril.pdf |
| View full study record |
| Document reference: 45146 |
| Study title: The Pharmacokinetics of Fosinopril in Children and Adolescent |
| Active substance: FOSINOPRIL |
| Study summary document link (including results): Protocol CV118-027 Fosinopril.pdf |
| View full study record |
| Document reference: 28600 |
| Study title: A DOUBLE-BLIND, PARALLEL-GROUP, SINGLE-DOSE, MULTICENTER, STUDY COMPARING THE SAFETY AND TOLERANCE OF INTRAVENOUSLY ADMINISTERED FOSPHENYTOIN VERSUS DILANTIN PARENTERAL IN THE TREATMENT OF PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): PhRMA Web Synopsis_2.pdf |
| View full study record |
| Document reference: 28609 |
| Study title: A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY OF TOLERANCE AND SAFETYOF MULTIPLE DOSES OF INTRAVENOUSLY ADMINISTERED FOSPHENYTOIN SODIUM VERSUS DILANTIN PARENTERAL IN NEUROSURGERY PATIENTS |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28607 |
| Study title: A DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, SINGLE-DOSE, MULTICENTER, SAFTEY, TOLERANCE AND PHARMACOKINETIC STUDY OF INTRAVENOUS FOSPHENYTOIN (CEREBYX) VERSUS INTRAVENOUS DILANTIN IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28613 |
| Study title: An open, randomised post-marketing clinical trial to assess the safety and reactogenicity of GlaxoSmithKline Biologicals¿ Haemophilus influenzae type b (Hib) tetanus conjugate vaccine (Hiberix¿) co-administered with Chinese local DTPw vaccine when compared to Chinese local DTPw vaccine administered alone, in healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41128 |
| Study title: Clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine administered either mixed as a single injection or separate into opposite sites with SB Biologicals¿ DTPa vaccine, or formulation A of SB Biologicals¿ Hib conjugate vaccine separately into opposite sites with SB Biologicals¿ DTPa vaccine at 13 months of age in infants primed in study 208108/032 (Hib-032). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41150 |
| Study title: Clinical study to assess the immunological memory induced by a primary course using different formulations of Hib conjugate vaccines in several combinations with acellular pertussis vaccines by giving one dose of unconjugated PRP co-administered with SB Biologicals¿ DTPa-HBV combined vaccine at 12-24 months of age in infants primed in study DTPa-HBV-037. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41146 |
| Study title: Report on clinical study with iv fucidin in the treatment of severe staphylococcal infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28686 |
| Study title: Sputum penetration of fusidic acid in patients with cystic fibrosis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28717 |
| Study title: Staemmler-H-G, Rodeck-H, Linzenmeier-G. On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel. Deutsche medizinische Wochenschrift (1946), {Dtsch-Med-Wochenschr}, 6 Sep 1968, vol. 93, no. 36, p. 1714-6, ISSN: 0012-0472. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28665 |
| Study title: Staemmler-H-G, Rodeck-H, Loss-G. The Effect Of Fusidic-Acid Anti Infect On Staphylococcus Infections In Children Abstract From Deutsch-Med-Wschr 91-45 2013-2017 November 11 1996 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28666 |
| Study title: Study of fusidic acid administered intravenously for the treatment of severe staphylococcus infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28685 |
| Study title: Systemic or Local Treatment of Erythrasma. Thorn P Scand J Prim Health Care 1991 9 35-39 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28671 |
| Study title: Therapeutic assessment of application of calcipotriol ointment (Daivonex®) in children with psoriasis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28704 |
| Study title: Treatment of skin infections with two dosages of fusidic acid (500 mg/day and 1 g/day) compared with pristinamycin 2 g/day : a multicentre randomised study; L. Machet, A. Puissant, L. Vaillant t le groupe d’étude des infections cutanéesNouvelles Dermatologiques 1994; 13: 512-9 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28683 |
| Study title: A comparative study of Fucidin H cream and Hydrocortisone cream in children (4-17 years) with a flare-up of atopic dermatitis. A study using non-invasive bioengineering techniques. |
| Active substance: FUSIDIC ACID AND HYDROCORTISONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28726 |
| Study title: 945-405 GABAPENTIN PEDIATRIC ADD-ON TRIAL: K RANDOMIZED, DOOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP MULTICENTER STUDY IN PATIENTS WITH PARTIAL SEIZURES. (945-305). |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28730 |
| Study title: A 12 WEEK, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP MULTICENTER STUDY TO DETERMINE THE EFFICACY OF GABAPENTIN (CI-945) 900MG DAILY AND THE DOSE RESPONSE CHARACTERISTICS AND SAFETY OF GABAPENTIN 900MG AND 1200MG ORAL DAILY DOSES AS ADD ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28731 |
| Study title: Open, randomised, clinical study to evaluate the interference on the immunogenicity of vaccine antigens, when Haemophilus influenzae type b tetanus conjugate and combined diphtheria, tetanus, acellular pertussis vaccines are co-administered, either in one single or two separate injections as a primary vaccination course to healthy infants at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41136 |
| Study title: Open, randomized clinical study of the immunogenicity and reactogenicity of the SB Biologicals¿ DTPa and Hib conjugate vaccines, either mixed in one syringe or given in two separate injections, to healthy infants at the age of 2, 4, 6 and 18 months, or the administration of a dose of plain PRP at the age of 12 months in infants primed with Hib conjugate vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41135 |
| Study title: Phase II open randomized primary vaccination study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals (GSK) Haemophilus influenzae type b (Hib) conjugate vaccine administered either mixed or in two separated injections with commercially available DTPw vaccine (Government Pharmaceutical Organization: GPO) as compared to GSK Biologicals¿ Hib administered mixed with GSK Biologicals¿ DTPw vaccine in healthy infants, aged 2, 4 and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41158 |
| Study title: Phase IV primary vaccination study to assess the immunogenicity and reactogenicity of concomitant administration of Haemophilus influenzae type b (Hib) vaccine with either diphtheria-tetanus-whole cell pertussis vaccine and hepatitis B vaccine or with quadrivalent diphtheria-tetanus-whole cell pertussis-hepatitis B vaccine |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41152 |
| Study title: DOUBLE-BLIND, DOSE CONTROLLED, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF THREE DOSES OF GABAPENTIN IN COMPARISON WITH OPEN-LABEL CARBAMAZEPINE AS MONOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPILEPSY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28772 |
| Study title: DOUBLE-BLIND, PARALLEL GROUP COMPARISON OF GABAPENTIN VERSUS PLACEBO AS ADD-ON THERAPY FOR EPILEPSY IN CHILDREN |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28773 |
| Study title: DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDIES OF THE SAFETY AND EFFICACY OF GABAPENTIN MONOTHERAPY IN PATIENTS WITH CHILDHOOD ABSENCE EPILEPSY NAIVE TO ANTIEPILEPTIC DRUG THERAPY (945-19 & 945-20) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28774 |
| Study title: DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF NEURONTIN (GABAPENTIN) IN MIGRAINE PROPHYLAXIS ADMINISTERED IN DOSES DIVIDED THREE TIMES A DAY (TID) PROTOCOL 945-400193) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28775 |
| Study title: GABAPENTIN ADJUNCTIVE TREATMENT IN PATIENTS WITH BIPOLAR DISORDER |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28776 |
| Study title: GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH EPILEPSY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28777 |
| Study title: GABAPENTIN IN PATIENT MONOTHERAPY TRIAL: A DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28778 |
| Study title: GABAPENTIN MONOTHERAPY TRIAL: A 36-WEEK, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF GABAPENTIN VERSUS CARBAMAZEPINE IN PPATIENTS WITH PARTIAL EPILEPSY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28779 |
| Study title: GABAPENTIN OPEN-LABEL, FOLLOW-ON TRIAL IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28780 |
| Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Treatment of Pediatirc Migraine; Headache September 2002. pp:780-786.St. Charles CS et al.: A comparison of ibuprofen versus acetaminophen with codein in the young tonsillectomy. PubMed. Bennie RE et al.: Postoperative analgesia with preoperative oral ibuprofen or acetaminophen in children undergoing myringotomy. PubMed. Kokki H. et al.: Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in Children;PEDIATRICS Volume 120, Number 4, October 2007. Clark E.... |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29609 |
| Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover-Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29542 |
| Study title: Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover-Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. Kraemer C. und Evers S.: Eine randomisierte, doppelblinde, placebokontrollierte, Crossover-Studie zur Wirksamkeit von Ibuprofen und Zolmitriptan akuten Migräneattacke bei Kindern; Neurology 2006;67;497-499; original published online Jun 14, 2006. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29603 |
| Study title: Latte J & Taverner D. Clinical trial of 3 days of treatment with oral pseudoephedrine for the common cold in the southern hemisphere. Am J Rhinol 2007; 21(4):452-5 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29506 |
| Study title: Latte J et al. A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza. Clin Exp Pharmacol Physiol 2004; 31(7): 429-32 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29508 |
| Study title: Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Teratment of Pediatirc Migraine; Headache September 2002. pp:780-786. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29543 |
| Study title: Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Teratment of Pediatirc Migraine; Headache September 2002. pp:780-786. Lewis D. et al.: Children`s Ibuprofen Suspension for the Acute Teratment of Pediatirc Migraine; Headache September 2002. pp:780-786. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29604 |
| Study title: Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391)Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29576 |
| Study title: Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29587 |
| Study title: Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18)Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29599 |
| Study title: An analgesic combination. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29813 |
| Study title: Meran A et al. A cross-over comparison of acrivastine, pseudoephedrine and their combination in seasonal allergic rhinitis. Rhinology 1990; 28(1): 33-40 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29514 |
| Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28603 |
| Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28602 |
| Study title: AN OPEN-LABEL STUDY OF INTRAVENOUS FOSPHENYTOIN (CEREBYX) ON PLASMA FORMATE, PHOSPHATE, AND CALCIUM CONCENTRATIONS IN NEONATAL PEDIATRIC PATIENTS |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28605 |
| Study title: AN OPEN-LABEL, MULTICENTER STUDY ASSESSING THE SAFETY AND TOLERANCE OF AN INTRAMUSCULARLY ADMINISTERED LOADING DOSE OF FOSPHENYTOIN IN PATIENTS REQUIRING A LOADING DOSE OF PHENYTOIN. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 28610 |
| Study title: AN OPEN-LABEL, SAFETY, TOLERANCE AND PHARMACOKINETIC STUDY OF INTRAVENOUS AND INTRAMUSCULAR FOSPHENYTOIN (CEREBYX) IN CHILDREN |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): 982-028 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 28612 |
| Study title: OPEN LABEL STUDY OF CEREBYX IN PEDIATRIC PATIENTS WITH SEIZURES |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28611 |
| Study title: OPEN LABELLED, MULTICENTER STUDY OF THE SAFETY AND TOLERANCE OF INTRAMUSCULARLY-ADMINISTRED, MULTIDOSE FOSPHENYTOIN IN HOSPITALIZED NEUROSURGERY PATIENTS. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): 982-014 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 28606 |
| Study title: OPEN-LABEL, RATE-ESCALATION, MULTICENTER STUDY TO ASSESS SAFETY, TOLERANCE AND PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED FOSPHENYTOIN SODIUM IN THE ACUTE TREATMENT OG GENERALIZED CONVULSIVE STATUS EPILEPTICUS. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): PhRMA Web Synopsis.pdf |
| View full study record |
| Document reference: 28608 |
| Study title: PILOT STUDY TO DETERMINE THE FEASIBILITY OF FLUCONAZOLE FOR INDUCTION TREATMENT AND SUPPRESSION OF RELAPSE OF HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28601 |
| Study title: Phase I-II study of high-dose fotemustine followed by autologous peripheral blood stem-cell transplant in children and adolescents with relapsed or refractory malignant solid tumours |
| Active substance: FOTEMUSTINE |
| Study summary document link (including results): fotemustine_CL1-10036-305_spreadsheet.xls |
| View full study record |
| Document reference: 28614 |
| Study title: Safety and pharmacokinetic profile of the pasteurized purified antitetanus serum (pasteurized pats) associated with adsorbed Td vaccine |
| Active substance: Fragments F(ab')2 of Antitetanus Immunoglobulins (Pasteurized) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41392 |
| Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, Edström S. Arch Otorhinolaryngol. 1985;242(2):135-9. |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): A randomized clinical trial of two topical preparations.pdf |
| View full study record |
| Document reference: 28623 |
| Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002 |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45272 |
| Study title: Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28621 |
| Study title: A 12 WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY TO DETERMINE THE EFFICACY OF GABAPENTIN (CI-945) 900-MG DAILY AND THE DOSE RESPONSE CHARACTERISTICS AND SAFETY OF GABAPENTIN 900-MG AND 1200-MG ORAL DAILY DOSES AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURES. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28732 |
| Study title: A 26 WEEK DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY OFCONVERSION FROM MARKETED ANTIEPILEPTIC DRUG THERAPY TO GABAPENTIN MONOTHERAPY IN PATIENTS W/ COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES: . |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28733 |
| Study title: A 3 WEEK, DOUBLE BLIND, PILOT STUDY OF THE SAFETY AND TOLERANCE OF GABAPENTIN (CI-945) ADMINISTERED AS ADD-ON THERAPY WITHOUT TITRATION TO PATIENTS WITH REFRACTORY EPILEPSY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28734 |
| Study title: A 3-MONTH, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, SINGLE CENTER STUDY, TO EVALUATE THE EFFICACY AND SAFETY OF GABAPENTIN (CI-945) IN PATIENTS WITH SPASTICITY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28735 |
| Study title: A DOUBLE BLIND PLACEBO CONTROLLED, PARALLEL GROUP, MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN (CI-945) AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY UNCONTROLLED PARTIAL EPILEPSY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28736 |
| Study title: Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475Coarctation of the aorta: pre and postoperative evaluation with MRI and MR angiography: correlation with echocardiography and surgery; Didier D; Int. J. Cardiovasc. Imaging.; 2006 vol.22 p.457-475 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28871 |
| Study title: Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46Collateral flow in coarctation of the aorta with magnetic resonance velocity mapping: correlation to morphological imaging of collateral vessels; Holmqvist C; JMRI; 2002 vol.15 p.39-46 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28861 |
| Study title: Contrast-enhanced thoracic 3D-MR angiography in infants and children;Holmqvist C; Acta Radiol.; 2001 vol.42 p.50-58Contrast-enhanced thoracic 3D-MR angiography in infants and children;Holmqvist C; Acta Radiol.; 2001 vol.42 p.50-58 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28854 |
| Study title: Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610Diffusion weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma; Dubrulle F; Radiology; 2006 vol.238 n.2 p.604-610 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28868 |
| Study title: Doppelblinde, randomisierte, Placebo-kontrollierte, monozentrische Studie zum Nachweis der therapeutischen Wirksamkeit und Verträglichkeit von Ichthraletten® gegenüber Placebo bei Akne papulopustulosaSAPHO syndrome: MR appearance of vertebral involvement; Laredo JD; Radiology; 2007 vol.242 n.3 p.825-831 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28874 |
| Study title: Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220Dynamic gadolinium enhanced subtraction MR imaging a simple technique for the early diagnosis of Legg-Calve-Perthes disease: preliminary results;Sebag G; Pediatr. Radiol.; 1997 vol.27 p.216-220 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28852 |
| Study title: Femoral head vascularisation in Legg-Calve-Perthes disease: comparison of dynamic gadolinium-enhanced subtraction MRI with bone scintigraphy; Lamer S; Pediatr. Radiol.; 2002 vol.32 p.580-585Femoral head vascularisation in Legg-Calve-Perthes disease: comparison of dynamic gadolinium-enhanced subtraction MRI with bone scintigraphy; Lamer S; Pediatr. Radiol.; 2002 vol.32 p.580-585 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28862 |
| Study title: Gadolinium DOTA enhanced MRI of painful osseous crises in children with sickle-cell anemia;Bonnerot V; Pediatr. Radiol.; 1994 vol.24 p.92-95Gadolinium DOTA enhanced MRI of painful osseous crises in children with sickle-cell anemia;Bonnerot V; Pediatr. Radiol.; 1994 vol.24 p.92-95 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28841 |
| Study title: Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692Gd-DOTA enhanced MR imaging in two cases of Sturge-Weber syndrome;Lipski S; AJNR; 1990 vol.11 p.690-692 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28840 |
| Study title: Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357Gd-DOTA: chemistry toxicity and clinical results;Bonnemain B; Liver imaging current trends and new techniques; Ferruci J.T. Stark D.D.; Andiver Medical Publishers Boston 1990; p.349-357 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28843 |
| Study title: Sauder RA, Rafferty JF, Bilenki AL, Berkowitz ID. Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991 May;84(5):646-8.Sauder RA, Rafferty JF, Bilenki AL, Berkowitz ID. Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991 May;84(5):646-8. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29104 |
| Study title: Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999 Sep;6(9):953-6.Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999 Sep;6(9):953-6. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29106 |
| Study title: Stucki P, Scalfaro P, de Halleux Q, Vermeulen F, Rappaz I, Cotting J. Successful management of severe respiratory failure combining helium/oxygen gas mixture with non-invasive high-frequency percussive ventilation. Crit Care Med 2002;30(3):692-694.Stucki P, Scalfaro P, de Halleux Q, Vermeulen F, Rappaz I, Cotting J. Successful management of severe respiratory failure combining helium/oxygen gas mixture with non-invasive high-frequency percussive ventilation. Crit Care Med 2002;30(3):692-694. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29107 |
| Study title: Tepper RS, Asdell S. Comparison of helium dilution and nitrogen washout measurements of functional residual capacity in infants and very young children. Pediatric pulmonology. 1992;13(4):250-4.Tepper RS, Asdell S. Comparison of helium dilution and nitrogen washout measurements of functional residual capacity in infants and very young children. Pediatric pulmonology. 1992;13(4):250-4. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29108 |
| Study title: Terregino C, Nairn S, Chansky M. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5:1130 1133.Terregino C, Nairn S, Chansky M. The effect of heliox on croup: a pilot study. Acad Emerg Med 1998;5:1130 1133. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29109 |
| Study title: Ulhoa CAG, Larner L. Helium-oxygen (Heliox) mixture in airway obstruction. J Pediatr (Rio J) 2000 Jan-Feb;76(1):73-8.Ulhoa CAG, Larner L. Helium-oxygen (Heliox) mixture in airway obstruction. J Pediatr (Rio J) 2000 Jan-Feb;76(1):73-8. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29110 |
| Study title: Weber JE, Chudnofsky CR, Younger JG, Larkin L, Boczar M, Wilkerson MD, Zuriekat GY, Nolan B, Eicke DM. A randomized comparison of helium-oxygen mixture (heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001;107(6):1-4.Weber JE, Chudnofsky CR, Younger JG, Larkin L, Boczar M, Wilkerson MD, Zuriekat GY, Nolan B, Eicke DM. A randomized comparison of helium-oxygen mixture (heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics 2001;107(6):1-4. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29111 |
| Study title: Weir M. Vocal cord dysfunction mimics asthma and may respond to heliox. Clin Pediatr 2002;41(1):37-41.Weir M. Vocal cord dysfunction mimics asthma and may respond to heliox. Clin Pediatr 2002;41(1):37-41. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29112 |
| Study title: Williams J, Stewart K, Tobias JD, Berkenbosch JW. Therapeutic benefits of helium-oxygen delivery to infants via nasal cannula. Pediatr Emerg Care 2004 Sep;20(9):574-8.Williams J, Stewart K, Tobias JD, Berkenbosch JW. Therapeutic benefits of helium-oxygen delivery to infants via nasal cannula. Pediatr Emerg Care 2004 Sep;20(9):574-8. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29113 |
| Study title: OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS MONOTHERAPY OR ADD-ON THERAPY IN THE LONG-TERM TREATMENT OF EPILEPTIC SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28790 |
| Study title: OPEN-LABEL, LONG-TERM EXTENSION, MULTI-CENTER STUDY TO DETERMINE SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURE |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28791 |
| Study title: OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE PERCENTAGE OF PATIENTS WITH FOCAL ( PARTIAL ONSET) SEIZURES, WHO ARE INSUFFICIENTLY CONTROLLED BY ANTIEPILEPTIC MONOTHERAPY, BECOMING SEIZURE-FREE IN AT LEAST ONE FOCAL SEIZURE TYPE UNDER ADD-ON THERPAY WITH GABAPENTIN (NEURONTIN) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28792 |
| Study title: PATIENTS WITH PARTIAL SEIZURES (WITH OUR WITHOUT SECONDARY GENERALIZATION. "AUS-STEPS". DOUBLE BLIND |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28793 |
| Study title: PHASE IIA, OPEN-LABEL, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN 600 MG TO 1800 MG DAILY AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL EPILEPSY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28794 |
| Study title: PK IN CHILDREN |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28795 |
| Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Psuedoephedrine HCl Suspension in Children. Aug 1999. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29560 |
| Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg plus caffeine 64 mg, ibuprofen 400 mg and placebo in the treatment of post-operative pain following third molar extraction. CSR 103. Protocol 87-713A, Unpublished Report 229. |
| Active substance: IBUPROFEN + CAFFEINE + ACETYLSALICYLIC ACID |
| Study summary document link (including results): acetylsalicylic acid_ caffeine_ibuprofen 87-713A.pdf |
| View full study record |
| Document reference: 47432 |
| Study title: A randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental pain. CSR 112. |
| Active substance: IBUPROFEN AND CAFFEINE |
| Study summary document link (including results): caffeine_ibuprofen 87-731B.pdf |
| View full study record |
| Document reference: 47261 |
| Study title: |
| Active substance: IBUPROFEN AND DEXTROMETHOPRHAN |
| Study summary document link (including results): dextromethorphan_ibuprofen 96-617.pdf |
| View full study record |
| Document reference: 47891 |
| Study title: A double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental pain. CSR 122. Protocol 89-907, Unpublished Report 248. |
| Active substance: IBUPROFEN AND NAPROXEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47888 |
| Study title: |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 11-201.pdf |
| View full study record |
| Document reference: 47397 |
| Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Stat Rpt 84. Protocol 6-639, Unpublished Report 209. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 6-639.pdf |
| View full study record |
| Document reference: 47396 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with sore throat pain. CSR 162. Protocol 89-949, 90-001, Unpublished Report 288. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 89-949_90-001.pdf |
| View full study record |
| Document reference: 47404 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. CSR 161. Protocol 90-002, 90-003, Unpublished Report 287. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 90-002_3.pdf |
| View full study record |
| Document reference: 47405 |
| Study title: A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. CSR 136. Protocol 88-828, Unpublished Report 262. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 88-828.pdf |
| View full study record |
| Document reference: 47401 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 52. Protocol 4-403, Unpublished Report 164. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 4-403.pdf |
| View full study record |
| Document reference: 47392 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 51. Protocol 4-411, Unpublished Report 163. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 4-411.pdf |
| View full study record |
| Document reference: 47394 |
| Study title: Treatment of acute tonsillo−pharyngitis: a comparative study of spiramycin and erythromycin. Suprihati, Noersinggih, Hoedijono R. Current medical research and opinion, {Curr−Med−Res−Opin}, 1984, vol. 9, no. 3, p. 192−6. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26523 |
| Study title: Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 : Comparative clinical trial of anti-diarrhoeal drugs. - Gupta S. - 1977 (14:639-644) |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28617 |
| Study title: Open dose finding study on effects and tolerability of Egb 761 in children with attention deficit/hyperactovity syndrome (ADHS) |
| Active substance: Ginkgo biloba (herb)/ Ginkgo biloba leaves (35-67:1), (herb)/ HERB: 40 mg Ginkgo bilobae fol. extr. sicc. (35 - 67 : 1), corresponding to 9.6 mg ginkgo flavone glycosides and 2.4 mg terpene lactones./ HERB: Dry extract of Ginkgo biloba leaves 40 mg, standardized to 9.6 mg (24%) Ginkgo flavone glycosides and 2.4 mg (6%) terpene lactones (ginkgolides and bilobalide)./ HERB: extract (50:1) from Gi... |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40012 |
| Study title: Glatiramer acetate treatment in patients with childhood juvenile onset multiple sclerosis - Kornek B, Bernert G, Balassy C, et al. - 2003 (Neuropediatrics 2003; 34: 120-126) Glatiramer acetate treatment in patients with childhood juvenile onset multiple sclerosis - Kornek B, Bernert G, Balassy C, et al. - 2003 (Neuropediatrics 2003; 34: 120-126) |
| Active substance: GLATITRAMER |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28958 |
| Study title: An open-label, multicenter, single-dose study to evaluate the pharmacokinetics of glimepiride (Amaryl®) in pediatric patients with type 2 diabetes mellitus - Sponsor Sanofi - 26/02/2004 |
| Active substance: GLIMEPIRIDE |
| Study summary document link (including results): Glimepiride-Study 2.pdf |
| View full study record |
| Document reference: 28971 |
| Study title: Glimipiride versus Metformin as Monotherapy in Paediatric Subject with Type 2 Diabetes Mellitus : A Single Bind Comparaison Study - sponsor sanofi - 15/11/2004 |
| Active substance: GLIMEPIRIDE |
| Study summary document link (including results): Glimepiride-Study 1.pdf |
| View full study record |
| Document reference: 28972 |
| Study title: Clinical trial of a new oral antidiabetic agent: gliquidone or ARDF-26. |
| Active substance: GLIQUIDONE |
| Study summary document link (including results): Gliquidone_U77-0366_synopsis.pdf |
| View full study record |
| Document reference: 28973 |
| Study title: Böhmer D., Ambrus P., Szögy A. and Haralambie G. Chondropathia patellae of young sportsmen Therapiewoche 1982; 32(41): 4897-901Böhmer D., Ambrus P., Szögy A. and Haralambie G. Chondropathia patellae of young sportsmen Therapiewoche 1982; 32(41): 4897-901 |
| Active substance: GLUCOSAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28975 |
| Study title: Rovati L.C., Giacovelli G. and Setnikar I. A multicenter clinical trial on the efficacy and tolerability of glucosamine sulphate (DONA®) in the treatment of osteoarthritis. (1989)Rovati L.C., Giacovelli G. and Setnikar I. A multicenter clinical trial on the efficacy and tolerability of glucosamine sulphate (DONA®) in the treatment of osteoarthritis. (1989) |
| Active substance: GLUCOSAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28976 |
| Study title: Souschek K. Efficacy of glucosamine in juvenile osteochondrosis Ortopädische Praxis 1973; 9(11): 383-6Souschek K. Efficacy of glucosamine in juvenile osteochondrosis Ortopädische Praxis 1973; 9(11): 383-6 |
| Active substance: GLUCOSAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28974 |
| Study title: BSS Alcon Studies: Clinical Evaluation of the Safety of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus for Use During Cataract Extraction in Pediatric Patients. |
| Active substance: GLUCOSE AND GLUTATHIONE AND SODIUM BICARBONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28977 |
| Study title: Prospective investigation to assess the efficacy of one monotherapy (NAAGA) versus one bitherapy (NAAGA + Levocabastine) in the treatment of mild and moderate seasonal and intra-annual allergic conjunctivitis. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA |
| Active substance: GLUTAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28978 |
| Study title: Study of the clinical and biological efficacity of NAAXIA SINE® in vernal keratoconjunctivitis |
| Active substance: GLUTAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28979 |
| Study title: Bieber T; Randomised, placebo-controlled, double-blind efficacy study of the emollient V0034CR in addition to a moderately potent corticosteroid in the acute phase of treatment of atopic dermatitis in infants. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR3041B.xls |
| View full study record |
| Document reference: 28980 |
| Study title: Blanchet-Bardon C; Efficacité et tolérance de la préparation RD 569B – NY2903 dans le traitement symptomatique des ichtyoses modérées. 1995 |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): RD569B94CR301.xls |
| View full study record |
| Document reference: 28981 |
| Study title: Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130Imaging of cervico-thoracic lymphangiomas in children;Borecky N; Pediatr. Radiol.; 1995 vol.25 p.127-130 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28850 |
| Study title: Intersticial MR lymphography with gadoterate meglumine: initial experience in humans;Ruehm SG; Radiology; 2001 vol.220 p.816-821Intersticial MR lymphography with gadoterate meglumine: initial experience in humans;Ruehm SG; Radiology; 2001 vol.220 p.816-821 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28860 |
| Study title: Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation;Drape JL; Radiology; 1993 vol.188 p.227-234 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28847 |
| Study title: Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631Juvenil spondylodiscitis: the value of magnetic resonance imaging a report of two cases; Plasschaert H; Acta. Othop. Belg.; 2004 vol.70 p.627-631 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28866 |
| Study title: Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTAHerve Somma C; Radiology; 1992 vol.182 p.93-98Juvenile rheumatoid arthritis of the knee: MR evaluation with Gd-DOTAHerve Somma C; Radiology; 1992 vol.182 p.93-98 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28845 |
| Study title: Double-blind, randomised clinical study to evaluate the consistency of the immunogenicity and reactogenicity of three consecutive production lots of SB Biologicals¿ Hib formulation B vaccine, co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, and in comparison to the SB Biologicals¿ Hib formulation A vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41140 |
| Study title: Double-blind, randomised clinical study to evaluate the immunogenicity and reactogenicity of four different lots of SB Biologicals' Hib vaccine co-administered with SB Biologicals¿ DTPa vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 3, 4½ and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41138 |
| Study title: Double-blind, randomised, comparative, multicentre, clinical study to assess the immunogenicity and reactogenicity of three lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b (Hib) tetanus conjugate vaccine when administered simultaneously with SmithKline Beecham Biologicals' tricomponent DTPa vaccine, reconstituted in one single injection, as a primary vaccination course in healthy infants at the age of 3 and 5 months (referred to in this report as Hib-10). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41131 |
| Study title: Open clinical study to assess the immunogenicity and reactogenicity of a booster dose of formulation B of SB Biologicals¿ Hib conjugate vaccine mixed with SB Biologicals¿ DTPa vaccine as a single injection at 12 or 15-18 months of age in healthy children primed with SB Biologicals¿ Hib conjugate vaccines co-administrated with DTPa-HBV vaccine in study DTPa-HBV-038 |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41144 |
| Study title: Open clinical study to assess the immunogenicity and reactogenicity of a dose of SB Biologicals¿ plain PRP vaccine at 12 months of age followed by SB Biologicals¿ DTPa-HBV vaccine at 15 to 18 months of age in children primed with a new formulation of SB Biologicals¿ Hib conjugate vaccine mixed with DTPa-HBV combined vaccine as a single injection (group 5 of study DTPa-HBV-023). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41143 |
| Study title: Open clinical study to assess the safety of SmithKline Beecham Biologicals' Haemophilus influenzae type b conjugate vaccine mixed with SmithKline Beecham Biologicals' diphtheria, tetanus, tricomponent acellular pertussis vaccine and administered in one single injection, given as a primary vaccination course to healthy infants at 3, 4 and 5 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41132 |
| Study title: Clinical Safety Evaluation Study of sanofi pasteur’s AVAXIM 80U Pediatric Administered, at a First Step in 20 Healthy Adolescents, and at a Second Step in 20 Healthy Toddlers in China |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47490 |
| Study title: Comparative immunogenicity trial of Avaxim 80 vs Havrix 720 and Vaqta in 1-15 years old children |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47488 |
| Study title: Comparative study of two vaccination schedules of an inactivated Hepatitis A vaccine (80U) in Argentinean infants |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47486 |
| Study title: Immunogenicity and safety of an inactivated hepatitis A vaccine (80 AgU) after simultaneous administration with either TETRAct-HIB + OPV or DTacP-IPV//Act-HIB vaccine in 16 to 19 month-old toddlers |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40918 |
| Study title: Immunogenicity and safety of AVAXIM-Pediatric and HAVRIX 720, in chilean subjects from 1 to 15 years of age |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47489 |
| Study title: Large scale multicentre safety study of inactivated hepatitis A vaccine (80 U) in children - ASIA |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40914 |
| Study title: Large scale multicentre safety study of inactivated hepatitis A vaccine (80 U) in children - EUROPE |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40913 |
| Study title: Large scale multicentre safety study of inactivated hepatitis A vaccine (80 U) in children - SOUTH AMERICA Immunogenicity on a subgroup of Argentinean children |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47484 |
| Study title: Open study of immunogenicity and safety of the P.M. sv. hepatitis A vaccine (80 Antigen Units) in children - ISRAEL |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40912 |
| Study title: Open study of safety and immunogenicity of the P.M. sv. hepatitis A vaccine (80 U) in Brasilian children |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47485 |
| Study title: Randomised open study of immunogenicity and safety of inactivated hepatitis a vaccine (80 U) in children: comparison of three vaccination shedules (0-6 months / 0-12 months / 0-18 months) |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40917 |
| Study title: Safety and immunogenicity study of 3 consistency batches of inactivated hepatitis A vaccine (80 U) in children |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40916 |
| Study title: Safety and immunogenicity study of a new paediatric inactivated Hepatitis A vaccine (80 U) in Taiwanese children |
| Active substance: Hepatitis A Vaccine for Children (80 U/dose) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47487 |
| Study title: |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47185 |
| Study title: An open label, prospective, post-marketing surveillance study to evaluate the safety of Euvax B inj. |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47186 |
| Study title: Comparative study of the immunogenicity and safety of the Lucky Goldstar hepatitis B vaccine versus SmithKline Beecham hepatitis B vaccine in Argentinian newborns |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47183 |
| Study title: Comparative study of the immunogenicity and safety of two recombinant Hepatitis B vaccines : Euvax B and Engerix B in European adolescents. |
| Active substance: Hepatitis B Surface Antigen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47182 |
| Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29029 |
| Study title: Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 Paul IM et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114(1):85-90 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29030 |
| Study title: Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146Paul IM et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161(12):1140-1146 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29031 |
| Study title: Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 Taylor AJ et al. Efficacy of cough suppressants in children. J Pediatr 1993; 122(5 Pt 1):799-802 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29032 |
| Study title: A double-blind, multi-clinic single dose evaluation of the comparative analgesic efficacy of acetaminophen 650 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery. Stat Rpt 67. Protocol 4-406, Unpublished Report 186 |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 4-406.pdf |
| View full study record |
| Document reference: 47393 |
| Study title: Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29941 |
| Study title: Noya F, Rench MA, Garcia-Prats JA, et al. Disposition of an immunoglobulin in very low birth weight neonates. J Ped, 1988; 112: 278-283Noya F, Rench MA, Garcia-Prats JA, et al. Disposition of an immunoglobulin in very low birth weight neonates. J Ped, 1988; 112: 278-283 |
| Active substance: HUMAN NORMAL IMMUNOGLOBULIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29160 |
| Study title: Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IGIV3I 10% Grifols [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases (PID) |
| Active substance: Human normal immunoglobulin |
| Study summary document link (including results): IG304 (synopsis).pdf |
| View full study record |
| Document reference: 45252 |
| Study title: An immunogenicity and safety study in females 9-23 years of age in Korea |
| Active substance: human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39682 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Husteel (drops) [AWB-AT] |
| Active substance: Husteel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40028 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Husteel (drops) [AWB-085] |
| Active substance: Husteel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40029 |
| Study title: 4th ed. American Medical Association - AMA Departement of Drugs: AMA Drug Evaluation - 1980 - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29164 |
| Study title: A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. - Baden M et al - 1972 (Pediatrics 1972; 50: 526-34) - In publication Martindale The extra pharmacopoeia in dossier 01353 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29165 |
| Study title: A general practitioner study to evaluate the efficacy of Proctossedyl Ointment in the treatment of acute fissure-in-ano - No author - 1970 ( The British journal of Clinical Practice 1970;24 N°7) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29166 |
| Study title: A Randomized, Double-Blind, Vehicle-Controlled Clinical Trial of the Efficacy and Safety of 1.0% Hydrocortisone and a Mixture of Antioxidants, Separately and in Combination, in Reducing the Severity of Disease Symptoms in Children, Aged 2 to 6 Years, with Atopic Dermatitis |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): hydrocortisone 957-010.pdf |
| View full study record |
| Document reference: 47742 |
| Study title: Butenandt O. "Kinderkrankheiten" in: Kaiser H., Kley H. K. "Cortisontherapie", 11th ed. Thieme Verlag Stuttgart New York 2002; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29167 |
| Study title: Carbohydrate Metabolism in the Newborn - Creery RDG - 1968 (Lancet 1968; 291: 594-595 in Extracts from Martindale - 28th Edition - No author - 1982 (Hydrocortisone p 473-474)) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29168 |
| Study title: Chronic topical corticosteroid use simulating congenital glaucoma - Kass MA et al - 1972 ( Journal of Pediatric 1972; 81: 1175-1177) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29169 |
| Study title: Blanchet-Bardon C; Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel groups V0034 CR versus vehicle. Study Report ongoing. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR3091B.xls |
| View full study record |
| Document reference: 28982 |
| Study title: The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. American Journal of Opthalmology 1997; 124(2): 141-157.The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. American Journal of Opthalmology 1997; 124(2):... |
| Active substance: Foscarnet |
| Study summary document link (including results): SOCA studies 1997 (B).pdf |
| View full study record |
| Document reference: 39655 |
| Study title: The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. American Journal of Opthalmology 1997; 124(1): 61-70.The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. American Journal of Opthalmology 1997; 124(1): 61-70. |
| Active substance: Foscarnet |
| Study summary document link (including results): SOCA studies 1997 (a).pdf |
| View full study record |
| Document reference: 39654 |
| Study title: Tomasik T, Opozda A, Pietrzyk JJ. 2010.Cytomegalovirus infection-- diagnostic and therapeutic difficulties in neonatal intensive care unit. Przegl Lek. 2010;67(1):18-24.Tomasik T, Opozda A, Pietrzyk JJ. 2010.Cytomegalovirus infection-- diagnostic and therapeutic difficulties in neonatal intensive care unit. Przegl Lek. 2010;67(1):18-24. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Tomasik T et al 2010.pdf |
| View full study record |
| Document reference: 39603 |
| Study title: Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant. 2008 Feb;41(4):371-6.Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kobayashi T, Takasugi K, Iseki T, Tojo A, Asano S.Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation. Bone Marrow Transplant. 2008 Feb;41(4):371-6. |
| Active substance: Foscarnet |
| Study summary document link (including results): Tomonari A et al 2008.pdf |
| View full study record |
| Document reference: 39616 |
| Study title: Tran TH, Stanescu D, Caspers-Velu L, Rozenberg F, Liesnard C, Gaudric A et al. Clinical characteristics of acute HSV-2 retinal necrosis. [Review] [42 refs]. American Journal of Ophthalmology 2004; 137(5):872-879.Tran TH, Stanescu D, Caspers-Velu L, Rozenberg F, Liesnard C, Gaudric A et al. Clinical characteristics of acute HSV-2 retinal necrosis. [Review] [42 refs]. American Journal of Ophthalmology 2004; 137(5):872-879. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Tran TH et al 2004.pdf |
| View full study record |
| Document reference: 28591 |
| Study title: Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448Treatment of congenital cytomegalovirus: where are we now? Expert Review of Antiinfective Therapy 2007; 5(3):441-448 |
| Active substance: FOSCARNET |
| Study summary document link (including results): Michaels MG 2007.pdf |
| View full study record |
| Document reference: 39587 |
| Study title: Trizna Z Viral diseases of the skin: diagnosis and antiviral treatment. Paediatric Drugs. 2002; 4(1):9-19.Trizna Z Viral diseases of the skin: diagnosis and antiviral treatment. Paediatric Drugs. 2002; 4(1):9-19. |
| Active substance: Foscarnet |
| Study summary document link (including results): Trizna Z 2002.pdf |
| View full study record |
| Document reference: 39642 |
| Study title: Walton RC,Whitcup SM,Mueller BU, LewisLL, Pizzo PA,Nussenblatt RB. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology 1995;102(12):1865- 1870 1995;(12):1865- 1870. Walton RC,Whitcup SM,Mueller BU, LewisLL, Pizzo PA,Nussenblatt RB. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis. Ophthalmology 1995;102(12):1865- 1870 1995;(12):1865- 1870. |
| Active substance: Foscarnet |
| Study summary document link (including results): Walton RC et al 1995.pdf |
| View full study record |
| Document reference: 39676 |
| Study title: Open clinical study to evaluate persistence of antibodies induced by a primary vaccination course using SmithKline Beecham Biologicals¿ Hib vaccine mixed with SmithKline Beecham Biologicals' DTPa vaccine, and to assess immunogenicity and reactogenicity of a booster dose of the same vaccines at 15-20 months of age (referred to in this report as Hib-21). |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41134 |
| Study title: Open clinical study to evaluate the immunogenicity and reactogenicity of SB Biologicals' Hib vaccine, co-administered with routine DTPw vaccine into opposite limbs, as a primary vaccination course to healthy infants at the age of 2, 4 and 6 months. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41142 |
| Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-039 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered mixed with DTPa-HBV combined vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41145 |
| Study title: Open clinical study to evaluate the priming, in terms of antibody persistence and immunological memory, induced by the administration of SB Biologicals¿ Hib conjugate vaccine administered with DTPa-HBV vaccine in study DTPa-HBV-043 and to evaluate the immunogenicity and reactogenicity of a booster dose of SB Biologicals¿ Hib conjugate vaccine when administered either mixed or separately with DTPa-HBV combined vaccine. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41148 |
| Study title: Connolly KN, McGuirt WF. Avoiding intubation in the injured subglottis: the role of helium/oxygen gas mixture therapy. Ann Otol Rhinol Layrngol 2001;110(8):713-717.Connolly KN, McGuirt WF. Avoiding intubation in the injured subglottis: the role of helium/oxygen gas mixture therapy. Ann Otol Rhinol Layrngol 2001;110(8):713-717. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29072 |
| Study title: Corcoran TE, Shortall BP, Kim IK, Meza MP, Chigier N. Aerosol drug delivery using heliox and nebulizer reservoirs: results from an MRI-based pediatric model. J Aerosol Med 2003;16(3):263-71.Corcoran TE, Shortall BP, Kim IK, Meza MP, Chigier N. Aerosol drug delivery using heliox and nebulizer reservoirs: results from an MRI-based pediatric model. J Aerosol Med 2003;16(3):263-71. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29073 |
| Study title: Curtis JL, Mahlmeister M, Fink JB, Lampe G, Matthay MA, Stulbarg MS. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986 Sep;90(3):455-7.Curtis JL, Mahlmeister M, Fink JB, Lampe G, Matthay MA, Stulbarg MS. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986 Sep;90(3):455-7. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29074 |
| Study title: de Gamarra E, Moriette G, Farhat M, Walti H. Heliox tolerance in spontaneously breathing neonates with bronchopulmonary dysplasia. Biol Neonate 1998;74(3):193-9. de Gamarra E, Moriette G, Farhat M, Walti H. Heliox tolerance in spontaneously breathing neonates with bronchopulmonary dysplasia. Biol Neonate 1998;74(3):193-9. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29075 |
| Study title: DiCecco RJ, Rega PP. The application of heliox in the management of croup by an air ambulance service. Air Med J 2004;23(2):910-26.DiCecco RJ, Rega PP. The application of heliox in the management of croup by an air ambulance service. Air Med J 2004;23(2):910-26. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29076 |
| Study title: Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J 1979 May;26(3):206-12.Duncan PG. Efficacy of helium-oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J 1979 May;26(3):206-12. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29077 |
| Study title: Elleau C, Galperine R, Guenard H, Demarquez J. Helium-oxygen mixture in respiratory distress syndrome: A double blind study. J Pediatrics 1993;122:132-136.Elleau C, Galperine R, Guenard H, Demarquez J. Helium-oxygen mixture in respiratory distress syndrome: A double blind study. J Pediatrics 1993;122:132-136. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29078 |
| Study title: George R, Berkenbosch JW, Fraser RF 2nd, Tobias JD. Mechanical ventilation during pregnancy using a helium-oxygen mixture in a patient with respiratory failure due to status asthmaticus. J Perinatol 2001;21(6):395-398.George R, Berkenbosch JW, Fraser RF 2nd, Tobias JD. Mechanical ventilation during pregnancy using a helium-oxygen mixture in a patient with respiratory failure due to status asthmaticus. J Perinatol 2001;21(6):395-398. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29079 |
| Study title: GABAPENTIN PEDIATRIC MONOTHERAPY TRIAL: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY IN PEDIATRIC PATIENTS WITH BENIGN CHILDHOOD EPILEPSY WITH CENTROTEMPORAL SPIKES (BECTS) (PROTOCOL 945-094). |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28781 |
| Study title: NEURONTIN VS LAMOTRIGINE: A DOUBLE-BLIND MONOTHERAPY, PARALLEL-GROUP, MULTICENTER, COMPARATIVE STUDY IN PATIENTS WITH PARTIAL AND/OR GENERALIZED TONIC-CLONIC SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28782 |
| Study title: NONINTERVENTIONAL STUDY IN PATIENTS WITH PARTIAL SEIZURES TREATED WITH NEURONTIN |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28783 |
| Study title: OPEN LABEL MULTICENTRE STUDY OF THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF EPILEPTIC PATIENTS WITH PARTIALSEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28784 |
| Study title: OPEN LABEL PILOT STUDY OF GABAPENTIN IN JUVENILES WITH CEREBRAL SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28785 |
| Study title: OPEN LABEL, MULTICENTER, UNCONTROLLED 12 WEEK STUDY OF EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN REFRACTORY PARTIAL EPILESPY WITH OR WITHOUT SECONDARY GENERALIZATION. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28786 |
| Study title: OPEN MULTICENTRE OBSERVATIONNAL STUDY IN TWO GROUPS OF PATIENTS (FIRST LINE THERAPY OR SUBSTITUTION) AIMED TO OPTIMIZE THE USE OF GABAPENTIN ® AS A MONOTHERAPY IN PATIENTS SUFFERING FROM FOCAL EPILEPSY TO BECOME SEIZURE-FREE |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28787 |
| Study title: OPEN-LABEL ADD-ON COMPARISON OF GABAPENTIN AND LAMOTRIGINE IN ADULT PATIENTS WITH LEARNING DISABILITIES WHO HAVE REFRACTORY EPILEPSY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28788 |
| Study title: OPEN-LABEL EXTENSION OF A DOUBLE-BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY OF GABAPENTIN AS ADD-ON THERAPY IN CHILDREN WITH PARTIAL SEIZURES (945-87/187) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28789 |
| Study title: Clinical experience with gentamicin in neonates. - Sila R. - 1973 (Acta Pat. Microbiol. Scand. 81? sUPPL; 241: 130-136) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28894 |
| Study title: Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 Clinical Expert Statement - Renewal Application for Gentamicin sulfate (all strengths in EU) - T. Darragon - 13 Sept. 2004 |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28895 |
| Study title: Clinical Pharmacology evaluation of gentamicin in newborn infants. - McCracken - 1972 (J. of Infectious Dis. 124 : 884) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28896 |
| Study title: Comparative in-vitro studies of Knamycin and gentamicin : E-coli isolated from newborn infants -Backer CJ. - 1970 (Clin Res. Vol. 20 :1) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28897 |
| Study title: Consideration of Gentamicin for therapy of neonatal sepsis. - Klein JO. - 1969 (J. Infectious Dis. 119,4-5:361) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28898 |
| Study title: Diffusion dans le liquide céphalorachidien de gentamycine injectée par voie IM. Etude chez 5 enfants attents de méningite purulente. - Mariel C - 1971 (Therapie, 26:511-6) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28899 |
| Study title: Emploi de la gentamicine dans les infections graves du nouveau né. - Raynaud EJ. - 1971 (Gaz. Med. De France, 79, 38: 133-9) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28900 |
| Study title: Emploi de la Gentamicine dans les infections graves du nouveau-né - Raynaud EJ. & Al. - 1971 (Gazette Médicale de France) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28901 |
| Study title: Essai therapeutique en pédiatrie d'un nouvel antibiotique : la gentamicine. - Thieffry S. - 1968 (Medecine Infantile, 6 : 444-52) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28902 |
| Study title: Disorders of the adrenal gland - New et al - 1986 (In Gellis SS & Kayan BM (Ed): Current Pediatric Therapy, 12th ed., WB saundres, Philadelphia, 1986; pp 308-312) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29170 |
| Study title: Drug Interactions 4th ed - Hansten PD - 1979 (Lea & Frebiger, Philadelphia, PA, 1979) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29171 |
| Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 50μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in children aged 4-11 years with reversible airways disease |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMDT01-ICHE3.pdf |
| View full study record |
| Document reference: 28432 |
| Study title: A multi-centre, randomised, double-blind, parallel group study to validate the changes in tidal breathing lung function parameters versus FEV1 and PD20 assessments due to anti-inflammatory treatment in 5 to 10 years old mild to moderately symptomatic children with asthma. Extensive searching has revealed that no clinical report is available for this study. The clinical trial results were reported via publications; see citation below. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS30002-ICHE3.pdf |
| View full study record |
| Document reference: 28397 |
| Study title: A Multi-centre, Randomised, Parallel-Group, Open-Label Study to Assess the Long-Term Safety (Including Growth) of Fluticasone Propionate 100mcg bd via the Metered-Dose Inhaler and BabyhalerTM Spacer Device Compared With Sodium Cromoglycate 5mg qds Delivered via Metered Dose Inhaler and NebuhalerTM Spacer Device in Children aged 12-47 Months With Documented Evidence of Recurrent/Persistent Asthma-Like Symptoms over a 52-Week Treatment Period |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAS30009-ICHE3.pdf |
| View full study record |
| Document reference: 28394 |
| Study title: A multicenter, randomized, double-blind, parallel group vehicle-controlled study of the efficacy and safety of fluticasone propionate lotion 0.05% applied once daily for four weeks in the treatment of adult and pediatric subjects with moderate to severe atopic dermatitis Report No. NI1999/00008/00 |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30003.pdf |
| View full study record |
| Document reference: 45116 |
| Study title: A multicentre, blinded, parallel group, randomized study to compare the efficacy and tolerability of nebulised Fluticasone propionate 0.25mg administered twice daily versus nebulised Budesonide 0.5mg administered twice daily in children with mild asthma.. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLIC12-ICHE3.pdf |
| View full study record |
| Document reference: 28419 |
| Study title: A multicentre, randomised, double-blind, parallel group clinical trial to determine the safety and efficacy of nebulised fluticasone propionate 1mg twice daily compared with oral soluble prednisolone administered for 7 days to children aged 4 to 16 years with an acute asthma exacerbation. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLTB3002-ICHE3.pdf |
| View full study record |
| Document reference: 28420 |
| Study title: A multicentre, randomised, double-blinded, parallel-group comparison of the efficacy and tolerability of fluticasone propionate 100mcg bid with nedocromil MDI 4mg bid in mild-moderate asthmatic children |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLIC16-ICHE3.pdf |
| View full study record |
| Document reference: 28374 |
| Study title: A multiple-dose, open-label, 2-way crossover study in pediatric subjects with asthma aged 1 to < 4 years to compare the systemic exposure of fluticasone propionate 88mcg administered via the hydrofluoroalkane metered-dose inhaler using the valved holding chambers, Aerochamber Plus™ and Babyhaler™, with face-masks |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAS10002-ICHE3.pdf |
| View full study record |
| Document reference: 28438 |
| Study title: A phase III multicentre, open, parallel-group, randomised study to compare the efficacy and tolerability of fluticasone propionate 50 micrograms bd via the Diskhaler™ with inhaled sodium cromoglycate (Intal) 20 milligrams qds via the Spinhaler in asthmatic children with a clinic requirement for inhaled prophylactic therapy. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLUPD-AH90-N081-ICHE3.pdf |
| View full study record |
| Document reference: 28383 |
| Study title: Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for communitybased parenteral anti-infective therapy. Clinical Infectious Diseases 1997; 25(4):787-801.Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA. Practice guidelines for communitybased parenteral anti-infective therapy. Clinical Infectious Diseases 1997; 25(4):787-801. |
| Active substance: Foscarnet |
| Study summary document link (including results): Williams DN et al 1997.pdf |
| View full study record |
| Document reference: 39663 |
| Study title: Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention Med Klin (Munich). 2010 Jun;105(6):399- 403.Wittek M, Doerr HW, Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention Med Klin (Munich). 2010 Jun;105(6):399- 403. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Wittek M et al 2010.pdf |
| View full study record |
| Document reference: 39602 |
| Study title: Belkum-A, Snijders-S, van-leeuwen-W, Verbrugh-H, NouwenJ, Op--t-Veld- Koning-S, Van-M, van-Suijlekom-Smit-LW, van-der-Wouden-JC, Verduin-C. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. Journal of Clinical Microbiology, {J-Clin-Microbiol}, 1 Jul 2003, vol. 41, p. 3017-3021, ISSN: 0095-1137. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28667 |
| Study title: Bourget-P, Duhamel-J-F, Soerensen-H, Roiron-R. Clinical Pharmacy Department, Antoine Beclere Hospital, Clamart, France. Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension. Journal of clinical pharmacy and therapeutics, {J-Clin-Pharm-Ther}, Jun 1993, vol. 18, no. 3, p. 171-7, ISSN: 0269-4727. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28659 |
| Study title: Cannarozzo-C, Zagni-G-F. Osp.Gen.Reg. "Vittorio Emanuele II", Div.Dermatologica, Catania, Italia. Studio clinico sul fusidato di sodio in polvere per uso topico. Clin.Europea, anno xx, n.3, maggio-giugno 1981. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28661 |
| Study title: Chu-AC. Imperial College of Science, London, England. Incidence of resistance to fusidic acid in atopic eczema patients treated with topical fusidic acid, with or without topical steroid. 59th Annual Meeting American Academy of Dermatology, {59th-AAD}, 2 Mar 2001, p. abstr. 091. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28658 |
| Study title: Clinical study report Fucidin Creme Vol II (Efficacy and compatibility of Fucidin Crème)West German trial. 337 patients. 90 patients were under the age of 10, 63 patients aged 11-20. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28709 |
| Study title: Clinical trial of fusidic acid for lepromatous leprosy Franzblau S.G. et al ACC 1994; 38(7):1651-1654 LEO provided tablets |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28710 |
| Study title: Comparative effect of fusidic acid (Fucithalmic®) and ofloxacin (tarivid®) eye drops in acute conjunctivitis. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28649 |
| Study title: Comparative effect of fusidic acid gel 1% (Fucithalmic®) and norfloxacin 0.3% (Noroxin®) in acute bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28681 |
| Study title: Comparative effects of fusidic acid (1%) viscous eye drops (Fucithalmic® Unit Dose) and Chloramphenicol (0.5% ) eye drops (Minims® Chloramphenicol) in acute neonatal bacterial conjunctivitis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28679 |
| Study title: Comparative trial of Fucidin ointment and Fucidin cream in skin sepsis; Pakrooh H. J Int Med Res 1980; 8(6): 425-429 (LEO sponsored) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28644 |
| Study title: Comparison of Fusidic acid and Oxacillin in bacterial skin infections |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28711 |
| Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28721 |
| Study title: Data collection and treatment of children with Daivonex® ointment |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28706 |
| Study title: Efficacy and acceptability of Fusidic acid cream and mupirocin ointment in acute skin sepsis |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28700 |
| Study title: Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000;4(3):188-92.Gross MF, Spear RM, Peterson BM. Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit Care 2000;4(3):188-92. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29080 |
| Study title: Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514.Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29081 |
| Study title: Habib DM, Garner SS, Brandeburg S. Effect of Helium-Oxygen on Delivery of Albuterol in a Pediatric, Volume-Cycled, Ventilated Lung Model. Pharmacotherapy 1999;19(2):143-149.Habib DM, Garner SS, Brandeburg S. Effect of Helium-Oxygen on Delivery of Albuterol in a Pediatric, Volume-Cycled, Ventilated Lung Model. Pharmacotherapy 1999;19(2):143-149. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29082 |
| Study title: Haynes JM, Sargent RJ, Sweeney EL. Use of heliox to avoid intubation in a child with acute severe asthma and hypercapnia. Am J Crit Care 2003;12(1):28-30.Haynes JM, Sargent RJ, Sweeney EL. Use of heliox to avoid intubation in a child with acute severe asthma and hypercapnia. Am J Crit Care 2003;12(1):28-30. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29083 |
| Study title: Henchey K. Use of heliox therapy to relieve acute respiratory distress in an adolescent with cystic fibrosis: a case report. Am J Crit Care 2003;12(6):556-7.Henchey K. Use of heliox therapy to relieve acute respiratory distress in an adolescent with cystic fibrosis: a case report. Am J Crit Care 2003;12(6):556-7. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29084 |
| Study title: Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, Strauss R. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998 Oct;28(10):1731-6.Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, Strauss R. Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998 Oct;28(10):1731-6. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29085 |
| Study title: A DOUBLE BLIND, PLACEBO CONTROLLED, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF PARTIAL SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28737 |
| Study title: A DOUBLE-BLIND BRIDGING STUDY FOR THE EXTRAPOLATION OF DATA FROM OVERSEAS CLINICAL STUDIES; A STUDY IN REFRACTORY EPILEPSY (PARTIAL SEIZURE) USING AN ADD-ON THERAPY METHOD |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28738 |
| Study title: A DOUBLE-BLIND PARALLEL GROUP COMPARISON OF GABAPENTIN VS PLACEBO AS ADD-ON THERAPY FOR EPILEPSY IN CHILDREN |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28739 |
| Study title: A DOUBLE-BLIND PARALLEL GROUP COMPARISON OF GABAPENTIN VS SODIUM VALPROATE AS ADD-ON THERAPY IN EPILEPSY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28740 |
| Study title: A DOUBLE-BLIND, DOSE-CONTROLLED, MULTICENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF THREE DOSES OF GABAPENTIN (NEURONTIN) IN COMPARISON WITH OPEN-LABEL CARBAMAZEPINE AS MONOTHERAPY IN PATIENTS WITH NEWLY-DIAGNOSED EPILEPSY. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28741 |
| Study title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO DETERMINE THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF PARTIAL SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28742 |
| Study title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY, WITH AN OPEN-LABEL EXTENSION, OF THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE TREATMENT OF PHARMACOTHERAPY-RESISTANT CHILDHOOD SYMPTOMATIC EPILEPSIES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28743 |
| Study title: A LONG-TERM OPEN-LABEL STUDY IN CASES MIGRATED FROM AN EARLY PHASE II STUDY TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURE |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28744 |
| Study title: A LONG-TERM, MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GABAPENTIN AS ADD-ON THERAPY IN SUBJECTS WITH REFRACTORY EPILEPSY (PARTIAL SEIZURE) AND WHO TRANSFERRED FROM A DOUBLE BLIND BRIDGING STUDY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28745 |
| Study title: A MC TO ASSEST EFFICACY AND SAFTEY OF CI-945 IN CHILDREN AND ADOLESCENT WITH PARTIAL SEIZURES (MANET) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28746 |
| Study title: POST MARKETING SURVEILLANCE(PMS) STUDY OF NEURONTIN |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28796 |
| Study title: THE LONG TERM PHASE OF AN OPEN LABEL, UNCONTROLLED STUDY TO DETERMINE THE EFFICACY, SAFETY AND TOLERANCE OF ORALLY ADMINITERED GABAPENTIN AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY REFRACTORY UNCONTROLLED EPILEPTIC SEIZURES. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28797 |
| Study title: A clinical investigation of the pharmacokinetics of MULTIHANCE in healthy normal subjects from two to fifteen years of age. |
| Active substance: GADOBENIC ACID |
| Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_43779_10.xls |
| View full study record |
| Document reference: 28799 |
| Study title: Comparison of Safety and Efficacy of Gadobenate Dimeglumine and Gadopentetate Dimeglumine in Magnetic Resonance Imaging of Central Nervous System Disorders in Pediatric Patients. |
| Active substance: GADOBENIC ACID |
| Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_B19036036.xls |
| View full study record |
| Document reference: 28800 |
| Study title: Multicentre, within patient controlled trial to assess the efficacy of the contrast agent MultiHance, at a dose of 0.1 mmol/kg in MRI of the CNS in paediatric patients. |
| Active substance: GADOBENIC ACID |
| Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHanceMH110.xls |
| View full study record |
| Document reference: 28801 |
| Study title: Single Centre, open label, pharmacokinetic study; To obtain pharmacokinetic information in patients from 2-5 years of age. |
| Active substance: GADOBENIC ACID |
| Study summary document link (including results): EUdraCT-datafields for publication-Bracco-MultiHance_MH119.xls |
| View full study record |
| Document reference: 47524 |
| Study title: A phase III, double-blind, parallel-group, randomized, comparative, two-centre study on gadodiamide injection (Omniscan) and Magnevist® at 0.1 mmol/kg b.w. in MR examinations of the CNS in children and adolescents in a 0.5 T Philips Gyroscan MR unit at the University Hospital Eppendorf, Hamburg, Germany, and in a 1.5T Philips Gyroscan S15 MR unit at the Department of Diagnostic Radiology, University of Cologne, Cologne, Germany |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV033 Redacted.pdf |
| View full study record |
| Document reference: 47574 |
| Study title: A phase IVIII open study of gadodiamide injection (OMNISCAN(D) 0.3 mmol/kg b.w. used for MR examinations of patients with bone or soft tissue tumours |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): ISOV026 Redacted.pdf |
| View full study record |
| Document reference: 47568 |
| Study title: Gentamicin in the neonatal period. - McCracken GH. (Amer. J. Dis. Child, Dec. 120: 524-533) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28917 |
| Study title: Gentamicin in the newborn - Milner RDG - 1974 (Postgraduate Medical Journal 50 (Suppl 7):40-44) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28918 |
| Study title: Gentamicin in the newborn - Milner RSC - 1974 (Postgraduate Med. J., 50, Suppl 7: 40-44) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28919 |
| Study title: Gentamicin in the treatment of acute infantile enteritis. - Panero C. - 1966 (Minerva Pediatrica, 18, 204) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28920 |
| Study title: Gentamicin in the treatment of meningitis in neonates. Leelom JM. - 1969 (J. Infectious Dis., 119,4-5: 476) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28921 |
| Study title: Gentamicin in the treatment of sepsis in new born infants. - Elfving L. - 1973 (Acta path; microbio. Scand., section B 81 Suppl. 241: 124-129) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28922 |
| Study title: Gentamicin in urinary infections of children. - Holt RJ. - 1968 (Arch. Dis. Childhood, 43:329) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28923 |
| Study title: Gentamicin therapy for the neonate and young infant. - Nelson JD. - 1973 (Drugs, 6, 1: 56-57) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28924 |
| Study title: A phase III, randomised, double-blind, parallel group study to compare the efficacy of inhaled fluticasone propionate 100μg given once daily and fluticasone propionate 50μg given twice daily, both delivered via the multi-dose powder inhaler, in children aged 4–16 years with mild to moderate, stable asthma. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLTB3049-ICHE3.pdf |
| View full study record |
| Document reference: 28379 |
| Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40121-ICHE3.pdf |
| View full study record |
| Document reference: 28449 |
| Study title: A prospective dose titration study of the efficay and safety (fluvastatin sodium) in the treatment of children with heterozygous familial hypercholesterolemia |
| Active substance: FLUVASTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28455 |
| Study title: "Open label, phase III, dose titration, multicenter study to assess the efficacy and safety of fluvastatin sodium capsules and fluvastatin sodium extended-release tablets (20, 40 and 80 mg) given orally at bedtime for 114 weeks in pediatric patiens with heterozygous familial hypercholesterolemia" |
| Active substance: FLUVASTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28456 |
| Study title: Fluvoxamine for Children and Adolescents With Obsessive-Compulsive Disorder: A Randomized, Controlled, Multicenter Trial.(Statistical Data Included) Article from: Journal of the American Academy of Child and Adolescent Psychiatry,2001 | RIDDLE, MARK A.; REEVE, ELIZABETH A.; YARYURA-TOBIAS,JOSE A.; YANG, HWA MING; CLAGHORN, JAMES L.; GAFFNEY, GARY; GREIST,JOHN H.; HOLLAND, DONNA; McCONVILLE, BRIAN J.; PIGOTT, TERESA; WALKUP, JOHN T. |
| Active substance: FLUVOXAMINE |
| Study summary document link (including results): Bayer Pharma_Fluvoxamine Maleate_Riddle MA_2001_publication.pdf |
| View full study record |
| Document reference: 28457 |
| Study title: FLUVOXAMINE IN THE TREATMENT OF OBSESSIVE COMPULSIVE DISORDER: A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN OUTPATIENT CHILDREN AND ADOLESCENTS |
| Active substance: FLUVOXAMINE |
| Study summary document link (including results): Fluvoxamine-RH.114.02.01.pdf |
| View full study record |
| Document reference: 47713 |
| Study title: Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents;J . AM. ACAD. CHILD ADOLESC. PSYCHIATRY, 43:12, DECEMBER 2004 |
| Active substance: FLUVOXAMINE |
| Study summary document link (including results): A9R1546.pdf |
| View full study record |
| Document reference: 28458 |
| Study title: The Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents |
| Active substance: FLUVOXAMINE |
| Study summary document link (including results): Fluvoxamine-S114.1.102.pdf |
| View full study record |
| Document reference: 47714 |
| Study title: Clin Pharmacol Ther. 2007 May;81(5):685-91. Review. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta-analysis. Goh YI, Bollano E, Einarson TR, Koren G. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28461 |
| Study title: Haematologica. 2006 Aug;91(8):1113-6. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leucemia. Costea I, Moghrabi A, Laverdiere C, Graziani A, Krajinovic M. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28464 |
| Study title: J Child Neurol. 2007 Dec;22(12):1389-92. Homocysteine levels in epileptic children receiving antiepileptic drugs. Kurul S, Unalp A, Yiş U |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28459 |
| Study title: Monaldi Arch Chest Dis. 2006 Dec;66(4):275-85. Review.IT Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor. Caramia G, Belardinelli R. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28462 |
| Study title: Pediatr Hematol Oncol. 2007 Sep;24(6):417-30. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center. Karadeniz C, Oguz A, Citak EC, Uluoglu O, Okur V, Demirci S, Okur A, Aksakal N |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28460 |
| Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28701 |
| Study title: Efficacy and acceptability of fusidic acid cream and mupirocin ointment in facial impetigo. Sutton J.B. Curr Ther Res 1992; 51(5): 673-678 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28670 |
| Study title: Efficacy and safety of calcipotriol ointment in treating children (2-14 years) with psoriasis vulgaris |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28705 |
| Study title: J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):150-5. Use of gadolinium as an intraarterial contrast agent for pediatric neuroendovascular procedures. Burry MV, Cohen J, Mericle RA. J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):150-5. Use of gadolinium as an intraarterial contrast agent for pediatric neuroendovascular procedures. Burry MV, Cohen J, Mericle RA. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28802 |
| Study title: J Pediatr Surg. 1998 Jan;33(1):123-6. Gadolinium-infusion magnetic resonance angiogram: a new, noninvasive, and accurate method of preoperative localization of impalpable undescended testes. Lam WW, Tam PK, Ai VH, Chan KL, Cheng W, Chan FL, Leong L J Pediatr Surg. 1998 Jan;33(1):123-6. Gadolinium-infusion magnetic resonance angiogram: a new, noninvasive, and accurate method of preoperative localization of impalpable undescended testes. Lam WW, Tam PK, Ai VH, Chan KL, Cheng W, Chan FL, Leong L |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28807 |
| Study title: Lauenstein TC 2007Lauenstein TC 2007 |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): Lauenstein TC 2007.pdf |
| View full study record |
| Document reference: 47569 |
| Study title: Lundby B 1996; MRI in children given gadodiamide injection: safety and efficacy in CNS and body indicationsLundby B 1996; MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): Lundby B 1996.pdf |
| View full study record |
| Document reference: 47570 |
| Study title: Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. Magn Reson Imaging. 1999 Feb;17(2):229-35. Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements. Steen RG, Reddick WE, Ogg RJ, Langston JW. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28806 |
| Study title: Martin DR 2010; Decreased Incidence of NSF in Patients on Dialysis After Changing Gadolinium Contrast-Enhanced MRI ProtocolsMartin DR 2010; Decreased Incidence of NSF in Patients on Dialysis After Changing Gadolinium Contrast-Enhanced MRI Protocols |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): Martin DR 2010.pdf |
| View full study record |
| Document reference: 47571 |
| Study title: Open clinical studies with Gd-DTPA (dimeglumine gadopentetate) in cerebral and spinal diseases - summary of studies at 22 hoospitalsJ Mol Neurosci. 1996 Summer;7(2):87-90.Early diagnosis of Nelson's syndrome. Kasperlik-Zaluska AA, Walecki J, Jeske W, Migdalska B, Janik J, Bonicki W, Brzeziński J, Makowska A, Brzezińska A. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28812 |
| Study title: Open Clinical study in MRI to demonstrate the tolerance and efficacy of Gd-DTPA in the whole bodyPediatr Radiol. 1999 Nov;29(11):856-62. Potential utility of MRI in the evaluation of children at risk of renal scarring. Chan YL, Chan KW, Yeung CK, Roebuck DJ, Chu WC, Lee KH, Metreweli C. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28810 |
| Study title: Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. Pediatr Int. 2000 Jun;42(3):285-8. Assessment of disease activity and extent by magnetic resonance imaging in ulcerative colitis. Nozue T, Kobayashi A, Takagi Y, Okabe H, Hasegawa M. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28805 |
| Study title: |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28834 |
| Study title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE STUDY OF GABAPENTIN (CI-945) ADMINISTERED AS AN INITIAL DOSAGE OF 900 MG/DAY VERSUS A DOSAGE TITRATED TO 900 MG/DAY OVER THREE DAYS |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28747 |
| Study title: A MULTICENTER,DOUBLE-BLIND, DOUBLE-DUMMY RANDOMIZED, PARALLEL GROUP COMPARISON OF GABAPENTIN (CI945) AND AND SODIUM VALPROATE SR AS AS ADD-ON AND MONOTHERAPY IN PATIENTS WITH PARTIAL EPILEPSY UNCONTOLLED BY CARBAMAZAPINE THERAPY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28748 |
| Study title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER ACTUAL USE STUDY OF THE SAFETY AND TOLERABILITY OF GABAPENTIN 500 MG IN A POTENTIAL OTC POPULATION |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28749 |
| Study title: A REPORT OF A SINGLE-CENTER, PILOT STUDY COMPRISING A 12-WEEK, PLACEBO CONTROLLED, PARALLEL GROUP, DOUBLE BLIND PHASE, FOLLOWED BY A LONG-TERM, OPEN LABEL PHASE, TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN (CI-945) TAKEN AS ORAL DAILY DOSES AS ADD-ON THERAPY IN JUVENILE PATIENTS WITH MEDICALLY REFRACTORY PARTIAL SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28750 |
| Study title: A SAFETY AND EFFICACY STUDY OF EXTENDED OPEN-LABEL GABAPENTIN MONOTHERAPY FOLLOWING A DOUBLE-BLIND STUDY IN PATIENTS WITH COMPLEX PARTIAL OR SECONDARILY GENERALIZED SEIZURES |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28751 |
| Study title: A SINGLE DOSE BIOEQUIVALENCE STUDY COMPARING GABAPENTIN SYRUP FORMULATION TO 300MG NEURONTIN CAPSULES. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28752 |
| Study title: A SINGLE DOSE STUDY OF GABAPENTIN SYRUP (CI-945) PHARMACOKINETICS IN HEALTHY NEONATES, INFANTS AND CHILDREN. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28753 |
| Study title: Kawasaki disease associated coronary artery lesions with navigator echo-based respiratory gated three dimensional coronary magnetic resonance angiography compared with achocardiography in young children;Amino M; J. Tokyo Med. Univ.; 2004 vol.62 n.2 p.146-152Kawasaki disease associated coronary artery lesions with navigator echo-based respiratory gated three dimensional coronary magnetic resonance angiography compared with achocardiography in young children;Amino M; J. Tokyo Med. Univ.; 2004 vol.62 n.2 p.146-152 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28864 |
| Study title: Legg-Perthes-Calve diseases: staging by MRI using gadolinium;Ducou Le Pointe H; Pediatr. Radiol.; 1994 vol.24 p.88-91Legg-Perthes-Calve diseases: staging by MRI using gadolinium;Ducou Le Pointe H; Pediatr. Radiol.; 1994 vol.24 p.88-91 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28848 |
| Study title: Magnetic resonance findings in 92 acoustic neuromas;Duvoisin B; Eur. J. Radiol.; 1991 vol.13 p.96-102Magnetic resonance findings in 92 acoustic neuromas;Duvoisin B; Eur. J. Radiol.; 1991 vol.13 p.96-102 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28846 |
| Study title: MR to assess renal function in children; Rohrschneider WK; Eur. Radiol.; 2003 vol.13 p.1033-1045MR to assess renal function in children; Rohrschneider WK; Eur. Radiol.; 2003 vol.13 p.1033-1045 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28863 |
| Study title: MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis; Chateil JF; Br. J. Radiol.; 2001 vol.74 p.24-31MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis; Chateil JF; Br. J. Radiol.; 2001 vol.74 p.24-31 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28859 |
| Study title: MRI and ultrasound in children with juvenile chronic arthritis; Lamer S; Eur. J. Radiol.; 2000 vol.33 p.85-93MRI and ultrasound in children with juvenile chronic arthritis; Lamer S; Eur. J. Radiol.; 2000 vol.33 p.85-93 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28856 |
| Study title: Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI;Rodesch G; Neuroradiology; 1990 vol.32 p.26-32Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRI;Rodesch G; Neuroradiology; 1990 vol.32 p.26-32 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28838 |
| Study title: Oral contraceptive use and focal nodular hyperplasia of the liver;Mathieu D; Gastroenterology; 2000 vol.118 p.560-564Oral contraceptive use and focal nodular hyperplasia of the liver;Mathieu D; Gastroenterology; 2000 vol.118 p.560-564 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28855 |
| Study title: Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069Perfusion weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement;Ducreux D; AJNR; 2006 vol.27 p.1059-1069 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28870 |
| Study title: Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640Yoder KE et al. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clin Pediatr 2006; 45(7):633-640 |
| Active substance: GUAIFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29033 |
| Study title: Bjerre I, Blennow G. Methocarbamol in the treatment of cerebral palsy in children. Neuropadiatrie. 1971 Oct;3(2):140-6.Bjerre I, Blennow G. Methocarbamol in the treatment of cerebral palsy in children. Neuropadiatrie. 1971 Oct;3(2):140-6. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29038 |
| Study title: Chakrabarti A, Pandhi P, Jindal SK, Malik SK, Sharma PL. A comparative randomized doubleblind clinical trial of hexapneumine and clistine as antitussive agents. Int J Clin Pharmacol Ther Toxicol. 1987 Jun;25(6):310-2.Chakrabarti A, Pandhi P, Jindal SK, Malik SK, Sharma PL. A comparative randomized doubleblind clinical trial of hexapneumine and clistine as antitussive agents. Int J Clin Pharmacol Ther Toxicol. 1987 Jun;25(6):310-2. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29035 |
| Study title: Falliers CJ, Cato AE, Harris JR. Controlled assessment of oral bronchodilators for asthmatic children. J Int Med Res. 1978;6(4):326-36.Falliers CJ, Cato AE, Harris JR. Controlled assessment of oral bronchodilators for asthmatic children. J Int Med Res. 1978;6(4):326-36. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29036 |
| Study title: Jayaram S, Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial. J Indian Med Assoc.2000 Feb;98(2):68-70.Jayaram S, Desai A. Efficacy and safety of Ascoril expectorant and other cough formula in the treatment of cough management in paediatric and adult patients--a randomised double-blind comparative trial. J Indian Med Assoc.2000 Feb;98(2):68-70. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29034 |
| Study title: Lall JC, Gupta HL. Therapeutic trial of methocarbamol (Robinax) in tetanus neonatorum. Indian Pediatr. 1975 Jun;12(6):503-4.Lall JC, Gupta HL. Therapeutic trial of methocarbamol (Robinax) in tetanus neonatorum. Indian Pediatr. 1975 Jun;12(6):503-4. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29037 |
| Study title: Taylor WF, Siegel SC, Busser RJ, Strick L, Heimlich EM. A controlled evaluation of oral theophylline in asthmatic children. Ann Allergy. 1968 Oct;26(10):523-30.Taylor WF, Siegel SC, Busser RJ, Strick L, Heimlich EM. A controlled evaluation of oral theophylline in asthmatic children. Ann Allergy. 1968 Oct;26(10):523-30. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29039 |
| Study title: Unger DL, Unger L, Temple DE. Double-blind evaluation of an antiasthmatic agent. Ann Allergy. 1967 Oct;25(10):575-7.Unger DL, Unger L, Temple DE. Double-blind evaluation of an antiasthmatic agent. Ann Allergy. 1967 Oct;25(10):575-7. |
| Active substance: GUAIFENESIN AND CHLOROCYCLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29040 |
| Study title: Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2.Britton−M−G, Empey−D−W, John−G−C, Hodder−M, Hughes−D−T. Two doses of triprolidine for treatment of allergic rhinitis. Annals of allergy, {Ann−Allergy}, May 1979, vol. 42, no. 5, p. 330−2. |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29055 |
| Study title: An open label, phase II/III, non-drug comparative study of gadodiamide injection (Omniscan*) at 0.1 mmol/kg b.w. in MR examinations of the body (excluding the CNS) in children and adolescents at the University Hospital Eppendorf, Hamburg, Germany |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV035 Redacted.pdf |
| View full study record |
| Document reference: 47575 |
| Study title: An open phase III study of gadodiamide injection (Omniscan®) 0.1 mmol/kg b.w. used for MR examinations of the body (including the CNS) in children |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV032 Redacted.pdf |
| View full study record |
| Document reference: 47573 |
| Study title: An open, non-comparative, phase III study of gadodiamide injection (Omniscan®) 0.1 mmol/kg b.w. used for magnetic resonance examinations of the CNS in children from 6 months to 14 years of age in a 0.5 T Esaote MR unit |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): SOV031 Redacted.pdf |
| View full study record |
| Document reference: 47572 |
| Study title: Pediatr Res. 2007 Feb;61(2):209-14. Cytogenetic damage in blood lymphocytes and exfoliated epithelial cells of children with inflammatory bowel disease. Holland N, Harmatz P, Golden D, Hubbard A, Wu YY, Bae J, Chen C, Huen K, Heyman MB. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28463 |
| Study title: Pediatrics. 2006 Jul;118(1):180-8. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, Jilma B, Pollak A. |
| Active substance: FOLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28465 |
| Study title: CLINICAL EXPERIENCES WITH FORMOTEROL DRY SYRUP AGAINST PEDIATRIC BRONCHIAL ASTHMA - REVIEW ON ONE-TIME DOSAGE EFFICACY & DOSES |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG-3-4 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47823 |
| Study title: CLINICAL RESULTS OF REPEATED ADMINISTRATION OF FORMOTEROL (BD 40A) DRY SYRUP IN THE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBD G-3-5 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47824 |
| Study title: CLINICAL RESULTS WITH BD 40A (FORMOTEROL) DRY SYRUP IN CHILD BRONCHIAL ASTHMA. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG 3-19 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47825 |
| Study title: CLINICAL STUDIES ON FORMOTEROL (BD 40A) IN PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG 3-2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47826 |
| Study title: CLINICAL STUDIES ON FORMOTEROL (BD 40A) IN PEDIATRIC PATIENTS WITH BRONQUITIS. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBD G-5-2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47827 |
| Study title: CLINICAL STUDY ON FORMOTEROL (BD 40A) IN PEDIATRIC PATIENTS WITH BRONCHITIS. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG 5-3 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47828 |
| Study title: CLINICAL TRIAL OF FORMOTEROL (BD 40A) FOR BRONCHIAL ASTHMA IN CHILDREN. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBD G-3-1 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47829 |
| Study title: CLINICAL TRIAL TO COMPARE THE DURATION OF BRONCHODILATOR EFFECT OF FORMOTEROL METERED DOSE AEROSOL WITH SALBUTAMOL METERED DOSE AEROSOL IN CHILDREN WITH PERENNIAL ASTHMA. CLINICAL TRIAL SUMMARY AND REPORT |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 GS 20-GS20 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47830 |
| Study title: DOSE FINDING STUDY WITH 6, 12 AND 24 MCG INHALED FORMOTEROL IN CHILDREN WITH EXERCISE-INDUCED ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORD5 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47831 |
| Study title: DOUBLE-BLIND, 12-WEEK, PARALLEL-GROUP, MULTI-CENTRE TRIAL TO ASSESS FORMOTEROL DRY POWDER 12 UG AND 24 UG DAILY VS. SALBUTAMOL DRY POWDER 1200 UG DAILY IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DP_PD2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47832 |
| Study title: Double-blind, within-patient placebo-controlled trial comparing the effect of inhalation of formoterol dry powder capsules 12 ug at two different flow rates on the time-course of protection against exercise-induced bronchoconstriction in children with asthma |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DP-FL2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47833 |
| Study title: DOUBLE-BLIND, WITHIN-PATIENT, PLACEBO-CONTROLLED STUDY TO EVALUATE THE ONSET AND DURATION OF THE PROTECTIVE EFFECT OF A SINGLE DOSE OF INHALED FORMOTEROL DRY POWDER AGAINST EXERCISE-INDUCED ASTHMA IN ADOLESCENT AND ADULT ATHLETES. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 25827 02 069 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47834 |
| Study title: An open, multicenter clinical trial of Magnevist® in newborns and infants up to the second year of life in CNS indications |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_90104_study_synopsis.pdf |
| View full study record |
| Document reference: 28833 |
| Study title: Effectiveness and tolerance in the MRT of pediatric patients with CNS lesions; 1X I.V. PH. III - Berlex Report No. 88 493 |
| Active substance: GADOPENTETIC ACID |
| Study summary document link (including results): Bayer Pharma_Gadopentetate Dimeglumine_88493_study_synopsis.pdf |
| View full study record |
| Document reference: 28818 |
| Study title: Cambazard; Double blind, randomised, parallel group. Study of V0034CR cream versus vehicle in the management of atopic dermatitis in infants aged from 3 months to 24 months. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR201.xls |
| View full study record |
| Document reference: 28983 |
| Study title: Stalder; A multicentre, parallel group, double blind versus vehicle study, to evaluate the benefit of topical V0034CR compared to the vehicle in the treatment of atopic dermatitis in children between 4 and 24 months. Study Report 2004 |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR301.xls |
| View full study record |
| Document reference: 28984 |
| Study title: Szepietowski J; Efficacy, local tolerance and patient acceptability of an moisturising emollient on xerosis with or without pruritus, in patients undergoing maintenance renal dialysis (MRD). Study Report 2006 |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR302.xls |
| View full study record |
| Document reference: 28986 |
| Study title: Taieb A; Long term management of atopic dermatitis with the emollient V0034CR. A randomised, placebo-controlled, parallel groups, double-blind study in infants and children. |
| Active substance: GLYCEROL AND LIQUID PARAFFIN |
| Study summary document link (including results): V0034CR3071B.xls |
| View full study record |
| Document reference: 28985 |
| Study title: Bettinger-J et al. Comparison of different non-invasive test methods with respect to the effect of different moisturisers on the skin. Skin Research and Technology 1999;5;(1):21-27 |
| Active substance: GLYCEROL OR GLYCEROL AND LIQUID SUGAR |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28987 |
| Study title: Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope Foglia - Manzillo G, Giada F, Fteita N, Nessi I, Santarone M, Raviele A. Eur Heart J. 2007 Nov;28(21) : 2605-9. Epub 2007 Oct 2.Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope Foglia - Manzillo G, Giada F, Fteita N, Nessi I, Santarone M, Raviele A. Eur Heart J. 2007 Nov;28(21) : 2605-9. Epub 2007 Oct 2. |
| Active substance: GLYCERYL TRINITRATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28989 |
| Study title: Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children PENA Alexia Sophie, WILTSHIRE Esko, MACKENZIE Karen. GENT Roger. PIOTTO Lino. HIRTE Craig. COUPER Jennifer. The Journal of clinical endocrinology and metabolism. 2006; 91 (11) : 4467 - 4471Vascular endothelial and smooth muscle function relates to body mass index and glucose in obese and nonobese children PENA Alexia Sophie, WILTSHIRE Esko, MACKENZIE Karen. GENT Roger. PIOTTO Lino. HIRTE Craig. COUPER Jennifer. The Journal of clinical endocrinology and metabolism. 2006; 91 (11) : 4467 - 4471 |
| Active substance: GLYCERYL TRINITRATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28988 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Glyoxal compositum (ampoules) [AWB-AT] |
| Active substance: Glyoxal compositum-Heel - apmpoules |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40013 |
| Study title: Klinisches Gutachten gem. § 24 AMG über Kryptocur (HOE 471) zur Behandlung des Kryptorchismus mit verbesserter Dosierung - Prof. Dr. Seidel, 21.10.1981 Perizia clinica secondo § 24 della legge sui medicinali su Kryptocur per il trattamento del criptorchidismo con posologia migliorata. Prof. Seidel - (Exp.Report) 21/10/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28991 |
| Study title: Rapporto su uno studio con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Prof. Hocht (Clinical study) 30/9/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28992 |
| Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. Borkenstein (Clinical study) 25/9/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28993 |
| Study title: PMID = 20945944; DOI = 10.2165/11539140-000000000-00000PMID = 20945944; DOI = 10.2165/11539140-000000000-00000 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication.xls |
| View full study record |
| Document reference: 47122 |
| Study title: Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging; Stikkelbroeck NMML; Eur. Radiol.; 2004 vol.14 p.1802-1806 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28865 |
| Study title: Safety of approved MR contrast media for intravenous injection; Runge VM; JMRI; 2000 vol.12 p.205-213Safety of approved MR contrast media for intravenous injection; Runge VM; JMRI; 2000 vol.12 p.205-213 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28857 |
| Study title: Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712Sinus pericranii: advantages of MR imaging; Bigot JL; Pediatr. Radiol.; 2000 vol.30 p.710-712 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28858 |
| Study title: Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332Soft tissue signal abnormality associated with eosinophilic granuloma correlation of MR imaging with pathologic findings;Monroc M; Pediatr. Radiol.; 1994 vol.24 p.328-332 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28849 |
| Study title: Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265Subjective and objective image qualities: a comparison of sagittal T2-weighted spin-echo and turbo-spin-echo sequences in magnetic resonance imaging of the spine by use of a subjective ranking system;Gorres G; Rontgenpraxis; 1998 vol.51 p.258-265 |
| Active substance: GADOTERIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28853 |
| Study title: Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991;19(3):356-359Kemper KJ, Ritz RH, Benson MS, Bishop MS. Helium-oxygen mixture in the treatment of postextubation stridor in pediatric trauma patients. Crit Care Med 1991;19(3):356-359 |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29086 |
| Study title: Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T, Gracely E, Funt N, Thompson A. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005 Nov;116(5):1127-33.Kim IK, Phrampus E, Venkataraman S, Pitetti R, Saville A, Corcoran T, Gracely E, Funt N, Thompson A. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005 Nov;116(5):1127-33. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29087 |
| Study title: Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D, Cucruet T, Lacroix J; Canadian Critical Care Trials Group. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr 2005 Dec;147(6):812-7.Liet JM, Millotte B, Tucci M, Laflammme S, Hutchison J, Creery D, Cucruet T, Lacroix J; Canadian Critical Care Trials Group. Noninvasive therapy with helium-oxygen for severe bronchiolitis. J Pediatr 2005 Dec;147(6):812-7. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29089 |
| Study title: Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 Oct;26(4):720-35.Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 Oct;26(4):720-35. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29090 |
| Study title: Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994 Oct;18(4):206-10.Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994 Oct;18(4):206-10. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29091 |
| Study title: Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Heliox therapy in Infants with Acute bronchiolitis. Pediatrics 2002;109(1):68-73.Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Heliox therapy in Infants with Acute bronchiolitis. Pediatrics 2002;109(1):68-73. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29092 |
| Study title: Essai therapeutique en pédiatrie d'un nouvel antibiotique : La Gentamycine - Thieffry s; 1 Al - 1968 (Medecine infantile) - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28903 |
| Study title: Gentamicin : Clinical and laboratory studies in Infants and children - Nunnery AW - 1969 (J. Infect. Dis., 119, 4-5 : 460) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28904 |
| Study title: Gentamicin : Laboratory and clinical studies in infants and children - Nunnery AW - 1965 (4th Congr. Chemotherapy on Antimicrobial Agents and Chemotherapy, Oct. 17-21) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28905 |
| Study title: Gentamicin : Pharmacologic observations in newborns and infants. - Nunnery AW - 1969 (J. Infect. Dis., 119, 4-5 : 402) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28906 |
| Study title: Gentamicin in childhood infections - Marsden HB. & Al - 1970 - Publication in Gentamicin Registration Dossier - No author - 1977 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28907 |
| Study title: Gentamicin in Childhood infections. 6 Marsden HB. - 1970 (Curr. Ther. Res, 12 : 353) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28908 |
| Study title: Gentamicin in infections in infants with low birthweights. - Howard J. - 1971 (J. Infectious Dis. Dec. Suppl 124:232) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28909 |
| Study title: Gentamicin in neonatal period. - McCracken - 1971 (Amer. J. Dis. 120: 524-33) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28910 |
| Study title: Gentamicin In Newborn infants. - Paisley JW. - 1973 (Am. J. Dis. Child, 126, oct: 473) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28911 |
| Study title: Gentamicin in Pediatric Infections caused by Gram-Negative Organisms. - Del Valle - 1969 (J. of Infectious Dis. 119, 4-5 : 453) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28913 |
| Study title: Gentamicin in Pediatrics. II. Treatment of severe urinary-tract infections caused by Gram-negative Bacilli and of Staphylococcal infections - Holt RJ. Al. - 1971 (J. of Infectious Dis. 124 Suppl.: S257) - Publication in Gentamicin Registration Dossier - N |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28916 |
| Study title: Randomised comparative assessment of the immunogenicity and reactogenicity of three different lots of SmithKline Beecham Biologicals' Haemophilus influenzae type b vaccine and the Pasteur/Mérieux Haemophilus influenzae type b vaccine. The vaccines were administered to healthy infants as a primary vaccination course of three consecutive doses at 2, 4 and 6 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41130 |
| Study title: Randomised, double-blind clinical study to evaluate and compare the immunogenicity and reactogenicity of a booster dose of two formulations of SB Biologicals' Hib conjugate vaccine, when administered mixed in one syringe with SB Biologicals' DTPa vaccine to healthy children in their 2nd year of life. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41139 |
| Study title: Phase III Clinical Study of DF-098 (Bridging Study) |
| Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47491 |
| Study title: Placebo controlled randomised study of Haemophilus lnfluenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) associated with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV). |
| Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47493 |
| Study title: Placebo controlled randomized study of Haemophilus influenzae type b capsular polysaccharide tetanus conjugate vaccine (PRP-T) combined with Diphtheria-Tetanus-Pertussis and Inactivated Poliomyelitis vaccine (DTP-IPV). |
| Active substance: HaemophilusType b Vaccine Conjugated to Tetanus Protein |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47492 |
| Study title: Anderson L.T. Campbell M. et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms AM J Psychiat. 1984, 141, 1195Anderson L.T. Campbell M. et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms AM J Psychiat. 1984, 141, 1195 |
| Active substance: HALOPERIDOL |
| Study summary document link (including results): andersonabstract_haloperiol.pdf |
| View full study record |
| Document reference: 29065 |
| Study title: DOUBLE-BLIND, WITHIN-PATIENT, SINGLE-CENTRE, PLACEBO-CONTROLLED TRIAL OF TWO DOSES OF INHALED FORMOTEROL (12, 24 UG) AND 200 UG INHALED SALBUTAMOL IN CHILDREN WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 BA-AP1 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47835 |
| Study title: Duration of effects of inhaled formoterol versus salbutamol. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47836 |
| Study title: Asakura M, Ikegame K, Yoshihara S,Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. 2010. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010 Sep;92(2):351-9.Asakura M, Ikegame K, Yoshihara S,Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. 2010. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor. Int J Hematol. 2010 Sep;92(2):351-9. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Asakura M et al 2010.pdf |
| View full study record |
| Document reference: 39600 |
| Study title: Aschan J, Ringden O, Ljungman P, Lonnqvist B, Ohlman S. 1992. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1992; 24(2):143-150.Aschan J, Ringden O, Ljungman P, Lonnqvist B, Ohlman S. 1992. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian Journal of Infectious Diseases 1992; 24(2):143-150. |
| Active substance: Foscarnet |
| Study summary document link (including results): Aschan J et al 1992.pdf |
| View full study record |
| Document reference: 39625 |
| Study title: Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F. Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F. Combined foscarnet - ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (hsct). Bone Marrow Transplantation 1996;18SUPPL:110-4 1996. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bacigalupo A et al 1996 supplement.pdf |
| View full study record |
| Document reference: 39665 |
| Study title: Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT,Trespi G et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996;62(3):376-380 1996;(3):376-380.Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT,Trespi G et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996;62(3):376-380 1996;(3):376-380. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bacigalupo A et al 1996.pdf |
| View full study record |
| Document reference: 39664 |
| Study title: Beijing da Xue Xue Bao 2003; Yi(6):596-599.Eksborg S. The pharmacokinetics of antiviral therapy in paediatric patients. [Review] [42 refs]. Herpes 2003; 10(3):66-71.Beijing da Xue Xue Bao 2003; Yi(6):596-599.Eksborg S. The pharmacokinetics of antiviral therapy in paediatric patients. [Review] [42 refs]. Herpes 2003; 10(3):66-71. |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28593 |
| Study title: Bendel A, Gross T, Woods W, Edelman C, Balfour H. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet (North American Edition) 1993; 341(8856):1342.Bendel A, Gross T, Woods W, Edelman C, Balfour H. 1993. Failure of foscarnet in disseminated herpes zoster. Lancet (North American Edition) 1993; 341(8856):1342. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bendel A et al 1993.pdf |
| View full study record |
| Document reference: 39619 |
| Study title: Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964.Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrobial Agents & Chemotherapy 1997; 41(9):1961-1964. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bernstein DI et al 1997.pdf |
| View full study record |
| Document reference: 39656 |
| Study title: Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Research 2006; 71(2-3):154- 163.Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Research 2006; 71(2-3):154- 163. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Biron KK..pdf |
| View full study record |
| Document reference: 39589 |
| Study title: Clinical efficacy of dirithromycin in pharyngitis and tonsillitis. Müller O, Wettich K. The Journal of antimicrobial chemotherapy, { Mar 1993, vol. 31 Suppl C, p. 97−102. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26472 |
| Study title: Protection against the common cold in a boys' school |
| Active substance: DICHLOROBENZYL-ALCOHOL AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25949 |
| Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. Borkenstein (Clinical study) 25/9/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28994 |
| Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. M von der Ohe (Clinical study) 25/9/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28995 |
| Study title: Rapporto su uno studio non controllato con Kryptocur (denominazione sperimentale HOE 471) nel criptorchidismo. Dr. Pankrath (Clinical study) 25/9/1981 |
| Active substance: GONADORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28996 |
| Study title: Noncontrolled clinical trial of framycetin sulphate (sofrakay) bacterial diarrhoea and cholera in children. - Praharaj SC. - 1977 (Indian J. Pediatr. 44: 39-44) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28618 |
| Study title: Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukemia. - Storring RA -1977 (Lancet, 837-840) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28619 |
| Study title: Which dressing ? - Gough DCS - 1990 (Br. J. Urol. 65: 418-419) - Micromedex ref. in CES - Ohlrogge R. - 24 July 2004 - |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28620 |
| Study title: [Clinical trials of a collyrium associating desoxymethasone, framycetin and gramicidin] Ingignoli B, Bronner A. Bull Soc Ophtalmol Fr. 1971 Apr;71(4):433-44. |
| Active substance: FRAMYCETIN AND POLYMYXIN B/ FRAMYCETIN + OXEDRINE + POLYMYXIN B |
| Study summary document link (including results): Clinical trials of a collyrium associating desoxymethasone,.pdf |
| View full study record |
| Document reference: 28627 |
| Study title: Clinical Expert report – Dr Th. DOBMEYER – 27/09/2001 |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28632 |
| Study title: Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations - Luciani G.B. et al. - 1997 (Ann. Thorac. Surg. 64, 1133-1139) - Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 - |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28630 |
| Study title: Furosemide Pharmacokinetics and Pharmacodynamics in health and disease – An Update - Hammarlund-Udenaes M. et al. - 1989 (Journal of pharmacokinetics and biopharmaceutics, Vol 17, No.1) Publication in Clinical Expert Report - Dr Matti VERHO 05/1999 - Volume 18 |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28641 |
| Study title: Furosemide-associated fever - Amir J. et al. - 1996 (J Pediatr 128 : 163-164) - Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 - |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28631 |
| Study title: International PHVD Drug Trial Group;International randomized controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy; Lancet 352, 433-440 (1998) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28633 |
| Study title: Intratracheal furosemide in infants after cardiac surgery : its effects on lung mechanics and urinary output, and its levels in plasma and tracheal aspirate - Aufricht C. et AL. - 1997 ( Intensive Care Med. 23, 992-997) Publication in Clinical Expert Report - Dr. Med. Th. DOBMEYER - 27/08/2001 |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28634 |
| Study title: Klinge J.M, Schsrf J et al., Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery;Intensive Care Med, 23, 693-697 (1997) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28635 |
| Study title: Lochan S.R. et al., Coadministration of theophylline enhances diuretic response to furosemide in infants during extracoproreal membrane oxygenation:a a randomized controlled pilot study; J.Pediatr. 133, 86-89(1998)Lochan S.R. et al., Coadministration of theophylline enhances diuretic response to furosemide in infants during extracoproreal membrane oxygenation:a a randomized controlled pilot study; J.Pediatr. 133, 86-89(1998) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28636 |
| Study title: Melo R.E, Sole D. et al., Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children; J.Allergy Clin.Immunol. 99, 204-209 (1997)Melo R.E, Sole D. et al., Comparative efficacy of inhaled furosemide and disodium cromoglycate in the treatment of exercise-induced asthma in children; J.Allergy Clin.Immunol. 99, 204-209 (1997) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28637 |
| Study title: Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med 2006 Jan; Article in press.Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med 2006 Jan; Article in press. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29093 |
| Study title: Martinón-Torres R, Crespo Suarez PA, Silvia Barbara C, Castello Munoz A, Rodriguez Nuñez A, Martinón-Sanchez JM. Noninvasive ventilation with heliox in an infant with acute respiratory distress syndrome. An Pediatr (Barc) 2005 Jan;62(1):64-7.Martinón-Torres R, Crespo Suarez PA, Silvia Barbara C, Castello Munoz A, Rodriguez Nuñez A, Martinón-Sanchez JM. Noninvasive ventilation with heliox in an infant with acute respiratory distress syndrome. An Pediatr (Barc) 2005 Jan;62(1):64-7. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29094 |
| Study title: McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90.McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatric pulmonology. 1995;19(5):282-90. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29095 |
| Study title: Nasr SZ, Amato P, Wilmott RW. Predicted values for lung diffusing capacity in healthy children. Pediatr Pulmonol 1991;10(4):267-72.Nasr SZ, Amato P, Wilmott RW. Predicted values for lung diffusing capacity in healthy children. Pediatr Pulmonol 1991;10(4):267-72. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29096 |
| Study title: Nelson DS, McClellan L. Helium-oxygen mixtures as adjunctive support for refractory viral croup. Ohio State Med J 1982;78:729-30.Nelson DS, McClellan L. Helium-oxygen mixtures as adjunctive support for refractory viral croup. Ohio State Med J 1982;78:729-30. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29097 |
| Study title: Paret G. Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z. Helium/oxygen gas mixture in respiratory failure secondary to bronchiolitis: a new therapy. Pediatric Pulmonology 1996;22:322-323.Paret G. Dekel B, Vardi A, Szeinberg A, Lotan D, Barzilay Z. Helium/oxygen gas mixture in respiratory failure secondary to bronchiolitis: a new therapy. Pediatric Pulmonology 1996;22:322-323. |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29098 |
| Study title: Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8.Nikolov A, Burdarova I, Kolarov G, Veltova L. The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias. Akusherstvo i Ginekologiia 1999;38(2):46-8. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29010 |
| Study title: Paterson WF, McNeill E, Reid S, Hollman AS, Donaldson MDC. Efficacy of 'Zoladez LA' (goserelin) in the treatment of girls with central precocious or early puberty. Archives of Disease in Childhood 1998; 79(4):323-327.Paterson WF, McNeill E, Reid S, Hollman AS, Donaldson MDC. Efficacy of 'Zoladez LA' (goserelin) in the treatment of girls with central precocious or early puberty. Archives of Disease in Childhood 1998; 79(4):323-327. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29011 |
| Study title: Stanhope R, Brook CCD. Thelarche variant: A new syndrome of precocious sexual maturation? Acta Endocrinologica 1990; 123(5):481-486.Stanhope R, Brook CCD. Thelarche variant: A new syndrome of precocious sexual maturation? Acta Endocrinologica 1990; 123(5):481-486. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29012 |
| Study title: Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.Breyer P, Haider A, Pescovitz O. Clinical Obstetrics and Gynecology 1993; 36(3):764-772.Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle.Breyer P, Haider A, Pescovitz O. Clinical Obstetrics and Gynecology 1993; 36(3):764-772. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29013 |
| Study title: The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias]. [Review] [21 refs] Stanhope R, Brook CCD. Acta Endocrinologica 1990;123(5):481-486 1990;(5):481-486.The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias]. [Review] [21 refs] Stanhope R, Brook CCD. Acta Endocrinologica 1990;123(5):481-486 1990;(5):481-486. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29014 |
| Study title: Thelarche variant: A new syndrome of precocious sexual maturation? Thelarche variant: A new syndrome of precocious sexual maturation? |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29015 |
| Study title: A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. Mar 1991.A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. Mar 1991. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29668 |
| Study title: A Dose-Ranging Study of Ibuprofen Syrup in Pyrexia in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-MS86-534.pdf |
| View full study record |
| Document reference: 47557 |
| Study title: Comparison of ibuprofen, acetaminophen and placebo treatment of fever in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29462 |
| Study title: Comparison of the anti-pyretic activity of Ibuprofen and Paracetamol in children with pyrexia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-BR9095.pdf |
| View full study record |
| Document reference: 29418 |
| Study title: Demonstration of the analgesic efficacy and safety of liquid formulation of ibuprofen (10 mg/kg), acetaminophen (15 mg/kg) and placebo in the relief of orthodontic pain in children (WM-390) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29534 |
| Study title: Dockhorn RJ et al. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol 1996; 76(2):204-8 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29512 |
| Study title: Dose response study of Ibuprofen syrup in juvenile chronic arthritis (AMDBA83008) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29444 |
| Study title: Dose-response study of ibuprofen syrup in juvenile chronic arthritis (JCA). |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen-AMDBA83008.pdf |
| View full study record |
| Document reference: 47542 |
| Study title: Double blind, single dose study of the safety and analgesic efficacy of ibuprofen liquid, and placebo (liquid vehicle) following orthodontic treatment" (WM-402) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29535 |
| Study title: Double-Blind, Placebo-controlled, Maximum Use Safety and Tolerance Study of Advil Liquigel and Celebrex |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29526 |
| Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29558 |
| Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29624 |
| Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. CSR 167S. Protocol 91-113, Unpublished Report 293A and Unpublished Report 1475. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 91-113.pdf |
| View full study record |
| Document reference: 47452 |
| Study title: Efficacy and tolerance of Ibuprofen Syrup in juvenile chronic arthritis evaluation on joint involvement in patients weighting 10-25 kg. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29407 |
| Study title: Efficacy of rectal ibuprofen in controlling postoperative pain in children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29518 |
| Study title: Evaluation of Ibuprofen and Paracetamol in Infective Disorders of Children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-m83081.pdf |
| View full study record |
| Document reference: 48089 |
| Study title: Evaluation of the efficacy and safety of tramadol/APAP in oral surgical pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29482 |
| Study title: Evid Based Med. 2007 Oct;12(5):144. Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children. Ali S, Klassen TPEvid Based Med. 2007 Oct;12(5):144. Ibuprofen was more effective than codeine or acetaminophen for musculoskeletal pain in children. Ali S, Klassen TP |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29615 |
| Study title: Biron P, Bosi A, Cahn JY, Goldstone AH, Gorin NC, Link H Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Bone Marrow Transplantation 1994;13(2):209-12 1994;(2):209-212.Biron P, Bosi A, Cahn JY, Goldstone AH, Gorin NC, Link H Cytomegalovirus interstitial pneumonia in autologous bone marrow transplant recipients. Bone Marrow Transplantation 1994;13(2):209-12 1994;(2):209-212. |
| Active substance: Foscarnet |
| Study summary document link (including results): Biron P et al 1994.pdf |
| View full study record |
| Document reference: 39677 |
| Study title: Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Research~ 61(2):73-81, February 2004 2004;(2):-81, February. 2004. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Research~ 61(2):73-81, February 2004 2004;(2):-81, February. 2004. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Brady RC et al 2004.pdf |
| View full study record |
| Document reference: 28586 |
| Study title: Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.Pediatr Infect Dis J. 2008 Oct;27(10):946- 8.Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.Pediatr Infect Dis J. 2008 Oct;27(10):946- 8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bryan CJ et al 2008.pdf |
| View full study record |
| Document reference: 39611 |
| Study title: Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatric Drugs. 2002; 4(5):279-290.Bueno J, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Paediatric Drugs. 2002; 4(5):279-290. |
| Active substance: Foscarnet |
| Study summary document link (including results): Bueno J et al 2002.pdf |
| View full study record |
| Document reference: 39635 |
| Study title: Carbon C. New anti-VZV drugs: Perspectives. Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):924-927.Carbon C. New anti-VZV drugs: Perspectives. Medecine et Maladies Infectieuses 1998; 28(Special Issue SI):924-927. |
| Active substance: Foscarnet |
| Study summary document link (including results): Carbon C 1998.pdf |
| View full study record |
| Document reference: 39651 |
| Study title: Castelli F, Tomasoni L, Zeroli C, Suter F, Trespi G, Carosi G Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis. European Journal of Clinical Pharmacology 1997;52(5):397-401.Castelli F, Tomasoni L, Zeroli C, Suter F, Trespi G, Carosi G Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis. European Journal of Clinical Pharmacology 1997;52(5):397-401. |
| Active substance: Foscarnet |
| Study summary document link (including results): Castelli F et al 1997.pdf |
| View full study record |
| Document reference: 39657 |
| Study title: Caumes E, Bricaire F. Prevention of herpes simplex and varicella zoster infections in hiv infected patients. Annales de Medecine Interne 1997; 148(3):255-257.Caumes E, Bricaire F. Prevention of herpes simplex and varicella zoster infections in hiv infected patients. Annales de Medecine Interne 1997; 148(3):255-257. |
| Active substance: Foscarnet |
| Study summary document link (including results): Caumes E et al 1997.pdf |
| View full study record |
| Document reference: 39658 |
| Study title: Causey D, Davis R, Duppermann BD, Feinberg J, Heinemann MH, Jacobson MA et al. 1994. Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus reninitis. Antimicrobial Agents and Chemotherapy 1994; 38(5): 1190- 1193Causey D, Davis R, Duppermann BD, Feinberg J, Heinemann MH, Jacobson MA et al. 1994. Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus reninitis. Antimicrobial Agents and Chemotherapy 1994; 38(5): 1190- 1193 |
| Active substance: Foscarnet |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39678 |
| Study title: Cesaro S, Boaro MP, Pillon M, Calore E, Cermakova I, Perruccio K, Mengoli C, Messina C. Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.Int J Hematol. 2008 Sep;88(2):145-8.Cesaro S, Boaro MP, Pillon M, Calore E, Cermakova I, Perruccio K, Mengoli C, Messina C. Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia.Int J Hematol. 2008 Sep;88(2):145-8. |
| Active substance: Foscarnet |
| Study summary document link (including results): Cesaro S et al 2008.pdf |
| View full study record |
| Document reference: 39612 |
| Study title: Part IC - Clinical Expert report (volume 2) – Dr Matti VERHO – 05/1995 |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28638 |
| Study title: Reiter P.D. Makhlof R., et al., Comparison of 6-hour infusion versus bolus furosemide in premature infants. Pharmacotherapy 18, 63-68 (1998) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28639 |
| Study title: Romagnoli C, Zecca E at al., Furosemide does not prevent indomethacin-induced renal side effects in preterm infants, Clin.Pharmacol.Ther. 62, 181-186 (1997) |
| Active substance: FUROSEMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28640 |
| Study title: Experience with Fucidin® Gel preparations in general practice |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28690 |
| Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis) |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28673 |
| Study title: Final report for a trial of Fucidin® cream using both photographic and clinical assessments (Fucidin® cream in the treatment of superficial skin sepsis). |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28645 |
| Study title: Fucidin eye drops in acute, bacterial eye infections; Thanpaichitra, Bangkok Thailland |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28654 |
| Study title: Fucidin H Gel in acne |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28691 |
| Study title: Fucidin in various eye infections Open evaluation with fucidin eye drops and fucithalmic viscous eye drops |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28651 |
| Study title: Fucidin Ointment and Fucidin tablets in various indications |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28696 |
| Study title: Fucidin treatment of soft tissue infections in children: comparison of two dosages |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28688 |
| Study title: Fucidin versus erythromycin in skin and soft tissue infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28714 |
| Study title: Fucidin versus flucloxacillin in skin and soft tissue infection |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28715 |
| Study title: Fucidin® cream in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28682 |
| Study title: Fucidin® cream versus its vehicle and Bactroban® in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28675 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28668 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28674 |
| Study title: Fucidin® cream versus its vehicle in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28702 |
| Study title: Fucidin® levels in osteomyelitis. E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 Note this study is included for suspension, tablets and iv reports Study includes pts from 2-72. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28712 |
| Study title: Fucidin® levels in osteomyelitis.E H Chater et al. J Ir. Med. Assoc. 1972; 65: 506 -508 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28684 |
| Study title: Fucidin® ointment versus its vehicle and Bactroban® in the treatment of impetigo |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28703 |
| Study title: Thomas BC, Stanhope R, Leiper AD. Gonadotropin Releasing Hormone Analogue and Growth Hormone Therapy in Precocious and Premature Puberty following Cranial Irradiation for Acute Lymphoblastic Leukaemia. Hormone Research 1993; 39(1/2):25-29.Thomas BC, Stanhope R, Leiper AD. Gonadotropin Releasing Hormone Analogue and Growth Hormone Therapy in Precocious and Premature Puberty following Cranial Irradiation for Acute Lymphoblastic Leukaemia. Hormone Research 1993; 39(1/2):25-29. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29016 |
| Study title: Trueman JA, Tillmann V, Cusick CF, Foster P, Patel L, Hall CM et al. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Clinical Endocrinology 2002; 57(2):223-30.Trueman JA, Tillmann V, Cusick CF, Foster P, Patel L, Hall CM et al. Suppression of puberty with long-acting goserelin (Zoladex-LA): effect on gonadotrophin response to GnRH in the first treatment cycle. Clinical Endocrinology 2002; 57(2):223-30. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29017 |
| Study title: Tuvemo T. Treatment of central precocious puberty [Review]. Expert Opinion on Investigational Drugs 2006; 15(5):495-505.Tuvemo T. Treatment of central precocious puberty [Review]. Expert Opinion on Investigational Drugs 2006; 15(5):495-505. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29018 |
| Study title: Tuvemo T. Treatment of central precocious puberty. Expert Opinion on Investigational Drugs 2006; 15(5):495-505.Tuvemo T. Treatment of central precocious puberty. Expert Opinion on Investigational Drugs 2006; 15(5):495-505. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29019 |
| Study title: Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertility & Sterility 1993; 59(3):511-515.Waller KG, Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertility & Sterility 1993; 59(3):511-515. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29020 |
| Study title: A clinical study to evaluate the safety, tolerance, antiemetic efficacy and pharmacokinetic profile of BRL 43694A in paediatric patients receiving chemotherapy for malignant disease |
| Active substance: GRANISETRON |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29025 |
| Study title: A SINGLE-CENTER, NON-RANDOMIZED, OPEN-LABEL STUDY OF THE EFFICACY OF ORAL GABAPENTIN(CI-945) IN THE TREATMENT OF PATIENTS WITH GENERALIZED OR SYNPTOMATIC EPILEPSY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28754 |
| Study title: A SINGLE-DOSE STUDY OF NEURONTIN® (GABAPENTIN; CI-945) PHARMACOKINETICS IN HEALTHY PEDIATRIC SUBJECTS |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28755 |
| Study title: A STUDY IN HEALTHY VOLUNTEERS TO DETERMINE THE TASTE ACCEPTABILITY OF THREE GABAPENTIN (CI-945) LIQUID FORMULATIONS |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28756 |
| Study title: A STUDY IN PATIENTS WITH REFRACTORY PARTIAL SEIZURES TO DETERMINE THE EFFICACY AND SAFETY OF GABAPENTIN MONOTHERAPY COMPARED WITH CARBAMAZEPINE MONOTHERAPY AND COMBINATION THERAPY |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28757 |
| Study title: A STUDY OF POTENTIAL INTERACTION BETWEEN VALPROIC ACID AND GABAPENTIN IN EPILEPTIC PATIENTS MAINTAINED ON VALPROIC ACID. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28758 |
| Study title: AN EXTENDED OPEN-LABEL GABAPENTIN (CI-945) PEDIATRIC MONOTHERAPY TRIAL FOLLOWING A DOUBLE-BLIND STUDY (945-094) IN PEDIATRIC PATIENTS WITH BENIGN CHILDHOOD EPILEPSY WITH CENTROTEMPORAL SPIKES (BECTS) (PROTOCOL 945-095). |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28759 |
| Study title: AN OPEN LABEL EXTENSION STUDY OF GABAPENTIN IN CHILDREN WITH EPILEPSY WHO HAVE PARTICIPATED IN THE DOUBLE-BLIND STUDY GA 001 (945-430001) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28760 |
| Study title: AN OPEN LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF GABAPENTIN AS ADD-ON THERAPY IN THE EXTENDED TREATMENT OF EPILEPTIC SEIZURES. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28761 |
| Study title: AN OPEN LABEL, UNCONTROLLED PILOT STUDY OF THE SAFETY, TOLERANCE, AND EFFICACY OF GABAPENTIN (CI-945) AS ADD-ON THERAPY IN PATIENTS WITH MEDICALLY UNCONTROLLED SEIZURES. |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28762 |
| Study title: Our experiences with indocin in the treatment of postoperative pain and postoperative edemaa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29981 |
| Study title: Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29982 |
| Study title: The treatment of acute fissure-in-ano in children : evaluation of the efficacy of the Proctossedyl - No author - 1971 (Clinical Trials Journal 1971; 4: 9-13) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29184 |
| Study title: Topical Corticosteroids: Clinical Pharmacology and Therapeutic Use - Miller JA et al - 1980 (Drugs 1980; 19: 119-134) - Publication in Application for a reviewed license - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29185 |
| Study title: Treatment of haemorrhoids with Proctossedyl - Soegaard PK - No date (private communication) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29186 |
| Study title: Watterberg, K.L., et al., Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics, 2007. 120(1): p. 40-8. |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29187 |
| Study title: Peripherally inserted central venous catheters : success of scalp-vein access in infants and newborns;RACADIO JM; Radiology; 1999 vol.210 p.858 860Peripherally inserted central venous catheters : success of scalp-vein access in infants and newborns;RACADIO JM; Radiology; 1999 vol.210 p.858 860 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30424 |
| Study title: Khan, S. A. and Williamson, D. M. A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses Curr.Med.Res.Opin. 1977;5:354-358. |
| Active substance: HYDROCORTIZONE AND UREA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29189 |
| Study title: Effect on gingivitis of daily rinsing with 1.5 percent h2O2Boyd 1989 |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): Boyd_1989_effect on gingivitis of daily rinsing with 1.5 percent h2o2.pdf |
| View full study record |
| Document reference: 48175 |
| Study title: Efficacy and safety of stabilised hydrogen peroxide cream (crystacide) in mild to moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel. |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29191 |
| Study title: skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparasion with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29190 |
| Study title: Succesful treatment of molluscum contagiosum skin infection with hydrogen peroxide 1% cream. in the management of patients with psoriasis.; 12th congress of the European Academy of Dermatology & venerology |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29192 |
| Study title: Topical oral antiseptics, mouthwashes and throat remediesDarlington 1973 |
| Active substance: HYDROGEN PEROXIDE |
| Study summary document link (including results): Darlington_1973_Topical oral antiseptics, mouthwashes and throat remedies.pdf |
| View full study record |
| Document reference: 48176 |
| Study title: HDM9007 - Clinical observation to evaluate the patient oriented dosages of Palladon® retard with respect to circadian variations in pain intensity (0.1% of patients 10-19 years) (Germany); Protocol No.011-004: Open label, preliminary evaluation of the clinical effectiveness and steady state pharmacokinetics of a controlled release sprinkle formulation of hydromorphone in pediatric patients with chronic cancer pain. (terminated - lack of recruitment) |
| Active substance: HYDROMORPHONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29193 |
| Study title: "An overview of the treatment of Childhood SLE - E.D. Silverman and B. Lang- 1997 - Publication in CES 0533 - H. Dennequin - 28 Sept 2006 -" |
| Active substance: HYDROXYCHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29206 |
| Study title: Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30053 |
| Study title: Urinary metabolites of oxidative stress and nitric oxide in preterm and term infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30054 |
| Study title: Use of chlorbutin in the complex treatment of systemic forms of juvenile rheumatoid arthritisa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30055 |
| Study title: Use of indomethacin in patients with a gastrointestinal form of salmonellosisa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30056 |
| Study title: Virilization in a child with pseudohypoaldosteronism treated with indometacin |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30057 |
| Study title: When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30058 |
| Study title: Worldwide experience with etodolac (Lodine) 300 mg b.i.d. in the treatment of osteoarthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30059 |
| Study title: A Multicenter Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in the Treatment of Pediatric Patients with Active Crohn’s Disease • 20 week report synopsis |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47434 |
| Study title: A Multicenter Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in the Treatment of Pediatric Patients with Active Crohn’s Disease • 48 week report synopsis |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47435 |
| Study title: Comparison of chloral hydrate, meperidine, and hydroxyzine to midazolam regimens for oral sedation of pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE06B2013.pdf |
| View full study record |
| Document reference: 29239 |
| Study title: Comparison of hydroxyzine and cyproheptadine as antipruri- tics for atopic dermatitis in children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29370 |
| Study title: Comparison of oral midazolam with and without hydroxyzine in the sedation of pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE05B1415.pdf |
| View full study record |
| Document reference: 29339 |
| Study title: Comparison of three conscious sedation regimens for pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE07G0921.pdf |
| View full study record |
| Document reference: 29355 |
| Study title: Comparison of triazolam to a chloral hydrate / hydroxyzine combination in the sedation of pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B1305.pdf |
| View full study record |
| Document reference: 29303 |
| Study title: Comparison of two different dosages of hydroxyzine for sedation in the paediatric dental patient |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE07H2209.pdf |
| View full study record |
| Document reference: 29254 |
| Study title: Concerning the side effects of hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96J0916-translation.pdf |
| View full study record |
| Document reference: 29314 |
| Study title: Confronto clinico statistico fra tre farmaci nella preanesthesia del paziente pediatrico. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPI97B1125.pdf |
| View full study record |
| Document reference: 29324 |
| Study title: Conscious sedation and pulse oximetry: false alarms? |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91G3031.pdf |
| View full study record |
| Document reference: 29364 |
| Study title: Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Eur J Pediatr. 2002 Aug;161(8):438-41. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection.Cruzado D, Masserey-Spicher V, Roux L, Delavelle J, Picard F, Haenggeli CA. Eur J Pediatr. 2002 Aug;161(8):438-41. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30094 |
| Study title: Delogu C, Lozzi A, Campanelli A, De Ritis G, Pietropaoli P, Balbi P, Signore L.. Italian Journal of Anesthesiology [Italy]. 1982; 33(4):619-625. Cell- mediated immunity and immunomodulatory drugs in critically ill patientsDelogu C, Lozzi A, Campanelli A, De Ritis G, Pietropaoli P, Balbi P, Signore L.. Italian Journal of Anesthesiology [Italy]. 1982; 33(4):619-625. Cell- mediated immunity and immunomodulatory drugs in critically ill patients |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30096 |
| Study title: Di Blasi F, Ruvolo F, D'Amico P, Basile MI, Torre S, Violi L. Archivo di Medicina Interna. July-August, 1981; 33(4):1457-1467. Considerations on the use of methisoprinol: the treatment of acute viral hepatitisDi Blasi F, Ruvolo F, D'Amico P, Basile MI, Torre S, Violi L. Archivo di Medicina Interna. July-August, 1981; 33(4):1457-1467. Considerations on the use of methisoprinol: the treatment of acute viral hepatitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30097 |
| Study title: Dimova PS, Bojinova VS. J Child Neurol. 2004 Jul;19(7):548-52. Case of subacute sclerosing panencephalitis with atypical absences and myoclonic-atonic seizures as a first symptom.Dimova PS, Bojinova VS. J Child Neurol. 2004 Jul;19(7):548-52. Case of subacute sclerosing panencephalitis with atypical absences and myoclonic-atonic seizures as a first symptom. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30098 |
| Study title: Duman O, Balta G, Metinsoy M, Haspolat S.J Child Neurol. 2004 Jul;19(7):552-5. Unusual manifestation of subacute sclerosing panencephalitis: case with intracranial high-pressure symptoms.Duman O, Balta G, Metinsoy M, Haspolat S.J Child Neurol. 2004 Jul;19(7):552-5. Unusual manifestation of subacute sclerosing panencephalitis: case with intracranial high-pressure symptoms. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30099 |
| Study title: DuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitisDuRant RH, Dyken PR, Swift AV. J Pediatr Aug 1982;101(2):288-93 [Abstract]. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30100 |
| Study title: Feldman S, Hayes FA, Chaudhary S, Ossi M.. Antimicrob Agents Chemother. 1978 Sep;14(3):495-7. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled studyFeldman S, Hayes FA, Chaudhary S, Ossi M.. Antimicrob Agents Chemother. 1978 Sep;14(3):495-7. Inosiplex for localized herpes zoster in childhood cancer patients: preliminary controlled study |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30101 |
| Study title: Filipowicz A, Grudzinska B. Neurol Neurochir Pol. 1987 Jul-Aug;21(4-5):352-6. Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine.Filipowicz A, Grudzinska B. Neurol Neurochir Pol. 1987 Jul-Aug;21(4-5):352-6. Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30102 |
| Study title: Preoperative preparation for tonsillectomy with hydroxyzine hydrochloride in pediatric patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91G2920.pdf |
| View full study record |
| Document reference: 29348 |
| Study title: Quelques indications de l’ »Atarax » en pediatrie. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS92C2407.pdf |
| View full study record |
| Document reference: 29302 |
| Study title: Re-evaluation of hydroxyzine, droperidol,diazepam and pentazocine as premedicants in pediatric anesthesia. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D2136.pdf |
| View full study record |
| Document reference: 29368 |
| Study title: Repigmentacion de vitiligo y otras leucodermias con antihistaminicos h1 (estudio prospectivo 1983-1988). |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS91H0201.pdf |
| View full study record |
| Document reference: 29234 |
| Study title: Routine preoperative medication in dentistry for children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D1339.pdf |
| View full study record |
| Document reference: 29351 |
| Study title: Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas1951-Downs |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1951-Downs-Effect of topically applied fluorides in dental caries experiences on children residing in fluoride areas.pdf |
| View full study record |
| Document reference: 49131 |
| Study title: Enamel opacities in the incisors of school children in a community in the canton of ZurichSteiner 1984 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf |
| View full study record |
| Document reference: 49180 |
| Study title: Evaluation of a practise based preventative programme for adolescentsBlinkhorn et. al. Community Dent. Oral Epidemiol. 1981: 9: 275-279 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1981-blinkhorn-Evaluation of a Practice Basedpreventive programme for adolescents.pdf |
| View full study record |
| Document reference: 48771 |
| Study title: Fluoride - Ten year prospective study of deciduous and permanent dentitionFrederick J Margolis, Harold R Reames, Ernest Freshman, John C Macauley, Howard Mehaffey. Am J Dis Child - Vol 129. July 1975 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1975-margolis-Fluoride-tenyear prospective study of decidous and permanent dentition.pdf |
| View full study record |
| Document reference: 48768 |
| Study title: Fluoride absorption after the local applicationEinwag 1987 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Einwag 1987 Fluoride absorption after the local application.pdf |
| View full study record |
| Document reference: 49162 |
| Study title: Fluoride excretion in the urine of childrenFeuerle 1989 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Feuerle 1989 Fluoride excretion in the urine of children.pdf |
| View full study record |
| Document reference: 49164 |
| Study title: Fluoride level in surface enamelHotz 1987 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Hotz 1987 Fluoride level in surface enamel.pdf |
| View full study record |
| Document reference: 49168 |
| Study title: "cardiopathies congenitales et produits de contraste : essais d'un nouvel opacifiant; LERICHE H; Coeur; 1981 vol.2 n.3 p.261 264 " "cardiopathies congenitales et produits de contraste : essais d'un nouvel opacifiant; LERICHE H; Coeur; 1981 vol.2 n.3 p.261 264 " |
| Active substance: IOXITALAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30514 |
| Study title: "Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; GURSES C; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76" "Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; GURSES C; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76" |
| Active substance: IOXITALAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30510 |
| Study title: "etude comparative : ioxitalamate et ioxaglate en angiocardiographie : a propos de 50 enfants de moins de 5kg; HUGUET JF; in : contrast media in radiology ; numero special hexabrix ; AMIEL M MOREAU JF ; Springer Verlag berlin 1982 ; p.127 " "etude comparative : ioxitalamate et ioxaglate en angiocardiographie : a propos de 50 enfants de moins de 5kg; HUGUET JF; in : contrast media in radiology ; numero special hexabrix ; AMIEL M MOREAU JF ; Springer Verlag berlin 1982 ; p.127 " |
| Active substance: IOXITALAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30513 |
| Study title: "focal nodular hyperplasia : natural course observed with ct and mri; LECONTE I; J. Comput. Assist. Tomogr.; 2000 vol.24 n.1 p.61 66" "focal nodular hyperplasia : natural course observed with ct and mri; LECONTE I; J. Comput. Assist. Tomogr.; 2000 vol.24 n.1 p.61 66" |
| Active substance: IOXITALAMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30511 |
| Study title: 0.5 % Th 1165a drops: report of a joint trial for therapeutic assessment in paediatric in-patients with bronchospasm. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30581 |
| Study title: A dose response study of Ipatropium bromide and Fenoterol nebuliser solution in asthmatic children |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30685 |
| Study title: A double-blind, vehicle-controlled pharmacokinetic study of Atrovent nasal spray 0.06 % in children with naturally acquired common colds. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30557 |
| Study title: An overview of the treatment of Childhood SLE - E.D. Silverman and B. Lang- 1997 - Publication in CES 0533 - H. Dennequin - 28 Sept 2006 - |
| Active substance: HYDROXYCHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29202 |
| Study title: An overview of the treatment of Childhood SLE - E.D. Silverman and B. Lang- 1997 Publication in CES 0635 - H. Dennequin - 14 May 2007 - |
| Active substance: HYDROXYCHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29205 |
| Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 10-15 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. CSR 155. Protocol 89-945, Unpublished Report 281. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 89-945.pdf |
| View full study record |
| Document reference: 47403 |
| Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 12.5 mg/kg and 25 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. CSR 149. Protocol 89-932, Unpublished Report 275. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 89-932.pdf |
| View full study record |
| Document reference: 47402 |
| Study title: A single dose study to compare the efficacy of acetaminophen sustained release pediatric chewable tablets to ibuprofen suspension in febrile children. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 91-140.pdf |
| View full study record |
| Document reference: 47408 |
| Study title: A single dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 94-437.pdf |
| View full study record |
| Document reference: 47409 |
| Study title: A Single-Dose, Randomized, Double-Blind Trial to Compare the Efficacy and Safety of Ibuprofen Suspension 7.5 mg/kg with Acetaminophen Suspension 12.5 mg/kg for the Treatment of Febrile Children |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 96-608.pdf |
| View full study record |
| Document reference: 47411 |
| Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 95-516.pdf |
| View full study record |
| Document reference: 47410 |
| Study title: An Assessment of the Safety of Pediatric Ibuprofen (The Boston University Fever Study). |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 90-056 231.pdf |
| View full study record |
| Document reference: 47406 |
| Study title: Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22Carabaño−Aguado−I et al. Antipyretic effectiveness of ibuprofen and paracetamol. {An−Pediatr−Barc}, Feb 2005, vol. 62, no. 2, p. 117−22 |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29706 |
| Study title: double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of impacted third molars. Stat Rpt 60. Protocol 3-259, Unpublished Report 177. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 3-259.pdf |
| View full study record |
| Document reference: 47388 |
| Study title: No author. Ibuprofen versus paracetamol in febrile asthmatic children. {MED−TODAY}, 2002, Vol/Iss/Pg. 3/4 (10)No author. Ibuprofen versus paracetamol in febrile asthmatic children. {MED−TODAY}, 2002, Vol/Iss/Pg. 3/4 (10) |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29574 |
| Study title: Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 96-619.pdf |
| View full study record |
| Document reference: 47412 |
| Study title: The Safety of Antipyretic Medication Use Among Children Less Than Two Years of Age: A Subgroup Analysis of the Boston University Fever Study Data. Protocol 90-056, Unpublished Report CSR231S1. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 90-056 231S1.pdf |
| View full study record |
| Document reference: 47407 |
| Study title: Conscious sedation of pediatric dental patients using chloral hydrate, hydroxyzine, and nitrous oxide: a retrospective study of 382 sedations. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96C0601.pdf |
| View full study record |
| Document reference: 29310 |
| Study title: Conscious sedation of pediatric dental patients: an investigation of chloral hydrate, hydroxyzine pamoate, and meperidine vs. chloral hydrate and hydroxyzine pamoate. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92F0401.pdf |
| View full study record |
| Document reference: 29270 |
| Study title: De l’emploi de l’atarax dans la dyspepsie transitoire du nourrisson |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29264 |
| Study title: Degree of sedation. Incidence of vomiting and time of postoperative sleep with 3 different oral administration schedules of hydroxyzine chlorhydrate and chloral hydrate |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS91G3005.pdf |
| View full study record |
| Document reference: 29247 |
| Study title: Effect of hydroxyzine as a bronchodilator in asthmatic children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91B1207.pdf |
| View full study record |
| Document reference: 29260 |
| Study title: Effect of premedication with hydroxyzine on the behavior of child patients |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DS87A301P.pdf |
| View full study record |
| Document reference: 29224 |
| Study title: Effect of tranquillizers on the end-results of operations for muscle elongation by the method of Madroszkiewicz. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DPL78F181P.pdf |
| View full study record |
| Document reference: 29296 |
| Study title: Effectiveness of midazolam/hydroxyzine compared to chloral hydrate/hydroxyzine in sedating pedodontic patients |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE02H2305.pdf |
| View full study record |
| Document reference: 29276 |
| Study title: A Single Dose, Randomized, Open-Label, Single Center, Three-Way Crossover Pharmacokinetic Study of Children’s Advil® Cold & Sinus Suspension in 6 To <12 Year Old Children |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29660 |
| Study title: A Single Dose, Randomized, Open-Label, Single Center, Two-Way Crossover Pharmacokinetic Study of Advil® Cold & Sinus Tablets in Children |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29659 |
| Study title: A single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental painA single-dose, double-blind, placebo-controlled, randomized, 4 x 4 factorial study comparing combinations of ibuprofen in doses of 100 mg, 200 mg, and 400 mg and dextromethorphan hydrobromide in doses of 10 mg, 20 mg, and 40 mg with the components alone and placebo in postoperative dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29695 |
| Study title: A single-dose, randomized, double-blind trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. Dec 2000.A single-dose, randomized, double-blind trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile children. Dec 2000. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29696 |
| Study title: A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997.A single-dose, randomized, investigator-blinded trial to compare the efficacy and safety of ibuprofen suspension 7.5 mg/kg with acetaminophen suspension 12.5 mg/kg for the treatment of febrile patients. Aug 1997. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29697 |
| Study title: A study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgeryA study comparing the efficacy and safety of ibuprofen sustained release to ibuprofen regular release in the treatment of pain secondary to post-operative foot surgery |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29699 |
| Study title: Sedation of children undergoing CT and MR imaging: the association of oral hydroxyzine and rectal chloral hydrate. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPF97B1206.pdf |
| View full study record |
| Document reference: 29243 |
| Study title: Sensory response of schizophrenic children under atarax: a new method of measurement |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B0513.pdf |
| View full study record |
| Document reference: 29258 |
| Study title: Serial neurologic examination of hyperactive children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29301 |
| Study title: Sur le traitement a l’hydroxyzine des etats nerveux de l’enfance |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29229 |
| Study title: Symptomatic and physiologic effects of sedatives in anti- asthmatic preparations in children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29308 |
| Study title: The antipruritic effect of placebo versus hydroxyzine versus astemizole in children with severe atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29322 |
| Study title: The effect of metoclopramide and hydroxyzine in sedation of infants undergoing dental treatment. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE99H1813.pdf |
| View full study record |
| Document reference: 29320 |
| Study title: The effect of sleep on conscious sedation: a follow-up study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE98J3001.pdf |
| View full study record |
| Document reference: 29328 |
| Study title: The effect of sleep on conscious sedation. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE95C1702.pdf |
| View full study record |
| Document reference: 29327 |
| Study title: The effect of tranquilizers on the immediate skin wheal reaction. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29367 |
| Study title: The effectiveness of midazolam and hydroxyzine as sedative agents for young pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE97G1128.pdf |
| View full study record |
| Document reference: 29338 |
| Study title: The effects of nitrous oxide on behavior and physiological parameters during conscious sedation with a moderate dose of chloral hydrate and hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96L1315.pdf |
| View full study record |
| Document reference: 29300 |
| Study title: The efficacy of midazolam-famotidine suppository for premedication in children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPZ96D2915.pdf |
| View full study record |
| Document reference: 29274 |
| Study title: The evaluation of child behavior during dental examination and treatment using premedication and placebo. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE94G2807.pdf |
| View full study record |
| Document reference: 29352 |
| Study title: Überprüfung der Wirksamkeit und Verträglichkeit von Ichthocortin® Gel und Elidel® 1% Creme bei Kindern mit leichter bis mittelschwerer atopischer Dermatitis |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29758 |
| Study title: EFFICACY AND SAFETY COMPARISON OF IDARUBICIN LOCAL PRODUCT AND IMPORT PRODUCT IN PATIENTS WITH AML AND ALL: A PROSPECTIVE, CONTROLLED, RANDOMIZED, OPEN-LABLE AND MULTI-CENTER STUDY |
| Active substance: IDARUBICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29768 |
| Study title: THERAPY OF 'DE NOVO' ACUTE MYELOBLASTIC LEUKEMIA IN PEDIATRIC PATIENTS WITH AN I.V. IDARUBICIN COMBINATION |
| Active substance: IDARUBICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29769 |
| Study title: Stevens MC et al Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89 J Clin Oncol. 2005 Apr 20;23(12):2618-28. Epub 2005 Feb 22Stevens MC et al Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89 J Clin Oncol. 2005 Apr 20;23(12):2618-28. Epub 2005 Feb 22 |
| Active substance: IFOSFAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29770 |
| Study title: A double-blind, vehicle-controlled pharmacokinetic study of Atrovent nasal spray 0.06 % in children with naturally acquired common colds. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U97-3023_synopsis.pdf |
| View full study record |
| Document reference: 30714 |
| Study title: A four-way, single-dose crossover, dose-ranging study of inhaled Atrovent and placebo in children with chronic asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U93-0304_synopsis.pdf |
| View full study record |
| Document reference: 30709 |
| Study title: A multiple dose comparison of ipratropium bromide HFA-MDI and Atrovent MDI in a 12-week, double-blind, parallel group study in paediatric patients with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U98-0129_synopsis.pdf |
| View full study record |
| Document reference: 30717 |
| Study title: A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) with Rhinorrhea Associated with a Common Cold or Allergy |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30559 |
| Study title: A Phase IV Safety Trial in Pediatric Patients (Ages 2-5) with Rhinorrhea Associated with a Common Cold or Allergy |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U03-3585_synopsis.pdf |
| View full study record |
| Document reference: 30662 |
| Study title: A retrospective study of Atrovent nebuliser solution in wheezy infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30650 |
| Study title: A retrospective study of Atrovent nebuliser solution in wheezy infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U91-0623_synopsis.pdf |
| View full study record |
| Document reference: 30703 |
| Study title: A safety comparison of fenoterol hydrobromide HFA-MDI and Berotec MDI in a 12 week, double-blind, parallel group study in paediatric patients with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30544 |
| Study title: A safety comparison of fenoterol hydrobromide HFA-MDI and Berotec MDI in a 12 week, double-blind, parallel group study in paediatric patients with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30561 |
| Study title: A single-blind, placebo-controlled safety evaluation of Atrovent nasal spray 0.06 %, administered alone or in combination with over-the-counter cold therapies, in children with naturally acquired common colds. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30558 |
| Study title: A single-blind, placebo-controlled safety evaluation of Atrovent nasal spray 0.06 %, administered alone or in combination with over-the-counter cold therapies, in children with naturally acquired common colds. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U97-3216_synopsis.pdf |
| View full study record |
| Document reference: 30715 |
| Study title: Randomized, double-blind, parallel comparison of Atrovent Nasal Spray 0.03 % (42 mcg/nostril) versus placebo administered twice a day in pediatric patients with allergic or nonallergic perennial rhinitis with an optional six-month treatment comparison ... |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30556 |
| Study title: Randomized, double-blind, parallel comparison of Atrovent nasal spray 0.03% (42 mcg/nostril) versus placebo administered twice a day in pediatric patients with allergic or nonallergic perennial rhinitis with an optional 6 month treatment comparison of ... |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30636 |
| Study title: Randomized, double-blind, parallel comparison of Atrovent nasal spray 0.03% (42 mcg/nostril) versus placebo administered twice a day in pediatric patients with allergic or nonallergic perennial rhinitis with an optional 6 month treatment comparison of ... |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U95-3002_synopsis.pdf |
| View full study record |
| Document reference: 30711 |
| Study title: Report on an open therapeutical study of Berocillin suspension (pivampicillin-base) in pediatrics. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30589 |
| Study title: Report on the use of Berotec in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30584 |
| Study title: Report to Boehringer-Ingelheim, Australia on clinical trial to determine the optimum dose of nebulised ipratropium bromide (Atrovent) solution (0.020 %) in children with chronic asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30573 |
| Study title: Results of a study concerning children with an asthmatic syndrome treated with a parasymphathicolytic agent, the Sch 1000. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30575 |
| Study title: Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) Wahba−H. The Antipyretic Effect of Ibuprofen and Acetaminophen in Children. {PHARMACOTHERAPY}, 2004, Vol/Iss/Pg. 24/2 I (280−284) |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29571 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41118 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41120 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47325 |
| Study title: A comparative study of the safety and immunogenicity of two dosing schedules of an inactivated Hepatitis A vaccine in healthy infants. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41121 |
| Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 360 EL.U injected according to a 0, 1 and 6 month schedule in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47329 |
| Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 360 EL.U injected according to a 0, 1 and 6 month schedule in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47330 |
| Study title: A comparative, double-blind, randomized study to compare the immunogenicity and reactogenicity of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine containing 360EL.U injected according to 0, 1 and 6 month schedule in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47328 |
| Study title: A comparative, double-blind, randomizes study of two different lots of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine (360 EL.U) administered to healthy children according to a primary vaccination course at 0, 1 months and a booster at month 6. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41119 |
| Study title: A comparative, double-blind, randomizes study of two different lots of SmithKline Beecham Biologicals’ inactivated hepatitis A vaccine (360 EL.U) administered to healthy children according to a primary vaccination course at 0, 1 months and a booster at month 6. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47327 |
| Study title: A dose-ranging study to evaluate the safety, tolerability, and immunogenicity of formalin inactivate, alum adjuvanted Hepatitis A vaccine administered as a single dose plus a booster to healthy young infants |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41461 |
| Study title: A dose-ranging study to evaluate the safety, tolerability, and immunogenicity of formalin inactivate, alum adjuvanted Hepatitis A vaccine administered as a single dose plus a booster to healthy young infants |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41467 |
| Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41116 |
| Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47333 |
| Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47334 |
| Study title: A double-blind, randomised, controlled protective efficacy study of a primary course of an inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47331 |
| Study title: A double-blind, randomized, controlled protective efficacy study of a primary course of an inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47332 |
| Study title: Acetaminophen and ibuprofen : Fever and control - Kathleen A. Murphy - No date (Updates &Kidbits) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29639 |
| Study title: An assessment of the safety of pediatric ibuprofen : A practioner - based randomized Clinical trial - Samuel M. Lesko et al. - 22/03/1995 ( JAMA vol 273 n°12) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29641 |
| Study title: An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993.An Assessment of the Safety of Pediatric Ibuprofen ("Boston University Fever Study"). Dec 1993. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29701 |
| Study title: An Open-Label Study of the Safety of an Ibuprofen-Pseudoephedrine HCl Suspension in Children |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 99-086.pdf |
| View full study record |
| Document reference: 29649 |
| Study title: Children’s Advil ® Cold & Sinus Suspension Multiple-Dose Safety Study in Children 2 to <12 Years Old |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): Ibuprofen and Pseudoephedrine Clinical Trial Summaries.pdf |
| View full study record |
| Document reference: 29661 |
| Study title: A functional magnetic resonance imaging study of the long-term influences of early indomethacin exposure on language processing in the brains of prematurely born children. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29804 |
| Study title: A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29805 |
| Study title: A study of indomethacin combined with ritodrine in threatened preterm labor. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29806 |
| Study title: A three-month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and inference. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29807 |
| Study title: Action of the anti-inflammatory agent Lonazolac on experimentally-induced acute inflammation of human skina |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29808 |
| Study title: Acute effects of indomethacin on cerebral hemodynamics and oxygenation |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29809 |
| Study title: Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29810 |
| Study title: Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29811 |
| Study title: Aguiar T. Acta Med Port Jul-Aug 2000;13(4):193-8 Panencephalite esclerosante subagudaAguiar T. Acta Med Port Jul-Aug 2000;13(4):193-8 Panencephalite esclerosante subaguda |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30065 |
| Study title: Alternatives in drug treatment of chronic paroxysmal hemicrania. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29812 |
| Study title: Open Label clinical study of prophylaxis with Factor IX Concentrate (Human) vapor Heated, IMMUNO, in patients with hemophilia B |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29126 |
| Study title: Pharmacokinetic + safety profile study of Nanotiv |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29131 |
| Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29617 |
| Study title: A comparative pharmacodynamic evaluation of the antipyretic efficacy and safety of ibuprofen liquid vs acetaminophen in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29460 |
| Study title: A comparative study evaluating the analgesic effect of using MagnaBloc therapy, a single dose of ibuprofen 400 mg, or placebo in post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29495 |
| Study title: A comparative study evaluating the analgesic effect of using MagnaBloc therapy, a single dose of ibuprofen 400 mg, or placebo in post-operative dental pain. CSR 227. Protocol 96-614, Unpublished Report 670. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 96-614.pdf |
| View full study record |
| Document reference: 47457 |
| Study title: A comparative study evaluating the analgesic efficacy of a single dose of acetaminophen 1000 mg, acetaminophen 1000 mg/dextromethorphan hydrobromide 30 mg, ibuprofen 400 mg, dextromethorphan hydrobromide 30 mg, or placebo in post-operative dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29483 |
| Study title: A comparative study of Ibuprofen and Paracetamol in pyrexia in children by Dr Y K Amdekar, Institute of Child Health, Bombay India |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29430 |
| Study title: A comparative study of ibuprofen and paracetamol in pyrexia in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29470 |
| Study title: A comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12-hour observation in post-extraction dental pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29493 |
| Study title: A comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 93-343.pdf |
| View full study record |
| Document reference: 47454 |
| Study title: A comparative study of two dosage levels of Ibuprofen syrup in children with pyrexia A Kotob, Egypt |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29445 |
| Study title: A Comparative Study of Two Dosage Levels of Ibuprofen Syrup in Chidren with PyrexiaKotob−A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. {J−Int−Med−Res}, 1985, vol. 13, no. 2, p. 122−6 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen-kotob.xls |
| View full study record |
| Document reference: 29600 |
| Study title: a comparative two dosage level study of ibuprofen syrup in children with pyrexia. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29466 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29547 |
| Study title: A controlled double blind study to evaluate the analgesic efficacy of Ibuprofen following tonsillectomy in children from 5 to 13 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29413 |
| Study title: A dose range study of the antipyretic efficacy and safety of ibuprofen pediatric suspension in febrile children. Mar 1991. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29475 |
| Study title: Results of a study concerning children with an asthmatic syndrome treated with a parasymphathicolytic agent, the Sch 1000. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30665 |
| Study title: Statistical evaluation of a controlled double-blind cross-over study in children with exercise included asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30605 |
| Study title: Statistical report - A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30683 |
| Study title: Statistical report fenoterol by inhalation in asthmatic children: a dose-response study. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30612 |
| Study title: Statistical report: Atrovent by inhalation in asthmatic children, a dose response study. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30649 |
| Study title: Statistical report: Atrovent by inhalation in asthmatic children, a dose response study. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U86-0925_synopsis.pdf |
| View full study record |
| Document reference: 30687 |
| Study title: Statistical report: Fenoterol By Inhalation in Asthmatic Children - A Dose-Response Study (Low Dose). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30646 |
| Study title: Statistical report: Fenoterol by inhalation in asthmatic children: A dose-response study (Low dose). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30614 |
| Study title: Study of bronchospasmolytic action of ipratropium bromide in asthmatic children in intercritic period: dose action curve. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30631 |
| Study title: Study of bronchospasmolytic action of ipratropium bromide in asthmatic children in intercritic period: dose action curve. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U87-0945_synopsis.pdf |
| View full study record |
| Document reference: 30692 |
| Study title: Study of the action of Berodual as a chronic treatment on the non-specific bronchial hyper-reactivity in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30693 |
| Study title: Study of the efficacy and tolerance of ipratropium bromide solution adminstered by nebulisation in children during an asthma attack and with a theophylline infusion. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30550 |
| Study title: Study of the efficacy and tolerance of ipratropium bromide solution adminstered by nebulisation in children during an asthma attack and with a theophylline infusion. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U90-0055_synopsis.pdf |
| View full study record |
| Document reference: 30700 |
| Study title: A multi-centre assessment of acne vulgaris treated with topical isotretinoin. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_C0626_Final For Submission_27 Oct 2011.xls |
| View full study record |
| Document reference: 48306 |
| Study title: An Open Clinical and Photographic Evaluation of the Safety and Efficacy of Isotrex gel (0.05% isotretinoin) in the Treatment of Acne Vulgaris. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): Article 45_Ref_C0625_Final For Submission_27 Oct 2011.xls |
| View full study record |
| Document reference: 48305 |
| Study title: Bernstein A B, Benefit Risk Summary for Accutane for Pediatric Patients |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30766 |
| Study title: Frederick A*,Eberhardt D,Mcgarry C,Mclane J, Final Study Report: Efficacy and Safety of Accutane in Pediatric Patients versus Adult Patients-A Subgroup Analysis (Study NR15645) of Patients with Severe Recalcitrant Nodular Acne Treated with Accutane [Ident No: NR15645] |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30771 |
| Study title: A Phase IIIb, open, randomized, controlled, multicenter study of the immunogenicity and safety of GSK Biologicals' inactivated hepatitis A vaccine (Havrix¿) [720 El.U/ 0.5 mL dose] administered on a 0, 6-month schedule concomitantly with Wyeth Lederle's pneumococcal. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41126 |
| Study title: Piroxicam in acute musculoskeletal disorders and sports injuries. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29983 |
| Study title: Piroxicam in acute musculoskeletal disorders and sports injuries. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29984 |
| Study title: Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29985 |
| Study title: Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29986 |
| Study title: Pre-pubertal growth in the hyperprostaglandin E syndrome. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29989 |
| Study title: Prednisone administration in recent onset type I diabetes. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29987 |
| Study title: Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29988 |
| Study title: Presumed photic retinopathy after cataract surgery: an angiographic study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29990 |
| Study title: Prevention of brain hemorrhage in infants with low and extremely low birth weight and infants treated with surfactants. Late observation |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29991 |
| Study title: Prevention of intraventricular hemorrhage by indomethacin in male preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29992 |
| Study title: Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29993 |
| Study title: Preventive management of hypoglycemia in very low-birthweight infants following indomethacin therapy for patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29994 |
| Study title: Primary dysmenorrhea treated with indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29995 |
| Study title: Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29996 |
| Study title: Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29997 |
| Study title: Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29998 |
| Study title: Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29999 |
| Study title: Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30000 |
| Study title: Prophylactic indomethacin in the very low birth weight infant |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30001 |
| Study title: An evidence-based approach to predicting low IQ in very preterm infants from the neurological examination: outcome data from the indomethacin Indomethacin Intraventricular Hemorrhage Prevention Trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29814 |
| Study title: An open trial of indomethacin therapy in exacerbated phases of lepromatous leprosy. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29815 |
| Study title: Analgesic action of clometacin in ophthalmologya |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29816 |
| Study title: Analgesic and antiinflammatory effects of glucamethacin (a nonsteroidal antiinflammatory analgesic) after the removal of impacted third molars. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29817 |
| Study title: Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhage. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29818 |
| Study title: Antenatal exposure to steroids and the additional prophylaxis effect of indomethacin to prevent intraventricular hemorrhage. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29819 |
| Study title: Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29820 |
| Study title: Anti-inflammatory treatment of lumbago? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29821 |
| Study title: Burlo C, RotondoAggiornamento Pediatrico ; 1981. Methisoprinol in infantile viral infectionsBurlo C, RotondoAggiornamento Pediatrico ; 1981. Methisoprinol in infantile viral infections |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30079 |
| Study title: Caksen H, Odabas D, Atas B. Pediatr Neurol Jul 2002;27(1):75 [Abstract]. Seizures in a boy with subacute sclerosing panencephalitis during high-dose intrathecal interferon-alpha therapyCaksen H, Odabas D, Atas B. Pediatr Neurol Jul 2002;27(1):75 [Abstract]. Seizures in a boy with subacute sclerosing panencephalitis during high-dose intrathecal interferon-alpha therapy |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30080 |
| Study title: Calonghi GF, Sueri L, Cadeo GP, Del Massa M. Presented at del Convegno Internazionale sulla Isoprinosina®; April 28, 1979; Rome, Italy; 75-77. Treatment of acute viral hepatitis with Isoprinosine: double-blind clinical studyCalonghi GF, Sueri L, Cadeo GP, Del Massa M. Presented at del Convegno Internazionale sulla Isoprinosina®; April 28, 1979; Rome, Italy; 75-77. Treatment of acute viral hepatitis with Isoprinosine: double-blind clinical study |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30081 |
| Study title: Campbell C, Levin S, Humphreys P, Walop W, Brannan R. BMC Pediatr. 2005 Dec 15;5:47. Review. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.Campbell C, Levin S, Humphreys P, Walop W, Brannan R. BMC Pediatr. 2005 Dec 15;5:47. Review. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30082 |
| Study title: Catania S, Ginanni-Corradini S, Monacelli M, et al Eur Rev Med Pharmacol Sci. 1982; 4:353-356. Methisoprinol in the therapy of herpes zosterCatania S, Ginanni-Corradini S, Monacelli M, et al Eur Rev Med Pharmacol Sci. 1982; 4:353-356. Methisoprinol in the therapy of herpes zoster |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30083 |
| Study title: Catania S, Vittucci P, Monaceli M, et al.. Presented at the 7th International Congress of Infectious and Parasitic Diseases; June 7-11, 1982; Stockholm, Sweden; 203. Abstract 13:8. Antiviral treatment of chicken-pox and varicella-zoster in normal and compromised patientsCatania S, Vittucci P, Monaceli M, et al.. Presented at the 7th International Congress of Infectious and Parasitic Diseases; June 7-11, 1982; Stockholm, Sweden; 203. Abstract 13:8. Antiviral treatment of chicken-pox and varicella-zoster in normal and compromised patients |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30084 |
| Study title: Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369Antman KH et al Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma J Clin Oncol. 1989 Jan;7(1):126-31. Erratum in: J Clin Oncol 1989 Sep;7(9):1369 |
| Active substance: IFOSFAMIDE AND MESNA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29776 |
| Study title: Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2 |
| Active substance: IFOSFAMIDE AND MESNA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29777 |
| Study title: A Study of the Efficacy, Pharmaco-kinetics, Safety and Tolerability of Intravenously Administered Multiple doses of MK-787/MK-791 in Neonates, including Premature Infants. |
| Active substance: IMIPENEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29774 |
| Study title: Humanitarian Use of Imipenem/Cilastatin Sodium in Neonates. |
| Active substance: IMIPENEM AND CILASTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29775 |
| Study title: A multicentre, open, prospective study investigating clinical efficacy, safety, and pharmacokinetic properties of the human normal immunoglobulin for intravenous administration BT681 with intraindividual comparisons to previous standard treatment in patients with primary immunodeficiency disease (PID). |
| Active substance: IMMUNOGLOBULINS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29782 |
| Study title: A single-centre, non-blinded, randomised, parallel comparison of the efficacy and safety of intravenous versus rapid subcutaneous infusion of immunoglobulin in paediatric patients with Primary Immunodeficiency Disease |
| Active substance: IMMUNOGLOBULINS |
| Study summary document link (including results): 02 IG704 (synopsis).pdf |
| View full study record |
| Document reference: 29781 |
| Study title: Clinical study to demonstrate the efficacy of Octagam for replacement therapy in primary immunodeficiency syndromes (PID) |
| Active substance: IMMUNOGLOBULINS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29778 |
| Study title: Clinical study to evaluate the safety, efficacy and pharmacokinetics of Octagam for replacement therapy in primary immunodeficiency diseases (PID) |
| Active substance: IMMUNOGLOBULINS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29779 |
| Study title: Intravenous immunoglobuline in the treatment of Rhesus disease of the neonate. A randomized double blind placebo controlled trial |
| Active substance: IMMUNOGLOBULINS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29780 |
| Study title: A Phase 4 study to evaluate the safety and Immunogenicity of Imovax Polio in Korean Healthy Infants after primary immunization at 2, 4, and 6 months of age |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41199 |
| Study title: Antibody persistence in five-year old children who received a pentavalent combination vaccine in infancy |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41206 |
| Study title: Assessment of tolerance and immunogenicity of a ViCPs vaccine at 2 dosages |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41208 |
| Study title: Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29882 |
| Study title: Effect of indomethacin phonophoresis on the relief of temporomandibular joint pain. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29883 |
| Study title: Effect of inhaled indomethacin on exercise-induced bronchoconstriction in children with asthma. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29884 |
| Study title: Effect of intravenous diclofenac or indomethacin on the emergence from anaesthesia for tonsillectomy. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29885 |
| Study title: McLane J A*, Liss C, Leach E, Eberhardt D R, Bryce G F, Khoo K-C, Final Study Report / Open label extension of Protocol NR15645 to evaluate the efficacy and safety of a second course of Accutane for severe recalcitrant nodular acne in pediatric patients experiencing recurrence between 36 and 72 weeks of previous isotretinoin treatment |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30762 |
| Study title: McLane J A*, Mues B, Bryce G F, Khoo K-C, Evaluation of available post-marketing safety reports and published literature regarding epiphyseal closure in Accutane-treated pediatric patients with severe recalcitrant nodular acne |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30764 |
| Study title: Ondovik M S*, Eberhardt D R, Liss C, Khoo K-C, Clinical Study Report (Protocol NR 15806): Evaluation of the pharmacokinetics and safety of Accutane in pediatric and adult patients with severe recalcitrant nodular acne |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30763 |
| Study title: Ondovik M S*, Jackson K, Pentikis H S, Khoo K-C, Evaluation of the Pharmacokinetics of Isotretinoin in Pediatric and Adult Patients |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30767 |
| Study title: Shah L P*, Wu E, Eberhardt D R, Ondovik M, Bryce G F, Khoo K-C, An open-label study to evaluate the effect of a single course of Accutane therapy on bone mineral density in pediatric patients with severe recalcitrant nodular acne |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30765 |
| Study title: Shiomos C, Bebeau P, Smith R A, Drug Safety Report Roaccutane - Pediatric Report |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30768 |
| Study title: Shiomos C, Bebeau P, Smith R A, Drug Safety Report Roaccutane (isotretinoin) - Adverse Events reported for Roaccutane during the time period 1-June-2004 to 30-June 2005 in children and adolescents under 18 years old. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30769 |
| Study title: Treatment of acne vulgaris with topical isotretinoin |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30760 |
| Study title: Nolan T et al. Randozimed trial of laxatives in treatment of childhood encopresis. The Lancet 338, 1991, 8766: 523-527. |
| Active substance: Ispaghula mucilage;Ispaghula seed;Cassia angustifolia (fruit) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40041 |
| Study title: Sölter et al. Summary of clinical results with Prodiem Plain, a bowel-regulation agent. Today's Therapeutic Trends (1983); 1(1): 45-59. |
| Active substance: Ispaghula mucilage;Ispaghula seed;Cassia angustifolia (fruit) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40040 |
| Study title: PROPHYLAXIS OF FUNGAL INFECTION WITH DIFLUCAN IN PATIENTS WITH COLLAGEN DISEASE ON THE LONG TERM, AND LARGE-DOSAGE STEROID THERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27865 |
| Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27454 |
| Study title: Prophylaxis, costs and effectiveness of gram positive therapy in neatropenic children |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27818 |
| Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27643 |
| Study title: PROSPECTIVE COMPARATIVE TRIAL OF AMPHOTERICIN B VS. FCA IN NEONATAL SYSTEMIC FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28005 |
| Study title: Serum mepivacaine concentrations after intraoral injection in young children. Chin, K.L. et al, J. Calif.Dent. Assoc. 2003Serum mepivacaine concentrations after intraoral injection in young children. Chin, K.L. et al, J. Calif.Dent. Assoc. 2003 |
| Active substance: MEPIVACAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31606 |
| Study title: "Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study - Lomater C, Gattinara M, Gerloni V, Zeni S. Fantini F.-1994 - Publication in CES 0035 - ML BORG - 11 Jul 2002 -" |
| Active substance: HYDROXYCHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29204 |
| Study title: "Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study - Lomater C, Gattinara M, Gerloni V, Zeni S. Fantini F.-1994 - Publication in CES 0318 - J. Klausner - 10 Nov 2004 -" |
| Active substance: HYDROXYCHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29207 |
| Study title: "Lupus profundus in chidren: treatment with hydroxychloroquine - Fox JN, Klapman MH, Rowe L - 1987 - Publication in expert report on the clinical documentation N° 639.6.002 -" |
| Active substance: HYDROXYCHLOROQUINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29203 |
| Study title: Non-interventional study |
| Active substance: HYDROXYETHYLSTARCH |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29216 |
| Study title: A Controlled Study on the Effect of an Absorbable Sustained Release Artificial Tear Substitute on the Dry Eye Syndrome Frequently Associated with Familial Dysautonomia. |
| Active substance: HYDROXYPROPYL CELLULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29218 |
| Study title: Long Term Study of the Effect of a Sustained Release Artificial Tear Substitute (SR-AT) on Keratoconjunctivitis Sicca. |
| Active substance: HYDROXYPROPYL CELLULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29217 |
| Study title: Clinical response and adverse events in young patients with sickle cell disease treated with hydroxyurea2004 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 15205096.pdf |
| View full study record |
| Document reference: 48360 |
| Study title: Clinical response of patients with Sickle Cell Anemia to Cromolyn Sodium Nasal Spray2006 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 16941613.pdf |
| View full study record |
| Document reference: 48365 |
| Study title: Comparaison of busulfan, hydroxyurea and BMT in CML: BMT prolongs survival2004 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 15570285.pdf |
| View full study record |
| Document reference: 48362 |
| Study title: Comparative analysis of the impact of risk profile and drug therapy on survival in CML using Sokal's index and new score1997 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 9136944.pdf |
| View full study record |
| Document reference: 48356 |
| Study title: Hydroxyurea therapy in 49 patients with major beta thalassemia2009 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 19400608.pdf |
| View full study record |
| Document reference: 48368 |
| Study title: Hypereosinophilic syndrome: a multicentre, retrospective analysis of clinical characteristics and response to therapy2009 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 19910029.pdf |
| View full study record |
| Document reference: 48369 |
| Study title: Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series2005 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 16033874.pdf |
| View full study record |
| Document reference: 48364 |
| Study title: Intensive treatment and stem cell transplantation in chronic myelogenous leukaemia: long term follow up2004 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 15870485.pdf |
| View full study record |
| Document reference: 48363 |
| Study title: Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in CML II study1997 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 12886239.pdf |
| View full study record |
| Document reference: 48357 |
| Study title: Response to hydroxyurea treatment in Iranian transfusion dependent beta thalassemia patients2004 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 15477200.pdf |
| View full study record |
| Document reference: 48361 |
| Study title: Steroid treatment in children with Sickle Cell Disease2007 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 17339198.pdf |
| View full study record |
| Document reference: 48366 |
| Study title: The presence of alpha thalassemia trait blunts the response of hydroxycarbamide in patients with Sickle Cell Disease2008 |
| Active substance: HYDROXYUREA |
| Study summary document link (including results): 18764867.pdf |
| View full study record |
| Document reference: 48367 |
| Study title: A clinical trial with hydroxyzine on a group of maladjusted educationally subnormal children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29332 |
| Study title: Cazzola G, Cavalieri S, Solbiati M. (1978) Presented at del Convegno Nazionale della Societa Italiana per lo Studio delle Malattie Infettive e Parassitarie; September 16-17, Ancona, Italy; 1-23. Study of the activity of Isoprinosine® in herpes virus infections.Cazzola G, Cavalieri S, Solbiati M. (1978) Presented at del Convegno Nazionale della Societa Italiana per lo Studio delle Malattie Infettive e Parassitarie; September 16-17, Ancona, Italy; 1-23. Study of the activity of Isoprinosine® in herpes virus infections. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30086 |
| Study title: Chang TW, Heel RC. Drugs. Aug 1981;22(2):111-28. Ribavirin and inosiplex: a review of their present status in viral diseases.Chang TW, Heel RC. Drugs. Aug 1981;22(2):111-28. Ribavirin and inosiplex: a review of their present status in viral diseases. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30087 |
| Study title: Charieras JL, Plassart H. Medecine Tropicale. May-June, 1982; 42(3):316-318. Double-blind study of 59 cases of severe measles treated with IsoprinosineCharieras JL, Plassart H. Medecine Tropicale. May-June, 1982; 42(3):316-318. Double-blind study of 59 cases of severe measles treated with Isoprinosine |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30088 |
| Study title: Ciaula V, Miani F, Fenizi G, Giglio G. Rass Dermatol Sifilogr. Additional clinical studies on activity and curative capability of methisoprinolCiaula V, Miani F, Fenizi G, Giglio G. Rass Dermatol Sifilogr. Additional clinical studies on activity and curative capability of methisoprinol |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30089 |
| Study title: Clinical and histological results obtained in the treatment of chronic hepatitis Clinical and histological results obtained in the treatment of chronic hepatitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30090 |
| Study title: Cohen AL, Antonini GM, Stefano JC La Prensa Medica Argentina. 1973; 60(8):267-278. A clinical study of various viral infections treated with methisoprinol syrup.Cohen AL, Antonini GM, Stefano JC La Prensa Medica Argentina. 1973; 60(8):267-278. A clinical study of various viral infections treated with methisoprinol syrup. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30091 |
| Study title: Effects of dextroamphetamine, chlorpromazine, and hydroxy- zine on behavior and performance in hyperactive children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B1901.pdf |
| View full study record |
| Document reference: 29266 |
| Study title: Effects of hydroxyzine hydrochloride on the reaction time performance of schizophrenic children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B0504.pdf |
| View full study record |
| Document reference: 29257 |
| Study title: Efficacy of hydroxyzine vs diphenhydramine in atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29345 |
| Study title: Electromyography: its potential as an adjunct to other monitored parameters during conscious sedation in children receiving dental treatment. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91B1826.pdf |
| View full study record |
| Document reference: 29365 |
| Study title: Empleo del clorhidrato de hidroxicina en el tratamiento de la urticaria cronica. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DS76H021P.pdf |
| View full study record |
| Document reference: 29312 |
| Study title: Enuresis – a comparative study of imipramine and tranquillisers in its management |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE01A1818.pdf |
| View full study record |
| Document reference: 29272 |
| Study title: Erfahrungen mit dem ataraktikum masmoran in der paediatrie |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPD95A2602.pdf |
| View full study record |
| Document reference: 29275 |
| Study title: Evaluation of an alphaprodine-hydroxyzine combination as a sedative agent in the treatment of the pediatric dental patient |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29250 |
| Study title: Evaluation of an ataractic (hydroxyzine) in 2025 patients as an adjunct in oral surgery |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29223 |
| Study title: Evaluation of analgesic, sedative, antipyretic effects of the combination acetaminophen plus hydroxyzine in pediatrics. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPP92K0719.pdf |
| View full study record |
| Document reference: 29341 |
| Study title: Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29886 |
| Study title: Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29887 |
| Study title: Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29888 |
| Study title: Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29889 |
| Study title: Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29890 |
| Study title: Effects of indomethacin on cerebral haemodynamics in very preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29891 |
| Study title: Effects of indomethacin on cerebral hemodynamics at rest and during endotracheal suctioning in preterm neonates. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29892 |
| Study title: Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29893 |
| Study title: Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29894 |
| Study title: Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29895 |
| Study title: Effects of repeated indomethacin administration on cerebral oxygenation and haemodynamics in preterm infants: combined near infrared spectrophotometry and Doppler ultrasound study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29896 |
| Study title: Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29897 |
| Study title: Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29898 |
| Study title: Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29899 |
| Study title: Evaluation of bioequivalence of highly variable drugs using Monte Carlo simulations. I. Estimation of rate of absorption for single and multiple dose trials using Cmax. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29900 |
| Study title: Künzer Th., Retrospective investigation on children (2-12 years) concerning safety and tolerability and dosage of Echinacin Lozenges; unpublished report (1997) |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39726 |
| Study title: Taylor et al.JAMA December 3, 2003-Vol 290, No. 21 Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39728 |
| Study title: Weber et al. THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children |
| Active substance: (HERB) Purple cone flower, pressed juice, 1.7 - 2.5 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39729 |
| Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27396 |
| Study title: PROSPECTIVE OPEN PILOT COMPARATIVE STUDY OF SAFETY & EFFICACY OF FCA PARENTERAL/ORAL VS STANDARD PROPHYLACTIC REGIMEN IN PREVENTION OF FUNGAL INFECTIONS IN PTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY OR IN PTS SUFFERING FROM APLASTIC ANEMIA |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27761 |
| Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27648 |
| Study title: RANDOMIZED CONTROLLED STUDY COMPARING ORAL FLUCONAZOLE TO TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF VAGINAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28010 |
| Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27397 |
| Study title: RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE EFFICACY OF FLUCONAZOLE PARENTERAL/ORAL IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS WITH PANCYTOPENIA CAUSED BY CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML). |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27762 |
| Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27619 |
| Study title: RETROSPECTIVE CONTROLLED ANALYSIS OF FLUCONAZOLE PROPHYLAXIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27981 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27677 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN CRYPTOCOCCAL MENINGITIS IN PATIENTS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28039 |
| Study title: A study of the efficacy and safety of repeated nebulized therapy combining ipratropium bromide 0.25 mg plus salbutamol sulphate 3.0 mg versus salbutamol sulphate 3.0 mg alone in children with acute asthma |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U94-0664_synopsis.pdf |
| View full study record |
| Document reference: 30635 |
| Study title: A study of the efficacy and safety of repeated nebulized therapy combining ipratropium bromide 0.25 mg plus salbutamol sulphate 3.0 mg versus salbutamol sulphate 3.0 mg alone in children with acute asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30710 |
| Study title: Acute and therapeutic dose-response comparison of Th 1165a administered with the CHBS powder inhaler to children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U80-0167_synopsis.pdf |
| View full study record |
| Document reference: 30671 |
| Study title: Acute asthma management of children in the emergency department. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30701 |
| Study title: A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29282 |
| Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988.A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29665 |
| Study title: A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children. Dec 2003 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 00-131.pdf |
| View full study record |
| Document reference: 29477 |
| Study title: A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children. Dec 2003A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children. Dec 2003 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29666 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992.A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29667 |
| Study title: A Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus HeadacheA Double-Blind Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, an Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29669 |
| Study title: A double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental painA double-blind placebo controlled study comparing the safety and efficacy of ibuprofen 600 mg sustained release to ibuprofen 200 mg regular release, administered every four hours, in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29670 |
| Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 1000 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29662 |
| Study title: A double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extractionA double-blind single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg/caffeine 64 mg, ibuprofen 400 mg, and placebo in the treatment of post-operative pain following third molar extraction |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29671 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgeryA double-blind single dose evaluation of the efficacy and safety of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following oral surgery |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29672 |
| Study title: Evaluation of the effect of nitrous oxide and hydroxyzine in controlling the behavior of the pediatric dental patient. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE93B0817.pdf |
| View full study record |
| Document reference: 29337 |
| Study title: Exercise-induced asthma. Pharmacological assessment of single drugs and drug combinations |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29231 |
| Study title: Fixed drug eruption in the genital area in 15 boys. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE02G2901.pdf |
| View full study record |
| Document reference: 29311 |
| Study title: Hydroxyzine (HXZ) monotherapy or combination of hydroxyzine (HXZ) and ranitidine (R) for anaesthesia premedication in allergic children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPG92A0801.pdf |
| View full study record |
| Document reference: 29350 |
| Study title: Hydroxyzine by the i.m. or oral route in anaesthesia premedication of children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADAE92D1006.pdf |
| View full study record |
| Document reference: 29335 |
| Study title: Hydroxyzine for postoperative nausea and vomiting following ophthalmologic surgery. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29346 |
| Study title: Hydroxyzine HCl in the management of allergic conditions. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): CE67J301P.pdf |
| View full study record |
| Document reference: 29279 |
| Study title: Clinical Pharmacokinetics of Ibuprofen - Neal M. Davies - 02/1998 (Clin Pharmacokinet : 34 (2)) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29643 |
| Study title: Comparative Evaluation of antipyretic activity of ibuprofenand aspirin in children with pyrexia of varied aetiology - P W . Kandoth et al. - 1984 (J Int Med Res vol 12) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29644 |
| Study title: Díez−Domingo−J et al. Evaluation of the antipyretic safety and accuracy of two pediatric ibuprofen formulations. {An−Esp−Pediatr}, Nov 2000, vol. 53, no. 5, p. 436−40Díez−Domingo−J et al. Evaluation of the antipyretic safety and accuracy of two pediatric ibuprofen formulations. {An−Esp−Pediatr}, Nov 2000, vol. 53, no. 5, p. 436−40 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29707 |
| Study title: Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994.Efficacy and pharmacokinetic/pharmacodynamic profile of ibuprofen chewable tablets versus ibuprofen suspension in febrile children. Apr 1994. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29709 |
| Study title: Evaluation of the efficacy and safety of tramadol/APAP in oral surgical painEvaluation of the efficacy and safety of tramadol/APAP in oral surgical pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29711 |
| Study title: Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7Heremans−G et al. A single−blind parallel group study investigating the antipyretic properties of ibuprofen syrup versus acetylsalicylic acid syrup in febrile children. {Br−J−Clin−Pract}, Jun 1988, vol. 42, no. 6, p. 245−7 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29712 |
| Study title: Kotob−A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. {J−Int−Med−Res}, 1985, vol. 13, no. 2, p. 122−6Kotob−A. A comparative study of two dosage levels of ibuprofen syrup in children with pyrexia. {J−Int−Med−Res}, 1985, vol. 13, no. 2, p. 122−6 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29717 |
| Study title: Efficacy and safety of echinacea in treating upper respoiratory tract infections in children. A randomized controlled trial.Taylor JA, Weber W, Standish L et al. JAMA 2003;290: 2824-2830Efficacy and safety of echinacea in treating upper respoiratory tract infections in children. A randomized controlled trial.Taylor JA, Weber W, Standish L et al. JAMA 2003;290: 2824-2830 |
| Active substance: (HERB) Echinacea purpurea L extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39702 |
| Study title: Open non-randomised investigator-initiated study with EGb 761 + reading/spelling training vs. reading/spelling trainin |
| Active substance: (HERB) Dry extract from Ginkgo biloba leaves (35-67 :1), extraction solvent: acetone 60% (w/w). The extract is adjusted to 22.0 - 27.0 % ginkgo flavonoids calculated as ginkgo flavone glycosides and 5.0 - 7.0 % terpene lactones consisting of 2.8 - 3.4 % ginkgolides A, B, C and 2.6 - 3.2 % bilobalide and contains less than 5 ppm ginkgolic acids. |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39703 |
| Study title: Nesbit ME et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990 Oct;8(10):1664-74Nesbit ME et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol. 1990 Oct;8(10):1664-74 |
| Active substance: MITOXANTRONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32190 |
| Study title: An open label pilot study of St John's wort in juvenile depression; Findling, RL,; McNamara, NK et al.J Am Acad Child Adolesc Psychiatry 2003;42(8):908-914 |
| Active substance: (HERB) Hypericum perforatum L extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39705 |
| Study title: Symptoms of depression and psychovegatative disturbances in children under 12 years.; Hubner WD; Kirste T. Schweiz. Z. Ganzheitsmed. 2002;14(6): 318-324 |
| Active substance: (HERB) Hypericum perforatum L extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39706 |
| Study title: Nolan T et al., Randomized trial of laxatives in treatment of childhood encopresis. The Lancet 338, 1991, 8766: 523-52 |
| Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39710 |
| Study title: Roth OA.:Therapeutic observations on constipation.; Med. Welt 1969;20:536-7 |
| Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39709 |
| Study title: Sölter et al., Summary of clinical results with Prodiem Plain, a bowel-regulating agent. Today´s Therapeutic Trends (1983);1(1):45-59 |
| Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39707 |
| Study title: Zawodsky L., Problems of a double-blind trial, as exemplified by a laxative; Der Praktische Arzt 1976;30:1182-92 |
| Active substance: (HERB) Ispaghula husk Ispaghula seed Senna pods, Tinnevelly_and_(HERB) Ispaghula seed Ispaghula husk/ Plantago Ovata Tinnevelly Senna Pods/ |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39708 |
| Study title: Albrecht M./Strenge-Hesse et al: The treatment of Toxic liver damage with legalon; Z Klin Med;1992,47(2):87-92 |
| Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39714 |
| Study title: Grüngreiff K./Strenge-Hesse et al.:Nutzen der medikamentösen Lebertherpaie in der hausärztlichen Praxis. The Value of a drug therapy for liver disease in general practice. Die Medizinishe Welt 1995;46(4):222-227 |
| Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39713 |
| Study title: Hruby K et al., Pharmacotherapy of Amanita phalloides Poisoning with Silibinin.Wiener klin.Wochenschrift (and Human Toxicology); 1983; 7 (and 2 (2): 183-95 ) |
| Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39711 |
| Study title: Jodl J et al, Therapeutische Mög-lichkeiten mit Legalon in der Pädiatrie. Therapeutic uses of Legalon in paediatrics.Medica 1983; 4 (11): 3-6 |
| Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39715 |
| Study title: The physiological effects of supplemental oxygen versus nitrous oxide/oxygen during conscious sedation of pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE00L1003.pdf |
| View full study record |
| Document reference: 29290 |
| Study title: The preoperative sedation of children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADRE92D1302.pdf |
| View full study record |
| Document reference: 29349 |
| Study title: Acute asthma management of children in the emergency department. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30545 |
| Study title: Assessment of the effect of 2.5 mg and 5 mg Th 1165a Linctus in school children compared with placebo. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30590 |
| Study title: Assessment of the therapeutic effect and tolerance of Th 1165a Linctus in 12 infants and 12 school children at doses of 3 x 1.25 mg and 3 x 2.5 mg. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30591 |
| Study title: Assessment of the therapeutic effect of Th 1165a-linctus with several days' administration in infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30601 |
| Study title: Assessment of the therapeutical efficacy and tolerability of 7.5 mg Th 1165a-suppositories in school children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30586 |
| Study title: Assessment of therapeutic effect and tolerance of Th 1165a suppositories after repeated administration in infants and school children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30597 |
| Study title: Assessment of therapeutic efficacy and tolerance of Th 1165a 4.5 mg suppositories during administration for several days in infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30594 |
| Study title: Assessment of therapeutic efficacy and tolerance of Th 1165a 4.5 mg suppositories in infants and small children during multiple dosing. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30595 |
| Study title: Atrovent and Berotec in children with recurrent obstructive bronchitis |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U89-0249_synopsis.pdf |
| View full study record |
| Document reference: 30698 |
| Study title: Atrovent maintenance therapy of asthma and spastic bronchitis |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U84-0774_synopsis.pdf |
| View full study record |
| Document reference: 30677 |
| Study title: Berotec solution statistical report, study no. E79-234 protocol designation: IIF I. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30657 |
| Study title: Berotec solution summary of study - final report - phase III. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30656 |
| Study title: Berotec tablets + Theophylline summary of study - interim report - phase II. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30655 |
| Study title: Berotec tablets 2.5 mg summary of study - interim report - phase II. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30653 |
| Study title: Berotec tablets 5 mg + Theophylline summary of study - final report - phase III. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30658 |
| Study title: Berotec tablets summary of study - phase II - final report. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30654 |
| Study title: Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30553 |
| Study title: Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U92-0221_synopsis.pdf |
| View full study record |
| Document reference: 30705 |
| Study title: Buccally administered fenoterol aerosol in acute childhood asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30638 |
| Study title: Study on the acceptance of the multicapsule inhalator Boehringer Ingelheim M. Berodual inhalets are used. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30702 |
| Study title: Study on the obstruction in small airways. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30604 |
| Study title: Study on the response to fenoterol metered aerosol in a 14 day comparison with placebo. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30599 |
| Study title: Study on the therapeutic efficacy and tolerability of Th 1165a-suppositories in infants and school children, applied for several days in the evening. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30598 |
| Study title: Study on the therapeutic efficacy and tolerability of Th 1165a-suppositories in infants, applied for several days. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30596 |
| Study title: Study on the therapeutic efficacy and tolerability of Th 1165a-suppositories in school-children administered for several days. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30593 |
| Study title: A double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molarsA double-blind single dose evaluation of the efficacy and safety of ibuprofen 400 mg, ibuprofen 200 mg, APAP 1000 mg, and placebo in the treatment of pain following removal of the impacted third molars |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29674 |
| Study title: A randomized open study to investigate the boosting effect of VAQTA and AVAXIM following a single dose of AVAXIM (PM-MSD U98-XQ-003) |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41464 |
| Study title: A single-center, pilot study of the safety, tolerability, and immunogenicity of VAQTA in healthy infants ~6 months of age |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41463 |
| Study title: A study to assess the immunogenicity and reactogenicity of a Hepatitis A vaccine administered subcutaneously to patients with congenital coagulation disorders using a single primary dose and a booster dose at 6 months at a dose of 1440 ElU (in 1 ml) to adults and 720 ElU (in 0.5ml) in children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41124 |
| Study title: Administration of an Inactivated Hepatitis A Vaccine to Healthy Children Attending Day Care Centers |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41111 |
| Study title: Comparison of anti-IgE and anti-HLA immune responses after HAVRIX versus VAQTA inactivated Hepatitis A vaccine - "Comparison of immunogenicity of two hepatitis A vaccines - VAQTA® and HAVRIX® - in young adults." Ashur, Y., et al., Vaccine 17: 2290-2296, 1999 ) |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41465 |
| Study title: Evaluation of the safety, immunogenicity and protective efficacy of an inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41115 |
| Study title: Hepatitis A vaccine versus immune globulin for postexposure prophylaxis; Hepatitis A vaccine versus immune globulin for postexposure prophylaxisUniversity of Michigan sponsored study performed in Kazakhstan Publication Citation: Hepatitis A Vaccine versus Immune Globulin for Postexposure Prophylaxis. Victor, J.C., et al., N. Engl. J. Med. 357 (17): 1685-1694, 2007 |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41468 |
| Study title: Letson GW et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsJ Pediatr 2004;144:327-32Letson GW et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsJ Pediatr 2004;144:327-32 |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41112 |
| Study title: Local Registration Study - Russia |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41462 |
| Study title: Open multicentric study of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41109 |
| Study title: Open study of the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine administered to hemophiliac patients following the schedule 0, 1 months with a booster at 6 months.. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41122 |
| Study title: Open study of the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine administered to hemophilic patients following the schedule 0, 1 months with a booster at 6 months. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41123 |
| Study title: Open study to evaluate the immunogenicity and reactogenicity of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per ml dose injected according to a 0, 12 month schedule in healthy adolescents. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21206 |
| Study title: Randomised clinical study to assess immunogenicity and reactogenicity of SmithKline Beecham¿s inactivated Hepatitis A-Vaccine Havrix 1440 in healthy adolescents from their completed 14th to their completed 17th year of life, administered according to the schedule 0-6 or 0-12 months, |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21207 |
| Study title: Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391)Marchetti−F. Ibuprofene in pediatrics. {MED−BAMBINO}, 30 JUN 2001, Vol/Iss/Pg. 20/6 (387−391) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29720 |
| Study title: Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41Marriott−S−C et al. A dose ranging study of ibuprofen suspension as an antipyretic. {Arch−Dis−Child}, Sep 1991, vol. 66, no. 9, p. 1037−41 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29721 |
| Study title: Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18)Marriott−S−C, Stephenson−T−J. A double−blind dose−ranging trial with paediatric ibuprofen. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (15−18) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29722 |
| Study title: Mise au point sur la sécurité de l'ibuproféne à dose antalgique - N. Moore et al. - 1996 (Thérapie vol 51) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation - Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29652 |
| Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Pseudoephedrine HCl Suspension in Children |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 97-024.pdf |
| View full study record |
| Document reference: 29648 |
| Study title: Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Psuedoephedrine HCl Suspension in Children. Aug 1999.Multiple-Dose Pharmacokinetic Study of an Ibuprofen-Psuedoephedrine HCl Suspension in Children. Aug 1999. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29725 |
| Study title: Antipyretic effects of indomethacin in acute infectious diseases--a double blind testa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29822 |
| Study title: Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29823 |
| Study title: Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29824 |
| Study title: Azapropazone versus indomethacin in a double blind test with patients with ankylosing spondylitisa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29825 |
| Study title: Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29826 |
| Study title: Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29827 |
| Study title: Changes in cerebral, renal and mesenteric blood flow velocity during continuous and bolus infusion of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29828 |
| Study title: Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29829 |
| Study title: Clinical and laboratory observations: Successful treatment of Finnish congenital nephrotic syndrome with captopril and indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29830 |
| Study title: Clinical and objective assessments of naproxen through 5 years of clinical experience. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29831 |
| Study title: The spectrum of antihistamines adversely affecting pulmonary function in asthmatic children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29330 |
| Study title: The therapeutic effectiveness of nitrous oxide and chloral hydrate administered orally, rectally, and combined with hydroxyzine for pediatric dentistry. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29305 |
| Study title: The use of a tranquilizer in the management of behavior problems in a private pediatric practice. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29309 |
| Study title: The use of hydroxyzine hydrochloride (atarax) as a sedative agent in paediatric dentistry. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91B0814.pdf |
| View full study record |
| Document reference: 29269 |
| Study title: The use of Marax in the treatment of bronchial asthma. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B2841.pdf |
| View full study record |
| Document reference: 29283 |
| Study title: Tranquilisers – their present status in therapeutics. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D1513.pdf |
| View full study record |
| Document reference: 29359 |
| Study title: Treatment of arrhythmias during cardiac catheterisation of children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): RAD90J0513P.pdf |
| View full study record |
| Document reference: 29233 |
| Study title: Treatment of asthma with combined hydroxyzine-theophylline- ephedrine |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29256 |
| Study title: Treatment of secretory otitis media with local instillation of hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE94C2105.pdf |
| View full study record |
| Document reference: 29353 |
| Study title: Uber die klinische bedeutung der ataraktika “tranquillanten” unter besonderer berucksichtigung ihrer anwendung in der kinderheilkunde |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29222 |
| Study title: Urticaria cronica. Caracteristicas, diagnostico y tratamiento. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS92M2124.pdf |
| View full study record |
| Document reference: 29360 |
| Study title: Urticaria in thai children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D1427.pdf |
| View full study record |
| Document reference: 29357 |
| Study title: Use of intravenously given hydroxyzine for simple pain-pro- ducing office procedures |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92A2427.pdf |
| View full study record |
| Document reference: 29241 |
| Study title: Visual compatibility of hydroxyzine hydrochloride with various antineoplastic agents. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29299 |
| Study title: Zur pharmakotherapie kindlicher verhaltensstorungen. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): CD59M152P.pdf |
| View full study record |
| Document reference: 29267 |
| Study title: Buscopan plus (Buscopan-paracetamol-combinations film-coated tablets, suppositories, paediatric solution IK 19, IK 26). |
| Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
| Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U82-0481_synopsis.pdf |
| View full study record |
| Document reference: 47385 |
| Study title: Comparative safety and immunogenicity study of diphtheria, tetanus, acellular pertussis, poliomyelitis vaccine (DTacP-IPV) and diphtheria, tetanus, whole-cell pertussis, poliomyelitis vaccine (TETRACOQ®) given as a second booster to 4- to 7-year-old children |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41193 |
| Study title: Ketoconazole shampoo in the treatment of dandruff and/or seborrheic dermatitits: a randomized, double-blind placebo-controlled comparison of different concentrations |
| Active substance: KETOCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30831 |
| Study title: Th 1165a a metered aerosol. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30576 |
| Study title: Th 1165a metered aerosol (0.2 mg/puff): therapeutic assessment in children with bronchial asthma and spastic bronchitis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30579 |
| Study title: Th 1165a metered aerosol: pediatrics / therapeutic observations. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30578 |
| Study title: Th 1165a metered aerosol: therapy. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30580 |
| Study title: TH 1165a metered dose aerosol 0.2 mg per spray - F 9123538 Therapeutic observations in pediatrics. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30577 |
| Study title: Th 1165a suppositories 7.5 mg. An assessment of the effect of Th 1165a suppositories in school children during the night on the frequency of acute attacks of bronchospasm, on chronic dyspnoea, and the necessity for adjunctive therapy. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30585 |
| Study title: Th 1165a suppositories: Summary of the results of clinical trial. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30602 |
| Study title: Th-1165a-suppositories: summary of results of the clinical trial for medical approval. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30583 |
| Study title: The bronchodilator efficacy of Berotec or ephedrine. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30652 |
| Study title: The bronchodilator efficacy of Berotec tablets as measured after single doses (day 1) by comparison with the standard therapeutic agent (ephedrine) with particular emphasis on onset of action and duration of action. 2. The persistence of bronchodila... |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30651 |
| Study title: The clinical comparison of Fenoterol and salbutamol administered by inhalation. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30607 |
| Study title: The effect of administration technique on bronchodilator response to fenoterol in a metered dose inhaler. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30613 |
| Study title: The site of obstruction in exercise-induced asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30669 |
| Study title: Therapeutic testing for several weeks in bronchospastic children: daily use of Sch 1000 metered dose aerosol. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30564 |
| Study title: Therapeutic testing for several weeks in bronchospastic children: daily use of Sch 1000 metered dose aerosol. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U72-0222_synopsis.pdf |
| View full study record |
| Document reference: 30663 |
| Study title: Therapeutic testing of several days' duration, in bronchospastic children: daily administration of multiple doses of Sch 1000 metered-dose aerosol. Duration of study: 1 - 20 days. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30565 |
| Study title: Therapeutic testing of several days' duration, in bronchospastic children: daily administration of multiple doses of Sch 1000 metered-dose aerosol. Duration of study: 1 - 20 days. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U72-0227_synopsis.pdf |
| View full study record |
| Document reference: 30664 |
| Study title: Therapy with nebulised fenoterol 0.5% in asthmatic patients in the children's hospital Josefina Martinez de Ferrari. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30639 |
| Study title: Cavadini C, Siega-Riz AM, Popkin BM. US adolescent food intake trends from 1965 to 1996. Arch Dis Child. 2000 Jul; 83(1):18-24. |
| Active substance: Ispaghula seed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21223 |
| Study title: Cavadini C, Siega-Riz AM, Popkin BM. US adolescent food intake trends from 1965 to 1996. Arch Dis Child. 2000 Jul; 83(1):18-24. |
| Active substance: Ispaghula seed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40032 |
| Study title: .Hampl JS, Betts NM, Benes BA. The "age+5" rule: comparasion of dietery fiber intake among 4- to 10-year-old children. J Am Diet Assoc. 1998 Dec; 98(12):1418-23. |
| Active substance: Ispaghula seed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40033 |
| Study title: Leis R, Pavon P, Queiro T, Recarey D, Tojo R. Atherogenic diet and blood lipidprofile in children and adolescents from Galicia, NW Spain. The Galinut Study. Acta Paediatr. 1999 Jan; 88(1):19-23. |
| Active substance: Ispaghula seed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21224 |
| Study title: Randomized clinical study to assess immunogenicity and reactogenicity of SmithKline Beecham¿s inactivated Hepatitis A-Vaccine Havrix 720 in healthy adolescents from their completed 12th to their completed 15th year of life, administered according to the schedule 0-6 or 0-12 months. |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41125 |
| Study title: A Phase III randomised, open, controlled study to assess the safety and immunogenicity of concomitant administration of virosomal hepatitis A vaccine (Epaxal®) with DTPaHibIPV, OPV and MMR vaccines vs. non-concomitant administration in 12-15 month old children. |
| Active substance: Inactivated hepatitis A virus (strain RG-SB). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41087 |
| Study title: Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30003 |
| Study title: Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30004 |
| Study title: Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30005 |
| Study title: Prostaglandin synthetase inhibitors in treatment of primary dysmenorrheaa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30006 |
| Study title: Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30007 |
| Study title: Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30008 |
| Study title: Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30009 |
| Study title: Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30010 |
| Study title: Regional hemodynamic effects of dopamine in the indomethacin-treated preterm infant |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30011 |
| Study title: Renal functional impairment in preterm neonates related to intrauterine indomethacin exposure |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30012 |
| Study title: Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30014 |
| Study title: Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30015 |
| Study title: Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30016 |
| Study title: Risk period for intraventricular hemorrhage of the preterm neonate is independent of gestational age. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30017 |
| Study title: Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29832 |
| Study title: Clinical evaluation of indomethacin-containing patches for osteoarthritis and extremity trauma. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29833 |
| Study title: Clinical trials of intravenous indomethacin for closure of the patent ductus arteriosus |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29835 |
| Study title: Clinical trials with acemetacin on children and adolescents (author's transl)a |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29836 |
| Study title: Closure of the arterial canal induced by indometacin in premature neonates with severe congestive heart failure |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29837 |
| Study title: Cognitive outcome at 4 1/2 years of very low birth weight infants enrolled in the multicenter indomethacin intraventricular hemorrhage prevention trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29838 |
| Study title: Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29839 |
| Study title: Comparative effectiveness of voltaren and indomethacin in rheumatoid arthritis (according to the data of a double-blind study)a |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29840 |
| Study title: A Phase 1, Open-label Study Evaluating the Safety and Pharmacokinetics of a Single Intravenous Infusion of a Chimeric Monoclonal Antibody to Human TNFα (Infliximab) in Pediatric Inflammatory Bowel Disease Subjects Receiving Maintenance Treatment with Infliximab |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47439 |
| Study title: A Randomized, Double-blind Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Subjects with Polyarticular Juvenile Rheumatoid Arthritis |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47436 |
| Study title: A Randomized, Double-blind Study of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab) in Combination with Methotrexate for the Treatment of Subjects with Polyarticular Juvenile Rheumatoid Arthritis • OLE study report synopsis |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47437 |
| Study title: A Randomized, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab, REMICADE®) in Pediatric Subjects with Moderate to Severe Crohn’s Disease |
| Active substance: Infliximab |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47438 |
| Study title: A phase III double-blind, randomized, multicentric, comparative vaccination study of the immunogenicity and reactogenicity of a thiomersal-free formulation of Influsplit SSW® 2003/2004 versus the standard formulation of Influsplit SSW® 2003/2004 in children aged from 6 months to <6 years. |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): 100351 (FLU-056) synopsis.pdf |
| View full study record |
| Document reference: 48371 |
| Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability an immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years). |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47149 |
| Study title: A phase III, open-label, multi-centre study to evaluate the safety, tolerability and immunogenicity of CSL´s influenza vaccine in two paediatric populations, Group A (≥ 6 month to ≥ 3 years) and Group B (≥ 3 years to < 9 years). |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47150 |
| Study title: Comparative safety and immunogenicity study of diphtheria, tetanus, acellular pertussis, poliomyelitis vaccine (DTacP-IPV) and diphtheria, tetanus, poliomyelitis vaccine (DT POLIO®) administered as a booster in children aged 8 to 12 years |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41197 |
| Study title: Comparison of antibody response to killed Poliovirus (KPV) produced on vero cell substrate (MERIEUX) and reference standard KPV produced on monkey kidney cell substrate (RIJKS) |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41200 |
| Study title: Comparison of antibody response to killed poliovirus (KPV) produced on Verol cell substrate (Merieux) and reference standard KPV produced on monkey kidney cell substrate (RIJKS) |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41185 |
| Study title: Comparison of immungenicity of oral and inactivated polio vaccines in Indian infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41186 |
| Study title: Comparison of immunogenicity of oral and inactivated polio vaccines in Indian infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41201 |
| Study title: Comparison of the immunogenicity of an adsorbed tetanus diphtheria (low toxoid content) poliomyelitis (inactivated viruses) vaccine with that of an adsorbed tetanus-diphtheria (low toxoid content) vacine administered as boosters to healthy children aged 6 to 9 years |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41198 |
| Study title: Concomitant administration of a Haemophilus influenzae type b - Hepatitis b vaccine with a diphtheria, tetanus, acellular pertussis, inactivated polio combination vaccine in healthy infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41191 |
| Study title: Diminution of the anti-polyribosylribito phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae Type b vaccine by concurrent inactivated poliovirus vaccination |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41205 |
| Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41210 |
| Study title: Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29901 |
| Study title: Salbutamol Powder, Administered via a Multidose and a Single-Dose Powder Inhaler, in the Prevention of Exercise-Induced Asthma in ChildrenPEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY Volume 9, Number 3, 1995, Col et al. |
| Active substance: SALBUTAMOL |
| Study summary document link (including results): 15.01-CT-02-92 publication.pdf |
| View full study record |
| Document reference: 49210 |
| Study title: Leis R, Pavon P, Queiro T, Recarey D, Tojo R. Atherogenic diet and blood lipidprofile in children and adolescents from Galicia, NW Spain. The Galinut Study. Acta Paediatr. 1999 Jan; 88(1):19-23. |
| Active substance: Ispaghula seed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40034 |
| Study title: Saldanha LG. Fiber in the diet of US children: results of national surveys. Paediatrics. 1995 Nov; 96 (5 Pt 2): 994-7. |
| Active substance: Ispaghula seed |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40035 |
| Study title: Initial experience with Isradipine for the treatment of hypertension in children Strauser LM et al, South Med J; 93: 287-293; 2000Initial experience with Isradipine for the treatment of hypertension in children Strauser LM et al, South Med J; 93: 287-293; 2000 |
| Active substance: ISRAPIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30774 |
| Study title: Isradipine therapy in hypertensive pediatric patients Johnson CE et al, Ann Pharmacother; 31: 704-707; 1997Isradipine therapy in hypertensive pediatric patients Johnson CE et al, Ann Pharmacother; 31: 704-707; 1997 |
| Active substance: ISRAPIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30773 |
| Study title: Isradipine treatment of hypertension in children: a single-center experience Flynn JT, Pediatr Nephrol.; 17 (9): 748-53; 2002Isradipine treatment of hypertension in children: a single-center experience Flynn JT, Pediatr Nephrol.; 17 (9): 748-53; 2002 |
| Active substance: ISRAPIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30775 |
| Study title: Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451)Adame G Oral itraconazole in the treatment of tinea manus and tinea pedis. Clinical summary on R51211, August 1987. (14-54 years, LMD56451) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30793 |
| Study title: Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929)Alcantara R. Treatment of dermatomycosis with 100 mg itraconazole o.d. during fifteen or thirty days. Janssen Research Foundation Products Information service. Clinical research report, February 1988. (5-90 years, LMD59929) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30779 |
| Study title: An open evaluation of itraconazole oral solution in paediatric patients undergoing treatment for haematological malignancy or solid tumour. Safety findings. |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD129189_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 45124 |
| Study title: An open study on the pharmacokinetics and safety of itraconazole oral solution in 24 cystic fibrosis subjects |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): LMD172168_Interventional_Itraconazole.xls |
| View full study record |
| Document reference: 47581 |
| Study title: Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411)Boogaerts MA, Verhoef GE, Zachee P, Demuynck H, Verbist L, De Beulke K. Antifungal prophylaxis with itraconazole in prolonged neutropenia: Correlation with plasma levels. Proceedings of the 2nd internationa symposium on itraconazole, Antwerp, Belgium, June 22-23, 1989. Mycoses 32 (suppl.1), p.103-108, 1989. (9-78 years, LMD69411) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30811 |
| Study title: Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442)Coninx S, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea Corporis and tinea cruris. Clinical research report on R051211 no-71, May 1987. (2-78 years, LMD56442) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30784 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27674 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN LIFE THREATENING DEEP MYCOSES |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28036 |
| Study title: Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30018 |
| Study title: School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30019 |
| Study title: Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30020 |
| Study title: Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30021 |
| Study title: A comparison of the child’s behavior between two groups of oral sedative drugs. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPZ92F0536.pdf |
| View full study record |
| Document reference: 29347 |
| Study title: A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29280 |
| Study title: A prospective study of 2 sedation regimens in children: chloral hydrate, meperidine, and hydroxyzine versus midazolam, meperidine, and hydroxyzine. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE07C2107.pdf |
| View full study record |
| Document reference: 29340 |
| Study title: A randomized double-blind trial of chloral hydrate/ hydroxyzine versus midazolam/acetaminophen in the sedation of pediatric dental outpatients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE97G2901.pdf |
| View full study record |
| Document reference: 29321 |
| Study title: A randomized, controlled, crossover trial of oral midazolam and hydroxyzine for pediatric dental sedation. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE04B1014.pdf |
| View full study record |
| Document reference: 29244 |
| Study title: A retrospective study of chloral hydrate, meperidine, hydroxyzine, and midazolam regimens used to sedate children for dental care. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE01A1503.pdf |
| View full study record |
| Document reference: 29366 |
| Study title: A specific antihistaminic premedication anti H1 and anti H2 for pediatric anesthesia. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29292 |
| Study title: A study of 3 preoperative sedative combinations. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29354 |
| Study title: A study of quadriceps contracture-causing factor by the analysis of muscle injection according to medical records. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): RACH90J0558P.pdf |
| View full study record |
| Document reference: 29306 |
| Study title: A study to compare the effectiveness of temazepam and a chloral hydrate/hydroxyzine combination in sedating paediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE94F2815.pdf |
| View full study record |
| Document reference: 29356 |
| Study title: Acute urticaria in infancy and early childhood: a prospective study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE99E3106.pdf |
| View full study record |
| Document reference: 29307 |
| Study title: Adverse central nervous system effects of older antihistamines in children. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96K0715.pdf |
| View full study record |
| Document reference: 29344 |
| Study title: Adverse events and outcomes of conscious sedation for pediatric patients – study of an oral sedation regimen. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE02A0402.pdf |
| View full study record |
| Document reference: 29289 |
| Study title: A phase IV, open study to evaluate the reactogenicity and immunogenicity of SmithKline Beecham Biologicals' influenza split vaccine in children aged 6-36 months |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): 218352-003 (FLUARIX-003) synopsis.pdf |
| View full study record |
| Document reference: 48372 |
| Study title: Clinical Analysis of Influsplit SSW® 94 1 Fluarix in children of the ages of 3-6 years |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): Influ 02 94 _Synopsis.pdf |
| View full study record |
| Document reference: 48375 |
| Study title: Clinical Trial of the Reactogenicity and Immunogenicity of INFLUSPLIT SSW®92 in children aged from 1 to 4 years |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): INFLU 03 92 INFLU 04 92 synopsis.pdf |
| View full study record |
| Document reference: 48376 |
| Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 2000/2001 in children aged from 6 month to <6 years |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): 218352-044 (Influ 03-2000) synopsis.pdf |
| View full study record |
| Document reference: 48374 |
| Study title: Open immunization study to determine the reactogenicity and immunogenicity of Influsplit SSW® 98/99 in children upon completion of 6 month of live till completion of 18 years |
| Active substance: Influenza Vaccine (Split Virion, Inactivated) |
| Study summary document link (including results): 218352-031 (Influ 02-98) synopsis.pdf |
| View full study record |
| Document reference: 48373 |
| Study title: A Randomized, Endpoint-blind, Parallel Group Study to Demonstrate the Non-inferiority of the Subunit Influenza Vaccine Influvac® to the Subunit Influenza Vaccine Agrippal® in Healthy Children, Adults and Elderly in China |
| Active substance: influenza vaccine (subunit, inactivated) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47501 |
| Study title: Reactogenicity and Immunogenicity of InfluvacR in high-risk children between 6 months and 4 years of age. |
| Active substance: influenza vaccine (subunit, inactivated) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47502 |
| Study title: Hydroxyzine hydrochloride (Atarax). A new tranquilizer. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): CE56L121.pdf |
| View full study record |
| Document reference: 29323 |
| Study title: Hydroxyzine hydrochloride and methylphenidate hydrochloride in the management of enuresis |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29232 |
| Study title: Hydroxyzine hydrochloride in the management of children with behavior problems. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29298 |
| Study title: Hydroxyzine hydrochloride in treatment of behavioral disturbances in mentally retarded children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29262 |
| Study title: Hydroxyzine in anaesthesia premedication |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29315 |
| Study title: Hydroxyzine in the treatment and management of institutio- nalized mental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92A2108.pdf |
| View full study record |
| Document reference: 29236 |
| Study title: Hydroxyzine in the treatment of rheumatic chorea in children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29252 |
| Study title: Hydroxyzine prevents isolation-induced vocalization in guinea pig pups: comparison with chlorpheniramine and immepip. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE04K0103.pdf |
| View full study record |
| Document reference: 29287 |
| Study title: Hydroxyzine syrup (atarax) in the management of pediatric behavior problems |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29251 |
| Study title: Hydroxyzine versus cetirizine in the treatment of atopic dermatitis in children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DIE90J061 - Cetirizine.pdf |
| View full study record |
| Document reference: 29220 |
| Study title: Factors influencing successful closure with indomethacin of the patent ductus arteriosus in premature infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29903 |
| Study title: Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29904 |
| Study title: Flurbiprofen in the treatment of ankylosing spondylitis. A comparison with indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29905 |
| Study title: Furosemide does not prevent indomethacin-induced renal side effects in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29906 |
| Study title: Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29907 |
| Study title: Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29908 |
| Study title: High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29909 |
| Study title: Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29910 |
| Study title: Ibuprofen vs indomethacin for treatment of PDA in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29911 |
| Study title: Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29912 |
| Study title: Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29914 |
| Study title: Increase in serum digoxin concentrations after indomethacin therapy in a full-term neonate |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29915 |
| Study title: Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29916 |
| Study title: Indometacin as prophylaxis for heterotopic ossification after the operative treatment of fractures of the acetabulum. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29917 |
| Study title: Indometacin therapy for idiopathic dysmenorrhea (author's transl)a |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29918 |
| Study title: Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29919 |
| Study title: Götte and Roschke A supportive measure in the treatment of acute infections of the respiratory tract in children with recurring infections of the upper respiratory tract; päd (7) 2001 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39716 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27676 |
| Study title: SAFETY AND EFFECTIVENESS OF FLUCONAZOLE IN PATIENTS WITH NON-LIFE THREATENING MYCOSIS WHO CANNOT BE TREATED ADEQUATELY TREATED WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28038 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27651 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN CANCER PATIENTS WITH OROPHARYNGEAL AND OESOPHAGEAL CANDIDIASIS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28013 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27675 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE THREATENING DEEP MYCOSES. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28037 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27449 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH LIFE-THREATENING DEEP MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27813 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27426 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27791 |
| Study title: SAFETY AND EFFICACY OF FLUCONAZOLE PO VS. AMPHOTERICIN B SUSPENSION IN PREVENTION OF CANDIDIASIS IN LEUKEMIC PATIENTS UNDERGOING CHEMOTHERAPY. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27961 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27419 |
| Study title: Fluoride tablets in prevention of tooth decayG. Stolte, Aus dem Gesundheitsamt der Stadt SolingenM.Hoskova 1968. Ceskoslovenska pediatrie praha |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1968-hoscowa-Fluoride tablets in prevertion od tooth decay.pdf |
| View full study record |
| Document reference: 48784 |
| Study title: Fluoride toothpastes for preventing dental caries in children and adolescents2009-marinho, the cochrane collaboration |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2009-marinho-fluoride toothpastes for preventing dental caries in children and adolescents.pdf |
| View full study record |
| Document reference: 49091 |
| Study title: Clinical and spirometric evaluation of ipratropium bromide and salbutamol in children with bronchitis and preceding asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U87-0035_synopsis.pdf |
| View full study record |
| Document reference: 30689 |
| Study title: Alphaprodine-hydroxyzine sedation technique for children: a conservative approach. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29295 |
| Study title: An evaluation of hydroxyzine hydrochloride as a preopera- tive and post-operative adjunct in dental procedures. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29235 |
| Study title: An evaluation of the efficacy of hydroxyzine (Atarax-Vistaril) in controlling the behavior of child patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29288 |
| Study title: An investigation into the therapeutic action of hydroxyzine (atarax) in the treatment of nervous disorders and the control of the tobacco-habit. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D1425.pdf |
| View full study record |
| Document reference: 29358 |
| Study title: Antihistamine selection in patients with allergic rhinitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29361 |
| Study title: A double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental painA double-blind single dose study comparing the safety and efficacy of ibuprofen 200 mg, ibuprofen 400 mg, naproxen 200 mg, naproxen 400 mg and placebo in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29675 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638A, Unpublished Report TA93. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 86-638A.pdf |
| View full study record |
| Document reference: 29645 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638B, Unpublished Report TA94. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 86-638B.pdf |
| View full study record |
| Document reference: 29646 |
| Study title: A Double-Blind, Parallel Study to Compare the Efficacy and Side Effects of an Ibuprofen 400 mg/Pseudoephedrine 60 mg Combination, An Ibuprofen 200 mg/Pseudoephedrine 30 mg Combination, and Placebo in the Treatment of Sinus Headache. Protocol 86-638C, Unpublished Report TA95 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): ibuprofen_pseudoephedrine 86-638C.pdf |
| View full study record |
| Document reference: 29647 |
| Study title: A double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrheaA double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29676 |
| Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgeryA double-blind, single dose evaluation of the comparative analgesic efficacy of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29677 |
| Study title: A double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgeryA double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgery |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29678 |
| Study title: Hydroxyzine: pharmacokinetics and antipruritic effect in children with atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29342 |
| Study title: Idiopathic anaphylaxis: a series of 325 cases. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE95L1361.pdf |
| View full study record |
| Document reference: 29248 |
| Study title: Interaction between sedative premedicants and ketamine in man and in isolated perfused rat livers. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29294 |
| Study title: Interaction of ephedrine and theophylline. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29362 |
| Study title: Intranasal midazolam better at effecting amnesia after sedation than oral hydroxyzine: a pilot study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE96L1314.pdf |
| View full study record |
| Document reference: 29285 |
| Study title: Is chloral hydrate/hydroxyzine a good option for paediatric dental outpatient sedation ? |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE99C1134.pdf |
| View full study record |
| Document reference: 29227 |
| Study title: L’hydroxyzine dans la therapeutique des begaiements. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPF92D2132.pdf |
| View full study record |
| Document reference: 29369 |
| Study title: L’hydroxyzine dans le traitement des affections allergiques. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS92D0750.pdf |
| View full study record |
| Document reference: 29326 |
| Study title: L’idroxizina cloridrato nella pratica anestesiologica |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPI92A2223.pdf |
| View full study record |
| Document reference: 29240 |
| Study title: Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29726 |
| Study title: Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043)Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29729 |
| Study title: Over - the - counter Analgesics and Antipyretics : A critical Assessment - Elliot V. Hersh et al. - 16/02/2000 (Clinical Therapeutics / vol. 22, n°5) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation - Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29654 |
| Study title: Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140)Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29730 |
| Study title: Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728)Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29731 |
| Study title: Taylor et al. Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children.; JAMA December 3, 2003-Vol 290, No. 21 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39717 |
| Study title: Wber et al. Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children; THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39718 |
| Study title: Künzer,Retrospective investigation on children (2-12 years) concerning safety and tolerability and dosage of Echinacin Lozenges; unpublished report (1997) |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39722 |
| Study title: Schöneberger Einfluß der immunstimulierenden Wirkung von Preßsaft aus Herba Echinaceae purpureae auf Verlauf und Schweregrad von Erkältungskrankheiten (EC31J0.05)Z. für Immunbiologie in der Praxis, 2 (8), 1992, 18-22 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39721 |
| Study title: Taylor et al. Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children; JAMA December 3, 2003-Vol 290, No. 21 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39719 |
| Study title: Weber et al. Echinacea purpurea for Prevention of Upper Respiratory Tract Infections in Children; THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 11, Number 6, 2005, pp. 1021–1026 |
| Active substance: (HERB) Purple cone flower, dried pressed juice, 31.5 - 53.6 : 1, 85 % |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39720 |
| Study title: Effect of valerian, Valeriana edculis, on sleep difficulties in children with intellectual deficits: randomised trial.; Francis AJ, Dempster RJ. Phytomedicine 2002 May; 9(4): 273-279 |
| Active substance: (HERB) Valeriana officinalis L. extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39723 |
| Study title: Sleep disorders in Children. Observational study with a high dosage valerian extract.; Hintelmann C. Schweiz. Z. Ganzheitsmed. 2002;14( ): 404-407 |
| Active substance: (HERB) Valeriana officinalis L. extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39724 |
| Study title: A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children; Article published: Mueller SF; Klement S. Phytomedicine (Jena) 2006;13(6): 383-387 |
| Active substance: (HERB) Valeriana officinalis L. extract Melissa officinalis L. extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39725 |
| Study title: HX181-Appréciation en ouvert de l'activité et de la tolérance héxomedine solution chez l'enfant (dossier de modification de formule du 30/10/87) -partie IVB - Paupe and Prost - 27/04/1986Kettelhut, B. V., Berkebile, C., Bradley, D., and Metcalfe, D. D. Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Disease, Bethesda, Md 20892 A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis J.Allergy Clin.Immunol. 1989;83:866-870. |
| Active substance: HEXAMIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29119 |
| Study title: HX181-Open study to assess the activity and tolerance of hexomedine solution in children (french dossier-change in formulation-30/10/87)-partie IVB - Paupe and Prost - 27/04/1986Simons, F. E., Simons, K. J., Becker, A. B., and Haydey, R. P. Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis J.Pediatr. 1984;104:123-127. |
| Active substance: HEXAMIDINE |
| Study summary document link (including results): Hexamidine STUDY 0000103117.xls |
| View full study record |
| Document reference: 29120 |
| Study title: Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27.Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination. Ruza F, Alvarado F, Herruzo R, Delgado MA, García S, Dorao P, Goded F. Eur J Epidemiol. 1998 Oct;14(7):719-27. |
| Active substance: HEXETIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29121 |
| Study title: Thomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15sThomas JG et al. Managing the complexity of a dynamic biofilm. J Am Dent Assoc 2006; 137: 10s-15s |
| Active substance: HEXETIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29122 |
| Study title: Observational study Angina-Gastreu N R1 |
| Active substance: (HMP) Apis D4, Belladonna D4, Calcium iodatum D4, Hepar sulfuris D12, Kalium bichromicum D4, Lachesis D12, Marum verum D6, Mercurius sublimatus corrosivus D5, Phytolacca D4 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39731 |
| Study title: Clinical trial of a new bronchodilator fenoterol (Berotec) administered by inhalation to asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30588 |
| Study title: Clinical trial on Berotec syrup for bronchial Asthma in children (well-controlled comparative trial). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30609 |
| Study title: Clinical trial on Berotec syrup in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30608 |
| Study title: Clinical trial with Th 1165a metered aerosol in children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30600 |
| Study title: Combivent vs. salbutamol in patients with metacholine-induced bronchospasm |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U00-0040_synopsis.pdf |
| View full study record |
| Document reference: 30659 |
| Study title: Comparative double-blind study of the bronchodilating effect of ipratropium bromide administered as inhalation powder with two different powder inhalators in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30552 |
| Study title: Comparative double-blind study of the bronchodilating effect of ipratropium bromide administered as inhalation powder with two different powder inhalators in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U97-0051_synopsis.pdf |
| View full study record |
| Document reference: 30713 |
| Study title: Comparative study of ipratropium bromide and salbutamol in children with chronic bronchitis and / or asthmatic bronchitis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30551 |
| Study title: Comparative study of ipratropium bromide and salbutamol in children with chronic bronchitis and / or asthmatic bronchitis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U87-0397_synopsis.pdf |
| View full study record |
| Document reference: 30690 |
| Study title: Comparative study with Ipratropium bromide versus Salbutamol in 30 asymptomatiy asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30574 |
| Study title: Comparative study with Ipratropium bromide versus Salbutamol in 30 asymptomatiy asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U84-0911_synopsis.pdf |
| View full study record |
| Document reference: 30679 |
| Study title: Comparison of 2 weeks of therapy with IK 6 and fenoterol administered as a capsule with the aid of a powder inhaler in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30611 |
| Study title: Comparison of 2 weeks of therapy with IK 6 and fenoterol administered as a capsule with the aid of a powder inhaler in children with bronchial asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30675 |
| Study title: Comparison of Ba-253 and Atrovent metered aerosol in exercise-induced asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30566 |
| Study title: Comparison of Ba-253 and Atrovent metered aerosol in exercise-induced asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U78-0018_synopsis.pdf |
| View full study record |
| Document reference: 30666 |
| Study title: Comparison of nebulised fenoterol with that delivered by metered aerosol in children with asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30562 |
| Study title: Comparison of the bronchodilatory effect of nebulised ipratropium bromide and fenoterol in children with acute crisis of asthma. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30632 |
| Study title: Comparison of the bronchospasmolytic action of Berotec and Atrovent inhalation solution in infants |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U86-0413_synopsis.pdf |
| View full study record |
| Document reference: 30618 |
| Study title: Comparison of the bronchospasmolytic action of Berotec and Atrovent inhalation solution in infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30684 |
| Study title: Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6Nahata−M−C et al. Efficacy of ibuprofen in pediatric patients with fever. {Int−J−Clin−Pharmacol−Ther−Toxicol}, Mar 1992, vol. 30, no. 3, p. 94−6 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29583 |
| Study title: A double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headacheA double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headache |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29679 |
| Study title: A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. Feb 1988.A multiple dose study comparing the antipyretic efficacy and safety of 5-7 mg/kg of ibuprofen and 10-15 mg/kg of acetaminophen in febrile children. Feb 1988. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29680 |
| Study title: Fluoride tablets in pre-school age - effect on primary and permanent teethRoland Andersson, Hans Grahnen. Swed Dent J69 137 - 143 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1969-anderesson-Fluoride Tablets in Preschool Age - Effect on Primary and Permanent Teeth.pdf |
| View full study record |
| Document reference: 48767 |
| Study title: Open randomised controlled study to evaluate the safety and immunogenicity of a paediatric dose (0.25 mL) and the standard dose (0.5 mL) of Epaxal® with reference to Havrix Juniror® in healthy children and adolescents (³ 1-16 years) using a 0/6 month schedule. |
| Active substance: Inactivated hepatitis A virus (strain RG-SB). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21201 |
| Study title: Open randomised controlled study to evaluate the safety and immunogenicity of a paediatric dose (0.25 mL) and the standard dose (0.5 mL) of Epaxal® with reference to Havrix Juniror® in healthy children and adolescents (³ 1-16 years) using a 0/6 month schedule. |
| Active substance: Inactivated hepatitis A virus (strain RG-SB). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21202 |
| Study title: Open randomised controlled study to evaluate the safety and immunogenicity of a paediatric dose (0.25 mL) and the standard dose (0.5 mL) of Epaxal® with reference to Havrix Juniror® in healthy children and adolescents (³ 1-16 years) using a 0/6 month schedule. |
| Active substance: Inactivated hepatitis A virus (strain RG-SB). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41086 |
| Study title: Open, controlled randomised multi-centre study to assess and compare local reactions of a single dose of Epaxal® to Havrix Monodose® and Havrix Junior® (where applicable) in parallel-groups. |
| Active substance: Inactivated hepatitis A virus (strain RG-SB). |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41088 |
| Study title: HAB-051 |
| Active substance: inactivated hepatitis a virus and hepatitis b surface antigen (rdna) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41480 |
| Study title: HAB-052 |
| Active substance: inactivated hepatitis a virus and hepatitis b surface antigen (rdna) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41481 |
| Study title: HAB-164 Ext:038 Y10 |
| Active substance: inactivated hepatitis a, hepatitis b recombinant, adsorbed, vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41612 |
| Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
| Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41289 |
| Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
| Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41221 |
| Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
| Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41290 |
| Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months |
| Active substance: INACTIVATED INFLUENZA SPLIT VIRION VACCINE (TRITON X 100) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41291 |
| Study title: Evaluation of safety and immunogenicity of inactivated flu vaccine in children with underlying disease |
| Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41217 |
| Study title: Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29733 |
| Study title: Pharmacokinetics of oral decongestants - Isadore Kanfer et al. - 1993 (Pharmacotherapy ; 13) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29655 |
| Study title: Renal excretion of pseudoephedrine - D. Craig Brater et al - November 1980 ( Clin .Pharmacol.Ther/vol 28, n°5) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29656 |
| Study title: Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427)Starha−J et al. Ibuprofen as an antipyretic drug in childhood. {CESKO−SLOV−PEDIATR}, 1994, Vol/Iss/Pg. 49/7 (424−427) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29739 |
| Study title: The Safety of Antipyretic Medication Use Among Children Less Than Two Years of Age: A Subgroup Analysis of the Boston University Fever Study Data. Dec 1997.The Safety of Antipyretic Medication Use Among Children Less Than Two Years of Age: A Subgroup Analysis of the Boston University Fever Study Data. Dec 1997. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29740 |
| Study title: The safety profile of nonprescription ibuprofen in multiple-dose use : a meta-analysis - David E Kellstein- 1999 (J clin Pharmacol vol 39) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29657 |
| Study title: Visual hallucinations in a toddler : accidental ingestion of a sympathomimetic over-the-counter nasal decongestant - Kurtis L. Sauder et al. 19/09/1999 ( American journal of emergency medecine vol 15 n°5) - Publication in Rhinathiol tablets (ibuprofen/ pseudoephredin) Pharmaco-toxicological & clinical documentation- Poulain Dominique - 04/2001 - |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29658 |
| Study title: Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29841 |
| Study title: Comparative study of the clinical effects of ibuprofen and indomethacin in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29842 |
| Study title: Comparison between fluproquazone and indomethacin in treatment of primary dysmenorrhoea. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29843 |
| Study title: Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29844 |
| Study title: Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29845 |
| Study title: Comparison of single and multiple dose pharmacokinetics using clinical bioequivalence data and Monte Carlo simulations. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29846 |
| Study title: Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29847 |
| Study title: Complex treatment of acne with lipoic acida |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29848 |
| Study title: Clinical trial of IK-26. |
| Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
| Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U80-0288_synopsis.pdf |
| View full study record |
| Document reference: 23094 |
| Study title: Open study with IK19 in 50 children and 50 adults. |
| Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
| Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U79-0384_synopsis.pdf |
| View full study record |
| Document reference: 23092 |
| Study title: Spasmolytic-analgesic efficacy of the substance IK-26 in pediatry. |
| Active substance: HYOSCINE BUTYLBROMIDE AND PARACETAMOL |
| Study summary document link (including results): Hyoscine Butylbromide+Paracetamol_U80-0287_synopsis.pdf |
| View full study record |
| Document reference: 23093 |
| Study title: Commentary on the dosage of Buscopan® injection solution in children and juveniles. Boehringer Ingelheim in-house files, May 1995. |
| Active substance: HYOSCINE-N-BUTYLBROMIDE |
| Study summary document link (including results): Hyoscine Butylbromide_U96-0263_synopsis.pdf |
| View full study record |
| Document reference: 47311 |
| Study title: Expert clinical statement on Buscopan® liquid (hyoscine-N-butylbromide). |
| Active substance: HYOSCINE-N-BUTYLBROMIDE |
| Study summary document link (including results): Hyoscine Butylbromide_U95-0207_synopsis.pdf |
| View full study record |
| Document reference: 47310 |
| Study title: BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solution in children |
| Active substance: HYPERTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29376 |
| Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 |
| Active substance: HYPERTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29378 |
| Study title: Improved Acidosis Correction and Recovery of Mesothelial Cell Mass with Neutral-pH Bicarbonate Dialysis Solution among Children Undergoing Automated Peritoneal Dialysis, 2003 |
| Active substance: HYPERTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29377 |
| Study title: Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
| Active substance: HYPERTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29379 |
| Study title: 4. Arch Pediatr Adolesc Med. 2006 Feb;160(2):197-202. Comment in: Arch Pediatr Adolesc Med. 2006 Jul;160(7):757; Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Sarrell EM, Wielunsky E, Cohen HA4. Arch Pediatr Adolesc Med. 2006 Feb;160(2):197-202. Comment in: Arch Pediatr Adolesc Med. 2006 Jul;160(7):757; Antipyretic treatment in young children with fever: acetaminophen, ibuprofen, or both alternating in a randomized, double-blind study. Sarrell EM, Wielunsky E, Cohen HA |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29613 |
| Study title: A 12-week multicentre double-blind parallel group study comparing the action of Ibuprofen suspension and aspirin in the treatment of active juvenile rheumatoidarthritis. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29398 |
| Study title: A blinded, single-dose, parallel study comparing the antipyretic afficacy and safety of ibuprofen pediatric suspension and acetaminophen suspension in children with fever (AF 96-01) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): Ibuprofen Clinical Trial Summaries.pdf |
| View full study record |
| Document reference: 29533 |
| Study title: A Blinded, Single-Dose, Parallel Study Comparing the Antipyretic Efficacy and Safety of Ibuprofen Paediatric Suspension in Children with Fever |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29538 |
| Study title: A clinical trial to evaluate the efficacy and safety of compound pseudoephedrine hydrochloride sustained release capsule in patients with seasonal allergic rhinitis. Zhonghua Er Bi Yan Hou Ke Za Zhi 2004; 39(9):549-53 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29507 |
| Study title: Nurofen for Children in Febrile Children. Data held in Ukraine. Copy report, Protocol, Ethics and correspondence. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29393 |
| Study title: Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043)Olive−G et al. Randomized, double−blind, multicenter controlled trial of ibuprofen for tonsillitis and pharyngitis in children. {EUR−J−PHARMACOL}, 1990, Vol/Iss/Pg. 183/3 (1042−1043) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29602 |
| Study title: Open dose response study of Ibuprofen in juvenile chronic arthritis Dr P Manners of University of Western Australia, Perth, Australia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29422 |
| Study title: Open dose response study of Ibuprofen in juvenile chronic arthritis Dr P Manners of University of Western Australia, Perth, Australia |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29437 |
| Study title: Open label pharmacokinetic study of a single dose ibuprofen suppository in children with fever |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29474 |
| Study title: Open label pharmacokinetic study of a single dose ibuprofen suppository in children with fever |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29519 |
| Study title: Open Label Pharmacokinetic Study of a Single Dose Ibuprofen Suppository in Children with Fever |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 573-CHC-9127-001.pdf |
| View full study record |
| Document reference: 47458 |
| Study title: Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140)Pardo−J et al. Antipyretic efficacy and tolerability of oral ibuprofen, oral dipyrone and intramuscular dipyrone in children: A randomized controlled trial. {SAO−PAULO−MED−J}, 2006, Vol/Iss/Pg. 124/3 (135−140) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29568 |
| Study title: Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728)Pelen−F et al. Treatment of fever: Monotherapy with ibuprofen. Ibuprofen pediatric suspension containing 100 mg/5 ml(*), multicentre acceptability study conducted in hospital. {ANN−PEDIATR}, 1998, Vol/Iss/Pg. 45/10 (719−728) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29584 |
| Study title: Perrott−D−A et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: A Meta−analysis. {ARCH−PEDIATR−ADOLESC− MED}, 2004, Vol/Iss/Pg. 158/6 (521−526)Perrott−D−A et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: A Meta−analysis. {ARCH−PEDIATR−ADOLESC− MED}, 2004, Vol/Iss/Pg. 158/6 (521−526) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29570 |
| Study title: Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40Phadke−M−A et al. Ibuprofen in children with infective disorders−−antipyretic efficacy. {Br−J−Clin−Pract}, Nov−Dec 1985, vol. 39, no. 11−12, p. 437−40 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29596 |
| Study title: Pharmacodynamics of fever treatment with ibuprofen, acetaminophen and placebo in children. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29459 |
| Study title: Population pk study in premature infants for Ibuprofen Lysine IV |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29419 |
| Study title: Product-Ibuprofen Pediatric 03.88-05.90 Memos, Correspondence, IND memos, AMA Press release (03.21.95), Confidential Inv. Brochure chewable Tablet, Protocol Review (P/2750/0003, P/3100/0162, P/2000/0430), NDA 19-833, NDA 19-842, NDA-833, Arthritis and Rheumatism Journals (01.89) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29564 |
| Study title: Relazione sullo studio di palatabilità di Moment gocce. Valutazione comparativa a Novalgina gocce in soggetti volontari. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29455 |
| Study title: Indomethacin treatment of children suffering from nephrogenic diabetes insipidus or secondary tubulopathy associated with severe polyuria |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29942 |
| Study title: Immunogenicity and safety of P.M.sv, inactivated split influenza vaccine in children between 6 months and 3 years old |
| Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41477 |
| Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 3 to 8 years |
| Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41474 |
| Study title: Immunogenicity and tolerability of the Aventis Pasteur inactivated flu vaccine (IMOVAX GRIPE) in high risk and healthy children aged from 6 to 35 months |
| Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41476 |
| Study title: Safety of inactivated split-virion influenza vaccine administered by the intradermal route in healthy children |
| Active substance: Inactivated Influenza Split Virion Vaccine (Triton x 100) without Thiomersal |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45254 |
| Study title: Immunogenicity and safety of the inactivated, split virion influenza vaccine in high risk children aged from 6 to 35 months |
| Active substance: Inactivated Influenzae Split Virion Vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41475 |
| Study title: EVALUATION OF A NEW COMBINED INACTIVATED DTP-POLIO VACCINE |
| Active substance: Inactivated Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41181 |
| Study title: Successful treatment with indomethacin of three children with Bartter's syndrome |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30022 |
| Study title: Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30023 |
| Study title: Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30024 |
| Study title: Surgical closure of patent ductus arteriosus in 268 preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30025 |
| Study title: Symptomatic patent ductus arteriosus following prophylactic indomethacin. A clinical and biochemical appraisal. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30026 |
| Study title: Systematic review: intravenous Ibuprofen in preterm newborns. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30027 |
| Study title: The effect of antenatal dexamethasone administration on the fetal and neonatal ductus arteriosus. A randomized double-blind study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30028 |
| Study title: The effect of indomethacin on renal function in children with congenital nephrogenic diabetes insipidus |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30029 |
| Study title: The effects of indomethacin on refractoriness following exercise both with and without a bronchoconstrictor response. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30030 |
| Study title: The hemodynamic effects of antenatal indomethacin and a beta-sympathomimetic agent on the fetus and the newborn: a randomized study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30031 |
| Study title: The hemodynamically significant ductus arteriosus in critically ill full-term neonates - Two case reports? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30032 |
| Study title: The patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30033 |
| Study title: Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29849 |
| Study title: Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29850 |
| Study title: Controlled clinical trial of parsalmide in patients with subacute and chronic arthro-neuro-mypathiesa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29851 |
| Study title: Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29852 |
| Study title: Controlled therapeutic trial in IgA glomerulonephritisa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29853 |
| Study title: Decreased plasma glucose after indomethacin therapy in premature infants with patent ductus anteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29854 |
| Study title: Demographic and therapeutic determinants of pain reactivity in very low birth weight neonates at 32 Weeks' postconceptional Age. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29855 |
| Study title: Digoxin-indomethacin interaction |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29856 |
| Study title: Does furosemide prevent the indomethacin induced changes in renal function in prematures? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29857 |
| Study title: Does indomethacin prophylaxis benefit extremely low birth weight infants? Results of a placebo-controlled multicenter trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29858 |
| Study title: Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29859 |
| Study title: Does prophylactic intravenous infusion of indomethacin improve the management of postoperative pain in children? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29860 |
| Study title: Almishari MA. (1994). The Gulf Journal of Dermatology [Kuwait]. February,1(1):30-31. Isoprinosine® therapy in varicellaAlmishari MA. (1994). The Gulf Journal of Dermatology [Kuwait]. February,1(1):30-31. Isoprinosine® therapy in varicella |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30066 |
| Study title: Angioni G, Monni A, Piro S, Serru G. ]. Rassegna Medica Sarda. May 26, 1979; 82(5):1-19. Isoprinosina in the treatment of acute viral hepatitis Angioni G, Monni A, Piro S, Serru G. ]. Rassegna Medica Sarda. May 26, 1979; 82(5):1-19. Isoprinosina in the treatment of acute viral hepatitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30067 |
| Study title: Anlar B, Guven A, Kose G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A. J Neuroimmunol. 2005 Jun;163(1-2):195-8. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.Anlar B, Guven A, Kose G, Okur H, Kose O, Aydin OF, Kabakus N, Altunbasak S, Herguner O, Sonmez M, Serdaroglu A. J Neuroimmunol. 2005 Jun;163(1-2):195-8. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30068 |
| Study title: Anlar B, Yalaz K, Imir T, Turanli G. Eur Neurol. 1994;34(1):44-7. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.Anlar B, Yalaz K, Imir T, Turanli G. Eur Neurol. 1994;34(1):44-7. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30069 |
| Study title: Anlar B, Yalaz K, Oktem F, Kose G. Neurology. 1997 Feb;48(2):526-8. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.Anlar B, Yalaz K, Oktem F, Kose G. Neurology. 1997 Feb;48(2):526-8. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30070 |
| Study title: Inactivated poliovirus vaccine clinical expertise |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41184 |
| Study title: Large scale safety study of the DTacP-IPV {acellular TETRACOQ®) vaccine, administered in combination (one injection site) or in assocation two injection sites) with Haemophilus influenzae Type b vaccine (Act-HIB®) for primary and booster immunisation |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41203 |
| Study title: Merieux inactivated poliovirus vaccine Final report of clinical studies at Suny/Children's hospital, Buffalo, New York & John Hopkins University, Baltimore, Maryland |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41187 |
| Study title: Merieux inactivated poliovirus vaccine Final report of clinical studies at Suny/Children's hospital, Buffalo, New York & John Hopkins University, Baltimore, Maryland |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47469 |
| Study title: Phase III trial on the persistence of antibodies 5 years after a primo-vaccination and 4 years after a first booster with PENTAVAC® vaccine and the immunogenicity and safery of a second booster with TETRAVAC-ACELLULAIRE® vaccine at the ager of 5-6 years |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41194 |
| Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41207 |
| Study title: Randomised open trial of the safety and the immunogenicity of a combined dihtheria, tetanus, acellular pertussis and inactivated polio vaccine (DTacP-IPV) mixed with Haemophilus influenzae type b vaccine (Act-HIB®) given either at 3-5 and 12 or 2-4-6 and 13 months of age |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41190 |
| Study title: Safety and dose-escalation of a tetravalent Meningococcal polysaccharide diphtheria conjugate (A, C, Y AND W-135) vaccine adults, toodlers and infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41204 |
| Study title: Safety and dose-escalation of a tetravalent meningococcal polysaccharide diphtheria conjugate (A, C, Y and W-135) vaccine in adults, toddlers and infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47470 |
| Study title: Safety and immunogenicity of a diphteria, tetanus, acellular pertussis, enhanced inactivated trivalent poliovirus vaccine administered separately or combined with Haemophilus influenzae type b vaccine, to healthy Chilean infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41188 |
| Study title: Double-blind, multinational, multicentre, parallel-group, placebo-controlled design clinical trial of the efficacy and safety of nebulized beclomethasone dipropionate (400 mcg b.i.d.) plus as needed salbutamol versus as needed salbutamol or as needed salbutamol/beclomethasone fixed combination, in the 12-week treatment of young childrem with asthma symptoms.please see report |
| Active substance: SALBUTAMOL AND BECLOMETHASONE DIPROPIONATE |
| Study summary document link (including results): MC.PR.1404.002.05 publication.pdf |
| View full study record |
| Document reference: 49209 |
| Study title: On the use of a Beclometasone Dipropionate-Salbutamol combination in powder form in the topical treatment of allergic bronchial asthma in children: comparison with metered aerosol.Clin .Ped.,1982,64(3),102-116. G.Baldini et al |
| Active substance: SALBUTAMOL AND BECLOMETHASONE DIPROPIONATE |
| Study summary document link (including results): Art 45 EMA Chiesi Paediatric Studies.xls |
| View full study record |
| Document reference: 48879 |
| Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm. Report No. RM2005/00345/00 |
| Active substance: SALMETEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35593 |
| Study title: Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: a randomised, prospective study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29943 |
| Study title: Indomethacin, patent ductus arteriosus, and cerebral blood flow |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29944 |
| Study title: Indomethacin. Clinical and biologic study conducted with 73 patients |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29945 |
| Study title: Infantile cystinosis: A 3-year indomethacin (IDM) treatment |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29946 |
| Study title: Inhaled indomethacin prevents bronchoconstrictive response to distilled water but not to histamine in children with asthma. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29947 |
| Study title: Interaction between flurbiprofen and indomethacin in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29948 |
| Study title: Intestinal perforation after intravenous indomethacin in a premature infant |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29949 |
| Study title: Intestinal perforation following indomethacin therapy for patent ductus arteriosus |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29950 |
| Study title: Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29951 |
| Study title: Intravenous indomethacin as postoperative analgesic in children: acute effects on blood pressure, heart rate, body temperature and bleeding. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29952 |
| Study title: Intravenous indomethacin in the treatment of ureteric colic. A clinical multicentre study with pethidine and metamizol as the control preparations. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29953 |
| Study title: Intravenous indomethacin therapy in infants with a patent ductus arteriosus complicating other congenital heart defects. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29954 |
| Study title: Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29955 |
| Study title: Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29956 |
| Study title: Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29957 |
| Study title: Intraventricular hemorrhage of the preterm neonate: prevention studies. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29958 |
| Study title: Intraventricular hemorrhage of the preterm neonate: prevention studies. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29959 |
| Study title: Irreversible renal failure after indomethacin in steroid-resistant nephrosis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29960 |
| Study title: Is there a relationship between indomethacin-induced reduction in neonatal cerebral blood flow velocity and prostaglandin production? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29961 |
| Study title: The response of normal and asthmatic subjects to prostaglandins E2 and F2alpha by different routes, and their significance in asthma. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30035 |
| Study title: The silent ductus: its precursors and its aftermath. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30036 |
| Study title: The therapy with indomethacin in the Bartter's syndrome interferes with the height growth? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30037 |
| Study title: The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30038 |
| Study title: The use of indomethacin for the prevention of intraventricular brain hemorrhage in high-risk neonates. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30039 |
| Study title: The use of indomethacin in the treatment of pericarditis in childhood |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30040 |
| Study title: Arrhythmias during right heart catheterization |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B2815.pdf |
| View full study record |
| Document reference: 29281 |
| Study title: Assessment of the effects of 2 sedation regimens on cardiopulmonary parameters in pediatric dental patients: a retrospective study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE06J1502.pdf |
| View full study record |
| Document reference: 29238 |
| Study title: Ataraktika in der padiatrie |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPD92A0705.pdf |
| View full study record |
| Document reference: 29228 |
| Study title: Bullous mastocytosis : diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29263 |
| Study title: Cetirizine vs hydroxyzine. Atopic dermatitis in children. Statistical report |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): 9039 - Cetirizine - MRCE91M1101.pdf |
| View full study record |
| Document reference: 29221 |
| Study title: Cleft lip repair using intramuscular hydroxyzine sedation and local anesthesia |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE93L0414.pdf |
| View full study record |
| Document reference: 29277 |
| Study title: Clinical evaluation of hydroxyzine hydrochloride in pediatric anesthesia and its effect on arousal time. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29304 |
| Study title: Clinical evaluation of parenteral hydroxyzine for preoperative medication |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29265 |
| Study title: Clinical experience with hydroxyzine in preanesthetic medication. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92D2157.pdf |
| View full study record |
| Document reference: 29371 |
| Study title: Clinical impressions of hydroxyzine and other tranquilizers in a child guidance clinic. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29317 |
| Study title: Clinical observation to evaluate the patient oriented dosages of Palladon® retard with respect to circadian variations in pain intensity (0.1% of patients 10-19 years) (Germany) |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29374 |
| Study title: Clinical observation utilizing morphine sulfate and hydroxyzine pamoate for sedating apprehensive children for dental procedures: a nine-year report. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE91B2604.pdf |
| View full study record |
| Document reference: 29329 |
| Study title: Antonini G, Stefano GM, Spataro R, Coronel N, Andres FJ, Ink, RL, Scarpiello V, Genoves MH, Natelli C, Buey O, Ink JJornada Medica Argentina. January 27, 1971; 3(343):4-8. NPT10381 and bronchiolitis: new antiviral agentAntonini G, Stefano GM, Spataro R, Coronel N, Andres FJ, Ink, RL, Scarpiello V, Genoves MH, Natelli C, Buey O, Ink JJornada Medica Argentina. January 27, 1971; 3(343):4-8. NPT10381 and bronchiolitis: new antiviral agent |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30071 |
| Study title: Asawanonda P.. 1990. Graduate School of Chulalongkorn University Treatment of multiple warts with Isoprinosine: an open studyAsawanonda P.. 1990. Graduate School of Chulalongkorn University Treatment of multiple warts with Isoprinosine: an open study |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30072 |
| Study title: Aydin OF, Senbil N, Gurer YK. J Child Neurol. 2006 Mar;21(3):256-60. Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing PanencephalitisAydin OF, Senbil N, Gurer YK. J Child Neurol. 2006 Mar;21(3):256-60. Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing Panencephalitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30073 |
| Study title: Aydin OF, Senbil N, Kuyucu N, Gurer YK. J Child Neurol. 2003 Feb;18(2):104-8. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis.Aydin OF, Senbil N, Kuyucu N, Gurer YK. J Child Neurol. 2003 Feb;18(2):104-8. Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30074 |
| Study title: Azzara A, Meozzi A, Carulli G, Margelli A, Tangheroni F, Serravalle E, Ambrogi F. Presented at Session 18: Italian Society of Chemotherapy, 13th National Congress; June 9-11, 1983; Catania, Italy; 2(3):399-400. Normalization of neutrophilic functions in children suffering from recurrent chronic infections after cyclic therapy with methisoprinol.Azzara A, Meozzi A, Carulli G, Margelli A, Tangheroni F, Serravalle E, Ambrogi F. Presented at Session 18: Italian Society of Chemotherapy, 13th National Congress; June 9-11, 1983; Catania, Italy; 2(3):399-400. Normalization of neutrophilic functions in children suffering from recurrent chronic infections after cyclic therapy with methisoprinol. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30075 |
| Study title: Berker N, Batman C, Guven A, Ozalp S, Aslan O, Zilelioglu O.Am J Ophthalmol. 2004 Nov;138(5):879-81. Optic atrophy and macular degeneration as initial presentations of subacute sclerosing PanencephalitisBerker N, Batman C, Guven A, Ozalp S, Aslan O, Zilelioglu O.Am J Ophthalmol. 2004 Nov;138(5):879-81. Optic atrophy and macular degeneration as initial presentations of subacute sclerosing Panencephalitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30076 |
| Study title: Berth-Jones J, Hutchinson PE. Brit J Derm 1992;127:262-265. Modern treatment of warts: cure rates at 3 and 6 months.Berth-Jones J, Hutchinson PE. Brit J Derm 1992;127:262-265. Modern treatment of warts: cure rates at 3 and 6 months. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30077 |
| Study title: Bowszyc J et al. Przegl Dermatol. Jun 1983;60(3):283-290. Isoprinosine in the treatment of viral skin diseases.Bowszyc J et al. Przegl Dermatol. Jun 1983;60(3):283-290. Isoprinosine in the treatment of viral skin diseases. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30078 |
| Study title: Le chlorhydrate d’hydroxyzine comme medicament adjuvant dans l’anesthesie generale. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPI92D0131.pdf |
| View full study record |
| Document reference: 29318 |
| Study title: Les essais cliniques avec l’hydroxyzine sur un groupe d’enfants arrieres. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPF92D1019.pdf |
| View full study record |
| Document reference: 29333 |
| Study title: Maladjusted young social wards treated with hydroxyzine hydrochloride |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29259 |
| Study title: Management of tension and anxiety states with hydroxyzine hydrochloride |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): CE60H151P.pdf |
| View full study record |
| Document reference: 29261 |
| Study title: Mast cell quantification in the skin of children with atopic dermatitis : its value in diagnosis and in assessing the effctiveness of therapy |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE97H2007.pdf |
| View full study record |
| Document reference: 29268 |
| Study title: Methylpentynol and hydroxyzine as oral premedicants in children |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29230 |
| Study title: Monitoring of sedated pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92G0330.pdf |
| View full study record |
| Document reference: 29363 |
| Study title: Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29920 |
| Study title: Indomethacin and the stress response to hysterectomy. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29921 |
| Study title: Indomethacin as an analgesic after hysterectomy. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29922 |
| Study title: Indomethacin for prevention of intraventricular hemorrhage. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29923 |
| Study title: Indomethacin in extra-articular lesions. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29924 |
| Study title: Indomethacin in soft-tissue sports injuries. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29925 |
| Study title: Indomethacin in superficial thrombophlebitis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29926 |
| Study title: Indomethacin in the management of erythema nodosum leprosum--a double-blind controlled trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29927 |
| Study title: Indomethacin in the prevention of subependymal-intraventricular hemorrhage in preterm newborns with conventional mechanical ventilationa |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29928 |
| Study title: Indomethacin in the treatment of primary dysmenorrhoea. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29929 |
| Study title: Indomethacin in the treatment of rheumatic diseases |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29930 |
| Study title: Indomethacin in the treatment of uveitis. A double-blind trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29931 |
| Study title: Indomethacin in urticaria and histamine induced wealing. A double-blind evaluation. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29932 |
| Study title: Indomethacin prophylaxis for intraventricular hemorrhage in very low birth weight babies. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29933 |
| Study title: Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants? |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29935 |
| Study title: Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29936 |
| Study title: Indomethacin reduces the risks of severe intraventricular hemorrhage. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29937 |
| Study title: Indomethacin the treatment of glomerular nephropathies |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29938 |
| Study title: Indomethacin therapy on the first day of life in infants with very low birth weight. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29939 |
| Study title: Drug Therapy in Infants: Pharmacologic Principles and Clinical Experience - Roberts RJ - 1984 (WB Saunders, Philadelphia, 1984) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29172 |
| Study title: Drugs in Pregnancy. The Royal Women's Hospital - No author - 1993 (Batagol R (Ed) CSL Limited, Victoria, Australia, 1993) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29173 |
| Study title: Einfachblinde randomisierte Studie zur Wirksamkeit und Verträglichkeit eines Gels mit 2 % Ichthyol Natrium, hell und 0,2 % Hydrocortisonacetat bei Patienten mit mittelschwerer Neurodermitis. |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29174 |
| Study title: Endocrine disorders in newborn - Bongiovanni AM et al - 1981 - In Avery GB (Ed): Neonatalogy: Pathophysiology and Management of the Newborn, 2nd Ed. JB Lippincott, Philadelphia, 1981; pp 1104-1127) - Publication in the Comprehensive Summary of Hydrocortison in dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29162 |
| Study title: Guidelines for Administration in Intravenous Medications to Pediatric Patients - No author - 1984 (2nd ed American Society of Hospital Pharmacists, Bethesda, MD, 1984) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29175 |
| Study title: Increase in proteinuria due to steroid medicatio in chronic renal disease - Heymann W et al - 1969 ( Journal of Pediatric 1969; 72: 356) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29176 |
| Study title: Maguire, A.M., et al., Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency. Pediatrics, 2007. 120(1): p. e164-71. |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29177 |
| Study title: Neonatology: Pathophysiology and Management of the Newborn - Avery GB - 1981 (2nd ed. JB Lippincott Company, Philadelphia, PA, 1981) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29163 |
| Study title: No title - Harvey D - 1972 (Br. J. Hosp. Med. 1972; 8: 65 in Extracts from Martindale - 28th Edition - No author - 1982 (Hydrocortisone p 473-474)) - Compilation of clinical papers for the UK review of Medicines in 1983 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29179 |
| Study title: Premiloc |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29180 |
| Study title: Problems in Pediatric Drug Therapy - Pagliaro LA et al. - 1979 (Drug Intelligence Publications, Hamilton, Illinois 1979) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29181 |
| Study title: Prophylactic corticosteroids for pretherm birth -Crowley p - 2004 (in the Cochrane Library, Issue 2, 2004) - Publication in Hydrocortisone CES juillet 2004 all form - Bouvet A - 2004 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29182 |
| Study title: The Pediatric Drug handbook - Benitz WE - 1981 (Year Book Medical Publishers, Chicago, 1981) - Publication in the Comprehensive Summary of Hydrocortisone dated 27/06/1995 - |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29183 |
| Study title: Fluoride varnish for community based caries prevention in children1997-peterson |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1997-peterson-Fluoride varnish for community based caries prevention in children.pdf |
| View full study record |
| Document reference: 49124 |
| Study title: Fluoride varnish versus acidulated phosphate fluoride gel1995-seppa |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf |
| View full study record |
| Document reference: 49120 |
| Study title: Fluoride varnishes in caries prevention. |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42420 |
| Study title: Clinical observations on the use of hydroxyzine in anxiety- tension states and senile agitation. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29334 |
| Study title: Clinical pediatric experience with ataractic agent in less severe emotional states. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29293 |
| Study title: Clinical studies on hydroxyzine in childrens’ premedication in adenoidectomy and tonsillectomy. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): DID89A026P-ADPD94M1940.pdf |
| View full study record |
| Document reference: 29331 |
| Study title: Clinical study of hydroxyzine pamoate in pedodontics. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPS95H3104.pdf |
| View full study record |
| Document reference: 29245 |
| Study title: Comparative evaluation of combined preoperative medications for pediatric surgery. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29278 |
| Study title: Comparison between per os diazepam and hydroxyzine, as premedication in children undergoing ent operations. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): MDPG93B1801.pdf |
| View full study record |
| Document reference: 29316 |
| Study title: Comparison of a chloral hydrate / hydroxyzine combination with and without meperidine in the sedation of pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B1304.pdf |
| View full study record |
| Document reference: 29319 |
| Study title: A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995A phase III single dose study to compare the efficacy of ibuprofen chewable tablets to ibuprofen suspension in febrile children. Jun 1995 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29682 |
| Study title: A phase IV comparative study evaluating the onset of analgesia using a single dose of ibuprofen chewable tablets 400 mg, ibuprofen suspension 400 mg/20 ml or placebo in post-operative dental painA phase IV comparative study evaluating the onset of analgesia using a single dose of ibuprofen chewable tablets 400 mg, ibuprofen suspension 400 mg/20 ml or placebo in post-operative dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29683 |
| Study title: A phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrheaA phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrhea |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29684 |
| Study title: A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain A pilot comparative study evaluating the analgesic effect of using a single dose of an ibuprofen 200 mg / acetaminophen 650 mg combination or ibuprofen 400 mg in post-operative dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29663 |
| Study title: A randomized double-blind single dose study comparing ibuprofen 200 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of pain following orthopedic surgeryA randomized double-blind single dose study comparing ibuprofen 200 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of pain following orthopedic surgery |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29686 |
| Study title: A randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental painA randomized double-blind study comparing the efficacy of single doses of ibuprofen 200 mg, ibuprofen 400 mg, ibuprofen 200 mg plus caffeine 100 mg, ibuprofen 400 mg plus caffeine 200 mg, caffeine 100 mg, and placebo in the treatment of post-operative dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29687 |
| Study title: Narcotic sedation: an evaluation of cardiopulmonary para- meters and behavior modification in pediatric dental patients. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29242 |
| Study title: Negative effect on the electroencephalogram of hydroxyzine pamoate at therapeutic dosage. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29225 |
| Study title: On the use of an ataractic (hydroxyzine hydrochloride) in the treatment of enuresis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29297 |
| Study title: Paediatric mastocytosis : retrospective study of 15 cases |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPP02J2001.pdf |
| View full study record |
| Document reference: 29237 |
| Study title: Pediatric idiopathic anaphylaxis : experience with 22 patients |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE99H0215.pdf |
| View full study record |
| Document reference: 29249 |
| Study title: Pediatric premedication with diazepam or hydroxyzine. Oral versus intramuscular route. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29325 |
| Study title: Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29343 |
| Study title: Phenytoin-induced choreoathetosis in infancy: case reports and a review. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29284 |
| Study title: Pre-anaesthetic medication in paediatric day-care surgery |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29246 |
| Study title: Preanesthetic supplementation with hydroxyzine in the pediatric patient. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE95A2403.pdf |
| View full study record |
| Document reference: 29372 |
| Study title: Prednisolone alone and in combination with hydroxyzine |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29226 |
| Study title: Preliminary study on the use of hydroxyzine in psychosomatic affections |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): CE56F151P.pdf |
| View full study record |
| Document reference: 29253 |
| Study title: Preliminary survey of results obtained in infantile psychiatrics with a derivative of chlorobenzhydryl. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE92B2101-translation.pdf |
| View full study record |
| Document reference: 29271 |
| Study title: Premedication anti histaminique specifique anti H1 anti H2 en anesthesie pediatrique. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29291 |
| Study title: Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9Xiao Z. An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine (corrected) hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold. Chinese journal of internal medicine 2002; 41(8):547-9 |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29750 |
| Study title: Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526)Yilmaz−H−L et al. Intramuscular dipyrone versus oral ibuprofen or nimesulide for reduction of fever in the outpatient setting. {CLIN−DRUG−INVEST}, 2003, Vol/Iss/Pg. 23/8 (519−526) |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29751 |
| Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single Doses of MK0787/MK0791 in Neonates. |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29752 |
| Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single and Multiple Doses of MK0787/MK0791 in Neonates. |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29753 |
| Study title: Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29940 |
| Study title: Observational study Jutussin N R9 |
| Active substance: (HMP) Belladonna D4, Bryonia D3, Coccus cacti D6, Corallium rubrum D12, Cuprum aceticum D12, Drosera D4, Ipecacuanha D6, Spongia D6, Sticta D4 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39732 |
| Study title: Observational study Cysto-Gastreu R18 |
| Active substance: (HMP) Berberis vulgaris D4, Cantharis D4, Dulcamara D4, Equisetum hiemale D6, Eupatorium purpureum D6 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39733 |
| Study title: Observational study Hypotonie-Gastreu R44 |
| Active substance: (HMP) Crataegus D1, Laurocerasus D3, Oleander D3, Spartium scoparium D2 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39734 |
| Study title: Status of cyclopentolate as a cycloplegic in children: a comparison with atropine and homatropine. Khurana AK, Ahluwalia BK, Rajan C. Acta Ophthalmol (Copenh). 1988 Dec;66(6):721-4.Status of cyclopentolate as a cycloplegic in children: a comparison with atropine and homatropine. Khurana AK, Ahluwalia BK, Rajan C. Acta Ophthalmol (Copenh). 1988 Dec;66(6):721-4. |
| Active substance: HOMATROPIN |
| Study summary document link (including results): Status of cyclopentolate as a cycloplegic in children.pdf |
| View full study record |
| Document reference: 29123 |
| Study title: Efficacy of Tonsilotren in the treatment of acute angina catarrhalis. |
| Active substance: (Homeopathic) Per tablet: Atropinum sulfuricum D5 12,5 mg Hepar sulfuris D3 10,0 mg Kalium bichromicum D4 50,0 mg Silicea D2 5,0 mg Mercurius bijodatus D8 25,0 mg |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39745 |
| Study title: HPV-033 |
| Active substance: hpv-16 and hpv-18 l1 proteins |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41497 |
| Study title: A study to determine the safety of IMMUNO's virus-inactivated plasma derivatives in patients naive to blodd product administration Efficacy and Safety of Immunine in Continuous Infusion in patients with hemophilia B undergoing surgery Single Patient use of Factor IX Concentrates |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29127 |
| Study title: Clinical safety + efficacy study of Nanotiv during long-term prophylaxis and/or on demand treatment… |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29133 |
| Study title: Clinical study of recovery and half life of factor VII concentrate |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29137 |
| Study title: Coagulation Factor IX (Human) AlphaNine® SD Affinity Purified, Solvent Detergent Treated, An Open Label Study if Viral Safety in Previously Untreated Individuals with Hemophilia B |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29125 |
| Study title: Coagulation Factor IX (human) AlphanineSD affinity purified, solvent detergent treated, an open label study of viral safety in previously untreated subjects with Haemophilia B. |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): 01 ATC 91-11(synopsis).pdf |
| View full study record |
| Document reference: 47316 |
| Study title: Efficacy and safety in children with Haemophilia B treated with OCTANINE F |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29129 |
| Study title: Efficacy and safety of BETAFACT® in previously untreated haemophilia B patients |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29136 |
| Study title: Efficacy and safety of Factor IX (FIX) contained in FIX-GRIFOLS in patients with severe hereditary haemophilia B. |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): 03 IG104 (synopsis).pdf |
| View full study record |
| Document reference: 47318 |
| Study title: Efficacy and Safety of Immunine in Continuous Infusion in patients with hemophilia B undergoing surgery Single Patient use of Factor IX Concentrates |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29128 |
| Study title: Evaluation of Immunogenicity, Tolerability and Viral Safety in Haemophilia B Patients under Therapy with OCTANINE F |
| Active substance: HUMAN COAGULATION FACTOR IX |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29130 |
| Study title: A double-blind, placebo-controlled crossover study comparing the safety and efficacy of ibuprofen sustained release 600 mg and ibuprofen regular release 400 mg in the treatment of primary dysmenorrhea. CSR 130S. Protocol 88-852, Unpublished Report 256A. |
| Active substance: IBUPROFEN |
| Study summary document link (including results): ibuprofen 88-852.pdf |
| View full study record |
| Document reference: 47449 |
| Study title: A double-blind, single dose comparison of Advil (ibuprofen) vs Tylenul plus codeine vs. Placebo in the relief of post operative surgery pain" |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29531 |
| Study title: A double-blind, single dose comparison of ibuprofen vs. Acetaminophen vs. Placebo in the relief of post operative oral surgery pain |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29529 |
| Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of pain following oral surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29488 |
| Study title: A double-blind, single dose evaluation of the comparative analgesic efficacy of aspirin 800 mg plus caffeine 64 mg, ibuprofen 400 mg and placebo in the treatment of post-operative pain following third molar extraction |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29500 |
| Study title: A double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgery |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29486 |
| Study title: A double-blind, single dose evaluation of the comparative efficacy of acetaminophen 1000 mg, ibuprofen 200 mg, ibuprofen 400 mg, and placebo in the treatment of pain following periodontal surgery. Stat Rpt 66. Protocol 3-279, Unpublished Report 185. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 3-279.pdf |
| View full study record |
| Document reference: 47390 |
| Study title: A double-blind, single dose parallel study to compare analgesic efficacy and side effects profile of acetaminophen 1000 mg, ibuprofen 400 mg, ibuprofen 200 mg, and placebo in the treatment of muscle contraction ('tension') headache. Stat Rpt 77. Protocol 84-462, Unpublished Report 201. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 84-462.pdf |
| View full study record |
| Document reference: 47399 |
| Study title: A phase IV multicenter clinical investigation of the safety and efficacy of APAP 1000 mg (total daily dose of 4 grams), ibuprofen 400 mg (total daily dose of 1200 mg), and placebo in the management of the symptoms of primary dysmenorrhea. Stat Rpt 73. Protocol 4-400, Unpublished Report 193. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 4-400.pdf |
| View full study record |
| Document reference: 47391 |
| Study title: A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000.A Phase IV Randomized, Double-Blind, Multicenter Trial to Compare the Safety and Efficacy of Acetaminophen Suspension and Ibuprofen Suspension in the Treatment of Febrile Children. Dec 2000. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29685 |
| Study title: A Pilot Comparative Study Evaluating the Analgesic Effect of Using a Single Dose of an Ibuprofen 200 mg / Acetaminophen 650 mg Combination or Ibuprofen 400 mg in Post-Operative Dental Pain. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 98-053.pdf |
| View full study record |
| Document reference: 47413 |
| Study title: A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle Sprains |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 11-301.pdf |
| View full study record |
| Document reference: 47398 |
| Study title: A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. CSR 106. Protocol 86-642, Unpublished Report 232. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 86-642.pdf |
| View full study record |
| Document reference: 47400 |
| Study title: A single dose double-blind study comparing the efficacy of ibuprofen and children's Tylenol elixir. Stat Rpt 80. Protocol 5-535, Unpublished Report 205. |
| Active substance: IBUPROFEN AND PARACETAMOL |
| Study summary document link (including results): ibuprofen_paracetamol 5-535.pdf |
| View full study record |
| Document reference: 47395 |
| Study title: A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle SprainsA Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Efficacy of Acetaminophen Extended Release (3900 mg/day) and Ibuprofen (1200 mg/day) in the Treatment of Ankle Sprains |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29688 |
| Study title: A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. Jun 1989.A randomized, open label, parallel, single dose study of the antipyretic efficacy, safety, and blood levels of ibuprofen 6 mg/kg in febrile children with acetaminophen 10-15 mg/kg as a positive control for efficacy. Jun 1989. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29689 |
| Study title: A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995.A single dose study to compare the efficacy and side effects of ibuprofen suspension to placebo in children 5 through 11 years of age with post-operative pain secondary to either inguinal or umbilical herniorrhaphy. Jul 1995. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29691 |
| Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 12.5 mg/kg and 25 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. Oct 1991.A single dose study to compare the efficacy of acetaminophen elixir dosed at 12.5 mg/kg and 25 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. Oct 1991. |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29693 |
| Study title: Safety and immunogenicity of Imovax Polio vaccine in Korean infants, when given at 2,4 and 6 months of age |
| Active substance: Inactivated Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47471 |
| Study title: |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30060 |
| Study title: |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30061 |
| Study title: |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30062 |
| Study title: |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30063 |
| Study title: A case of haemorrhagic lung edema treated by indomethacin in a term infantBaker CJ, Melish NM, Hall RT, et al. and the multicenter group for the study of immune globulin in neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327 (4): 213-219 |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29790 |
| Study title: A clinical trial of indomethacin and ibuprofen in dysmenorrhea.Evaluation of prophylactic passive immunization using IGIV to prevent late onset neonatal infection among low birth weight(< 1750 grams) neonates. Baxter Internal ReportBB IND 1628: June, 1992 |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29791 |
| Study title: A clinical trial with indomethacin (indomee(R)) in low back pain and sciatica. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29792 |
| Study title: A comparative clinical trial of fenbufen and indomethacin in patients with rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29793 |
| Study title: A comparative evaluation of indomethacin, acetaminophen and placebo as antipyretic agents in children. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29794 |
| Study title: A comparative study of benoxaprofen and indomethacin in ankylosing spondylitis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29795 |
| Study title: Anwendungsbeobachtung Aknichthol soft N Lotio |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29757 |
| Study title: Anwendungsbeobachtung zu Natriumbituminosulfonat 20% (Ichtholan T) bei Neurodermitis |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29762 |
| Study title: Anwendungsbeobachtung zum Nachweis der Wirksamkeit und Verträglichkeit von Ichthoseptal® Creme bei Patienten mit Acne papulo-pustulosa bzw. entzündlicher Acne comedonica |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29763 |
| Study title: AWB bei Neurodermitis |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29764 |
| Study title: AWB bei Psoriasis bzw. seborrh. Ekzem |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29760 |
| Study title: Doppelblinde, kontrollierte klinische Prüfung zum Wirksamkeits- und Verträglichkeitsnachweis von Akne-Lotion I bei Patienten mit mittelschwererer Akne vulgaris |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29756 |
| Study title: Monozentrische, prospektive, randomisierte, kontrollierte Doppelblindstudie zum Nachweis der Wirksamkeit und Verträglichkeit von 4 % Natriumbituminosulfonat, hell in einer O/W-Emulsion versus der (angefärbten) Grundlage bei Kindern mit leichter bis mittelschwerer Neurodermitis |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29765 |
| Study title: Monozentrische, prospektive, randomisierte, kontrollierte, observer-blind Studie zum Nachweis der Wirksamkeit und Verträglichkeit von Natriumbituminosulfonat, hell (20 %ig) in einer Gelgrundlage (Ichtholan® T Gel) versus Fusidinsäure (2 %ig) in einer Cremegrundlage (Fucidine® Creme) bei Patienten mit bakteriell-bedingten Hauterkrankungen im Alter vom 4. Lebensmonat bis zum 18. Lebensjahr |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29761 |
| Study title: Überprüfung der Wirksamkeit und Verträglichkeit einer Milchschorf Creme bei Säuglingen und Kleinkindern bis zum vollendeten 2. Lebensjahr |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29759 |
| Study title: Überprüfung der Wirksamkeit und Verträglichkeit einer Neurodermitis Creme bei Säuglingen und Kindern bis zum vollendeten 6. Lebensjahr |
| Active substance: ICHTASOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29766 |
| Study title: Double-blind comparison of tolmetin sodium and indomethacin in ankylosing spondylitis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29861 |
| Study title: Double-blind cross-over comparison of flurbiprofen and indomethacin in osteoarthritis of the knee and hip |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29862 |
| Study title: Double-blind crossover comparison of naproxen and indomethacin in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29863 |
| Study title: Double-blind evaluation of intravenous indomethacin and oxycone-papaverine in the treatment of acute biliary pain. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29864 |
| Study title: Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29865 |
| Study title: Ductal patency in neonates with respiratory distress syndrome. A randomized surfactant trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29866 |
| Study title: Long term safety of ipratropium bromide in children with reversible obstructive pulmonary disease in stable period. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30634 |
| Study title: Long term safety of ipratropium bromide in children with reversible obstructive pulmonary disease in stable period. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U88-0151_synopsis.pdf |
| View full study record |
| Document reference: 30694 |
| Study title: Mechanisms of bronchial hyper-reactivity in cystic fibrosis |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U86-0564_synopsis.pdf |
| View full study record |
| Document reference: 30648 |
| Study title: Mechanisms of bronchial hyper-reactivity in cystic fibrosis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30643 |
| Study title: Mechanisms of bronchial hyper-reactivity in cystic fibrosis. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30647 |
| Study title: NA 872: final report of the respiratory distress syndrome in premature infants. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30603 |
| Study title: Phase IV safety trial in pediatric patients (age 2-5) |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30661 |
| Study title: Pilot assessment of the effect and tolerability of Th 1165a as a capsule administered with a powder inhaler and assessment of the powder inhaler. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30568 |
| Study title: Pilot assessment of the effect and tolerability of Th 1165a as a capsule administered with a powder inhaler and assessment of the powder inhaler. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30670 |
| Study title: Prophylactic treatment of wheezing in infants with hyper-reactive airways by oral Berotec solution. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30640 |
| Study title: Prospective study with fenoterol mdi in patients with bronchoconstrictions. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30617 |
| Study title: Randomized, Double-Blind, Parallel Comparison of Atrovent Nasal Spary 0.03% (42 μg/nostril) Versus Placebo Administered Twice a Day in Pediatric Patients with Allergic or Nonallergic Perennial Rhinitis with an Optional 6- Month Treatment Comparison of Atrovent Nasal Spray 0.03% (42 μg/nostril) Versus Beconase AQ (84 μg/nostril) |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): Ipratropium bromide_U96-3125_synopsis.pdf |
| View full study record |
| Document reference: 30712 |
| Study title: The site of obstruction in exercise-induced asthma. |
| Active substance: IPRATROPIUM AND FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30741 |
| Study title: A comparison of a combination of Ipratropium bromide and Salbutamol with Salbutamol alone in acute severe asthma. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U91-0747_synopsis.pdf |
| View full study record |
| Document reference: 30747 |
| Study title: A comparison of a combination of Ipratropium bromide and Salbutamol with Salbutamol alone in acute severe asthma. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30752 |
| Study title: A study of nebulised Ventolin versus nebulised Ventolin plus Atrovent in acute childhood asthma. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U88-0360_synopsis.pdf |
| View full study record |
| Document reference: 30746 |
| Study title: A study of nebulised Ventolin versus nebulised Ventolin plus Atrovent in acute childhood asthma. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30751 |
| Study title: Combined treatment with ipratropium bromide and beta-2 adrenoceptor stimulating agents in chronic childhood asthma |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U85-0434_synopsis.pdf |
| View full study record |
| Document reference: 30681 |
| Study title: Combined treatment with ipratropium bromide and beta-2 adrenoceptor stimulating agents in chronic childhood asthma. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30749 |
| Study title: safety and immunogenicity of immovax polio vaccine in Korean infants, whn given at 2, 4 and 6 months of age |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41182 |
| Study title: Safety and immunogenicity of PMSV diphtheria, tetanus, acellular pertussis, polio (DTacP-IPV) vaccine given mixed or separately with Haemophilus influenzae type b (Act-HIB®) vaccine, as a primary series. Comparison of three lots of DTacP-IPV vaccine given combined or separately with Act-HIB® |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41189 |
| Study title: Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen-to nineteen-month-old infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41192 |
| Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21209 |
| Study title: Safety of IPV of one or two doses in chinese infants |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41183 |
| Study title: Study of the booster effect of IPV vaccination on children |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41196 |
| Study title: The immune response after two doses of a new killed poliomyelitis vaccine |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41202 |
| Study title: Trial on the persistence of antibodies 4 years after a first booster with PENTAVAC® vaccine and the immunogenicity and safety of a second booster with TETRAVAC ACELLULAIRE® vaccine at the age of 5-6 years |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41195 |
| Study title: Open label study to evaluate the safety and immunogenicity of a hepatitis A vaccine (Avaxim 160U) |
| Active substance: Inactivated Hepatitis A vaccine adsorbed for adults (160 U) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47625 |
| Study title: OPEN STUDY OF IMMUNOGENICITY AND SAFETY OF THE P.M.sv. (160 U) HEPATlTlS A VACCINE ON CHILDREN AND ADULTS |
| Active substance: Inactivated Hepatitis A vaccine adsorbed for adults (160 U) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47624 |
| Study title: Open study of immunogenicity and safety of the P.M.sv. Hepatitis A vaccine (160 antigen units) in children |
| Active substance: Inactivated Hepatitis A vaccine adsorbed for adults (160 U) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47623 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41107 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41108 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41110 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41113 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41114 |
| Study title: A comparative study of fenbufen and indomethacin in patients with rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29796 |
| Study title: A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29797 |
| Study title: A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29798 |
| Study title: A comparison of indoprofen and indomethacin in the supportive treatment of soft-tissue injuries in football players: a pilot study. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29799 |
| Study title: A controlled clinical trial of TAI-284 acid in rheumatoid arthritis (author's transl)a |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29800 |
| Study title: A controlled clinical trial with indomethacin as an antipyretic in children. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29801 |
| Study title: A double-blind cross-over study of niflumic acid and indomethacin in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29802 |
| Study title: Therapeutic effect of non-steroidal anti-inflammatory agents in eye disease |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30041 |
| Study title: Therapeutic effectiveness of paracetamol in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30042 |
| Study title: Therapeutic interventions to prevent intracerebral hemorrhage in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30043 |
| Study title: Tocolysis in advanced preterm labor: impact on neonatal outcome. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30044 |
| Study title: Treatment of acute pain due to ureteral calculi with intravenous indomethacin or pethidine |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30045 |
| Study title: Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30046 |
| Study title: Treatment of patent ductus arteriosus with ibuprofen. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30047 |
| Study title: Treatment of premature labor with indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30048 |
| Study title: Treatment of renal colic by prostaglandin synthetase inhibitors and avafortan (analgesic antispasmodic). |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30049 |
| Study title: Treatment of renal colic by prostaglandin synthetase inhibitors and avafortan (analgesic antispasmodic). |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30050 |
| Study title: Treatment of ureteral and biliary pain with an injectable salt of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30051 |
| Study title: Treatment of ureteric colic. Intravenous versus rectal administration of indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30052 |
| Study title: Early administration of indomethacin to preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29867 |
| Study title: Early closure of ductus arteriosus with indomethacina |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29868 |
| Study title: Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29869 |
| Study title: Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29870 |
| Study title: Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29872 |
| Study title: Early-onset intraventricular hemorrhage in preterm neonates: incidence of neurodevelopmental handicap. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29873 |
| Study title: Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29874 |
| Study title: Effect in man of aspirin, standard indomethacin, and sustained release indomethacin preparations on gastric bleeding. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29875 |
| Study title: Effect of dopamine on failure of indomethacin to close the patent ductus arteriosus. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29876 |
| Study title: Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29877 |
| Study title: Effect of graduated intravenous and standard rectal doses of indomethacin on cerebral blood flow in healthy volunteers. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29878 |
| Study title: Effect of high dose ramipril with or without indomethacin on glomerular selectivity. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29879 |
| Study title: Effect of indometacin in a child with pseudohypoaldosteronism |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29880 |
| Study title: Effect of indomethacin on adenosine-induced bronchoconstriction. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29881 |
| Study title: Cornaglia-Farraris P, Pasino M, Maggio A, Barabino A, Perlino GF, Massimo L. In: Le immunodeficienze primitive in Italia. Rome, Italy: Acta Medica, Field Educational Italia SpA; 1982. Chapter 4. Therapeutic success with methisoprinol in a case of congenital immune deficiency: clinical and immunological observations after one year of clinical therapy.Cornaglia-Farraris P, Pasino M, Maggio A, Barabino A, Perlino GF, Massimo L. In: Le immunodeficienze primitive in Italia. Rome, Italy: Acta Medica, Field Educational Italia SpA; 1982. Chapter 4. Therapeutic success with methisoprinol in a case of congenital immune deficiency: clinical and immunological observations after one year of clinical therapy. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30092 |
| Study title: Cornaglia-Ferraris P, Koverech A.. International Journal of Immunopharmacology. [UK]. 1980; 2(3):193. (Abstract No. 23). Successful treatment with methisoprinol in a case of congenital immunodeficiencyCornaglia-Ferraris P, Koverech A.. International Journal of Immunopharmacology. [UK]. 1980; 2(3):193. (Abstract No. 23). Successful treatment with methisoprinol in a case of congenital immunodeficiency |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30093 |
| Study title: Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; Gurses C et al; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76Correlation between the adverse reactions to intravenous iodinated contrast media and IgE levels; Gurses C et al; Diagn. Interv. Radiol.; 2005 vol.11 p.74 76 |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30181 |
| Study title: Combined treatment with ipratropium bromide and beta-2 adrenoceptor stimulating agents in chronic childhood asthma. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30753 |
| Study title: Combivent vs. salbutamol in patients with metacholine-induced bronchospasm. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): Ipratropium bromide_salbutamol sulphate_U00-0040_synopsis.pdf |
| View full study record |
| Document reference: 30748 |
| Study title: Statistical report: Comparison of the use of salbutamol solution and the combination of salbutamol and ipratropium solution in the treatment of acute asthma attacks in children. |
| Active substance: IPRATROPIUM AND SALBUTAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30750 |
| Study title: Effectiveness and Safety of the Angiotensin II Antagonist Irbesartan in Children With Chronic Kidney Diseases |
| Active substance: irbesartan |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41533 |
| Study title: Experience with Irbesartan Use in Children 16 Years of Age and Younger: A Descriptive Study in Two Medical Claims Databases |
| Active substance: irbesartan |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45089 |
| Study title: Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children, 2002 Reduced Advanced Glycation Endproduct (AGE) Levels in Children on Automated Peritoneal Dialysis (PD) with PD-Fluids Containing Less Glucose Degradation Products (GDPs), 2003 |
| Active substance: ISOTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30758 |
| Study title: Statistical report: A dose response and duration of action study of Duovent nebuliser solution in paediatrics. |
| Active substance: ISOTONIC SOLUTIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30759 |
| Study title: A double-blind, placebo-controlled trial to evaluate the efficacy and safety of topically applied 0.1% isotretinoin cream for the treatment of acne vulgaris. |
| Active substance: ISOTRETINOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30761 |
| Study title: Open-label, Randomized, Dose Ranging Study of Three Different Doses of Ritonavir in Combination with 3TC+d4T in Children Infected with HIV |
| Active substance: ritonavir |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41580 |
| Study title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Cholesterol-Lowering Efficacy and Safety of Simvastatin as an Adjunct to Diet in Children and Adolescents With Familial Hypercholesterolemia |
| Active substance: SIMVASTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42224 |
| Study title: Double blind comparison of Sertraline and Placebo in children and adolescents with obsessive compulsive disorder. |
| Active substance: SERTRALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42126 |
| Study title: Duraphat varnish a 2 year clinical trial in 5 year old childeren1977-murray, Brit. Dental J |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1977-murray-Duraphat varnish a 2 year clinical trial in 5 year old childeren.pdf |
| View full study record |
| Document reference: 49103 |
| Study title: Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-school children1991-frostell |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1991-frostell-Effect of a partial substitution of invert sugar for surcose in combination with Duraphat treatment in caries development in pre-scho... |
| View full study record |
| Document reference: 49116 |
| Study title: Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental caries1979-koch |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1979-koch-Effect of fluoride varnish (Duraphat) treatment every 6 months compared with weekly mouthrinsing with 02 percent NaF solution on dental c... |
| View full study record |
| Document reference: 49105 |
| Study title: Effect of topical applied stannous fluoride on dental caries experience children1955-Howell |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1955-Howell-Effect of topical applied stannous fluoride on dental caries experience children.pdf |
| View full study record |
| Document reference: 49132 |
| Study title: |
| Active substance: Inactivated hepatitis A virus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41117 |
| Study title: Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)a |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29962 |
| Study title: Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29963 |
| Study title: Long-term variability of heart rate increases with successful closure of patent ductus arteriosus in preterm infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29964 |
| Study title: Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29965 |
| Study title: Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29966 |
| Study title: Low-dose irradiation and indomethacin prevent heterotopic ossification after acetabular fracture surgery. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29967 |
| Study title: Mannheimer lecture. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29968 |
| Study title: Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29969 |
| Study title: Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29970 |
| Study title: Near-infrared spectroscopy as a screening tool for patent ductus arteriosus in extremely low birth weight infants. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29972 |
| Study title: Neonatal consequences of the use of indomethacin during pregnancy. A prospective study of 83 pregnant women and 115 neonates |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29973 |
| Study title: Neonatal limb ischemia following maternal indomethacin treatment in twin pregnancies. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29974 |
| Study title: Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29975 |
| Study title: Neurodevelopmental outcome at 36 months' corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29976 |
| Study title: Neurodevelopmental outcome with early indomethacin. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29977 |
| Study title: Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29978 |
| Study title: Night medication in rheumatoid arthritis. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29979 |
| Study title: Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29980 |
| Study title: A non-randomised, single-centre, retrospective, controlled trial using stored serum samples to investigate the immunogenicity of NovoRapid® and Actrapid® in children and adolescents from onset of Type 1 diabetes. |
| Active substance: insulin detemir |
| Study summary document link (including results): ANA-1676 synopsis.pdf |
| View full study record |
| Document reference: 47338 |
| Study title: A single-centre, randomised, double-blind, cross-over trial comparing the within-subject variability of the pharmacokinetic profiles of insulin detemir and insulin glargine in children and adolescents with type 1 diabetes, LPLV October 2005 |
| Active substance: insulin detemir |
| Study summary document link (including results): NN304-1633-synopsis.pdf |
| View full study record |
| Document reference: 41577 |
| Study title: 28-Week multicenter, controlled, randomized, open clinical trial comparing HOE 901 insulin with NPH human insulin in children with type 1 diabetes mellitus |
| Active substance: INSULIN GLARGINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47339 |
| Study title: Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S301-5 Low-osmolality contrast media in cardiac radiology. Cumberland DC Invest Radiol. 1984 Nov-Dec;19(6 Suppl):S301-5 Low-osmolality contrast media in cardiac radiology. Cumberland DC |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30375 |
| Study title: Invest Radiol. 1991 Jul;26(7):665-70 A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Pelech AN, Allard SM, Hurd RT, Giddins NG, Collins GF Invest Radiol. 1991 Jul;26(7):665-70 A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Pelech AN, Allard SM, Hurd RT, Giddins NG, Collins GF |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30376 |
| Study title: J Comput Assist Tomogr. 2000 Mar-Apr;24(2):327-31 Gadolinium-enhanced magnetic resonance dacryocystography in patients with epiphora. Kirchhof K, Hähnel S, Jansen O, Zake S, Sartor K. J Comput Assist Tomogr. 2000 Mar-Apr;24(2):327-31 Gadolinium-enhanced magnetic resonance dacryocystography in patients with epiphora. Kirchhof K, Hähnel S, Jansen O, Zake S, Sartor K. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30377 |
| Study title: J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30378 |
| Study title: Open uncontrolled clinical trial of iotrolan 300 for gastrointestinal diagnosis in childrenTurk J Pediatr. 1995 Oct-Dec;37(4):305-13 The effects of contrast media on renal function in children: comparison of ionic and non-ionic agents. Buyan N, Arab M, Hasanoğlu E, Gökçora N, Ercan S |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30382 |
| Study title: A comparision of Iopromide and Iopamidol in computer tomography (CT) scanning of pediatric patients |
| Active substance: IOPROMIDE |
| Study summary document link (including results): Bayer Pharma_Iopromide_1114_study_synopsis.pdf |
| View full study record |
| Document reference: 46898 |
| Study title: A comparison of iopromide and iopamidol in CT scanning of pediatric patients |
| Active substance: IOPROMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30385 |
| Study title: Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. ; Zimmermann-M-B. European Journal of Clinical Nutrition, 2000, Vol /Iss/Pg. 54/3 (209-213)Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency. ; Zimmermann-M-B. European Journal of Clinical Nutrition, 2000, Vol /Iss/Pg. 54/3 (209-213) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30234 |
| Study title: Effect of supplementing iodine on child intellectual development in iodine deficient areas. ;Chen-Z-H. Chinese Journal of Endemiology, 2006, Vol/Iss/Pg. 25 /1 (75-77)Effect of supplementing iodine on child intellectual development in iodine deficient areas. ;Chen-Z-H. Chinese Journal of Endemiology, 2006, Vol/Iss/Pg. 25 /1 (75-77) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30235 |
| Study title: Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. Han-Y-M. Journal of Vascular and Interventional Radiology, 1999, Vol/Iss/Pg. 10/9 (1275-1280)Effectiveness of preoperative transarterial chemoembolization in presumed inoperable hepatoblastoma. Han-Y-M. Journal of Vascular and Interventional Radiology, 1999, Vol/Iss/Pg. 10/9 (1275-1280) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30236 |
| Study title: Effects of salt iodization in the treatment of endemic goiter in school children of rural origin in Cameroon. ;Ngogang-J. Annales d'Endocrinologie, 1993, Vol/Iss/Pg. 54/3 (191-196)Effects of salt iodization in the treatment of endemic goiter in school children of rural origin in Cameroon. ;Ngogang-J. Annales d'Endocrinologie, 1993, Vol/Iss/Pg. 54/3 (191-196) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30237 |
| Study title: Effects on school children of prophylaxis of mothers with iodized oil in an area of iodine deficiency. ; Fierro-Benitez-R. Journal of Endocrinological Investigation, 1988, Vol/Iss/Pg. 11/5 (327-335)Effects on school children of prophylaxis of mothers with iodized oil in an area of iodine deficiency. ; Fierro-Benitez-R. Journal of Endocrinological Investigation, 1988, Vol/Iss/Pg. 11/5 (327-335) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30238 |
| Study title: Efficacy of oral iodised oil is associated with anthropometric status in severely iodine-deficient schoolchildren in rural Malawi. ; Furnee-C-A. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/3 (345-352)Efficacy of oral iodised oil is associated with anthropometric status in severely iodine-deficient schoolchildren in rural Malawi. ; Furnee-C-A. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/3 (345-352) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30239 |
| Study title: Embolization and intra-vascular therapy in thoracic, abdominal and peripheral pediatric diseases. ; Brunelle-F. Annales de Pediatrie, 1983, Vol/Iss/Pg. 30/3 (189-193)Embolization and intra-vascular therapy in thoracic, abdominal and peripheral pediatric diseases. ; Brunelle-F. Annales de Pediatrie, 1983, Vol/Iss/Pg. 30/3 (189-193) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30240 |
| Study title: Embolization of arteriovenous malformations of the brain: Preliminary experience. ;Wilms-G. Journal Belge de Radiologie, 1993, Vol/Iss/Pg. 76/5 (299-303)Embolization of arteriovenous malformations of the brain: Preliminary experience. ;Wilms-G. Journal Belge de Radiologie, 1993, Vol/Iss/Pg. 76/5 (299-303) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30241 |
| Study title: Embolization of rolandic cortex arteriovenous malformations. ;Paulsen-R-D. Neurosurgery, 1999, Vol/Iss/Pg. 44/3 (479-486)Embolization of rolandic cortex arteriovenous malformations. ;Paulsen-R-D. Neurosurgery, 1999, Vol/Iss/Pg. 44/3 (479-486) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30242 |
| Study title: Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate. 02/12/2010Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate. 02/12/2010 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30243 |
| Study title: Emergent embolization for control of massive hemorrhage from a splanchnic artery with a new coaxial catheter system. ;Okazaki-M. Acta Radiologica, 1992, Vol/Iss/Pg. 33/1 (57-62)Emergent embolization for control of massive hemorrhage from a splanchnic artery with a new coaxial catheter system. ;Okazaki-M. Acta Radiologica, 1992, Vol/Iss/Pg. 33/1 (57-62) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30244 |
| Study title: Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains: a randomized, double-blind, placebo-controlled trial – SZYMANSKI H., PEJCZ J. and al. – 2006.Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains: a randomized, double-blind, placebo-controlled trial – SZYMANSKI H., PEJCZ J. and al. – 2006. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30973 |
| Study title: “Clinical report on the effect of lactitol for the treatment of intestinal stasis in newborns and toddlers" Investigator: Prof. M. T. Duillo Report date: 23.05.1986“Clinical report on the effect of lactitol for the treatment of intestinal stasis in newborns and toddlers" Investigator: Prof. M. T. Duillo Report date: 23.05.1986 |
| Active substance: LACTITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30986 |
| Study title: Comparative study beween lactitol and placebo in infants less than 2 years presenting constipationBaudon, J.J :, Bouillie, C. et al. (1995) A controlled study of lactitol in the treatment of constipation in dhildren. Rev. Pediatr., 4, 1-8. |
| Active substance: LACTITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30984 |
| Study title: Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I et al. A radiopharmaceuticals schedale for imaging in paediatrics. [piepsz-1990]Eur J Nucl Med 1990;17 : 127 – 129. Piepsz A 1990 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48690 |
| Study title: Pirotte B, Goldman S, Dewitte O, Massager N, Wikler D, Lefranc F, et al.. Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures. [pirotte-2006]J Neurosurg. 2006 Feb;104(2):238-53. Pirotte B 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48691 |
| Study title: Procedure Guideline for Tumor Imaging Using Fluorine- 1 8-FDGJ Nucl Med 1998; 3&13&1305. Heinrich R. Schelbert, Carl K. Hoh, Henry D. Royal, Manuel Brown, Magnus N. Dahlbom, Farrokh Dehdashti and Richard L. Wahl |
| Active substance: Steripet |
| Study summary document link (including results): schelbert-1998.pdf |
| View full study record |
| Document reference: 48744 |
| Study title: Mirmiran-P. International Journal for Vitamin and Nutrition Research, 2003, Vol/Iss/Pg. 73/3 (187-191)Mirmiran-P. International Journal for Vitamin and Nutrition Research, 2003, Vol/Iss/Pg. 73/3 (187-191) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30289 |
| Study title: Monographie Jod, Bundesanzeiger Nr. 236 vom 16.12.1989; Azizi-F. Journal of Endocrinological Investigation, 2001, Vol/Iss/Pg. 24/2 (72-77)Monographie Jod, Bundesanzeiger Nr. 236 vom 16.12.1989; Azizi-F. Journal of Endocrinological Investigation, 2001, Vol/Iss/Pg. 24/2 (72-77) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30290 |
| Study title: Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. ; Guan-Y-S. World Journal of Gastroenterology, 15 JUL 2004, Vol/Iss/Pg. 10/14 (2127-2129)Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization. ; Guan-Y-S. World Journal of Gastroenterology, 15 JUL 2004, Vol/Iss/Pg. 10/14 (2127-2129) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30291 |
| Study title: Neonatal screening for congenital hypothyroidism results and perspectives; François Delange. Horm Res 1997; 48:51-61Neonatal screening for congenital hypothyroidism results and perspectives; François Delange. Horm Res 1997; 48:51-61 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30292 |
| Study title: Nervous endemic cretinism in Eastern Nepal. ; White-N-J. Developmental Medicine and Child Neurology, 1977, Vol/Iss/Pg. 19/2 (208-212).Nervous endemic cretinism in Eastern Nepal. ; White-N-J. Developmental Medicine and Child Neurology, 1977, Vol/Iss/Pg. 19/2 (208-212). |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30293 |
| Study title: Notwendigkeit einer individuelen Jodprophylaxe, Ranke, M.; Kinderarzt 22, 617-622, 1991Notwendigkeit einer individuelen Jodprophylaxe, Ranke, M.; Kinderarzt 22, 617-622, 1991 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30294 |
| Study title: Optimal Strategy of Preoperative Transcatheter Arterial Chemoembolization for Hepatoblastoma. ; Ohtsuka-Y. Surgery Today, 2004, Vol/Iss/Pg. 34/2 (127-133)Optimal Strategy of Preoperative Transcatheter Arterial Chemoembolization for Hepatoblastoma. ; Ohtsuka-Y. Surgery Today, 2004, Vol/Iss/Pg. 34/2 (127-133) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30295 |
| Study title: Pediatric thoraco-lumbar paraspinal arteriovenous fistulas along the segmental nerve: Diagnosis and endovascular treatment. ; Niimi-Y. Interventional Neuroradiology, 2006, Vol/Iss /Pg. 12/SUPPL. 1 (158-162)Pediatric thoraco-lumbar paraspinal arteriovenous fistulas along the segmental nerve: Diagnosis and endovascular treatment. ; Niimi-Y. Interventional Neuroradiology, 2006, Vol/Iss /Pg. 12/SUPPL. 1 (158-162) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30296 |
| Study title: Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: A new circular ring compression device with a beveled edge. ; Ryu-C-W. American Journal of Neuroradiology, 2007, Vol/Iss /Pg. 28/3 (528-530)Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: A new circular ring compression device with a beveled edge. ; Ryu-C-W. American Journal of Neuroradiology, 2007, Vol/Iss /Pg. 28/3 (528-530) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30297 |
| Study title: Percutaneous embolization of a scalp arteriovenous malformation: Case report. ; Nistri-M. Rivista di Neuroradiologia, 2002, Vol/Iss/Pg. 15/6 (773-778)Percutaneous embolization of a scalp arteriovenous malformation: Case report. ; Nistri-M. Rivista di Neuroradiologia, 2002, Vol/Iss/Pg. 15/6 (773-778) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30298 |
| Study title: Percutaneous embolization with Ethiblocregistered trade mark of lymphatic cystic malformations with a review of the experience in 70 patients. ;Herbreteau-D. International Angiology, 1993, Vol/Iss/Pg. 12/1 (34-39)Percutaneous embolization with Ethiblocregistered trade mark of lymphatic cystic malformations with a review of the experience in 70 patients. ;Herbreteau-D. International Angiology, 1993, Vol/Iss/Pg. 12/1 (34-39) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30299 |
| Study title: The dental caries experience of 12 year old children in England and Wales2002-Pitts, Community Dental Health 2002 19, 46-53 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2002-Pitts-the dental caries experience of 12 year old children in England and Wales.pdf |
| View full study record |
| Document reference: 49089 |
| Study title: The effect of a fluoride gel used for supervising toothbrushing 15 to 30 times per yearMarthaler 1970 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Marthaler 1970 The effect of a fluoride gel.pdf |
| View full study record |
| Document reference: 49172 |
| Study title: The effect on human dental caries of weekly oral rinsing with a sodium fluoride mouth wash duraphat rinse clinical1971-Horowitz |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1971-Horowitz-the effect on human dental caries of weekly oral rinsing with a sodium fluoride mouthwashduraphat rinse clinical.pdf |
| View full study record |
| Document reference: 49127 |
| Study title: The effects of aminfluoride on nibition of caries in pre-school children and school children in rijekaOstric 1977 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Ostric 1977 The effects of aminfluoride.pdf |
| View full study record |
| Document reference: 49173 |
| Study title: The rationale for the administration of a NaF tablet supplement during pregnancy and postnatally in a private practice setting.Frances B. Glenn 1981, Journal of Dentistry for Children |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1981-Glenn-The Rationale for the Administration od a NaF Tablet Supple,ment during Pregnancy and Postnatally in a private practice setting.pdf |
| View full study record |
| Document reference: 48778 |
| Study title: The reduction of dental caries through use of a sodium fluoride mouthwash1960-Weisz |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1960-Weisz-the reduction of deental caries through use of a sodium fluoride mouthwash.pdf |
| View full study record |
| Document reference: 49125 |
| Study title: The relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico2004-stookey, caries research |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2004-stookey-the relative anticaries effectiveness of three fluoride-containing dentifrices in Puerto Rico.pdf |
| View full study record |
| Document reference: 49090 |
| Study title: The results of 3 year prophylaxis of caries through fluoride preparations in a solinger kindergarden G. Stolte, Aus dem Gesundheitsamt der Stadt Solingen |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1968-stolte-Ergebnisse dreijähriger Kariesprophylaxe durch orale Fluoridgaben in Solinger Kindergarten.pdf |
| View full study record |
| Document reference: 48783 |
| Study title: Use of fluorides by Finnish adolescentsHonkala ., Nyssonen V, Rimpela A, Scand J Dent Res 1984; 92: 517-23 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1984-honkala-Use of fluoride by finnish adolescents.pdf |
| View full study record |
| Document reference: 48769 |
| Study title: use of professionally administered flouride among Danish children1992-ambjerg |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1992-ambjerg-use of professionally administered flouride among Danish children.pdf |
| View full study record |
| Document reference: 49118 |
| Study title: Variation in caries prevalence related to combinations of dietary andoral hygiene habits and chewing fluoride tablets in 4 year old childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1978-granath-Caries prevalence related to combinations of dietary and oral hygiene habits and chewing fluoride tablets in 4 years old children.pdf |
| View full study record |
| Document reference: 48781 |
| Study title: Bowel preparation for colonoscopy with sodium picosulphate and magnesium citrate in children and adolescentsKawakami E, Portorreal A, Scuissiatto ML, Machado RS, Raguza D, Lozano L. , 2004, Arq Gastroenterol 2004; 41: 33 – 36 |
| Active substance: SODIUM PICOPSULPHATE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48902 |
| Study title: Is Bowel Preparation Required Before Cystoplasty in Children?Gundeti MS, Godpol PP, Wilcox DT. , 2006, The Journal of Urology 2006; 176: 1574 – 1577 |
| Active substance: SODIUM PICOPSULPHATE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48901 |
| Study title: Double-blind comparative study of Ultravist®, Solutrast® and Omnipaque® in excretory urography in children. |
| Active substance: IOPROMIDE |
| Study summary document link (including results): Bayer Pharma_Iopromide_85205_study_synopsis.pdf |
| View full study record |
| Document reference: 46900 |
| Study title: IOPROMIDE (SH L 414 C) in excretion urography in children. |
| Active substance: IOPROMIDE |
| Study summary document link (including results): Bayer Pharma_Iopromide_83111_study_synopsis.pdf |
| View full study record |
| Document reference: 46899 |
| Study title: Contrast quality and tolerability of iotrolan 300 in the diagnostic work-up of the upper gastrointestinal tract of infants and toddlers |
| Active substance: IOTROLAN |
| Study summary document link (including results): Bayer Pharma_Iotrolan_88058_study_synopsis.pdf |
| View full study record |
| Document reference: 30390 |
| Study title: Non-comparative open-label study of iotrolan 320 in angiocardiography in children up to 12 years of age |
| Active substance: IOTROLAN |
| Study summary document link (including results): Bayer Pharma_Iotrolan_94063_study_synopsis.pdf |
| View full study record |
| Document reference: 30389 |
| Study title: Open uncontrolled clinical trial of iotrolan 300 for gastrointestinal diagnosis in children |
| Active substance: IOTROLAN |
| Study summary document link (including results): Bayer Pharma_Iotrolan_86180_study_synopsis.pdf |
| View full study record |
| Document reference: 30388 |
| Study title: Open-label clinical study of iotrolan for assessment of subarachnoidal space in children |
| Active substance: IOTROLAN |
| Study summary document link (including results): Bayer Pharma_Iotrolan_85332_study_synopsis.pdf |
| View full study record |
| Document reference: 30391 |
| Study title: |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30393 |
| Study title: Evaluation of the accuracy of steady-state krypton-81m method for calculating right ventricular ejection fraction.Ham HR 1986, J Nucl Med. 1986 May;27(5):593-601. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Ham 1986.pdf |
| View full study record |
| Document reference: 48787 |
| Study title: Evaluation of the effects of nasal septal deviation and its surgery on nasal mucociliary clearance in both nasal cavities.Am J Rhinol. 2007 Mar-Apr;21(2):180-3. Ulusoy B 2007 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48790 |
| Study title: Evaluation of the ventilation-perfusion ratio in lung diseases by simultaneous anterior and posterior image acquisition. Ann Nucl Med. 1994 Nov;8(4):269-76. Nakata Y 1994 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48818 |
| Study title: Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. J Nucl Med. 1985 Sep;26(9): 1085-90. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Ahlgren 1985.pdf |
| View full study record |
| Document reference: 48786 |
| Study title: Extravasation from venous catheter: a serious complication potentially missed by lung imaging.Spicer KM 1983 J Nucl Med. 1983Nov;24(11):1023-6. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Spicer 1983.pdf |
| View full study record |
| Document reference: 48788 |
| Study title: Fatality immediately following rapid infusion of macroaggregates of 99mTc albumin (MAA) for lung scan. Radiology. 1968 Dec;91(6):1180-4 Vincent WR 1968 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48831 |
| Study title: Hepatopulmonary syndrome in Gaucher disease with right-to-left shunt: evaluation and measurement using Tc-99m MAA. Clin Nucl Med. 1999 Mar;24(3):164-6. Kim JH 1999 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48809 |
| Study title: Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med. 1987 Dec;28(12):1835-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48839 |
| Study title: Bone scans in neuroblastoma.Bhogate BM, Samuel AM, Ramanathan P. Indian J Cancer 1993 Mar;30(1):5-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48571 |
| Study title: "Controlled, randomised, parallel-group, single-centre clinical trial in patients; Duration: Expected treatment duration was 15 days. " Durand 1986 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Durand 1986.xls |
| View full study record |
| Document reference: 48149 |
| Study title: Controlled, randomised, single-blind, parallel-group, single-centre clinical trial in patients; Duration: Treatment was 4 weeks (28 consecutive days). Report 1744 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Report 1744.xls |
| View full study record |
| Document reference: 48152 |
| Study title: Gallet, J.P. (1990) Lactitol monohydrate (Importal) for treatment of constipation in children. Results of a clinical investigation. Rev. Pediatr, 26 (8), 1-8.Gallet, J.P. (1990) Lactitol monohydrate (Importal) for treatment of constipation in children. Results of a clinical investigation. Rev. Pediatr, 26 (8), 1-8. |
| Active substance: LACTITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30987 |
| Study title: Kokki H, Tuomilehto H, Karvinen M. Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children. Eur J Clin Pharmacol. 2001 Nov;57(9):643-7.Kokki H, Tuomilehto H, Karvinen M. Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children. Eur J Clin Pharmacol. 2001 Nov;57(9):643-7. |
| Active substance: LACTITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30988 |
| Study title: “Metabolism of lactitol” Investigator: Prof. H. Doorenbos Report date: NR“Metabolism of lactitol” Investigator: Prof. H. Doorenbos Report date: NR |
| Active substance: LACTITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30985 |
| Study title: Open-label, non-comparative clinical trial in patients and healthy subjects. Doorenbos H |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Doorenbos H.xls |
| View full study record |
| Document reference: 48147 |
| Study title: Open-label, non-comparative clinical trial in patients Gallet JP 1990 |
| Active substance: Lactitol |
| Study summary document link (including results): Importal_Gallet JP_1990.xls |
| View full study record |
| Document reference: 48155 |
| Study title: Open-label, non-comparative clinical trial in patients Duillo MT 1986 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Duillo MT_1986.xls |
| View full study record |
| Document reference: 48148 |
| Study title: Open-label, non-comparative clinical trial in patients. D'Apuzzo 1986 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_D'Apuzzo V_1986.xls |
| View full study record |
| Document reference: 48146 |
| Study title: Open-label, non-comparative clinical trial in patients. Gallet 1986 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Gallet_JP_1986.xls |
| View full study record |
| Document reference: 48150 |
| Study title: Open-label, non-comparative clinical trial in patients. Giambonini S_1986 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Giambonini S_1986.xls |
| View full study record |
| Document reference: 48151 |
| Study title: Placebo controlled, randomised, double-blind, parallel-group, multicentre clinical trial in patients; Duration: Treatment was 14 consecutive days;Medication: Sachets containing 2.5 g lactitol or 2.5 g placebo. Report Zy 15060 BG-95-F7 |
| Active substance: Lactitol |
| Study summary document link (including results): 2011_EMAspreadsheet_Importal_Report Zy 15060 BG-95-F7.xls |
| View full study record |
| Document reference: 48153 |
| Study title: Experimental use of macrodex as a prophylaxis against post-operative thrombo-embolism.KOEKENBERG LJ. Bull Soc Int Chir. 1962 Sep-Oct;21:501-12. |
| Active substance: Dextran |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48938 |
| Study title: Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40.Renck H, Ljungström KG, Hedin H, Richter W. Acta Chir Scand. 1983;149(4):355-60. |
| Active substance: Dextran |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48941 |
| Study title: Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch. ;Huang-F. British Journal of Radiology, 2003, Vol/Iss/Pg. 76/910 (746-749)Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch. ;Huang-F. British Journal of Radiology, 2003, Vol/Iss/Pg. 76/910 (746-749) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30300 |
| Study title: Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement. Alomari-A-I. Journal of Vascular and Interventional Radiology, 2006, Vol/Iss/Pg. 17/10 (1639-1648), 0443.Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement. Alomari-A-I. Journal of Vascular and Interventional Radiology, 2006, Vol/Iss/Pg. 17/10 (1639-1648), 0443. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30301 |
| Study title: Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d'Ivoire. ;Zimmermann-M. American Journal of Clinical Nutrition, 2000, Vol/Iss /Pg. 71/1 (88-93)Persistence of goiter despite oral iodine supplementation in goitrous children with iron deficiency anemia in Cote d'Ivoire. ;Zimmermann-M. American Journal of Clinical Nutrition, 2000, Vol/Iss /Pg. 71/1 (88-93) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30302 |
| Study title: Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography. ;Fairlie-N-C. Clinical Radiology, 1991, Vol/Iss/Pg. 44/4 (273-274)Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography. ;Fairlie-N-C. Clinical Radiology, 1991, Vol/Iss/Pg. 44/4 (273-274) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30303 |
| Study title: Efficacy and safety of loratadina-betamethasone combination in the initial treatment of severe perennial allergic rhinitis in children |
| Active substance: LARATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31019 |
| Study title: Efficacy and Safety of SCH 29851 8 mg in Subjects with Allergic Rhinitis |
| Active substance: LARATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31017 |
| Study title: Efficacy and Safety of SCH 29851 in 8 mg in Subjects with Allergic Rhinitis |
| Active substance: LARATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31015 |
| Study title: Efficacy and Safety of SCH 29851 in 8 mg in Subjects with Allergic Rhinitis |
| Active substance: LARATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31018 |
| Study title: HEALTH ECONOMIC DRUG UTILIZATION OBSERVATION "XPENSE" FOR COMPARISON OF THE COSTS OF DIFFERENT MEDICAL GLAUCOMA THERAPIES |
| Active substance: LATANOPROST/LATANOPROST AND TIMOLOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31021 |
| Study title: Björklund SI. Miniture enema in children’s practice. The Swedish Medical Journal 1961:58:2763-2766. Devaux j, Bernard JL, Mouly-Bandini a, Raybaud CI. Use of a peptisant gel in a pediatric ward. Méditerranée Médicale 1975:3:65-68 No.67 (English translation). Björklund SI. Miniture enema in children’s practice. The Swedish Medical Journal 1961:58:2763-2766. Devaux j, Bernard JL, Mouly-Bandini a, Raybaud CI. Use of a peptisant gel in a pediatric ward. Méditerranée Médicale 1975:3:65-68 No.67 (English translation). |
| Active substance: LAURYL SULPHATE AND SORBITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31024 |
| Study title: Grosse K-P, Keller KM, Behrens R, Becker M. Chronische Obstipation im Kindesalter. Monatsschr Kinderheilk 1990:138:231-233. Grosse K-P, Keller KM, Behrens R, Becker M. Chronische Obstipation im Kindesalter. Monatsschr Kinderheilk 1990:138:231-233. |
| Active substance: LAURYL SULPHATE AND SORBITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31026 |
| Study title: Nolan T, Debelle G, Oberklaid F, Coffey C. Randomised trial of laxatives in treatment of childhood encopresis. Lancet 1991:338:523-527. Nolan T, Debelle G, Oberklaid F, Coffey C. Randomised trial of laxatives in treatment of childhood encopresis. Lancet 1991:338:523-527. |
| Active substance: LAURYL SULPHATE AND SORBITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31025 |
| Study title: Pharmacia Consumer Pharma report on the Clinical Documenation on Microlax Enema; Helsingborg May 1995, Jan RundegrenPharmacia Consumer Pharma report on the Clinical Documenation on Microlax Enema; Helsingborg May 1995, Jan Rundegren |
| Active substance: LAURYL SULPHATE AND SORBITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31027 |
| Study title: Rett A. Die Obstipaton als Klinisch-terapeutishes Problem hirngeschädigter Kinder. Therapeutische Umschau 1996:23:165-169. Rett A. Die Obstipaton als Klinisch-terapeutishes Problem hirngeschädigter Kinder. Therapeutische Umschau 1996:23:165-169. |
| Active substance: LAURYL SULPHATE AND SORBITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31022 |
| Study title: Strauss P. Die Behandlung der kindlichen Obstipation unter Verwendung eies neuen Mikroklistiers. Deut Med J 1965:16:476-478. Strauss P. Die Behandlung der kindlichen Obstipation unter Verwendung eies neuen Mikroklistiers. Deut Med J 1965:16:476-478. |
| Active substance: LAURYL SULPHATE AND SORBITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31023 |
| Study title: |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47352 |
| Study title: Randomised trial of two pharmacological methods of bowel preparation for day case colonoscopyPinfield A, Stringer MD., 1999, Arch Dis child 1999; 80: 181 - 183 |
| Active substance: SODIUM PICOPSULPHATE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48903 |
| Study title: Safety of Picolax in inflammatory bowel disease.Evans M, Walker-Smith J, Williams Ch., 1989, BMJ 1989; 299: 1101 – 1102 |
| Active substance: SODIUM PICOPSULPHATE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48900 |
| Study title: The superiority of topical application of stannous fluoride on primary teeth1957-McDonald |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1957-McDonald-the superiority of topical application of stannous fluoride on primary teeth.pdf |
| View full study record |
| Document reference: 49135 |
| Study title: The use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children1972-Brandt |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1972-Brandt-the use of a sodium fluoride mouthwash in reducing the dental caries increment in eleven year old english school children.pdf |
| View full study record |
| Document reference: 49128 |
| Study title: Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water1982-seppa |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1982-seppa-Three year report on caries prevention using I fluoride varnish for caries risk children in a community with fluoridated water.pdf |
| View full study record |
| Document reference: 49109 |
| Study title: Topical application of a fluoride protective varnish for caries prophylaxis1973-maiwald |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1973-maiwald-Topical application of a fluoride protective varnish for caries prophylaxis.pdf |
| View full study record |
| Document reference: 49101 |
| Study title: Trends in total caries experience2000-Brown |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2000-Brown-trends in total caries experience.pdf |
| View full study record |
| Document reference: 49097 |
| Study title: Two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children1965-Torell |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1965-Torell-two-year clinical tests with different methods of local caries-preventive fluorine application in swedish school-children.pdf |
| View full study record |
| Document reference: 49126 |
| Study title: Fluorine concentration in primary tooth enamel in 6 year olds after 3 years of daily intake of fluoride-containing tablets.J. Widenheim, Lars G Petersson, Goran Koch 1984, Swed Dent J |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1984-widenheim-Fluoide concentration in primary tooth enamel in 6 years oldy after 3 years of daily intake of fluoridecontaining tablets.pdf |
| View full study record |
| Document reference: 48777 |
| Study title: Fluroide in the prevention of caries in the pre-school childRugg 19990. J. Dent |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1990-Rugg_Gunn-Fluoride in the Prevention of Caries in the Pre-school Child.pdf |
| View full study record |
| Document reference: 48774 |
| Study title: Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children1994-skold, Community Dent. Oral Epidemiol. 1994 22:18-24 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1994-skold-Four year study of caries inhibition of intensive Duraphat application in 11-15 year old children.pdf |
| View full study record |
| Document reference: 49119 |
| Study title: Gingival recession and wedge-shaped defects with regular use of an amine fluoride-containing gel applied with a toothbrushSchiffner 1995 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Schiffner 1995 Gingival recession and wedge-shaped.pdf |
| View full study record |
| Document reference: 49177 |
| Study title: High-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic bands2010-AlMulla |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2010-AlMulla-high-fluoride toothpaste and no post-brushing water rinsing on enamel demineralization using an in-sit caries model with orthodontic b... |
| View full study record |
| Document reference: 49098 |
| Study title: Bone scintigraphy in calcific discitis of childhood. Delpassand ES, Barron BJ, Gundzik JM. J Nucl Med. 1990 Feb;31(2):234-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48843 |
| Study title: Bone scintigraphy in testicular tumors.Braga FJ, Arbex MA, Haddad J, Maes A. Clin Nucl Med 2001 Feb;26(2):117-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48577 |
| Study title: K.E.E.P.E.R. (KEPPRA(R) EPILEPSY EVALUATION OF PATIENT TIME TO RESPONSE). A PHASE IV, OPEN-LABEL, MULTI-CENTER, COMMUNITY-BASED TRIAL STUDYING THE SAFETY AND EFFICACY OF LEVETIRACETAM AS ADD-ON THERAPY IN ADULT PATIENTS WITH TREATMENT-RESISTANT, PARTIAL-ONSET EPILEPSY. |
| Active substance: levetiracetam |
| Study summary document link (including results): N01030 - Levetiracetam - RRCE02E1301.pdf |
| View full study record |
| Document reference: 31147 |
| Study title: Bone scintigraphy in the diagnosis and follow up of Perthes' disease.Cavailloles F, Bok B, Bensahel H. Eur J Nucl Med 1982;7(7):327-30. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48588 |
| Study title: Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastomaMacdonald WB. Stevens MM. Dalla Pozza L. Bergin M. Menser MA. Howman-Giles R. et al. J Nucl Med 1993Jul;34(7):1082-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48502 |
| Study title: Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000 Sep;118(3):615-24. Krowka MJ 2000 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48803 |
| Study title: Irreversible long-term pulmonary functional impairments after adenovirus type-7 pneumonia: assessment with xenon-133 ventilation and Tc-99m MAA perfusion studies. Eur Radiol. 2000;10(9):1411-5. Suga K 2000 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48802 |
| Study title: Krypton-81m ventilation and technetium-99m macroaggregated albumin perfusion scintigraphy for detection of pulmonary embolism: the first experience in Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 2000 Dec;63(12):876-84. Cherng SC 2000 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48801 |
| Study title: Late pulmonary scintigraphic defects after uneventful recovery from focal pneumonia in children: comparison with initial radiograph. Med Sci. 2002 Jul;18(7):334-9. Kaohsiung J 2002 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48798 |
| Study title: Late pulmonary scintigraphic defects after uneventful recovery from simple focal pneumonia of childhood. Br J Radiol. 1993 Nov;66(791):1031-4. Kenney IJ 1993 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48819 |
| Study title: Gastric uptake of Tc-99m MDP in a child treated with isotretinoin.Franco A, Hampton WR, Greenspan BS, Holm AL, O'Mara RE. Clin Nucl Med 1993 18(6):510-1. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48723 |
| Study title: Acute asthma management of children in the emergency department. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30563 |
| Study title: Low dose oral iodized oil for control of iodine deficiency in children. ; Zimmermann-M. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/2 (139-141)Low dose oral iodized oil for control of iodine deficiency in children. ; Zimmermann-M. British Journal of Nutrition, 2000, Vol/Iss/Pg. 84/2 (139-141) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30283 |
| Study title: Dal Monte. Gastroenterology Dept Bellaria Hospital, Regional Hospital Institution-Hospital of Bologna Dal Monte. Gastroenterology Dept Bellaria Hospital, Regional Hospital Institution-Hospital of Bologna |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30095 |
| Study title: AN 05134405 Medline 20070101. TI (Use of cyproheptadine to obtain recovery of the weight curve after tonsillectomy. Clinico-statistical observations on 91 cases). TT Sull'impiego della ciproeptadina per l'ottenimento di una ripresa della curva ponderale dopo l'intervento di tonsillectomia. Osservazioni clinico-statistich su 91 casi. SO Minerva otorinolaringologica, {Minerva-Otorinolaringol}, Sep-Oct 1971, vol. 21, no. 5, p. 191-5, ISSN: 0026-4938. AU Fior-R. YR 1971.AN 05134405 Medline 20070101. TI (Use of cyproheptadine to obtain recovery of the weight curve after tonsillectomy. Clinico-statistical observations on 91 cases). TT Sull'impiego della ciproeptadina per l'ottenimento di una ripresa della curva ponderale dopo l'intervento di... |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25204 |
| Study title: Phase IV Efficacy and Safety Study of Reformulated CoTylenol Tablets. Nov 1978. |
| Active substance: DEXTROMETHOPRHAN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25797 |
| Study title: Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25301 |
| Study title: Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - |
| Active substance: DAUNORUBICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25617 |
| Study title: No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25401 |
| Study title: Paul IM et al. Dose-response relationship with increasing doses of dextromethorphan for children with cough. Clin Ther 2004; 26(9):1508-1514 |
| Active substance: Dextromethorphan + GUAFENESIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25913 |
| Study title: Gikas P, Mokbel K. Management of gynaecomastia: an update [Review]. International Journal of Clinical Practice 2007; 61(7):1209-1215.Gikas P, Mokbel K. Management of gynaecomastia: an update [Review]. International Journal of Clinical Practice 2007; 61(7):1209-1215. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43085 |
| Study title: AN OPEN STUDY OF CEFOPERAZONE PLUS SULBACTAM IN THE TREATMENT OF SEVERE SKIN AND SKIN STRUCTURE INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42638 |
| Study title: CLINICAL USEFULNESS OF SULTAMICILLIN FINE GRANULES FOR TONSILLITIS AND ACUTE BRONCHITIS OF CHILDREN |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43006 |
| Study title: Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphomaRadiotherapy and Oncology 73 (2004) 277–283. Young K. Leea,e,*, Gary Cookb, Maggie A. Flowera, Carl Rowbottomc, Mehdi Shahidid, Bhupinder Sharmab, Steve Webba |
| Active substance: Steripet |
| Study summary document link (including results): lee-2004.pdf |
| View full study record |
| Document reference: 48736 |
| Study title: Application of Intravenous Contrast in PET/CT:Does It Really Introduce Significant Attenuation Correction Error?J Nucl Med 2005; 46:283–291. Yat-Yin Yau, MD1; Wing-Sze Chan, BSc1; Yat-Man Tam, MSc1; Phil Vernon, PhD2; So Wong1; Marc Coel, MD3; and Simon Kwok-Fai Chu1 |
| Active substance: Steripet |
| Study summary document link (including results): yau-2005.pdf |
| View full study record |
| Document reference: 48747 |
| Study title: ARSAC (Administration of Radioactive Substances Advisory Committee). Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and Use of Sealed Radioactive Sources.Chilton, Didcot, 2006. [arsac-2006]. ARSAC 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48626 |
| Study title: |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47353 |
| Study title: |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47354 |
| Study title: Double-blind, eight-month extension study to collect durability of efficacy data and additional safety data in patients with juvenile rheumatoid arthritis completing the double-blind comparison study HWA486/3503 of leflunomide versus methotrexate |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): Leflunomide-Study 3.pdf |
| View full study record |
| Document reference: 47350 |
| Study title: Efficacy and safety of leflunomide versus methotrexate in the treatment of pediatric patients with juvenile rheumatoid arthritis (JRA) |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): Leflunomide-Study 2.pdf |
| View full study record |
| Document reference: 47349 |
| Study title: Phase IB Trial of Leflunomide in Pediatric Subjects with Polyarticular Course Juvenile Rheumatoid Arthritis (JRA) |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): Leflunomide-Study 1.pdf |
| View full study record |
| Document reference: 47348 |
| Study title: Population pharmacokinetics of A77 1726 (M1) after oral administration of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis |
| Active substance: LEFLUNOMIDE |
| Study summary document link (including results): Leflunomide-Study 4.pdf |
| View full study record |
| Document reference: 47351 |
| Study title: Compatibility of Lomaherpan Cream in children with herpes simplex labialis 1995 |
| Active substance: Lemon balm dry extract |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40047 |
| Study title: Q Clinical impact of fluorine-18fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.JNucl Med Mol Imaging. 2006 Mar;50(1):68-77. Andrieux A 2006 |
| Active substance: SteriPET |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48624 |
| Study title: Rigacci L, Castagnoli A, Dini C, Carpaneto A, Matteini M, Alterini R. FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. [rigacci-2005]Oncol Rep. 2005 Nov;14(5):1209-14. 18. Rigacci L 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48692 |
| Study title: Rini JN, Manalili EY, Hoffman MA, Karayalcin G, Mehrotra B, Tomas MB, et alFDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. [rini-2002]Clin Nucl Med. 2002 Aug;27(8):572-7. F-18. Rini JN 2002 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48693 |
| Study title: Rixham PA, Roberts G. The new EANM paediatric dosage card : how does it affect UK centres working under the ARSAC guidelines? [rixham-2009]Nucl Med Comm 2009; 319 – 321. Rixham PA 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48694 |
| Study title: Schifter T, Hoffman JM, Hatten HP Jr, Hanson MW, Coleman RE, DeLong GR.. Neuroimaging in infantile autism. [schifter-1994]J Child Neurol. 1994 Apr;9(2):155-61. Schifter T 1994 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48695 |
| Study title: Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O.. Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. [schmitz-2001]Eur Spine J. 2001 Dec;10(6):534-9. Schmitz A 2001 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48696 |
| Study title: Shulkin BL, Goodin GS, McCarville MB, Kaste SC, Krasin MJ, Hudson MM, Metzger M.. Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. [shulkin-2009 Leuk Lymphoma. 2009 Nov;50(11):1794-802. Shulkin BL 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48698 |
| Study title: Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC.. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. [shulkin-1996]Radiology. 1996 Jun;199(3):743-50. Shulkin BL 1996 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48697 |
| Study title: Incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluoridated water1971-Englander |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1971-Englander-incremental rates of dental caries after repeated topical sodium fluoride applications in children with lifelong consumption of fluo... |
| View full study record |
| Document reference: 49093 |
| Study title: Jarman underproveleged area scores, tooth decay and the effect of water fluoridation1997-jones |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1997-jones-Jarman underproveleged area scores, tooth decay and the effect of water fluoridation.pdf |
| View full study record |
| Document reference: 49123 |
| Study title: Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes1980-treide |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1980-treide-Kollective Karies pravention in Vorchulatter unter Verwendung eines Fluoridhaltingen lackes.pdf |
| View full study record |
| Document reference: 49107 |
| Study title: Kollektive VorbeugungsprogrammeMagri 1986 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Magri 1986 Kollektive Vorbeugungsprogramme.pdf |
| View full study record |
| Document reference: 49169 |
| Study title: Long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients1994-boyd |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1994-boyd - long term evaluation of a SnF2 gel for control of gingivitis and decalcification in adolescent orthodontic patients.pdf |
| View full study record |
| Document reference: 49157 |
| Study title: NHS dental epidemology programme for England2010-Rooney |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2010-Rooney-NHS dental epidemology programme for England.pdf |
| View full study record |
| Document reference: 49092 |
| Study title: Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries: a reactors comments1981-Stamm. Journal of Dentistry for Children, March - April, 1951 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1981-Stamm-Perspectives on the use of Prenatal Fluoride Administration for Prevention of Dental Caries.pdf |
| View full study record |
| Document reference: 48772 |
| Study title: Pharmacokinetics of Fluoride gelsEkstrand 1981, Caries Res 15:213 - 220 (1981) |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Ekstrand 1981 Pharmacokinetics of Fluoride gels.pdf |
| View full study record |
| Document reference: 49163 |
| Study title: Pilot caries prevention- Modellversuch der KariesprophylaxeStöhr 1979 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Steiner 1984 Enamel opacities in the incisors of school children.pdf |
| View full study record |
| Document reference: 49181 |
| Study title: Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Duraphat1980-ekstrand, Caries Res, 14: 185-189 1980 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1980-ekstrand-Plasma fluoride concentration and urinary fluoride excretion in children following application of the fluoride containing varnish Dur... |
| View full study record |
| Document reference: 49106 |
| Study title: Pre-eruptive effect of NaF tablets on caries in children from 12 to 17 years of ageJ. Widenheim, Dowen Birked, Lars Granath, Georg Lindgren 1986. Community Dent Oral Epidemiol |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1986-Widenheim-Preeruptive effect of NaF Tablets on Caries in Children from 12 to 17 years of age.pdf |
| View full study record |
| Document reference: 48776 |
| Study title: Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications1959-Abdul-Gaffar, J DENT RES 1959 38: 901 H. Abdul-Ghaffar and Joseph C. Muhler |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1959-Abdul-Gaffar- Pretreatment of teeth with sodium fluoride prior to stannous fluoride applications.pdf |
| View full study record |
| Document reference: 49136 |
| Study title: Prevention of caries progress in xerostomic patients by topical fluoride applicationsMarkitziu 1982 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Markitziu 1982 Prevention of caries progress.pdf |
| View full study record |
| Document reference: 49171 |
| Study title: L'Ipratropium bromide in the treatment of asthma-like bronchitis in babies.Clin.Ped. 1981,63,1-7Corrias A. et al ClinPed 1981, Corrias |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): ClinPed 1981, Corrias.pdf |
| View full study record |
| Document reference: 48889 |
| Study title: Measurements on the rapid and medium-acting bronchodilating effect of ipratropium bromide administered by aerosol in children with allergic bronchial asthma. Arch Med Int 1981,33,25-40Capristo A. et al ArchMedInterna 1981, Capristo |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): ArchMedInterna 1981, Capristo.pdf |
| View full study record |
| Document reference: 48888 |
| Study title: Role of buclizine hydrochloride in promoting weight gain in children |
| Active substance: Buclizine |
| Study summary document link (including results): DE81G307P - Buclizine hydrochloride.pdf |
| View full study record |
| Document reference: 42007 |
| Study title: A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Investigative radiology (1991), 26(7), 665-70 Pelech AN 1991 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48863 |
| Study title: A) Open non-comparative pilot study B) randomized, double-blind, parallel study using Amipaque (metrizamide) 300 mgI/ml as comparison in pediatric urography to assess the safety, tolerability and image effectiveness of iohexol 300 mgI/ml firstly in an open study and later compared to Amipaque 300 mgI/ml.Applicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48887 |
| Study title: Impact of ibuprofen administration on renal drug clearance in the first weeks of life. |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29913 |
| Study title: A comparative study to compare the effects of BDP and BUD of symptoms, peak-flow diaries. Lung function and hypothalamic-adrenal function |
| Active substance: BUDESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48892 |
| Study title: Comparison of the risk of nocturnal hypoglycemia in adolescents with type 1 diabetes mellitus given either HOE901 with lispro or NPH insulin with regular human insulin, as multiple injection regimens |
| Active substance: INSULIN GLARGINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47341 |
| Study title: Morning Lantus® (insulin glargine [rDNA origin] injection) vs. intermediateacting insulin twice daily as basal insulin in a multiple daily injection regimen with Humalog® (insulin lispro injection [rDNA Origin]) in pediatrics with type 1 diabetes mellitus: an activeontrolled, open, randomized, gender-stratified, two arm, parallel-group study. |
| Active substance: INSULIN GLARGINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47342 |
| Study title: Multicenter, open, uncontrolled clinical extension trial of HOE901 in type 1 diabetic children previously participating in study HOE901/3003. |
| Active substance: INSULIN GLARGINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47340 |
| Study title: Lai C.L. Open, pilot (phase II) study comparing patients treated with interferon alfa-2a with an untreated control group, in chinese chidren with chronic hepatitis B (Protocol 0-10002); 30th May 1988 (Leitz G.J., Rochefort E., Ryff J.C.) |
| Active substance: INTERFERON ALPHA (2A) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30188 |
| Study title: V. Carreno M.D. Open, single centre pilot (phase II) study comparing patients treated with interferon alfa-2a with an untreated control group in children with chronic hepatitis B (Protocol 0-10002); 30th May 1988 (Leitz G.J., Rochefort E., Ryff J.C.) |
| Active substance: INTERFERON ALPHA (2A) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30189 |
| Study title: Treatment of Early Onset Mulitple Sclerosis with Suboptimal Dose of Interferon Beta-1a (Pakdaman et al) |
| Active substance: Interferon beta-1a |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41483 |
| Study title: |
| Active substance: INTERFERON GAMMA (1B |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47176 |
| Study title: 107.162, 107.235 - A Population pharmacokinetic analysis for meloxicam in pediatric juvenile rheumatoid arthritis patients – A combined analysis of pharmacokinetic data obtained in studies 107.162 and 107.235 |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30200 |
| Study title: 137158 - Clinical efficacy of recombinant human interferon-gamma in chronic granulomatous disease. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30192 |
| Study title: ARSAC website http://www.arsac.org.uk/newsletter/newsletters.htm ; accessed 27 January 2010 [arsac-2009]ARSAC 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48627 |
| Study title: Bar-Shalom R, Gaitini D, Keidar Z, Israel O.. Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. [bar-shalam-2004Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1105-13. Epub 2004 Mar 9. Bar-Shalom R 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48628 |
| Study title: Barrington SF, Begent J, Lynch T, Schleyer P, Biassoni L, Ramsden W, et al.. Guidelines for the use of PET–CT in children. [barrington-2008]Nucl Med Commun 2008; 29:418–424. Barrington SF 2008 |
| Active substance: Steripet |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48629 |
| Study title: Bastiaannet E, Oyen WJ, Meijer S, Hoekstra OS, Wobbes T, Jager PL, et al.. Impact of 18F] fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients. [bastiaannet-2006]Br J Surg. 2006 Feb;93(2):243-9. Bastiaannet E 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48631 |
| Study title: Bestic JM, Peterson JJ, Bancroft LW.. Review. Erratum in: Radiographics. 2010 Jan-Feb;30(1):301. Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected]. [bestic-2009] Radiographics. 2009 Sep-Oct;29(5):1487-500. Bestic JM 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48632 |
| Study title: Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, Arends B, Verzijlbergen FJ, Zijlstra J, Paans AM, Comans EF,. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. [boellaard-2008]Pruim J Eur J Nucl Med Mol Imaging 2008 12:2320–2333. Boellaard R 2008 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48633 |
| Study title: Borgwardt L, Højgaard L, Carstensen H, Laursen H, Nowak M, Thomsen C, et al.. Increased fluorine-18 2-fluoro-2-deoxy-Dglucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion. [borgwardt-2005]J Clin Oncol. 2005 May 1;23(13):3030-7. Borgwardt L 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48634 |
| Study title: Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, et al.. Epub 2006 Jan 11. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. [brenner-2006]Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. Brenner W 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48635 |
| Study title: Buchmann I, Reinhardt M, Elsner K, Bunjes D, Altehoefer C, Finke J, et al.. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. [buchmann-2001]Cancer. 2001 Mar 1;91(5):889-99. Buchmann I, 2001 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48636 |
| Study title: Endemic goiter in rural peru: Effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitres populations; E.A. Pretell. Pan American Health Organization: Chapter 34 :419-437Endemic goiter in rural peru: Effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitres populations; E.A. Pretell. Pan American Health Organization: Chapter 34 :419-437 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30245 |
| Study title: Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2- cyanoacrylate. ; Dhiman-R-K. Journal of Clinical Gastroenterology, 2002, Vol /Iss/Pg. 35/3 (222-227)Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2- cyanoacrylate. ; Dhiman-R-K. Journal of Clinical Gastroenterology, 2002, Vol /Iss/Pg. 35/3 (222-227) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30246 |
| Study title: Strategy of goitre and cretinism control in Central Africa; C H Thilly. International journal of epidemiology Vol. 6 n0. 1: 43-54Strategy of goitre and cretinism control in Central Africa; C H Thilly. International journal of epidemiology Vol. 6 n0. 1: 43-54 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30325 |
| Study title: Strumatherapie heute, Köbberling; Med. Klein. 87, 374-377, 1992Strumatherapie heute, Köbberling; Med. Klein. 87, 374-377, 1992 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30326 |
| Study title: Successful left hepatectomy for hepatocellular carcinoma in a child after transcatheter arterial chemoembolization: Report of a survival. ; Uemura-S, T. European Journal of Pediatric Surgery, 1993, Vol /Iss/Pg. 3/1 (54-56)Successful left hepatectomy for hepatocellular carcinoma in a child after transcatheter arterial chemoembolization: Report of a survival. ; Uemura-S, T. European Journal of Pediatric Surgery, 1993, Vol /Iss/Pg. 3/1 (54-56) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30327 |
| Study title: Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolization. ; Kitahara-S. Journal of Pediatric Surgery, 1995, Vol/Iss/Pg. 30/12 (1709-1712)Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolization. ; Kitahara-S. Journal of Pediatric Surgery, 1995, Vol/Iss/Pg. 30/12 (1709-1712) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30328 |
| Study title: Technique of the lipiodol test in pediatrics (Russian). ; Livshitz-E-G. LAB-DELO, 1973, Vol/Iss/Pg. 12/- (740-741). Technique of the lipiodol test in pediatrics (Russian). ; Livshitz-E-G. LAB-DELO, 1973, Vol/Iss/Pg. 12/- (740-741). |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30329 |
| Study title: Techniques and Applications of Transcatheter Embolization Procedures in Pediatric Cardiology. ; Sim-J-Y. Journal of Interventional Cardiology, 2003, Vol /Iss/Pg. 16/5 (425-448)Techniques and Applications of Transcatheter Embolization Procedures in Pediatric Cardiology. ; Sim-J-Y. Journal of Interventional Cardiology, 2003, Vol /Iss/Pg. 16/5 (425-448) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30330 |
| Study title: The effect of varying doses of oral iodized oil in the prophylaxis of endemic goitre in elementary schools children. ; Abuye-C. Ethiopian Medical Journal, 1995, Vol/Iss/Pg. 33/2 (115-123)The effect of varying doses of oral iodized oil in the prophylaxis of endemic goitre in elementary schools children. ; Abuye-C. Ethiopian Medical Journal, 1995, Vol/Iss/Pg. 33/2 (115-123) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30331 |
| Study title: The huon peninsula endemic: The effectiveness of an intramuscular depot of iodized oil in the control of endemic goitre.;Mc Cullagh. The medicinal journal of Australia 769-777The huon peninsula endemic: The effectiveness of an intramuscular depot of iodized oil in the control of endemic goitre.;Mc Cullagh. The medicinal journal of Australia 769-777 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30332 |
| Study title: A dose-finding study of a super-long acting luteinizing hormone releasing hormone analogue in the treatment of central precocious puberty |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31052 |
| Study title: A study of clinical utility of a sustained release injection of leuprorelin acetate in the treatment of patients with central precocious puberty |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31051 |
| Study title: Clinical trial to evaluate efficacy and tolerability of subcutaneously administered leuprorelin acetate as a 1-month depot in a weight-dependent dosage in female patients with central precocious puberty + Biometrical report- interim results on bone metabolism |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): 2011-08-11 Leuprorelin EC08(128)_EC108 Synopsis.pdf |
| View full study record |
| Document reference: 31043 |
| Study title: Efficacy and safety of leuprorelin 3.75 mg administered by subcutanous injection every 28 days in the treatment of central precocious puberty |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): 2011-08-11 Leuprorelin TAP-III-90-004 Synopsis.pdf |
| View full study record |
| Document reference: 31050 |
| Study title: Leuproreline acetate in the treatment of central precocious puberty: a 12-month, multicenter, randomised, equivalence trial of two different depot formulations |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): Leuprorelin_LEUb_CPP3M14_Synopsis.pdf |
| View full study record |
| Document reference: 31048 |
| Study title: Leuproreline acetate in the treatment of central precocious puberty: a 12-month, multicenter, randomised, equivalence trial of two different depot formulations |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): Leuprorelin_LEUb_CPP3M14_Synopsis.pdf |
| View full study record |
| Document reference: 31045 |
| Study title: Lupron Injection (Lupron depot) combined results of independent investigators' studies of Leuprolide acetate in the treatment of central precocious puberty |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): 2011-08-11 Leuprorelin P-90-053 Synopsis.pdf |
| View full study record |
| Document reference: 31049 |
| Study title: Prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel1979-shannon |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1979-shannon - prevention of decalcification in orthodontic patients by daily self treatment with 0.4 percent SnF2 gel.pdf |
| View full study record |
| Document reference: 49154 |
| Study title: Preventive effect of high-fluoride dentifrice in caries-active adolescents2010-Nordstrom |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2010-Nordstrom-preventive effect of high-fluoride dentifrice in caries-active adolescents.pdf |
| View full study record |
| Document reference: 49099 |
| Study title: Reduction in dental caries with four concentrations of sodium fluoride in a dentifrice: a meta-analysis evaluation2001-Bartizek, The journal of clinical dentistry |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2001-Bartizek-reduction in dental caries with four concentrations of sodium fluoride in a dentifrice.pdf |
| View full study record |
| Document reference: 49087 |
| Study title: Relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year2001-Biesbrock, Community dentistry and oral epidemiology |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2001-Biesbrock-relative anti-caries efficacy of 1100, 1700, 2200 and 2800 ppm fluoride ion in a sodium fluoride dentifrice over 1 year.pdf |
| View full study record |
| Document reference: 49088 |
| Study title: Results of a 3-year oral hygiene programmeDénes 1991, european Journal of Orthodontics 13 (1991) 129-133 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Dénes 1991 Results of a 3-year oral hygiene programme.pdf |
| View full study record |
| Document reference: 49161 |
| Study title: Results of a group prophylaxis programmeBüttner 1985 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Büttner 1985 Results of a group prophylaxis programme.pdf |
| View full study record |
| Document reference: 49158 |
| Study title: Results of a three-year investigation about Zahneputzen with an amine fluoride gels - Ergebnisse einer dreijährigen untersuchung uber Zahneputzen mit einem Aminfluorid-geleSzöke 1989 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Szöke 1989 Ergebnisse einer dreijährigen.pdf |
| View full study record |
| Document reference: 49182 |
| Study title: Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months1985-clark |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1985-clark-Results of the Sherbrooke-Lac Megtanic fluoride varnish study after 20 months.pdf |
| View full study record |
| Document reference: 49112 |
| Study title: Sodium fluoride tablets for childrenFrancis A. Arnold, F.J. McClure, Carl. L. White. Dental Vol 1. No. 1. October 1960 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1960-Arnold-Sodium fluoride tablets for children.pdf |
| View full study record |
| Document reference: 48766 |
| Study title: stannous fluoride topically applied os effective-data at the end of a five years study1965-Rothhaar |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf |
| View full study record |
| Document reference: 49148 |
| Study title: Stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients1977-shannon |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1977-shannon - stannous fluoride versus sodium fluoride in preventive treatment of orthodontic patients.pdf |
| View full study record |
| Document reference: 49153 |
| Study title: No title |
| Active substance: Somatropin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41752 |
| Study title: Rovamycine (Spiramycine) RP5337 - Etude clinique nationale de la rovamycine sirop pediatrique |
| Active substance: SPIRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42590 |
| Study title: A TWO YEAR MULTI-CENTRE STUDY OF GENOTROPIN TREATMENT OF SHORT PUBERTAL CHILDREN WITH INTRAUTERINE GROWTH RETARDATION |
| Active substance: Somatropin |
| Study summary document link (including results): 93-8122-002 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 41681 |
| Study title: 137163 - To study the effect duration of two different doses of IFN-gamma in patients with chronic granulomatous disease (CGD) on functional responses of neutrophils (PMN). |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30193 |
| Study title: 137177 - The immunomodulatory impact of Imukin (IFNgamma-1b) on clinical and laboratory data in the treatment of atopic dermatitis. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30194 |
| Study title: A phase III randomized, controlled open label trial of actimmune (Interferon gamma-1b, rIFN-alpha1b) in patients with severe, congenital (malignant) osteopetrosis. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30205 |
| Study title: An open phase III follow-up (5 years) trial of recombinant human interferon gamma-1b in patients with chronic granulomatous disease (CGD) to evaluate safety and efficacy of long-term interferon gamma-1b treatment - 5-year-follow-up safety report. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30191 |
| Study title: BL 103836,GCGD4-002 - Long-term safety and efficacy of Actimmune therapy in children with chronic granulomatous disease (CGD): Summary of data from the National Institutes of Health cohort in children initiating Actimmune prior to 1 year of age and prior to 3 years of age, respectively. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30198 |
| Study title: Clinical efficacy of recombinant human interferon-gamma in chronic granulomatous disease. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30202 |
| Study title: EBI 4.20,IP 137.3,137.3 - Interferon gamma-1b (IF-RC 1001 XX G): Safety, Efficacy and Pharmacokinetics of 0.1 mg/sqm, 0.25 mg/sqm and 0.5 mg/sqm Interferon gamma-1b for 2 or more Weeks Subcutaneaously Administered to Patients with Lymphomas, Plasmocytomas and Solid Tumors. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30199 |
| Study title: I0016g(A),CH 9903,137.41 - An open phase III follow-up (5 years) trial of recombinant human interferon gamma-1b in patients with chronic granulomatous disease (CGD) to evaluate safety and efficacy of long-term interferon gamma-1b treatment - 5-year-follow-up safety report. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30196 |
| Study title: I0286n - Post marketing surveillance study of Actimmune (recombinant human interferon gamma-Ib) in patients with chronic granulomatous disease. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30195 |
| Study title: I0681s - A phase III randomized, controlled open label trial of actimmune (Interferon gamma-1b, rIFN-alpha1b) in patients with severe, congenital (malignant) osteopetrosis. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30197 |
| Study title: |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30394 |
| Study title: |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30395 |
| Study title: 3 D CT angiography for detection of vascular complications in pediatric liver transplantation; CHENG YF; C Liver Transplant.; 2004 vol.10 n.2 p.248 2523 D CT angiography for detection of vascular complications in pediatric liver transplantation; CHENG YF; C Liver Transplant.; 2004 vol.10 n.2 p.248 252 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30402 |
| Study title: Appendicitis in children : low dose CT with a phantom based simulation technique initial observations; FEFFERMAN NR; Radiology; 2005 vol.237 p.641 646Appendicitis in children : low dose CT with a phantom based simulation technique initial observations; FEFFERMAN NR; Radiology; 2005 vol.237 p.641 646 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30396 |
| Study title: Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis.; CAHILL AM; Pediatr. Radiol.; 2007 vol.37 p544 548 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30397 |
| Study title: Blunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?; MAVRIDIS SP; South. Med. J.; 2000 vol.93 n.4 p.403 405Blunt trauma in intoxicated patients: is computed tomography of the abdomen always necessary?; MAVRIDIS SP; South. Med. J.; 2000 vol.93 n.4 p.403 405 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30398 |
| Study title: Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570Children with macrocrania : clinical and imaging predictors of disorders requiring surgery; MEDINA LS; AJNR; 2001 vol.22 p.564 570 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30399 |
| Study title: Endovascular Therapy for Priapism Secondary to Perineal Trauma; Ayrton C. J Trauma. 2001;50:571-584Endovascular Therapy for Priapism Secondary to Perineal Trauma; Ayrton C. J Trauma. 2001;50:571-584 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30247 |
| Study title: Endovascular treatment in vein of Galen aneurysms. Case report. ;Battistella-P-A. Rivista di Neuroradiologia, 1994, Vol/Iss/Pg. 7/4 (671-681)Endovascular treatment in vein of Galen aneurysms. Case report. ;Battistella-P-A. Rivista di Neuroradiologia, 1994, Vol/Iss/Pg. 7/4 (671-681) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30248 |
| Study title: Endovascular treatment of arteriovenous fistulas complicating percutaneous renal biopsy in three paediatric cases. ;Bilge-I. Nephrology Dialysis Transplantation, 1999, Vol/Iss/Pg. 14/11 (2726-2730)Endovascular treatment of arteriovenous fistulas complicating percutaneous renal biopsy in three paediatric cases. ;Bilge-I. Nephrology Dialysis Transplantation, 1999, Vol/Iss/Pg. 14/11 (2726-2730) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30250 |
| Study title: Endovascular treatment of spinal arteriovenous fistula in a young child with hereditary hemorrhagic telangiectasia. Case report. ;Stephan-M-J. Journal of Neurosurgery, 2005, Vol/Iss/Pg. 103 PEDIATRICS/SUPPL. 5 (462-465)Endovascular treatment of spinal arteriovenous fistula in a young child with hereditary hemorrhagic telangiectasia. Case report. ;Stephan-M-J. Journal of Neurosurgery, 2005, Vol/Iss/Pg. 103 PEDIATRICS/SUPPL. 5 (462-465) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30251 |
| Study title: Etude de deux foyers d’endémie goitreuse au Niger : Belley-Koira et Tiguey-Tallawal; R. Aquaron. Annales d’Endocrinologie (Paris) 1990, 51, 231-240Etude de deux foyers d’endémie goitreuse au Niger : Belley-Koira et Tiguey-Tallawal; R. Aquaron. Annales d’Endocrinologie (Paris) 1990, 51, 231-240 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30252 |
| Study title: Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-Lipiodol suspension in a child with hepatoblastoma. Ohtsubo-K. Journal of Japan Society for Cancer Therapy, 1990, Vol/Iss/Pg. 25/1 (31-39)Evaluation of the intra-hepatic arterial injection therapy of cisplatin (CDDP)-Lipiodol suspension in a child with hepatoblastoma. Ohtsubo-K. Journal of Japan Society for Cancer Therapy, 1990, Vol/Iss/Pg. 25/1 (31-39) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30253 |
| Study title: Facial intraosseous arteriovenous malformations: CT and MR features. ; Remonda-L. Journal of Computer Assisted Tomography, 1995, Vol/Iss/Pg. 19/2 (277-281)Facial intraosseous arteriovenous malformations: CT and MR features. ; Remonda-L. Journal of Computer Assisted Tomography, 1995, Vol/Iss/Pg. 19/2 (277-281) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30254 |
| Study title: Goitre and cretinism in the high Himalayas; H.K Ibbertson. NZ med. J 1974, 80: 484-488Goitre and cretinism in the high Himalayas; H.K Ibbertson. NZ med. J 1974, 80: 484-488 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30255 |
| Study title: Guidelines For Iodine Prophylaxis Following Nuclear Accidents, WHO 1989Guidelines For Iodine Prophylaxis Following Nuclear Accidents, WHO 1989 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30256 |
| Study title: Hemobilia: Transcatheter Occlusive Therapy and Long-term Follow-up;Renan Uflacker. Cardiovasc Intervent Radiol (1989) 12:136-141Hemobilia: Transcatheter Occlusive Therapy and Long-term Follow-up;Renan Uflacker. Cardiovasc Intervent Radiol (1989) 12:136-141 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30257 |
| Study title: Hepatocellular carcinoma after transcatheter hepatic arterial embolization: A histopathologic study of 84 resected cases. Higuchi-T. Cancer , 1994, Vol/Iss/Pg. 73/9 (2259-2267)Hepatocellular carcinoma after transcatheter hepatic arterial embolization: A histopathologic study of 84 resected cases. Higuchi-T. Cancer , 1994, Vol/Iss/Pg. 73/9 (2259-2267) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30258 |
| Study title: Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization. ;Jin-Wook-Chung, J. American Journal of Roentgenology, 1995, Vol/Iss/Pg. 165/2 (315-321)Hepatocellular carcinoma and portal vein invasion: Results of treatment with transcatheter oily chemoembolization. ;Jin-Wook-Chung, J. American Journal of Roentgenology, 1995, Vol/Iss/Pg. 165/2 (315-321) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30259 |
| Study title: Hepatocellular carcinoma outcomes based on indicated treatment strategy. ; Rose-A-T. American Surgeon, 1998, Vol/Iss/Pg. 64/12 (1128-1135)Hepatocellular carcinoma outcomes based on indicated treatment strategy. ; Rose-A-T. American Surgeon, 1998, Vol/Iss/Pg. 64/12 (1128-1135) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30260 |
| Study title: "Randomised, multi-centric, open-label, comparative clinical trial in patients; Duration: Treatment was 3 weeks." Baudon JJ 1995 |
| Active substance: Lactitol |
| Study summary document link (including results): Importal_Baudon JJ_1995-OK.xls |
| View full study record |
| Document reference: 48154 |
| Study title: Tuomilehto H, et all. Comparison of intravenous and oral ketoprofen for postoperative pain after adenoidectomy in children. Br J Anaesth. 2000 Aug;85(2):224-7. Tuomilehto H, et all. Comparison of intravenous and oral ketoprofen for postoperative pain after adenoidectomy in children. Br J Anaesth. 2000 Aug;85(2):224-7. |
| Active substance: LACTITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30989 |
| Study title: Husz S, Kriza J, Dobozy A Presented at the Roundtable Symposium on Immunology, Hungarian Immunology Congress; October 25-28, 1989; Szeged, Hungary. (English translation) . Immunological studies in atopic dermatitis before and after Isoprinosine® treatmentHusz S, Kriza J, Dobozy A Presented at the Roundtable Symposium on Immunology, Hungarian Immunology Congress; October 25-28, 1989; Szeged, Hungary. (English translation) . Immunological studies in atopic dermatitis before and after Isoprinosine® treatment |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30122 |
| Study title: Husz S, Kriza J, Kiss M, Oobozy A Gygyszereink [Hungary]; 1991; 41 :217-220. Prolonged Isoprinosine® treatment in atopic dermatitisHusz S, Kriza J, Kiss M, Oobozy A Gygyszereink [Hungary]; 1991; 41 :217-220. Prolonged Isoprinosine® treatment in atopic dermatitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30123 |
| Study title: Huttenlocher, P:. Subacute Sclerosing Panencephalitis, 2nd Inti. Symp. SSPE, 1985:176-184. Follow-up of SSPE Patients on Long- Term Therapy with InosiplexHuttenlocher, P:. Subacute Sclerosing Panencephalitis, 2nd Inti. Symp. SSPE, 1985:176-184. Follow-up of SSPE Patients on Long- Term Therapy with Inosiplex |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30124 |
| Study title: Ink J, Andres FJ, Antonini GM, Scarpiello V, Stefano JC, Coronel N, Genoves MH, Spataro R, Natelli C, Buey O, Ink RL, Goijman I, Pernas N, Andres RJ, Sumay OR, Casal I, Cudemo OLa Prensa Medica Argentina; January 8, 1971; 45(57):2050-2064. NPT10.381 Antiviral AgentInk J, Andres FJ, Antonini GM, Scarpiello V, Stefano JC, Coronel N, Genoves MH, Spataro R, Natelli C, Buey O, Ink RL, Goijman I, Pernas N, Andres RJ, Sumay OR, Casal I, Cudemo OLa Prensa Medica Argentina; January 8, 1971; 45(57):2050-2064. NPT10.381 Antiviral Agent |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30125 |
| Study title: Ink J, Antonini GM. NPT10381: Prensa Universitaria [Argentina]. September 8, 1970; 324:6121-6124.Ink J, Antonini GM. NPT10381: Prensa Universitaria [Argentina]. September 8, 1970; 324:6121-6124. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30126 |
| Study title: Ink J. Buenos Aires, Argentina: Teodoro Alvarez Hospital and Del Carmen Hospital. 1972. (Summary expert clinical report to Newport Pharmaceuticals International, Inc.) Isoprinosine® syrup against different acute viral diseasesInk J. Buenos Aires, Argentina: Teodoro Alvarez Hospital and Del Carmen Hospital. 1972. (Summary expert clinical report to Newport Pharmaceuticals International, Inc.) Isoprinosine® syrup against different acute viral diseases |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30127 |
| Study title: Janeczko J, Baranowska M, Romanowska B. (1991) Przeglad Epidemiologiczny.; 45(4):267-271. Effect of Isoprinosine® and acyclovir on the clinical course of chickenpox and herpes zosterJaneczko J, Baranowska M, Romanowska B. (1991) Przeglad Epidemiologiczny.; 45(4):267-271. Effect of Isoprinosine® and acyclovir on the clinical course of chickenpox and herpes zoster |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30128 |
| Study title: The role and limitation of living donor liver transplantation for hepatocellular carcinoma. ; Lo-C-M. Liver Transplantation, 2004, Vol/Iss/Pg. 10/3 (440-447)The role and limitation of living donor liver transplantation for hepatocellular carcinoma. ; Lo-C-M. Liver Transplantation, 2004, Vol/Iss/Pg. 10/3 (440-447) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30333 |
| Study title: The use of iodized oil in goiter prevention.;John Kevany. American Journal of Public Health 1970 60 919-925The use of iodized oil in goiter prevention.;John Kevany. American Journal of Public Health 1970 60 919-925 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30334 |
| Study title: The value of embolization in the prognosis of renal cell carcinoma.; Basche-S. Annales de Radiologie, 1988, Vol/Iss/Pg. 31/6 (333-336) The value of embolization in the prognosis of renal cell carcinoma.; Basche-S. Annales de Radiologie, 1988, Vol/Iss/Pg. 31/6 (333-336) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30335 |
| Study title: Therapeutic arterial embolization of tumors and vascular lesions in the maxillofacial region and skull base. ; Heuser-L. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1990, Vol/Iss/Pg. 152/5 (544-549)Therapeutic arterial embolization of tumors and vascular lesions in the maxillofacial region and skull base. ; Heuser-L. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1990, Vol/Iss/Pg. 152/5 (544-549) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30336 |
| Study title: Transarterial chemoembolization in the treatment of hepatoblastoma in children.; Vogl-T-J. European Radiology, 2006, Vol/Iss/Pg. 16/6 (1393-1396) Transarterial chemoembolization in the treatment of hepatoblastoma in children.; Vogl-T-J. European Radiology, 2006, Vol/Iss/Pg. 16/6 (1393-1396) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30337 |
| Study title: Transarterial embolization of aneurysms associated with spinal cord arteriovenous malformations. Report of four cases. ; Konan-A-V. Journal of Neurosurgery, 1999, Vol/Iss/Pg. 90/1 SUPPL. (148-154)Transarterial embolization of aneurysms associated with spinal cord arteriovenous malformations. Report of four cases. ; Konan-A-V. Journal of Neurosurgery, 1999, Vol/Iss/Pg. 90/1 SUPPL. (148-154) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30338 |
| Study title: Transcatheter arterial chemoembolization in the treatment of hepatoblastoma. ; Oue-T. Journal of Pediatric Surgery, 1998, Vol/Iss/Pg. 33/12 (1771-1775)Transcatheter arterial chemoembolization in the treatment of hepatoblastoma. ; Oue-T. Journal of Pediatric Surgery, 1998, Vol/Iss/Pg. 33/12 (1771-1775) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30339 |
| Study title: Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children.Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. Pediatr Radiol 2008;38:841-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48583 |
| Study title: Osteoma: a diagnoiss for radicular pain of extremities.Ebrahimzadeh MH, Ahmadzadeh-Chabock H, Ebrahimzadeh AR. Osteoid Orthopedics 2009; 32(11):821. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48718 |
| Study title: Osteosarcoma of the proximal humerus.Belasco J, Watts H. Med Pediatr Oncol 1983;11(1):46-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48569 |
| Study title: Peroperative isotopic detection in the treatment of osteoid osteoma in childrenLacheretz M, Herbaux B. Hossein-Foucher C. Lecouffe P. Richir M. Chirurgie 1989;115(7):413-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48494 |
| Study title: Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.Bouvier JF, Philip T, Chauvot P, Brunat Mentigny M, Ducrettet F, Maïassi N, et al. Prog Clin Biol Res 1988;271:707-20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48575 |
| Study title: Potentially misleading bone scan findings in patients with hepatoblastoma.Archer D, Babyn P, Gilday D, Greenberg MA. Clin Nucl Med 1993 Dec;18(12):1026-31 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48529 |
| Study title: Presacral tumor associated with the Currarino triad in an adolescent.Horii T. Tsuchiya H. Tomita K. Surg 2001;121{1-2):114-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48488 |
| Study title: Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agentsLopez-Longo FJ. Menard HA. Carreno L. eosin J. Ballesteros R. Monteagudo I. J Rheumatol 1987 Oct;14(5):991-4 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48499 |
| Study title: Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in prim ry osteosarcoma.Franzius C. Bielack S. Flege S, Sciuk J, Jurgens H. Schober 0. Nucl Med 2002 Aug;43(8):1012-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48483 |
| Study title: Publication 53: Radiation dose to patients from radiopharmaceuticalsICRP (lnternation Commission on Radiological Protection). Pergamon Press 1987 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48489 |
| Study title: Publication 80: Radiation dose to patients from radiopharmaceuticalsICRP (lnternation Commission on Radiological Protection). Addendum to ICRP Publication 53. Pergamon Press 1998 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48490 |
| Study title: Publication of result-related information on paediatric studies submitted under Article 45 of the Regulation (EC) No 1901/2006 (‘Paediatric Regulation’) Amerscan Medronate ra.gehealthcare@ge.com |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48833 |
| Study title: Pyogenic sacroiliitis - a comparison between paediatric and adult patientsWu M-S, Chang S-S, Lee S-H, Lee C-C. Rheumatology 2007;46:1684-7 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48765 |
| Study title: Pyogenic sacroiliitis, the missed diagnosis?Abbott GT, Carty H. Br J Radiol 1993 Feb;66(782):120-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48520 |
| Study title: Lytic bone lesion in a 12-year-old.Blackmore CC, Perkins A. Acad Radiol 1995 Jun;2(6):541-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48573 |
| Study title: Lytic Bone Lesion in a 12-Year-OldC. Craig Blackmore, MD, and Anthony Perkins, MD Acad Radiol. 1995 Jun;2(6):541-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48835 |
| Study title: Chronic inflammatory appendiceal conditions that mimic acute appendicitis on helical CT; CHECKOFF JL; AJR; 2002 vol.179 p.731 734Chronic inflammatory appendiceal conditions that mimic acute appendicitis on helical CT; CHECKOFF JL; AJR; 2002 vol.179 p.731 734 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30400 |
| Study title: Clinical doses of contrast media; OLDER RA in : trends in contrast media; springer; berlin; 1999 p.75 80Clinical doses of contrast media; OLDER RA in : trends in contrast media; springer; berlin; 1999 p.75 80 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30401 |
| Study title: Computed tomographic findings of distensible orbital venous anomalies; WOO KI; Ophtalm. Plast. Reconstr. Surg.; 2002 vol.18 n.2 p.114 120Computed tomographic findings of distensible orbital venous anomalies; WOO KI; Ophtalm. Plast. Reconstr. Surg.; 2002 vol.18 n.2 p.114 120 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30403 |
| Study title: Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26Contrast agents in neuroimaging; BYRD SE; Neuroimaging Clinics North America; 1994 vol.4 n.1 p.9 26 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30404 |
| Study title: Contrast media use in paediatrics; BABYN PS; Adv. X Ray Contrast; 1993 vol.1 p.74 85Contrast media use in paediatrics; BABYN PS; Adv. X Ray Contrast; 1993 vol.1 p.74 85 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30405 |
| Study title: CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis; BAKER ME; Radiology; 2003 vol.227 p.73 79CT depiction of portal vein thrombi after creation of ileal pouch-anal anastomosis; BAKER ME; Radiology; 2003 vol.227 p.73 79 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30406 |
| Study title: CT of appendicitis in children; CALLAHAN MJ; Radiology; 2002 vol.224 p.325 332CT of appendicitis in children; CALLAHAN MJ; Radiology; 2002 vol.224 p.325 332 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30407 |
| Study title: CT of small bowel ischemia associated with obstruction in emergency department patients ; diagnostic performance evaluation; SHEEDY SP; Radiology; 2006 vol.241 n.3 p.729 736CT of small bowel ischemia associated with obstruction in emergency department patients ; diagnostic performance evaluation; SHEEDY SP; Radiology; 2006 vol.241 n.3 p.729 736 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30408 |
| Study title: Double Blind, parallel group study to compare the efficacy and safety of Ioversol 350 and Iohexol 350 in Pediatric Patients undergoing Angiocardiography |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30392 |
| Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30362 |
| Study title: Can plasma iohexol disappearance be used to measure GFR in children with chronic kidney disease? Nature Clinical Practice Nephrology (2006), 2(11), 608- 609, Schwartz GJ 2006 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48861 |
| Study title: Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations Acta paediatrica (1994), 83(4), 418-22 Lindblad HG 1994 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48859 |
| Study title: Comparison of intravenous contrast agents for CT studies in children Acta radiologica (Stockholm, Sweden : 1987) (1992), 33(6), 592-5 Cohen MD 1987 |
| Active substance: IOHEXOL |
| Study summary document link (including results): Cohen MD 1987.pdf |
| View full study record |
| Document reference: 48868 |
| Study title: A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. Urganci N, Akyildiz B, Polat TB. Pediatr Int. 2005 Feb;47(1):15-9.A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. Urganci N, Akyildiz B, Polat TB. Pediatr Int. 2005 Feb;47(1):15-9. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30997 |
| Study title: A DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY OF LACTULOSE IN THE TREATMENT OF ENCOPRESIS IN CHILDREN WITH CHRONIC CONSTIPATION |
| Active substance: LACTULOSE |
| Study summary document link (including results): Lactulose-RH105.0101.pdf |
| View full study record |
| Document reference: 31005 |
| Study title: A pilot, open, parallel group study of the effect of lactulose on stool bacterial composition in children suffering from cystic fibrosis (antibiotic-treated and untreated) and healthy childrenConstipation in childood: a controlled comparison between lactulose and standardized senna.; Perkin J.M. - Current Medical Research and Opinion, 1977; 4(8): 540-543 |
| Active substance: LACTULOSE |
| Study summary document link (including results): lactulose-s1053101.pdf |
| View full study record |
| Document reference: 30991 |
| Study title: An open, group comparative study with Duphalac syrup versus lactulose crystalline in constipated children |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30990 |
| Study title: An open, randomized group comparative study with lactulose syrup (Duphalac~ versus lactulose crystalline in constipated children. |
| Active substance: LACTULOSE |
| Study summary document link (including results): Lactulose-H.105.910NL.pdf |
| View full study record |
| Document reference: 31006 |
| Study title: Clinical efficacy of duphalac in the treatment of functional constipations. Shevtsov SA. Eksp Klin Gastroenterol. 2005;(6):58-60.Clinical efficacy of duphalac in the treatment of functional constipations. Shevtsov SA. Eksp Klin Gastroenterol. 2005;(6):58-60. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30994 |
| Study title: Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Gremse DA, Hixon J, Crutchfield A. Clin Pediatr (Phila). 2002 May;41(4):225-9.Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Gremse DA, Hixon J, Crutchfield A. Clin Pediatr (Phila). 2002 May;41(4):225-9. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30999 |
| Study title: Double blind randomised controlled trial of topical glyceryl trinitrate in anal fissure. Kenny SE, Irvine T, Driver CP, Nunn AT, Losty PD, Jones MO, Turnock RR, Lamont; GL, Lloyd DA. Arch Dis Child. 2001 Nov;85(5):404-7.Double blind randomised controlled trial of topical glyceryl trinitrate in anal fissure. Kenny SE, Irvine T, Driver CP, Nunn AT, Losty PD, Jones MO, Turnock RR, Lamont; GL, Lloyd DA. Arch Dis Child. 2001 Nov;85(5):404-7. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31004 |
| Study title: Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, Abdelatif A, Baranes C, Benoît S, Benssoussan A, Boussioux JL, Boyer P, Brunet E, Delorme J, François-Cecchin S, Gottrand F, Grassart M, Hadji S, Kalidjian A, Languepin J, Leissler C, Lejay D, Livon D, Lopez JP, Mougenot JF, Risse JC, Rizk C, Roumaneix D, Schirrer J, Thoron B, Kalach N. J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):625-33.Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, Abdelatif A, Baranes C, Benoît S, Benssoussan A, ... |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30996 |
| Study title: Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. Peng YZ, Yuan ZQ, Xiao GX. Burns. 2001 Mar;27(2):145-9.Effects of early enteral feeding on the prevention of enterogenic infection in severely burned patients. Peng YZ, Yuan ZQ, Xiao GX. Burns. 2001 Mar;27(2):145-9. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31002 |
| Study title: Choi SJ, Kim JS, Kim JH, Oh SJ, Lee JG, Kim CJ, et al.. Epub 2005 Feb 15. [18F]3'-deoxy-3'- fluorothymidine PET for the diagnosis and grading of brain tumors. [choi-2005]Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9. Choi SJ 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48637 |
| Study title: Clinical Implications of Different Image Reconstruction Parameters for Interpretation of Whole-Body PET Studies in Cancer Patients.J Nucl Med 2004; 45:559–566. Heiko Scho¨der, MD1; Yusuf E. Erdi, DSc2; Kenneth Chao, BS1; Mithat Gonen, PhD3; Steven M. Larson, MD1; and Henry W.D. Yeung, MD1. |
| Active substance: Steripet |
| Study summary document link (including results): schulte-1999.pdf |
| View full study record |
| Document reference: 48746 |
| Study title: Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia - Kojima S. et al - 2000 (Blood 96: 2049 - 2054) - Publication - Ref18 of Clinical Expert Report - |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31034 |
| Study title: Limited mobilization effect of G-CSF (Lenograstim) for blood stem cells in children with solid tumors - Kawano Y. et al (Eur J Cancer - 31:238)Limited mobilization effect of G-CSF (Lenograstim) for blood stem cells in children with solid tumors - Kawano Y. et al (Eur J Cancer - 31:238) |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31041 |
| Study title: Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia - Ohara A. et al - 1997 (Blood 90: 1009 - 1013) - Publication - Ref22 of Clinical Expert Report - |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31035 |
| Study title: rG-CSF injection. Protocol for double blind controlled clinical trial. Bone Marow Transplantation - by The Japanese rG-CSF clinical study group. |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31036 |
| Study title: rG-CSF injection. Protocol for phase II clinical trial. Bone Marow Transplantation - by The Japanese rG-CSF clinical study group. |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31037 |
| Study title: Toxicity study by intravenous administration to rhesus Monkey for 13 weeks |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31038 |
| Study title: Retrospective survey for documentation of appllication and dosage of CM Leptandra comp. (drops) in children < 12 years of age [Bef-016] |
| Active substance: Leptandra compositum |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40046 |
| Study title: A Dose Finding Study of a Super Long-Acting Luteinizing Hormone-Releasing Hormone Analog (Leuprolide Acetate Depot, TAP-144-SR) in the Treatment of Central Precocious Puberty |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31046 |
| Study title: Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated communities1972-Swejda |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1972-Swejda-Fluorides in community programms-A study of four years of various fluorides applied topically to the teeth of children in fluoridated c... |
| View full study record |
| Document reference: 49150 |
| Study title: Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake1984-Widenheim |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1984-Widenheim-Fluorine concentration in primary tooth enamel in 6 year old after 3 years of daily intake.pdf |
| View full study record |
| Document reference: 49155 |
| Study title: Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children1964-Mercer |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1964-Mercer-Effect on a 30 second topical stannous fluoride treatement on dental caries reductions in children.pdf |
| View full study record |
| Document reference: 49146 |
| Study title: Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride1965-Gish |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1965-Gish-Effect on dental caries in children in a natural fluoride area of combined use of three agents containing stannous fluoride.pdf |
| View full study record |
| Document reference: 49147 |
| Study title: Effect on dental caries in children in a non fluoride area of combined use of three agents containing stannous fluoride1964-Bixler |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1964-Bixler-Effect on dental caries in children in a non fluoride ares of combined use of three agents containing stannous fluoride.pdf |
| View full study record |
| Document reference: 49145 |
| Study title: Effectiveness of fornightly tooth brushing with amine fluorides in caries-prone subjectsRan 1991 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Ran 1991 Effectiveness of fornightly tooth brushing.pdf |
| View full study record |
| Document reference: 49176 |
| Study title: Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial1996-bravo, Community Dent. Oral Epidemiol. 1996: 24: 42-6 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1995-seppa-Fluoride varnish versus acidulated phosphate fluoride gel.pdf |
| View full study record |
| Document reference: 49121 |
| Study title: Neuroblastoma presenting clinically as hip osteomyelitis: a "signature" diagnosis on skeletal scintigraphy.Applegate K, Connolly LP, Treves ST. Pediatr Radiol 1995 Nov;25 Suppl 1:S93-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48528 |
| Study title: Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosisUrso S, Pacciani E, Fariello G, Colajacomo M, Fassari FM, Randisi F, et al. Radiol Med 1995 Sep;90(3):212-8 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48763 |
| Study title: Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. Kevin A. Cawley, Allen D. Dvorak, and Michael D. Wilmot J NucÃMed 24: 14-16,1983 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48838 |
| Study title: Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis.Cawley KA, Dvorak AD, Wilmot MD. J Nucl Med 1983 Jan;24(1):14-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48589 |
| Study title: Nuclear medicine studies of aging--IV. Femoral proximal to distal radionuclide uptake gradientGrimmond AP. Hosain F. Spencer RP. lnt J Rod Appllnstrum B 1988;15(5):529-30 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48486 |
| Study title: Nonsurgical rapid maxillary expansion effects on craniofacial structures in young adult females.Baydas B, Yavuz I, Uslu H, Dagsuyu IM, Ceylan I. Angle Ortho 2006;76:759-67. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48568 |
| Study title: Wu PS, Chiu NT, Lee BF, Yao WJ, W Chen HH. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations. Clin Nucl Med. 2002 Aug;27(8):567-71. Wu PS, Chiu NT, Lee BF, Yao WJ, W Chen HH. Clinical significance of solitary rib hot spots on bone scans in patients with extraskeletal cancer: correlation with other clinical manifestations. Clin Nucl Med. 2002 Aug;27(8):567-71. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43444 |
| Study title: Kokyu To Junkan. 1989 Sep;37(9):1003-7. [Significance of decreased washout rate in hypertrophic cardiomyopathy by exercise Tl-201 myocardial scintigraphy] [Article in Japanese] Inoue S, Nezuo S, Tadaoka S, Hasegawa K, Kawahara Y, Kakumae S, Nakamura T,Kokyu To Junkan. 1989 Sep;37(9):1003-7. [Significance of decreased washout rate in hypertrophic cardiomyopathy by exercise Tl-201 myocardial scintigraphy] [Article in Japanese] Inoue S, Nezuo S, Tadaoka S, Hasegawa K, Kawahara Y, Kakumae S, Nakamura T, |
| Active substance: THALLIUM 201T1 CHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44656 |
| Study title: Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral densityLubushitzky R. Front D. losi levsky G. Bettman L. Frenkel A. Kolodny GM. et al. J Nucl Med 1998 Jan;39(1):104-7 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48500 |
| Study title: Radionuclide imaging in bilateral os trigonum syndrome in a young athlete. Minoves M, Company A, Ardevol J, Matas RB, Costansa JM, Setoain J, Domenech-Torné FM. Clin Nucl Med. 2001 Mar;26(3):237-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43458 |
| Study title: Radionuclide imaging in the evaluation of osteomyelitis and septic arthritis.Kim EE, Haynie TP, Lowry PA, Harle TS. Crit Rev Diagn Imaging 1989; 29(3):257-305 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48751 |
| Study title: Tc-99m MDP, thallium- 201 chloride and Tc-99m MAG3 renal uptake in subacute and chronic radiation nephritis compared.Degirmenci B, Uysal K, Bekis R, Cetingoz R, Kaya GC, Durak H. Ann Nucl Med 2001 Oct;15(5):447-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48599 |
| Study title: Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathiesKim SK. Miller JH. J Nucl Med 2002 Jul;43(7):896-900 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48493 |
| Study title: COMPARISON OF INTRAVENOUS CONTRAST AGENTS FOR CT STUDIES IN CHILDRENM.D. CoHEN, E. HERMAN, D. HERRON, S. J. WHITE and J. A. SMITH Acta Radiol. 1992 Nov;33(6):592-5. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48851 |
| Study title: Comparison of low-osmolar contrast media in paediatric cardiac angiography. The British journal of radiology (1987), 60(710), 133-5 Rubin CME 1987 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48865 |
| Study title: Comparison of iohexol with barium in gastrointestinal studies of infants and children Am J Roentgenol. 1991 Feb; 156(2): 345-50 Cohen MD 1991 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48855 |
| Study title: Excretory urography with iohexol: evaluation in children Radiology (1986), 161(3), 625-30 Magill HL 1986 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48860 |
| Study title: Experiences with iohexol (Omnipaque) at urography Pediatr Radio! (1987) 17: 491-492 Fjelldal A 1987 Pediatr Radio! (1987) 17: 491-492 Fjelldal A 1987 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48867 |
| Study title: Phase 1 Pilot Trial of Interferon alfa-2a in Children with Japanese Viral Encephalitis |
| Active substance: INTERFERON ALPHA (2A) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30187 |
| Study title: HyRhabdomyolysis after intraoperative myelography Paediatr Anaesth 2004 Jun; 14(6):509-13 Canbay O 2004 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48853 |
| Study title: Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Acta Radiol. 1989 Nov-Dec; 30(6):643-6 Stake G 1989 |
| Active substance: IOHEXOL |
| Study summary document link (including results): Stake G 1989.pdf |
| View full study record |
| Document reference: 48872 |
| Study title: Iodine in contrast agents and skin disinfectants is the major cause for hypothyroidism in premature infants during intensive care Horm Res. 1987;28(1):42-9 l'Allemand D 1987 |
| Active substance: IOHEXOL |
| Study summary document link (including results): l'Allemand D 1987.pdf |
| View full study record |
| Document reference: 48869 |
| Study title: Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatrica (Oxford, United Kingdom) (2009), 98(10), 1568-1574 Ahmet A 2009 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48852 |
| Study title: Iohexol and metrizamide for urography in infants and children. Acta Radiol Suppl. 1983; 366: 39-41 Stake G 1983 |
| Active substance: IOHEXOL |
| Study summary document link (including results): Stake G 1983.pdf |
| View full study record |
| Document reference: 48871 |
| Study title: Iohexol for contrast enhancement of bowel in paediatric abdominal CT. Acta Radiol. 1990 Nov; 31(6): 601-4 Smevik B 1990 |
| Active substance: IOHEXOL |
| Study summary document link (including results): Smevik B 1990.pdf |
| View full study record |
| Document reference: 48870 |
| Study title: Iohexol in paediatric myelography. An open non-comparative trial Neuroradiology (1986), 28(1), 65-8 Kendall B 1986 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48858 |
| Study title: Myelography with iohexol (Omnipaque); a clinical report with special reference to the adverse effects. Neuroradiology. 1988; 30(2):169-74 Skalpe IO 1988 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48866 |
| Study title: Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects. The Central African journal of medicine (1996), 42(7), 192-5. Ndosi BN 1996 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48862 |
| Study title: Open, non-comparative study in angiocardiography in children, Angiocardiography: evaluate safety, tolerance and the radiographic properties of of iohexol in pediatric use. Systolic blood pressure, ECG parameters, body temperature, visualization and adverse reactions were recorded.Applicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48882 |
| Study title: Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient ManagementRachel Bar-Shalom, MD1; Nikolai Yefremov, MD1; Ludmila Guralnik, MD2; Diana Gaitini, MD2,3; Alex Frenkel, DSc1; Abraham Kuten, MD3,4; Hernan Altman, MBA5; Zohar Keidar, MD, PhD1; and Ora Israel, MD1,3. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 44 • No. 8 • August 2003 |
| Active substance: Steripet |
| Study summary document link (including results): bar-shalom-2003.pdf |
| View full study record |
| Document reference: 48623 |
| Study title: Clinical Usefulness of 18F-FDG PET in Nasopharyngeal Carcinoma Patients with Questionable MRI Findings for Recurrence Biomedicine & Pharmacotherapy 60 (2006) 593–606. C. Nannia, D. Rubellob,*, P. Castelluccia, M. Farsada, R. Franchia, L. Rampinb M.D. Grossc, A. Al-Nahhasd, S. Fantia |
| Active substance: Steripet |
| Study summary document link (including results): ng-2004-b.pdf |
| View full study record |
| Document reference: 48739 |
| Study title: Comparison of 18F-FDG and 11C-Methionine for PET-Guided Stereotactic Brain Biopsy of GliomasJ Nucl Med 2004; 45:1293–1298. Benoit Pirotte, MD1; Serge Goldman, MD, PhD2; Nicolas Massager, MD1; Philippe David, MD3; David Wikler, MS1; Arlette Vandesteene, MD, PhD4; Isabelle Salmon, MD, PhD5; Jacques Brotchi, MD, PhD1; and Marc Levivier, MD, PhD1 |
| Active substance: Steripet |
| Study summary document link (including results): pirotte-2004.pdf |
| View full study record |
| Document reference: 48742 |
| Study title: Connolly LP, Connolly SA.. Thymic uptake of radiopharmaceuticals. [connolly-2003]Clin Nucl Med. 2003 Aug;28(8):648-51. Connolly LP 2003 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48638 |
| Study title: De González AB, Mahesh M, Kim K-P, Bhargavan M, Lewis R, Mettler F, Land C. Arch Projected cancer risks from computed tomographic scans performed in the United States in 2007. [de-gonzalez-2009]Intern Med 2009; 169 : 2071 - 2077. De González AB 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48639 |
| Study title: Developmental hemispheric asymmetry of interregional metabolic correlation of the auditory cortex in deaf subjects.NeuroImage 19 (2003) 777–783 .E. Kang,a D.S. Lee,a,* J.S. Lee,a H. Kang,a C.H. Hwang,b S.H. Oh,b C.S. Kim,b J.-K. Chung,a M.C. Lee,a M.J. Jang,a,c Y.J. Lee,c P. Morosan,d and K. Zillesd |
| Active substance: Steripet |
| Study summary document link (including results): kang-2003.pdf |
| View full study record |
| Document reference: 48734 |
| Study title: Dietlein M, Krug B, Groth W, Smolarz K, Scheidhauer K, Psaras T, et al.. Positron emission tomography using 18Ffluorodeoxyglucose in advanced stages of malignant melanoma: a comparison of ultrasonographic and radiological methods of diagnosis. [dietlein-1999]Nucl Med Commun. 1999 Mar;20(3):255-61. Dietlein M 1999 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48640 |
| Study title: Dizendorf EV, Baumert BG, von Schulthess GK, Lütolf UM, Steinert HC.. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. [dizendorf-2003]J Nucl Med. 2003 Jan;44(1):24-9. Dizendorf EV 2003 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48641 |
| Study title: Dobbeleir A, Ham H, Goethals I, Keppens J, D'Asseler Y, Van de Wiele C.. F-18 FDG-PET in children: do we have enough counts? [dobbeleir-2010]Nucl Med Commun. 2010 Mar;31(3):190-4. Dobbeleir A 2010 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48642 |
| Study title: Early Irradiation Effects Observed on Magnetic Resonance Imaging and Angiography, and Positron Emission Tomography for Arteriovenous Malformations Treated by Gamma Knife Radiosurgery. Stereotact Funct Neurosurg 1995;61(suppl1):25S-269. 1VY Glio? D.H.C. Pollb, R.S. Lilic, 1VY Cll~i~lCg.Y~ ,S llio1~~, S.S. Cllalgc, C.Y Cllo~lgK~;,Y CIze~zS~.,H . Yellc, L.S. Leeb |
| Active substance: Steripet |
| Study summary document link (including results): guo-1994.pdf |
| View full study record |
| Document reference: 48730 |
| Study title: Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant LymphomaJ Nucl Med 2001; 42:1139–1143. Heiko Scho¨der, Joubin Meta, Cecilia Yap, Maryam Ariannejad, Jyotsna Rao, Michael E. Phelps, Peter E. Valk, Jim Sayre, and Johannes Czernin |
| Active substance: Steripet |
| Study summary document link (including results): schoder-2001.pdf |
| View full study record |
| Document reference: 48745 |
| Study title: Treatment of goitrous hypothyroidism with iodized oil supplementation in an area of iodine deficiency. ; Azizi-F. Experimental and Clinical Endocrinology and Diabetes, 1996, Vol/Iss/Pg. 104/5 (387-391)Treatment of goitrous hypothyroidism with iodized oil supplementation in an area of iodine deficiency. ; Azizi-F. Experimental and Clinical Endocrinology and Diabetes, 1996, Vol/Iss/Pg. 104/5 (387-391) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30340 |
| Study title: Treatment of IDJWI Island endemic goiter by iodized oil; F. Delange. In. Endemic goiter. J.B Stanbury Ed. Pan American Health Organization. Scientific publication n° 193 : 118-131, 1968Treatment of IDJWI Island endemic goiter by iodized oil; F. Delange. In. Endemic goiter. J.B Stanbury Ed. Pan American Health Organization. Scientific publication n° 193 : 118-131, 1968 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30341 |
| Study title: Treatment of Unresectable Primary Liver Cancer: With Reference to Cytoreduction and Sequential Resection.; Zhao-You Tang. World J. Surg. 19, 47-52, 1995.Treatment of Unresectable Primary Liver Cancer: With Reference to Cytoreduction and Sequential Resection.; Zhao-You Tang. World J. Surg. 19, 47-52, 1995. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30342 |
| Study title: Uptake of Lipiodol(trademark) -cytotoxic conjugates by hepatoblastoma cells. ;Towu-E. British Journal of Surgery, 2002, Vol/Iss/Pg. 89/4 (437-441)Uptake of Lipiodol(trademark) -cytotoxic conjugates by hepatoblastoma cells. ;Towu-E. British Journal of Surgery, 2002, Vol/Iss/Pg. 89/4 (437-441) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30343 |
| Study title: Use of lipiodol, an iodinated oil preparation, in regions with moderate iodine deficiency. ; Sviridenko-Yu-N. Problemy Endokrinologii, 1995, Vol/Iss/Pg. 41/6 (8-11)Use of lipiodol, an iodinated oil preparation, in regions with moderate iodine deficiency. ; Sviridenko-Yu-N. Problemy Endokrinologii, 1995, Vol/Iss/Pg. 41/6 (8-11) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30344 |
| Study title: A bi-centre randomised, parallel group, double-blind phase III comparison between iodixanol (VISIPAQUE) 150 mg I/ml and 270 mg I/ml and iohexal (Omnipaque) 140 mg I/ml and 300 mg I/ml Report DXC064 (date Jun 1999) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXC064 Redacted.pdf |
| View full study record |
| Document reference: 48211 |
| Study title: A comparison of iopromide and iopamidol in CT scanning of pediatric patientsJ Radiol. 1999 Jul;80(7):727-32. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study] [Article in French] Roriz R, de Gevigney G, Finet G, Nantois-Collet C, Borch KW, Amiel M, Beaune J. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30380 |
| Study title: A PHASE IV, OPEN-LABEL, MULTI-CENTER COMMUNITY-BASED TRIAL STUDYING THE SAFETY AND EFFICACY OF KEPPRA. AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH UNCONTROLLED PARTIAL EPILEPSY. S.K.A.T.E. : SAFETY OF KEPPRA. AS ADJUNCTIVE THERAPY IN EPILEPSY. |
| Active substance: levetiracetam |
| Study summary document link (including results): N01031 - Levetiracetam - RRCE04G2602.pdf |
| View full study record |
| Document reference: 41540 |
| Study title: ANWENDUNG DER IN DEUTSCHLAND ZUGELASSENEN KEPPRA(R) - TABLETTEN ALS ZUSATZBEHANDLUNG BEI ERWACHSENEN PATIENTEN MIT FOKALEN EPILEPSIEN. |
| Active substance: levetiracetam |
| Study summary document link (including results): ARVD02L1406 - Levetiracetam.pdf |
| View full study record |
| Document reference: 41539 |
| Study title: BRIDGING STUDY OF L059 (LEVETIRACETAM) IN PATIENTS WITH EPILEPSY BY DOUBLE BLIND METHOD. |
| Active substance: levetiracetam |
| Study summary document link (including results): N165 - Levetiracetam - RRCE04C3001.pdf |
| View full study record |
| Document reference: 41541 |
| Study title: A study to compare the efficacy and safety of 0.0625% Levobupivacaine, 1 IJg.mr1 fentanyl, 0.0625% levobupivacaine plus1 IJg.mr1 fentanyl and 0.125% Levobupivacaine when administered as an extradural infusion in paediatric patients undergoing elective abdominal or urological surgery |
| Active substance: LEVOBUVICAINE HCL |
| Study summary document link (including results): Levobupivacaine-30716.pdf |
| View full study record |
| Document reference: 47651 |
| Study title: Reflex sympathetic dystrophy associated with deep peroneal nerve entrapment.Para no E. Pavone V. Greco F. Majorana M. Trifiletti RR. Brain Dev 1998 Mar;20(2):80-2 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48509 |
| Study title: Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. Reiman RE, Rosen G, Gelbard AS, Benua RS, Laughlin JS. Imaging of primary Ewing sarcoma with 13N-L-glutamate. Radiology. 1982 Feb;142(2):495-500. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44093 |
| Study title: Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. Clin Nucl Med. 1999 Jun;24(6):435-9. Tc-99m DTPA used as reference imaging to evaluate the distribution of other tumor-seeking tracers in tumors associated with neurofibromatosis. Suga K, Hirabayashi A, Kishimoto K, Kume N, Matsumoto T, Matsunaga N. |
| Active substance: THALLIUM 201T1 CHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44556 |
| Study title: Technetium 99m-methylene diphosphonate bone scans in children with reflex neurovascular dystrophy.Laxer RM. Allen RC. Malleson PN. Morrison RT. Petty RE. J Pediatr 1985Mar;106(3):437-40 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48496 |
| Study title: Technetium-99 m-MDP scintigraphy and long-term follow-up of musculoskeletal sarcoma reconstructed with pasteurized autologous bone graft.Ahmed AR. Arch Orthop Trauma Surg 2009;129:475-482 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48524 |
| Study title: Technetium-99m-methylene diphosphonate uptake in the fetal skeleton at 30 weeks gestationMcKenzie AF. Budd RS. Yang C. Shapiro B. Hicks RJ. J Nucl Med 1994 Aug;35(8):1338-41 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48506 |
| Study title: Thallium-201 scintigraphy in childhood osteosarcoma: Comparison with Technituim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.Ilhan IE, Gulin V, Berberoglu S, Kapucuoglu N, Cila A, Eke S. Quantitative Hematol Oncol 2005;22(2):153-62 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48725 |
| Study title: The bone scan in desseminated BCGitis.Alavi M, Safavi S. Hell J Nucl Med 2008;11(1):46-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48526 |
| Study title: Role of skeletal scintigraphy in soft tissue sarcoma: Improving the diagnostic yieldBarai S, Bandopadhayaya GP, Chumber S, Gupta DK, Patel CD, Dhanpati H. J Postgrad Med 2004a Jul-Sep;50(3):180-3; discussion 183-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48562 |
| Study title: [The diagnostic importance of a quantitative evaluation of gamma scintigraphy in Perthes' disease in children]. Russian. Dmitrienkov BN, Fedin AV, Zhvaniia TG, Subbotina EN. Med Radiol (Mosk). 1989 Jul;34(7):19-23. Russian. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43784 |
| Study title: The role of 99Tcmsestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.Burak Z, Yuksel DA, Cetingul N, Kantar M, Ozkilic H, Moretti JL. Nucl Med Comm 1999; 20(11):991-1000. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48586 |
| Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with acute otitis media or otitis media with effusion after single oral administration of 20mg/kg or 30mg/kg of a telithromycin pediatric suspension |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41566 |
| Study title: Sacro-iliitis in infants: a difficult diagnosis. 4 casesPratte L. Docquier P- L. Joint Bone Spine 2009: 76:313 -5 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48510 |
| Study title: The role of ultrasound and isotope scanning in the management of irritable hipsGopakumar TS. Vaishya R. Klenerman L. Carty H. Eur J Radiol 1992 Sep;15(2):113-7 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48484 |
| Study title: Open, non-comparative study in the GI tract in children and infants to evaluate the suitability/tolerability of iohexol in the GI tract in infants/children by monitoring patient reactions, taste acceptance and visualization.Applicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48885 |
| Study title: Open, non-comparative study Myelography study: evaluate safety, tolerance and image quality of iohexol in pediatric use.Applicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48884 |
| Study title: Open, non-comparative study to evaluate the suitability/tolerability of iohexol in abdominal CT in infants/children by monitoring patient reactions, taste acceptance and image qualityApplicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48886 |
| Study title: Paediatric angiocardiography with iohexol Invest Radiol 1985 Jan-Feb; 20(1 Suppl): S75-8 Carlsson EC 1985 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48854 |
| Study title: Paediatric myelography with iohexol Paediatric radiology (1992), 22(4), 290-2. Fjelldal et al. Experiences with iohexol (Omnipaque) at urography Paediatric radiology (1987), 17(6), 491-2 Dube LJ 1987 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48857 |
| Study title: Randomized double-blind, parallel study(open two-group comparison on consecutive patients) in pediatric angiography. Angiocardiography: the aim of the study was to compare iohexol to the best tolerated contrast medium in angiocardiography at present approved for routing use.Applicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48883 |
| Study title: Randomized, single-blind, parallel study in pediatric urography to study the safety, tolerance and radiographic properties of iohexol 300 mg I/ml compared to a conventional ionic CM, Urografin 290 mg I/ml, in pediatric urography.Applicant's study report |
| Active substance: IOHEXOL |
| Study summary document link (including results): Copy of List of studies Omnipaque- pediatric.xls |
| View full study record |
| Document reference: 48880 |
| Study title: The use of low osmolality water soluble (LOWS) contrast media in the paediatric gastro-intestinal tract. A report of 115 examinations Paediatric radiology (1986), 16(1), 47-52 Ratcliffe JF 1986 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48864 |
| Study title: Tracheobronchography in children Laryngoscope. 1996 Oct; 106(10): 1248-54 Deutsch ES 1996 |
| Active substance: IOHEXOL |
| Study summary document link (including results): 2011-09 GE Omnipaque response List of published articles.doc |
| View full study record |
| Document reference: 48856 |
|
Study title: Renal prostaglandin E |
| Active substance: INDOMETHACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30013 |
| Study title: Interferon gamma-1b (IF-RC 1001 XX G): Safety, Efficacy and Pharmaco- kinetics of 0.1 mg/sqm, 0.25 mg/sqm and 0.5 mg/sqm Interferon gamma-1b for 2 or more Weeks Sub- cutaneaously Administered to Patients with Lympho- mas, Plasmo- cytomas and Solid Tumors. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30201 |
| Study title: Long-term safety and efficacy of Actimmune therapy in children with chronic granulomatous disease (CGD): Summary of data from the National Institutes of Health cohort in children initiating Actimmune prior to 1 year of age and prior to 3 years of age, respectively. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30206 |
| Study title: Long-term safety and efficay of Actimmune therapy in young children with chronic granulomatous disease (CGD): An integrated summary of data extracted from Studies I0016g, I0016g(A),I0034g, and I0286n in children initiating Actimmune therapy prior to 1 year of age and prior to 3 years of age, respectively. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30207 |
| Study title: Post marketing surveillance study of Actimmune (recombinant human interferon gamma-Ib) in patients with chronic granulomatous disease. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30190 |
| Study title: The immunomodulatory impact of Imukin (IFNgamma-1b) on clinical and laboratory data in the treatment of atopic dermatitis. |
| Active substance: INTERFERON GAMMA (1B) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30204 |
| Study title: Falk MS, Truitt AK, Coakley FV, Kashani-Sabet M, Hawkins RA, Franc B.. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma. [falk-2007]Nucl Med Commun. 2007 Apr;28(4):273-80. Falk MS 2007 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48643 |
| Study title: Fisher RS, Frost JJ. J Nucl Med.. [fisher-1991]1991 Apr;32(4):651-9. Epilepsy. Fisher RS 1991 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48644 |
| Study title: Franzius C, Daldrup-Link HE, Wagner-Bohn A, Sciuk J, Heindel WL, Jurgens H, et al.. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. [franzius-2002]Franzius C 2002. Ann Oncol. 2002 Jan;13(1):157-60 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48645 |
| Study title: Franzius C, Schober O.. Assessment of therapy response by FDG PET in pediatric patients. [franzius-2003]Q J Nucl Med. 2003 Mar;47(1):41-5. Franzius C 2003 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48646 |
| Study title: Franzius C, Schulte M, Hillmann A, Winkelmann W, Jürgens H, Bockisch A, et al.. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group] [Article in German] [franzius-2001]Chirurg. 2001 Sep;72(9):1071-7. Franzius C 2001 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48647 |
| Study title: Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, et al.. FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison. [friedberg-2004]Leuk Lymphoma. 2004 Jan;45(1):85-92. Friedberg JW 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48650 |
| Study title: RM2002/00111/00 An open label long term observational study of the safety and tolerability of sumatriptan nasal spray in the treatment of migraine in adolescents. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUM40276-ICHE3.pdf |
| View full study record |
| Document reference: 43075 |
| Study title: Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, et al.. Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. [furth-2006]J Pediatr Hematol Oncol. 2006 Aug;28(8):501-12. Furth C 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48652 |
| Study title: Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S, Kobe C, Denecke T, Stöver B, Hautzel H, Henze G, Hundsdoerfer P.. Epub 2009 Aug 10.Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. [furth-2009]J Clin Oncol. 2009 Sep 10;27(26):4385-91. Furth C 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48651 |
| Study title: Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH.. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. [gaillard-1995]Neurology. 1995 Jan;45(1):123-6. Gaillard WD 1995 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48653 |
| Study title: Hypothyroid patients showing shortened responsiveness to oral iodized oil have paradoxically low serum thyroglobulin and low thyroid reserve. Thyroglobulin/thyrotropin ratio as a measure of thyroid damage. ;Contempre-B. European Journal of Endocrinology, 1996, Vol/Iss /Pg. 134/3 (342-351)Hypothyroid patients showing shortened responsiveness to oral iodized oil have paradoxically low serum thyroglobulin and low thyroid reserve. Thyroglobulin/thyrotropin ratio as a measure of thyroid damage. ;Contempre-B. European Journal of Endocrinology, 1996, Vol/Iss /Pg. 134/3 (342-351) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30261 |
| Study title: effects of self-applied topical fluoride preparations in orthodontic patients2000-alexander |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 2000-alexander-effects of self-applied topical fluoride preparations in orthodontic patients.pdf |
| View full study record |
| Document reference: 49096 |
| Study title: Enamel changes and dental caries in 7 years old children given fluoride tablets from shortly after birthA. Thylstrup, O. Fejerskov, C. Brunn, J. Kann 1979. Brit Dent. |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1979-thylstrup-Enamel Changes and Dental Caries in 7-Year-Old children fiven fluoride tablets from shortly after birth.pdf |
| View full study record |
| Document reference: 48779 |
| Study title: A 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate1988-Stephen, Community Dent Oral Epidemiology 16:321-5 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1988-Stephen-a 3 year oral health dose response study of sodium monofluorophosphate dentifrices with and without zinc citrate.pdf |
| View full study record |
| Document reference: 49085 |
| Study title: A 48-month survival analysis comparing sealant (Delton) with fluoride varnish (Duraphat) in 6-8 year old children1997-bravo |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1996-bravo-Effectiveness of visible light fissure sealant (Delton) versus fluoride varnish (Duraphat) 24 month clinical trial.pdf |
| View full study record |
| Document reference: 49122 |
| Study title: A Community Study of Fluoride Tablets for School Children in Portsmouth1982-Allmark. Br Dent J 1982: 153: 426 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1982-Allmark-A Community Study od Fluoride Tablets for School Children in Portsmouth.pdf |
| View full study record |
| Document reference: 48773 |
| Study title: A home care program of chemical preventive dentistry for orthodontic patients1973-landry |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1973-landry-a home care program of chemical preventive dentistry for orthodontic patients.pdf |
| View full study record |
| Document reference: 49151 |
| Study title: a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years1962-Gish |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1962-Gish-a new approach to the topical application of fluorides for the reduction od dental caries in children-results at the end of five years.pdf |
| View full study record |
| Document reference: 49143 |
| Study title: A new approach to the topical application of fluorides for the reduction of dental caries in children1957-gish |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1957-gish-a new approach to the topical application of fluorides for the reduction of dental caries in children.pdf |
| View full study record |
| Document reference: 49133 |
| Study title: A new approach to the topical application of fluorides in children with results at the end of four years1959-Gish |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1959-Gish-A new approach to the topical application of fluorides in children with results at the end of four years.pdf |
| View full study record |
| Document reference: 49137 |
| Study title: A newapproach to the topical application of fluorides in children with results at the end of two years1957-gish |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1957-Gish-A newapproach to the topical application of fluorides in children with results at the end of two years.pdf |
| View full study record |
| Document reference: 49134 |
| Study title: A study of a single application of eight persent stannous fluoride1959-Jordan |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1959-Jordan-A study of a single application of eight persent stannous fluoride.pdf |
| View full study record |
| Document reference: 49138 |
| Study title: A three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children1987-Lu, Journal of dentistry for children, July-August 1987 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1987-Lu-a three year clinical comparison of a sodium monofluorophosphate dentifrice with sodium fluoride dentifrices on dental caries in children.pdf |
| View full study record |
| Document reference: 49083 |
| Study title: The suspected scaphoid fracture and isotope bone imaging. Brown JN. Injury. 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48836 |
| Study title: The suspected scaphoid fracture and isotope bone imaging.Brown JN. Injury 1995 Sep;26(7):479-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48582 |
| Study title: The symptomatic hip in childhood: scintigraphic findings in the presence of a normal radiograph. Gordon I, Peters AM, Nunn R. Skeletal Radiol. 1987;16(5):383-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43880 |
| Study title: Three-phase radionuclide bone imaging in stress injury of the anterior iliac crestRockett JF. J Nucl Med 1990 Sep;31(9):1554-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48512 |
| Study title: Scintigraphic and radiographic findings in eosinophilic granuloma.Benz-Bohm G, Georgi P. Radiologe 1981 Apr;21(4):195-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48570 |
| Study title: Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell diseaseRoo S. Solomon N. MillerS. Dunn E. J Pediatr 1985 Nov;107(5):685-8 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48511 |
| Study title: Scintigraphic evaluation of calcinosis in juvenile dermatomyositis with Tc-99m MDP.Bar-Sever Z, Mukamel M, Harel L, Hardoff R. Clin Nucl Med 2000 Dec;25(12):1013-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48565 |
| Study title: Scintigraphic findings in progressive diaphyseal dysplasiaLundy MM. Billingsley JL. Redwine MD. Turnbull GL. Brown T J. J Nucl Med 1982 Apr;23(4):324-5 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48501 |
| Study title: Scintigraphic findings of osteomyelitis after intraosseous infusion in a child.Barron BJ, Tran HD, Lamki LM. Clin Nucl Med 1994 Apr;19(4):307-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48564 |
| Study title: Unexpected stomach uptake of technetium-99m-MDPSpicer JA. Slaton CK. Raveill TG. Baxter KG. Preston DF. Hladik WB. J Nucl Med Tech 1999 27(1):43-4 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48517 |
| Study title: Unusual Tc-99m MDP and I-123 MIBG images in focal pyelonephritisJacobs A, Lenoir P, Delree M, Ramet J, Piepsz A. Clin Nucl Med 1990 15(11):821-4 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48749 |
| Study title: Scintigraphy of lower extremity cadaveric bone allografts in osteosarcoma patients.Bar-Sever Z, Connolly LP, Gebhardt MC, Treves ST. Clin Nucl Med 1997 Aug;22(8):532-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48567 |
| Study title: Scintigraphy of Toddler's FractureJohn H. Miller and Ronald A. Sanderson. J Nucl Med 29:2001-2003,1988 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48846 |
| Study title: Scintigraphy of toddler's fractureMiller JH. Sanderson RA. J Nucl Med 1988 Dec;29(12):2001-3 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48507 |
| Study title: Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP.Bylander B, Hansson LI, Kärrholm J, Naversten Y. Acta Radiol Diagn 1983;24(1):85-96. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48587 |
| Study title: Serum osteocalcin and other indices of bone formation: an 8-decade population study in healthy men and womenWorsfold M. Sharp CA. Davie MW. Clinica Chimica Acta 1988 178(2):225-35 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48518 |
| Study title: Use of 99m-Tc-MDP Spect for assessment of mandibular growth: development of normal values.Fahey FH, Abramson ZR, Padwa BL, Zimmerman RE, Zurakowski D, Nissenbaum M, et al. Eur J Nucl Med Mol Imaging 2010;37:1002-10. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48722 |
| Study title: International Commission on Radiological Protection, Radiation Dose to Patients from RadiopharmaceuticalsICRP Pergamon Press 1998) - Publication 80 |
| Active substance: Iobenguane |
| Study summary document link (including results): ICPR-1998.pdf |
| View full study record |
| Document reference: 48116 |
| Study title: A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B(12) binding capacity in a young Japanese female. ; Kanai-T. Japanese Journal of Clinical Oncology, 01 JUN 2004, Vol/Iss/Pg. 34/6 (346-351)A case of postoperative recurrence of fibrolamellar hepatocellular carcinoma with increased vitamin B(12) binding capacity in a young Japanese female. ; Kanai-T. Japanese Journal of Clinical Oncology, 01 JUN 2004, Vol/Iss/Pg. 34/6 (346-351) |
| Active substance: IOBITRITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30213 |
| Study title: Detection of coronary complications after the arterial switch operation for transposition of the great arteries : first experience with multislice computed tomography in children; Ou P et al; Thorac.Cardiovasc. Surg.; 2006 vol.131 p.639 643Detection of coronary complications after the arterial switch operation for transposition of the great arteries : first experience with multislice computed tomography in children; Ou P et al; Thorac.Cardiovasc. Surg.; 2006 vol.131 p.639 643 |
| Active substance: IOBITRITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30211 |
| Study title: Intravenous contrast media in uroradiology : evaluation of safety and tolerability in almost 50,000 patients; Wendt M. et al; Med. Princ. Pract.; 2006 vol.15 p.358 361Intravenous contrast media in uroradiology : evaluation of safety and tolerability in almost 50,000 patients; Wendt M. et al; Med. Princ. Pract.; 2006 vol.15 p.358 361 |
| Active substance: IOBITRITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30210 |
| Study title: Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: A randomized, controlled, double-blind study. ; Zimmermann-M-B.American Journal of Clinical Nutrition, 01 JAN 2006, Vol/Iss/Pg. 83/1 (108-114)Iodine supplementation improves cognition in iodine-deficient schoolchildren in Albania: A randomized, controlled, double-blind study. ; Zimmermann-M-B.American Journal of Clinical Nutrition, 01 JAN 2006, Vol/Iss/Pg. 83/1 (108-114) |
| Active substance: IOBITRITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30212 |
| Study title: Results of the Safety and Efficiency of Iobitridol in more than 61,000 Patients; Petersein J. et al. / Eur Radiol (2003) 13: 2006-2011Results of the Safety and Efficiency of Iobitridol in more than 61,000 Patients; Petersein J. et al. / Eur Radiol (2003) 13: 2006-2011 |
| Active substance: IOBITRITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30209 |
| Study title: Safety of iobitridol in the general population and at-risk patients; Hammerstingl RM et al; Eur. Radiol.; 2006 vol.16 n.6 p.1288 1297Safety of iobitridol in the general population and at-risk patients; Hammerstingl RM et al; Eur. Radiol.; 2006 vol.16 n.6 p.1288 1297 |
| Active substance: IOBITRITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30208 |
| Study title: A case of undifferentiated sarcoma of the liver in which chemo- embolization with cisplatin-lipiodol suspension was effective. ; Araki-T. Japanese Journal of Clinical Radiology, 1994, Vol /Iss/Pg. 39/3 (419-422)A case of undifferentiated sarcoma of the liver in which chemo- embolization with cisplatin-lipiodol suspension was effective. ; Araki-T. Japanese Journal of Clinical Radiology, 1994, Vol /Iss/Pg. 39/3 (419-422) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30214 |
| Study title: erste erfahrungen mit hexabrix bei der ausscheidungsurographie im kindesalter; Reither M., Fortschr. Med.; 1981 vol.99 n.20 p.771 773erste erfahrungen mit hexabrix bei der ausscheidungsurographie im kindesalter; Reither M., Fortschr. Med.; 1981 vol.99 n.20 p.771 773 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30438 |
| Study title: Evaluation de l'efficacite diagnostique et de la tolerance clinique du ioversol en tomodensitometrie "corps entier" chez l'enfant : essai non comparatif de phase III; PANUEL M; Ann. Radiol.; 1992 vol.35 n.4 bis p.280-283Evaluation de l'efficacite diagnostique et de la tolerance clinique du ioversol en tomodensitometrie "corps entier" chez l'enfant : essai non comparatif de phase III; PANUEL M; Ann. Radiol.; 1992 vol.35 n.4 bis p.280-283 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30409 |
| Study title: Evaluation of the post-shunt status with electron beam computed tomography in cyanotic congenital heart disease; CHOI BW; Yonsei Med. J.; 2003 vol.44 n.2 p.249 258Evaluation of the post-shunt status with electron beam computed tomography in cyanotic congenital heart disease; CHOI BW; Yonsei Med. J.; 2003 vol.44 n.2 p.249 258 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30410 |
| Study title: Extrahepatic metastases of hepatocellular carcinoma; KATYAL S; Radiology; 2000 vol.216 p.698 703Extrahepatic metastases of hepatocellular carcinoma; KATYAL S; Radiology; 2000 vol.216 p.698 703 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30411 |
| Study title: Interpreting the results of pediatric central venous catheter studies; KIM FM; Radiographics; 1996 vol.16 n.4 p.747 754Interpreting the results of pediatric central venous catheter studies; KIM FM; Radiographics; 1996 vol.16 n.4 p.747 754 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30412 |
| Study title: Hypothyroidism in an area of endemic goiter and cretinism in Central Java, Indonesia;G. Hennemann. J. Clin. Endocrinology metabolism 1997 44 3 481-490Hypothyroidism in an area of endemic goiter and cretinism in Central Java, Indonesia;G. Hennemann. J. Clin. Endocrinology metabolism 1997 44 3 481-490 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30262 |
| Study title: Hypothyroidism in cretins and non-cretinous subjects in an area of severe iodine deficiency in Central Java;Robbins J. et Coll. Thyroid research. Amsterdam excerpta medica 1975 378: 501-504Hypothyroidism in cretins and non-cretinous subjects in an area of severe iodine deficiency in Central Java;Robbins J. et Coll. Thyroid research. Amsterdam excerpta medica 1975 378: 501-504 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30263 |
| Study title: Infant Survivals is improved by Oral Iodine supplementation; Claudine Cobra. J. Nutr. 127 : 574-578, 1997Infant Survivals is improved by Oral Iodine supplementation; Claudine Cobra. J. Nutr. 127 : 574-578, 1997 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30264 |
| Study title: Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308)Influence of iodine supplementation on serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) levels in severe iodine deficiency. ;Özön-A. Turkish Journal of Pediatrics, 2004, Vol/Iss/Pg. 46/4 (303-308) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30265 |
| Study title: Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407)Influence of nutritional state on the disposal of orally and intramuscularly administered iodized oil to iodine repleted older children and adult women. Fierro-Benitez-R. Journal of Endocrinological Investigation, 1989, Vol/Iss/Pg. 12/6 (405-407) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30266 |
| Study title: Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. ;Ogita-S. Regional Cancer Treatment, 1992, Vol/Iss/Pg. 5/3-4 (106-109)Intraarterial chemotherapy with Lipiodol for initially unresectable hepatoblastomas in children. ;Ogita-S. Regional Cancer Treatment, 1992, Vol/Iss/Pg. 5/3-4 (106-109) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30267 |
| Study title: Intrahepatic Arterial Injections of Cisplatin-Phosphatidylcholine-Lipiodol Suspension in Two Unresectable Hepatoblastoma Cases;Kohji Sue. Medical and Pediatric Oncology 17:496-500 (1989)Intrahepatic Arterial Injections of Cisplatin-Phosphatidylcholine-Lipiodol Suspension in Two Unresectable Hepatoblastoma Cases;Kohji Sue. Medical and Pediatric Oncology 17:496-500 (1989) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30268 |
| Study title: Investigation report of iodine deficiency disorders in Linxia, Gansu Province. Su-X-H. Chinese Journal of Endemiology , 2005, Vol/Iss/Pg. 24 /3 (297-299)Investigation report of iodine deficiency disorders in Linxia, Gansu Province. Su-X-H. Chinese Journal of Endemiology , 2005, Vol/Iss/Pg. 24 /3 (297-299) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30269 |
| Study title: Iodine supplementation in a goitre endemic area.;Babikir Elnagar. Comprehensive summaries of Uppsala Dissertations from the Faculty of Medicines 608: 20-26Iodine supplementation in a goitre endemic area.;Babikir Elnagar. Comprehensive summaries of Uppsala Dissertations from the Faculty of Medicines 608: 20-26 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30270 |
| Study title: Iodine supplementation: A comparison of oral and intramuscular methods in the improvement of thyroid function and prophylaxis of goitre. ; Malone-F-J. Trace Elements and Electrocytes, 1996, Vol /Iss/Pg. 13/3 (133-135)Iodine supplementation: A comparison of oral and intramuscular methods in the improvement of thyroid function and prophylaxis of goitre. ; Malone-F-J. Trace Elements and Electrocytes, 1996, Vol /Iss/Pg. 13/3 (133-135) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30271 |
| Study title: Iodine-induced hypothyroidism and goiter following lipiodol(TM) lymphography. ;Heidemann-P-H. European Journal of Pediatrics, 1982, Vol/Iss/Pg. 138 /1 (82-83)Iodine-induced hypothyroidism and goiter following lipiodol(TM) lymphography. ;Heidemann-P-H. European Journal of Pediatrics, 1982, Vol/Iss/Pg. 138 /1 (82-83) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30272 |
| Study title: Iodine-induced hypothyroidism following lymphography. ;Heidemann-P. Pediatric Research, 1981, Vol/Iss/Pg. 15/12 (No. 192)Iodine-induced hypothyroidism following lymphography. ;Heidemann-P. Pediatric Research, 1981, Vol/Iss/Pg. 15/12 (No. 192) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30273 |
| Study title: Iodized oil as a complement to iodized salt in schoolchildren in endemic goiter in Romania. ;Simescu-M Hormone Research, 2002, Vol/Iss/Pg. 58/2 (78-82)Iodized oil as a complement to iodized salt in schoolchildren in endemic goiter in Romania. ;Simescu-M Hormone Research, 2002, Vol/Iss/Pg. 58/2 (78-82) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30275 |
| Study title: Amounts of fluorides in self administered dental products: safety considerations for childrenStanley B Heifetz, Herschel S Horowitz. Pediatrics Vol 77No. 6 June 1986 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1986-heifetz-Amounts of fluoride in self-administered dental products-safety consideration for children.pdf |
| View full study record |
| Document reference: 48770 |
| Study title: An assessment of two dental health education programmes for school children in the Lothian region of ScotlandC. Wight, A.S. Blinkhorn 1988. Journal of Pediatric Dentistry |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1988-wight-An Assessment of Two Dental Health Education programmes for school children in the lothian region of scotland.pdf |
| View full study record |
| Document reference: 48775 |
| Study title: An open study to investigate what happens with a lozenge that is given to a 3-5 year old child that are told to leave it be in their mouth.Mejàre et al. (1987-09-23) |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48943 |
| Study title: Assessment of the effectiveness of supervised oral hygiene programmes by means of different indicesMaiwald 1993 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Maiwald 1993 Assessment of the effectiveness.pdf |
| View full study record |
| Document reference: 49170 |
| Study title: Caries epidemiological studies- Kariesepidemiologische UntersuchungenBüttner 1995 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Büttner 1995 Kariesepidemiologische Untersuchungen.pdf |
| View full study record |
| Document reference: 49160 |
| Study title: Caries increment in primary teeth after application of Duraphat fluoride varnish1982-grogzka |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1982-grogzka-Caries increment in primary teeth after application of Duraphat fluoride varnish.pdf |
| View full study record |
| Document reference: 49108 |
| Study title: Fries P.. Final Report. Munich, Germany; Dermatological Clinic and Polyclinic of Technical University of Munich; 04 February.1985. Treatment of herpes simplex virus infection with Delimmun®. Fries P.. Final Report. Munich, Germany; Dermatological Clinic and Polyclinic of Technical University of Munich; 04 February.1985. Treatment of herpes simplex virus infection with Delimmun®. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30103 |
| Study title: Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T et al. Brain and Development. 1987; 9(3):270-282. Clinical effects of MND-19 (inosiplexl on subacute sclerosing panencephalitis: a multi-institutional collaborative study.Fukuyama Y, Nihei K, Matsumoto S, Ebina T, Kamoshita S, Sato T et al. Brain and Development. 1987; 9(3):270-282. Clinical effects of MND-19 (inosiplexl on subacute sclerosing panencephalitis: a multi-institutional collaborative study. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30104 |
| Study title: Gadoth M et al. Beilinson Hospital 1980. . Stimulation of interferon production by inospilex in SSPEGadoth M et al. Beilinson Hospital 1980. . Stimulation of interferon production by inospilex in SSPE |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30105 |
| Study title: Gallais H, Kadio A, Odehouri K, Moreau J, Bertrand EDBulletin of the Society of Exotic Pathology. September- October, 1981; 74(5):553-561. . Effect of Isoprinosine in tropical measles: double-blind study (200 cases)Gallais H, Kadio A, Odehouri K, Moreau J, Bertrand EDBulletin of the Society of Exotic Pathology. September- October, 1981; 74(5):553-561. . Effect of Isoprinosine in tropical measles: double-blind study (200 cases) |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30106 |
| Study title: Gallet J-P. Bulletin Officiel du Ministere de la Sante [Official gazette of the Ministry ofHealth, Paris]. June 3, 1986; 86(19): 1-12. Expert Clinician in Pediatrics report. Endorsement report concerning double-blind study of Isoprinosine and a placebo for the treatment of severe or complicated measles Gallet J-P. Bulletin Officiel du Ministere de la Sante [Official gazette of the Ministry ofHealth, Paris]. June 3, 1986; 86(19): 1-12. Expert Clinician in Pediatrics report. Endorsement report concerning double-blind study of Isoprinosine and a placebo for the treatment of severe or complicated measles |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30107 |
| Study title: Galli M, Lazzarin A, Moroni M, Zanussi C. In: Immunomodulation: New Frontiers and Advances. Fudenberg HH, Whitten HD, Ambrogi F, eds. New York, New York, USA; Plenum Press; 1984; 385-397. Treatment of recurrent viral infectious diseases by methisoprinol.Galli M, Lazzarin A, Moroni M, Zanussi C. In: Immunomodulation: New Frontiers and Advances. Fudenberg HH, Whitten HD, Ambrogi F, eds. New York, New York, USA; Plenum Press; 1984; 385-397. Treatment of recurrent viral infectious diseases by methisoprinol. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30108 |
| Study title: Uterine blush in multiphase bone imaging.Mandell GA. Harcke HT. Sharkey C. Brooks K. J Nucl Med 1986a Jan;27(1):51-5 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48503 |
| Study title: Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphyDavenport MS, Brown RKJ, Frey KA. AJR 2009;193:338-42. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48596 |
| Study title: Shoulder Pain in a young break-dancer evaluated with bone scintigraphy.Khoury JJ, Laberant N, Jerushalmi J. Clin Nucl Med 2009;34:916-7 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48750 |
| Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Moilanen et al. |
| Active substance: testa triticum |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Testa triticum tricum_1.xlsx |
| View full study record |
| Document reference: 49079 |
| Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Moilanen et al. |
| Active substance: testa triticum |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Testa triticum tricum_1.xlsx |
| View full study record |
| Document reference: 49080 |
| Study title: Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.Gordon I. Peters AM. Gutman A, Morony S. Dicks-Mireaux C. Pritchard J. J Nucl Med 1990Feb;31(2):129-34 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48485 |
| Study title: Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scansGordon I, Peters AM, Gutman A, Morony S, Dicks-Mireaux C, Pritchard J. J Nucl Med 1990Feb;31(2):129-34 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48724 |
| Study title: Skeletal scintigraphy of young patients with low-back pain and a lumbosacral transitional vertebra. Connolly LP, d'Hemecourt PA, Connolly SA, Drubach LA, Micheli LJ, Treves ST. J Nucl Med. 2003 Jun;44(6):909-14. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48842 |
| Study title: Small rounded B-cell lymphoma of bone presented by limp, with a positive multifocal 99mTC MDP bone scintigraphy pattern and a negative 99mTc HMPAO-labled leukocytes studyPerez RH, Farto JCA, Arias IA, Regi AR, Vazquez JMP. J Pediatr Hematol Oncol 2008:30:443-446 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48753 |
| Study title: Adrenocortical suppression increases the risk of relapse in nephrotic syndromeAdrenocortical suppression increases the risk of relapse in nephrotic syndrome |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44459 |
| Study title: Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors. J Nucl Med. 2002 Nov;43(11):1452-6. Taki J 2002 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48797 |
| Study title: Preoperative diagnosis of bronchial atresia presenting with recurrent respiratory symptoms in an infant. Turk J Pediatr. 2000 Oct-Dec;42(4):348-51. Yüksel H 2000 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48800 |
| Study title: Prevalence of deep venous thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies. Ann Nucl Med. 2001 Dec;15(6):495-7. Kinuya K 2001 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48799 |
| Study title: Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis. J Nucl Med. 1995 Nov;36(11):2006-8. Oyen WJ 2006 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48817 |
| Study title: Intravenous digital subtraction angiography for the evaluation of renal artery blood flow following the removal of a neuroblastoma; YAMAGIWA I; Surg. Today; 1994 vol.24 p.973-977Intravenous digital subtraction angiography for the evaluation of renal artery blood flow following the removal of a neuroblastoma; YAMAGIWA I; Surg. Today; 1994 vol.24 p.973-977 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30413 |
| Study title: Intravenous use of ionic and nonionic contrast agents in children; COHEN MD; Radiology; 1994 vol.191 p.793-794Intravenous use of ionic and nonionic contrast agents in children; COHEN MD; Radiology; 1994 vol.191 p.793-794 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30414 |
| Study title: Iodine and hypothyroidism in neonates with congenital heart disease; LINDER N; Arch. Dis. Child.; 1997 vol.77 p.239 240Iodine and hypothyroidism in neonates with congenital heart disease; LINDER N; Arch. Dis. Child.; 1997 vol.77 p.239 240 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30415 |
| Study title: Ioversol (optiray) a new contrast media in the pediatric praxis; LOMBAY B; in : year book of pediatric radiology ; current problems of pediatric radiology ; Borsod County Teaching Hospital Hongrie ; 1994 vol.6 p.43 47Ioversol (optiray) a new contrast media in the pediatric praxis; LOMBAY B; in : year book of pediatric radiology ; current problems of pediatric radiology ; Borsod County Teaching Hospital Hongrie ; 1994 vol.6 p.43 47 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30416 |
| Study title: Ioversol 300 : etude clinique en urographie intraveineuse pediatrique; MONTAGNE JP; Ann. Radiol.; 1992 vol.35 n.4 bis p.307-310Ioversol 300 : etude clinique en urographie intraveineuse pediatrique; MONTAGNE JP; Ann. Radiol.; 1992 vol.35 n.4 bis p.307-310 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30417 |
| Study title: Is administration of enteric contrast material safe before abdominal CT in children who require sedation ? experience with chloral hydrate and pentobarbital; ZIEGLER MA; AJR; 2003 vol.180 p.13 15Is administration of enteric contrast material safe before abdominal CT in children who require sedation ? experience with chloral hydrate and pentobarbital; ZIEGLER MA; AJR; 2003 vol.180 p.13 15 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30418 |
| Study title: Mechanisms of severe immediate reactions to iodinated contrast material; LAROCHE D; Radiology; 1998 vol.209 p.183 190Mechanisms of severe immediate reactions to iodinated contrast material; LAROCHE D; Radiology; 1998 vol.209 p.183 190 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30419 |
| Study title: Nonoperative management of blunt liver trauma : the value of follow-up abdominal computed tomography scans; CUFF RF; Am. Surg.; 2000 vol.66 p.332 336Nonoperative management of blunt liver trauma : the value of follow-up abdominal computed tomography scans; CUFF RF; Am. Surg.; 2000 vol.66 p.332 336 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30420 |
| Study title: Oral contrast agents for CT of abdominal trauma in pediatric patients : a comparison of dilute hypaque and water; HALSTED MJ; AJR; 2004 vol.182 p.1555 1559Oral contrast agents for CT of abdominal trauma in pediatric patients : a comparison of dilute hypaque and water; HALSTED MJ; AJR; 2004 vol.182 p.1555 1559 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30421 |
| Study title: Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography.Pediatr cardiol. 2005 Jul-Aug: 26(4):413-7: Safety and Efficacy of Itravenous Contrast Imaging in Pediatrich Echocardiography. |
| Active substance: Perflutren |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41585 |
| Study title: Controlling conditioning-related emesis in children undergoing bone marrow transplantationOncol Nurs Forum 1997; 24 (9): 1539-44; Mehta NH., 1997 |
| Active substance: PERPHENAZINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48910 |
| Study title: Preoperative oral antiemetics for reducing postoperative vomiting after tonsillectomy in childrenFujii Y., 1999, Anesth Analg. 1999 Jun; 88 (6): 1298-30 |
| Active substance: PERPHENAZINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48911 |
| Study title: A controlled clinical comparison of nasal decongestants in acute rhinitis.Curr Ther Res 1966; 8: 91-3, Haines HL., 1966 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48916 |
| Study title: Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.Sentongo TA, Cohran V, Korff S, Sullivan C, Iyer K, Zheng X. J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):41-7.Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.Sentongo TA, Cohran V, Korff S, Sullivan C, Iyer K, Zheng X. J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):41-7. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30992 |
| Study title: Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. J Pediatr Surg. 2001 Apr;36(4):587-92.Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. J Pediatr Surg. 2001 Apr;36(4):587-92. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31001 |
| Study title: PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. Gut. 2004 Nov;53(11):1590-4.PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Mäkel W, Taminiau J, Benninga M. Gut. 2004 Nov;53(11):1590-4. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30998 |
| Study title: Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial.Rendeli C, Ausili E, Tabacco F, Focarelli B, Pantanella A, Di Rocco C, Genovese O, Fundarò C. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1259-65.Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial.Rendeli C, Ausili E, Tabacco F, Focarelli B, Pantanella A, Di Rocco C, Genovese O, Fundarò C. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1259-65. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30995 |
| Study title: Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics.Marsilio R, D'Antiga L, Zancan L, Dussini N, Zacchello F. Clin Chem. 1998 Aug;44(8 Pt 1):1685-91.Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics.Marsilio R, D'Antiga L, Zancan L, Dussini N, Zacchello F. Clin Chem. 1998 Aug;44(8 Pt 1):1685-91. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31003 |
| Study title: The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.Twiss IM, Burggraaf J, Schoemaker RC, van Elburg RM, den Hartigh J, Cohen AF, Vermeij P. Clin Pharmacol Ther. 2001 Jun;69(6):431-7.The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.Twiss IM, Burggraaf J, Schoemaker RC, van Elburg RM, den Hartigh J, Cohen AF, Vermeij P. Clin Pharmacol Ther. 2001 Jun;69(6):431-7. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31000 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Lamioflur (drops) [AWB-AT] |
| Active substance: Lamioflur |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40045 |
| Study title: A Multi-Center, Double-blind, Placebo-controlled, Parallel Evaluation of LAMICTAL as Add-on Therapy with Valproic Acid for the Treatment of Generalized Seizures in Paediatric and Adult Patients. |
| Active substance: LAMOTRIGINE |
| Study summary document link (including results): Study SCAA3001-Lamotrigine.xls |
| View full study record |
| Document reference: 31009 |
| Study title: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Evaluation of Lamotrigine Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures [Data from the Open-label Continuation Phase] |
| Active substance: LAMOTRIGINE |
| Study summary document link (including results): Lamotrigine-Lamotrigine-LAM40097-ICHE3.pdf |
| View full study record |
| Document reference: 31007 |
| Study title: A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of lamotrigine in subjects with neuropathic pain and inadequate pain relief with gabapentin, tricyclic antidepressants or non-narcotic analgesics. |
| Active substance: LAMOTRIGINE |
| Study summary document link (including results): Lamotrigine-Lamotrigine-NPP30010-ICHE3.pdf |
| View full study record |
| Document reference: 31008 |
| Study title: Lamotrigine: a single-blind dose-ranging study in patients with epilepsy. |
| Active substance: LAMOTRIGINE |
| Study summary document link (including results): Lamotrigine-Lamotrigine-UK25-ICHE3.pdf |
| View full study record |
| Document reference: 31010 |
| Study title: Open, multicentre study to evaluate the efficacy and tolerability of leuprorelin acetate 3,75 mg (enantone depot) in central precocious puberty treatment |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31054 |
| Study title: Open, multicentre, study to evaluate the efficacy and tolerability of leuprorelin acetate 3,75 mg (enantone depot) in central precocious puberty treatment |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31044 |
| Study title: Study of Lupron Depot in the treatment of central precocious puberty, interim summary |
| Active substance: LEUPRORELIN |
| Study summary document link (including results): Leuprorelin_M90-516_synopsis.pdf |
| View full study record |
| Document reference: 31053 |
| Study title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED STUDY: 16-WEEK EVALUATION OF THE EFFICACY AND SAFETY OF LEVETIRACETAM (LEV) AS ADD-ON THERAPY IN ADULTS AND ADOLESCENTS OLDER THAN 16 YEARS SUFFERING FROM PARTIAL SEIZURES. |
| Active substance: levetiracetam |
| Study summary document link (including results): N01102 - Levetiracetam - RRCE05F1502.pdf |
| View full study record |
| Document reference: 41537 |
| Study title: A KOREAN OPEN-LABEL, MULTI-CENTER, COMMUNITY-BASED TRIAL ASSESSING THE EFFICACY AND SAFETY OF LEVETIRACETAM AS ADJUNCTIVE THERAPY IN ADULT SUBJECTS WITH UNCONTROLLED PARTIAL EPILEPSY FOR BRIDGING PURPOSE WITH A SIMILAR STUDY ON CAUCASIAN EPILEPTIC SUBJECTS. |
| Active substance: levetiracetam |
| Study summary document link (including results): N01099 - Levetiracetam - RRCE05B2803.pdf |
| View full study record |
| Document reference: 41536 |
| Study title: A MULTICENTER, DOUBLE-BLIND, FOLLOW-UP TRIAL EVALUATING THE LONG-TERM SAFETY OF LEVETIRACETAM (1000 TO 3000 MG/DAY B.I.D.) AND CARBAMAZEPINE (400 TO 1200 MG/DAY ORAL B.I.D.), USED AS MONOTHERAPY IN SUBJECTS ( 16 YEARS) COMING FROM THE N01061 TRIAL. |
| Active substance: levetiracetam |
| Study summary document link (including results): N01093 - Levetiracetam - RRCE05L2109.pdf |
| View full study record |
| Document reference: 41534 |
| Study title: A PHASE IV - PHARMACOVIGILANCE STUDY OF KEPPRA(R) GREECE - S.K.A.T.E. : SAFETY OF KEPPRA(R) AS ADJUNCTIVE THERAPY IN EPILEPSY. |
| Active substance: levetiracetam |
| Study summary document link (including results): N01035 - Levetiracetam - RRCE05J1501.pdf |
| View full study record |
| Document reference: 41535 |
| Study title: Caries increments-tooth discoloration-and state of oral hygiene in children1965-Wellock |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1965-Wellock-Caries increments-tooth discoloration-and state of oral hygiene in children.pdf |
| View full study record |
| Document reference: 49149 |
| Study title: Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study1991-peterson, Caries Res. 1991:25:70-73 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1991-peterson-Caries inhibiting effect of different modes of Duraphat reapplication-A three year radiographic study.pdf |
| View full study record |
| Document reference: 49117 |
| Study title: Caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF1988-Ripa- JADA Volume 116, January 1988 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1988-Ripa-caries inhibition of mixed NaF-Na2PO3F dentifrices containing 1000 and 2500 ppmF.pdf |
| View full study record |
| Document reference: 49084 |
| Study title: Caries prevention by daily fluoride mouthrinsingRugg-Gunn 1973 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Rugg-Gunn 1973 Caries prevention by daily fluoride mouthrinsing.pdf |
| View full study record |
| Document reference: 49129 |
| Study title: Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data1986-kirkegaard |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1986-kirkegaard-Caries preventive effect of Duraphat Varnish versus fluoride mouthrinses-5 year data.pdf |
| View full study record |
| Document reference: 49113 |
| Study title: Caries preventive effect of fluoride varnish application performed two or four times a year1990-seppa |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1990-seppa-Caries preventive effect of fluoride varnish application performed two or four times a year.pdf |
| View full study record |
| Document reference: 49115 |
| Study title: Pulmonary scintigraphic findings in children with pectus excavatum by the comparison of chest radiograph indices. Clin Nucl Med. 1992 Nov;17(11):874-6 Kao CH 1992 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48820 |
| Study title: Pulmonary ventilation/perfusion and reverse mismatches in an infant. Clin Nucl Med. 1985 Oct;10(10):708-9. Slavin JD 1985 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48828 |
| Study title: Quantitative lung perfusion scintigraphy in postoperative evaluation of congenital right ventricular outflow tract obstructive lesions. Clin Nucl Med. 1996 Jun;21(6):471-6. Kim JH 1996 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48814 |
| Study title: Radioimmunodetection of melanoma: preliminary results of a prospective study. Int J Biol Markers. 1986 Jan-Apr;1(1):47-54. Buraggi G 1986 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48827 |
| Study title: Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride. Stauss J, Hahn K, Mann M, De Palma D. Eur J Nucl Med Mol Imaging. (8 pages) Published online: www.eanm.org/scientific_info/guidelines/EJNMMI_Bone_Scintigraphy_in_Children.pdf |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48759 |
| Study title: Renal uptake on lung perfusion scintigraphy in a patient with primary pulmonary hypertension. Clin Nucl Med. 2005 May;30(5):329-30. Kaya M 2005 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48792 |
| Study title: Reversal of intrapulmonary shunting in cirrhosis after liver transplantation demonstrated by perfusion lung scan. J Nucl Med. 1991 May;32(5):862-4. Levin DP 1991 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48823 |
| Study title: Reversed intrapulmonary right-to-left shunt after banding of the patent ductus venosus. Clin Nucl Med. 2003 Oct;28(10):827-33. Suga K 2003 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48795 |
| Study title: Scintigraphic evaluation of the Eustachian tube functions. Rev Laryngol Otol Rhinol (Bord). 1999;120(2):123-5. Celen Z 1999 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48807 |
| Study title: Spontaneous abrupt changes in the distribution of ventilation: a cause for apparent mismatching on ventilation/perfusion scintigraphy. Br J Radiol. 1989 Jun;62(738):536-43. Peters AM 1989 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48825 |
| Study title: Surgery of congenital heart disease assessed by radionuclide scintigraphy. J Thorac Cardiovasc Surg. 1975 May;69(5):767-75. Gates GF 1975 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48830 |
| Study title: Tc-99m MAA perfusion lung scanning in hepatopulmonary syndrome. Clin Nucl Med. 1999 Aug;24(8):616-7. Nishiyama Y 1999 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48808 |
| Study title: Reflux of nasopharyngeal content into middle ear through the eustachian tube Eur Arch Otorhinolaryngol. 2004 Sep;261(8):439-44. Epub 2003 Nov 18. Ayanoglu E 2003 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48794 |
| Study title: Chapter 7: Radionuclide techniques. In: Resnick D and Kransdorf MJ eds. Bone and joint imaging. 3rd Ed. Philidelphia. PA.Schneider R. Elsevier Saunders; 2005:86-117 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48515 |
| Study title: A topical decongestant for children.The Eye, Ear, Nose and Throat Monthly 1968; 47: 121-3, Neffson AH., 1976 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48923 |
| Study title: A topical nasal decongestant for children.J Med Soc New Jersey 1976; 64: 260-1, Weimann ML., 1976 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48924 |
| Study title: Aikman PM, Bremner AD, de Burca B, et al.,1975, The Practitioner 1975; 214: 685-8 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48913 |
| Study title: An open, not-controlled study to assess the safety and efficacy of oxymetazoline 0.01 % in infants suffering from rhinitisPlease see report |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 6529-660-59-190375 - Nasivin 0.01% (Oxymetazoline hydrochloride) - Semmelmayer 1972 - EUdraCT_reduced datafields for Interim publication.xls |
| View full study record |
| Document reference: 48992 |
| Study title: Clinical note: Double-blind comparison of the duration of effect of oxymetazoline and phenylephrine in children..Ann Allergy 1966; 24: 250-1, Neidorff AH., 1966 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48919 |
| Study title: Double-blind study of nasal decongestion with oxymetazoline and phenylephrine in asthmatic children with rhinitis.Rev Allergy 1966; 20: 863-8, Green M., 1966 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48918 |
| Study title: En klinisk prövning av näsdroppar för spädbarn. (Clinical trials of nosedrops for infants).Z Allg Med 1974; 11: 535-7, Rüggeberg F., 1974 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48926 |
| Study title: Essais cliniques du chlorhydrate d’oxymétazoline. (Clinical trials with oxymetazoline hydrochloride).Le Progrès Medical. 1965; 93: 321-3, Chatelet J., 1965 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48921 |
| Study title: Evaluation of oxymetazoline paediatric in the treatment of congestion.J Matern Child Health 1976; 1: 32-3, Cannon NL., Dalgleisch J., Franks HL. et al., 1976 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48920 |
| Study title: A single-blind trial to investigate the ethiology of bacterial respiratory tract infections and the efficacy of penicillin V (Kåvepenin) and erythromycin (Ery-Max) in these infections.Hovelius et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_10.xlsx |
| View full study record |
| Document reference: 49041 |
| Study title: An open, randomized trila to evaluate if dose and frequency given bt American Heart Association coul be reduced (250 000 units x3 for 10 days)for streptococcal pharyngitis.Breese et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_3.xlsx |
| View full study record |
| Document reference: 49034 |
| Study title: Compare the effect of treatment with penicillin V in children with AOM for 5 and 10 days respectively and to investigate whether a higher dose of penicillin V is associated with a beneficial result.Ingvarsson et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_11.xlsx |
| View full study record |
| Document reference: 49042 |
| Study title: Gaillard WD. Ment Retard Dev Disabil Res. Structural and functional imaging in children with partial epilepsy. [gaillard-2000]Rev. 2000;6(3):220-6. Gaillard WD 2000 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48654 |
| Study title: Gallamini A, Rigacci L, Merli F, Nassi L, Bosi A, Capodanno I et al.. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advance stage Hodgkin's disease. [gallamini-2006]Haematologica 2006 Apr;91(4):475-81. Gallamini A 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48655 |
| Study title: Hain SF, O'Doherty MJ, Lucas JD, Smith MA. Nucl Med Commun. 1999 Sep;20(9):845-8. Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma. [hain-1999] Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG,. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. [hain-2000]Huddart RA. Br J Cancer. 2000 Oct;83(7):863-9. Hain SF 2000 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48656 |
| Study title: Hikima A, Mochizuki H, Oriuchi N, Endo K, Morikawa A..Semiquantitative analysis of interictal glucose metabolism between generalized epilepsy and localization related epilepsy. [hikima-2004]Ann Nucl Med. 2004 Oct;18(7):579-84. Hikima A 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48657 |
| Study title: Hoegerle S, Juengling F, Otte A, Altehoefer C, Moser EA, Nitzsche EU.. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? [hoegerle 1998]Radiology. 1998 Oct;209(1):253-8. Hoegerle S 1998 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48658 |
| Study title: Holm S, Borgwardt L, Loft A, Graff J, Law I, Højgaard L. Paediatric doses – a critical appraisal of the EANM paediatric dosage card. [holm-2007]Eur J Nucl Med Mol Imaging 2007; 34 : 1713 - 1718. Holm S 2007 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48659 |
| Study title: Hostility differentiates the brain metabolic effects of nicotine.Cognitive Brain Research 18 (2004) 142–148. James H. Fallona, David B. Keatorb, James Mbogoric, Jessica Turnerd, Steven G. Potkine. |
| Active substance: Steripet |
| Study summary document link (including results): fallon-2004.pdf |
| View full study record |
| Document reference: 48728 |
| Study title: Hudson MM, Krasin MJ, Kaste SC.. Epub 2004 Jan 27. PET imaging in pediatric Hodgkin's lymphoma. [hudson-2004]Pediatr Radiol. 2004 Mar;34(3):190-8. Hudson MM 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48660 |
| Study title: Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR.. Epub 2005 Jun 6. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma. [hutchings-2005]Ann Oncol. 2005 Jul;16(7):1160-8. Hutchings M 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48661 |
| Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFOXITIN/DOXYCYCLINE OR CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42626 |
| Study title: Imaging the epileptic brain with positron emission tomography.Neuroimag Clin N Am 13 (2003) 705– 716. Csaba Juha´sz, MD, PhDa,b,*, Harry T. Chugani, MDa,b |
| Active substance: Steripet |
| Study summary document link (including results): juhasz-2003.pdf |
| View full study record |
| Document reference: 48733 |
| Study title: Jacobs F, Thierens H, Piepsz A, Bacher K, van de Wiele C, Ham H et al. Optimised tracer-dependent dosage cards to obtain weight-independent effective doses. [jacobs 2005Eur J Nucl Med Mol Imaging 2005; 32 : 581 - 588. Jacobs F 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48662 |
| Study title: Jasper N, Däbritz J, Frosch M, Loeffler M, Weckesser M, Foell D.. Epub. Diagnostic value of [(18)F]-FDG PET/CT in children with fever of unknown origin or unexplained signs of inflammation. [jasper-2010] Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):136-45. Jasper N 2010 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48663 |
| Study title: Caries preventive effect of high fluoride and xylitol containing dentifrices1992-Cutress- |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1992-Cutress-caries preventive effect of high fluoride and xylitol containing dentifrices.pdf |
| View full study record |
| Document reference: 49094 |
| Study title: Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India1984-tewari- |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1984-tewari-Caries preventive effect of three topical fluorides_1% years clinical trial in Chandigarh schoolchildren of North India.pdf |
| View full study record |
| Document reference: 49111 |
| Study title: Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse1987-seppa, Caries Res. 1987:21: 375-379 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1987-seppa-Caries preventive effect of two fluoride varnishes and a fluoride mouthrinse.pdf |
| View full study record |
| Document reference: 49114 |
| Study title: Caries preventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study1975-koch, Community Dentl Oral Epidemiol, 1975: 3: 262-266 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1975-koch-Cariespreventive effort of a fluoride-containing varnish (Duraphat) after 1 year s study.pdf |
| View full study record |
| Document reference: 49102 |
| Study title: Caries rate, enamel fluoride concentration after fortnightly brushing with aminfluoride gelRan 1987 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Ran 1987 Caries rate, enamel fluoride concentration.pdf |
| View full study record |
| Document reference: 49175 |
| Study title: Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma. ; Izumi-R. Hepato-Gastroenterology, 1996, Vol/Iss/Pg. 43/12 (1415-1420)Postoperative adjuvant locoregional chemotherapy in patients with hepatocellular carcinoma. ; Izumi-R. Hepato-Gastroenterology, 1996, Vol/Iss/Pg. 43/12 (1415-1420) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30304 |
| Study title: Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. ;Czauderna-P. Pediatric Blood and Cancer, 2006, Vol/Iss/Pg. 46/7 (825-828)Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. ;Czauderna-P. Pediatric Blood and Cancer, 2006, Vol/Iss/Pg. 46/7 (825-828) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30306 |
| Study title: Preoperative Chemoembolization for Hepatocellular Carcinoma.02/12/2010Mario Morino. Journal of Surgical Oncology Supplement 3:91-93 (1993)Preoperative Chemoembolization for Hepatocellular Carcinoma.02/12/2010Mario Morino. Journal of Surgical Oncology Supplement 3:91-93 (1993) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30307 |
| Study title: Preoperative percutaneous portal vein embolization: Evaluation of adverse events in 188 patients. ; Di-Stefano-D-R. Radiology, 2005, Vol/Iss/Pg. 234/2 (625-630)Preoperative percutaneous portal vein embolization: Evaluation of adverse events in 188 patients. ; Di-Stefano-D-R. Radiology, 2005, Vol/Iss/Pg. 234/2 (625-630) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30308 |
| Study title: Preoperative Porgal Vein Embolization for Extension of Hepatectomy Indications.;Thierry de Baere. Hepatology Vol. 24, No. 6, 1996.Preoperative Porgal Vein Embolization for Extension of Hepatectomy Indications.;Thierry de Baere. Hepatology Vol. 24, No. 6, 1996. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30309 |
| Study title: Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for I.A. administration and lipid microspheres for I.P. or I.V. administration.;Fukushima Shoji. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury 2, Edited by K.V. Honn et al., Plenum Press, New York 1997Preparation of two dosage forms containing antitumor prostaglandin and their antitumor effect in vitro and in vivo: Lipiodol solution for I.A. administration and lipid microspheres for I.P. or I.V. administration.;Fukushima Shoji. Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury 2, Edited by K.V. Honn et al., Plenum Press, New York 1997 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30310 |
| Study title: Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. ; Wachter-W. Journal of Epidemiology and Community Health, 1986, Vol/Iss/Pg. 40/1 (86-91)Prevalence of goitre and hypothyroidism in Southern Tanzania: Effect of iodised oil on thyroid hormone deficiency. ; Wachter-W. Journal of Epidemiology and Community Health, 1986, Vol/Iss/Pg. 40/1 (86-91) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30311 |
| Study title: Caries reduction and cost benefit after 3 years of sucking fluoride tablets daily at schoolK.W. Stephen, D. Campbell 1978. Brit Dent J 1978 144, 202 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1978-stephen-Caries Reduction and Cost Benefit After 3 Years of Sucking Fluoride Tablets Daily at school.pdf |
| View full study record |
| Document reference: 48780 |
| Study title: Cherubism: diagnostic imaging and review of the literature in JapanHitomi G. Nishide N. Mitsui K. Ora l Surg Oral Med Oral Pathol Oral Radial Endod 1996 May;81(5):623-8 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48487 |
| Study title: Tc-99m MAA total-body imaging to detect intrapulmonary right-to-left shunts and to evaluate the therapeutic effect in pulmonary arteriovenous shunts. Clin Nucl Med. 1996 Mar;21(3):197-202. Lu G 1996 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48815 |
| Study title: The contribution of perfusion scintigraphy in the evaluation of children suffering from recurrent localized pneumonia. Eur J Nucl Med. 1990;17(3-4):152-5. Hardoff R 1990 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48824 |
| Study title: The incidence and severity of hypoxia associated with 99Tcm Technegas ventilation scintigraphy and 99Tcm MAA perfusion scintigraphy. Br J Radiol. 1992 May;65(773):403-8. James JM 1992 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48821 |
| Study title: Transcatheter infusion of 99mTc MAA for predicting response of intra-arterial chemotherapy in osteogenic sarcoma. Eur J Cancer Clin Oncol. 1985 Jan;21(1):35-42. Kim EE 1985 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48829 |
| Study title: Tc-99m MAA SPECT in pectus excavatum: assessment of perfusion volume changes after correction by the Nuss procedure. Clin Nucl Med. 2005 Dec;30(12):779-82. Kinuya K 2005 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48791 |
| Study title: Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998 Feb;114(2):305-10. Abrams GA 1998 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48812 |
| Study title: Chronic recurrent multifocal osteomyelitis (CRMO) with symmetric involvement of both femora: X-ray, bone scintigram, and MR imaging findings in one case. Buck FM, Treumann TC, Winiker H, Strobel K. J Magn Reson Imaging. 2007 Aug;26(2):422-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48837 |
| Study title: Chronic recurrent multifocal osteomyelitis involving the mandible in a 4-year-old girl: a case report and a review of the literatureOtsuka K. Hamakawa H. Kayahara H. Tanioka H. J Oral Maxillofac Surg 1999 Aug;57(8):1013-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48508 |
| Study title: Hematogenous pyogenic vertebral osteomyelitis: diagnostic value of radionuclide bone imaging.Adatepe MH, Powell OM, Isaacs GH, Nichols K, Cefola R. J Nucl Med 1986 Nov;27(11):1680-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48523 |
| Study title: |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48495 |
| Study title: |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48504 |
| Study title: 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.El-Maghraby T. Gulf J Oncol 2007 (2):33-41. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48720 |
| Study title: 201Tl scintigraphic evaluation of tumor mass and viability of bone and soft-tissue tumors.Tsuda T, Kubota M, Yoshida S, Shibata M, Wakabayashi J, Obata H, et al. Kaku Igaku 1994 Dec;31(12):1477-94 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48762 |
| Study title: (99m)Tc-MDP scintigraphic findings in children with leukemia: value of early and delayed whole-body imagingShalaby-Rana E, Majd M. J Nucl Med 2001 Jun;42(6):878-83 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48514 |
| Study title: "Cold spots" in pediatric bone imagingRosovsky M. Goldfarb CR. Finestone H. Ongseng F. Semin Nucl Med 1994 Apr;24(2):184-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48513 |
| Study title: Determine concentration of pcV in serum and in middle ear exudate and to isolate bacteria in the ear exsudate during the course of treatment with penicillin V in acute otitis media in children.Ingvarsson et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_15.xlsx |
| View full study record |
| Document reference: 49046 |
| Study title: determine concentration of pcV in serum and in middle ear exudate at various intervals of administration of different doses and to correlate the susceptibility in vitro of H Infl to pcVKamme et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_5.xlsx |
| View full study record |
| Document reference: 49036 |
| Study title: Double-blinded, Randomized parallel groups design trial, the primary objective of the study was to evaluate the taste of two formulations of phenoxymethylpenicillin suspension in children. The secondary objectives were to study age-related differences in taste perception, to evaluate the acceptability of the suspensions, and to determine patient compliance.Bagger-Sjöbäck et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_12.xlsx |
| View full study record |
| Document reference: 49043 |
| Study title: Klinische Prüfung von Oxymetazolin-HCl-Nasentropfen für Säuglinge (Nasivin™ 0.01 %). (Clinical trials of oxymetazoline hydrochloride nasal drops for babies (Nasivin™ 0.01 %)).Draco por Medico 1968; 9: 6-8, Svenningsen N., 1968 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48925 |
| Study title: Oxymetazoline spray in otorhinolaryngology.Curr Ther Res 1966; 8: 91-3, Haines HL., 1966 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48915 |
| Study title: Physiological and clinical estimate of the relief of nasal flow obstruction in allergic rhinitis: effects of topical decongestant (oxymetazoline).J Asthma Res 1969; 7: 65-73, Cohen BM, Duffy EP., 1969 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48922 |
| Study title: A novel approach to flow quantification in brain arteriovenous malformations prior to enbucrilate embolization: Use of insoluble contrast (Ethiodol droplet) angiography. ; Wakhloo-A-K. Journal of Neurosurgery, 1998, Vol/Iss/Pg. 89/3 (395-404)A novel approach to flow quantification in brain arteriovenous malformations prior to enbucrilate embolization: Use of insoluble contrast (Ethiodol droplet) angiography. ; Wakhloo-A-K. Journal of Neurosurgery, 1998, Vol/Iss/Pg. 89/3 (395-404) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30215 |
| Study title: Accidental successful treatment of a rare case of diffuse peritoneal lymphangiomatosis; G. Silecchia. British Journal of Surgery 1994, 81, 1286-1289Accidental successful treatment of a rare case of diffuse peritoneal lymphangiomatosis; G. Silecchia. British Journal of Surgery 1994, 81, 1286-1289 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30216 |
| Study title: Accurate preoperative evaluation of liver mass lesions without fine- needle biopsy. ; Torzilli-G. Hepatology, 1999, Vol/Iss/Pg. 30/4 (889-893)Accurate preoperative evaluation of liver mass lesions without fine- needle biopsy. ; Torzilli-G. Hepatology, 1999, Vol/Iss/Pg. 30/4 (889-893) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30217 |
| Study title: Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. ; Lau-W-Y. Lancet, 06 MAR 1999, Vol/Iss/Pg. 353/9155 (797-801)Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: A prospective randomised trial. ; Lau-W-Y. Lancet, 06 MAR 1999, Vol/Iss/Pg. 353/9155 (797-801) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30218 |
| Study title: Kabickova E, Sumerauer D, Cumlivska E, Drahokoupilova E, Nekolna M, ChanovaM, et al.. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. [kabickova-2006]Haematologica. 2006 Apr;91(4):475-81. Kabickova E 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48664 |
| Study title: Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, et al.. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. [kamel-2002]Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):346-50. Kamel E 2002 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48665 |
| Study title: Kaneta T, Hakamatsuka T, Yamada T, Takase K, Sato A, Higano S, et al.. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature. [kaneta-2006]Ann Nucl Med. 2006 Jan;20(1):79-82. Kaneta T 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48666 |
| Study title: Kaplan AM, Bandy DJ, Manwaring KH, Chen K, Lawson MA, Moss SD, et al.. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. [kaplan-1999]J Neurosurg. 1999 Nov;91(5):797-803. Kaplan AM 1999 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48667 |
| Study title: Kaste SC, Howard SC, McCarville EB, Krasin MJ, Kogos PG, Hudson MM.. Epub 2004 Nov 16. 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's. [kaste-2005]Pediatr Radiol. 2005 Feb;35(2):141-54. Kaste SC 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48668 |
| Study title: Koga H, Sasaki M, Kuwabara Y, Nakagawa M, Hayashi K, Kaneko K, et al.. Lesion detectability of a gamma camera based coincidence system with FDG in patients with malignant tumors: a comparison with dedicated positron emission tomography. [koga-2004]Ann Nucl Med. 2004 Apr;18(2):131-6. Koga H 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48669 |
| Study title: Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ.. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. [kostakaglu-2002]Cancer. 2002 Feb 15;94(4):879-88. Kostakoglu L 2002 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48670 |
| Study title: Krug B, Heidenreich A, Dietlein M, Lackner K. Rofo.. [The lymph node staging of malignant testicular germ-cell tumors] [Translated] [krug-1999-en]1999 Aug;171(2):87-94. Krug B 1999 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48671 |
| Study title: Lamusuo S, Ruottinen HM, Knuuti J, Härkönen R, Ruotsalainen U, Bergman J, et al.. Comparison of [18F]FDGPET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. [lamusuo-1997]J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):743-8. Lamusuo S 1997 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48672 |
| Study title: Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, EANM Dosimetry and Paediatrics Committees.. The new EANM paediatric dosage card. [lassman-2007]Eur J Nucl Med Mol Imaging 2007; 34:796–798. Lassmann M 2007 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48673 |
| Study title: Galli V, Canonaco F, Rozzi N.(1980) Clinica Pediatrica.; 62:1-11. Therapy with methisoprinol in pediatric pathologiesGalli V, Canonaco F, Rozzi N.(1980) Clinica Pediatrica.; 62:1-11. Therapy with methisoprinol in pediatric pathologies |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30109 |
| Study title: Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, Jallu A. Brain Dev. 1993 Sep-Oct;15(5):346-55. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.Gascon G, Yamani S, Crowell J, Stigsby B, Nester M, Kanaan I, Jallu A. Brain Dev. 1993 Sep-Oct;15(5):346-55. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30110 |
| Study title: Gascon GG, Yamani S, Cafege A, Flock L, al-Sedairy S, Parhar RS, Crowell J, Nester M, Kanaan I, Jallu MA. Ann Neurol. 1991 Aug;30(2):227-8. Treatment of subacute sclerosing panencephalitis with alpha interferon.Gascon GG, Yamani S, Cafege A, Flock L, al-Sedairy S, Parhar RS, Crowell J, Nester M, Kanaan I, Jallu MA. Ann Neurol. 1991 Aug;30(2):227-8. Treatment of subacute sclerosing panencephalitis with alpha interferon. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30111 |
| Study title: Geiger S, Peuten M. Inform Artz 1985;2:30-35. Treatment of herpetic and recurrent apthae with inosiplex.Geiger S, Peuten M. Inform Artz 1985;2:30-35. Treatment of herpetic and recurrent apthae with inosiplex. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30112 |
| Study title: Ginsberg T. Third Int Symposium on SSPE, India 30-31 Oct 1989. Isoprinosine in subacute sclerosing panencephalitis: Confirmation and extension of beneficial clinical results in the US and Canada by a recent study in Japan.Ginsberg T. Third Int Symposium on SSPE, India 30-31 Oct 1989. Isoprinosine in subacute sclerosing panencephalitis: Confirmation and extension of beneficial clinical results in the US and Canada by a recent study in Japan. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30113 |
| Study title: Grasso E. (1979) Isoprinosina; April 28,; Rome, Italy; 87-93. Isoprinosina treatment in viral mononucleosis and epidemic parotitis [in English]. Presented at del Convegno Internazionale sullaGrasso E. (1979) Isoprinosina; April 28,; Rome, Italy; 87-93. Isoprinosina treatment in viral mononucleosis and epidemic parotitis [in English]. Presented at del Convegno Internazionale sulla |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30114 |
| Study title: Gross G, Jogerst C, Schőpf.. Acta Derm Venereol. 1986;66(1):76-80. Systemic treatment of mollusca contagiosa with inosiplexGross G, Jogerst C, Schőpf.. Acta Derm Venereol. 1986;66(1):76-80. Systemic treatment of mollusca contagiosa with inosiplex |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30115 |
| Study title: Radiological aspects of a case of Waldmann's disease. ; Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538)Radiological aspects of a case of Waldmann's disease. ; Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30319 |
| Study title: Radiological aspects of a case of Waldmann's disease. Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538)Radiological aspects of a case of Waldmann's disease. Guery-V. Journal de Radiologie, 1990, Vol/Iss/Pg. 71/10 (535-538) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30318 |
| Study title: Randomized clinical trial comparing different iodine interventions in school children. ; Zhao-J. Public Health Nutrition, 1999, Vol/Iss/Pg. 2/2 (173-178)Randomized clinical trial comparing different iodine interventions in school children. ; Zhao-J. Public Health Nutrition, 1999, Vol/Iss/Pg. 2/2 (173-178) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30320 |
| Study title: Reversibility of severe hypothyroidism with supplementary iodine in patients with endemic cretinism. ; Vanderpas-J-B. New England Journal of Medicine, 1986, Vol/Iss/Pg. 315/13 (791-795).Reversibility of severe hypothyroidism with supplementary iodine in patients with endemic cretinism. ; Vanderpas-J-B. New England Journal of Medicine, 1986, Vol/Iss/Pg. 315/13 (791-795). |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30321 |
| Study title: Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects; Jean B Vanderpas. Am J Clin Nutr Suppl 1993 ;57 :271S-5S.Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects; Jean B Vanderpas. Am J Clin Nutr Suppl 1993 ;57 :271S-5S. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30322 |
| Study title: Serum thyroglobulin and urinary iodine concentration are the most appropriate indicators of iodine status and thyroid function under conditions of increasing iodine supply in schoolchildren in Benin. ; Briel-T-V-D. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/10 (2701-2706), ISSN: 0022-3166Serum thyroglobulin and urinary iodine concentration are the most appropriate indicators of iodine status and thyroid function under conditions of increasing iodine supply in schoolchildren in Benin. ; Briel-T-V-D. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/10 (2701-2706), ISSN: 0022-3166 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30323 |
| Study title: Spontaneous scalp arteriovenous fistula in a child with Hartnup disease. ; Kim-D-M. Journal of Endovascular Therapy, 2004, Vol/Iss/Pg. 11/3 (348-350)Spontaneous scalp arteriovenous fistula in a child with Hartnup disease. ; Kim-D-M. Journal of Endovascular Therapy, 2004, Vol/Iss/Pg. 11/3 (348-350) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30324 |
| Study title: Comparison of bone and gallium-67 imaging in heroin users' arthritis.Bittini A, Dominguez PL, Martinez Pueyo ML, López Longo FJ, Monteagudo I, Carreño L. J Nucl Med 1985 Dec;26(12):1377-81. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48572 |
| Study title: Comparison of planar scintigraphy alone and with SPECT for the initial evaluation of femoral neck stress fracture.Bryant LR, Song WS, Banks KP, Bui-Mansfield LT, Bradley YC. AJR 2008;191:1010-1015. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48584 |
| Study title: Hip pain in an 18-year-old manRajaram A, Tamurian RM, Reith JD, Bush CH. Clin Orthop Relat Res 2008;466:248-54 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48754 |
| Study title: Hematogenous Pyogenic Vertebral Osteomyelitis:Diagnostic Value of Radionucide Bone ImagingMustafa H. Adatepe, Oscar M. Powell, Gilbert H. Isaacs, Kenneth Nichols, and Raymond Cefola. J Nucl Med 27:1680-1685, 1986 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48832 |
| Study title: A protocol of plain radiographs, hip ultrasound, and triple phase bone scans in the evaluation of the painful pediatric hip.Alexander JE, Seibert JJ, Aronson J, Williamson SL, Glasier CM, Rodgers AB, et al. Clin Pediatr 1988 Apr;27(4):175-81. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48527 |
| Study title: A report of two cases of brucellar sacroiliitis without systematic manifestations in GreeceThoma S, Patsiogiannis N, Dempegiotis P, Filiopoulos K. J Pediatr Orthop 2009 29:375-79 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48761 |
| Study title: Accumulation of Tc-99m MDP in diaphragm and retroperitoneum of a battered child. Sty JR, Carmody TJ, Ruiz ME. Clin Nucl Med. 1995 Oct;20(10):931. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43583 |
| Study title: Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecansLitchman HM, McCullough RW, Gandsman EJ, Schatz SL. J Pediatr Orthop 1988 Mar;8(2):208-12 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48752 |
| Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Cisneros GJ, Kaban LB. J Oral Maxillofac Surg. 1984 Aug;42(8):513-20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): cisneros-1984.pdf |
| View full study record |
| Document reference: 48840 |
| Study title: Acute hematogenous osteomyelitis of children: assessment of skeletal scintigraphy-based diagnosis in the era of MRI. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. J Nucl Med. 2002 Oct;43(10):1310-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48841 |
| Study title: Activation of the growth plates on three-phase bone scintigraphy: the explanation for the overgrowth of fractured femurs.Elba CSC, Etchebehere EC, Caron M, Pereira JA, Lima MC, Santos AO, et al. Eur J Nucl Med 2001 Jan;28(1):72-80. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48719 |
| Study title: Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.Brenner W, Sieweke N, Bohuslavizki KH, Kampen WU, Zuhayra M, Clausen M, et al. Nuklearmedizin 2000 Aug;39(5):127-32. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48578 |
| Study title: Age-related changes in skull uptake on bone scintigraphy: a quantitative study.Sadeghi R, Zakavi SR, Ghasemov M, Kakhki VRD. Nucl Med Rev 2008; 11 (2):67-69 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48756 |
| Study title: DECREASED TRACER UPTAKE IN BONE TISSUE IN PAEDIATRIC REFLEX SYMPATHETIC DYSTROPHYX. Le Loet, J. Lefort, A. Daragon, B. Derumeaux, P. Deshayes Rheumatology Department, La Prévotière, Hôpital de Bois Guillaume, BP 100, F 76230 Bois Guillaume |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48845 |
| Study title: Assessment of an intervention study on iodine deficiency in Burkina Faso (1990-1993). ; Casas-C-A. Atencion Primaria, 30 APR 1998, Vol/Iss/Pg. 21/7 (462-465)Assessment of an intervention study on iodine deficiency in Burkina Faso (1990-1993). ; Casas-C-A. Atencion Primaria, 30 APR 1998, Vol/Iss/Pg. 21/7 (462-465) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30219 |
| Study title: Äthiopathogenese und Therapie der Jodmangelstruma, Gärtner, R.; Z. ärtzl. Fortbildung 89, 27-31, 1995Äthiopathogenese und Therapie der Jodmangelstruma, Gärtner, R.; Z. ärtzl. Fortbildung 89, 27-31, 1995 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30220 |
| Study title: Cerebral av angiomas: 3-dimensional demonstration by spiral CT. ; Rieger-J. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1994, Vol/Iss/Pg. 161/6 (489-494)Cerebral av angiomas: 3-dimensional demonstration by spiral CT. ; Rieger-J. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren, 1994, Vol/Iss/Pg. 161/6 (489-494) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30221 |
| Study title: Chemical pneumonitis with iodoliposputosis following lymphangiography in children.; Stoegmann-W. Fortschritte auf den Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1974, Vol/Iss/Pg. 121/1 (43-48). Chemical pneumonitis with iodoliposputosis following lymphangiography in children.; Stoegmann-W. Fortschritte auf den Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1974, Vol/Iss/Pg. 121/1 (43-48). |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30222 |
| Study title: Cognitive and motor functions of iodine-deficient but euthyroid children in Bangladesh do not benefit from iodized poppy seed oil (Lipiodol). ; Huda-S-N. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/1 (72-77)Cognitive and motor functions of iodine-deficient but euthyroid children in Bangladesh do not benefit from iodized poppy seed oil (Lipiodol). ; Huda-S-N. Journal of Nutrition, 2001, Vol/Iss/Pg. 131/1 (72-77) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30223 |
| Study title: Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE). ; Yodono-H. Cancer Chemotherapy and Pharmacology, Supplement, 1994, Vol/Iss/Pg. 33/- (S79-S83)Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE). ; Yodono-H. Cancer Chemotherapy and Pharmacology, Supplement, 1994, Vol/Iss/Pg. 33/- (S79-S83) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30224 |
| Study title: Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report; K. Tanaka. J Clin Pathol 2005;58:884-887.Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report; K. Tanaka. J Clin Pathol 2005;58:884-887. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30225 |
| Study title: Coverage and cost of iodized oil capsule distribution in Tanzania. ;Peterson-S. Health Policy and Planning, 1999, Vol/Iss/Pg. 14 /4 (390-399)Coverage and cost of iodized oil capsule distribution in Tanzania. ;Peterson-S. Health Policy and Planning, 1999, Vol/Iss/Pg. 14 /4 (390-399) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30226 |
| Study title: Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate. ;Choi-Y-H. Journal of Vascular and Interventional Radiology, 2002, Vol/Iss/Pg. 13/5 (475-482)Craniofacial cavernous venous malformations: Percutaneous sclerotherapy with use of ethanolamine oleate. ;Choi-Y-H. Journal of Vascular and Interventional Radiology, 2002, Vol/Iss/Pg. 13/5 (475-482) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30227 |
| Study title: Diagnosis and management of vein of Galen aneurysmal malformations. ; Gailloud-P. Journal of Perinatology, 2005, Vol/Iss/Pg. 25/8 (542-551)Diagnosis and management of vein of Galen aneurysmal malformations. ; Gailloud-P. Journal of Perinatology, 2005, Vol/Iss/Pg. 25/8 (542-551) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30228 |
| Study title: Diagnostic and therapeutic value of lymphography in persistent postoperative chylothorax. ; Thambo-J-B. Archives des Maladies du Coeur et des Vaisseaux, 2004, Vol/Iss/Pg. 97/5 (546-548)Diagnostic and therapeutic value of lymphography in persistent postoperative chylothorax. ; Thambo-J-B. Archives des Maladies du Coeur et des Vaisseaux, 2004, Vol/Iss/Pg. 97/5 (546-548) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30229 |
| Study title: Pediatric hepatic CT : an injection protocol;ROCHE KJ; Pediatr. Radiol.; 1996 vol.26 p.502 507Pediatric hepatic CT : an injection protocol;ROCHE KJ; Pediatr. Radiol.; 1996 vol.26 p.502 507 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30422 |
| Study title: Perforated versus non perforated acute appendicitis : accuracy of multidetector CT detection; BIXBY SD; Radiology ; 2006 vol.241 n.3 p.780 786Perforated versus non perforated acute appendicitis : accuracy of multidetector CT detection; BIXBY SD; Radiology ; 2006 vol.241 n.3 p.780 786 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30423 |
| Study title: Iodized oil in the prophylaxis of endemic goiter in Argentina;Tomas Watanabe. Reprint from Endemic Goiter and cretinism: continuing threats to world health PAHO scientific publication 292, 1974: 231-240 Iodized oil in the prophylaxis of endemic goiter in Argentina;Tomas Watanabe. Reprint from Endemic Goiter and cretinism: continuing threats to world health PAHO scientific publication 292, 1974: 231-240 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30276 |
| Study title: Iron supplementation in goitrous, iron-deficient children improves their response to oral iodized oil. ;Zimmermann-M. European Journal of Endocrinology, 2000, Vol/Iss /Pg. 142/3 (217-223)Iron supplementation in goitrous, iron-deficient children improves their response to oral iodized oil. ;Zimmermann-M. European Journal of Endocrinology, 2000, Vol/Iss /Pg. 142/3 (217-223) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30277 |
| Study title: J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations. Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30345 |
| Study title: J Invasive Cardiol. 2003 Mar;15(3):133-8. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA. J Invasive Cardiol. 2003 Mar;15(3):133-8. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30346 |
| Study title: Jodblockade der Schilddrüse, Schicha H.; Gustav Fischer Verlag, 1994Jodblockade der Schilddrüse, Schicha H.; Gustav Fischer Verlag, 1994 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30278 |
| Study title: Jodmangelstruma: Medikamentöse Therapie bei Kindern, Jugendlichen, jungen Erwachsenen und Schwangeren, Hehrmann, R.; Apotheker J. 8, 29-34, 1994Jodmangelstruma: Medikamentöse Therapie bei Kindern, Jugendlichen, jungen Erwachsenen und Schwangeren, Hehrmann, R.; Apotheker J. 8, 29-34, 1994 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30279 |
| Study title: Jodprophylaxe und Strumatherapie mit Jodid, Finke R. et al.; Z.Allg. Med. 68, 984-989, 1992Jodprophylaxe und Strumatherapie mit Jodid, Finke R. et al.; Z.Allg. Med. 68, 984-989, 1992 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30280 |
| Study title: Lipiodol computerized tomography: How sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? ; Ngan-H. British Journal of Radiology, 1990, Vol/Iss/Pg. 63/754 (771-775)Lipiodol computerized tomography: How sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? ; Ngan-H. British Journal of Radiology, 1990, Vol/Iss/Pg. 63/754 (771-775) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30281 |
| Study title: Liver transplantation in the therapy of hepatocellular carcinoma: A revision of our series. ; Lucena-de-la-Poza-J-L. Transplantation Proceedings, 2002, Vol/Iss/Pg. 34/1 (260-261)Liver transplantation in the therapy of hepatocellular carcinoma: A revision of our series. ; Lucena-de-la-Poza-J-L. Transplantation Proceedings, 2002, Vol/Iss/Pg. 34/1 (260-261) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30282 |
| Study title: Lymphangiography, therapeutic method of a surgical wound of the thoracic canal: Report of a case (1). ; Tiemtaoure-B. Journal de Radiologie, 2007, Vol/Iss/Pg. 88/1 C1 (69-71)Lymphangiography, therapeutic method of a surgical wound of the thoracic canal: Report of a case (1). ; Tiemtaoure-B. Journal de Radiologie, 2007, Vol/Iss/Pg. 88/1 C1 (69-71) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30284 |
| Study title: Lymphography in primary lymphooedema of the leg in children. With reference to seven lymphographies. Manlot-G. Annales de Radiologie, 1976, Vol/Iss/Pg. 19/1 (41-55)Lymphography in primary lymphooedema of the leg in children. With reference to seven lymphographies. Manlot-G. Annales de Radiologie, 1976, Vol/Iss/Pg. 19/1 (41-55) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30285 |
| Study title: Clinical assessment of the latrogenicGatto 1988 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Gatto 1988 Clinical assessment of the latrogenic.pdf |
| View full study record |
| Document reference: 49166 |
| Study title: Clinical evaluations on the biocompatibility- Valutazioni cliniche sulla biocompatibilitaGatto 1989 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Gatto 1989 Valutazioni cliniche sulla biocompatibilita.pdf |
| View full study record |
| Document reference: 49167 |
| Study title: Clinical study of an amine fluoride gel and acidulated phosphate fluoride gelShern 1976 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Shern 1976 Clinical study of an amine fluoride.pdf |
| View full study record |
| Document reference: 49178 |
| Study title: Collective preschool caries prevention using a fluoride-containing varnish] [Article in German] |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42543 |
| Study title: Comments on the biocompatibility - Osservazioni sulla biocompatibilitaGallusi 1988 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Gallusi 1988 Osservazioni sulla biocompatibilita.pdf |
| View full study record |
| Document reference: 49165 |
| Study title: Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous fluoride1961-Mercer |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1961-Mercer-Comparision of a single application of stannous fluoride with a single application of sodium fluoride or two applications of stannous f... |
| View full study record |
| Document reference: 49141 |
| Study title: Comparision of three self applied topical fluoride preparationsfor control of decalcification1993-boyd |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1993-boyd - comparision of three self applied topical fluoride preparationsfor control of decalcification.pdf |
| View full study record |
| Document reference: 49156 |
| Study title: Comparison of three prevention programs -Vergleich dreier Prophylaxe ProgrammeBüttner 1987 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Büttner 1987 Vergleich dreier Prophylaxe Programme.pdf |
| View full study record |
| Document reference: 49159 |
| Study title: Haddad FS, Dhib-Jalbut S.. 1986 Elsevier Science Publishers Inopsiplex in the treatment of SSPEHaddad FS, Dhib-Jalbut S.. 1986 Elsevier Science Publishers Inopsiplex in the treatment of SSPE |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30117 |
| Study title: Han CY, Lin HF, Shin PY, Liu CK, Liu CS. Kaohsiung J Med Sci. 2003 Aug;19(8):416-20. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report Han CY, Lin HF, Shin PY, Liu CK, Liu CS. Kaohsiung J Med Sci. 2003 Aug;19(8):416-20. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30118 |
| Study title: Himawan T, Kho LKAbstracts of Scientific Papers: Asian Congress of Pediatrics; May 1-2, 1974; Manila, Philippines: Philippines Pediatric Society; 1974. Abstract 64. Experiences in the treatment of dengue hemorrhagic fever with Isoprinosine.Himawan T, Kho LKAbstracts of Scientific Papers: Asian Congress of Pediatrics; May 1-2, 1974; Manila, Philippines: Philippines Pediatric Society; 1974. Abstract 64. Experiences in the treatment of dengue hemorrhagic fever with Isoprinosine. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30119 |
| Study title: Horiguchi Y, Ohya T. No To Hattatsu. 1995 May;27(3):231-7. Successful treatment of subacute sclerosing panencephalitis with long-term intrathecal large dose of alpha-interferon--a case reportHoriguchi Y, Ohya T. No To Hattatsu. 1995 May;27(3):231-7. Successful treatment of subacute sclerosing panencephalitis with long-term intrathecal large dose of alpha-interferon--a case report |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30120 |
| Study title: Hosoya M, Shigeta S et alAntimicrob Agents Chemother Mar 2001;45(3):943-5. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.Hosoya M, Shigeta S et alAntimicrob Agents Chemother Mar 2001;45(3):943-5. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30121 |
| Study title: Hypertrophic osteoarthropathy in a child with follicular bronchiolitis.Boas SR, Charron M, Ledesma-Medina J, Noyes BE, Kurland G. Clin Nucl Med 1995 Jan;20(1):49- 51. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48574 |
| Study title: I-131 MIBG imaging after bone marrow transplantation for neuroblastoma.Englaro EE, Gelfand MJ, Harris RE, Smith HS. Radiology 1992 182(2):515-20 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48721 |
| Study title: Detection of adrenal metastasis from osteosarcoma by Tc-99m MOP scintigraphyKauffman WM. Winer-Muram H. Sandlund JT. Clin Nucl Med 1995 20(8):741 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48492 |
| Study title: Diffuse femoral uptake on bone scan after fracture in an infantRoach J, Höschl R. Q J Nucl Med 1996 Jun;40(2):194-6 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48755 |
| Study title: Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate.Flynn BM. Treves ST. J Nucl Med 1987 Apr;28(4):532-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48482 |
| Study title: Discovery of a renal medullary carcinoma in an adolescent male with sickle cell trait by Tc-99m methylene disphosponate bone scintigraphy.Brown JM, Berkey BD, Brooks JA. Clin Nucl Med 2008;33:896-900. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48581 |
| Study title: Does I- 131-MIBG underestimate skeletal disease burden in neuroblastoma?Barai S, Bandopadhayaya GP, Malhotra A, Agarwal S, Kumar R, Dhanapathi H. J Postgrad Med 2004b Oct-Dec;50(4):257-61. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48563 |
| Study title: Increased activity on immediate phase of bone imaging does not always indicate increased blood volume.Webster DL, Hurwitz GA, DeVeber LL, Troster M, Driedger AA. Clin Nucl Med 1986 Nov;11(11):749-50 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48764 |
| Study title: Intense muscle uptake of Ga-67 citrate and Tc-99m MDP in a patient with aplastic anemia.Batte WG Jr., Yeh SD, Rosenblum MK, Larson SM. Clin Nucl Med 1991 Jun;16(6):421-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48566 |
| Study title: Intraoperative radionuclide detection in the treatment of paediatric osteoid osteoma.M. Lacheretz, B. Herbaux, C. Hossein-Foucher, P. Lecouffe, M. Richir. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48844 |
| Study title: Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastomaShulkin BL. Shapiro B. Hutchinson RJ. J Nucl Med 1992 Oct;33(10):1735-40 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48516 |
| Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44191 |
| Study title: Assessment of mandibular growth by skeletal scintigraphyKaban LB. Cisneros GJ. Heyman S. Treves S. J Oral Maxillofac Surg 1982 Jan;40(1):18-22 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48491 |
| Study title: Bandopadhyaya G. Malhotra A. Soft tissue uptake of Tc99m-MDP in acute lymphoblastic leukemia.Marwah A. Kumar R. Dasan J B. Choudhury S. Bandopadhyaya G. Malhotra A. Cl in Imaging 2002 May-Jun;26(3):206-8 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48505 |
| Study title: Effects of renal failure and metabolic diseases upon bone scanning in children.Schumichen C. Annales de Radiologie 1983 26(6):498-504 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48758 |
| Study title: peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155peritoneographie : utilisation d'un nouveau produit de contraste faiblement hyperosmolaire (AG 62-27)progres en peritoneographie grace a l'utilisationd'un nouveau produit de contraste faiblement hyperosmolaire (hexabrix); Rozenberg R., J. Radiol.; 1981 vol.62 n.2 p.123-126 J. Belge Radiol.; 1981 vol.64 p.151-155 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30439 |
| Study title: Reduced radiation dose helical chest CT : effect on reader evaluation of structures and lung findings;MAYO JR; Radiology; 2004 vol.232 p.749 756Reduced radiation dose helical chest CT : effect on reader evaluation of structures and lung findings;MAYO JR; Radiology; 2004 vol.232 p.749 756 |
| Active substance: IOVERSOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30425 |
| Study title: Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children – VANDERHOOF J.A., WHITNEY D.B. and al. – 1999.Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children – VANDERHOOF J.A., WHITNEY D.B. and al. – 1999. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30966 |
| Study title: Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children – SHORNIKOVA A.V., CASAS I.A. and al. – 1997. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children – SHORNIKOVA A.V., CASAS I.A. and al. – 1997. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30967 |
| Study title: Lactobacillus therapy for acute infectious diarrhea in children: a meta analysis – VAN NIEL C.W., FEUDTNER C. and al. – 2005. Lactobacillus therapy for acute infectious diarrhea in children: a meta analysis – VAN NIEL C.W., FEUDTNER C. and al. – 2005. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30968 |
| Study title: Limitations of probiotic therapy in acute, severe dehydrating diarrhea – COSTA-RIBEIRO H., RIBEIRO T.C. and al. – 2003. Limitations of probiotic therapy in acute, severe dehydrating diarrhea – COSTA-RIBEIRO H., RIBEIRO T.C. and al. – 2003. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30969 |
| Study title: Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea – GUARINO A., BERNI CANANI R. and al. – 1997.Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea – GUARINO A., BERNI CANANI R. and al. – 1997. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30970 |
| Study title: Prevention of diarrhea by the probiotic, Lactobacillus GG – DUPONT H. – 1999Prevention of diarrhea by the probiotic, Lactobacillus GG – DUPONT H. – 1999 |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30974 |
| Study title: Probiotics for pediatric antibiotic-associated diarrhea: a meta analysis of randomized placebo-controlled trials – JOHNSTON B.C., SUPINA A.L. and al. – 2006.Probiotics for pediatric antibiotic-associated diarrhea: a meta analysis of randomized placebo-controlled trials – JOHNSTON B.C., SUPINA A.L. and al. – 2006. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30971 |
| Study title: Short report: a placebo-controlled study of Lactobacillus GG colonization in one-to-three-year-old Peruvian children – SHEEN P., OBERHELMAN R.A. and al. – 1995.Short report: a placebo-controlled study of Lactobacillus GG colonization in one-to-three-year-old Peruvian children – SHEEN P., OBERHELMAN R.A. and al. – 1995. |
| Active substance: LACTIC ACID PRODUCING ORGANISMS AND COMBINATIONS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30972 |
| Study title: Vergleichende Doppel-Blindprüfung zwischen Neseril™, einem neuen Nasentropfenpräparat, und Ephedrin. (Comparative double-blind trial between Neseril™ (Nasivin), a new nasal-drop formulation, and ephedrine).Särtryck ur Svenska Läkartidningen 1964; 61: 3204-13, Thulin A, Walther BW., 1964 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48917 |
| Study title: Management of pediatric liver tumors. ; Bowman-L-C. Surgical Oncology Clinics of North America, 1996, Vol/Iss/Pg. 5/2 (451-459)Management of pediatric liver tumors. ; Bowman-L-C. Surgical Oncology Clinics of North America, 1996, Vol/Iss/Pg. 5/2 (451-459) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30286 |
| Study title: Management of Pericentral Arteriovenous Malformations; James I. Ausman. Neurol Med Chir Suppl (Tokyo) 38, 208 ~ 216, 1998Management of Pericentral Arteriovenous Malformations; James I. Ausman. Neurol Med Chir Suppl (Tokyo) 38, 208 ~ 216, 1998 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30287 |
| Study title: Mild iodine deficiency is associated with elevated hearing thresholds in children in Benin. ; Van-den-Briel-T European Journal of Clinical Nutrition, 2001, Vol /Iss/Pg. 55/9 (763-768)Mild iodine deficiency is associated with elevated hearing thresholds in children in Benin. ; Van-den-Briel-T European Journal of Clinical Nutrition, 2001, Vol /Iss/Pg. 55/9 (763-768) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30288 |
| Study title: A study to test the efficacy of E45 Cream on nappy rash |
| Active substance: LANOLIN SOFT PARAFFIN AND FAT PRODUCTS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31012 |
| Study title: Efficacy and tolerability of lactitol solution versus lactulose syrup in patients (children) suffering from chronic functional constipation. Investigator: Dr. Med. A.C. Douwes Report date: 04.11.1996 |
| Active substance: LANREOTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31014 |
| Study title: Evaluation of the efficacy and safety of Somatuline sustained release form in adolescent with constitutive tall stature |
| Active substance: LANREOTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31013 |
| Study title: A double blind, multi-centre, randomised, placebo-controlled study to assess the efficacy,tolerability and compliance profile of a triple therapy regimen (lansoprazole, amoxicilline and tinidazole) in comparison with the standard double therapy (amoxicilline and tinidazole), given for one week to children with Hpylori gastritis. |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_HP-AG-97-01-EC428-Synopsis.pdf |
| View full study record |
| Document reference: 47614 |
| Study title: A phase I, multi-centre, double-blind, randomized study consisting of a 7-day pre-treatment period and a 5-day treatment period of either lansoprazole 15mg or 30mg (capsules) in 12-17 year-olds with symptomatic, endoscopically (oesophagitis grade ³1) and/or histologically proven (borderline or abnormal from oesophageal biopsies) GERD. |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_M97-640-Synopsis.pdf |
| View full study record |
| Document reference: 47612 |
| Study title: A phase I, multi-centre, randomised, parallel group, open-label, single- and repeated-dose studies to evaluate the pharmacokinetic and pharmacodynamic profile of lansoprazole in neonates with clinically-evident GERD |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_c03-042-synopsis.pdf |
| View full study record |
| Document reference: 47606 |
| Study title: A Phase II, open-label, parallel group, 8-12 weeks study to assess the safety and efficacy of once daily administration of lansoprazole 15 mg or 30 mg in male and female adolescents aged 12 to 17 years with GERD including non-erosive GERD and erosive oesophagitis. |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_M00-158-Synopsis.pdf |
| View full study record |
| Document reference: 47613 |
| Study title: A phase II, single-centre, open-label pharmacokinetic and pharmacodynamic study of lansoprazole 30mg/1.73m2 in children aged 18 days to 14 years who required anti-secretory treatment |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_FH-93-749-54 Synopsis _EC430__English.pdf |
| View full study record |
| Document reference: 47609 |
| Study title: A phase II, two-centre, open-label study in patients aged 3 months to 13 years with endoscopically-proven reflux oesophagitis. |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_AG-II-95-028-Synopsis.pdf |
| View full study record |
| Document reference: 47610 |
| Study title: "Four- week intraveinous study of AG-1749 in rats - H. Miajyiama et al. - 25/07/1990 - Lanzor 30 mg-preclinical studies-" |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47616 |
| Study title: Intravenous single dose toxicology study of AG-1749 - IV Formulation in mice and rats - H. Miajyima et al. - 19/08/1991 - Lanzor 30 mg-preclinical studies-" |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47615 |
| Study title: Prevention and control of iodine deficiency: A review of a study on the effectiveness of oral iodized oil in Malawi. ;Furnee-C-A. European Journal of Clinical Nutrition, 1997, Vol /Iss/Pg. 51/SUPPL. 4 (9-10)Prevention and control of iodine deficiency: A review of a study on the effectiveness of oral iodized oil in Malawi. ;Furnee-C-A. European Journal of Clinical Nutrition, 1997, Vol /Iss/Pg. 51/SUPPL. 4 (9-10) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30312 |
| Study title: Prophylaxis and treatment of endemic goiter in Peru with iodized oil; E. A. Pretell. J. Clin Endocr 29: 1586-1969Prophylaxis and treatment of endemic goiter in Peru with iodized oil; E. A. Pretell. J. Clin Endocr 29: 1586-1969 |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30313 |
| Study title: Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. ; Tajima-T. Journal of Vascular and Interventional Radiology, 01 SEP 2002, Vol/Iss/Pg. 13/9 I (893-900)Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer. ; Tajima-T. Journal of Vascular and Interventional Radiology, 01 SEP 2002, Vol/Iss/Pg. 13/9 I (893-900) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30314 |
| Study title: Pulmonary embolism: A fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma. ;Czauderna-P. Journal of Pediatric Surgery, 2005, Vol/Iss/Pg. 40/10 (1647-1650)Pulmonary embolism: A fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma. ;Czauderna-P. Journal of Pediatric Surgery, 2005, Vol/Iss/Pg. 40/10 (1647-1650) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30315 |
| Study title: Pulmonary lesions following lymphography in childhood. ;Pollak-A. Rontgen-Blatter, 1973, Vol/Iss/Pg. 26/7 (296-300). Pulmonary lesions following lymphography in childhood. ;Pollak-A. Rontgen-Blatter, 1973, Vol/Iss/Pg. 26/7 (296-300). |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30316 |
| Study title: Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia. Yamaura-K. European Journal of Anaesthesiology 2000, Vol /Iss/Pg. 17/11 (704-708)Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia. Yamaura-K. European Journal of Anaesthesiology 2000, Vol /Iss/Pg. 17/11 (704-708) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30317 |
| Study title: A Multi-Institutional Study of Optimal Use of Recombinant Granulocyte Colony Stimulating Factor (Lenograstim) in Pediatric Malignancies-III - Kawa K. et al - 1999 (Biotherapy - 13(4):361-367)A Multi-Institutional Study of Optimal Use of Recombinant Granulocyte Colony Stimulating Factor (Lenograstim) in Pediatric Malignancies-III - Kawa K. et al - 1999 (Biotherapy - 13(4):361-367) |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31040 |
| Study title: A multicenter European randomized parallel-group phase III study to evaluate safety and efficacy of rHuG-CSF (lenograstim) in the first 12 weeks of the treatment of de novo severe aplastic anemia - 1998 (Blood, 92 (10) suppl 1 : abs 1551, p 376 a) |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31028 |
| Study title: A multicenter non-randomized open-label dose-escalating phase I-II study (pharmakokinetic and dose-ranging) of intravenous or subcutaneous administration of rG-CSF for a maximum of 21 days to reduce duration of neutropenia in children having received COPAdM1 and / or COPAdM2 chemotherapy course for advanced lymphoma |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31029 |
| Study title: A Phase III multicenter, double blind, randomized, parallel-group, vehicle controlled study to evaluate the safety and efficacy of 5µg/kg/day recombinant Granulocyte Colony Stimulating Factor (rHuG-CSF) in the treatment of patients who have undergone bone marrow transplantation (BMT). |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31030 |
| Study title: An open label, multicenter study to evaluate the pharmacokinetics of 5uG / KG / day of recombinant granulocyte colony stimulating factor (rHuG-CSF) in the treatment of pediatric patients who have undergone bone marrow transplantation (BMT) - No author - No date - Clinical study documentation GHBA 271 study - Vol. 6 - |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31031 |
| Study title: Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO / EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). - Bacigalupo A. et al - 2000 (Blood 95: 1931 - 1931) - Publication - Ref17 of Clinical Expert Report - |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31032 |
| Study title: European Pjhase II study of open label administration of subcutaneous rHuG-CSF treatment in congenital agranulocytosis in children. |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31033 |
| Study title: Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology - Patte C. et al - 2002 (J Clin Oncol. Jan 15;20(2):441-8)Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology - Patte C. et al - 2002 (J Clin Oncol. Jan 15;20(2):441-8) |
| Active substance: LENOGRASTIM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31039 |
| Study title: Efficiency of the bone scan for occult limping toddlers.Aronson J, Garvin K, Seibert J, Glasier C, Tursky EA. J Pediatr Orthop 1992 Jan;12(1):38-44 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48530 |
| Study title: Isotope bone scans in the assessment of children with hip pain or limp.Bower GD, Sprague P, Geijsel H, Holt K, Lovegrove FT. Pediatr Radiol 1985;15(5):319-23. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48576 |
| Study title: Esthesioneuroblastoma imaged with bone scintigraphy.Acker R, Leonard JC. Clin Nucl Med 1986 Sep;11(9):670-1. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48522 |
| Study title: 99Tcm-MAA lung scintigraphy in patients with Behçet's disease: its value and correlation with clinical course and other diagnostic modalities. Nucl Med Commun. 2000 Feb;21(2):171-9. Caglar M 2000 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48804 |
| Study title: Abnormal brain perfusion demonstrated by Tc-99m MAA total-body scan in two children with complex congenital heart disease. Ann Nucl Med. 1998 Oct;12(5):297-302. Suga K 1998 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48810 |
| Study title: Acute paraquat intoxication: using nuclear pulmonary studies to predict patient outcome. Chest. 1999 Sep;116(3):709-14. Kao CH 1999 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48806 |
| Study title: Arteriovenous shunt measurement during endovascular therapy for cerebrospinal lesions. AJNR Am J Neuroradiol. 1997 Oct;18(9):1679-89. Mariani L 1997 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48813 |
| Study title: Aspiration of nasal secretions into the lungs in patients with acute sinonasal infections. Laryngoscope. 2000 Jan;110(1):107-10. Ozagar A 2000 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48805 |
| Study title: Evaluation of growth in children using quantitative bone scintigraphy.Celen Z, Zincirkeser S, Ozkiliç S, Nacar F. J Int Med Res 1999;27(6):286-91. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48590 |
| Study title: Extraosseous accumulation of (99m)Tc-HMDP to radiation nephropathy, mimicking recurrent neuroblastoma.Abe K, Sasaki M, Kuwabara Y, Koga H, Baba S, Kaneko K, et al. Ann Nucl Med 2005 Feb;19(1):35-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48521 |
| Study title: Bilateral pulmonary artery aneurysms in a patient with Behcet syndrome: evaluation with radionuclide angiography and V/Q lung scanning. Clin Nucl Med. 1998 Nov;23(11):735-8. Basoglu T 1998 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48811 |
| Study title: Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol. Ann Nucl Med. 1995 Nov;9(4):171-8. Sundram FX 1995 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48816 |
| Study title: Correlation of diagnostic imaging and subsequent autopsy findings in patients with pulmonary embolism. Patriquin L, Khorasani R, Polak JF. AJR Am J Roentgenol. 1998 Aug;171(2):347-9 Comment in: AJR Am J Roentgenol. 1998 Aug;171(2):293. AJR Am J Roentgenol. 1999 Jun;172(6):1691-3. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc |
| View full study record |
| Document reference: 48244 |
| Study title: Bhogate BM, Samuel AM, Ramanathan P. Bone scans in neuroblastoma. Indian J Cancer. 1993 Mar;30(1):5-9. Bhogate BM, Samuel AM, Ramanathan P. Bone scans in neuroblastoma. Indian J Cancer. 1993 Mar;30(1):5-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43671 |
| Study title: Wirksames und sicheres Rhinologikum für Säuglinge. (Effective and safe rhinological agent for infants).Pädiatrische Nachrichten 2000; 3: 14-15, Teichmann B, Tschaikin M., 2000 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48927 |
| Study title: Klinische Erfahrungen mit Nasivin. (Clinical experience with Nasivin)..,The Practitioner 1975; 214: 685-8, Aikman PM, Bremner AD, de Burca B, et al., 1975 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48914 |
| Study title: Evaluate in children the taste of two different phenoxymethylpenicillins, one containing aspartame.Norstedt |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_13.xlsx |
| View full study record |
| Document reference: 49044 |
| Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
| View full study record |
| Document reference: 49031 |
| Study title: Investigate how absorption is influenced by volume, composition and food intake.Forsman et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_1.xlsx |
| View full study record |
| Document reference: 49032 |
| Study title: investigate serum concentrations achieved with potassium salt of penicillin V i n2 different galenic forms.Perlhagen et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_2.xlsx |
| View full study record |
| Document reference: 49033 |
| Study title: Investigate the minimum age limit in children accepting penicillin administered as tablets instead of mixture.Edvardsson et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_14.xlsx |
| View full study record |
| Document reference: 49045 |
| Study title: Investigate the possibility to administer penicillin V in a twice daily dosage regimen.Edlund et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_6.xlsx |
| View full study record |
| Document reference: 49037 |
| Study title: "Infantile anorexia treated with degreased whole bone substance", Vidal Perez Fernandez, Medicina, 1969, 49 : 169-171"Infantile anorexia treated with degreased whole bone substance", Vidal Perez Fernandez, Medicina, 1969, 49 : 169-171 |
| Active substance: OSSEIN HYDROXYAPATITE COMPOUND |
| Study summary document link (including results): Ossopan nr1.xls |
| View full study record |
| Document reference: 47590 |
| Study title: Open-label, single-arm, multicenter study to evaluate the efficacy and tolerability of Creon for children in infants with pancreatic exocrine insufficiency caused by cystic fibrosis |
| Active substance: Pancreatin |
| Study summary document link (including results): Pancreatin-S248-3003.pdf |
| View full study record |
| Document reference: 47673 |
| Study title: Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol 1996; 76(2):204-8 Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol 1996; 76(2):204-8 |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33636 |
| Study title: Valuatazioni su pazienti pediatrici recoverati per diarrea acuta dal 1990 al 1996 (valuations about paeditric admissions inhospital for acute diarrhea from 1990 to 1996) - Casini T. and al. - 1997 (Ped. Med. Chir., 1997, 19: 31-5)Valuatazioni su pazienti pediatrici recoverati per diarrea acuta dal 1990 al 1996 (valuations about paeditric admissions inhospital for acute diarrhea from 1990 to 1996) - Casini T. and al. - 1997 (Ped. Med. Chir., 1997, 19: 31-5) |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47064 |
| Study title: Phase I, multi-centre, randomised, parallel group, open-label, single- and repeated-dose studies to evaluate the pharmacokinetic and pharmacodynamic profile of lansoprazole in infants with clinically-evident GERD |
| Active substance: LANSOPRAZOLE |
| Study summary document link (including results): Lansoprazole_c03-043-synopsis.pdf |
| View full study record |
| Document reference: 47608 |
| Study title: Assessment of the efficacy and safety of Somatuline sustained release form in adolescent with constitutive tall stature |
| Active substance: LARATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31020 |
| Study title: Lee JK, Liu RS, Shiang HR, Pan DH.. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. [lee-2003]J Comput Assist Tomogr. 2003 Jul-Aug;27(4):525-9. Lee JK 2003 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48674 |
| Study title: Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, et al.. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. [levivier-1995]J Neurosurg. 1995 Mar;82(3):445-52. Levivier M 1995 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48675 |
| Study title: McCarville MB.. Review. PET-CT imaging in pediatric oncology. [mccarville-2009]Cancer Imaging. 2009 Jun 29;9:35-43. McCarville MB 2009 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48676 |
| Study title: Metz-Lutz MN, Filippini M.. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. [metz-lutz-2006]Epilepsia. 2006;47 Suppl 2:71-5. Metz-Lutz MN 2006 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48677 |
| Study title: Modafinil-induced hippocampal activation in narcolepsyNeuroscience Letters 422 (2007) 91–96. Yu Kyeong Kima, In-Young Yoon b,∗, Yoon-Kyung Shin b, Sang Soo Choa, Sang Eun Kima. |
| Active substance: Steripet |
| Study summary document link (including results): kim-2007.pdf |
| View full study record |
| Document reference: 48735 |
| Study title: Mody RJ, Bui C, Hutchinson RJ, Yanik GA, Castle VP, Frey KA, Shulkin BL.. FDG PET imaging of childhood sarcomas. [mody-2010]Pediatr Blood Cancer. 2010 Feb;54(2):222-7. Mody RJ 2010 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48678 |
| Study title: Moll AC, Hoekstra OS, Imhof SM, Comans EF, Schouten-van Meeteren AY, van der Valk P, et al. Ophthalmic Genet. 2004 Mar;25(1):31-5. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. [moll-2004]Moll AC 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48679 |
| Study title: Muzik O, Pourabdollah S, Juhasz C, Chugani DC, Janisse J, Draghici S.. Application of an objective method for localizing bilateral cortical FDG PET abnormalities to guide the resection ofepileptic foci. [muzik-2005]IEEE Trans Biomed Eng. 2005 Sep;52(9):1574-81. Muzik O 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48680 |
| Study title: Myocardial Viability Assessed by Positron Emission Tomography in Infants and Children After the Arterial Switch Operation and Suspected Infarction(J Am Coll Cardiol 2000;36:1676–83). Carsten Rickers, MD,* Karin Sasse, MD,* Ralph Buchert, PHD,† Heiko Stern, MD,* Jo¨rg van den Hoff, PHD,‡ Martin Lu¨beck, MD,† Jochen Weil, MD* |
| Active substance: Steripet |
| Study summary document link (including results): rickers-2000.pdf |
| View full study record |
| Document reference: 48743 |
| Study title: Natsume J, Kumakura Y, Bernasconi N, Soucy JP, Nakai A, Rosa P, et al.. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. [natsume-2003]Neurology. 2003 Mar 11;60(5):756-61. Natsume J 2003 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48681 |
| Study title: Control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fluoride gel1974-stratemann |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1974-stratemann - control of decalcification in orthodontic patients by daily self administered application of a water free 0.4 percent stannous fl... |
| View full study record |
| Document reference: 49152 |
| Study title: Controlled trial of fluoride in vitamin drops for prevention of caries in childrenLars-Eric Granath, Holger Rootzen, Elso Liljegren, Kerstin Hoist, Lennart Kohler 1978. Caries Res 12: 83-92lENNART hAMBERG 1971, THE LANCET, February 27 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1971-hamberg-Controlled trial of Fluoride in Vitamins Drops for Prevention od Caries in Children.pdf |
| View full study record |
| Document reference: 48782 |
| Study title: Djelovanje aminofluorida - elmex gelee na: Effect of amine fluorideRajic 1977 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Rajic 1977 Djelovanje aminofluorida - elmex gelee na.pdf |
| View full study record |
| Document reference: 49174 |
| Study title: Decrease in DMF tooth numbersSigrist 1975 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): Sigrist 1975 Decrease in DMF tooth numbers.pdf |
| View full study record |
| Document reference: 49179 |
| Study title: The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area1960-Muhler |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1960-Muhler-The anticariogenic effectiveness od a single application of stannous fluoride in children residing in an optimum fluoride area.pdf |
| View full study record |
| Document reference: 49140 |
| Study title: the anticariogenic effects of one and two X application of stannous fluoride on the deciduous and permanent teeth of children1962-Salter |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49144 |
| Study title: The caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren1994-DePaola |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1994-DePaola-the caries inhibitory effect of a fluoride gel (PreviDent) ina self-brushing home based programm for shoolchildren.pdf |
| View full study record |
| Document reference: 49095 |
| Study title: The caries preventing effect of mouthrinsing with 0.025 percent sodium fluoride solution in Swedish children. Forsman B. Community Dent Oral Epidemiol. 1974;2(2):58-65. |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48944 |
| Study title: The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar1984-holm |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1984-holm-The caries preventive effect of a fluoride varnish in the fissures of the first permanent molar.pdf |
| View full study record |
| Document reference: 49110 |
| Study title: The caries prophylactic effect of Fluorlack after years of use in paediatric/adolescent dental care: Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege1978-leiser |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1978-leiser-Karies prophylaktische Wirkung von Fluorlack nach mehrjahriger Anwendung in der Jugendzahnpflege.pdf |
| View full study record |
| Document reference: 49104 |
| Study title: The caries-preventive effect of a fluoride varnish in the fissures of the first permanent molar. |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42369 |
| Study title: The clinical anticariogenic effectiveness of supplementary fluoride vitamin preparations - result at the end of four yearsDavid K. Hennon, Georg K Stookey, Joseph C Muhler 1967. Journal of dentistry for children. |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1967-hennon-Ciinical Anticariogenic Effectivenoss of Supplementary Fluoride-Vitamin Preparations-Results at the end of four years.pdf |
| View full study record |
| Document reference: 48785 |
| Study title: The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice1959-Muhler, J DENT RES 1959 38: 994 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1959-Muhler-The combined antocariogenic effeccts of a single stannous fluoride treatement and the unsupervised use of stannous fluoride dentifrice.pdf |
| View full study record |
| Document reference: 49139 |
| Study title: Correlation of pulmonary 99mTc-DTPA ventilation and 99mTc-MAA perfusion scans with pulmonary function tests in asymptomatic asthmatic children. Nucl Med Commun. 2003 Jul;24(7):819-24. Dai ZK 2003 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48796 |
| Study title: Diagnosis of thrombosis of the deep veins of the lower extremities and pelvis and pulmonary thromboembolism using 99Tcm human serum albumin macroaggregates. Nucl Med Commun. 1989 Mar;10(3):141-7. Stevan M 1989 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48826 |
| Study title: Diffusing capacity is not measurably affected by routine lung perfusion scanning.Morris T A 1988, J Nucl Med. 1988 Jul;29(7):1268-71. |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): Morris 1988.pdf |
| View full study record |
| Document reference: 48789 |
| Study title: Bone imaging for lower extremity pain in athletes.Brill DR. Clin Nucl Med 1983 Mar;8(3):101-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48579 |
| Study title: The Therapeutic Efficacy of Human Insulin (recombinant DNA) in Patients with Insulin-dependent Diabetes Mellitus: A Comparative Study with Purified Porcine Insulin |
| Active substance: INSULIN (HUMAN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30182 |
| Study title: Use of Biosynthetic Human Insulin (BHI), Mixed Beef-Pork (MBP) or Purified Pork (PPI), NPH or Lente Alone, or in Combination with Neutral Regular Insulin in Type I and Type II Diabetic Patients |
| Active substance: INSULIN (HUMAN) |
| Study summary document link (including results): Human insulin - B5K-MC-IBAL redacted CSR.PDF |
| View full study record |
| Document reference: 30185 |
| Study title: A 24-week, randomised, multi-centre, open-labelled, parallel-group trial to investigate the safety of NN304 (insulin detemir) and Neutral protamine hagedorn (NPH) human insulin in children with type 1 diabetes on a basal-bolus regimen |
| Active substance: insulin detemir |
| Study summary document link (including results): NN304-1604 ICTR Synopsis.pdf |
| View full study record |
| Document reference: 47337 |
| Study title: A 32 Week, Open-labelled, Randomised, Cross-over Trial comparing Efficacy and Safety of Insulin Detemir and Insulin Semilente, both administered at bedtime, in Children, Adolescents and Young Adults with Type 1 Diabetes on Basal-Bolus Regimen, LPLV November 2005 |
| Active substance: insulin detemir |
| Study summary document link (including results): NN304-1630-synopsis.pdf |
| View full study record |
| Document reference: 41576 |
| Study title: [Bone isotope hypofixation in algodystrophy in children]Le Loet X, Lefort J, Daragon A, Derumeaux B, Deshayes P. Rev Rhum Mal Osteoartic. 1987 Jan;54(1):53. French. No abstract available |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43881 |
| Study title: Bone isotope hypofixation in algodystrophy in childrenLe Loet X. Lefort J. Daragon A. Derumeaux B. Deshayes P. Rev Rhum Mal Osteoartic 1987 Jan;54(1):53 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48497 |
| Study title: Fone-scan-like pattern with 99TcM(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism.Akbunar AT, Orhan B, Alper E. Nucl Med Commun 2000;21:181-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48525 |
| Study title: "Oxybutynin Chlorhydrate for the Treatment of Urinary Incontinence and Hyperactive Bladder in Children. - Aubert D et al. - Ann Pediatr (Paris). 1986 (33 (7): 629-634) - Publication in UK registration file -" "Oxybutynin Chlorhydrate for the Treatment of Urinary Incontinence and Hyperactive Bladder in Children. - Aubert D et al. - Ann Pediatr (Paris). 1986 (33 (7): 629-634) - Publication in UK registration file -" |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32987 |
| Study title: The comparative antipyretic efffect of N-acetyl-P-aminophenol and acetylsalicylic acid" - Margaret T. Colgan and A.A. Mitz, Houston, Texas, USA - The Journal of PediatricsThe comparative antipyretic efffect of N-acetyl-P-aminophenol and acetylsalicylic acid" - Margaret T. Colgan and A.A. Mitz, Houston, Texas, USA - The Journal of Pediatrics |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45755 |
| Study title: Use of the antiseptic Octenisept in children at the Fachklinik Hornheide.1996. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32736 |
| Study title: Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25501 |
| Study title: EA O'Neil, WJ Chwals, MD O'Shea, CS Turner. Dexamethasone Treatment During Ventilator Dependency: Possible Life Threatening Gastrointestinal Complications. Archives of Disease in Childhood 1992 67:10-11 USA |
| Active substance: DEXAMETHASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25690 |
| Study title: An open study to Investigating the safety and efficiacy of Dextran-Ringer after blood loss during surgery.Zetterström et al. (1986-03-09) |
| Active substance: Dextran |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48940 |
| Study title: Clinical evaluation of priming solutions for pump oxygenator perfusion. Ann Thorac Surg. 1975 May;19(5):529-36. Lee WH Jr, Rubin JW, Huggins MP. |
| Active substance: Dextran |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48899 |
| Study title: Dextran therapy for pregnancy-associated deep thrombophlebitis.Wallach RC. Am J Obstet Gynecol. 1972 Mar;112(5):613-8. |
| Active substance: Dextran |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48939 |
| Study title: Effect of dextran on blood volume and interactions with volume regulatory systems.Haldemann G, Schaer H, Spring C, Frey P, Gebauer U, Hossli G. Intensive Care Med. 1979 Mar;5(1):11-4. |
| Active substance: Dextran |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48937 |
| Study title: Diffuse lymphatic dysplasia with hepatic oil embolism. Tatezawa-T. American Journal of Roentgenology, 1978, Vol/Iss/Pg. 131/5 (898-900)Diffuse lymphatic dysplasia with hepatic oil embolism. Tatezawa-T. American Journal of Roentgenology, 1978, Vol/Iss/Pg. 131/5 (898-900) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30230 |
| Study title: Effect of 10 yr of the iodine supplementation on the hearing threshold of iodine deficient schoolchildren. ; Azizi-F. Journal of Endocrinological Investigation, 2005, Vol/Iss/Pg. 28/7 (595-598)Effect of 10 yr of the iodine supplementation on the hearing threshold of iodine deficient schoolchildren. ; Azizi-F. Journal of Endocrinological Investigation, 2005, Vol/Iss/Pg. 28/7 (595-598) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30231 |
| Study title: Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren. ; Furnee-C-A. American Journal of Clinical Nutrition, 1997, Vol/Iss /Pg. 66/6 (1422-1427)Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren. ; Furnee-C-A. American Journal of Clinical Nutrition, 1997, Vol/Iss /Pg. 66/6 (1422-1427) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30232 |
| Study title: Effect of iodized oil treatment on the development of thyroid autoimmunity in adolescent females. ; Hashim-F-A Annals of Saudi Medicine, 2000, Vol/Iss/Pg. 20/5-6 (445-446)Effect of iodized oil treatment on the development of thyroid autoimmunity in adolescent females. ; Hashim-F-A Annals of Saudi Medicine, 2000, Vol/Iss/Pg. 20/5-6 (445-446) |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30233 |
| Study title: Naumann R, Beuthien-Baumann B, Reiß A, Schulze J, Hänel A, Bredow J, et al.. Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. [naumann-2004]BrJ Cancer. 2004 Feb 9;90(3):620-5. Naumann R 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48682 |
| Study title: Newberg A, Hassan A,. Cerebral metabolic changes associated with Lyme disease. [newberg-2002]Alavi A. Nucl Med Commun. 2002 Aug;23(8):773-7. Newberg A 2002 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48683 |
| Study title: Ng SH, Chang JT, Chan SC, Ko SF, Wang HM, Liao CT, et al.. Epub 2004 Mar 9. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. [ng-2004-a]Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1073-80. Ng SH 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48684 |
| Study title: Novak L, Emri M, Molnar P, Balkay L, Lengyel Z. Subcortical [18F]fluorodeoxyglucose uptake in lesional epilepsy in patients with intracranial tumour. [novak-2004]Tron L. Nucl Med Commun. 2004 Feb;25(2):123-8. Novak L 2004 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48685 |
| Study title: Nuclear Medicine in Pediatric Neurology and Neurosurgery: Epilepsy and Brain Tumors.Semin Nucl Med 37:357-381. Shekhar Patil, MD,* Lorenzo Biassoni, MD,† and Lise Borgwardt, MD, PhD |
| Active substance: Steripet |
| Study summary document link (including results): patil-2007.pdf |
| View full study record |
| Document reference: 48741 |
| Study title: O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, et al.. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. [oconnell-2005]Acta Neurochir Suppl. 2005;95:165-8. O'Connell MT 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48686 |
| Study title: Otsuka H, Graham MM, Kubo A, Nishitani H.. The effect of oral contrast on large bowel activity in FDG-PET/CT. [otsuka-2005]Ann Nucl Med. 2005 Apr;19(2):101- 8. Otsuka H 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48687 |
| Study title: Papathanassiou D, Becker S, Amir R, Menéroux B, Liehn JC.. Epub 2005 Aug 31. Respiratory motion artefact n the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source. [papathanassiou-2005]Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1422-8. Papathanassiou D 2005 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48688 |
| Study title: PET and PET/CT in Pediatric Oncology.Semin Nucl Med 37:316-331. Hossein Jadvar, MD, PhD, MPH, MBA,* Leonard P. Connolly, MD,† Frederic H. Fahey, DSc,† and Barry L. Shulkin, MD, MBA‡ |
| Active substance: Steripet |
| Study summary document link (including results): jadvar-2007.pdf |
| View full study record |
| Document reference: 48732 |
| Study title: PET in pediatric diseasesRadiol Clin N Am 43 (2005) 135 – 152 .Hossein Jadvar, MD, PhDa,b,*, Abass Alavi, MDc, Ayse Mavi, MDd, Barry L. Shulkin, MD, MBAe |
| Active substance: Steripet |
| Study summary document link (including results): jadvar-2005.pdf |
| View full study record |
| Document reference: 48731 |
| Study title: Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, et al.. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans. [picardi-2007]Leuk Lymphoma. 2007 Sep;48(9):1721-7. Picardi M 2007 |
| Active substance: Steripet |
| Study summary document link (including results): 2011-09 GE response Template List of published articles.doc |
| View full study record |
| Document reference: 48689 |
| Study title: Chicaud P, Demange J, Drouin P, Debry G. Action du fénofibrate chez des enfants hypercholestérolémiques. Recul de 18 mois. La Presse médicale 1984; 13:417-419Chicaud P, Demange J, Drouin P, Debry G. Action du fénofibrate chez des enfants hypercholestérolémiques. Recul de 18 mois. La Presse médicale 1984; 13:417-419 |
| Active substance: FENOFIBRATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27028 |
| Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44113 |
| Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44190 |
| Study title: Smith MA, Jones EA, Strachan RK, Nicoll JJ, Best JJ, Tothill P, Hughes SP. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg Br. 1987 May;69(3):441-7. Smith MA, Jones EA, Strachan RK, Nicoll JJ, Best JJ, Tothill P, Hughes SP. Prediction of fracture healing in the tibia by quantitative radionuclide imaging. J Bone Joint Surg Br. 1987 May;69(3):441-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43863 |
| Study title: So Y, Chung JK, Seong SC, Sohn YJ, Kang HS, Lee DS, Lee MC. Usefulness of 99Tcm-MDP knee SPET for pre-arthroscopic evaluation of patients with internal derangements of the knee. Nucl Med Commun. 2000 Jan;21(1):103-9. So Y, Chung JK, Seong SC, Sohn YJ, Kang HS, Lee DS, Lee MC. Usefulness of 99Tcm-MDP knee SPET for pre-arthroscopic evaluation of patients with internal derangements of the knee. Nucl Med Commun. 2000 Jan;21(1):103-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43490 |
| Study title: Tc-99m MDP bone and Ga-67 citrate scintigraphy of Erdheim-Chester disease in a child. Sohn MH, Kim MW, Kang YH, Jeong HJ. Clin Nucl Med. 2006 Feb;31(2):90-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43379 |
| Study title: Solav S. Bone scintiscanning in osteolytic lesions. Clin Nucl Med. 2004 Jan;29(1):12-20. Solav S. Bone scintiscanning in osteolytic lesions. Clin Nucl Med. 2004 Jan;29(1):12-20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43407 |
| Study title: Sommer HJ, Knop J, Heise U, Winkler K, Delling G. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging. Cancer. 1987 Jan 15;59(2):252-8. Sommer HJ, Knop J, Heise U, Winkler K, Delling G. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging. Cancer. 1987 Jan 15;59(2):252-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43876 |
| Study title: Spencer JD, Maisey M. A prospective scintigraphic study of avascular necrosis of bone in renal transplant patients. Clin Orthop Relat Res. 1985 Apr;(194):125-35. Spencer JD, Maisey M. A prospective scintigraphic study of avascular necrosis of bone in renal transplant patients. Clin Orthop Relat Res. 1985 Apr;(194):125-35. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43948 |
| Study title: Magill HL, Strang MS. Paraspinal metastasis of Wilm's tumor visualized on bone imaging. J Nucl Med. 1981 May;22(5):481-2. No abstract available. Magill HL, Strang MS. Paraspinal metastasis of Wilm's tumor visualized on bone imaging. J Nucl Med. 1981 May;22(5):481-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44126 |
| Study title: Ultrasonic signs of pelvic osteomyelitis in children. Mah ET, LeQuesne GW, Gent RJ, Paterson DC. Pediatr Radiol. 1994;24(7):484-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43639 |
| Study title: Mahan S, Jolles PR. MAI osteomyelitis. 18-year scintigraphic follow-up. Clin Nucl Med. 1995 Jul;20(7):594-8. Mahan S, Jolles PR. MAI osteomyelitis. 18-year scintigraphic follow-up. Clin Nucl Med. 1995 Jul;20(7):594-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43597 |
| Study title: Maigne JY, Boulahdour H, Chatellier G. Value of quantitative radionuclide bone scanning in the diagnosis of sacroiliac joint syndrome in 32 patients with low back pain. Eur Spine J. 1998;7(4):328-31. Maigne JY, Boulahdour H, Chatellier G. Value of quantitative radionuclide bone scanning in the diagnosis of sacroiliac joint syndrome in 32 patients with low back pain. Eur Spine J. 1998;7(4):328-31. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43524 |
| Study title: Malik MH. Simultaneous dual isotope studies in the diagnosis of infection. J Nucl Med. 1985 Jul;26(7):722-5. Malik MH. Simultaneous dual isotope studies in the diagnosis of infection. J Nucl Med. 1985 Jul;26(7):722-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43938 |
| Study title: Malizos KN, Soucacos PN, Vragalas V, Dailiana ZH, Schina I, Fotopoulos A. Three phase bone scanning and digital arteriograms for monitoring vascularized fibular grafts in femoral head necrosis. Int Angiol. 1995 Sep;14(3):319-26. Malizos KN, Soucacos PN, Vragalas V, Dailiana ZH, Schina I, Fotopoulos A. Three phase bone scanning and digital arteriograms for monitoring vascularized fibular grafts in femoral head necrosis. Int Angiol. 1995 Sep;14(3):319-26. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43586 |
| Study title: [Osteochondrosis deformans coxae juvenilis (Legg-Calvé-Perthes disease) in the MR tomogram: diagnosis and follow-up assessment correlated with x-rays and skeletal scintigraphy] Ranner G. Rofo. 1990 Aug;153(2):124-30. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43757 |
| Study title: Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease. Rao S, Solomon N, Miller S, Dunn E. J Pediatr. 1985 Nov;107(5):685-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43929 |
| Study title: Raymond J, Dumas JM, Lisbona R. Nuclear imaging as a screening test for patients referred for intraarticular facet block. J Can Assoc Radiol. 1984 Sep;35(3):291-2. Raymond J, Dumas JM, Lisbona R. Nuclear imaging as a screening test for patients referred for intraarticular facet block. J Can Assoc Radiol. 1984 Sep;35(3):291-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43984 |
| Study title: Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol. 1993 Oct;20(9):635-40. Reddy MS, Palcanis KG, Barnett ML, Haigh S, Charles CH, Jeffcoat MK. Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. J Clin Periodontol. 1993 Oct;20(9):635-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43649 |
| Study title: [Metastatic calcifications detected by Tc-99m MDP bone scanning in patients with hypercalcemia: case report] Japanese. Sugita R, Nakamura M, Sakamoto K, Watabe N. Rinsho Hoshasen. 1990 Mar;35(3):419-22. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43766 |
| Study title: Sun SS, Tsai SC, Su CC, Kao CH. Diffuse liver and spleen accumulation on Tc-99m methylene diphosphonate bone scan. Semin Nucl Med. 2001 Jul;31(3):253-4. No abstract available. Sun SS, Tsai SC, Su CC, Kao CH. Diffuse liver and spleen accumulation on Tc-99m methylene diphosphonate bone scan. Semin Nucl Med. 2001 Jul;31(3):253-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43451 |
| Study title: Sundram FX, Chua ET, Goh AS, Toh HJ, Khor TH, Chua EJ. Bone scintigraphy in nasopharyngeal carcinoma. Clin Radiol. 1990 Sep;42(3):166-9. Sundram FX, Chua ET, Goh AS, Toh HJ, Khor TH, Chua EJ. Bone scintigraphy in nasopharyngeal carcinoma. Clin Radiol. 1990 Sep;42(3):166-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43755 |
| Study title: Sternal uptake on bone scintigraphy: age-related variants. Syed GM, Fielding HW, Collier BD. Nucl Med Commun. 2005 Mar;26(3):253-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43390 |
| Study title: Sziklas JJ, Vento JA, Spencer RP, Rosenberg RJ. Radiogallium accumulation in heterotopic bone. Clin Nucl Med. 1985 May;10(5):376. No abstract available. Sziklas JJ, Vento JA, Spencer RP, Rosenberg RJ. Radiogallium accumulation in heterotopic bone. Clin Nucl Med. 1985 May;10(5):376. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43945 |
| Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44228 |
| Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44275 |
| Study title: Kroiss A, Böck F, Perneczky G, Auinger C, Weidlich G, Kleinpeter G, Brenner H. [Immunoscintigraphy for the detection of inflammation foci in bone and joint diseases] Wien Klin Wochenschr. 1990 Dec 21;102(24):713-7. German. Kroiss A, Böck F, Perneczky G, Auinger C, Weidlich G, Kleinpeter G, Brenner H. [Immunoscintigraphy for the detection of inflammation foci in bone and joint diseases] Wien Klin Wochenschr. 1990 Dec 21;102(24):713-7. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43751 |
| Study title: Prolonged low-back pain in young athletes: a prospective case series study of findings and prognosis. Kujala UM, Kinnunen J, Helenius P, Orava S, Taavitsainen M, Karaharju E. Eur Spine J. 1999;8(6):480-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43496 |
| Study title: A randomized, double-blind, double dummy, parallel group comparison of fluticasone propionate inhalation powder (50mcg BID) via DiskusTM with oral montelukast (5mg QD) chewable tablets in children 6–12 years of age with persistent asthma |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FPD40013-ICHE3.pdf |
| View full study record |
| Document reference: 28428 |
| Study title: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Trial Assessing the Efficacy and Safety of Fluticasone Propionate 50 or 100mcg BID via the Multi-Dose Powder Inhaler, Fluticasone Propionate 50 or 100mcg BID via the Diskhaler and Placebo in Subjects Aged 4 to 11 Years with Chronic Asthma |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLTA2006-ICHE3.pdf |
| View full study record |
| Document reference: 28423 |
| Study title: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 12-Week Trial of Inhaled Fluticasone Propionate 88mcg BID versus Placebo in Propellant GR106642X in Pediatric Subjects 4 to 11 Years of Age With Asthma |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAP30010-ICHE3.pdf |
| View full study record |
| Document reference: 28391 |
| Study title: A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNS30003-ICHE3.pdf |
| View full study record |
| Document reference: 28368 |
| Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf |
| View full study record |
| Document reference: 28417 |
| Study title: A Randomized, Open-Label, 2-Way Crossover, Repeat-Dose Study in Pediatric Subjects with Asthma, Age 4-11 Years, to Compare Systemic Exposure of Fluticasone Propionate 2x44mcg Following Administration by Metered-Dose Inhalers Containing Hydrofluoroalkane or Chlorofluorocarbon Propellants |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAP10006-ICHE3.pdf |
| View full study record |
| Document reference: 28441 |
| Study title: A single centre, randomised, double blind, cross over study to investigate longitudinal growth using knemometry in children with seasonal and perennial rhinitis during treatment with fluticasone propionate aqueous nasal spray (FPANS) 100mcg/day and placebo. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNM40181-ICHE3.pdf |
| View full study record |
| Document reference: 28415 |
| Study title: A Study to Determine the Systemic Activity of a Single Dose of Fluticasone Propionate via the Diskus in Asthmatic Children Inhaling at Different Inspiratory Flows |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLTB4009-ICHE3.pdf |
| View full study record |
| Document reference: 28382 |
| Study title: Comparison of fluticasone powder 1mg/day to budesonide powder 1mg/day in deterioration of severe asthma in children: a double-blind, randomised, multicentre study with parallel groups. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone -Propionate-FLPB0145-ICHE3.pdf |
| View full study record |
| Document reference: 28404 |
| Study title: "Calello DP, Osterhoudt KC, Henretig FM.New and novel antidotes in pediatrics.Pediatr Emerg Care. 2006 Jul;22(7):523-30. Review. Erratum in: Pediatr Emerg Care. 2007 Feb;23(2):82. " "Calello DP, Osterhoudt KC, Henretig FM.New and novel antidotes in pediatrics.Pediatr Emerg Care. 2006 Jul;22(7):523-30. Review. Erratum in: Pediatr Emerg Care. 2007 Feb;23(2):82. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28466 |
| Study title: "Caravati EM, Heileson HL, Jones M. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255-9. " "Caravati EM, Heileson HL, Jones M. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255-9. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28469 |
| Study title: "Casavant MJ. Fomepizole in the treatment of poisoning. Pediatrics. 2001 Jan;107(1):170. " "Casavant MJ. Fomepizole in the treatment of poisoning. Pediatrics. 2001 Jan;107(1):170. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28472 |
| Study title: Pan MH, Wu YW, Yen RF, Tzen KY, Liao SL, Kao CH. Different fibrovascularization rate between coralline hydroxyapatite and high density porous polyethylene (Medpore) measured by 99mTc-MDP bone scintigraphy 6 months after intraorbital implantation. Nucl Med Commun. 2003 Dec;24(12):1237-41. Pan MH, Wu YW, Yen RF, Tzen KY, Liao SL, Kao CH. Different fibrovascularization rate between coralline hydroxyapatite and high density porous polyethylene (Medpore) measured by 99mTc-MDP bone scintigraphy 6 months after intraorbital implantation. Nucl Med Commun. 2003 Dec;24(12):1237-41. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44245 |
| Study title: Panoutsopoulos G, Ilias I, Parcharidou A, Christakopoulou I. [Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma] Rev Esp Med Nucl. 2002 Jul;21(4):294-5. Spanish. No abstract available. Panoutsopoulos G, Ilias I, Parcharidou A, Christakopoulou I. [Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma] Rev Esp Med Nucl. 2002 Jul;21(4):294-5. Spanish. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43437 |
| Study title: Ibis E, Erbay G, Aras G, Isitman AT, Krasnow AZ, Collier BD. Three-phase bone scintigraphy in Maffucci's syndrome. Clin Nucl Med. 1992 Jun;17(6):505-6. No abstract available. Ibis E, Erbay G, Aras G, Isitman AT, Krasnow AZ, Collier BD. Three-phase bone scintigraphy in Maffucci's syndrome. Clin Nucl Med. 1992 Jun;17(6):505-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43696 |
| Study title: ICRP (lnternation Commission on Radiological Protection). Publication 53: Radiation dose to patients from radiopharmaceuticals.ICRP (lnternation Commission on Radiological Protection). Publication 53: Radiation dose to patients from radiopharmaceuticals. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47920 |
| Study title: ICRP Publication 80: Radiation dose to patients from radiopharmaceuticals (Addendum to ICRP Publication 53)..ICRP Publication 80: Radiation dose to patients from radiopharmaceuticals (Addendum to ICRP Publication 53).. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47921 |
| Study title: Ikawa G, dos Santos PA, Yamaguchi KT, Stroh-Recor C, Ibello R. Frostbite and bone scanning: the use of 99m-labeled phosphates in demarcating the line of viability in frostbite victims. Orthopedics. 1986 Sep;9(9):1257-61. Ikawa G, dos Santos PA, Yamaguchi KT, Stroh-Recor C, Ibello R. Frostbite and bone scanning: the use of 99m-labeled phosphates in demarcating the line of viability in frostbite victims. Orthopedics. 1986 Sep;9(9):1257-61. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43897 |
| Study title: A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma. Ikekubo K, Habuchi Y, Jeong S, Yamaguchi H, Saiki Y, Ito H, Hino M, Higa T. Clin Nucl Med. 1986 Nov;11(11):777-80. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43888 |
| Study title: Findings on magnetic resonance imaging of the spine and femur in a case of McCune-Albright syndrome. Inamo Y, Hanawa Y, Kin H, Okuni M. Pediatr Radiol. 1993;23(1):15-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43674 |
| Study title: Efficacy of Ambroxol (Surbronc) in acute respiratory exacerbation in cystic fibrosis. |
| Active substance: AMBROXOL |
| Study summary document link (including results): Ambroxol Hydrochloride_U92-0170_Synopsis.pdf |
| View full study record |
| Document reference: 46548 |
| Study title: Miraglia del Giudice et al On the use of an extemporary combination of ambroxol and beclometasone dipropionate by aerosol in childhood allergic asthma. Comparative measurements. Riv.Pat.Clin.Tuberc.Pneumol.1985,56,37-48RivPatClinTub Pneumol 1985, Miraglia del Giudice. RivPatClinTub Pneumol 1985, Miraglia del Giudice |
| Active substance: AMBROXOL |
| Study summary document link (including results): RivPatClinTub Pneumol 1985, Miraglia del Giudice.pdf |
| View full study record |
| Document reference: 48875 |
| Study title: Reinert S, Widlitzek H, Venderink DJ. The value of magnetic resonance imaging in the diagnosis of mandibular osteomyelitis. Br J Oral Maxillofac Surg. 1999 Dec;37(6):459-63. Reinert S, Widlitzek H, Venderink DJ. The value of magnetic resonance imaging in the diagnosis of mandibular osteomyelitis. Br J Oral Maxillofac Surg. 1999 Dec;37(6):459-63. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43493 |
| Study title: Rencus T, Smith J, Munn S, Elgazzar A. Displaced uterus simulating aneurysm on a multiphase bone scan. Clin Nucl Med. 2003 Jul;28(7):574-6. No abstract available. Rencus T, Smith J, Munn S, Elgazzar A. Displaced uterus simulating aneurysm on a multiphase bone scan. Clin Nucl Med. 2003 Jul;28(7):574-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43418 |
| Study title: Rhoad RC, Davidson RS, Heyman S, Dormans JP, Drummond DS. Pretreatment bone scan in SCFE: a predictor of ischemia and avascular necrosis. J Pediatr Orthop. 1999 Mar-Apr;19(2):164-8. Rhoad RC, Davidson RS, Heyman S, Dormans JP, Drummond DS. Pretreatment bone scan in SCFE: a predictor of ischemia and avascular necrosis. J Pediatr Orthop. 1999 Mar-Apr;19(2):164-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43511 |
| Study title: Riebel T, Knop J, Winkler K, Delling G. [Comparative x-ray and nuclear medical studies of osteosarcomas to evaluate the effectiveness of preoperative chemotherapy] Rofo. 1986 Oct;145(4):365-72. German. Riebel T, Knop J, Winkler K, Delling G. [Comparative x-ray and nuclear medical studies of osteosarcomas to evaluate the effectiveness of preoperative chemotherapy] Rofo. 1986 Oct;145(4):365-72. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43891 |
| Study title: Quantitative sacroiliac joint scintigraphy in normal subjects and patients with sacroiliitis. Kaçar G, Kaçar C, Karayalçin B, Güngör F, Tuncer T, Erkiliç M. Ann Nucl Med. 1998 Jun;12(3):169-73. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43530 |
| Study title: Imaging of McCune-Albright syndrome using bone single photon emission computed tomography. Kairemo KJ, Verho S, Dunkel L. Eur J Pediatr. 1999 Feb;158(2):123-6. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43513 |
| Study title: Specific or superfluous? Doubtful clinical value of granulocyte scintigraphy in osteomyelitis in children. Kaiser S, Jacobsson H, Hirsch G. J Pediatr Orthop B. 2001 Apr;10(2):109-12. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43453 |
| Study title: Early detection of subperiosteal abscesses by ultrasonography. A means for further successful treatment in pediatric osteomyelitis. Kaiser S, Rosenborg M. Pediatr Radiol. 1994;24(5):336-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43641 |
| Study title: Estimate plasma peak concentrations of ampicillin obtained after rectal administration of single doses of ampicillin suppositories given to children.Movin et al. (1987-06-15) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_25.xlsx |
| View full study record |
| Document reference: 49024 |
| Study title: Evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate the short term efficiacy in the treatment of acute otitis media. The study was comparative against amoxycillin suspension.Bagger-Sjöbäck et al. (1986-11-28) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_19.xlsx |
| View full study record |
| Document reference: 49018 |
| Study title: Investigate the rapidity of change in excretion rate of Ampicillin and Methicillin in the days after birth and demonstrate the effect of premature birth upon the excretion rates.Boe et al. (Pediatrics, vol. 39, no. 2, Feb 1967) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_8.xlsx |
| View full study record |
| Document reference: 49001 |
| Study title: The role of bone scintigraphy in osteogenic sarcoma. Rees CR, Siddiqui AR, duCret R. Skeletal Radiol. 1986;15(5):365-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43924 |
| Study title: Progressive diaphyseal dysplasia (Engelmann disease(: scintigraphic-radiographic-clinical correlations. Kumar B, Murphy WA, Whyte MP. Radiology. 1981 Jul;140(1):87-92. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44121 |
| Study title: Multifocal non-Hodgkin lymphoma in an infant with cardiac involvement: whole-body MR imaging. Kumar J, Seith A, Bakhshi S, Sharma R, Kumar A. Pediatr Radiol. 2007 Mar;37(3):321-4. Epub 2007 Jan 30. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43367 |
| Study title: Kumar R, Balachandran S. Unilateral septic sacro-iliitis. Importance of the anterior view of the bone scan. Clin Nucl Med. 1983 Sep;8(9):413-5. Kumar R, Balachandran S. Unilateral septic sacro-iliitis. Importance of the anterior view of the bone scan. Clin Nucl Med. 1983 Sep;8(9):413-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44031 |
| Study title: Kumar R, Dilip S, Padhy AK, Malhotra R, Malhotra A, Machineni S, Sharma R. Three-phase bone imaging in the early diagnosis of osteochondritis dissecans of the patella. Clin Nucl Med. 1998 Aug;23(8):540-1. No abstract available. Kumar R, Dilip S, Padhy AK, Malhotra R, Malhotra A, Machineni S, Sharma R. Three-phase bone imaging in the early diagnosis of osteochondritis dissecans of the patella. Clin Nucl Med. 1998 Aug;23(8):540-1. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43528 |
| Study title: Nielsen PT, Hedeboe J, Thommesen P. Bone scintigraphy in the evaluation of fracture of the carpal scaphoid bone. Acta Orthop Scand. 1983 Apr;54(2):303-6. Nielsen PT, Hedeboe J, Thommesen P. Bone scintigraphy in the evaluation of fracture of the carpal scaphoid bone. Acta Orthop Scand. 1983 Apr;54(2):303-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44042 |
| Study title: Nishiyama Y, Yamamoto Y, Toyama Y, Satoh K, Ohkawa M, Tanabe M. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors. Clin Nucl Med. 2000 Mar;25(3):200-5. Nishiyama Y, Yamamoto Y, Toyama Y, Satoh K, Ohkawa M, Tanabe M. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors. Clin Nucl Med. 2000 Mar;25(3):200-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43491 |
| Study title: Nishiyama Y, Yamamoto Y, Yokoe K, Kawaguchi Y, Toyama Y, Satoh K, Ohkawa M. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors. Ann Nucl Med. 2004 May;18(3):235-41. Nishiyama Y, Yamamoto Y, Yokoe K, Kawaguchi Y, Toyama Y, Satoh K, Ohkawa M. A comparative study of 201Tl scintigraphy and three-phase bone scintigraphy following therapy in patients with bone and soft-tissue tumors. Ann Nucl Med. 2004 May;18(3):235-41. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43402 |
| Study title: Noel AW, Heyman S. Scintigraphic findings in infantile hemangioendothelioma. Clin Nucl Med. 1986 Jun;11(6):413-6. Noel AW, Heyman S. Scintigraphic findings in infantile hemangioendothelioma. Clin Nucl Med. 1986 Jun;11(6):413-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43908 |
| Study title: Normal anatomic variant: scintigraphy of the ischiopubic synchondrosis. Cawley KA, Dvorak AD. Wilmot MD. Nucl Med 1983 Jan;24{1):14-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48468 |
| Study title: Isotope scanning with Tc99m-MDP of the spine and the costosternal junctions of patients with idiopathic scoliosis. Normelli H, Lewander R. Acta Radiol Diagn (Stockh). 1985 Jul-Aug;26(4):397-401. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43936 |
| Study title: "De Brabander N, Wojciechowski M, De Decker K, De Weerdt A, Jorens PG. Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature. Eur J Pediatr. 2005 Mar;164(3):158-61. Epub 2004 Dec 1. Review. " "De Brabander N, Wojciechowski M, De Decker K, De Weerdt A, Jorens PG. Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature. Eur J Pediatr. 2005 Mar;164(3):158-61. Epub 2004 Dec 1. Review. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28468 |
| Study title: "Harry P, Jobard E, Briand M, Caubet A, Turcant A. Ethylene glycol poisoning in a child treated with 4-methylpyrazole. Pediatrics. 1998 Sep;102(3):E31. " "Harry P, Jobard E, Briand M, Caubet A, Turcant A. Ethylene glycol poisoning in a child treated with 4-methylpyrazole. Pediatrics. 1998 Sep;102(3):E31. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28475 |
| Study title: "Shannon M. Toxicology reviews: fomepizole--a new antidote. Pediatr Emerg Care. 1998 Apr;14(2):170-2. " "Shannon M. Toxicology reviews: fomepizole--a new antidote. Pediatr Emerg Care. 1998 Apr;14(2):170-2. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28476 |
| Study title: "Tenenbein M. Recent advancements in pediatric toxicology. Pediatr Clin North Am. 1999 Dec;46(6):1179-88, vii. Review. " "Tenenbein M. Recent advancements in pediatric toxicology. Pediatr Clin North Am. 1999 Dec;46(6):1179-88, vii. Review. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28473 |
| Study title: "Wiley JF 2nd. Novel therapies for ethylene glycol intoxication. Curr Opin Pediatr. 1999 Jun;11(3):269-73. Review. " "Wiley JF 2nd. Novel therapies for ethylene glycol intoxication. Curr Opin Pediatr. 1999 Jun;11(3):269-73. Review. " |
| Active substance: FOMEPIZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28474 |
| Study title: A 12 month multi-center, randomized, dbdd trial to examine the long-term tolerability of formoterol 1mg via the mddpi, both as b.i.d maintenance therapy and as on-demand-use on top of maintenane, in patients with persistent asthma. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47791 |
| Study title: A 12 week randomized, double-blind, double-dummy, placebo controlled, parallel group study in adolescents and adults with persistent asthma comparing the safety and efficacy of two doses of formoterol fumarate b.i.d. administered from the multi-dose powder |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47792 |
| Study title: A 12-month comparison of Oxis® (formoterol) Turbuhaler® and Bricanyl® (terbutaline)Turbuhaler both used as needed in subjects with asthma not using anti-inflammatory treatment |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0716 Study Synopsis.pdf |
| View full study record |
| Document reference: 47793 |
| Study title: A 12-month comparison of Oxis® (formoterol) Turbuhaler® and Bricanyl®(terbutaline) Turbuhaler® both used as needed in patients with asthma on anti-inflammatory treatment |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0714 Study Synopsis.pdf |
| View full study record |
| Document reference: 47794 |
| Study title: A 12-week randomized, multicenter, double-blind, double-dummy, placebo and active controlled, parallel group study evaluating the safety and efficacy of Formoterol fumarate (10 µg b.i.d.) delivered by the multi-dose dry powder inhaler (MDDPI) versus place |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258F2302 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47795 |
| Study title: A 12-week randomized, multicenter, double-blind, double-dummy, placebo and active controlled, parallel group study evaluating the safety, efficacy, and pharmacokinetics of Foradil (formoterol fumarate) (10 mg bid) delivered by the multi-dose dry powder in |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47796 |
| Study title: Effects on the respiratory tract and male reproductive organs in young rats given formoterol fumarate (D2522) in lactose by the inhalation route for 3 months |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47838 |
| Study title: Efficacy and safety of budesonide/formoterol Turbuhaler in a fixed combination in steroid-using asthmatic children – COMIC. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47839 |
| Study title: Efficacy and tolerability of four single doses of formoterol Turbuhaler compared to salmeterol Diskhaler 50μg and placebo in children with bronchial asthma. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0002 Study Synopsis.pdf |
| View full study record |
| Document reference: 47840 |
| Study title: Intenzo C, Kim S, Millin J, Park C. Scintigraphic patterns of the reflex sympathetic dystrophy syndrome of the lower extremities. Clin Nucl Med. 1989 Sep;14(9):657-61. Intenzo C, Kim S, Millin J, Park C. Scintigraphic patterns of the reflex sympathetic dystrophy syndrome of the lower extremities. Clin Nucl Med. 1989 Sep;14(9):657-61. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43780 |
| Study title: Ishibashi K, Miyamae T. [Classification of bone scintigrams in hemodialysis patients] Kaku Igaku. 1985 Mar;22(3):367-76. Japanese. No abstract available. Ishibashi K, Miyamae T. [Classification of bone scintigrams in hemodialysis patients] Kaku Igaku. 1985 Mar;22(3):367-76. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43952 |
| Study title: Septic arthritis of a lumbar facet joint due to pyonex. Ishibe M, Inoue M, Saitou K. Arch Orthop Trauma Surg. 2001;121(1-2):90-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43464 |
| Study title: Isotope bone scanning for acute osteomyelitis and septic arthritis in children. Tuson CE, Hoffman EB, Mann MD. J Bone Joint Surg Br. 1994 Mar;76(2):306-10. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43633 |
| Study title: Uterine blush mimicking a hypervascular tumour in the pelvis as demonstrated by a triple-phase bone scan. Tzen KY, Yen TC. Nucl Med Commun. 1998 Jun;19(6):605-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43509 |
| Study title: Uno K, Uchida Y, Sakata S, Minoshima S, Okada J, Yoshikawa K, Arimizu N, Karikomi M, Kitakata Y, Suzuki Y. [Visualization of the female breast in bone scintigraphy] Kaku Igaku. 1992 Oct;29(10):1201-6. Japanese. Uno K, Uchida Y, Sakata S, Minoshima S, Okada J, Yoshikawa K, Arimizu N, Karikomi M, Kitakata Y, Suzuki Y. [Visualization of the female breast in bone scintigraphy] Kaku Igaku. 1992 Oct;29(10):1201-6. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43685 |
| Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43732 |
| Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44173 |
| Study title: Assessment of growth activity in the mandibular condyles by single-photon emission computed tomography (SPECT). Kajan ZD, Motevasseli S, Nasab NK, Ghanepour H, Abbaspur F. Aust Orthod J. 2006 Nov;22(2):127-30. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43368 |
| Study title: Age-related normal variants of sternal uptake on bone scintigraphy.Kakhki VD, Zakavi SR. Clin Nucl Med. 2006 Feb;31(2):63-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43380 |
| Study title: Kaneda K, Kurakami C, Minami A. Free vascularized fibular strut graft in the treatment of kyphosis. Spine. 1988 Nov;13(11):1273-7. Kaneda K, Kurakami C, Minami A. Free vascularized fibular strut graft in the treatment of kyphosis. Spine. 1988 Nov;13(11):1273-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43804 |
| Study title: Kantarjian HM, Bledin AG, Kim EE, Gutierrez CR, Haynie TP. Uptake of 99mTc-methylene disphosphonate in calcinosis cutis. J Am Acad Dermatol. 1982 Dec;7(6):804-6. No abstract available. Kantarjian HM, Bledin AG, Kim EE, Gutierrez CR, Haynie TP. Uptake of 99mTc-methylene disphosphonate in calcinosis cutis. J Am Acad Dermatol. 1982 Dec;7(6):804-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44065 |
| Study title: Kao PF, Tzen KY, Chang LY, You DL, Yang JY. 99Tcm-MDP scintigraphy in high-voltage electrical burn patients. Nucl Med Commun. 1997 Sep;18(9):846-52. Erratum in: Nucl Med Commun 1998 Jan;19(1):90. Kao PF, Tzen KY, Chang LY, You DL, Yang JY. 99Tcm-MDP scintigraphy in high-voltage electrical burn patients. Nucl Med Commun. 1997 Sep;18(9):846-52. Erratum in: Nucl Med Commun 1998 Jan;19(1):90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43541 |
| Study title: Safety and Immunogenicity of Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis (TdcP) Vaccine Compared to Tetanus and Diphtheria Toxoids Adsorbed (Td) in Adolescents and Adults 11-64 Years of Age |
| Active substance: purif tetan toxoid,purif dipht toxoid,purif pert toxoid,purif filamentous haemaggl,purif fimbriae (agglutinogens 2 & 3),purif pertactin (69kda membrane protein)-inact polio vacc |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41432 |
| Study title: Safety of four acellular pertussis combination vaccines (Infantrix-IPV, Boostrix, Covaxis and repevax) given a booster dose to six-year-old Finnish children |
| Active substance: purif tetan toxoid,purif dipht toxoid,purif pert toxoid,purif filamentous haemaggl,purif fimbriae (agglutinogens 2 & 3),purif pertactin (69kda membrane protein)-inact polio vacc |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41433 |
| Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21216 |
| Study title: Effectiveness of a Vi capsular polysaccharide vaccine |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41448 |
| Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41447 |
| Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers |
| Active substance: Purified Vi capsular polysaccharide of Salmonella typhi (Ty2 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21215 |
| Study title: ANTHELMINTIC EFFICACY OF PYRANTEL PAMOATE VS. MEBENDAZOLE IN PATIENTS WITH ASCARIASIS. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): PRT-II-84-001-002-003 EMA Paediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 46148 |
| Study title: EFFICACY AND SAFETY OF OXANTEL-PYRANTEL PAMOATE TAB. AGAINST MULTIPLE INTESTINAL HELNINTHIC/NEMATODE INFECTIONS WITH TRICHURIS TRICHURIA. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46146 |
| Study title: EFFICACY AND SAFETY OF OXANTEL/PYRANTEL PAMOATE TABLET AGAINST MULTIPLE INTESTINAL HELMINTHIC/NEMATODE INFECTIONS WITH TRICHURIS TRICHURIA. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46145 |
| Study title: Fibrodysplasia ossificans progressiva: case report. Nucci A, Queiroz LD, Santos AD, Camargo EE, Moura-Ribeiro MV. Arq Neuropsiquiatr. 2000 Jun;58(2A):342-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43482 |
| Study title: Bone stress lesions in ballet dancers: scintigraphic assessment. Nussbaum AR, Treves ST, Micheli L. AJR Am J Roentgenol. 1988 Apr;150(4):851-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43821 |
| Study title: Nuti R, Vattimo A, Turchetti V, Righi G. 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man. J Endocrinol Invest. 1984 Oct;7(5):445-8. Nuti R, Vattimo A, Turchetti V, Righi G. 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man. J Endocrinol Invest. 1984 Oct;7(5):445-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43980 |
| Study title: O'Duffy EK, Clunie GP, Gacinovic S, Edwards JC, Bomanji JB, Ell PJ. Foot pain: specific indications for scintigraphy. Br J Rheumatol. 1998 Apr;37(4):442-7. O'Duffy EK, Clunie GP, Gacinovic S, Edwards JC, Bomanji JB, Ell PJ. Foot pain: specific indications for scintigraphy. Br J Rheumatol. 1998 Apr;37(4):442-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43533 |
| Study title: Herndon WA, Alexieva BT, Schwindt ML, Scott KN, Shaffer WO. Nuclear imaging for musculoskeletal infections in children. J Pediatr Orthop. 1985 May-Jun;5(3):343-7. Herndon WA, Alexieva BT, Schwindt ML, Scott KN, Shaffer WO. Nuclear imaging for musculoskeletal infections in children. J Pediatr Orthop. 1985 May-Jun;5(3):343-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43946 |
| Study title: Herrera M, Silverman ED, Cole RL. Hepatic abscess detected on a three-phase bone scan. Clin Nucl Med. 2002 Apr;27(4):307-8. No abstract available. Herrera M, Silverman ED, Cole RL. Hepatic abscess detected on a three-phase bone scan. Clin Nucl Med. 2002 Apr;27(4):307-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43449 |
| Study title: Hersek N, Canay S, Caner B, Ulutuncel N. Bone SPECT imaging of patients with internal derangement of temporomandibular joint before and after splint therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Nov;94(5):576-80. Hersek N, Canay S, Caner B, Ulutuncel N. Bone SPECT imaging of patients with internal derangement of temporomandibular joint before and after splint therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Nov;94(5):576-80. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43431 |
| Study title: Hervás Benito I, González Cabezas P, Saura Quiles A, Pérez Velasco R, Bello Arques P, Mateo Navarro A. [Visualization of pulmonary metastasis of osteosarcoma with 99mTc-HMDP] Rev Esp Med Nucl. 2001 Dec;20(7):558-9. Spanish. No abstract available. Hervás Benito I, González Cabezas P, Saura Quiles A, Pérez Velasco R, Bello Arques P, Mateo Navarro A. [Visualization of pulmonary metastasis of osteosarcoma with 99mTc-HMDP] Rev Esp Med Nucl. 2001 Dec;20(7):558-9. Spanish. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43450 |
| Study title: Cherubism: diagnostic imaging and review of the literature in Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 May;81(5):623-8. Review. Hitomi G, Nishide N, Mitsui K. Cherubism: diagnostic imaging and review of the literature in Japan. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 May;81(5):623-8. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43567 |
| Study title: Hod N, Horne T. "Cold" and "hot" osteomyelitis on bone scintigraphy. Clin Nucl Med. 2003 Nov;28(11):927-8. Hod N, Horne T. "Cold" and "hot" osteomyelitis on bone scintigraphy. Clin Nucl Med. 2003 Nov;28(11):927-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43412 |
| Study title: EFFICACY AND TOLERABILITY STUDY IN CHILDREN OVER A 15 DAY PERIOD |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFOR C6 II (DFORC6Y) Art45 listing 2011.xls |
| View full study record |
| Document reference: 47841 |
| Study title: EFFICACY OF FORMOTEROL (BD 40A) WITH SINGLE DOSE FOR BRONCHIAL ASTHMA IN CHILDREN: CLINICAL RESULTS IN 8 INSTITUTIONS |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG 3-3 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47842 |
| Study title: Eformoterol versus salmeterol: reduction in short acting bronchodilator usage in asthmatic children treated with inhaled steroids: FACT. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): BU-037-0004 Study Synopsis.pdf |
| View full study record |
| Document reference: 47843 |
| Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45268 |
| Study title: INFLUENCE ON BRONCHIAL HYPERRESPONSIVENESS USING A LONG ACTING (FORMOTEROL) AND A SHORT ACTING (SALBUTAMOL) BETA-2 SYMPATHOMIMETIC IN CHILDREN WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORD2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47845 |
| Study title: Investigation on the safety and efficacy of miflonide together with foradil in patients with moderate to severe asthma bronchiale which is not adequately controlled by other inhalative combinations of long-acting beta 2-agonists and corticosteroids. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45269 |
| Study title: Investigation on the safety and efficacy of miflonide together with foradil in patients with moderate to severe asthma bronchiale which is not adequately controlled by other inhalative combinations of long-acting beta 2-agonists and corticosteroids. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258DDE03 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47846 |
| Study title: MULTI-CENTRE, DOUBLE-BLIND, BETWEEN-PATIENT COMPARISON OF MULTIPLE DOSES OF 12 UG FORMOTEROL METERED DOSE AEROSOL VERSUS MULTIPLE DOSES OF 200 MYG SALBUTAMOL METERED-DOSE AEROSOL IN CHILDREN WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45270 |
| Study title: MULTI-CENTRE, DOUBLE-BLIND, BETWEEN-PATIENT COMPARISON OF MULTIPLE DOSES OF 12 UG FORMOTEROL METERED DOSE AEROSOL VERSUS MULTIPLE DOSES OF 200 MYG SALBUTAMOL METERED-DOSE AEROSOL IN CHILDREN WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 BA-RP1 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47847 |
| Study title: MULTI-CENTRE, DOUBLE-BLIND, THREE-MONTH, BETWEEN-PATIENT COMPARISON OF 6 UG B.I.D. AND 12 UG B.I.D. DAILY FORMOTEROL AEROSOL VERSUS 200 UG T.I.D. DAILY SALBUTAMOL AEROSOL IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES (E.G. BRONCHIAL ASTHMA) |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45271 |
| Study title: MULTI-CENTRE, DOUBLE-BLIND, THREE-MONTH, BETWEEN-PATIENT COMPARISON OF 6 UG B.I.D. AND 12 UG B.I.D. DAILY FORMOTEROL AEROSOL VERSUS 200 UG T.I.D. DAILY SALBUTAMOL AEROSOL IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES (E.G. BRONCHIAL ASTHMA) |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 SP PD2 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47848 |
| Study title: Report on an Open Cross-Over Comparison of Flurbiprofen and Naproxen in Juvenile Spondylitis, Definite and Probable |
| Active substance: FLURBIPROFEN |
| Study summary document link (including results): Flurbiprofen-M84-121.pdf |
| View full study record |
| Document reference: 47461 |
| Study title: Serum Concentrations of Flurbiprofen in Children After a Single Oral Dose of 22.5 mg or 27 mg of the Drug, following a Multidose Regime |
| Active substance: FLURBIPROFEN |
| Study summary document link (including results): flurbiprofen-dm7620.pdf |
| View full study record |
| Document reference: 48075 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28346 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28347 |
| Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44220 |
| Study title: Levine E, De Smet AA, Neff JR, Martin NL. Scintigraphic evaluation of giant cell tumor of bone. AJR Am J Roentgenol. 1984 Aug;143(2):343-8. Levine E, De Smet AA, Neff JR, Martin NL. Scintigraphic evaluation of giant cell tumor of bone. AJR Am J Roentgenol. 1984 Aug;143(2):343-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43991 |
| Study title: Levinsohn EM, Sternick A, Echeverria TS, Yuan HA. Acute hematogenous osteomyelitis of the rib. Skeletal Radiol. 1982;8(4):291-3. Levinsohn EM, Sternick A, Echeverria TS, Yuan HA. Acute hematogenous osteomyelitis of the rib. Skeletal Radiol. 1982;8(4):291-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44097 |
| Study title: Acute osteomyelitis in children: combined Tc-99m and Ga-67 imaging. Lewin JS, Rosenfield NS, Hoffer PB, Downing D. Radiology. 1986 Mar;158(3):795-804. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43915 |
| Study title: A "harness" distribution pattern on pediatric Ga-67 scintigraphy. Lewis GW, Mansberg R, Howman-Giles R. Clin Nucl Med. 1999 Jul;24(7):527-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43505 |
| Study title: [The application radionuclide bone imaging in the treatment of hallux valgus] Li W, Peng JJ, Zhou YX. Zhonghua Wai Ke Za Zhi. 1994 Dec;32(12):757-9. Chinese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43607 |
| Study title: Lim ST, Sohn MH, Park SA. Tc-99m MDP three-phase bone scintigraphy in disciplinary exercise-induced rhabdomyolysis. Clin Nucl Med. 2000 Jul;25(7):558-9. No abstract available. Lim ST, Sohn MH, Park SA. Tc-99m MDP three-phase bone scintigraphy in disciplinary exercise-induced rhabdomyolysis. Clin Nucl Med. 2000 Jul;25(7):558-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43480 |
| Study title: Lin D, Alavi A, Dalinka M. Bone scan evaluation of patellar activity. Int J Nucl Med Biol. 1981;8(1):105-9. No abstract available. Lin D, Alavi A, Dalinka M. Bone scan evaluation of patellar activity. Int J Nucl Med Biol. 1981;8(1):105-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44135 |
| Study title: Lin D, Alavi A, Dalinka M. Scintigraphic evaluation of the hyoid bone and the thyroid--cricoid cartilage. Int J Nucl Med Biol. 1981;8(1):96-104. No abstract available. Lin D, Alavi A, Dalinka M. Scintigraphic evaluation of the hyoid bone and the thyroid--cricoid cartilage. Int J Nucl Med Biol. 1981;8(1):96-104. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44133 |
| Study title: Open comparative trial to evaluate the effectiveness of gonorrhae in males.Fluker |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_9.xlsx |
| View full study record |
| Document reference: 48999 |
| Study title: Open multicentre trial to evaluate the efficacy of amoxicllin in GP.Leigh et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_10.xlsx |
| View full study record |
| Document reference: 48996 |
| Study title: Open parallell group to evalutate the efficacy for 2 different dose regimens for untreated maxillar sinuitis.Sydow et al. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_13.xlsx |
| View full study record |
| Document reference: 48998 |
| Study title: TO ASSESS THE COMPARATIVE ANTHELMINTIC EFFICACY OF PYRANTEL PAMOATE AND MEBENDAZOLE IN ENTEROBIASIS AND ASCARIASIS. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): PRT-II-84-001-002-003 EMA Paediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 46149 |
| Study title: TO ASSESS THE EFFECT OF QUARTERLY TREATMENTS OVER A PERIOD OF ONE YEAR ON THE PREVALENCE OF ASCARIASIS, ANCYLOSTOMIASIS AND ENTEROBIASIS IN A RESIDENTIAL INSTITUTE FOR CHILDREN. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46151 |
| Study title: TO ESTIMATE THE PERCENTAGE OF AT-RISK FAMILIES IN A HIGH-PREVALENCE AREA HAVING TWO OR MORE MEMBERS WITH ROUND-WORM HOOKWORM INFECTION. "AT-RISK" FAMILIES HAS ONE MEMBER INFECTED. "AFFECTED" FAMILIES HAS 2 OR MORE INFECTED MEMBERS. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): PRT-II-85-002 EMEA Pediatric Web Synopsis.pdf |
| View full study record |
| Document reference: 46150 |
| Study title: R.Ammer, Penka Demirova Drumeva, A.Völp: Nicht toxische Alternative zur Behandlung von Kopfläusen, päd (9) 2003 |
| Active substance: Pyrethrum extract, Pyrethrins content 25% (m/m) (HERB) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40147 |
| Study title: Afifi AK, Bell WE: Tests for juvenile myastenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 8, 403 – 411 (1993) Afifi AK, Bell WE: Tests for juvenile myastenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 8, 403 – 411 (1993) |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35224 |
| Study title: Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11.Afifi AK, Bell WE. Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome. J Child Neurol 1993;8:403-11. |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35228 |
| Study title: Alhalel A et al. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine. Aviat Space Environ Med. 1995 Nov;66(11):1037-40Alhalel A et al. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine. Aviat Space Environ Med. 1995 Nov;66(11):1037-40 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35198 |
| Study title: Tam YH, Yeung CK, Lee KH. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Aliment Pharmacol Ther. 2006 Jul 1;24(1):81-6.Tam YH, Yeung CK, Lee KH. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Aliment Pharmacol Ther. 2006 Jul 1;24(1):81-6. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35277 |
| Study title: Wells TG, Heulitt MJ, Taylor BJ, Fasules JW, Kearns GL. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol. 1998 May;38(5):402-7.Wells TG, Heulitt MJ, Taylor BJ, Fasules JW, Kearns GL. Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation. J Clin Pharmacol. 1998 May;38(5):402-7. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35280 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Ranunculus-Homaccord (drops) [AWB-AT] |
| Active substance: Ranunculus-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40150 |
| Study title: A Multicenter Safety Study of SR29142 in Cancer Patients (LTS3025). |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47279 |
| Study title: A Phase II, Open-Label, Multicenter Study of SR29142 as a Uricolytic Therapy for the Prophylaxis and Treatment of Hyperuricemia in Patients With Leukemias or Lymphomas (ACT2511) |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47275 |
| Study title: A Phase II, Open-Label, Multicenter Study of SR29142 as a Uricolytic Therapy for the Prophylaxis and Treatment of Hyperuricemia in Patients with Leukemias or Lymphomas (ACT2694) |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47276 |
| Study title: An open-label, randomized, multicenter comparison of SR29142 versus allopurinol for the prophylaxis and treatment of hyperuricemia in pediatric patients with leukemia or lymphoma (EFC2975) |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47277 |
| Study title: Hod N, Horne T. Interesting presentation of renal and adjacent rib infection on bone scintigraphy: the additive value of tissue phase images. Clin Nucl Med. 2004 Nov;29(11):720-2. No abstract available. Hod N, Horne T. Interesting presentation of renal and adjacent rib infection on bone scintigraphy: the additive value of tissue phase images. Clin Nucl Med. 2004 Nov;29(11):720-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43395 |
| Study title: Hodder SC, Rees JI, Oliver TB, Facey PE, Sugar AW. SPECT bone scintigraphy in the diagnosis and management of mandibular condylar hyperplasia. Br J Oral Maxillofac Surg. 2000 Apr;38(2):87-93. Hodder SC, Rees JI, Oliver TB, Facey PE, Sugar AW. SPECT bone scintigraphy in the diagnosis and management of mandibular condylar hyperplasia. Br J Oral Maxillofac Surg. 2000 Apr;38(2):87-93. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43481 |
| Study title: Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Diagn Imaging. 1981;50(5):277-84. Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Diagn Imaging. 1981;50(5):277-84. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44132 |
| Study title: [Scintigraphic aspect of infantile cortical hyperostosis (Caffey's disease)] French. Taillefer R, Danais S, Marton D. J Can Assoc Radiol. 1983 Mar;34(1):12-5. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44046 |
| Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43847 |
| Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44180 |
| Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44227 |
| Study title: Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. Takahashi T, Kakuhara N, Katsuragawa S, Kojima Y, Hirose A, Nakasato T, Yoshioka K, Kato K, Yanagisawa T. [Quantitative study of diffuse increased 99mTc-methylene diphosphonate accumulation of both kidneys] Radioisotopes. 1987 Oct;36(10):519-22. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44274 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28348 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28349 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28350 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28351 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28352 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28353 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28354 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28355 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28356 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28357 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28358 |
| Study title: |
| Active substance: FLURIBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28359 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28360 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28361 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPO40003.pdf |
| View full study record |
| Document reference: 28362 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-DENB4016-ICHE3.pdf |
| View full study record |
| Document reference: 28369 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FAD101-Fluticasone Propionate-Flixotide Diskus.xls |
| View full study record |
| Document reference: 28370 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FAD102-Fluticasone Propionate-Flixotide Diskus.xls |
| View full study record |
| Document reference: 28371 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAS30006-ICHE3.pdf |
| View full study record |
| Document reference: 28372 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAS40019-ICHE3.pdf |
| View full study record |
| Document reference: 28373 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study Fluticasone_Propionate-PED-FLTA2008.xlsx |
| View full study record |
| Document reference: 28377 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28378 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28381 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FMS40016-Fluticasone.xls |
| View full study record |
| Document reference: 28385 |
| Study title: Due to the lack of good diagnostic techniques it can be difficult to diagnose asthma in young children. The symptoms can be such that anti-inflammatory medication is given as test medication; however there is a lack of clinical data in a large group of wheezy infants using objective endpoints. The aim of this study was to evaluate the effects of fluticasone propionate on lung function and symptom scores in infants with recurrent and persistent wheeze. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS30060-ICHE3.pdf |
| View full study record |
| Document reference: 28398 |
| Study title: Lin DS, Alavi A. Bone scan evaluation of degenerative joint disease of the spine. Int J Nucl Med Biol. 1982;9(1):63-4. No abstract available. Lin DS, Alavi A. Bone scan evaluation of degenerative joint disease of the spine. Int J Nucl Med Biol. 1982;9(1):63-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44104 |
| Study title: Evaluation of arthritis in Reiter's disease by bone scintigraphy and radiography. Lin WY, Wang SJ, Lan JL. Clin Rheumatol. 1995 Jul;14(4):441-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43596 |
| Study title: Lin WY, Wang SJ, Lang JL, Hsu CY, Kao CH, Liao SQ, Yeh HW. Bone scintigraphy in evaluation of heel pain in Reiter's disease: compared with radiography and clinical examination. Scand J Rheumatol. 1995;24(1):18-21. Lin WY, Wang SJ, Lang JL, Hsu CY, Kao CH, Liao SQ, Yeh HW. Bone scintigraphy in evaluation of heel pain in Reiter's disease: compared with radiography and clinical examination. Scand J Rheumatol. 1995;24(1):18-21. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43605 |
| Study title: Papanicolaou N. Osteoid osteoma: operative confirmation of complete removal by bone scintigraphy. Radiology. 1985 Mar;154(3):821-2. Papanicolaou N. Osteoid osteoma: operative confirmation of complete removal by bone scintigraphy. Radiology. 1985 Mar;154(3):821-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43957 |
| Study title: Paramsothy M, Peng LH, Samuel D. Diagnostic value of radionuclide technetium 99m-MDP skeletal survey in acute leukaemia. Australas Radiol. 1983 Nov;27(3):295-6. No abstract available. Paramsothy M, Peng LH, Samuel D. Diagnostic value of radionuclide technetium 99m-MDP skeletal survey in acute leukaemia. Australas Radiol. 1983 Nov;27(3):295-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44023 |
| Study title: Reflex sympathetic dystrophy associated with deep peroneal nerve entrapment. Parano E, Pavone V, Greco F, Majorana M, Trifiletti RR. Brain Dev. 1998 Mar;20(2):80-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43534 |
| Study title: Park CH, Kapadia D, O'Hara AE. Three phase bone scan findings in stress fracture. Clin Nucl Med. 1981 Dec;6(12):587-8. No abstract available. Park CH, Kapadia D, O'Hara AE. Three phase bone scan findings in stress fracture. Clin Nucl Med. 1981 Dec;6(12):587-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44106 |
| Study title: Park HM, Hunt-Reimann A, Appledorn CR, Siddiqui A. A comet-tail imaging artifact. Due to a "hot" point source and faulty electronics. Clin Nucl Med. 1993 Apr;18(4):341-2. No abstract available. Park HM, Hunt-Reimann A, Appledorn CR, Siddiqui A. A comet-tail imaging artifact. Due to a "hot" point source and faulty electronics. Clin Nucl Med. 1993 Apr;18(4):341-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43669 |
| Study title: Early scintigraphic findings of occult femoral and tibial fractures in infants. Park HM, Kernek CB, Robb JA. Clin Nucl Med. 1988 Apr;13(4):271-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43819 |
| Study title: Scintigraphic evaluation of extremity pain in children: its efficacy and pitfalls. Park HM, Rothschild PA, Kernek CB. AJR Am J Roentgenol. 1985 Nov;145(5):1079-84. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43930 |
| Study title: Open pilot study to evaluate different dosages in various infections.Murdoch |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_8.xlsx |
| View full study record |
| Document reference: 48997 |
| Study title: Open single centertrial to evaluate efficacy and safety of amoxicillin for treatment of UTIParsons et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_11.xlsx |
| View full study record |
| Document reference: 48995 |
| Study title: Role of bone scans in assessment of skeletal age. Spencer RP, Sami S, Karimeddini M, Sziklas JJ, Rosenberg R. Int J Nucl Med Biol. 1981;8(1):33-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44134 |
| Study title: Spencer RP, Sziklas JJ, Rosenberg R, Yoo JH, Weidner FA. Hemivertebral "disappearance" on bone scan. J Nucl Med. 1981 May;22(5):454-6. Spencer RP, Sziklas JJ, Rosenberg R, Yoo JH, Weidner FA. Hemivertebral "disappearance" on bone scan. J Nucl Med. 1981 May;22(5):454-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44125 |
| Study title: Long-term scintigraphic appearance of extremities following bone tumor resection and allograft reconstruction. Smith JT, Smith LM, Rinsky L, Goris ML. Clin Nucl Med. 1991 Dec;16(12):907-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43722 |
| Study title: Effect of growth hormone on metaphyseal uptake of 99mTc-methylene diphosphonate. Klingensmith WC 3rd, Klingensmith GJ, Tollefsen SE, Schalch DS. J Clin Endocrinol Metab. 1981 Jun;52(6):1162-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44123 |
| Study title: Kloos RT, Rufini V, Gross MD, Shapiro B. Bone scans in neurofibromatosis: neurofibroma, plexiform neuroma and neurofibrosarcoma. J Nucl Med. 1996 Nov;37(11):1778-83. Kloos RT, Rufini V, Gross MD, Shapiro B. Bone scans in neurofibromatosis: neurofibroma, plexiform neuroma and neurofibrosarcoma. J Nucl Med. 1996 Nov;37(11):1778-83. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43558 |
| Study title: Knop J, Delling G, Heise U, Winkler K. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis. Chir Organi Mov. 1990;75(1 Suppl):36-7. No abstract available. Knop J, Delling G, Heise U, Winkler K. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis. Chir Organi Mov. 1990;75(1 Suppl):36-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43773 |
| Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43774 |
| Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44176 |
| Study title: Takebayashi S, Ono Y, Matsui K. [The changes in renal uptake of 99mTc-MDP after radiotherapy in the neuroblastoma (author's transl)] Kaku Igaku. 1981 Jul;18(6):859-62. Japanese. No abstract available. Takebayashi S, Ono Y, Matsui K. [The changes in renal uptake of 99mTc-MDP after radiotherapy in the neuroblastoma (author's transl)] Kaku Igaku. 1981 Jul;18(6):859-62. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44120 |
| Study title: Battered child syndrome. Uncommon pelvic fractures detected by bone scintigraphy. Tan TX, Gelfand MJ. Clin Nucl Med. 1997 May;22(5):321-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43552 |
| Study title: Craniofacial fibrous dysplasia showing marked involution postoperatively. Tanaka Y, Tajima S, Maejima S, Umebayashi M. Ann Plast Surg. 1993 Jan;30(1):71-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43678 |
| Study title: Osteoid osteoma of the proximal femur: new techniques in diagnosis and treatment. Kumar SJ, Harcke HT, MacEwen GD, Ger E. J Pediatr Orthop. 1984 Nov;4(6):669-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43978 |
| Study title: [Algodystrophy, a little known disease in children. General review apropos of 4 cases] French. Labenne M, Bertrand AM, Wendling D, Onimus M, Laurain JM, Amsallem D. Ann Pediatr (Paris). 1987 Oct;34(8):603-8. Review. French. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43850 |
| Study title: [Peroperative isotopic detection in the treatment of osteoid osteoma in children] French. Lacheretz M, Herbaux B, Hossein-Foucher C, Lecouffe P, Richir M. Chirurgie. 1989;115(7):413-6. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43798 |
| Study title: Lagard D, Dupont S, Boutry N, Delfaut E, Cotten A. [Cortical septic osteitis: two cases] J Radiol. 2000 Jan;81(1):54-8. French. Lagard D, Dupont S, Boutry N, Delfaut E, Cotten A. [Cortical septic osteitis: two cases] J Radiol. 2000 Jan;81(1):54-8. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43494 |
| Study title: Lamki L, Willis RB. Radionuclide findings of pyomyositis. Clin Nucl Med. 1982 Oct;7(10):465-7. No abstract available. Lamki L, Willis RB. Radionuclide findings of pyomyositis. Clin Nucl Med. 1982 Oct;7(10):465-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44073 |
| Study title: Lammer J, Fueger GF, Fotter R, Nicoletti R. [A computer macro-programme for osteoscintimetry and activity profile in Perthe's disease (author's transl)] Rofo. 1982 Jan;136(1):14-21. German. Lammer J, Fueger GF, Fotter R, Nicoletti R. [A computer macro-programme for osteoscintimetry and activity profile in Perthe's disease (author's transl)] Rofo. 1982 Jan;136(1):14-21. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44103 |
| Study title: To determine the blood and tonsil levels of ampicillin after rectal and oral administration.Baba et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_9.xlsx |
| View full study record |
| Document reference: 49009 |
| Study title: To investigate the absorption and excretion of ampicillin from supporitories given to children.Iwai et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_12.xlsx |
| View full study record |
| Document reference: 49010 |
| Study title: To investigate the absorption and excretion of ampicillin from supporitories given to children.Nakazawa et al. (1983-05-16) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_16.xlsx |
| View full study record |
| Document reference: 49015 |
| Study title: To investigate the absorption of ampicillin from suppositories in children.Motohiro et al. (1983-05-09) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_15.xlsx |
| View full study record |
| Document reference: 49012 |
| Study title: Effect of long-term treatment with fluticasone propionate on bone density, growth and lung function in childhood asthma. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS40175-ICHE3.pdf |
| View full study record |
| Document reference: 28388 |
| Study title: Efficacy of treatment with inhaled fluticasone and the effect of priming and activation of PMN cells in children with allergy and asthma. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS40229-ICHE3.pdf |
| View full study record |
| Document reference: 28405 |
| Study title: FLU9705: a multi-centre, parallel group, randomised, double-blind study to investigate the efficacy of fluticasone propionate 100 mcg MDI bd versus placebo MDI bd both via Babyhaler™ spacer in 1 to 5 year old children with asthma or asthma-like symptoms during a 6 months study period. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS40256-ICHE3.pdf |
| View full study record |
| Document reference: 28395 |
| Study title: Nebulised Fluticasone propionate in an upper respiratory tract inflammatory disorder (rhinopharyngitis): a multicentre, randomised, blinded, parallel group study of the efficacy and safety of nebulised fluticasone propionate 0.5mg daily compared with nebulised beclomethasone dipropionate 0.8mg daily in children suffering from acute rhinopharyngitis. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLIC09-ICHE3.pdf |
| View full study record |
| Document reference: 28422 |
| Study title: Pharmacodynamics of the 88mcg BID dose of the Hydrofluoroalkane propellant formulation of inhaled Fluticasone Propionate following Administration via the Metered-dose Inhaler in Pediatric Subjects 4 to 11 years of age with Asthma |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAP19052-ICHE3.pdf |
| View full study record |
| Document reference: 28390 |
| Study title: Prevention of Otitis media in children." 6) "A randomized, double-blind, placebo-controlled study examining the effect of fluticasone propionate aqueous nasal spray in antibiotic therapy in the treatment of chronic rhinosinusitis in paediatric patients." |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNM40083-ICHE3.pdf |
| View full study record |
| Document reference: 28367 |
| Study title: Report on a multicentre, randomised, double-blind, parallel-group clinical trial to compare the efficacy and safety of the dry powder formulation of fluticasone proprionate (FP) 200μg/day with fluticasone proprionate 400μg/day administered for 6 weeks from a multidose powder device (Diskus™) to paediatric patients with chronic asthma. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLTB3051-ICHE3.pdf |
| View full study record |
| Document reference: 28380 |
| Study title: Systemic exposure of the fluticasone propionate from the hydrofluoroalkane propellant formulation via the metered-dose inhaler with and without a spacer in pediatric subjects 4 to 11 years of age with asthma. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FAP19058-ICHE3.pdf |
| View full study record |
| Document reference: 28418 |
| Study title: Treatment with inhaled corticosteroids in wheezing pre-school children: is there a predictable effect? |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone -Propionate-FMS40257-ICHE3.pdf |
| View full study record |
| Document reference: 28396 |
| Study title: A multi-centre, randomised, open-label, parallel group clinical trial to assess the efficacy and safety of Salmeterol/Fluticasone Propionate combination product (2x 25/125μg/actuation, bd) via a hydrofluoroalkane metereddose inhaler compared with Salmeterol/Fluticasone Propionate Accuhaler™ (50/250μg bd) in adult Chinese patients with mild to moderate asthma. |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30021-ICHE3.pdf |
| View full study record |
| Document reference: 28452 |
| Study title: A 12-week randomized, multicenter, double-blind, placebo controlled, parallel group study in children (aged 5-12, inclusive) with persistent asthma evaluating the safety, efficacy and pharmacokinetics of Foradil (formoterol fumarate) 10 mg bid delivered b |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 0604 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47797 |
| Study title: Paulsen HU, Rabøl A, Sørensen SS. Bone scintigraphy of human temporomandibular joints during Herbst treatment: a case report. Eur J Orthod. 1998 Aug;20(4):369-74. Paulsen HU, Rabøl A, Sørensen SS. Bone scintigraphy of human temporomandibular joints during Herbst treatment: a case report. Eur J Orthod. 1998 Aug;20(4):369-74. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43525 |
| Study title: Paulus G, Hirschfelder U, Feistel H. [Computer-assisted quantitative bone scintigraphy in the treatment planning of condylar hyperplasia] Fortschr Kiefer Gesichtschir. 1987;32:180-1. German. No abstract available. Paulus G, Hirschfelder U, Feistel H. [Computer-assisted quantitative bone scintigraphy in the treatment planning of condylar hyperplasia] Fortschr Kiefer Gesichtschir. 1987;32:180-1. German. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43884 |
| Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44118 |
| Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44238 |
| Study title: Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. Ishii C, Mori Y, Hata Y, Katsuyama N, Fujioka M, Fukazawa W, Hashimoto H, Horiuchi T, Fujioka M, Kawakami K. [Clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Radioisotopes. 1981 Jul;30(7):401-3. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44285 |
| Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44086 |
| Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44187 |
| Study title: Parker BR. Neuroblastoma with extraosseous uptake of bone-seeking radionuclide. AJR Am J Roentgenol. 1981 May;136(5):1032-4. No abstract available. Parker BR. Neuroblastoma with extraosseous uptake of bone-seeking radionuclide. AJR Am J Roentgenol. 1981 May;136(5):1032-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44124 |
| Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44223 |
| Study title: Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol. 1990;19(3):165-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44270 |
| Study title: Minoves M, Bassa P, Clemente A, Rivas A, Riera E, Setoain J, Costansa JM. Incidental finding of varicocele detected on a blood-pool image on Tc-99m HMDP bone scintigraphy. Clin Nucl Med. 2000 Nov;25(11):947-8. No abstract available. Minoves M, Bassa P, Clemente A, Rivas A, Riera E, Setoain J, Costansa JM. Incidental finding of varicocele detected on a blood-pool image on Tc-99m HMDP bone scintigraphy. Clin Nucl Med. 2000 Nov;25(11):947-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43472 |
| Study title: Becker muscular dystrophy associated with focal myositis on bone scintigraphy. Minshew PT, Silverman ED, Samuels-Botts C. Clin Nucl Med. 2000 Dec;25(12):1010-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43470 |
| Study title: Sacroiliitis as a sole manifestation of Brucella melitensis infection in a child. Miron D, Garty I, Tal I, Horovitz Y, Kedar A. Clin Nucl Med. 1987 Jun;12(6):466-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43860 |
| Study title: The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis. Miron SD, Khan MA, Wiesen EJ, Kushner I, Bellon EM. Clin Rheumatol. 1983 Dec;2(4):407-14. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44020 |
| Study title: Osteomyelitis in the neonate. Clinical aspects and the role of radiography and scintigraphy in diagnosis and management. Mok PM, Reilly BJ, Ash JM. Radiology. 1982 Dec;145(3):677-82. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44066 |
| Study title: Mondal A, Bhatnagar A, Sharma R, Behari V, Sawroop K, Khanna CM. Evaluation of the healing process in fractures using early and delayed bone scanning. Australas Radiol. 1994 Nov;38(4):284-7. Mondal A, Bhatnagar A, Sharma R, Behari V, Sawroop K, Khanna CM. Evaluation of the healing process in fractures using early and delayed bone scanning. Australas Radiol. 1994 Nov;38(4):284-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43608 |
| Study title: Investigate the relationship between relapses in H. influenzae meningitis and the ability of ampicillin to penetrate to the CSF.Coleman et al. (The journal of pediatrics May 1969) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
| View full study record |
| Document reference: 49008 |
| Study title: Single-blind trial to evaluate the efficacy and safety of ampicillin suppositories in bacterial pneumonia in children using i.v. ampicillin as reference drug.Motohiro et al. (1983-05-09) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_21.xlsx |
| View full study record |
| Document reference: 49020 |
| Study title: Study plasma concentrations after rectal administration of ampicillin suppositories to children.Movin et al. (1987-06-15) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_23.xlsx |
| View full study record |
| Document reference: 49022 |
| Study title: Lammer J, Nicoletti R, Fueger GF, Fink W. Osteoscintimetry--a method of semiquantitative evaluation of skeletal scintigrams by use of profiles and a macro function for computer processing. Eur J Nucl Med. 1982;7(8):364-9. Lammer J, Nicoletti R, Fueger GF, Fink W. Osteoscintimetry--a method of semiquantitative evaluation of skeletal scintigrams by use of profiles and a macro function for computer processing. Eur J Nucl Med. 1982;7(8):364-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44099 |
| Study title: LaMont RL, Muz J, Heilbronner D, Bouwhuis JA. Quantitative assessment of femoral head involvement in Legg-Calvé-Perthes disease. J Bone Joint Surg Am. 1981 Jun;63(5):746-52. LaMont RL, Muz J, Heilbronner D, Bouwhuis JA. Quantitative assessment of femoral head involvement in Legg-Calvé-Perthes disease. J Bone Joint Surg Am. 1981 Jun;63(5):746-52. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44122 |
| Study title: Transient severe metastatic calcification in acute renal failure. Landau D, Krymko H, Shalev H, Agronovich S. Pediatr Nephrol. 2007 Apr;22(4):607-11. Epub 2006 Dec 21. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43369 |
| Study title: O'Reilly RJ, Cook DJ, Gaffney RD, Angel KR, Paterson DC. Can serial scintigraphic studies detect delayed fracture union in man? Clin Orthop Relat Res. 1981 Oct;(160):227-32. O'Reilly RJ, Cook DJ, Gaffney RD, Angel KR, Paterson DC. Can serial scintigraphic studies detect delayed fracture union in man? Clin Orthop Relat Res. 1981 Oct;(160):227-32. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44110 |
| Study title: Review of spondylolisthesis and spondylolysis in paediatric practice. Oakley RH, Carty H. Br J Radiol. 1984 Oct;57(682):877-85. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43981 |
| Study title: Oates E, Sarno RC. Imaging of pelvic rhabdomyosarcoma by bone scintigraphy. Eur J Nucl Med. 1987;13(6):297-9. Oates E, Sarno RC. Imaging of pelvic rhabdomyosarcoma by bone scintigraphy. Eur J Nucl Med. 1987;13(6):297-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43879 |
| Study title: Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. [Semiquantitative SPECT of anterior dislocation of the temporomandibular joint disk] Rofo. 1987 Jan;146(1):13-7. German. Erratum in: ROFO 1987 Apr;146(4):487. Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. [Semiquantitative SPECT of anterior dislocation of the temporomandibular joint disk] Rofo. 1987 Jan;146(1):13-7. German. Erratum in: ROFO 1987 Apr;146(4):487. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43886 |
| Study title: Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. Semiquantitative SPECT imaging for assessment of bone reactions in internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 1987 Dec;45(12):1022-8. Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. Semiquantitative SPECT imaging for assessment of bone reactions in internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 1987 Dec;45(12):1022-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43840 |
| Study title: Oh SN, Jee WH, Cho SM, Kim SH, Kang HS, Ryu KN, Cho CS. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging. 2004 Jul-Aug;28(4):305-9. Oh SN, Jee WH, Cho SM, Kim SH, Kang HS, Ryu KN, Cho CS. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging. 2004 Jul-Aug;28(4):305-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43400 |
| Study title: A 3-month, placebo-controlled efficacy study of formoterol Turbuhaler 4.5μg and 9μg b.i.d. (corresponding to the metered doses 6μg and 12μg, respectively) in asthmatic children aged 6 to 17 years. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0003 Study Synopsis.pdf |
| View full study record |
| Document reference: 47798 |
| Study title: A 3-week, multicenter study investigating patient use and functionality of the Foradil Certihaler device in patients with asthma. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258F2309 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47799 |
| Study title: A 3-week, open-label, uncontrolled, multicenter study evaluating the functionality of the Foradil Certihaler device in patients with Asthma. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47801 |
| Study title: A 6 months comparison of the safety and efficacy profiles of OXIS (formoterol) Turbuhaler as needed and BRICANYL (terbutaline) Turbuhaler as needed in children with asthma on anti-inflammatory treatment. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0695 Study Synopsis.pdf |
| View full study record |
| Document reference: 47802 |
| Study title: A double-blind, placebo-controlled efficacy study of formoterol Turbuhaler 4.5μg and 9μg (corresponding to the metered doses of 6μg and 12μg, respectively) in asthmatic children. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47803 |
| Study title: A NEW BRONCHODILATOR, IN THE PEDIATRIC PATIENTS WITH NON-ASTHMATIC RESPIRATORY DISORDERS. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG 5-4 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47804 |
| Study title: A RANDOMISED, DOUBLE-BLIND, CROSS-OVER, MULTI-CENTRE STUDY COMPARING THE EFFICACY AND TOLERABILITY OF FORMOTEROL 12 UG INHALED TWICE DAILY WITH SALBUTAMOL 100 UG INHALED FOUR TIMES DAILY IN THE TREATMENT OF ASTHMA IN CHILDREN |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 NBG 8937 Art45 Listing.xls |
| View full study record |
| Document reference: 47805 |
| Study title: A randomized double-blind, cross-over comparison of inhaled formoterol 12 ug and salbutamol 200 ug in children with exercise induced asthma |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 FO-DK1Art45 listing 2011.xls |
| View full study record |
| Document reference: 47807 |
| Study title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTIPLE DOSE (1 WEEK) FINDING, MULTICENTER, CROSSOVER STUDY IN CHILDREN AGED 5 TO 12 WITH PERSISTENT ASTHMA COMPARING 4 DOSES (5, 10, 15 AND 30 UG) OF FORMOTEROL BID ADMINISTERED FROM THE MULTIPLE DOSE DRY |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 0602 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47808 |
| Study title: A randomized, multi-centre, double-blind, double-dummy placebo controlled single-dose cross-over study to demonstrate that 12 and 24 mg of formoterol delivered by concept1 has a bronchodilator efficacy which is equivalent to the same dose of formoterol de |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47811 |
| Study title: A randomized, multicenter, double-blind, double-dummy, placebo controlled, cross-over dose ranging study to evaluate the safety and efficacy of single doses of formoterol fumarate (6,12 and 24 ug) via an hfa pmdi versus placebo and versus formoterol fumar |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47809 |
| Study title: MULTI-CENTRE, OPEN LABEL, NON COMPARATIVE STUDY OF MULTIPLEDOSES OF 12 MYG FORMOTEROL METERED DOSE AEROSOL IN CHILDREN WITH BROCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 BA-RP1F Art45 listing 2011.xls |
| View full study record |
| Document reference: 47849 |
| Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44234 |
| Study title: Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. Ishine M, Kawamura M, Koizumi M, Itoh H, Murase K, Inatsuki S, Iio A, Hamamoto K. [Basic and clinical studies of 99mTc-hydroxymethylene diphosphonate for skeletal imaging agent] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 Apr 25;42(4):389-97. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44281 |
| Study title: Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. Uren RF, Howman-Giles R. The 'cold hip' sign on bone scan. A retrospective review. Clin Nucl Med. 1991 Aug;16(8):553-6. PMID: 1934806 [PubMed - indexed for MEDLINE] 372: Caner BE, Ercan MT, Bekdik CF, Varoğlu E, Müezzinoğlu S, Duman Y, Erbengi GF. Visualization of bone pathologies and lung cancer with 99mTc-glucose phosphate: a comparative study. Nuklearmedizin. 1991 Aug;30(4):132-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44267 |
| Study title: Urman M, Ammann W, Sisler J, Lentle BC, Llyod-Smith R, Loomer R, Fisher C. The role of bone scintigraphy in the evaluation of talar dome fractures. J Nucl Med. 1991 Dec;32(12):2241-4. Urman M, Ammann W, Sisler J, Lentle BC, Llyod-Smith R, Loomer R, Fisher C. The role of bone scintigraphy in the evaluation of talar dome fractures. J Nucl Med. 1991 Dec;32(12):2241-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43720 |
| Study title: [Nonspecific osteomyelitis in childhood and adolescence. The contribution of imaging diagnosis] Italian. Urso S, Pacciani E, Fariello G, Colajacomo M, Fassari FM, Randisi F, Certo A, Liberatore M, Pagnotta G. Radiol Med (Torino). 1995 Sep;90(3):212-8. Italian. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43589 |
| Study title: Usui K, Yamamoto W, Shuke N, Aburano T, Yamanaka Y, Tokusashi Y, Miyokawa N. Scintigraphic findings of tibial adamantinoma on a three-phase bone scan. Clin Nucl Med. 2000 Dec;25(12):1057-8. No abstract available. Usui K, Yamamoto W, Shuke N, Aburano T, Yamanaka Y, Tokusashi Y, Miyokawa N. Scintigraphic findings of tibial adamantinoma on a three-phase bone scan. Clin Nucl Med. 2000 Dec;25(12):1057-8. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43467 |
| Study title: Vade A, Jeske J. Infiltrating lipoma of the chest wall. Pediatr Radiol. 1993;23(6):469-70. No abstract available. Vade A, Jeske J. Infiltrating lipoma of the chest wall. Pediatr Radiol. 1993;23(6):469-70. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43679 |
| Study title: Moore AE, Blake GM, Fogelman I. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration. Nucl Med Commun. 2007 Mar;28(3):187-92. Moore AE, Blake GM, Fogelman I. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration. Nucl Med Commun. 2007 Mar;28(3):187-92. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43366 |
| Study title: Moragas M, Lomeña F, Herranz R, García A, Piera C, Muxí A, Bassa P, Catafau A, Pavía A, Setoain J. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection. Nucl Med Commun. 1991 May;12(5):417-27. Moragas M, Lomeña F, Herranz R, García A, Piera C, Muxí A, Bassa P, Catafau A, Pavía A, Setoain J. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection. Nucl Med Commun. 1991 May;12(5):417-27. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43736 |
| Study title: Morrison SC, Makley JT, O'Donnell J. Skeletal scintigraphic appearance of an auto-transplanted osteoarticular plug: epiphyseal transplant. Pediatr Radiol. 2003 Jul;33(7):482-4. Epub 2003 Apr 26. Morrison SC, Makley JT, O'Donnell J. Skeletal scintigraphic appearance of an auto-transplanted osteoarticular plug: epiphyseal transplant. Pediatr Radiol. 2003 Jul;33(7):482-4. Epub 2003 Apr 26. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43423 |
| Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44237 |
| Study title: Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. Hamada S, Miyamura T, Okimura T, Yamamoto T, Nishiki M, Miyatani H, Kobayashi M, Tonami H, Takarada A, Yamagishi T, Higashi K, Chatani T. [A case of melorheostosis-correlation with sclerotome map and bone scan image (author's transl)] Rinsho Hoshasen. 1981 Aug 26;26(8):897-900. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44284 |
| Study title: Age-related changes in the hemodynamics of the femoral head as evaluated by early phase of bone scintigraphy. Hamaguchi H, Fujioka M, Takahashi KA, Hirata T, Ishida M, Sakao K, Ushijima Y, Kubota T, Nishimura T, Kubo T. Ann Nucl Med. 2006 Jan;20(1):35-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43378 |
| Study title: Ohta H, Hojo M, Shintaku M, Komibuchi T, Okamoto S. Tc-99m HMDP and Ga-67 imaging along with CT and MRI in fibrous dysplasia of the temporal bone. Clin Nucl Med. 1997 May;22(5):328-30. No abstract available. Ohta H, Hojo M, Shintaku M, Komibuchi T, Okamoto S. Tc-99m HMDP and Ga-67 imaging along with CT and MRI in fibrous dysplasia of the temporal bone. Clin Nucl Med. 1997 May;22(5):328-30. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43551 |
| Study title: Okimura T, Higashi K, Nakagawa T, Kobayashi S, Tohda N. [A case of myositis ossificans with abnormal uptake of 99mTc-MDP and 67Ga-citrate] Rinsho Hoshasen. 1985 Jan;30(1):157-9. Japanese. No abstract available. Okimura T, Higashi K, Nakagawa T, Kobayashi S, Tohda N. [A case of myositis ossificans with abnormal uptake of 99mTc-MDP and 67Ga-citrate] Rinsho Hoshasen. 1985 Jan;30(1):157-9. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43968 |
| Study title: Okuyama T, Suzuki H, Nakamoto K, Suzuki S. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors] Kaku Igaku. 1982 Dec;19(10):1519-30. Japanese. No abstract available. Okuyama T, Suzuki H, Nakamoto K, Suzuki S. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors] Kaku Igaku. 1982 Dec;19(10):1519-30. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44063 |
| Study title: Holder LE, Michael RH. The specific scintigraphic pattern of "shin splints in the lower leg": concise communication. J Nucl Med. 1984 Aug;25(8):865-9. Holder LE, Michael RH. The specific scintigraphic pattern of "shin splints in the lower leg": concise communication. J Nucl Med. 1984 Aug;25(8):865-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43988 |
| Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44107 |
| Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44188 |
| Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44235 |
| Study title: Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. Honda H, Oshiumi Y, Kamoi I, Ichiya Y, Wada M, Matsuura K. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)] Kaku Igaku. 1981 Nov;18(9):1315-9. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44282 |
| Study title: ONSET OF ACTION IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORC3 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47851 |
| Study title: OPEN LONG TERM TRIAL ON FORMOTEROL METERED DOSE AEROSOL IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORE6 - D 042 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47852 |
| Study title: Open-label, multi-center, non-controlled follow-up study over 3 months on the safety of Formoterol Easyhaler in approximately 35 asthmatic pediatric patients initially treated in study |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47855 |
| Study title: Open, 12-month, follow-up of a 3-month, comparative, multi-centre, double-blind trial to assess the long-term tolerability and efficacy of formoterol 12 ug dry powder capsules in children with reversible obstructive airways diseases |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DP-PD2F Art45 listing 2011.xls |
| View full study record |
| Document reference: 47853 |
| Study title: Open, multi-center, randomized, two fold crossover safety study comparing Formoterol Easyhaler vs. Foradil Aerolizer over a treatment period comprising two times 3-months in 70 asthmatic pediatric patients. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47854 |
| Study title: PLACEBO-CONTROLLED, COMPARATIVE, SINGLE-CENTER, DOUBLE-BLIND, WITHIN-PATIENT, TRIAL TO COMPARE THE MAGNITUDE AND DURATION OF PROTECTION AGAINST EXERCISE-INDUCED BRONCHOCONSTRICTION OF INHALED FORMOTEROL DRY POWDER CAPSULES 12 UG WITH THAT OF SALBUTAMOL DR |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DPPD3 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47856 |
| Study title: PLACEBO-CONTROLLED, COMPARATIVE, SINGLE-CENTRE, DOUBLE-BLIND, WITHIN-PATIENT TRIAL TO COMPARE THE EXTENT AND DURATION OF PROTECTION AGAINST EXERCISE-INDUCED BRONCHOCONSTRICTION OF 12 UG INHALED FORMOTEROL AEROSOL WITH THAT OF 200 UG INHALED SALBUTAMOL AER |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 SP PD4 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47857 |
| Study title: PLACEBO-CONTROLLED, DOSE-FINDING, SINGLE-CENTRE, DOUBLE-BLIND, WITHIN-PATIENT TRIAL OF DIFFERENT DOSES OF INHALED FORMOTEROL DRY POWDER (6, 12, 24 UG) AND 400 UG INHALED SALBUTAMOL DRY POWDER IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DP-PD6 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47858 |
| Study title: Preliminary 14 day pilot inhalation study of an HFA-propelled Foradil inhalation aerosol in juvenile beagle dogs |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47859 |
| Study title: PREVENTIVE EFFECT AND TOLERABILITY OF FORMOTEROL COMPARED WITH THAT OF SALBUTAMOL IN CHILDREN WITH EXERCISE-INDUCED ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47860 |
| Study title: Protective effect of single doses of formoterol Turbuhaler 4.5μg and 9μg (corresponding to the metered doses 6μg and 12μg, respectively) compared with terbutaline Turbuhelr 0.5mg and placebo in children with exercise-induced bronchoconstriction (EIB). |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0149 Study Synopsis.pdf |
| View full study record |
| Document reference: 47861 |
| Study title: RESULTS OF CLINICAL USE OF BD 40A DRY SYRUP FOR PEDIATRIC BRONQUIAL-ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 YBDG 3-6 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47862 |
| Study title: Single dose toxicity of formoterol fumarate (D2522) in young rats after oral administration. |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47863 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28386 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28387 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28392 |
| Study title: Behrendt H et alMitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemiaCancer. 1995 Jul 15;76(2):339-42.Behrendt H et alMitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemiaCancer. 1995 Jul 15;76(2):339-42. |
| Active substance: MITOXANTRONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32083 |
| Study title: Van Campenhout A, Moens P, Fabry G. Serial bone scintigraphy in Legg-Calvé-Perthes disease: correlation with the Catterall and Herring classification. J Pediatr Orthop B. 2006 Jan;15(1):6-10. Van Campenhout A, Moens P, Fabry G. Serial bone scintigraphy in Legg-Calvé-Perthes disease: correlation with the Catterall and Herring classification. J Pediatr Orthop B. 2006 Jan;15(1):6-10. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43382 |
| Study title: van den Oever M, Merrick MV, Scott JH. Bone scintigraphy in symptomatic spondylolysis. J Bone Joint Surg Br. 1987 May;69(3):453-6. van den Oever M, Merrick MV, Scott JH. Bone scintigraphy in symptomatic spondylolysis. J Bone Joint Surg Br. 1987 May;69(3):453-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43865 |
| Study title: Generalized soft tissue calcification in children and adolescents with end stage renal failure. van Diemen-Steenvoorde R, Donckerwolcke RA, de Haas G. Eur J Pediatr. 1986 Sep;145(4):293-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43893 |
| Study title: Influence of age and gender on quantitative sacroiliac joint scintigraphy. Lin WY, Wang SJ. J Nucl Med. 1998 Jul;39(7):1269-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43531 |
| Study title: Litchman HM, McCullough RW, Gandsman EJ, Schatz SL. Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecans. J Pediatr Orthop. 1988 Mar-Apr;8(2):208-12. Litchman HM, McCullough RW, Gandsman EJ, Schatz SL. Computerized blood flow analysis for decision making in the treatment of osteochondritis dissecans. J Pediatr Orthop. 1988 Mar-Apr;8(2):208-12. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43824 |
| Study title: Liu JX. [Early quantitative detection of vascularity of the reduced femoral head of congenital hip dislocation by scintigraphy] Zhonghua Wai Ke Za Zhi. 1990 May;28(5):292-4, 318. Chinese. Liu JX. [Early quantitative detection of vascularity of the reduced femoral head of congenital hip dislocation by scintigraphy] Zhonghua Wai Ke Za Zhi. 1990 May;28(5):292-4, 318. Chinese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43764 |
| Study title: Hypertrophic pulmonary osteoarthropathy in nasopharyngeal carcinoma: an early sign of pulmonary metastasis. Liu RS, Chen YK, Yen SH, Chu YK, Chu LS, Chen KY, Yeh SH. Nucl Med Commun. 1995 Sep;16(9):785-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43591 |
| Study title: Liu RS, Chou CS, Yeh SH. Three-phase bone scintigraphy in Pellegrini-Stieda disease. Clin Nucl Med. 1987 Jan;12(1):47-9. Liu RS, Chou CS, Yeh SH. Three-phase bone scintigraphy in Pellegrini-Stieda disease. Clin Nucl Med. 1987 Jan;12(1):47-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43877 |
| Study title: Primary septic arthritis in heroin users: early diagnosis by radioisotopic imaging and geographic variations in the causative agents. Lopez-Longo FJ, Ménard HA, Carreño L, Cosin J, Ballesteros R, Monteagudo I. J Rheumatol. 1987 Oct;14(5):991-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43846 |
| Study title: A double blind trial to evaluate the incidence of diarrhea and C. difficile toxin (CDT) folloing therapy with ampicillin (AMP), amoxicillin (AMOX), or trimethoprim-sulfamethoxazole (TMP-SMX) for otitis media.Hyams et al. (Pediatr Infect Dis. 1984 Sep-Oct;3(5):433-6) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_30.xlsx |
| View full study record |
| Document reference: 49029 |
| Study title: Hamscho N, Grünwald F. Prognosis of primary osteosarcoma. J Nucl Med. 2003 Jun;44(6):996-7; author reply 997. No abstract available. Hamscho N, Grünwald F. Prognosis of primary osteosarcoma. J Nucl Med. 2003 Jun;44(6):996-7; author reply 997. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43420 |
| Study title: Han CS, Wood MB, Bishop AT, Cooney WP 3rd. Vascularized bone transfer. J Bone Joint Surg Am. 1992 Dec;74(10):1441-9. Han CS, Wood MB, Bishop AT, Cooney WP 3rd. Vascularized bone transfer. J Bone Joint Surg Am. 1992 Dec;74(10):1441-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43681 |
| Study title: Unexpected stomach uptake of technetium-99m-MDP. Spicer JA, Slaton CK, Raveill TG, Baxter KG, Preston DF, Hladik WB. J Nucl Med Technol. 1999 Mar;27(1):43-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43508 |
| Study title: Spitz J, Becker C, Tittel K, Weigand H. [Clinical relevance of whole body skeletal scintigraphy in multiple injury and polytrauma patients] Unfallchirurgie. 1992 Jun;18(3):133-47. German. Spitz J, Becker C, Tittel K, Weigand H. [Clinical relevance of whole body skeletal scintigraphy in multiple injury and polytrauma patients] Unfallchirurgie. 1992 Jun;18(3):133-47. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43695 |
| Study title: Spitz J, Lauer I, Tittel K, Wiegand H. Scintimetric evaluation of remodeling after bone fractures in man. J Nucl Med. 1993 Sep;34(9):1403-9. Spitz J, Lauer I, Tittel K, Wiegand H. Scintimetric evaluation of remodeling after bone fractures in man. J Nucl Med. 1993 Sep;34(9):1403-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43654 |
| Study title: [The age dependence of traumatically induced bone remodeling as studied in the bone scintigram] German Spitz J, Lauer I, Tittel K. Nuklearmedizin. 1991 Oct;30(5):155-60. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43726 |
| Study title: Springorum HW, Bostel F, Puhl W, Georgi P. [Spinal scintigraphy following Harrington's spondylodesis] Z Orthop Ihre Grenzgeb. 1984 May-Jun;122(3):255-9. German. Springorum HW, Bostel F, Puhl W, Georgi P. [Spinal scintigraphy following Harrington's spondylodesis] Z Orthop Ihre Grenzgeb. 1984 May-Jun;122(3):255-9. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44001 |
| Study title: Occult fracture of the calcaneus--another toddler's fracture. Starshak RJ, Simons GW, Sty JR. Pediatr Radiol. 1984;14(1):37-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44017 |
| Study title: Horii T, Tsuchiya H, Tomita K. Presacral tumor associated with the Currarino triad in an adolescent. Arch Orthop Trauma Surg. 2001;121(1-2):114-6. Horii T, Tsuchiya H, Tomita K. Presacral tumor associated with the Currarino triad in an adolescent. Arch Orthop Trauma Surg. 2001;121(1-2):114-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43465 |
| Study title: Horne T, Mogle P, Finsterbush A, Gordin M. Increased uptake of 99mTc-MDP in calcified synovial sarcoma. Eur J Nucl Med. 1983;8(2):75-6. No abstract available. Horne T, Mogle P, Finsterbush A, Gordin M. Increased uptake of 99mTc-MDP in calcified synovial sarcoma. Eur J Nucl Med. 1983;8(2):75-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44054 |
| Study title: The technetium phosphate bone scan in the diagnosis of osteomyelitis in childhood. Howie DW, Savage JP, Wilson TG, Paterson D. J Bone Joint Surg Am. 1983 Apr;65(4):431-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44041 |
| Study title: Multifocal pyomyositis. Diagnosis on technetium-99m MDP bone scan. Howman-Giles R, McCauley D, Brown J. Clin Nucl Med. 1984 Mar;9(3):149-51. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44004 |
| Study title: Taylor GA, Shea N, O'Brien T, Hall JE, Treves ST. Osteoid osteoma: localization by intraoperative magnification scintigraphy. Pediatr Radiol. 1986;16(4):313-6. PMID: 3725449 [PubMed - indexed for MEDLINE] Taylor GA, Shea N, O'Brien T, Hall JE, Treves ST. Osteoid osteoma: localization by intraoperative magnification scintigraphy. Pediatr Radiol. 1986;16(4):313-6. PMID: 3725449 [PubMed - indexed for MEDLINE] |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43922 |
| Study title: [Osteomyelitis in children: sometimes hard to recognize] Dutch. te Pas AB, Feith SW, Wit JM. Ned Tijdschr Geneeskd. 2002 Aug 17;146(33):1547-50. Dutch. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43438 |
| Study title: Teixeira AB, Sá de Camargo Etchebehere EC, Santos AO, Lima MC, Ramos CD, Camargo EE. Scintigraphic findings of dysplasia epiphysealis hemimelica: a case report. Clin Nucl Med. 2001 Feb;26(2):162. No abstract available. Teixeira AB, Sá de Camargo Etchebehere EC, Santos AO, Lima MC, Ramos CD, Camargo EE. Scintigraphic findings of dysplasia epiphysealis hemimelica: a case report. Clin Nucl Med. 2001 Feb;26(2):162. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43460 |
| Study title: Rectus femoris muscle bone-image uptake in a sprinter. Telepak RJ, Hartshorne MF, Bauman JM, Cawthon MA. Clin Nucl Med. 1986 May;11(5):365. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43911 |
| Study title: Thämmig R, Schulze K, Niederle J. [Display of a primary neuroblastoma in the bone scintigram] Rofo. 1981 Aug;135(2):239-40. German. No abstract available. Thämmig R, Schulze K, Niederle J. [Display of a primary neuroblastoma in the bone scintigram] Rofo. 1981 Aug;135(2):239-40. German. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44116 |
| Study title: To investigate the absorption of ampicillin from suppositories.Kida et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_13.xlsx |
| View full study record |
| Document reference: 49013 |
| Study title: To study changes in fecal bacterial flora, including its sensitivity to ampicillin, after rectal and oral administration of ampicillin. Fecal ampicillin concetrations were also studied.Motohiro et al. (1986-10-17) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_14.xlsx |
| View full study record |
| Document reference: 49014 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone -Propionate-FAS30007-ICHE3.pdf |
| View full study record |
| Document reference: 28393 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28400 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28401 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FLIC22 Fluticasone Propionate Fixotide nebules.xls |
| View full study record |
| Document reference: 28402 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FMDT08-Fluticasone Propionate-Flixotide Diskus.xls |
| View full study record |
| Document reference: 28403 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FPC40002-Fluticasone propionate-Cutivate - approved.xls |
| View full study record |
| Document reference: 28406 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FLNT52-Fluticasone_Flixonase.xls |
| View full study record |
| Document reference: 28410 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FLNT59-Fluticasone_Flixonase.xls |
| View full study record |
| Document reference: 28411 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FLNT60-FNM30026-Fluticasone_Flixonase.xls |
| View full study record |
| Document reference: 28412 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FPC40001-Fluticasone propionate-Cutivate - approved.xls |
| View full study record |
| Document reference: 28427 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28429 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLT411.pdf |
| View full study record |
| Document reference: 28430 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28431 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLT412.pdf |
| View full study record |
| Document reference: 28433 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28439 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28440 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL10005.pdf |
| View full study record |
| Document reference: 47739 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FPL30004.pdf |
| View full study record |
| Document reference: 47740 |
| Study title: Intense gallbladder uptake associated with chemotherapy. An unusual finding in pediatric skeletal scintigraphy. Lowry PA, Carstens C. Clin Nucl Med. 1995 Nov;20(11):976-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43579 |
| Study title: Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density. Lubushitzky R, Front D, Iosilevsky G, Bettman L, Frenkel A, Kolodny GM, Israel O. J Nucl Med. 1998 Jan;39(1):104-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43538 |
| Study title: Lucchi A, Tani G, Mancini AM, Rossi C, Mancuso A, De Florio L. [Morphologic and scintigraphic correlations in the cranial localization of neuroblastoma. Study of 29 cases] Radiol Med (Torino). 1984 Sep;70(9):639-40. Italian. No abstract available. Lucchi A, Tani G, Mancini AM, Rossi C, Mancuso A, De Florio L. [Morphologic and scintigraphic correlations in the cranial localization of neuroblastoma. Study of 29 cases] Radiol Med (Torino). 1984 Sep;70(9):639-40. Italian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43983 |
| Study title: Principles of staging of soft-tissue sarcomas. Peabody TD, Simon MA. Clin Orthop Relat Res. 1993 Apr;(289):19-31. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43670 |
| Study title: Peller PJ, Ho VB, Kransdorf MJ. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach. Radiographics. 1993 Jul;13(4):715-34. Peller PJ, Ho VB, Kransdorf MJ. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach. Radiographics. 1993 Jul;13(4):715-34. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43659 |
| Study title: Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL. J Pediatr Hematol Oncol. 1999 Jan-Feb;21(1):13-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43514 |
| Study title: Pevarski DJ, Drane WE, Scarborough MT. The usefulness of bone scintigraphy with SPECT images for detection of pulmonary metastases from osteosarcoma. AJR Am J Roentgenol. 1998 Feb;170(2):319-22. Pevarski DJ, Drane WE, Scarborough MT. The usefulness of bone scintigraphy with SPECT images for detection of pulmonary metastases from osteosarcoma. AJR Am J Roentgenol. 1998 Feb;170(2):319-22. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43537 |
| Study title: Phillips CD, Williamson BR. Osteosarcoma with pericardial metastases seen on bone scan. Clin Nucl Med. 1987 Nov;12(11):899-900. No abstract available. Phillips CD, Williamson BR. Osteosarcoma with pericardial metastases seen on bone scan. Clin Nucl Med. 1987 Nov;12(11):899-900. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43841 |
| Study title: Comparison of radiographic and radionuclide skeletal surveys in battered children. Pickett WJ, Faleski EJ, Chacko A, Jarrett RV. South Med J. 1983 Feb;76(2):207-12. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44049 |
| Study title: A Double-blind, Placebo-controlled trial: comparison of the clinical and bacteriological effectiveness of ampicillin and a placebo.Nelson et al. (Ann NY Acad Sci 145 1967) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_6.xlsx |
| View full study record |
| Document reference: 49006 |
| Study title: A prospective study of rash incidence in 532 patients treated with Amipicillin intravenously is reported.Scioli et al. (Boll 1st Sieroter Milan 1983;62;287-91) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_1.xlsx |
| View full study record |
| Document reference: 49000 |
| Study title: A Single-blind, randomized trial to Evaluate the efficacy and safety of ampicillin suppositories in the treatment of acute suppurative otitis media by a well controlled method using ampicillin dry syrup as control.Baba et al. (1985-09-27) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_20.xlsx |
| View full study record |
| Document reference: 49019 |
| Study title: Spencer RP, Sziklas JJ, Zubi SM. Disassociation of splenic accumulation of Tc-99m MDP and radiocolloid. Clin Nucl Med. 1991 Oct;16(10):747-9. Spencer RP, Sziklas JJ, Zubi SM. Disassociation of splenic accumulation of Tc-99m MDP and radiocolloid. Clin Nucl Med. 1991 Oct;16(10):747-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43728 |
| Study title: Stauss J, Connolly LP, Perez-Rossello J, Treves ST. Pediatric acute pyelonephritis: diagnosis facilitated by skeletal scintigraphy. Clin Nucl Med. 2003 Oct;28(10):855-7. No abstract available. Stauss J, Connolly LP, Perez-Rossello J, Treves ST. Pediatric acute pyelonephritis: diagnosis facilitated by skeletal scintigraphy. Clin Nucl Med. 2003 Oct;28(10):855-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43413 |
| Study title: A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma. Stokkel MP, Linthorst MF, Borm JJ, Taminiau AH, Pauwels EK. J Cancer Res Clin Oncol. 2002 Jul;128(7):393-9. Epub 2002 Jun 13. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43446 |
| Study title: Strömqvist B, Brismar J, Hansson LI, Palmer J. Technetium-99m-methylenediphosphonate scintimetry after femoral neck fracture. A three-year follow-up study. Clin Orthop Relat Res. 1984 Jan-Feb;(182):177-89. Strömqvist B, Brismar J, Hansson LI, Palmer J. Technetium-99m-methylenediphosphonate scintimetry after femoral neck fracture. A three-year follow-up study. Clin Orthop Relat Res. 1984 Jan-Feb;(182):177-89. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44018 |
| Study title: Kobayashi H, Tanaka K, Sakuma S. [99mTc-MDP abnormal uptake in the femur shaft in hemi-lateral hip joint disorders] Kaku Igaku. 1990 Aug;27(8):833-40. Japanese. Kobayashi H, Tanaka K, Sakuma S. [99mTc-MDP abnormal uptake in the femur shaft in hemi-lateral hip joint disorders] Kaku Igaku. 1990 Aug;27(8):833-40. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43756 |
| Study title: Kobayashi Y, Ozaki T, Takeda Y, Kawai A, Inoue H. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases. Acta Orthop Scand. 1998 Dec;69(6):611-6. Kobayashi Y, Ozaki T, Takeda Y, Kawai A, Inoue H. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases. Acta Orthop Scand. 1998 Dec;69(6):611-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43519 |
| Study title: Köhnlein S, Brinkmann G, Körner T, Kreusch T, Bohuslavizki KH, Heller M. [Magnetic resonance tomography in the diagnosis of mandibular osteomyelitis] Rofo. 1997 Jul;167(1):52-7. German. Köhnlein S, Brinkmann G, Körner T, Kreusch T, Bohuslavizki KH, Heller M. [Magnetic resonance tomography in the diagnosis of mandibular osteomyelitis] Rofo. 1997 Jul;167(1):52-7. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43547 |
| Study title: Koo KH, Kim R, Cho SH, Song HR, Lee G, Ko GH. Angiography, scintigraphy, intraosseous pressure, and histologic findings in high-risk osteonecrotic femoral heads with negative magnetic resonance images. Clin Orthop Relat Res. 1994 Nov;(308):127-38. Koo KH, Kim R, Cho SH, Song HR, Lee G, Ko GH. Angiography, scintigraphy, intraosseous pressure, and histologic findings in high-risk osteonecrotic femoral heads with negative magnetic resonance images. Clin Orthop Relat Res. 1994 Nov;(308):127-38. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43609 |
| Study title: Koppers B, Riel K. [3-phase scintigraphy in epicondylitis humeri radialis] Rofo. 1982 Aug;137(2):147-51. German. No abstract available. Koppers B, Riel K. [3-phase scintigraphy in epicondylitis humeri radialis] Rofo. 1982 Aug;137(2):147-51. German. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44077 |
| Study title: The diagnostic importance of a quantitative evaluation of gamma scintigraphy in Perthes' disease in children.Dmitrienkov BN, Fed in AV, Zhvaniia TG, Subbotina EN. Med Radiol1989 Jul;34(7):19-23. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48477 |
| Study title: [The early diagnosis of Perthes disease: the value of bone scintigraphy and magnetic resonance imaging in comparison with x-ray findings] German. Theissen P, Rütt J, Linden A, Smolarz K, Voth E, Schicha H. Nuklearmedizin. 1991 Dec;30(6):265-71. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43717 |
| Study title: Thomas BP, Spottswood SE, Wushensky CA. The hot spur sign of diastematomyelia. Clin Nucl Med. 2007 Apr;32(4):292-4. No abstract available. Thomas BP, Spottswood SE, Wushensky CA. The hot spur sign of diastematomyelia. Clin Nucl Med. 2007 Apr;32(4):292-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43364 |
| Study title: Tiel-van Buul MM, van Beek EJ, Broekhuizen AH, Bakker AJ, Bos KE, van Royen EA. Radiography and scintigraphy of suspected scaphoid fracture. A long-term study in 160 patients. J Bone Joint Surg Br. 1993 Jan;75(1):61-5. Tiel-van Buul MM, van Beek EJ, Broekhuizen AH, Bakker AJ, Bos KE, van Royen EA. Radiography and scintigraphy of suspected scaphoid fracture. A long-term study in 160 patients. J Bone Joint Surg Br. 1993 Jan;75(1):61-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43677 |
| Study title: Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease. Landgren O, Axdorph U, Jacobsson H, Johansson B, Grimfors G, Björkholm M. Med Oncol. 2000 Aug;17(3):174-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43478 |
| Study title: Lange RH, Lange TA, Rao BK. Correlative radiographic, scintigraphic, and histological evaluation of exostoses. J Bone Joint Surg Am. 1984 Dec;66(9):1454-9. Lange RH, Lange TA, Rao BK. Correlative radiographic, scintigraphic, and histological evaluation of exostoses. J Bone Joint Surg Am. 1984 Dec;66(9):1454-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43975 |
| Study title: Lange W, Wicke A, Stern W, Staudte H. [Osteoid osteoma of the spine. The current differential diagnostic aspects] Rofo. 1991 Apr;154(4):450-2. German. No abstract available. Lange W, Wicke A, Stern W, Staudte H. [Osteoid osteoma of the spine. The current differential diagnostic aspects] Rofo. 1991 Apr;154(4):450-2. German. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43743 |
| Study title: Extremity osteosarcoma in childhood: prognostic value of radiologic imaging. Lawrence JA, Babyn PS, Chan HS, Thorner PS, Pron GE, Krajbich IJ. Radiology. 1993 Oct;189(1):43-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43647 |
| Study title: The painful accessory navicular. Lawson JP, Ogden JA, Sella E, Barwick KW. Skeletal Radiol. 1984;12(4):250-62. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44012 |
| Study title: Technetium 99m-methylene diphosphonate bone scans in children with reflex neurovascular dystrophy. Laxer RM, Allen RC, Malleson PN, Morrison RT, Petty RE. J Pediatr. 1985 Mar;106(3):437-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43956 |
| Study title: To study the absorption and excretion of the 250 mg ampicillin supporitory in children.Nishimura et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_18.xlsx |
| View full study record |
| Document reference: 49017 |
| Study title: To study the pharmacokinetics of ampicillin suppositories in children.Toyonaga et al. (1983-05-06) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_17.xlsx |
| View full study record |
| Document reference: 49016 |
| Study title: A multicentre, randomised, double-blind, double-dummy, parallel group comparison of three treatments : 1) salmeterol/fluticasone propionate (SFC) (50/100mcg strength) bd via DISKUS/ACCUHALER inhaler, 2) fluticasone propionate 200mcg bd via DISKUS/ACCUHALER inhaler, 3) fluticasone propionate 100mcg bd via DISKUS/ACCUHALER inhaler in children aged 4-11 years with asthma |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40012-ICHE3.pdf |
| View full study record |
| Document reference: 28443 |
| Study title: A pilot single centre, randomised, double-blind, crossover study to demonstrate the superiority of Salmeterol/fluticasone propionate combination product 50/100mcg bd versus fluticasone propionate 100mcg bd when treated for two weeks with respect to activity levels in children aged 7-15 years. |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40101-ICHE3.pdf |
| View full study record |
| Document reference: 28448 |
| Study title: A Randomized, Double-Blind, 12-Week Trial Evaluating the Safety of the Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Symptomatic Pediatric Subjects (4-11 Years) With Asthma |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30031-ICHE3.pdf |
| View full study record |
| Document reference: 28453 |
| Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SFA100314-ICHE3.pdf |
| View full study record |
| Document reference: 28454 |
| Study title: A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and in Adolescent Subjects with Activity-Induced Bronchospasm |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SFA100316-ICHE3.pdf |
| View full study record |
| Document reference: 47594 |
| Study title: An observational study to assess the health related quality of life impact of treating poorly controlled asthmatic children with Seretide(tm) 50/100mcg |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM3802-ICHE3.pdf |
| View full study record |
| Document reference: 28442 |
| Study title: Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate (FP) combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine plus symptoms or based on symptoms only (Children Asthma Therapy Optimal”) |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAS30018-ICHE3.pdf |
| View full study record |
| Document reference: 28451 |
| Study title: Prospective, parallel-group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticasone propionate 50/250 mcg (Seretide) twice a day. ADERE PROJECT (Pediatric) |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-ADERE-PEDIATRIC-1-ICHE3.pdf |
| View full study record |
| Document reference: 28444 |
| Study title: Randomised, double-blind, comparator study to demonstrate the superiority of salmeterol/fluticasone propionate combination DISKUS™ 50/100mcg bd over fluticasone propionate DISKUS™/ACCUHALER™ 200mcg bd with respect to airway physiology in asthmatic children treated for 6 weeks. |
| Active substance: FLUTICASONE AND SALMETEROL |
| Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40100-ICHE3.pdf |
| View full study record |
| Document reference: 28447 |
| Study title: Ashraf MS et al Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child Med Pediatr Oncol. 1997 Jan;28(1):62-4Ashraf MS et al Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child Med Pediatr Oncol. 1997 Jan;28(1):62-4 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24737 |
| Study title: Pickuth D, McCready VR. Focal areas of increased renal tracer uptake on bone scans can mimic metastases in the lower ribs. Br J Radiol. 1996 May;69(821):407-9. Pickuth D, McCready VR. Focal areas of increased renal tracer uptake on bone scans can mimic metastases in the lower ribs. Br J Radiol. 1996 May;69(821):407-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43568 |
| Study title: Reduced perfusion and uptake of Tc-99m HDP in the iliac bone. A rare presentation of pelvic osteomyelitis. Pijpers R, Ekkelkamp S, Roos JC, Teule GJ. Clin Nucl Med. 1994 Jun;19(6):516-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43623 |
| Study title: The role of radioisotopic methods in imaging of intervertebral disc inflammation in children. Pilecki S, Gierach M, Drobik P, Kurylak A, Trzcinska I, Hagner W, et al. Nucl Med Rev Cent East Eur. 2006;9(1):72-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43375 |
| Study title: Quantitative sacro-iliac scintigraphy. I. Methodological aspects. Pitkänen M, Lahtinen T, Hyödynmaa S, Mutru O, Länsimies E. Scand J Rheumatol. 1982;11(4):199-202. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44096 |
| Study title: Israel O, Gips S, Jerushalmi J, Frenkel A, Front D. Osteomyelitis and soft-tissue infection: differential diagnosis with 24 hour/4 hour ratio of Tc-99m MDP uptake. Radiology. 1987 Jun;163(3):725-6. Israel O, Gips S, Jerushalmi J, Frenkel A, Front D. Osteomyelitis and soft-tissue infection: differential diagnosis with 24 hour/4 hour ratio of Tc-99m MDP uptake. Radiology. 1987 Jun;163(3):725-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43861 |
| Study title: Bone SPET of symptomatic lumbar spondylolysis. Itoh K, Hashimoto T, Shigenobu K, Yamane S, Tamaki N. Nucl Med Commun. 1996 May;17(5):389-96. Erratum in: Nucl Med Commun 1996 Aug;17(8):732-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43566 |
| Study title: Neonatal adrenal haemorrhage at bone scintigraphy: a case report. Jacobsson H, Kaiser S, Granholm T, Ringertz HG. Pediatr Radiol. 1998 Nov;28(11):896-8. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43522 |
| Study title: Routine bone scintigraphy in primary staging of soft tissue sarcoma; Is it worthwhile? Jager PL, Hoekstra HJ, Leeuw J, van Der Graaf WT, de Vries EG, Piers D. Cancer. 2000 Oct 15;89(8):1726-31. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43475 |
| Study title: Bone scan in diagnosis of lymphoma with extensive bone marrow necrosis--a case report. Jain D, Pattari S, Rajesh LS, Varma N, Mittal BR. Indian J Pathol Microbiol. 2004 Jul;47(3):394-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43381 |
| Study title: A Single-blinded, Randomized trial to evaluate the efficacy and safety of 125 mg ampicillin suppositories in the treatment of acute respiratory tract infections in pediatric patients using ampicillin dry syrup as control.Nishimura et al. (1983-05-04) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_22.xlsx |
| View full study record |
| Document reference: 49021 |
| Study title: Clarify the effects of age, dosage, and route of administration on ampicillin-associated diarrhea in pediatric patients.Phillips et al. (PEDIATRICS Vol. 58 No. 6 Dec. 1976) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_5.xlsx |
| View full study record |
| Document reference: 49004 |
| Study title: Compare ampicillin and choramphenicol, both being given by the parenteral route in the therapyt of typhoid fever.Kaye et al. (Annals Ney York Academy of Sciences 145, 1967) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_3.xlsx |
| View full study record |
| Document reference: 49002 |
| Study title: Koppers B. [Axial and semi-axial views of the pelvis in bone scintigraphy. Technic, anatomy, limitations, possibilities] Rofo. 1983 Jun;138(6):722-31. German. Koppers B. [Axial and semi-axial views of the pelvis in bone scintigraphy. Technic, anatomy, limitations, possibilities] Rofo. 1983 Jun;138(6):722-31. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44035 |
| Study title: [Early diagnosis of bone infarction in children with sickle cell anemia by MDP 99m Tc scanning] Koren A, Fedchteyn S, Katsuni E. Harefuah. 1982 Mar 1;102(5):182-5. Hebrew. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44090 |
| Study title: Koren A, Garty I, Ben-Ami M, Katzuni E. Uncommon orbital bone infarctions in a sickle cell anemia patient. Clin Nucl Med. 1984 Dec;9(12):721-2. No abstract available. Koren A, Garty I, Ben-Ami M, Katzuni E. Uncommon orbital bone infarctions in a sickle cell anemia patient. Clin Nucl Med. 1984 Dec;9(12):721-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43973 |
| Study title: Knop J, Stritzke P, Montz R, Delling G, Winkler K. [Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma] Nuklearmedizin. 1985 Apr;24(2):75-81. German. Knop J, Stritzke P, Montz R, Delling G, Winkler K. [Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma] Nuklearmedizin. 1985 Apr;24(2):75-81. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43950 |
| Study title: Morrison WB, Schweitzer ME, Bock GW, Mitchell DG, Hume EL, Pathria MN, Resnick D. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging. Radiology. 1993 Oct;189(1):251-7. Morrison WB, Schweitzer ME, Bock GW, Mitchell DG, Hume EL, Pathria MN, Resnick D. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging. Radiology. 1993 Oct;189(1):251-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43650 |
| Study title: The role of bone scintigraphy in predicting femoral head collapse following cervical fractures in children. Mortensson W, Rosenborg M, Gretzer H. Acta Radiol. 1990 May;31(3):291-2. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43763 |
| Study title: Scintigraphy in the diagnosis of occult fractures of the calcaneus. Moss EH, Carty H. Skeletal Radiol. 1990;19(8):575-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43772 |
| Study title: Tc-99m nanocolloid and Tc-99m MDP three-phase bone imaging in osteomyelitis and septic arthritis. A comparative study. Mudun A, Unal S, Aktay R, Akmehmet S, Cantez S. Clin Nucl Med. 1995 Sep;20(9):772-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43587 |
| Study title: Murayama T, Munakata A, Narita K, Fujita K, Fujii K. [Retrospective study of renal images on bone scans] Rinsho Hoshasen. 1989 Mar;34(3):335-8. Japanese. Murayama T, Munakata A, Narita K, Fujita K, Fujii K. [Retrospective study of renal images on bone scans] Rinsho Hoshasen. 1989 Mar;34(3):335-8. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43793 |
| Study title: Murray IP, Ford JC. Tc-99m medronate scintigraphy in mandibular condylar hyperplasia. Clin Nucl Med. 1982 Oct;7(10):474-5. No abstract available. Murray IP, Ford JC. Tc-99m medronate scintigraphy in mandibular condylar hyperplasia. Clin Nucl Med. 1982 Oct;7(10):474-5. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44072 |
| Study title: Leckie RG, Watabe JT, Shanley DJ, Werner M. Tc-99m HDP bone scintigraphy of ameloblastoma with panorex, CT, MRI, and gross correlation. Clin Nucl Med. 1993 Apr;18(4):350-2. No abstract available. Leckie RG, Watabe JT, Shanley DJ, Werner M. Tc-99m HDP bone scintigraphy of ameloblastoma with panorex, CT, MRI, and gross correlation. Clin Nucl Med. 1993 Apr;18(4):350-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43668 |
| Study title: Lee BE, Robinson JL. The use of technetium-99m-labeled white blood cell scan in the management of a case of group A streptococcus necrotizing fasciitis with polymyositis. Clin Infect Dis. 1999 Jan;28(1):153-4. No abstract available. Lee BE, Robinson JL. The use of technetium-99m-labeled white blood cell scan in the management of a case of group A streptococcus necrotizing fasciitis with polymyositis. Clin Infect Dis. 1999 Jan;28(1):153-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43515 |
| Study title: Lee DY, Seong SC, Choi IH, Chung CY, Chang BS. Changes of blood flow of the femoral head after subtrochanteric osteotomy in Legg-Perthes' disease: a serial scintigraphic study. J Pediatr Orthop. 1992 Nov-Dec;12(6):731-4. Lee DY, Seong SC, Choi IH, Chung CY, Chang BS. Changes of blood flow of the femoral head after subtrochanteric osteotomy in Legg-Perthes' disease: a serial scintigraphic study. J Pediatr Orthop. 1992 Nov-Dec;12(6):731-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43684 |
| Study title: Okuyama T, Suzuki H, Umehara I, Kuwabara Y, Suzuki S, Takagi M. Diagnosis of aneurysmal bone cyst of the mandible. A report of two cases with emphasis on scintigraphic approaches. Clin Nucl Med. 1985 Nov;10(11):786-90. Okuyama T, Suzuki H, Umehara I, Kuwabara Y, Suzuki S, Takagi M. Diagnosis of aneurysmal bone cyst of the mandible. A report of two cases with emphasis on scintigraphic approaches. Clin Nucl Med. 1985 Nov;10(11):786-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43928 |
| Study title: Ongolo-Zogo P, Thiesse P, Sau J, Desuzinges C, Blay JY, Bonmartin A, Bochu M, Philip T. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy. Eur Radiol. 1999;9(5):907-14. Ongolo-Zogo P, Thiesse P, Sau J, Desuzinges C, Blay JY, Bonmartin A, Bochu M, Philip T. Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy. Eur Radiol. 1999;9(5):907-14. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43506 |
| Study title: Oni OO, Graebe A, Pearse M, Gregg PJ. Prediction of the healing potential of closed adult tibial shaft fractures by bone scintigraphy. Clin Orthop Relat Res. 1989 Aug;(245):239-45. Oni OO, Graebe A, Pearse M, Gregg PJ. Prediction of the healing potential of closed adult tibial shaft fractures by bone scintigraphy. Clin Orthop Relat Res. 1989 Aug;(245):239-45. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43782 |
| Study title: Tc-99m MDP uptake secondary to soft tissue extravasation of calcium gluconate in a newborn thought to have osteomyelitis. Orellana P, Velasquez C, Meneses L, Urioste A, Carreño JE, Garcíia CJ, Sabroso F, Cruces P. Clin Nucl Med. 2002 Sep;27(9):653-5. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44246 |
| Study title: Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med. 1985 Feb;26(2):125-32. Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med. 1985 Feb;26(2):125-32. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43958 |
| Study title: A randomized, multicenter, placebo-controlled parallel group study of four months duration per patient to evaluate the safety and efficacy of treatment with 24 µg b.i.d. and 12 µg b.i.d. formoterol, double-blind, and 12 µg b.i.d. formoterol with additio |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47810 |
| Study title: A SINGLE CENTRE, DOUBLE-BLIND, WITHIN-PATIENT COMPARATIVE TRIAL WITH CUMULATIVE DOSES OF FORMOTEROL AND SALBUTAMOL METERED DOSE AEROSOLS IN CHILDREN WITH ASTHMA.INTEGRATED STUDY REPORT (CLINICAL AND STATISTICAL) |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 GS 19 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47812 |
| Study title: A single dose study evaluating peak inspiratory flow rate and forced inspiratory vital capacity in children and adults with asthma of differing severity after administration of a placebo capsule for inhalation when using the aerolizer device |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 0061 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47813 |
| Study title: A single dose, randomised, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the efficacy, safety and tolerability of FormoterolHFA pMDI 12 mcg per actuation administered by means of a "spacer"device (AeroCha |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47814 |
| Study title: A Single Dose, Randomized, Double-Blind, Double-Dummy, 4-way Crossover Trial Comparing 12 mcg and 24 mcg of Foradil Aerolizer, 180 mcg Albuterol Metered-Dose Inhaler (MDI) Versus Placebo in the Prevention of Exercise-Induced Bronchospasm in Pediatric Pati |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258D 0402 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47815 |
| Study title: A SINGLE-CENTRE, DOUBLE-BLIND STUDY COMPARING FORMOTEROL AND SALBUTAMOL DRY POWDER CAPSULES FOR INHALATION WITH REGARD TO DURATION OF BRONCHODILATORY EFFECT, ASTHMA SYMPTOMS, ADVERSE REACTIONS, AND PREFERENCE IN THE TREATMENT OF CHILDREN WITH ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DP PD5 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47816 |
| Study title: A six months, randomised, open, parallel group, multicentre study to examine efficacy and safety of as needed versus maintenance use of Oxis® Turbuhaler® (formoterol) 9 μg in subjects well controlled on maintenance treatment with inhaled corticosteroids a |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0739 Study Synopsis.pdf |
| View full study record |
| Document reference: 47817 |
| Study title: A three month, double blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 mcg twice daily of Formoterol-HFA and 12 mcg twice daily of Formoterol-DPI (Foradil Aerolizer) in childrem with persistent asthma |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47818 |
| Study title: A twelve-month, double-blind, between-patient, placebo-controlled trial comparing the safety, tolerability and efficacy of 12 ug and 25 ug twice daily formoterol dry powder capsules for inhalation delivered by a single -dose inhaler (aeroliser) in childre |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 2702049 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47819 |
| Study title: A twelve-week, double-blind, parallel group trial comparing the safety, tolerability and efficacy of formoterol dry powder capsules for inhalation delivered by a single-dose inhaler versus albuterol metered-dose inhaler (mdi) versus placebo in patients wi |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258D0040 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47820 |
| Study title: A twelve-week, double-blind, parallel group trial comparing the safety, tolerability and efficacy of formoterol dry powder capsules for inhalation delivered by a single-dose inhaler versus albuterol metered-dose inhaler (mdi) versus placebo in patients wi |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258D0041 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47821 |
| Study title: BIOMETRIC REPORT ON A CLINICAL STUDY WITH FORMOTEROL (TWO 6-UG PUFFS) VERSUS FENOTEROL (TWO 0.2-MG PUFFS) IN CHILDREN WITH REVERSIBLE DISEASES OF THE AIRWAYS |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORB5 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47822 |
| Study title: Sweeney LE Hypophosphataemic rickets after ifosfamide treatment in children Clin Radiol. 1993 May;47(5):345-7Sweeney LE Hypophosphataemic rickets after ifosfamide treatment in children Clin Radiol. 1993 May;47(5):345-7 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25142 |
| Study title: Jánoskuti L, Szilvási I, Papp G, Róna E, Benedek S, Fekete S. Bone scanning and radiography in the evaluation of patients with malignant lymphoma. Rofo. 1988 Oct;149(4):427-8. Jánoskuti L, Szilvási I, Papp G, Róna E, Benedek S, Fekete S. Bone scanning and radiography in the evaluation of patients with malignant lymphoma. Rofo. 1988 Oct;149(4):427-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43808 |
| Study title: Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43731 |
| Study title: Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44172 |
| Study title: Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44185 |
| Study title: Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44232 |
| Study title: Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44279 |
| Study title: Velchik MG, Heyman S, Makler PT Jr, Goldstein HA, Alavi A. Bone scintigraphy: differentiating benign cortical irregularity of the distal femur from malignancy. J Nucl Med. 1984 Jan;25(1):72-4. Velchik MG, Heyman S, Makler PT Jr, Goldstein HA, Alavi A. Bone scintigraphy: differentiating benign cortical irregularity of the distal femur from malignancy. J Nucl Med. 1984 Jan;25(1):72-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44015 |
| Study title: Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44141 |
| Study title: Murray IP, Rossleigh MA, Dixon J. Clin Nucl Med. 1995 Jun;20(6):560-1. No abstract available. Murray IP, Rossleigh MA, Dixon J. Clin Nucl Med. 1995 Jun;20(6):560-1. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43599 |
| Study title: Photopenia in skeletal scintigraphy of suspected bone and joint infection. Murray IP. Clin Nucl Med. 1982 Jan;7(1):13-20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44095 |
| Study title: [Osteoscintigraphy in the evaluation of a bone transplant in cranioplasty in children] Russian. Mytnikov AM, Smirnov IuN, Ivanov LB, Eshankulov GS, Bukhanov VE. Med Radiol (Mosk). 1989 Apr;34(4):46-9. Russian. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43790 |
| Study title: Han JS, Kim YG, Kim S, Lee MC, Lee JS, Kim SH. Bone scintigraphy in acute renal failure with severe loin pain and patchy renal vasoconstriction. Nephron. 1991;59(2):254-60. Han JS, Kim YG, Kim S, Lee MC, Lee JS, Kim SH. Bone scintigraphy in acute renal failure with severe loin pain and patchy renal vasoconstriction. Nephron. 1991;59(2):254-60. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43750 |
| Study title: Hanash KA, Bissada NK, Abla A, Esmail D, Dowling A. Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia. Cancer. 1984 Jul 1;54(1):172-6. Hanash KA, Bissada NK, Abla A, Esmail D, Dowling A. Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia. Cancer. 1984 Jul 1;54(1):172-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43993 |
| Study title: Hanna SL, Fletcher BD, Fairclough DL, Jenkins JH 3rd, Le AH. Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy. Skeletal Radiol. 1991;20(2):79-84. Hanna SL, Fletcher BD, Fairclough DL, Jenkins JH 3rd, Le AH. Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy. Skeletal Radiol. 1991;20(2):79-84. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43749 |
| Study title: Harcke HT, Conway JJ, Tachdjian MO, Dias LS, Noble HB, MacEwen GD, Weiss S. Scintigraphic localization of bone lesions during surgery. Skeletal Radiol. 1985;13(3):211-6. Harcke HT, Conway JJ, Tachdjian MO, Dias LS, Noble HB, MacEwen GD, Weiss S. Scintigraphic localization of bone lesions during surgery. Skeletal Radiol. 1985;13(3):211-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43966 |
| Study title: Angular deformity of the lower extremity: evaluation with quantitative bone scintigraphy. Work in progress. Harcke HT, Zapf SE, Mandell GA, Sharkey CA, Cooley LA. Radiology. 1987 Aug;164(2):437-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43854 |
| Study title: Study the antibacterial and clinical efficacy of ampicillin as well as of its side-effects in comparison with penicillin V, our hitherto best peroral penicillin for scarlet fever therapy.Ström (Acta Paediatr Scand. 1968 Jul;57(4):285-8) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_31.xlsx |
| View full study record |
| Document reference: 49030 |
| Study title: The primary objective was to evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate short term efficacy in the treatment of acute otitis media. The study was comparative against amoxIcillin suspension.Bagger-Sjöbäck et al. (1987-07-22) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_24.xlsx |
| View full study record |
| Document reference: 49023 |
| Study title: Murray IP, Frater CJ. Prominence of the C2 vertebra on SPECT. A normal variant. Clin Nucl Med. 1994 Oct;19(10):855-9. Murray IP, Frater CJ. Prominence of the C2 vertebra on SPECT. A normal variant. Clin Nucl Med. 1994 Oct;19(10):855-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43614 |
| Study title: Intraoperative use of the mobile gamma camera in localizing and excising osteoid osteomas of the spine. Osebold WR, Lester EL, Hurley JH, Vincent RL. Spine. 1993 Oct 1;18(13):1816-28. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43648 |
| Study title: Oshiro N, Bito S, Ito H, Morimoto Y, Ikekubo K, Ishihara T, Mori T. [Fundamental and clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Kaku Igaku. 1982 Mar;19(2):305-11. Japanese. No abstract available. Oshiro N, Bito S, Ito H, Morimoto Y, Ikekubo K, Ishihara T, Mori T. [Fundamental and clinical evaluation of bone scintigraphy with 99mTc-HMDP (author's transl)] Kaku Igaku. 1982 Mar;19(2):305-11. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44091 |
| Study title: Templeton JE, Bauer TW, Lietman SA. Chronic bilateral thigh and knee disconfort in an 18-year-old manTempleton JE, Bauer TW, Lietman SA. Clin Orthop Relat Res 2008;466:507-13 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44205 |
| Study title: Howman-Giles R, Rahilly PM. Technetium-99m methylene diphosphonate accumulation in the diaphragm after severe ischemia. Clin Nucl Med. 1983 Sep;8(9):416-7. No abstract available. Howman-Giles R, Rahilly PM. Technetium-99m methylene diphosphonate accumulation in the diaphragm after severe ischemia. Clin Nucl Med. 1983 Sep;8(9):416-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44030 |
| Study title: Partial growth plate closure: apex view on bone scan. Howman-Giles R, Trochei M, Yeates K, Middleton R, Barrett I, Scougall J, Whiteway D. J Pediatr Orthop. 1985 Jan-Feb;5(1):109-11. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43970 |
| Study title: Multifocal osteomyelitis in childhood. Review by radionuclide bone scan. Howman-Giles R, Uren R. Clin Nucl Med. 1992 Apr;17(4):274-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43700 |
| Study title: Target imaging diagnosis of human brain glioma. Clinical analysis of 40 cases. Huang Q, He G, Lan Q, Li X, Qian Z, Chen J, Lu Z, Du Z. Chin Med J (Engl). 1996 Jan;109(1):93-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43572 |
| Study title: Hudson TM. Scintigraphy of aneurysmal bone cysts. AJR Am J Roentgenol. 1984 Apr;142(4):761-5. Hudson TM. Scintigraphy of aneurysmal bone cysts. AJR Am J Roentgenol. 1984 Apr;142(4):761-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44002 |
| Study title: Hui C, Lau KK. Intracranial Tc99m MDP uptake in Sturge-Weber syndrome. Australas Radiol. 2003 Mar;47(1):75-7. Hui C, Lau KK. Intracranial Tc99m MDP uptake in Sturge-Weber syndrome. Australas Radiol. 2003 Mar;47(1):75-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43428 |
| Study title: Humphry A, Gilday DL, Brown RG. Bone scintigraphy in chondroblastoma. Radiology. 1980 Nov;137(2):497-9. Humphry A, Gilday DL, Brown RG. Bone scintigraphy in chondroblastoma. Radiology. 1980 Nov;137(2):497-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44138 |
| Study title: Aoyama R, Nagata K, Clinical results with ampicillin-cloxacillin for intravenous drip (author's transl.) The Japanese Journal of antibiotics, (Jpn-J_Antiot.), Nov.1978, vol. 31, no. 11, p. 681-4Aoyama R, Nagata K, Clinical results with ampicillin-cloxacillin for intravenous drip (author's transl.) The Japanese Journal of antibiotics, (Jpn-J_Antiot.), Nov.1978, vol. 31, no. 11, p. 681-4 |
| Active substance: AMPICILLIN AND CLOXACILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46646 |
| Study title: To study the absorption of ampicillin suppositories in children.Jozaki et al. (1983-03-10) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_11.xlsx |
| View full study record |
| Document reference: 49011 |
| Study title: SINGLE-CENTRE, DOUBLE-BLIND WITHIN-PATIENT COMPARISON OF THE PROTECTIVE EFFECT OF INHALED PLACEBO, SALBUTAMOL (200 MCG), AND FORMOTEROL (12 AND 24 MCG) ON METHACHOLINE-INDUCED BRONCHOCONSTRICTION IN CHILDREN WITH BRONCHIAL ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 BA-EP1 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47864 |
| Study title: Single-dose, double-blind, double dummy, mono-center, randomized two fold crossover study to assess the therapeutic equivalence of Formoterol versus Foradil Aerolizer 12 μg/dose in asthmatic pediatric subjects followed by a 1 month open-label period with |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47865 |
| Study title: STATISTICAL REPORT ON AN OPEN, NON-COMPARATIVE STUDY WITH FORMOTEROL-METERED DOSE AEROSOL (2 X DAILY 12 MCG) IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE DISEASES OF THE RESPIRATORY TRACT |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORC5 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47866 |
| Study title: Testicular effects of formoterol fumarate (D2522) given orally to young rats for three months, using salbutamol sulphate as a reference compound |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47867 |
| Study title: THE EFFECT OF INHALED BETA-AGONISTS ON CHRONIC NONALLERGIC AIRWAY RESPONSIVENESS IN CHILDREN WITH ASTHMA |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 BA-EP4 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47868 |
| Study title: TO COMPARE THE BRONCHODILATOR EFFICACY, DURATION OF EFFECT,AND SYSTEMIC TOLERABILITY OF SINGLE INHALED DOSES OF FORMOTEROL, SALBUTAMOL ANF PLACEBO IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASE (ASTHMA). CLINICAL TRIAL SUMMARY AND REPORT |
| Active substance: FORMOTEROL |
| Study summary document link (including results): FOR258 DFORC4 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47869 |
| Study title: Tolerability of high dose formoterol vs. high dose terbutaline in asthmatic children after inhalation via Turbuhaler |
| Active substance: FORMOTEROL |
| Study summary document link (including results): SD-037-0738 Study Synopsis.pdf |
| View full study record |
| Document reference: 47870 |
| Study title: |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21230 |
| Study title: |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28556 |
| Study title: |
| Active substance: FOSCARNET |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28557 |
| Study title: |
| Active substance: Foscarnet |
| Study summary document link (including results): Griffiths PD. et al 1993.pdf |
| View full study record |
| Document reference: 39621 |
| Study title: |
| Active substance: Foscarnet |
| Study summary document link (including results): Kocoshis SA et al 1993.pdf |
| View full study record |
| Document reference: 39623 |
| Study title: |
| Active substance: Foscarnet |
| Study summary document link (including results): Jacobson MA_Wulfsohn M etal 1994.pdf |
| View full study record |
| Document reference: 39634 |
| Study title: |
| Active substance: Foscarnet |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39680 |
| Study title: Abdel-Haq NM, Asmar BI. Human herpesvirus 6 (HHV6) infection. Indian Journal of Pediatrics~ 71(1):89-96, January 2004 2004;(1):-96, January 2004. Abdel-Haq NM, Asmar BI. Human herpesvirus 6 (HHV6) infection. Indian Journal of Pediatrics~ 71(1):89-96, January 2004 2004;(1):-96, January 2004. |
| Active substance: FOSCARNET |
| Study summary document link (including results): Abdel-Haq NM et al 2004.pdf |
| View full study record |
| Document reference: 28585 |
| Study title: AIDS Clinical Trials Group of the National Institute of Allergy and Infectious diseases. AIDS 8(4), 451-459. 1994.MCGRATH BJ, NEWMAN CL. AIDS Clinical Trials Group of the National Institute of Allergy and Infectious diseases. AIDS 8(4), 451-459. 1994.MCGRATH BJ, NEWMAN CL. |
| Active substance: FOSCARNET |
| Study summary document link (including results): MCGRATH BJ and Newman CL 1994.pdf |
| View full study record |
| Document reference: 28572 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FLU-KI-4186-Fluticasone propionate-Cutivate - approved.xls |
| View full study record |
| Document reference: 47741 |
| Study title: Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44192 |
| Study title: Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44239 |
| Study title: Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. Vattimo A, Martini G, Pisani M. Bone uptake of 99mTc-MDP in man: its relationship with local blood flow. J Nucl Med Allied Sci. 1982 Jul-Sep;26(3):173-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44082 |
| Study title: Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43828 |
| Study title: Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44179 |
| Study title: Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44226 |
| Study title: Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Lemerle J, Parmentier C. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases] Bull Cancer. 1988;75(1):97-106. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44273 |
| Study title: Multifocal osteoarticular tuberculosis resembling skeletal metastatic disease. Evaluation with Tc-99m MDP and Ga-67 citrate. Hardoff R, Efrat M, Gips S. Clin Nucl Med. 1995 Mar;20(3):279-81. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43603 |
| Study title: Harris SA, Quayle AA, Testa HJ. Radionuclide bone scanning in the diagnosis and management of condylar hyperplasia. Nucl Med Commun. 1984 Jun;5(6):373-80. Harris SA, Quayle AA, Testa HJ. Radionuclide bone scanning in the diagnosis and management of condylar hyperplasia. Nucl Med Commun. 1984 Jun;5(6):373-80. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43994 |
| Study title: Scintimetry in transient synovitis of the hip in the child.Hasegawa Y, Wingstrand H, Gustafson T. Acta Orthop Scand. 1988 Oct;59(5):520-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43806 |
| Study title: Hasegawa Y. [Quantitative assessment of bone scintigraphy in hip joint disease] Nippon Seikeigeka Gakkai Zasshi. 1985 May;59(5):517-32. Japanese. Hasegawa Y. [Quantitative assessment of bone scintigraphy in hip joint disease] Nippon Seikeigeka Gakkai Zasshi. 1985 May;59(5):517-32. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43944 |
| Study title: Strömqvist B, Hansson LI, Nilsson LT, Thorngren KG. Prognostic precision in postoperative 99mTc-MDP scintimetry after femoral neck fracture. Acta Orthop Scand. 1987 Oct;58(5):494-8. Erratum in: Acta Orthop Scand 1988 Apr;59(2):244. Strömqvist B, Hansson LI, Nilsson LT, Thorngren KG. Prognostic precision in postoperative 99mTc-MDP scintimetry after femoral neck fracture. Acta Orthop Scand. 1987 Oct;58(5):494-8. Erratum in: Acta Orthop Scand 1988 Apr;59(2):244. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43849 |
| Study title: Strömqvist B. Femoral head vitality after intracapsular hip fracture. 490 cases studied by intravital tetracycline labeling and Tc-MDP radionuclide imaging. Acta Orthop Scand Suppl. 1983;200:1-71. No abstract available. Strömqvist B. Femoral head vitality after intracapsular hip fracture. 490 cases studied by intravital tetracycline labeling and Tc-MDP radionuclide imaging. Acta Orthop Scand Suppl. 1983;200:1-71. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44059 |
| Study title: Stulberg BN, Levine M, Bauer TW, Belhobek GH, Pflanze W, Feiglin DH, Roth AI. Multimodality approach to osteonecrosis of the femoral head. Clin Orthop Relat Res. 1989 Mar;(240):181-93. Stulberg BN, Levine M, Bauer TW, Belhobek GH, Pflanze W, Feiglin DH, Roth AI. Multimodality approach to osteonecrosis of the femoral head. Clin Orthop Relat Res. 1989 Mar;(240):181-93. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43792 |
| Study title: Intraoperative 99m technetium bone imaging in the treatment of benign osteoblastic tumors. Sty J, Simons G. Clin Orthop Relat Res. 1982 May;(165):223-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44085 |
| Study title: Sty JR, Boedecker RA, Babbitt DP. Skull scintigraphy in infantile hypophosphatasia. J Nucl Med. 1979 Apr;20(4):305-6. No abstract available. Sty JR, Boedecker RA, Babbitt DP. Skull scintigraphy in infantile hypophosphatasia. J Nucl Med. 1979 Apr;20(4):305-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44145 |
| Study title: The primary objective was to evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions in pediatric patients. The secondary objective was to evaluate efficacy of a twice daily dosage regimen in the treatment of acute otitis media. The study was comparative against amoxIcillin suspension.Albertini et al. (1987-09-11) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_26.xlsx |
| View full study record |
| Document reference: 49025 |
| Study title: The primary objective was to evaluate the safety of ampicillin suppositories with special emphasis on local intolerance reactions. The study was comparative against amoxIcillin suspension.Albertini et al. (1987-09-11) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_27.xlsx |
| View full study record |
| Document reference: 49026 |
| Study title: Hung GL, Stewart CA, Yeo E, Ansari AN, Wang A, Greenfield L. Incidental demonstration of cerebral infarction on bone scintigraphy in sickle cell disease. Clin Nucl Med. 1990 Oct;15(10):671-2. No abstract available. Hung GL, Stewart CA, Yeo E, Ansari AN, Wang A, Greenfield L. Incidental demonstration of cerebral infarction on bone scintigraphy in sickle cell disease. Clin Nucl Med. 1990 Oct;15(10):671-2. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43752 |
| Study title: Hung WT, Su CT. Diagnosis of atretic prolonged obstructive jaundice; technetium 99m hepatolite excretion study. J Pediatr Surg. 1990 Jul;25(7):797-800. Hung WT, Su CT. Diagnosis of atretic prolonged obstructive jaundice; technetium 99m hepatolite excretion study. J Pediatr Surg. 1990 Jul;25(7):797-800. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43759 |
| Study title: Tindale WB, Martel AL, Barber DC. The use of image registration in the analysis of bone scans for the assessment of temporomandibular joint uptake. Nucl Med Commun. 1999 Jan;20(1):49-59. Tindale WB, Martel AL, Barber DC. The use of image registration in the analysis of bone scans for the assessment of temporomandibular joint uptake. Nucl Med Commun. 1999 Jan;20(1):49-59. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43517 |
| Study title: Accumulation of Tc-99m HMDP in bony structures of immature teratoma in a child. Tohyama J, Ohba S, Sugie C, Ogino H, Hara M, Shibamoto Y. Clin Nucl Med. 2003 Apr;28(4):334-5. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43424 |
| Study title: Tonami N. [Role of nuclear medicine in orthopedic surgery] Nippon Seikeigeka Gakkai Zasshi. 1987 Apr;61(4):411-24. Japanese. No abstract available. Tonami N. [Role of nuclear medicine in orthopedic surgery] Nippon Seikeigeka Gakkai Zasshi. 1987 Apr;61(4):411-24. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43870 |
| Study title: Muscular injury in a child diagnosed by 99mTc-MDP bone scan. Tondeur M, Haentjens M, Piepsz A, Ham HR. Eur J Nucl Med. 1989;15(6):328-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43797 |
| Study title: Tondeur M, Sand A, Ham H. Interobserver reproducibility in the interpretation of bone scans from patients suspected of having reflex sympathetic dystrophy. Clin Nucl Med. 2005 Jan;30(1):4-10. Tondeur M, Sand A, Ham H. Interobserver reproducibility in the interpretation of bone scans from patients suspected of having reflex sympathetic dystrophy. Clin Nucl Med. 2005 Jan;30(1):4-10. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43393 |
| Study title: Tovi F, Gatot A. Bone scan diagnosis of masked mastoiditis. Ann Otol Rhinol Laryngol. 1992 Aug;101(8):707-9. No abstract available. Tovi F, Gatot A. Bone scan diagnosis of masked mastoiditis. Ann Otol Rhinol Laryngol. 1992 Aug;101(8):707-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43693 |
| Study title: Toxey J, Achong DM. Skeletal angiomatosis limited to the hand: radiographic and scintigraphic correlation. J Nucl Med. 1991 Oct;32(10):1912-4. Toxey J, Achong DM. Skeletal angiomatosis limited to the hand: radiographic and scintigraphic correlation. J Nucl Med. 1991 Oct;32(10):1912-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43724 |
| Study title: A double blind, double dummy, crossover study to compare the systemic pharmacodynamic effects and safety of inhaled fluticasone propionate Nebules™ 1mg bd with oral prednisolone administered for 7 days to children aged 4 to 16 years with asthma |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLTB3055-ICHE3.pdf |
| View full study record |
| Document reference: 28421 |
| Study title: A double blind, double dummy, placebo controlled trial of Fluticasone propionate aqueous nasal spray and oral Ketotifen in children with perennial rhinitis aged between 2 and 4 years. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLNQ12-ICHE3.pdf |
| View full study record |
| Document reference: 28364 |
| Study title: A double-blind, 2x2 Factohal Study to evaluate the effects of treatment with intranasal fluticasone propionate and use of Otovent mechanical ventilation of the middle ear on the need for surgery in children aged 4-8 with chronic or recurrent otitis media. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FLNL45-Fluticasone_Flixonase.xls |
| View full study record |
| Document reference: 28363 |
| Study title: A Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Study to Compare the Potential Short-Term Growth Effect of Fluticasone Propionate Aqueous Nasal Spray, Beclomethasone Dipropionate Aqueous Nasal Spray, and Placebo in Adolescents with Perennial Allergic Rhinitis. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Study FNM40007-Fluticasone_Flixonase.xls |
| View full study record |
| Document reference: 28365 |
| Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once- versus twice-daily versus placebo for two weeks in adolescent patients with seasonal allergic rhinitis |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLN-305-ICHE3.pdf |
| View full study record |
| Document reference: 28407 |
| Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate given once daily versus placebo for two weeks in pediatric patients with seasonal allergic rhinitis |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FLN-320-ICHE3.pdf |
| View full study record |
| Document reference: 28408 |
| Study title: A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate versus placebo for four weeks in pediatric patients with seasonal allergic rhinitis |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNM30008-ICHE3.pdf |
| View full study record |
| Document reference: 28409 |
| Study title: A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Assess the Potential Growth Effects of a One-Year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) Versus Placebo in Prepubescent, Pediatric Subjects with Perennial Allergic Rhinitis |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNM40017-ICHE3.pdf |
| View full study record |
| Document reference: 28414 |
| Study title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Potential Effects of a Six-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on the HPA-Axis in ≥2 and <4 Year Old Subjects with Allergic Rhinitis. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNM40183-ICHE3.pdf |
| View full study record |
| Document reference: 28416 |
| Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to compare the efficacy and safety of fluticasone propionate 400μg daily with budesonide 400μg daily in children with asthma. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS30037-ICHE3.pdf |
| View full study record |
| Document reference: 28426 |
| Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 100μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in adult and paediatric patients with reversible airways disease. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-propionate-FMDT02-ICHE3.pdf |
| View full study record |
| Document reference: 28424 |
| Study title: Effect of the combination of ipratropium bromide and fenoterol (berodual) in patients with asthmatic crises comparative study with fenoterol (Berotec). |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30682 |
| Study title: Scintigraphic findings in progressive diaphyseal dysplasia. Lundy MM, Billingsley JL, Redwine MD, Turnbull GL, Brown TJ. J Nucl Med. 1982 Apr;23(4):324-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44087 |
| Study title: Lusins JO, Elting JJ, Cicoria AD, Goldsmith SJ. SPECT evaluation of lumbar spondylolysis and spondylolisthesis. Spine. 1994 Mar 1;19(5):608-12. Lusins JO, Elting JJ, Cicoria AD, Goldsmith SJ. SPECT evaluation of lumbar spondylolysis and spondylolisthesis. Spine. 1994 Mar 1;19(5):608-12. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43631 |
| Study title: Lusins JO, Elting JJ, Cicoria AD, Goldsmith SJ. SPECT evaluation of unilateral spondylolysis. Clin Nucl Med. 1994 Jan;19(1):1-5. Lusins JO, Elting JJ, Cicoria AD, Goldsmith SJ. SPECT evaluation of unilateral spondylolysis. Clin Nucl Med. 1994 Jan;19(1):1-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43636 |
| Study title: Lytic bone lesion in a 12-year-old. Blackmore CC. Perkins A. Acad Radiol1995 Jun;2(6):541-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48465 |
| Study title: Gallium-67 and technetium-99m-methylene diphosphonate skeletal scintigraphy in determining prognosis for children with stage IV neuroblastoma. Macdonald WB, Stevens MM, Dalla Pozza L, Bergin M, Menser MA, Howman-Giles R, Uren RF. J Nucl Med. 1993 Jul;34(7):1082-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43662 |
| Study title: Podrasky AE, Stark DD, Hattner RS, Gooding CA, Moss AA. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP. AJR Am J Roentgenol. 1983 Sep;141(3):469-72. Podrasky AE, Stark DD, Hattner RS, Gooding CA, Moss AA. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP. AJR Am J Roentgenol. 1983 Sep;141(3):469-72. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44033 |
| Study title: Pogrel MA, Kopf J, Dodson TB, Hattner R, Kaban LB. A comparison of single-photon emission computed tomography and planar imaging for quantitative skeletal scintigraphy of the mandibular condyle. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):226-31. Pogrel MA, Kopf J, Dodson TB, Hattner R, Kaban LB. A comparison of single-photon emission computed tomography and planar imaging for quantitative skeletal scintigraphy of the mandibular condyle. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Aug;80(2):226-31. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44261 |
| Study title: Pseudomonas sacroiliac osteomyelitis: diagnosis by gallium citrate Ga 67 scan. Pope TL, Teague WG, Kossack R, Bray ST, Flannery DB. Am J Dis Child. 1982 Jul;136(7):649-50. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44081 |
| Study title: Large cell lymphoma of bone presented by limp. Postovsky S, Bialik V, Keidar Z, Eppelman M, Militianu D, Ben Izhak OB, Ben Arush MW. J Pediatr Orthop B. 2001 Jan;10(1):81-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43455 |
| Study title: Compare the achieved ampicillin concentrations in CSF following intravenous and intramuscular routes of administration, and to correlate the clinical and laboratory responses in patients treated by the two routes.Wilson et al. (AM J Dis Child/Vol 129, Feb 1975) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_4.xlsx |
| View full study record |
| Document reference: 49003 |
| Study title: Compare the tolerability of Ampicillin, Amoxicillin and Trimethoprim-Sulfamethoxazole in children with otitis media.Feder (Antimicrobial agents and chemotherapy, Mar. 1982. p. 426-427) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_29.xlsx |
| View full study record |
| Document reference: 49028 |
| Study title: Sty JR, Starshak RJ, Casper JT. Extraosseous accumulation of Tc-99m MDP. Metastatic intracranial neuroblastoma. Clin Nucl Med. 1983 Jan;8(1):26-7. No abstract available. Sty JR, Starshak RJ, Casper JT. Extraosseous accumulation of Tc-99m MDP. Metastatic intracranial neuroblastoma. Clin Nucl Med. 1983 Jan;8(1):26-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44061 |
| Study title: Accumulation of Tc-99m MDP in the spleen of a battered child. Sty JR, Starshak RJ, Hubbard A. Clin Nucl Med. 1982 Jun;7(6):292. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44083 |
| Study title: Sty JR, Starshak RJ, Oechler HW. Extraosseous uptake of Tc-99m-MDP in congenital fibromatosis. Clin Nucl Med. 1981 Mar;6(3):123. No abstract available. Sty JR, Starshak RJ, Oechler HW. Extraosseous uptake of Tc-99m-MDP in congenital fibromatosis. Clin Nucl Med. 1981 Mar;6(3):123. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44129 |
| Study title: Sty JR, Starshak RJ. Abnormal Tc-99m MDP renal images associated with myoglobinuria. Clin Nucl Med. 1982 Oct;7(10):476. No abstract available. Sty JR, Starshak RJ. Abnormal Tc-99m MDP renal images associated with myoglobinuria. Clin Nucl Med. 1982 Oct;7(10):476. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44071 |
| Study title: The role of bone scintigraphy in the evaluation of the suspected abused child. Sty JR, Starshak RJ. Radiology. 1983 Feb;146(2):369-75. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44051 |
| Study title: Bone infarction in children with sickle cell disease: early diagnosis and differentiation from osteomyelitis. Koren A, Garty I, Katzuni E. Eur J Pediatr. 1984 Jun;142(2):93-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43995 |
| Study title: Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44084 |
| Study title: Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44186 |
| Study title: Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44233 |
| Study title: Tumeh SS, Aliabadi P, Weissman BN, McNeil BJ. Disease activity in osteomyelitis: role of radiography. Radiology. 1987 Dec;165(3):781-4. Tumeh SS, Aliabadi P, Weissman BN, McNeil BJ. Disease activity in osteomyelitis: role of radiography. Radiology. 1987 Dec;165(3):781-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43838 |
| Study title: Tuncel M, Erbas B, Mahmoudian B. Gamut: soft tissue uptake of bone radiopharmaceuticals. Semin Nucl Med. 2003 Oct;33(4):334-7. No abstract available. Tuncel M, Erbas B, Mahmoudian B. Gamut: soft tissue uptake of bone radiopharmaceuticals. Semin Nucl Med. 2003 Oct;33(4):334-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43410 |
| Study title: Turba E, Fagioli G, Mancini AF, Rosito P, Galli A, Alvisi P. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy. J Nucl Biol Med. 1993 Sep;37(3):107-14. Turba E, Fagioli G, Mancini AF, Rosito P, Galli A, Alvisi P. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy. J Nucl Biol Med. 1993 Sep;37(3):107-14. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43655 |
| Study title: Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. Leet AI, Magur E, Lee JS, Wientroub S, Robey PG, Collins MT. J Bone Joint Surg Am. 2004 Mar;86-A(3):531-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43405 |
| Study title: Left distal femoral diaphysis metaphyseal injury in a 13-year-old patient.Delgado Garcia M, Mitjavila Casanovas M, Balsa Breton MA, Castillejos Rodriguez L, Alonso Garcia P, Canamaque Garcia L, et al. Rev Esp Med Nucl 2000 Sep;19{5):356-60. [in Spanish] |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48474 |
| Study title: [An unusual bone scintigram in osteomyelitis. A case report] Lehner G, Kessel HF, Hoffmann D. Radiologe. 1992 Sep;32(9):441-3. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43689 |
| Study title: Leslie WD, Reinhold C, Rosenthall L, Tau C, Glorieux FH. Panostotic fibrous dysplasia. A new craniotubular dysplasia. Clin Nucl Med. 1992 Jul;17(7):556-60. Leslie WD, Reinhold C, Rosenthall L, Tau C, Glorieux FH. Panostotic fibrous dysplasia. A new craniotubular dysplasia. Clin Nucl Med. 1992 Jul;17(7):556-60. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43694 |
| Study title: Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43562 |
| Study title: Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44165 |
| Study title: The imaging diagnosis of nonpyogenic discitis in children.Grünebaum M, Horodniceanu C, Mukamel M, Varsano I, Lubin E. Pediatr Radiol. 1982;12(3):133-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44102 |
| Study title: False positive bone scan secondary to sympathectomy following resection of a ganglioneuroblastoma or affect of unilateral sympathectomy of bone scan in the pediatric patient. Haggstrom JA, Brown JC. Nebr Med J. 1988 Mar;73(3):67-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43823 |
| Study title: Siegel Y, Golan H, Thein R. 99mTc-methylene diphosphonate single photon emission tomography of the knees: intensity of uptake and its correlation with arthroscopic findings. Nucl Med Commun. 2006 Sep;27(9):689-93. Siegel Y, Golan H, Thein R. 99mTc-methylene diphosphonate single photon emission tomography of the knees: intensity of uptake and its correlation with arthroscopic findings. Nucl Med Commun. 2006 Sep;27(9):689-93. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43372 |
| Study title: Silva F, Laguna R, Acevedo M, Ruíz C, Orduña E. Clin Nucl Med. 1995 Oct;20(10):913-5. Silva F, Laguna R, Acevedo M, Ruíz C, Orduña E. Clin Nucl Med. 1995 Oct;20(10):913-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43584 |
| Study title: Silvestro L, Bona G, Leonessa M, Giusti M, Mussa GC. [Importance of bone scintigraphy in skeletal diseases] Minerva Pediatr. 1983 Nov 15;35(21):1051-7. Italian. No abstract available. Silvestro L, Bona G, Leonessa M, Giusti M, Mussa GC. [Importance of bone scintigraphy in skeletal diseases] Minerva Pediatr. 1983 Nov 15;35(21):1051-7. Italian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44022 |
| Study title: Silvestro L, Savant Levet P, Gallina MR. [Role of sequential Tc99m-MDP and Ga-67 scintigraphy in the diagnosis of osteoarticular infections] Minerva Pediatr. 1988 Feb;40(2):103-8. Italian. No abstract available. Silvestro L, Savant Levet P, Gallina MR. [Role of sequential Tc99m-MDP and Ga-67 scintigraphy in the diagnosis of osteoarticular infections] Minerva Pediatr. 1988 Feb;40(2):103-8. Italian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43826 |
| Study title: [Scintigraphy in the diagnosis and follow-up of bone neoplasms in childhood] Silvestro L, Testa A, Mussa GC. Minerva Pediatr. 1987 May 31;39(10):463-70. Italian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43862 |
| Study title: Sires BS, Benda PM, Stanley RB Jr, Rosen CE. Orbital osteoid osteoma. Arch Ophthalmol. 1999 Mar;117(3):414-5. No abstract available. Sires BS, Benda PM, Stanley RB Jr, Rosen CE. Orbital osteoid osteoma. Arch Ophthalmol. 1999 Mar;117(3):414-5. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43510 |
| Study title: Skeletal scintigraphy of young patients with low-back pain and a lumbosacral transitional vertebra. Connolly LP, d'Hemecourt PA, Connolly SA, Drubach LA, Micheli U, Treves ST. J Nucl Med 2003 Jun;44{6):909-14. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48473 |
| Study title: "Relationships between amiodarone dosage, drug concentrations, and adverse side effects. Heger J et al. - 1983 (Am. Hearth J., 106: 931-935) ; - Publication in CES EXPCRC-CES0172-EN01, CES EXPCRC-CES0173-EN01, CES EXPCRC-CES0206-EN01 -" "Relationships between amiodarone dosage, drug concentrations, and adverse side effects. Heger J et al. - 1983 (Am. Hearth J., 106: 931-935) ; - Publication in CES EXPCRC-CES0172-EN01, CES EXPCRC-CES0173-EN01, CES EXPCRC-CES0206-EN01 -" |
| Active substance: AMIODARONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45156 |
| Study title: Baldini G. et al Controlled clinical study on the activity of a new formulation of Ambroxol in asthma-like bronchitis in children.MinervaPed,1989,Baldini |
| Active substance: AMBROXOL |
| Study summary document link (including results): MinervaPed,1989,Baldini.pdf |
| View full study record |
| Document reference: 48876 |
| Study title: [Articular complications in sickle cell-thalassemia after childhood. Diagnostic problems] Italian. Potente G. Radiol Med (Torino). 1988 Nov;76(5):409-13. Italian. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43805 |
| Study title: Sacro-iliitis in infants: a difficult diagnosis. 4 cases.Pratte L. Docquier P- L. Joint Bone Spine 2009; 76:313-5 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47922 |
| Study title: Intense muscle uptake of Tc-99m MDP and Ga-67 citrate in massive rhabdomyolysis. Provan I, Murray C, Mansberg VJ, Rossleigh MA. Clin Nucl Med. 1997 Jul;22(7):463-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43548 |
| Study title: Solitary infantile myofibromatosis of the skull. Queralt JA, Poirier VC. AJNR Am J Neuroradiol. 1995 Mar;16(3):476-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43602 |
| Study title: Ramseyer LT, Leonard JC, Stacy TM. Bone scan findings in craniometaphyseal dysplasia. Clin Nucl Med. 1993 Feb;18(2):137-9. Ramseyer LT, Leonard JC, Stacy TM. Bone scan findings in craniometaphyseal dysplasia. Clin Nucl Med. 1993 Feb;18(2):137-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43673 |
| Study title: Magnetic resonance imaging in children with acute hip pain. Ranner G, Ebner F, Fotter R, Linhart W, Justich E. Pediatr Radiol. 1989;20(1-2):67-71. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43799 |
| Study title: Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44219 |
| Study title: Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res. 1991 Sep;26(5):415-21. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44266 |
| Study title: Johnson RP, Collier BD, Carrera GF. The os trigonum syndrome: use of bone scan in the diagnosis. J Trauma. 1984 Aug;24(8):761-4. Johnson RP, Collier BD, Carrera GF. The os trigonum syndrome: use of bone scan in the diagnosis. J Trauma. 1984 Aug;24(8):761-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43987 |
| Study title: Describing three children, two with meningitis and one with septicemia, from whom ampicillin-resistant Haemophilus influenzae type B were isolated from the CSF, blood or both. At least one case represents ampicillin failure in the treatment of H. influenzae meningitis because of resistence of the organism to the drug.Ousama et al. (JAMA, July 15 1974, Vol 229, No 3) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_7.xlsx |
| View full study record |
| Document reference: 49007 |
| Study title: Determine the plasma concentrations after rectal administration of ampicillin suppositories in children, and when possible to estimate the urine concentrations of ampicillin and the bioavailability of the suppository.Eriksson et al. (1991-08-12) |
| Active substance: AMPICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ampicillin_28.xlsx |
| View full study record |
| Document reference: 49027 |
| Study title: Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. Kosuda S, Kondo M, Masaki H, Endo M, Ando Y, Takagi Y, Kubo A, Hashimoto S. [Significance of bone scintigraphy in the observation of the therapeutic effects in metastatic bone cancer] Nippon Igaku Hoshasen Gakkai Zasshi. 1982 May 25;42(5):454-66. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44280 |
| Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43855 |
| Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44181 |
| Study title: [Advantages and disadvantages of peroperative isotopic localization in the excision of osteoid osteoma. Considerations apropos of 6 cases] French. Nachin P, Gille P, Aubert D, De La Salle R, Giordan H, Cardot JC. Chir Pediatr. 1986;27(2):65-8. French. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43921 |
| Study title: Cost-appropriateness of whole body vs limited bone imaging for suspected focal sports injuries. Clin Nucl Med. 1986 Jul;11(7):469-73. Nagle CE. Clin Nucl Med. 1986 Jul;11(7):469-73. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43904 |
| Study title: Nair N, Goyal V, Nair CN. Uptake of Tc-99m MDP by a primitive neuroectodermal tumor of the liver. Clin Nucl Med. 1998 Aug;23(8):548-9. No abstract available. Nair N, Goyal V, Nair CN. Uptake of Tc-99m MDP by a primitive neuroectodermal tumor of the liver. Clin Nucl Med. 1998 Aug;23(8):548-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43527 |
| Study title: Nair N. Bone scanning in Ewing's sarcoma. J Nucl Med. 1985 Apr;26(4):349-52. Nair N. Bone scanning in Ewing's sarcoma. J Nucl Med. 1985 Apr;26(4):349-52. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43947 |
| Study title: Nakayama T, Saitoh Y, Yatabe K, Sueishi M, Kawai M. [Diagnosis of inflammatory myopathy; usefulness of 99mTc MDP scintigraphy and muscle MRI for determination of affected sites] Rinsho Shinkeigaku. 1999 Nov;39(11):1114-7. Japanese. Nakayama T, Saitoh Y, Yatabe K, Sueishi M, Kawai M. [Diagnosis of inflammatory myopathy; usefulness of 99mTc MDP scintigraphy and muscle MRI for determination of affected sites] Rinsho Shinkeigaku. 1999 Nov;39(11):1114-7. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43492 |
| Study title: Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44212 |
| Study title: Otsuka N, Morita R, Yamamoto T, Muranaka A, Tomomitsu T, Yanagimoto S, Sone T, Fukunaga M. A case of synovial sarcoma with bone metastasis identified by bone marrow scintigraphy. Clin Nucl Med. 1985 Apr;10(4):260-3. Otsuka N, Morita R, Yamamoto T, Muranaka A, Tomomitsu T, Yanagimoto S, Sone T, Fukunaga M. A case of synovial sarcoma with bone metastasis identified by bone marrow scintigraphy. Clin Nucl Med. 1985 Apr;10(4):260-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43949 |
| Study title: Otsuka N, Yoneda M, Sawai M, Saito J, Nagai K, Muranaka A, Terashima H, Yanagimoto S, Ito Y. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate] Kaku Igaku. 1982 Dec;19(10):1573-8. Japanese. No abstract available. Otsuka N, Yoneda M, Sawai M, Saito J, Nagai K, Muranaka A, Terashima H, Yanagimoto S, Ito Y. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate] Kaku Igaku. 1982 Dec;19(10):1573-8. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44278 |
| Study title: Oza UD, Oates E. Rhabdomyolysis of bilateral teres major muscles. Clin Nucl Med. 2003 Feb;28(2):126-7. No abstract available. Oza UD, Oates E. Rhabdomyolysis of bilateral teres major muscles. Clin Nucl Med. 2003 Feb;28(2):126-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43430 |
| Study title: Ozcan Z, Burak Z, Kumanlioğlu K, Sabah D, Başdemir G, Bilkay B, Cetingül N, Ozkiliç H. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy. Nucl Med Commun. 1999 Jan;20(1):41-8. Ozcan Z, Burak Z, Kumanlioğlu K, Sabah D, Başdemir G, Bilkay B, Cetingül N, Ozkiliç H. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy. Nucl Med Commun. 1999 Jan;20(1):41-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44256 |
| Study title: Ozcan Z, Erenel G, Aksoylar S, Kansoy S, Burak Z, Ozkiliç H. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma. Clin Nucl Med. 1999 Apr;24(4):267-70. Ozcan Z, Erenel G, Aksoylar S, Kansoy S, Burak Z, Ozkiliç H. False-negative scintigraphy with Tc-99m sestamibi in stage IV neuroblastoma. Clin Nucl Med. 1999 Apr;24(4):267-70. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43501 |
| Study title: Palestro C, Lawrence LP, Strashun AM, Goldsmith SJ. Technetium-99m MDP accumulation in hepatic metastasis from osteogenic sarcoma. Clin Nucl Med. 1987 Apr;12(4):329-30. No abstract available. Palestro C, Lawrence LP, Strashun AM, Goldsmith SJ. Technetium-99m MDP accumulation in hepatic metastasis from osteogenic sarcoma. Clin Nucl Med. 1987 Apr;12(4):329-30. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43867 |
| Study title: Smirnov IuN, Mytnikov AM, Ivanov LB, Suchkov VV, Strunin EG. [Distant compression fracture in a child with dysplastic changes in the spine] Med Radiol (Mosk). 1988 Jul;33(7):79-80. Russian. No abstract available. Smirnov IuN, Mytnikov AM, Ivanov LB, Suchkov VV, Strunin EG. [Distant compression fracture in a child with dysplastic changes in the spine] Med Radiol (Mosk). 1988 Jul;33(7):79-80. Russian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43813 |
| Study title: Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate. Smith FW, Gilday DL, Ash JM, Reid RH. Radiology. 1980 Nov;137(2):501-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44137 |
| Study title: Smith FW, Gilday DL. Scintigraphic appearances of osteoid osteoma. Radiology. 1980 Oct;137(1 Pt 1):191-5. Smith FW, Gilday DL. Scintigraphic appearances of osteoid osteoma. Radiology. 1980 Oct;137(1 Pt 1):191-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44140 |
| Study title: Detection of adrenal metastasis from osteosarcoma by Tc-99m MDP scintigraphy. Kauffman WM, Winer-Muram H, Sandlund JT. Clin Nucl Med. 1995 Aug;20(8):741. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43592 |
| Study title: Kawano M, Taki J, Tsuchiya H, Tomita K, Tonami N. Predicting the outcome of distraction osteogenesis by 3-phase bone scintigraphy. J Nucl Med. 2003 Mar;44(3):369-74. Kawano M, Taki J, Tsuchiya H, Tomita K, Tonami N. Predicting the outcome of distraction osteogenesis by 3-phase bone scintigraphy. J Nucl Med. 2003 Mar;44(3):369-74. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43425 |
| Study title: Cervical involvement in juvenile-onset ankylosing spondylitis with bone scintigraphy. Kekilli E, Yagmur C, Aydin OM. Rheumatol Int. 2004 May;24(3):164-5. Epub 2003 Sep 20. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43414 |
| Study title: Multiple osteoid osteomas of the fifth lumbar vertebra. A case report. Keret D, Harcke HT, MacEwen GD, Bowen JR. Clin Orthop Relat Res. 1989 Nov;(248):163-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43777 |
| Study title: Kerscher A, Fleiner B, Bohuslaviski KH, Clausen M. [Skeletal scintigraphy in the treatment planning for hemimandibular elongation] Nuklearmedizin. 1995 Jun;34(3):110-4. German. Kerscher A, Fleiner B, Bohuslaviski KH, Clausen M. [Skeletal scintigraphy in the treatment planning for hemimandibular elongation] Nuklearmedizin. 1995 Jun;34(3):110-4. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43600 |
| Study title: Kim HC, Alavi A, Russell MO, Schwartz E. Differentiation of bone and bone marrow infarcts from osteomyelitis in sickle cell disorders. Clin Nucl Med. 1989 Apr;14(4):249-54. Kim HC, Alavi A, Russell MO, Schwartz E. Differentiation of bone and bone marrow infarcts from osteomyelitis in sickle cell disorders. Clin Nucl Med. 1989 Apr;14(4):249-54. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43788 |
| Study title: Kim JW, Nam KW, Yoo JJ, Kim HJ. The role of preoperative bone scan for determining the treatment method for femoral neck fracture. Int Orthop. 2007 Feb;31(1):61-4. Epub 2006 May 13.Kim JW, Nam KW, Yoo JJ, Kim HJ. The role of preoperative bone scan for determining the treatment method for femoral neck fracture. Int Orthop. 2007 Feb;31(1):61-4. Epub 2006 May 13. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43376 |
| Study title: Jones MM, Moore WH, Brewer EJ, Sonnemaker RE, Long SE. Radionuclide bone/joint imaging in children with rheumatic complaints. Skeletal Radiol. 1988;17(1):1-7. Jones MM, Moore WH, Brewer EJ, Sonnemaker RE, Long SE. Radionuclide bone/joint imaging in children with rheumatic complaints. Skeletal Radiol. 1988;17(1):1-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43832 |
| Study title: Jonsson K, Jónsson A, Sloth M, Kopylov P, Wingstrand H. CT of the wrist in suspected scaphoid fracture. Acta Radiol. 1992 Sep;33(5):500-1. Jonsson K, Jónsson A, Sloth M, Kopylov P, Wingstrand H. CT of the wrist in suspected scaphoid fracture. Acta Radiol. 1992 Sep;33(5):500-1. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43691 |
| Study title: Joyce JM, Conrad G, Shih WJ, Ryo UY. Arterial thrombosis and insufficiency causing diffusely decreased uptake by skeleton of a limb. Semin Nucl Med. 1991 Apr;21(2):165-6. No abstract available. Joyce JM, Conrad G, Shih WJ, Ryo UY. Arterial thrombosis and insufficiency causing diffusely decreased uptake by skeleton of a limb. Semin Nucl Med. 1991 Apr;21(2):165-6. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43742 |
| Study title: Unilateral medullary sponge kidney detected on bone scan. Juweid M, Richards CH, Heyman S. Clin Nucl Med. 1993 Jan;18(1):73-4. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43675 |
| Study title: Juweid ME, Menda Y, O'Dorisio MS, Bushnell D, Blake M, Madsen M, Johnson J, Graham MM. 111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma. Nucl Med Commun. 2002 Oct;23(10):983-9. Juweid ME, Menda Y, O'Dorisio MS, Bushnell D, Blake M, Madsen M, Johnson J, Graham MM. 111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma. Nucl Med Commun. 2002 Oct;23(10):983-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43435 |
| Study title: Assessment of mandibular growth by skeletal scintigraphy. Kaban LB, Cisneros GJ, Heyman S, Treves S. J Oral Maxillofac Surg. 1982 Jan;40(1):18-22. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44094 |
| Study title: Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. Veldman JE, Mulder PH, Ruijs SH, de Haas G, van Waes PF, Hoekstra A. Early detection of asymptomatic hereditary chemodectoma with radionuclide scintiangiography. A possibility for family screening and surveillance. Arch Otolaryngol. 1980 Sep;106(9):547-52. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44286 |
| Study title: Veluvolu P, Zoch TW, Miller RW, Weir JG, Mulligan CM, Moen SL. Pseudo-bladder sign in an unsuspected pregnancy. Appearance in bone imaging. Clin Nucl Med. 1992 Dec;17(12):982-3. No abstract available. Veluvolu P, Zoch TW, Miller RW, Weir JG, Mulligan CM, Moen SL. Pseudo-bladder sign in an unsuspected pregnancy. Appearance in bone imaging. Clin Nucl Med. 1992 Dec;17(12):982-3. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43682 |
| Study title: Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43404 |
| Study title: Narang D, Bharati B, Bhattacharya A, Mittal BR. Radionuclide bone scintigraphy in Engelmann-Camurati disease. Arch Dis Child. 2004 Aug;89(8):737. No abstract available. Narang D, Bharati B, Bhattacharya A, Mittal BR. Radionuclide bone scintigraphy in Engelmann-Camurati disease. Arch Dis Child. 2004 Aug;89(8):737. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43399 |
| Study title: Malignant fibrous histiocytoma of the mandible. Narvaez JA, Muntane A, Narvaez J, Martin F, Monfort JL, Pons LC. Skeletal Radiol. 1996 Jan;25(1):96-9. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43573 |
| Study title: Ncube BA. Pyogenic sacroiliitis in children. Br J Clin Pract. 1988 Apr;42(4):154-7. No abstract available. Ncube BA. Pyogenic sacroiliitis in children. Br J Clin Pract. 1988 Apr;42(4):154-7. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43822 |
| Study title: Nepola JV, Seabold JE, Marsh JL, Kirchner PT, el-Khoury GY. Diagnosis of infection in ununited fractures. Combined imaging with indium-111-labeled leukocytes and technetium-99m methylene diphosphonate. J Bone Joint Surg Am. 1993 Dec;75(12):1816-22. Nepola JV, Seabold JE, Marsh JL, Kirchner PT, el-Khoury GY. Diagnosis of infection in ununited fractures. Combined imaging with indium-111-labeled leukocytes and technetium-99m methylene diphosphonate. J Bone Joint Surg Am. 1993 Dec;75(12):1816-22. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43644 |
| Study title: Nicholson RL, Manglal-Lan B, Wilkins K. Reverse oblique reconstruction for SPECT of the spine. Clin Nucl Med. 1991 Jul;16(7):478-81. Nicholson RL, Manglal-Lan B, Wilkins K. Reverse oblique reconstruction for SPECT of the spine. Clin Nucl Med. 1991 Jul;16(7):478-81. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43733 |
| Study title: Hashkes PJ, Gorenberg M, Oren V, Friedland O, Uziel Y. "Growing pains" in children are not associated with changes in vascular perfusion patterns in painful regions. Clin Rheumatol. 2005 Aug;24(4):342-5. Epub 2004 Nov 26. Hashkes PJ, Gorenberg M, Oren V, Friedland O, Uziel Y. "Growing pains" in children are not associated with changes in vascular perfusion patterns in painful regions. Clin Rheumatol. 2005 Aug;24(4):342-5. Epub 2004 Nov 26. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43386 |
| Study title: Haskok SN, Konez O. Mixed form lymphatic malformation of the foot simulating acute soft-tissue lesion on 3-phase bone scintigraphy. Clin Nucl Med. 2004 Jan;29(1):48-50. No abstract available. Haskok SN, Konez O. Mixed form lymphatic malformation of the foot simulating acute soft-tissue lesion on 3-phase bone scintigraphy. Clin Nucl Med. 2004 Jan;29(1):48-50. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43406 |
| Study title: Hayasaka K, Amoh K. [Extra-osseous tumor uptake of bone seeking agents] Kaku Igaku. 1982 Sep;19(8):1243-8. Japanese. No abstract available. Hayasaka K, Amoh K. [Extra-osseous tumor uptake of bone seeking agents] Kaku Igaku. 1982 Sep;19(8):1243-8. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44075 |
| Study title: Hayasaka K, Arakawa K, Sugie H, Amoh K. [An experience with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) as a new bone scanning agent] Radioisotopes. 1984 Oct;33(10):714-6. Japanese. No abstract available. Hayasaka K, Arakawa K, Sugie H, Amoh K. [An experience with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) as a new bone scanning agent] Radioisotopes. 1984 Oct;33(10):714-6. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43979 |
| Study title: Hayasaka K, Sugie H, Saitoh Y, Arakawa K, Amoh K. [Extraosseous tumor uptake of 99m-Tc-MDP] Rinsho Hoshasen. 1985 Jan;30(1):61-5. Japanese. No abstract available. Hayasaka K, Sugie H, Saitoh Y, Arakawa K, Amoh K. [Extraosseous tumor uptake of 99m-Tc-MDP] Rinsho Hoshasen. 1985 Jan;30(1):61-5. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43967 |
| Study title: Phase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold FormulaPhase IV Safety and Efficacy Study of C-30 Liquid Cough-Cold Formula |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29061 |
| Study title: Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63.Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63. |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29053 |
| Study title: Purello−D−Ambrosio−F, Tigano−F, Gallesio−M−T, Chevallier−P, Janssens− M. Astemizole−D compared with triprolidine−D (Actifedregistered trade mark) for acute treatment of perennial allergic rhinitis. Journal of Pharmaceutical Medicine {J−PHARM−MED}, 1994, Vol/Iss/Pg. 4 /1 (15−22). Purello−D−Ambrosio−F, Tigano−F, Gallesio−M−T, Chevallier−P, Janssens− M. Astemizole−D compared with triprolidine−D (Actifedregistered trade mark) for acute treatment of perennial allergic rhinitis. Journal of Pharmaceutical Medicine {J−PHARM−MED}, 1994, Vol/Iss/Pg. 4 /1 (15−22). |
| Active substance: GUAIFENESIN AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29054 |
| Study title: Kuhn JJ, Hendley JO, Adams KF, Clark JW, Gwaltney JM. Antitussive effect of guaifenesin in young adults with natural colds. Chest 1982 82;6: 713-718Kuhn JJ, Hendley JO, Adams KF, Clark JW, Gwaltney JM. Antitussive effect of guaifenesin in young adults with natural colds. Chest 1982 82;6: 713-718 |
| Active substance: GUAIFENESIN OR GUAIFENESIN AND LEVOMENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29063 |
| Study title: Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308.Parvez−L, Vaidya−M, Sakhardande−A, Subburaj−S, Rajagopalan−T−G. Evaluation of antitussive agents in man. Pulmonary pharmacology, {Pulm−Pharmacol}, Oct−Dec 1996, vol. 9, no. 5−6, p. 299−308. |
| Active substance: GUAIFENESIN OR GUAIFENESIN AND LEVOMENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29062 |
| Study title: Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63.Pujet−J−C, Keddad−K, Sévenier−F, Jolivet−Landreau−I. Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study). Thérapie, {Therapie}, Sep−Oct 2002, vol. 57, no. 5, p. 457−63. |
| Active substance: GUAIFENESIN OR GUAIFENESIN AND LEVOMENTHOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29064 |
| Study title: |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41161 |
| Study title: A phase II, double-blind, randomized study to compare the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals¿ Tritanrix¿-HepBlow thio/Hib2.5 Gödöllö to GSK Biologicals¿ Tritanrix¿-HepB/Hiberix¿Gödöllö when administered as a three-dose primary vaccination course to healthy infants at 6, 10 and 14 weeks of age. A dose of unconjugated Hib vaccine (plain PRP booster) will be administered at the age of 10 months to 50% of the subjects. Note: This report presents the results pertaining to the plain PRP challenge at 10 months of age. |
| Active substance: Haemophilus influenzae type b capsular polysaccharide (PRP) conjugated to tetanus toxoid (TT) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41159 |
| Study title: "Fluoxetine Vs Placebo In Obsessive Compulsive " |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28337 |
| Study title: Fluoxetine Vs Placebo In Ocd Relapse Prevention |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28328 |
| Study title: Fluoxetine Vs Placebo In Post Natal Depression |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28326 |
| Study title: "Fluoxetine vs. Placebo in the Acute Treatment of Major Depressive Disorder in Children and Adolescents |
| Active substance: FLUOXETINE |
| Study summary document link (including results): fluoxetine B1Y-MC-X065 Clinical Study Synopsis.pdf |
| View full study record |
| Document reference: 28343 |
| Study title: Natural history and distribution of bone and bone marrow infarction in sickle hemoglobinopathies. Kim SK, Miller JH. J Nucl Med. 2002 Jul;43(7):896-900. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43447 |
| Study title: Kirchner B, Hillmann A, Lottes G, Sciuk J, Bartenstein P, Winkelmann W, Schober O. Intraoperative, probe-guided curettage of osteoid osteoma. Eur J Nucl Med. 1993 Jul;20(7):609-13. Kirchner B, Hillmann A, Lottes G, Sciuk J, Bartenstein P, Winkelmann W, Schober O. Intraoperative, probe-guided curettage of osteoid osteoma. Eur J Nucl Med. 1993 Jul;20(7):609-13. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43658 |
| Study title: Kirchner PT, Simon MA. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1984 Mar;66(3):319-27. Kirchner PT, Simon MA. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1984 Mar;66(3):319-27. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44005 |
| Study title: Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Mentzel HJ, Kentouche K, Sauner D, Fleischmann C, Vogt S, Gottschild D, Zintl F, Kaiser WA. Eur Radiol. 2004 Dec;14(12):2297-302. Epub 2004 Jul 9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43401 |
| Study title: Merkel KD, Brown ML, Dewanjee MK, Fitzgerald RH Jr. Comparison of indium-labeled-leukocyte imaging with sequential technetium-gallium scanning in the diagnosis of low-grade musculoskeletal sepsis. A prospective study. Merkel KD, Brown ML, Dewanjee MK, Fitzgerald RH Jr. Comparison of indium-labeled-leukocyte imaging with sequential technetium-gallium scanning in the diagnosis of low-grade musculoskeletal sepsis. A prospective study. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43951 |
| Study title: Flare response in Ewing's sarcoma. Meyer JR, Shulkin BL. Clin Nucl Med. 1991 Nov;16(11):807-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43723 |
| Study title: Middendorf PR, Marti RK. [Difficulties and possibilities in the detection and removal of osteoid osteoma] Ned Tijdschr Geneeskd. 1985 May 18;129(20):929-32. Dutch. No abstract available. Middendorf PR, Marti RK. [Difficulties and possibilities in the detection and removal of osteoid osteoma] Ned Tijdschr Geneeskd. 1985 May 18;129(20):929-32. Dutch. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43943 |
| Study title: Milachowski KA, Keyl W, Zwingers T. [Scintigraphic findings in fracture of the vertebral body] Unfallchirurgie. 1987 Apr;13(2):93-8. German. Erratum in: Unfallchirurgie 1987 Aug;13(4):230. Milachowski KA, Keyl W, Zwingers T. [Scintigraphic findings in fracture of the vertebral body] Unfallchirurgie. 1987 Apr;13(2):93-8. German. Erratum in: Unfallchirurgie 1987 Aug;13(4):230. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43866 |
| Study title: Scintigraphy of toddler's fracture. Miller JH, Sanderson RA. J Nucl Med. 1988 Dec;29(12):2001-3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43801 |
| Study title: comparative single blind parallell clinical efficacy and tolerance with amoxicillin suspension 50 mg/mlx2 and compare with amoxicillin suspension 25 mg/ml x3.Olsson et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Amoxillin_12.xlsx |
| View full study record |
| Document reference: 48994 |
| Study title: Effect and tolerance of amoxicillin with and without probenecid.Alergant. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48969 |
| Study title: Efficacy in General PracticeJorna J Lees |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48971 |
| Study title: Evaluate efficacy in spefic infections and to compare amoxicillin 250 mg qid and 500 mg bd.Andrews et al |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48972 |
| Study title: Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44150 |
| Study title: Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44197 |
| Study title: Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. Verdú Rico J, Mínguez Vega M, Martínez Caballero A, Antón Leal MA, Jover Díaz R, Riera Ayora M, Muñoz Acosta JM, Caballero Carpena O. [Extraosseous accumulation of 99mTc-HMDP in knees with synovial effusion] Rev Esp Med Nucl. 2004 May-Jun;23(3):162-5. Spanish. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44244 |
| Study title: Vernigora IP, Prokopchuk VF, Gritsaĭ NP, Radchenko DP. [Scintigraphy in the prognosis of the outcome of a free autoplasty in cases of suppurative infection] Ortop Travmatol Protez. 1988 Sep;(9):62. Russian. No abstract available. Vernigora IP, Prokopchuk VF, Gritsaĭ NP, Radchenko DP. [Scintigraphy in the prognosis of the outcome of a free autoplasty in cases of suppurative infection] Ortop Travmatol Protez. 1988 Sep;(9):62. Russian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43811 |
| Study title: Vorne M, Saukko T. Detection of malignant soft tissue tumors in bone imaging. Eur J Nucl Med. 1984;9(4):180-4. Vorne M, Saukko T. Detection of malignant soft tissue tumors in bone imaging. Eur J Nucl Med. 1984;9(4):180-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44008 |
| Study title: Unexpected myocardial uptake on bone scintigraphy in an infant with Kawasaki disease. Macdonald WB, Troedson RG. Clin Nucl Med. 2001 May;26(5):455. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43454 |
| Study title: Machida K, Makita K, Nishikawa J, Ohtake T, Iio M. Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med. 1986 Jun;11(6):426-9. Machida K, Makita K, Nishikawa J, Ohtake T, Iio M. Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med. 1986 Jun;11(6):426-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43907 |
| Study title: A rare cause of rickets in a young child. Machiels F, De Maeseneer M, Van Snick A, Rayen I, Desprechins B, Osteaux M. J Belge Radiol. 1995 Oct;78(5):276-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43585 |
| Study title: Madsen JL. Scintigraphic detection of clavicular hyperostosis in a patient with fulminant acne. Clin Nucl Med. 1988 May;13(5):345. Madsen JL. Scintigraphic detection of clavicular hyperostosis in a patient with fulminant acne. Clin Nucl Med. 1988 May;13(5):345. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43818 |
| Study title: Haynie TP. Prognosis by nuclear medicine: can functional staging of cancer patients predict therapeutic response and survival? J Nucl Med. 1993 Jul;34(7):1087-9. No abstract available. Haynie TP. Prognosis by nuclear medicine: can functional staging of cancer patients predict therapeutic response and survival? J Nucl Med. 1993 Jul;34(7):1087-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43661 |
| Study title: Heinle A, Carrasquillo JA, Neumann RD. Two unusual cases of metastatic osteosarcoma detected by Tc-99m MDP bone scintigraphy. Clin Nucl Med. 1989 Dec;14(12):889-93. Heinle A, Carrasquillo JA, Neumann RD. Two unusual cases of metastatic osteosarcoma detected by Tc-99m MDP bone scintigraphy. Clin Nucl Med. 1989 Dec;14(12):889-93. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43776 |
| Study title: Hejgaard N, Diemer H. Bone scan in the patellofemoral pain syndrome. Int Orthop. 1987;11(1):29-33. Hejgaard N, Diemer H. Bone scan in the patellofemoral pain syndrome. Int Orthop. 1987;11(1):29-33. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43882 |
| Study title: Helms CA, Hattner RS, Vogler JB 3rd. Osteoid osteoma: radionuclide diagnosis. Radiology. 1984 Jun;151(3):779-84. Helms CA, Hattner RS, Vogler JB 3rd. Osteoid osteoma: radionuclide diagnosis. Radiology. 1984 Jun;151(3):779-84. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43998 |
| Study title: Hematogenous pyogenic vertebral osteomyelitis: diagnostic value of radionuclide bone imaging. Adatepe MH. Powell OM. Isaacs GH. Nichols K. Cefola R. J Nucl Med 1986 Nov;27(11):1680-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48463 |
| Study title: Abnormal Tc-99m MDP renal images associated with hemolytic streptococcal sepsis. Sty JR, Wells RG, Ruiz ME. Clin Nucl Med. 1995 Oct;20(10):944. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43582 |
| Study title: Suematsu T, Yoshida S, Motohara T, Fujiwara H, Nishii H, Komiyama T, Yanase M, Mizutani M. [Diffusely increased uptake in the skull in normal bone scans] Kaku Igaku. 1992 May;29(5):599-605. Japanese. Suematsu T, Yoshida S, Motohara T, Fujiwara H, Nishii H, Komiyama T, Yanase M, Mizutani M. [Diffusely increased uptake in the skull in normal bone scans] Kaku Igaku. 1992 May;29(5):599-605. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43698 |
| Study title: Infantile infectious sacroiliitis. Sueoka BL, Johnson JF, Enzenauer R, Kolina JS. Pediatr Radiol. 1985;15(6):403-5. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43960 |
| Study title: Resolved splenic accumulation of Tc-99m HMDP after recovery of disseminated intravascular coagulation in a patient with rhabdomyosarcoma. Suga K, Matsunaga N, Kawamura T, Hara A, Kume N. Clin Nucl Med. 1999 Jun;24(6):414-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43507 |
| Study title: Sugimura K, Narabayashi I, Yamazaki K, Fukugawa T, Sugimura C, Matsuo M, Nishiyama S, Kimura S. [Bone scintigraphic findings in 2 cases of myositis ossificans progressiva] Kaku Igaku. 1983 Jul;20(6):875-9. Japanese. No abstract available. Sugimura K, Narabayashi I, Yamazaki K, Fukugawa T, Sugimura C, Matsuo M, Nishiyama S, Kimura S. [Bone scintigraphic findings in 2 cases of myositis ossificans progressiva] Kaku Igaku. 1983 Jul;20(6):875-9. Japanese. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44034 |
| Study title: Fluoxetine: In Depression And Ocd (Compassionate Use) |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28332 |
| Study title: Fluoxetine/Placebo In Panic Disorder |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28338 |
| Study title: Impact Of Fluoxetine On Growth In Children And Adolescents |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28330 |
| Study title: Pharmacokinetic Assessment of Fluoxetine and Norfluoxetine in Preadolescent and Adolescent Patients |
| Active substance: FLUOXETINE |
| Study summary document link (including results): fluoxetine B1Y-MC-HCIU Clinical Study Summary.pdf |
| View full study record |
| Document reference: 47357 |
| Study title: "Prozac.Epidemiological Study In Obsessional Compulsive Disorder " |
| Active substance: FLUOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28336 |
| Study title: Tomoxetine + fluoxetine for Poor Metabolizer exposures |
| Active substance: FLUOXETINE |
| Study summary document link (including results): fluoxetine B4Z-MC-LYAQ Clinical Study Summary.pdf |
| View full study record |
| Document reference: 28333 |
| Study title: Reimão R, Lefévre AB.: Evaluation of flurazepam and placebo on sleep disorders in childhood. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13. |
| Active substance: FLURAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28345 |
| Study title: VALUTAZIONE IN PEDIATRIA DELL'ATTIVITA' IPNOINDUCENTE DEL FLURAZEPAM GOCCE (VAL 779) Rapisarda V.; Germana B. Formazione Psichiatrica, December 1, 1980 , No. 4/- (181-190) Evaluation of flurazepam and placebo on sleep disorders in childhood. Reimão R, Lefévre AB. Arq Neuropsiquiatr. 1982 Mar;40(1):1-13. |
| Active substance: FLURAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28344 |
| Study title: |
| Active substance: FLURBIPROFEN |
| Study summary document link (including results): Flurbiprofen-M87-097.pdf |
| View full study record |
| Document reference: 47460 |
| Study title: Flurbiprofen in the Tretment of Juvenile Rheumatoid Arhtritis |
| Active substance: FLURBIPROFEN |
| Study summary document link (including results): flurbiprofen-m86055-bass.xls |
| View full study record |
| Document reference: 48078 |
| Study title: Pharmacokinetics of Oral and Rectal Flurbiprofen in Childrene |
| Active substance: FLURBIPROFEN |
| Study summary document link (including results): flurbiprofen-m84016-scaroni.xls |
| View full study record |
| Document reference: 48076 |
| Study title: Post-Tonsillectomy Treatment with Flurbiprofen and Phenylprenazone in Children |
| Active substance: FLURBIPROFEN |
| Study summary document link (including results): flurbiprofen-m84017-catalano.xls |
| View full study record |
| Document reference: 48077 |
| Study title: A placebo controlled trial during the pollen season comparing the effects of intranasal Beclomethasone dipropionate and intranasal Fluticasone propionate in children and young adults with asthma and allergic rhinitis. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FNM40054-ICHE3.pdf |
| View full study record |
| Document reference: 28366 |
| Study title: A randomised, double-blind, double-dummy, parallel group, multicentre study to compare the effect on growth measured by stadiometry of fluticasone propionate (100μg bd) administered via DISKUS™ with budesonide (200μg bd) administered via Turbuhaler in prepubescent children. |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FMS40001-ICHE3.pdf |
| View full study record |
| Document reference: 28384 |
| Study title: A Randomized, Double-Blind, Double Dummy, Parallel Group Comparison of Fluticasone Propionate Inhalation Powder (50mcg BID) via DiskusTM with Oral Montelukast (5mg QD) Chewable Tablets in Children 6–12 years of Age with Persistent Asthma |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Fluticasone-Propionate-FPD40012-ICHE3.pdf |
| View full study record |
| Document reference: 28389 |
| Study title: Minematsu K, Tsuchiya H, Taki J, Tomita K. Blood flow measurement during distraction osteogenesis. Clin Orthop Relat Res. 1998 Feb;(347):229-35. Minematsu K, Tsuchiya H, Taki J, Tomita K. Blood flow measurement during distraction osteogenesis. Clin Orthop Relat Res. 1998 Feb;(347):229-35. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43535 |
| Study title: Sequential radionuclide bone imaging in avascular pediatric hip conditions. Minikel J, Sty J, Simons G. Clin Orthop Relat Res. 1983 May;(175):202-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44038 |
| Study title: 111In-labelled leucocyte and 99mTc-methylene diphosphonate bone scanning in pelvic osteomyelitis. Hall FM, Conybeare ME, Coakley AJ, Mountford PJ, Wells CP. Eur J Nucl Med. 1983;8(9):393-4. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44056 |
| Study title: Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence. Hall-Craggs MA, Shaw D, Pritchard J, Gordon I. Skeletal Radiol. 1990;19(1):33-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43770 |
| Study title: Evaluate the efficacy of amoxicillin i ndifferent dosages i nthe treatment of gonococcal urethritis in the male. Compare the results with stnadard treatment.Watt et al. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48970 |
| Study title: Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. Paediatric experience. Min.Ped.1984,36(3),127-138. Romano C. et al. Minerva Pediatrica 1984, Romano |
| Active substance: AMBROXOL |
| Study summary document link (including results): Minerva Pediatrica 1984, Romano.pdf |
| View full study record |
| Document reference: 48874 |
| Study title: Miller TW, Heck LL, Kight JL, McCarroll JR, Shelbourne KD, Van Hove ED. A clinical and radiological review of stress fractures in competitive and non-competitive athletes. Indiana Med. 1987 Oct;80(10):942-9. No abstract available. Miller TW, Heck LL, Kight JL, McCarroll JR, Shelbourne KD, Van Hove ED. A clinical and radiological review of stress fractures in competitive and non-competitive athletes. Indiana Med. 1987 Oct;80(10):942-9. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43848 |
| Study title: A phase III, observer-blind, single-centre, randomized study to evaluate safety and immunogenicity of three lots of DTwPHib full liquid vaccine (Chiron Vaccines; now Novartis Vaccines) and of American Home Product (AHP-Wyeth) Tetramune (DTwPHib) vaccine administered to healthy infants at 2, 3 and 4 months of age.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V38P2.xlsx |
| View full study record |
| Document reference: 49184 |
| Study title: A randomized, stratified, double blind trial to compare safety and efficacy of the Fluvirin® Vaccine (a purified surface antigen vaccine) with Connaught Inactivated Influenza Vaccine Fluzone® (a split virion vaccine) in healthy children aged 6 to 47 months of age.Nicolay 1999, Vaccine 17 (1999) 2223-2228 |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): MPL-318-01.xlsx |
| View full study record |
| Document reference: 49190 |
| Study title: Esomeprazole Magnesium: An 8 Week Oral (Gavage) Toxicity and Toxicokinetic Study in the Neonatal and Young Adult Beagle Dog (a Complementary Study). AstraZeneca R&D Södertälje, Safety Assessment, Sweden (Charles River Laboratories Preclinical Services Mo |
| Active substance: ESOMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26610 |
| Study title: Diptheria booster vaccination one or two injections_1999Nicolay 1999, Vaccine 17 (1999) 2223-2228 |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Nicolay_Diptheria booster vaccination one or two injections_1999.pdf |
| View full study record |
| Document reference: 49189 |
| Study title: Pilar 1983Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Pilar 1983.pdf |
| View full study record |
| Document reference: 49188 |
| Study title: An open label, not randomized, age stratified trial to study safety and efficacy of the vaccine in subjects from 6 to 35 months of age.Please see report - study report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): MEMUFL-95-001.xlsx |
| View full study record |
| Document reference: 49191 |
| Study title: Publication_8T-201RAPlease see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Publication_8T-201RA.pdf |
| View full study record |
| Document reference: 49187 |
| Study title: Response to Diphtheria and Tetanus Booster Vaccination in pediatric renal transplantTransplantation, Issue: Volume 64(2),27 July 1997,pp 237-241, Enke |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49193 |
| Study title: Safety and immunogenicity of anew fully liquid DTPw-HepB-Hib combination vaccine in infantsKanra_et_al_2006_Publication |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): Kanra_et_al_2006_Publication.pdf |
| View full study record |
| Document reference: 49192 |
| Study title: Gregianin LJ et al Clinical and pharmacokinetic study of fractionated doses of oral etoposide in pediatric patients with advanced malignancies Med Sci Monit 2002 Sep;8(9):PI70-7Gregianin LJ et al Clinical and pharmacokinetic study of fractionated doses of oral etoposide in pediatric patients with advanced malignancies Med Sci Monit 2002 Sep;8(9):PI70-7 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24913 |
| Study title: Controlled study on the efficacy of Flour-Vigantoletten 1000 in prophylaxis of rachitis -Kontrollierte Studie zur rachitisprophylaktischen Wirkung von Flour-Vigantoletten 1000.Ther d Gegenw 1976; 115: 2076-2087 Pohlandt F., 1976 |
| Active substance: COLECALCIFEROL AND SODIUM FLUORIDE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48990 |
| Study title: Casanova M et al Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors Pediatr Hematol Oncol 2005 Apr-May;22(3):189-98Casanova M et al Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors Pediatr Hematol Oncol 2005 Apr-May;22(3):189-98 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24816 |
| Study title: Schiavetti A et al Ten-day schedule oral etoposide therapy in advanced childhood malignancies J Pediatr Hematol Oncol 2000 Mar-Apr;22(2):119-24Schiavetti A et al Ten-day schedule oral etoposide therapy in advanced childhood malignancies J Pediatr Hematol Oncol 2000 Mar-Apr;22(2):119-24 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25110 |
| Study title: open uncontrolled study to evaluate the acceptance and tolerance of flucloxacillin suspension.Lidgren. Clinical trial on flucloxacillin suspension in children. |
| Active substance: FLUCLOXACILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_2.xlsx |
| View full study record |
| Document reference: 49075 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV FCA IN THE TREATMENT OF CANDIDIASIS IN THE LEUKEMIC PATIENTS |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27941 |
| Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27663 |
| Study title: Anticancer Res. 2003 Jul-Aug;23(4):3513-6. Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings. Tsai MH, Huang WS, Tsai JJ, Chen YK, Changlai SP, Kao CH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28141 |
| Study title: JM Espadaler. Ensayo de la CDPcolina en el tratamiento de los trastornos del aprendizaje del niño. Med Clin (Barc), 71: 357-361, 1978JM Espadaler. Ensayo de la CDPcolina en el tratamiento de los trastornos del aprendizaje del niño. Med Clin (Barc), 71: 357-361, 1978 |
| Active substance: CITICOLINE |
| Study summary document link (including results): Espadaler CITICOLINE MONOSODIUM_Ferrer Internacional.xls |
| View full study record |
| Document reference: 24296 |
| Study title: Radionuclide studies in paediatric nephro-urologyPiepsz A. Eur J Radiol. 2002 Aug;43(2):146-53. |
| Active substance: CHROMIUM 51 |
| Study summary document link (including results): Piepsz A 2002.pdf |
| View full study record |
| Document reference: 24091 |
| Study title: Guillonneau M, Jacqz Aigrain E, Galliot M, Binet M-H, Darbois Y. Colchicine is excreted at high concentrations in human breast milk. European journal of obstetrics&Gynecology and Reproductive Biology 1995; 61:177-178Guillonneau M, Jacqz Aigrain E, Galliot M, Binet M-H, Darbois Y. Colchicine is excreted at high concentrations in human breast milk. European journal of obstetrics&Gynecology and Reproductive Biology 1995; 61:177-178 |
| Active substance: COLCHICINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24588 |
| Study title: FABIE M.;BARTHELEMY R. Clinical Study of a locally active solution. Rev. Odonto-stomatol. Midi Fr., 1969, 4, 267-273. |
| Active substance: CHLORHEXIDINE AND CHLOROBUTANOL |
| Study summary document link (including results): Eludril_Fabie.xls |
| View full study record |
| Document reference: 23897 |
| Study title: De Martini et al Clofoctol: microbiological, pharmacological and clinical aspects. Farmaci,1999,23(6)202-208 -aspetti microbiologici, farmacologici e clinici.Farmaci vol. 23 n.6-'99, De Martini Farmaci,1999,23(6)202-208 |
| Active substance: clofoctol |
| Study summary document link (including results): Art 45 EMA Chiesi Paediatric Studies.xls |
| View full study record |
| Document reference: 48991 |
| Study title: TEST ON TERATOGENIC EFFECT - RATS, ORAL ADMINISTRATION |
| Active substance: CLOMIPRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24381 |
| Study title: Pitsiu−Maria, Hussein−Ziad, Majid−Oneeb, Aarons−Leon, de−Longueville− Marc, Stockis−Armel. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years. British journal of clinical pharmacology, {Br−J−Clin−Pharmacol}, Apr 2004, vol. 57, no. 4, p. 402−11.Pitsiu−Maria, Hussein−Ziad, Majid−Oneeb, Aarons−Leon, de−Longueville− Marc, Stockis−Armel. Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years. British journal of clinical pharmacology, {Br−J−Clin−Pharmacol}, Apr 2004, vol. 57, no. 4, p. 402−11. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23670 |
| Study title: A report on the method of treatment of chronic osteomyelitis at the Clinic of Infectious Diseases in Lund, which is both general and local in antibiotics administration. Comparisons are made with reports on the same general, but without the local treatment.Hedström (Scand J Infec Dis 1: 175-180, 1969) |
| Active substance: CLOXACILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Cloxacillin_1.xlsx |
| View full study record |
| Document reference: 49082 |
| Study title: symptomatic treatment of migraine in children: a systemic review of medications trials |
| Active substance: CHLORPHENAMINE AND PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24048 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with sore throat pain. Dec 1992. |
| Active substance: CODEINE_AND_PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24563 |
| Study title: Experience with rnebendazol in children with multiple intestinal helminthiasis. 1974 |
| Active substance: MEBENDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31553 |
| Study title: Compare the effectiveness in the treatment of chronic constipation of a lactulose preparation ("Duphalac") and "irritant" laxatives containing senna, anthraquinone derivatives or bisacodyl.Connolly et al |
| Active substance: LACTULOSE |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Lactulose_2.xlsx |
| View full study record |
| Document reference: 49067 |
| Study title: Compare the effects of chemotherapy, chemotherapy combined with Lactulose, or Lactulose alone with regard to curtailing the pathological excretion of salmonellae.Sander-Treske et al |
| Active substance: LACTULOSE |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Lactulose_4.xlsx |
| View full study record |
| Document reference: 49069 |
| Study title: Forlax in the treatment of childhood constipation: a randomized, controlled, multicenter clinical study. Wang BX, Wang MG, Jiang MZ, Xu CD, Shao CH, Jia LY, Huang ZH, Xu XH. Zhongguo Dang Dai Er Ke Za Zhi. 2007 Oct;9(5):429-32.Forlax in the treatment of childhood constipation: a randomized, controlled, multicenter clinical study. Wang BX, Wang MG, Jiang MZ, Xu CD, Shao CH, Jia LY, Huang ZH, Xu XH. Zhongguo Dang Dai Er Ke Za Zhi. 2007 Oct;9(5):429-32. |
| Active substance: LACTULOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30993 |
| Study title: Minuck M. Postoperative Analgesia - Comparison of Methotrimeprazine (Nozinan) and Meperidine (Demerol) as Postoperative Minuck M. Postoperative Analgesia - Comparison of Methotrimeprazine (Nozinan) and Meperidine (Demerol) as Postoperative |
| Active substance: LEVOPROMAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31164 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Cinnamomum-Homaccord N (drops) [AWB-AT] |
| Active substance: Cinnamomum-Homaccord N |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39829 |
| Study title: A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. Eur J Pediatr 1997; 156: 94-98 Touati G et al., 1997 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48951 |
| Study title: Analysis of Physical and Mental Developmernt of Children With Aplasia, Hypoplasia and Ectopy of the Thyroid GlandEndocrine Reg 2006; 40: 7-14 Pniewska-Siark B., 2006 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48978 |
| Study title: Children With Congenital Hypothyroidism and Their Siblings: Do They Really Differ?Rovet JF., 2005 Horm Res 2006; 66: 240-248 Pediatrics 2005; 1145 (1): e52-e57 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48956 |
| Study title: Cognition and Behaviour at School Entry in Children With Congenital Hypothyroidism Treated Early With High-Dose LevothyroxineJ Pediatr 2004; 144: 747-752 Simoneau-Roy J., 2004 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48980 |
| Study title: Effect of long-term L-thyroxine treatment on bone mineral density in young adults with congenital hypothyroidismEur J Endocrinol 2004; 151: 689-694 Salerno M., 2004 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48984 |
| Study title: Investigate the clinical use of Lactulose as laxative in constipated children.Bush |
| Active substance: LACTULOSE |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Lactulose_3.xlsx |
| View full study record |
| Document reference: 49068 |
| Study title: To compare lactulose with standardized senna syrup in treatment of constipated children.Perkin |
| Active substance: LACTULOSE |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Lactulose_1.xlsx |
| View full study record |
| Document reference: 49066 |
| Study title: Improved Radiation Protection of the Thyroid Gland with Thyroxine, Methimazole, and Potassium Iodide during Diagnostic and Therapeutic Use of Radiolabeled Metaiodobenzylguanidine in Children with Neuroblastoma Cancer2003; 98: 389-396 Van Santen HM., 2003 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48986 |
| Study title: Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidismJ Pediatr 2000; 136: 292-297 Bongers-Schokking JJ., 2000 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48982 |
| Study title: Levothyroxine in Euthyroid Autoimmune Thyroiditis and Type 1 Diabetes: A Randomized, Controlled TrialJ Clin Endocrinol Metab 2007; 92: 1647-1652 Karges B., 2007 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48983 |
| Study title: Longitudinal Assessment of L-T4 Therapy for Congenital Hypothyroidism: Differences Between Athyreosis vs Ectopia and Delayed vs Normal Bone Age, Garcia MF 2000 J Pediatr Endocrinol Metab 2000; 13: 63-69 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48953 |
| Study title: LT4-monopreparation versus LT4-LT3-compound preparation in the treatment of diffuse endemic goitreActa Endocrinologica (Copenh) 1986, 113: 242-248 Bongers H.; 1986 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48988 |
| Study title: Motor nerve conduction velocity in very preterm infants in relation to L-thyroxine supplementationJ Pediatr 1998; 132: 64-69 Smit BJ., 1998 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48981 |
| Study title: Pyridostigmine and metoclopramide do not restore the TSH response to TRH-inhibited by L-thyroxine treatment in children with goiter. J Endocrinol Invest 2000; 23: 744-747, Radetti G., 2000 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48952 |
| Study title: Relationship of Etiology to Treatment in Congenital HypothyoidismJ Clin Endocrinol Metab 2001; 86: 186-191 Hanukoglu A., 2001 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48985 |
| Study title: Effects of Early High-Dose Levothyroxine Treatment on Auditory Brain Even-Related Potentials at School Entry in children with Congenital Hypothyroidism Marti S., 2006 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48955 |
| Study title: Therapie der Jodmangelstruma bei Jugendlichen mit Jodid oder einer Kombination von Jodid und Levothyroxin unter besonderer Berücksichtigung der Lipidparameter. Rönnefarth G., 1996 Klin Pädiatr 1996; 208: 123-128 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48954 |
| Study title: Three-Year follow-up of borderline congenital hypothyroidismJ Pediatr 2000; 136: 53-56 Daliva AL., 2000 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48979 |
| Study title: Treatment for congenital hypothyroidism: Thyroxine alone or thyroxine plus triiodothyronine?Pediatrics 2003, 111, 5: 1055-60 Cassio A., 2003 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48987 |
| Study title: Triiodothyronine and thyroxine treatment of diffuse non-toxic goiter evaluated by ultrasonic scanningActa Endocrinol (Copenh) 1982; 100: 382-387 Perrild, H., 1982Acta Endocrinol (Copenh) 1982; 100: 382-387 Perrild, H., 1982 |
| Active substance: LEVOTHYROXINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48989 |
| Study title: LT4-monopreparation versus LT4-LT3-compound preparation in the treatment of diffuse endemic goitreActa Endocrinologica (Copenh) 1986, 113: 242-248 Bongers H.; 1986 |
| Active substance: LIOTHYRONINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48976 |
| Study title: Triiodothyronine and thyroxine treatment of diffuse non-toxic goiter evaluated by ultrasonic scanning Acta Endocrinol (Copenh) 1982; 100: 382-387 Perrild, H., 1982 |
| Active substance: LIOTHYRONINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48977 |
| Study title: Submission of result-related information on paediatric studies submitted under Article 45 of the Paediatric Regulation No 1901/2006. Product concerned by this submission: Claritine/Clarityn Syrup and Associated Tradenames (loratadine)Merck Sharp & Dohme (Europe), Inc. Clos du Lynx 5 Lynx Binnenhof B-1200 Brussels |
| Active substance: LORATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48848 |
| Study title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lovastatin as an Adjunct to Diet in the Treatment of Adolescent Males WitH Hypercholesterolemia of Familial Basis |
| Active substance: LOVASTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31473 |
| Study title: Multicentre, randomised, comparative double-blind and double placebo study in two parallel groups, of the efficacy and safety of ketoprofen (0.5 mg/kg/dose), versus paracetamol (15 mg/kg/dose), in repeated doses, in the treatment of febrile conditions in children aged 6 months to 6 years. |
| Active substance: KETOPROFEN |
| Study summary document link (including results): Ketoprofen-Study 4.pdf |
| View full study record |
| Document reference: 30864 |
| Study title: Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31137 |
| Study title: Immunogenicity and safety of Rouvax vaccine in different age-group Thai children |
| Active substance: LIVE ATTENUATED MEASLES (SCHWARZ STRAIN) VACCINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41242 |
| Study title: A Kr-81m inhalation method for detection of absence of uniform ventilation in asthma.Clin Nucl Med. 1981 Oct;6(10):463-7. Kawakami K 1981 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48561 |
| Study title: [A measurement of V/V distribution by intravenous injection of Kr-81m and Tc-99m-MAA--a comparative study with Xe-133 inhalation method] [Article in Japanese]Kaku Igaku. 1988 Apr;25(4):323-9. Ohtani Y 1988 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48542 |
| Study title: A model for assessing bronchial mucus transport.Pediatr Radiol. 1985;15(3):161-4. Ham HR 1985 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48549 |
| Study title: Airway responses to repeated exercises detected by krypton-81m in asthmatic children.J Asthma. 1992;29(6):375-81.Obata T 1992 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48537 |
| Study title: Can dynamic krypton-81m imaging separate regional ventilation and volume?Lythgoe MF 1992. J Nucl Med. 1992 Nov;33(11):1935-9. Comment in:J Nucl Med. 1992 Nov;33(11):1939-42. |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48534 |
| Study title: Donaldson SS et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):125-35.Donaldson SS et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):125-35. |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24848 |
| Study title: Study title not availableStudy title not available |
| Active substance: DICLOFENAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26005 |
| Study title: Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: A report from the SIOP 93-01 nephroblastoma trial and study |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25433 |
| Study title: Comparative assessment of the effects of 6-methyl-prednisolone and deflazacort in the maintenance therapy of rheumatoid arthritis patients - Colombo B, Sinigaglia L, Cagnoli M and Imbimbo B - 1986 - Report (reference 39) in the Clinical Documentation Deflazacort 6mg tablet - 04/1991 - |
| Active substance: DEFLAZACORT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25632 |
| Study title: Medical examiner reports of dextromethorphan exposures in the drug abuse warning network. -McElwee NE. et al.- 1991 (J. Clin. Res. Pharmacoepidemiol.; 5: 167) - Publication of Part IV Dextromethorphan HBr Syrup 1% - |
| Active substance: DEXTROMETHORPHAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25835 |
| Study title: Osborn, D.A., N. Evans, and M. Kluckow, Left ventricular contractility in extremely premature infants in the first day and response to inotropes. Pediatr Res, 2007. 61(3): p. 335-40. Osborn, D.A., N. Evans, and M. Kluckow, Left ventricular contractility in extremely premature infants in the first day and response to inotropes. Pediatr Res, 2007. 61(3): p. 335-40. |
| Active substance: DOBUTAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26290 |
| Study title: Denhoff et al.: Treatment of spastic cerebral-palsied children with sodium dantrolene; Dev. Med. Child. Neurol. 17, 736-742 (1975)Denhoff et al.: Treatment of spastic cerebral-palsied children with sodium dantrolene; Dev. Med. Child. Neurol. 17, 736-742 (1975) |
| Active substance: DANTROLENE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25533 |
| Study title: Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol. 2007 Oct;22(10):1191-7.Mehta V, Singhi P, Singhi S. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol. 2007 Oct;22(10):1191-7. |
| Active substance: DIAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25938 |
| Study title: AN 15211696 Medline 20070101. TI Cyproheptadine is an effective appetite stimulant in cystic fibrosis. SO Pediatric pulmonology, {Pediatr-Pulmonol}, Aug 2004, vol. 38, no. 2, p. 129-34, ISSN: 8755-6863. AU Homnick-Douglas-N, Homnick-Benjamin-D, Reeves-Andrew-J, Marks-John-H, Pimentel-Ronald-S, Bonnema-Sally-K. IN Division of Pediatric Pulmonology, Department of Pediatrics, Kalamazoo Center for Medical Studies, Michigan State University, 49008, USA. Homnick@kcms.msu.edu. YR 2004.AN 15211696 Medline 20070101. TI Cyproheptadine is an effective appetite stimulant in cystic fibrosis. SO Pediatric pulmonology, {Pediatr-Pulmonol}, Aug 2004, vol. 38, no. 2, p. 129-34, ISSN: 8755-6863. AU Homnick-Douglas-N, Homnick-Benjamin-D, Reeves-Andrew-J, Marks-John-H, Pimentel-Ron... |
| Active substance: CYPROHEPTADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25235 |
| Study title: Doppler study of myometrium in invasive gestational trophoblastic disease. |
| Active substance: DACTINOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25333 |
| Study title: Fon GT, Wong WS, Gold RH, Kaiser LR. Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review. AJR Am J Roentgenol. 1981 Jul;137(1):103-8. Fon GT, Wong WS, Gold RH, Kaiser LR. Skeletal metastases of melanoma: radiographic, scintigraphic, and clinical review. AJR Am J Roentgenol. 1981 Jul;137(1):103-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44119 |
| Study title: Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid−resistant idiopathic nephrotic syndrome.Kumar NS, Singh A K, Mishra RN, Prakash J. The Journal of the Association of Physicians of India, Jun 2004, vol. 52, p. 454−8, Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid−resistant idiopathic nephrotic syndrome.Kumar NS, Singh A K, Mishra RN, Prakash J. The Journal of the Association of Physicians of India, Jun 2004, vol. 52, p. 454−8, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45535 |
| Study title: Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head−up tilt test response.Walton SA, Berk M, Brook S. The Journal of clinical psychiatry, Nov 1996, vol. 57, no. 11, p. 543−6, Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head−up tilt test response.Walton SA, Berk M, Brook S. The Journal of clinical psychiatry, Nov 1996, vol. 57, no. 11, p. 543−6, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45545 |
| Study title: Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function−−a pilot study.Ostman−Smith I, Wettrell G, Riesenfeld T. Journal of the American College of Cardiology, 15 Nov 1999, vol. 34, no. 6, p.1813−22, Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function−−a pilot study.Ostman−Smith I, Wettrell G, Riesenfeld T. Journal of the American College of Cardiology, 15 Nov 1999, vol. 34, no. 6, p.1813−22, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45541 |
| Study title: (Effect of verapamil with renal disease basic−prescription on hemorheology indexes of type II nephrotic syndrome).Liang D, Li DD. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui Zhongguo Zhong yi yan jiu yuan zhu ban, Feb 1993, vol. 13, no. 2, p. 86−7, 68, (Effect of verapamil with renal disease basic−prescription on hemorheology indexes of type II nephrotic syndrome).Liang D, Li DD. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui Zhongguo Zhong yi yan jiu yuan zhu ban, Feb 1993, vol. 13, no. 2, p. 86−7, 68, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45551 |
| Study title: Effectiveness of the combination verapamil and chlorpromazine in the treatment of severe manic or mixed patients.Lenzi A, Marazziti D, Raffaelli S, Cassano GB. Progress in neuro−psychopharmacology & biological psychiatry, May 1995, vol. 19, no. 3, p. 519−28, Effectiveness of the combination verapamil and chlorpromazine in the treatment of severe manic or mixed patients.Lenzi A, Marazziti D, Raffaelli S, Cassano GB. Progress in neuro−psychopharmacology & biological psychiatry, May 1995, vol. 19, no. 3, p. 519−28, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45548 |
| Study title: Effects of verapamil on anthracycline−induced cardiomyopathy: preliminary results of a prospective multicenter trial.Kraft J, Grille W, Appelt M, Hossfeld DK, Eichelbaum M, Koslowski B, Quabeck K, Kuse R, Büchner T, Hiddemann W, et al. Haematology and blood transfusion, 1990, vol. 33, p. 566−70,Effects of verapamil on anthracycline−induced cardiomyopathy: preliminary results of a prospective multicenter trial.Kraft J, Grille W, Appelt M, Hossfeld DK, Eichelbaum M, Koslowski B, Quabeck K, Kuse R, Büchner T, Hiddemann W, et al. Haematology and blood transfusion, 1990, vol. 33, p. 566−70, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45560 |
| Study title: Caustic ingestion and esophageal function.J Pediatr Gastroenterol Nutr. 1990 Feb;10(2):164-8. Cadranel S 1990 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48538 |
| Study title: Clinical applications of radionuclide lung scanning in infants and children.Br J Radiol. 1981 Jul;54(643):576-85. Gordon I 1981 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48553 |
| Study title: Determination of right ventricular ejection fraction in children with cystic fibrosis.Pediatr Pulmonol. 1987 Jan-Feb;3(1):24-8. Piepsz A 1987 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48543 |
| Study title: Effect of posture on regional ventilation in children.Pediatr Pulmonol. 1992 Apr;12(4):227-32. Davies H 1992 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48536 |
| Study title: Effects of posture on the distribution of pulmonary ventilation and perfusion in children and adults.Thorax. 1989 Jun;44(6):480-4.Bhuyan U 1989 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48540 |
| Study title: Evaluation of esophageal transit in children and in infants by means of Krypton-81m.Pediatr Radiol. 1985;15(3):161-4. Ham HR 1985 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48548 |
| Study title: Evaluation of the Accuracy of Steady-State Krypton-Sim Method for Calculating Right Ventricular Ejection FractionHamphrey R. Ham. Philipe R. Franken, Bernard Georges, Eric Delcourt, Marcel Guillaume, and Amnon Piepsz.J NucÃMed 27:593-601, 1986 |
| Active substance: krypton |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48531 |
| Study title: Investigating the small lung: which imaging procedure?Arch Dis Child. 1982 Sep;57(9):696-701. Gordon I 1982 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48551 |
| Study title: Krypton-81m ventilation and technetium-99m macroaggregated albumin perfusion scintigraphy for detection of pulmonary embolism: the first experience in Taiwan. |
| Active substance: krypton |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48532 |
| Study title: Krypton-81m: a better radiopharmaceutical for assessment of regional lung function in children.Radiology. 1979 Mar;130(3):741-7. Li DK 1979 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48558 |
| Study title: Late pulmonary scintigraphic defects after uneventful recovery from simple focal pneumonia of childhood.Kenney IJ 1993 |
| Active substance: krypton |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48533 |
| Study title: Provocation test for children with bronchial asthma monitored by 81mKr ventilation and perfusion lung scans.Eur J Nucl Med. 1985;10(1-2):81-3. Uchiyama G 1985 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48547 |
| Study title: Bronchiectasis in childhood. Comparison of chest roentgenograms, bronchography and lung scintigraphy.Pediatr Radiol. 1980 Jul;9(4):193-8. Vandevivere J 1980 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48556 |
| Study title: Pulmonary ventilation and perfusion studies in infants and children.J Thorac Imaging. 1986 Oct;1(4):49-56. Gainey MA 1986 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48544 |
| Study title: [Pulmonary ventilation studies of asthmatic children with Kr-81m (author's transl)] [Article in Japanese]Nippon Igaku Hoshasen Gakkai Zasshi. 1979 May 25;39(5):499-505.Uchiyama G 1979 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48557 |
| Study title: Quantitative approach to the study of regional lung function in children using krypton 81m.Br J Radiol. 1980 Oct;53(634):950-9. Ciofetta G 1980 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48554 |
| Study title: Assessment of lung perfusion impairment in patients with pulmonary artery-occlusive and chronic obstructive pulmonary diseases with noncontrast electrocardiogram-gated fast-spin-echo perfusion MR imaging. J Magn Reson Imaging. 2004 Oct;20(4):601-11. Ogasawara N 2004 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48793 |
| Study title: COMPARATIVE STUDY OF AMPICILLIN/SULBACTAM VS CEFOTAXIME PLUS AMPICILLIN IN PREVENTING INFECTIONS OF BACTERIAL ETIOLOGY IN PATIENTS UNDERGOING ELECTIVE LIVER TRANSPLANTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42657 |
| Study title: Bilchik T, Heyman S, Siegel A, Alavi A. Osteoid osteoma: the role of radionuclide bone imaging, conventional radiography and computed tomography in its management. J Nucl Med. 1992 Feb;33(2):269-71. No abstract available. Bilchik T, Heyman S, Siegel A, Alavi A. Osteoid osteoma: the role of radionuclide bone imaging, conventional radiography and computed tomography in its management. J Nucl Med. 1992 Feb;33(2):269-71. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43707 |
| Study title: Ansell BM, Hall MA, Loftus JK, Woo P, Neumann V, Harvey A, Sills JA, Swinson D, Insley J, Amos R, et al.; Clinical Research Center, Middlesex, U.K. Clin Exp Rheumatol 1991 Mar-Apr;9(2):201-3; A multicentre pilot study of sulphasalazine in juvenile chronic arthritis.Ansell BM, Hall MA, Loftus JK, Woo P, Neumann V, Harvey A, Sills JA, Swinson D, Insley J, Amos R, et al.; Clinical Research Center, Middlesex, U.K. Clin Exp Rheumatol 1991 Mar-Apr;9(2):201-3; A multicentre pilot study of sulphasalazine in juvenile chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42879 |
| Study title: Use of Tc-99m MAA in determining the etiology of increasing cyanosis following SVC-PA anastomosis for the hypoplastic left heart syndrome. Clin Nucl Med. 1991 Jun;16(6):410-2. Glass T 1991 |
| Active substance: TECHNETIUM (99m) |
| Study summary document link (including results): 2011-09 GE response Maasol List of published articles.doc |
| View full study record |
| Document reference: 48822 |
| Study title: Comparison of Bone and Gallium-67 Imagingin Heroin Users'ArthritisA. Bittini, P L. Dominguez, M. L. Martinez Pueyo, F. J. Lopez Longo, I. Monteagudo, and L. Carreflo. J Nuci Med 26:1377—1381, 1985 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48834 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH RECURRENT TONSILLITIS DUE TO GABHS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43022 |
| Study title: Fucidin® ointment: survey of clinical trial. Fucidin® ointment was applied once daily to 10 children with impetigo, 2 patients with eczema and 20 adults with infected ulcers. Treatment was successful in all cases of impetigo and in patients with superficial leg ulcers whereas the treatment of 6 patients with 'deeper' ulcers was discontinued because of pain on application. Inflammation was also seen in another subject. |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28678 |
| Study title: INTRAVENOUS FOSPHENYTOIN AND INTRAMUSCULAR FOSPHENYTOIN IN CHILDREN WITH SEIZURES. |
| Active substance: FOSPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28604 |
| Study title: Chong AL, Clinton F, Breatnach F, O'Marcaigh A, Butler K, O'Meara A. Cytomegalovirus infection in paediatric haemopoietic stem cell transplantation.Ir Med J. 2008 Jan;101(1):17-21.Chong AL, Clinton F, Breatnach F, O'Marcaigh A, Butler K, O'Meara A. Cytomegalovirus infection in paediatric haemopoietic stem cell transplantation.Ir Med J. 2008 Jan;101(1):17-21. |
| Active substance: Foscarnet |
| Study summary document link (including results): Chong et al 2008.pdf |
| View full study record |
| Document reference: 39614 |
| Study title: USE OF GABAPENTIN FOR SYMPTOM CONTROL IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER - A PILOT STUDY. (PELLOCK/WATEMBERG) |
| Active substance: GABAPENTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28798 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF INTRAABDOMINAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42859 |
| Study title: Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.Speders S, Sosna J, Schumacher A, Pfennigsdorf G. Journal of cardiovascular pharmacology, 1989, vol. 13 Suppl 4, p. S47−9,Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.Speders S, Sosna J, Schumacher A, Pfennigsdorf G. Journal of cardiovascular pharmacology, 1989, vol. 13 Suppl 4, p. S47−9, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45561 |
| Study title: Single-dose amoxicillin therapy with follow-up urine culture. Effective initial management for acute uncomplicated urinary tract infections. Savard-Fenton M, Fenton BW, Reller LB, Lauer BA, Byyny RL. Am J Med. 1982 Dec;73(6):808-13. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48968 |
| Study title: Single-dose versus conventional therapy of urinary tract infections in female adolescents.Fine JS, Jacobson MS. Pediatrics. 1985 May;75(5):916-20. |
| Active substance: AMOXICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48967 |
| Study title: Investigating the neurotoxicity of penicillin G at different serum- and CSF-concentrations.Holloway et al. (The American journal of clinical pathology, 1969 Jun;51(6):705-8) |
| Active substance: BENZATHINE BENZYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Benzylpenicillin sodium_1.xlsx |
| View full study record |
| Document reference: 49070 |
| Study title: Investigating the neurotoxicity of penicillin G at different serum- and CSF-concentrations.Lerner et al. (Ann NY Acad Sci 145, 310-8, no 2 1967) |
| Active substance: BENZATHINE BENZYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Benzylpenicillin sodium_2.xlsx |
| View full study record |
| Document reference: 49071 |
| Study title: An Open-Label, Dose-Titration Safety Study of Atomoxetine Hydrochloride in Outpatient Japanese Children with Attention-Deficit/Hyperactivity Disorder |
| Active substance: ATOMOXETINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21979 |
| Study title: The purpose uf this study was to determine what beneficiaI effect, if any, large doses of penicillin G procaine have on the treatment of hospitalized patients with pneumococcal pneumonia of varying severity, and to examine the effect of this treatment on the colonization and superinfection rates in these patients.Brewin et al. (JAMA 230:409-413, 1974) |
| Active substance: BENZATHINE BENZYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Benzylpenicillin sodium_3.xlsx |
| View full study record |
| Document reference: 49072 |
| Study title: |
| Active substance: BENZENTHONIUM AND LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22286 |
| Study title: A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M. J Am Soc Nephrol. 1999 Jan;10(1):101-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49225 |
| Study title: A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients.Offner G, Broyer M, Niaudet P, Loirat C, Mentser M, Lemire J, Crocker JF, Cochat P, Clark G, Chodoff L, Korn A, Hall M. Transplantation. 2002 Oct 15;74(7):961-6. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49257 |
| Study title: A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation.Benfield MR1, Tejani A, Harmon WE, McDonald R, Stablein DM, McIntosh M, Rose S; CCTPT Study Group. Pediatr Transplant. 2005 Jun;9(3):282-92. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49267 |
| Study title: Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcome.Benseler SM, Bargman JM, Feldman BM, Tyrrell PN, Harvey E, Hebert D, Silverman ED. Rheumatology (Oxford). 2009 Feb;48(2):176-82 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49288 |
| Study title: Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S. Aliment Pharmacol Ther. 2006 Jul 15;24(2):331-42. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49272 |
| Study title: [Regional cerebral blood flow image by the method of single photon emission computed tomography: continuous intracarotid injection of krypton-81m (author's transl)] [Article in Japanese]Kaku Igaku. 1980 Aug;17(7):829-32. Maeda T 1980 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48555 |
| Study title: Regional ventilation in infancy. Reversal of adult pattern.N Engl J Med. 1985 Dec 26;313(26):1626-8. Davies H, 1985 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48546 |
| Study title: [Results of lung perfusion and lung ventilation scintigraphy following surgery of diaphragmatic defects] [Article in German]Z Kinderchir. 1983 Feb;38(1):28-30. Hofmann U 1983 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48550 |
| Study title: Right ventricular performance and pulmonary haemodynamics in adolescent and adult patients with cystic fibrosisEur J Pediatr. 1988 Dec;148(3):187-92.Burghuber OC 1988 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48541 |
| Study title: The use of Kr-81m in ventilation imaging.Clin Nucl Med. 1982 Mar;7(3):122-30. Pommet R 1982 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48560 |
| Study title: Ventilation-perfusion scintigraphy in suspected pulmonary embolism: correlation with pulmonary angiography and refinement of criteria for interpretation.Radiology. 1986 May;159(2):383-90.Spies WG 1986 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48545 |
| Study title: Uchida Y. Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye – A multicenter double-blind phase III study. No report dateUchida Y. Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye – A multicenter double-blind phase III study. No report date |
| Active substance: LOMEFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31362 |
| Study title: Radionuclide assessment of the effects of chest physical therapy on ventilation in cystic fibrosis.Phys Ther. 1982 Jun;62(6):820-7. DeCesare JA 1982 |
| Active substance: krypton |
| Study summary document link (including results): 2011-09 GE response Krypton List of published articles.doc |
| View full study record |
| Document reference: 48552 |
| Study title: Von Kleist-Retzow J-C et al., Klinik und Therapie d.Knollenblätterpilzverg. im Kindesalter. Clinical findings and treatment of Amanita phalloides poisoning in childhood); Monatsschrift fur Kinderheilkunde; 143/11 (1118-1127); 1995 |
| Active substance: (HERB) Milk thistle fruit, dry extract, 36 - 44 : 1 (Silymarin 77.5 %) (Legalon) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39712 |
| Study title: Safety and immunogenicity of acellular pertussis combined with tetanus and diphtheria toxoids adsorbed and inactivated poliomyelitis vaccine (TdcP-IPV) in adolescents and adults compared to Td-mlPV and cP given separately in adolescents and compared to TdcP or Td given separately with IPV or cP in adults |
| Active substance: Inactivatd Poliomyelitis Vaccine (Vero cells) (40/8/32) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21208 |
| Study title: McIntyre−J, Hull−D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. {Arch−Dis−Child}, Feb 1996, vol. 74, no. 2, p. 164−7McIntyre−J, Hull−D. Comparing efficacy and tolerability of ibuprofen and paracetamol in fever. {Arch−Dis−Child}, Feb 1996, vol. 74, no. 2, p. 164−7 |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29580 |
| Study title: Wirksamkeit von Ichthocortin® Gel auf grampositive Bakterien bei Patienten mit Neurodermitis |
| Active substance: HYDROCORTIZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29188 |
| Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. (Jan 1988) |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29380 |
| Study title: A three month, double blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 mcg twice daily of Formoterol-HFA and 12 mcg twice daily of Formoterol-DPI (Foradil Aerolizer) in childrem with persistent asthmaStudy report |
| Active substance: cur |
| Study summary document link (including results): RA-RS-3301-002-05 (Synopsis).doc |
| View full study record |
| Document reference: 49214 |
| Study title: Comparison of the effect of atropine and cyclopentolate on myopia.Yen MY, Liu JH, Kao SC, Shiao CH. Ann Ophthalmol. 1989 May;21(5):180-2, 187. Comparison of the effect of atropine and cyclopentolate on myopia.Yen MY, Liu JH, Kao SC, Shiao CH. Ann Ophthalmol. 1989 May;21(5):180-2, 187. |
| Active substance: CYCLOPENTOLATE |
| Study summary document link (including results): Comparison of the effect of atropine and cyclopentolate on m.pdf |
| View full study record |
| Document reference: 24707 |
| Study title: Maurer HM et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993 Mar 1;71(5):1904-22Maurer HM et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993 Mar 1;71(5):1904-22 |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25011 |
| Study title: Clinical experiences with encephabol -Klinische Erfahrungen mit EncephabolMed Klin 1976; 45: 1958-1961, Glatzel J |
| Active substance: PYRITINOL |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48912 |
| Study title: 37. Osimani et al., An Fac Med Montev 1963; 48: 34-41 37. Osimani et al., An Fac Med Montev 1963; 48: 34-41 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39566 |
| Study title: James LP, Stowe CD, Farrar HC, Menendez AA, Argao EA. The pharmacokinetics of oral ranitidine in children and adolescents with cystic fibrosis. J Clin Pharmacol. 1999 Dec;39(12):1242-7.James LP, Stowe CD, Farrar HC, Menendez AA, Argao EA. The pharmacokinetics of oral ranitidine in children and adolescents with cystic fibrosis. J Clin Pharmacol. 1999 Dec;39(12):1242-7. |
| Active substance: RANITIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35279 |
| Study title: Schellong-G. University Children's Hospital Muenster, Germany. Pediatric Hodgkin's disease: treatment in the late 1990s. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, {Ann-Oncol}, 1998, vol. 9 Suppl 5, p. S115-9, 28 refs, ISSN: 0923-7534.Schellong-G. University Children's Hospital Muenster, Germany. Pediatric Hodgkin's disease: treatment in the late 1990s. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, {Ann-Oncol}, 1998, vol. 9 Suppl 5, p. S115-9, 28 refs, ISSN: 0923-7534. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34836 |
| Study title: To determine if systemic absorption of (pyrvinium pamoate) C1-316 occures in children following single oral doses of 5 mg/kg.Heffelfinger |
| Active substance: PYRVINIUM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Pyrvin embonate_1.xls |
| View full study record |
| Document reference: 49077 |
| Study title: Treatment of Refractory Arrhythmias with Propafenone in Pediatric Patients |
| Active substance: PROPAFENONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35058 |
| Study title: ANTHELMINTIC EFFICACY OF PYRANTEL PAMOATE VS. MEBENDOZOLE IN PATIENTS WITH ASCARIASIS. |
| Active substance: PYRANTEL PAMOATE |
| Study summary document link (including results): PRT-II-84-001-002-003 EMA Paediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 46147 |
| Study title: Healy-G-B. Dept. Otolaryngol., Harvard Med. Sch., Boston, Mass., United States. Malignant tumors of the head and neck in children: diagnosis and treatment. Otolaryngologic Clinics of North America {OTOLARYNGOL-CLIN-NORTH-AM}, 1980, Vol/Iss/Pg. 13/3 (483-488).Healy-G-B. Dept. Otolaryngol., Harvard Med. Sch., Boston, Mass., United States. Malignant tumors of the head and neck in children: diagnosis and treatment. Otolaryngologic Clinics of North America {OTOLARYNGOL-CLIN-NORTH-AM}, 1980, Vol/Iss/Pg. 13/3 (483-488). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34736 |
| Study title: Evaluation of the effects of fixed combinations of sustained−release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.Cifková R, Nakov R, Novozámská E, Hejl Z, Petrzílková Z, Poledne R, Stávek P, Compagnone D. Journal of human hypertension, Jun 2000, vol. 14, no. 6, p. 347−54, Evaluation of the effects of fixed combinations of sustained−release verapamil/trandolapril versus captopril/hydrochlorothiazide on metabolic and electrolyte parameters in patients with essential hypertension.Cifková R, Nakov R, Novozámská E, Hejl Z, Petrzílková Z, Poledne R, Stávek P, Compagnone D. Journal of human hypertension, Jun 2000, vol. 14, no. 6, p. 347−54, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45539 |
| Study title: Factors influencing the prediction of steady state concentrations of digoxin.Nakamura T, Kakumoto M, Yamashita K, Takara K, Tanigawara Y, Sakaeda T, Okumura K. Biological & pharmaceutical bulletin, Apr 2001, vol. 24, no. 4, p. 403−8,Factors influencing the prediction of steady state concentrations of digoxin.Nakamura T, Kakumoto M, Yamashita K, Takara K, Tanigawara Y, Sakaeda T, Okumura K. Biological & pharmaceutical bulletin, Apr 2001, vol. 24, no. 4, p. 403−8, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45538 |
| Study title: Gilligan DM, Chan WL, Joshi J, Clarke P, Fletcher A, Krikler S, Oakley CM. Journal of the American College of Cardiology, Jun 1993, vol. 21, no. 7, p. 1672−9, Gilligan DM, Chan WL, Joshi J, Clarke P, Fletcher A, Krikler S, Oakley CM. Journal of the American College of Cardiology, Jun 1993, vol. 21, no. 7, p. 1672−9, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45552 |
| Study title: Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia.Dai GZ, Zeng B, ZhangYL, Lu YX. Chinese medical journal, , Jun 1990, vol. 103, no. 6, p. 460−3, Intravenous tetrandrine in terminating acute episodes of paroxysmal supraventricular tachycardia.Dai GZ, Zeng B, ZhangYL, Lu YX. Chinese medical journal, , Jun 1990, vol. 103, no. 6, p. 460−3, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45558 |
| Study title: Kiowski W, Bühler FR, Fadayomi MO, Erne P, Müller FB, Hulthén UL, Bolli P. The American journal of cardiology, 6 Dec 1985, vol. 56, no. 16, p. 81H−85H, Kiowski W, Bühler FR, Fadayomi MO, Erne P, Müller FB, Hulthén UL, Bolli P. The American journal of cardiology, 6 Dec 1985, vol. 56, no. 16, p. 81H−85H, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45564 |
| Study title: Lechenie sindroma Reino blokatorami vkhoda kal'tsiia. (Treatment of Raynaud's syndrome with calcium entry blockers).Shcherbakov AB, Guseva NG, Mach ES. Terapevticheskii arkhiv, 1987, vol. 59, no. 4, p. 89−92, Lechenie sindroma Reino blokatorami vkhoda kal'tsiia. (Treatment of Raynaud's syndrome with calcium entry blockers).Shcherbakov AB, Guseva NG, Mach ES. Terapevticheskii arkhiv, 1987, vol. 59, no. 4, p. 89−92, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45562 |
| Study title: Otsenka vozmozhnosti individual'nogo podbora antiaritmicheskoi terapii. (Evaluation of the possibility of selection of individual anti− arrhythmia therapy).Antonchenko IV, Gimrikh EO, Popov SV, Chekhov AM, Borisova EV, Savenkova GM, Plekhanov IG. Kardiologiia, Mar 1991, vol. 31, no. 3, p. 43−5, Otsenka vozmozhnosti individual'nogo podbora antiaritmicheskoi terapii. (Evaluation of the possibility of selection of individual anti− arrhythmia therapy).Antonchenko IV, Gimrikh EO, Popov SV, Chekhov AM, Borisova EV, Savenkova GM, Plekhanov IG. Kardiologiia, Mar 1991, vol. 31, no. 3, p. 43−5, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45554 |
| Study title: Betaxolol in the treatment of arterial hypertension: summary of clinical studies - MR95, MR17, MR107 Betaxolol Core Dossier - April 1999 - Part IVB1 Clinical documentation Volume 2 |
| Active substance: BETAXOLOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41926 |
| Study title: Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.Goebel JC, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Br J Ophthalmol. 2011 Feb;95(2):209-13 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49293 |
| Study title: Azathioprine for long-term maintenance of remission in autoimmune hepatitis.Johnson PJ, McFarlane IG, Williams R. N Engl J Med. 1995 Oct 12;333(15):958-63. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49215 |
| Study title: Azathioprine in patients with juvenile chronic arthritis: a longterm followup study.Savolainen HA1, Kautiainen H, Isomäki H, Aho K, Verronen P. J Rheumatol. 1997 Dec;24(12):2444-50. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49222 |
| Study title: Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Inflamm Bowel Dis. 2006 Sep;12(9):831-6. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49274 |
| Study title: Basiliximab: efficacy and tolerability in adults and children.Mocarquer A, Pinto V, Buckel E, Lagos E, Pefaur J, Ramirez K, Morales J, Rosatti P, Elberg A; Simulect Multicenter Study Group of Chile. Transplant Proc. 2003 Nov;35(7):2518-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49259 |
| Study title: Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy.Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, Perfumo F. J Nephrol. 2002 Mar-Apr;15(2):123-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49253 |
| Study title: Combinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation.Sarna S, Sipilä I, Rönnholm K, Koistinen R, Holmberg C. J Clin Endocrinol Metab. 1996 Apr;81(4):1476-82. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49217 |
| Study title: Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?Yoshikawa N, Ito H. Nephrol Dial Transplant. 1999 May;14(5):1097-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49227 |
| Study title: Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.Ramakrishna J1, Langhans N, Calenda K, Grand RJ, Verhave M. J Pediatr Gastroenterol Nutr. 1996 Apr;22(3):296-302. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49218 |
| Study title: Comparison between mycophenolate mofetil and azathioprine based immunosuppression in pediatric renal transplantation from living related donors.Antoniadis A, Papachristou F, Gakis D, Takoudas D, Sotiriou I. Transplant Proc. 1998 Dec;30(8):4085-6. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49224 |
| Study title: Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population.Hindorf U1, Peterson C, Almer S. Ther Drug Monit. 2004 Dec;26(6):673-8. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49266 |
| Study title: Comparison of three different methods of estimating the glomerular filtration rate in children after renal transplantation.al-Harbi N, Lireman D. Am J Nephrol. 1997;17(1):68-71. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49219 |
| Study title: Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.Adu D, Pall A, Luqmani RA, Richards NT, Howie AJ, Emery P, Michael J, Savage CO, Bacon PA. QJM. 1997 Jun;90(6):401-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49221 |
| Study title: A phase III comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental painA phase III comparative study of the pharmacokinetic/pharmacodynamic and safety profiles of ibuprofen extended release, ibuprofen regular release and placebo during a 12 hour observation in post-extraction dental pain |
| Active substance: IBUPROFEN AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29681 |
| Study title: American Association for Respiratory Care (AARC). Clinical practice guideline: Single-breath carbon monoxide diffusing capacity, 1999 update. Resp Care 1999 May;44(5):539-546American Association for Respiratory Care (AARC). Clinical practice guideline: Single-breath carbon monoxide diffusing capacity, 1999 update. Resp Care 1999 May;44(5):539-546 |
| Active substance: HELIUM AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29067 |
| Study title: Facilitation of delayed alternation performance in adult rats following chronic hydroxyzine treatment in infancy. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29273 |
| Study title: A Single Dose, Randomized, Open-Label, Single Center, Two-Way Crossover Pharmacokinetic Study of Advil® Cold & Sinus Tablets in Children |
| Active substance: IBUPROFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29539 |
| Study title: Breitfeld PP et al Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.J Pediatr Hematol Oncol 2001 May;23(4):225-33 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26691 |
| Study title: Uptake pharmacokinetics of the Fentanyl Oralet in children scheduled for central venous access removal: implications for the timing of initiating painful procedures; Paediatr Anaesth 2002, 12(7):594-9 |
| Active substance: FENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27190 |
| Study title: Submission of result-related information on paediatric studies submitted under Article 45 of the Paediatric Regulation No 1901/2006. Product concerned by this submission: Cedax Suspension/Keimax and Associated Tradenames (Ceftibuten)Merck Sharp & Dohme (Europe), Inc. Clos du Lynx 5 Lynx Binnenhof B-1200 Brussels |
| Active substance: CEFTIBUTEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48847 |
| Study title: Submission of result-related information on paediatric studies submitted under Article 45 of the Paediatric Regulation No 1901/2006. Product concerned by this submission: Uroced/Cedax and Associated Tradenames (Ceftibuten)Merck Sharp & Dohme (Europe), Inc. Clos du Lynx 5 Lynx Binnenhof B-1200 Brussels |
| Active substance: CEFTIBUTEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48850 |
| Study title: Oral Cefixime is Similar to Continued Intravenous Antibiotics in the Empirical (Clin Infect Dis 2001; 32: 36-43); Paganini HR. Oral Cefixime is Similar to Continued Intravenous Antibiotics in the Empirical (Clin Infect Dis 2001; 32: 36-43); Paganini HR. |
| Active substance: CEFIXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23421 |
| Study title: An open randomised multicentre comparison of cefuroxime axetil suspension and amoxycillin syrup in the treatment of children with pharyngitis and tonsillitis. |
| Active substance: CEFUROXIME |
| Study summary document link (including results): Study CAET94 Cefuroxime Axetil (Suspension).xls |
| View full study record |
| Document reference: 47731 |
| Study title: Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin. Dillon HC Jr. J Am Acad Dermatol. 1983 Feb;8(2):177-81. |
| Active substance: Cephalexin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48898 |
| Study title: Erfahrungen mit einem Faktor II-, IX- und X-Konzentrat. Laboratoriumsuntersuchungen, In-Vivo-Recovery und klinische Ergebnisse. Global-Druck und Verlag, Heidelberg, (1980).(Vinazzer H, Bergmann H.) |
| Active substance: FACTOR VIII INHIBITOR BYPASSING ACT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26997 |
| Study title: 99mTc-HMPAO single photon emission computed tomography (SPECT) in both asphyxiated and epileptic children with or without status epilepticusJ Child Neurol. 2005 Jul; 20(7):560-5. Oner n 2005 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48618 |
| Study title: "Weir-J-H. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation. The Journal of clinical psychiatry, {J-Clin-Psychiatry}, Dec 1978, vol. 39, no. 12, p. 841-7, ISSN: 0160-6689. " "Weir-J-H. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation. The Journal of clinical psychiatry, {J-Clin-Psychiatry}, Dec 1978, vol. 39, no. 12, p. 841-7, ISSN: 0160-6689. " |
| Active substance: PRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34644 |
| Study title: Pilot study of pimecrolimus in vitiligo treatment |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34109 |
| Study title: OPEN, NON-COMPARATIVE STUDY DAY THE EFFICACY AND TOLERATION OF PIROXICAM FAST DISSOLVING DOSAGE FROM (FDDF) IN THE TREATMENT OF ACUTE MUSCULOSKELETAL DISORDERS. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34387 |
| Study title: Statistical report: the dose response curve of fenoterol in the range 3 mcg - 1000 mcg in asthmatic children. |
| Active substance: IPRATROPIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30615 |
| Study title: Study defined factors in the pathogenesis for relapse (bacteriological and clinical) in 337 children with URT infections with cultured group A beta hemolytic streptococci.Rosenstein et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_4.xlsx |
| View full study record |
| Document reference: 49035 |
| Study title: Study the absorption of different salts of pc-V in syrup form and also to investigate whether gastrointestinal diseases, leading to malabsorption affects the absorption of pc in varying rates for different salts.Bolme et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_8.xlsx |
| View full study record |
| Document reference: 49039 |
| Study title: Study the effects of a twice a day dosage of penicillin V instead of three times a day.Nordbring et el |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_7.xlsx |
| View full study record |
| Document reference: 49038 |
| Study title: Study the effects of a twice a day dosage of potassium penicillin G, instead of three times a day.Vann et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_9.xlsx |
| View full study record |
| Document reference: 49040 |
| Study title: To evaluate the efficacy and safety of penicillin V in the treatment of acute tonsillitis in adults, when given as two or three daily doses.Mosbaek et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_16.xlsx |
| View full study record |
| Document reference: 49047 |
| Study title: To study the clinical efficacy of penicillin V given to children as a daily dosage of 50 mg/kg/day divided into two or three doses.Rundcrantz et al |
| Active substance: PHENOXYMETHYLPENICILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Phenoyxmethyl penicillin_17.xlsx |
| View full study record |
| Document reference: 49048 |
| Study title: Palatal tremor in childhood: clinical and therapeutic considerations |
| Active substance: PIRACETAM |
| Study summary document link (including results): ADPE07D0626 - Piracetam.pdf |
| View full study record |
| Document reference: 45926 |
| Study title: Treatment of recurrent bacteriuria with mecillinam; Verrier Jones E:R: and Asscher A.W:. 1975, JAC, 1: 193-196 LEO sponsored Treatment of recurrent bacteriuria with mecillinam; Verrier Jones E:R: and Asscher A.W:. 1975, JAC, 1: 193-196 LEO sponsored |
| Active substance: PIVMECILLINAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34526 |
| Study title: Clinical investigator’s report (pediatrics). |
| Active substance: PHOLCODINE |
| Study summary document link (including results): Pholcodine_STUDY_640.6.003_Lajouanine.xls |
| View full study record |
| Document reference: 34034 |
| Study title: Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome.Vaksmann G, D−Hoinne C, Lucet V, Guillaumont S, Lupoglazoff JM, Chantepie A, Heart , Jan 2006 (epub: 14 Apr 2005) , vol. 92, no. 1, p. 101−4, Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome.Vaksmann G, D−Hoinne C, Lucet V, Guillaumont S, Lupoglazoff JM, Chantepie A, Heart , Jan 2006 (epub: 14 Apr 2005) , vol. 92, no. 1, p. 101−4, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45534 |
| Study title: Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.Fetsch T, Bauer P, Engberding R, Koch−Hans P, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe−Hans J, Treese N , Breithardt G. European heart journal, Aug 2004, vol. 25, no. 16, p. 1385−94, Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.Fetsch T, Bauer P, Engberding R, Koch−Hans P, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe−Hans J, Treese N , Breithardt G. European heart journal, Aug 2004, vol. 25, no. 16, p. 1385−94, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45536 |
| Study title: Superiority of lithium over verapamil in mania: a randomized, controlled, single−blind trial.Walton SA, Berk M, Brook S. The Journal of clinical psychiatry, Nov 1996, vol. 57, no. 11, p. 543−6, Superiority of lithium over verapamil in mania: a randomized, controlled, single−blind trial.Walton SA, Berk M, Brook S. The Journal of clinical psychiatry, Nov 1996, vol. 57, no. 11, p. 543−6, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45544 |
| Study title: Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta PC, Riesen WF. Drugs, 1992, vol. 44 Suppl 1, p. 74−84,Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.Ferrier C, Ferrari P, Weidmann P, Keller U, Beretta PC, Riesen WF. Drugs, 1992, vol. 44 Suppl 1, p. 74−84, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45553 |
| Study title: Traitement médical de la myocardiopathie hypertrophique. Comparaison entre le propranolol et le vérapamil. (Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil).Bouhour JB, Potiron M, Chiffoleau S, Lefévre M, Louvet S. Archives des maladies du coeur et des vaisseaux, Jan 1987, vol. 80, no. 1, p. 76−82, Traitement médical de la myocardiopathie hypertrophique. Comparaison entre le propranolol et le vérapamil. (Medical treatment of hypertrophic myocardiopathy. Comparison of propranolol and verapamil).Bouhour JB, Potiron M, Chiffoleau S, Lefévre M, Louvet S. Archives des maladies du coeur et des vaisseaux, Jan 1987, vol. 80, no. 1, p. 76−82, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45563 |
| Study title: Uso del verapamil nel trattamento dell'emicrania senza aura. (The use of verapamil in the treatment of hemicrania without aura).Fonzari M, Santoloci D, Farinini D. La Clinica terapeutica, Apr 1994, vol. 144, no. 4, p. 329−32, Uso del verapamil nel trattamento dell'emicrania senza aura. (The use of verapamil in the treatment of hemicrania without aura).Fonzari M, Santoloci D, Farinini D. La Clinica terapeutica, Apr 1994, vol. 144, no. 4, p. 329−32, |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45549 |
| Study title: Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross−over. (Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double−blind randomized cross−over study).Paterna S, Martino SG, Campisi D, Cascio IN, Marsala BA. La Clinica terapeutica, 31 Jul 1990, vol. 134, no. 2, p. 119−25, Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross−over. (Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double−blind random... |
| Active substance: VERAPAMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45557 |
| Study title: Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.Pettersson B1, Almer S, Albertioni F, Söderhäll S, Peterson C. Ther Drug Monit. 2002 Jun;24(3):351-8. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49254 |
| Study title: Effect of early immunomodulator use in moderate to severe pediatric Crohn disease.Punati J, Markowitz J, Lerer T, Hyams J, Kugathasan S, Griffiths A, Otley A, Rosh J, Pfefferkorn M, Mack D, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Mezoff A, Leleiko N, Keljo D, Crandall W; Pediatric IBD Collaborative Research Group. Inflamm Bowel Dis. 2008 Jul;14(7):949-54 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49284 |
| Study title: Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC. J Dermatolog Treat. 2009;20(3):141-5. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49287 |
| Study title: Efficacy of long-term azathioprine for relapsing nephrotic syndrome.Hiraoka M, Tsukahara H, Hori C, Ohshima Y, Momoi T, Seo A, Mayumi M. Pediatr Nephrol. 2000 Aug;14(8-9):776-8. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49248 |
| Study title: Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM. Inflamm Bowel Dis. 2006 Nov;12(11):1053-7. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49276 |
| Study title: Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis.Camargo PR, Snitcowsky R, da Luz PL, Mazzieri R, Higuchi ML, Rati M, Stolf N, Ebaid M, Pileggi F. Pediatr Cardiol. 1995 Mar-Apr;16(2):61-8. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49216 |
| Study title: Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation.Jungraithmayr TC, Wiesmayr S, Staskewitz A, Kirste G, Bulla M, Fehrenbach H, Dippell J, Greiner C, Griebel M, Helmchen U, Klaus G, Leichter HE, Mihatsch MJ, Michalk DV, Misselwitz J, Plank C, Tönshoff B, Weber LT, Zimmerhackl LB; German Pediatric Renal Transplantation Study Group. Transplantation. 2007 Apr 15;83(7):900-5. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49279 |
| Study title: Follow-up of children with autoimmune hepatitis treated with cyclosporine.Cuarterolo M, Ciocca M, Velasco CC, Ramonet M, González T, López S, Garsd A, Alvarez F. J Pediatr Gastroenterol Nutr. 2006 Nov;43(5):635-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49277 |
| Study title: Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R. Pediatr Transplant. 2005 Aug;9(4):498-503. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49268 |
| Study title: Heart transplantation in patients with previous Fontan operations.Gamba A1, Merlo M, Fiocchi R, Terzi A, Mammana C, Sebastiani R, Ferrazzi P. J Thorac Cardiovasc Surg. 2004 Feb;127(2):555-62. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49261 |
| Study title: Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.Clark G1, Walsh G, Deshpande P, Koffman G. Nephrol Dial Transplant. 2002 Jul;17(7):1304-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49255 |
| Study title: Al-Kandari et al. Regional cerebral blood flow in patients with sickle cell disease: study with single photon emission computed tomographyAnnals of nuclear medicine (2007), 21(8), 439-45. Al-Kandari fa 2007 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48604 |
| Study title: Altiay et al. 99mTc-HMPAO brain perfusion single-photon emission computed tomography in children with Down syndrome: relationship to epilepsy, thyroid functions, and congenital heart diseaseJournal of child neurology (2006), 21(7) 610-4. altiay s 2006 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48605 |
| Study title: Brain Perfusion SPECT in Juvenile Neuro-Behc¸et’s DiseaseSilvia Vignola, Flavio Nobili, Paolo Picco, Marco Gattorno, Antonella Buoncompagni, Paolo Vitali, Giuliano Mariani, and Guido Rodriguez. THE JOURNAL OF NUCLEAR MEDICINE • Vol. 42 • No. 8 • August 2001 |
| Active substance: CERETEC |
| Study summary document link (including results): vignola s 2001.pdf |
| View full study record |
| Document reference: 48603 |
| Study title: Cerebral Perfusion in Children With Alice in Wonderland SyndromeYung-Ting Kuo, MD*†, Nan-Chang Chiu, MD†, Ein-Yiao Shen, MD†, Che-Sheng Ho, MD†, and Ming-Che Wu, MD‡ PEDIATRIC NEUROLOGY Vol. 19 No. 2 |
| Active substance: CERETEC |
| Study summary document link (including results): kuo yt 1998.pdf |
| View full study record |
| Document reference: 48594 |
| Study title: Chang et al. Comparison between technetium-99m hexamethylpropylene amineoxide labeled white blood cell abdomen scan and abdominal sonography to detect appendicitis in children with an atypical clinical presentation. Hepatogastroenterology.Hepatogastroenterology. 2003 Mar-Apr;50(50):426-9. Chen-chang c 2003 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48606 |
| Study title: Charron et al. Assessment of terminal ileal and colonic inflammation in Crohn's disease with 99mTc-WBC.Acta Paediatr. 1999 Feb; 88(2):193-8 charron m 1999 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48607 |
| Study title: Charron et al. Temporal correlation of the erythrocyte sedimentation rate with Tc-99m WBC uptake on children with inflammatory bowel diseasesClin Nucl Med. 2003 Nov; 28(11):905-7. charron m 2003 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48622 |
| Study title: Comparison of brain perfusion SPECT and MRI findings in children with neuronal ceroid-lipofuscinosis and in their families.Ann Nucl Med. 2002 May; 16(3):201-6. sayit e 2002 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48620 |
| Study title: Congenital Middle Fossa Arachnoid Cysts May Cause Global Brain Ischaemia: A Study with 99Tc-Hexamethylpropyleneamineoxime Single Photon Emission Computerised Tomography ScansS. Sgourosa S. Chapmanb. Pediatr Neurosurg 2001;35:188–194 |
| Active substance: CERETEC |
| Study summary document link (including results): sgouros s 2001.pdf |
| View full study record |
| Document reference: 48601 |
| Study title: De Camargo et al. Brain hypoperfusion in adolescents dependent of multiple drugs, Arquivos de neuro-psiquiatriaArquivos de neuro-psiquiatria (2010), 68(2), 161-7. de camargo ecs 2010 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48608 |
| Study title: Diagnostic performance of 18F-FDG PET and ictal 99mTc-HMPAO SPET in pediatric temporal lobe epilepsy: Quantitative analysis by statistical parametric mapping, statistical probabilistic anatomical map, and subtraction ictal SPETJong Jin Lee a, Won Jun Kang a, Dong Soo Lee a,*, Jae Sung Lee a, Hee Hwang b, Ki Joong Kim b, Yong-Seung Hwang b, June-Key Chung a, Myung Chul Lee a. Seizure (2005) 14, 213—220 |
| Active substance: CERETEC |
| Study summary document link (including results): lee jj 2005.pdf |
| View full study record |
| Document reference: 48595 |
| Study title: Differences in 99mTc-HMPAO brain SPET perfusion imaging between Tourette’s syndrome and chronic tic disorder in childrenNan-Tsing Chiu1, Ying-Chao Chang2, Bi-Fang Lee1, Chao-Ching Huang3, Shan-Tair Wang4. European Journal of Nuclear Medicine Vol. 28, No. 2, February 2001 |
| Active substance: CERETEC |
| Study summary document link (including results): nan-tsing chiu 2001.pdf |
| View full study record |
| Document reference: 48597 |
| Study title: Decroix J, et al Oral itraconazole in the treatment of dermatomycosis. A multicenter evaluation of different treatment schedules. Clinical summary on R51211, August 1987. (10-86 years, LMD56447)Decroix J, et al Oral itraconazole in the treatment of dermatomycosis. A multicenter evaluation of different treatment schedules. Clinical summary on R51211, August 1987. (10-86 years, LMD56447) |
| Active substance: ITRACONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30789 |
| Study title: A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndromeEur J Pediatr (1992) 151 : 372-376, B. Robertson |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): EURO 1.pdf |
| View full study record |
| Document reference: 49240 |
| Study title: A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndromeEur J Pediatr (1992) 151 : 372-376, B. Robertson |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): EURO 1.pdf |
| View full study record |
| Document reference: 49241 |
| Study title: A Randomized, Multicenter Masked Comparison Trial of Poractant Alfa (Curosurf) versus Beractant (Survanta) in the Treatment of Respiratory Distress Syndrome in Preterm InfantsRangasamy Ramanathan, |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): DL-032 publication.pdf |
| View full study record |
| Document reference: 49238 |
| Study title: Comparison of Prophylaxis and Rescue Treatment With Curosurf in Neonates Less than 30 Weeks' Gestation: A Randomized TrialPediatrics 1993;92;768, Johannes Egberts, |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): 50.01-CT-02-93 publication.pdf |
| View full study record |
| Document reference: 49231 |
| Study title: Follow up on Infants Treated with Porcine Surfactant Replacement for Severe Neonatal and Infant Respiratory Distress Syndrome: Antigenic Reactivity Evaluation(Marraro G.) |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): 50.01-CT-02-93 publication.pdf |
| View full study record |
| Document reference: 49232 |
| Study title: Modifications of Surfactant Phospholipid Pattern in Premature Infants Treated with Curosurf. Clinical and Dietary Correlations.(Haumont D, Clercx A, Rossle C, Biver A, Carpentier Y A.) |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): Haumont D. (Published paper 910177).pdf |
| View full study record |
| Document reference: 49244 |
| Study title: Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curo4 trial)Please see report |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): EURO VI publication.pdf |
| View full study record |
| Document reference: 49243 |
| Study title: Nasal Continuous Positive Airway Pressure and Early Surfactant Therapy for Respiratory Distress Syndrome in Newborns of Less Than 30 Weeks’ GestationHenrik Verder, |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): Verder H (publication paper).pdf |
| View full study record |
| Document reference: 49247 |
| Study title: Porcine surfactant replacement therapy in newborns of 25-3 1 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low dosesActa Paediatr 84: 913-21. 1995, H Walti |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): 50.01-CT-04-93 publication.pdf |
| View full study record |
| Document reference: 49234 |
| Study title: Prophylactic or Early Selective Surfactant Combined With nCPAP in Very Preterm InfantsPediatrics 2010;125;e1402 |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): DM.PR.5000.002.04 publication.pdf |
| View full study record |
| Document reference: 49239 |
| Study title: Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trialj. Pennat. Med, 24 (1996) 609-620, Giulio Bevilacqua1, |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): 50.00-CT-02-90 publication.pdf |
| View full study record |
| Document reference: 49228 |
| Study title: Randomised ,multicentre,clinical study on the treatment with natural surfactant of neonatal respiratory distress syndrome in premature infants : comparison between early and late treatmentPediatrics, VOLUME 82 NOVEMBER 1988 NUMBER 5 |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): CH-CUR-0003 publication..pdf |
| View full study record |
| Document reference: 49237 |
| Study title: Randomised european multicentre trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome : single vs multiple doses of CurosurfPediatrics 1992;89;13 |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): EURO IV publication.pdf |
| View full study record |
| Document reference: 49242 |
| Study title: Surfactant replacement therapy in severe neonatal respiratory distress syndrome (RDS)Pediatrics, VOLUME 82 NOVEMBER 1988 NUMBER 5 |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): CH-CUR-001 publication.pdf |
| View full study record |
| Document reference: 49236 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF 0.5% TOPICAL PIROXICAM GEL IN THE TREATMENT OF ACUTE MUSCULOSKELETAL (AMS) DISORDERS. |
| Active substance: PIROXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34457 |
| Study title: Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.Cucchiara S1, Romeo E, Viola F, Cottone M, Fontana M, Lombardi G, Rutigliano V, de'Angelis GL, Federici T. Dig Liver Dis. 2008 Jul;40 Suppl 2:S260-4 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49285 |
| Study title: Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis. 2004 May;36(5):342-7. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49264 |
| Study title: Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. J Pediatr Surg. 1997 May;32(5):688-90. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49220 |
| Study title: Interventions for idiopathic steroid-resistant nephrotic syndrome in children.Habashy D, Hodson E, Craig J. Cochrane Database Syst Rev. 2004;(2):CD003594. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49263 |
| Study title: Interventions for idiopathic steroid-resistant nephrotic syndrome in children.Habashy D, Hodson E, Craig J. Cochrane Database Syst Rev. 2004;(2):CD003594. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49270 |
| Study title: Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.Schmidt S, Mellström D, Norjavaara E, Sundh SV, Saalman R. Inflamm Bowel Dis. 2009 Dec;15(12):1844-50 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49290 |
| Study title: Medical Therapy for Crohn's DiseaseHanauer SB. 1999 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49275 |
| Study title: Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y. J Pediatr Gastroenterol Nutr. 2009 May;48(5):526-30 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49292 |
| Study title: Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.Ohtsuka Y, Arai K, Aoyagi Y, Fujii T, Yamakawa Y, Ohtani K, Ikuse T, Baba Y, Inage E, Kudo T, Suzuki R, Nagata S, Shimizu T. J Gastroenterol Hepatol. 2010 Oct;25(10):1626-30 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49294 |
| Study title: Monitoring azathioprine metabolite levels and thiopurine methyl transferase (TPMT) activity in children with inflammatory bowel disease.Paerregaard A, Schmiegelow K. Scand J Gastroenterol. 2002 Mar;37(3):371-2. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49252 |
| Study title: Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data.Webb NJ, Prokurat S, Vondrak K, Watson AR, Hughes DA, Marks SD, Moghal NE, Fitzpatrick MM, Milford DV, Saleem MA, Jones CA, Friman S, Van Damme-Lombaerts R, Janssen F, Hamer C, Rhodes S. Pediatr Nephrol. 2009 Jan;24(1):177-82 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49286 |
| Study title: Myasthenia gravis in children: a longitudinal study.Ashraf VV, Taly AB, Veerendrakumar M, Rao S. Acta Neurol Scand. 2006 Aug;114(2):119-23. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49273 |
| Study title: Mycophenolate mofetil in pediatric renal transplantation.Benfield MR, Symons JM, Bynon S, Eckhoff D, Herrin J, Harmon W, Kohaut E. Pediatr Transplant. 1999 Feb;3(1):33-7. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49229 |
| Study title: Non-corticosteroid treatment for nephrotic syndrome in children (part I).Hodson EM, Willis NS, Craig JC. Cochrane Database Syst Rev. 2010, Issue 4 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49281 |
| Study title: Effects of long-term methylphenidate treatment: A pilot follow-up clinical and SPECT studyAynur Pekcanlar Akaya,⁎, Gamze Çapa Kaya b, Neslihan İnal Emiroğlu a, Aysel Aydın b, E. Serap Monkulc,d, Cengiz Taşçı b, Süha Miral a, Hatice Durak b. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 1219–1224 |
| Active substance: CERETEC |
| Study summary document link (including results): akay ap 2006.pdf |
| View full study record |
| Document reference: 48592 |
| Study title: Functional assessment of intracranial arachnoid cysts with TC99 m-HMPAO SPECT: a preliminary report.Childs Nerv Syst. 2006 Sep;22(9):1091-7. martínez-Lage jf 2006 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48614 |
| Study title: Gibson et al. 99Tcm-HMPAO leucocyte labelling in orofacial granulomatosis and gastrointestinal Crohn's disease in childhood and early adulthoodNuclear medicine communications (2000), 21(2), 155-8. gibson j 2000 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48610 |
| Study title: Griffiths et al. 99mTechnetium HMPAO imaging in children with the Sturge- Weber syndrome: a study of nine cases with CT and MRI correlationNeuroradiology (1997), 39(3), 219-24. Griffiths pd 1997 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48611 |
| Study title: Hwang et al. Regional cerebral perfusion abnormalities in developmental language disorder. Statistical parametric mapping analysisEur Arch Psychiatry Clin Neurosci. 2006 Apr;256(3):131-7. hwang jw 2006 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48612 |
| Study title: Improving the diagnosis of acute appendicitis in children with atypical clinical findings using the technetium-99m hexamethylpropylene amine oximelabelled white-blood-cell abdomen scan.Pediatr Radiol. 2002 Sep;32(9):663-6. yan dc 2002 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48621 |
| Study title: La gammagrafía con leucocitos marcados con 99mTc-HMPAO en el diagnóstico y seguimiento de la enfermedad inflamatoria intestinalJ. Verdú Ricoa, M. Juste Ruizb, R. Jovera, J. Muñoz Acostaa, J. Muñoza, A. Martínez Caballeroa, A. Antón Leala y O. Caballero Carpenaa. An Pediatr (Barc). 2006;64(5):457-63 |
| Active substance: CERETEC |
| Study summary document link (including results): verdu j 2006.pdf |
| View full study record |
| Document reference: 48602 |
| Study title: Parietal lobe epileptic focus identified on SPECT-MRI fusion imaging in a case of epilepsia partialis continua.Clin Nucl Med. 2006 Dec;31(12):826-8. matthews r 2006 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48615 |
| Study title: SPECT FINDINGS IN CHILDREN WITH SPECIFIC LANGUAGE IMPAIRMENTMarianne Ors1, Erik Ryding1, Magnus Lindgren2, Peik Gustafsson3, Gösta Blennow4 and Ingmar Rosén1. Cortex, (2005) 41, 316-326 |
| Active substance: CERETEC |
| Study summary document link (including results): ors m 2005.pdf |
| View full study record |
| Document reference: 48598 |
| Study title: Tc-99 HMPAO cerebral SPECT imaging in brain death patients with complex spinal automatismTurkish journal of trauma & emergency surgery : TJTES (2002), 8(4), 198-201. Kahveci sf 2002 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48613 |
| Study title: Tc-99m HMPAO labeled white blood cell imaging in a child with eosinophilic lung diseaseClinical nuclear medicine (2008), 33(1), 38-40 moralidis r 2008 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48616 |
| Study title: Kremens B et al, High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma, Med Pediatr Oncol. 1994;23(6):470-5 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26950 |
| Study title: Diler et al. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.Yonsei Med J. 2004 Feb 29; 45(1):90-9 diler rs 2004 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48609 |
| Study title: Surfactant-A nti-Surfactant Immune Complexes in Infants With Respiratory Distress SyndromeDAVID S. STRAYER, MD, PhD, |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): Strayer DS et al;.pdf |
| View full study record |
| Document reference: 49246 |
| Study title: Treatment of severe meconium aspiration syndrome with porcine surfactant: A multicentre, randomized, controlled trialActa Pædiatrica, 2005; 94: 896–902 |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): IM.PR.5001.00 publication.pdf |
| View full study record |
| Document reference: 49245 |
| Study title: A 5-year, multicenter, open-label, parallel group, randomized study to demonstrate the short and long-term safety of Elidel (pimecrolimus, ASM981) cream 1% in the treatment of mild to moderate atopic dermatitis in infants (3 − < 12 months of age)Study report |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): Pimecrolimus Art.45 study.pdf |
| View full study record |
| Document reference: 49194 |
| Study title: Efficacy of hydroxyzine in the treatment of trichotillomania: an open-label study. |
| Active substance: HYDROXYZINE |
| Study summary document link (including results): ADPE03E2706.pdf |
| View full study record |
| Document reference: 29313 |
| Study title: In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): Comparison of autologous peripheral blood stem cells (PBSC) from adults and children. Valteau-Couanet D et al. Bone Marrow Transplant June. 13, 2001, 869-75 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28274 |
| Study title: A 3-week, open -label, uncontrolled, multicenter study evaluating the functionality of the Foradil Certihaler device in Patients with asthma |
| Active substance: FORMOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47800 |
| Study title: Retrospective survey for documentation of appllication and dosage of Gastricumeel (tablets) in children < 12 years of age [Bef-013] |
| Active substance: Gastricumeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40006 |
| Study title: Randomized study to investigate the effects on growth and the safety of the treatment with recombinant growth hormone in 1 to 2-year-old children with growth retardation due to chronic kidney failure |
| Active substance: Somatropin |
| Study summary document link (including results): GHCRF-E-2_Norditropin.pdf |
| View full study record |
| Document reference: 41789 |
| Study title: ADHD: new pharmacological treatments on the horizon. FA Lopez, Journal of Developmental and Behavioral Pediatrics - JDBP 2006, 27(5): 410-6 ADHD: new pharmacological treatments on the horizon. FA Lopez, Journal of Developmental and Behavioral Pediatrics - JDBP 2006, 27(5): 410-6 |
| Active substance: MODAFINIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45670 |
| Study title: "Long-Term Efficacy of Anticholinergic and Alpha-blocking Drugs in the Detrusor of Children with Myelomeningocele - Bouchot O et al. - Journal d'Urologie - 1988 (94(2): 83-86) - Publication in UK registration file - " "Long-Term Efficacy of Anticholinergic and Alpha-blocking Drugs in the Detrusor of Children with Myelomeningocele - Bouchot O et al. - Journal d'Urologie - 1988 (94(2): 83-86) - Publication in UK registration file - " |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32983 |
| Study title: 18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours Biomedicine & Pharmacotherapy 60 (2006) 593–606. C. Nannia, D. Rubellob,*, P. Castelluccia, M. Farsada, R. Franchia, L. Rampinb M.D. Grossc, A. Al-Nahhasd, S. Fantia |
| Active substance: Steripet |
| Study summary document link (including results): nanni-2006.pdf |
| View full study record |
| Document reference: 48738 |
| Study title: Détermination de la CMI avec Ercefuryl de 47 souches d’entérobactéries isolées chez des enfants diarrhéiques - Doucet Ch. - 1989 (Méd. Afr. Noire, 36 (12): 963-4) - Publication in Clinical Expert Report - Lassale C. - July 1998 - |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47068 |
| Study title: Surfactant therapy and Ig E levels in the neonatal period(Amato M, Markus HP) |
| Active substance: PORACTANT ALFA |
| Study summary document link (including results): Amato M, MArkus HP (publication paper).pdf |
| View full study record |
| Document reference: 49235 |
| Study title: An open-labeled study evaluating the safety and efficacy of growth hormone therapy in short children with chronic renal insufficiency |
| Active substance: Somatropin |
| Study summary document link (including results): 91-003 and 91-004 EMA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 41709 |
| Study title: Nabilone: an effective antiemetic in patients receiving cancer chemotherapy |
| Active substance: NABILONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32438 |
| Study title: Non-corticosteroid treatment for nephrotic syndrome in children (part II).Hodson EM, Willis NS, Craig JC. Cochrane Database Syst Rev. 2010, Issue 4 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49282 |
| Study title: Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease.Kader HA, Wenner WJ Jr, Telega GW, Maller ES, Baldassano RN. J Clin Gastroenterol. 2000 Jun;30(4):409-13. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49233 |
| Study title: Oral tacrolimus treatment of severe colitis in children.Bousvaros A1, Kirschner BS, Werlin SL, Parker-Hartigan L, Daum F, Freeman KB, Balint JP, Day AS, Griffiths AM, Zurakowski D, Ferry GD, Leichtner AM. J Pediatr. 2000 Dec;137(6):794-9. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49249 |
| Study title: Outcome of pediatric renal transplants in a developing country.Gulati S, Kumar A, Sharma RK, Gupta A, Bhandari M, Kumar A, Srivastava A. Pediatr Nephrol. 2004 Jan;19(1):96-100 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49260 |
| Study title: Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years.Jungraithmayr T, Staskewitz A, Kirste G, Böswald M, Bulla M, Burghard R, Dippell J, Greiner C, Helmchen U, Klare B, Klaus G, Leichter HE, Mihatsch MJ, Michalk DV, Misselwitz J, Plank C, Querfeld U, Weber LT, Wiesel M, Tönshoff B, Zimmerhackl LB; German Pediatric Renal Transplantation Study Group. Transplantation. 2003 Feb 27;75(4):454-61. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49258 |
| Study title: Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort.Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed A; Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Arthritis Rheum. 2009 May;60(5):1496-507 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49289 |
| Study title: Prospective randomized trial of azathioprine in cryopreserved valved allografts in children.Shaddy RE1, Lambert LM, Fuller TC, Profaizer T, Thompson DD, Baker SI, Osborne KA, Hawkins JA. Ann Thorac Surg. 2001 Jan;71(1):43-7; discussion 47-8. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49250 |
| Study title: Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.Bergstein J, Leiser J, Andreoli SP. Clin Nephrol. 1998 Jan;49(1):9-14. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49223 |
| Study title: Safety and efficacy of TOR inhibitors in pediatric renal transplant recipients.Ettenger RB1, Grimm EM. Am J Kidney Dis. 2001 Oct;38(4 Suppl 2):S22-8. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49251 |
| Study title: Severe Henoch-Schönlein nephritis: resolution with azathioprine and steroids.Singh S1, Devidayal, Kumar L, Joshi K, Minz RW, Datta U. Rheumatol Int. 2002 Aug;22(4):133-7. Epub 2002 Jul 5. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49256 |
| Study title: Short-term cyclosporine induces a remission of autoimmune hepatitis in children.Alvarez F, Ciocca M, Cañero-Velasco C, Ramonet M, de Davila MT, Cuarterolo M, Gonzalez T, Jara-Vega P, Camarena C, Brochu P, Drut R, Alvarez E. J Hepatol. 1999 Feb;30(2):222-7. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49226 |
| Study title: The relationship between 99mTc-HMPAO brain SPECT and the scores of real life rating scale in autistic childrenMeryem Kayaa,*, Serap Karasalihog˘lub, Funda U¨ stu¨na, Aziz Gu¨ltekina, Tevfik Fikret C¸ ermika, Yes¸im Fazlıog˘lub, Mevlu¨t Tu¨rec, O¨ mer N. Yig˘itbas¸ıa, S¸ akir Berkardaa. Brain & Development 24 (2002) 77–81 |
| Active substance: CERETEC |
| Study summary document link (including results): kaya m 2002.pdf |
| View full study record |
| Document reference: 48593 |
| Study title: Transient Posterior Encephalopathy Induced by Chemotherapy in ChildrenRocı´o Sa´nchez-Carpintero, MD, PhD*, Juan Narbona, MD, PhD*, Reyes Lo´pez de Mesa, MD*, Javier Arbizu, MD‡, and Luis Sierrasesu´maga, MD, PhD†. Pediatr Neurol 2001;24:145-148. |
| Active substance: CERETEC |
| Study summary document link (including results): Sanchez r 2001.pdf |
| View full study record |
| Document reference: 48600 |
| Study title: Usefulness of Tc-99m HMPAO-labeled WBC heart scan to predict impaired ventricular function and coronary artery dilation in children with Kawasaki diseaseHsiu-Bao Hsua, Yun-Ching Fub,c,*, Shih-Chuan Tsaid, Ruoh-Fang Yene, Betau Hwangc,f. International Journal of Cardiology 92 (2003) 65– 69 |
| Active substance: CERETEC |
| Study summary document link (including results): hsiu-bao h 2003.pdf |
| View full study record |
| Document reference: 48591 |
| Study title: Utility of Tc 99m HMPAO SPECT in the early diagnosis of Rasmussen's syndromeItalian journal of neurological sciences (1998), 19(4),217-20. paladin f 1998 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48619 |
| Study title: Tc-99m-HMPAO SPECT in the diagnosis of brain death in childrenPediatrics international : official journal of the Japan Pediatric Society (2004), 46(6), 711-4. okuyaz c 2005 |
| Active substance: CERETEC |
| Study summary document link (including results): 2011-09 GE cer-ces response List of published articles.doc |
| View full study record |
| Document reference: 48617 |
| Study title: Th 1165a metered aerosol: therapy. |
| Active substance: FENOTEROL |
| Study summary document link (including results): Fenoterol hydrobromide_U70-0143_synopsis.pdf |
| View full study record |
| Document reference: 27035 |
| Study title: Evaluation of the efficacy and tolerance of RU51807 (cefpodoxime proxetil) in children with skin and soft tissue infections |
| Active substance: CEFPODOXIME |
| Study summary document link (including results): CEFPODOXIME STUDY FF8980740.xls |
| View full study record |
| Document reference: 47975 |
| Study title: Ciprandi−G, Tosca−M, Ricca−V, Passalacqua−G, Fregonese−L, Fasce−L, Canonica−G−W. Cetirizine treatment of allergic cough in children with pollen allergy. Allergy, Jul 1997, vol. 52, no. 7, p. 752−4.Ciprandi−G, Tosca−M, Ricca−V, Passalacqua−G, Fregonese−L, Fasce−L, Canonica−G−W. Cetirizine treatment of allergic cough in children with pollen allergy. Allergy, Jul 1997, vol. 52, no. 7, p. 752−4. |
| Active substance: CETIRIZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23659 |
| Study title: Schellong G et al High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.J Clin Oncol 1999 Dec;17(12):3736-44 |
| Active substance: ETOPOSIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26772 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A study of the safety and efficacy of RG 5029Y (triamcinolone acetonide) aqueous nasal spray in patients with perennial allergic rhinitis -Procaccini RL -24/02/1994 |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46853 |
| Study title: Study the therapeutic action (control and prevention fo asthma attacks) and safety of Triamcinolone hexacetonide in 60 ambulatory patients exhibiting asthma, by means of a trial in which it would be compared with other steroids.Valdés |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48965 |
| Study title: Open, phase IIIb multicentric study of the immunogenicity and reactogenicity of the co-administration of Priorix (measles-mumps-rubella) and Infanrix Polio-Hib in each thigh to healthy infants aged 16 to 20 months. |
| Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47872 |
| Study title: Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and DaSilva, J. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys Biol.Psychiatry 1974;8:177-189. Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and DaSilva, J. Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys Biol.Psychiatry 1974;8:177-189. |
| Active substance: ORPHENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32900 |
| Study title: A multicentre double-blind group comparative study of the efficacy and safety of nedocromil sodium 2% ophthalmic solution in the treatment of Ragweed- induced seasonal allergic conjunctivitis - Melamed et al. - 1986 - Application for marketing autorisation - TILAVIST (Nedocromil Sodium 2% Eye drops) - Clinical documentation - OP Van Bijsterveld - 07/04/1993 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46990 |
| Study title: Surgery. 1985 Dec;98(6):1189-96. Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy. Talpos GB, Jackson CE, Froelich JW, Kambouris AA, Block MA, Tashjian AH Jr Surgery. 1985 Dec;98(6):1189-96. Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy. Talpos GB, Jackson CE, Froelich JW, Kambouris AA, Block MA, Tashjian AH Jr |
| Active substance: THALLIUM 201T1 CHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44708 |
| Study title: J Nucl Med. 1987 Jan;28(1):47-52. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. J Nucl Med. 1987 Jan;28(1):47-52. Thallium-201 brain tumor imaging: a comparative study with pathologic correlation. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. |
| Active substance: THALLIUM 201T1 CHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44608 |
| Study title: Am J Cardiol. 1996 Jul 15;78(2):175-81. Evaluation of myocardial ischemia and infarction by signal-averaged electrocardiographic late potentials in children with Kawasaki disease. Ogawa S, Nagai Y, Zhang J, Yuge K, Hino Y, Jimbo O, Fukazawa R, Hayashi RAm J Cardiol. 1996 Jul 15;78(2):175-81. Evaluation of myocardial ischemia and infarction by signal-averaged electrocardiographic late potentials in children with Kawasaki disease. Ogawa S, Nagai Y, Zhang J, Yuge K, Hino Y, Jimbo O, Fukazawa R, Hayashi R |
| Active substance: THALLIUM 201T1 CHLORIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44508 |
| Study title: Snow RD, Lecklitner ML. Musculoskeletal findings in Klippel-Trenaunay syndrome. Clin Nucl Med. 1991 Dec;16(12):928-30. Snow RD, Lecklitner ML. Musculoskeletal findings in Klippel-Trenaunay syndrome. Clin Nucl Med. 1991 Dec;16(12):928-30. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43721 |
| Study title: Undesirable events with radiopharmaceuticals.Santos-Oliveira R. Tohoku J Exp Med 2009;217:251-7 |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48757 |
| Study title: Ianovskaia EM, Torbenko VP, Mironov SP, Riazantseva VI. [A radionuclide method used in post-traumatic stiffness of the elbow joint] Khirurgiia (Mosk). 1988 Dec;(12):117-9. Russian. No abstract available. Ianovskaia EM, Torbenko VP, Mironov SP, Riazantseva VI. [A radionuclide method used in post-traumatic stiffness of the elbow joint] Khirurgiia (Mosk). 1988 Dec;(12):117-9. Russian. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43802 |
| Study title: Strenge-Hesse Postmarkting surveillance study (evaluation of 154 Legalon-SIL-case reports,18 children) 1983-1992 Internal Report; Cesko-Slovenska Pediatrie; VOL: 61 (6); p. 350-356 /2006/Internal Report, Strenge-Hesse, March 1996 |
| Active substance: Silibinine dihydrogen succinate, disodium |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39873 |
| Study title: GM2002/00081/00 A double blind, placebo controlled two way cross over study investigating the efficacy of sumatriptan nasal spray in children's migraine. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): sumatriptan-SUM40019-ICHE3.pdf |
| View full study record |
| Document reference: 43074 |
| Study title: A fluoride dose response evaluation in an anticaries clinical trial1992-Marks, J Dent Res(71)6:1286-1291, June 1992 |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1992-Marks-a fluoride dose response evaluation in an anticaries clinical trial.pdf |
| View full study record |
| Document reference: 49086 |
| Study title: Non-corticosteroid treatment for nephrotic syndrome in children (part III).Hodson EM, Willis NS, Craig JC. Cochrane Database Syst Rev. 2010, Issue 4 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49283 |
| Study title: Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H; Japanese Pediatric IgA Nephropathy Treatment Study Group. Clin J Am Soc Nephrol. 2006 May;1(3):511-7. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49280 |
| Study title: Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial.Kelly D1, Jara P, Rodeck B, Lykavieris P, Burdelski M, Becker M, Gridelli B, Boillot O, Manzanares J, Reding R. Lancet. 2004 Sep 18-24;364(9439):1054-61. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49265 |
| Study title: The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.Arora-Gupta N, Davies P, McKiernan P, Kelly DA. Pediatr Transplant. 2004 Apr;8(2):145-50. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49262 |
| Study title: The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation.Anguita A, Repetto HA, Rodriguez-Rilo L, Vazquez LA, Iturzaeta A, Morrone G, Deheza R, Maldonado L, Goldberg JL. Transplant Proc. 1999 Sep;31(6):2279. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49230 |
| Study title: Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.Ooi CY, Bohane TD, Lee D, Naidoo D, Day AS. Aliment Pharmacol Ther. 2007 Apr 15;25(8):941-7. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49278 |
| Study title: Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study.Hutchinson C, Elbers J, Halliday W, Branson H, Laughlin S, Armstrong D, Hawkins C, Westmacott R, Benseler SM. Lancet Neurol. 2010 Nov;9(11):1078-84 |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49295 |
| Study title: Twelve years experience of juvenile dermatomyositis in North India.Singh S, Bansal A. Rheumatol Int. 2006 Apr;26(6):510-5. |
| Active substance: Azathioprine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 49269 |
| Study title: produits de contraste et principes d'injection en acquisition helicoidale; DEBELLE L; in : scanner helicoidal ; principes et modalites pratique d'utilisation ; BLUM A. REGENT D. ; Masson Paris 1995 ; p.45 52produits de contraste et principes d'injection en acquisition helicoidale; DEBELLE L; in : scanner helicoidal ; principes et modalites pratique d'utilisation ; BLUM A. REGENT D. ; Masson Paris 1995 ; p.45 52 |
| Active substance: BARIUM SULPHATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22197 |
| Study title: Ritzel G. Letter: Ascorbic acid and the common cold.JAMA. 1976 Mar 15;235(11):1108. |
| Active substance: ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21878 |
| Study title: Valor profilactico de la vitamina C en infecciones respiratorias agudas del escolar. (Prophylactic value of vitamin C in acute respiratory tract infections in schoolchildren.)Bancalari A, Seguel C, Neira F, et al., 1984, Rev Med Chil. 1984;112(9):871-6 |
| Active substance: ASCORBIC ACID |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48908 |
| Study title: Valor profilactico de la vitamina C en infecciones respiratorias agudas del escolar. (Prophylactic value of vitamin C in acute respiratory tract infections in schoolchildren.)Bancalari A, Seguel C, Neira F, et al., 1984, Rev Med Chil. 1984;112(9):871-6 |
| Active substance: ASCORBIC ACID |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48909 |
| Study title: Graf. P. (1996) Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperactivity. Rhinology, 34, 9-13. |
| Active substance: XYLOMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45643 |
| Study title: Analyse critique des études cliniques Abbott, contains study 75-030 of Depakene syrup in epileptic children - Canlorbe P. - 03/04/1981 |
| Active substance: VALPROIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45447 |
| Study title: A Formulation of Aerosolized Tobramycin (BramitobR) in the Treatment of Patients with Cystic Fibrosis and Pseudomonas aeruginosa Infection A Double-Blind, Placebo-Controlled, Multicenter StudyChuchalinet al, Pediatr Drugs 2007; 9 Suppl. 1: 21-31 |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): DM.RS.10000.002.04 publication.pdf |
| View full study record |
| Document reference: 49196 |
| Study title: Efficacy, Safety, and Local Pharmacokinetics of Highly Concentrated Nebulized Tobramycin in Patients with Cystic Fibrosis Colonized with Pseudomonas aeruginosaLenoir et al, Pediatr Drugs 2007; 9 Suppl. 1: 11-20, 1174-5878/07/0001-0011/ |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): DM.PR.10000.001.01 publication.pdf |
| View full study record |
| Document reference: 49195 |
| Study title: Tobramycin sulfate elimination in premature infants. Arbeter AM, Saccar CL, Eisner S, Sarni E, Yaffe SJ. J Pediatr. 1983 Jul;103(1):131-5. |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48896 |
| Study title: Schmidt LM. Topical dermatologic therapy for the pediatrician. Pediatr Clin North Am. 1978 May;25(2):191-208. Schmidt LM. Topical dermatologic therapy for the pediatrician. Pediatr Clin North Am. 1978 May;25(2):191-208. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44831 |
| Study title: Final report on clinical trials of K 75 - Rhi and K 76 - Rhi (Rhinospray drops). |
| Active substance: TRAMAZOLINE |
| Study summary document link (including results): Tramazoline Hydrochloride_U68-0083_synopsis.pdf |
| View full study record |
| Document reference: 46698 |
| Study title: |
| Active substance: venticoll |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48220 |
| Study title: A double-blind, randomised trial to compare treatment results for trimethoprim treatment in a once a day-dosage regimen with conventional thrice a day pivmecillinam in female patients with cystitis.Örsten et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_7.xlsx |
| View full study record |
| Document reference: 49065 |
| Study title: Compare the effectiveness of trimethoprim alone with both co-trimoxazole and sulphamethizole for the treatment of uncomplicated urinary tract infections in general practice.Keenan et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_6.xlsx |
| View full study record |
| Document reference: 49064 |
| Study title: Evaluate the prophylactic efficacy of trimetoprim in urinary tract infections and its effect on the normal gastrointestinal and periurethral bacterial flora.Lidin-Janson et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_3.xlsx |
| View full study record |
| Document reference: 49061 |
| Study title: Investigate the efficacy of trimethoprim administered once daily for three days.Ahlmén et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_4.xlsx |
| View full study record |
| Document reference: 49062 |
| Study title: Investigate the efficacy of trimethoprim in the long-term treatment of urinary tract infections in children.Helle |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_2.xlsx |
| View full study record |
| Document reference: 49060 |
| Study title: Phase 1, Multicenter open-label trial to gain additional experience with topiramate among subjects with infantile spasms |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44912 |
| Study title: An open study to compare the clinical efficacy and tolerance of two sustained action corticosteroids in ORL manifestations.Larger (Publication Thérapeutique, No. 3 (Suppl.), Apr. 1979) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48963 |
| Study title: Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975.Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b. Journal of Clinical Oncology 1999;17(3):968-975 1999;(3):968-975. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43110 |
| Study title: Topical stannous fluoride as a caries preventive for preschool children1962-Burgess |
| Active substance: SODIUM FLUORIDE |
| Study summary document link (including results): 1962-Burgess-Topical stannous fluoride as a caries preventive for preschool children.pdf |
| View full study record |
| Document reference: 49142 |
| Study title: Familial juvenile hypertrophy of the breast. Familial juvenile hypertrophy of the breast. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43262 |
| Study title: Indagine clinica preliminare del trazodone in preanestesia. |
| Active substance: TRAZODONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46728 |
| Study title: Myopia progression in young school children. A prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops. Jensen H. Acta Ophthalmol Suppl. 1991;(200):1-79. Myopia progression in young school children. A prospective study of myopia progression and the effect of a trial with bifocal lenses and beta blocker eye drops. Jensen H. Acta Ophthalmol Suppl. 1991;(200):1-79. |
| Active substance: TIAGABINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 38486 |
| Study title: Utilidad de la tizanidina. Seguimiento de un ano en el tratamiento de la espasticidad en la paralysis (The usefulness of tizanidine. A one−year follow−up of the treatment of spasticity in infantile cerebral palsy). Vásquez BA, Arellano SME, León HSR, Morales OMG. Revista de neurologia, Aug 1−15 2006, vol. 43, no. 3, p. 132−6Utilidad de la tizanidina. Seguimiento de un ano en el tratamiento de la espasticidad en la paralysis (The usefulness of tizanidine. A one−year follow−up of the treatment of spasticity in infantile cerebral palsy). Vásquez BA, Arellano SME, León HSR, Morales OMG. Revista de neurologia, Aug 1−15 2006, vol. 43, no. 3, p. 132−6 |
| Active substance: TINZANIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44790 |
| Study title: 41. Phase 3, double-blind, parallel-group, safety and efficacy study of TPM monotherapy in adults with refractory partial epilepsy. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44975 |
| Study title: Pharmacokinetics of teicoplanin in children. - Tarral E, Jehl F, Tarral A et al. (1988) - Journal of Antimicrobial Chematherapy 21, Supplement A, 47-51. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44306 |
| Study title: Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. Levin TL, Berdon WE, Haller JO, Ruzal-Shapiro C, Hurlet-Jenson A. Intrasplenic masses of "preserved" functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol. 1996 Sep;26(9):646-9. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44259 |
| Study title: A double blinded trial to compare once a day dose regimen of trimethoprim with standard dose of two tablets twice daily of co-trimoxazole in the treatment of uncomplicated urinary tract infections in general practice.Cartwright et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_5.xlsx |
| View full study record |
| Document reference: 49063 |
| Study title: Yuen et al. Phenytoin dosage prediction in paediatric patients. Clin Pharmacokinet 1989; 16:254-60Yuen et al. Phenytoin dosage prediction in paediatric patients. Clin Pharmacokinet 1989; 16:254-60 |
| Active substance: PHENYLEPHRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33943 |
| Study title: Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogamma-globulinemia |
| Active substance: Bacterial lysate |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41840 |
| Study title: Assessment of Efficacy and Systemic Safety of a New Chlorofluorocarbon-Free Formulation of Inhaled Beclomethasone Dipropionate in Asthmatic ChildrenPEDIATRIC ASTHMA, ALLERGY & IMMUNOLOGY, Volume 15, Number 3, 2002 |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): DM-RS-3303-05-00 pubblication.pdf |
| View full study record |
| Document reference: 49208 |
| Study title: Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. Terzano C Allegra L Barkai L , Cremonesi G. Eur Rev Med Pharmacol Sci. 2000, 4:17-24. |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): MC.PR.1400.001.98 publication.pdf |
| View full study record |
| Document reference: 49203 |
| Study title: Comparison of nebulized beclomethasone dipropionate and nebulized budesonide in asthma of infants and children. Multicentre, randomized, controlled, open-label study versus reference product in 2 parallel groups over 14 weeks including a 2-week run-in, in severe or persistent asthma in infants and young children of the equivalent safety and efficacy of the addition, to the usual maintenance treatment, of 800 mg of nebulized beclomethasone dipropionate or 750mg of nebulized Pulmicort® twice a day.study synopsis. Please see report |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): 14.06.CT.01.91 (Synopsis).doc |
| View full study record |
| Document reference: 49206 |
| Study title: Double Blind Double Dummy Multicenter Randomized Parallel-Group Design Trial of the Efficacy and Tolerability of Beclomethasone Dipropionate Suspension for Nebulization and Beclomethasone Dipropionate Spray Via a Metered Dose Inhaler Plus Spacer in the 4-Week Treatment of the Exacerbation of Asthma in Pediatric Patients Terzano C Allegra L Barkai L , Cremonesi G. Eur Rev Med Pharmacol Sci. 2000, 4:17-24. |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): DM.RS.1404.001.99 publication.pdf |
| View full study record |
| Document reference: 49204 |
| Study title: Double-Blind Randomized Parallel Group Design Multicentre Study of the Efficacy and Tolerability of Two Nasal Spray Presentations of Beclomethasone Dipropionate ( Clenil Aqua, Chiesi and Beconase Aqua®, Glaxo) 200 mcg/bid in Patients with Allergic RhinitisMarni Et AL |
| Active substance: becLAMETHASONE |
| Study summary document link (including results): R9010291 publication.pdf |
| View full study record |
| Document reference: 49198 |
| Study title: Double-Blind Randomized Parallel Group Design Multicentre Study of the Efficacy and Tolerability of Two Nasal Spray Presentations of Beclomethasone Dipropionate ( Clenil Aqua, Chiesi and Beconase Aqua®, Glaxo) 200 mcg/bid in Patients with Allergic Rhinitisstudy synopsis |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): 14.06.CT.01.91 (Synopsis).doc |
| View full study record |
| Document reference: 49199 |
| Study title: Evidence of adequacy of the performance of the Pulvinal by measuring through-device Peak Inspiratory Flow Rate in severe airways obstruction in adults and children.Dal Negro et al, J.Aerosol Med 2001, 14(3) 343-349 |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): Published Paper (Dal Negro).pdf |
| View full study record |
| Document reference: 49200 |
| Study title: Hendriksz-C-J, Preece-M-A, Chakrapani-A. Department of Clinical Inherited Metabolic Disorders, Birmingham Children's Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK. Successful pregnancy in a treated patient with biotinidase deficiency. Journal of inherited metabolic disease, {J-Inherit-Metab-Dis}, 2005, vol. 28, no. 5, p. 791-2, ISSN: 0141-8955.Hendriksz-C-J, Preece-M-A, Chakrapani-A. Department of Clinical Inherited Metabolic Disorders, Birmingham Children's Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK. Successful pregnancy in a treated patient with biotinidase deficiency. Journal of inherited metabolic disease, {J-Inherit-Metab-Dis}, 2005, vol. 28, no. 5, p. 791-2, ISSN: 0141-8955. |
| Active substance: BIOTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22596 |
| Study title: An open study to investigate the clinical efficacy of Triamcinolone hexacetonide in diseases of the ear in children.Larras-Martenot (Les Cahier d´O.R.L. 14(4): 415-416, 1979) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48964 |
| Study title: Clinical trial to investigate the efficacy of Lederspan.Gedda |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48961 |
| Study title: Clinical trial to investigate the efficacy of Triamcinolone hexacetonide in patients with chronic articular reumatism.Kodama et al. |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48962 |
| Study title: [Injections and local infiltrations of triamcinolone hexacetonide (Lederle) in rheumatology]. [Article in Spanish] De Usobiaga JL. Rev Esp Reum Enferm Osteoartic. 1970 Apr;13(6):349-59. |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48960 |
| Study title: To show the effect of trimethoprim alone in patients with difficult urinary tract infections.Parkkulainen et al |
| Active substance: TRIMETHOPRIM |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Trimetoprim_1.xlsx |
| View full study record |
| Document reference: 49059 |
| Study title: A multicentre study for open assessment of the efficacy and safety of TILADE (Nedocromil sodium) QID in the management of Asthma in children - H. Eigen et al. - 1990 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46994 |
| Study title: "A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Biederman, et al., Journal of Clinical Psychiatry 2006, 67(5): 727-35. |
| Active substance: MODAFINIL |
| Study summary document link (including results): EUdraCT_reduced_datafields_for_Interim_publication-Modafinil.xls |
| View full study record |
| Document reference: 45291 |
| Study title: "Grinschgl G. Die Kombinationsbehandlung zerebraler Krampfanfälle unter besonderer Berücksichtigung der Epilepsie. Wien Klin Wochenschr 1952; 64/20: 362-365 " "Grinschgl G. Die Kombinationsbehandlung zerebraler Krampfanfälle unter besonderer Berücksichtigung der Epilepsie. Wien Klin Wochenschr 1952; 64/20: 362-365 " |
| Active substance: MEPHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31604 |
| Study title: Safety and efficacy comparison of two dosing regimens of MetroGel-Vaginal(R) in the treatment of bacterial vaginosis: a multicenter, randomized, single-blind, parallel comparison.Soper DE1, Livengood C, Sheehan KL, Fenner DE, Martens MG, Nelson AL, Ismail M, Thorp JM, Lappin M, Fleury FJ, Long BJ, Blackwelder T, Sweet RL, Sagov S. Prim Care Update Ob Gyns. 1998 Jul 1;5(4):150. |
| Active substance: METRONIDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48942 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Mezereum-Homaccord (drops) [AWB-AT] |
| Active substance: Mezereum-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40071 |
| Study title: Submission of result-related information on paediatric studies submitted under Article 45 of the Paediatric Regulation No 1901/2006. Product concerned by this submission: Nasonex and Associated Tradenames (Mometasone Furoate)Merck Sharp & Dohme (Europe), Inc. Clos du Lynx 5 Lynx Binnenhof B-1200 Brussels |
| Active substance: MOMETAZONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48849 |
| Study title: Miser JS et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.J Clin Oncol. 2004 Jul 15;22(14):2873-6.Miser JS et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.J Clin Oncol. 2004 Jul 15;22(14):2873-6. |
| Active substance: MITOXANTRONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32177 |
| Study title: An open study to investigate the clinical efficacy and grade of pain relief in patients recieving Triamcinolone hexacetonide by intra-articular injections or paravertebral infusions.Bonilla |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48959 |
| Study title: Do inhaled steroids change the response to inhaled ß-agonists in children? |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-3001 Study Synopsis.pdf |
| View full study record |
| Document reference: 44403 |
| Study title: Holter-monitored cardiac arrhythmias during induction of anaesthesia in children aged 1-3 years. Britisch Journal Anaesthesia 82 (suppl. 1): 147-148, 1999 Holter-monitored cardiac arrhythmias during induction of anaesthesia in children aged 1-3 years. Britisch Journal Anaesthesia 82 (suppl. 1): 147-148, 1999 |
| Active substance: TRAMADOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45019 |
| Study title: Neuropathic osteonecrosis of the knee in childhood. Two cases of myelomeningocele. Kjaerulff H, Hejgaard N. Acta Orthop Scand. 1987 Aug;58(4):436-40. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43852 |
| Study title: Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A: Trospium chloride for the treatment of detrusor instability in children; J. Urol. 2003; 170(5): 1978-1981Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A: Trospium chloride for the treatment of detrusor instability in children; J. Urol. 2003; 170(5): 1978-1981 |
| Active substance: TROSPIUM |
| Study summary document link (including results): 14532838.pdf |
| View full study record |
| Document reference: 46886 |
| Study title: Radionuclide imaging of the patellofemoral joint in young adults with anterior knee pain.Dye SF, Boll DA. Orthop Clin North Am 1986 Apr;17(2):249-62. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48478 |
| Study title: Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.La Grutta S , Nicolini G, Capristo C, Bellodi SC, Rossi GA (Monaldi Arch Chest Dis. 2007 Mar;67:30-8.) |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): MC.PR.1400.003.01 publication.pdf |
| View full study record |
| Document reference: 49202 |
| Study title: Open Randomized Parallel Group Design Trial Investigating the Efficacy and Tolerability of Beclomethasone Dipropionate (100 mcg qid) Dry Powder Delivered from Two Different Powder Inhalers (Chiesi and Glaxo) in the Treatment of Chronic Asthma in ChildrenJOURNAL OF AEROSOL MEDICINE, Volume 13, Number 1, 2000 |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): 15.02-CT-92-Pubblication.pdf |
| View full study record |
| Document reference: 49201 |
| Study title: Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydroflouroalkane-134aPEDIATRIC ALLERGY AND IMMUNOLOGY, Pediatr Allergy Immunol 2006: 17: 613–619 |
| Active substance: BECLAMETHASONE |
| Study summary document link (including results): DM-PR-3303-004-03-publication.pdf |
| View full study record |
| Document reference: 49207 |
| Study title: Comparative Evaluation of Cefixime versus Amoxicillin-Clavulate Following Ceftriaxone Therapy of PneumoniaClin Pediatr 1996; 35: 629-633, Amir J., 1996 |
| Active substance: CEFIXIME |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48974 |
| Study title: Comparative Evaluation of Cefpodoxime Versus Cefixime in children with Lower Respiratory Tract InfectionsIndian J Pediatr 2004; 71: 517-521 Sengupta J. |
| Active substance: CEFIXIME |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48975 |
| Study title: |
| Active substance: BUSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33742 |
| Study title: Safety_FertilitySafety_Fertility |
| Active substance: BLEOMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22812 |
| Study title: Application of S-CMC to otitis media with effusion. - Yukiko Ito et al.- 1992 (Journal reference not readable, 85:5;815-819) ; Publication M90 French validation registration dossier 05/1995 |
| Active substance: CARBOCYSTEINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23308 |
| Study title: An open study to examine whether enhanced control of asthma, assessed by peal flow measurements, was associated wth improvments in patients lifestyles |
| Active substance: BUDESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48890 |
| Study title: emploi d'un nouvel opacifiant triiode en cystographie et pour certains examens digestifs chez l'enfant; COUSSEMENT A; J. Radiol.; 1973 vol.54 n.12 p.67-68emploi d'un nouvel opacifiant triiode en cystographie et pour certains examens digestifs chez l'enfant; COUSSEMENT A; J. Radiol.; 1973 vol.54 n.12 p.67-68 |
| Active substance: BISACODYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 22725 |
| Study title: Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
| Active substance: CARBOMER |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23350 |
| Study title: Double blind, double dummy, multinational, multicenter, parallel-group design clinical trial of the efficacy and tolerability of budesonide spray aerosol (200 µg unit dose twice daily) administered via pMDI using the HFA-134a or the CFC propellant in a 12-week treatment period of mild to moderate persistent asthma in pediatric patients. Comparison with an open-label control group treated with budesonide HFA-134a (200 µg unit dose twice daily) given with the ‘JET’ spacer device |
| Active substance: BUDESONIDE |
| Study summary document link (including results): DM-PR-3307-003-03.doc |
| View full study record |
| Document reference: 49197 |
| Study title: Effect of budesonide on bronchial hyperresponsiveness and pulmonary function in patients with mild to moderate asthma.Kivity S, Fireman E, Greif J, Schwarz Y, Topilsky M. Ann Allergy. 1994 Apr;72(4):333-6. |
| Active substance: BUDESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48891 |
| Study title: Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children (ages 8 months to 6 years). |
| Active substance: BUDESONIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48432 |
| Study title: Efficacy and tolerability of morniflumate in the treatment of acute pharyngotonsillitis in children. Clinica,anno XXIX, 77-84, gennaio-giugno 1990R.Riondino et al, 1990. Clinica Europea 1990, Riondino |
| Active substance: MORNIFLUMATE |
| Study summary document link (including results): Clinica Europea 1990, Riondino.pdf |
| View full study record |
| Document reference: 48878 |
| Study title: Treatment of acute bronchitis in childhood with morniflumate. Clinica,anno XXIX, 77-84, gennaio-giugno 1990L.Longo et al , 1990. Clinica Europea 1990 Longo |
| Active substance: MORNIFLUMATE |
| Study summary document link (including results): Clinica Europea 1990 Longo.pdf |
| View full study record |
| Document reference: 48877 |
| Study title: Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and childrenOlkkola KT, Hamunen K, Maunuksela EL., 1995, Clin Pharmacokinet 1995; 5: 385-404 |
| Active substance: MORPHINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48931 |
| Study title: Epidural and intravenous bolus morphine for postoperative analgesia in infantsCan J Anaesth 1996; 12: 1203-10, Haberkern CM, Lynn AM, Geiduschek JM, Nespeca MK, Jacobson LE, Bratton SL, Pomietto M., 1996 |
| Active substance: MORPHINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48928 |
| Study title: Recommended use of morphine in neonates, infants and children based on a literature review: Part 2 - Clinical use.Paediatr Anaesth 1997; 2: 93-101, Kart T, Christrup LL, Rasmussen M., 1997 |
| Active substance: MORPHINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48929 |
| Study title: Single-dose caudal epidural morphine in children: safe, effective, and easy.J Clin Anesth 1991; 5: 386-90, Serlin S., 1991 |
| Active substance: MORPHINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48932 |
| Study title: The maturation of morphine clearance and metabolismMcRorie TI, Lynn AM, Nespeca MK, Opheim KE, Slattery JT., 1992, Am J Dis Child 1992; 8: 972-6 |
| Active substance: MORPHINE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48930 |
| Study title: Hofmann S, Knoefler R, Lorenz N, et al. Clinical experiences with low molecular weight heparins in pediatric patients. Thrombosis Research 2001;103: 345–53." |
| Active substance: NADROPARIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32450 |
| Study title: Quach et al. Thyroid and hepatic function after high-dose (131) I-metaiodobenzylguanidine ((131 I) -MIBG) therapy for neuroblastoma Pediatr Blood Cancer. 2010 Sep 9 |
| Active substance: META-IODOBENZYLGUANIDINE |
| Study summary document link (including results): 2011-09 GE response 131 Meta-lodobenzylguanidine.doc |
| View full study record |
| Document reference: 48326 |
| Study title: Bacigalupo A et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood. 1991 Apr 1;77(7):1423-8.Bacigalupo A et al. Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia. Blood. 1991 Apr 1;77(7):1423-8. |
| Active substance: MITOXANTRONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32227 |
| Study title: Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Vejar M, Fragasso G, Hackett D, Lipkin DP, Maseri A, Born GV, Ciabattoni G, Patrono C. Thrombosis and haemostasis, 12 Apr 1990, vol. 63, no. 2, p. 163−8Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Vejar M, Fragasso G, Hackett D, Lipkin DP, Maseri A, Born GV, Ciabattoni G, Patrono C. Thrombosis and haemostasis, 12 Apr 1990, vol. 63, no. 2, p. 163−8 |
| Active substance: DILTIAZEM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26148 |
| Study title: A new bowel preparation for elective colon and rectal surgery. A prospective, randomized clinical trial.Wolff BG, Beart RW Jr, Dozois RR, Pemberton JH, Zinsmeister AR, Ready RL, Farnell MB, Washington JA 2nd, Heppell J. Archives of surgery (Chicago Ill. : 1960), Jul 1988, vol. 123, no. 7, p. 895−900 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26507 |
| Study title: Lee WT, Leung SS, Wang SH, Xu YC, Zeng WP, Lau J, Oppenheimer SJ, Cheng JC. Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. Am J Clin Nutr. 1994 Nov; 60(5):744-50. Lee WT, Leung SS, Wang SH, Xu YC, Zeng WP, Lau J, Oppenheimer SJ, Cheng JC. Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. Am J Clin Nutr. 1994 Nov; 60(5):744-50. |
| Active substance: CALCIUM CARBONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 23155 |
| Study title: Bisoprolol treatment in children with hyperkinetic heart syndromeEur J Echocardiography 1999; Suppl: S66, Jurko A., 1999 |
| Active substance: Bisoprolol |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48905 |
| Study title: β-Blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.Pediatr Nephrol 2002; 17: 345-350; Sorof JM., 2002 |
| Active substance: BISOPROLOL AND HYDROCHLOROTHIAZIDE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48907 |
| Study title: |
| Active substance: FLUTICASONE |
| Study summary document link (including results): Synopsis-Fluticasone Propionate-CUTIVATE-FLD40004.pdf |
| View full study record |
| Document reference: 28434 |
| Study title: AJNR Am J Neuroradiol. 2003 Mar;24(3):373-81. MR ventriculography for the study of CSF flow. Joseph VB, Raghuram L, Korah IP, Chacko AG. AJNR Am J Neuroradiol. 2003 Mar;24(3):373-81. MR ventriculography for the study of CSF flow. Joseph VB, Raghuram L, Korah IP, Chacko AG. |
| Active substance: GADODIAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28803 |
| Study title: Neurology. 1995 Jan;45(1):123-6. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH. |
| Active substance: FLUDEOXYGLUCOSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28201 |
| Study title: Bericht über die klinische Prüfung von 9alpha-Fluorhydrocortison zur Behandlung hypotoner und orthostatischerKreislaufregulationsstörungen, Arzneim Forsch (Drug Research) 1971; 21: 1144-1149, Legeler HJ. , 1971 |
| Active substance: FLUDOCORTISONE |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48904 |
| Study title: Corticosteroids administered by nebulization to children with bronchial asthma.Terzano C, Barkai L, Cremonesi G., Adv Ther. 2001 Nov-Dec;18:253-60. |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): MC-PR-3502-001-99 publication.pdf |
| View full study record |
| Document reference: 49211 |
| Study title: Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children.Piacentini G.L. et al, Allergy 1990,45, 612-616 |
| Active substance: FLUNISOLIDE |
| Study summary document link (including results): Published paper (Piacentini).pdf |
| View full study record |
| Document reference: 49212 |
| Study title: Aspects of pharmacology of Gentamicin in Newborn Infants - Andersen JH. & Al - 1972 ( Acta Paediat. Scand. 61:343-9) - Publication in Gentamicin Registration Dossier - 1978 -Aspects of pharmacology of Gentamicin in Newborn Infants - Andersen JH. & Al - 1972 ( Acta Paediat. Scand. 61:343-9) - Publication in Gentamicin Registration Dossier - 1978 - |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28890 |
| Study title: Gentamicin in the treatment of acute and chronic pyelonephritis in childrenMed Klinik 1970; 65 (12): 552-557, Kienitz M., 1970 |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48933 |
| Study title: Doutre MS, Grosshans E, Saiag P. Herpes virus infection in the immunocompetent child and adult. Cutaneous and mucous herpes. Annales de Dermatologie et de Venereologie. 2002; 129(10 Suppl~):2S27-2S35, Octobre.2002.Doutre MS, Grosshans E, Saiag P. Herpes virus infection in the immunocompetent child and adult. Cutaneous and mucous herpes. Annales de Dermatologie et de Venereologie. 2002; 129(10 Suppl~):2S27-2S35, Octobre.2002. |
| Active substance: Foscarnet |
| Study summary document link (including results): Doutre MS et al 2002.pdf |
| View full study record |
| Document reference: 39636 |
| Study title: A randomized, double-blind trial to determine whether 1 g of erythromycin daily for a week is as a effective as the 2 g daily dose but without the adverse gastrointestinal effects associated with the larger dose.Linnemann et al. (Sexually transmitted diseases, Vol 14, No. 2) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_4.xlsx |
| View full study record |
| Document reference: 49052 |
| Study title: A single-blind trial to investigate the ethiology of bacterial respiratory tract infections and the efficacy of penicillin V (Kåvepenin) and erythromycin (Ery-Max) in these infections.Hovelius et al. (Clinical practice and Therapy, suppl 1, 1982) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_1.xlsx |
| View full study record |
| Document reference: 49049 |
| Study title: A Double blind, placebo-controlled trial for further evaluation of the effect of these preparations in migraine and also of their side-effects.Kallós et al. (Translation of a paper from The Swedish Medical journal (Svenska Läkartidningen) 1958:55:1782 No. 24) |
| Active substance: ergotamine |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ergotamine_1.xlsx |
| View full study record |
| Document reference: 49073 |
| Study title: Comparisons of the effect of ergotamine tartrate adminislered intramuscularly, by inhalation (Medihaler ergotamine) or rectally in combination with meprobamate, chlorcyc1izine, and caffeine (Anervan suppositories ):t, in the treatment of migraine attacks.Kallós et al. REPRINTED FROM HEADACHE, October, 1964 |
| Active substance: ergotamine |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Ergotamine_2.xlsx |
| View full study record |
| Document reference: 49074 |
| Study title: Compare the clinical efficacy and tolerance of a new erythromycin formulation, when administered twice or four times daily in acute bronchitis.Pekkanen (Rhinology, 21, 00-00, 1983) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_2.xlsx |
| View full study record |
| Document reference: 49050 |
| Study title: Liver transplantation in the therapy of hepatocellular carcinoma: A revision of our series. |
| Active substance: Ethyl esters of iodized fatty acids of poppy seed oil |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39920 |
| Study title: Double-blinded, randomized trial to evaluate the efficacy of early erythromycin treatment on the duration of fecal excretion and diarrhea associated with Campylobacter jejuni.Salazar-Lindo et al. (The Journal Of Pediatrics, Aug, 1986) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_6.xlsx |
| View full study record |
| Document reference: 49054 |
| Study title: Postoperative emesis after pediatric strabismus surgery. the effect of dixyrazine compared to droperidol |
| Active substance: DIXYRAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26278 |
| Study title: PHARMACOKINETICS OF VOLTAREN IN CHILDRENPHARMACOKINETICS OF VOLTAREN IN CHILDREN |
| Active substance: DICLOFENAC |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26072 |
| Study title: Examine the variability in erythromycin pharmacokinetics after single dose intravenous administration, determine the linearity of pharmacokinetic parameters after administration of different doses, evaluate the usefulness of non-invasive sampling techniques in studying erythromycin pharmacokinetics.Klaustin et al. (Br. J. Am. Pharmac. 1980, 273-279) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_7.xlsx |
| View full study record |
| Document reference: 49055 |
| Study title: Investigate how compliance among children may be related to form and dosage of the medicine.Norstedt |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_3.xlsx |
| View full study record |
| Document reference: 49051 |
| Study title: Investigate if Bordetella pertussis bacterias, that disappear after a couple of days of erythromycin treatment, returns after completed treatment.Quiding Boström Läkartidningen 1981 |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_10.xlsx |
| View full study record |
| Document reference: 49058 |
| Study title: Pharmacokinetic and antibacterial activity of daily gentamicinArchives Dis Childhood 1992; 67: 57-61, Skopnik H., 1992. |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48935 |
| Study title: Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery. Snir M et al. Ophthalmic Surg Lasers. January 1, 2000, 31-7 |
| Active substance: FLUOROURACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28277 |
| Study title: Treatment of Neonatal Sepsis with Ceftriaxone/Gentamicin and with Azlocillin/Gentamicin: A Clinical Comparison of Efficacy and Tolerability Chemotherapy1988; 34: 158-163, Wiese G. |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48934 |
| Study title: Fucithalmic, chloramphenicol or no treatment after squint surgery in children. A single blind randomised study.Kearns P.P. 1992, Acta Ophthalmol, 70:132-134 |
| Active substance: FUSIDIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48459 |
| Study title: Bassi F, Serio M. Treatment with an LH-RH agonist ('Zoladex' depot) in patients with precocious puberty. (Ita, English translation). Drugs under Experimental and Clinical Research 1990;16(Suppl):33-37 1990;(Suppl):33-37.Bassi F, Serio M. Treatment with an LH-RH agonist ('Zoladex' depot) in patients with precocious puberty. (Ita, English translation). Drugs under Experimental and Clinical Research 1990;16(Suppl):33-37 1990;(Suppl):33-37. |
| Active substance: GOSERELIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29003 |
| Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27481 |
| Study title: CLINICAL EVALUATION OF FLUCONAZOLE (UK-49,858) IN IV DRIP ENJECTION FROM EFFICACY AND SAFETY IN PEDIATRIC SYSTEMIC MYCOSIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27933 |
| Study title: ONCE-WEEKLY ORAL FCA VS. PLACEBO IN THE PREVENTION OF MUCOCUTANEOUS FUNGAL INFECTIONS IN PATIENTS DISCHARGED FROM THE HOSPITAL AFTER BONE MARROW TRANSPLANTATION. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27611 |
| Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27520 |
| Study title: Quality of life in a double-blind, randomised, placebo-controlled parallel study comparing the efficacy and safety of three dosage strengths of fexofenadine HCl (15, 30 and 60 mg BID) in paediatric patients (ages 6 to 11 years) in the treatment of Seasonal Allergic Rhinitis, 22 April 1998 |
| Active substance: FEXOFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27259 |
| Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH GASTRO-INTESTINAL CANDIDIASIS. |
| Active substance: FLUCONAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27784 |
| Study title: A comparative study of Fucidin H cream and Hydrocortisone cream in children (4-17 years) with a flare-up of atopic dermatitis. A study using non-invasive bioengineering techniques. |
| Active substance: FRAMYCETIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 28625 |
| Study title: Once daily aminoglycoside dosing in full term neonatesPediatr Infect Dis J 1995; 14: 71-72, Skopnik H., 1995 |
| Active substance: GENTAMYCIN |
| Study summary document link (including results): 20140709_Art 45 Studies.xlsx |
| View full study record |
| Document reference: 48936 |
| Study title: An open uncontrolled study to evaluate the effect of treatment and tolerance of a flucloxacillin nsyrup.Price et al Flucloxacillin in the treatment of infectious conditions in children. |
| Active substance: FLUCLOXACILLIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Flukloxacillin_1.xlsx |
| View full study record |
| Document reference: 49076 |
| Study title: Investigate the bioavailability of 2 commercially available pediatric suspensions of erythromycin containing the stearate salt and the ethylsuccinate ester, respectively.Eriksson et al. (Scand J Infcect Dis 13: 211-215, 1981) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_9.xlsx |
| View full study record |
| Document reference: 49057 |
| Study title: Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady state intranasal levocabastine. Tran J Q, Di Cicco R A, Sheth S B, Tucci M, Peng L, Jorkasky D K, Hursting M J, Benincosa L J. Journal of clinical pharmacology, {May 1999, vol. 39, no. 5, p. 513 9. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26441 |
| Study title: Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Jamali F, Barrington KJ, Finer NN, Coutts RT, Torok-Both GA. Dev Pharmacol Ther. 1988;11(5):253-7. |
| Active substance: Doxapram |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48895 |
| Study title: The effect of an infusion of doxapram on morphine analgesia. Gupta PK, Dundee JW. Anaesthesia. 1974 Jan;29(1):40-3. |
| Active substance: Doxapram |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48894 |
| Study title: Role of doxapram in reducing pulmonary complications after major surgery. Gawley TH, Dundee JW, Gupta PK, Jones CJ. Br Med J. 1976 Jan 17;1(6002):122-4. |
| Active substance: Doxapram |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48893 |
| Study title: Study the effect of erythromycin on diarrheal illnesses in a clinical trial among children at an orphanage in Bangkok, Thailand.Taylor et al. (Antimicrobial agents and chemotherapy, March 1987, p. 438-442) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_5.xlsx |
| View full study record |
| Document reference: 49053 |
| Study title: Study the epidemiology, natural history, treatment and prevention of perinatally aquired chlamydial infections.Grossman et al. (Elsevier biomedical press, 1982) |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Erythomycin ethylsuccinate_8.xlsx |
| View full study record |
| Document reference: 49056 |
| Study title: To determine the apparent bioavailability of Dicloxacillin in children of ages ranging from 6 days to 11,5 years.Smith et al. (Dev Pharmacol Ther 1990;14:35-44) |
| Active substance: dicloxacillin |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication Recip_Dikloxacillin_1.xlsx |
| View full study record |
| Document reference: 49078 |
| Study title: Noel G 1967Noel G 1967 |
| Active substance: DROPROPIZINE |
| Study summary document link (including results): Noel G.xls |
| View full study record |
| Document reference: 47540 |
| Study title: A modified schedule for routine pertussis immunization |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40996 |
| Study title: A phase II, double blind, randomized, double center, controlled study to evaluate the safety and immunogenicity of four formulations of DTwPHib combined vaccine containing different concentrations of Hib conjugate in healthy infants at 3, 4, 5 months of age.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V45P1.xlsx |
| View full study record |
| Document reference: 49183 |
| Study title: A phase II, open-label, randomized, single-center, comparative study evaluating safety, tolerability and immunogenicity of three vaccinations of the DTPHib combined vaccine (Chiron Vaccines; now Novartis Vaccines) in comparison to separate vaccinations of DTP (Chiron Behring; now Novartis Vaccines) and Hib/AlPO4 (Chiron Vaccines; now Novartis Vaccines) vaccines, when administered to 2, 3, 4 months old healthy infants.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V38P1.xlsx |
| View full study record |
| Document reference: 49186 |
| Study title: A phase II, open-label, single-centre, singal-arm, extension study to evaluate the safety and immunogenicity of a booster vaccination of the DTPHib combined vaccine (Chiron Vaccines; now Novartis Vaccines) administered to 18-20 months old healthy infants who had previously received either DTPHib combined vaccine or separate administrations of DTP (Chiron Behring; now Novartis Vaccines) and Hib/AlPO4 (Chiron Vaccines; now Novartis Vaccines) vaccines at 2, 3 and 4 months of age.Please see report- sturdy report |
| Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) |
| Study summary document link (including results): V38P1E1.xlsx |
| View full study record |
| Document reference: 49185 |
| Study title: Vecchi-V, Pileri-S, Burnelli-R, Bontempi-N, Comelli-A, Testi-A-M, Carli-M, Sotti-G, Rosati-D, Di-Tullio-M-T, et al. III Department of Pediatrics, Bologna University, Italy. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. Cancer, {Cancer}, 15 Sep 1993, vol. 72, no. 6, p. 2049-57, ISSN: 0008-543X.Vecchi-V, Pileri-S, Burnelli-R, Bontempi-N, Comelli-A, Testi-A-M, Carli-M, Sotti-G, Rosati-D, Di-Tullio-M-T, et al. III Department of Pediatrics, Bologna University, Italy. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. Cancer, {Cancer}, 15 Sep 1993, vol. 72, no. 6, p. 2049-57, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34871 |
| Study title: Vietti-T-J, Coulter-D-M. Edward Mallinckrodt Dept. Ped., Washington Univ. Sch. Med., St Louis, Mo., United States. Anticancer agents used in the treatment of childhood leukemias. Cancer Bulletin {CANCER-BULL}, 1978, Vol/Iss/Pg. 30/5 (148-159).Vietti-T-J, Coulter-D-M. Edward Mallinckrodt Dept. Ped., Washington Univ. Sch. Med., St Louis, Mo., United States. Anticancer agents used in the treatment of childhood leukemias. Cancer Bulletin {CANCER-BULL}, 1978, Vol/Iss/Pg. 30/5 (148-159). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34872 |
| Study title: Walker-R-W, Rosenblum-M-K. Memorial Sloan-Kettering Cancer Cnt., 1275 York Avenue, New York, NY 10021, United States. Childhood medulloblastoma. Revue Neurologique {REV-NEUROL}, 1992, Vol/Iss/Pg. 148/6-7 (467-476), ISSN: 0035-3787.Walker-R-W, Rosenblum-M-K. Memorial Sloan-Kettering Cancer Cnt., 1275 York Avenue, New York, NY 10021, United States. Childhood medulloblastoma. Revue Neurologique {REV-NEUROL}, 1992, Vol/Iss/Pg. 148/6-7 (467-476), ISSN: 0035-3787. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34873 |
| Study title: Weiner-M-A, Leventhal-B-G, Marcus-R, Brecher-M, Ternberg-J, Behm-F-G, Cantor-A, Wharam-M, Chauvenet-A. Hackensack Medical Center, NJ. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Ped iatric Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Sep 1991, vol. 9, no. 9, p. 1591-8, ISSN: 0732-183X.Weiner-M-A, Leventhal-B-G, Marcus-R, Brecher-M, Ternberg-J, Behm-F-G, Cantor-A, Wharam-M, Chauvenet-A. Hackensack Medical Center, NJ. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Ped iatric Oncology Group study. Journal of clinical oncology ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34875 |
| Study title: Corrias A et al. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study. Group of Italian Society of Pediatric Endocrinology and Diabetology. J Endocrinol Invest. 2000 Feb;23(2):84-9Corrias A et al. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study. Group of Italian Society of Pediatric Endocrinology and Diabetology. J Endocrinol Invest. 2000 Feb;23(2):84-9 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35190 |
| Study title: De Haes A et al. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. Anesth Analg. 2002 Sep;95(3):588-96De Haes A et al. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors. Anesth Analg. 2002 Sep;95(3):588-96 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35187 |
| Study title: DeLuca G et al. GH secretion in thalassemia patients with short stature. Horm Res. 1995;44(4):158-63DeLuca G et al. GH secretion in thalassemia patients with short stature. Horm Res. 1995;44(4):158-63 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35200 |
| Study title: Janka-G-E, Lau-B-M, Haas-R-J, et-al. Dept. Haematol. Oncol., Child. Hosp., Univ. Munich, Germany. Combination chemotherapy and radiotherapy for Hodgkin's disease in children. European Journal of Pediatrics {EUR-J-PEDIATR}, 1978, Vol/Iss/Pg. 127 /4 (287-292).Janka-G-E, Lau-B-M, Haas-R-J, et-al. Dept. Haematol. Oncol., Child. Hosp., Univ. Munich, Germany. Combination chemotherapy and radiotherapy for Hodgkin's disease in children. European Journal of Pediatrics {EUR-J-PEDIATR}, 1978, Vol/Iss/Pg. 127 /4 (287-292). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34747 |
| Study title: Sellami-M, Auclerc-G, Weil-M, et-al. Service d'Oncologie Medicale, Hopital de la Salpetriere, F 75661 Paris, France. Malignant melanoma of children and adolescents. A report of 37 cases. Bulletin du Cancer {BULL-CANCER}, 1986, Vol/Iss/Pg. 73/1 (2-7).Sellami-M, Auclerc-G, Weil-M, et-al. Service d'Oncologie Medicale, Hopital de la Salpetriere, F 75661 Paris, France. Malignant melanoma of children and adolescents. A report of 37 cases. Bulletin du Cancer {BULL-CANCER}, 1986, Vol/Iss/Pg. 73/1 (2-7). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34841 |
| Study title: Shalet-S-M, Whitehead-E, Jones-P-H-M. Christie Hosp., Manchester, United Kingdom. Testicular dysfunction ater combination chemotherapy for Hodgkin's disease in childhood. Pediatric Research {PEDIATR-RES}, 1981, Vol/Iss/Pg. 15/12 (No. 165).Shalet-S-M, Whitehead-E, Jones-P-H-M. Christie Hosp., Manchester, United Kingdom. Testicular dysfunction ater combination chemotherapy for Hodgkin's disease in childhood. Pediatric Research {PEDIATR-RES}, 1981, Vol/Iss/Pg. 15/12 (No. 165). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34842 |
| Study title: Shalet-S-M. Dep. Endocrinol., Christie Hosp., Manchester M20 9BX, United Kingdom. Abnormalities of growth and gonadal function in children treated for malignant disease: A review. Journal of the Royal Society of Medicine {J-R-SOC-MED}, 1982, Vol/Iss/Pg. 75/8 (641-647).Shalet-S-M. Dep. Endocrinol., Christie Hosp., Manchester M20 9BX, United Kingdom. Abnormalities of growth and gonadal function in children treated for malignant disease: A review. Journal of the Royal Society of Medicine {J-R-SOC-MED}, 1982, Vol/Iss/Pg. 75/8 (641-647). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34843 |
| Study title: Shapiro-W-R. Chemotherapy of primary malignant brain tumors in children. Cancer, {Cancer}, Mar 1975, vol. 35, no. 3 suppl, p. 965-72, ISSN: 0008-543X.Shapiro-W-R. Chemotherapy of primary malignant brain tumors in children. Cancer, {Cancer}, Mar 1975, vol. 35, no. 3 suppl, p. 965-72, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34844 |
| Study title: Sherins-R-J, Olweny-C-L, Ziegler-J-L. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. The New England journal of medicine, {N-Engl-J-Med}, 6 Jul 1978, vol.299, no. 1, p. 12-6, ISSN: 0028-4793.Sherins-R-J, Olweny-C-L, Ziegler-J-L. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. The New England journal of medicine, {N-Engl-J-Med}, 6 Jul 1978, vol.299, no. 1, p. 12-6, ISSN: 0028-4793. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34845 |
| Study title: Sinniah-D, Lin-H-P. Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood. Cancer, {Cancer}, May 1979, vol. 43, no. 5, p. 1587-9, ISSN: 0008-543X.Sinniah-D, Lin-H-P. Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood. Cancer, {Cancer}, May 1979, vol. 43, no. 5, p. 1587-9, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34846 |
| Study title: Desjardins R_1981 Desjardins R_1981 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Desjardins R_1981_publication.pdf |
| View full study record |
| Document reference: 34999 |
| Study title: Ross RJ et al. Growth hormone response to overnight growth hormone-releasing hormone infusion and oral pyridostigmine in children with short stature. Acta Paediatr Scand Suppl. 1989;349:114-6Ross RJ et al. Growth hormone response to overnight growth hormone-releasing hormone infusion and oral pyridostigmine in children with short stature. Acta Paediatr Scand Suppl. 1989;349:114-6 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35216 |
| Study title: Singer W et al. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin Neurophysiol. 2006 Oct;23(5):476-81Singer W et al. Acetylcholinesterase inhibition in patients with orthostatic intolerance. J Clin Neurophysiol. 2006 Oct;23(5):476-81 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35182 |
| Study title: Singer W et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1294-8Singer W et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1294-8 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35186 |
| Study title: Singer W et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006 Apr;63(4):513-8Singer W et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006 Apr;63(4):513-8 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35183 |
| Study title: Somnier FE et al. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. Eur J Neurol. 1999 Sep;6(5):555-63Somnier FE et al. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. Eur J Neurol. 1999 Sep;6(5):555-63 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35191 |
| Study title: Turner GA, Williams JD, Baker DJ. Effect of pretreatment with oral pyridostigmine on subsequent activity of alcuronium in non-anaesthetized subjects. Br J Anaesth. 1991 Mar;66(3):365-9Turner GA, Williams JD, Baker DJ. Effect of pretreatment with oral pyridostigmine on subsequent activity of alcuronium in non-anaesthetized subjects. Br J Anaesth. 1991 Mar;66(3):365-9 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35208 |
| Study title: Wong BL. Management of the Child With Weakness. Semin Pediatr Neurol. December 1, 2006, 271-8Wong BL. Management of the Child With Weakness. Semin Pediatr Neurol. December 1, 2006, 271-8 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35177 |
| Study title: Ziv I et al. Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine. Br J Clin Pharmacol. 1992 May;33(5):507-10 Ziv I et al. Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine. Br J Clin Pharmacol. 1992 May;33(5):507-10 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35203 |
| Study title: A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infectionA controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35237 |
| Study title: Antiviral therapy in neonatal chronic lung disease.109Antiviral therapy in neonatal chronic lung disease.109 |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35234 |
| Study title: Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47)Bozzo TM. The Effect of Encephabol in School Children with States of Mental Exhaustion (Minerva Medicopsicologica 1970; 2 (12): 44-47) |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35240 |
| Study title: Krizsa J, Husz S, Dobozy A. (1989). Szent-Gyrgyi Albert University Medical School, Hungary, Dermatological Department. Expert Clinical Study report. Inosiplex treatment of patients with herpes zosterKrizsa J, Husz S, Dobozy A. (1989). Szent-Gyrgyi Albert University Medical School, Hungary, Dermatological Department. Expert Clinical Study report. Inosiplex treatment of patients with herpes zoster |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30134 |
| Study title: Kynclova S, Mydlil S Presented at the Czechoslovakian Symposium on Isoprinosine®; October, 1989; Prague. (Abstract only). First experience with Isoprinosine®/Modimunal® treatment in childrenKynclova S, Mydlil S Presented at the Czechoslovakian Symposium on Isoprinosine®; October, 1989; Prague. (Abstract only). First experience with Isoprinosine®/Modimunal® treatment in children |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30135 |
| Study title: Lento FG, Baretti C, Salemo R, Tandurella S.. Vittorio Emanuele III Hospital, Gela, Italy. 1980. Clinical Study Report . Treatment of varicella and measles with methisoprinolLento FG, Baretti C, Salemo R, Tandurella S.. Vittorio Emanuele III Hospital, Gela, Italy. 1980. Clinical Study Report . Treatment of varicella and measles with methisoprinol |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30136 |
| Study title: Lento FG, Cannata G, Baretti C, Salemo R, Tandurella S.. Clinica Europea. Nov-Dec 1981;20(6):3-8. Preliminary results obtained with methisoprinol in the treatment of measles and varicellaLento FG, Cannata G, Baretti C, Salemo R, Tandurella S.. Clinica Europea. Nov-Dec 1981;20(6):3-8. Preliminary results obtained with methisoprinol in the treatment of measles and varicella |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30137 |
| Study title: Lento FG, Cannata G, Cannata M, et al.. Presented at del Convegno Siculo-Calabro di Malattie Infettive e Parassitarie; February 6-7, 1981, Messina, Italy. Report on 10 cases of herpes zoster treated with methisoprinolLento FG, Cannata G, Cannata M, et al.. Presented at del Convegno Siculo-Calabro di Malattie Infettive e Parassitarie; February 6-7, 1981, Messina, Italy. Report on 10 cases of herpes zoster treated with methisoprinol |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30138 |
| Study title: Lento G, Tandurella S, Baretti C, Cannata G, Salerno R. G Ital Potol Sci Affin 1982;28(1):9-15. Patients suffering from herpes zoster treated with methisoprinol.Lento G, Tandurella S, Baretti C, Cannata G, Salerno R. G Ital Potol Sci Affin 1982;28(1):9-15. Patients suffering from herpes zoster treated with methisoprinol. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30139 |
| Study title: Litzman J, et al . 1999 Scripta Medca (BRNO) 72 (4) 115 -124. Isoprinosine in the treatment of children with frequent respiratory tract infections and minor T lymphocyte immunodeficiency. Litzman J, et al . 1999 Scripta Medca (BRNO) 72 (4) 115 -124. Isoprinosine in the treatment of children with frequent respiratory tract infections and minor T lymphocyte immunodeficiency. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30140 |
| Study title: Litzman J, Lokaj J, Krejci M, Pesak S, Morgan G. Eur J Pediatr 1999 Jan;158(1):32-7. Isoprinosine does not protect against frequent respiratory tract infections in childhood.Litzman J, Lokaj J, Krejci M, Pesak S, Morgan G. Eur J Pediatr 1999 Jan;158(1):32-7. Isoprinosine does not protect against frequent respiratory tract infections in childhood. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30141 |
| Study title: A multicentre randomised, parallel group, double-blind phase III comparison between iodixanol (VISIPAQUE) 150 mg I/ml and 320 mg I/ml and iohexol (Omnipaque) 140 mg I/ml and 300 mg I/ml Report DXC060 (date Jun 1999) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXC060 Redacted.pdf |
| View full study record |
| Document reference: 48210 |
| Study title: A phase III, randomised, blinded comparison of Iodixanol (VISIPAQUE; 320 mgI/mL) and OMNIPAQUE 350 (Iohexol) in pediatric patients requiring angiocardiographyStudy Report 1968 (Date May 1996) |
| Active substance: IODIXANOL |
| Study summary document link (including results): Study Report 1968 Redacted.pdf |
| View full study record |
| Document reference: 48204 |
| Study title: A phase III, randomised, double blind comparison of Iodixanol (VISIPAQUE; 270 mgI/mL and 320 mgI/mL) and OMNIPAQUE 300 (Iohexol) in pediatric patients requiring computed tomography (CT) scanning of the headStudy Report 1966 (Date Jan 1996) |
| Active substance: IODIXANOL |
| Study summary document link (including results): Study Report 1966 Redacted.pdf |
| View full study record |
| Document reference: 48202 |
| Study title: A phase III, randomised, double blind comparison of Iodixanol (VISIPAQUE; 270 mgI/mL and 320 mgI/mL) and OMNIPAQUE 300 (Iohexol) in pediatric patients requiring computed tomography (CT) scanning of the bodyStudy Report 1967 (Date Dec 1995) |
| Active substance: IODIXANOL |
| Study summary document link (including results): Study Report 1967 Redacted.pdf |
| View full study record |
| Document reference: 48203 |
| Study title: Pharmacokinetic study of a single dose of propofol in paediatric burnt patients under 3 years old. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 0859FC-0003 Study Synopsis.pdf |
| View full study record |
| Document reference: 46135 |
| Study title: Propofol in pedriatic patients aged 1 month to 6 years |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47083 |
| Study title: Study of intravenous Diprivan (propofol) to determine an effective dose when used as an induction agent in pediatric patients undergoing various surgical procedures |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46122 |
| Study title: Study of intravenous Diprivan (propofol) to determine an effective dose when used as an induction agent in pediatric patients undergoing various surgical procedures under one hour duration |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46123 |
| Study title: The pharmacokinetics of Diprivan (propofol) in pediatric patients |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46121 |
| Study title: The safety of Diprivan (propofol) anesthesia versus standard anesthetic techniques in pediatric subjects less than 36 months of age |
| Active substance: PROPOFOL |
| Study summary document link (including results): 0859US0046 Study Synopsis.pdf |
| View full study record |
| Document reference: 46126 |
| Study title: The safety, efficacy and pharmacokinetics of ZD0859#1 vs. Diprivan (propofol) injection when used for maintenance of anaesthesia in children. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 0859IL0058 Study Synopsis.pdf |
| View full study record |
| Document reference: 46136 |
| Study title: Therapeutic equivalence of a deep propofol sedation in children aged 1 month to 8 years undergoing magnet resonance imaging |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46120 |
| Study title: To determine wether a modified propofol preparation shows any effect on the incidence of injection pain in children undergoing elective surgery under general anesthesia. |
| Active substance: PROPOFOL |
| Study summary document link (including results): BBMDE-0312.xls |
| View full study record |
| Document reference: 47082 |
| Study title: Tolerability of Propofol Braun 1% compared with Disoprivan 1% |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46119 |
| Study title: Codispoti M, Mankad PS: Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice. Perfusion 2000; 15: 191-201 Codispoti M, Mankad PS: Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice. Perfusion 2000; 15: 191-201 |
| Active substance: PROTAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35086 |
| Study title: Effect of different doses of protamine in cyanotic and acyonotic children in congenital heart surgery. Bayrak H et al. Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi ( Gogus-Kalp-Damar Anestezi Yogun Bakim Dernegi Derg. ) (Turkey) , March 1, 2007 , 13/1 (24-30) Effect of different doses of protamine in cyanotic and acyonotic children in congenital heart surgery. Bayrak H et al. Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi ( Gogus-Kalp-Damar Anestezi Yogun Bakim Dernegi Derg. ) (Turkey) , March 1, 2007 , 13/1 (24-30) |
| Active substance: PROTAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35084 |
| Study title: Slanina-J, Wannenmacher-M, Spratler-J. Abteilung Strahlentherapie, Universitatsklinikum Freiburg i.Br, D 7800 Freiburg i.Br., Germany. Pregnancy and development of the child after treatment of Hodgkin's disease. Strahlentherapie {STRAHLENTHERAPIE}, 1985, Vol/Iss/Pg. 161/9 (558-564).Slanina-J, Wannenmacher-M, Spratler-J. Abteilung Strahlentherapie, Universitatsklinikum Freiburg i.Br, D 7800 Freiburg i.Br., Germany. Pregnancy and development of the child after treatment of Hodgkin's disease. Strahlentherapie {STRAHLENTHERAPIE}, 1985, Vol/Iss/Pg. 161/9 (558-564). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34847 |
| Study title: Smith-K-L, Johnson-D, Hustu-O, et-al. St. Jude Child. Res. Hosp., Memphis, Tenn. 381101, United States. Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease. Cancer {CANCER}, 1974, Vol/Iss/Pg. 33/1 (38-46).Smith-K-L, Johnson-D, Hustu-O, et-al. St. Jude Child. Res. Hosp., Memphis, Tenn. 381101, United States. Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease. Cancer {CANCER}, 1974, Vol/Iss/Pg. 33/1 (38-46). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34848 |
| Study title: Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, Shockley DH, Weaver NL, Carlos RQ, Ransom JL. Ann Pharmacother. 2005 Jun;39(6):1029-33;Epub 2005 Apr 26. 2. Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, Shockley DH, Weaver NL, Carlos RQ, Ransom JL. Ann Pharmacother. 2005 Jun;39(6):1029-33;Epub 2005 Apr 26. 2. |
| Active substance: PROXYMETHACAINE |
| Study summary document link (including results): Efficacy of sucrose to reduce pain in premature infants.pdf |
| View full study record |
| Document reference: 46139 |
| Study title: Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Marsh VA, Young WO, Dunaway KK, Kissling GE, Carlos RQ, Jones SM, Shockley DH, Weaver NL, Ransom JL, Gal P. Ann Pharmacother. 2005 May;39(5):829-33;Epub 2005 Mar 29. Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Marsh VA, Young WO, Dunaway KK, Kissling GE, Carlos RQ, Jones SM, Shockley DH, Weaver NL, Ransom JL, Gal P. Ann Pharmacother. 2005 May;39(5):829-33;Epub 2005 Mar 29. |
| Active substance: PROXYMETHACAINE |
| Study summary document link (including results): Efficacy of topical anesthetics to reduce pain in premature .pdf |
| View full study record |
| Document reference: 46140 |
| Study title: Paediatric cycloplegia: a new approach. Shah P, Jacks AS, Adams GG. Eye. 1997;11 ( Pt 6):845-6. Paediatric cycloplegia: a new approach. Shah P, Jacks AS, Adams GG. Eye. 1997;11 ( Pt 6):845-6. |
| Active substance: PROXYMETHACAINE |
| Study summary document link (including results): Paediatric cycloplegia.pdf |
| View full study record |
| Document reference: 46142 |
| Study title: Topical anesthesia during infant eye examinations: does it reduce stress? Saunders RA, Miller KW, Hunt HH. Ann Ophthalmol. 1993 Dec;25(12):436-9. Topical anesthesia during infant eye examinations: does it reduce stress? Saunders RA, Miller KW, Hunt HH. Ann Ophthalmol. 1993 Dec;25(12):436-9. |
| Active substance: PROXYMETHACAINE |
| Study summary document link (including results): Topical anesthesia during infant eye examinations.pdf |
| View full study record |
| Document reference: 46143 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35159 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35160 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35161 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35162 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35163 |
| Study title: Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35231 |
| Study title: Ekert-H, Waters-K-D, Smith-P-J, Toogood-I, Mauger-D. Department of Clinical Hematology and Oncology, Royal Children's Hospital, Parkville, Australia. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Dec 1988, vol. 6, no. 12, p. 1845-50, ISSN: 0732-183X.Ekert-H, Waters-K-D, Smith-P-J, Toogood-I, Mauger-D. Department of Clinical Hematology and Oncology, Royal Children's Hospital, Parkville, Australia. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol},... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34704 |
| Study title: Ekert-H, Waters-K-D. Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1983, vol. 11, no. 5, p. 322-6, ISSN: 0098-1532.Ekert-H, Waters-K-D. Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1983, vol. 11, no. 5, p. 322-6, ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34705 |
| Study title: Ekert-H. Dr. H. Ekert, Department Haematology-Oncology, Royal Children's Hospital, Parkville, Vic, 3052, Australia Massive mediastinal Hodgkin's disease in childhood: Results of treatment from four Australian oncology centres 1972-1993. Cancer Research Therapy and Control {CANCER-RES-THER-CONTROL}, 1996, Vol/Iss/Pg. 5/1 (41-47), ISSN: 1064-0525.Ekert-H. Dr. H. Ekert, Department Haematology-Oncology, Royal Children's Hospital, Parkville, Vic, 3052, Australia Massive mediastinal Hodgkin's disease in childhood: Results of treatment from four Australian oncology centres 1972-1993. Cancer Research Therapy and Control {CANCER-RES-THER-CONTROL}, 1996, Vol/Iss/Pg. 5/1 (41-47), ISSN: 1064-0525. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34706 |
| Study title: Ekert-H. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 241-6, ISSN: 0927-3042. Ekert-H. Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 241-6, ISSN: 0927-3042. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34707 |
| Study title: Ekert-H. Treatment of childhood Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Mar 1991, vol. 9, no. 3, p. 528-9, ISSN: 0732-183X.Ekert-H. Treatment of childhood Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Mar 1991, vol. 9, no. 3, p. 528-9, ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34708 |
| Study title: A randomised, parallel, double-blind phase III comparison between iodixanol, 270 mg I/ml and 320 mg I/ml and iohexol (Omnipaque) 300 mg I/ml Trial No. DXV039 (date Dec 1995) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXV039 Redacted.pdf |
| View full study record |
| Document reference: 48206 |
| Study title: A randomised, parallel, double-blind phase III comparison between iodixanol, 270 mg I/ml and 320 mg I/ml and iohexol (Omnipaque) 300 mg I/ml Trial No. DXV038 (date Mar 1996) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXV038 Redacted.pdf |
| View full study record |
| Document reference: 48207 |
| Study title: Acad Radiol. 1996 Sep;3 Suppl 3:S524-7. Comparison of iodixanol with iohexol in excretory urography. Siegle RL, Gavant ML. Acad Radiol. 1996 Sep;3 Suppl 3:S524-7. Comparison of iodixanol with iohexol in excretory urography. Siegle RL, Gavant ML. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30348 |
| Study title: AJR Am J Roentgenol. 2002 Aug;179(2):437-44. Multidetector CT: detection of active hemorrhage in patients with blunt abdominal trauma. Willmann JK, Roos JE, Platz A, Pfammatter T, Hilfiker PR, Marincek B, Weishaupt D. AJR Am J Roentgenol. 2002 Aug;179(2):437-44. Multidetector CT: detection of active hemorrhage in patients with blunt abdominal trauma. Willmann JK, Roos JE, Platz A, Pfammatter T, Hilfiker PR, Marincek B, Weishaupt D. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30351 |
| Study title: An open phase II trial with iodixanol 320 mg I/ml and a double-blind, parallel, randomised phase III trial with iodixanol 320 mg I/ml compared to iohexol (Omnipaque) 350 mg I/ml Trial No. DXV036 (date Mar 1996) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXV036 Redacted.pdf |
| View full study record |
| Document reference: 48209 |
| Study title: An open phase II trial with iodixanol 320 mg I/mL, and a randomised, parallel, double-blind phase III comparison between iodixanol (VISIPAQUE), 270 mg I/ml and 320 mg I/ml, and iohexol (Omnipaque) 300 mg I/ml Trial No. DXV041 (date Dec 1995) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXV041 Redacted.pdf |
| View full study record |
| Document reference: 48205 |
| Study title: Clin Radiol. 1993 Oct;48(4):268-72. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. Clin Radiol. 1993 Oct;48(4):268-72. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30354 |
| Study title: Complications with Outpatient Angiography and Interventional ProceduresYoung N 2002. Cardiovasc Intervent Radiol (2002) 25:123–126 |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48199 |
| Study title: A single-blind trial to compare the efficacy, tolerability and safety of levocabastine nasal spray as compared to sodiumcromoglycate nasal spray in children aged 6 months to 5 years with perennial allergic rhinitis. Part I. Clinical Research Report Dated April 1998A single-blind trial to compare the efficacy, tolerability and safety of levocabastine nasal spray as compared to sodiumcromoglycate nasal spray in children aged 6 months to 5 years with perennial allergic rhinitis. Part I. Clinical Research Report Dated April 1998 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31116 |
| Study title: A single-blind trial to compare the efficacy, tolerability and safety of levocabastine nasal spray as compared to sodiumcromoglycate nasal spray in children aged 6 months to 5 years with perennial allergic rhinitis. Part I. Clinical Research Report Dated April 1998A single-blind trial to compare the efficacy, tolerability and safety of levocabastine nasal spray as compared to sodiumcromoglycate nasal spray in children aged 6 months to 5 years with perennial allergic rhinitis. Part I. Clinical Research Report Dated April 1998 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31126 |
| Study title: An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05% reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Acta Ophthalmica Scandinavica 78, p.48-51,2000An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05% reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Acta Ophthalmica Scandinavica 78, p.48-51,2000 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31136 |
| Study title: Antihistaminikum als Nasenspray und Augentropfen in der allergologischen Praxis. Allergo Journal 7(5), p.275-277, 1998Antihistaminikum als Nasenspray und Augentropfen in der allergologischen Praxis. Allergo Journal 7(5), p.275-277, 1998 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31124 |
| Study title: 56. Vazquez, Encarna-cion, Sem Med Mex 1963; 39: 179-181 56. Vazquez, Encarna-cion, Sem Med Mex 1963; 39: 179-181 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39585 |
| Study title: 6. Baranski et al., Rev Inst Med trop 1971; 13: 422-427 6. Baranski et al., Rev Inst Med trop 1971; 13: 422-427 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39535 |
| Study title: 7. Barrios, An Hosp Milit Centr 1960; 2: 9-12 7. Barrios, An Hosp Milit Centr 1960; 2: 9-12 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39536 |
| Study title: 8. Beck et al., Am J Trop Med Hyg 1959; 8: 349-352 8. Beck et al., Am J Trop Med Hyg 1959; 8: 349-352 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39537 |
| Study title: 9. Beck, J Am MEd Assoc 1964; 189: 511 9. Beck, J Am MEd Assoc 1964; 189: 511 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39538 |
| Study title: Alexander et al., Tijdschr Geneeskd 1970; 26: 333-335 Alexander et al., Tijdschr Geneeskd 1970; 26: 333-335 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39532 |
| Study title: A 3-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase IIIb Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL¿) Immediate-release Tablets in Daily Doses of 400 mg and 600 mg Compared with Placebo in the Treatment of Children and Adolescents with Bipolar I Mania |
| Active substance: QUETIAPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45051 |
| Study title: A Pilot Trial of Quetiapine (SEROQUEL¿) in Adolescents with the Spectrum of Psychotic Disorders (5077US/0018) DRAFT Clinical Study Report Synopsis |
| Active substance: QUETIAPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45054 |
| Study title: A Study to Characterize the Steady-State Pharmacokinetics, Safety and Tolerability of Quetiapine Fumarate (SEROQUEL¿) in Children and Adolescents with Selected Psychotic Disorders |
| Active substance: QUETIAPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45055 |
| Study title: Seroquel: "A NON-COMPARATIVE, OPEN-LABEL STUDY TO DEMONSTRATE THE EFFICACY AND TOLERABILITY OF QUETIAPINE IN ADOLESCENT PATIENTS WITH AN ACUTE SCHIZOPHRENIC EPISODE". |
| Active substance: QUETIAPINE |
| Study summary document link (including results): D1441C09025 Study Synopsis.pdf |
| View full study record |
| Document reference: 45052 |
| Study title: Tolerability and Pharmacokinetics of Quetiapine (SEROQUEL¿) in Adolescents with Selected Psychotic Disorders |
| Active substance: QUETIAPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45053 |
| Study title: A STUDY OF PHARMACOKINETICS OF QUINAPRIL IN PEDIATRIC PATIENTS |
| Active substance: QUINAPRIL |
| Study summary document link (including results): 0906-000-434 EMEA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 45056 |
| Study title: AN 8-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO DETERMINE THE SAFETY AND EFFICACY OF QUINAPRIL IN PEDIATRIC PATIENTS WITH HYPERTENSION |
| Active substance: QUINAPRIL |
| Study summary document link (including results): 0906-427 EMEA Pediatrics Web Synopsis.pdf |
| View full study record |
| Document reference: 45057 |
| Study title: Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68)Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45059 |
| Study title: 54. Suzuki, Yamauchi, Jpn J Parasitol 1961; 10: 298-301 54. Suzuki, Yamauchi, Jpn J Parasitol 1961; 10: 298-301 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39583 |
| Study title: 55. Turner, Johnson, J Pediatr 1962; 60: 243-251 55. Turner, Johnson, J Pediatr 1962; 60: 243-251 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39584 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35167 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35168 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35169 |
| Study title: 49. Aquilonius SM, Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin Pharmacokinet 1986;11(3):236-49.49. Aquilonius SM, Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin Pharmacokinet 1986;11(3):236-49. |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35141 |
| Study title: 50. Lindenschmidt Th, Aleksic D. Der paralytische Ileus in der Chirurgie. Internistische Praxis 1970;10(3):447-58.50. Lindenschmidt Th, Aleksic D. Der paralytische Ileus in der Chirurgie. Internistische Praxis 1970;10(3):447-58. |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35142 |
| Study title: Comparative study of the immunogenicity and protective efficacy of GlaxoSmithKline (GSK) Biologicals’ RIT’s rec-DNA hepatitis B vaccine (10 mg) injected with or without hepatitis B immunoglobulin (HBIg) in newborns of HBeAg+ mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47767 |
| Study title: Comparative study of the immunogenicity and protective efficacy of GlaxoSmithKline (GSK) Biologicals’ RIT’s rec-DNA hepatitis B vaccine (10 ıg) injected with orwithout hepatitis B immunoglobulin (HBIg) in newborns of HBeAg+ mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47768 |
| Study title: Comparative study of the immunogenicity and protective efficacy of GlaxoSmithKline (GSK) Biologicals rec-DNA hepatitis B vaccine (10 mg) injected with or without hepatitis B immunoglobulin (HBIg) in newborns of HBeAg+ mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47754 |
| Study title: Comparative study of the immunogenicity and safety of two doses of Engerix-B administered to healthy infants at 2, 4 and 6 months of age. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47763 |
| Study title: Comparative study of the immunogenicity and safety of two doses of Engerix-B in healthy adolescents. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47762 |
| Study title: |
| Active substance: PSEUDOEPHEDRINE/ PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35166 |
| Study title: Comparative study of the immunogenicity and safety of two dosing schedules in neonates. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47755 |
| Study title: Immunogenicity and protective efficacy of Smith Kline -RIT's rec-DNA hepatitis b vaccine (10mcg) in newborns of HBsAg positive or negative mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47766 |
| Study title: Immunogenicity and protective efficacy of Smith Kline RIT's rec-DNA Hepatitis B vaccine in newborns of HbsAg positive or negative mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47757 |
| Study title: Immunogenicity and protective efficacy of Smith Kline RIT's rec-DNA Hepatitis B vaccine in newborns of HbsAg positive or negative mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47758 |
| Study title: Immunogenicity and protective efficacy of Smith Kline RIT's rec-DNA Hepatitis B vaccine in newborns of HbsAg positive or negative mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47759 |
| Study title: Immunogenicity and protective efficacy of Smith Kline RIT's rec-DNA Hepatitis B vaccine in newborns of HbsAg positive or negative mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47760 |
| Study title: Immunogenicity and protective efficacy of Smith Kline RIT's rec-DNA Hepatitis B vaccine in newborns of HbsAg positive or negative mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47761 |
| Study title: Open, randomized study to evaluate the immunogenicity of Engerix®-B when administered according to a vaccination schedule of 0, 1 and 12 months to healthy adolescents at two different doses (10 µg vs 20 µg). |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47753 |
| Study title: Risk of peripartal transmission of hepatitis B in children born to Hepatitis B positive mothers. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47765 |
| Study title: Ettinger-L-J, Sinniah-D, Siegel-S-E, Fishman-L-S, Segall-H-D, Soni-D, Bennetts-G-A, Schultz-D-H, Raphael-D. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. Journal of neuro-oncology, {J-Neurooncol}, 1985, vol. 3, no. 3, p. 263-9, ISSN: 0167-594X.Ettinger-L-J, Sinniah-D, Siegel-S-E, Fishman-L-S, Segall-H-D, Soni-D, Bennetts-G-A, Schultz-D-H, Raphael-D. Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. Journal of neuro-oncology, {J-Neurooncol}, 1985, vol. 3, no. 3, p. 263-9, ISSN: 0167-594X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34709 |
| Study title: Pakisch-B, Urban-C, Slavc-I, Poier-E, Stucklschweiger-G, Oberbauer-R, Mokry-M, Poschauko-J, Hammer-J, Leitner-H, Hackl-A. Abteilung fur Strahlentherapie, Radiologische Universitatsklinik, Augenbruggerplatz 9, A-8036 Graz, Austria. Hyperfractionated radiotherapy and polychemotherapy in brain stem tumors in children. Child's Nervous System {CHILD-S-NERV-SYST}, 1992, Vol/Iss/Pg. 8/4 (215-218), ISSN: 0256-7040.Pakisch-B, Urban-C, Slavc-I, Poier-E, Stucklschweiger-G, Oberbauer-R, Mokry-M, Poschauko-J, Hammer-J, Leitner-H, Hackl-A. Abteilung fur Strahlentherapie, Radiologische Universitatsklinik, Augenbruggerplatz 9, A-8036 Graz, Austria. Hyperfractionated radiotherapy and polychemotherapy in brain stem tumors in children. Child's Nervous System {CHILD-S-NERV-SYST}, ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34801 |
| Study title: Paolucci-G, Vecchi-V, Rosito-P, Paolucci-P, Burnelli-R, Pession-A, Mancini-A-F, Vivarelli-F. Clinica Pediatrica III, Universita degli Studi, Via Massaren11, 40138 Bologna, Italy. New perspectives in pediatric oncology. Rivista Italiana di Pediatria {RIV-ITAL-PEDIATR}, 1991, Vol/Iss/Pg. 17/4 (475-487), ISSN: 0392-5161.Paolucci-G, Vecchi-V, Rosito-P, Paolucci-P, Burnelli-R, Pession-A, Mancini-A-F, Vivarelli-F. Clinica Pediatrica III, Universita degli Studi, Via Massaren11, 40138 Bologna, Italy. New perspectives in pediatric oncology. Rivista Italiana di Pediatria {RIV-ITAL-PEDIATR}, 1991, Vol/Iss/Pg. 17/4 (475-487), ISSN: 0392-5161. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34802 |
| Study title: Papadakis-V, Vlachopapadopoulou-E, Van-Syckle-K, Ganshaw-L, Kalmanti- M, Tan-C, Sklar-C. Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. Gonadal function in young patients successfully treated for Hodgkin disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, May 1999, vol. 32, no. 5, p. 366-72, ISSN: 0098-1532.Papadakis-V, Vlachopapadopoulou-E, Van-Syckle-K, Ganshaw-L, Kalmanti- M, Tan-C, Sklar-C. Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. Gonadal function in young patients successfully treated for Hodgkin disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, May 1999, vol. 32, no. 5, p. 366-72, ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34803 |
| Study title: Pendergrass-T-W, Milstein-J-M, Geyer-J-R, Mulne-A-F, Kosnik-E-J, Morris-J-D, Heideman-R-L, Ruymann-F-B, Stuntz-J-T, Bleyer-W-A. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Aug 1987, vol. 5, no. 8, p. 1221-31, ISSN: 0732-183X.Pendergrass-T-W, Milstein-J-M, Geyer-J-R, Mulne-A-F, Kosnik-E-J, Morris-J-D, Heideman-R-L, Ruymann-F-B, Stuntz-J-T, Bleyer-W-A. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34804 |
| Study title: Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. Current Medical Research and Opinion 14(3), p. 161-170,1998Azelastine eye drops in the treatment of seasonal allergic conjunctivitis or rhinoconjunctivitis in young children. Current Medical Research and Opinion 14(3), p. 161-170,1998 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31134 |
| Study title: Clinical evaluation of R50547 eye drops on allergic conjunctivitis and vernal conjunctivitis. A sungle masked comparative study with Sodium Cromoglicate eye drops |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31066 |
| Study title: Clinical laboratory data related to the safety of levocabastine eye drops and nasal spray. An evaluation based on 27 studies in 655 subjects (6-81 yrs) |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): LMD45257_Interventional_Levocabastine.xls |
| View full study record |
| Document reference: 31071 |
| Study title: Comparison of levocabastine a new selective H1-receptor antagonist and disodium cromoglycate in a nasal provocation test with allergen (11-44 yrs) |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): LMD62501_Interventional_Levocabastine.xls |
| View full study record |
| Document reference: 31076 |
| Study title: Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitis. Clinical and Experimental Allergy 29, p. 1367-1 377, 1999 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31118 |
| Study title: Sackmann-Muriel-F, Zubizarreta-P, Gallo-G, Scopinaro-M, Alderete-D, Alfaro-E, Casak-S, Chantada-G, Felice-M-S, Quinteros-R. Hematology Department, Hospital de Pediatria Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Dec 1997, vol. 29, no. 6, p. 544-52, ISSN: 0098-1532.Sackmann-Muriel-F, Zubizarreta-P, Gallo-G, Scopinaro-M, Alderete-D, Alfaro-E, Casak-S, Chantada-G, Felice-M-S, Quinteros-R. Hematology Department, Hospital de Pediatria Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34820 |
| Study title: Sackmann-Muriel-F, Diez-B, Schvartzman-E, et-al. Oncology Department, Hospital de Ninos, 1425 Buenos Aires, Argentina. Comparison of two consecutive trials for treatment of childhood non-Hodgkin's lymphoma. Cancer {CANCER}, 1984, Vol/Iss/Pg. 54/12 (2863-2868).Sackmann-Muriel-F, Diez-B, Schvartzman-E, et-al. Oncology Department, Hospital de Ninos, 1425 Buenos Aires, Argentina. Comparison of two consecutive trials for treatment of childhood non-Hodgkin's lymphoma. Cancer {CANCER}, 1984, Vol/Iss/Pg. 54/12 (2863-2868). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34821 |
| Study title: Sackmann-Muriel-F, Maschio-M, Santarelli-M-T, Pavlovsky-S. Results of therapy for Hodgkin's disease in childhood. The Argentine Group for Treatment of Acute Leukemia. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 271-5, ISSN: 0927-3042.Sackmann-Muriel-F, Maschio-M, Santarelli-M-T, Pavlovsky-S. Results of therapy for Hodgkin's disease in childhood. The Argentine Group for Treatment of Acute Leukemia. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 271-5, ISSN: 0927-3042. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34822 |
| Study title: Sackmann-Muriel-F. Unid. Hematol., Hosp. Ninos, Buenos Aires, Argentina. Recent advances in treatment of children with non-Hodgkin lymphoma. Revista del Hospital de Ninos {REV-HOSP-NINOS}, 1978, Vol/Iss/Pg. 20 /80 (156-161).Sackmann-Muriel-F. Unid. Hematol., Hosp. Ninos, Buenos Aires, Argentina. Recent advances in treatment of children with non-Hodgkin lymphoma. Revista del Hospital de Ninos {REV-HOSP-NINOS}, 1978, Vol/Iss/Pg. 20 /80 (156-161). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34823 |
| Study title: Green-D-M, Brecher-M-L, Lindsay-A-N, et-al. Dept. Ped., Roswell Park Mem. Inst., Buffalo, N.Y. 14263, United States. Gonadal function in pediatric patients following treatment for Hodgkin disease. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1981, Vol/Iss/Pg.9/3 (235-244).Green-D-M, Brecher-M-L, Lindsay-A-N, et-al. Dept. Ped., Roswell Park Mem. Inst., Buffalo, N.Y. 14263, United States. Gonadal function in pediatric patients following treatment for Hodgkin disease. Medical and Pediatric Oncology {MED-PEDIATR-ONCOL}, 1981, Vol/Iss/Pg.9/3 (235-244). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34726 |
| Study title: Grill-J, Le-Deley-M-C, Gambarelli-D, Raquin-M-A, Couanet-D, Pierre- Kahn-A, Habrand-J-L, Doz-F, Frappaz-D, Gentet-J-C, Edan-C, Chastagner-P, Kalifa-C. Department of Pediatrics, Institut Gustave Roussy, Villejuif, France. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, 1 Mar 2001, vol. 19, no. 5, p. 1288-96, ISSN: 0732-183X.Grill-J, Le-Deley-M-C, Gambarelli-D, Raquin-M-A, Couanet-D, Pierre- Kahn-A, Habrand-J-L, Doz-F, Frappaz-D, Gentet-J-C, Edan-C, Chastagner-P, Kalifa-C. Department of Pediatrics, Institut Gustave Roussy, ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34727 |
| Study title: Gulati-S-C, Vega-R, Gee-T, et-al. Department of Medicine and Pediatrics, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, NY 10021, United States. Growth and development of children born to patients after cancer therapy. Cancer Investigation {CANCER-INVEST}, 1986, Vol/Iss/Pg. 4/3 (197-205).Gulati-S-C, Vega-R, Gee-T, et-al. Department of Medicine and Pediatrics, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, NY 10021, United States. Growth and development of children born to patients after cancer therapy. Cancer Investigation {CANCER-INVEST}, 1986, Vol/Iss/Pg. 4/3 (197-205). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34728 |
| Study title: Gutjahr-P. Universitats-Kinderklinik, 6500 Mainz 1, Germany. Second neoplasms following tumor and leukaemia therapy in childhood: Report on 64 cases. Deutsche Medizinische Wochenschrift {DTSCH-MED-WOCHENSCHR}, 1985, Vol /Iss/Pg. 110/42 (1599-1606).Gutjahr-P. Universitats-Kinderklinik, 6500 Mainz 1, Germany. Second neoplasms following tumor and leukaemia therapy in childhood: Report on 64 cases. Deutsche Medizinische Wochenschrift {DTSCH-MED-WOCHENSCHR}, 1985, Vol /Iss/Pg. 110/42 (1599-1606). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34729 |
| Study title: Haddad-S-F, Menezes-A-H, Bell-W-E, Godersky-J-C, Afifi-A-K, Bale-J-F. Division of Neurosurgery, Department of Surgery, The University of Iowa, Iowa City, IA 52242, United States. Brain tumors occurring before 1 year of age: A retrospective review of 22 cases in an 11-year period (1977-1987). Neurosurgery {NEUROSURGERY}, 1991, Vol/Iss/Pg. 29/1 (8-13), ISSN: 0148-396X.Haddad-S-F, Menezes-A-H, Bell-W-E, Godersky-J-C, Afifi-A-K, Bale-J-F. Division of Neurosurgery, Department of Surgery, The University of Iowa, Iowa City, IA 52242, United States. Brain tumors occurring before 1 year of age: A retrospective review of 22 cases in an 11-year period (1977-1987). Neurosurgery {NEUROSURGERY}, 1991, Vol/Iss/Pg. 29/1 (8-13), ISSN: 0148-396X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34730 |
| Study title: Haglund-U, Hayder-S, Zech-L. Dept. Med. Cell Genet., Med. Nobel Inst., Karolinska Inst., S-104 01 Stockholm, Sweden. Sister chromatid exchanges and chromosome aberrations in children after treatment for malignant lymphoma. Cancer Research {CANCER-RES}, 1980, Vol/Iss/Pg. 40/12 (4786-4790).Haglund-U, Hayder-S, Zech-L. Dept. Med. Cell Genet., Med. Nobel Inst., Karolinska Inst., S-104 01 Stockholm, Sweden. Sister chromatid exchanges and chromosome aberrations in children after treatment for malignant lymphoma. Cancer Research {CANCER-RES}, 1980, Vol/Iss/Pg. 40/12 (4786-4790). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34731 |
| Study title: Borowitz SM, et all. Treatment of childhood constipation by primary care physicians: efficacy and predictors of outcome. Pediatrics. 2005 Apr;115(4):873-7. |
| Active substance: Rabarbar + senna |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40148 |
| Study title: Spiller HA, et all. Skin breakdown and blisters from senna-containing laxatives in young children. Ann Pharmacother. 2003 May;37(5):636-9. |
| Active substance: Rabarbar + senna |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40149 |
| Study title: Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Subjects |
| Active substance: RABEPRAZOLE |
| Study summary document link (including results): Rabeprazole-E3810-A001-202 (synopsis).pdf |
| View full study record |
| Document reference: 35258 |
| Study title: Single and Multiple Dose Pharmacokinetics and Safety Study of Rabeprazole Sodium in 12 to 16 Year Old Subjects |
| Active substance: RABEPRAZOLE |
| Study summary document link (including results): Rabeprazole-E3810-A001-119 CSR synopsis.pdf |
| View full study record |
| Document reference: 35257 |
| Study title: A phase III, randomised, controlled, multicenter study in adults, investigating the antibody response to postexposure rabies vaccination combined with Human Rabies Immune Globuline (HRIG) between two types of tissue culture rabies vaccines, Purified vero cell rabies vaccine (PVRV) and Purified chick embryo cell rabies vaccine (PCECV) |
| Active substance: RABIES VACCINE FOR HUMAN USE PREPARED FROM CELL CULTURE (DIPLOID CELLS) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48384 |
| Study title: Jenkin-D, Doyle-J, Berry-M, Blanchette-V, Chan-H, Doherty-M, Freedman-M, Greenberg-M, Panzarella-T, Saunders-F, et al. Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. Medical and pediatric oncology, {Med-Pediatr-Oncol}, 1990, vol. 18, no. 4, p. 265-72, ISSN: 0098-1532.Jenkin-D, Doyle-J, Berry-M, Blanchette-V, Chan-H, Doherty-M, Freedman-M, Greenberg-M, Panzarella-T, Saunders-F, et al. Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without la... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34748 |
| Study title: Jenkin-D, Chan-H, Freedman-M, Greenberg-M, Gribbin-M, McClure-P, Saunders-F, Sonley-M. Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation. Cancer treatment reports, {Cancer-Treat-Rep}, Apr 1982, vol. 66, no. 4, p. 949-59, ISSN: 0361-5960.Jenkin-D, Chan-H, Freedman-M, Greenberg-M, Gribbin-M, McClure-P, Saunders-F, Sonley-M. Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation. Cancer treatment reports, {Cancer-Treat-Rep}, Apr 1982, vol. 66, no. 4, p. 949-59, ISSN: 0361-5960. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34749 |
| Study title: Jenkin-D, Doyle-J. Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 247-56, ISSN: 0927-3042.Jenkin-D, Doyle-J. Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 247-56, ISSN: 0927-3042. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34750 |
| Study title: Jenkin-D, Freedman-M, McClure-P, Peters-V, Saunders-F, Sonley-M. Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report. Cancer, {Cancer}, Jul 1979, vol. 44, no. 1, p. 80-6, ISSN: 0008-543X.Jenkin-D, Freedman-M, McClure-P, Peters-V, Saunders-F, Sonley-M. Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report. Cancer, {Cancer}, Jul 1979, vol. 44, no. 1, p. 80-6, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34751 |
| Study title: Perrone-L, Sinisi-A-A, Di-Tullio-M-T, Casale-F, Indolfi-P, Manzo-T, Coppola-G, Bellastella-A, Faggiano-M. Department of Pediatrics, University of Naples, Naples, Italy. Endocrine function in subjects treated for childhood Hodgkin's disease. Journal of Pediatric Endocrinology {J-PEDIATR-ENDOCRINOL}, 1989, Vol /Iss/Pg. 3/3 (175-179), ISSN: 0334-018X.Perrone-L, Sinisi-A-A, Di-Tullio-M-T, Casale-F, Indolfi-P, Manzo-T, Coppola-G, Bellastella-A, Faggiano-M. Department of Pediatrics, University of Naples, Naples, Italy. Endocrine function in subjects treated for childhood Hodgkin's disease. Journal of Pediatric Endocrinology {J-PEDIATR-ENDOCRINOL}, 1989, Vol /Iss/Pg. 3/3 (175-179), ISSN: 0334-018X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34805 |
| Study title: Khalil S_1996Khalil S_1996 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Khalil S_1996_publication.pdf |
| View full study record |
| Document reference: 35002 |
| Study title: Koenig HJ_1990Koenig HJ_1990 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Koenig HJ_1990_publication.pdf |
| View full study record |
| Document reference: 35004 |
| Study title: Mayzner ZE_1996Mayzner ZE_1996 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Mayzner ZE_1996_publication.pdf |
| View full study record |
| Document reference: 35007 |
| Study title: McKee K_1991McKee K_1991 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_McKee K_1991_publication.pdf |
| View full study record |
| Document reference: 35008 |
| Study title: Nad R_1975Nad R_1975 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Nad R_1975_publication.pdf |
| View full study record |
| Document reference: 35009 |
| Study title: New modalities in postoperative nausea and vomiting. |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): New modalities in postoperative nausea and vomiting.pdf |
| View full study record |
| Document reference: 35028 |
| Study title: Pascarella MA_1983Pascarella MA_1983 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Pascarella MA_1983_publication.pdf |
| View full study record |
| Document reference: 35012 |
| Study title: Paul AK_1984Paul AK_1984 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Paul AK_1984_publication.pdf |
| View full study record |
| Document reference: 35013 |
| Study title: Pre-anaesthetic medication in paediatric day-care surgery. |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Pre-anaesthetic medication in paediatric day-care surgery.pdf |
| View full study record |
| Document reference: 35040 |
| Study title: Promethazine in general anaesthesia - Loyn W.G.G.- (Brit. J. Anaesth. 1956, 28, 126.) - Publication in PHENERGAN therapeutic summary 6th edition May & Baker Ltd.1976 - |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35041 |
| Study title: Publication 8 in PHENERGAN 25mg tablet, 0.1% syrup, 2,5% sol for injection. Clinical documentation. June 1988. Anaesthesia in children. -Anglade G.- (Maroc médical (1970), 50, 545-561.) |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35043 |
| Study title: Geist ET_1982Geist ET_1982 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Geist ET_1982_publication.pdf |
| View full study record |
| Document reference: 35001 |
| Study title: Publication in PROMETHAZINE Safety and efficacy review of medicines following UK authorities review of psychotropic and centrally acting drugs. May&Baker Ltd. Company April 1980. |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35045 |
| Study title: Compassionate use of SR29142 for prevention or treatment of hyperuricemia at multiple centers in Europe, Australasia, and Asia (LTS3256) |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47280 |
| Study title: Compassionate use of SR29142 for prevention or treatment of hyperuricemia at multiple centers in the United States and Canada (LTS3257) |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47281 |
| Study title: Evaluation of single agent rasburicase in treatment/ prevention of hyperuricemia associated with tumor lysis syndrome in adult and paediatric patients with lymphoma/ leukemia/solid tumor or malignancies at their first relapse or refractory disease |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41509 |
| Study title: Non-comparative open label |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47284 |
| Study title: Open label, single arm, multicentric Phase IV |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47283 |
| Study title: Open-label, multi-center study of SR29142 as uricolytic therapy/prophylaxis for hyperuricemia in pediatric patients with newly diagnosed hematological malignacies at high risk for Tumor Lysis Syndrome |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41508 |
| Study title: Phase IV study of Rasburicase for treatment of hyperuricemia in patients with tumoral lysis syndrome (Code: L_9436) |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47282 |
| Study title: Phase IV, compassionate use program of rasburicase for treatment of hyperuricemia in children and adolescent patients with tumor lysis syndrome |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47278 |
| Study title: Single arm, open label Phase IV |
| Active substance: rasburicase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47285 |
| Study title: Lo Iacono F, Agnello D, Malizia R, Balsamo M. Aggiornamento Pediatrico. 1982; 33(1):85-90. Methisoprinol in the treatment of certain diseases of the upper respiratory tract in children .Lo Iacono F, Agnello D, Malizia R, Balsamo M. Aggiornamento Pediatrico. 1982; 33(1):85-90. Methisoprinol in the treatment of certain diseases of the upper respiratory tract in children . |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30142 |
| Study title: Lokaj J, Wiedermannov, Litzman J. Presented at the Czechoslovakian Symposium on Isoprinosine®; October, 1989; Prague. (Abstract only). Importance of immunological laboratory examination while indicating and controlling treatment with Isoprinosine®/Modimunal®Lokaj J, Wiedermannov, Litzman J. Presented at the Czechoslovakian Symposium on Isoprinosine®; October, 1989; Prague. (Abstract only). Importance of immunological laboratory examination while indicating and controlling treatment with Isoprinosine®/Modimunal® |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30143 |
| Study title: Lowy M, Ledoux-Corbusier M, Achten G, Wybran J. . J Am Acad Dermatol. Jan 1985;12(1 Pt 1):78-84. Clinical and immunologic response to Isoprinosine in alopecia areata and alopecia universalis: association with autoantibodiesLowy M, Ledoux-Corbusier M, Achten G, Wybran J. . J Am Acad Dermatol. Jan 1985;12(1 Pt 1):78-84. Clinical and immunologic response to Isoprinosine in alopecia areata and alopecia universalis: association with autoantibodies |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30144 |
| Study title: An open label prospective study to observe the postmarketing safety of Euvax B Inj. |
| Active substance: Recombinant DNA Hepatitis B Surface Antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41089 |
| Study title: A randomized double-blind study evaluating the safety, tolerability and efficacy of SMOF 20% compared to Intralipid in premature infants |
| Active substance: REFINED SOYBEAN OIL; MEDIUM CHAINED TRIGLYCERIDES; REFINED OLIVE OIL; FISH OIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40152 |
| Study title: A randomized double-blind study of safety and efficacy of SMOF 20% vs. Intralipid 20% in infants and children requiring long-term parenteral nutrition |
| Active substance: REFINED SOYBEAN OIL; MEDIUM CHAINED TRIGLYCERIDES; REFINED OLIVE OIL; FISH OIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40151 |
| Study title: |
| Active substance: REMIFENTANIL |
| Study summary document link (including results): Study PED-USAA3119 Remifentanil Hydrochloride.xls |
| View full study record |
| Document reference: 47737 |
| Study title: Schaison-G-S. Service d'Hematologie Pediatrique, Hopital Saint Louis, 1, Avenue Claude Vellefaux,75475 Parix Cedex 10, France. Current treatment of Hodgkin's disease in children. Pathologie Biologie {PATHOL-BIOL}, 1994, Vol/Iss/Pg. 42/10 (1026-1027), ISSN: 0369-8114.Schaison-G-S. Service d'Hematologie Pediatrique, Hopital Saint Louis, 1, Avenue Claude Vellefaux,75475 Parix Cedex 10, France. Current treatment of Hodgkin's disease in children. Pathologie Biologie {PATHOL-BIOL}, 1994, Vol/Iss/Pg. 42/10 (1026-1027), ISSN: 0369-8114. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34824 |
| Study title: Schapira-D-V, Chudley-A-E. Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy. Cancer, {Cancer}, 1 Sep 1984, vol. 54, no. 5, p. 800-3, ISSN: 0008-543X.Schapira-D-V, Chudley-A-E. Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy. Cancer, {Cancer}, 1 Sep 1984, vol. 54, no. 5, p. 800-3, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34825 |
| Study title: Schellong-G, Braemswig-J, Ludwig-R, Gerein-V, Jobke-A, Juergens-H, Kabisch-H, Stollmann-B, Weinel-P, Gadner-H, et al. (Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82). Klinische Paediatrie, {Klin-Padiatr}, May-Jun 1986, vol. 198, no. 3, p. 137-46, ISSN: 0300-8630.Schellong-G, Braemswig-J, Ludwig-R, Gerein-V, Jobke-A, Juergens-H, Kabisch-H, Stollmann-B, Weinel-P, Gadner-H, et al. (Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82). Kl... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34826 |
| Study title: Schellong-G, Bramswig-J-H, Hornig-Franz-I, Schwarze-E-W, Potter-R, Wannenmacher-M. Universitat Kinderklinik, Albert Schweitzer Str. 33, D-48149 Munster, Germany. Hodgkin's disease in children: Combined modality treatment for stages IA, IB, and IIA. Annals of Oncology {ANN-ONCOL}, 1994, Vol/Iss/Pg. 5/SUPPL. 2 (113-115), ISSN: 0923-7534.Schellong-G, Bramswig-J-H, Hornig-Franz-I, Schwarze-E-W, Potter-R, Wannenmacher-M. Universitat Kinderklinik, Albert Schweitzer Str. 33, D-48149 Munster, Germany. Hodgkin's disease in children: Combined modality treatment for stages IA, IB, and IIA. Annals of Oncology {ANN-ONCOL}, 1994, Vol/Iss/Pg. 5/SUPPL. 2 (113-115), ISSN: 0923-7534. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34827 |
| Study title: Schellong-G, Potter-R, Bramswig-J, Wagner-W, Prott-F-J, Dorffel-W, Korholz-D, Mann-G, Rath-B, Reiter-A, Weissbach-G, Riepenhausen-M, Thiemann-M, Schwarze-E-W. Dr. G. Schellong, Univ.-Kinderklinik, Albert-Schweitzer-Strasse 33, D-48129 Munster, Germany e-mail: schellon@uni-muenster.de. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1999, Vol/Iss/Pg. 17/12 (3736-3744), ISSN: 0732-183X.Schellong-G, Potter-R, Bramswig-J, Wagner-W, Prott-F-J, Dorffel-W, Korholz-D, Mann-G, Rath-B, Reiter-A, Weissbach-G, Riepenhausen-M, Thiemann-M, Schwarze-E-W. Dr. G. Schellong, Univ.-Kinderklinik, Albert-Schweitzer-Strasse 33, D-48129 Munster, Germany e-mail: schel... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34828 |
| Study title: Kwiatkowski JL, Manno CS: Blood transfusion support in pediatric cardiovascular surgey. Transfusion Science 1999; 21: 63-72 Kwiatkowski JL, Manno CS: Blood transfusion support in pediatric cardiovascular surgey. Transfusion Science 1999; 21: 63-72 |
| Active substance: PROTAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35087 |
| Study title: Pouard P: Review of Efficacy Parameters. Ann Thorac Surg 1998; 65: S40-4 Pouard P: Review of Efficacy Parameters. Ann Thorac Surg 1998; 65: S40-4 |
| Active substance: PROTAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35085 |
| Study title: Donaubauer J et al. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clin Endocrinol. April 1, 2003, 456-63Donaubauer J et al. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clin Endocrinol. April 1, 2003, 456-63 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35179 |
| Study title: Eakman GD et al. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab. 1996 Mar;81(3):1217-23Eakman GD et al. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab. 1996 Mar;81(3):1217-23 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35196 |
| Study title: Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993 Nov;23(11):1263-75.Eiermann B, Sommer N, Winne D, Schumm F, Maier U, Breyer-Pfaff U. Renal clearance of pyridostigmine in myasthenic patients and volunteers under the influence of ranitidine and pirenzepine. Xenobiotica. 1993 Nov;23(11):1263-75. |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35222 |
| Study title: Fagan M, Khine H. Pediatric neurologic potpourri: Cases to remember. Clin Pediatr Emerg Med. September 1, 2003, 207-14Fagan M, Khine H. Pediatric neurologic potpourri: Cases to remember. Clin Pediatr Emerg Med. September 1, 2003, 207-14 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35178 |
| Study title: Ghigo E et al. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol Psychiatry. 1994 Nov 15;36(10):689-95Ghigo E et al. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol Psychiatry. 1994 Nov 15;36(10):689-95 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35201 |
| Study title: Ghigo E et al. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol (Oxf). 1990 Jun;32(6):763-7Ghigo E et al. Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine. Clin Endocrinol (Oxf). 1990 Jun;32(6):763-7 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35213 |
| Study title: An open label, multicenter, international pilot study evaluating the efficacy and safety of Pegylated interferon alfa-2a in combination with ribavirin in pediatric and teenage patients with CHC virus infection (CHIPS) [100 children adolescents aged 6 – 18 years with CHC (all genotypes)] |
| Active substance: RIBAVIRIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35302 |
| Study title: Pegylated Interferon with and without ribavirin for children with HCV (PEDS – C) [112 children and adolescents aged 5-18 years with CHC (all genotypes) that are able to swallow tablets] |
| Active substance: RIBAVIRIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35303 |
| Study title: Donati F et al. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade. Can J Anaesth. 1987 Nov;34(6):589-93 Donati F et al. Neostigmine, pyridostigmine and edrophonium as antagonists of deep pancuronium blockade. Can J Anaesth. 1987 Nov;34(6):589-93 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35218 |
| Study title: EFFICACY AND SAFETY OF AN INTERMITTENT REGIMEN INCLUDING RIFABUTIN (AMSAMYCIN LM 427) IN THE TREATMENT OF OUT-PATIENTS WITH MYCOBACTERIAL PULMONARY INFECTIONS. FARMITALIA CARLO ERBA INTERNAL REPORT LM 427/713I, OCTOBER 1990 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35374 |
| Study title: EFFICACY AND SAFETY OF RIFABUTIN (AMSAMYCIN LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/714I NOVEMBER 1990 AGE RANGE 14-79 YEARS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35369 |
| Study title: EFFICACY AND SAFETY OF RIFABUTIN (AMSAMYCIN LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/715I NOVEMBER 1990 AGE RANGE 15 -65 YEARSPuri H C et al. Severe hypertension in children with renal |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35370 |
| Study title: Sedation for paediatric computed tomography |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Sedation for paediatric computed tomography.pdf |
| View full study record |
| Document reference: 35048 |
| Study title: Sedation in children scanned with high-field magnetic resonance; the experience at The Hospital for Sick Children, Great Ormond Street. |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Sedation in children scanned with high-field magnetic resonance; the experience at The Hospital for Sick Children, Great Ormond Street.pdf |
| View full study record |
| Document reference: 35049 |
| Study title: Early ribavirin aerosol treatment of respiratory syncytial virus infection in high-risk children.Early ribavirin aerosol treatment of respiratory syncytial virus infection in high-risk children. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35239 |
| Study title: Early ribavirin treatment of respiratory syncytial viral infection in high-risk children.Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35238 |
| Study title: Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35233 |
| Study title: Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35235 |
| Study title: Romiti M_1980Romiti M_1980 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Romiti M_1980_publication.pdf |
| View full study record |
| Document reference: 35014 |
| Study title: Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group.Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35232 |
| Study title: Hanck A: Verhütung und Behandlung der postoperativen Darmatonie und anderer Formen der paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977; 27 (39): 6878, 6881-4,6887. Hanck A: Verhütung und Behandlung der postoperativen Darmatonie und anderer Formen der paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977; 27 (39): 6878, 6881-4,6887. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35229 |
| Study title: Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo.Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35230 |
| Study title: Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis.Ribavirin effect on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. |
| Active substance: PYRITINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35236 |
| Study title: Abdallah et al., Egypt Med Assoc 1965; 48: 396-398 Abdallah et al., Egypt Med Assoc 1965; 48: 396-398 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39530 |
| Study title: Luna Solano JL, Silva Baeza JC.. Ed Medico [Mexico] April 1973;23(1):57- 58,61 Methisporinol in some common infectious viraliseasesLuna Solano JL, Silva Baeza JC.. Ed Medico [Mexico] April 1973;23(1):57- 58,61 Methisporinol in some common infectious viraliseases |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30145 |
| Study title: Malfroot A, Wybran J, Duchateau J, Zissus G. (1981). Pediatric Research. January-December,15:1180. Abstract 11. Successful treatment of a systemic CMV infection with IsoprinosineMalfroot A, Wybran J, Duchateau J, Zissus G. (1981). Pediatric Research. January-December,15:1180. Abstract 11. Successful treatment of a systemic CMV infection with Isoprinosine |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30146 |
| Study title: Mechanisms of severe immediate reactions to iodinated contrast material; Laroche D et al; Radiology; 1998 vol.209 p.183 190Mechanisms of severe immediate reactions to iodinated contrast material; Laroche D et al; Radiology; 1998 vol.209 p.183 190 |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30180 |
| Study title: Mehta PD, Kulczycki J, Patrick BA, Sobczyk W, Wisniewski HM. J Neurol Sci. 1992 May;109(1):64-8. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis.Mehta PD, Kulczycki J, Patrick BA, Sobczyk W, Wisniewski HM. J Neurol Sci. 1992 May;109(1):64-8. Effect of treatment on oligoclonal IgG bands and intrathecal IgG synthesis in sequential cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30147 |
| Study title: Minarro A, Linfante E, et alLa SemanaMedica {Argentina] Aug 91973;80(4379): 362-372 Results obtained using antiviral(NPl13) on diverse pediatric viral infections.Minarro A, Linfante E, et alLa SemanaMedica {Argentina] Aug 91973;80(4379): 362-372 Results obtained using antiviral(NPl13) on diverse pediatric viral infections. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30148 |
| Study title: Moroni M, Lazzarin A, Galli M.. Presented at the 15th National Congress of the Italian Society of Clinical Allergology and Immunology. October 30-November 1, 1981; Rome, Italy; 73-84. Immunoterapia delle infezioni chroniche e recidivanti. Moroni M, Lazzarin A, Galli M.. Presented at the 15th National Congress of the Italian Society of Clinical Allergology and Immunology. October 30-November 1, 1981; Rome, Italy; 73-84. Immunoterapia delle infezioni chroniche e recidivanti. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30149 |
| Study title: Moroni P, Baratta L, Baratta B. Chron Dermatologica 1980;11:3-8. Cytologic effects in herpes zoster.Moroni P, Baratta L, Baratta B. Chron Dermatologica 1980;11:3-8. Cytologic effects in herpes zoster. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30150 |
| Study title: Muscianese V, Koverech A, Simoni R Chron Derm 1980;10(1):3-11. Il metisoprinolo nelle virosi cutanee.Muscianese V, Koverech A, Simoni R Chron Derm 1980;10(1):3-11. Il metisoprinolo nelle virosi cutanee. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30151 |
| Study title: Nunan B, Tonelli E. Jomal de pediatria [Brazil] Nov-Dec 1972;37(11-12):325-328. Therapy of certain acute viral diseases with Isoprinosine Nunan B, Tonelli E. Jomal de pediatria [Brazil] Nov-Dec 1972;37(11-12):325-328. Therapy of certain acute viral diseases with Isoprinosine |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30152 |
| Study title: Ochocka M, Chmielewska D, Matysiak M. Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(3):343-9 Isoprinosine in the treatment of herpes virus infections in children with leukaemia and malignant lymphoma.Ochocka M, Chmielewska D, Matysiak M. Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(3):343-9 Isoprinosine in the treatment of herpes virus infections in children with leukaemia and malignant lymphoma. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30153 |
| Study title: Patel P, Gemmell R, Carruth JASJ Laryngol Otol Dec 1987 101(12):1306-1307. Inosine pranobex in recurrent laryngeal papillomatosis.Patel P, Gemmell R, Carruth JASJ Laryngol Otol Dec 1987 101(12):1306-1307. Inosine pranobex in recurrent laryngeal papillomatosis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30154 |
| Study title: Cytogenetic analysis of peripheral blood lymphocytes after arteriography (exposure to x-rays and contrast medium)Popova L 2005. Radio/ Oncol 2005; 39(2): 153-8. |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48197 |
| Study title: Eur J Radiol. 1993 Nov;17(3):203-9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Palmers Y, De Greef D, Grynne BH, Smits J, Put E Eur J Radiol. 1993 Nov;17(3):203-9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Palmers Y, De Greef D, Grynne BH, Smits J, Put E |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30349 |
| Study title: Bartkowski S.B., Krystkowa K.M., Pruszkiewicz W., Zapala J.: Follow-up results of surgical treatment of post-traumatic diplopia. Bartkowski S.B., Krystkowa K.M., Pruszkiewicz W., Zapala J.: Follow-up results of surgical treatment of post-traumatic diplopia. |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35103 |
| Study title: Bedavanija A, Singalavanija A, Kombara M.: Solcoseryl Eye Gel: An Effective Adjunct in the Treatment of Chronic Ulcers of the Cornea. J.med. Assoc. Thailand 68, 415-418 (1985). Bedavanija A, Singalavanija A, Kombara M.: Solcoseryl Eye Gel: An Effective Adjunct in the Treatment of Chronic Ulcers of the Cornea. J.med. Assoc. Thailand 68, 415-418 (1985). |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35104 |
| Study title: Egorova G.B., Avetisov S.E., Churkina M.N., Rybakova E.: A comparative assessment of contact lens tolerance and a study of possibilities for its improvement. Egorova G.B., Avetisov S.E., Churkina M.N., Rybakova E.: A comparative assessment of contact lens tolerance and a study of possibilities for its improvement. |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35099 |
| Study title: Gerkowicz K.; Toczolowski J.; Hamerski W.; Jedrzejewski D.; Gerkowicz M.: Evaluation of the effectiveness of Solcoseryl Eye-Gel in the treatment of some corneal diseases. Klin. Oczna 87: 21-22, 1985. Gerkowicz K.; Toczolowski J.; Hamerski W.; Jedrzejewski D.; Gerkowicz M.: Evaluation of the effectiveness of Solcoseryl Eye-Gel in the treatment of some corneal diseases. Klin. Oczna 87: 21-22, 1985. |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35106 |
| Study title: Joannidis P: Doppelblinde klinische Prüfung von Solcoseryl Dental Adhäsipaste als Wundverband nach oral-chirurgischen Eingriffen. Dissertetion, durchgeführt unter der Leitung von Prof. Dr. A. Schrpeder, Direktor der Klinik für Zahnerhaltung der Univ. Bern, 1983 Joannidis P: Doppelblinde klinische Prüfung von Solcoseryl Dental Adhäsipaste als Wundverband nach oral-chirurgischen Eingriffen. Dissertetion, durchgeführt unter der Leitung von Prof. Dr. A. Schrpeder, Direktor der Klinik für Zahnerhaltung der Univ. Bern, 1983 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35094 |
| Study title: Krasny J.; Krejci L.; Rezek P.: Solcoseryl eye gel in pediatric ophthalmology practice. Ceskol. Oftalm. 42, 1986, No. 6, 448-453. Krasny J.; Krejci L.; Rezek P.: Solcoseryl eye gel in pediatric ophthalmology practice. Ceskol. Oftalm. 42, 1986, No. 6, 448-453. |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35102 |
| Study title: "Krekeler G: Clinical study to assess the effect of Solcoseryl adhesive oinment on wound healing. Unpublished report 1979 Felber P, Gasser F: Double-blind clinical trial of Solcoseryl Dental Adhesive Paste for treating dental sores. Schweiz. Mschr. Zahnheilkunde, 1983, 93, 362-372" "Krekeler G: Clinical study to assess the effect of Solcoseryl adhesive oinment on wound healing. Unpublished report 1979 Felber P, Gasser F: Double-blind clinical trial of Solcoseryl Dental Adhesive Paste for treating dental sores. Schweiz. Mschr. Zahnheilkunde, 1983, 93, 362-372" |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35092 |
| Study title: Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68)Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45064 |
| Study title: EFFICACY AND SAFETY OF RIFABUTIN (AMSAMYCIN LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/706I OCTOBER 1990 D93 AGE RANGE 15- 62 YEARS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35372 |
| Study title: PARTIALLY RANDOMIZED DOSE COMPARSION TRAIL OF COMPASSIONATE USE RIFABUTIN (AMSAMYCIN LM 427) IN AIDS OATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX INFECTION FCE REPORT LM 427/723I FEBRUARY 1991 AGE RANGE 1-62 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35376 |
| Study title: PARTIALLY RANDOMIZED, DOSE COMPARISON TRIAL OF COMPASSIONATE USE RIFABUTIN (AMSAMYCIN LM 427) IN NON-AIDS PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX INFECTION. FCE REPORT: LM 427/719I MARCH, 1991 AGE RANGE: 0-91 YRS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35377 |
| Study title: RIFABUTIN FOR THE TREATMENT OF NEWLY DIAGNOSIED PULMONARYTUBERCULOIS: A MULTINATIONAL, RANDOMIZED COMPARATIVE STUDY VERUS RIFAMPICIN LUIS JULIO GONZALES-MONTANER AGE RANGE 15-67 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35375 |
| Study title: SAFETY OF RIFABUTIN (AMSAMYCIN, LM 427) IN PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS. FCE REPORT LM 427/708I OCTOBER 1990 AGE RANGE: 15-68 YRS |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35371 |
| Study title: THE COMPASSIONATE USE OF RIFABUTIN FOR THE TREATMENT OF MYCOBACTERIU AVIUM COMPLEX DISEASE IN HIV POSITIVE PATIENTS. FCE REPORTS LM 427/720I JANUARY 1991 AGE RANGE 5 -61 |
| Active substance: RIFABUTIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35373 |
| Study title: Clinical Expert Statement for MA Renewal in Slovenial - Djebbar F. & Verdoncq B. - 12 July 2007 |
| Active substance: RIFAMPICIN/ISONIAZID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35378 |
| Study title: Clinical Certificate for MA Renewal in Slovenia - Verdoncq B. - 10 July 2007 (0703-CC-RIF+ISO+PYR-SLOVENIA-BV-10.07.07) |
| Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35379 |
| Study title: Referenced in Rifater Registration Dossier - Clinical Documentation - Update April 1998 : The use of fixed-dose combinations in antituberculosis chemotherapy. Rationale for their application in daily, intermittant and pediatric regimens. - Acoccella G. - 1990 (Bulletin of the Int. Union Against Tuberculosis and Lung Disease, 65, 2-3: 77-83) |
| Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35380 |
| Study title: Spectrophotofluorometric assay for Isoniazid and Acetyl Isoniazid in Plasma adapted tp pediatric studies - Clin. Chem., 23(4), 745 - Olson W.A. Et al (1977) Spectrophotofluorometric assay for Isoniazid and Acetyl Isoniazid in Plasma adapted tp pediatric studies - Clin. Chem., 23(4), 745 - Olson W.A. Et al (1977) |
| Active substance: RIFAMPICIN/ISONIAZID/PYRAZINAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45141 |
| Study title: Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project - Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ et al - 1994 (Pneumologie, 48(10): 761 - 4)Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project - Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ et al - 1994 (Pneumologie, 48(10): 761 - 4) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35381 |
| Study title: Matus-Ridley-M, Nicosia-S-V, Meadows-A-T. Children's Cancer Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States. Gonadal effects of cancer therapy in boys. Cancer {CANCER}, 1985, Vol/Iss/Pg. 55/10 (2353-2363).Matus-Ridley-M, Nicosia-S-V, Meadows-A-T. Children's Cancer Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, United States. Gonadal effects of cancer therapy in boys. Cancer {CANCER}, 1985, Vol/Iss/Pg. 55/10 (2353-2363). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34782 |
| Study title: Mauch-P-M, Weinstein-H, Botnick-L, Belli-J, Cassady-J-R. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer, {Cancer}, 1 Mar 1983, vol. 51, no. 5, p. 925-32, ISSN: 0008-543X.Mauch-P-M, Weinstein-H, Botnick-L, Belli-J, Cassady-J-R. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease. Cancer, {Cancer}, 1 Mar 1983, vol. 51, no. 5, p. 925-32, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34783 |
| Study title: 11. Botero et al., Bol Chil Parasitol 1966; 21: 111-114 11. Botero et al., Bol Chil Parasitol 1966; 21: 111-114 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39540 |
| Study title: 12. Bruhn, Padelt, Padiatr Grenzgeb 1968 ; 7 : 331341 12. Bruhn, Padelt, Padiatr Grenzgeb 1968 ; 7 : 331341 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39541 |
| Study title: 13. Brus et al., Polski Tygodnik Lekarski 1976; 31: 195-197 13. Brus et al., Polski Tygodnik Lekarski 1976; 31: 195-197 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39542 |
| Study title: 14. Bumbalo et al., Am J Trop Med Hyg 1958; 7: 212-214 14. Bumbalo et al., Am J Trop Med Hyg 1958; 7: 212-214 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39543 |
| Study title: Farah-R, Golomb-H-M, Hallahan-D-E, Desser-R-K, Griem-M-L, Blough-R, Ultmann-J-E, Weichselbaum-R-R. Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, United States. Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. International Journal of Radiation Oncology Biology Physics {INT-J- RADIAT-ONCOL-BIOL-PHYS}, 1989, Vol/Iss/Pg. 17/4 (761766), ISSN: 0360-3016.Farah-R, Golomb-H-M, Hallahan-D-E, Desser-R-K, Griem-M-L, Blough-R, Ultmann-J-E, Weichselbaum-R-R. Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, United States. Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. International Journal of Radiation Oncology Biology Physics {INT-J- RADIAT-... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34710 |
| Study title: Fernandez-Bouzas-A, Ramirez-Jimenez-H, Vazquez-Zamudio-J, Alonso- Vanegas-M, Mendizabal-Guerra-R. Department of Neuroradiology, Hospital 20 de Noviembre, ISSSTE, Mexico City. Brain calcifications and dementia in children treated with radiotherapy and intrathecal methotrexate. Journal of neurosurgical sciences, {J-Neurosurg-Sci}, Oct-Dec 1992, vol. 36, no. 4, p. 211-4, ISSN: 0390-5616.Fernandez-Bouzas-A, Ramirez-Jimenez-H, Vazquez-Zamudio-J, Alonso- Vanegas-M, Mendizabal-Guerra-R. Department of Neuroradiology, Hospital 20 de Noviembre, ISSSTE, Mexico City. Brain calcifications and dementia in children treated with radiotherapy and intrathecal methotrexate. Journal of neurosurgical sciences, {J-Neurosurg-Sci}, Oct-Dec 1992, vol. 36, no. 4, p... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34711 |
| Study title: Fink-F-M, Ausserer-B, Dengg-K, Pallua-A-K, Twerdy-K, Frommhold-H, Berger-H. Department of Pediatrics, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Long term remission of intrinsic brainstem gliomas: The case reports of two children. Wiener Klinische Wochenschrift {WIEN-KLIN-WOCHENSCHR}, 1991, Vol/Iss /Pg. 103/13 (392-395), ISSN: 0043-5325.Fink-F-M, Ausserer-B, Dengg-K, Pallua-A-K, Twerdy-K, Frommhold-H, Berger-H. Department of Pediatrics, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Long term remission of intrinsic brainstem gliomas: The case reports of two children. Wiener Klinische Wochenschrift {WIEN-KLIN-WOCHENSCHR}, 1991, Vol/Iss /Pg. 103/13 (392-395), ISSN: 0043-5325. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34712 |
| Study title: Flamant-F, Rodary-C, Voute-P-A, Otten-J. Pediatric Department, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the international society of pediatric oncology (SIOP) preliminary results. Radiotherapy and Oncology {RADIOTHER-ONCOL}, 1985, Vol/Iss/Pg. 3/3 (227-236).Flamant-F, Rodary-C, Voute-P-A, Otten-J. Pediatric Department, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the international society of pediatric oncology (SIOP) preliminary results. Radiotherapy and Oncology {RADIOTHER-ONCOL}, 1985, Vol/Iss/Pg. 3/3 (227-236). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34713 |
| Study title: 10. Biguet et al., Presse Med 1959; 67: 1739-1740 10. Biguet et al., Presse Med 1959; 67: 1739-1740 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39539 |
| Study title: Eur J Radiol. 1993 Nov;17(3):203-9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Palmers Y, De Greef D, Grynne BH, Smits J, Put E Eur J Radiol. 1993 Nov;17(3):203-9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Palmers Y, De Greef D, Grynne BH, Smits J, Put E |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30353 |
| Study title: : Eur Radiol. 1997;7 Suppl 4:S123-6 Iopentol (Imagopaque 350) compared with iohexol (Omnipaque 350) in paediatric cardioangiography. A clinical trial assessing adverse events, ECG, blood pressure and diagnostic information. Kunnen M, De Greef D, Skinningsrud K : Eur Radiol. 1997;7 Suppl 4:S123-6 Iopentol (Imagopaque 350) compared with iohexol (Omnipaque 350) in paediatric cardioangiography. A clinical trial assessing adverse events, ECG, blood pressure and diagnostic information. Kunnen M, De Greef D, Skinningsrud K |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30356 |
| Study title: Eur Radiol. 1998;8(6):1054-7. Myelography with a dimeric (iodixanol) and a monomeric (iohexol) contrast medium: a clinical multicentre comparative study. Skalpe IO, Bonneville JF, Grane P, Gyldenstedt C, Otto B, Kristoffersen DT, Svaland MG. Eur Radiol. 1998;8(6):1054-7. Myelography with a dimeric (iodixanol) and a monomeric (iohexol) contrast medium: a clinical multicentre comparative study. Skalpe IO, Bonneville JF, Grane P, Gyldenstedt C, Otto B, Kristoffersen DT, Svaland MG. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30352 |
| Study title: Evaluation of a coronary-cameral fistula: benefits of coronary dual-source MDCT angiography in childrenLerner CB 2008. Pediatr Radiol (2008) 38:874–878 |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48201 |
| Study title: Experiences with iohexol and iodixanol during cardioangiography in an unselected patient population.Int J Cardiol. 2001 Sep-Oct;80(2-3):143-51. Flinck A, Gottfridsson B. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30347 |
| Study title: Frequency, Management, and Outcome of Extravasation of Nonionic Iodinated Contrast Medium in 69 657 Intravenous InjectionsWang CL 2007. Radiology: Volume 243: Number 1-April 2007 |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48198 |
| Study title: Iodixanol in paediatric excretory urography: efficiency and safety compared to iohexolDacher JN 1998. Pediatr Radiol (1998) 28: 112-114 |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48195 |
| Study title: Iodixanol Pharmacokinetics in ChildrenJohnson WH 2001 Pediatr Cardiol 22:223–227, 2001 |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48196 |
| Study title: J Comput Assist Tomogr. 2000 Mar-Apr;24(2):327-31 Gadolinium-enhanced magnetic resonance dacryocystography in patients with epiphora. Kirchhof K, Hähnel S, Jansen O, Zake S, Sartor K. J Comput Assist Tomogr. 2000 Mar-Apr;24(2):327-31 Gadolinium-enhanced magnetic resonance dacryocystography in patients with epiphora. Kirchhof K, Hähnel S, Jansen O, Zake S, Sartor K. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30355 |
| Study title: Lange-B, Littman-P. Div. Oncol., Hosp. Univ. Pennsylvania, Philadelphia, PA 19104, United States. Management of Hodgkin's disease in children and adolescents. Cancer {CANCER}, 1983, Vol/Iss/Pg. 51/8 (1371-1377).Lange-B, Littman-P. Div. Oncol., Hosp. Univ. Pennsylvania, Philadelphia, PA 19104, United States. Management of Hodgkin's disease in children and adolescents. Cancer {CANCER}, 1983, Vol/Iss/Pg. 51/8 (1371-1377). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34768 |
| Study title: Willoughby CR, Tesh JM, McAnulty PA, Tesh SA, Wilby OK. Teratology study of NY-198 in the rat (segment II). 1986. Internal Report |
| Active substance: LOMEFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31400 |
| Study title: Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68)Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45069 |
| Study title: Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68)Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45074 |
| Study title: Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68)Acceptability and efficacy of intra-rectal Quinine alkaloids as a pre-transfer treatment of non-per os malaria in peripheral health care facilities in Mopti, Mali - Mahamadou A Thera et al. - 22/05/2007 (Malaria Journal, 6:68) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45079 |
| Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45060 |
| Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45070 |
| Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45075 |
| Study title: McClain-K-L, Heise-R, Day-D-L, Lee-C-K, Woods-W-G, Aeppli-D. Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. The American journal of pediatric hematology/oncology, {Am-J-Pediatr-Hematol-Oncol}, Summer 1990, vol. 12, no. 2, p. 147-54, 29 refs, ISSN: 0192-8562.McClain-K-L, Heise-R, Day-D-L, Lee-C-K, Woods-W-G, Aeppli-D. Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. The American journal of pediatric hematology/o... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34785 |
| Study title: McClain-K, Heise-R, Day-D-L, Lee-C-K-K, Woods-G, Aeppli-D. Department of Pediatrics, The University of Minnesota School of Medicine, Minneapolis, MN, United States. Hodgekin's disease in children: Correlation of clinical characteristics, staging procedures, and treatment at the university of Minnesota. American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR-HEMATOL-ONCOL}, 1990, Vol/Iss/Pg. 12/2 (147-154), ISSN: 0192-8562.McClain-K, Heise-R, Day-D-L, Lee-C-K-K, Woods-G, Aeppli-D. Department of Pediatrics, The University of Minnesota School of Medicine, Minneapolis, MN, United States. Hodgekin's disease in children: Correlation of clinical characteristics, staging procedures, and treatment at the university of Minnesota. American Jo... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34784 |
| Study title: Meadows-A-T, Silber-J. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, United States. Delayed consequences of therapy for childhood cancer. Ca-A Cancer Journal for Clinicians {CA-CANCER-J-CLIN}, 1985, Vol/Iss /Pg. 35/5 (271-286).Meadows-A-T, Silber-J. Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, United States. Delayed consequences of therapy for childhood cancer. Ca-A Cancer Journal for Clinicians {CA-CANCER-J-CLIN}, 1985, Vol/Iss /Pg. 35/5 (271-286). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34786 |
| Study title: Morgenfeld-M-C, Pavlovsky-A, Suarez-A, Somoza-N, Pavlovsky-S, Palau- M, Barros-C-A. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. Cancer, {Cancer}, Oct 1975, vol. 36, no. 4, p. 1241-9, ISSN: 0008-543X.Morgenfeld-M-C, Pavlovsky-A, Suarez-A, Somoza-N, Pavlovsky-S, Palau- M, Barros-C-A. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. Cancer, {Cancer}, Oct 1975, vol. 36, no. 4, p. 1241-9, ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34787 |
| Study title: Weiner-M-A, Leventhal-B, Brecher-M-L, Marcus-R-B, Cantor-A, Gieser-P- W, Ternberg-J-L, Behm-F-G, Wharam-M-D-Jr, Chauvenet-A-R. W, Ternberg-J-L, Behm-F-G, Wharam-M-D-Jr, Chauvenet-A-R College of Physicians and Surgeons of Columbia University, New York, USA. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Aug 1997, vol. 15, no. 8, p. 2769-79, ISSN: 0732-183X.Weiner-M-A, Leventhal-B, Brecher-M-L, Marcus-R-B, Cantor-A, Gieser-P- W, Ternberg-J-L, Behm-F-G, Wharam-M-D-Jr, Chauvenet-A-R. W, Ternb... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34874 |
| Study title: Fryer-C-J, Hutchinson-R-J, Krailo-M, Collins-R-D, Constine-L-S, Hays- D-M, Heller-R-M, Davis-P-C, Nachman-J, O-Brien-R-T, O-Neill-J-A, Pringle-K-C, Trigg-M-E, Hammond-G-D. Childrens Cancer Study Group, Operations Office, 199 North Lake Ave, Pasadena, CA 91101, United States. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: A report from the Childrens Cancer Study Group. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1990, Vol/Iss/Pg. 8/12 (1971-1980), ISSN: 0732-183X.Fryer-C-J, Hutchinson-R-J, Krailo-M, Collins-R-D, Constine-L-S, Hays- D-M, Heller-R-M, Davis-P-C, Nachman-J, O-Brien-R-T, O-Neill-J-A, Pringle-K-C, Trigg-M-E, Hammond-G-D. Childrens Cancer Study Group, Operations... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34714 |
| Study title: Petera-J, Macharova-H, Pohankova-R, Malir-A, Coupek-P, Konecný-M, Patera-J, Pecina-J, Drbal-J, Koukalova-H, Vasova-I. Masaryk Memorial Cancer Institute, Brno, Czech Republic. Petera @fuhk.cz. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute. Neoplasma, {Neoplasma}, 2000, vol. 47, no. 2, p. 129-32, ISSN: 0028-2685.Petera-J, Macharova-H, Pohankova-R, Malir-A, Coupek-P, Konecný-M, Patera-J, Pecina-J, Drbal-J, Koukalova-H, Vasova-I. Masaryk Memorial Cancer Institute, Brno, Czech Republic. Petera @fuhk.cz. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute. Neoplasma, {Neoplasma}, 2000, vol. 47, no. 2, p. 129-32, ISSN: 0028-2685. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34806 |
| Study title: Petronio-J, Edwards-M-S-B, Prados-M, Freyberger-S, Rabbitt-J, Silver- P, Levin-V-A. c/o Editorial Office, 1360 Ninth Avenue, San Francisco, CA 94122, United States. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. Journal of Neurosurgery {J-NEUROSURG}, 1991, Vol/Iss/Pg. 74/5 (701-708), ISSN: 0022-3085.Petronio-J, Edwards-M-S-B, Prados-M, Freyberger-S, Rabbitt-J, Silver- P, Levin-V-A. c/o Editorial Office, 1360 Ninth Avenue, San Francisco, CA 94122, United States. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. Journal of Neurosurgery {J-NEUROSURG}, 1991, Vol/Iss/Pg. 74/5 (701-708), ISSN: 0022-3085. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34807 |
| Study title: Pezzotta-S, Cordero-Di-Montezemolo-L, Knerich-R, Arrigoni-M, Barbara- A, Besenzon-L, Brach-del-Prever-A, Fidani-P, Locatelli-D, Loiacono-G, Magrassi-L, Perilongo-G, Rigobello-L, Urgesi-A, Madon-E. Dept. of Surg., Neurosurgical Clinic, University of Pavia, IRCCS Policlinico San Matteo, Piazzale Golgi, 2, I-27100 Pavia, Italy. CNS-85 trial: A cooperative pediatric CNS tumor study - results of treatment of medulloblastoma patients. Child's Nervous System {CHILD-S-NERV-SYST}, 1996, Vol/Iss/Pg. 12/2 (87-96), ISSN: 0256-7040.Pezzotta-S, Cordero-Di-Montezemolo-L, Knerich-R, Arrigoni-M, Barbara- A, Besenzon-L, Brach-del-Prever-A, Fidani-P, Locatelli-D, Loiacono-G, Magrassi-L, Perilongo-G, Rigobello-L, Urgesi-A, Madon-E. Dept. of Surg., Neurosurgical Clinic, University of Pavia, ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34808 |
| Study title: Pezzotta-S, Knerich-R, Butti-G. ICNG Coord. Cent., Neurosurg. Clin., Univ. Pavia, 27100 Pavia, Italy. Chemotherapy for medulloblastoma in children. Current status and future prospects. Child's Brain {CHILD-S-BRAIN}, 1982, Vol/Iss/Pg. 9/3-4 (294-298).Pezzotta-S, Knerich-R, Butti-G. ICNG Coord. Cent., Neurosurg. Clin., Univ. Pavia, 27100 Pavia, Italy. Chemotherapy for medulloblastoma in children. Current status and future prospects. Child's Brain {CHILD-S-BRAIN}, 1982, Vol/Iss/Pg. 9/3-4 (294-298). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34809 |
| Study title: Lemerle-J, Bernard-A, Kalifa-C. Serv. Cancerol. Inf., Inst. Gustave Roussy, Villejuif, France. Management and follow up of antitumoral chemotherapy of the child. Revue du Praticien {REV-PRAT}, 1977, Vol/Iss/Pg. 27/5 (237-247).Lemerle-J, Bernard-A, Kalifa-C. Serv. Cancerol. Inf., Inst. Gustave Roussy, Villejuif, France. Management and follow up of antitumoral chemotherapy of the child. Revue du Praticien {REV-PRAT}, 1977, Vol/Iss/Pg. 27/5 (237-247). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34770 |
| Study title: Leventhal-B-G. Johns Hopkins Oncology Center, Baltimore, MD, United States. Management of stage I-II Hodgkin's disease in children. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1990, Vol/Iss/Pg. 8/7 (1123-1124), ISSN: 0732-183X.Leventhal-B-G. Johns Hopkins Oncology Center, Baltimore, MD, United States. Management of stage I-II Hodgkin's disease in children. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1990, Vol/Iss/Pg. 8/7 (1123-1124), ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34771 |
| Study title: Leverger-G, Oberlin-O, Schaison-G, Lemerle-J. (Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation). Nouvelle revue francaise d'hematologie, {Nouv-Rev-Fr-Hematol}, 1987,vol. 29, no. 1, p. 83-5.vol. 29, no. 1, p. 83-5.Leverger-G, Oberlin-O, Schaison-G, Lemerle-J. (Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation). Nouvelle revue francaise d'hematologie, {Nouv-Rev-Fr-Hematol}, 1987,vol. 29, no. 1, p. 83-5.vol. 29, no. 1, p. 83-5. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34773 |
| Study title: Leverger-G, Oberlin-O, Schaison-G, Lemerle-J. ( Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation). Nouvelle revue francaise d'hematologie {Nouv-Rev-Fr-Hematol} 1987, VOL: 29 (1), P: 83-5.Leverger-G, Oberlin-O, Schaison-G, Lemerle-J. ( Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation). Nouvelle revue francaise d'hematologie {Nouv-Rev-Fr-Hematol} 1987, VOL: 29 (1), P: 83-5. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34772 |
| Study title: Loeuille-G-A. Consultation d'Endocrinologie Pediatrique, Hopital Regional, 59037 Lille Cedex, France. Endocrine surveillance of children after antineoplastic radiotherapy and chemotherapy. LARC Medical {LARC-MED}, 1985, Vol/Iss/Pg. 5/10 (562-566).Loeuille-G-A. Consultation d'Endocrinologie Pediatrique, Hopital Regional, 59037 Lille Cedex, France. Endocrine surveillance of children after antineoplastic radiotherapy and chemotherapy. LARC Medical {LARC-MED}, 1985, Vol/Iss/Pg. 5/10 (562-566). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34774 |
| Study title: Longo-D-L, Russo-A, Duffey-P-L, Hubbard-S-M, Glatstein-E, Hill-J-B, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Feb 1991, vol. 9, no. 2, p. 227-35, ISSN: 0732-183X.Longo-D-L, Russo-A, Duffey-P-L, Hubbard-S-M, Glatstein-E, Hill-J-B, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34775 |
| Study title: Lawhorn-T-I, Stone-H-H, Martin-J-D-Jr. Chemotherapy in solid tumors of childhood. Oncology, {Oncology}, 1972, vol. 26, no. 2, p. 250-8, 22 refs, ISSN: 0030-2414.Lawhorn-T-I, Stone-H-H, Martin-J-D-Jr. Chemotherapy in solid tumors of childhood. Oncology, {Oncology}, 1972, vol. 26, no. 2, p. 250-8, 22 refs, ISSN: 0030-2414. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34769 |
| Study title: Hamilton-V-M, Norris-C, Bunin-N, Goldwein-J-W, Bunin-G-R, Lange-B, Meadows-A-T. Division of Oncology, Children's Hospital of Philadelphia, Pennsylvania 19104, USA. Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, {J-Pediatr- Hematol-Oncol}, Feb 2001, vol. 23, no. 2, p. 84-8, ISSN: 1077-4114.Hamilton-V-M, Norris-C, Bunin-N, Goldwein-J-W, Bunin-G-R, Lange-B, Meadows-A-T. Division of Oncology, Children's Hospital of Philadelphia, Pennsylvania 19104, USA. Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34732 |
| Study title: Hartmann-O, Oberlin-O, Beaujean-F, Brugieres-L, Valteau-D, Vassal-G, Lemerle-J. Departement de Pediatrie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. High-dose chemotherapy followed by autologous bone marrow transplantation in children's metastatic Ewing sarcoma. Bulletin du Cancer {BULL-CANCER}, 1990, Vol/Iss/Pg. 77/2 (181-187), ISSN: 0007-4551.Hartmann-O, Oberlin-O, Beaujean-F, Brugieres-L, Valteau-D, Vassal-G, Lemerle-J. Departement de Pediatrie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. High-dose chemotherapy followed by autologous bone marrow transplantation in children's metastatic Ewing sarcoma. Bulletin du Cancer {BULL-CANCER}, 1990, Vol/Iss/Pg. 77/2 (181-187), ISSN: 0007-4551. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34733 |
| Study title: Hassel-J-U, Braemswig-J-H, Schlegel-W, Schellong-G. Universitaets-Kinderklinik, Muenster. (Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study). Klinische Paediatrie {Klin-Padiatr} 1991 Jul-Aug, VOL: 203 (4), P: 268-72, ISSN: 0300-8630.Hassel-J-U, Braemswig-J-H, Schlegel-W, Schellong-G. Universitaets-Kinderklinik, Muenster. (Testicular function after OPA/COMP chemotherapy without procarbazine in boys with Hodgkin's disease. Results in 25 patients of the DAL-HD-85 study). Klinische Paediatrie {Klin-Padiatr} 1991 Jul-Aug, VOL: 203 (4), P: 268-72, ISSN: 0300-8630. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34734 |
| Study title: Hayani-A, Mahoney-D-H-Jr, Taylor-L-D. Department of Pediatrics, Baylor College of Medicine, Houston, TX. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. Journal of neuro-oncology, {J-Neurooncol}, Sep 1992, vol. 14, no. 1, p. 57-62, ISSN: 0167-594X.Hayani-A, Mahoney-D-H-Jr, Taylor-L-D. Department of Pediatrics, Baylor College of Medicine, Houston, TX. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. Journal of neuro-oncology, {J-Neurooncol}, Sep 1992, vol. 14, no. 1, p. 57-62, ISSN: 0167-594X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34735 |
| Study title: Heath-John-A, Turner-Christopher-D, Poussaint-Tina-Young, Scott-R- Michael, Goumnerova-Liliana, Kieran-Mark-W. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. john.heath@rch.org.au. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience. Pediatric hematology and oncology, {Pediatr-Hematol-Oncol}, Oct-Nov 2003, vol. 20, no. 7, p. 497-504, ISSN: 0888-0018.Heath-John-A, Turner-Christopher-D, Poussaint-Tina-Young, Scott-R- Michael, Goumnerova-Liliana, Kieran-Mark-W. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. john.heath@rch.org.au. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34737 |
| Study title: Whitehead-E, Shalet-S-M, Jones-P-H, Beardwell-C-G, Deakin-D-P. Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Archives of disease in childhood, {Arch-Dis-Child}, Apr 1982, vol. 57, no. 4, p. 287-91, ISSN: 1468-2044.Whitehead-E, Shalet-S-M, Jones-P-H, Beardwell-C-G, Deakin-D-P. Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Archives of disease in childhood, {Arch-Dis-Child}, Apr 1982, vol. 57, no. 4, p. 287-91, ISSN: 1468-2044. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34876 |
| Study title: Wiedrich-T, Keller-D, Arya-S-A, Gilbert-E. Department of Pathology, University of Wisconsin Center for Health Sciences and Medical School, Madison, WI 53792, United States. Adverse histopathologic effects of chemotherapeutic agents in childhood leukemia and lymphoma. Pediatric Pathology {PEDIATR-PATHOL}, 1984, Vol/Iss/Pg. 2/3 (267-283).Wiedrich-T, Keller-D, Arya-S-A, Gilbert-E. Department of Pathology, University of Wisconsin Center for Health Sciences and Medical School, Madison, WI 53792, United States. Adverse histopathologic effects of chemotherapeutic agents in childhood leukemia and lymphoma. Pediatric Pathology {PEDIATR-PATHOL}, 1984, Vol/Iss/Pg. 2/3 (267-283). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34877 |
| Study title: Woo-S-Y, Donaldson-S-S, Cox-R-S. Department of Therapeutic Radiology, Stanford University Medical Center, Stanford, CA 94305, United States. Astrocytoma in children: 14 years' experience at Stanford University Medical Center. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1988, Vol/Iss/Pg. 6/6 (1001-1007), ISSN: 0732-183X.Woo-S-Y, Donaldson-S-S, Cox-R-S. Department of Therapeutic Radiology, Stanford University Medical Center, Stanford, CA 94305, United States. Astrocytoma in children: 14 years' experience at Stanford University Medical Center. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1988, Vol/Iss/Pg. 6/6 (1001-1007), ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34879 |
| Study title: Yaniv-I, Saab-A, Cohen-I-J, Goshen-Y, Loven-D, Stark-B, Tamary-H, Zaizov-R. Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease. Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology, {J-Pediatr- Hematol-Oncol}, Feb 1996, vol. 18, no. 1, p. 76-80, ISSN: 1077-4114.Yaniv-I, Saab-A, Cohen-I-J, Goshen-Y, Loven-D, Stark-B, Tamary-H, Zaizov-R. Department of Pediatric Hematology Oncology, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease. Journal of pediatric hem... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34880 |
| Study title: Ghigo E et al. Growth hormone responses to pyridostigmine in normal adults and in normal and short children. Clin Endocrinol (Oxf). 1987 Dec;27(6):669-73Ghigo E et al. Growth hormone responses to pyridostigmine in normal adults and in normal and short children. Clin Endocrinol (Oxf). 1987 Dec;27(6):669-73 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35217 |
| Study title: Ghigo E, Mazza E, Imperiale E, Rizzi G, Benso L, Müller EE, Camanni F, Massara F. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature. J Clin Endocrinol Metab. 1987 Sep;65(3):452-6.Ghigo E, Mazza E, Imperiale E, Rizzi G, Benso L, Müller EE, Camanni F, Massara F. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature. J Clin Endocrinol Metab. 1987 Sep;65(3):452-6. |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35221 |
| Study title: Phuphanich-S, Edwards-M-S-B, Levin-V-A, et-al. Neuro-Oncology Service, Brain Tumor Research Center, Department of Neurological Surgery, School of Medicine, University of California, San Francisco, CA, United States. Supratentorial malignant gliomas of childhood. Results of treatment with radiation therapy and chemotherapy. Journal of Neurosurgery {J-NEUROSURG}, 1984, Vol/Iss/Pg. 60/3 (495-499).Phuphanich-S, Edwards-M-S-B, Levin-V-A, et-al. Neuro-Oncology Service, Brain Tumor Research Center, Department of Neurological Surgery, School of Medicine, University of California, San Francisco, CA, United States. Supratentorial malignant gliomas of childhood. Results of treatment with radiation therapy and chemotherapy. Journal of Neurosurgery {J-NEUROSURG}, 1984, V... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34810 |
| Study title: Please refer to the product: SINERTEC Under Licence of MSDPlease refer to the product: SINERTEC Under Licence of MSD |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34811 |
| Study title: Sedation in pediatric neuroimaging: The science and the art. |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Sedation in pediatric neuroimaging The science and the art.pdf |
| View full study record |
| Document reference: 35050 |
| Study title: Synergistic effect of promethazine with gentamycin in frequently recurring |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Synergistic effect of promethazine with gentamycin in frequently recurring.pdf |
| View full study record |
| Document reference: 35053 |
| Study title: Wallace G_1963Wallace G_1963 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Wallace G_1963_publication.pdf |
| View full study record |
| Document reference: 35015 |
| Study title: Banzas |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Banzas_NoPublicado.pdf |
| View full study record |
| Document reference: 48123 |
| Study title: Berthaud |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Berthaux_NoPublicado.pdf |
| View full study record |
| Document reference: 48124 |
| Study title: Blumenbach |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Blumenbach_TherapieWoche,Cuaderno36,p.1699-1701,1969_ORIG.pdf |
| View full study record |
| Document reference: 48125 |
| Study title: Bulgarelli |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Bulgarelli_NoPublicado.pdf |
| View full study record |
| Document reference: 48135 |
| Study title: Combes-Hamelle |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48126 |
| Study title: Experiencas en clinica pediatrica con psico-soma jarabe |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Arima_NoPublicado.pdf |
| View full study record |
| Document reference: 48122 |
| Study title: Honda |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48127 |
| Study title: Kishiro_ShinyakuToRinsho |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Kishiro_ShinyakuToRinsho_vol.3,p.44-48,1967_ORIG.pdf |
| View full study record |
| Document reference: 48128 |
| Study title: KUNIOMI YOKOTA |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): KUNIOMI YOKOTA_ORIG.pdf |
| View full study record |
| Document reference: 48129 |
| Study title: Marques De Carvalho |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): MarquesDeCarvalho_Bol.daClin.Psiq.,II,1,p.6-22,1963_ORIG.pdf |
| View full study record |
| Document reference: 48130 |
| Study title: Mises_RevueNeuropsychiatrieInfantile |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Mises_RevueNeuropsychiatrieInfantile_vol.6,p.483-485,1966_ORIG.pdf |
| View full study record |
| Document reference: 48131 |
| Study title: Puech_Semaine Des Hopitaux |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48132 |
| Study title: Urgesi-A, Vasario-E, Monetti-U, et-al. Universita di Torino, Istituto di Radiologia, Divisione di Radioterapia, 10126 Torino, Italy. Treatment of childhood brain stem tumors with irradiation and chemotherapy. Preliminary results. Minerva Pediatrica {MINERVA-PEDIATR}, 1985, Vol/Iss/Pg. 37/20 (779-785).Urgesi-A, Vasario-E, Monetti-U, et-al. Universita di Torino, Istituto di Radiologia, Divisione di Radioterapia, 10126 Torino, Italy. Treatment of childhood brain stem tumors with irradiation and chemotherapy. Preliminary results. Minerva Pediatrica {MINERVA-PEDIATR}, 1985, Vol/Iss/Pg. 37/20 (779-785). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34862 |
| Study title: Vailati-G, Occhiogrosso-M, Belsanti-M, et-al. Catt. Neurochir., Univ. Bari, Bari, Italy. Medulloblastomas and other intracranial brain tumors in infacy and childhood: Late effects of chemio and radiotherapy. Folia Oncologica {FOLIA-ONCOL}, 1982, Vol/Iss/Pg. 5/3 (523-529).Vailati-G, Occhiogrosso-M, Belsanti-M, et-al. Catt. Neurochir., Univ. Bari, Bari, Italy. Medulloblastomas and other intracranial brain tumors in infacy and childhood: Late effects of chemio and radiotherapy. Folia Oncologica {FOLIA-ONCOL}, 1982, Vol/Iss/Pg. 5/3 (523-529). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34863 |
| Study title: van-den-Berg-H, Furstner-F, van-den-Bos-C, Behrendt-H. Department of Pediatric Oncology, Emma Children Hospital AMC, University of Amsterdam, Amsterdam; The Netherlands. h.vandenberg@amc.uva.nl. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatric blood & cancer, {Pediatr-Blood-Cancer}, Mar 2004, vol. 42, no. 3, p. 210-5, ISSN: 1545-5009.van-den-Berg-H, Furstner-F, van-den-Bos-C, Behrendt-H. Department of Pediatric Oncology, Emma Children Hospital AMC, University of Amsterdam, Amsterdam; The Netherlands. h.vandenberg@amc.uva.nl. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatric blood & cancer, {Pediatr-Blood-Cancer}, Mar 2004,... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34864 |
| Study title: van-den-Berg-H, Zsiros-J, Behrendt-H. Emma Kinderziekenhuis AMC, University of Amsterdam, The Netherlands. Treatment of childhood Hodgkin's disease without radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Jun 1997, vol. 15, no. 6, p. 2247-53, ISSN: 0732-183X.van-den-Berg-H, Zsiros-J, Behrendt-H. Emma Kinderziekenhuis AMC, University of Amsterdam, The Netherlands. Treatment of childhood Hodgkin's disease without radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Jun 1997, vol. 15, no. 6, p. 2247-53, ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34865 |
| Study title: van-Eys-J, Cangir-A, Coody-D, Smith-B. MOPP regimen as primary chemotherapy for brain tumors in infants. Journal of neuro-oncology, {J-Neurooncol}, 1985, vol. 3, no. 3, p. 237-43, ISSN: 0167-594X.van-Eys-J, Cangir-A, Coody-D, Smith-B. MOPP regimen as primary chemotherapy for brain tumors in infants. Journal of neuro-oncology, {J-Neurooncol}, 1985, vol. 3, no. 3, p. 237-43, ISSN: 0167-594X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34866 |
| Study title: Perani V. Riv Patol Clin Sep/Oct 1978;33(5):1-15. . Clinical evaluation of the efficacy of a new antiviral drug, methisoprinol, in pediatric infectionsPerani V. Riv Patol Clin Sep/Oct 1978;33(5):1-15. . Clinical evaluation of the efficacy of a new antiviral drug, methisoprinol, in pediatric infections |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30155 |
| Study title: Perani V. Rivista di Patalogia e Clinica Sept-Oct 1978;33(5):361-372. Clinical evaluation of the efficacy of a new antiviral drug, methisoprinol, in pediatric infections.Perani V. Rivista di Patalogia e Clinica Sept-Oct 1978;33(5):361-372. Clinical evaluation of the efficacy of a new antiviral drug, methisoprinol, in pediatric infections. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30156 |
| Study title: Schellong-G, Braemswig-J-H, Hoernig-Franz-I, Schwarze-E-W, Poetter-R, Wannenmacher-M. Children's Hospital, University of Muenster, Germany. Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, {Ann-Oncol}, 1994, vol. 5 Suppl 2, p. 113-5, ISSN: 0923-7534.Schellong-G, Braemswig-J-H, Hoernig-Franz-I, Schwarze-E-W, Poetter-R, Wannenmacher-M. Children's Hospital, University of Muenster, Germany. Hodgkin's disease in children: combined modality treatment for stages IA, IB, and IIA. Results in 356 patients of the German/Austrian Pediatric Study Group. Annals of oncology : official j... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34829 |
| Study title: Schellong-G, Braemswig-J-H, Hoernig-Franz-I. University Childrens Hospital, Department of Haematology and Oncology, Muenster, Germany. Pediatric Oncology Group. Treatment of children with Hodgkin's disease-results of the German Pediatric Oncology Group. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, {Ann-Oncol}, Sep 1992, vol. 3 Suppl 4, p. 73-6, ISSN: 0923-7534.Schellong-G, Braemswig-J-H, Hoernig-Franz-I. University Childrens Hospital, Department of Haematology and Oncology, Muenster, Germany. Pediatric Oncology Group. Treatment of children with Hodgkin's disease-results of the German Pediatric Oncology Group. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, {Ann-Oncol}... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34830 |
| Study title: Schellong-G, Braemswig-J-H, Schwarze-E-W, Wannenmacher-M. Children's Hospital University of Muenster, FRG. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies. Bulletin du cancer, {Bull-Cancer}, 1988, vol. 75, no. 1, p. 41-51,Schellong-G, Braemswig-J-H, Schwarze-E-W, Wannenmacher-M. Children's Hospital University of Muenster, FRG. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies. Bulletin du cancer, {Bull-Cancer}, 1988, vol. 75, no. 1, p. 41-51, |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34831 |
| Study title: Schellong-G, Bramswig-J-H, Schwarze-E-W, Wannenmacher-M. Children's Hospital University of Munster, D-4400 Munster, Germany. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: The sequence of the German DAL multicenter studies. Bulletin du Cancer {BULL-CANCER}, 1988, Vol/Iss/Pg. 75/1 (41-51), ISSN: 0007-4551.Schellong-G, Bramswig-J-H, Schwarze-E-W, Wannenmacher-M. Children's Hospital University of Munster, D-4400 Munster, Germany. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: The sequence of the German DAL multicenter studies. Bulletin du Cancer {BULL-CANCER}, 1988, Vol/Iss/Pg. 75/1 (41-51), ISSN: 0007-4551. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34832 |
| Study title: Schellong-G, Hoernig-I, Schwarze-E-W, Wannenmacher-M. Kinderklinik, Muenster, FRG. Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, {Recent-Results-Cancer-Res}, 1989, vol. 117, p. 205-13, 7 refs, ISSN: 0080-0015.Schellong-G, Hoernig-I, Schwarze-E-W, Wannenmacher-M. Kinderklinik, Muenster, FRG. Risk factor adapted treatment of Hodgkin's lymphoma in childhood: strategies and results of three consecutive multicenter studies in the Federal Republic of Germany. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les reche... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34833 |
| Study title: Giustina A et al. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients. Acta Endocrinol (Copenh). 1991 Nov;125(5):510-7Giustina A et al. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients. Acta Endocrinol (Copenh). 1991 Nov;125(5):510-7 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35205 |
| Study title: Giustina A et al. Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin Endocrinol (Oxf). 1991 Dec;35(6):491-8Giustina A et al. Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. Clin Endocrinol (Oxf). 1991 Dec;35(6):491-8 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35204 |
| Study title: Giustina A et al. Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. J Clin Endocrinol Metab. 1990 Dec;71(6):1486-90 Giustina A et al. Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. J Clin Endocrinol Metab. 1990 Dec;71(6):1486-90 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35211 |
| Study title: Glikson M et al. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects. Fundam Appl Toxicol. 1991 Feb;16(2):288-98Glikson M et al. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects. Fundam Appl Toxicol. 1991 Feb;16(2):288-98 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35209 |
| Study title: Guzzaloni G, Grugni G, Morabito F. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children. Minerva Endocrinol. 1998 Dec;23(4):99-104Guzzaloni G, Grugni G, Morabito F. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children. Minerva Endocrinol. 1998 Dec;23(4):99-104 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35192 |
| Study title: Gyermek L. Clinical studies on the reversal of the neuromuscular blockade produced by pancuronium bromide. I. The effects of glycopyrrolate and pyridostigmine. Curr Ther Res Clin Exp. 1975 Sep;18(3):377-86Gyermek L. Clinical studies on the reversal of the neuromuscular blockade produced by pancuronium bromide. I. The effects of glycopyrrolate and pyridostigmine. Curr Ther Res Clin Exp. 1975 Sep;18(3):377-86 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35219 |
| Study title: Hanck A. Verhuetung und Behandlung der postoperativen Daratonie und anderer Formen des paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977;27:6878, 1881-4, 6887. Hanck A. Verhuetung und Behandlung der postoperativen Daratonie und anderer Formen des paralytischen Ileus mit Bepanthen Roche. Therapiewoche 1977;27:6878, 1881-4, 6887. |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35227 |
| Study title: Hepatic enzyme abnormalities in children on triple therapy for tuberbulosis - Corrigan D, Paton J. - 1999 (Pediatr Pulmonol. 27(1): 37 - 42) Hepatic enzyme abnormalities in children on triple therapy for tuberbulosis - Corrigan D, Paton J. - 1999 (Pediatr Pulmonol. 27(1): 37 - 42) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35382 |
| Study title: Intraventricular chemotherapy in neonatal meningitis - E. L. Lee et al - 1977 (J. Pediat., 91. 991 - 995) Intraventricular chemotherapy in neonatal meningitis - E. L. Lee et al - 1977 (J. Pediat., 91. 991 - 995) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35383 |
| Study title: Wilson |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): Wilson_NoPublicado.pdf |
| View full study record |
| Document reference: 48134 |
| Study title: Wirksamkeit und Vertraeglichkeit von Rytmonorm 10 mg, Dragees, bei Kindern - Ergebnisse einer multizentrischen Studie - (Efficacy and safety of Rytmonorm 10 mg sugar-coated tablets in children - Results of a multicentre study -) |
| Active substance: PROPAFENONE |
| Study summary document link (including results): propafenone-m03681.pdf |
| View full study record |
| Document reference: 35059 |
| Study title: A comparative evaluation of Diprivan (propofol) versus standard anesthetic techniques when administered for the induction and maintenance of general anesthesia in pediatric patients undergoing surgical procedures of one hour or greater duration |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46124 |
| Study title: 16. Cabrera, Garcia, MD J 1961 ; 10 : 217-220 16. Cabrera, Garcia, MD J 1961 ; 10 : 217-220 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39545 |
| Study title: 17. Carlier, Witry, Rev Med Liege 1965; 20: 461-465 17. Carlier, Witry, Rev Med Liege 1965; 20: 461-465 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39546 |
| Study title: 18. Cervova, Cs Pediat 1973; 28: 43 18. Cervova, Cs Pediat 1973; 28: 43 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39547 |
| Study title: 19. Chavarria, Lizano, Indian Pract 1967; 20: 25-29 19. Chavarria, Lizano, Indian Pract 1967; 20: 25-29 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39548 |
| Study title: 2. Adiao et al., J Philipp Med Assoc 1961; 37: 485-488 2. Adiao et al., J Philipp Med Assoc 1961; 37: 485-488 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39531 |
| Study title: 20. Cho et al., Korean J of Parasitology 1977; 2: 100-108 20. Cho et al., Korean J of Parasitology 1977; 2: 100-108 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39549 |
| Study title: 21. Davis, Am J Dis Child 1966; 112: 49-51 21. Davis, Am J Dis Child 1966; 112: 49-51 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39550 |
| Study title: 22. Desai, BMJ 1962; 2: 1583-1585 22. Desai, BMJ 1962; 2: 1583-1585 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39551 |
| Study title: 23. Eriksen, Ugeskr Laeg 1964; 126: 801-803 23. Eriksen, Ugeskr Laeg 1964; 126: 801-803 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39552 |
| Study title: 24. Fossati, Minerva Med 1964; 55: 3578-3580 24. Fossati, Minerva Med 1964; 55: 3578-3580 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39553 |
| Study title: 25. Fritz, Wiener Med Wochenschrift 1965; 115: 122-124 25. Fritz, Wiener Med Wochenschrift 1965; 115: 122-124 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39554 |
| Study title: 26. Garin, Pediatrie 1962; 17: 551-559 26. Garin, Pediatrie 1962; 17: 551-559 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39555 |
| Study title: Takamuro_ShinyakuToRinsho |
| Active substance: PROMETHAZINE AND MAGNESIUM BROMHYDRATE GLUTAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 48133 |
| Study title: 27. Giberti, Lenge, Prensa Med Arg 1961; 48: 2096-2097 27. Giberti, Lenge, Prensa Med Arg 1961; 48: 2096-2097 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39556 |
| Study title: 15. Bumbalo et al., Am J Dis Child 1960; 99: 617-621 15. Bumbalo et al., Am J Dis Child 1960; 99: 617-621 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39544 |
| Study title: 28. Grinenko et al., Med Parazitol 1970; 39: 390-391 28. Grinenko et al., Med Parazitol 1970; 39: 390-391 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39557 |
| Study title: 29. Hsieh et al., J Formosan Med Assoc 1963; 62: 373-378 29. Hsieh et al., J Formosan Med Assoc 1963; 62: 373-378 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39558 |
| Study title: Poeta G. Rass Dermatol Sifilogr 1980;33:29-34 . Therapeutic use of methisoprinol in the treatment of herpes virus infectionsPoeta G. Rass Dermatol Sifilogr 1980;33:29-34 . Therapeutic use of methisoprinol in the treatment of herpes virus infections |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30157 |
| Study title: Precchia et al. Chemioterapia Antimicrobia [Italy] Jan 1981 4 (1): 64 -69 Methisoprinol in the therapy of viral diseases: preliminary data relative to a set of diseasesPrecchia et al. Chemioterapia Antimicrobia [Italy] Jan 1981 4 (1): 64 -69 Methisoprinol in the therapy of viral diseases: preliminary data relative to a set of diseases |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30159 |
| Study title: Precchia et al. Methisoprinol in the therapy of viral diseases: preliminary data relative to a set of diseases Chemioterapia Antimicrobia [Italy] Jan 1981 4 (1): 64 -69, 32 patients, 2 months – 10 years, 500 mg tablet Precchia et al. Methisoprinol in the therapy of viral diseases: preliminary data relative to a set of diseases Chemioterapia Antimicrobia [Italy] Jan 1981 4 (1): 64 -69, 32 patients, 2 months – 10 years, 500 mg tablet |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30160 |
| Study title: Robert J, Ghipponi J, Guerrier G, Noiret A, Springer G, Carron R. Gazette Medicale [original in French]. 1987; 94(45):60-62. Prevention of recurrent respiratory infections in children with [use of] Isoprinosine®Robert J, Ghipponi J, Guerrier G, Noiret A, Springer G, Carron R. Gazette Medicale [original in French]. 1987; 94(45):60-62. Prevention of recurrent respiratory infections in children with [use of] Isoprinosine® |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30161 |
| Study title: Rouis BO, HamzaM, Doumbe P Laboratoires Delande; Paris 1987. Clinical Study Report Double-blind, placebo-controlled study of Isoprinosine for the treatment of severe or complicated measles.Rouis BO, HamzaM, Doumbe P Laboratoires Delande; Paris 1987. Clinical Study Report Double-blind, placebo-controlled study of Isoprinosine for the treatment of severe or complicated measles. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30162 |
| Study title: Salas MA, Rossotti N et al. Orient Med 1972;21:551-555. Treatment of some pediatric viral infections with IsoprinosineSalas MA, Rossotti N et al. Orient Med 1972;21:551-555. Treatment of some pediatric viral infections with Isoprinosine |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30163 |
| Study title: Santangelo G, Lombardo S, Randazzo S, Maccarrone N, Amato M. Aggiornamento Pediatrico; 1981; 32:1-24. Viruxan® in the treatment of viral infections in children. Therapeutic prospects for the treatment of recurrent viral infections in infants.Santangelo G, Lombardo S, Randazzo S, Maccarrone N, Amato M. Aggiornamento Pediatrico; 1981; 32:1-24. Viruxan® in the treatment of viral infections in children. Therapeutic prospects for the treatment of recurrent viral infections in infants. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30164 |
| Study title: Schaison, AG. (1977) [in French]. In: Journal Officiel du Hpital Saint-Louis, Paris. May 6. Expert Clinical Report. Isoprinosine in the immunodepressed patient: discussion of the results of a clinical study on the effectiveness conducted in a leukemia treatment centerSchaison, AG. (1977) [in French]. In: Journal Officiel du Hpital Saint-Louis, Paris. May 6. Expert Clinical Report. Isoprinosine in the immunodepressed patient: discussion of the results of a clinical study on the effectiveness conducted in a leukemia treatment center |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30165 |
| Study title: Serdaroglu A, Gucuyener K, Dursun I, Aydin K, Okuyaz C, Subasi M, Or M, Ozkan B. Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):405-10. Macular retinitis as a first sign of subacute sclerosing panencephalitis: the importance of early diagnosisSerdaroglu A, Gucuyener K, Dursun I, Aydin K, Okuyaz C, Subasi M, Or M, Ozkan B. Ocul Immunol Inflamm. 2005 Sep-Oct;13(5):405-10. Macular retinitis as a first sign of subacute sclerosing panencephalitis: the importance of early diagnosis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30166 |
| Study title: Sobczyk W, Kulczycki J, Pilkowska E, Iwinska B, Milewska D, Szmigielski S. Neurol Neurochir Pol. 1991 Sep-Oct;25(5):626-33. Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparationsSobczyk W, Kulczycki J, Pilkowska E, Iwinska B, Milewska D, Szmigielski S. Neurol Neurochir Pol. 1991 Sep-Oct;25(5):626-33. Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30167 |
| Study title: Sobczyk W, Pilkowska E, Iwinska-Buksowicz B, Jakubowska T. Neurol Neurochir Pol. 1997 Nov-Dec;31(6):1147-56. Polish. Assessment of early treatment results with antineoplaston AS2-1 in subacute sclerosing PanencephalitisSobczyk W, Pilkowska E, Iwinska-Buksowicz B, Jakubowska T. Neurol Neurochir Pol. 1997 Nov-Dec;31(6):1147-56. Polish. Assessment of early treatment results with antineoplaston AS2-1 in subacute sclerosing Panencephalitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30168 |
| Study title: J Radiol. 1999 Jul;80(7):727-32. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study] [Article in French] Roriz R, de Gevigney G, Finet G, Nantois-Collet C, Borch KW, Amiel M, Beaune J. J Radiol. 1999 Jul;80(7):727-32. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study] [Article in French] Roriz R, de Gevigney G, Finet G, Nantois-Collet C, Borch KW, Amiel M, Beaune J. |
| Active substance: IODIXANOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30350 |
| Study title: Kryst L, Kowalik S, Barthowski S, Henning g: Multicenter comparative clinical trial of the treatment of alveolitis after tooth extraction with Solcoseryl Dental Adhesive Paste and Apernyl. Czas. Stomat. 1990, 43, 334-341 Kryst L, Kowalik S, Barthowski S, Henning g: Multicenter comparative clinical trial of the treatment of alveolitis after tooth extraction with Solcoseryl Dental Adhesive Paste and Apernyl. Czas. Stomat. 1990, 43, 334-341 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35091 |
| Study title: Krystkowa M. Krystyna; Hydzikowa Marta: Application of Solcoseryl eye-gel in the treatment of certain corneal and conjunctival disease. Transl. from Klin. Ozna (Warszawa) 86, 457-495 (1985) Krystkowa M. Krystyna; Hydzikowa Marta: Application of Solcoseryl eye-gel in the treatment of certain corneal and conjunctival disease. Transl. from Klin. Ozna (Warszawa) 86, 457-495 (1985) |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35101 |
| Study title: "Marichy J. et al: The wound healing efffect of Solcoseyl oinment in the treatment of children with burns. Acta Therap. Brussels 10, 107-117 (1984) " "Marichy J. et al: The wound healing efffect of Solcoseyl oinment in the treatment of children with burns. Acta Therap. Brussels 10, 107-117 (1984) " |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35095 |
| Study title: Menna F., Napolitano F.: The application of Cysteine gel and Solcoseryl eye gel in different corneal diseases. Proceedings of the IVth World Congress of Ergophtalmology, Italy, May, 1985. Editor: Gennaro G, Naples. Menna F., Napolitano F.: The application of Cysteine gel and Solcoseryl eye gel in different corneal diseases. Proceedings of the IVth World Congress of Ergophtalmology, Italy, May, 1985. Editor: Gennaro G, Naples. |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35105 |
| Study title: Metah D: Treatment of lesions of the oral mucosa with Solcoseryl Dental Adhesive Paste. Zahnärztliche Praxis, 1987; 38 (4) 137-139 " Metah D: Treatment of lesions of the oral mucosa with Solcoseryl Dental Adhesive Paste. Zahnärztliche Praxis, 1987; 38 (4) 137-139 " |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35097 |
| Study title: Nakova N, Belazelkaska Z, Bogdanovski I, Glavas E: SDAP for the treatment of chronic recurrent aphthous stomatitis and decubital ulcers in the buccal cavity. Accepted for publication by serbian Dental Journal 1, 1991 Nakova N, Belazelkaska Z, Bogdanovski I, Glavas E: SDAP for the treatment of chronic recurrent aphthous stomatitis and decubital ulcers in the buccal cavity. Accepted for publication by serbian Dental Journal 1, 1991 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35098 |
| Study title: Osamu Maki: Clinical use of Solcoseryl Eeye-gel in anterior ocular diseases. Jap. Rev.clin. Ophtal. 63, 488-489, (1968) Osamu Maki: Clinical use of Solcoseryl Eeye-gel in anterior ocular diseases. Jap. Rev.clin. Ophtal. 63, 488-489, (1968) |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35100 |
| Study title: Popov N: Solcoseryl Dental Adhesive Paste - Results of a clinical investigation and its use with oral implants. Stomatologija 1988, 6, 47-50 Popov N: Solcoseryl Dental Adhesive Paste - Results of a clinical investigation and its use with oral implants. Stomatologija 1988, 6, 47-50 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35088 |
| Study title: La Rifamycine SV dans les infections pulmonaires aigüe en pédiatrie - M. De Vriendt - 1967 (Brux. Méd., 47. 169 - 181) La Rifamycine SV dans les infections pulmonaires aigüe en pédiatrie - M. De Vriendt - 1967 (Brux. Méd., 47. 169 - 181) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35384 |
| Study title: Valoracion de la Rifamicina SV en la practica pediatrica - O. Turro et al - 1965 (Sem. Med., 127. 239 - 241.) Valoracion de la Rifamicina SV en la practica pediatrica - O. Turro et al - 1965 (Sem. Med., 127. 239 - 241.) |
| Active substance: RIFAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35385 |
| Study title: Beseghi; Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children; European Review for Medical and Pharmacological SciencesBeseghi; Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children; European Review for Medical and Pharmacological Sciences |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): rifaximin-article-Beseghi.pdf |
| View full study record |
| Document reference: 47563 |
| Study title: Curr Med Res Opin. 1997;14(1):39-45. An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea. Frisari L, Viggiano V, Pelagalli M. Curr Med Res Opin. 1997;14(1):39-45. An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea. Frisari L, Viggiano V, Pelagalli M. |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): 2011-05-20-Clin Dat Results-Alfa Wassermann.xls |
| View full study record |
| Document reference: 47566 |
| Study title: De Castro; RIFAXIMIN TREATMENT FOR ACUTE RECURRENT DIARRHEA IN CHILDREN WITH GENITOURINARY DISORDERSDe Castro; RIFAXIMIN TREATMENT FOR ACUTE RECURRENT DIARRHEA IN CHILDREN WITH GENITOURINARY DISORDERS |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): rifaximin-article-De Castro.pdf |
| View full study record |
| Document reference: 47564 |
| Study title: Muniyappa; Use of Rifaximin in Pediatric Patients with Inflammatory Bowel DiseaseMuniyappa; Use of Rifaximin in Pediatric Patients with Inflammatory Bowel Disease |
| Active substance: RIFAXIMIN |
| Study summary document link (including results): rifaximin-article-Muniyappa.pdf |
| View full study record |
| Document reference: 47565 |
| Study title: Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Arch Ophthalmol. 2003 Dec;121(12):1716-21.Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Arch Ophthalmol. 2003 Dec;121(12):1716-21. |
| Active substance: RIMEXOLONE |
| Study summary document link (including results): Ocular-hypertensive and anti-inflammatory response to rimexo.pdf |
| View full study record |
| Document reference: 35387 |
| Study title: A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study of One year Duration Followed by 2 Years of Open-label Treatment to Determine the Safety and Efficacy of Orally Administered 2.5 mg or 5.0 mg Daily Risedronate, in Children ≥ 4 to < 16 Years Old with Osteogenesis Imperfecta |
| Active substance: RISEDRONIC ACID |
| Study summary document link (including results): Risedronate sodium - Study 1.pdf |
| View full study record |
| Document reference: 35389 |
| Study title: Muriel-F-S, Roca-Garcia-C, Schwartz-L, et-al. Grupo Argentino Tratam. Leucem. Aguda, Buenos Aires, Argentina. Comparison of two consecutive trials for treatment of childhood non-Hodgkin lymphoma. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (778).Muriel-F-S, Roca-Garcia-C, Schwartz-L, et-al. Grupo Argentino Tratam. Leucem. Aguda, Buenos Aires, Argentina. Comparison of two consecutive trials for treatment of childhood non-Hodgkin lymphoma. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (778). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34788 |
| Study title: 30. Kleinschmidt, Med Welt 1963; 14: 377-379 30. Kleinschmidt, Med Welt 1963; 14: 377-379 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39559 |
| Study title: 31. Kluska, Tzegota, Wiad Parazytol 1965; 11: 619-620 31. Kluska, Tzegota, Wiad Parazytol 1965; 11: 619-620 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39560 |
| Study title: 32. Marzullo, Squadrini, G Mal Infett Parassit 1963; 15: 465-467 32. Marzullo, Squadrini, G Mal Infett Parassit 1963; 15: 465-467 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39561 |
| Study title: 33. Milosavljevic, Lambrechts, Rev Med Liege 1964; 19: 449-452 33. Milosavljevic, Lambrechts, Rev Med Liege 1964; 19: 449-452 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39562 |
| Study title: 34. Molla, Donald, J Int Med Res 1977; 5: 136-138 34. Molla, Donald, J Int Med Res 1977; 5: 136-138 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39563 |
| Study title: Garaventa-A, Haupt-R, Panarello-C, Dodero-P, Gambini-C, Gambaro-M. Department of Pediatric Haematology/Oncology, G. Gaslini Children's Hospital, Genova, Italy. Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Mar 2001, vol. 36, no. 3, p. 396-7, ISSN: 0098-1532.Garaventa-A, Haupt-R, Panarello-C, Dodero-P, Gambini-C, Gambaro-M. Department of Pediatric Haematology/Oncology, G. Gaslini Children's Hospital, Genova, Italy. Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Mar 2001, vol. 36, no. 3, p. 396-7, ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34715 |
| Study title: Garber-J-E. Dana-Farber Cancer Institute, Boston, MA 02115, United States. Long-term follow-up of children exposed in utero to antineoplastic agents. Seminars in Oncology {SEMIN-ONCOL}, 1989, Vol/Iss/Pg. 16/5 (437-444). ISSN: 0093-7754.Garber-J-E. Dana-Farber Cancer Institute, Boston, MA 02115, United States. Long-term follow-up of children exposed in utero to antineoplastic agents. Seminars in Oncology {SEMIN-ONCOL}, 1989, Vol/Iss/Pg. 16/5 (437-444). ISSN: 0093-7754. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34716 |
| Study title: Gentet-J-C, Bouffet-E, Doz-F, Tron-P, Roche-H, Thyss-A, Plantaz-D, Stephan-J-L, Mottolese-C, Ponvert-D, Carrie-C, Raybaud-C, Brunat-Mentigny-M, Choux-M, Philip-T, Zucker-J-M, Bernard-J-L. Service d'Oncologie Pediatrique, Hopital d'Enfants de la Timone,13385 Marseille Cedex 5, France. Preirradiation chemotherapy including 'eight drugs in 1 day' regimen and high-dose methotrexate in childhood medulloblastoma: Results of the M7 French Cooperative Study. Journal of Neurosurgery {J-NEUROSURG}, 1995, Vol/Iss/Pg. 82/4 (608-614), ISSN: 0022-3085.Gentet-J-C, Bouffet-E, Doz-F, Tron-P, Roche-H, Thyss-A, Plantaz-D, Stephan-J-L, Mottolese-C, Ponvert-D, Carrie-C, Raybaud-C, Brunat-Mentigny-M, Choux-M, Philip-T, Zucker-J-M, Bernard-J-L. Service d'Oncologie Pediatrique, Hopital... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34717 |
| Study title: Geyer-J-R, Finlay-J-L, Boyett-J-M, Wisoff-J, Yates-A, Mao-L, Packer-R-J. Publications Office, Childrens Cancer Group, P.O. Box 60012, Arcadia, CA 91066-6012, United States. Survival of infants with malignant astrocytomas: A report from the Childrens Cancer Group. Cancer {CANCER}, 1995, Vol/Iss/Pg. 75/4 (1045-1050), ISSN: 0008-543X.Geyer-J-R, Finlay-J-L, Boyett-J-M, Wisoff-J, Yates-A, Mao-L, Packer-R-J. Publications Office, Childrens Cancer Group, P.O. Box 60012, Arcadia, CA 91066-6012, United States. Survival of infants with malignant astrocytomas: A report from the Childrens Cancer Group. Cancer {CANCER}, 1995, Vol/Iss/Pg. 75/4 (1045-1050), ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34718 |
| Study title: Iodine-supplementation trials;Peter OD Pharoah. Am J Clin Nutr Suppl 1993;57:276S-9S. Iodine-supplementation trials;Peter OD Pharoah. Am J Clin Nutr Suppl 1993;57:276S-9S. |
| Active substance: IODINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30274 |
| Study title: Three Dimensional CT Angiography for Patients with Congenital Heart Disease: Scanning Protocol for Pediatric PatientsJelnin V 2006. Catheterization and Cardiovascular Interventions 67:120-126 (2006) |
| Active substance: IODIXANOL |
| Study summary document link (including results): 2011-09 GE Visipaque response List of published articles.doc |
| View full study record |
| Document reference: 48200 |
| Study title: J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT. Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA. J Nucl Med Technol. 2007 Mar;35(1):21-6.Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT. Stokkel MP, Dibbets-Schneider P, Koestering E, Dragoiescu C, Blokland KA. |
| Active substance: ioflupane (123l) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41498 |
| Study title: Neurology. 2001 Jan 23;56(2):266-7. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. O'Sullivan JD, Costa DC, Gacinovic S, Lees AJ.Neurology. 2001 Jan 23;56(2):266-7. SPECT imaging of the dopamine transporter in juvenile-onset dystonia. O'Sullivan JD, Costa DC, Gacinovic S, Lees AJ. |
| Active substance: ioflupane (123l) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41501 |
| Study title: Neurology. 2004 Dec 14;63(11):2097-103. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P. Neurology. 2004 Dec 14;63(11):2097-103. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. Varrone A, Pellecchia MT, Amboni M, Sansone V, Salvatore E, Ghezzi D, Garavaglia B, Brice A, Brunetti A, Bonavita V, De Michele G, Salvatore M, Pappatà S, Barone P. |
| Active substance: ioflupane (123l) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41499 |
| Study title: Double-blind comparative study of Ultravist, Solutrast and Omnipaque in excretory urography in children |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30357 |
| Study title: Transplacental passage in rats and rabbits |
| Active substance: CICLOSPORIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24112 |
| Study title: Acta Radiol Diagn (Stockh). 1984;25(2):155-8 Iohexol and metrizoate in urography in children. Comparison between a non-ionic and an ionic contrast medium. Bolz KD, Skalpe IO, Gutteberg TJ Acta Radiol Diagn (Stockh). 1984;25(2):155-8 Iohexol and metrizoate in urography in children. Comparison between a non-ionic and an ionic contrast medium. Bolz KD, Skalpe IO, Gutteberg TJ |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30358 |
| Study title: Acta Radiol Suppl. 1983;366:126-33 Non-ionic contrast media in cardioangiography in infants. A comparison of iohexol and metrizamide. Hellström M, Jacobsson B, Eriksson BO, Jagenburg R Acta Radiol Suppl. 1983;366:126-33 Non-ionic contrast media in cardioangiography in infants. A comparison of iohexol and metrizamide. Hellström M, Jacobsson B, Eriksson BO, Jagenburg R |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30359 |
| Study title: Acta Radiol Suppl. 1983;366:25-9 Iohexol in urography. Survey and present state. Ekelund L. Acta Radiol Suppl. 1983;366:25-9 Iohexol in urography. Survey and present state. Ekelund L. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30360 |
| Study title: Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T Acta Radiol. 1989 Nov-Dec;30(6):643-6 Influence of urography on renal function in children. A double blind study with metrizoate and iohexol. Stake G, Monn E, Rootwelt K, Golman K, Monclair T |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30361 |
| Study title: EMLA: an aid to suture removal following cleft lip repair. |
| Active substance: LIDOCAINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31218 |
| Study title: Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426)Dose-dependant Resoption of quinine after intrarectal administration to children with moderate Plasmodium falciparum Malaria - Eric Pussard et al. - 11/2004 (Antimicrobial agents and Chimiotherapy;vol. 48,No. 11:4422-4426) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45080 |
| Study title: Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152)Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45061 |
| Study title: Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152)Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45066 |
| Study title: Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152)Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45071 |
| Study title: Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152)Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45076 |
| Study title: Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152)Pilot feasibility study of an emergency paediatric kit for intra-rectal quinine administration used by the personnel of community-based health care units in Senegal - A Ndiaye Jean-Louis - 15/11/2007 (Malaria Journal, 6:152) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45081 |
| Study title: Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45)Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45062 |
| Study title: Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45)Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45067 |
| Study title: Muwakkit-S, Geara-F, Nabbout-B, Farah-R-A, Shabb-N-S, Hajjar-T, Khogali-M. Department of Pediatrics, American University of Beirut Medical Center, Lebanon. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. Radiation oncology investigations, {Radiat-Oncol-Investig}, 1999, vol. 7, no. 6, p. 365-73, ISSN: 1065-7541.Muwakkit-S, Geara-F, Nabbout-B, Farah-R-A, Shabb-N-S, Hajjar-T, Khogali-M. Department of Pediatrics, American University of Beirut Medical Center, Lebanon. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. Radiation oncology investigations, {Radiat-Oncol-Investig}, 1999, vol. 7, no. 6, p. 365-73, ISSN: 1065-7541. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34789 |
| Study title: Neidhardt-M-K. I Kinderklinik, Augsburg, Germany. Treatment of medulloblastoma in children: Results and conclusions. Wiener Medizinische Wochenschrift {WIEN-MED-WOCHENSCHR}, 1983, Vol /Iss/Pg. 133/SUPPL. 78 (39-45).Neidhardt-M-K. I Kinderklinik, Augsburg, Germany. Treatment of medulloblastoma in children: Results and conclusions. Wiener Medizinische Wochenschrift {WIEN-MED-WOCHENSCHR}, 1983, Vol /Iss/Pg. 133/SUPPL. 78 (39-45). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34792 |
| Study title: Neidhardt-M, Bailey-C-C, Gnekow-A, Kleihues-P, Michaelis-J, Wellek-S. (Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Societe Internationale d'Oncologie Pediatrique (SIOP)). Klinische Paediatrie {Klin-Padiatr} 1987 May-Jun, VOL: 199 (3), P: 188-92, ISSN: 0300-8630.Neidhardt-M, Bailey-C-C, Gnekow-A, Kleihues-P, Michaelis-J, Wellek-S. (Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Societe Internationale d'Oncologie Pediatrique (SIOP)). Klinische Paediatrie {Klin-Padiatr} 1987 May-Jun, VOL: 199 (3), P: 188-92, ISSN: 0300-8630. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34790 |
| Study title: Neidhardt-M, Habermalz-H-J, Henze-G, Langermann-H-J. (Medulloblastoma study of the German Society for Pediatric Oncology, a first report). Klinische Paediatrie {Klin-Padiatr} 1982 Jul-Aug, VOL: 194 (4), P: 257-61, ISSN: 0300-8630.Neidhardt-M, Habermalz-H-J, Henze-G, Langermann-H-J. (Medulloblastoma study of the German Society for Pediatric Oncology, a first report). Klinische Paediatrie {Klin-Padiatr} 1982 Jul-Aug, VOL: 194 (4), P: 257-61, ISSN: 0300-8630. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34791 |
| Study title: Oberlin-O, Habrand-J-L, Schaison-G, Leverger-G, Zucker-J-M, Olive-D, Lemerle-J. Departement de pediatrie, Institut Gustave-Roussy, Villejuif, France. (Hodgkin's disease in children. Current therapeutic strategies). Bulletin du cancer {Bull-Cancer} 1988, VOL: 75 (1), P: 53-60, ISSN: 0007-4551.Oberlin-O, Habrand-J-L, Schaison-G, Leverger-G, Zucker-J-M, Olive-D, Lemerle-J. Departement de pediatrie, Institut Gustave-Roussy, Villejuif, France. (Hodgkin's disease in children. Current therapeutic strategies). Bulletin du cancer {Bull-Cancer} 1988, VOL: 75 (1), P: 53-60, ISSN: 0007-4551. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34793 |
| Study title: Oberlin-O, Bayle-C, Lemerle-J. Service de Pediatrie, Institut Gustave-Roussy, 94800 Villejuif, France. Hodgkin's disease of the child. Clinical and therapeutic peculiarities. Revue du Praticien {REV-PRAT}, 1984, Vol/Iss/Pg. 34/21 (1081-1084)Oberlin-O, Bayle-C, Lemerle-J. Service de Pediatrie, Institut Gustave-Roussy, 94800 Villejuif, France. Hodgkin's disease of the child. Clinical and therapeutic peculiarities. Revue du Praticien {REV-PRAT}, 1984, Vol/Iss/Pg. 34/21 (1081-1084) |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34794 |
| Study title: Geyer-J-R, Pendergrass-T-W, Milstein-J-M, Bleyer-W-A. Department of Pediatrics, University of Washington, Seattle, WA, United States. Eight drugs in one day chemotherapy in children with brain tumors: A critical toxicity appraisal. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1988, Vol/Iss/Pg. 6/6 (996-1000), ISSN: 0732-183X.Geyer-J-R, Pendergrass-T-W, Milstein-J-M, Bleyer-W-A. Department of Pediatrics, University of Washington, Seattle, WA, United States. Eight drugs in one day chemotherapy in children with brain tumors: A critical toxicity appraisal. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1988, Vol/Iss/Pg. 6/6 (996-1000), ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34719 |
| Study title: Prados-M, Levin-V. Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, CA 94143-0520, United States. Malignant supratentorial gliomas in childhood. Pediatric Neuroscience {PEDIATR-NEUROSCI}, 1987, Vol/Iss/Pg. 13/3 (144-151), ISSN: 0255-7975.Prados-M, Levin-V. Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, CA 94143-0520, United States. Malignant supratentorial gliomas in childhood. Pediatric Neuroscience {PEDIATR-NEUROSCI}, 1987, Vol/Iss/Pg. 13/3 (144-151), ISSN: 0255-7975. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34812 |
| Study title: Ramsay-N-K, Coccia-P-F, Krivit-W, Bloomfield-C-D, Nesbit-M-E. Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemia. Cancer treatment reports, {Cancer-Treat-Rep}, Nov 1976, vol. 60, no. 11, p. 1683-5, ISSN: 0361-5960.Ramsay-N-K, Coccia-P-F, Krivit-W, Bloomfield-C-D, Nesbit-M-E. Vinblastine, procarbazine, and cytosine arabinoside in combination for reinduction of childhood acute myelocytic leukemia. Cancer treatment reports, {Cancer-Treat-Rep}, Nov 1976, vol. 60, no. 11, p. 1683-5, ISSN: 0361-5960. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34813 |
| Study title: Rana-S-R, Haddy-T-B, Ashayeri-E, Goldson-A-L. Intraoperative radiotherapy in childhood malignant astrocytoma. Journal of the National Medical Association, {J-Natl-Med-Assoc}, Apr 1984, vol. 76, no. 4, p. 409-11, ISSN: 0027-9684.Rana-S-R, Haddy-T-B, Ashayeri-E, Goldson-A-L. Intraoperative radiotherapy in childhood malignant astrocytoma. Journal of the National Medical Association, {J-Natl-Med-Assoc}, Apr 1984, vol. 76, no. 4, p. 409-11, ISSN: 0027-9684. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34814 |
| Study title: Roettinger-E-M. (Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group). Strahlentherapie und Onkologie : Organ der Deutschen oentgengesellschaft ... (et al), {Strahlenther-Onkol}, May 1995, vol. 171, no. 5, p. 303-4, ISSN: 0179-7158.Roettinger-E-M. (Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group). Strahlentherapie und Onkologie : Organ der Deutschen oentgengesellschaft ... (et al), {Strahlenther-Onkol}, May ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34815 |
| Study title: Rosenberg-S-A, Kaplan-H-S. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. International journal of radiation oncology biology physics, {Int-J-Radiat-Oncol-Biol-Phys}, Jan 1985, vol. 11, no. 1, p. 5-22, ISSN: 0360-3016.Rosenberg-S-A, Kaplan-H-S. The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984. International journal of radiation oncology biology physics, {Int-J-Radiat-Oncol-Biol-Phys}, Jan 1985, vol. 11, no. 1, p. 5-22, ISSN: 0360-3016. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34816 |
| Study title: Cook MR et al. Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. Aviat Space Environ Med. 2001 Dec;72(12):1102-6Cook MR et al. Side effects of low-dose pyridostigmine bromide are not related to cholinesterase inhibition. Aviat Space Environ Med. 2001 Dec;72(12):1102-6 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35189 |
| Study title: van-Eys-J, Cangir-A, Pack-R, Baram-T. Department of Pediatrics, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston 77030.. Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors. Cancer treatment reports, {Cancer-Treat-Rep}, Oct 1987, vol. 71, no. 10, p. 973-4, ISSN: 0361-5960. van-Eys-J, Cangir-A, Pack-R, Baram-T. Department of Pediatrics, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston 77030.. Phase I trial of procarbazine as a 5-day continuous infusion in children with central nervous system tumors. Cancer treatment reports, {Cancer-Treat-Rep}, Oct 1987, vol. 71, no. 10, p. 973-4, ISSN: 0361-5960. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34867 |
| Study title: Andersen M et al. Evaluation of growth hormone assays using ratio plots. Clin Chem. 1998 May;44(5):1032-8 Andersen M et al. Evaluation of growth hormone assays using ratio plots. Clin Chem. 1998 May;44(5):1032-8 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35193 |
| Study title: Aquilonius SM, Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin Pharmacokinet 1986;11(3):236-49.Aquilonius SM, Hartvig P. Clinical pharmacokinetics of cholinesterase inhibitors. Clin Pharmacokinet 1986;11(3):236-49. |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35225 |
| Study title: Arvat E et al. The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome. Dementia. 1996 Sep-Oct;7(5):288-92Arvat E et al. The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome. Dementia. 1996 Sep-Oct;7(5):288-92 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35194 |
| Study title: Burke G et al. Distinct phenotypes of congenital acetylcholine receptor deficiency. Neuromuscul Disord. 2004 Jun;14(6):356-64Burke G et al. Distinct phenotypes of congenital acetylcholine receptor deficiency. Neuromuscul Disord. 2004 Jun;14(6):356-64 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35185 |
| Study title: Cappa M et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991 Jan;14(1):41-5Cappa M et al. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation. J Endocrinol Invest. 1991 Jan;14(1):41-5 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35210 |
| Study title: Coiro V et al. Age-dependent decrease in the growth hormone response to growth hormone-releasing hormone in normally cycling women. Fertil Steril. 1996 Aug;66(2):230-4Coiro V et al. Age-dependent decrease in the growth hormone response to growth hormone-releasing hormone in normally cycling women. Fertil Steril. 1996 Aug;66(2):230-4 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35195 |
| Study title: Cook JE, Kolka MA, Wenger CB. Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment. Mil Med. 1992 May;157(5):250-4 Cook JE, Kolka MA, Wenger CB. Chronic pyridostigmine bromide administration: side effects among soldiers working in a desert environment. Mil Med. 1992 May;157(5):250-4 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35202 |
| Study title: Cook MR et al. Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Psychopharmacology (Berl). 2002 Jul;162(2):186-92Cook MR et al. Physiological and performance effects of pyridostigmine bromide in healthy volunteers: a dose-response study. Psychopharmacology (Berl). 2002 Jul;162(2):186-92 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35188 |
| Study title: Hegewald-G, Reddemann-H, Barenwald-G, Schwanengel-H. Pathol. Inst., Ernst-Moritz-Arndt-Univ., 2200 Greifswald, Germany. Ultrastructural findings in the liver of children survived a long time after antineoplatic polychemotherapy. Archiv fur Geschwulstforschung {ARCH-GESCHWULSTFORSCH}, 1982, Vol/Iss /Pg. 52/5 (397-405).Hegewald-G, Reddemann-H, Barenwald-G, Schwanengel-H. Pathol. Inst., Ernst-Moritz-Arndt-Univ., 2200 Greifswald, Germany. Ultrastructural findings in the liver of children survived a long time after antineoplatic polychemotherapy. Archiv fur Geschwulstforschung {ARCH-GESCHWULSTFORSCH}, 1982, Vol/Iss /Pg. 52/5 (397-405). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34738 |
| Study title: Heikens-J, Behrendt-H, Adriaanse-R, Berghout-A. Department of Internal Medicine, University of Amsterdam, The Netherlands. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer, {Cancer}, 1 Nov 1996, vol. 78, no. 9, p. 2020-4, ISSN 0008-543X.Heikens-J, Behrendt-H, Adriaanse-R, Berghout-A. Department of Internal Medicine, University of Amsterdam, The Netherlands. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer, {Cancer}, 1 Nov 1996, vol. 78, no. 9, p. 2020-4, ISSN 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34739 |
| Study title: Horowitz-M-E, Mulhern-R-K, Kun-L-E, Kovnar-E, Sanford-R-A, Simmons-J, Hayes-F-A, Jenkins-III-J-J. Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States. Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment. Cancer {CANCER}, 1988, Vol/Iss/Pg. 61/3 (428-434), ISSN: 0008-543X.Horowitz-M-E, Mulhern-R-K, Kun-L-E, Kovnar-E, Sanford-R-A, Simmons-J, Hayes-F-A, Jenkins-III-J-J. Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN, United States. Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment. Cancer {CANCER}, 1988, Vol/Iss/Pg. 61/3 (428-434), ISSN: 0008-543X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34740 |
| Study title: Hudson-M-M, Greenwald-C, Thompson-E, Wilimas-J, Marina-N, Fairclough- D, Kauffman-W, Bozeman-P, Mackert-P-W, Abromowitch-M, Jenkins-J, Boulden-T, Kun-L. Department of Hematology-Oncology, St Jude Children's Research Hospital, PO Box 318, Memphis, TN 38101, United States. Efficacy and toxicity of multiagent chemotherapy and low-dose involved- field radiotherapy in children and adolescents with Hodgkin's disease. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1993, Vol/Iss/Pg. 11/1 (100-108), ISSN: 0732-183X.Hudson-M-M, Greenwald-C, Thompson-E, Wilimas-J, Marina-N, Fairclough- D, Kauffman-W, Bozeman-P, Mackert-P-W, Abromowitch-M, Jenkins-J, Boulden-T, Kun-L. Department of Hematology-Oncology, St Jude Children's Research Hospital, PO Box 318, Memphis... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34741 |
| Study title: Huma-Z, Boulad-F, Black-P, Heller-G, Sklar-C. Department of Pediatrics, Memorial Sloan-Kettering Cancer Ctr., 1275 York Ave, New York, NY 10021, United States. Growth in children after bone marrow transplantation for acute leukemia. Blood {BLOOD}, 1995, Vol/Iss/Pg. 86/2 (819-824), ISSN: 0006-4971.Huma-Z, Boulad-F, Black-P, Heller-G, Sklar-C. Department of Pediatrics, Memorial Sloan-Kettering Cancer Ctr., 1275 York Ave, New York, NY 10021, United States. Growth in children after bone marrow transplantation for acute leukemia. Blood {BLOOD}, 1995, Vol/Iss/Pg. 86/2 (819-824), ISSN: 0006-4971. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34742 |
| Study title: Zeltzer-L-K, LeBaron-S, Zeltzer-P-M. Department of Pediatrics, The University of Texas Health Science Center, San Antonio, TX 78284, United States. A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer. American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR-HEMATOL-ONCOL}, 1984, Vol/Iss/Pg. 6/1 (5-16).Zeltzer-L-K, LeBaron-S, Zeltzer-P-M. Department of Pediatrics, The University of Texas Health Science Center, San Antonio, TX 78284, United States. A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer. American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR-HEMATOL-ONCOL}, 1984, Vol/Iss/Pg. 6/1 (5-16). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34882 |
| Study title: Zeltzer-L, LeBaron-S, Zeltzer-P-M. Division of Adolescent Medicine, Department of Pediatrics, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78284, United States. The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. Journal of Clinical Oncology {J-CLIN-ONCOL}, 1984, Vol/Iss/Pg. 2/6 (683-690).Zeltzer-L, LeBaron-S, Zeltzer-P-M. Division of Adolescent Medicine, Department of Pediatrics, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78284, United States. The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. Journal of Clinical Oncolo... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34881 |
| Study title: Zolezzi-P, Rubio-J, Cardemil-B, Born-R, Moraleda-L, Ramos-M-I, Albornoz-C, Amigo-O, Kyling-A, Badilla-V, et al. Instituto de Hematologia, Facultad de Medicina, Universidad Austral de Chile. (Hodgkin's disease in children. Modified COPP combined treatment and radiotherapy in advanced stages). Revista chilena de pediatria {Rev-Chil-Pediatr} 1990 Mar-Apr, VOL: 61 (2), P: 74-6, ISSN: 0370-4106.Zolezzi-P, Rubio-J, Cardemil-B, Born-R, Moraleda-L, Ramos-M-I, Albornoz-C, Amigo-O, Kyling-A, Badilla-V, et al. Instituto de Hematologia, Facultad de Medicina, Universidad Austral de Chile. (Hodgkin's disease in children. Modified COPP combined treatment and radiotherapy in advanced stages). Revista chilena de pediatria {Rev-Chil-Pediatr} 1990 Mar-Apr, VOL: 61 (2), P: 74-6, ISSN: 0... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34883 |
| Study title: "Publication mentioned in CES made available in 2007 for national renewals: Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. L.L. Dupuis, P.C. Nathan, Paediatric drugs 2003; 5(9): 597-613." "Publication mentioned in CES made available in 2007 for national renewals: Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. L.L. Dupuis, P.C. Nathan, Paediatric drugs 2003; 5(9): 597-613." |
| Active substance: PROCHLOPERAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34969 |
| Study title: Clinical Report - Ph. VERIN - 06.11.1973 |
| Active substance: PROCYANIDOLIC OLIGOMERS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40140 |
| Study title: Efficacité et tolérance du progabide (SL 76.002) dans les syndromes spastiques d'origine cérébrale chez des enfants, adolescents, jeunes adultes - Ferriere G. - 04/1981 |
| Active substance: PROGABIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34972 |
| Study title: "Quality of life and micronised progesterone (200 mg) in adolescent menstrual cycle disorders" |
| Active substance: PROGESTERONE |
| Study summary document link (including results): EUdraCT_reduced datafields for Interim publication_Besins.xls |
| View full study record |
| Document reference: 34993 |
| Study title: Double-blind randomized comparison of proglumetacin and naproxen sodium in the treatment of patients with ankle sprains [Current Therapeutic Research 1995, 56(7): 639-48].Double-blind randomized comparison of proglumetacin and naproxen sodium in the treatment of patients with ankle sprains [Current Therapeutic Research 1995, 56(7): 639-48]. |
| Active substance: PROGLUMETACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34995 |
| Study title: Rosenthal-J, Arush-M-W-B, Kuten-A, Arie-J-B, Shahar-M-B, Robinson-E. Pediatric Oncology Unit, Rambam Medical Center, Haifa 31096, Israel. Hodgkin's disease in childhood: Treatment modalities, outcome and epidemiological aspects: The Northern Israel Cancer Center experience. American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR- HEMATOL-ONCOL}, 1994, Vol/Iss/Pg. 16/2 (138-142), ISSN: 0192-8562.Rosenthal-J, Arush-M-W-B, Kuten-A, Arie-J-B, Shahar-M-B, Robinson-E. Pediatric Oncology Unit, Rambam Medical Center, Haifa 31096, Israel. Hodgkin's disease in childhood: Treatment modalities, outcome and epidemiological aspects: The Northern Israel Cancer Center experience. American Journal of Pediatric Hematology/Oncology {AM-J-PEDIATR- HEMATOL-ONC... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34817 |
| Study title: A comparative evaluation of Diprivan /Diprivan N20 versus thiopental/halothane/N20 versus Diprivan/Diprivan when administered for the induction and maintenance of general anesthesia in pedaitric patients undergoing general surgical procedures of one hour or greater duration |
| Active substance: PROPOFOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46125 |
| Study title: A comparison of Diprivan (propofol) and thiopentone for induction of anaesthesia in children. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0208 Study Synopsis.pdf |
| View full study record |
| Document reference: 46131 |
| Study title: A comparison of the characteristics of propofol and methohexitone for induction and maintenance of anaesthesia in children. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0248 Study Synopsis.pdf |
| View full study record |
| Document reference: 46134 |
| Study title: A comparison of the characteristics of propofol and thiopentone for induction of general anaesthesia for paediatric surgery. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0186 Study Synopsis.pdf |
| View full study record |
| Document reference: 46129 |
| Study title: A comparison of venous tolerability and injection pain of Propofol diluted in a lipid emulsion and standard Propofol in the induction of anesthesia in children |
| Active substance: PROPOFOL |
| Study summary document link (including results): BBM0201-09_ICH-280306_FINAL-VERSION.pdf |
| View full study record |
| Document reference: 47084 |
| Study title: A multicenter, comparative, randomized trial to determine the overall safety and efficacy of 1% Diprivan vs 2% Diprivan vs standard agents without disodium edetate for sedation of trauma, postsurgical, or critically ill paediatric subjects. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 0859IL0068 Study Synopsis.pdf |
| View full study record |
| Document reference: 46137 |
| Study title: A preliminary evaluation of the characteristics of propofol (Diprivan) for induction of general anaesthesia for paediatric surgery. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0141 Study Synopsis.pdf |
| View full study record |
| Document reference: 46128 |
| Study title: A study to assess the pharmacokinetics of propofol in young children after a single dose for induction of anaesthesia. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0243 Study Synopsis.pdf |
| View full study record |
| Document reference: 46130 |
| Study title: Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab. 1989 Feb;68(2):290-39 Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab. 1989 Feb;68(2):290-39 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35215 |
| Study title: Corrias A et al. GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. J Endocrinol Invest. April 20, 2000, 84-9Corrias A et al. GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. J Endocrinol Invest. April 20, 2000, 84-9 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35181 |
| Study title: Remifentanil/Propofol versus Desflurane/N2O in general surgery, opthalmic surgery and ENT surgery in children |
| Active substance: REMIFENTANIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35286 |
| Study title: Remifentanil/propofol versus remifentanil/sevoflurane in- and outpatient paediatric surgery |
| Active substance: REMIFENTANIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35288 |
| Study title: Remifentanil/Propofol versus Sevofluran/N2O für allgemeinchirurgische und HNO-Eingriffe bei Kindern: Ein Vergleich der Hämodynamik, des Einschlaf- und Aufwachverhaltens sowie der anästhesierelevanten Zeiten |
| Active substance: REMIFENTANIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35287 |
| Study title: Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985 |
| Active substance: RETINOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35292 |
| Study title: A randomised controlled trial comparing low molecular weight heparin (reviparin sodium) to standard of practice unfractionated heparin plus a vitamin K antagonist for the treatment of venous thromboembolism in a pediatric patient population. |
| Active substance: REVIPARIN |
| Study summary document link (including results): Reviparin-CL052.pdf |
| View full study record |
| Document reference: 45107 |
| Study title: An open-label dose-finding trial of low molecular weight heparin LU 47311 (Clivarine®) for the prophylaxis of deep vein thrombosis/pulmonary embolism in children with short term placement of central venous catheters. |
| Active substance: REVIPARIN |
| Study summary document link (including results): Reviparin-CL057.pdf |
| View full study record |
| Document reference: 35289 |
| Study title: An open-label, dose-finding trial of low molecular weight heparin (Clivarine®) for the treatment of deep vein thrombosis/pulmonary embolism in a pediatric patient population. |
| Active substance: REVIPARIN |
| Study summary document link (including results): Reviparin-CL022.pdf |
| View full study record |
| Document reference: 35291 |
| Study title: An open-label, multicenter, randomized trial comparing low molecular weight heparin (reviparin) to standard of care for the prophylaxis of deep vein thrombosis/pulmonary embolism in children with short term placement of central venous catheters. |
| Active substance: REVIPARIN |
| Study summary document link (including results): Reviparin-CL055.pdf |
| View full study record |
| Document reference: 35290 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Rheuma-Heel (tablets) [AWB-AT] |
| Active substance: Rheuma-Heel/ Rhumeel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40154 |
| Study title: Sobczyk W, Pilkowska E, Iwinska-Buksowicz B. Neurol Neurochir Pol. 1999 Jul-Aug;33(4):797-805. The evaluation of the use of antineoplaston AS2-1 treatment in subacute sclerosing panencephalitisSobczyk W, Pilkowska E, Iwinska-Buksowicz B. Neurol Neurochir Pol. 1999 Jul-Aug;33(4):797-805. The evaluation of the use of antineoplaston AS2-1 treatment in subacute sclerosing panencephalitis |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30169 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Rhododendroneel S (drops) [AWB-AT] |
| Active substance: Rhododendroneel/ Rhododendroneel S |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40153 |
| Study title: Dr Martinez (publication 20-30 years ago in neonates) 15 infants aged from 9 days to 1 year old 1973Dr Martinez (publication 20-30 years ago in neonates) 15 infants aged from 9 days to 1 year old 1973 |
| Active substance: RHUBARB AND SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35293 |
| Study title: Schellong-G, Poetter-R, Braemswig-J, Wagner-W, Prott-F-J, Doerffel-W, Koerholz-D, Mann-G, Rath-B, Reiter-A, Weissbach-G, Riepenhausen-M, Thiemann-M, Schwarze-E-W. Department of Pediatric Hematology and Oncology, University Children's Hospital, Germany. schellon@uni-muenster.de. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German- Austrian Pediatric Hodgkin's Disease Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Dec 1999, vol. 17, no. 12, p. 3736-44, ISSN: 0732-183X.Schellong-G, Poetter-R, Braemswig-J, Wagner-W, Prott-F-J, Doerffel-W, Koerholz-D, Mann-G, Rath-B, Reiter-A, Weissbach-G, Riepenhausen-M, Thi... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34834 |
| Study title: Schellong-G. Department of Haematology and Oncology, University Children's Hospital, Muenster, Germany. Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group. Bailliere's clinical haematology, {Baillieres-Clin-Haematol}, Sep 1996, vol. 9, no. 3, p. 619-34, ISSN: 0950-3536.Schellong-G. Department of Haematology and Oncology, University Children's Hospital, Muenster, Germany. Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paediatric Study Group. Bailliere's clinical haematology, {Baillieres-Clin-Haematol}, Sep 1996, vol. 9, no. 3, p. 619-34, ISSN: 0950-3536. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34835 |
| Study title: Schmitt-C, Bordigoni-P, Chastagner-P, Galloy-M-A, Bey-P, Sommelet-D. Service de Medecine Infantile II, Hopital d'Enfants, C.H.U., Nancy, France. Hodgkin's disease in childhood. Annales Medicales de Nancy et de l'Est {ANN-MED-NANCY-EST}, 1992, Vol /Iss/Pg. 31/1 (75-78), ISSN: 0221-3796.Schmitt-C, Bordigoni-P, Chastagner-P, Galloy-M-A, Bey-P, Sommelet-D. Service de Medecine Infantile II, Hopital d'Enfants, C.H.U., Nancy, France. Hodgkin's disease in childhood. Annales Medicales de Nancy et de l'Est {ANN-MED-NANCY-EST}, 1992, Vol /Iss/Pg. 31/1 (75-78), ISSN: 0221-3796. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34837 |
| Study title: Schut-L, Rosenstock-J-G. Neurosurg. Serv.Child. Hosp.PhiladelphiaPa. 19146, United States. Treatment of intracranial neoplasms in children. Seminars in Oncology {SEMIN-ONCOL}, 1974, Vol/Iss/Pg. 1/1 (9-15).Schut-L, Rosenstock-J-G. Neurosurg. Serv.Child. Hosp.PhiladelphiaPa. 19146, United States. Treatment of intracranial neoplasms in children. Seminars in Oncology {SEMIN-ONCOL}, 1974, Vol/Iss/Pg. 1/1 (9-15). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34838 |
| Study title: Schwabe-D, Gussetis-E, Jacobi-G, Gerein-V, Kornhuber-B. Klinik. J.W. Goethe Univ., Zentrum der Kinderheilkunde, Theodor- Stern-Kai 7,6000 Frankfurt 70, Germany. High-dose methotrexate combined with '8 in 1' in the treatment of class III/IV brain tumors in children. Klinische Padiatrie {KLIN-PADIATR}, 1992, Vol/Iss/Pg. 204/2 (72-77), ISSN: 0300-8630.Schwabe-D, Gussetis-E, Jacobi-G, Gerein-V, Kornhuber-B. Klinik. J.W. Goethe Univ., Zentrum der Kinderheilkunde, Theodor- Stern-Kai 7,6000 Frankfurt 70, Germany. High-dose methotrexate combined with '8 in 1' in the treatment of class III/IV brain tumors in children. Klinische Padiatrie {KLIN-PADIATR}, 1992, Vol/Iss/Pg. 204/2 (72-77), ISSN: 0300-8630. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34839 |
| Study title: Seiler-R-W, Bernasconi-S, Berchtold-W, Feldges-A, Imbach-P, Luethi-A, Pluess-H-J, Vassella-F, Wyss-M, Wagner-H-P. Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report. Helvetica paediatrica acta, {Helv-Paediatr-Acta}, Jul 1981, vol. 36, no. 3, p. 249-54, ISSN: 0018-022X.Seiler-R-W, Bernasconi-S, Berchtold-W, Feldges-A, Imbach-P, Luethi-A, Pluess-H-J, Vassella-F, Wyss-M, Wagner-H-P. Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report. Helvetica paediatrica acta, {Helv-Paediatr-Acta}, Jul 1981, vol. 36, no. 3, p. 249-54, ISSN: 0018-022X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34840 |
| Study title: Henze T. Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring. Fortschr Neurol Psychiatr. 1996 Mar;64(3):110-21. Henze T. Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring. Fortschr Neurol Psychiatr. 1996 Mar;64(3):110-21. |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35223 |
| Study title: Kirk JM et al. Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children. Clin Endocrinol (Oxf). 1991 May;34(5):407-11Kirk JM et al. Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children. Clin Endocrinol (Oxf). 1991 May;34(5):407-11 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35207 |
| Study title: Loche S et al. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children. Pediatr Res. 1990 Apr;27(4 Pt 1):405-7Loche S et al. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children. Pediatr Res. 1990 Apr;27(4 Pt 1):405-7 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35214 |
| Study title: Loche S et al. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children. Clin Endocrinol (Oxf). 1990 Aug;33(2):187-92Loche S et al. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children. Clin Endocrinol (Oxf). 1990 Aug;33(2):187-92 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35212 |
| Study title: Morita M, Gabbai AA, Oliveira ASB, Penn AS: Myasthenia gravis in children. Arq Neuropsiquiatr 2001, 59 (3-B): 681-685 Morita M, Gabbai AA, Oliveira ASB, Penn AS: Myasthenia gravis in children. Arq Neuropsiquiatr 2001, 59 (3-B): 681-685 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35220 |
| Study title: Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesth Intensive Care. 2004 Oct;32(5):649-52Oh AY, Kim SD, Kim CS. Early and late reversal of rocuronium with pyridostigmine during sevoflurane anaesthesia in children. Anaesth Intensive Care. 2004 Oct;32(5):649-52 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35184 |
| Study title: Peino R. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. J Clin Endocrinol Metab. 1996 Mar;81(3):909-13Peino R. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. J Clin Endocrinol Metab. 1996 Mar;81(3):909-13 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35197 |
| Study title: Procopio M et al. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. Int J Obes Relat Metab Disord. 1995 Feb;19(2):108-12Procopio M et al. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. Int J Obes Relat Metab Disord. 1995 Feb;19(2):108-12 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35199 |
| Study title: Radetti G et al. Pyridostigmine and metoclopramide do not restore the TSH response to TRH inhibited by L-thyroxine treatment in children with goiter. J Endocrinol Invest. December 1, 2000, 744-7Radetti G et al. Pyridostigmine and metoclopramide do not restore the TSH response to TRH inhibited by L-thyroxine treatment in children with goiter. J Endocrinol Invest. December 1, 2000, 744-7 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35180 |
| Study title: Ram Z et al. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers. Isr J Med Sci. 1991 Nov-Dec;27(11-12):664-8 Ram Z et al. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers. Isr J Med Sci. 1991 Nov-Dec;27(11-12):664-8 |
| Active substance: PYRIDOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35206 |
| Study title: A study to assess the use of propofol for induction and maintenance of anaesthesia by continuous infusion for paediatric procedures. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0238 Study Synopsis.pdf |
| View full study record |
| Document reference: 46133 |
| Study title: An assessment of the characteristics of propofol for maintenance of anaesthesia by infusion for paediatric surgery. |
| Active substance: PROPOFOL |
| Study summary document link (including results): 035868_0187 Study Synopsis.pdf |
| View full study record |
| Document reference: 46132 |
| Study title: EEG during intravenous anaesthesia with propofol in children |
| Active substance: PROPOFOL |
| Study summary document link (including results): 0859FC-0018 Study Synopsis.pdf |
| View full study record |
| Document reference: 46127 |
| Study title: 35. do Nascimento et al., Hosp Rio de Brasilia 1962; 61: 117-121 35. do Nascimento et al., Hosp Rio de Brasilia 1962; 61: 117-121 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39564 |
| Study title: 36. Nassif et al., J Trop Med Hyg 1974 ; 77 : 270-271 36. Nassif et al., J Trop Med Hyg 1974 ; 77 : 270-271 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39565 |
| Study title: 38. Padelt, Flentje, childrenärztl Prax 1967; 35: 93-97 38. Padelt, Flentje, childrenärztl Prax 1967; 35: 93-97 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39567 |
| Study title: 39. Palicka, Cesk Pediatr 1971; 26: 563-565 39. Palicka, Cesk Pediatr 1971; 26: 563-565 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39568 |
| Study title: 4. Asmera et al., Ceskoslovenska pediatrie 1971; 26: 456-458 4. Asmera et al., Ceskoslovenska pediatrie 1971; 26: 456-458 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39533 |
| Study title: 40. Pawlowski, Kolo-wrotkiewicz, Wiad Parazytol 1964; 10: 443-446 40. Pawlowski, Kolo-wrotkiewicz, Wiad Parazytol 1964; 10: 443-446 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39569 |
| Study title: 41. Pazdziora, Cesk Epidemiol Mikrobiol Immunol 1976; 25: 50-55 41. Pazdziora, Cesk Epidemiol Mikrobiol Immunol 1976; 25: 50-55 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39570 |
| Study title: 42. Pistoletti, Igiene Sania Publ 1962; 18: 42-45 42. Pistoletti, Igiene Sania Publ 1962; 18: 42-45 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39571 |
| Study title: 43. Plotnikov et al., Med Parazytol 1970; 39: 38: 387-390 43. Plotnikov et al., Med Parazytol 1970; 39: 38: 387-390 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39572 |
| Study title: 44. Priebe, Münch Med Wochenschr 1961; 103: 1730-1732 44. Priebe, Münch Med Wochenschr 1961; 103: 1730-1732 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39573 |
| Study title: 45. Reitano, Pane, Riv Pediatr Seciliana 1960; 15: 270-288 45. Reitano, Pane, Riv Pediatr Seciliana 1960; 15: 270-288 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39574 |
| Study title: 46. Rodriguez et al., J Pediatr 1960; 25: 324-330 46. Rodriguez et al., J Pediatr 1960; 25: 324-330 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39575 |
| Study title: 47. Salem et al., J Egypt Pub Health Assoc 1961; 26: 225-233 47. Salem et al., J Egypt Pub Health Assoc 1961; 26: 225-233 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39576 |
| Study title: 48. Sandars, Med J Aust 1963; 1: 722-725 48. Sandars, Med J Aust 1963; 1: 722-725 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39577 |
| Study title: Spicak V, Polackova M, Tlaskalova H, Kacirek E. Presented at the 8th European Immunology Meeting; August 30 - September 5, 1987; Zagreb, Yugoslavia. (Abstract only). Modimunal®/Isoprinosine® in the treatment of asthmatic children.Spicak V, Polackova M, Tlaskalova H, Kacirek E. Presented at the 8th European Immunology Meeting; August 30 - September 5, 1987; Zagreb, Yugoslavia. (Abstract only). Modimunal®/Isoprinosine® in the treatment of asthmatic children. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30170 |
| Study title: Spicak V, Polackova M, Tlaskalova H, Kaminkova J, Vanecek K. Presented at the 4th International Conference on Immunopharmacology; Kyoto, Japan; 1988. (Abstract only). Immunomodulation by Isoprinosine® in the treatment of asthmatic childrenSpicak V, Polackova M, Tlaskalova H, Kaminkova J, Vanecek K. Presented at the 4th International Conference on Immunopharmacology; Kyoto, Japan; 1988. (Abstract only). Immunomodulation by Isoprinosine® in the treatment of asthmatic children |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30171 |
| Study title: Sueri L, Ielasi G, Del Massa M. (1979). Presented at del Convegno Internazionale sulla Isoprinosina; April 28, Rome, Italy; 87-93. Isoprinosine® in the treatment of some acute infectious diseases of viral origin: open and double-blind studySueri L, Ielasi G, Del Massa M. (1979). Presented at del Convegno Internazionale sulla Isoprinosina; April 28, Rome, Italy; 87-93. Isoprinosine® in the treatment of some acute infectious diseases of viral origin: open and double-blind study |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30172 |
| Study title: Tekgul H, Tutuncuoglu S, Kutukculer N, Dizdarer G, Huseyinov A. J Child Neurol. 1999 Jul;14(7):418-21. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis.Tekgul H, Tutuncuoglu S, Kutukculer N, Dizdarer G, Huseyinov A. J Child Neurol. 1999 Jul;14(7):418-21. Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30173 |
| Study title: Tepebasili I, Caksen H, Odabas D, Atas B, Akbayram S. J Emerg Med. 2004 Apr;26(3):356-9. Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course.Tepebasili I, Caksen H, Odabas D, Atas B, Akbayram S. J Emerg Med. 2004 Apr;26(3):356-9. Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30174 |
| Study title: Therapeutic agent for viral disease: preliminary information Therapeutic agent for viral disease: preliminary information |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30175 |
| Study title: Von Frenkell AR.. Laboratoires Delande; Paris 1987. Clinical Study Report. Statistical study concerning the clinical double blind study of Isoprinosine and a placebo for the the treatment of severe or complicated measlesVon Frenkell AR.. Laboratoires Delande; Paris 1987. Clinical Study Report. Statistical study concerning the clinical double blind study of Isoprinosine and a placebo for the the treatment of severe or complicated measles |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30176 |
| Study title: Wiedermann D, Widermannova D, Lokaj J. Scripta Medica [Czech edition from Brno]. 1986; 59(7):415-424. Several parameters of cellular and humoral immune function in children with recurrent respiratory infections treated with Isoprinosine®.Wiedermann D, Widermannova D, Lokaj J. Scripta Medica [Czech edition from Brno]. 1986; 59(7):415-424. Several parameters of cellular and humoral immune function in children with recurrent respiratory infections treated with Isoprinosine®. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30177 |
| Study title: Wiedermann D, Wiedermannova D, Lokaj J. International Journal of Immunopharmacology 1987; 9(8):947-949. .Immunorestoration in children with recurrent respiratory infections treated with Isoprinosine®.Wiedermann D, Wiedermannova D, Lokaj J. International Journal of Immunopharmacology 1987; 9(8):947-949. .Immunorestoration in children with recurrent respiratory infections treated with Isoprinosine®. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30178 |
| Study title: Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y. Neurology. 1992 Mar;42(3 Pt 1):488-91. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.Yalaz K, Anlar B, Oktem F, Aysun S, Ustacelebi S, Gurcay O, Gucuyener K, Renda Y. Neurology. 1992 Mar;42(3 Pt 1):488-91. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30179 |
| Study title: Insulin Lispro versus Humulin R in Adolescent Patients with Type I Diabetes |
| Active substance: INSULIN (HUMAN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30183 |
| Study title: The Exclusive Use of Neutral Regular Human Insulin (rDNA) in the Treatment of Insulin-Dependent Diabetes Mellitus in Patients Who Have Never Received Insulin |
| Active substance: INSULIN (HUMAN) |
| Study summary document link (including results): Human insulin - B5K-MC-IBAI redacted CSR.PDF |
| View full study record |
| Document reference: 30184 |
| Study title: Acta Radiol. 1992 Nov;33(6):592-5 Comparison of intravenous contrast agents for CT studies in children. Cohen MD, Herman E, Herron D, White SJ, Smith JA Acta Radiol. 1992 Nov;33(6):592-5 Comparison of intravenous contrast agents for CT studies in children. Cohen MD, Herman E, Herron D, White SJ, Smith JA |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30363 |
| Study title: Porteder H, Henning G: Improvment in wound healing after oral implantation with Solcoseryl Dental Adhesive paste. das deutsche Ärzteblatt, 1996, &, 320-323 Porteder H, Henning G: Improvment in wound healing after oral implantation with Solcoseryl Dental Adhesive paste. das deutsche Ärzteblatt, 1996, &, 320-323 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35090 |
| Study title: Sato Y, Takashima A, Oka S: A double-blind study of the clinical efficacy of Solcoseryl in childblains. Kis to Rinsho,. Clin Rep 1975; 9 2453-2489 Sato Y, Takashima A, Oka S: A double-blind study of the clinical efficacy of Solcoseryl in childblains. Kis to Rinsho,. Clin Rep 1975; 9 2453-2489 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35096 |
| Study title: Trzcinska-Dabrowska Z.; Kanigowska K.: Solcoseryl eye-gel preparation in the treatment of selected corneal diseases. Klin. Oczna 89: 27-28 (1987). Trzcinska-Dabrowska Z.; Kanigowska K.: Solcoseryl eye-gel preparation in the treatment of selected corneal diseases. Klin. Oczna 89: 27-28 (1987). |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35107 |
| Study title: Vamos I, Kövesi G: Experince in use of Solcoseryl Dental adhesive Paste. Különenyomat 1980, 73, 361-363 Vamos I, Kövesi G: Experince in use of Solcoseryl Dental adhesive Paste. Különenyomat 1980, 73, 361-363 |
| Active substance: PROTEIN FREE DIALYSATE OF CALF BLOOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35089 |
| Study title: A study to determine the safety of virus inactivated factor concentrates in Hameophiliacs Naive to Blood Product Admiinistration (International Factor Safety Study) A study to determine the safety of virus inactivated factor concentrates in Hameophiliacs Naive to Blood Product Admiinistration (International Factor Safety Study) |
| Active substance: PROTHROMBIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35112 |
| Study title: "Behandlung einer Hemmkörperhämophilie B mit hochdosierter Factor IX-Substitution. In: Landbeck,G., Marx R. (Hrsg.): 15 Hämophilie-Symposium Hamburg, 1984, Springer-Verlag, Berlin, Heidelberg, New York, Tokyo: 251-254 (1986).(Kraus B et al.) " "Behandlung einer Hemmkörperhämophilie B mit hochdosierter Factor IX-Substitution. In: Landbeck,G., Marx R. (Hrsg.): 15 Hämophilie-Symposium Hamburg, 1984, Springer-Verlag, Berlin, Heidelberg, New York, Tokyo: 251-254 (1986).(Kraus B et al.) " |
| Active substance: PROTHROMBIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35111 |
| Study title: "Erfahrungen mit einem Faktor II-, IX- und X-Konzentrat. Laboratoriumsuntersuchungen, In-Vivo-Recovery und klinische Ergebnisse. Global-Druck und Verlag, Heidelberg, (1980).(Vinazzer H, Bergmann H.) " "Erfahrungen mit einem Faktor II-, IX- und X-Konzentrat. Laboratoriumsuntersuchungen, In-Vivo-Recovery und klinische Ergebnisse. Global-Druck und Verlag, Heidelberg, (1980).(Vinazzer H, Bergmann H.) " |
| Active substance: PROTHROMBIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35109 |
| Study title: "Factor X survival and therapeutic factor X levels in the abnormal factor X (factor X FRIULI) COAGULATION DISORDER. Acta Haematol (1974) 52: 223-231.(Girolami A et al.) " "Factor X survival and therapeutic factor X levels in the abnormal factor X (factor X FRIULI) COAGULATION DISORDER. Acta Haematol (1974) 52: 223-231.(Girolami A et al.) " |
| Active substance: PROTHROMBIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35110 |
| Study title: "Laboratory and clinical evaluation of concentrates for treatment of haemophilia. Acta Clin Belg (1975) 30: 437-448. (Verstraete M, Vermylen J. ) " "Laboratory and clinical evaluation of concentrates for treatment of haemophilia. Acta Clin Belg (1975) 30: 437-448. (Verstraete M, Vermylen J. ) " |
| Active substance: PROTHROMBIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35108 |
| Study title: Donaldson-S-S, Berberich-F-R, Kaplan-H-S. Stanford Univ. Sch. Med., Stanford, Calif. 94305, United States. A program of low dose radiation and MOPP chemotherapy for pediatric Hodgkin's disease. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-730).Donaldson-S-S, Berberich-F-R, Kaplan-H-S. Stanford Univ. Sch. Med., Stanford, Calif. 94305, United States. A program of low dose radiation and MOPP chemotherapy for pediatric Hodgkin's disease. Proceedings of the American Association for Cancer Research {PROC-AM-ASSOC-CANCER-RES}, 1981, Vol/Iss/Pg. Vol. 22/- (C-730). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34698 |
| Study title: Donaldson-S-S, Kaplan-H-S. Div. Radiat. Ther., Dept. Radiol., Stanford Univ. Med. Cent., Stanford, CA 94305, United States. Complications of treatment of Hodgkin's disease in children. Cancer Treatment Reports {CANCER-TREAT-REP}, 1982, Vol/Iss/Pg. 66/4 (977-989).Donaldson-S-S, Kaplan-H-S. Div. Radiat. Ther., Dept. Radiol., Stanford Univ. Med. Cent., Stanford, CA 94305, United States. Complications of treatment of Hodgkin's disease in children. Cancer Treatment Reports {CANCER-TREAT-REP}, 1982, Vol/Iss/Pg. 66/4 (977-989). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34699 |
| Study title: Donaldson-S-S, Link-M-P, McDougall-I-R, Parker-B-R, Shochat-S-J. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low- dose irradiation and alternating ABVD/MOPP chemotherapy. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 307-15, ISSN: 0927-3042.Donaldson-S-S, Link-M-P, McDougall-I-R, Parker-B-R, Shochat-S-J. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low- dose irradiation and alternating ABVD/MOPP chemotherapy. Cancer treatment and research, {Cancer-Treat-Res}, 1989, vol. 41, p. 307-15, ISSN: 0927-3042. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34700 |
| Study title: Donaldson-S-S, Link-M-P. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, May 1987, vol. 5, no. 5, p. 742-9, ISSN: 0732-183X.Donaldson-S-S, Link-M-P. Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, May 1987, vol. 5, no. 5, p. 742-9, ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34701 |
| Study title: Duffner-P-K, Cohen-M-E, Anderson-S-W, et-al. Department of Neurology, Buffalo Children's Hospital, Buffalo, NY 14222, United States. Long-term effects of treatment on endocrine function in children with brain tumors. Annals of Neurology {ANN-NEUROL}, 1983, Vol/Iss/Pg. 14/5 (528-532).Duffner-P-K, Cohen-M-E, Anderson-S-W, et-al. Department of Neurology, Buffalo Children's Hospital, Buffalo, NY 14222, United States. Long-term effects of treatment on endocrine function in children with brain tumors. Annals of Neurology {ANN-NEUROL}, 1983, Vol/Iss/Pg. 14/5 (528-532). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34702 |
| Study title: Duffner-P-K, Cohen-M-E. Department of Neurology, Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, United States. Changes in the approach to central nervous system tumors in childhood. Pediatric Clinics of North America {PEDIATR-CLIN-NORTH-AM}, 1992, Vol /Iss/Pg. 39/4 (859-877), ISSN: 0031-3955.Duffner-P-K, Cohen-M-E. Department of Neurology, Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, United States. Changes in the approach to central nervous system tumors in childhood. Pediatric Clinics of North America {PEDIATR-CLIN-NORTH-AM}, 1992, Vol /Iss/Pg. 39/4 (859-877), ISSN: 0031-3955. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34703 |
| Study title: 49. Sanders, Hall, J Lab Clin Med 1960; 56: 413-416 49. Sanders, Hall, J Lab Clin Med 1960; 56: 413-416 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39578 |
| Study title: 5. Bandyopadhyay, Chowdhury, Bull Calcutta Scool Trop Med 1961; 2: 125 5. Bandyopadhyay, Chowdhury, Bull Calcutta Scool Trop Med 1961; 2: 125 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39534 |
| Study title: 50. Seth, J Indian Med Assoc 1962; 38: 528-530 50. Seth, J Indian Med Assoc 1962; 38: 528-530 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39579 |
| Study title: 51. Silli, Riv Clin Pediatr 1968; 81: 1331-1334 51. Silli, Riv Clin Pediatr 1968; 81: 1331-1334 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39580 |
| Study title: 52. Suarez, Domingo, Rev Esp Pediatr 1961; 17: 557-561 52. Suarez, Domingo, Rev Esp Pediatr 1961; 17: 557-561 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39581 |
| Study title: 53. Sudigbia, et al., Paediatr Indon 1970; 10: 125-130 53. Sudigbia, et al., Paediatr Indon 1970; 10: 125-130 |
| Active substance: PYRVINIUM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39582 |
| Study title: Geyer-J-R, Zeltzer-P-M, Boyett-J-M, Rorke-L-B, Stanley-P, Albright-A- L, Wisoff-J-H, Milstein-J-M, Allen-J-C, Finlay-J-L, et al. Children's Hospital and Medical Center, Seattle, WA. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Aug 1994, vol. 12, no. 8, p. 1607-15, ISSN: 0732-183X.Geyer-J-R, Zeltzer-P-M, Boyett-J-M, Rorke-L-B, Stanley-P, Albright-A- L, Wisoff-J-H, Milstein-J-M, Allen-J-C, Finlay-J-L, et al. Children's Hospital and Medical Center, Seattle, WA. Survival of infants with primitive neuroectodermal tumors or malignan... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34720 |
| Study title: Geyer-R, Levy-M, Berger-M-S, Milstein-J, Griffin-B, Bleyer-W-A. Depts. Ped./Neuro Surg./Radia., Children's Hos./Medical Care, University of Washington, Seattle, WA, United States. Infants with medulloblastoma: a single institution review of survival. Neurosurgery {NEUROSURGERY}, 1991, Vol/Iss/Pg. 29/5 (707-711), ISSN: 0148-396X.Geyer-R, Levy-M, Berger-M-S, Milstein-J, Griffin-B, Bleyer-W-A. Depts. Ped./Neuro Surg./Radia., Children's Hos./Medical Care, University of Washington, Seattle, WA, United States. Infants with medulloblastoma: a single institution review of survival. Neurosurgery {NEUROSURGERY}, 1991, Vol/Iss/Pg. 29/5 (707-711), ISSN: 0148-396X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34721 |
| Study title: Glynne-Jones-R, Whitaker-S-J, Plowman-P-N. Department of Radiotherapy, St Bartholomew's Hospital, London. The 'urn' portal; an alternative to the 'mantle' portal in the chemoradiotherapy management of paediatric Hodgkin's disease. Clinical oncology (Royal College of Radiologists (Great Britain)), {Clin-Oncol-R-Coll-Radiol}, Jul 1990, vol. 2, no. 4, p. 235-40, ISSN: 0936-6555.Glynne-Jones-R, Whitaker-S-J, Plowman-P-N. Department of Radiotherapy, St Bartholomew's Hospital, London. The 'urn' portal; an alternative to the 'mantle' portal in the chemoradiotherapy management of paediatric Hodgkin's disease. Clinical oncology (Royal College of Radiologists (Great Britain)), {Clin-Oncol-R-Coll-Radiol}, Jul 1990, vol. 2, no. 4, p. 235-40, ISSN: 0936-6555. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34722 |
| Study title: Acta Radiol. 1994 Mar;35(2):186-90 Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol. Wiklund LM, Brolin I, Sjöholm K Acta Radiol. 1994 Mar;35(2):186-90 Nonionic contrast media in pediatric CT. A comparative study of intravenous use of iopentol and iohexol. Wiklund LM, Brolin I, Sjöholm K |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30364 |
| Study title: Br J Radiol. 1987 Feb;60(710):133-5. Comparison of low-osmolar contrast media in paediatric cardiac angiography. Rubin CM, Ogilvie BC, Keeton BR Br J Radiol. 1987 Feb;60(710):133-5. Comparison of low-osmolar contrast media in paediatric cardiac angiography. Rubin CM, Ogilvie BC, Keeton BR |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30366 |
| Study title: Cent Afr J Med. 1996 Jul;42(7):192-5 Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects. Ndosi BN, Ndosi NK, Kazema RR Cent Afr J Med. 1996 Jul;42(7):192-5 Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects. Ndosi BN, Ndosi NK, Kazema RR |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30367 |
| Study title: Clin Radiol. 1993 Oct;48(4):268-72. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. Clin Radiol. 1993 Oct;48(4):268-72. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30368 |
| Study title: Contrast quality and tolerability of iotrolan 300 in the diagnostic work-up of the upper gastrointestinal tract of infants and toddlers |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30384 |
| Study title: Double-blind comparative study of Ultravist, Solutrast and Omnipaque in excretory urography in childrenAJR Am J Roentgenol. 1991 Feb;156(2):345-50 Comparison of iohexol with barium in gastrointestinal studies of infants and children. Cohen MD, Towbin R, Baker S, Davis S, Becker C, Eggleston DE, Kehler M, Smith JA, Cory DA, White SJ. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30365 |
| Study title: Double-blind comparative study of Ultravist, Solutrast and Omnipaque in excretory urography in childrenJ Invasive Cardiol. 2003 Mar;15(3):133-8. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. Sutton AG, Finn P, Campbell PG, Price DJ, Hall JA, Stewart MJ, Davies A, Linker NJ, De Belder MA. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30379 |
| Study title: Eur J Radiol. 1993 Nov;17(3):203-9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Palmers Y, De Greef D, Grynne BH, Smits J, Put E Eur J Radiol. 1993 Nov;17(3):203-9. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Palmers Y, De Greef D, Grynne BH, Smits J, Put E |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30370 |
| Study title: Eur Radiol. 1997;7 Suppl 4:S120-2 Iopentol (Imagopaque 300) compared with iohexol (Omnipaque 300) and diatrizoate (Urografin 292) in pediatric urography. A clinical trial assessing adverse events and diagnostic information. Lanning P, Brekke O. Eur Radiol. 1997;7 Suppl 4:S120-2 Iopentol (Imagopaque 300) compared with iohexol (Omnipaque 300) and diatrizoate (Urografin 292) in pediatric urography. A clinical trial assessing adverse events and diagnostic information. Lanning P, Brekke O. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30371 |
| Study title: Eur Radiol. 1998;8(6):1054-7. Myelography with a dimeric (iodixanol) and a monomeric (iohexol) contrast medium: a clinical multicentre comparative study. Skalpe IO, Bonneville JF, Grane P, Gyldenstedt C, Otto B, Kristoffersen DT, Svaland MG. Eur Radiol. 1998;8(6):1054-7. Myelography with a dimeric (iodixanol) and a monomeric (iohexol) contrast medium: a clinical multicentre comparative study. Skalpe IO, Bonneville JF, Grane P, Gyldenstedt C, Otto B, Kristoffersen DT, Svaland MG. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30372 |
| Study title: Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:108-10 Clinical experience with iohexol versus iopromide in excretory urography. Bischoff W Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd. 1989;128:108-10 Clinical experience with iohexol versus iopromide in excretory urography. Bischoff W |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30373 |
| Study title: Int J Cardiol. 2001 Sep-Oct;80(2-3):143-51. Experiences with iohexol and iodixanol during cardioangiography in an unselected patient population. Flinck A, Gottfridsson B. Int J Cardiol. 2001 Sep-Oct;80(2-3):143-51. Experiences with iohexol and iodixanol during cardioangiography in an unselected patient population. Flinck A, Gottfridsson B. |
| Active substance: IOHEXOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30374 |
| Study title: Anesthetic effects from low concentrations of proparacaine and benoxinate. Jauregui MJ, Sanders TJ, Polse KA. J Am Optom Assoc. 1980 Jan;51(1):37-41.Anesthetic effects from low concentrations of proparacaine and benoxinate. Jauregui MJ, Sanders TJ, Polse KA. J Am Optom Assoc. 1980 Jan;51(1):37-41. |
| Active substance: PROXYMETHACAINE |
| Study summary document link (including results): Anesthetic effects from low concentrations of proparacaine a.pdf |
| View full study record |
| Document reference: 46144 |
| Study title: Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45)Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45077 |
| Study title: Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45)Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45082 |
| Study title: Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059)Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45063 |
| Study title: Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059)Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45068 |
| Study title: Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059)Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45073 |
| Study title: Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059)Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45078 |
| Study title: Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45)Rectal versus intravenous Quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomised, double bind clinical trial - Jane Achan - 1/12/2007 (Clinical Infectious Diseases 45) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45072 |
| Study title: Oberlin-O, Boilletot-A, Leverger-G, et-al. Institut Gustave-Roussy 94800, Villejuif, France. Clinical staging, primary chemotherapy and involved field radiotherapy in childhood Hodgkin's disease. European Paediatric Haematology and Oncology {EUR-PAEDIATR-HAEMATOL-ONCOL}, 1985, Vol/Iss/Pg. 2/2 (65-70).Oberlin-O, Boilletot-A, Leverger-G, et-al. Institut Gustave-Roussy 94800, Villejuif, France. Clinical staging, primary chemotherapy and involved field radiotherapy in childhood Hodgkin's disease. European Paediatric Haematology and Oncology {EUR-PAEDIATR-HAEMATOL-ONCOL}, 1985, Vol/Iss/Pg. 2/2 (65-70). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34795 |
| Study title: Oberlin-O, Leverger-G, Pacquement-H, Raquin-M-A, Chompret-A, Habrand- J-L, Terrier-Lacombe-M-J, Bey-P, Bertrand-Y, Rubie-H, et al. Pediatrics Department, Institut Gustave Roussy, Villejuif, France. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Oct 1992, vol. 10, no. 10, p. 1602-8, ISSN: 0732-183X.Oberlin-O, Leverger-G, Pacquement-H, Raquin-M-A, Chompret-A, Habrand- J-L, Terrier-Lacombe-M-J, Bey-P, Bertrand-Y, Rubie-H, et al. Pediatrics Department, Institut Gustave Roussy, Villejuif, France. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34796 |
| Study title: Oberlin-O. Department of Pediatricts, Institut Gustave Roussy,94805 Villejuif Cedex, France. Present and future strategies of treatment in childhood Hodgkin's lymphomas. Annals of Oncology {ANN-ONCOL}, 1996, Vol/Iss/Pg. 7/SUPPL. 4 (S73- S78), ISSN: 0923-7534.Oberlin-O. Department of Pediatricts, Institut Gustave Roussy,94805 Villejuif Cedex, France. Present and future strategies of treatment in childhood Hodgkin's lymphomas. Annals of Oncology {ANN-ONCOL}, 1996, Vol/Iss/Pg. 7/SUPPL. 4 (S73- S78), ISSN: 0923-7534. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34797 |
| Study title: Olive-D, Philip-T, Zucker-J-M, et-al. Service de Medicine Infantile II, Hopital d'Enfants, 54511 Vandoeuvre Cedex 11, France. Efficacy of '8 drugs in 1 day' regimen in the treatment of poor risk childhood brain tumors. European Paediatric Haematology and Oncology {EUR-PAEDIATR-HAEMATOL-ONCOL}, 1985, Vol/Iss/Pg. 2/1 (57-58).Olive-D, Philip-T, Zucker-J-M, et-al. Service de Medicine Infantile II, Hopital d'Enfants, 54511 Vandoeuvre Cedex 11, France. Efficacy of '8 drugs in 1 day' regimen in the treatment of poor risk childhood brain tumors. European Paediatric Haematology and Oncology {EUR-PAEDIATR-HAEMATOL-ONCOL}, 1985, Vol/Iss/Pg. 2/1 (57-58). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34798 |
| Study title: Olive-D. Serv. Ped. 'A', CHU, Nancy, France. Advances in the management of chemotherapy in solid tumors in children. Archives Francaises de Pediatrie {ARCH-FR-PEDIATR}, 1976, Vol/Iss/Pg. 33/6 (607-620).Olive-D. Serv. Ped. 'A', CHU, Nancy, France. Advances in the management of chemotherapy in solid tumors in children. Archives Francaises de Pediatrie {ARCH-FR-PEDIATR}, 1976, Vol/Iss/Pg. 33/6 (607-620). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34799 |
| Study title: Ortin-T-T, Shostak-C-A, Donaldson-S-S. CA 94305. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. International journal of radiation oncology biology physics, {Int-J- Radiat-Oncol-Biol-Phys}, Oct 1990, vol. 19, no. 4, p. 873-80, ISSN: 0360-3016.Ortin-T-T, Shostak-C-A, Donaldson-S-S. CA 94305. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. International journal of radiation oncology biology physics, {Int-J- Radiat-Oncol-Biol-Phys}, Oct 1990, vol. 19, no. 4, p. 873-80, ISSN: 0360-3016. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34800 |
| Study title: A Study to Compare the Efficacy and Safety of 0.25% Levobupivacaine to 0.25% Bupivacaine when Administered as a Caudal Extradural for PostOperative Analgesia in Paediatric In-Patients Undergoing Elective Orthopaedic or Major Urological Surgery |
| Active substance: LEVOBUVICAINE HCL |
| Study summary document link (including results): Levobupivacaine-30590.pdf |
| View full study record |
| Document reference: 47650 |
| Study title: Astudy to assess the efficacy and safety of 0.25% levobupivacaine when administered as a caudal injection in paediatric patients undergoing hernia repair, circumcision or orchidopexy. |
| Active substance: LEVOBUVICAINE HCL |
| Study summary document link (including results): Levobupivacaine-30585.pdf |
| View full study record |
| Document reference: 47649 |
| Study title: Double-Blind Randomized Controlled Trial of05% L.evobupivacaine for Post-Operative Pain Control in Pediatric Patients Foliowing Hernia Repair Surgery |
| Active substance: LEVOBUVICAINE HCL |
| Study summary document link (including results): Levobupivacaine-CS007.pdf |
| View full study record |
| Document reference: 47648 |
| Study title: A comparative study of the treatment of seasonal rhinoconjunctivitis with levocabastine, up-to date and classical H1 inhibitors. 18"' Congress of the European Academy of Allergy and Clinical Immunology, Brussels, Belgium, NO-P292, July 3-7, 1999A comparative study of the treatment of seasonal rhinoconjunctivitis with levocabastine, up-to date and classical H1 inhibitors. 18"' Congress of the European Academy of Allergy and Clinical Immunology, Brussels, Belgium, NO-P292, July 3-7, 1999 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31132 |
| Study title: A double masked study on the effect of opthlamic levocabastine vs placebo on the signs and symptomsof allergic conjunctivitis |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31063 |
| Study title: A double-blind placebo-controlled study of levocabastine eye drops and nose spray in patients with hay fever (13-73 yrs) |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31093 |
| Study title: A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, p.1173-1180, 1999A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 54, p.1173-1180, 1999 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31138 |
| Study title: A placebo-controlled trial of the therapeutic value of levocabastine eye drops used as required in the treatment of seasonal allergic conjunctivitis (13.1-56.7 yrs) |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): LMD62493_Interventional_Levocabastine.xls |
| View full study record |
| Document reference: 31105 |
| Study title: A single-blind trial to compare the efficacy, tolerability and safety of levocabastine nasal spray as compared to sodiumcromoglycate nasal spray in children aged 6 months to 5 years with perennial allergic rhinitis. Part I. Clinical Research Report Dated April 1998 |
| Active substance: LEVOCABASTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31059 |
| Study title: Gobel-U, Kauther-K, Seibert-H, et-al. Univ. Kinderklin. B, Univ., D-4000 Dusseldorf, Germany. Evaluation of combination chemotherapy with high-dose methotrexate ollowed by citrovorum factor rescue (CFR) and COPP in children with recurrent brain tumours. Acta Neurochirurgica {ACTA-NEUROCHIR}, 1982, Vol/Iss/Pg. 62/1-2 (129-130).Gobel-U, Kauther-K, Seibert-H, et-al. Univ. Kinderklin. B, Univ., D-4000 Dusseldorf, Germany. Evaluation of combination chemotherapy with high-dose methotrexate ollowed by citrovorum factor rescue (CFR) and COPP in children with recurrent brain tumours. Acta Neurochirurgica {ACTA-NEUROCHIR}, 1982, Vol/Iss/Pg. 62/1-2 (129-130). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34723 |
| Study title: Goldis-Gh. Clin. Pediat. 'Fundeni' IMF, Bucuresti, Romania. Children and the cancerous diseases (present general aspects in pediatric oncology). Pediatrie {PEDIATRIE}, 1982, Vol/Iss/Pg. 31/1 (3-14).Goldis-Gh. Clin. Pediat. 'Fundeni' IMF, Bucuresti, Romania. Children and the cancerous diseases (present general aspects in pediatric oncology). Pediatrie {PEDIATRIE}, 1982, Vol/Iss/Pg. 31/1 (3-14). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34724 |
| Study title: Micromedex. Diphenhydramine Hydrochloride. Thomson Healthcare. 1974-2005 medizinishes Informationssystem Vol.125 expires 9/2005, 2005Micromedex. Diphenhydramine Hydrochloride. Thomson Healthcare. 1974-2005 medizinishes Informationssystem Vol.125 expires 9/2005, 2005 |
| Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25712 |
| Study title: Scott, M.R.Report of a double-blind trial of Pyralvex against placebo in the relief of pain associated with mouth ulcers. 1987 49 subjects (36 evaluable) 16 m, 20 f, 7-67 y (39.2)Scott, M.R.Report of a double-blind trial of Pyralvex against placebo in the relief of pain associated with mouth ulcers. 1987 49 subjects (36 evaluable) 16 m, 20 f, 7-67 y (39.2) |
| Active substance: RHUBARB AND SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35294 |
| Study title: Vorberg, G. Erfolgreiche Behandlung von entzündlichen Veränderungen der Mund- und Rachenschleimhaut sowie des Zahnfleisches mit Pyralves. 1982, 28:2972-2973 aged 15 - 72 years, 60 patientsVorberg, G. Erfolgreiche Behandlung von entzündlichen Veränderungen der Mund- und Rachenschleimhaut sowie des Zahnfleisches mit Pyralves. 1982, 28:2972-2973 aged 15 - 72 years, 60 patients |
| Active substance: RHUBARB AND SALICYLIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35296 |
| Study title: Placebo-controlled comparison of levamisole, pyrantel pamoate, thiabendazole, piperazine citrate, and varlaus dosages of mebendazole in the treatment of ascariasis and trichuriasis in children. 1975 |
| Active substance: MEBENDAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31539 |
| Study title: A randomized study of Ultiva versus Halothane in neonates and infants undergoing surgery for pyloric stenosis |
| Active substance: REMIFENTANIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35285 |
| Study title: Longo-D-L, Young-R-C, Wesley-M, Hubbard-S-M, Duffey-P-L, Jaffe-E-S, DeVita-V-T-Jr. Twenty years of MOPP therapy for Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Sep 1986, vol. 4, no. 9, p. 1295-306, ISSN: 0732-183X.Longo-D-L, Young-R-C, Wesley-M, Hubbard-S-M, Duffey-P-L, Jaffe-E-S, DeVita-V-T-Jr. Twenty years of MOPP therapy for Hodgkin's disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Sep 1986, vol. 4, no. 9, p. 1295-306, ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34776 |
| Study title: Luker-G-D, Siegel-M-J. Department of Radiology, Mallinckrodt Institute of Radiology, Washington Univ. School of Medicine, 510 S Kingshighway Blvd, St Louis, MO 63110, United States. Mediastinal Hodgkin disease in children: Response to therapy. Radiology {RADIOLOGY}, 1993, Vol/Iss/Pg. 189/3 (737-740), ISSN: 0033-8419.Luker-G-D, Siegel-M-J. Department of Radiology, Mallinckrodt Institute of Radiology, Washington Univ. School of Medicine, 510 S Kingshighway Blvd, St Louis, MO 63110, United States. Mediastinal Hodgkin disease in children: Response to therapy. Radiology {RADIOLOGY}, 1993, Vol/Iss/Pg. 189/3 (737-740), ISSN: 0033-8419. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34777 |
| Study title: Lipiodol computerized tomography: How sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? |
| Active substance: Ethyl esters of iodized fatty acids of poppy seed oil |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39899 |
| Study title: A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis. Vincent F, Ross JB, Dalton M, Wort AJ. Journal of the American Academy of Dermatology, Mar 1992, vol. 26, no. 3 Pt 2, p. 458−61. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26479 |
| Study title: Th 1165a metered aerosol: pediatrics / therapeutic observations. |
| Active substance: FENOTEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 27033 |
| Study title: Efficacy and safety of loratadina-betamethasone combination in the initial treatment of severe perennial allergic rhinitis in children |
| Active substance: LARATADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 31016 |
| Study title: The effectiveness of the homeopathic remedy Rhinital in the out-patient treatment of children suffering from perennial and seasonal rhinitis |
| Active substance: Luffa operculata, Cardiospermum halicacabum, Galphimia glauca |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39743 |
| Study title: Liberal use of antibiotics and its effect in neonatal staphylococcal infection, with particular reference to erythromycin.Forfar J O, Keay A J, Maccabe A F, Gould J C, Bain A D. Lancet, {Lancet}, 6 Aug 1966, vol. 2, no. 7458, p. 295−300, ISSN: 0140−6736. |
| Active substance: ERYTHROMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 26564 |
| Study title: Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059)Safety and Efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children : randomised clinical trial - Hubert Barennes et al. - 15/11/2007 (BMJ;332:1055-1059) |
| Active substance: QUININE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45083 |
| Study title: A comparative study of two different doses of Smith Kline-RIT rec-DNA Hepatitis B vaccine (10 mcg and 20 mcg). |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47756 |
| Study title: A comparative, Single-Blind, Randomised Study of the Immunogenicity and Safety of Engerix-B administered at two different dose levels. |
| Active substance: r-DNA hepatitis B surface antigen (HBsAg) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47764 |
| Study title: Hunger-S-P, Link-M-P, Donaldson-S-S. Department of Pediatrics, Stanford University School of Medicine, CA 94305. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Oct 1994, vol. 12, no. 10, p. 2160-6, ISSN: 0732-183X.Hunger-S-P, Link-M-P, Donaldson-S-S. Department of Pediatrics, Stanford University School of Medicine, CA 94305. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Oct 1994, vol. 12, no. 10, p. 2160-6, ISSN: 0732-183X. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34743 |
| Study title: Hutchinson-R-J, Fryer-C-J, Davis-P-C, Nachman-J, Krailo-M-D, O-Brien-R-T, Collins-R-D, Whalen-T, Reardon-D, Trigg-M-E, Gilchrist-G-S. C.S. Mott Children's Hospital, Ann Arbor, MI, USA. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, {J-Clin-Oncol}, Mar 1998, vol. 16, no. 3, p. 897-906, ISSN: 0732-183X.Hutchinson-R-J, Fryer-C-J, Davis-P-C, Nachman-J, Krailo-M-D, O-Brien-R-T, Collins-R-D, Whalen-T, Reardon-D, Trigg-M-E, Gilchrist-G-S. C.S. Mott Children's Hospital, Ann Arbor, MI, USA. MOPP or radiation in addition to ABVD i... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34744 |
| Study title: Ilveskoski-I, Saarinen-U-M, Wiklund-T, Perkkioe-M, Salmi-T-T, Lanning-M, Maekipernaa-A, Pihko-H. Children's Hospital, University of Helsinki, Finland. Ototoxicity in children with malignant brain tumors treated with the 8 in 1 chemotherapy protocol. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jul 1996, vol. 27, no. 1, p. 26-31, ISSN: 0098-1532.Ilveskoski-I, Saarinen-U-M, Wiklund-T, Perkkioe-M, Salmi-T-T, Lanning-M, Maekipernaa-A, Pihko-H. Children's Hospital, University of Helsinki, Finland. Ototoxicity in children with malignant brain tumors treated with the 8 in 1 chemotherapy protocol. Medical and pediatric oncology, {Med-Pediatr-Oncol}, Jul 1996, vol. 27, no. 1, p. 26-31, ISSN: 0098-1532. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34745 |
| Study title: Jacobi-G. Abt. Pad. Neurol., Zent. Kinderheilk., 6000 Frankfurt am M. 70, Germany. Intracranial tumors in children. Aktuelle Neurologie {AKTUEL-NEUROL}, 1982, Vol/Iss/Pg. 9/1 (42-50).Jacobi-G. Abt. Pad. Neurol., Zent. Kinderheilk., 6000 Frankfurt am M. 70, Germany. Intracranial tumors in children. Aktuelle Neurologie {AKTUEL-NEUROL}, 1982, Vol/Iss/Pg. 9/1 (42-50). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34746 |
| Study title: |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35044 |
| Study title: A controled surgical series treated with promethazine before inducation. - Smith A.H.- (N.Y. State J. Med. 19/03/1959, 1024-9). - Publication in PROMETHAZINE Safety and efficacy review of medicines following UK authorities review of psychotropic and centrally acting drugs. May&Baker Ltd. Company April 1980 - |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34996 |
| Study title: Acute poisoning in a children's hospital A 2-year experience |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Acute poisoning in a children's hospital A 2-year experience.pdf |
| View full study record |
| Document reference: 35052 |
| Study title: Advanced pediatric joint imaging |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Advanced pediatric joint imaging.pdf |
| View full study record |
| Document reference: 35046 |
| Study title: Adverse effects of meperidine, promethazine, and chlorpromazine for sedation in pediatric patients. |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Adverse effects of meperidine, promethazine, and chlorpromazine for sedation in pediatric patients.pdf |
| View full study record |
| Document reference: 35000 |
| Study title: Adverse reactions in children |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Adverse reactions in children.pdf |
| View full study record |
| Document reference: 35038 |
| Study title: An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia.pdf |
| View full study record |
| Document reference: 35030 |
| Study title: Anasthesia for paediatric cardiac catheterization and angiocardiography. - Moffitt E.A. Dawson B. O'Neill N.C.- 1961 (Anaesth. And Analg., 1961, 40, 483.) - Publication in PHENERGAN therapeutic summary 6th edition May & Baker Ltd.1976 - |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35003 |
| Study title: Annotation The use of psychotropic medications in children A British view |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Annotation The use of psychotropic medications in children A British view.pdf |
| View full study record |
| Document reference: 35029 |
| Study title: Banerjee SR_1977Banerjee SR_1977 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Banerjee SR_1977_publication.pdf |
| View full study record |
| Document reference: 23338 |
| Study title: Blanc VF_1991; Antiemetic prophylaxis with promethazine or droperidol in paediatric outpatient strabismus surgeryBlanc VF_1991; Antiemetic prophylaxis with promethazine or droperidol in paediatric outpatient strabismus surgery |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): Bayer Pharma_Promethazine_Blanc VF_1991_publication.pdf |
| View full study record |
| Document reference: 34998 |
| Study title: Clinical observations with promethazine hydrochloride (PHERNERGAN ELIXIR), in paediatric practice. - Sarma D.N. Dass C.S.- (Indian Med. J., 1978, 72 (9), 156-157.) - Publication in PHENERGAN Tableelt 25mg, Syrup 1%, Sol inj 2,5%. Syndthesis documentation. French validation dossier 17/06 |
| Active substance: PROMETHAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 35011 |
| Study title: Randomized,double-blind study of the efficacy and tolerability of proglumetacin versus diclofenac in sports trauma [Current Therapeutic Research 1993, 53(6):630-4]. Randomized,double-blind study of the efficacy and tolerability of proglumetacin versus diclofenac in sports trauma [Current Therapeutic Research 1993, 53(6):630-4]. |
| Active substance: PROGLUMETACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34994 |
| Study title: Goldman-A, Pritchard-J. Hospital For Sick Children, London WC1N 3JH, United Kingdom. Current management of children with cancer. Prescribers' Journal {PRESCR-J}, 1985, Vol/Iss/Pg. 25/1 (2-11).Goldman-A, Pritchard-J. Hospital For Sick Children, London WC1N 3JH, United Kingdom. Current management of children with cancer. Prescribers' Journal {PRESCR-J}, 1985, Vol/Iss/Pg. 25/1 (2-11). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34725 |
| Study title: Rousseau-P, Habrand-J-L, Sarrazin-D, Kalifa-C, Terrier-Lacombe-M-J, Rekacewicz-C, Rey-A. Department of Radiation Oncology, Montreal General Hospital, 1650 Cedar Ave, Montreal, Que. H3G 1A4, Canada. Treatment of intracranial ependymomas of children: Review of a 15- year experience. International Journal of Radiation Oncology Biology Physics {INT-J- RADIAT-ONCOL-BIOL-PHYS}, 1994, Vol/Iss/Pg. 28/2 (381-386), ISSN: 0360-3016.Rousseau-P, Habrand-J-L, Sarrazin-D, Kalifa-C, Terrier-Lacombe-M-J, Rekacewicz-C, Rey-A. Department of Radiation Oncology, Montreal General Hospital, 1650 Cedar Ave, Montreal, Que. H3G 1A4, Canada. Treatment of intracranial ependymomas of children: Review of a 15- year experience. International Journal of Radiation Oncology Biology Physics {... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34818 |
| Study title: Sackmann-Muriel-F, Bonesana-A-C, Pavlovsky-S, Papendieck-C, Morgenfeld-M, Penchansky-L, Schwartz-L, Kvicala-R, Sica-M, Ojeda-F. Hodgkin's disease in childhood: therapy results in Argentina. The American journal of pediatric hematology/oncology, {Am-J-Pediatr-Hematol-Oncol}, Fall 1981, vol. 3, no. 3, p. 247-54, ISSN: 0192-8562.Sackmann-Muriel-F, Bonesana-A-C, Pavlovsky-S, Papendieck-C, Morgenfeld-M, Penchansky-L, Schwartz-L, Kvicala-R, Sica-M, Ojeda-F. Hodgkin's disease in childhood: therapy results in Argentina. The American journal of pediatric hematology/oncology, {Am-J-Pediatr-Hematol-Oncol}, Fall 1981, vol. 3, no. 3, p. 247-54, ISSN: 0192-8562. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34819 |
| Study title: Kato Z, Asano T, Kondo N. J Child Neurol. 2006 Feb;21(2):177-8. Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis.Kato Z, Asano T, Kondo N. J Child Neurol. 2006 Feb;21(2):177-8. Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30129 |
| Study title: Kho LK, Wulur H, Himawan T.. Abstracts of Scientific Papers: Asian Congress of Pediatrics; May 1-2, 1974; Manila, Philippines: Philippines Pediatric Society; 1974. Abstract 1. Experiences in the management of dengue hemorrhagic feverKho LK, Wulur H, Himawan T.. Abstracts of Scientific Papers: Asian Congress of Pediatrics; May 1-2, 1974; Manila, Philippines: Philippines Pediatric Society; 1974. Abstract 1. Experiences in the management of dengue hemorrhagic fever |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30130 |
| Study title: Kho LK. Report to Newport Pharmaceuticals, Inc: September 20, 1973. Isoprinosine in dengue fever, hepatitis, herpes zoster opthalmicus.Kho LK. Report to Newport Pharmaceuticals, Inc: September 20, 1973. Isoprinosine in dengue fever, hepatitis, herpes zoster opthalmicus. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30131 |
| Study title: Kowalik-Mikolajewska B, Barszcz T, Ladyzynska E, Wojnarowski M. Polski Tygodnik Lekarski. 1993; 48(11-13):263-264. Markers of chronic hepatitis B in children after completion of therapy with Isoprinosine Kowalik-Mikolajewska B, Barszcz T, Ladyzynska E, Wojnarowski M. Polski Tygodnik Lekarski. 1993; 48(11-13):263-264. Markers of chronic hepatitis B in children after completion of therapy with Isoprinosine |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30132 |
| Study title: Kowalik-Mikolajewska B. Polski Tygodnik Lekarski. 1993; 48(11-13):258-260. The course of chronic hepatitis B in children and attempts at modifying its treatment. Kowalik-Mikolajewska B. Polski Tygodnik Lekarski. 1993; 48(11-13):258-260. The course of chronic hepatitis B in children and attempts at modifying its treatment. |
| Active substance: INOSINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 30133 |
| Study title: Maity-A, Goldwein-J-W, Lange-B, D-Angio-G-J. Department of Radiation Oncology, Hospital of the University of Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia 19104. Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania experience. University of Pennsylvania experience. Cancer, {Cancer}, 1 Jun 1992, vol. 69, no. 11, p. 2755-60, ISSN: 0008-543X.Maity-A, Goldwein-J-W, Lange-B, D-Angio-G-J. Department of Radiation Oncology, Hospital of the University of Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia 19104. Mediastinal masses in children with Hodgkin's disease. An ... |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34779 |
| Study title: Makhonova-L-A, Polyakov-V-E, Susuleva-N-A, Ilyashenko-V-V. Detsk. Gematol. Otd., Vsesojuzn. Onkol. Nauch. Tsent., AMN SSSR, Moscow, Russia. Role of polychemotherapy in the program treatment of children with Hodgkin's disease. Pediatriya - Zhurnal im G.N. Speranskogo {PEDIATRIYA}, 1981, Vol/Iss /Pg. 60/8 (36-39).Makhonova-L-A, Polyakov-V-E, Susuleva-N-A, Ilyashenko-V-V. Detsk. Gematol. Otd., Vsesojuzn. Onkol. Nauch. Tsent., AMN SSSR, Moscow, Russia. Role of polychemotherapy in the program treatment of children with Hodgkin's disease. Pediatriya - Zhurnal im G.N. Speranskogo {PEDIATRIYA}, 1981, Vol/Iss /Pg. 60/8 (36-39). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34780 |
| Study title: Mamelak-A-N, Prados-M-D, Obana-W-G, Cogen-P-H, Edwards-M-S-B. Department of Neurological Surgery, c/o The Editorial Office, 1360 Ninth Avenue, San Francisco, CA 94122, United States. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. Journal of Neurosurgery {J-NEUROSURG}, 1994, Vol/Iss/Pg. 81/1 (24-30) , ISSN: 0022-3085. Mamelak-A-N, Prados-M-D, Obana-W-G, Cogen-P-H, Edwards-M-S-B. Department of Neurological Surgery, c/o The Editorial Office, 1360 Ninth Avenue, San Francisco, CA 94122, United States. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. Journal of Neurosurgery {J-NEUROSURG}, 1994, Vol/Iss/Pg. 81/1 (24-30) , ISSN: 0022-3085. |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34781 |
| Study title: Van-Eys-J, Cangir-A. Dept. Ped., M.D. Anderson Hosp., Houston, Tex. 77030, United States. Chemotherapy for childhood brain tumors. Journal of Pediatrics {J-PEDIATR}, 1978, Vol/Iss/Pg. 93/3 (544-546).Van-Eys-J, Cangir-A. Dept. Ped., M.D. Anderson Hosp., Houston, Tex. 77030, United States. Chemotherapy for childhood brain tumors. Journal of Pediatrics {J-PEDIATR}, 1978, Vol/Iss/Pg. 93/3 (544-546). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34868 |
| Study title: Van-Eys-J. Dept. Ped., Univ. Texas Syst. Cancer Cent., M.D. Anderson Hosp. Tum. Inst., Houston, Tex., United States. Chemotherapy for gliomas in children. Cancer Bulletin {CANCER-BULL}, 1975, Vol/Iss/Pg. 27/1 (16-19).Van-Eys-J. Dept. Ped., Univ. Texas Syst. Cancer Cent., M.D. Anderson Hosp. Tum. Inst., Houston, Tex., United States. Chemotherapy for gliomas in children. Cancer Bulletin {CANCER-BULL}, 1975, Vol/Iss/Pg. 27/1 (16-19). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34869 |
| Study title: Van-Eys-J. Division of Pediatrics, The University of Texas M.D. AndersonHospital and Tumor Institute, Houston, TX, United States. The improved outlook for children with brain tumors. Cancer Bulletin {CANCER-BULL}, 1986, Vol/Iss/Pg. 38/1 (19-23).Van-Eys-J. Division of Pediatrics, The University of Texas M.D. AndersonHospital and Tumor Institute, Houston, TX, United States. The improved outlook for children with brain tumors. Cancer Bulletin {CANCER-BULL}, 1986, Vol/Iss/Pg. 38/1 (19-23). |
| Active substance: PROCARBAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34870 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44316 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Drug experience reports on 2 children receiving overdosage of teicoplaninReport in Clinical documentation for Marketing Authorisation Application (June 1987): Drug experience reports on 2 children receiving overdosage of teicoplanin |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44317 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Del Favero A. - 28 November 1985Report in Clinical documentation for Marketing Authorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Del Favero A. - 28 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Gram positive - Del Favero.xls |
| View full study record |
| Document reference: 44318 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Martino - 28 November 1985Report in Clinical documentation for Marketing Authorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Martino - 28 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Serious infections - Martino.xls |
| View full study record |
| Document reference: 44320 |
| Study title: Report in Clinical documentation for Marketing Authorisation Application (March 1987): European Multicentre open study of teicoplanin in Gram-positive infection ; 1987 sponsor summary - P.J. Lewis - 6 April 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87-42.xls |
| View full study record |
| Document reference: 44310 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical Pharmacology of teicoplanin in children - Milner R.D.G., Whincup G. - 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical Pharmacology of teicoplanin in children - Milner R.D.G., Whincup G. - 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY pharmacological.xls |
| View full study record |
| Document reference: 44315 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Concia E., Andreoni M., Suter F. - 4 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 357.DLI.1075.xls |
| View full study record |
| Document reference: 44296 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Dietrich H.A., Fell J.J., Pugnetti P. - 6 February 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY LP-SM-0025.xls |
| View full study record |
| Document reference: 44297 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 356.DLI.1074.xls |
| View full study record |
| Document reference: 44298 |
| Study title: Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-upPerindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-up |
| Active substance: PERINDOPRIL |
| Study summary document link (including results): perindopril_CL3-09490-123-FRA_publication_Duboc_2007.pdf |
| View full study record |
| Document reference: 47712 |
| Study title: Preventive effect of perindopril on the onset and progression of left ventricular dysfunction in subjects suffering from Duchenne Muscular Dystrophy. Double-blind multicentre, placebo-controlled study of 2 and 4 mg of perindopril in 60 subjects over a period of 3 years. |
| Active substance: PERINDOPRIL |
| Study summary document link (including results): perindopril_CL3-09490-123-FRA_publication_Duboc_2005.pdf |
| View full study record |
| Document reference: 45864 |
| Study title: A multi-center, 6-week, open label study to document the visual treatment characteristics of Elidel (pimecrolimus) cream 1% (twice daily application) by photography in patients >2 years old in the treatment of mild to moderate atopic dermatitis. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2314 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34089 |
| Study title: A multi-center, 6-week, open label study to document the visual treatment characteristicsof Elidel (pimecrolimus) cream 1% (twice daily application) by photography in patients >2 years old in the treatment of mild to moderate atopic dermatitis. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2435 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47710 |
| Study title: A multicenter , non-interventional study about pimecrolimus 1 % cream, to measure the drug consumption and cosmetical tolerability in the treatment of mild or moderate atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CHU03 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34113 |
| Study title: A prospective, open label proof of concept study |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CBE01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 48117 |
| Study title: A randomized, double-blind, multicenter study of the blood concentrations, safety and efficacy of 1% SDZ ASM981 cream administered up to four times daily in adolescents and adults with atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CUS01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34138 |
| Study title: A randomized, multi-center, parallel-group, double-blind, vehicle-controlled study to evaluate the time of pruritus improvement during the first week of pimecrolimus cream 1% treatment in patients >2 years old with mild to moderate atopic dermatitis. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CUS08 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34104 |
| Study title: A Retrospective Analysis of Elidel (pimecrolimus cream 1%) for the Treatment of Facial Vitiligo. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47708 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN (UNASYN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42753 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN (UNASYN) IN THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42754 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULPERAZONE IN THE TREATMENT OF INFECTIONS IN LEUKEMIC CHILDREN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42759 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF CEFOPERAZONE/SULBACTAM (1:1) IN THE EMPIRICAL TREATMENT OF SYSTEMIC INFECTIONS IN ADULT PATIENTS IN HOSPITAL KUALA LUMPUR |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42847 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42851 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTION. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42854 |
| Study title: AN OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF BONE/JOINT INFECTIONS AND OSTEOMYELITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42857 |
| Study title: AN OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF SURGICAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42849 |
| Study title: AN OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42852 |
| Study title: AN OPEN, PROSPECTIVE STUDY OF SBT/CFP (1:1) IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42861 |
| Study title: AN OPEN, PROSPECTIVE, STUDY OF THE EFFICACY AND SAFETY OF SBT/CFP (1:1) IN THE TREATMENT OF NOSOCOMIAL PNEUMONIA, IN ADULT PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42869 |
| Study title: CLINICAL EVALUATION IF SULPERAZON (SP) FOR INFECTIONS WITH UNDERLYING DISEASES IN THE FIELD OF UROLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42769 |
| Study title: CLINICAL EVALUATION OF SBT/CFP FOR RESPIRATORY TRACT INFECTIONS IN PREMATURE BORN BABIES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42760 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR HBTI COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42791 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH DIGESTIVE MALIGNANT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42797 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42798 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH CEREBROVASCULAR DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42786 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH DIGESTIVE MALIGNANT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42783 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH GYNECOLOGICAL MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42814 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42781 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42820 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANT DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42782 |
| Study title: A single-centre, randomised, double-blind, placebo-controlled pilot study of cross-over design testing nifedipine in patients with cystic fibrosis. |
| Active substance: NIFEPIDINE |
| Study summary document link (including results): Bayer Pharma_Nifedipine_1123_study_synopsis.pdf |
| View full study record |
| Document reference: 32631 |
| Study title: A study to determine the effect of nifedipine (Adalat Retard) on early renal allograft function and cyclosoprin nephrotoxicity. |
| Active substance: NIFEPIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32633 |
| Study title: "DRUCKSENKUNG DER PULMONALEN HYPERTENSION DURCH BAYA1040, SUBLINGUAL, IM RAHMEN VON BRONCHOPULMONALER DYSPLASIE BEI KINDERN UNTER 2 JAHRE" |
| Active substance: NIFEPIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32635 |
| Study title: Open, non controlled, non randomised, unicenter pilot study to investigate the long-term efficacy of Adalat® drops and Adalat® retard 10 mg tablets in children with pulmonary hypertension and with peripheral pulmonary stenosis |
| Active substance: NIFEPIDINE |
| Study summary document link (including results): Bayer Pharma_Nifedipine_1555_study_synopsis.pdf |
| View full study record |
| Document reference: 32632 |
| Study title: "PILOTSTUDIE: LANGZEITWIRKUNG VON ADALAT TROPFEN UND ADALAT RETARD BEI KINDERN MIT PULMONALER HYPERTONIE UND PERIPHEREN PULMONALSTENOSEN." |
| Active substance: NIFEPIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32636 |
| Study title: Dr. Benezis Essai contrôle en double aveugle etablissant l'efficacité et la tolerance de l'acide niflumique gélule par rapport au placébo et au diclofenac dans les tendinites du membre inférieur. |
| Active substance: NIFLUMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32637 |
| Study title: Dr. M. Chelly.Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines. |
| Active substance: NIFLUMIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32638 |
| Study title: A propos du traitement des diarrhées aiguës du nourrisson.Essai d’un nouvel antiseptique intestinal : le 27.109 R.C - Riedweg M, Herlier M. - 1964 (J. Méd. Lyon, 5 Mai 1964) - Publication in Clinical Expert Report - Lassale C. - July 1998 - |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47065 |
| Study title: Clinical Expert Statement - Renewal of the MA for Nifuroxazide Capsules - Guigen S. & Verdoncq B. - 15/11/2007 |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47067 |
| Study title: Diarrhées infantiles et médicaments antidiarrhétiques en France - No author - 09/1996 (Pimed) - Publication in Clinical Expert Report - Lassale C. - July 1998 - |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47069 |
| Study title: Recherche d'une éventuelle absorption digestive du nifuroxazide au cours des gastro-entérites aigues infantiles - Colle M. Battin J. Guinebault P. - 16/07/85 |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47070 |
| Study title: The management of acute diarrhea in children: oral rehydratation, maintenance, and nutritiaonal therapy - Duggan C. et al. - 1992 (Morb. Mortal. Wkly. Rep., 1992, 41 (RR-16): 1-20)The management of acute diarrhea in children: oral rehydratation, maintenance, and nutritiaonal therapy - Duggan C. et al. - 1992 (Morb. Mortal. Wkly. Rep., 1992, 41 (RR-16): 1-20) |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47063 |
| Study title: "Tolerability of Nimesulide and Ketoprofen in Paediatric Patients with Traumatic or Surgical Fractures, Facchini R et al. Drugs 46 (Suppl.1): 238-241, 1993 (only studies with patients 12-17 years are included, as use below 12 is contraindicated)" "Tolerability of Nimesulide and Ketoprofen in Paediatric Patients with Traumatic or Surgical Fractures, Facchini R et al. Drugs 46 (Suppl.1): 238-241, 1993 (only studies with patients 12-17 years are included, as use below 12 is contraindicated)" |
| Active substance: NIMESULIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32648 |
| Study title: British-Scandinavian co-operative headinjury study (HIT-I) |
| Active substance: NIMODIPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32649 |
| Study title: Anticonvulsant toxicity in paediatric out-patients. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32659 |
| Study title: A screening study for potential intestinal absorption of nifuroxazide in infants presenting with acute gastro-enteritis - Battin J. Guinebault P. Colle M. - 18/12/2002 |
| Active substance: NIFUROXAZIDE |
| Study summary document link (including results): NIFUROXAZIDE 86 00311-EN-00.xls |
| View full study record |
| Document reference: 47066 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and safety of teicoplanin in the treatment of infections caused by Gram-positive cocci. A summary report of over 298 cases treated in France - Garaud J.J., Tarra -17/02/1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87.03.xls |
| View full study record |
| Document reference: 44299 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Martinetto P. - 22 November 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Martinetto P. - 22 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Gram positive - Martinetto.xls |
| View full study record |
| Document reference: 44319 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): European Multicentre open study of teicoplanin in Gram-positive infection ; 1987 sponsor summary - P.J. Lewis - 6 April 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87-42.xls |
| View full study record |
| Document reference: 44300 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Terragna A. - 28 November 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Terragna A. - 28 November 1985 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY Serious infections - Terragna.xls |
| View full study record |
| Document reference: 44321 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Pharmacokinetics of teicoplanin in paediatric patients - Rosina R., Bernareggi A., Danese A., Cavenaghi L - 14 November 1986 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 348.DLI 1039.xls |
| View full study record |
| Document reference: 44301 |
| Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients - Garaud J.J. - 9 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY EG-87-16.xls |
| View full study record |
| Document reference: 44302 |
| Study title: Summary - Clinical documentation for Marketing Autorisation Application - June 1987Summary - Clinical documentation for Marketing Autorisation Application - June 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44322 |
| Study title: Summary of clinical studies of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections in the UK and Eire- Concia E., Andreoni M., Suter F. - 4 March 1987 ; Report in Clinical documentation for Marketing Autorisation Application - June 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44303 |
| Study title: Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. - Lemerle S, De la Roque F, Lamy R, et al. - J Antimicrob Chemother 1988; 21, S.A.: 112-116.Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. - Lemerle S, De la Roque F, Lamy R, et al. - J Antimicrob Chemother 1988; 21, S.A.: 112-116. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44324 |
| Study title: Teicoplanin in gram-positive paediatric infections. (Abstract) In: Abstracts of the 8th mediterranean congress of chemotherapy. - Careddi P, Boccazzi A, Mosconi G. - Athens, 24-29 May 1992: 236.Teicoplanin in gram-positive paediatric infections. (Abstract) In: Abstracts of the 8th mediterranean congress of chemotherapy. - Careddi P, Boccazzi A, Mosconi G. - Athens, 24-29 May 1992: 236. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44325 |
| Study title: AD on face: A 6-month study with 3 week randomized, multicenter, double blind, vehicle-controlled, parallel phase followed by 23 week open-label phase to study the safety and efficacy of 1% SDS ASM981 cream in pediatric subjects with atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CES01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34102 |
| Study title: An investigator initiated study to explore the effectiveness of pimecrolimus cream 1% used twice daily (BID) for the treatment of facial vitiligo |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CUS28 Art45 listing 2011.xls |
| View full study record |
| Document reference: 48121 |
| Study title: Graf et al. Ten days' Use of Oxymetazoline Nasal Spray With or Without Benzalkonium Chloride in Patients With Vasomotor Rhinits. Arch Otolaryngol Head Neck Surg 1999; 125: 1128-1132Graf et al. Ten days' Use of Oxymetazoline Nasal Spray With or Without Benzalkonium Chloride in Patients With Vasomotor Rhinits. Arch Otolaryngol Head Neck Surg 1999; 125: 1128-1132 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33042 |
| Study title: Graf, Hallén. Effect on the Nasal Mucosa of Long-Term Treatment With Oxymetazoline, Benzalkonium Chloride, and Placebo Nasal Sprays. Laryngoscope 1996; 106:605-609Graf, Hallén. Effect on the Nasal Mucosa of Long-Term Treatment With Oxymetazoline, Benzalkonium Chloride, and Placebo Nasal Sprays. Laryngoscope 1996; 106:605-609 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33041 |
| Study title: Grävinghoff 1972Grävinghoff 1972 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47265 |
| Study title: GrossmanGrossman |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47267 |
| Study title: Petczelies 1972Petczelies 1972 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47264 |
| Study title: Semmelmayer 1972Semmelmayer 1972 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33040 |
| Study title: Wolf 1973Wolf 1973 |
| Active substance: OXYMETAZOLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47266 |
| Study title: Treatment of trachoma in the West Bank. Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Eye. 1988;2 ( Pt 5):471-5.Treatment of trachoma in the West Bank. Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Eye. 1988;2 ( Pt 5):471-5. |
| Active substance: OXYTETRACYCLINE |
| Study summary document link (including results): Treatment of trachoma in the West Bank. Chumbley LC, Viswalingam ND, Thomson IM, Zeidan MA. Eye. 1988;2 ( Pt 5)471-5.pdf |
| View full study record |
| Document reference: 33043 |
| Study title: Study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.Doz F; Gentet J C et al. British journal of cancer Mar 2 2001, 84 (5) p604-10 , Study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.Doz F; Gentet J C et al. British journal of cancer Mar 2 2001, 84 (5) p604-10 , |
| Active substance: PACLITAXEL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33044 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Paeonia-Salbe-Heel (ointment) [AWB-AT] |
| Active substance: Paeonia-Heel - Salbe |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40092 |
| Study title: Study PALIOROS-PSZ-1001 is a multicenter, open-label, single- and multiple-dose study in subjects aged 10 to 17 years, inclusive, diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform disorder to evaluate pharmcokinetics and tolerability. |
| Active substance: PALIPERIDONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45719 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR INFLAMMATION OF PELVIC DEAD SPACE POST-OPERATION OF GYNECOLOGICAL MALIGNANT DISEASE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42823 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR RESPIRATORY TRACT INFECTION (RTI) OR SEPSIS COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42793 |
| Study title: CLINICAL EVALUATION OF SULPERAZON (SP) FOR URINARY TRACT INFECTIONS (UTI) WITH UNDERLYING DISEASES IN THE FIELD OF UROLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42803 |
| Study title: CLINICAL EVALUATION OF SULPERAZON AND PIPERACILLIN FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42838 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42822 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42830 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42831 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42832 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42836 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42841 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42842 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42844 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42827 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42845 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42819 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42818 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42808 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42816 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42811 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR INFECTIONS WITH TOTAL PARENTAL NUTRITION (T.P.N.) PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42776 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR POST-OPERATIVE INFECTIONS IN THE FIELD OF PLASTIC SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42771 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASE ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42772 |
| Study title: Deaths in young children receiving nitrazepam. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32660 |
| Study title: Human pharmacokinetics of nitrazepam:effect of age and disease. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32661 |
| Study title: Improvement of mental retardation plus epilepsy in children following management. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32654 |
| Study title: Incidence of Death in Patients with Intractable Epilepsy during Nitrazepam therapy. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32662 |
| Study title: Infantile spasms. A retrospective study of 105 cases. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32658 |
| Study title: Infantile spasms. Comparative trial of nitrazepam and corticotropin. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32652 |
| Study title: Nitrazepam for refractory infantile spasms and the Lennox-Gastaut syndrome. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32656 |
| Study title: Nitrazepam for the treatment of Lennox-Gastaut syndrome. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32655 |
| Study title: Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32653 |
| Study title: Seizures with clonazepam: Discontinuation and suggestions for safe discontinuation rates in children. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32657 |
| Study title: Short-term nonhormonal and nonsteroid treatment in West syndrome. Short-term nonhormonal and nonsteroid treatment in West syndrome. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32650 |
| Study title: West syndrome: clinical and electroencephalographic follow up of 70 patients and response to its treatment with adrenocorticotropic hormone, prednisone, vigabatrin, nitrazepam and valproate. |
| Active substance: NITRAZEPAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32651 |
| Study title: Nitrix oxide for inhalation, INOMAX® INOT22 1-Year and 3-Year Follow up report: comparison of supplemental Oxygen and nitric oxide for inhalation plus oxygen in the evaluation of the reactivity of the pulmonary vasculature during acute pulmonary vasodilator testing |
| Active substance: Nitric oxide |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41519 |
| Study title: Bortone L, Picetti E, Mergoni M. Anaesthesia with sevoflurane in children: Nitrous oxide does not increase postoperative vomiting. Paediatric Anaesthesia. 2002; 12(9):775-9. Bortone L, Picetti E, Mergoni M. Anaesthesia with sevoflurane in children: Nitrous oxide does not increase postoperative vomiting. Paediatric Anaesthesia. 2002; 12(9):775-9. |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32663 |
| Study title: Byhahn C, Strouhal U, Westphal K. The anaesthesiologist's occupational exposure to sevoflurane and nitrous oxide during inhalation mask induction and general anaesthesia in paediatric anaesthesia. Anaesthesiologie und Reanimation. 2000; 25(1):12-6. Byhahn C, Strouhal U, Westphal K. The anaesthesiologist's occupational exposure to sevoflurane and nitrous oxide during inhalation mask induction and general anaesthesia in paediatric anaesthesia. Anaesthesiologie und Reanimation. 2000; 25(1):12-6. |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32664 |
| Study title: Felmet K, Robins B, Tilford D, Hayflick SJ. Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. Journal of Pediatrics. 2000; 137(3):427-8. Felmet K, Robins B, Tilford D, Hayflick SJ. Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. Journal of Pediatrics. 2000; 137(3):427-8. |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32665 |
| Study title: Goldman LJ. Anesthetic uptake of sevoflurane and nitrous oxide during an inhaled induction in children. Anesthesia and Analgesia. 2003; 96(2):400-6 Goldman LJ. Anesthetic uptake of sevoflurane and nitrous oxide during an inhaled induction in children. Anesthesia and Analgesia. 2003; 96(2):400-6 |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32666 |
| Study title: Teicoplanin in the treatment of gram positive infections in paediatric patients. (Abstract) In: Abstracts of the 7th mediterranean congress of chemotherapy. - Becker L, Fell JJ, Dieterich HA. -Barcelona, 20-25 May 1990: 183.Teicoplanin in the treatment of gram positive infections in paediatric patients. (Abstract) In: Abstracts of the 7th mediterranean congress of chemotherapy. - Becker L, Fell JJ, Dieterich HA. -Barcelona, 20-25 May 1990: 183. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44326 |
| Study title: A 4-week repeated dose toxicity study of HMR3647 administered orally to young Beagle dogs followed by a 4-weeek recovery period |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41545 |
| Study title: A 4-week repeated dose toxicity study of HMR3647 administered to young rats |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41544 |
| Study title: Activity of telithromycin against erythromycin susceptible and resistant Streptococcus pyogenes and Streptococcus pneumoniae isolates from paediatric origin |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41554 |
| Study title: Activity of telithromycin and comparators against paediatric respiratory tract infection (RTI) isolates collected across Canada over the past 3 years (1997-1998, 1998-1999, and 1999-2000) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41558 |
| Study title: Activity of telithromycin on clinical isolates of Streptococcus pyogenes and Streptococcus pneumoniae from paediatric patients in different regions of Italy |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41553 |
| Study title: Determination of the susceptibility of isolates of Streptococcus pneumoniae and Streptococcus pyogenes, from paediatric patients, to telithromycin and comparator compounds and identification of the mechanism of resistance in erythromycin A-resistant strains |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41551 |
| Study title: Evaluation of pharmacokinetics, safety, efficacy and acceptability of HMR3647 (20mg/kg and 30mg/kg q.d.) in pediatric patients with infection (a non-blind, randomised, parallel-group comparative study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41572 |
| Study title: Evaluation of telithromycin on acute otitis media in an experimental animal model (chinchilla) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41563 |
| Study title: Evaluation of the Safety, Efficacy, Pharmacokinetics and Acceptability of HMR 3647 20 mg/kg QD for 5 Days with Acute Otitis Media in Children(Multicenter, open label, non comparative study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41574 |
| Study title: Evaluation of the Safety, Pharmacokinetics, Efficacy and Acceptability of HMR 3647 20mg/kg QD for 5-7 Days with Community Acquired Pneumonia (CAP) in children. (Multicenter, open label, non comparative study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41573 |
| Study title: Experimental studies of otitis media due to Streptococcus pneumoniae treated with HMR3647 |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41562 |
| Study title: HMR3647: Exploratory 7-day oral toxicity study in Sprague Dawley juvenile rats (from postnatal day 5) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41546 |
| Study title: HMR3647: Single-dose toxicokinetic study in neonatal Sprague Dawley rats |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41543 |
| Study title: In vitro actibity of telithromycin (HMR3647) against Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates from paediatric patients in Greece |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41552 |
| Study title: In vitro activity of antimicrobial agents against Streptococcus pyogenes in paediatrics : a Belgian multicenter study |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41560 |
| Study title: In vitro activity of telithromycin (HMR3647) against strains of S.pneumoniae and S. pyogenes isolated in Iceland and comparison with other antimicrobials |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41556 |
| Study title: In vitro activity of telithromycin and multiple comparison antibiotics against recent clinical isolates from children |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41559 |
| Study title: In vitro activity of telithromycin, including well characterized erythromycin. A - resistant clinical isolates of S. pneumoniae and S.pyogenes in paediatrics |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41549 |
| Study title: A Phase 1111 Study of the Safety. Tolerance and Pharmacokinetics ofMEDI-493. a Humanized Monoclonal Antibody to Respiratory Syncytial Virus. Administered Intramuscularly in Children with a History of Prematurity or Bronchopulmonary Dysplasia |
| Active substance: palivizumab |
| Study summary document link (including results): palivizumab-mi-cp011.pdf |
| View full study record |
| Document reference: 48096 |
| Study title: A Phase 1111 Study of the Safety. Tolerance and Pharmacokinetics ofMEDI-493. a Humanized Monoclonal Antibody to Respiratory Syncytial Virus. Administered Intramuscularly in Children with a History of Prematurity or Bronchopulmonary Dysplasia |
| Active substance: palivizumab |
| Study summary document link (including results): palivizumab-mi-cp012.pdf |
| View full study record |
| Document reference: 48097 |
| Study title: A Phase 2, Open-Label, Prospective, Safety and pK Study to Assess the Extended Use of Synagis (Seven Injections) in Infants and Children with or without CLD |
| Active substance: palivizumab |
| Study summary document link (including results): palivizumab-w00-350.pdf |
| View full study record |
| Document reference: 48108 |
| Study title: A phase III combined study of efficacy and side effects profile of extended release acetaminophen pediatric chewable tablets compared to acetaminophen eight-hour extended release pediatric suspension in the treatment of febrile children. Aug 1998.A phase III combined study of efficacy and side effects profile of extended release acetaminophen pediatric chewable tablets compared to acetaminophen eight-hour extended release pediatric suspension in the treatment of febrile children. Aug 1998. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33333 |
| Study title: A phase III double-blind, single dose study of the comparative antipyretic effectiveness and safety of standard and double standard (C-47) doses of acetaminophen in febrile children. Jan 1984.A phase III double-blind, single dose study of the comparative antipyretic effectiveness and safety of standard and double standard (C-47) doses of acetaminophen in febrile children. Jan 1984. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33340 |
| Study title: A Phase III Multiple Dose Use Study of APAP Extended Release Pediatric Chewable Tablets Compared to Children's Tylenol Chewable Tablets in the Treatment of Febrile Children. Dec 1994.A Phase III Multiple Dose Use Study of APAP Extended Release Pediatric Chewable Tablets Compared to Children's Tylenol Chewable Tablets in the Treatment of Febrile Children. Dec 1994. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33336 |
| Study title: A Phase III Multiple Dose Use Study of APAP Extended Release Pediatric Suspension Compared to Children's Tylenol Elixir in the Treatment of Febrile Children. 94-406, Unpublished Report CSR204. May 1997.A Phase III Multiple Dose Use Study of APAP Extended Release Pediatric Suspension Compared to Children's Tylenol Elixir in the Treatment of Febrile Children. 94-406, Unpublished Report CSR204. May 1997. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33335 |
| Study title: A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, and placebo in febrile children. Aug 1992.A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, and placebo in febrile children. Aug 1992. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33342 |
| Study title: A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, choline salicylate and placebo in febrile children. Jun 1991.A phase IV double-blind multicenter study comparing the antipyretic effectiveness of aspirin, acetaminophen, choline salicylate and placebo in febrile children. Jun 1991. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33343 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTION (RTI) WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASES, ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42768 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42792 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (COPD). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42809 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (COPD ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42817 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS COMPLICATED WITH STOMACH CANCER OR COLON CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42824 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH CEREBROVASCULAR DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42834 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42778 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42801 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42840 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42843 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (COPD ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42837 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) OR SEPSIS COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42828 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) WITH UNDERLYING DISEASE (COPD ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42821 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS (RTI) IN PATIENTS WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ETC.) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42835 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR RESPIRATORY TRACT INFECTIONS IN PATIENTS WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASES, ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42765 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE INFECTIONS COMPLICATED WITH GYNECOLOGICAL MALIGNANT DISEASE, ETC. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42775 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE INFECTIONS COMPLICATED WITH THE MALIGNANT DISEASES IN THE FIELD OF E.N.T. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42800 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE INFECTIONS IN THE FIELD OF INTENSIVE CARE UNIT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42810 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS COMPLICATED WITH DIGESTIVE SYSTEM MALIGNANT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42767 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF ENT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42780 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF ENT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42784 |
| Study title: McNeely JK, Buczulinski B, Rosner DR. Severe neurological impairment in an infant after nitrous oxide anesthesia. Anesthesiology. 2000; 93(6):1549-50. McNeely JK, Buczulinski B, Rosner DR. Severe neurological impairment in an infant after nitrous oxide anesthesia. Anesthesiology. 2000; 93(6):1549-50. |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32667 |
| Study title: Ou X, Li B, Du H. Clinical study: The effects of inhaling nitrous oxide for analgesia labor on pregnant women and fetus. Zhonghua Fu Chan Ke Za Zhi 2001 Jul;.36(7):399-401 Ou X, Li B, Du H. Clinical study: The effects of inhaling nitrous oxide for analgesia labor on pregnant women and fetus. Zhonghua Fu Chan Ke Za Zhi 2001 Jul;.36(7):399-401 |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32668 |
| Study title: PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852 PA Averley, NM Girdler, S Bond, N Steen, J Steele. A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide⁄sevoflurane. Anaesthesia, 2004, 59, pages 844–852 |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32669 |
| Study title: Puttick N, Rosen M. Propofol induction and maintenance with nitrous oxide in paediatric outpatient dental anaesthesia. A comparison with thioopentone-nitrous oxide-halothane. Anaesthesia. 1988; 43(8):646-9. Puttick N, Rosen M. Propofol induction and maintenance with nitrous oxide in paediatric outpatient dental anaesthesia. A comparison with thioopentone-nitrous oxide-halothane. Anaesthesia. 1988; 43(8):646-9. |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32670 |
| Study title: Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. New England Journal of Medicine. 2003; 349(1):45-50. Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. New England Journal of Medicine. 2003; 349(1):45-50. |
| Active substance: NITROUS OXIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32671 |
| Study title: Abdelkefi A, Abdennebi YB, Mellouli F, Othman TB, Torjman L, Ladeb S, Aouf S, Béjaoui M, Abdeladhim AB. Effectiveness of fixed 50% nitrous oxide oxygen mixture and EMLA cream for insertion of central venous catheters in children. Pediatr Blood Cancer 2004;43;777-779 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32673 |
| Study title: Annequin D, Carbajal R, Chauvin P, Gall O, Tourniaire B, Murat I. Fixed 50% nitrous oxide oxygen mixture for painful procedures: A French survey. Pediatrics 2000 Apr;105(4):E47. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32675 |
| Study title: Baskett PJF, Hyland J, Deane M, Wray G. Analgesia for burns dressing in children. A dose-finding study for phenoperidine and droperidol with and without 50 per cent nitrous oxide and oxygen. Br J Anaesth 1969 Aug;41(8):684-8. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32676 |
| Study title: Beh T, Splinter W, Kim J. In children, nitrous oxide decreases pain on injection of propofol mixed with lidocaine.Can J Anesth 2002;49(10);1061-1063 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32677 |
| Study title: Berge TI. Acceptance and side effects of nitrous oxide oxygen sedation for oral surgical procedures. Acta Odontol Scand 1999 Aug;57(4):201-6. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32678 |
| Study title: Braam MJI, Bath AP, Spauwen PHM, Bailie FB. Survey of analgesia regimens in burns centres in the UK. Burns 1994 Aug;20(4):360-2. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32679 |
| Study title: Bryan RA. The success of inhalation sedation for comprehensive dental care within the Community Dental Service. Int J Paediatr Dent 2002 Nov;12(6):410-4. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32680 |
| Study title: Burton JH, Auble TE, Fuchs SM. Effectiveness of 50% nitrous oxide/50% oxygen during laceration repair in children. Acad Emerg Med 1998 Feb;5(2):112-7. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32681 |
| Study title: Investigation of the efficacy, safety and acceptability of HMR 3647 (1-g divided 20% fine granule packets) in paediatric patients with infections ( a multi-center collaborative single-group non blinded study) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41575 |
| Study title: macrolide-resistant streptococci among pediatric patients in Denmark, Luxemburg, The Netherlands and Turkey |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41548 |
| Study title: Minimal inhibittory concentrations of telithromycin (Ketek) against Streptococcus pneumoniae, Heamophilus influenzae and Moraxella catarrhalis strains isolated from specimen of young patients (17 years old or less) and from specimen of adults (18 years old and older) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41557 |
| Study title: Multicenter, Phase II, open-label study of the efficacy, safety, acceptability, and pharmacokinetics of telithromycin, after repeated oral administration of either of two doses, once daily, for 5 days or 7 to 10 days, in the treatment of respiratory tracts infections in children of 6 months to 12 years |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41569 |
| Study title: Multicenter, Phase II, open-label study of the efficacy, safety, acceptability, and pharmacokinetics of telithromycin, following administration of 20mg/kg once daily, for 5 days in the treatment of acute otitis media in children |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41570 |
| Study title: Multicenter, Phase II, open-label study of the efficacy, safety, acceptability, and pharmacokinetics of telithromycin, following administration of 15mg/kg twice daily, for 5 days in the treatment of acute otitis media in children |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41571 |
| Study title: Open Study to determine the concentration of telithromycin in middle ear fluid and plasma in infants/children with otitis media with effusion after multiple oral administration of 20mg/kg, once daily for 5 days or 15mg/kg twice daily for 4.5/5 days of telithromycin pediatric suspension |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41568 |
| Study title: Open Study to determine the concentration of telithromycin in the extracellular and intracellular compartments of middle ear fluid in children with acute otitis media or otitis media with spontaneous effusion after single oral administration of a telithromycin pediatric suspension |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41567 |
| Study title: Pattern of killing of telithromycin and azithromycin against various strains of Streptococcus pneumoniae |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41561 |
| Study title: Pharmacokinetics of Telithromycin (HMR3647) in infants and children suffering from bacterial lower respiratory tract infections after single oral administration of 30mg/kg of a telithromyucin suspension (50mg/ml) |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41565 |
| Study title: Susceptibility of 1034 Streptococcus pneumoniae and 1039 Streptococcus pyogenes strains from paediatric patients in ten central and eastern European contries to telithromycin, erythromycin A, azithromycin, clarithromycin, clindamycin, levofloxacin, quinupristin/dalfopristin, and penicillin G |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41555 |
| Study title: Telithromycin : epidemiological multicenter study on macrolide resistance of S.pneumoniae and S.pyogenes in the pediatric population in Germany, 2000- 2001 |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41550 |
| Study title: Telithromycin epidemiological survey in Austria isolates from paediatric patients |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41547 |
| Study title: U.S Survey of Telithromycin Activity against Streptococcus pyogenes |
| Active substance: telithromycin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41564 |
| Study title: Evaluation of Prednisone, Vincristine and Teniposide Combination Therapy for Refractory Childhood Lymphocytic Leukemia |
| Active substance: TENIPOSIDE |
| Study summary document link (including results): teniposide 106-020.pdf |
| View full study record |
| Document reference: 46912 |
| Study title: A double blind, parallel, multicenter comparison of tenoxicam with naproxene in the treatment of children and adolescents suffering from Juvenile Chronic Arthritis (JCA). |
| Active substance: TENOXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44339 |
| Study title: Open-label 40 weeks extension of study S-12159 to follow-up the long-term tolerability and efficacy of tenoxicam in children and adolescents suffering from juvenile rheumatoid arthritis (JRA) treated for up to one year. |
| Active substance: TENOXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44338 |
| Study title: Open-label short-term study to find the adequate dosage tenoxicam for the treatment of children and adolescents suffering from juvenile rheumatoid arthritis. |
| Active substance: TENOXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44337 |
| Study title: A randomized, investigator-blinded, parallel, single dose, multicenter study to compare for eight hours the efficacy and side effects profile of sustained release acetaminophen pediatric chewable tablets (20-30 mg/kg) compared to regular strength, conventional release acetaminophen pediatric chewable tablets (10-25 mg/kg) in the treatment of febrile children. Jan 1990.A randomized, investigator-blinded, parallel, single dose, multicenter study to compare for eight hours the efficacy and side effects profile of sustained release acetaminophen pediatric chewable tablets (20-30 mg/kg) compared to regular strength, conventional release acetaminophen pediatric chewable tablets (10-25 mg/kg) in the treatment of febrile children. Jan 1990. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33338 |
| Study title: A single dose study to compare the efficacy of acetaminophen elixir dosed at 10-15 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. Feb 1992.A single dose study to compare the efficacy of acetaminophen elixir dosed at 10-15 mg/kg and ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg in febrile children. Feb 1992. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33325 |
| Study title: Burow et al. Kopflausbefall in Deutschland: Korrelation zwischen Häufigkeit des "Resistenz-Gens" und klinischer Wirksamkeit von 0,5 % Permethrin-Lösung. Kinder- und Jugendarzt 2010;41(3):224-228Burow et al. Kopflausbefall in Deutschland: Korrelation zwischen Häufigkeit des "Resistenz-Gens" und klinischer Wirksamkeit von 0,5 % Permethrin-Lösung. Kinder- und Jugendarzt 2010;41(3):224-228 |
| Active substance: PERMETHRIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33897 |
| Study title: Hamm et al. Treatment of scabies with 5 % permethrin cream: results of a German multicenter study. J Dtsch Dermatol Ges 2006;4(5): 407-413Hamm et al. Treatment of scabies with 5 % permethrin cream: results of a German multicenter study. J Dtsch Dermatol Ges 2006;4(5): 407-413 |
| Active substance: PERMETHRIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33896 |
| Study title: Fujii Y. Anti-emetic efficacy of prophylactic granisetron compared with perphenazine for the prevention of post-operative vomiting in children (Eur J Anesthesiol 1999; 16: 304-307)Fujii Y. Anti-emetic efficacy of prophylactic granisetron compared with perphenazine for the prevention of post-operative vomiting in children (Eur J Anesthesiol 1999; 16: 304-307) |
| Active substance: PERPHENAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33898 |
| Study title: Splinter W. Prophylaxis for vomiting by children after tonsillectomy: dexamethasone versus perphenazine (Anest Analg 19976; 85: 534-537Splinter W. Prophylaxis for vomiting by children after tonsillectomy: dexamethasone versus perphenazine (Anest Analg 19976; 85: 534-537 |
| Active substance: PERPHENAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33900 |
| Study title: Splinter WM. Perphenazine decreases vomiting by children after tonsillectomy (Can J Anesth 1997; 44 /12): 1308-1310)Splinter WM. Perphenazine decreases vomiting by children after tonsillectomy (Can J Anesth 1997; 44 /12): 1308-1310) |
| Active substance: PERPHENAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33899 |
| Study title: Splinter WM. Prophylaxis for vomiting by children after tonsillectomy: ondansetron versus perphenazine (Br J Anesthesia 1998; 80: 155-158)Splinter WM. Prophylaxis for vomiting by children after tonsillectomy: ondansetron versus perphenazine (Br J Anesthesia 1998; 80: 155-158) |
| Active substance: PERPHENAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33901 |
| Study title: AWB Petadolex for long term prophylaxis of migraine in children and aldolescents |
| Active substance: Petasitidis extr. e rad. spiss. (28 – 44 :1); extraction solvent: CO2 (HERB)* |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40124 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF PLASTIC SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42802 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OR UROLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42787 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS IN THE FIELD OF UROLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42789 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42785 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR THE POST-OPERATIVE PERITONITIS THE FIELD OF GYNECOLOGIA |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42770 |
| Study title: CLINICAL EVALUATION OF SULPERAZON FOR UTI WITH UNDERLYING DISEASES IN THE FIELD OF UROLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42764 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR HBTI COMPLICATED WITH HEPATO- BILIARY TRACT DISEASES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42833 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42812 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42807 |
| Study title: CLINICAL EVALUATION OF SULPERAZONE FOR INFECTIONS COMPLICATED WITH HEPATO-BILIARY TRACT MALIGNANCY DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42804 |
| Study title: CLINICAL EVALUATION OF UNASYN-SIV IN THE TREATMENT OF PERFORATIVE PERITONITIS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42713 |
| Study title: CLINICAL EVALUATION SULPERAZON (SP) FOR INFECTIONS COMPLICATED WITH CNS DISEASES SUCH AS CEREBROVASCULAR DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42774 |
| Study title: CLINICAL STUDY OF SULBACTAM/CEFOPERAZONE IN CHILDREN WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42761 |
| Study title: CLINICAL TRIAL OF SULPERAZON (SP) PLUS FOSFOMYCIN/ARBEKACIN FOR RESPIRATORY TRACT INFECTIONS IN PATIENTS WITH UNDERLYING DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42763 |
| Study title: CLINICAL TRIAL OF SULPERAZON (SP) PLUS FOSFOMYCIN/ARBEKACIN/VANCOMYCIN FOR MRSA AND GRAM NEG RODS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42766 |
| Study title: CLINICAL TRIAL OF SULPERAZON ALONE OR SULPERAZON PLUS DALACIN-S FOR INFECTIONS IN PATIENTS WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42826 |
| Study title: CLINICAL TRIAL OF SULPERAZON PLUS FOSFOMYCIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS. STUDY COMPARATIVE TO WHETHER PATIENTS RECEIVES SBT/CFP OR FOSFOMYCIN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42825 |
| Study title: COMBINED THERAPY OF SBT/CFP AND CLINDAMYCIN (CLDM) FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42773 |
| Study title: COMBINED THERAPY OF SULBACTAM/CEFOPERAZONE AND DOXYCYCLINE FOR MRSA RESPIRATORY TRACT INFECTIONS (RTI) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42762 |
| Study title: COMBINED THERAPY OF SULPERAZON AND AMIKACIN (AMK) FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS OF CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42779 |
| Study title: COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR RESPIRATORY TRACT INFECTIONS (RTI) WITH UNDERLYING DISEASES (COPD ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42806 |
| Study title: COMBINED THERAPY OF SULPERAZON AND PIPERACILLIN (OR AMIKACIN) FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42777 |
| Study title: Cleary AG, Ramamon AV, Baildam E, Birch A, Sills JA, Davidson JE. Nitrous oxide analgesia during intra-articular injection for juvenile idiopathic arthritis. Arch Dis Child 2002;86:416-418. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32682 |
| Study title: Abdeladhim AB. Effectiveness of fixed 50% nitrous oxide oxygen mixture and EMLA cream for insertion of central venous catheters in children. Pediatr Blood Cancer 2004;43;777-779 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32674 |
| Study title: Constant I, Abbas M, Boucheseiche S, Laude D, Murat I. Non-invasive assessment of cardiovascular autonomic activity induced by brief exposure to 50% nitrous oxide in children. Br J Anaesth 2002;88(5):637-43. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32683 |
| Study title: Dunn-Russell T, Adair SM, Sams DR, Russell CM, Barenie JT. Oxygen saturation and diffusion hypoxia in children following nitrous oxide sedation. Pediatr Dent 1993 Mar-Apr;15(2):88-92. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32684 |
| Study title: Ekbom K, Jakobsson J, Marcus C. Nitrous oxide inhalation is a safe and effective way to facilitate procedures in paediatric outpatient departments. Arch Dis Child 2005;90:1073-1076. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32685 |
| Study title: Erbe RW, Salis RJ. Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide – A cautionary tale. N Engl J Med 2003;349(1):5-6. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32686 |
| Study title: Evans JK, Buckley SL, Alexander AH, Gilpin AT. Analgesia for the reduction of fractures in children: A comparison of nitrous oxide with intramuscular sedation. J Pediatr Orthop 1995 Jan-Feb;15(1):73-7. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32687 |
| Study title: Fauroux B, Onody P, Gall O, Tourniaire B, Koscielny S, Clément A. The efficacy of premixed nitrous oxide and oxygen for fiberoptic bronchoscopy in paediatric patients: A randomised, double-blind, controlled study. Chest 2004 Jan;125(1):315-21. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32688 |
| Study title: Felmet K, Robins B, Tilford D, Hayflick SJ. Acute neurologic decompensation in an infant with cobalamin deficiency exposed to nitrous oxide. J Paediatr 2000;137;427-428 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32689 |
| Study title: Fishman G, Botzer E, Marouani N, DeRowe A. Nitrous oxide-oxygen inhalation for outpatient otologic examination and minor procedures performed on the uncooperative child. International Journal of Pediatric Otorhinolaryngology 2005;69:501-504. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32690 |
| Study title: Frampton A, Browne GJ, Lam LT, Cooper MG, Lane LG. Nurse administered relative analgesia using high concentration nitrous oxide to facilitate minor procedures in children in an emergency department. Emerg Med J 2003;20:410-413. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32691 |
| Study title: Gall O, Annequin D, Benoit G, Van Glabeke E, Vrancea F, Murat I. Adverse events of premixed nitrous oxide and oxygen for procedural sedation in children. Lancet 2001;358:1514-15. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32692 |
| Study title: Gamis AS, Knapp JF, Glenski JA. Nitrous oxide analgesia in a pediatric emergency department. Ann Emerg Med 1989 Feb;18:177-181. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32693 |
| Study title: Gregory PR, Sullivan JA. Nitrous oxide compared with intravenous regional anesthesia in pediatric forearm fracture manipulation. J Pediatr Orthop 1996;16:187-191. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32694 |
| Study title: Griffin GC, Campbell VD, Jones R. Nitrous oxide-oxygen sedation for minor surgery. JAMA 1981 June 19;245(23):2411-2413. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32695 |
| Study title: Heafield R, Jackson R. Entonox and its use in the orthopaedic out-patient department. The Pain Network Newsletter 2001 Summer;29:4-6. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32696 |
| Study title: Hee HI, Goy RWL, Ng AS. Effective reduction of anxiety and pain during venous cannulation in children: a comparison of analgesic efficacy conferred by nitrous oxide, EMLA and combination. Paed Anaesth 2003;13:210-216. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32697 |
| Study title: Hennrikus WL, Shin AY, Klingelberger CE. Self-administered nitrous oxide and a haematoma block for analgesia in the Outpatient reduction of fractures in children. J Bone Joint Surg 1995;77A(3);335-339 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32698 |
| Study title: Hennrikus WL, Simpson RB, Klingelberger CE, Reis MT. Self-administered nitrous oxide analgesia for pediatric fracture reductions. J Pediatr Orthoped 1994;14:538-542. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32699 |
| Study title: Single dose pharmacokinetic study of tenoxicam in children and adolescents ruffering from Juvenile Rheumathoid Arthritis (JRA). |
| Active substance: TENOXICAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44340 |
| Study title: A randomized, doble-blind, parallel group study to determine the effective duration (1,2 or 4 weeks) and safety of Lamisil (tablets) given once daily to patients with tinea capitis due to Trichophyton species (mainly T. tonsurans) |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFO327 T201MR.xls |
| View full study record |
| Document reference: 44355 |
| Study title: A randomized, double-blind, parallel group study to determine the effective duration (6, 8, 10 or 12 weeks) and safety of LamisilÒ (tablets) given once daily to patients with tinea capitis due to Microsporum species (mainly M. canis). |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFO327 T202MR.xls |
| View full study record |
| Document reference: 44356 |
| Study title: EVALUATIONS OF TOLERABILITY AND EFFICACY OF ORAL SF 86-327 IN CHILDREN TREATED FOR FUNGAL INFECTIONS. A SUMMARY OF DATA FROM EXPERIENCE OTHER THAN SPECIAL CLINICAL TRIALS IN CHILDREN |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFE700MR.xls |
| View full study record |
| Document reference: 44357 |
| Study title: Gupta et al, 2003 (overview article of studies) |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44341 |
| Study title: Jones, 1995: overview of six clinical studies, 152 children were evaluated for efficacy, 196 for tolerability. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44342 |
| Study title: MULTICENTRIC, RANDOMIZED SINGLE-BLIND STUDY OF EFFICACY, SAFETY AND TOLERABILITY OF TERBINAFINE [LAMISIL(R)] TABLETS, ONCE DAILY, FOR 1, 2 OR 4 WEEKS IN THE TREATMENT OF TINEA CAPITIS IN CHILDREN |
| Active substance: TERBINAFINE |
| Study summary document link (including results): LASBR 06-22493MR.xls |
| View full study record |
| Document reference: 44349 |
| Study title: Nejjam et al, 1996: 12 children 5-11 years old |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44343 |
| Study title: OPEN STUDY TO DETERMINE THE EFFICACY OF 62.5 MG/D TERBINAFINE IN THE TREATMENT OF CHILDREN WITH TINEA CAPITIS. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFE302 E-00 001MR.xls |
| View full study record |
| Document reference: 44352 |
| Study title: PILOT STUDY OF TERBINAFINE IN CHILDREN SUFFERING FROM TINEA CAPITIS: EVALUATION OF THE EFFICACY, SAFETY AND PHARMACOKINETICS SHORT TITLE: LAMISIL(R) _ EFFICACY, SAFETY, PHARMACOKINETICS IN CHILDREN |
| Active substance: TERBINAFINE |
| Study summary document link (including results): SFE 306MR.xls |
| View full study record |
| Document reference: 44353 |
| Study title: Study 1 - Gupta et al, 2003 (overview aricle of studies). |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44344 |
| Study title: Study 2 - Jones, 1995: overview of six clinical studies, 152 children were evaluated for efficacy, 196 for tolerability. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44345 |
| Study title: Study 3 - Nejjam et al, 1996: 12 children 5-11 years old. |
| Active substance: TERBINAFINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44346 |
| Study title: A comparison in children with chronic asthma, of terbutaline sulphate administered either as a metered aerosol with Nebuhaler(TM) or as a nebulised solution. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2104 Study Synopsis.pdf |
| View full study record |
| Document reference: 44385 |
| Study title: A comparison of Bricanyl Turbuhaler to Ventolin Inhaler in asthmatic children currently using Ventolin Inhaler. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44429 |
| Study title: A comparison of terbutaline Turbuhaler and salbutamol aerosol inhaler in paediatric asthmatic patients with reversible airways obstruction. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-9209 Summary.pdf |
| View full study record |
| Document reference: 44430 |
| Study title: A comparison of terbutaline Turbuhaler® and salbutamol Rotahaler in asthmatic pre-school children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44427 |
| Study title: A comparison of the Bricanyl Turbohaler and Ventolin Rotahaler in asthmatic children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2131 interventional.xls |
| View full study record |
| Document reference: 44416 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN VS. CLAVULANIC ACID/AMOXICILLIN IN PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43024 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF PARENTERAL SBT/AMP FOLLOWED BY ORAL STM IN THE TREATMENT OF BACTERIAL INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42955 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF PARENTERAL SBT/AMP, FOLLOWED BY ORAL SULTAMICILLIN IN THE TREATMENT OF PATIENTS WITH THE ENTERIC FEVER SYNDROME. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42954 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF STM BID VS AUGMENTIN TID FOR THE TREATMENT OF RESPIRATORY TRACT OR UNCOMPLICATED URINARY TRACT INFECTIONS |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43018 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER AND LOWER RESPIRATORY TRACT INFECTION AND UNCOMPLICATED URINARY TRACT INFECTION. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43048 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE ORAL DOSE OF 2.25 GM OF STM & PRABENECID 1 GM WITH AND WITHOUT PROBENECIDE IN THE TREATMENT OF GONORRHEA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43062 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF SBT/AMP/STM IN THE TREATMENT OF (RTI) RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42951 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF SULTAMICILLIN IN THE TREATMENT OF PATIENTS WITH LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43012 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF STM (SBT/AMP) GIVEN ORALLY BID IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42982 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF STM GIVEN ORALLY BID IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42981 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF STM IN THE TREATMENT OF PATIENTS WITH DIAGNOSED CASES OF UTI. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43060 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY TWICE A DAY IN PEDIATRIC INFECTIONS. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42983 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULTAMICILLIN IN THE TREATMENT OF A VARIETY OF CHILDHOOD INFECTIONS, E.G., OTITIS MEDIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43061 |
| Study title: TO EVALUATE THE EFFICACY OF STM IN THE TREATMENT OF PATIENTS WITH DIAGNOSED CASES OF BRONCHO-PNEUMONIA. |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43059 |
| Study title: TO STUDY THE EFFICACY AND SAFETY OF ORAL STM FOR THE TREATMENT OF ACUTE PNEUMOPATHY AND LOWER RESPIRATORY TRACT INFECTION |
| Active substance: SULTAMICILLIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42991 |
| Study title: "Ospolot bei Kindern mit BNS. Prüferinitiierte Studie". Publication: Debus EM, Kurlemann G., Epilepsia 2004; 45/2: 103 - 108 |
| Active substance: SULTIAME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43065 |
| Study title: Experimentation clinique du 1403RD chez l'enfant - Delagrange - 10/08/68 |
| Active substance: SULTOPRIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43066 |
| Study title: Sultopiride study in paediatric psychiatry - Delagrange - 02/08/89 |
| Active substance: SULTOPRIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43067 |
| Study title: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Cross-Over Study to Investigate the Efficacy, Safety and Tolerability of Sumatriptan Nasal Spray (10mg or 20mg) in the Treatment of Acute Migraine in Patients Aged 12-17. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUM30042-ICHE3.pdf |
| View full study record |
| Document reference: 43068 |
| Study title: GCV/93/006 A Double-Blind study to compare the efficacy & safety of oral sumatriptan (50mg-100mg) |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-S2CT40-ICHE3.pdf |
| View full study record |
| Document reference: 43071 |
| Study title: COMBINED THERAPY OF SULPERAZON AND PIPERACILLIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS OF CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42788 |
| Study title: COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN VS METRONIDAZOLE/GENTAMICIN IN COLORECTAL SURGERY PROPHYLAXIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42676 |
| Study title: COMPARATIVE STUDY ON THE PROPHYLAXIS OF ABDOMINAL SURGERIES WITH INJECTABLE SULBACTAM - AMPICILLIN (UNASYN) VERSUS CEPHALOSPORINS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42679 |
| Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFUROXIME IN THE TREATMENT OF PERIORBITAL CELLULITIS AND/OR OTHER FACIAL CELLULITIS AND/OR EPIGLOTTIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42642 |
| Study title: COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CEFUROXIME IN THE TREATMENT OF SKIN AND/OR SKIN STRUCTURE INFECTIONS (E.G., PERIORBI-TAL CELLULITIS) AND/OR OSTEOMYELITIS/SUPPURATIVE ARTHRITIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42643 |
| Study title: CONTROLLED, BLINDED, RANDOMIZED CLINICAL TRIAL OF THE EFFICACY AND TOXICITY OF AMPICILLIN/SULBACTAM VS AMPICILLIN/GENTAMYCIN/CLINDAMYCIN IN POSTPARTUM ENDOMETRIOSIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42658 |
| Study title: DETERMINATION OF AMPICILLIN/SULBACTAM IN HUMAN MILK |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42633 |
| Study title: DRUG TREATMENT VERSUS EXPECTANT MANAGEMENT OF PRETERM PREMATURE RUPTURE OF MEMBRANES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42652 |
| Study title: EFFICACY AND SAFETY OF BID DOSAGE OF PARENTERAL SULBACTAM/AMPICILLIN IN MILD-MODERATE SURGICAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42733 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP FOLLOWED BY ORAL SULTAMICILLIN IN THE TREATMENT OF OSTEOMYELITIS AND BONE/JOINT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42749 |
| Study title: A multicentre randomised, parallel group, double-blind phase III comparison between iodixanol (VISIPAQUE) 270 mg I/ml and 320 mg I/ml, and iohexol (Omnipaque) 300 mg I/ml Trial No. DXV037 (date Dec 1995) |
| Active substance: IODIXANOL |
| Study summary document link (including results): DXV037 Redacted.pdf |
| View full study record |
| Document reference: 48208 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42685 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42695 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN THE PERIOPERATIVE PROPHYLAXIS IN MAXILLOFACIAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42704 |
| Study title: EFFICACY AND SAFETY OF SBT/AMP IN THE TREATMENT OF DOCUMENTED COMMUNITY OR NOSOCOMIAL INFECTIONS IN GENERAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42706 |
| Study title: EFFICACY AND SAFETY OF SBT/CFP IN MODERATE TO SEVERE BACTERIAL INFECTIONS IN SURGICAL PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42848 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN (UNASYN) VS. PIPERCILLIN IN PATIENTS WITH EXACERBATION OF CHRONIC AND ACUTE LOWER RESPIRATORY INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42703 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN ACUTE ENT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42692 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN NEWBORN PATIENTS WITH SEVERE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42701 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN PATIENTS WITH SEVERE ORL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42702 |
| Study title: Houpt MI, Limb R, Livingston RL. Clinical effects of nitrous oxide conscious sedation in children. Pediatric Dentistry 2004;26(1);29-36 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32700 |
| Study title: Jackson D. A trial of premixed nitrous oxide and oxygen in dental anaesthesia in children. Brit J Anaesth 1975;39;161-164 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32701 |
| Study title: Kanagasundaram SA, Lane LJ, Cavalletto BP, Keneally JP, Cooper MG. Efficacy and safety of nitrous oxide in alleviating pain and anxiety during painful procedures. Arch Dis Child 2001;84:492-495. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32702 |
| Study title: Kennedy TL, Gore LB. Middle ear effusions and the nitrous oxide myth. Laryngoscopy 1982 Feb;92(2):169-72. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32703 |
| Study title: Lassen HCA, Henriksen E, Neukirch F, Kristensen HS. Severe bone marrow depression after prolonged nitrous oxide anaesthesia. Lancet 1956;April;527-530 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32704 |
| Study title: Lembert N, Wodey E, Geslot D, Ecoffey C. Prévention de la douleur à l’injection du propofol chez l’infant: comparaison de l’inhalation de protoxyde d’azote à l’injection de lidocaine. Ann Fr Anesth Réanim 2002;21;263-270 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32705 |
| Study title: Luhmann JD, Kennedy RM, Jaffe DM, McAllister JD. Continuous-flow delivery of nitrous oxide and oxygen: A safe and cost-effective technique for inhalation analgesia and sedation of pediatric patients. Pediatric Emergency Care 1999;15(6):388-392. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32706 |
| Study title: Luhmann JD, Kennedy RM, Porter FL, Miller JP, Jaffe DM. A randomized clinical trial of continuous-flow nitrous oxide and midazolam for sedation of young children during laceration repair. Annals of Emergency Medicine 2001;37(1):20-27. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32707 |
| Study title: McNeely JK, Buczulinski B, Rosner D. Severe neurological impairment in an infant after nitrous oxide anesthesia. Anesthesiology 2000;93(6);1549-1550 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32708 |
| Study title: Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 2003;349:45-50. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32709 |
| Study title: Vetter TR. A comparison of EMLA cream versus nitrous oxide for pediatric venous cannulation. J Clin Anesth 1995;7;486-490 |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32710 |
| Study title: Wilson KE, Girdler NM, Welbury RR. Randomized, controlled, crossover clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions. British Journal of Anaesthesia 2003 Dec;91(6):850-856. |
| Active substance: NITROUS OXIDE AND OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32711 |
| Study title: A Prospective Registry of European Hemophilia B Patients Receiving BeneFIX (Nonacog Alfa, Recombinant Human Factor IX) for Usual Use |
| Active substance: NONACOG ALFA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41494 |
| Study title: An Open-Label, Single-Arm, Safety and Efficacy Study of Recombinant Human Factor IX (rFIX; BeneFIX®) in Children Less Than 6 Years of Age With Severe Hemophilia B |
| Active substance: NONACOG ALFA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41493 |
| Study title: In Vitro Evaluation of Allergic Reactions in hemophilia B Subjects who have Exhibited a Systemic Allergic Response after Exposure to BeneFIX (Nonacog Alfa; recombinant Factor IX) |
| Active substance: NONACOG ALFA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41496 |
| Study title: A. Huber: Which contraceptive for adolescents? Sexualmedizin 9; 154-157 (1980) |
| Active substance: NONOXINOL-9 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32719 |
| Study title: H. Brehm, W. Haase: The alternative to hormonal contraception?, Med. Welt 26 (N.F.; 1610-1617 (1975) |
| Active substance: NONOXINOL-9 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32717 |
| Study title: J. Dimpfl, W. Salomon, K.-H. Schicketanz: The sperizidal barrier. Sexualmedizin 13; 95-98 (1984) J.Balmer, P.Hartmann, K.-H Schicketanz: Sexual behaviour during intravaginal contraception. Sexualmedizin 15: 244-248 (1986) |
| Active substance: NONOXINOL-9 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32720 |
| Study title: W. Salomon, W. Haase: Intravaginal contraception. Results of a prospective long-term study of the foam ovoid. Sexualmedizin 6; 198-202(1977) |
| Active substance: NONOXINOL-9 |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32718 |
| Study title: A Multicenter, Open‑Label Study to Compare On‑Demand Treatment With 2 Prophylaxis Regimens of Recombinant Coagulation Factor IX (BeneFIX) Reformulated Drug Product (rFIX‑R) in Subjects With Severe Hemophilia B |
| Active substance: NONACOG ALFA |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41495 |
| Study title: A comparison of the efficacy of terbutaline delivered via Turbuhaler® and pressurised metered dose inhaler (pMDI) plus Nebuhaler® in the treatment of moderate to severe acute asthmatic children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44428 |
| Study title: A comparison of the efficacy of terbutaline sulphate, inhaled via Turbuhaler and via nebulization, in the management of acute severe asthma in small children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2200 Summary.pdf |
| View full study record |
| Document reference: 44412 |
| Study title: A cumulative dose-response study of terbutaline in asthmatic children. A comparison between Turbuhaler and metered dose inhaler (MDI) |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2129 interventional.xls |
| View full study record |
| Document reference: 44408 |
| Study title: A double-blind comparison between terbutaline Turbuhaler and terbutaline metered dose inhaler (MDI). |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-9032 interventional.xls |
| View full study record |
| Document reference: 44405 |
| Study title: A double-blind study comparing Bricanyl MDI and Bricanyl Turbuhaler in patients with acute asthmatic attacks. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2214.pdf |
| View full study record |
| Document reference: 44413 |
| Study title: A comparison of Bricanyl Turbuhaler and Berotec dry powder inhaler in asthmatic children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2135.pdf |
| View full study record |
| Document reference: 44417 |
| Study title: A six-week study of Bricanyl Turbuhaler in the treatment of asthmatic adults. A multicentre study to be carried out in Denmark, Finland, Norway, Sweden and the United Kingdom. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2114 Summary.pdf |
| View full study record |
| Document reference: 44415 |
| Study title: A twelve-week, double-blind, randomized study to assess safety and efficacy of Bricanyl Turbuhaler in asthmatic children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2212 Summary.pdf |
| View full study record |
| Document reference: 44404 |
| Study title: An assessment of small children's ability to use Bricanyl Turbuhaler according to age. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2191.pdf |
| View full study record |
| Document reference: 44425 |
| Study title: An evaluation of the respiratory and cardiovascular effects of oral terbutaline in asthmatic pediatric children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44390 |
| Study title: Assessment of Turbuhaler in patients with severe acute asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2215.pdf |
| View full study record |
| Document reference: 44411 |
| Study title: Bricanyl Turbuhaler in hyperreactive patients. A comparison with Bricanyl metered dose inhaler (MDI) and placebo MDI. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2201.pdf |
| View full study record |
| Document reference: 44410 |
| Study title: Bricanyl Turbuhaler in pre-school children with asthma. A comparison with Ventolin Rotahaler. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2159 interventional.xls |
| View full study record |
| Document reference: 44420 |
| Study title: Clinical investigation of Bricanyl Retard. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44397 |
| Study title: Clinical Trial to evaluate the efficacy of terbutaline in preventing exercise induced asthma when administered to children via the spacer aerosol. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-6032.pdf |
| View full study record |
| Document reference: 44435 |
| Study title: Comparison of Bricanyl depot tablets 5 mg and ordinary tablets 2.5 mg in children with bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44395 |
| Study title: GCV/93/008 A Double-Blind study to compare the efficacy & safety of oral Sumartriptan (50mg or 100mg) in the treatment of migraine in adolescents |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-S2CT37-ICHE3.pdf |
| View full study record |
| Document reference: 43070 |
| Study title: GCV/96/007 A double-blind,randomised,placebo-controlled study to compare the safety & efficacy of oral sumatriptan (25mg,50mg, &100mg) in the acute treatment of migraine in adolescents. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUMB2003-ICHE3.pdf |
| View full study record |
| Document reference: 43080 |
| Study title: GM1997/00059/00 An open design study to evalute repeat dose oral sumatriptan 100mg in the acute treatment of adolescent migraine during a six month period. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUMB3005-ICHE3.pdf |
| View full study record |
| Document reference: 43081 |
| Study title: GM2002/00080/00 Single centre, placebo controlled, double blind randomised crossover, single attack study evaluating the efficacy and tolerability of sumatriptan nasal spray 10mg for the acute treatment of migraine in children suffering from refractory migraine |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUM30009-ICHE3.pdf |
| View full study record |
| Document reference: 43072 |
| Study title: RM1998/00017/00 A double blind placebo controlled parallel group study to evaluate three dose levels (5mg, 10mg and 20mg) of sumatripaten nasal spray in the acute treatment of a single migraine attack in adolescent migraineurs (12-17 yrs of age). |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUMA3005-ICHE3.pdf |
| View full study record |
| Document reference: 43078 |
| Study title: RM1998/00018/00 An open label study to evaluate the long term safety, tolerability and efficacy of sumatriptan nasal spray in the acute treatment of mutiple migraine attacks in adolescent migraineurs (12-17 yrs of age). |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUMA3006-ICHE3.pdf |
| View full study record |
| Document reference: 43079 |
| Study title: RM2003/00271/00 A double blind placebo controlled, parallel group study to evaluate two dose levels (5mg and 20mg) of sumatriptan nasal spray in the acute treatment of a single migraine attack in adolescent migraineurs (12-17 yrs). |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUM30045-ICHE3.pdf |
| View full study record |
| Document reference: 43073 |
| Study title: S2CQ30 A multicentre placebo-controlled study on the efficacy and safety of oral sumatriptan (100mg) in the treatment of migraine in adolescents. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Study S2CQ30(SUM9291)-Sumatriptan-Imigranxlsx.xls |
| View full study record |
| Document reference: 43076 |
| Study title: UCR/96/001 A randomised,double-blind,placebo-controlled study of the safety & efficacy of 25mg,50mg, &100mg oral sumatriptan in adolescent migraine subjects. |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-SUMA2002-ICHE3.pdf |
| View full study record |
| Document reference: 43077 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Syzygium compositum (drops) [AWB-AT] |
| Active substance: Syzygium compositum-Heel - Tropfen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40250 |
| Study title: Lecha M, 2005: Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience. (556 patients aged 6-86 years; 6 % <18 years) |
| Active substance: TACALCITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43083 |
| Study title: publication : Golnick (1998) German study on 5205 patients including 153 children between 5 and 18 years |
| Active substance: TACALCITOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43082 |
| Study title: |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47775 |
| Study title: GCV/92/005 An in-clinical pilot study to examine the safety & efficacy of oral GR43175 (50mg or 100mg) |
| Active substance: SUMATRIPTAN |
| Study summary document link (including results): Sumatriptan-S2CP46-ICHE3.pdf |
| View full study record |
| Document reference: 43069 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42742 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42743 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN PARENTERAL IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42739 |
| Study title: EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN VS. CEFTAZIDIME IN CHILDREN WITH BACTERIAL INFECTIONS OF LOWER RESPIRATORY TRACT. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42705 |
| Study title: EFFICACY AND TOLERANCE OF SULBACTAM/AMPICILLIN FOLLOWED BY ORAL SULTAMICILLIN IN PATIENTS WITH HEAD AND NECK ABSCESSES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42670 |
| Study title: EFFICACY AND TOLERATION OF SBT/AMP IN MILD SEVERE GYN-OB INFECTIONS (PID, ENDOMETRITIS, ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42681 |
| Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IN PATIENTS WITH NON-SEVERE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42729 |
| Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN VS. NETILMICIN PLUS METRONIDAZOLE USED IN SHORT TERM PERIOPERATIVE PROPHYLAXIS IN PATIENTS WHO UNDERGO ABDOMINAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42709 |
| Study title: EFFICACY AND TOLERATION OF UNASYN IN TREATMENT OF INFECTIONS OF THE RESPIRATORY TRACT, GASTROINTESTINAL TRACT, SKIN AND SAFE TISSUES AND UROGENITAL TRACT |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42675 |
| Study title: EFFICACY OF SBT.AMP IN VARIOUS INFECTIONS IN CHILDREN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42741 |
| Study title: EFFICACY OF UNASYN IN PATIENTS WITH ACUTE DISEASE OF THE LUNGS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42691 |
| Study title: MULTICENTER CLINICAL STUDY OF SBT/AMP IN PEDIATRIC PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42673 |
| Study title: MULTICENTER OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SBT/AMP IN BACTERIAL LOWER RESPIRATORY TRACT INFECTIONS IN ADULT PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42735 |
| Study title: MULTICENTER OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN GYNECOLOGICAL AND OBSTETRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42669 |
| Study title: MULTICENTRIC OPEN NONCOMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SBT/AMP IN INTRA-ABDOMINAL SURGICAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42736 |
| Study title: MULTICENTRIC, OPEN NONCOMPARATIVE STUDY OF EFFICACY AND SAFETY OF SBT/AMP IN BACTERIAL LOWER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42734 |
| Study title: NONCOMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP IN THE TREATMENT OF PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42730 |
| Study title: OPEN COMPARATIVE STUDY OF SBT/AMP VS. AMPICILLIN IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS IN ADULT PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42699 |
| Study title: OPEN COMPARATIVE STUDY OF SULBACTAM/CEFOPERAZONE (1:2) VS. CEFTAZIDIME PLUS AMIKACIN IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42865 |
| Study title: OPEN MULTICENTRIC STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION SBT/CFP (1:2) IN THE TREATMENT OF PATIENTS (ADULTS AND CHILDREN) WITH SEVERE INFECTIONS (VTI) |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42864 |
| Study title: OPEN NON-COMPARATIVE EVALUATION IN THE PROPHYLAXIS OF SURGICAL WOUND INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42684 |
| Study title: OPEN NON-COMPARATIVE SAFETY/EFFICACY STUDY SULBACTAM/AMPICILLIN IM/IV IN THE TREATMENT OF BACTERIOLOGICAL ENT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42745 |
| Study title: Norfloxacin interferes with cyclosporine disposition in pediatric patients undergoing renal transplantation; Clin. Pharmacol. Ther. 1995 Sep. 58(3): 322-327 |
| Active substance: NORFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32721 |
| Study title: Post-marketing surveillance study 2006-2007 on specific immunotherapy with NHD Mites/Pollen preparations in a Cluster-doseescalationregimen. Age of patients: 4-65 Years |
| Active substance: NovoHelisenDepot Mites/Pollen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47787 |
| Study title: A 24-week open – label randomized cross-over study to monitor the plasma phenylalanine concentrations of subjects with phenylketonuria, aged 8 to 30 years, using Aminogran 1g tablets supplement to manage at least 50% of their protein substitute requirements or using standard diet supplement (Aminogran 1g tablets excluded) |
| Active substance: NUTRIENTS WITHOUT PHENYLALANINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32722 |
| Study title: Acid-Base status in dietary treatment of phenylketonuria |
| Active substance: NUTRIENTS WITHOUT PHENYLALANINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32725 |
| Study title: Are tablets a practical source of protein substitute in phenylketonuria? |
| Active substance: NUTRIENTS WITHOUT PHENYLALANINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32726 |
| Study title: Comparison of an amino acid mixture and protein hydrolysates in treatment of infants with phenylketonuria |
| Active substance: NUTRIENTS WITHOUT PHENYLALANINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32724 |
| Study title: Mineral and trace – metal Balances in Children receiving normal and synthetic diets |
| Active substance: NUTRIENTS WITHOUT PHENYLALANINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32723 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Nux vomica-Homaccord (drops) [AWB-006] |
| Active substance: Nux vomica-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40084 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Nux vomica-Homaccord (drops) [AWB-AT] |
| Active substance: Nux vomica-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40085 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Nux vomica-Homaccord (injection solution) [AWB-081] |
| Active substance: Nux vomica-Homaccord |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40086 |
| Study title: Alban J.Current therapeutic research 1972; 14(4):158-161 Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants PMID: 4623594 http://www.ncbi.nlm.nih.gov/pubmed?term=4623594 Alban J.Current therapeutic research 1972; 14(4):158-161 Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants PMID: 4623594 http://www.ncbi.nlm.nih.gov/pubmed?term=4623594 |
| Active substance: Nystatin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45239 |
| Study title: De Wet PM, Rode H, van Dyk A, Millar AJ W: Perianal Canidosis-a comparative study with mupirocin and nystatin. Int J Dermatol 1999;38(8):618-22.De Wet PM, Rode H, van Dyk A, Millar AJ W: Perianal Canidosis-a comparative study with mupirocin and nystatin. Int J Dermatol 1999;38(8):618-22. |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32728 |
| Study title: Freitag V.; Schumacher G.; Sternowsky H-J. Der Kinderarzt 1983; 14(2):177-178 Soor im Mund- und Windelbereich (Thrush in the mouth and nappy area) Freitag V.; Schumacher G.; Sternowsky H-J. Der Kinderarzt 1983; 14(2):177-178 Soor im Mund- und Windelbereich (Thrush in the mouth and nappy area) |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45240 |
| Study title: Kozinn PJ. et al.: Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B. Antibiotics Annual 1956/57:128-13Kozinn PJ. et al.: Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B. Antibiotics Annual 1956/57:128-13 |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32727 |
| Study title: Munz D, Powell KR, Pai CH: Treatment of candidal diaper dermatitis: double blind placebo controlled com¬parison of topical nystatin with topical plus oral nystatin. J Pediatr 101 1022 – 1025 (1982)Munz D, Powell KR, Pai CH: Treatment of candidal diaper dermatitis: double blind placebo controlled com¬parison of topical nystatin with topical plus oral nystatin. J Pediatr 101 1022 – 1025 (1982) |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32729 |
| Study title: Comparison of Bricanyl depot tablets 5 mg b.i.d. and ordinary tablets 2.5 mg t.i.d. in children with bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44394 |
| Study title: Comparison of Bricanyl depot tablets 5 mg b.i.d. and ordinary tablets 2.5 mg t.i.d. in children with bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44432 |
| Study title: Comparison of Bricanyl(R) depot tablets 5 mg b.i.d. with ordinary oral ß-agonist treatment b.i.d. in children with bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44396 |
| Study title: Comparison of the effects of inhaled and oral terbutaline and their combination on large and small airways's function in patients with chronic bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2161.pdf |
| View full study record |
| Document reference: 44422 |
| Study title: Comparison of the effects of inhaled dry powder and aerosol terbutaline on large and small airways' function in patients with chronic bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2160.pdf |
| View full study record |
| Document reference: 44421 |
| Study title: Determination of the efficacy of Bricanyl in children using the Turbuhaler (DEBUT). |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2110 interventional.xls |
| View full study record |
| Document reference: 44431 |
| Study title: Bricanyl Turbuhaler in pre-school children with asthma. A comparison with nebuhaler. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2155 Study Synopsis.pdf |
| View full study record |
| Document reference: 44419 |
| Study title: Dose response study of subcutaneous terbutaline and epinephrine in children with acute asthma. (N B! Study code fictitious: allocated for Clint pusposes) |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2550 interventional.xls |
| View full study record |
| Document reference: 44382 |
| Study title: Effect of controlled-release terbutaline and budesonide alone and in combination in asthmatics. A multi-center study. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2167 Summary.pdf |
| View full study record |
| Document reference: 44399 |
| Study title: Effect of oral terbutaline on exercise-induced asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2589 interventional.xls |
| View full study record |
| Document reference: 44391 |
| Study title: Efficacy and safety of Bricanyl Turbuhaler in children. A dose-response study in steady state. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2209 Study Synopsis.pdf |
| View full study record |
| Document reference: 44402 |
| Study title: Efficacy and safety of Bricanyl Turbuhaler in children. A dose-response study in steady state. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2207 Study Synopsis.pdf |
| View full study record |
| Document reference: 44434 |
| Study title: Treatment of Pneumocystis carinii pneumonitis. Siegel, S.E., Wolff, L.J., Baehner, R.L. and Hammond D. (1984) American Journal of Disease of Children 138:1051-1054Treatment of Pneumocystis carinii pneumonitis. Siegel, S.E., Wolff, L.J., Baehner, R.L. and Hammond D. (1984) American Journal of Disease of Children 138:1051-1054 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45837 |
| Study title: Unusual complications of pentamidine in the treatment of Pneumocystis cariniii pneumonia. Wang, J.J., Freeman, A.I., Gaeta , J.F., and Sinks, L.F. (1970) Journal of Pediatrics 77:311-314Unusual complications of pentamidine in the treatment of Pneumocystis cariniii pneumonia. Wang, J.J., Freeman, A.I., Gaeta , J.F., and Sinks, L.F. (1970) Journal of Pediatrics 77:311-314 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45838 |
| Study title: A Phase 2, Randomized, Double-Blind Study To Evaluate the Dosing Concentration and Application Frequency of Tacrolimus Gel in the Treatment of Mild to Moderate Psoriasis in Pediatric and Adult subjects |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41599 |
| Study title: A Phase 3 Long-Term Open Label Study to Evaluate the Safety ofOnce Daily 0.3% Tacrolimus Gel in the Treatment of Psoriasis - |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41603 |
| Study title: A Phase 3, Randomized, Double-Blind Study Comparing Twice Daily FK506 Cream 0.03% Versus Cream Vehicle in the Treatment of Atopic Dermatitis in Pediatric Subjects |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47773 |
| Study title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Once Daily 0.3% FK506 Gel Versus Gel Vehicle in the Treatment of Psoriasis - |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41601 |
| Study title: A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Once Daily 0.3% Tacrolimus Gel Versus Gel Vehicle in the Treatment of Psoriasis - |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41600 |
| Study title: An open-label study to evaluate the safety of topically applied tacrolimus ointment for the treatment of atopic dermatitis. |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47776 |
| Study title: Phase 3, randomized, double-blind, multi-center, vehicle-controlled, parallel, two-treatment group study stratified by baseline PSGA and investigative site to evaluate the efficacy and safety of tacrolimus cream 0.03% applied twice daily (bid) compared to cream vehicle applied bid for the treatment of atopic dermatitis. |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47772 |
| Study title: PRO-002 Final Statistical Report (18OCT2002)_Synopsis_Tacrolimus |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47774 |
| Study title: Tacrolimus ointment is effective for facial and intertriginous psoriasis ( J Am Acad Dermatol 2004;51:723-30.) - |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41602 |
| Study title: Tacrolimus Pharmacokinetics after Topical Administration of Tacrolimus Cream 0.01% and 0.03% to Pediatric Subjects with Atopic Dermatitis |
| Active substance: Tacrolimus |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41604 |
| Study title: Golnick (1998) German study on 5205 patients including 153 children between 5 and 18 years |
| Active substance: TALCACITOL MONOHYDRATE (EFALIZUMAB) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 36704 |
| Study title: 6Tamoxifen therapy for cyclical mastalgia: Dose randomized trial. Abriata G, Bahamonde J, Bazzani M, Bernasconi C, Boccalandro S, Biondini L et al. Breast 6(4)()(pp 212-213), 1997 Date of Publication: Aug 1997 1997;(4):212-213.6Tamoxifen therapy for cyclical mastalgia: Dose randomized trial. Abriata G, Bahamonde J, Bazzani M, Bernasconi C, Boccalandro S, Biondini L et al. Breast 6(4)()(pp 212-213), 1997 Date of Publication: Aug 1997 1997;(4):212-213. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43294 |
| Study title: Abriata G, Bahamonde J, Bazzani M, Bernasconi C, Boccalandro S, Biondini L et al. 6Tamoxifen therapy for cyclical mastalgia: Dose randomized trial. Breast 1997; (4):212-213.Abriata G, Bahamonde J, Bazzani M, Bernasconi C, Boccalandro S, Biondini L et al. 6Tamoxifen therapy for cyclical mastalgia: Dose randomized trial. Breast 1997; (4):212-213. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43152 |
| Study title: Acker JC, Bossen EH, Halperin EC. The management of desmoid tumors. International Journal of Radiation Oncology Biology Physics 1993; 26(5) 851-858.Acker JC, Bossen EH, Halperin EC. The management of desmoid tumors. International Journal of Radiation Oncology Biology Physics 1993; 26(5) 851-858. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43158 |
| Study title: Adolescent gynecomastia: Differential diagnosis and management. Mahoney CP. Pediatric Clinics of North America 37(6)()(pp 1389-1404), 1990 Date of Publication: 1990 1990;(6):1389-1404.Adolescent gynecomastia: Differential diagnosis and management. Mahoney CP. Pediatric Clinics of North America 37(6)()(pp 1389-1404), 1990 Date of Publication: 1990 1990;(6):1389-1404. |
| Active substance: TAMOXIFEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43311 |
| Study title: THE TREATMENT OF ACUTE PELVIC INFECTIONS WITH PARENTERAL SBT/AMP. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42744 |
| Study title: OPEN, NON-COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF SBT/AMP IMIV IN THE TREATMENT OF PEDIATRICS WITH VARIOUS BACTERIAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42689 |
| Study title: PROCEDURE FOR THE STUDY OF UNASYN USED IN PROPHYLAXIS IN TREATMENT OF ABDOMINAL WOUND SURGERY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42720 |
| Study title: RANDOMIZED CONTROLLED CLINICAL TRIAL COMPARING CEFAZOLIN + METRONIDAZOLE TO AMPICILLIN/SULBACTAM IN MAJOR HEAD & NECK SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42664 |
| Study title: SAFETY AND EFFICACY OF SBT/AMP IN ADULTS WITH LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42718 |
| Study title: SBT/AMP - OPEN TRIAL. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42671 |
| Study title: SBT/AMP NON-COMPARATIVE OPEN TRIAL. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42672 |
| Study title: THE COMPARISON OF SULBACTAM/AMPICILLIN (UNASYN) AND AMPICILLIN/GENTAMICIN IN THE TREATMENT OF CHORIOAMNIONITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42665 |
| Study title: THE EVALUATION OF CLINICAL EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN (UNASYN) IN THE TREATMENT OF COMMUNITY-ACQUIRED INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42750 |
| Study title: THE NECESSITY FOR GRAM NEGATIVE ANTIMICROBIAL COVERAGE IN THE PREVENTION OF INFECTION FOLLOWING HEAD AND NECK SURGERY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42628 |
| Study title: Observational use study of the tolerability of Octenisept in premature infants with a gestational age of less than 27 weeks, at the Department of Neonatology of the Charite Campus Virchow Clinic.(Director: Prof. Dr. med. Michael Obladen.2002. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32734 |
| Study title: Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. C. Buhrer, S. Bahr, J. Siebert, R. Wettstein, C. Geffers and M. Obladen. Journal of Hospital Infection (2002) 51: 305-307.Use of 2% 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. C. Buhrer, S. Bahr, J. Siebert, R. Wettstein, C. Geffers and M. Obladen. Journal of Hospital Infection (2002) 51: 305-307. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41626 |
| Study title: Use of Octenisept for pre-operative skin and mucous membrane antisepsis and for supportive wound and suture treatment in small children and babies. UNIV-KLINIK FUR CHIRURGIE.1998. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32737 |
| Study title: A randomised, multicenter, double-blind trial of Sandostatin LAR Depot (40 mg) versus saline-control in the treatment of pediatric hypothalamic obesity |
| Active substance: OCTREOTIDE |
| Study summary document link (including results): Novartis Octreotide_Sandostatin LAR Study B2403_31Aug2011.xls |
| View full study record |
| Document reference: 32741 |
| Study title: A randomized, multicenter, double-blind trial of Sandostatin LAR Depot (40 mg) versus saline-control in the treatment of pediatric hypothalamic obesity |
| Active substance: OCTREOTIDE |
| Study summary document link (including results): Novartis Octreotide_Sandostatin LAR Study B2403E1_31Aug2011.xls |
| View full study record |
| Document reference: 32742 |
| Study title: OPEN NON-COMPARATIVE STUDY TO DETERMINE THE CONCENTRATION OF SBT/AMP IN JUVENILE CARTILAGE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42688 |
| Study title: A randomized, multicenter, double-blind trial of Sandostatin LAR Depot (40 mg) versus saline-control in the treatment of pediatric hypothalamic obesity |
| Active substance: OCTREOTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32743 |
| Study title: Arrighi, Antonello: Homotoxicological versus conventional treatment regimens in the prophylaxis and treatment of pediatric seasonal allergic rhinitis. Biol Ther 2006 (journal spring):8-10 [IIT-publication] |
| Active substance: Oculoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40088 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Oculoheel (tablets) [AWB-AT] |
| Active substance: Oculoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40087 |
| Study title: Oral nystatin profilaxis to prevent invasive candidiasis in neonatal intensive care unit 2006 |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41622 |
| Study title: Mora S. Longitudinal Changes of Bone Density and Bone Resorption in Hyperthyroid Girls During Treatment, J Bone Miner Res 1999; 14: 1971-77Mora S. Longitudinal Changes of Bone Density and Bone Resorption in Hyperthyroid Girls During Treatment, J Bone Miner Res 1999; 14: 1971-77 |
| Active substance: OBIDOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32731 |
| Study title: Schendekehl TK. Therapie und Verlauf der Juvenilen Hyperthyreose, Schweiz Med Wochenschr 1997; 127 (Suppl 87): Abstract 51 Schendekehl TK. Therapie und Verlauf der Juvenilen Hyperthyreose, Schweiz Med Wochenschr 1997; 127 (Suppl 87): Abstract 51 |
| Active substance: OBIDOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32733 |
| Study title: Van Santen HM. Improved Radiation Protection of the Thyroid Gland with Thyroxine, Methimazole, and Potassium Iodide during Diagnostic and Therapeutic Use of Radiolabeled Metaiodobenzylguanidine in Children with Neuroblastoma, Cancer 2003; 98: 389-396 Van Santen HM. Improved Radiation Protection of the Thyroid Gland with Thyroxine, Methimazole, and Potassium Iodide during Diagnostic and Therapeutic Use of Radiolabeled Metaiodobenzylguanidine in Children with Neuroblastoma, Cancer 2003; 98: 389-396 |
| Active substance: OBIDOXIME |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32732 |
| Study title: "Addendum to the clinical expert report, Local and systemic tolerability in babies and premature infants. Author: Priv. Doz. Dr. med. E. Sebastian Debus.2003. " |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32735 |
| Study title: "Experience report of the use of Octenisept in children prior to urological procedures. UNIVERSITY TEACHING HOSPITAL OF THE JOHANNES GUTENBERG UNIVERSITY, MAINZ. 1996. "Experience report of the use of Octenisept in children prior to urological procedures. UNIVERSITY TEACHING HOSPITAL OF THE JOHANNES GUTENBERG UNIVERSITY, MAINZ. 1996. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32740 |
| Study title: Bereston ES: Nystatin in the treatment of Candida albicans infections South Med J 50 547-550. (1957)Bereston ES: Nystatin in the treatment of Candida albicans infections South Med J 50 547-550. (1957) |
| Active substance: NYSTATIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 29021 |
| Study title: Observational study of the use of Octenisept on babies and neonates at the Pediatric Clinic of Gera Hospital.1996. |
| Active substance: OCTENIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32738 |
| Study title: Long-acting terbutaline administered by mouth to children aged 8 - 14 years with chronic asthma. A comparison with Theo-Dur. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2092 Summary.pdf |
| View full study record |
| Document reference: 44398 |
| Study title: Multicenter study of the effect of terbutaline in children with whooping cough. (Drs JA Gray, Edinburgh: WC Love, Glasgow: the United Kingdom) |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44389 |
| Study title: Optimal inhalation flow rate for Bricanyl(R) Turbuhaler powder inhaler 0.25 mg/dose in asthmatic children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2110 interventional.xls |
| View full study record |
| Document reference: 44406 |
| Study title: Optimal inhalation technique for Bricanyl Turbuhaler in children with asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2157 interventional.xls |
| View full study record |
| Document reference: 44409 |
| Study title: Oral terbutaline in chronic childhood asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2045 interventional.xls |
| View full study record |
| Document reference: 44393 |
| Study title: Zethionate injection 200 mg and 300 mg abridged application for a product licence. Part IV Clinical documentation - Volume 1.Zethionate injection 200 mg and 300 mg abridged application for a product licence. Part IV Clinical documentation - Volume 1. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45839 |
| Study title: Anaesthesia et Analgesia Current Researches - Rita L. et al. - 1970 (49 : 377) - Publication in Expert Report on the clinical documentation - Steru D. and BRENOT C. - 01/1990 - |
| Active substance: PENTAZOCINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45840 |
| Study title: Hemoclar-rapport final d'étude : essai pilote del'hémoclar (CB 8061) dans la néphrose de l'enfant.C 327A - Kieffer G. - 23/06/1987 |
| Active substance: PENTOSAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45841 |
| Study title: Blood radioactivity profile and whole body autoradiography in infant and adult rats following oral administration of 14C-BL 191 - Wheatley-Brown - 31/05/1985 |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45842 |
| Study title: Disposition of pentoxifylline in neonatal rats in relation to its pharmacological effect - Tabata - 2/05/1988 |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45843 |
| Study title: Group B strepto-coccus induces tumor necrosis factor in neonatal piglets: Effect of the tumor necrosis factor inhibitor pentoxifylline on haemodynamics and gas exchange. Am. Rev. Respir. Dis. 143:598-604 - Gibson - 1991 - Publication in pharmacological-toxicological expert reportGroup B strepto-coccus induces tumor necrosis factor in neonatal piglets: Effect of the tumor necrosis factor inhibitor pentoxifylline on haemodynamics and gas exchange. Am. Rev. Respir. Dis. 143:598-604 - Gibson - 1991 - Publication in pharmacological-toxicological expert report |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45844 |
| Study title: Pentoxifylline reduces ventilatory disturbances in experimental meconium aspiration. Annual meeting of the pediatric societies, Balimore. Ped Research. 51, n°4 Part 2: 394A - Kohonen - April 2002 - Publication in NDA Annual Report -Pentoxifylline reduces ventilatory disturbances in experimental meconium aspiration. Annual meeting of the pediatric societies, Balimore. Ped Research. 51, n°4 Part 2: 394A - Kohonen - April 2002 - Publication in NDA Annual Report - |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45845 |
| Study title: Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in Kawasaki disease. Current-Ther-research,64;2:96-115 - Best-Brookie - February 2003 - Publication in NDA Annual Report -Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in Kawasaki disease. Current-Ther-research,64;2:96-115 - Best-Brookie - February 2003 - Publication in NDA Annual Report - |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45846 |
| Study title: Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic-rheologic infusion therapy. Michael Streppel, Claus Wittekindt, Hasso von Wedel, Martin Walger, Hans Jakob Schondorf, Olaf Michel, Eberhard Stennert. International Journal of Pediatric Otorhinolaryngology 57 (2001) 129-136 |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45848 |
| Study title: A 12 week multi-center study consisting of a 6 week double-blind, randomized, vehicle controlled, parallel group phase, followed by a 6 week open label phase, to assess the efficacy and safety of Elidel Cream 1% in mild to moderate head and neck atopic dermatitis patients (2-11 years of age, inclusive) intolerant of topical corticosteroids. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2440 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34091 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR INFECTIONS COMPLICATED WITH CNS DISEASES SUCH AS CEREBROVASCULAR DISORDER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42794 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR P. AERUGINOSA RESPIRATORY TRACT INFECTIONS (RTI). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42839 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH UNDERLYING DISEASES (CHRONIC OBSTRUCTIVE PULMONARY DISEASES, ETC.). |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42790 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RIP) COMPLICATED WITH MALIGNANT DISEASE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42813 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42815 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) FOR RESPIRATORY TRACT INFECTIONS (RTI) IN COMPLICATED LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42805 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON (SP) AND FOSFOMYCIN (FOM) TO RESPIRATORY TRACT INFECTIONS (RTI) COMPLICATED WITH LUNG CANCER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42799 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR FOR RESPIRATORY TRACT INFECTIONS COMPLICATED WITH LUNG CANCER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42829 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42795 |
| Study title: TIME-LAG COMBINED THERAPY OF SULPERAZON AND FOSFOMYCIN FOR SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGICAL DISORDERS OF CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42796 |
| Study title: TO ASSESS THE EFFICACY AND SAFETY OF A SINGLE DOSE OF STUDY MEDICATION IN TREATMENT OF URINARY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42728 |
| Study title: TO ASSESS THE SAFETY AND EFFICACY OF SULBACTAM/AMPICILLIN IN THE TREATMENT OF DOCUMENTED INFECTIONS AFTER SURGICAL OPERATION IN THE ABDOMINAL REGION. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42700 |
| Study title: TO COMPARE AND ASSESS THE EFFICACY OF SBT/AMP VS CEFOXITIN IN THE PREVENTION OF INFECTIVE COMPLICATIONS FOLLOWING RECTAL SURGERY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42698 |
| Study title: THE USE OF CEFOPERAZONE PLUS SULBACTAM IN THE TREATMENT OF OSTEOMYELITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42631 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF A SINGLE DOSE IM S/A PLUS PROBENECID AND SINGLE DOSES OF S/A WITHOUT PROBENECID IN TREATMENT OF |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42756 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF A SINGLE DOSE OF SULBACTAM/ AMPICILLIN IM PLUS ORAL PROBENECID IN THE TREATMENT OF GONORRHEA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42721 |
| Study title: TO COMPARE THE EFFICACY AND SAFETY OF SBT/AMP VS GENTAMYCIN/ORNIDAZOLE BY PARENTERAL ROUTE FOR TREATMENT OF ABDOMINAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42693 |
| Study title: TO CONTINUE TO COMPARE THE EFFICACY AND SAFETY OF SULBACTAM AND AMPICILLIN CO-ADMINISTERED INTRAVENOUSLY WITH THAT OF CONVENTIONAL THERAPY CHLORAMPHENICOL & AMPICILLIN IN THE TREATMENT OF INFANTS & CHILDREN BACTERIAL MENINGITIS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42644 |
| Study title: TO DETERMINE THE EFFICACY AND SAFETY OF SBT/AMP FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42726 |
| Study title: TO DETERMINE THE EFFICACY AND SAFETY OF SBT/AMP FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH URTI. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42727 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Oculoheel (eye drops) [AWB-099] |
| Active substance: Oculoheel |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40089 |
| Study title: A multi-centre, randomised, double masked, parallel-group study completed in the USA, Mexico and Brazil comparing the safety and efficacy of topical Ofloxacin 0.3% ophthalmix solution against that of topical Trimethoprim sulphate/Polymyxin B sulphate combination ophthalmic solution as a positive control, in infants, from birth to 31 days of age, with bacterial conjunctivitis. |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41625 |
| Study title: Etude de l'efficacité et de la tolérance de l'ofloxacine en solution auriculaire dans le traitement des otorrhées purulentes de l'enfant sur aérateur transtympanique, sur cavité d'évidement et sur otite chronique à tympan ouvert. - Dr Narcy - Fev. 1995 |
| Active substance: OFLOXACIN |
| Study summary document link (including results): Ofloxacin STUDY FD.93.280.04.xls |
| View full study record |
| Document reference: 32745 |
| Study title: John W.Warren et al., Guidelines fro Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women, Clinical Infectious Diseases, 1999; 29:745-58 |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32757 |
| Study title: John W.Warren et al., Guidelines fro Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women, Clinical Infectious Diseases, 1999; 29:745-58 |
| Active substance: Ofloxacin |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32767 |
| Study title: Metabolic fate of DL 8280. Distribution of DL-8280 to articular cartilage in immature dog after multiple administration. - TACHIZAWA - 26 March 1985 (ofloxacin Daiichi Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32746 |
| Study title: Repeated-dose (30 days) intravenous toxicity study of HOE280 (K 82 9164) in immature sprague dawley rats. - Fuchs - 18 March 1986 (ofloxacin Hoechst Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32749 |
| Study title: Repeated-dose (30 days) intravenous toxicity study of HOE280 (K 82 9164) in immature wistar rats - No author - 18 March 1986 (ofloxacin Hoechst Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32750 |
| Study title: Special Toxicity : Effects of orally administered DL-8280 for 7 days on the knee and elbow joints of immature rats. Comparison with structurally relating compounds - ONO - 30 June 1984 (ofloxacin Daiichi Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32751 |
| Study title: Special Toxicity : Effects of orally administered DL-8280 on diarthric joints of immature dogs (no effect dose level and reversibility of arthropathy). - 0N0 - 6 Apr. 1984 (ofloxacin Daiichi Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32752 |
| Study title: Special Toxicity : Effects of orally administered DL-8280 on diarthric joints of immature dogs. - ONO - 30 Jan. 1984 (ofloxacin Daiichi Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32753 |
| Study title: Special Toxicity : Effects of orally administered DL-8280 on the knee and elbow joints of immature rats. - ONO - 26 Jul. 1982 (ofloxacin Daiichi Dossier) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32754 |
| Study title: Special Toxicity : Joint toxicity of DR-3355 in Juvenile Rats: Comparison with DR-3354 and Ofloxacin. - Michiyuki Kato - 1990 (Levofloxacin MAA Initial - MRP Dossier - Vol. 46: 167-183) |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32755 |
| Study title: Nasal wash in allergic rhinitis |
| Active substance: OHER NASAL PREPARATIONS_NATURAL ELMS SALT |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32758 |
| Study title: Ofloxacin Auricular Solution : Clinical Expert Report - Dr Ichou - Fev. 1995 |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32748 |
| Study title: Pharmacokinetics of terbutaline in asthmatic children after intravenous administration. (N B! Study code fictitious: allocated for Clint pusposes) |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2611 interventional.xls |
| View full study record |
| Document reference: 44383 |
| Study title: Pilot study of Bricanyl retard in asthmatic children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-9073.pdf |
| View full study record |
| Document reference: 44400 |
| Study title: Terbutaline in the acute treatment of children with bronchial asthma. (N B! Study code fictitious: allocated for Clint pusposes) |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44384 |
| Study title: Terbutaline in breast milk. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-8023 interventional.xls |
| View full study record |
| Document reference: 44392 |
| Study title: The effect and side effects of terbutaline sustained release tablets in children exhibiting symptoms of nocturnal asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44401 |
| Study title: The effect of Bricanyl Turbuhaler and Bricanyl chlorofluorocarbon (CFC) inhaler on exercise-induced asthma in children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2178 interventional.xls |
| View full study record |
| Document reference: 44414 |
| Study title: The effect of Bricanyl Turbuhaler and Ventolin inhalation powder in Rotacaps on exercise induced asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2154 interventional.xls |
| View full study record |
| Document reference: 44418 |
| Study title: The effect of terbutaline 0.4 mg Turbuhaler (prototype) and salbutamol inhalation powder 0.2 mg in Rotacaps, on acute asthma bronchiale in children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-2102 interventional.xls |
| View full study record |
| Document reference: 44407 |
| Study title: The effects of inhaled terbutaline sulfate and salbutamol on airway caliber, using the aerosol and dry powder systems of drug delivery. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44426 |
| Study title: The efficacy of terbutaline in children with cough. A double-blind placebo controlled study. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2172 Summary.pdf |
| View full study record |
| Document reference: 44388 |
| Study title: The use of Nebuhaler(TM) in children with acute asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): Terbutaline Bricanyl 01-6063 interventional.xls |
| View full study record |
| Document reference: 44387 |
| Study title: The use of the Nebuhaler in acute asthma in children. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): CSR 01-2638.pdf |
| View full study record |
| Document reference: 44386 |
| Study title: Treatment of exercise induced asthma in adualts. A comparison between Bricanyl Turbuhaler and Ventolin metered dose inhaler. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2186 Study Synopsis.pdf |
| View full study record |
| Document reference: 44424 |
| Study title: Use and acceptability of the Bricanyl Turbuhaler in children with bronchial asthma. |
| Active substance: TERBUTALINE |
| Study summary document link (including results): 01-2176 Summary.pdf |
| View full study record |
| Document reference: 44423 |
| Study title: Double-blnd clinical trial with two Terfenadine suspension formulations. |
| Active substance: TERFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44436 |
| Study title: Double-blnd clinical trial with two Terfenadine tablet formulations at 60 mg. |
| Active substance: TERFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44438 |
| Study title: Terfenadin-Suspension versus Clemastin-Sirup bei Kindern mit akuter Pollenrhinitis |
| Active substance: TERFENADINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44437 |
| Study title: A 12 week multicenter study consisting of a 6 week double blind, randomized, vehicle controlled, parallel group phase, followed by a 6 week open label phase, to assess the safety and efficacy of Elidel® Cream 1% in mild to moderate head and neck atopic dermatitis of patients intolerant of topical corticosteroids |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2442 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34092 |
| Study title: A 12-week open-label, multicenter, effectiveness and safety study of Elidel (pimecrolimus) cream 1% in subjects with atopic dermatitis. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CEG01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34098 |
| Study title: A 20-week study with a 4 week randomized, multi-center, double-blind, vehicle-controlled, parallel-group phase followed by a 12 week open label phase and a 4 week follow-up phase to study the efficacy and safety of 1% SDZ ASM981 cream in pediatric subjects with atopic dermatitis and to collect information about the time and extent of relapse. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CDE04 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34093 |
| Study title: A 26-week study with a 6-week, randomized, multi-center, investigator-blinded, exploratory comparative trial of the tolerability, safety and efficacy of Elidel® (pimecrolimus, SDZ ASM981) cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric subjects with moderate atopic dermatitis, followed by a 20-week open-label phase to study the safety of Elidel® (pimecrolimus, SDZ ASM981) cream 1%. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2406 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47707 |
| Study title: A 26-week, randomized, multicenter, parallel-group, double-blind, vehicle-controlled study to evaluate the incidence of atopic dermatitis flares when ASM981 (pimecrolimus) cream 1% is used at the first signs and/or symptoms of atopic dermatitis and its safety and tolerability in children and adolescents 2 - 17 years of age |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2406 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34132 |
| Study title: A 27 week study, 3 week randomized, multicenter, double blind, parallel group, vehicle control and 24 week open label phase, to evaluate efficacy , tolerability and safety, of ASM 981 (pimecrolimus) cream 1% in pediatric patients with mild to moderate atopic dermatitis in face |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981MX01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34099 |
| Study title: Bass JL, Gozal D. Oxygen therapy for bronchiolitis. Pediatrics 2007; 119:611Bass JL, Gozal D. Oxygen therapy for bronchiolitis. Pediatrics 2007; 119:611 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45401 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF SBT/AMP FOR THE TREATMENT OF PATIENTS WITH METHICILLIN-RESISTANT STAPH INFECTIONS OF THE SKIN AND SOFT TISSUE. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42725 |
| Study title: TO DOCUMENT THE EFFICACY AND SAFETY OF SBT/AMP IN MODERATE TO SEVERE PEDIATRIC INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42680 |
| Study title: TO EVALUATE THE CLINICAL AND BACTERIOLOGICAL EFFICACY, SAFETY AND TOLERABILITY OF SULBACTAM/AMPICILLIN IN THE TREATMENT OF SKIN/SOFT TISSUE INFECTIONS OF BACTERIAL ETIOLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42746 |
| Study title: TO EVALUATE THE CLINICAL AND BACTERIOLOGICAL EFFICACY, SAFETY AND TOLERATION OF UNASYN IM/IV IN VARIOUS INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42687 |
| Study title: TO EVALUATE THE CLINICAL EFFICACY OF S/S IN HOSPITALIZED PATIENT WITH URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42682 |
| Study title: TO EVALUATE THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN IN THE TREATMENT OF GYNECOLOGICAL INFECTIONS OF BACTERIAL ETIOLOGY, INCLUDING, BUT NOT NECESSARILY LIMITED TO: PELVIC INFLAMMATORY DISEASE, ENDOMETRITIS, SALPINGITIS, BARTHELINITIS, ETC. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42716 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SBT/AMP GIVEN IM TWICE A DAY IN NON-SEVERE INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42724 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN GIVEN INTRAMUSCULARLY THREE/FOUR TIMES PER DAY TO PATIENTS WITH VARIOUS INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42715 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN GIVEN INTRAVENOUSLY EVERY 8 HOURS COMPARED TO NETILMYCIN 100 MG, PLUS METRONIDAZOLE TWO TIMES A DAY IN THE TREATMENT OF PATIENTS WITH INTRA ABDOMINAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42708 |
| Study title: TO EVALUATE THE EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IM/IV IN THE TREATMENT OF SURGICAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42714 |
| Study title: TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF SBT/AMP IN THE TREATMENT OF MODERATE TO SEVERE SKIN/SOFT TISSUE OR BACTERIAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42748 |
| Study title: TO EVALUATE THE EFFICACY, SAFETY AND TOLERATION OF SBT/AMP IN THE TREATMENT OF BACTERIAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42747 |
| Study title: TO EVALUATE THE SAFETY AND EFFICACY OF SULBACTAM/AMPICILLIN COMPARED TO CEFOTETAN IN THE TREATMENT OF BACTERIAL ETIOLOGY INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42697 |
| Study title: TO STUDY THE EFFICACY AND SAFETY OF SBT/AMP IN THE TREATMENT OF INFECTIONS IN NEONATES. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42694 |
| Study title: UNASYN IM/IV, OPEN, NON COMPARATIVE EVALUATION IN THE TREATMENT OF ACUTE AND CHRONIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42683 |
| Study title: Prevention of early otorrhea in ventilation tubes Epstein JS, Beane J, Hubbell R. Otolaryngol Head Neck Surg. 1992 Dec;107(6 Pt 1): 758-62 "This prospective randomized study of 430 children, ages 6 months to 15 years, examined the efficacy of sulfacetamide/prednisolone otic drops used for 3 days postoperatively in reducing the incidence of otorrhea at 1 week after the placement of Donaldson tubes" Prevention of early otorrhea in ventilation tubes Epstein JS, Beane J, Hubbell R. Otolaryngol Head Neck Surg. 1992 Dec;107(6 Pt 1): 758-62 "This prospective randomized study of 430 children, ages 6 months to 15 years, examined the efficacy of sulfacetamide/prednisolone otic drops used for 3 days postoperatively in reducing the incidence of otorrhea at 1 week after the placement of Donaldson t... |
| Active substance: SULFACETAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42875 |
| Study title: TO DETERMINE THE SAFETY AND EFFICACY OF PARENTERAL SULBACTAM/AMPICILLIN FOLLOWED BY ORAL SULTAMICILLIN IN TREATING SEVERE LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42677 |
| Study title: "Prophylaxis of Bacterial Infections after Bone Msrrow Transplantation - E. Gluckman, C. Roudet, I. Hirsch, A. Devergie, H. Bourdeau, C. Arlet - Chemotherapy 1991; 33 (suppl 1): 33-38" |
| Active substance: OFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32756 |
| Study title: Efficacy and Safety of Olanzapine in Patients with Borderline Personality Disorder: A Randomized, Flexible-Dose, Double-Blind Comparison with Placebo |
| Active substance: OLANZAPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32759 |
| Study title: Long-Term Open-Label Trial of Olanzapine in Children with Childhood Onset of Schizophrenia |
| Active substance: OLANZAPINE |
| Study summary document link (including results): Olanzapine - F1D-MC-HGCT Synopsis redacted batch numbers.pdf |
| View full study record |
| Document reference: 32760 |
| Study title: Open-Label Study of Olanzapine in Children with Pervasive Developmental Disorder |
| Active substance: OLANZAPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32761 |
| Study title: A Comparative, Randomized, Single-Dose, 2-Way Crossover Bioavailability Study of a Compounded 4 mg/mL Olmesartan Medoxomil Suspension (Total Dose 40 mg) and 40 mg Olmesartan Medoxomil Tablets (Benicar®) in Healthy Adult Volunteers Under Fasting Conditions |
| Active substance: OLMESARTAN MEDOXOMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32762 |
| Study title: An Open-Label Study of the Single-Dose Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patients with Hypertension |
| Active substance: OLMESARTAN MEDOXOMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32763 |
| Study title: Dose-Ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents with Hypertension |
| Active substance: OLMESARTAN MEDOXOMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32764 |
| Study title: Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference. Leonardi A, Zafirakis P. Curr Med Res Opin. 2004 Aug;20(8):1167-73. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference. Leonardi A, Zafirakis P. Curr Med Res Opin. 2004 Aug;20(8):1167-73. |
| Active substance: olopatadine |
| Study summary document link (including results): Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions a double-masked, environmental study of patient preference. Leonardi A, Z... |
| View full study record |
| Document reference: 41584 |
| Study title: Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Adv Ther. 2003 Mar-Apr;20(2):79-91. Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis: a real-world comparison of efficacy and ocular comfort. Ganz M, Koll E, Gausche J, Detjen P, Orfan N. Adv Ther. 2003 Mar-Apr;20(2):79-91. |
| Active substance: olopatadine |
| Study summary document link (including results): Ketotifen fumarate and olopatadine hydrochloride in the treatment of allergic conjunctivitis a real-world comparison of efficacy and ocular comfort... |
| View full study record |
| Document reference: 41583 |
| Study title: Olsalazine vs sulfalazine in mild to moderate childhood ulcerative colitis: results of the Paediatrici gastroenterology Collaborative Research Group Clinical TrialFerry et al |
| Active substance: OLSALAZINE |
| Study summary document link (including results): Ferry et al - Olsalazine sodium.pdf |
| View full study record |
| Document reference: 32765 |
| Study title: Tolerance of olsalazine in young patients treated for ulcerative colitis |
| Active substance: OLSALAZINE |
| Study summary document link (including results): L342G26R1 - Olsalazine sodium.pdf |
| View full study record |
| Document reference: 32766 |
| Study title: A bioavailability study of omeprazole comparing three different liquid formulations after single dose administration to healthy volunteers, 17 November 1996 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41623 |
| Study title: A Multi-Center, Open-Label Study to Evaluate Omeprazole for the Treatment of Gastrointestinal Symptoms Associated with Acid-Related Disorders in Pediatric Subjects (Ages 2 through 16 years, Inclusive), 9 August 2000 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32788 |
| Study title: The Use of Remestyp in the Paediatric Gynecology treating Juvenile MetrorrhagiaJ. Hořejší, Československá gynekologie 1980, 45 (5): 292-294The Use of Remestyp in the Paediatric Gynecology treating Juvenile MetrorrhagiaJ. Hořejší, Československá gynekologie 1980, 45 (5): 292-294 |
| Active substance: TERLIPRESSIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44439 |
| Study title: Briet, E et al. The prophylactiv treatment of hemophilia B Leyden with anabolic steroids. Ann. Intern. Med. 1985; 103: 225-226.Ann. Intern. Med. 1985; 103: 225-226Briet, E et al. The prophylactiv treatment of hemophilia B Leyden with anabolic steroids. Ann. Intern. Med. 1985; 103: 225-226.Ann. Intern. Med. 1985; 103: 225-226 |
| Active substance: TESTOSTERONE UNDECANOATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44441 |
| Study title: Endres W, et al. Priapism in Fabry's disease during testosterone treatment. Klin Wochenschr 1987;65:925; Klin Wochenschr 1987;65:925Endres W, et al. Priapism in Fabry's disease during testosterone treatment. Klin Wochenschr 1987;65:925; Klin Wochenschr 1987;65:925 |
| Active substance: TESTOSTERONE UNDECANOATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44440 |
| Study title: Immuntherapie bei kindern mit hilfe eines multibakteriellen ribosomenpräparates |
| Active substance: Tetanus Vaccine (Adsorbed) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41393 |
| Study title: Effect of tetrabenazine on tics and Sleep of Gilles de la Tourette's Syndrome (Neurology 1984). Effect of tetrabenazine on tics and Sleep of Gilles de la Tourette's Syndrome (Neurology 1984). |
| Active substance: TETRABENAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44443 |
| Study title: Only case reports/review: - Comparaison of weight gain in treatments for Tourette Syndrome: tetrabenazine versus neuroleptic drug (J.Child Neurol. 2008). - Only case reports/review: - Comparaison of weight gain in treatments for Tourette Syndrome: tetrabenazine versus neuroleptic drug (J.Child Neurol. 2008). - |
| Active substance: TETRABENAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44442 |
| Study title: Abeyagunawardena, A. S., Hindmarsh, P., and Trompeter, R. S.Abeyagunawardena, A. S., Hindmarsh, P., and Trompeter, R. S. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44457 |
| Study title: Adrenal function improves in asthmatic children on inhaled steroids: a longitudinal studyAdrenal function improves in asthmatic children on inhaled steroids: a longitudinal study |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44463 |
| Study title: Arch.Dis.Child 2007;92:585-588.Arch.Dis.Child 2007;92:585-588. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44460 |
| Study title: Azam, M., Bhatti, N., and Krishin, J.Azam, M., Bhatti, N., and Krishin, J. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44468 |
| Study title: Brain Dev. 1996;18:456-460.Brain Dev. 1996;18:456-460. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44479 |
| Study title: Brain Dev. 1999;21:461-467.Brain Dev. 1999;21:461-467. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44475 |
| Study title: Children's Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan. muneeb@sat.net.pkChildren's Hospital, Pakistan Institute of Medical Sciences, Islamabad, Pakistan. muneeb@sat.net.pk |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44469 |
| Study title: Children's Hospital, University of Helsinki, FinlandChildren's Hospital, University of Helsinki, Finland |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44477 |
| Study title: Fitzgerald DA, Kilham HA. Croup: Assessment and evidence-based management. Medical Journal of Australia. 2003; 179(7):372-7.Fitzgerald DA, Kilham HA. Croup: Assessment and evidence-based management. Medical Journal of Australia. 2003; 179(7):372-7. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45402 |
| Study title: Gleeson JG, Green S, Price JF. Air or oxygen as driving gas for nebulised salbutamol. Arch Dis Child 1988; 63:900-4.Gleeson JG, Green S, Price JF. Air or oxygen as driving gas for nebulised salbutamol. Arch Dis Child 1988; 63:900-4. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45403 |
| Study title: Inwald D, Roland M, Kuitert L, Sheila AM, Petros A. Oxygen treatment of acute severe asthma. BMJ (Indian ed) 2001; 17:732-4.Inwald D, Roland M, Kuitert L, Sheila AM, Petros A. Oxygen treatment of acute severe asthma. BMJ (Indian ed) 2001; 17:732-4. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45404 |
| Study title: Inwald D, Roland M, Kuitert L, Sheila AM, Petros A. Oxygen treatment of acute severe asthma. BMJ (Indian ed) 2001;17:732-4.Inwald D, Roland M, Kuitert L, Sheila AM, Petros A. Oxygen treatment of acute severe asthma. BMJ (Indian ed) 2001;17:732-4. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45417 |
| Study title: Kinsey VE. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956;56:481-543. Kinsey VE. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956;56:481-543. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45405 |
| Study title: Macey PM, Woo MA, Harper RM. Hyperoxic brain effects are normalized by addition of CO2. PLoS Med. 2007 May;4(5):e173Macey PM, Woo MA, Harper RM. Hyperoxic brain effects are normalized by addition of CO2. PLoS Med. 2007 May;4(5):e173 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45420 |
| Study title: Neonatal inhaled nitric oxide study group. Inhaled nitric oxide in full term and nearly full term infants with hypoxic respiratory failure. NEJM 1997 Feb 27; 336(9):597-604.Neonatal inhaled nitric oxide study group. Inhaled nitric oxide in full term and nearly full term infants with hypoxic respiratory failure. NEJM 1997 Feb 27; 336(9):597-604. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45406 |
| Study title: Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatric Pulmonology 1998; 26:424-428Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatric Pulmonology 1998; 26:424-428 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45407 |
| Study title: Saugstad OD, Rootwelt T, Aalen O. Resuscitation of Asphyxiated Newborn Infants With Room Air or Oxygen: An International Controlled Trial: The Resair 2 Study Pediatrics 1998; 102;E1Saugstad OD, Rootwelt T, Aalen O. Resuscitation of Asphyxiated Newborn Infants With Room Air or Oxygen: An International Controlled Trial: The Resair 2 Study Pediatrics 1998; 102;E1 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45408 |
| Study title: Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968; 42:565-589Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968; 42:565-589 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45409 |
| Study title: Chen CC, Lin YT, Yang YH, et al.; J Formos Med Assoc (China (Republic:1949-)), Feb 2002, 101(2) p110-6; Sulfasalazine therapy for juvenile rheumatoid arthritis.Chen CC, Lin YT, Yang YH, et al.; J Formos Med Assoc (China (Republic:1949-)), Feb 2002, 101(2) p110-6; Sulfasalazine therapy for juvenile rheumatoid arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42882 |
| Study title: Christensen LA, Fallingborg J, Jacobson BA, " Bioavailability of 5-aminosalicylic acid from slow release 5-aminosalicylic acid drug and sulfasalasine in normal children." Did Dis Sci 38 (1993) 1831-1836Christensen LA, Fallingborg J, Jacobson BA, " Bioavailability of 5-aminosalicylic acid from slow release 5-aminosalicylic acid drug and sulfasalasine in normal children." Did Dis Sci 38 (1993) 1831-1836 |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42877 |
| Study title: Emery HM; Curr Opin Rheumatol (United States), Sep 1993, 5(5) p629-33 Treatment of juvenile rheumatoid arthritis.Emery HM; Curr Opin Rheumatol (United States), Sep 1993, 5(5) p629-33 Treatment of juvenile rheumatoid arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42883 |
| Study title: Ferry GD, Kirschner BS, Grand RJ, Issemann RM, Griffiths AM et al., Olsalasine versus sulfasalasine in mild to moderate childhood ulcerative colitis: results of the pediatric gastroenterology collaborative research group clinical trial. J Chromatogr 162 (1979) 237-243Ferry GD, Kirschner BS, Grand RJ, Issemann RM, Griffiths AM et al., Olsalasine versus sulfasalasine in mild to moderate childhood ulcerative colitis: results of the pediatric gastroenterology collaborative research group clinical trial. J Chromatogr 162 (1979) 237-243 |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42878 |
| Study title: Gedalia A, Barash J, Press J, et al. Clin Rheumatol (Belgium), Dec 1993, 12(4) p511-4; Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis. Gedalia A, Barash J, Press J, et al. Clin Rheumatol (Belgium), Dec 1993, 12(4) p511-4; Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42884 |
| Study title: Hertzberger-ten Cate R, Cats A ; Clin Exp Rheumatol (Italy), Jan-Feb 1991, 9(1) p85-8; Toxicity of sulfasalazine in systemic juvenile chronic arthritis.Hertzberger-ten Cate R, Cats A ; Clin Exp Rheumatol (Italy), Jan-Feb 1991, 9(1) p85-8; Toxicity of sulfasalazine in systemic juvenile chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42885 |
| Study title: Huang JL, Chen LC.; Clin Rheumatol 1998;17(5):359-63; Sulphasalazine in the treatment of children with chronic arthritis.Huang JL, Chen LC.; Clin Rheumatol 1998;17(5):359-63; Sulphasalazine in the treatment of children with chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42886 |
| Study title: Huang JL, Hung IJ, Hsieh KH.; Asian Pac J Allergy Immunol 1997 Jun;15(2):71-5; Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.Huang JL, Hung IJ, Hsieh KH.; Asian Pac J Allergy Immunol 1997 Jun;15(2):71-5; Sulphasalazine therapy in chronic uveitis of children with chronic arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42887 |
| Study title: Ilowite NT; Pediatrics (United States), Jan 2002, 109(1) p109-15. Current treatment of juvenile rheumatoid arthritis.Ilowite NT; Pediatrics (United States), Jan 2002, 109(1) p109-15. Current treatment of juvenile rheumatoid arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42888 |
| Study title: A Multicenter, Randomized Open-Label, Pharmacokinetics and pH Assessment Study to Evaluate a Single Dose of Omeprazole in a Pediatric Population Ages 0 Months – 24 Months, Inclusive, 3 January 2001 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32790 |
| Study title: A Multicenter, Randomized, Single-Blind Study to Evaluate Omeprazole for the Treatment of Clinically Diagnosed GERD in Pediatric Patients Ages 0 months through 24 months, Inclusive, 18 October 2000 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32791 |
| Study title: A Multicenter, Retrospective Study to Evaluate the Effect of Multiple Doses of Omeprazole on Gastric or Esophageal pH in a Pediatric Population, 17 November 2000 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32792 |
| Study title: A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection. |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32784 |
| Study title: A Randomized, Single-Center, Open-label, Two-period Crossover, Pharmacokinetic Study to Evaluate the Bioequivalence of a Single 20 mg Omeprazole Dose Administered as an Intact Capsule and as an Open Capsule in Healthy Male and Female Volunteers, 30 September 1999 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32787 |
| Study title: An Open-label, Multicenter, Pharmacokinetic Study to Evaluate the Bioavailability of a Single Dose of Omeprazole in a Pediatric Population, 7 March 2000 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32786 |
| Study title: An Open-label, Multicenter, Pharmacokinetic Study to Evaluate the Bioavailability of Single and Multiple Doses of Omeprazole in a Pediatric Population, 23 May 2000 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32789 |
| Study title: Dose finding study of omeprazole given orally to young rats for up to 8 days. Astra Safety Assessment, Södertälje, Sweden. 12 January 1994. |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32769 |
| Study title: Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32785 |
| Study title: Effect of omeprazole on the efficacy of amoxicillin and clarithromycin for the treatment of Helicobacter pylori associated gastritis in children, 22 February 2001 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32793 |
| Study title: Evaluation of the role of acidic and non-acidic reflux in recurrent respiratory and chronic ear, nose,and throat (ENT) diseases in children by using multichannel intraluminal impedance (MII) apparatus |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32778 |
| Study title: General toxicity of omeprazole given orally to young rats for 1 month. AstraZeneca R&D Södertälje, Safety Assessment, Sweden |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32783 |
| Study title: Histologic findings in children treated with long-term proton pump inhibitors (PPIs) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32782 |
| Study title: Omeprazole in children with reflux esophagitis-an open dose finding study and an evaluation of the safety and efficacy during maintenance treatment. Interim report 1996 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32794 |
| Study title: Pharmacokinetics and pharmacodynamics of the infusion formulation of omeprazole in children when treatment is not possible |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32780 |
| Study title: PK/PD study on omeprazole in children with gastro-esophageal reflux |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32771 |
| Study title: Characteristics of Children Receiving Proton Pump Inhibitors Continously for up to 11 years duration |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32781 |
| Study title: Plasma concentrations of omeprazole in young rats after oral administration. Astra Safety Assessment, Södertälje, Sweden. 13 January 1994. |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32770 |
| Study title: Department of Allergy and Pneumonology, P. Penteli Children's Hospital, Penteli, Greece. kpriftis@otenet.grDepartment of Allergy and Pneumonology, P. Penteli Children's Hospital, Penteli, Greece. kpriftis@otenet.gr |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44462 |
| Study title: Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. asiri26@hotmail.comDepartment of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. asiri26@hotmail.com |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44458 |
| Study title: Department of Pediatrics, Shiga Medical Center for Children, Moriyama, Japan. ito-mccs@mx.biwa.ne.jpDepartment of Pediatrics, Shiga Medical Center for Children, Moriyama, Japan. ito-mccs@mx.biwa.ne.jp |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44454 |
| Study title: Department of Pediatrics, Tokyo Women's Medical University, JapanDepartment of Pediatrics, Tokyo Women's Medical University, Japan |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44473 |
| Study title: Dermatologica 1980;160:261-269.Dermatologica 1980;160:261-269. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44467 |
| Study title: Heiskala, H., Riikonen, R., Santavuori, P., Simell, O., Airaksinen, E., Nuutila, A., and Perheentupa, J.Heiskala, H., Riikonen, R., Santavuori, P., Simell, O., Airaksinen, E., Nuutila, A., and Perheentupa, J. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44476 |
| Study title: Low-dose ACTH therapy for West syndrome: initial effects and long-term outcomeLow-dose ACTH therapy for West syndrome: initial effects and long-term outcome |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44455 |
| Study title: Marten, R. H., Byrne, J. P., Peiris, S., Butler, J., and Keenan, J.Marten, R. H., Byrne, J. P., Peiris, S., Butler, J., and Keenan, J. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44465 |
| Study title: Neuroimmunomodulation. 2006;13:56-62.Neuroimmunomodulation. 2006;13:56-62. |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44464 |
| Study title: Adjunctive intra-operative local anaesthesia in paediatric strabismus surgery: a randomized controlled trial. Carden SM, Colville DJ, Davidson AJ, McKenzie IM, Mackey DA, McKenzie J, Elder JE. Aust N Z J Ophthalmol. 1998 Nov;26(4):289-97. Adjunctive intra-operative local anaesthesia in paediatric strabismus surgery: a randomized controlled trial. Carden SM, Colville DJ, Davidson AJ, McKenzie IM, Mackey DA, McKenzie J, Elder JE. Aust N Z J Ophthalmol. 1998 Nov;26(4):289-97. |
| Active substance: TETRACAINE |
| Study summary document link (including results): Adjunctive intra-operative local anaesthesia in paediatric strabismus surgery a randomized controlled trial. Carden SM, Colville DJ, Davids.pdf |
| View full study record |
| Document reference: 44446 |
| Study title: Open study on pain free cutting of split skin grafts using local anaesthetic cream1988 |
| Active substance: TETRACAINE |
| Study summary document link (including results): Tetracaine_1988.xls |
| View full study record |
| Document reference: 48143 |
| Study title: Open study to assess efficacy and safety of Tetracaine in children undergoing venepuncture or cannulation1992 |
| Active substance: TETRACAINE |
| Study summary document link (including results): Tetracaine_Amegel199201.xls |
| View full study record |
| Document reference: 48144 |
| Study title: Open study to collect clinical results, particularly in children with a preparation of Tetracaine gel 4% w/w1990 |
| Active substance: TETRACAINE |
| Study summary document link (including results): Tetracaine_1990.xls |
| View full study record |
| Document reference: 48142 |
| Study title: A comparative study of high-dose and low-dose ACTH therapy for West syndromeA comparative study of high-dose and low-dose ACTH therapy for West syndrome |
| Active substance: TETRACOSACTIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44474 |
| Study title: Wong−A et al. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: Results of a multinational, randomized, modified double− blind study. {CLIN−PEDIATR}, 2001, Vol/Iss/Pg. 40/6 (313−324)Wong−A et al. Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: Results of a multinational, randomized, modified double− blind study. {CLIN−PEDIATR}, 2001, Vol/Iss/Pg. 40/6 (313−324) |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45770 |
| Study title: Yaffe−S−J. Comparative efficacy of aspirin and acetaminophen in the reduction of fever in children. {Arch−Intern−Med}, 23 Feb 1981, vol. 141, no. 3 Spec No, p. 286−92Yaffe−S−J. Comparative efficacy of aspirin and acetaminophen in the reduction of fever in children. {Arch−Intern−Med}, 23 Feb 1981, vol. 141, no. 3 Spec No, p. 286−92 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45771 |
| Study title: |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33260 |
| Study title: |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33261 |
| Study title: |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33262 |
| Study title: Agbolosu−N−B et al. Efficacy of tepid sponging versus paracetamol in reducing temperature in febrile children. {ANN−TROP−PAEDIATR}, 1997, Vol/Iss/Pg. 17/3 (283−288)Agbolosu−N−B et al. Efficacy of tepid sponging versus paracetamol in reducing temperature in febrile children. {ANN−TROP−PAEDIATR}, 1997, Vol/Iss/Pg. 17/3 (283−288) |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33291 |
| Study title: Cedrato−A−E et al. (Comparison of the antipyretic effect of a single dose of dipyrone, paracetamol and diclofenac resinate. A multicenter clinical trial). {Medicina−B−Aires}, 1989, vol. 49, no. 6, p. 635−6Cedrato−A−E et al. (Comparison of the antipyretic effect of a single dose of dipyrone, paracetamol and diclofenac resinate. A multicenter clinical trial). {Medicina−B−Aires}, 1989, vol. 49, no. 6, p. 635−6 |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33249 |
| Study title: Friedman−A−D, Barton−L−L. Efficacy of sponging vs acetaminophen for reduction of fever. Sponging Study Group. {Pediatr−Emerg−Care}, Mar 1990, vol. 6, no. 1, p. 6−7Friedman−A−D, Barton−L−L. Efficacy of sponging vs acetaminophen for reduction of fever. Sponging Study Group. {Pediatr−Emerg−Care}, Mar 1990, vol. 6, no. 1, p. 6−7 |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33252 |
| Study title: Gehri−Mario et al. When fever, paracetamol? Theory and practice in a paediatric outpatient clinic. {Pharm−World−Sci}, Jun 2005, vol. 27, no. 3, p. 254−7Gehri−Mario et al. When fever, paracetamol? Theory and practice in a paediatric outpatient clinic. {Pharm−World−Sci}, Jun 2005, vol. 27, no. 3, p. 254−7 |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33270 |
| Study title: Imundo LF, Jacobs JC J Rheumatol (Canada), Feb 1996, 23(2) p360-6. Sulfasalazine therapy for juvenile rheumatoid arthritis.Imundo LF, Jacobs JC J Rheumatol (Canada), Feb 1996, 23(2) p360-6. Sulfasalazine therapy for juvenile rheumatoid arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42889 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Eggenberger, Yverdon, Switzerland. 16.04.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45243 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Salzberg, Birsfelden/ Switzerland. 26.04.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45244 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Herz, Basel/Switzerland. 01.05.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45245 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report. Dr. Vich, Winterthur/ Switzerland. 01.05.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45246 |
| Study title: Braunsteiner A*,Habermacher B: Clinical acceptability, tolerability and efficacy of BACTRIM syrup (Ro 06-2580/103) in children. An open uncontrolled study. Final study report by Dr. D'Aruzzo, Mendrisio/Switzerland. 10.05.1985 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45247 |
| Study title: Cunningham M*,Barsanti F,Merrell R,Lentz E: Final Study Report: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone Versus Single-Dose IM Bicillin CR plus Oral Trimethoprim-Sulfamethoxazole for the Treatment of Uncomplicated Acute Otitis Media in Infants and Children (Howie Protocol) |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45248 |
| Study title: Cunningham M*,Barsanti F,Merrell R,Lentz E: Final Study Report: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-Day Oral (PO) Course of Trimethorprim-sulfamethoxazole for the Treatment of Acute Otitis Media in Infants and Children (Klein Protocol) |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45249 |
| Study title: Havas L: DOSAGE OF PHARMACEUTICALS IN CHILDREN B-0054340 |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45251 |
| Study title: M. Sieniawska ,,Clinical evaluation of the prep. Biseptol 480 for i.v. use in children with bacterial infections" |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45242 |
| Study title: Reggiani G: PHARMACOKINETIC STUDIES OF TRIMETHOPRIM-SULFAMETHOXAZOLE IN CHILDREN WITH GASTROENTERITIS (MANUSCRIPT BY M.I. MARKS, M. KAZEMI, B. HALES AND A.H. NEIMS, ROCHE DEVELOPMENTAL PHARMACOLOGY UNIT, MCGILL UNIVERSITY, MONTREAL) |
| Active substance: Sulfamethoxazole trimethoprim |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45250 |
| Study title: Bondesen S, Nielsen OH, Schou JB, Jensen PH, Lassen LB, Binder V, Krasilnikoff PA, Dano P, Honore Hansen S, Norby Rasmussen S, Hvidberg EF. Steady-state kinetics of 5-aminosalicylic acid and sulphapyridine during sulfasalazine prophylaxis in ulcerative colitis. Scan J Gastroent 21 (1986) 693-700.Bondesen S, Nielsen OH, Schou JB, Jensen PH, Lassen LB, Binder V, Krasilnikoff PA, Dano P, Honore Hansen S, Norby Rasmussen S, Hvidberg EF. Steady-state kinetics of 5-aminosalicylic acid and sulphapyridine during sulfasalazine prophylaxis in ulcerative colitis. Scan J Gastroent 21 (1986) 693-700. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42897 |
| Study title: Single dose toxicity of omeprazole in young rats after oral administration. Astra Safety Assessment, Södertälje, Sweden. 13 January 1994 |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32768 |
| Study title: Study about relationship between asthma and GERD in children (NO) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32772 |
| Study title: The impact of omeprazole on children with cystic fibrosis who require high dose pancreatic enzymes. |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32777 |
| Study title: Therapy control in children <1 year of age treated with omeprazole (SE) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32779 |
| Study title: Treatment of Helicobacter pylori gastritis in paediatrics: improvement of the eradication rate by adjunction of omeprazole to dual antibiotheraphy (BE) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32774 |
| Study title: Treatment of Helicobacter pylori infection in children with recurrent abdominal pain (EE and FI) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32773 |
| Study title: Treatment of irritable infants with omeprazole. A double bind placebo controlled prospective study (Australia) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32776 |
| Study title: Use of magnesium omeprazole (MOPRAL) for treating pathological gastroesophagael reflux in children (Mexico) |
| Active substance: OMEPRAZOLE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32775 |
| Study title: |
| Active substance: ONDASETRON |
| Study summary document link (including results): Study S3AM45 Ondansetron.xlsx |
| View full study record |
| Document reference: 47087 |
| Study title: Cough,wheeze and astma diagnosis in children - KP. Jones - 1993 (Clin Exp Allergy) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47002 |
| Study title: Cough,wheeze and astma diagnosis in children - KP. Jones - 1993 (Clin Exp Allergy) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47027 |
| Study title: Cromolyn sodium in the treatment of children with severe, perennial asthma - BA. Berman et al. - 1975 (Pediatrics vol 55) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47028 |
| Study title: Effects of nedocromil sodium on exercise induced bronchoconstriction exacerbated by inhalation of cold air - S. Oseid et al. - 1995 (Scand J Med Sci Sports vol 5) - Publication in Nedocromil sodium HFA- 227- metered dose inhaler-Part IV clinical Documentation - no author- 26/03/1998 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47003 |
| Study title: Estudio comparativo del effecto protector del cromoglicato y el nedocromil en ninos con asma de esfuerzo - A. Rabameda et al. - 1993 ( Rev Esp Alergol Immnunol Clin vol 8) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47029 |
| Study title: Exercise induced asthma in children-protection with nedocromil sodium -In inflammation : Its clinical revelance in airways disease - JM. Henricksen - 1986 (RAI International Congress - Publication in Tilade CFC-Free metered dose inhaler nedocromil sodium-vol2 response to CSM questions references - no author - 09/ 1999 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47030 |
| Study title: Il Nedocromil sodium nel trattamento dell'asma cronico infantile. Studio in doppio cieco vs placebo - A. Corrias et al. - 1990 (Ped Med Chir (Med Surg Ped) vol 12) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47031 |
| Study title: Inhibition of exercise -induced asthma (EIA) by nedocromil sodium and sodium cromoglycate in children - E. Novembre et al. - 1993 ( J Allergy Clin Immunol vol 91) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47032 |
| Study title: Randomised prospective masked study comparing patient comfort following the instillation of topical proxymetacaine and amethocaine. Shafi T, Koay P. Br J Ophthalmol. 1998 Nov;82(11):1285-7. Randomised prospective masked study comparing patient comfort following the instillation of topical proxymetacaine and amethocaine. Shafi T, Koay P. Br J Ophthalmol. 1998 Nov;82(11):1285-7. |
| Active substance: TETRACAINE |
| Study summary document link (including results): Randomised prospective masked study comparing patient comfort following the instillation of topical proxymetacaine and amethocaine. Shafi T.pdf |
| View full study record |
| Document reference: 44445 |
| Study title: Single-blinded, reference drug controlled to assess the comparative efficacy and safety of Tetracaine gel versus EMLA cream prior to venepuncture or venous cannulation 1993 |
| Active substance: TETRACAINE |
| Study summary document link (including results): Tetracaine_Amegel199302.xls |
| View full study record |
| Document reference: 48145 |
| Study title: Subconjunctival bupivacaine versus topical amethocaine in strabismus surgery. Habib NE, el-Kasaby HT, Marczak AM, Hsuan J. Eye. 1993;7 ( Pt 6):757-9. Subconjunctival bupivacaine versus topical amethocaine in strabismus surgery. Habib NE, el-Kasaby HT, Marczak AM, Hsuan J. Eye. 1993;7 ( Pt 6):757-9. |
| Active substance: TETRACAINE |
| Study summary document link (including results): Subconjunctival bupivacaine versus topical amethocaine in strabismus surgery. Habib NE, el-Kasaby HT, Marczak AM, Hsuan J. Eye. 1993;7.pdf |
| View full study record |
| Document reference: 44447 |
| Study title: The effect of topical tetracaine eye drops on emergence behavior and pain relief after strabismus surgery. Anninger W, Forbes B, Quinn G, Schreiner MS. J AAPOS. 2007 Jun;11(3):273-6;Epub 2007 Mar 26.The effect of topical tetracaine eye drops on emergence behavior and pain relief after strabismus surgery. Anninger W, Forbes B, Quinn G, Schreiner MS. J AAPOS. 2007 Jun;11(3):273-6;Epub 2007 Mar 26. |
| Active substance: TETRACAINE |
| Study summary document link (including results): The effect of topical tetracaine eye drops on emergence behavior and pain relief after strabismus surgery. Anninger W, Forbes B, Quinn G, S.pdf |
| View full study record |
| Document reference: 44444 |
| Study title: Topical amethocaine in strabismus surgery. Watson DM. Anaesthesia. 1991 May;46(5):368-70.Topical amethocaine in strabismus surgery. Watson DM. Anaesthesia. 1991 May;46(5):368-70. |
| Active substance: TETRACAINE |
| Study summary document link (including results): Topical amethocaine in strabismus surgery. Watson DM. Anaesthesia. 1991 May;46(5)368-70.pdf |
| View full study record |
| Document reference: 44448 |
| Study title: Yeo E, Miller JH. Pulmonary gallium-67 uptake in diffuse pulmonary calcinosis. Pediatr Radiol. 1996 Nov;26(11):825-6. Yeo E, Miller JH. Pulmonary gallium-67 uptake in diffuse pulmonary calcinosis. Pediatr Radiol. 1996 Nov;26(11):825-6. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43557 |
| Study title: Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43391 |
| Study title: Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44148 |
| Study title: Publication in NDA Annual Report: Inhibition of meconium induced activation of granulocytes from neonates and adults by pentoxifylline. - Klin -Padiatr. 214(6): 347-52 - Tegtmeyer - Nov-Dec 2002Publication in NDA Annual Report: Inhibition of meconium induced activation of granulocytes from neonates and adults by pentoxifylline. - Klin -Padiatr. 214(6): 347-52 - Tegtmeyer - Nov-Dec 2002 |
| Active substance: PENTOXYFILLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45847 |
| Study title: Antitussive effect of carbetapentane (toclase) to infantile respiratory tract disturbances. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): ARCE92G0601 - Pentoxyverine.pdf |
| View full study record |
| Document reference: 45854 |
| Study title: Antitussive wirkung von pentoxyverin. eine randomisierte kontrollierte doppelblindstudie. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): ARCD94F2701 - Pentoxyverine.pdf |
| View full study record |
| Document reference: 45850 |
| Study title: Anwendung von Sedotussin Suppositorien (8 mg) bei Sauglingen und Kleinkindern mit Husten verschiedener genese. integrieter Abschlussbericht. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45855 |
| Study title: Clinical study;Administration of Sedotussin to infants and young children. Final evaluation and expert report involving 5,024 patients. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): ARCE94C1701(2) - Pentoxyverine.pdf |
| View full study record |
| Document reference: 47360 |
| Study title: Experimentation du sirop ucb 2543 expectorant chez l'enfant. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): DF68B006 - Pentoxyverine.pdf |
| View full study record |
| Document reference: 45856 |
| Study title: Expertise clinique du sirop "uc 2543" des laboratoire ucepha. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): ARCF92G0616 - Pentoxyverine.pdf |
| View full study record |
| Document reference: 45851 |
| Study title: Expertise clinique du sirop "uc-2543 - expectorant" des laboratoires UCEPHA. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): ARCF99D1205 - Pentoxyverine.pdf |
| View full study record |
| Document reference: 45849 |
| Study title: Final report of the study of the possible relation between pentoxyverin dispensing and respiratory depression in children. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): DE85C261 - Pentoxyverine.pdf |
| View full study record |
| Document reference: 45852 |
| Study title: Hustenbehandlung bei akuten und chronisch entzundlichen Erkrankungen der Atemwege im sauglings- und kindesalter mit Sedotussin Expectorans Sauglingszapfchen. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): DID88H112.pdf |
| View full study record |
| Document reference: 45858 |
| Study title: Open, single-dose, phase i study to evaluate the pharmacokinetic parameters of pentoxyverine and its major metabolites in plasma and urine of children with upper respiratory tract infection. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): 9738 - Pentoxyverine - MRCE99K0801.pdf |
| View full study record |
| Document reference: 45861 |
| Study title: Pentoxyverine effectively controls irritating cough in preschool children. |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45853 |
| Study title: Tableau synoptique des essais avec le produit : "sirop expectoclase". |
| Active substance: PENTOXYVERINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45857 |
| Study title: Besedovsky A, Li BUK. Across the developmental continuum of irritable bowel syndrome: Clinical and pathophysiologic considerations. CURR GASTROENTEROL REP 2004; 6(3): 247−253 |
| Active substance: Peppermint Oil 0.200 ml |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40115 |
| Study title: Brooks CD; J Rheumatol (Canada), Apr 2001, 28(4) p845-53; Sulfasalazine for the management of juvenile rheumatoid arthritis.Brooks CD; J Rheumatol (Canada), Apr 2001, 28(4) p845-53; Sulfasalazine for the management of juvenile rheumatoid arthritis. |
| Active substance: SULFASALAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42880 |
| Study title: Treatment of metastatic bone pain with strontium-89. Robinson RG 1987 Int J Rad Appl Instrum B. 1987; 14(3):219-22 R G Robinson et al. |
| Active substance: STRONTIUM 89 |
| Study summary document link (including results): 2011-09 GE Metastron response List of published articles.doc |
| View full study record |
| Document reference: 48215 |
| Study title: Arguelles-Martin F. Sucralfate versus cimetidine in the treatment of reflux oesophagitis in children. Am J Med 1989; 86 (suppl 6A): 73-76. Arguelles-Martin F. Sucralfate versus cimetidine in the treatment of reflux oesophagitis in children. Am J Med 1989; 86 (suppl 6A): 73-76. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42602 |
| Study title: Chiang. Chronic duodenal ulcer in children: clinical observation and response to treatment. J Pediatr Gastroenterol Nutr 1989; 8: 161-165. Chiang. Chronic duodenal ulcer in children: clinical observation and response to treatment. J Pediatr Gastroenterol Nutr 1989; 8: 161-165. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42607 |
| Study title: Dr. Kuwabara's study reported in 1987 13 Children (11 boys and 2 girls, from 1-year-old to 14-year-old) Gastric ulcer or duodenal ulcer treated by Ulcerlmin (Sucralfate) and/or Gastrozepin (Pirenzepine)Dr. Kuwabara's study reported in 1987 13 Children (11 boys and 2 girls, from 1-year-old to 14-year-old) Gastric ulcer or duodenal ulcer treated by Ulcerlmin (Sucralfate) and/or Gastrozepin (Pirenzepine) |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42610 |
| Study title: Dr. Nagita's study reported in 1986 14 Children (9 boys and 5 girls, from 1-year-old to 13-year-old) Gastric ulcer or duodenal ulcer treated by Ulcerlmin (Sucralfate)Dr. Nagita's study reported in 1986 14 Children (9 boys and 5 girls, from 1-year-old to 13-year-old) Gastric ulcer or duodenal ulcer treated by Ulcerlmin (Sucralfate) |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42611 |
| Study title: Esteban F, Soldado L, Delgado M, Barrueco JC, Solanellas J. The usefulness of sucralfate in postoperative improvement of children's tonsillectomy. Anales O.R.L. Iber-Amer 2000, XXVII, 4, 393-404.Esteban F, Soldado L, Delgado M, Barrueco JC, Solanellas J. The usefulness of sucralfate in postoperative improvement of children's tonsillectomy. Anales O.R.L. Iber-Amer 2000, XXVII, 4, 393-404. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42609 |
| Study title: Hermans . Primary duodenogastric reflux in children and adolescents. Eur J Pediatr 2003; 162: 598-602. Hermans . Primary duodenogastric reflux in children and adolescents. Eur J Pediatr 2003; 162: 598-602. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42604 |
| Study title: Lopez-Herce J. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and Sucralfate. Crit Care Med 1992; 20: 1082-1089. Lopez-Herce J. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and Sucralfate. Crit Care Med 1992; 20: 1082-1089. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42608 |
| Study title: Lopriore. Ventilator-associated pneumonia and upper airway colonization with Gram negative bacilli: the role of stress ulcer prophylaxis in children. Intensice Care Med 2002; 28: 763-767. Lopriore. Ventilator-associated pneumonia and upper airway colonization with Gram negative bacilli: the role of stress ulcer prophylaxis in children. Intensice Care Med 2002; 28: 763-767. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42605 |
| Study title: Shenep JL. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mycositis. J Pediatr 1988; 113: 758-763. Shenep JL. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mycositis. J Pediatr 1988; 113: 758-763. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42603 |
| Study title: Long -term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group - no author -2000 ( N-Engl-J-Med) |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47033 |
| Study title: Long -term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group - no author -2000 ( N-Engl-J-Med) - Publication in Clinical Expert Statement - Renewal application for : Nedocromil-Sodium (all formulations) - DR. Rolf Ohlrogge - 08/12/2005 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47034 |
| Study title: Comparison of the protective effects of cromolyn sodium in the treatment of exercice-induced asthma in children - FM. De Benedictis et al. - 1994 (J Allergy Clin Immunol vol 94) - Publication dans le Rapport d'expert clinique sur la compatibilité sur Tiliade et des chambres de mélanges -Tilade 2 mg/ dose, suspension pour inhalation buccale pour flacon pressurisé - Clotilde Bremard-Oury - 07/1996 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47001 |
| Study title: Multicentre double-bind crossover study comparing flavoured nedocromil sodium (Tilade mint) 16 mg daily and matching placebo, both delivered via a large volume spacer in the management of paediatric asthma - Dr A R Harndern et al. - 30/03/1994 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47004 |
| Study title: Multicentre double-blind group comparative study assess the efficacy of substituting nedocromil sodium (Tilade) 8 mg daily and sodium cromoglycate (Intal) 20 mg daily in paediatric patients currently maintained on sodium cromoglycate 20 mg daily - D. Hilde et al. - 1993 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47005 |
| Study title: Nedocromil sodium (TILADE) in the treatment of the severe forms of asthma in children - V. Petru et al. - 1991 (Cesk Pediatr vol 46) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47035 |
| Study title: Nedocromil sodium - A preliminary review of its pharmacodynamic and pharmakocinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease -John P. Gonzalez et al.- 1987 (Drugs vol 34) - Publication in Tilade CFC-Free metered dose inhaler nedocromil sodium-vol2 response to CSM questions references - no author - 09/ 1999 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47036 |
| Study title: Nedocromil sodium (FPL 59002KP) Safety evaluation - Summary of safety evaluation studies SE 5660/7, January 1987 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47020 |
| Study title: Nedocromil sodium (TILADE) in the treatment of the severe forms of asthma in children - V. Petru et al. - 1991 (Cesk Pediatr vol 46) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47038 |
| Study title: Nedocromil sodium for chronic asthma in children. - A-V. Sridhar et al. - 2006 (Cochrane database of systematics review vol 3) - Publication in Nedocromil Sodium CFC-free Inhaler Corporate Data Sheet - no author - 25/06/2003 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47039 |
| Study title: Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids - MF. Bone et al. - 1989 ( Thorax vol 44) - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) -Clinical documentation -29/08/1995 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47040 |
| Study title: Nedocromil sodium Safety evaluation- Summary of safety evaluation studies- B. Clark- 01/ 1987 - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) - Pre Clinical documentation -29/08/1995 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47007 |
| Study title: Nedocromil sodium vs sodium cromoglycate pressurised aerosol in the prevention of bronconstriction induced by ultrasonic nebulized distilled water in asthmatic children - E. Spezia et al. - 1993 -Pediatr Pulmonol vol 16) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47041 |
| Study title: Prevalence of asthma in Melbourne schoolchildren : changes over 26 years - CF. Robertson et al. - 1991 (BMJ vo l 302) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47024 |
| Study title: Protective effect of nedocromil sodium (4 mg) given by metered dose inhaler, with or whithout an extension tube (Autry-Altounyan Spacer Device), Against exercise-induced bronchoconstriction in children with asthma : A placebo-controlled double-blind crossover trial - A. Boner - 1986 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47008 |
| Study title: Nedocromil Sodium (Eye drops) Corporate Data Sheet - no author - 11/10/2000 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47037 |
| Study title: Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44195 |
| Study title: Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. Yildiz M, Tunc SE, Sahin M, Okudan B, Aydin O, Suslu H, Ozbek M. Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up? Rheumatol Int. 2006 Jan;26(3):220-3. Epub 2005 Feb 3. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44242 |
| Study title: Yilmaz M, Yilmaz K, Celen Z, Sirikci A, Ozkiliç S, Zincirkeser S. Bilateral symmetrically increased Tc-99m MDP cranial uptake in Hurler syndrome. Clin Nucl Med. 2002 Dec;27(12):915. No abstract available. Yilmaz M, Yilmaz K, Celen Z, Sirikci A, Ozkiliç S, Zincirkeser S. Bilateral symmetrically increased Tc-99m MDP cranial uptake in Hurler syndrome. Clin Nucl Med. 2002 Dec;27(12):915. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43427 |
| Study title: Yoffe N, Besser MI, Sobel JD, Front D. [Early diagnosis of pyogenic sacroiliac infection using 67-gallium scintigram] Harefuah. 1983 Jan 16;104(2):55-6. Hebrew. No abstract available. Yoffe N, Besser MI, Sobel JD, Front D. [Early diagnosis of pyogenic sacroiliac infection using 67-gallium scintigram] Harefuah. 1983 Jan 16;104(2):55-6. Hebrew. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44052 |
| Study title: Two cases of pediatric bone disease (eosinophilic granuloma and Brodie's abscess) showing similar scintigraphic and radiographic findings. Yoshikawa M, Sugawara Y, Kikuchi T, Nakata S, Mochizuki T, Ikezoe J, Sakayama K. Clin Nucl Med. 2000 Dec;25(12):986-90. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43466 |
| Study title: A 3 week randomized, multicenter, double blind, vehicle-controlled, parallel-group study to evaluate the efficacy and safety of Pimecrolimus cream 1% in children between 2-12 years with mild to moderate atopic dermatitis (Speed Study) |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CES02 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34103 |
| Study title: A 3-month open label study assessing the efficacy and tolerability of Elidel (pimecrolimus) cream 1% in patients with mild or moderate atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CSA01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34116 |
| Study title: A 3-month open label, national, Quality of Life and safety study with Elidel (pimecrolimus) cream 1% in children (2-12 years) with atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CZA01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34119 |
| Study title: A 6-month open label, multi-national, effectiveness, and safety study of Elidel® (pimecrolimus) Cream, 1% in subjects with atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2405 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34133 |
| Study title: A 6-month open label, multi-national, effectiveness, and safety study of Elidel® (pimecrolimus) Cream, 1% in subjects with atopic dermatitis |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C2405 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34134 |
| Study title: A 6-month study of the utility of Elidel cream 1% in the long-term management of pediatric patients with severe AD |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CDE10 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34095 |
| Study title: A 6-month, randomized, multi-center, parallelgroup, double-blind, vehicle controlled study to evaluate the efficacy and safety of ASM981 (pimecrolimus) cream 1% BID vs. standard of care in the management of mild to moderate atopic dermatitis in children 3 months to 11 years. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CUS04 Art45 listing 2011.xls |
| View full study record |
| Document reference: 47706 |
| Study title: A 6-week open label, national, post-marketing surveillance program to obtain photographic documentation of mild to moderate atopic eczema lesions before and after treatment with Elidel (pimecrolimus) cream 1% in children from 2 years and above and adults with atopic ezcema |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34120 |
| Study title: Yildizdas D. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with Sucralfate, ranitidine, and omeprazole. J Crit Care 2002; 17: 240-245. Yildizdas D. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with Sucralfate, ranitidine, and omeprazole. J Crit Care 2002; 17: 240-245. |
| Active substance: SUCRALFATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42606 |
| Study title: Comparison of intranasal midazolam and sufentanil premedication pediatric outpatients. Clinical Pharmacology and Therapeutics 59, p. 314-348, 1996Comparison of intranasal midazolam and sufentanil premedication pediatric outpatients. Clinical Pharmacology and Therapeutics 59, p. 314-348, 1996 |
| Active substance: SUFENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42622 |
| Study title: Fentanly versus sufentanil: plasma concentrations during continuous epidural postoerative infusion in children. British Journal of Anaethesia 85, p.615-617, 2000Fentanly versus sufentanil: plasma concentrations during continuous epidural postoerative infusion in children. British Journal of Anaethesia 85, p.615-617, 2000 |
| Active substance: SUFENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42621 |
| Study title: The combination sufentanil-bupivascaine in post-operative patient controlled epidural analgesia. Von H. LuewenThe combination sufentanil-bupivascaine in post-operative patient controlled epidural analgesia. Von H. Luewen |
| Active substance: SUFENTANYL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42623 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VERSUS CEFTRIAXONE IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42629 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VERSUS CEFOTAXIME IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42649 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VERSUS CEFUROXIME IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42645 |
| Study title: A COMPARATIVE STUDY OF PARENTERAL AMPICILLIN/SULBACTAM VS AMPICILLIN AND CHLORAMPHENICOL IN THE TREATMENT OF ACUTE BACTERIAL MENINGITIS IN INFANTS AND CHILDREN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42640 |
| Study title: A COMPARATIVE STUDY OF SBT/AMP IN COMPLICATED URINARY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42674 |
| Study title: A COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP VS CEFUROXIME IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42717 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS METRONIDAZOLE/GENTAMYCIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42635 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CEFOXITIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42632 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CEFOXITIN/DOXYCYCLINE OR CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF GYNECOLOGICAL OR OBSTETRICAL INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42630 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CEFTRIAXONE IN`THE TREATMENT OF SKIN AND/OR SKIN STRUCTURE INFECTIONS (E.G. PERIORBITAL CELLULITIS) AND/OR OSTEOMYELITIS/SUPPURATIVE ARTHRITIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42641 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CLINDAMYCIN PLUS GENTAMICIN VERSUS CEFOXITIN IN THE TREATMENT OF POST PARTUM ENDOMETRITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42651 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VERSUS CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF POST CESAREAN SECTION ENDOMETRITIS INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42636 |
| Study title: Publication in Nedocromil sodium HFA-227-metered dose inhaler -Expert report on clinical documentation -Critical evaluation - H. Staudinger - 09/04/1998 |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47042 |
| Study title: Report of a double-blind group comparative trial comparing nedocromil sodium (2 mg four times a day) and placebo in the management of bronchial asthma in children - R. Ronchetti - 1986 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47009 |
| Study title: Report of an open assessment of nedocromil sodium (4 mg given four times a day) in the management of bronchial asthma in children - L. Businco - 1986 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47010 |
| Study title: Report on a double-blind crossover study to compare the efficacy and duration of action of nedocromil sodium (4 mg) and placebo, Given by pressurised aerosol exercise-induced asthma in children, carried out - M. Silvermann - 1986 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47011 |
| Study title: Report on a matched-pairs double-blind comparative study on the effects of nedocromil sodium (4mg * 4) with placebo on non-specific bronchial reactivity changes in asthmatic children when re-exposed to allergen (House Dust Mite) in a natural environment - Prof. Boner - 1987 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47012 |
| Study title: Report on a Multicentre Blinded Group Comparative Study Comparative Nedocromil Sodium (Tilade), Beclomethasone Dipropionate (Becotide) and Placebo in the Management of Asthma |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47021 |
| Study title: Safety evaluation - Dentomint : Summary of toxicité - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) - Pre Clinical documentation -29/08/1995 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47013 |
| Study title: Sodium nedocromil modifies bronchial hyperreactivity in asthmatic children - BM. Ricci et al. - 1993 (Eur Respi J vol 6 suppl 17) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47043 |
| Study title: Spacing devices and metered-dose inhalers in childhood asthma - H. Levinson et al. - 1983 (J Pediatrics vol 46) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47044 |
| Study title: Summary of the Pharmacokinetics of Nedocromil Sodium in children - MG. Neale - 1994 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47014 |
| Study title: The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial ashma - AJ. Williams et al. - 1986 (Eur J Resp Dis vol 69) - Publication in Product licence application TILADE MINT AEROSOL (nedocromil sodium) -Clinical documentation -29/08/1995 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47045 |
| Study title: The protective effect of nedocromil sodium exercise-induced asthma - CP Bauer et al. - 1986 (European Journal of Respiratory disease vol 69) - Publication in Tilade CFC-Free metered dose inhaler nedocromil sodium-vol2 response to CSM questions references - no author - 09/ 1999 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47046 |
| Study title: Tilad mint aerosole - Clinical documentation PART IV |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47022 |
| Study title: Tratamiento con nedocromil sodico en ninos con asma cronica grave. Estudio preliminar - JL. Madrazo et al. - 1991 ( Rev Esp Alergol Immunol Clin suppl 2 vol 6) - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47047 |
| Study title: Twelve month open assessment study of the safety and acceptability of flavoured nedocromil sodium (4 mg, QID) in the management of paediatric asthma - J. Cater et al. - 1993 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 - |
| Active substance: NEDOCROMIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47015 |
| Study title: Caudal ropivacaine and neostigmine in pediatric surgeryCaudal ropivacaine and neostigmine in pediatric surgery |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47048 |
| Study title: Young MR, Lowry JH, Laird JD, Ferguson WR. 99Tcm-MDP bone scanning of injuries of the carpal scaphoid. Injury. 1988 Jan;19(1):14-7. Young MR, Lowry JH, Laird JD, Ferguson WR. 99Tcm-MDP bone scanning of injuries of the carpal scaphoid. Injury. 1988 Jan;19(1):14-7. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43836 |
| Study title: Yu JQ, Zhuang H, Posteraro A, Reddy S, Alavi A. Transiently increased MDP activity in the soft tissue of lower extremity caused by iliofemoral venous thrombosis. Clin Nucl Med. 2005 Nov;30(11):742-3. No abstract available. Yu JQ, Zhuang H, Posteraro A, Reddy S, Alavi A. Transiently increased MDP activity in the soft tissue of lower extremity caused by iliofemoral venous thrombosis. Clin Nucl Med. 2005 Nov;30(11):742-3. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43383 |
| Study title: Yui N, Kinoshita F, Akiyama Y, Koakutsu M, Umeda T. [Clinical evaluation of transaxial bone imaging with 99mTc-phosphate compounds] Radioisotopes. 1982 Oct;31(10):521-8. Japanese. Yui N, Kinoshita F, Akiyama Y, Koakutsu M, Umeda T. [Clinical evaluation of transaxial bone imaging with 99mTc-phosphate compounds] Radioisotopes. 1982 Oct;31(10):521-8. Japanese. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44069 |
| Study title: Yunus MB, Berg BC, Masi AT. Multiphase skeletal scintigraphy in primary fibromyalgia syndrome: a blinded study. J Rheumatol. 1989 Nov;16(11):1466-8. Yunus MB, Berg BC, Masi AT. Multiphase skeletal scintigraphy in primary fibromyalgia syndrome: a blinded study. J Rheumatol. 1989 Nov;16(11):1466-8. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43779 |
| Study title: Unusual bone scan of a child with osteogenesis imperfecta. Yurekli Y, Erdogan S, Cullu E. Clin Nucl Med. 2003 Feb;28(2):156. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43429 |
| Study title: Yurtkuran M, Yurtkuran M, Alp A, Sivrioglu K, Dilek K, Tamgaç F, Alper E, Tunali S, Saricaoğlu H, Nasircilar A. Hand involvement in Behçet's disease. Joint Bone Spine. 2006 Dec;73(6):679-83. Epub 2006 Mar 15. Yurtkuran M, Yurtkuran M, Alp A, Sivrioglu K, Dilek K, Tamgaç F, Alper E, Tunali S, Saricaoğlu H, Nasircilar A. Hand involvement in Behçet's disease. Joint Bone Spine. 2006 Dec;73(6):679-83. Epub 2006 Mar 15. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43377 |
| Study title: Zebedin D, Fotter R, Reittner P, Preidler KW, Mache C, Szolar DH. [Chronic recurrent multifocal osteomyelitis of the lower jaw] Rofo. 1998 Nov;169(5):551-4. German. No abstract available. Zebedin D, Fotter R, Reittner P, Preidler KW, Mache C, Szolar DH. [Chronic recurrent multifocal osteomyelitis of the lower jaw] Rofo. 1998 Nov;169(5):551-4. German. No abstract available. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43521 |
| Study title: Zhibin Y, Quanyong L, Libo C, Jun Z, Hankui L, Jifang Z, Ruisen Z. The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med. 2004 Mar;29(3):177-80. Zhibin Y, Quanyong L, Libo C, Jun Z, Hankui L, Jifang Z, Ruisen Z. The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med. 2004 Mar;29(3):177-80. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43403 |
| Study title: A dermal embryo-fetal development study in rats |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34126 |
| Study title: A double-blind, randomized, placebo-controlled, paired study to evaluate the efficacy and safety of combined use of Elidel and Cutivate in children with severe atopic dermatitis. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47709 |
| Study title: Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968;42:565-589Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968;42:565-589 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45415 |
| Study title: Subcommittee on diagnosis and management of bronchiolitis (American Academy of Pediatrics). Diagnosis and management of bronchiolitis. Pediatrics 2006; 118(4):1774-1793Subcommittee on diagnosis and management of bronchiolitis (American Academy of Pediatrics). Diagnosis and management of bronchiolitis. Pediatrics 2006; 118(4):1774-1793 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45410 |
| Study title: Tay-Uyboco JS, Kwiatkowski K, Cates DB, Kavanagh L, Rigatto H. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr. 1989; 115:456–459.Tay-Uyboco JS, Kwiatkowski K, Cates DB, Kavanagh L, Rigatto H. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr. 1989; 115:456–459. |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45411 |
| Study title: The British guidelines on management of asthma. Thorax 2003; 58(suppl)S1:1-83The British guidelines on management of asthma. Thorax 2003; 58(suppl)S1:1-83 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45416 |
| Study title: The STOP-ROP Multicenter Study Group Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes. Pediatrics 2000; 105;295-310The STOP-ROP Multicenter Study Group Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes. Pediatrics 2000; 105;295-310 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45412 |
| Study title: The STOP-ROP Multicenter Study Group Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes. Pediatrics 2000;105;295-310The STOP-ROP Multicenter Study Group Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), A Randomized, Controlled Trial. I: Primary Outcomes. Pediatrics 2000;105;295-310 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45418 |
| Study title: UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75-82UK Collaborative ECMO Trial Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996; 348: 75-82 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45413 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM PLUS DOXYCYCLINE VERSUS CEFOXITIN/DOXYCYCLINE IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42660 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOTETAN FOR THE PREVENTION OF INFECTION FOLLOWING CESAREAN SECTION IN HIGH RISK PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42656 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOXITIN AS EARLY EMPIRIC THERAPY FOLLOWING PENETRATING AND BLUNT TRAUMA TO THE ABDOMEN |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42662 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOXITIN FOR THE PREVENTION OF INFECTION FOLLOWING CESAREAN SECTION IN HIGH RISK PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42634 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CEFOXITIN IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42653 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VERSUS CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF POST-CAESAREAN SECTION ENDOMETRITIS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42667 |
| Study title: A COMPARISON OF AMPICILLIN/SULBACTAM VS CEFAZOLIN OR CEFOTETAN FOR THE PREVENTION OF INFECTION FOLLOWING CESAREAN SECTION IN HIGH RISK PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42659 |
| Study title: A COMPARISON OF CEFOBID (CEFOPERAZONE) PLUS SULBACTAM VERSUS PRIMAXIN (IMIPENEN-CILASTATIN) IN THE THERAPY OF FEBRILE NEUTROPENIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42661 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS AMIKACIN OR GENTAMICIN PLUS AMPICILLIN AND METRONIDAZOLE IN THE TREATMENT OFPATIENTS WITH AN INTRA-ABDOMINAL INFECTION |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42637 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS AMPICILLIN PLUS TOBRAMYCIN IN THE TREATMENT OF PATIENTS WITH BILIARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42655 |
| Study title: A COMPARISON OF AMPICILLIN PLUS SULBACTAM VS CLINDAMYCIN PLUS GENTAMICIN VS CEFOXITIN IN THE TREATMENT OF POSTPARTUM ENDOMETRITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42627 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS CEFOTAXIME IN THE TREATMENT OF RECURRENT OR COMPLICATED URINARY TRACT INFECTIONS OF BACTERIAL ETIOLOGY |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42639 |
| Study title: A COMPARISON OF CEFOPERAZONE PLUS SULBACTAM VERSUS PRIMAXIN (IMIPENEM-CILASTATIN) IN THE THERAPY OF FEBRILE NEUTROPENIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42666 |
| Study title: A COMPARISON OF SULPERAZONE (SULBACTAM/CEFOPERAZONE) VERSUS CEFOBID (CEFOPERAZONE) IN THE TREATMENT OF INTRA ABDOMINAL INFECTIONS OF BACTERIAL ETIOLOGY. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42846 |
| Study title: A DOUBLE-BLIND COMPARATIVE STUDY OF ONCE VS TWICE ADMINISTRATION OF SBT/AMP IV IN THE PROPHYLAXIS OF POST-HYSTERECTOMY GYNECOLOGICAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42712 |
| Study title: A MULTICENTER COMPARISON OF 2:1 AMPICILLIN/SULBACTAM (UNASYN) VSCEFUROXIME IN THE TREATMENT OF SKIN AND/OR SKIN STRUCTURE INFEC-TIONS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42646 |
| Study title: A MULTICENTER COMPARISON OF 2:1 AMPICILLIN/SULBACTAM (UNASYN) + OPTIONAL AMINOGLYCOSIDE VS AMPICILLIN AMINOGLYCOSIDE IN THE TREATMENT OF INTRA-ABDOMINAL INFECTIONS OF BACTERIAL ETIOLOGY IN OSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42647 |
| Study title: A MULTICENTER STUDY OF 2:1 AMPICILLIN/SULBACTAM (UNASYN) IN THE TREATMENT OF PERIORBITAL/PRESEPTAL AND FACIAL CELLULITIS OF BACTERIAL ETIOLOGY IN HOSPITALIZED PEDIATRIC PATIENTS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42648 |
| Study title: A NON-COMPARATIVE STUDY OF UNASYN IM/IV (SULBACTAM/AMPICILLIN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF COMMUNITY ACQUIRED INFECTIONS. A MULTICENTER TRIAL. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42737 |
| Study title: A NON-COMPARATIVE STUDY TO ASSESS THE EFFICACY AND SAFETY OF SULBACTAM/ AMPICILLIN IN PEDIATRIC PATIENTS IN BACTERIAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42723 |
| Study title: Dose response study of caudal neostigmine for postoperative analgesia in paediatric patients undergoing genitourinary surgery.Dose response study of caudal neostigmine for postoperative analgesia in paediatric patients undergoing genitourinary surgery. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47049 |
| Study title: Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47050 |
| Study title: Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47051 |
| Study title: Ghigo E et al.: Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children. Journal of Clinical Endocrinology and Metabolism (J. CLIN. ENDOCRINOL. METAB. ) (United States) , May 24, 1991, 72/2 (467-470) Ghigo E et al.: Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children. Journal of Clinical Endocrinology and Metabolism (J. CLIN. ENDOCRINOL. METAB. ) (United States) , May 24, 1991, 72/2 (467-470) |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47052 |
| Study title: Gwinnutt CL, Walker RW, Meakin G.: Antagonism of intense atracurium-induced neuromuscular block in children. Br J Anaesth. 1991 Jul;67(1):13-6.Gwinnutt CL, Walker RW, Meakin G.: Antagonism of intense atracurium-induced neuromuscular block in children. Br J Anaesth. 1991 Jul;67(1):13-6. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47053 |
| Study title: Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children.Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47054 |
| Study title: Kumar P et al.: Caudal additives in pediatrics: A comparison among midazolam, ketamine, and neostigmine coadministered with bupivacaine. Anesthesia and Analgesia ( Anesth. Analg. ) (United States) , July 1, 2005 , 101/1 (69-73) Kumar P et al.: Caudal additives in pediatrics: A comparison among midazolam, ketamine, and neostigmine coadministered with bupivacaine. Anesthesia and Analgesia ( Anesth. Analg. ) (United States) , July 1, 2005 , 101/1 (69-73) |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47055 |
| Study title: Mahajan R.; Grover V.K.; Chari P.: Caudal neostigmine with bupivacaine produces a dose-independent analgesic effect in children. Canadian Journal of Anesthesia ( Can. J. Anesth. ) (Canada), August 1, 2004 , 51/7 (702-706) Mahajan R.; Grover V.K.; Chari P.: Caudal neostigmine with bupivacaine produces a dose-independent analgesic effect in children. Canadian Journal of Anesthesia ( Can. J. Anesth. ) (Canada), August 1, 2004 , 51/7 (702-706) |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47056 |
| Study title: Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47057 |
| Study title: Turan A, Memiş D, Başaran UN, Karamanlioğlu B, Süt N.: Caudal ropivacaine and neostigmine in pediatric surgery. Anesthesiology. 2003 Mar;98(3):719-22.Turan A, Memiş D, Başaran UN, Karamanlioğlu B, Süt N.: Caudal ropivacaine and neostigmine in pediatric surgery. Anesthesiology. 2003 Mar;98(3):719-22. |
| Active substance: NEOSTIGMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47058 |
| Study title: Early bisphosphonate treatment in infants with severe osteogenesis imperfecta.(study published in 2006) |
| Active substance: NERIDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47061 |
| Study title: [A case of Maffucci's syndrome] German. Zöller A, Hör G, Köbrich U. Nuklearmedizin. 1993 Jun;32(3):156-8. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): 2011-09 GE Medronate response List of published articles.doc |
| View full study record |
| Document reference: 43663 |
| Study title: Zompatori M, Gavelli G, Bernasconi A, Fabbri M, Sturani C, Galavotti V. [Pulmonary eosinophilic granuloma in adults. Case histories and a review of the literature] Radiol Med (Torino). 1989 Apr;77(4):347-53. Review. Italian. Zompatori M, Gavelli G, Bernasconi A, Fabbri M, Sturani C, Galavotti V. [Pulmonary eosinophilic granuloma in adults. Case histories and a review of the literature] Radiol Med (Torino). 1989 Apr;77(4):347-53. Review. Italian. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43791 |
| Study title: [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases] German. Zorn-Bopp E, Büll U, Münzing W, Lang P, Moser EA. Nuklearmedizin. 1983 Feb;22(1):24-30. German. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): 2011-09 GE Medronate response List of published articles.doc |
| View full study record |
| Document reference: 44048 |
| Study title: Zwillich SH, Comer SS, Lee E, Erdman WA, Lipsky PE. Treatment of the seronegative spondyloarthropathies with sulfasalazine. J Rheumatol Suppl. 1988 Sep;16:33-9. Review. Zwillich SH, Comer SS, Lee E, Erdman WA, Lipsky PE. Treatment of the seronegative spondyloarthropathies with sulfasalazine. J Rheumatol Suppl. 1988 Sep;16:33-9. Review. |
| Active substance: TECHNETIUM (99mTc) MEDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 43812 |
| Study title: Mora S. Longitudinal Changes of Bone Density and Bone Resorption in Hyperthyroid Girls During Treatment, J Bone Miner Res 1999; 14: 1971-77Mora S. Longitudinal Changes of Bone Density and Bone Resorption in Hyperthyroid Girls During Treatment, J Bone Miner Res 1999; 14: 1971-77 |
| Active substance: TEGAFUR/URACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44287 |
| Study title: Schendekehl TK. Therapie und Verlauf der Juvenilen Hyperthyreose, Schweiz Med Wochenschr 1997; 127 (Suppl 87): Abstract 51Schendekehl TK. Therapie und Verlauf der Juvenilen Hyperthyreose, Schweiz Med Wochenschr 1997; 127 (Suppl 87): Abstract 51 |
| Active substance: TEGAFUR/URACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44289 |
| Study title: Van Santen HM. Improved Radiation Protection of the Thyroid Gland with Thyroxine, Methimazole, and Potassium Iodide during Diagnostic and Therapeutic Use of Radiolabeled Metaiodobenzylguanidine in Children with Neuroblastoma, Cancer 2003; 98: 389-396Van Santen HM. Improved Radiation Protection of the Thyroid Gland with Thyroxine, Methimazole, and Potassium Iodide during Diagnostic and Therapeutic Use of Radiolabeled Metaiodobenzylguanidine in Children with Neuroblastoma, Cancer 2003; 98: 389-396 |
| Active substance: TEGAFUR/URACIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44288 |
| Study title: A once a day antimicrobial therapy. Teicoplanin and ceftriaxone in the treatment of febrile neutropenic children with acute leukaemia. - Schaison, G ., Leverger, G ., Artel, G ., Pecking, D. -28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles 1988 ; 23-26 October : 33.A once a day antimicrobial therapy. Teicoplanin and ceftriaxone in the treatment of febrile neutropenic children with acute leukaemia. - Schaison, G ., Leverger, G ., Artel, G ., Pecking, D. -28th Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles 1988 ; 23-26 October : 33. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44323 |
| Study title: CES for MA renewal in Austria - Bruno Verdoncq - 28 February 2007 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44290 |
| Study title: Clinical and pharmacokinetic study of teicoplanin in children. - Kafetsis DA, Tspra H, Gianacopoulou C, Karamitsos S. -(Abstract) In: Abstract book of the 15th international congress of chemotherapy. Istanbul, 19-24 July 1987:322. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44304 |
| Study title: Dagan R, Einhorm M, Howard CB, Williams AH. Outpatient and inpatient teicoplanin treatment for serious grm-positive infections in children. Pediatr Infedt Dis J 1993; 12 (6/2): S 17-S 20. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44311 |
| Study title: Vento M, Asensi M, Sastre J, García-Sala F, Lloret A, Viña J. Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. Journal of Pediatrics 2003; 142:240-246Vento M, Asensi M, Sastre J, García-Sala F, Lloret A, Viña J. Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. Journal of Pediatrics 2003; 142:240-246 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45414 |
| Study title: Vento M, Asensi M, Sastre J, García-Sala F, Pallardó FV, Viña J. Resuscitation With Room Air Instead of 100% Oxygen Prevents Oxidative Stress in Moderately Asphyxiated Term Neonates. Pediatrics 2001;107;642-647Vento M, Asensi M, Sastre J, García-Sala F, Pallardó FV, Viña J. Resuscitation With Room Air Instead of 100% Oxygen Prevents Oxidative Stress in Moderately Asphyxiated Term Neonates. Pediatrics 2001;107;642-647 |
| Active substance: OXYGEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45419 |
| Study title: Götte−R, Liedtke−R. (On the antipyretic effect of paracetamol. Clinical investigation with two different forms of application (author's transl)). {Med−Klin}, 6 Jan 1978, vol. 73, no. 1, p. 28−33Götte−R, Liedtke−R. (On the antipyretic effect of paracetamol. Clinical investigation with two different forms of application (author's transl)). {Med−Klin}, 6 Jan 1978, vol. 73, no. 1, p. 28−33 |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33266 |
| Study title: Lal−A et al. Antipyretic effects of nimesulide, paracetamol and ibuprofen− paracetamol. {INDIAN−J−PEDIATR}, 2000, Vol/Iss/Pg. 67 /12 (865−870)Lal−A et al. Antipyretic effects of nimesulide, paracetamol and ibuprofen− paracetamol. {INDIAN−J−PEDIATR}, 2000, Vol/Iss/Pg. 67 /12 (865−870) |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33283 |
| Study title: Wilson−J−T et al. Acetaminophen controlled−release sprinkles versus acetaminophen immediate−release elixir in febrile children. {J−CLIN−PHARMACOL}, 2000, Vol/Iss/Pg. 40/4 (360−369)Wilson−J−T et al. Acetaminophen controlled−release sprinkles versus acetaminophen immediate−release elixir in febrile children. {J−CLIN−PHARMACOL}, 2000, Vol/Iss/Pg. 40/4 (360−369) |
| Active substance: PARACETAMOL AND CAFFEINE AND CHLORPHENAMINE AND DEXTROMETHORPHAN AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33285 |
| Study title: A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988.A comparative dose range evaluation of the antipyretic efficacy and safety of ibuprofen liquid at three different doses in children. Jan 1988. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33331 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992.A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with ear pain. Dec 1992. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33317 |
| Study title: A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with sore throat pain. Dec 1992.A comparison of the efficacy and safety of ibuprofen suspension dosed at 5 mg/kg and 10 mg/kg and acetaminophen elixir dosed at 12.5 mg/kg to placebo in children with sore throat pain. Dec 1992. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33332 |
| Study title: A NONCOMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP IN THE TREATMENT OF PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42686 |
| Study title: A PLACEBO-CONTROLLED DOUBLE-BLIND PROSPECTIVE STUDY OF THE EFFICACY OF UNASYN IN MANAGING PRETERM PREMATURE RUPTURE OF THE MEMBRANES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42663 |
| Study title: A PROSPECTIVE, RANDOMIZED, EVALUATION OF AMPICILLIN/SULBACTAM VS CLINDAMYCIN/GENTAMICIN FOR TREATMENT OF CHORIOAMNIONITIS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42668 |
| Study title: A RANDOMIZED, COMPARATIVE TRIAL OF CEFOPERAZONE/SULBACTAM VS. CEFTAZIDIME VS. PRIMAXIN FOR THE TREATMENT OF INSTITUTIONALLY ACQUIRED DISEASES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42654 |
| Study title: AMPICILLIN/SULBACTAM VERSUS PLACEBO FOR THE INHIBITION OF PREMATURE LABOR OF PATIENTS ON TOCOLYSIS AND IN THE PROLONGATION OF THE LATENT PERIOD AFTER PREMATURE RUPTURE OF THE FETAL MEMBRANES |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42650 |
| Study title: AN OPEN COMPARATIVE PERIOPERATIVE PROPHYLAXIS STUDY OF SULBACTAM/ AMPICILLIN IN SINGLE DOSE VS. PROCAINE PENICILLIN PLUS CHLORAMPHENICOL IN PATIENTS WHO UNDERGO CAESAREAN SECTION |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42711 |
| Study title: AN OPEN COMPARATIVE STUDY OF SBT/CFP VS. CEFTAZIDIME PLUS AMIKACIN IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42867 |
| Study title: AN OPEN COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF PARENTERAL SBT/AMP VS CEFOTAXIME IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42690 |
| Study title: AN OPEN EVALUATION OF SULBACTAM/AMPICILLIN IN THE MANAGEMENT OF CEREBRO-SPINAL MENINGITIS EMPIDERMICA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42757 |
| Study title: AN OPEN MULTICENTER STUDY OF SBT/CFP (1:2) IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ABDOMINAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42871 |
| Study title: AN OPEN MULTICENTER STUDY OF SULBACTAM/CEFOPERAZONE (1:2) IN THE TREATMENT OF PEDIATRIC PATIENTS WITH MODERATE OR SEVERE BACTERIAL INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42870 |
| Study title: AN OPEN MULTICENTRIC STUDY OF SULBACTAM/CEFOPERAZONE (1:2) IN THE TREATMENT OF PATIENTS WITH INTRAHOSPITALARY PNEUMONIA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42862 |
| Study title: AN OPEN MULTICENTRIC STUDY OF SULPERAZONE (SULBACTAM/CEFOPERAZONE 1:2) IN THE TREATMENT OF PATIENTS WITH INTRAHOSPITALARY PNEUMONIA. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42872 |
| Study title: AN OPEN NON COMPARATIVE STUDY OF PARENTERAL SULBACTAM/AMPICILLIN IN THE TREATMENT OF MIXED AEROBIC/ANAEROBIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42722 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SBT/AMP PARENTERAL IN THE TREATMENT OF GENERAL PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42731 |
| Study title: An open non-comparative study of Sulbactam plus Ampicillin in Serious Infections in Paediatric Patients |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42874 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN I.V. IN THE TREATMENT OF HOSPITALIZED INFECTION PATIENTS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42707 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN I.V. IN THE TREATMENT OF INTRA ABDOMINAL INFECTION |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42710 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/CEFOPERAZONE (1:1) IN THE EMPIRICAL TREATMENT OF MODERATE TO SEVERE SYSTEMIC INFECTION IN ADULT PATIENTS IN HOSPITAL |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42866 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SBT/CFP IN THE TREATMENT OF URINARY TRACT INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42850 |
| Study title: Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. (study published in 2005) |
| Active substance: NERIDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47062 |
| Study title: Reduction of plasma taurine level in children affected by osteogenesis imperfecta during bisphosphonate therapy. (study published in 2007) |
| Active substance: NERIDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47060 |
| Study title: Holoshina T.V., Opatsa I.A.:Alternative approaches to treat children suffering from nocturnal enuresis. Biological Therapy (Ukraine), 2003, 3: 21-26 [IIT-publication] |
| Active substance: Nervoheel - Tabletten |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40081 |
| Study title: Retrospective survey for documentation of appllication and dosage of Nervoheel N (tablets) in children < 12 years of age [Bef-019] |
| Active substance: Nervoheel N |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40082 |
| Study title: Bacopoulou, 2009;Netilmicin in the neonate: pharmacokinetic analysis and influence of parenteral nutrition Pharm World Sci (2009) 31:365–368 DOI 10.1007/s11096-009-9278-z |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32622 |
| Study title: Bouissou, 2008; PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).Prospective, Randomized Trial Comparing Short and Long Intravenous Antibiotic Treatment of Acute Pyelonephritis in Children: Dimercaptosuccinic Acid Scintigraphic Evaluation at 9 Months |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32619 |
| Study title: Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children; publication from american society for microbiology "antimicrobial agents and chemotherapy, july 1992, p 1499-1503, vol 36, No 7. |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32618 |
| Study title: Contopoulos-Ioannidis et. Al ; PEDIATRICS Vol. 114 No. 1 July 2004 Extended-Interval Aminoglycoside Administration for Children: A Meta-analysis |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32623 |
| Study title: Optimalisation of Netilmicin dosage based on therapeutic drug monitoring during the first days of life in very pre-term neonates (gestational age 23-32 weeks); MED.WIEKU ROZWOJ.,2009, XIII,4,252-259 |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32621 |
| Study title: Sherwin, 2008;Individualising netilmicin dosing in neonates. Eur J Clin Pharmacol (2008) 64:1201–1208 DOI 10.1007/s00228-008-0536-0 |
| Active substance: NETILMICIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32620 |
| Study title: High levels of serum prostaglandin e2 in children with osteogenesis imperfecta are reduced by neridronate treatment. Not Available (study published in 2008) |
| Active substance: NERIDRONIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47059 |
| Study title: Prospective, multicenter, observational study to document therapeutic data relating to treatment with Neuro-Injeel Ampullen (ampoules) [AWB-AT] |
| Active substance: Neuro-Injeel Ampullen |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40083 |
| Study title: Post-marketing study 2001-2005 with NHD Pollen in patients with saisonal allergic rhinitis, conjunctivitis and possibly asthmatic disorders, so far only statistical analysis. Age of patients: 5-67 Years |
| Active substance: NHD POLLEN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47786 |
| Study title: "The effect of continuous epidural analgesia with sufentanil and bupivacaine during and after thoracic surgery on the plasma cortisol concentration and pain relief" |
| Active substance: NICOMORPHINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32624 |
| Study title: Hurt RD et al. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Arch Pediatr Adolesc med 2000; 154: 31-37 |
| Active substance: NICOTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32628 |
| Study title: Killen JD et al. Randomised clinical trial of the effiacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol 2004; 72: 729-735 |
| Active substance: NICOTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32627 |
| Study title: Kleges LM et al. Use in nicotine replacement therapy in adolescent smokers and nonsmokers. Arch Pediatr Adolesc Med 2003; 157: 517-522 |
| Active substance: NICOTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32630 |
| Study title: Moolchan ET et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.Pediatrics 2005; 115: 407-414 |
| Active substance: NICOTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32625 |
| Study title: Prochazka AV et al. A randomsied trial of nortriptyline combined with transdermal nicotine for smoking cessation. Arch Intern Med 2004; 164: 2229-2233 |
| Active substance: NICOTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32626 |
| Study title: Smith TA et al. Nicotine patch therapy in adolescent smokers. Pediatrics 1996; 98: 659-667 |
| Active substance: NICOTINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32629 |
| Study title: Efficacy and tolerability of teicoplanin in treatment of Gram-positive infections in children - Kafetzis D.A., Romeo B. - 20 February 1987 ; Report in Clinical documentation for Marketing Autorisation Application (June 1987) |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): Teicoplanin STUDY DRC 359.DLI.1077.xls |
| View full study record |
| Document reference: 44291 |
| Study title: Expert Report in Clinical documentation for Marketing Autorisation Application (June 1987): Pharmacokinetic study of teicoplanin in paediatrics after a single dose of 6 mg/kg - Tarral A., Thomson G., Geisert J., Willard D., Monteil H. - 9 February 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44292 |
| Study title: Expert Report on the Clinical documentation for Marketing Authorisation Application - Peter J Lewis - 18 March 1986 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44293 |
| Study title: Expert Report on the Clinical documentation for Marketing Authorisation Application - Peter J Lewis - 9 March 1987 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44309 |
| Study title: Expert Report on the Clinical documentation for Marketing Autorisation Application - Peter J Lewis - 20 November 1989 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44308 |
| Study title: Expert Report on the Clinical documentation for Marketing Autorisation Application - Peter J Lewis - 20 November 1989Expert Report on the Clinical documentation for Marketing Autorisation Application - Peter J Lewis - 20 November 1989 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44314 |
| Study title: Expert Report to amend therapeutic indications: Treatment of neonates - Haydn Clifford Cash - April 1992 amended July 1992 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44294 |
| Study title: Expert Report to amend therapeutic indications: Treatment of paediatric patients - Roscigno G. - 28 June 1991 |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44295 |
| Study title: Open Study on teicoplanin efficacy and tolerability for the treatment of gram-positive infection in children. (Abstract) In: Abstracts of the 17th international congress of chemotherapy.- Careddu P, Boccazzi A, Mosconi G. - Berlin, 23-28 June 1991; Abstract: No. 1259.Open Study on teicoplanin efficacy and tolerability for the treatment of gram-positive infection in children. (Abstract) In: Abstracts of the 17th international congress of chemotherapy.- Careddu P, Boccazzi A, Mosconi G. - Berlin, 23-28 June 1991; Abstract: No. 1259. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44327 |
| Study title: Efficacy and safety of teicoplanin in the treatment of infections caused by gram-positive cocci. A summary of over 298 cases in France.Efficacy and safety of teicoplanin in the treatment of infections caused by gram-positive cocci. A summary of over 298 cases in France. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44312 |
| Study title: Open study on the efficacy and tolerability of teicoplanin in the treatment of Gram positive infection in children.Open study on the efficacy and tolerability of teicoplanin in the treatment of Gram positive infection in children. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44313 |
| Study title: Outpatient and inpatient teicoplanin treatment for serious grm-positive infections in children. - Dagan R, Einhorm M, Howard CB, Williams AH. -Pediatr Infedt Dis J 1993; 12 (6/2): S 17-S 20. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44305 |
| Study title: Pharmacokinetics of teicoplanin in pediatric patients. - Terragna A, Ferrea G, Loy A et al. (1988). - Antimicrobial Agents and Chemotherapy 32, 1223-1226. |
| Active substance: TEICOPLANIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44307 |
| Study title: A double-blind multiple dose study of the comparative antipyretic effectiveness and safety of standard and double standard doses of acetaminophen in febrile children. Jun 1986.A double-blind multiple dose study of the comparative antipyretic effectiveness and safety of standard and double standard doses of acetaminophen in febrile children. Jun 1986. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33339 |
| Study title: A phase II study comparing the efficacy and pharmacokinetic/pharmacodynamic profile of acetaminophen extended release suspension, acetaminophen extended release chewable tablets, and acetaminophen elixir in febrile children. Jun 1997.A phase II study comparing the efficacy and pharmacokinetic/pharmacodynamic profile of acetaminophen extended release suspension, acetaminophen extended release chewable tablets, and acetaminophen elixir in febrile children. Jun 1997. |
| Active substance: PARACETAMOL AND CHLORPHENAMINE AND ASCORBIC ACID |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33334 |
| Study title: Kline RM et al. Enteric−coated, pH−dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J PEDIATR 2001; 138(1): 125−128 |
| Active substance: Peppermint Oil 0.200 ml |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40117 |
| Study title: Liu JH et al. Enteric−coated peppermint−oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 1997; 32(6): 765−8 |
| Active substance: Peppermint Oil 0.200 ml |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40116 |
| Study title: Miranda A, Sood M. Treatment options for chronic abdominal pain in children and adolescents. CURR TREAT OPTIONS GASTROENTEROL 2006; 9(5): 409−415 |
| Active substance: Peppermint Oil 0.200 ml |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21225 |
| Study title: Miranda A, Sood M. Treatment options for chronic abdominal pain in children and adolescents. CURR TREAT OPTIONS GASTROENTEROL 2006; 9(5): 409−415 |
| Active substance: Peppermint Oil 0.200 ml |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40113 |
| Study title: Verträglichkeit und Wirksamkeit von Pinimenthol® Erkältungssalbe bei Patienten mit Erkältungskrankheiten der Luftwege. |
| Active substance: per 100g: Kampfer (raz.) 7g Eukalyptusöl 11g Kiefernnadelöl 9,5g Latschenkiefernöl 1,5g Terpentinöl ger. 1g Guajazulen 0,005g/ per 100g: Kampfer (raz.) 7g Eukalyptusöl 11g Kiefernnadelöl 9,5g Latschenkiefernöl 1,5g Terpentinöl ger. 1g Guajazulen 0,005g |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40118 |
| Study title: Efficacy of Tonsiotren for acute angina catarrhalis. |
| Active substance: Per tablet: Atropinum sulfuricum D5 12,5 mg Hepar sulfuris D3 10,0 mg Kalium bichromicum D4 50,0 mg Silicea D2 5,0 mg Mercurius bijodatus D8 25,0 mg |
| Study summary document link (including results): |
| View full study record |
| Document reference: 39744 |
| Study title: Clinical Expertise - Study N° ERI 175 - Pr. Bouletreau - Nov 83 |
| Active substance: PERFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45862 |
| Study title: Clinical Expertise - Study N° ERI 177 - Pefloxacin for infections intensive care - Pr Lhoste - Nov 84 |
| Active substance: PERFLOXACIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45863 |
| Study title: Campo JV. Coping with ignorance: Exploring pharmacologic management for pediatric functional abdominal pain. J PEDIATR GASTROENTEROL NUTR 2005; 41(5): 569−574 |
| Active substance: Peppermint Oil 0.200 ml |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40114 |
| Study title: Study of high doses in infant psychiatry: neuroses, psychoses, evolving dysharmony, behaviour disorders. Dr R. Mises, fondation Vallee (Gentilly), 01/1970 - Study mentioned in the summary report - Doc. 000632 |
| Active substance: PERICIAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33893 |
| Study title: Study of the efficacy of the oral drop formulation in children and adolescents. Dr F. Larbre, Hopital Debrousse (Lyon), 05/1964 - Study mentioned in the summary report - |
| Active substance: PERICIAZINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33894 |
| Study title: 10 weeks toxicity study by oral route (gavage) in juvenile rats followed by a 3-week recovery period. |
| Active substance: PERINDOPRIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45866 |
| Study title: 2 weeks toxicity study by oral route (gavage) in juvenile rats. Ongoing |
| Active substance: PERINDOPRIL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45865 |
| Study title: Acceptability, safety, pharmacokinetics and effects on blood pressure of a paediatric formulation of perindopril S 90652 (daily dose 0.025 to 0.135 mg/kg) in hypertensive children -an open, non comparative, 3-month then at least 24-months duration multicentre study. |
| Active substance: PERINDOPRIL |
| Study summary document link (including results): perindopril_CL2-90652-002_synopsis.pdf |
| View full study record |
| Document reference: 45867 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTION. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42853 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42855 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IMIV SBT/CPZ IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42856 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42696 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42738 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42740 |
| Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN IMIV IN VARIOUS INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42758 |
| Study title: An Open Non-Comparative Study using a combination of Sulbactam plus Ampicillin or Penicillin G in serious but not life threatening infections in Paediatric Patients |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42873 |
| Study title: AN OPEN NON-COMPARATIVE STUDY, Q COMBINATION OF SULBACTAM SODIUM WITH AMPICILLIN IN SERIOUS INFECTIONS. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42625 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IM/IV SULBACTAM/CFP IN THE TREATMENT OF INTRAABDOMINAL INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42860 |
| Study title: AN OPEN NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SBT/AMP PARENTERAL FOLLOWED OF ORAL STM FOR THE TREATMENT OF PATIENTS WITH LOWER RESPIRATORY TRACT INFECTIONS INCLUDING BRONCHO-PNEUMONIA AND ASPIRATION PNEUMONIA |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42755 |
| Study title: AN OPEN PLACEBO COMPARATIVE STUDY OF SBT/AMP-IV IN THE PROPHYLAXIS OF POST SURGICAL OBSTETRIC AND GYNECOLOGICAL INFECTIONS. A MULTICENTRIC TRIAL DURATION OF STUDY APP. ONE POST-SURGERY WEEK. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42719 |
| Study title: AN OPEN STUDY OF PARENTERAL SULBACTAM SODIUM/AMPICILLIN. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42624 |
| Study title: AN OPEN, COMPARATIVE STUDY OF SBT/CFP VS. PIPERACILLIN PLUS AMIKACIN IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42868 |
| Study title: AN OPEN, COMPARATIVE STUDY OF SULBACTAM/CEFOPERAZONE PLUS AMIKACIN VS. CEFTAZIDIME PLUS AMIKACIN (1:2) IN THE TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER. |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42863 |
| Study title: AN OPEN, COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SBT/CPZ (1:1) PLUS AMIKACIN VS CEFTAZIDIME PLUS AMIKACIN IN THE EMPIRIC TREATMENT OF NEUTROPENIC PATIENTS WITH FEVER |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42858 |
| Study title: AN OPEN, NON-COMPARATIVE MULTICENTER STUDY OF SULBACTAM/AMPICILLIN (UNASYN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42751 |
| Study title: AN OPEN, NON-COMPARATIVE MULTICENTER STUDY ON THE EFFICACY AND TOLERABILITY OF SULTAMICILLIN (SULBACTAM/AMPICILLIN) IN THE TREATMENT OF CHILDREN PATIENTS WITH SKIN AND SUBCUTANEOUS TISSUE INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42678 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY IN PARENTERAL SULBACTAM/AMPICILLIN IN CASES OF MIXED AEROBIC/ANAEROB INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42732 |
| Study title: AN OPEN, NON-COMPARATIVE STUDY OF SULBACTAM/AMPICILLIN (UNASYN) ADMINISTERED INTRAVENOUSLY FOR THE TREATMENT OF PEDIATRIC INFECTIONS |
| Active substance: SULBACTAM |
| Study summary document link (including results): |
| View full study record |
| Document reference: 42752 |
| Study title: Jürgens H et al The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years Klin Padiatr. 1988 May-Jun;200(3):243-52. GermanJürgens H et al The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years Klin Padiatr. 1988 May-Jun;200(3):243-52. German |
| Active substance: CYCLOPHOSPHAMIDE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 24944 |
| Study title: Final Summary of Japanese Retrospective Surveillance and Prospective Studies in Children Less than 1 Year of Age. |
| Active substance: oseltamivir |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47896 |
| Study title: - The Completed NIH Chart Review - CASG 113 FSR |
| Active substance: oseltamivir |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47898 |
| Study title: "Contribution to recalcification therapy in pediatric medicine", Talavera R., Acta Pediatrica Espanola, 1962, 1-25 "Contribution to recalcification therapy in pediatric medicine", Talavera R., Acta Pediatrica Espanola, 1962, 1-25 |
| Active substance: OSSEIN HYDROXYAPATITE COMPOUND |
| Study summary document link (including results): Ossopan nr5.xls |
| View full study record |
| Document reference: 47718 |
| Study title: "Monitoring the whole bone-recalciferous therapy", Martin-Santana J., Archivos de Pediatria, 1966, 31(94): 33-44"Monitoring the whole bone-recalciferous therapy", Martin-Santana J., Archivos de Pediatria, 1966, 31(94): 33-44 |
| Active substance: OSSEIN HYDROXYAPATITE COMPOUND |
| Study summary document link (including results): Ossopan nr4.xls |
| View full study record |
| Document reference: 47717 |
| Study title: Open-label, cross-over, randomized, reference-controlled, multicenter study to investigate the parents’ preference for Creon for children over Creon 12000 U in infants with pancreatic exocrine insufficiency due to cystic fibrosis |
| Active substance: Pancreatin |
| Study summary document link (including results): Pancreatin-S245-3118.pdf |
| View full study record |
| Document reference: 47669 |
| Study title: "OPEN-LABEL, MULTICENTRE, RANDOMISED CROSSOVER STUDY TO lNVESTlGATE THE PATIENT'S PREFERENCE OF CREON to 000 MINIMICROSPHERES OVER CREON 12000 IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY CAUSED BY CYSTIC FIBROSIS". |
| Active substance: Pancreatin |
| Study summary document link (including results): Pancreatin-K245-5002.pdf |
| View full study record |
| Document reference: 47655 |
| Study title: Open-label, randomized, three-way, cross-over single-center study to Prove the equivalence of a single dose of Creon® 10,000 Minimicrospheres™ and Pancrease by using the 13C-mixed triglyceride breath test in patients with pancreatic exocrine insufficiency due to cystic fibrosis |
| Active substance: Pancreatin |
| Study summary document link (including results): Pancreatin-S245-3111.pdf |
| View full study record |
| Document reference: 47667 |
| Study title: Open. randomized. crossover, multicenter study to investigate relative patient preference for Creane 10 000 Minimicrospheres1M versus Creone 8 000 microspheres in patients with pancreatic exocrine insufficiency caused by cystic fibrosis. |
| Active substance: Pancreatin |
| Study summary document link (including results): Pancreatin-S245-3105.pdf |
| View full study record |
| Document reference: 47666 |
| Study title: Randomized, open-label, cross-over study comparing the efficacy and tolerance of Creon® Forte and Cotazym S Forte® in children and young adults with cystic fibrosis |
| Active substance: Pancreatin |
| Study summary document link (including results): Pancreatin-K224-5010.pdf |
| View full study record |
| Document reference: 45111 |
| Study title: 10.) Oral enzyme therapy in the treat- ment of recurrent respiratory inflamma- tions in patients with indication of immunological in- vestigation before start of treatment |
| Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40102 |
| Study title: 11.) Systemic en- zyme therapy in the treatement of supra- condylar fractures of the humerus in Children |
| Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40103 |
| Study title: 12.) Influence of Wobenzym treat- ment in children with increased sickness rate |
| Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40104 |
| Study title: 14.) Oral Enzyme Therapy of Re- current Respiratory Inflammations in Children |
| Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40105 |
| Study title: Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9.Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9. |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25751 |
| Study title: Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9.Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group. Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9. |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44821 |
| Study title: Appendix I to Ephynal (dl-α-tocopherol) NDA pharmacokinetic profile (for Vitamin E) in premature neonated following intramuscular administration |
| Active substance: TOCOPHEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47788 |
| Study title: Kalra V. Vitamin E Administration and Reversal of Neurological Deficits in Protein-Energy Malnutrition. Journal of Tropical Pediatrics 2001; 47: 39-48. Kalra V. Vitamin E Administration and Reversal of Neurological Deficits in Protein-Energy Malnutrition. Journal of Tropical Pediatrics 2001; 47: 39-48. |
| Active substance: TOCOPHEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44822 |
| Study title: Pharmacokinetic profile for vitamin E in premature neonated following intramuscular administration |
| Active substance: TOCOPHEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44823 |
| Study title: Tolerability and acceptability of Ro 01-4065/342, EPHYNAL effervescent tablets |
| Active substance: TOCOPHEROL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47790 |
| Study title: 3. Numbers LC. Clinical experiences with tolnaftate. J Am Podiatry Assoc. 1967 . 3. Numbers LC. Clinical experiences with tolnaftate. J Am Podiatry Assoc. 1967 . |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44826 |
| Study title: 4. Robinson HM, Jr., Raskin J. Tolnaftate, a potent topical antifungal agent. Arch Dermatol. 1965 Apr;91(4):372-6. 4. Robinson HM, Jr., Raskin J. Tolnaftate, a potent topical antifungal agent. Arch Dermatol. 1965 Apr;91(4):372-6. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44827 |
| Study title: A comparison of 0.3% Tobramycin Ophthalmic Solution (TOBREX New) vs TOBREX Ophthalmic Solution (TOBREX) for Treatment of Bacterial Conjunctivitis (C9998). |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44819 |
| Study title: Carpenter WE. Tolnaftate, its effectiveness in pedal mycosis. A preliminary report. J Am Podiatry Assoc. 1966 Dec;56(12):541-6.Jun;57(6):275 Carpenter WE. Tolnaftate, its effectiveness in pedal mycosis. A preliminary report. J Am Podiatry Assoc. 1966 Dec;56(12):541-6.Jun;57(6):275 |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44824 |
| Study title: Jacobs PH. Fungal infections in childhood. Pediatr Clin North Am. 1978 May;25(2):357-70. Jacobs PH. Fungal infections in childhood. Pediatr Clin North Am. 1978 May;25(2):357-70. |
| Active substance: TOLNAFTATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44829 |
| Study title: 38. TOPAMAX in der Behandlung des WEST Syndrom (TOPAMAX in the treatment of West Syndrom (patients < 2 years)). |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44972 |
| Study title: 38. Topamax in der Therapie kindlicher Epilepsien (Topamax in the Therapy of Childlike Epilepsy) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44881 |
| Study title: Clinical evaluation of TOBRADEX Ophthalmic Suspension versus Tobramycin Ophthalmic Solution (TOBREX) (C9192), |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44818 |
| Study title: Efficacy and safety of Ciprofloxacin Ophthalmic Ointment versus TOBREX Ophthalmic Ointment for treating bacterial conjunctivitis in children (C9129), |
| Active substance: TOBRAMYCIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44816 |
| Study title: A study comparing the efficacy and safety of acetaminophen sustained release 1300 mg to acetaminophen regular release 650 mg in the treatment of post-operative dental pain. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): paracetamol 88-856.pdf |
| View full study record |
| Document reference: 47509 |
| Study title: A Study Comparing the Efficacy and Safety of Acetaminophen Sustained Release 1300 mg to Acetaminophen Regular Release 650 mg in the Treatment of Post-Operative Episiotomy Pain. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): paracetamol 88-857.pdf |
| View full study record |
| Document reference: 47510 |
| Study title: An evaluation of the efficacy and safety of C-14 elixir in pediatric patients with symptomatology requiring an analgesic and/or antipyretic. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): paracetamol 0-206.pdf |
| View full study record |
| Document reference: 47503 |
| Study title: An open trial to assess the acceptability and tolerance of Lonarid mono syrup in children. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): Paracetamol_U96-0101_synopsis.pdf |
| View full study record |
| Document reference: 45778 |
| Study title: An open trial to investigate pharmacokinetics as well as efficacy and safety of 0.25 mg/kg meloxicam suspension administered once daily in children with juvenile rheumatoid arthritis over a treatment period of up to 52 weeks (3 months results). |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45776 |
| Study title: An open trial to investigate pharmacokinetics as well as efficacy and safety of 0.25 mg/kg meloxicam suspension administered once daily in children with juvenile rheumatoid arthritis over a treatment period of up to 52 weeks - 12 months results. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45777 |
| Study title: Clinical trial comparing the safety and efficacy of acetaminophen with that of ibuprofen in the treatment of acute musculo-skeletal injury |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45788 |
| Study title: Clinical trial comparing the safety and efficacy of acetaminophen with that of ibuprofen in the treatment of acute musculo-skeletal injury |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45795 |
| Study title: Comparison of the antipyretic activity of ibuprofen and paracetamol in children with pyrexia. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45802 |
| Study title: Management of middle-ear effusions in children. Hughes KB. J Laryngol Otol. 1984 Jul;98(7):677-84.Management of middle-ear effusions in children. Hughes KB. J Laryngol Otol. 1984 Jul;98(7):677-84. |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33642 |
| Study title: Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol 1977; 86(2 pt. 1):235-42Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol 1977; 86(2 pt. 1):235-42 |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33639 |
| Study title: Sperber SJ et al. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch Fam Med 2000; 9(10):979-85 Sperber SJ et al. Effectiveness of pseudoephedrine plus acetaminophen for treatment of symptoms attributed to the paranasal sinuses associated with the common cold. Arch Fam Med 2000; 9(10):979-85 |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 25781 |
| Study title: Treatment of the common cold. Supiyaphun P, Kerekhanjananarong V, Saengpanich S, Cutchavaree A. J Med Assoc Thai. 2003 Jun;86 Suppl 2:S362-72.Treatment of the common cold. Supiyaphun P, Kerekhanjananarong V, Saengpanich S, Cutchavaree A. J Med Assoc Thai. 2003 Jun;86 Suppl 2:S362-72. |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33640 |
| Study title: Steele R.W., Tanaka P.T., Lara R.P., Bass J.W. : Evaluation of sponging and of oral antipyretic therapy to reduce fever. J. Pediatr. 1970Steele R.W., Tanaka P.T., Lara R.P., Bass J.W. : Evaluation of sponging and of oral antipyretic therapy to reduce fever. J. Pediatr. 1970 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45751 |
| Study title: Study of the pharmacokinetic linearity of three paediatric doses of paracetamol (50, 125, and 250mg) administered as a new Synthelabo formulation, and their bioequivlence with a standard formulation of DOLIPRANE dosed at 16mg healthy male young volunteers. Open, randomised, cross-over and single-center study. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): 2890 98 FR 001.pdf |
| View full study record |
| Document reference: 47077 |
| Study title: Tarlin−L et al. A comparison of the antipyretic effect of acetaminophen and aspirin. Another approach to poison prevention. {Am−J−Dis−Child}, Dec 1972, vol. 124, no. 6, p. 880−2Tarlin−L et al. A comparison of the antipyretic effect of acetaminophen and aspirin. Another approach to poison prevention. {Am−J−Dis−Child}, Dec 1972, vol. 124, no. 6, p. 880−2 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45752 |
| Study title: Tepid sponging and paracetamol for reduction of body temperature in febrile children. {MED J AUST}, 04 FEB 2002, Vol/Iss/Pg. 176/3 (130) Tepid sponging and paracetamol for reduction of body temperature in febrile children. {MED J AUST}, 04 FEB 2002, Vol/Iss/Pg. 176/3 (130) |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45753 |
| Study title: The antipyretic use of acetaminophen versus ibuprofen in a pediatric care setting. {P T}, 2000, Vol/Iss/Pg. 25/8 (395 397) The antipyretic use of acetaminophen versus ibuprofen in a pediatric care setting. {P T}, 2000, Vol/Iss/Pg. 25/8 (395 397) |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45754 |
| Study title: Tramadol hydrochloride: analgesic pharmacodynamics-pharmacokinetics in dental-extraction pain |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45727 |
| Study title: Trial of oral paracetamol solution in febrile children. Ann Pediatr Paris, Feb 1983, vol. 30, no. 2, p. 131-3 Trial of oral paracetamol solution in febrile children. Ann Pediatr Paris, Feb 1983, vol. 30, no. 2, p. 131-3 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45756 |
| Study title: ULTRAM® tramadol HCl: Safety and efficacy in dental-extraction pain |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45728 |
| Study title: Ulukol−B et al. Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections. {EUR−J−CLIN−PHARMACOL}, 1999, Vol/Iss/Pg. 55/9 (615−618Ulukol−B et al. Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections. {EUR−J−CLIN−PHARMACOL}, 1999, Vol/Iss/Pg. 55/9 (615−618 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45757 |
| Study title: Shannon, M. W. and Townsend, M. K. The Pediatric Environmental Health Center, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Adverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning Ann.Pharmacother. 2000;34:15-18. Shannon, M. W. and Townsend, M. K. The Pediatric Environmental Health Center, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Adverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning Ann.Pharmacother. 2000;34:15-18. |
| Active substance: PENICILLAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33838 |
| Study title: "Medical Treatment of Essential Enuresis with Oxybutynin Hydrochloride and Imipramine - Laurenti C et al. - Min Urol Nefr - 1987 (39: 195-200) - Publication in UK registration file - " "Medical Treatment of Essential Enuresis with Oxybutynin Hydrochloride and Imipramine - Laurenti C et al. - Min Urol Nefr - 1987 (39: 195-200) - Publication in UK registration file - " |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32984 |
| Study title: "Oxybutynin Chloride in enuresis/Randomized clinical study - Marconi A M et al - Urologia - 1984 (51(2): 262-263) - Publication in UK registration file -" "Oxybutynin Chloride in enuresis/Randomized clinical study - Marconi A M et al - Urologia - 1984 (51(2): 262-263) - Publication in UK registration file -" |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32985 |
| Study title: "Oxybutynin and the Prevention of Urinary Incontinence in Spina bifida - M. Hehir, J.M. Fitzpatrick - Eur. Urol. - 1985 (11: 254-256) - Publication in UK registration file - " "Oxybutynin and the Prevention of Urinary Incontinence in Spina bifida - M. Hehir, J.M. Fitzpatrick - Eur. Urol. - 1985 (11: 254-256) - Publication in UK registration file - " |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32986 |
| Study title: "Oxybutynin Chloride (Ditropan) in Enuresis - Buttarazzi P J. - The Journal of Urology - 1977 (118: 46) - Publication in UK registration file -" "Oxybutynin Chloride (Ditropan) in Enuresis - Buttarazzi P J. - The Journal of Urology - 1977 (118: 46) - Publication in UK registration file -" |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32988 |
| Study title: "Oxybutynin Chloride on the Pure Unstable Bladder. Preliminary Controlled Study versus Placebo - Bono A V et al. - Urologia - 1982 (49: 764-768) - Publication in UK registration file -" "Oxybutynin Chloride on the Pure Unstable Bladder. Preliminary Controlled Study versus Placebo - Bono A V et al. - Urologia - 1982 (49: 764-768) - Publication in UK registration file -" |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32989 |
| Study title: Oxybutynin does not affect cyclosporin blood levels - Springate JE - J Drug Monit - 2001; 23(2):155-156 Oxybutynin does not affect cyclosporin blood levels - Springate JE - J Drug Monit - 2001; 23(2):155-156 |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32995 |
| Study title: "Oxybutynin Efficacy in the Treatment of Primary Enuresis - Lovering J S et al. - Pediatrics - 1988 (82(1): 104-106) - Publication in UK registration file - " "Oxybutynin Efficacy in the Treatment of Primary Enuresis - Lovering J S et al. - Pediatrics - 1988 (82(1): 104-106) - Publication in UK registration file - " |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32990 |
| Study title: "Oxybutynin in Bladder Spasm, Neurogenic Bladder and Enuresis - Thompson I M and Lauvetz R. - Urology - 1976 (8: 452-454) - Publication in UK registration file - " "Oxybutynin in Bladder Spasm, Neurogenic Bladder and Enuresis - Thompson I M and Lauvetz R. - Urology - 1976 (8: 452-454) - Publication in UK registration file - " |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32991 |
| Study title: Plasma levels of Oxybutynin chloride in children - Autret E, Jonville AP, Dutertre JP, Bertiere MC, Robert M, Averous M. Couet W - Eur J Clin Pharmacol - 1994; 46:83-85 Plasma levels of Oxybutynin chloride in children - Autret E, Jonville AP, Dutertre JP, Bertiere MC, Robert M, Averous M. Couet W - Eur J Clin Pharmacol - 1994; 46:83-85 |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32996 |
| Study title: Valutazione dell’effetto antalgico e della tollerabilità di un nuovo dosaggio di paracetamolo sciroppo nelle faringotonsilliti in pediatria. Studio in doppio cieco verso placebo, controllato verso ketoprofene sale di lisina. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45774 |
| Study title: 39. TOPAMAX in Patienten mit fokalen und generalisierten tonisch klonischen Anfällen (TOPAMAX in Patients with Focally and Generalised Tonic Clonic Seizures) TOP-GER-3 (patients > 12) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44882 |
| Study title: 4. A pilot study of topiramate in childhood absence epilepsy. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44938 |
| Study title: 37. Topamax 1st line add on (patients >12 years) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44902 |
| Study title: 37. TOPAMAX in Patienten mit fokalen und generalisierten tonisch klonischen Anfällen (TOPAMAX in Patients with Focally and Generalised Tonic Clonic Seizures (patients > 12 years)). |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44971 |
| Study title: 4. Phase 3, randomized, double-blind, PBO-controlled, parallel group, multicenter, dose-response study to evaluate the efficacy and safety of TPM vs. PBO in migraine prophylaxis (plus OL Ext) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44837 |
| Study title: 40. Phase 3, open-label, safety and efficacy, adjunctive or monotherapy study in adults with refractory partial epilepsy originally entered in Studies Y1/Y2/Y3, and who received PBO in the original study. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44974 |
| Study title: 41. TOPAMAX in der Behandlung des WEST Syndrom (TOPAMAX in the treatment of West Syndrom) (patients < 2 years) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44903 |
| Study title: 5. Phase 3, randomized, double-blind, parallel group, multicenter, PBO- and active-controlled, dose-response study to evaluate the efficacy and safety of 2 doses of TPM vs. PBO and PROP in migraine prophylaxis (plus blinded Ext) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44838 |
| Study title: 39. Open-label, safety and efficacy, adjunctive or monotherapy study in asubjects ? 14 years of age with any seizure type. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44973 |
| Study title: 5. Topiramate clinical trial in primary generalized tonic-clonic seizures (long-term extension). |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44939 |
| Study title: 6. Open study of topamax as adjunct treatment in patients with partial onset seizures : assessing the low and slow titration regimen. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44940 |
| Study title: 6. Phase 3, randomized, double-blind, parallel group, multicenter, PBO- and active-controlled, dose-response study to evaluate the efficacy and safety of 2 doses of TPM vs. PBO and PROP in migraine prophylaxis (plus blinded Ext) |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44839 |
| Study title: 7. Open naturalistic individual dose optimisation trial assessing tolerability and efficacy of topiramate |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44874 |
| Study title: 7. Open naturalistic individual dose optimisation trial assessing tolerability and efficacy of topiramate. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44941 |
| Study title: 7. Single centre topiramate monotherapy trial |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44840 |
| Study title: 8. Phase 3, open-label, PK, safety, and tolerability study of TPM adjunctive therapy in pediatric subjects with Lennox-Gastaut syndrome |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44841 |
| Study title: 9. Long-term, open-label study of topamax (topiramate) used as adjunctive therapy in patients with partial onset seizures with or without secondary generalization. |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44943 |
| Study title: 9. Phase 3, double-blind, PBO-controlled, parallel group, add-on trial to evaluate the safety and efficacy study of TPM vs. PBO as adjunctive therapy in subjects with Lennox-Gastaut syndrome |
| Active substance: TOPIRAMATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44842 |
| Study title: Publication in CES0506 - Lavin B - 30/06/2006 Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seeasonal allergic rhinitis - Gross - 2002 (Annals of allergy asthma & immunology 89; 1: 56-62, 2002) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46833 |
| Study title: Yoder−K−E, Shaffer−M−L, La−Tournous−S−J, Paul−I−M. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clinical Pediatrics {CLIN−PEDIATR}, 2006, Vol/Iss/Pg. 45/7 (633−640).Yoder−K−E, Shaffer−M−L, La−Tournous−S−J, Paul−I−M. Child assessment of dextromethorphan, diphenhydramine, and placebo for nocturnal cough due to upper respiratory infection. Clinical Pediatrics {CLIN−PEDIATR}, 2006, Vol/Iss/Pg. 45/7 (633−640). |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33624 |
| Study title: Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis. Vuurman EF, van Veggel LM, Sanders RL, Muntjewerff ND, O'Hanlon, JF. Ann Allergy Asthma Immunol. 1996 Mar;76(3):247-52. |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33725 |
| Study title: Management of middle-ear effusions in children. Hughes KB. J Laryngol Otol. 1984 Jul;98(7):677-84. |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33723 |
| Study title: Treatment of the common cold. Supiyaphun P, Kerekhanjananarong V, Saengpanich S, Cutchavaree A. J Med Assoc Thai. 2003 Jun;86 Suppl 2:S362-72. |
| Active substance: PARACETAMOL AND PSEUDOEPHEDRINE AND TRIPTOLIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33724 |
| Study title: |
| Active substance: PARACETAMOL AND TRAMADOL |
| Study summary document link (including results): paracetamol 95-530 TRAMAP-ANAG-007.pdf |
| View full study record |
| Document reference: 47513 |
| Study title: A multinational, multicentre, prospective, Zaldiar post marketing surveillance observation to assess the safety of Zaldiar (tramadol/paracetamol 37.5 mg/325 mg) and patient satisfaction in the routine Latin American clinical setting |
| Active substance: PARACETAMOL AND TRAMADOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44977 |
| Study title: Evaluation of the efficacy and safety of tramadol with acetaminophen (RWJ-26898-002-AQ-22) in oral surgical pain |
| Active substance: PARACETAMOL AND TRAMADOL |
| Study summary document link (including results): paracetamol TRAMAP-ANAG-002.pdf |
| View full study record |
| Document reference: 47519 |
| Study title: Evaluation of the efficacy and safety of tramadol with acetaminophen (RWJ-26898-002-AQ-22) in oral surgical pain |
| Active substance: PARACETAMOL AND TRAMADOL |
| Study summary document link (including results): paracetamol TRAMAP-ANAG-003.pdf |
| View full study record |
| Document reference: 47520 |
| Study title: Evaluation of the efficacy and safety of tramadol/apap in oral surgical pain |
| Active substance: PARACETAMOL AND TRAMADOL |
| Study summary document link (including results): paracetamol TRAMAP-ANAG-010.pdf |
| View full study record |
| Document reference: 47521 |
| Study title: Respilene: expertise clinique en pédiatrie. Clinical study report in paediatrics - Lajouanine P. - 06/04/72Respilene: expertise clinique en pédiatrie. Clinical study report in paediatrics - Lajouanine P. - 06/04/72 |
| Active substance: PHENYLEPHRINE AND PREDNISOLONE_PHENYEPHRINE ANDZINC SULPHATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33958 |
| Study title: Albani M. An effective dose schedule for phentoin treatment of status epilepticus in infancy and childhood. Neuropädiatrie 1977; 8: 286-292Albani M. An effective dose schedule for phentoin treatment of status epilepticus in infancy and childhood. Neuropädiatrie 1977; 8: 286-292 |
| Active substance: PHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33969 |
| Study title: Fritsch G. Bioverfügbarkeit von Diphenylhydantoin - Freie Säure - Serumspiegeluntersuchungen eines Präparates mit Laktose als Tablettenbasis. Monatsschr. Kinderheilkd. 1980; 128: 648-650Fritsch G. Bioverfügbarkeit von Diphenylhydantoin - Freie Säure - Serumspiegeluntersuchungen eines Präparates mit Laktose als Tablettenbasis. Monatsschr. Kinderheilkd. 1980; 128: 648-650 |
| Active substance: PHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33968 |
| Study title: Grinschgl G. Die Kombinationsbehandlung zerebraler Krampfanfälle unter besonderer Berücksichtigung der Epilepsie. Wien Klin Wochenschr 1952; 64/20: 362-365Grinschgl G. Die Kombinationsbehandlung zerebraler Krampfanfälle unter besonderer Berücksichtigung der Epilepsie. Wien Klin Wochenschr 1952; 64/20: 362-365 |
| Active substance: PHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33967 |
| Study title: Tanner, M. S., Bhave, S. A., Pradhan, A. M., and Pandit, A. N. Department of Child Health, University of Leicester Clinical trials of penicillamine in Indian childhood cirrhosis Arch.Dis.Child 1987;62:1118-1124. Tanner, M. S., Bhave, S. A., Pradhan, A. M., and Pandit, A. N. Department of Child Health, University of Leicester Clinical trials of penicillamine in Indian childhood cirrhosis Arch.Dis.Child 1987;62:1118-1124. |
| Active substance: PENICILLAMINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33848 |
| Study title: Canadian experience with Pneumodine ( Pentamidine isethionate) in the treatment of Pneumocystis carinii Pneumonia : A retrospective analysis of the results of patients receiving Pneumodine as emergency treatment during 1986, 1987 and the first half of 1988.Canadian experience with Pneumodine ( Pentamidine isethionate) in the treatment of Pneumocystis carinii Pneumonia : A retrospective analysis of the results of patients receiving Pneumodine as emergency treatment during 1986, 1987 and the first half of 1988. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45821 |
| Study title: Cardiac arrest after intravenous pentamidine in an infant. Miller H.C. The pediatric infectious disease journal 1993 Aug, Vol :12 (8), p:694-6; ISSN : 0891-3668Cardiac arrest after intravenous pentamidine in an infant. Miller H.C. The pediatric infectious disease journal 1993 Aug, Vol :12 (8), p:694-6; ISSN : 0891-3668 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45822 |
| Study title: Comparison of pentamdine isethionate abd trimethoprim-sulfametoxazole in the treatment of Pneumocystis carinii pneumonia. Walter T. Hughes M.D., Sandor Feldman M.D, Subhash C. Chaudary M.D., Michael J. Ossi M.D., Frederick Cox M.D. and S.K. Sanyal MBBS, Memphis-Tenn. The Journal of Pediatrics Vol 92 N° 2 p. 285-291Comparison of pentamdine isethionate abd trimethoprim-sulfametoxazole in the treatment of Pneumocystis carinii pneumonia. Walter T. Hughes M.D., Sandor Feldman M.D, Subhash C. Chaudary M.D., Michael J. Ossi M.D., Frederick Cox M.D. and S.K. Sanyal MBBS, Memphis-Tenn. The Journal of Pediatrics Vol 92 N° 2 p. 285-291 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45823 |
| Study title: Isethionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Documentation clinique - Synthèse bibliographique - Aout 1987.Isethionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Documentation clinique - Synthèse bibliographique - Aout 1987. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45824 |
| Study title: Iséthionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Rapport d'expert concernant la documentation clinique - R. Woehrle - 20 Mai 1988Iséthionate de pentamidine Poudre pour usage parentéral dosée à 200 et 300 mg - Rapport d'expert concernant la documentation clinique - R. Woehrle - 20 Mai 1988 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45825 |
| Study title: Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Karl A. Western, M.D., David R., Perera, M.D. and Myrong G. Schultz, D.V.M, M.D. Annals of Internal Medicine 73 : 695-702, 1970Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Karl A. Western, M.D., David R., Perera, M.D. and Myrong G. Schultz, D.V.M, M.D. Annals of Internal Medicine 73 : 695-702, 1970 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45826 |
| Study title: J Asthma. 2004;41(3):285-7. Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children. Gourgiotis D, Papadopoulos NG, Bossios A, Zamanis P, Saxoni-Papageorgiou PJ Asthma. 2004;41(3):285-7. Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children. Gourgiotis D, Papadopoulos NG, Bossios A, Zamanis P, Saxoni-Papageorgiou P |
| Active substance: PIDOTIMOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34074 |
| Study title: Viitanen H, et all. Analgesic efficacy of rectal acetaminophen and ibuprofen alone or in combination for paediatric day-case adenoidectomy. Br J Anaesth. 2003 Sep;91(3):363-7.Viitanen H, et all. Analgesic efficacy of rectal acetaminophen and ibuprofen alone or in combination for paediatric day-case adenoidectomy. Br J Anaesth. 2003 Sep;91(3):363-7. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45760 |
| Study title: Walson−P−D et al. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. {AM−J−DIS−CHILD}, 1992, Vol /Iss/Pg. 146/5 (626−632)Walson−P−D et al. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. {AM−J−DIS−CHILD}, 1992, Vol /Iss/Pg. 146/5 (626−632) |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45762 |
| Study title: Walson−P−D et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. {Clin−Pharmacol−Ther}, Jul 1989, vol. 46, no. 1, p. 9−17Walson−P−D et al. Ibuprofen, acetaminophen, and placebo treatment of febrile children. {Clin−Pharmacol−Ther}, Jul 1989, vol. 46, no. 1, p. 9−17 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45763 |
| Study title: Walson−P−D. Ibuprofen versus paracetamol for the treatment of fever in children. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (19−21)Walson−P−D. Ibuprofen versus paracetamol for the treatment of fever in children. {BR−J−CLIN−PRACT}, 1990, Vol/Iss /Pg. 44/8 SUPPL. 70 (19−21) |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45764 |
| Study title: Weisse−M−E et al. Fever response to acetaminophen in viral vs. bacterial infections. {Pediatr−Infect−Dis−J}, Dec 1987, vol. 6, no. 12, p. 1091−4Weisse−M−E et al. Fever response to acetaminophen in viral vs. bacterial infections. {Pediatr−Infect−Dis−J}, Dec 1987, vol. 6, no. 12, p. 1091−4 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45765 |
| Study title: When fever, paracetamol? Theory and practice in a paediatric outpatient clinic. {Pharm World Sci}, Jun 2005, vol. 27, no. 3, p. 254-7 When fever, paracetamol? Theory and practice in a paediatric outpatient clinic. {Pharm World Sci}, Jun 2005, vol. 27, no. 3, p. 254-7 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45766 |
| Study title: Wilson, Brown, Bocchini, Kearno; Ther Drug Monitoring 1982Wilson, Brown, Bocchini, Kearno; Ther Drug Monitoring 1982 |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45767 |
| Study title: Wilson−J−T et al. Acetaminophen controlled−release sprinkles versus acetaminophen immediate−release elixir in febrile children. {J−CLIN−PHARMACOL}, 2000, Vol/Iss/Pg. 40/4 (360−369)Wilson−J−T et al. Acetaminophen controlled−release sprinkles versus acetaminophen immediate−release elixir in febrile children. {J−CLIN−PHARMACOL}, 2000, Vol/Iss/Pg. 40/4 (360−369) |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45768 |
| Study title: Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome. Celijne M. Stahl-Baylis, M.D. Concetta M.Kalman, R.N., and Oscar L. Laskin, M.D. NY. Clin. Pharmacol. Ther. March 1986Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome. Celijne M. Stahl-Baylis, M.D. Concetta M.Kalman, R.N., and Oscar L. Laskin, M.D. NY. Clin. Pharmacol. Ther. March 1986 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45827 |
| Study title: Van Esch, Van Steensel-Moll, Steyerberg, Offringa, Habbema, Derksen-Lubsen; Arch Pediatr Adolesc Med Van Esch, Van Steensel-Moll, Steyerberg, Offringa, Habbema, Derksen-Lubsen; Arch Pediatr Adolesc Med |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45758 |
| Study title: Publication in Expert Report - Critical Evaluation - Banerji DD - 06/12/1999 An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray on long-term groqth in children - Rachelefsky GS - 1998 (J. Allergy Clin. Immunol. 101: S236) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46834 |
| Study title: Publication in PSUR Long term safety and efficacy of triamcinolone acetonide aqueous nasal spray for the treatment of perennial allergic rhinitis - Koepke JW - 1997 (Allergy and Asthma Proc. 18: 33-37) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46835 |
| Study title: Publication in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticoids - Wolthers OD - 1993 (Acta Paediatr 82:635-640) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46836 |
| Study title: Publication in Rapport d'Expert sur la documentation clinique - Staudinger H - Update Dossier 24/03/1997 International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Management of Rhinitis - No Author - 1994 (Allergy 19:5-34) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46837 |
| Study title: Publication in Rapport d'Expert sur la documentation pharmaco-toxicologique - Roquet F - 15/08/1995 A thirty day comparison of the oral toxicity of CL 30,980 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b-hydroxy-16a,17a-(isopropylidenedioxy)-21-(tetrahydropyran-2-yloxy)- and CL 22,353 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b,21-dihydroxy-16a,17a-(isopropylidenedioxy)- in rats - Kanegis LA - 26/09/1960 (Safety Evaluation.studies. PR Volume 6, 2694-2726) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46838 |
| Study title: Publication in Response Document of MRP type II variation - Banerji D - 16/05/2000 A long-term (1 year) safety study of triamcinolone acetonide (TAA) HFA oral inhaler in asthmatic children - Weinberg EG - 1999 (European Respiratory Journal 14 (S30) abstract P361, p42s) |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46839 |
| Study title: Report in Expert Report - Critical Evaluation - Banerji DD - 06/12/1999 A phase III, single center, randomised, cross-over paediatric trial with Nasacort AQ nasal spray assessing short term growth in patients with allergic rhinitis - Kane R- 15/08/2007 |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46840 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in patients with perennial allergic rhinitis - No Author - No date |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46841 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in patients with seasonal (ragweed) allergic rhinitis - No Author - No date |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46842 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in patients with seasonal allergic rhinitis - No Author - No date |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46843 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in patients with seasonal ragweed allergic rhinitis - No Author - No date |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46844 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in pediatric patients with perennial allergic rhinitis - No Author - No date |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46845 |
| Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in pediatric patients with perennial allergic rhinitis - No Author - No date |
| Active substance: TRIAMCINOLONE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 46846 |
| Study title: Strotzka H. Die Kombinationsbehandlung der behandlungsresistenten Epilepsie. Wien Med Wochenschr 1951; 101/24-25: 465-468Strotzka H. Die Kombinationsbehandlung der behandlungsresistenten Epilepsie. Wien Med Wochenschr 1951; 101/24-25: 465-468 |
| Active substance: PHENYTOIN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33966 |
| Study title: A randomised, double-blind, placebo-controlled, multi-centre, Phase I trial investigating the safety of Grazax® in children aged 5-12 years with grass pollen induced rhinoconjunctivitis (with/without asthma) |
| Active substance: Phleum pratense |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40130 |
| Study title: Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children |
| Active substance: PHLEUM PRATENSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34030 |
| Study title: Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children |
| Active substance: Phleum pratense |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40128 |
| Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
| Active substance: PHLEUM PRATENSE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34028 |
| Study title: Immunotherapy in children with allergic asthma: Effect on bronchial hyperreactivity and pharmacotherapy |
| Active substance: Phleum pratense |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40126 |
| Study title: Respilene: expertise clinique en pédiatrie. Clinical study report in paediatrics - Lafargues G. - 23/03/72Respilene: expertise clinique en pédiatrie. Clinical study report in paediatrics - Lafargues G. - 23/03/72 |
| Active substance: PHENYLEPHRINE AND PREDNISOLONE_PHENYEPHRINE ANDZINC SULPHATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 33957 |
| Study title: Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatric Pulmonology 1998; 26:424-428Poets CF. When do infants need additional inspired oxygen? A review of the current literature. Pediatric Pulmonology 1998; 26:424-428 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32944 |
| Study title: Saugstad OD, Rootwelt T, Aalen O. Resuscitation of Asphyxiated Newborn Infants With Room Air or Oxygen: An International Controlled Trial: The Resair 2 Study Pediatrics 1998; 102;E1Saugstad OD, Rootwelt T, Aalen O. Resuscitation of Asphyxiated Newborn Infants With Room Air or Oxygen: An International Controlled Trial: The Resair 2 Study Pediatrics 1998; 102;E1 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32945 |
| Study title: Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida - Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E - BJU International - 2001; 87:674-677Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida - Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E - BJU International - 2001; 87:674-677 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32924 |
| Study title: Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968; 42:565-589Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968; 42:565-589 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32946 |
| Study title: J Chemother. 1999 Apr;11(2):126-30. Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome. La Mantia I, Grillo C, Mattina T, Zaccone P, Xiang M, Di Mauro M, Meroni PL, Nicoletti F.J Chemother. 1999 Apr;11(2):126-30. Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome. La Mantia I, Grillo C, Mattina T, Zaccone P, Xiang M, Di Mauro M, Meroni PL, Nicoletti F. |
| Active substance: PIDOTIMOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34075 |
| Study title: Namazova Baranova, Kharit, Tuzankina et al 2010; Results of a multicentre study of pidotimod therapy in the prevention of acute respiratory infections in ailing children.Namazova Baranova, Kharit, Tuzankina et al 2010; Results of a multicentre study of pidotimod therapy in the prevention of acute respiratory infections in ailing children. |
| Active substance: PIDOTIMOD |
| Study summary document link (including results): Namazova_VSP_2-2010_pidotimod+ENG transl.pdf |
| View full study record |
| Document reference: 34071 |
| Study title: Rev Alerg Mex. 2005 Jan-Feb;52(1):25-38. Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico. de la Torre González C, Pacheco Ríos A, Escalante Domínguez AJ, del Río Navarro BE.Rev Alerg Mex. 2005 Jan-Feb;52(1):25-38. Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico. de la Torre González C, Pacheco Ríos A, Escalante Domínguez AJ, del Río Navarro BE. |
| Active substance: PIDOTIMOD |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34069 |
| Study title: Vargas Correa JB, Espinosa Morales S, Bolanos Ancona JC, Farfan Ale JA. “Pidotimod in recurring respiratory infection in children with allergic rhinitis, asthma, or both conditions.” Publication: Rev Alerg Mex 2002; 49: 27-32, (Polichem Ref. N. 0680).Vargas Correa JB, Espinosa Morales S, Bolanos Ancona JC, Farfan Ale JA. “Pidotimod in recurring respiratory infection in children with allergic rhinitis, asthma, or both conditions.” Publication: Rev Alerg Mex 2002; 49: 27-32, (Polichem Ref. N. 0680). |
| Active substance: PIDOTIMOD |
| Study summary document link (including results): Vargas Correa_2002_pidotimod.pdf |
| View full study record |
| Document reference: 34078 |
| Study title: Eyedrop instillation for reluctant children. Smith SE. Br J Ophthalmol. 1991 Aug;75(8):480-1.Eyedrop instillation for reluctant children. Smith SE. Br J Ophthalmol. 1991 Aug;75(8):480-1. |
| Active substance: PILOCARPINE |
| Study summary document link (including results): Eyedrop instillation for reluctant children.pdf |
| View full study record |
| Document reference: 34079 |
| Study title: Kwitko M. L., Curr Opin Ophthalmology 1990; 1: 127-132Kwitko M. L., Curr Opin Ophthalmology 1990; 1: 127-132 |
| Active substance: PILOCARPINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34080 |
| Study title: |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981 0301-0301E1 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34081 |
| Study title: |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981 0315E1 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34082 |
| Study title: Long term double blind controlled studies in children |
| Active substance: OXYBUTYNIN |
| Study summary document link (including results): Oxybutynin STUDY Marion 012-059.xls |
| View full study record |
| Document reference: 33002 |
| Study title: Pneumocystis carinii pneumonia and altered host resistance : treatement of one patient with pentamidine isethionate. Patterson, J.H. , Lindsey, I.L., Edwards, E.S. and Logan Jr., W.D. (1966) Pediatrics 38:388-397Pneumocystis carinii pneumonia and altered host resistance : treatement of one patient with pentamidine isethionate. Patterson, J.H. , Lindsey, I.L., Edwards, E.S. and Logan Jr., W.D. (1966) Pediatrics 38:388-397 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45828 |
| Study title: Pneumocystis carinii pneumonia and congenital hypogammaglobulinaemia. W.C. Marshall, H.J. Weston and Martin Bodian. Archives of Disease in Childhood, 1964, 39, 18.Pneumocystis carinii pneumonia and congenital hypogammaglobulinaemia. W.C. Marshall, H.J. Weston and Martin Bodian. Archives of Disease in Childhood, 1964, 39, 18. |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45829 |
| Study title: Pneumocystis carinii pneumonia associated with hypogammaglobulinaemia responding to pentamidine. Rodgers T.S., Haggie M.H.K. The Lancet, May 9, 1964, p.1042Pneumocystis carinii pneumonia associated with hypogammaglobulinaemia responding to pentamidine. Rodgers T.S., Haggie M.H.K. The Lancet, May 9, 1964, p.1042 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45830 |
| Study title: Pneumocystis carinii pneumonia in an adopted vietnamese infant. Redman, J.C. (1974) Journal of the American Medical association 230 : 1561-1563Pneumocystis carinii pneumonia in an adopted vietnamese infant. Redman, J.C. (1974) Journal of the American Medical association 230 : 1561-1563 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45831 |
| Study title: Pneumocystis carinii pneumonia in children with cancer. Diagnosis and treatment. Johnson, H.D. and Johnson, W.W. (1970). Journal of the American Medical Association 214 : 1067-1073Pneumocystis carinii pneumonia in children with cancer. Diagnosis and treatment. Johnson, H.D. and Johnson, W.W. (1970). Journal of the American Medical Association 214 : 1067-1073 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45832 |
| Study title: Rapport d'expert sur la documentation pharmacologie humaine et clinique : Dr. F. Pichon - Juin 1989Rapport d'expert sur la documentation pharmacologie humaine et clinique : Dr. F. Pichon - Juin 1989 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45833 |
| Study title: Successful treatment of Pneumocystis carinii pneumonitis in a patient with congenital hypogammaglobulinaemia. Robbins, J.B., Miller, R.H.; Arean, V.M. and Pearson , H.A. (1965). New England Journal of Medicine 272:708-713Successful treatment of Pneumocystis carinii pneumonitis in a patient with congenital hypogammaglobulinaemia. Robbins, J.B., Miller, R.H.; Arean, V.M. and Pearson , H.A. (1965). New England Journal of Medicine 272:708-713 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45834 |
| Study title: Treatment of Pneumocystis carinii in children. Lipson, A., Marshall, W.C., and Hayward, A.R. (1977) Archives of disease in childhood 52 : 314-319Treatment of Pneumocystis carinii in children. Lipson, A., Marshall, W.C., and Hayward, A.R. (1977) Archives of disease in childhood 52 : 314-319 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45835 |
| Study title: Treatment of Pneumocystis carinii pneumonia in infancy Ivady, G. and Paldy, L. (1976). National Cancer Institute Monograph 43:201-208Treatment of Pneumocystis carinii pneumonia in infancy Ivady, G. and Paldy, L. (1976). National Cancer Institute Monograph 43:201-208 |
| Active substance: PENTAMIDINE ISETHIONATE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45836 |
| Study title: |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981C1301 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34083 |
| Study title: 271/87: Steady-state pharmcokinetics and phamacodynamics of theophylline, in asthmatic children of 9 - 13 years, after unequal twice-daily dosing of the oral sustained-release formulation BY158K |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): Study report 271-87 Theopyhlline -synopsis.pdf |
| View full study record |
| Document reference: 44730 |
| Study title: 84/83: Theophylline retard (250 mg): Clinical efficacy / tolerability and pharmacokinetics |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): Study report 84-83 Theophylline - synopsis English.pdf |
| View full study record |
| Document reference: 44728 |
| Study title: Dose-dependent kinetics for theophylline obersvations among ambulatory asthmatic children Sarrazin J Pediatr 19801 97(5) 825-8 in Annual Report 02Dose-dependent kinetics for theophylline obersvations among ambulatory asthmatic children Sarrazin J Pediatr 19801 97(5) 825-8 in Annual Report 02 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44722 |
| Study title: Effect of age on patients of theophylline metabolism Grygiel - No author - 1980 (Clin Pharmacol Therp 1980 28(4) 456-62 in Annual report 02)Effect of age on patients of theophylline metabolism Grygiel - No author - 1980 (Clin Pharmacol Therp 1980 28(4) 456-62 in Annual report 02) |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44727 |
| Study title: Efficacy of a 12 hour sustained release preparations in maintaining therapeutic serum theophylline levels in asthmatic children Kelly Pediatrics 1980, 66(1): 97-102 in Annual Report 02Efficacy of a 12 hour sustained release preparations in maintaining therapeutic serum theophylline levels in asthmatic children Kelly Pediatrics 1980, 66(1): 97-102 in Annual Report 02 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44723 |
| Study title: Eriksson et al. Combined theofylline/beta-agonists maintenance therapy in chronic asthma. Eur J Respir Dis 1983; 64:172-177Eriksson et al. Combined theofylline/beta-agonists maintenance therapy in chronic asthma. Eur J Respir Dis 1983; 64:172-177 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44718 |
| Study title: Kjellman et al. Theofylline Pharmacokinetics in Children, Comparing Sustained Release Spheres (Theo-Dur sprinkle) with Elixir. Eur J Pediatr 1988; 148:278-280Kjellman et al. Theofylline Pharmacokinetics in Children, Comparing Sustained Release Spheres (Theo-Dur sprinkle) with Elixir. Eur J Pediatr 1988; 148:278-280 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44719 |
| Study title: Laursen et al. Effects of Enprofylline and Theofylline on Exercise-Induced Asthma. Allergy 1985; 40: 506-509Laursen et al. Effects of Enprofylline and Theofylline on Exercise-Induced Asthma. Allergy 1985; 40: 506-509 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44716 |
| Study title: Laursen et al. Long-term oral therapy of asthma with terbutaline and theofyllin, alone and combined. Eur J Respir Dis 1985; 66: 82-90Laursen et al. Long-term oral therapy of asthma with terbutaline and theofyllin, alone and combined. Eur J Respir Dis 1985; 66: 82-90 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44717 |
| Study title: Lönnerholm et al. Combined Treatment With Sustained-Release Theopylline and Beta2-adrenoreceotor-stimulatin Agents in Chronoc Childhood Asthma. Br. Med J. 1981; 282: 1029-1031.Lönnerholm et al. Combined Treatment With Sustained-Release Theopylline and Beta2-adrenoreceotor-stimulatin Agents in Chronoc Childhood Asthma. Br. Med J. 1981; 282: 1029-1031. |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44715 |
| Study title: Metaproterenol and theophylline in asthmatic children Rachelefsky Ann Allergy 1980, 45(4) 207-12 in Annual Report 02Metaproterenol and theophylline in asthmatic children Rachelefsky Ann Allergy 1980, 45(4) 207-12 in Annual Report 02 |
| Active substance: THEOPHYLLINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 44724 |
| Study title: Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968;42:565-589Sinclair JC, Engel K, Silverman WA. Early correction of hypoxemia and acidemia in infants of low birth weight. A controlled trial of oxygen breathing, rapid alkali infusion and assisted ventilation. Pediatrics 1968;42:565-589 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32952 |
| Study title: Study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.Doz F; Gentet J C et al. British journal of cancer Mar 2 2001, 84 (5) p604-10 ,Study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.Doz F; Gentet J C et al. British journal of cancer Mar 2 2001, 84 (5) p604-10 , |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32962 |
| Study title: Subcommittee on diagnosis and management of bronchiolitis (American Academy of Pediatrics). Diagnosis and management of bronchiolitis. Pediatrics 2006; 118(4):1774-1793Subcommittee on diagnosis and management of bronchiolitis (American Academy of Pediatrics). Diagnosis and management of bronchiolitis. Pediatrics 2006; 118(4):1774-1793 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32947 |
| Study title: Successful Treatment of Nocturnal Enuresis: A Practical Approach - Maizels M and Rosenbaum D. - Primary Care - 1985 (12(4): 621-635) - Publication in UK registration file - Successful Treatment of Nocturnal Enuresis: A Practical Approach - Maizels M and Rosenbaum D. - Primary Care - 1985 (12(4): 621-635) - Publication in UK registration file - |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32916 |
| Study title: Tay-Uyboco JS, Kwiatkowski K, Cates DB, Kavanagh L, Rigatto H. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr. 1989; 115:456–459.Tay-Uyboco JS, Kwiatkowski K, Cates DB, Kavanagh L, Rigatto H. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr. 1989; 115:456–459. |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32948 |
| Study title: The British guidelines on management of asthma. Thorax 2003; 58(suppl)S1:1-83The British guidelines on management of asthma. Thorax 2003; 58(suppl)S1:1-83 |
| Active substance: OXITRIPTAN |
| Study summary document link (including results): |
| View full study record |
| Document reference: 32953 |
| Study title: Demonstration of the Analgesic Efficacy and Safety of Liquid Formulations of Ibuprofen (10mg/kg), Acetaminophen (15mg/kg), and Placebo in the relief of Orthodontic Pain in Children |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45792 |
| Study title: Demonstration of the Analgesic Efficacy and Safety of Liquid Formulations of Ibuprofen (10mg/kg), Acetaminophen (15mg/kg), and Placebo in the relief of Orthodontic Pain in Children |
| Active substance: PARACETAMOL |
| Study summary document link (including results): Paracetamol Clinical Trial Summaries.pdf |
| View full study record |
| Document reference: 45798 |
| Study title: Double-blind comparison of the taste of children's anacin-3 liquid vs. children tylenol liquid in normal children |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45786 |
| Study title: Double-blind, single-dose study of the safety and analgesic efficacy of ibuprofen liquid, acetaminophen liquid, and placebo (liquid vehicle) following orthodontic treatmen |
| Active substance: PARACETAMOL |
| Study summary document link (including results): Paracetamol Clinical Trial Summaries.pdf |
| View full study record |
| Document reference: 45799 |
| Study title: Equal antipyretic effectiveness of oral and rectal acetaminophen: a randomized controlled trial |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45800 |
| Study title: Essai comparatif en double aveugle évaluant l’efficacité et la tolérance d’une dose de charge de 30 mg/kg de paracétamol versus 15 mg/kg dans la fièvre de l’enfant pesant entre 4 et 26 kg. Essai en double aveugle, comparatif sur deux groupes parallèles, multicentrique, phase III.Publication = Treluyer JM. Et al : Antipyretic efficacy of an initial 30 mg/kg loading dose of acetaminophen versus a 15 mg/kg maintenance dose. |
| Active substance: PARACETAMOL |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45780 |
| Study title: AWB Petadolex for the treatment of asthma |
| Active substance: Petasitidis extr. e rad. spiss. (28 – 44 :1); extraction solvent: CO2 (HERB)* |
| Study summary document link (including results): |
| View full study record |
| Document reference: 40123 |
| Study title: Comparison of IM pethidine, diazepam and flunitrazepam as premedicants in children undergoing otolaryngological surgery - L Lindgren Br J. - 1979 (Anaesth 1979, 51 321-327) - Publication in expert report DOL01VOL2 - |
| Active substance: PETHIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45868 |
| Study title: Side effects of opiods during short-term administration:effect of age, gender and race. M. Soledad Clinical Pharmacology & Therapeutics Volu 74, (2), 102-112 including in the ex-ante documentationSide effects of opiods during short-term administration:effect of age, gender and race. M. Soledad Clinical Pharmacology & Therapeutics Volu 74, (2), 102-112 including in the ex-ante documentation |
| Active substance: PETHIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45869 |
| Study title: Urinary excretion and metabolism of pethidine and norpethidine in the newborn - M Hogg Br - 1977 ( J. Anaesth 1977, 45:891-898) - Publication in expert report DOL01VOL2 -Urinary excretion and metabolism of pethidine and norpethidine in the newborn - M Hogg Br - 1977 ( J. Anaesth 1977, 45:891-898) - Publication in expert report DOL01VOL2 - |
| Active substance: PETHIDINE |
| Study summary document link (including results): |
| View full study record |
| Document reference: 45870 |
| Study title: An observational study collecting data on the efficacy and tolerability of Elidel® (pimecrolimus) cream 1% in patients with mild or moderate atopic dermatitis after one and six weeks in real life practice. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CSA02 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34117 |
| Study title: An open-label, single-arm study to determine the efficacy of 1% Elidel (pimecrolimus) cream in the treatment of pityriasis alba. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34105 |
| Study title: An oral fertility and early embryonic development study in rats |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34124 |
| Study title: EFFECTIVE ELI – Evaluation of EFFECTIVEness of ELIdel in prevention of flares |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CSI01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34118 |
| Study title: Efficacy of Elidel in vitiligo vulgaris |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): |
| View full study record |
| Document reference: 34108 |
| Study title: Elidel (pimecrolimus) cream 1% on drug consumption and drug utilization in subjects >2 years of age with mild to moderate atopic dermatitis using Elidel cream 1% in routine daily treatment practice |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CBE03 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34110 |
| Study title: Elidel PMS trial with Elidel in patients with AD. |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CDE07 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34094 |
| Study title: Elidel Tolerability, Safety and Efficacy in Dermatitis Atopic Patients (El-Tosca) |
| Active substance: PIMECROLIMUS |
| Study summary document link (including results): ASM981CID01 Art45 listing 2011.xls |
| View full study record |
| Document reference: 34114 |
